_unit_id,_created_at,_canary,_id,_started_at,_channel,_trust,_worker_id,_country,_region,_city,_ip,direction,b1,b2,direction_gold,e1,e2,relation,relex_relcos,sent_id,sentence,term1,term2,twrex
502808353,7/13/2014 14:00:26,,1321898469,7/13/2014 13:59:48,tremorgames,0.8611,24449707,CAN,QC,Laval,96.21.249.72,PHEOCHROMOCYTOMA diagnosed by HYPERTENSION,194,91,,206,107,diagnosed by,0.824163383692134,902961-FS1-13,This case demonstrates a typical presentation of pheochromocytoma and the need to consider PHEOCHROMOCYTOMA early in the differential diagnosis of hypertensive emergency or difficult to control HYPERTENSION,HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
502808353,7/13/2014 15:02:14,,1321929338,7/13/2014 15:01:45,clixsense,0.6917,15189335,GBR,K3,Peterborough,81.156.166.189,PHEOCHROMOCYTOMA diagnosed by HYPERTENSION,194,91,,206,107,diagnosed by,0.824163383692134,902961-FS1-13,This case demonstrates a typical presentation of pheochromocytoma and the need to consider PHEOCHROMOCYTOMA early in the differential diagnosis of hypertensive emergency or difficult to control HYPERTENSION,HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
502808353,7/13/2014 16:06:36,,1321954983,7/13/2014 16:05:39,pedtoclick,0.5837,20864559,GBR,B8,Bromley,213.106.94.78,HYPERTENSION diagnosed by PHEOCHROMOCYTOMA,194,91,,206,107,diagnosed by,0.824163383692134,902961-FS1-13,This case demonstrates a typical presentation of pheochromocytoma and the need to consider PHEOCHROMOCYTOMA early in the differential diagnosis of hypertensive emergency or difficult to control HYPERTENSION,HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
502808353,7/13/2014 16:16:29,,1321958927,7/13/2014 16:15:14,clixsense,0.625,25595227,CAN,SK,North Battleford,24.72.96.119,no_relation,194,91,,206,107,diagnosed by,0.824163383692134,902961-FS1-13,This case demonstrates a typical presentation of pheochromocytoma and the need to consider PHEOCHROMOCYTOMA early in the differential diagnosis of hypertensive emergency or difficult to control HYPERTENSION,HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
502808353,7/13/2014 16:31:51,,1321965040,7/13/2014 16:31:12,instagc,0.6948,20183814,USA,,,166.182.83.213,PHEOCHROMOCYTOMA diagnosed by HYPERTENSION,194,91,,206,107,diagnosed by,0.824163383692134,902961-FS1-13,This case demonstrates a typical presentation of pheochromocytoma and the need to consider PHEOCHROMOCYTOMA early in the differential diagnosis of hypertensive emergency or difficult to control HYPERTENSION,HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
502808353,7/13/2014 16:32:02,,1321965122,7/13/2014 16:31:44,elite,0.3923,28276268,USA,CA,San Diego,76.88.95.100,PHEOCHROMOCYTOMA diagnosed by HYPERTENSION,194,91,,206,107,diagnosed by,0.824163383692134,902961-FS1-13,This case demonstrates a typical presentation of pheochromocytoma and the need to consider PHEOCHROMOCYTOMA early in the differential diagnosis of hypertensive emergency or difficult to control HYPERTENSION,HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
502808353,7/13/2014 16:42:26,,1321969060,7/13/2014 16:41:47,instagc,0.7262,24252915,GBR,B7,Bristol,77.98.139.82,HYPERTENSION diagnosed by PHEOCHROMOCYTOMA,194,91,,206,107,diagnosed by,0.824163383692134,902961-FS1-13,This case demonstrates a typical presentation of pheochromocytoma and the need to consider PHEOCHROMOCYTOMA early in the differential diagnosis of hypertensive emergency or difficult to control HYPERTENSION,HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
502808360,7/13/2014 13:50:38,,1321893766,7/13/2014 13:50:33,neodev,0.8333,17610000,GBR,I2,Manchester,90.200.140.201,HEMOPTYSIS causes BRONCHIAL CARCINOMA,220,138,,230,157,causes,0.7715167498104591,902532-FS1-4,"A chest x ray showing a large tumor like opacity in the left lower lobe and endoscopy visualizing a budding mass suggested a diagnosis of BRONCHIAL CARCINOMA in a 55 year old, tobacco smoking Cambodian who consulted for HEMOPTYSIS and altered general status.",HEMOPTYSIS,BRONCHIAL CARCINOMA,RO-disease_may_have_finding
502808360,7/13/2014 13:56:55,,1321896785,7/13/2014 13:56:30,instagc,0.6667,19378092,USA,PA,Reading,174.55.181.238,no_relation,220,138,,230,157,causes,0.7715167498104591,902532-FS1-4,"A chest x ray showing a large tumor like opacity in the left lower lobe and endoscopy visualizing a budding mass suggested a diagnosis of BRONCHIAL CARCINOMA in a 55 year old, tobacco smoking Cambodian who consulted for HEMOPTYSIS and altered general status.",HEMOPTYSIS,BRONCHIAL CARCINOMA,RO-disease_may_have_finding
502808360,7/13/2014 14:02:04,,1321899178,7/13/2014 14:01:39,instagc,0.9097,18960682,GBR,,,86.29.147.112,no_relation,220,138,,230,157,causes,0.7715167498104591,902532-FS1-4,"A chest x ray showing a large tumor like opacity in the left lower lobe and endoscopy visualizing a budding mass suggested a diagnosis of BRONCHIAL CARCINOMA in a 55 year old, tobacco smoking Cambodian who consulted for HEMOPTYSIS and altered general status.",HEMOPTYSIS,BRONCHIAL CARCINOMA,RO-disease_may_have_finding
502808360,7/13/2014 15:04:09,,1321930308,7/13/2014 15:03:39,prodege,0.6014,27979711,CAN,ON,Stouffville,99.247.121.227,no_relation,220,138,,230,157,causes,0.7715167498104591,902532-FS1-4,"A chest x ray showing a large tumor like opacity in the left lower lobe and endoscopy visualizing a budding mass suggested a diagnosis of BRONCHIAL CARCINOMA in a 55 year old, tobacco smoking Cambodian who consulted for HEMOPTYSIS and altered general status.",HEMOPTYSIS,BRONCHIAL CARCINOMA,RO-disease_may_have_finding
502808360,7/13/2014 15:12:05,,1321933826,7/13/2014 15:10:41,uniquerewards,0.8194,20281752,GBR,M1,Slough,86.136.105.36,no_relation,220,138,,230,157,causes,0.7715167498104591,902532-FS1-4,"A chest x ray showing a large tumor like opacity in the left lower lobe and endoscopy visualizing a budding mass suggested a diagnosis of BRONCHIAL CARCINOMA in a 55 year old, tobacco smoking Cambodian who consulted for HEMOPTYSIS and altered general status.",HEMOPTYSIS,BRONCHIAL CARCINOMA,RO-disease_may_have_finding
502808360,7/13/2014 15:32:34,,1321941899,7/13/2014 15:32:24,prodege,0.621,2143114,CAN,BC,Vancouver,24.84.160.12,BRONCHIAL CARCINOMA causes HEMOPTYSIS,220,138,,230,157,causes,0.7715167498104591,902532-FS1-4,"A chest x ray showing a large tumor like opacity in the left lower lobe and endoscopy visualizing a budding mass suggested a diagnosis of BRONCHIAL CARCINOMA in a 55 year old, tobacco smoking Cambodian who consulted for HEMOPTYSIS and altered general status.",HEMOPTYSIS,BRONCHIAL CARCINOMA,RO-disease_may_have_finding
502808360,7/13/2014 15:58:38,,1321951961,7/13/2014 15:57:36,prodege,0.596,27934334,GBR,E4,Loughton,86.162.38.12,no_relation,220,138,,230,157,causes,0.7715167498104591,902532-FS1-4,"A chest x ray showing a large tumor like opacity in the left lower lobe and endoscopy visualizing a budding mass suggested a diagnosis of BRONCHIAL CARCINOMA in a 55 year old, tobacco smoking Cambodian who consulted for HEMOPTYSIS and altered general status.",HEMOPTYSIS,BRONCHIAL CARCINOMA,RO-disease_may_have_finding
502808368,7/13/2014 13:51:06,,1321893985,7/13/2014 13:51:00,neodev,0.8333,17610000,GBR,I2,Manchester,90.200.140.201,SEIZURES causes EPILEPSY,107,71,,115,79,causes,0.9363291775690441,904755-FS1-4,"Although effective treatment can prevent seizures in most persons with EPILEPSY some persons have frequent SEIZURES, which can lead to brain damage, disability, and diminished quality of life (2,3.",SEIZURES,EPILEPSY,RO-has_definitional_manifestation
502808368,7/13/2014 14:37:50,,1321916245,7/13/2014 14:37:35,instagc,0.7431,15445601,USA,FL,Jacksonville,24.129.68.254,EPILEPSY causes SEIZURES,107,71,,115,79,causes,0.9363291775690441,904755-FS1-4,"Although effective treatment can prevent seizures in most persons with EPILEPSY some persons have frequent SEIZURES, which can lead to brain damage, disability, and diminished quality of life (2,3.",SEIZURES,EPILEPSY,RO-has_definitional_manifestation
502808368,7/13/2014 15:03:50,,1321930193,7/13/2014 15:03:17,elite,0.7333,28397222,GBR,,,31.49.231.211,EPILEPSY causes SEIZURES,107,71,,115,79,causes,0.9363291775690441,904755-FS1-4,"Although effective treatment can prevent seizures in most persons with EPILEPSY some persons have frequent SEIZURES, which can lead to brain damage, disability, and diminished quality of life (2,3.",SEIZURES,EPILEPSY,RO-has_definitional_manifestation
502808368,7/13/2014 15:04:38,,1321930597,7/13/2014 15:04:10,prodege,0.6014,27979711,CAN,ON,Stouffville,99.247.121.227,no_relation,107,71,,115,79,causes,0.9363291775690441,904755-FS1-4,"Although effective treatment can prevent seizures in most persons with EPILEPSY some persons have frequent SEIZURES, which can lead to brain damage, disability, and diminished quality of life (2,3.",SEIZURES,EPILEPSY,RO-has_definitional_manifestation
502808368,7/13/2014 15:14:02,,1321934482,7/13/2014 15:13:02,uniquerewards,0.8194,20281752,GBR,M1,Slough,86.136.105.36,EPILEPSY causes SEIZURES,107,71,,115,79,causes,0.9363291775690441,904755-FS1-4,"Although effective treatment can prevent seizures in most persons with EPILEPSY some persons have frequent SEIZURES, which can lead to brain damage, disability, and diminished quality of life (2,3.",SEIZURES,EPILEPSY,RO-has_definitional_manifestation
502808368,7/13/2014 15:34:40,,1321942739,7/13/2014 15:34:23,neodev,0.3417,28336203,USA,PA,Harrisburg,50.149.53.150,SEIZURES causes EPILEPSY,107,71,,115,79,causes,0.9363291775690441,904755-FS1-4,"Although effective treatment can prevent seizures in most persons with EPILEPSY some persons have frequent SEIZURES, which can lead to brain damage, disability, and diminished quality of life (2,3.",SEIZURES,EPILEPSY,RO-has_definitional_manifestation
502808368,7/13/2014 16:06:07,,1321954824,7/13/2014 16:05:42,prodege,0.5529999999999999,28039757,GBR,L8,Southport,109.155.158.54,EPILEPSY causes SEIZURES,107,71,,115,79,causes,0.9363291775690441,904755-FS1-4,"Although effective treatment can prevent seizures in most persons with EPILEPSY some persons have frequent SEIZURES, which can lead to brain damage, disability, and diminished quality of life (2,3.",SEIZURES,EPILEPSY,RO-has_definitional_manifestation
502808374,7/13/2014 13:45:50,,1321891500,7/13/2014 13:45:17,clixsense,0.9167,27871219,NLD,07,Amsterdam,87.210.207.223,FUNGI causes FUNGAL INFECTIONS,43,0,,48,17,causes,0.9931270663228409,903639-FS1-4,"FUNGAL INFECTIONS may be caused by several FUNGI the most important of these being Candida species including C. albicans, C. glabrata, C. krusei, C. tropicalis, C. parapsilosis, and C. guillermondii.",FUNGI,FUNGAL INFECTIONS,RO-has_causative_agent
502808374,7/13/2014 13:59:47,,1321898141,7/13/2014 13:59:01,tremorgames,0.8611,24449707,CAN,QC,Laval,96.21.249.72,FUNGI causes FUNGAL INFECTIONS,43,0,,48,17,causes,0.9931270663228409,903639-FS1-4,"FUNGAL INFECTIONS may be caused by several FUNGI the most important of these being Candida species including C. albicans, C. glabrata, C. krusei, C. tropicalis, C. parapsilosis, and C. guillermondii.",FUNGI,FUNGAL INFECTIONS,RO-has_causative_agent
502808374,7/13/2014 14:08:31,,1321902264,7/13/2014 14:07:59,prodege,0.9444,23977248,GBR,B5,Wembley,82.28.55.95,FUNGI causes FUNGAL INFECTIONS,43,0,,48,17,causes,0.9931270663228409,903639-FS1-4,"FUNGAL INFECTIONS may be caused by several FUNGI the most important of these being Candida species including C. albicans, C. glabrata, C. krusei, C. tropicalis, C. parapsilosis, and C. guillermondii.",FUNGI,FUNGAL INFECTIONS,RO-has_causative_agent
502808374,7/13/2014 14:22:02,,1321908767,7/13/2014 14:21:26,instagc,0.7389,19686223,CAN,BC,Surrey,154.20.155.106,FUNGI causes FUNGAL INFECTIONS,43,0,,48,17,causes,0.9931270663228409,903639-FS1-4,"FUNGAL INFECTIONS may be caused by several FUNGI the most important of these being Candida species including C. albicans, C. glabrata, C. krusei, C. tropicalis, C. parapsilosis, and C. guillermondii.",FUNGI,FUNGAL INFECTIONS,RO-has_causative_agent
502808374,7/13/2014 14:45:21,,1321920120,7/13/2014 14:45:05,neodev,0.7569,14861092,GBR,I2,Manchester,90.194.137.76,FUNGI causes FUNGAL INFECTIONS,43,0,,48,17,causes,0.9931270663228409,903639-FS1-4,"FUNGAL INFECTIONS may be caused by several FUNGI the most important of these being Candida species including C. albicans, C. glabrata, C. krusei, C. tropicalis, C. parapsilosis, and C. guillermondii.",FUNGI,FUNGAL INFECTIONS,RO-has_causative_agent
502808374,7/13/2014 16:45:21,,1321970014,7/13/2014 16:44:58,neodev,0.6552,27597779,CAN,AB,Calgary,68.146.86.137,FUNGAL INFECTIONS causes FUNGI,43,0,,48,17,causes,0.9931270663228409,903639-FS1-4,"FUNGAL INFECTIONS may be caused by several FUNGI the most important of these being Candida species including C. albicans, C. glabrata, C. krusei, C. tropicalis, C. parapsilosis, and C. guillermondii.",FUNGI,FUNGAL INFECTIONS,RO-has_causative_agent
502808374,7/13/2014 17:12:50,,1321979289,7/13/2014 17:12:22,prodege,0.6151,2422962,USA,IA,Honey Creek,12.73.110.97,FUNGI causes FUNGAL INFECTIONS,43,0,,48,17,causes,0.9931270663228409,903639-FS1-4,"FUNGAL INFECTIONS may be caused by several FUNGI the most important of these being Candida species including C. albicans, C. glabrata, C. krusei, C. tropicalis, C. parapsilosis, and C. guillermondii.",FUNGI,FUNGAL INFECTIONS,RO-has_causative_agent
502808380,7/13/2014 13:55:56,,1321896293,7/13/2014 13:55:20,instagc,0.6667,19378092,USA,PA,Reading,174.55.181.238,LYMPHOMA PATIENTS WITHOUT IPSID causes WEIGHT LOSS,66,10,,77,41,causes,0.9901475429766742,902589-FS1-4,"Among the LYMPHOMA PATIENTS WITHOUT IPSID 65% had abdominal pain, WEIGHT LOSS abdominal masses, obstruction, and perforation.",WEIGHT LOSS,LYMPHOMA PATIENTS WITHOUT IPSID,RO-disease_may_have_finding
502808380,7/13/2014 14:08:31,,1321902265,7/13/2014 14:07:59,prodege,0.9444,23977248,GBR,B5,Wembley,82.28.55.95,LYMPHOMA PATIENTS WITHOUT IPSID causes WEIGHT LOSS,66,10,,77,41,causes,0.9901475429766742,902589-FS1-4,"Among the LYMPHOMA PATIENTS WITHOUT IPSID 65% had abdominal pain, WEIGHT LOSS abdominal masses, obstruction, and perforation.",WEIGHT LOSS,LYMPHOMA PATIENTS WITHOUT IPSID,RO-disease_may_have_finding
502808380,7/13/2014 16:18:04,,1321959522,7/13/2014 16:17:32,instagc,0.7496,22391553,CAN,NB,Bathurst,156.34.43.239,LYMPHOMA PATIENTS WITHOUT IPSID causes WEIGHT LOSS,66,10,,77,41,causes,0.9901475429766742,902589-FS1-4,"Among the LYMPHOMA PATIENTS WITHOUT IPSID 65% had abdominal pain, WEIGHT LOSS abdominal masses, obstruction, and perforation.",WEIGHT LOSS,LYMPHOMA PATIENTS WITHOUT IPSID,RO-disease_may_have_finding
502808380,7/13/2014 16:27:27,,1321963000,7/13/2014 16:26:53,rewardsspot,0.5546,24482174,GBR,H9,London,46.23.68.180,LYMPHOMA PATIENTS WITHOUT IPSID causes WEIGHT LOSS,66,10,,77,41,causes,0.9901475429766742,902589-FS1-4,"Among the LYMPHOMA PATIENTS WITHOUT IPSID 65% had abdominal pain, WEIGHT LOSS abdominal masses, obstruction, and perforation.",WEIGHT LOSS,LYMPHOMA PATIENTS WITHOUT IPSID,RO-disease_may_have_finding
502808380,7/13/2014 16:32:05,,1321965137,7/13/2014 16:31:53,instagc,0.6948,20183814,USA,,,166.182.83.213,LYMPHOMA PATIENTS WITHOUT IPSID causes WEIGHT LOSS,66,10,,77,41,causes,0.9901475429766742,902589-FS1-4,"Among the LYMPHOMA PATIENTS WITHOUT IPSID 65% had abdominal pain, WEIGHT LOSS abdominal masses, obstruction, and perforation.",WEIGHT LOSS,LYMPHOMA PATIENTS WITHOUT IPSID,RO-disease_may_have_finding
502808380,7/13/2014 16:57:10,,1321974188,7/13/2014 16:56:30,clixsense,0.6639,28037714,GBR,I4,Mitcham,94.4.232.118,LYMPHOMA PATIENTS WITHOUT IPSID causes WEIGHT LOSS,66,10,,77,41,causes,0.9901475429766742,902589-FS1-4,"Among the LYMPHOMA PATIENTS WITHOUT IPSID 65% had abdominal pain, WEIGHT LOSS abdominal masses, obstruction, and perforation.",WEIGHT LOSS,LYMPHOMA PATIENTS WITHOUT IPSID,RO-disease_may_have_finding
502808380,7/13/2014 17:01:32,,1321975667,7/13/2014 17:00:38,prodege,0.6048,28255346,GBR,L9,Sheffield,2.125.183.137,LYMPHOMA PATIENTS WITHOUT IPSID causes WEIGHT LOSS,66,10,,77,41,causes,0.9901475429766742,902589-FS1-4,"Among the LYMPHOMA PATIENTS WITHOUT IPSID 65% had abdominal pain, WEIGHT LOSS abdominal masses, obstruction, and perforation.",WEIGHT LOSS,LYMPHOMA PATIENTS WITHOUT IPSID,RO-disease_may_have_finding
502808387,7/13/2014 13:42:13,,1321890074,7/13/2014 13:41:57,clixsense,1.0,27793793,GBR,C5,Chester,151.230.27.155,BACTERIA causes BACTERIURIA,75,49,,83,60,causes,0.34815531191139604,903858-FS1-4,Organisms which were isolated from patients with BACTERIURIA of over 10(3) BACTERIA per ml of urine regardless of grade of pyuria were studied.,BACTERIA,BACTERIURIA,RO-has_causative_agent
502808387,7/13/2014 13:45:15,,1321891301,7/13/2014 13:44:25,clixsense,0.9167,27871219,NLD,07,Amsterdam,87.210.207.223,BACTERIURIA causes BACTERIA,75,49,,83,60,causes,0.34815531191139604,903858-FS1-4,Organisms which were isolated from patients with BACTERIURIA of over 10(3) BACTERIA per ml of urine regardless of grade of pyuria were studied.,BACTERIA,BACTERIURIA,RO-has_causative_agent
502808387,7/13/2014 13:55:19,,1321895985,7/13/2014 13:54:52,instagc,0.6667,19378092,USA,PA,Reading,174.55.181.238,no_relation,75,49,,83,60,causes,0.34815531191139604,903858-FS1-4,Organisms which were isolated from patients with BACTERIURIA of over 10(3) BACTERIA per ml of urine regardless of grade of pyuria were studied.,BACTERIA,BACTERIURIA,RO-has_causative_agent
502808387,7/13/2014 14:23:57,,1321909701,7/13/2014 14:23:37,clixsense,0.765,17648398,GBR,K4,Plymouth,89.241.102.134,BACTERIA causes BACTERIURIA,75,49,,83,60,causes,0.34815531191139604,903858-FS1-4,Organisms which were isolated from patients with BACTERIURIA of over 10(3) BACTERIA per ml of urine regardless of grade of pyuria were studied.,BACTERIA,BACTERIURIA,RO-has_causative_agent
502808387,7/13/2014 16:02:01,,1321953260,7/13/2014 16:01:03,prodege,0.596,27934334,GBR,E4,Loughton,86.162.38.12,BACTERIA causes BACTERIURIA,75,49,,83,60,causes,0.34815531191139604,903858-FS1-4,Organisms which were isolated from patients with BACTERIURIA of over 10(3) BACTERIA per ml of urine regardless of grade of pyuria were studied.,BACTERIA,BACTERIURIA,RO-has_causative_agent
502808387,7/13/2014 16:14:04,,1321957945,7/13/2014 16:14:01,bitcoinget,0.5274,27786287,USA,FL,Jacksonville,76.106.186.209,no_relation,75,49,,83,60,causes,0.34815531191139604,903858-FS1-4,Organisms which were isolated from patients with BACTERIURIA of over 10(3) BACTERIA per ml of urine regardless of grade of pyuria were studied.,BACTERIA,BACTERIURIA,RO-has_causative_agent
502808387,7/13/2014 16:15:04,,1321958418,7/13/2014 16:14:49,fusioncash,0.7619,22139728,USA,,,66.67.91.242,BACTERIA causes BACTERIURIA,75,49,,83,60,causes,0.34815531191139604,903858-FS1-4,Organisms which were isolated from patients with BACTERIURIA of over 10(3) BACTERIA per ml of urine regardless of grade of pyuria were studied.,BACTERIA,BACTERIURIA,RO-has_causative_agent
502808401,7/13/2014 14:02:13,,1321899251,7/13/2014 14:01:58,tremorgames,0.8611,24449707,CAN,QC,Laval,96.21.249.72,no_relation,87,114,,95,132,treats,0.38490017945974997,904608-FS1-2,A possible role of LEU in sensomotor cortex is limitation of intensity and duration of SEIZURES and prevention of STATUS EPILEPTICUS,SEIZURES,STATUS EPILEPTICUS,RO-has_definitional_manifestation
502808401,7/13/2014 14:37:21,,1321916008,7/13/2014 14:36:56,instagc,0.7431,15445601,USA,FL,Jacksonville,24.129.68.254,STATUS EPILEPTICUS treats SEIZURES,87,114,,95,132,treats,0.38490017945974997,904608-FS1-2,A possible role of LEU in sensomotor cortex is limitation of intensity and duration of SEIZURES and prevention of STATUS EPILEPTICUS,SEIZURES,STATUS EPILEPTICUS,RO-has_definitional_manifestation
502808401,7/13/2014 14:45:43,,1321920343,7/13/2014 14:45:21,neodev,0.7569,14861092,GBR,I2,Manchester,90.194.137.76,no_relation,87,114,,95,132,treats,0.38490017945974997,904608-FS1-2,A possible role of LEU in sensomotor cortex is limitation of intensity and duration of SEIZURES and prevention of STATUS EPILEPTICUS,SEIZURES,STATUS EPILEPTICUS,RO-has_definitional_manifestation
502808401,7/13/2014 15:17:45,,1321935927,7/13/2014 15:17:08,quickrewards,0.6764,20452113,USA,NY,Port Henry,108.176.206.207,no_relation,87,114,,95,132,treats,0.38490017945974997,904608-FS1-2,A possible role of LEU in sensomotor cortex is limitation of intensity and duration of SEIZURES and prevention of STATUS EPILEPTICUS,SEIZURES,STATUS EPILEPTICUS,RO-has_definitional_manifestation
502808401,7/13/2014 15:58:01,,1321951720,7/13/2014 15:57:34,prodege,0.669,27096445,GBR,H9,London,86.186.168.254,no_relation,87,114,,95,132,treats,0.38490017945974997,904608-FS1-2,A possible role of LEU in sensomotor cortex is limitation of intensity and duration of SEIZURES and prevention of STATUS EPILEPTICUS,SEIZURES,STATUS EPILEPTICUS,RO-has_definitional_manifestation
502808401,7/13/2014 16:19:54,,1321960101,7/13/2014 16:19:15,prodege,0.7709999999999999,19192508,USA,OK,Broken Arrow,70.177.111.89,no_relation,87,114,,95,132,treats,0.38490017945974997,904608-FS1-2,A possible role of LEU in sensomotor cortex is limitation of intensity and duration of SEIZURES and prevention of STATUS EPILEPTICUS,SEIZURES,STATUS EPILEPTICUS,RO-has_definitional_manifestation
502808401,7/13/2014 16:46:47,,1321970578,7/13/2014 16:46:20,neodev,0.6552,27597779,CAN,AB,Calgary,68.146.86.137,no_relation,87,114,,95,132,treats,0.38490017945974997,904608-FS1-2,A possible role of LEU in sensomotor cortex is limitation of intensity and duration of SEIZURES and prevention of STATUS EPILEPTICUS,SEIZURES,STATUS EPILEPTICUS,RO-has_definitional_manifestation
502808415,7/13/2014 14:18:19,,1321907136,7/13/2014 14:17:57,clixsense,0.625,25402344,CAN,ON,Wawa,24.109.124.45,CHRONIC HEPATITIS C VIRUS INFECTION treats CHRONIC HEPATITIS B VIRUS INFECTIONS,147,64,,183,99,treats,0.609994281330419,903762-FS1-2,Recombinant IFN alpha is now used as the basis for treatment of CHRONIC HEPATITIS C VIRUS INFECTION and can also be used to treat certain forms of CHRONIC HEPATITIS B VIRUS INFECTIONS.,CHRONIC HEPATITIS B VIRUS INFECTIONS,CHRONIC HEPATITIS C VIRUS INFECTION,RO-has_causative_agent
502808415,7/13/2014 15:59:52,,1321952418,7/13/2014 15:59:20,prodege,0.669,27096445,GBR,H9,London,86.186.168.254,no_relation,147,64,,183,99,treats,0.609994281330419,903762-FS1-2,Recombinant IFN alpha is now used as the basis for treatment of CHRONIC HEPATITIS C VIRUS INFECTION and can also be used to treat certain forms of CHRONIC HEPATITIS B VIRUS INFECTIONS.,CHRONIC HEPATITIS B VIRUS INFECTIONS,CHRONIC HEPATITIS C VIRUS INFECTION,RO-has_causative_agent
502808415,7/13/2014 16:13:56,,1321957875,7/13/2014 16:13:51,bitcoinget,0.5274,27786287,USA,FL,Jacksonville,76.106.186.209,no_relation,147,64,,183,99,treats,0.609994281330419,903762-FS1-2,Recombinant IFN alpha is now used as the basis for treatment of CHRONIC HEPATITIS C VIRUS INFECTION and can also be used to treat certain forms of CHRONIC HEPATITIS B VIRUS INFECTIONS.,CHRONIC HEPATITIS B VIRUS INFECTIONS,CHRONIC HEPATITIS C VIRUS INFECTION,RO-has_causative_agent
502808415,7/13/2014 16:21:23,,1321960531,7/13/2014 16:20:43,prodege,0.7709999999999999,19192508,USA,OK,Broken Arrow,70.177.111.89,no_relation,147,64,,183,99,treats,0.609994281330419,903762-FS1-2,Recombinant IFN alpha is now used as the basis for treatment of CHRONIC HEPATITIS C VIRUS INFECTION and can also be used to treat certain forms of CHRONIC HEPATITIS B VIRUS INFECTIONS.,CHRONIC HEPATITIS B VIRUS INFECTIONS,CHRONIC HEPATITIS C VIRUS INFECTION,RO-has_causative_agent
502808415,7/13/2014 16:26:23,,1321962508,7/13/2014 16:25:35,instagc,0.6639,25990856,USA,NV,Las Vegas,68.108.98.78,no_relation,147,64,,183,99,treats,0.609994281330419,903762-FS1-2,Recombinant IFN alpha is now used as the basis for treatment of CHRONIC HEPATITIS C VIRUS INFECTION and can also be used to treat certain forms of CHRONIC HEPATITIS B VIRUS INFECTIONS.,CHRONIC HEPATITIS B VIRUS INFECTIONS,CHRONIC HEPATITIS C VIRUS INFECTION,RO-has_causative_agent
502808415,7/13/2014 16:31:11,,1321964783,7/13/2014 16:30:49,instagc,0.6948,20183814,USA,,,166.182.83.213,no_relation,147,64,,183,99,treats,0.609994281330419,903762-FS1-2,Recombinant IFN alpha is now used as the basis for treatment of CHRONIC HEPATITIS C VIRUS INFECTION and can also be used to treat certain forms of CHRONIC HEPATITIS B VIRUS INFECTIONS.,CHRONIC HEPATITIS B VIRUS INFECTIONS,CHRONIC HEPATITIS C VIRUS INFECTION,RO-has_causative_agent
502808415,7/13/2014 16:47:06,,1321970740,7/13/2014 16:46:49,neodev,0.6552,27597779,CAN,AB,Calgary,68.146.86.137,no_relation,147,64,,183,99,treats,0.609994281330419,903762-FS1-2,Recombinant IFN alpha is now used as the basis for treatment of CHRONIC HEPATITIS C VIRUS INFECTION and can also be used to treat certain forms of CHRONIC HEPATITIS B VIRUS INFECTIONS.,CHRONIC HEPATITIS B VIRUS INFECTIONS,CHRONIC HEPATITIS C VIRUS INFECTION,RO-has_causative_agent
502813474,7/13/2014 15:35:31,,1321943086,7/13/2014 15:35:17,clixsense,0.9167,15189335,GBR,K3,Peterborough,81.156.166.189,MIGRAINE causes HEADACHE,254,166,,262,174,causes,0.7453559924999301,904663-FS1-4,"Gamma aminobutyric acid levels in saliva were 36.8 +/  49.8 pmol/mL in the patients with migraine during headache attacks, 17.9 +/  25.2 pmol/mL in the patients with MIGRAINE in interictal periods, 16.0 +/  18.3 pmol/mL in the patients with tension type HEADACHE during active headache periods, 14.1 +/  6.8 pmol/mL in the patients with tension type headache in headache free periods, and 21.6 +/  22.7 pmol/mL in the healthy controls.",HEADACHE,MIGRAINE,RO-has_definitional_manifestation
502813474,7/13/2014 15:36:13,,1321943427,7/13/2014 15:36:05,neodev,0.7292,28336203,USA,PA,Harrisburg,50.149.53.150,MIGRAINE causes HEADACHE,254,166,,262,174,causes,0.7453559924999301,904663-FS1-4,"Gamma aminobutyric acid levels in saliva were 36.8 +/  49.8 pmol/mL in the patients with migraine during headache attacks, 17.9 +/  25.2 pmol/mL in the patients with MIGRAINE in interictal periods, 16.0 +/  18.3 pmol/mL in the patients with tension type HEADACHE during active headache periods, 14.1 +/  6.8 pmol/mL in the patients with tension type headache in headache free periods, and 21.6 +/  22.7 pmol/mL in the healthy controls.",HEADACHE,MIGRAINE,RO-has_definitional_manifestation
502813474,7/13/2014 15:38:21,,1321944262,7/13/2014 15:38:07,instagc,0.7153,18960682,GBR,,,86.29.147.112,no_relation,254,166,,262,174,causes,0.7453559924999301,904663-FS1-4,"Gamma aminobutyric acid levels in saliva were 36.8 +/  49.8 pmol/mL in the patients with migraine during headache attacks, 17.9 +/  25.2 pmol/mL in the patients with MIGRAINE in interictal periods, 16.0 +/  18.3 pmol/mL in the patients with tension type HEADACHE during active headache periods, 14.1 +/  6.8 pmol/mL in the patients with tension type headache in headache free periods, and 21.6 +/  22.7 pmol/mL in the healthy controls.",HEADACHE,MIGRAINE,RO-has_definitional_manifestation
502813474,7/13/2014 15:38:46,,1321944434,7/13/2014 15:38:14,clixsense,0.7361,27871219,NLD,07,Amsterdam,87.210.207.223,MIGRAINE causes HEADACHE,254,166,,262,174,causes,0.7453559924999301,904663-FS1-4,"Gamma aminobutyric acid levels in saliva were 36.8 +/  49.8 pmol/mL in the patients with migraine during headache attacks, 17.9 +/  25.2 pmol/mL in the patients with MIGRAINE in interictal periods, 16.0 +/  18.3 pmol/mL in the patients with tension type HEADACHE during active headache periods, 14.1 +/  6.8 pmol/mL in the patients with tension type headache in headache free periods, and 21.6 +/  22.7 pmol/mL in the healthy controls.",HEADACHE,MIGRAINE,RO-has_definitional_manifestation
502813474,7/13/2014 15:40:30,,1321945076,7/13/2014 15:39:53,instagc,0.7889,28301350,GBR,K4,Plymouth,89.241.102.134,MIGRAINE causes HEADACHE,254,166,,262,174,causes,0.7453559924999301,904663-FS1-4,"Gamma aminobutyric acid levels in saliva were 36.8 +/  49.8 pmol/mL in the patients with migraine during headache attacks, 17.9 +/  25.2 pmol/mL in the patients with MIGRAINE in interictal periods, 16.0 +/  18.3 pmol/mL in the patients with tension type HEADACHE during active headache periods, 14.1 +/  6.8 pmol/mL in the patients with tension type headache in headache free periods, and 21.6 +/  22.7 pmol/mL in the healthy controls.",HEADACHE,MIGRAINE,RO-has_definitional_manifestation
502813474,7/13/2014 15:42:04,,1321945706,7/13/2014 15:41:59,neodev,0.6488,17610000,GBR,I2,Manchester,90.200.140.201,HEADACHE causes MIGRAINE,254,166,,262,174,causes,0.7453559924999301,904663-FS1-4,"Gamma aminobutyric acid levels in saliva were 36.8 +/  49.8 pmol/mL in the patients with migraine during headache attacks, 17.9 +/  25.2 pmol/mL in the patients with MIGRAINE in interictal periods, 16.0 +/  18.3 pmol/mL in the patients with tension type HEADACHE during active headache periods, 14.1 +/  6.8 pmol/mL in the patients with tension type headache in headache free periods, and 21.6 +/  22.7 pmol/mL in the healthy controls.",HEADACHE,MIGRAINE,RO-has_definitional_manifestation
502813474,7/13/2014 16:10:58,,1321956642,7/13/2014 16:10:43,bitcoinget,0.4236,27786287,USA,FL,Jacksonville,76.106.186.209,no_relation,254,166,,262,174,causes,0.7453559924999301,904663-FS1-4,"Gamma aminobutyric acid levels in saliva were 36.8 +/  49.8 pmol/mL in the patients with migraine during headache attacks, 17.9 +/  25.2 pmol/mL in the patients with MIGRAINE in interictal periods, 16.0 +/  18.3 pmol/mL in the patients with tension type HEADACHE during active headache periods, 14.1 +/  6.8 pmol/mL in the patients with tension type headache in headache free periods, and 21.6 +/  22.7 pmol/mL in the healthy controls.",HEADACHE,MIGRAINE,RO-has_definitional_manifestation
502813476,7/13/2014 15:43:55,,1321946403,7/13/2014 15:43:12,prodege,0.6736,27096445,GBR,H9,London,86.186.168.254,no_relation,489,242,,497,258,treats,0.35921060405355,903790-FS1-2,"It was concluded (1) that CFI values were reduced following a minor adjustment to the fluoride concentration in drinking water, (2) that dental fluorosis develops during the maturation stage of enamel development, (3) that the development of DENTAL FLUOROSIS may occur over a period of 16 to 24 months, commencing from 12 to 32 months following enamel secretion, and (4) that Dean's index is a suitable instrument for monitoring the effects on dental fluorosis of minor adjustments to the FLUORIDE concentration in drinking water.",FLUORIDE,DENTAL FLUOROSIS,RO-has_causative_agent
502813476,7/13/2014 15:53:05,,1321949702,7/13/2014 15:52:40,uniquerewards,0.6917,20281752,GBR,M1,Slough,86.136.105.36,FLUORIDE treats DENTAL FLUOROSIS,489,242,,497,258,treats,0.35921060405355,903790-FS1-2,"It was concluded (1) that CFI values were reduced following a minor adjustment to the fluoride concentration in drinking water, (2) that dental fluorosis develops during the maturation stage of enamel development, (3) that the development of DENTAL FLUOROSIS may occur over a period of 16 to 24 months, commencing from 12 to 32 months following enamel secretion, and (4) that Dean's index is a suitable instrument for monitoring the effects on dental fluorosis of minor adjustments to the FLUORIDE concentration in drinking water.",FLUORIDE,DENTAL FLUOROSIS,RO-has_causative_agent
502813476,7/13/2014 16:10:01,,1321956283,7/13/2014 16:09:01,bitcoinget,0.4236,27786287,USA,FL,Jacksonville,76.106.186.209,DENTAL FLUOROSIS treats FLUORIDE,489,242,,497,258,treats,0.35921060405355,903790-FS1-2,"It was concluded (1) that CFI values were reduced following a minor adjustment to the fluoride concentration in drinking water, (2) that dental fluorosis develops during the maturation stage of enamel development, (3) that the development of DENTAL FLUOROSIS may occur over a period of 16 to 24 months, commencing from 12 to 32 months following enamel secretion, and (4) that Dean's index is a suitable instrument for monitoring the effects on dental fluorosis of minor adjustments to the FLUORIDE concentration in drinking water.",FLUORIDE,DENTAL FLUOROSIS,RO-has_causative_agent
502813476,7/13/2014 16:10:38,,1321956548,7/13/2014 16:09:44,fusioncash,0.6208,22139728,USA,,,66.67.91.242,FLUORIDE treats DENTAL FLUOROSIS,489,242,,497,258,treats,0.35921060405355,903790-FS1-2,"It was concluded (1) that CFI values were reduced following a minor adjustment to the fluoride concentration in drinking water, (2) that dental fluorosis develops during the maturation stage of enamel development, (3) that the development of DENTAL FLUOROSIS may occur over a period of 16 to 24 months, commencing from 12 to 32 months following enamel secretion, and (4) that Dean's index is a suitable instrument for monitoring the effects on dental fluorosis of minor adjustments to the FLUORIDE concentration in drinking water.",FLUORIDE,DENTAL FLUOROSIS,RO-has_causative_agent
502813476,7/13/2014 16:25:29,,1321962127,7/13/2014 16:24:55,rewardsspot,0.5812,24482174,GBR,H9,London,46.23.68.180,FLUORIDE treats DENTAL FLUOROSIS,489,242,,497,258,treats,0.35921060405355,903790-FS1-2,"It was concluded (1) that CFI values were reduced following a minor adjustment to the fluoride concentration in drinking water, (2) that dental fluorosis develops during the maturation stage of enamel development, (3) that the development of DENTAL FLUOROSIS may occur over a period of 16 to 24 months, commencing from 12 to 32 months following enamel secretion, and (4) that Dean's index is a suitable instrument for monitoring the effects on dental fluorosis of minor adjustments to the FLUORIDE concentration in drinking water.",FLUORIDE,DENTAL FLUOROSIS,RO-has_causative_agent
502813476,7/13/2014 16:35:55,,1321966712,7/13/2014 16:35:36,instagc,0.4853,25990856,USA,NV,Las Vegas,68.108.98.78,no_relation,489,242,,497,258,treats,0.35921060405355,903790-FS1-2,"It was concluded (1) that CFI values were reduced following a minor adjustment to the fluoride concentration in drinking water, (2) that dental fluorosis develops during the maturation stage of enamel development, (3) that the development of DENTAL FLUOROSIS may occur over a period of 16 to 24 months, commencing from 12 to 32 months following enamel secretion, and (4) that Dean's index is a suitable instrument for monitoring the effects on dental fluorosis of minor adjustments to the FLUORIDE concentration in drinking water.",FLUORIDE,DENTAL FLUOROSIS,RO-has_causative_agent
502813476,7/13/2014 16:38:55,,1321967878,7/13/2014 16:38:38,instagc,0.5571,20183814,USA,,,166.182.83.213,FLUORIDE treats DENTAL FLUOROSIS,489,242,,497,258,treats,0.35921060405355,903790-FS1-2,"It was concluded (1) that CFI values were reduced following a minor adjustment to the fluoride concentration in drinking water, (2) that dental fluorosis develops during the maturation stage of enamel development, (3) that the development of DENTAL FLUOROSIS may occur over a period of 16 to 24 months, commencing from 12 to 32 months following enamel secretion, and (4) that Dean's index is a suitable instrument for monitoring the effects on dental fluorosis of minor adjustments to the FLUORIDE concentration in drinking water.",FLUORIDE,DENTAL FLUOROSIS,RO-has_causative_agent
502813492,7/13/2014 15:25:54,,1321939135,7/13/2014 15:25:29,clixsense,0.9167,15189335,GBR,K3,Peterborough,81.156.166.189,PREECLAMPSIA causes PREGNANCY COMPLICATIONS,121,153,,144,165,causes,0.811107105653813,901876-FS1-4,"Pregnancy is associated with increased oxidative stress, and exaggeration of oxidative damage is considered important in PREGNANCY COMPLICATIONS such as PREECLAMPSIA",PREGNANCY COMPLICATIONS,PREECLAMPSIA,RO-disease_has_finding
502813492,7/13/2014 15:34:46,,1321942757,7/13/2014 15:34:37,prodege,1.0,2143114,CAN,BC,Vancouver,24.84.160.12,PREECLAMPSIA causes PREGNANCY COMPLICATIONS,121,153,,144,165,causes,0.811107105653813,901876-FS1-4,"Pregnancy is associated with increased oxidative stress, and exaggeration of oxidative damage is considered important in PREGNANCY COMPLICATIONS such as PREECLAMPSIA",PREGNANCY COMPLICATIONS,PREECLAMPSIA,RO-disease_has_finding
502813492,7/13/2014 15:36:53,,1321943697,7/13/2014 15:36:46,neodev,0.5278,25224036,CAN,ON,Sudbury,67.204.218.187,PREGNANCY COMPLICATIONS causes PREECLAMPSIA,121,153,,144,165,causes,0.811107105653813,901876-FS1-4,"Pregnancy is associated with increased oxidative stress, and exaggeration of oxidative damage is considered important in PREGNANCY COMPLICATIONS such as PREECLAMPSIA",PREGNANCY COMPLICATIONS,PREECLAMPSIA,RO-disease_has_finding
502813492,7/13/2014 15:42:13,,1321945759,7/13/2014 15:42:05,neodev,0.6488,17610000,GBR,I2,Manchester,90.200.140.201,PREGNANCY COMPLICATIONS causes PREECLAMPSIA,121,153,,144,165,causes,0.811107105653813,901876-FS1-4,"Pregnancy is associated with increased oxidative stress, and exaggeration of oxidative damage is considered important in PREGNANCY COMPLICATIONS such as PREECLAMPSIA",PREGNANCY COMPLICATIONS,PREECLAMPSIA,RO-disease_has_finding
502813492,7/13/2014 15:58:56,,1321952074,7/13/2014 15:58:46,clixsense,0.6639,27793793,GBR,C5,Chester,151.230.27.155,PREECLAMPSIA causes PREGNANCY COMPLICATIONS,121,153,,144,165,causes,0.811107105653813,901876-FS1-4,"Pregnancy is associated with increased oxidative stress, and exaggeration of oxidative damage is considered important in PREGNANCY COMPLICATIONS such as PREECLAMPSIA",PREGNANCY COMPLICATIONS,PREECLAMPSIA,RO-disease_has_finding
502813492,7/13/2014 16:02:20,,1321953348,7/13/2014 16:02:03,clixsense,0.6083,25402344,CAN,ON,Wawa,24.109.124.45,PREGNANCY COMPLICATIONS causes PREECLAMPSIA,121,153,,144,165,causes,0.811107105653813,901876-FS1-4,"Pregnancy is associated with increased oxidative stress, and exaggeration of oxidative damage is considered important in PREGNANCY COMPLICATIONS such as PREECLAMPSIA",PREGNANCY COMPLICATIONS,PREECLAMPSIA,RO-disease_has_finding
502813492,7/13/2014 16:10:23,,1321956461,7/13/2014 16:10:03,bitcoinget,0.4236,27786287,USA,FL,Jacksonville,76.106.186.209,no_relation,121,153,,144,165,causes,0.811107105653813,901876-FS1-4,"Pregnancy is associated with increased oxidative stress, and exaggeration of oxidative damage is considered important in PREGNANCY COMPLICATIONS such as PREECLAMPSIA",PREGNANCY COMPLICATIONS,PREECLAMPSIA,RO-disease_has_finding
502813494,7/13/2014 15:35:55,,1321943260,7/13/2014 15:35:25,clixsense,0.7361,27871219,NLD,07,Amsterdam,87.210.207.223,no_relation,273,209,,278,217,causes,0.8838834764831841,903891-FS1-4,65   The older nonsedating antihistamines terfenadine and astemizole were associated with prolongation of the QT interval and the occurrence of atypical (torsade de pointes) ventricular tachycardia after both OVERDOSE and coadministration of macrolide antibiotics or other DRUGS that interfere with their elimination.,DRUGS,OVERDOSE,RO-has_causative_agent
502813494,7/13/2014 15:37:01,,1321943727,7/13/2014 15:36:54,neodev,0.5278,25224036,CAN,ON,Sudbury,67.204.218.187,OVERDOSE causes DRUGS,273,209,,278,217,causes,0.8838834764831841,903891-FS1-4,65   The older nonsedating antihistamines terfenadine and astemizole were associated with prolongation of the QT interval and the occurrence of atypical (torsade de pointes) ventricular tachycardia after both OVERDOSE and coadministration of macrolide antibiotics or other DRUGS that interfere with their elimination.,DRUGS,OVERDOSE,RO-has_causative_agent
502813494,7/13/2014 15:46:22,,1321947181,7/13/2014 15:45:43,prodege,0.6736,27096445,GBR,H9,London,86.186.168.254,DRUGS causes OVERDOSE,273,209,,278,217,causes,0.8838834764831841,903891-FS1-4,65   The older nonsedating antihistamines terfenadine and astemizole were associated with prolongation of the QT interval and the occurrence of atypical (torsade de pointes) ventricular tachycardia after both OVERDOSE and coadministration of macrolide antibiotics or other DRUGS that interfere with their elimination.,DRUGS,OVERDOSE,RO-has_causative_agent
502813494,7/13/2014 16:03:33,,1321953807,7/13/2014 16:02:32,elite,0.75,28397222,GBR,,,31.49.231.211,DRUGS causes OVERDOSE,273,209,,278,217,causes,0.8838834764831841,903891-FS1-4,65   The older nonsedating antihistamines terfenadine and astemizole were associated with prolongation of the QT interval and the occurrence of atypical (torsade de pointes) ventricular tachycardia after both OVERDOSE and coadministration of macrolide antibiotics or other DRUGS that interfere with their elimination.,DRUGS,OVERDOSE,RO-has_causative_agent
502813494,7/13/2014 16:12:06,,1321957134,7/13/2014 16:11:50,fusioncash,0.6208,22139728,USA,,,66.67.91.242,DRUGS causes OVERDOSE,273,209,,278,217,causes,0.8838834764831841,903891-FS1-4,65   The older nonsedating antihistamines terfenadine and astemizole were associated with prolongation of the QT interval and the occurrence of atypical (torsade de pointes) ventricular tachycardia after both OVERDOSE and coadministration of macrolide antibiotics or other DRUGS that interfere with their elimination.,DRUGS,OVERDOSE,RO-has_causative_agent
502813494,7/13/2014 16:26:13,,1321962424,7/13/2014 16:25:35,rewardsspot,0.5812,24482174,GBR,H9,London,46.23.68.180,DRUGS causes OVERDOSE,273,209,,278,217,causes,0.8838834764831841,903891-FS1-4,65   The older nonsedating antihistamines terfenadine and astemizole were associated with prolongation of the QT interval and the occurrence of atypical (torsade de pointes) ventricular tachycardia after both OVERDOSE and coadministration of macrolide antibiotics or other DRUGS that interfere with their elimination.,DRUGS,OVERDOSE,RO-has_causative_agent
502813494,7/13/2014 16:29:48,,1321964096,7/13/2014 16:28:52,elite,0.304,28276268,USA,CA,San Diego,76.88.95.100,OVERDOSE causes DRUGS,273,209,,278,217,causes,0.8838834764831841,903891-FS1-4,65   The older nonsedating antihistamines terfenadine and astemizole were associated with prolongation of the QT interval and the occurrence of atypical (torsade de pointes) ventricular tachycardia after both OVERDOSE and coadministration of macrolide antibiotics or other DRUGS that interfere with their elimination.,DRUGS,OVERDOSE,RO-has_causative_agent
502833446,7/13/2014 18:43:45,,1322046457,7/13/2014 18:43:34,prodege,1.0,2143114,CAN,BC,Vancouver,24.84.160.12,ISCHEMIA is location of BLOOD VESSELS,59,92,,72,100,is location of,0.8219949365267859,905469-FS1-9,"Similarly, HNE was determined during ischemia in the brain BLOOD VESSELS of rats exposed to ISCHEMIA/reperfusion injury of the brain.",BLOOD VESSELS,ISCHEMIA,RO-has_finding_site
502833446,7/13/2014 19:12:57,,1322059808,7/13/2014 19:12:40,neodev,0.7917,18517457,GBR,,,86.29.147.112,no_relation,59,92,,72,100,is location of,0.8219949365267859,905469-FS1-9,"Similarly, HNE was determined during ischemia in the brain BLOOD VESSELS of rats exposed to ISCHEMIA/reperfusion injury of the brain.",BLOOD VESSELS,ISCHEMIA,RO-has_finding_site
502833446,7/13/2014 19:15:22,,1322060714,7/13/2014 19:14:50,rewardsspot,0.6111,24482174,GBR,H9,London,46.23.68.180,ISCHEMIA is location of BLOOD VESSELS,59,92,,72,100,is location of,0.8219949365267859,905469-FS1-9,"Similarly, HNE was determined during ischemia in the brain BLOOD VESSELS of rats exposed to ISCHEMIA/reperfusion injury of the brain.",BLOOD VESSELS,ISCHEMIA,RO-has_finding_site
502833446,7/13/2014 19:40:57,,1322070316,7/13/2014 19:40:19,neodev,0.4395,27756039,CAN,ON,Toronto,174.119.96.184,no_relation,59,92,,72,100,is location of,0.8219949365267859,905469-FS1-9,"Similarly, HNE was determined during ischemia in the brain BLOOD VESSELS of rats exposed to ISCHEMIA/reperfusion injury of the brain.",BLOOD VESSELS,ISCHEMIA,RO-has_finding_site
502833446,7/13/2014 19:42:33,,1322071280,7/13/2014 19:41:41,instagc,0.5111,19686223,CAN,BC,Surrey,154.20.155.106,no_relation,59,92,,72,100,is location of,0.8219949365267859,905469-FS1-9,"Similarly, HNE was determined during ischemia in the brain BLOOD VESSELS of rats exposed to ISCHEMIA/reperfusion injury of the brain.",BLOOD VESSELS,ISCHEMIA,RO-has_finding_site
502833446,7/13/2014 19:55:12,,1322081920,7/13/2014 19:54:43,prodege,0.4734,7664351,USA,NY,Cicero,74.111.0.21,no_relation,59,92,,72,100,is location of,0.8219949365267859,905469-FS1-9,"Similarly, HNE was determined during ischemia in the brain BLOOD VESSELS of rats exposed to ISCHEMIA/reperfusion injury of the brain.",BLOOD VESSELS,ISCHEMIA,RO-has_finding_site
502833446,7/13/2014 20:41:12,,1322124182,7/13/2014 20:40:55,tremorgames,0.5373,28013393,USA,CA,Rancho Cordova,71.197.67.37,BLOOD VESSELS is location of ISCHEMIA,59,92,,72,100,is location of,0.8219949365267859,905469-FS1-9,"Similarly, HNE was determined during ischemia in the brain BLOOD VESSELS of rats exposed to ISCHEMIA/reperfusion injury of the brain.",BLOOD VESSELS,ISCHEMIA,RO-has_finding_site
502833454,7/13/2014 18:50:39,,1322049678,7/13/2014 18:50:17,clixsense,0.875,27871219,NLD,07,Amsterdam,87.210.207.223,PHEOCHROMOCYTOMA diagnosed by MULTIPLE ENDOCRINE NEOPLASIA TYPE 2,23,85,,39,120,diagnosed by,0.8427009716003839,906351-FS1-13,Analysis of hereditary PHEOCHROMOCYTOMA two gene tests are established: detection of MULTIPLE ENDOCRINE NEOPLASIA TYPE 2 (MEN 2) using mutational analysis of RET gene and detection of von Hippel Lindau syndrome using mutational analysis of VHL gene.,PHEOCHROMOCYTOMA,MULTIPLE ENDOCRINE NEOPLASIA TYPE 2,RO-has_manifestation
502833454,7/13/2014 19:30:41,,1322066510,7/13/2014 19:30:29,clixsense,0.6319,25419319,GBR,H8,Liverpool,94.4.192.228,PHEOCHROMOCYTOMA diagnosed by MULTIPLE ENDOCRINE NEOPLASIA TYPE 2,23,85,,39,120,diagnosed by,0.8427009716003839,906351-FS1-13,Analysis of hereditary PHEOCHROMOCYTOMA two gene tests are established: detection of MULTIPLE ENDOCRINE NEOPLASIA TYPE 2 (MEN 2) using mutational analysis of RET gene and detection of von Hippel Lindau syndrome using mutational analysis of VHL gene.,PHEOCHROMOCYTOMA,MULTIPLE ENDOCRINE NEOPLASIA TYPE 2,RO-has_manifestation
502833454,7/13/2014 19:31:56,,1322066921,7/13/2014 19:31:11,clixsense,0.6278,15189335,GBR,K3,Peterborough,81.156.166.189,PHEOCHROMOCYTOMA diagnosed by MULTIPLE ENDOCRINE NEOPLASIA TYPE 2,23,85,,39,120,diagnosed by,0.8427009716003839,906351-FS1-13,Analysis of hereditary PHEOCHROMOCYTOMA two gene tests are established: detection of MULTIPLE ENDOCRINE NEOPLASIA TYPE 2 (MEN 2) using mutational analysis of RET gene and detection of von Hippel Lindau syndrome using mutational analysis of VHL gene.,PHEOCHROMOCYTOMA,MULTIPLE ENDOCRINE NEOPLASIA TYPE 2,RO-has_manifestation
502833454,7/13/2014 19:39:16,,1322069579,7/13/2014 19:38:19,prodege,0.4734,7664351,USA,NY,Cicero,74.111.0.21,MULTIPLE ENDOCRINE NEOPLASIA TYPE 2 diagnosed by PHEOCHROMOCYTOMA,23,85,,39,120,diagnosed by,0.8427009716003839,906351-FS1-13,Analysis of hereditary PHEOCHROMOCYTOMA two gene tests are established: detection of MULTIPLE ENDOCRINE NEOPLASIA TYPE 2 (MEN 2) using mutational analysis of RET gene and detection of von Hippel Lindau syndrome using mutational analysis of VHL gene.,PHEOCHROMOCYTOMA,MULTIPLE ENDOCRINE NEOPLASIA TYPE 2,RO-has_manifestation
502833454,7/13/2014 19:40:11,,1322069955,7/13/2014 19:39:32,vivatic,0.5806,25451531,GBR,,,83.67.28.193,PHEOCHROMOCYTOMA diagnosed by MULTIPLE ENDOCRINE NEOPLASIA TYPE 2,23,85,,39,120,diagnosed by,0.8427009716003839,906351-FS1-13,Analysis of hereditary PHEOCHROMOCYTOMA two gene tests are established: detection of MULTIPLE ENDOCRINE NEOPLASIA TYPE 2 (MEN 2) using mutational analysis of RET gene and detection of von Hippel Lindau syndrome using mutational analysis of VHL gene.,PHEOCHROMOCYTOMA,MULTIPLE ENDOCRINE NEOPLASIA TYPE 2,RO-has_manifestation
502833454,7/13/2014 19:41:18,,1322070456,7/13/2014 19:40:41,sendearnings,0.5385,11896941,USA,FL,Seminole,97.106.105.251,PHEOCHROMOCYTOMA diagnosed by MULTIPLE ENDOCRINE NEOPLASIA TYPE 2,23,85,,39,120,diagnosed by,0.8427009716003839,906351-FS1-13,Analysis of hereditary PHEOCHROMOCYTOMA two gene tests are established: detection of MULTIPLE ENDOCRINE NEOPLASIA TYPE 2 (MEN 2) using mutational analysis of RET gene and detection of von Hippel Lindau syndrome using mutational analysis of VHL gene.,PHEOCHROMOCYTOMA,MULTIPLE ENDOCRINE NEOPLASIA TYPE 2,RO-has_manifestation
502833454,7/13/2014 20:25:50,,1322111299,7/13/2014 20:25:29,gifthulk,0.6079,21916793,GBR,,,87.113.87.199,PHEOCHROMOCYTOMA diagnosed by MULTIPLE ENDOCRINE NEOPLASIA TYPE 2,23,85,,39,120,diagnosed by,0.8427009716003839,906351-FS1-13,Analysis of hereditary PHEOCHROMOCYTOMA two gene tests are established: detection of MULTIPLE ENDOCRINE NEOPLASIA TYPE 2 (MEN 2) using mutational analysis of RET gene and detection of von Hippel Lindau syndrome using mutational analysis of VHL gene.,PHEOCHROMOCYTOMA,MULTIPLE ENDOCRINE NEOPLASIA TYPE 2,RO-has_manifestation
502833455,7/13/2014 18:51:27,,1322050076,7/13/2014 18:51:04,clixsense,0.875,27871219,NLD,07,Amsterdam,87.210.207.223,MAGNESIUM MALABSORPTION causes MAGNESIUM DEFICIENCY,119,191,,139,214,causes,0.9958932064677041,907364-FS1-4,"The decreased bone magnesium concentration and the increased retention of magnesium in the magnesium load test suggest MAGNESIUM DEFICIENCY in post menoposal osteoporosis, probably caused by MAGNESIUM MALABSORPTION.",MAGNESIUM DEFICIENCY,MAGNESIUM MALABSORPTION,RO-may_prevent
502833455,7/13/2014 19:00:25,,1322054319,7/13/2014 19:00:18,neodev,0.8333,17610000,GBR,I2,Manchester,90.200.140.201,MAGNESIUM DEFICIENCY causes MAGNESIUM MALABSORPTION,119,191,,139,214,causes,0.9958932064677041,907364-FS1-4,"The decreased bone magnesium concentration and the increased retention of magnesium in the magnesium load test suggest MAGNESIUM DEFICIENCY in post menoposal osteoporosis, probably caused by MAGNESIUM MALABSORPTION.",MAGNESIUM DEFICIENCY,MAGNESIUM MALABSORPTION,RO-may_prevent
502833455,7/13/2014 19:39:35,,1322069723,7/13/2014 19:38:49,neodev,0.4395,27756039,CAN,ON,Toronto,174.119.96.184,MAGNESIUM MALABSORPTION causes MAGNESIUM DEFICIENCY,119,191,,139,214,causes,0.9958932064677041,907364-FS1-4,"The decreased bone magnesium concentration and the increased retention of magnesium in the magnesium load test suggest MAGNESIUM DEFICIENCY in post menoposal osteoporosis, probably caused by MAGNESIUM MALABSORPTION.",MAGNESIUM DEFICIENCY,MAGNESIUM MALABSORPTION,RO-may_prevent
502833455,7/13/2014 20:23:29,,1322109223,7/13/2014 20:22:43,elite,0.6726,28503042,USA,OK,Oakwood,64.250.220.169,MAGNESIUM MALABSORPTION causes MAGNESIUM DEFICIENCY,119,191,,139,214,causes,0.9958932064677041,907364-FS1-4,"The decreased bone magnesium concentration and the increased retention of magnesium in the magnesium load test suggest MAGNESIUM DEFICIENCY in post menoposal osteoporosis, probably caused by MAGNESIUM MALABSORPTION.",MAGNESIUM DEFICIENCY,MAGNESIUM MALABSORPTION,RO-may_prevent
502833455,7/13/2014 20:25:07,,1322110664,7/13/2014 20:24:48,gifthulk,0.6079,21916793,GBR,,,87.113.87.199,MAGNESIUM MALABSORPTION causes MAGNESIUM DEFICIENCY,119,191,,139,214,causes,0.9958932064677041,907364-FS1-4,"The decreased bone magnesium concentration and the increased retention of magnesium in the magnesium load test suggest MAGNESIUM DEFICIENCY in post menoposal osteoporosis, probably caused by MAGNESIUM MALABSORPTION.",MAGNESIUM DEFICIENCY,MAGNESIUM MALABSORPTION,RO-may_prevent
502833455,7/13/2014 20:25:45,,1322111220,7/13/2014 20:24:58,instagc,0.5603,23149109,USA,NC,Durham,75.189.206.205,MAGNESIUM MALABSORPTION causes MAGNESIUM DEFICIENCY,119,191,,139,214,causes,0.9958932064677041,907364-FS1-4,"The decreased bone magnesium concentration and the increased retention of magnesium in the magnesium load test suggest MAGNESIUM DEFICIENCY in post menoposal osteoporosis, probably caused by MAGNESIUM MALABSORPTION.",MAGNESIUM DEFICIENCY,MAGNESIUM MALABSORPTION,RO-may_prevent
502833455,7/13/2014 21:30:33,,1322165773,7/13/2014 21:30:01,instagc,0.5667,20183814,USA,,,166.182.81.241,MAGNESIUM MALABSORPTION causes MAGNESIUM DEFICIENCY,119,191,,139,214,causes,0.9958932064677041,907364-FS1-4,"The decreased bone magnesium concentration and the increased retention of magnesium in the magnesium load test suggest MAGNESIUM DEFICIENCY in post menoposal osteoporosis, probably caused by MAGNESIUM MALABSORPTION.",MAGNESIUM DEFICIENCY,MAGNESIUM MALABSORPTION,RO-may_prevent
502833458,7/13/2014 19:21:54,,1322063248,7/13/2014 19:21:48,prodege,0.6403,6011370,CAN,BC,Richmond,70.79.45.148,OVARIES is location of EPITHELIAL OVARIAN CANCER,89,0,,96,25,is location of,0.911684611677103,902339-FS1-9,EPITHELIAL OVARIAN CANCER (EOC) arises from the epithelial layer covering the surface of OVARIES and i.p.,OVARIES,EPITHELIAL OVARIAN CANCER,RO-disease_has_primary_anatomic_site
502833458,7/13/2014 19:34:01,,1322067547,7/13/2014 19:33:22,clixsense,0.6278,15189335,GBR,K3,Peterborough,81.156.166.189,OVARIES is location of EPITHELIAL OVARIAN CANCER,89,0,,96,25,is location of,0.911684611677103,902339-FS1-9,EPITHELIAL OVARIAN CANCER (EOC) arises from the epithelial layer covering the surface of OVARIES and i.p.,OVARIES,EPITHELIAL OVARIAN CANCER,RO-disease_has_primary_anatomic_site
502833458,7/13/2014 19:39:34,,1322069719,7/13/2014 19:39:13,elite,0.5556,28276268,USA,CA,San Diego,76.88.95.100,EPITHELIAL OVARIAN CANCER is location of OVARIES,89,0,,96,25,is location of,0.911684611677103,902339-FS1-9,EPITHELIAL OVARIAN CANCER (EOC) arises from the epithelial layer covering the surface of OVARIES and i.p.,OVARIES,EPITHELIAL OVARIAN CANCER,RO-disease_has_primary_anatomic_site
502833458,7/13/2014 19:42:09,,1322071064,7/13/2014 19:41:29,vivatic,0.5806,25451531,GBR,,,83.67.28.193,OVARIES is location of EPITHELIAL OVARIAN CANCER,89,0,,96,25,is location of,0.911684611677103,902339-FS1-9,EPITHELIAL OVARIAN CANCER (EOC) arises from the epithelial layer covering the surface of OVARIES and i.p.,OVARIES,EPITHELIAL OVARIAN CANCER,RO-disease_has_primary_anatomic_site
502833458,7/13/2014 19:49:29,,1322076548,7/13/2014 19:48:48,instagc,0.475,27770607,USA,TX,El Paso,72.183.244.51,no_relation,89,0,,96,25,is location of,0.911684611677103,902339-FS1-9,EPITHELIAL OVARIAN CANCER (EOC) arises from the epithelial layer covering the surface of OVARIES and i.p.,OVARIES,EPITHELIAL OVARIAN CANCER,RO-disease_has_primary_anatomic_site
502833458,7/13/2014 20:24:57,,1322110510,7/13/2014 20:24:23,instagc,0.5603,23149109,USA,NC,Durham,75.189.206.205,OVARIES is location of EPITHELIAL OVARIAN CANCER,89,0,,96,25,is location of,0.911684611677103,902339-FS1-9,EPITHELIAL OVARIAN CANCER (EOC) arises from the epithelial layer covering the surface of OVARIES and i.p.,OVARIES,EPITHELIAL OVARIAN CANCER,RO-disease_has_primary_anatomic_site
502833458,7/13/2014 20:25:28,,1322110918,7/13/2014 20:25:08,gifthulk,0.6079,21916793,GBR,,,87.113.87.199,OVARIES is location of EPITHELIAL OVARIAN CANCER,89,0,,96,25,is location of,0.911684611677103,902339-FS1-9,EPITHELIAL OVARIAN CANCER (EOC) arises from the epithelial layer covering the surface of OVARIES and i.p.,OVARIES,EPITHELIAL OVARIAN CANCER,RO-disease_has_primary_anatomic_site
502833460,7/13/2014 18:43:05,,1322046006,7/13/2014 18:42:51,prodege,1.0,2143114,CAN,BC,Vancouver,24.84.160.12,FOLIC ACID treats NEURAL TUBE DEFECTS,107,75,,126,85,treats,0.99654575824488,907098-FS1-2,The results of the MRC Vitamin Study have established the specific role of FOLIC ACID in the prevention of NEURAL TUBE DEFECTS,NEURAL TUBE DEFECTS,FOLIC ACID,RO-may_prevent
502833460,7/13/2014 19:07:28,,1322057443,7/13/2014 19:06:51,clixsense,0.6806,19803139,NLD,11,Leiden,82.139.76.131,no_relation,107,75,,126,85,treats,0.99654575824488,907098-FS1-2,The results of the MRC Vitamin Study have established the specific role of FOLIC ACID in the prevention of NEURAL TUBE DEFECTS,NEURAL TUBE DEFECTS,FOLIC ACID,RO-may_prevent
502833460,7/13/2014 19:40:51,,1322070283,7/13/2014 19:40:12,vivatic,0.5806,25451531,GBR,,,83.67.28.193,no_relation,107,75,,126,85,treats,0.99654575824488,907098-FS1-2,The results of the MRC Vitamin Study have established the specific role of FOLIC ACID in the prevention of NEURAL TUBE DEFECTS,NEURAL TUBE DEFECTS,FOLIC ACID,RO-may_prevent
502833460,7/13/2014 19:40:55,,1322070310,7/13/2014 19:40:16,instagc,0.5111,19686223,CAN,BC,Surrey,154.20.155.106,FOLIC ACID treats NEURAL TUBE DEFECTS,107,75,,126,85,treats,0.99654575824488,907098-FS1-2,The results of the MRC Vitamin Study have established the specific role of FOLIC ACID in the prevention of NEURAL TUBE DEFECTS,NEURAL TUBE DEFECTS,FOLIC ACID,RO-may_prevent
502833460,7/13/2014 20:24:36,,1322110252,7/13/2014 20:24:05,elite,0.6726,28503042,USA,OK,Oakwood,64.250.220.169,FOLIC ACID treats NEURAL TUBE DEFECTS,107,75,,126,85,treats,0.99654575824488,907098-FS1-2,The results of the MRC Vitamin Study have established the specific role of FOLIC ACID in the prevention of NEURAL TUBE DEFECTS,NEURAL TUBE DEFECTS,FOLIC ACID,RO-may_prevent
502833460,7/13/2014 20:26:36,,1322111891,7/13/2014 20:25:45,instagc,0.5603,23149109,USA,NC,Durham,75.189.206.205,FOLIC ACID treats NEURAL TUBE DEFECTS,107,75,,126,85,treats,0.99654575824488,907098-FS1-2,The results of the MRC Vitamin Study have established the specific role of FOLIC ACID in the prevention of NEURAL TUBE DEFECTS,NEURAL TUBE DEFECTS,FOLIC ACID,RO-may_prevent
502833460,7/13/2014 20:40:28,,1322123521,7/13/2014 20:39:43,tremorgames,0.5373,28013393,USA,CA,Rancho Cordova,71.197.67.37,FOLIC ACID treats NEURAL TUBE DEFECTS,107,75,,126,85,treats,0.99654575824488,907098-FS1-2,The results of the MRC Vitamin Study have established the specific role of FOLIC ACID in the prevention of NEURAL TUBE DEFECTS,NEURAL TUBE DEFECTS,FOLIC ACID,RO-may_prevent
502833466,7/13/2014 19:00:47,,1322054457,7/13/2014 19:00:40,neodev,0.8333,17610000,GBR,I2,Manchester,90.200.140.201,BIPOLAR DISORDER treats OLANZAPINE,138,80,,154,90,treats,0.9958932064677041,907595-FS1-2,"1]  Tohen M, Greil W, Calabrese JR, Sachs GS, Yatham LN, Oerlinghausen BM, et alOLANZAPINE versus lithium in the maintenance treatment of BIPOLAR DISORDER: a 12 month, randomized, double blind, controlled clinical trial.",BIPOLAR DISORDER,OLANZAPINE,RO-may_treat
502833466,7/13/2014 19:30:50,,1322066527,7/13/2014 19:30:42,clixsense,0.6319,25419319,GBR,H8,Liverpool,94.4.192.228,OLANZAPINE treats BIPOLAR DISORDER,138,80,,154,90,treats,0.9958932064677041,907595-FS1-2,"1]  Tohen M, Greil W, Calabrese JR, Sachs GS, Yatham LN, Oerlinghausen BM, et alOLANZAPINE versus lithium in the maintenance treatment of BIPOLAR DISORDER: a 12 month, randomized, double blind, controlled clinical trial.",BIPOLAR DISORDER,OLANZAPINE,RO-may_treat
502833466,7/13/2014 19:48:01,,1322075288,7/13/2014 19:47:07,instagc,0.475,27770607,USA,TX,El Paso,72.183.244.51,no_relation,138,80,,154,90,treats,0.9958932064677041,907595-FS1-2,"1]  Tohen M, Greil W, Calabrese JR, Sachs GS, Yatham LN, Oerlinghausen BM, et alOLANZAPINE versus lithium in the maintenance treatment of BIPOLAR DISORDER: a 12 month, randomized, double blind, controlled clinical trial.",BIPOLAR DISORDER,OLANZAPINE,RO-may_treat
502833466,7/13/2014 20:24:04,,1322109712,7/13/2014 20:23:30,elite,0.6726,28503042,USA,OK,Oakwood,64.250.220.169,OLANZAPINE treats BIPOLAR DISORDER,138,80,,154,90,treats,0.9958932064677041,907595-FS1-2,"1]  Tohen M, Greil W, Calabrese JR, Sachs GS, Yatham LN, Oerlinghausen BM, et alOLANZAPINE versus lithium in the maintenance treatment of BIPOLAR DISORDER: a 12 month, randomized, double blind, controlled clinical trial.",BIPOLAR DISORDER,OLANZAPINE,RO-may_treat
502833466,7/13/2014 20:57:26,,1322137964,7/13/2014 20:57:14,neodev,0.526,18755947,GBR,H2,Accrington,80.47.185.52,OLANZAPINE treats BIPOLAR DISORDER,138,80,,154,90,treats,0.9958932064677041,907595-FS1-2,"1]  Tohen M, Greil W, Calabrese JR, Sachs GS, Yatham LN, Oerlinghausen BM, et alOLANZAPINE versus lithium in the maintenance treatment of BIPOLAR DISORDER: a 12 month, randomized, double blind, controlled clinical trial.",BIPOLAR DISORDER,OLANZAPINE,RO-may_treat
502833466,7/13/2014 21:38:18,,1322171296,7/13/2014 21:38:05,fusioncash,0.5768,22139728,USA,,,66.67.91.242,OLANZAPINE treats BIPOLAR DISORDER,138,80,,154,90,treats,0.9958932064677041,907595-FS1-2,"1]  Tohen M, Greil W, Calabrese JR, Sachs GS, Yatham LN, Oerlinghausen BM, et alOLANZAPINE versus lithium in the maintenance treatment of BIPOLAR DISORDER: a 12 month, randomized, double blind, controlled clinical trial.",BIPOLAR DISORDER,OLANZAPINE,RO-may_treat
502833466,7/13/2014 22:35:26,,1322220171,7/13/2014 22:34:43,elite,0.6571,28397222,GBR,,,31.49.231.211,OLANZAPINE treats BIPOLAR DISORDER,138,80,,154,90,treats,0.9958932064677041,907595-FS1-2,"1]  Tohen M, Greil W, Calabrese JR, Sachs GS, Yatham LN, Oerlinghausen BM, et alOLANZAPINE versus lithium in the maintenance treatment of BIPOLAR DISORDER: a 12 month, randomized, double blind, controlled clinical trial.",BIPOLAR DISORDER,OLANZAPINE,RO-may_treat
502833467,7/13/2014 18:57:33,,1322053006,7/13/2014 18:57:27,neodev,0.8333,25224036,CAN,ON,Sudbury,67.204.218.187,TUBERCULOSIS diagnosed by TUBERCULIN,149,93,,161,103,diagnosed by,0.308606699924184,906725-FS1-13,Depletion of T gamma cells from in vitro cell culture consistently and selectively increased TUBERCULIN responsiveness of T cells from patients with TUBERCULOSIS,TUBERCULOSIS,TUBERCULIN,RO-may_diagnose
502833467,7/13/2014 19:12:34,,1322059678,7/13/2014 19:11:56,rewardsspot,0.6111,24482174,GBR,H9,London,46.23.68.180,no_relation,149,93,,161,103,diagnosed by,0.308606699924184,906725-FS1-13,Depletion of T gamma cells from in vitro cell culture consistently and selectively increased TUBERCULIN responsiveness of T cells from patients with TUBERCULOSIS,TUBERCULOSIS,TUBERCULIN,RO-may_diagnose
502833467,7/13/2014 19:41:45,,1322070821,7/13/2014 19:40:58,neodev,0.4395,27756039,CAN,ON,Toronto,174.119.96.184,no_relation,149,93,,161,103,diagnosed by,0.308606699924184,906725-FS1-13,Depletion of T gamma cells from in vitro cell culture consistently and selectively increased TUBERCULIN responsiveness of T cells from patients with TUBERCULOSIS,TUBERCULOSIS,TUBERCULIN,RO-may_diagnose
502833467,7/13/2014 20:25:36,,1322111097,7/13/2014 20:24:37,elite,0.6726,28503042,USA,OK,Oakwood,64.250.220.169,TUBERCULOSIS diagnosed by TUBERCULIN,149,93,,161,103,diagnosed by,0.308606699924184,906725-FS1-13,Depletion of T gamma cells from in vitro cell culture consistently and selectively increased TUBERCULIN responsiveness of T cells from patients with TUBERCULOSIS,TUBERCULOSIS,TUBERCULIN,RO-may_diagnose
502833467,7/13/2014 20:59:41,,1322140144,7/13/2014 20:58:33,neodev,0.526,18755947,GBR,H2,Accrington,80.47.185.52,no_relation,149,93,,161,103,diagnosed by,0.308606699924184,906725-FS1-13,Depletion of T gamma cells from in vitro cell culture consistently and selectively increased TUBERCULIN responsiveness of T cells from patients with TUBERCULOSIS,TUBERCULOSIS,TUBERCULIN,RO-may_diagnose
502833467,7/13/2014 21:38:18,,1322171294,7/13/2014 21:38:05,fusioncash,0.5768,22139728,USA,,,66.67.91.242,TUBERCULOSIS diagnosed by TUBERCULIN,149,93,,161,103,diagnosed by,0.308606699924184,906725-FS1-13,Depletion of T gamma cells from in vitro cell culture consistently and selectively increased TUBERCULIN responsiveness of T cells from patients with TUBERCULOSIS,TUBERCULOSIS,TUBERCULIN,RO-may_diagnose
502833467,7/13/2014 22:34:42,,1322219526,7/13/2014 22:33:55,elite,0.6571,28397222,GBR,,,31.49.231.211,TUBERCULOSIS diagnosed by TUBERCULIN,149,93,,161,103,diagnosed by,0.308606699924184,906725-FS1-13,Depletion of T gamma cells from in vitro cell culture consistently and selectively increased TUBERCULIN responsiveness of T cells from patients with TUBERCULOSIS,TUBERCULOSIS,TUBERCULIN,RO-may_diagnose
502833476,7/13/2014 19:12:39,,1322059693,7/13/2014 19:12:18,neodev,0.7917,18517457,GBR,,,86.29.147.112,TUBERCULIN causes TUBERCULOSIS,149,93,,161,103,causes,0.308606699924184,906725-FS1-4,Depletion of T gamma cells from in vitro cell culture consistently and selectively increased TUBERCULIN responsiveness of T cells from patients with TUBERCULOSIS,TUBERCULOSIS,TUBERCULIN,RO-may_diagnose
502833476,7/13/2014 19:14:07,,1322060244,7/13/2014 19:13:34,rewardsspot,0.6111,24482174,GBR,H9,London,46.23.68.180,no_relation,149,93,,161,103,causes,0.308606699924184,906725-FS1-4,Depletion of T gamma cells from in vitro cell culture consistently and selectively increased TUBERCULIN responsiveness of T cells from patients with TUBERCULOSIS,TUBERCULOSIS,TUBERCULIN,RO-may_diagnose
502833476,7/13/2014 19:38:19,,1322069278,7/13/2014 19:37:40,prodege,0.4734,7664351,USA,NY,Cicero,74.111.0.21,no_relation,149,93,,161,103,causes,0.308606699924184,906725-FS1-4,Depletion of T gamma cells from in vitro cell culture consistently and selectively increased TUBERCULIN responsiveness of T cells from patients with TUBERCULOSIS,TUBERCULOSIS,TUBERCULIN,RO-may_diagnose
502833476,7/13/2014 19:40:24,,1322070076,7/13/2014 19:40:01,elite,0.5556,28276268,USA,CA,San Diego,76.88.95.100,TUBERCULIN causes TUBERCULOSIS,149,93,,161,103,causes,0.308606699924184,906725-FS1-4,Depletion of T gamma cells from in vitro cell culture consistently and selectively increased TUBERCULIN responsiveness of T cells from patients with TUBERCULOSIS,TUBERCULOSIS,TUBERCULIN,RO-may_diagnose
502833476,7/13/2014 20:40:28,,1322123522,7/13/2014 20:39:43,tremorgames,0.5373,28013393,USA,CA,Rancho Cordova,71.197.67.37,no_relation,149,93,,161,103,causes,0.308606699924184,906725-FS1-4,Depletion of T gamma cells from in vitro cell culture consistently and selectively increased TUBERCULIN responsiveness of T cells from patients with TUBERCULOSIS,TUBERCULOSIS,TUBERCULIN,RO-may_diagnose
502833476,7/13/2014 21:37:22,,1322170494,7/13/2014 21:37:11,fusioncash,0.5768,22139728,USA,,,66.67.91.242,TUBERCULIN causes TUBERCULOSIS,149,93,,161,103,causes,0.308606699924184,906725-FS1-4,Depletion of T gamma cells from in vitro cell culture consistently and selectively increased TUBERCULIN responsiveness of T cells from patients with TUBERCULOSIS,TUBERCULOSIS,TUBERCULIN,RO-may_diagnose
502833476,7/13/2014 22:34:42,,1322219541,7/13/2014 22:33:55,elite,0.6571,28397222,GBR,,,31.49.231.211,no_relation,149,93,,161,103,causes,0.308606699924184,906725-FS1-4,Depletion of T gamma cells from in vitro cell culture consistently and selectively increased TUBERCULIN responsiveness of T cells from patients with TUBERCULOSIS,TUBERCULOSIS,TUBERCULIN,RO-may_diagnose
502833479,7/13/2014 19:16:02,,1322060979,7/13/2014 19:15:27,rewardsspot,0.6111,24482174,GBR,H9,London,46.23.68.180,VERNAL KERATOCONJUNCTIVITIS treats TYPE I ALLERGIC REACTIONS,251,143,,278,168,treats,0.328797974610715,900240-FS1-2,"When topically applied to the eye before allergen exposure, ocular sodium cromoglycate prevents many of the signs and symptoms associated with TYPE I ALLERGIC REACTIONS (which includes hayfever, acute allergic and chronic allergic conjunctivitis, and VERNAL KERATOCONJUNCTIVITIS) and giant papillary conjunctivitis.",VERNAL KERATOCONJUNCTIVITIS,TYPE I ALLERGIC REACTIONS,RO-cause_of
502833479,7/13/2014 19:39:34,,1322069718,7/13/2014 19:39:13,elite,0.5556,28276268,USA,CA,San Diego,76.88.95.100,TYPE I ALLERGIC REACTIONS treats VERNAL KERATOCONJUNCTIVITIS,251,143,,278,168,treats,0.328797974610715,900240-FS1-2,"When topically applied to the eye before allergen exposure, ocular sodium cromoglycate prevents many of the signs and symptoms associated with TYPE I ALLERGIC REACTIONS (which includes hayfever, acute allergic and chronic allergic conjunctivitis, and VERNAL KERATOCONJUNCTIVITIS) and giant papillary conjunctivitis.",VERNAL KERATOCONJUNCTIVITIS,TYPE I ALLERGIC REACTIONS,RO-cause_of
502833479,7/13/2014 19:39:47,,1322069840,7/13/2014 19:39:16,prodege,0.4734,7664351,USA,NY,Cicero,74.111.0.21,no_relation,251,143,,278,168,treats,0.328797974610715,900240-FS1-2,"When topically applied to the eye before allergen exposure, ocular sodium cromoglycate prevents many of the signs and symptoms associated with TYPE I ALLERGIC REACTIONS (which includes hayfever, acute allergic and chronic allergic conjunctivitis, and VERNAL KERATOCONJUNCTIVITIS) and giant papillary conjunctivitis.",VERNAL KERATOCONJUNCTIVITIS,TYPE I ALLERGIC REACTIONS,RO-cause_of
502833479,7/13/2014 20:25:45,,1322111221,7/13/2014 20:24:58,instagc,0.5603,23149109,USA,NC,Durham,75.189.206.205,VERNAL KERATOCONJUNCTIVITIS treats TYPE I ALLERGIC REACTIONS,251,143,,278,168,treats,0.328797974610715,900240-FS1-2,"When topically applied to the eye before allergen exposure, ocular sodium cromoglycate prevents many of the signs and symptoms associated with TYPE I ALLERGIC REACTIONS (which includes hayfever, acute allergic and chronic allergic conjunctivitis, and VERNAL KERATOCONJUNCTIVITIS) and giant papillary conjunctivitis.",VERNAL KERATOCONJUNCTIVITIS,TYPE I ALLERGIC REACTIONS,RO-cause_of
502833479,7/13/2014 20:38:50,,1322122155,7/13/2014 20:38:23,tremorgames,0.5373,28013393,USA,CA,Rancho Cordova,71.197.67.37,no_relation,251,143,,278,168,treats,0.328797974610715,900240-FS1-2,"When topically applied to the eye before allergen exposure, ocular sodium cromoglycate prevents many of the signs and symptoms associated with TYPE I ALLERGIC REACTIONS (which includes hayfever, acute allergic and chronic allergic conjunctivitis, and VERNAL KERATOCONJUNCTIVITIS) and giant papillary conjunctivitis.",VERNAL KERATOCONJUNCTIVITIS,TYPE I ALLERGIC REACTIONS,RO-cause_of
502833479,7/13/2014 21:37:38,,1322170790,7/13/2014 21:37:23,fusioncash,0.5768,22139728,USA,,,66.67.91.242,no_relation,251,143,,278,168,treats,0.328797974610715,900240-FS1-2,"When topically applied to the eye before allergen exposure, ocular sodium cromoglycate prevents many of the signs and symptoms associated with TYPE I ALLERGIC REACTIONS (which includes hayfever, acute allergic and chronic allergic conjunctivitis, and VERNAL KERATOCONJUNCTIVITIS) and giant papillary conjunctivitis.",VERNAL KERATOCONJUNCTIVITIS,TYPE I ALLERGIC REACTIONS,RO-cause_of
502833479,7/13/2014 22:37:04,,1322221411,7/13/2014 22:36:09,elite,0.6571,28397222,GBR,,,31.49.231.211,no_relation,251,143,,278,168,treats,0.328797974610715,900240-FS1-2,"When topically applied to the eye before allergen exposure, ocular sodium cromoglycate prevents many of the signs and symptoms associated with TYPE I ALLERGIC REACTIONS (which includes hayfever, acute allergic and chronic allergic conjunctivitis, and VERNAL KERATOCONJUNCTIVITIS) and giant papillary conjunctivitis.",VERNAL KERATOCONJUNCTIVITIS,TYPE I ALLERGIC REACTIONS,RO-cause_of
502904666,7/14/2014 10:13:07,,1322705753,7/14/2014 10:13:01,neodev,0.6944,17610000,GBR,I2,Manchester,90.200.140.201,GYRATE ATROPHY diagnosed by HYPERORNITHINEMIA,17,76,,30,93,diagnosed by,0.544331053951817,900023-FS1-13,The diagnosis of GYRATE ATROPHY was confirmed biochemically and clinically; HYPERORNITHINEMIA and a deficiency of ornithine ketoacid transaminase were confirmed biochemically.,GYRATE ATROPHY,HYPERORNITHINEMIA,RO-cause_of
502904666,7/14/2014 10:36:58,,1322722547,7/14/2014 10:35:59,clixsense,0.625,6344740,USA,WA,Longview,71.193.162.200,no_relation,17,76,,30,93,diagnosed by,0.544331053951817,900023-FS1-13,The diagnosis of GYRATE ATROPHY was confirmed biochemically and clinically; HYPERORNITHINEMIA and a deficiency of ornithine ketoacid transaminase were confirmed biochemically.,GYRATE ATROPHY,HYPERORNITHINEMIA,RO-cause_of
502904666,7/14/2014 10:41:38,,1322725944,7/14/2014 10:40:42,prodege,0.5958,24403612,CAN,ON,Ajax,99.242.234.239,no_relation,17,76,,30,93,diagnosed by,0.544331053951817,900023-FS1-13,The diagnosis of GYRATE ATROPHY was confirmed biochemically and clinically; HYPERORNITHINEMIA and a deficiency of ornithine ketoacid transaminase were confirmed biochemically.,GYRATE ATROPHY,HYPERORNITHINEMIA,RO-cause_of
502904666,7/14/2014 10:50:30,,1322732552,7/14/2014 10:49:36,elite,0.6026,28397222,GBR,Y4,Usk,31.50.223.75,no_relation,17,76,,30,93,diagnosed by,0.544331053951817,900023-FS1-13,The diagnosis of GYRATE ATROPHY was confirmed biochemically and clinically; HYPERORNITHINEMIA and a deficiency of ornithine ketoacid transaminase were confirmed biochemically.,GYRATE ATROPHY,HYPERORNITHINEMIA,RO-cause_of
502904666,7/14/2014 10:58:52,,1322738317,7/14/2014 10:58:23,instagc,0.4815,23149109,USA,NC,Durham,75.189.206.205,GYRATE ATROPHY diagnosed by HYPERORNITHINEMIA,17,76,,30,93,diagnosed by,0.544331053951817,900023-FS1-13,The diagnosis of GYRATE ATROPHY was confirmed biochemically and clinically; HYPERORNITHINEMIA and a deficiency of ornithine ketoacid transaminase were confirmed biochemically.,GYRATE ATROPHY,HYPERORNITHINEMIA,RO-cause_of
502904666,7/14/2014 11:50:37,,1322775130,7/14/2014 11:49:57,elite,0.6935,28322695,GBR,A3,Barnsley,217.44.205.195,no_relation,17,76,,30,93,diagnosed by,0.544331053951817,900023-FS1-13,The diagnosis of GYRATE ATROPHY was confirmed biochemically and clinically; HYPERORNITHINEMIA and a deficiency of ornithine ketoacid transaminase were confirmed biochemically.,GYRATE ATROPHY,HYPERORNITHINEMIA,RO-cause_of
502904666,7/14/2014 12:14:55,,1322790896,7/14/2014 12:14:12,clixsense,0.6319,8100278,USA,FL,Orlando,98.70.77.97,GYRATE ATROPHY diagnosed by HYPERORNITHINEMIA,17,76,,30,93,diagnosed by,0.544331053951817,900023-FS1-13,The diagnosis of GYRATE ATROPHY was confirmed biochemically and clinically; HYPERORNITHINEMIA and a deficiency of ornithine ketoacid transaminase were confirmed biochemically.,GYRATE ATROPHY,HYPERORNITHINEMIA,RO-cause_of
502904670,7/14/2014 10:13:15,,1322705882,7/14/2014 10:13:09,neodev,0.6944,17610000,GBR,I2,Manchester,90.200.140.201,ABDOMINAL MASS causes WILMS' TUMOR,112,17,,125,29,causes,0.923380516876639,902763-FS1-4,In comparison to WILMS' TUMOR renal cell carcinoma in childhood and adolescence usually presents with a smaller ABDOMINAL MASS which is frequently not palpable or visible on plain abdominal radiographs.,ABDOMINAL MASS,WILMS' TUMOR,RO-disease_may_have_finding
502904670,7/14/2014 10:20:09,,1322710600,7/14/2014 10:19:14,clixsense,0.7139,27871219,NLD,07,Amsterdam,87.210.207.223,WILMS' TUMOR causes ABDOMINAL MASS,112,17,,125,29,causes,0.923380516876639,902763-FS1-4,In comparison to WILMS' TUMOR renal cell carcinoma in childhood and adolescence usually presents with a smaller ABDOMINAL MASS which is frequently not palpable or visible on plain abdominal radiographs.,ABDOMINAL MASS,WILMS' TUMOR,RO-disease_may_have_finding
502904670,7/14/2014 11:04:26,,1322741783,7/14/2014 11:04:04,gifthulk,0.7087,21916793,GBR,,,87.113.87.199,WILMS' TUMOR causes ABDOMINAL MASS,112,17,,125,29,causes,0.923380516876639,902763-FS1-4,In comparison to WILMS' TUMOR renal cell carcinoma in childhood and adolescence usually presents with a smaller ABDOMINAL MASS which is frequently not palpable or visible on plain abdominal radiographs.,ABDOMINAL MASS,WILMS' TUMOR,RO-disease_may_have_finding
502904670,7/14/2014 11:08:30,,1322744736,7/14/2014 11:07:47,clixsense,0.5853,27969116,NLD,,,91.213.37.165,no_relation,112,17,,125,29,causes,0.923380516876639,902763-FS1-4,In comparison to WILMS' TUMOR renal cell carcinoma in childhood and adolescence usually presents with a smaller ABDOMINAL MASS which is frequently not palpable or visible on plain abdominal radiographs.,ABDOMINAL MASS,WILMS' TUMOR,RO-disease_may_have_finding
502904670,7/14/2014 11:35:56,,1322764776,7/14/2014 11:35:24,clixsense,0.4976,21689102,CAN,ON,Oshawa,70.24.112.89,WILMS' TUMOR causes ABDOMINAL MASS,112,17,,125,29,causes,0.923380516876639,902763-FS1-4,In comparison to WILMS' TUMOR renal cell carcinoma in childhood and adolescence usually presents with a smaller ABDOMINAL MASS which is frequently not palpable or visible on plain abdominal radiographs.,ABDOMINAL MASS,WILMS' TUMOR,RO-disease_may_have_finding
502904670,7/14/2014 11:47:15,,1322772665,7/14/2014 11:46:34,rewardsspot,0.5710000000000001,24482174,GBR,H9,London,46.23.68.180,no_relation,112,17,,125,29,causes,0.923380516876639,902763-FS1-4,In comparison to WILMS' TUMOR renal cell carcinoma in childhood and adolescence usually presents with a smaller ABDOMINAL MASS which is frequently not palpable or visible on plain abdominal radiographs.,ABDOMINAL MASS,WILMS' TUMOR,RO-disease_may_have_finding
502904670,7/14/2014 11:50:03,,1322774711,7/14/2014 11:49:37,clixsense,0.3881,24763049,GBR,,,86.133.47.213,WILMS' TUMOR causes ABDOMINAL MASS,112,17,,125,29,causes,0.923380516876639,902763-FS1-4,In comparison to WILMS' TUMOR renal cell carcinoma in childhood and adolescence usually presents with a smaller ABDOMINAL MASS which is frequently not palpable or visible on plain abdominal radiographs.,ABDOMINAL MASS,WILMS' TUMOR,RO-disease_may_have_finding
502904673,7/14/2014 10:27:31,,1322715953,7/14/2014 10:27:25,instagc,0.7986,27753923,GBR,,,188.30.192.65,CUSHING'S SYNDROME causes DEXAMETHASONE AND METYRAPONE TESTS,118,55,,135,89,causes,0.577350269189626,906906-FS1-4,This study prospectively evaluated the accuracy of the DEXAMETHASONE AND METYRAPONE TESTS in determining the cause of CUSHING'S SYNDROME in a series of 25 unselected patients.,CUSHING'S SYNDROME,DEXAMETHASONE AND METYRAPONE TESTS,RO-may_diagnose
502904673,7/14/2014 11:01:15,,1322739788,7/14/2014 11:00:29,instagc,0.4815,23149109,USA,NC,Durham,75.189.206.205,no_relation,118,55,,135,89,causes,0.577350269189626,906906-FS1-4,This study prospectively evaluated the accuracy of the DEXAMETHASONE AND METYRAPONE TESTS in determining the cause of CUSHING'S SYNDROME in a series of 25 unselected patients.,CUSHING'S SYNDROME,DEXAMETHASONE AND METYRAPONE TESTS,RO-may_diagnose
502904673,7/14/2014 11:06:58,,1322743625,7/14/2014 11:06:26,clixsense,0.5853,27969116,NLD,,,91.213.37.165,no_relation,118,55,,135,89,causes,0.577350269189626,906906-FS1-4,This study prospectively evaluated the accuracy of the DEXAMETHASONE AND METYRAPONE TESTS in determining the cause of CUSHING'S SYNDROME in a series of 25 unselected patients.,CUSHING'S SYNDROME,DEXAMETHASONE AND METYRAPONE TESTS,RO-may_diagnose
502904673,7/14/2014 11:48:55,,1322773919,7/14/2014 11:48:21,clixsense,0.3881,24763049,GBR,,,86.133.47.213,DEXAMETHASONE AND METYRAPONE TESTS causes CUSHING'S SYNDROME,118,55,,135,89,causes,0.577350269189626,906906-FS1-4,This study prospectively evaluated the accuracy of the DEXAMETHASONE AND METYRAPONE TESTS in determining the cause of CUSHING'S SYNDROME in a series of 25 unselected patients.,CUSHING'S SYNDROME,DEXAMETHASONE AND METYRAPONE TESTS,RO-may_diagnose
502904673,7/14/2014 12:08:26,,1322786681,7/14/2014 12:07:54,prodege,0.4702,28039757,GBR,L8,Southport,109.155.158.54,no_relation,118,55,,135,89,causes,0.577350269189626,906906-FS1-4,This study prospectively evaluated the accuracy of the DEXAMETHASONE AND METYRAPONE TESTS in determining the cause of CUSHING'S SYNDROME in a series of 25 unselected patients.,CUSHING'S SYNDROME,DEXAMETHASONE AND METYRAPONE TESTS,RO-may_diagnose
502904673,7/14/2014 12:12:10,,1322789211,7/14/2014 12:11:16,clixsense,0.6319,8100278,USA,FL,Orlando,98.70.77.97,no_relation,118,55,,135,89,causes,0.577350269189626,906906-FS1-4,This study prospectively evaluated the accuracy of the DEXAMETHASONE AND METYRAPONE TESTS in determining the cause of CUSHING'S SYNDROME in a series of 25 unselected patients.,CUSHING'S SYNDROME,DEXAMETHASONE AND METYRAPONE TESTS,RO-may_diagnose
502904673,7/14/2014 12:18:44,,1322793192,7/14/2014 12:18:12,prodege,0.6286,24913101,GBR,,,146.90.205.21,no_relation,118,55,,135,89,causes,0.577350269189626,906906-FS1-4,This study prospectively evaluated the accuracy of the DEXAMETHASONE AND METYRAPONE TESTS in determining the cause of CUSHING'S SYNDROME in a series of 25 unselected patients.,CUSHING'S SYNDROME,DEXAMETHASONE AND METYRAPONE TESTS,RO-may_diagnose
502904679,7/14/2014 10:13:56,,1322706256,7/14/2014 10:13:30,instagc,0.7903,24252915,GBR,B7,Bristol,77.98.139.82,VARICELLA ZOSTER VIRUS causes ZOSTER (SHINGLES),44,7,,65,24,causes,1.0,903737-FS1-4,Herpes ZOSTER (SHINGLES) is caused when the VARICELLA ZOSTER VIRUS that has remained latent since an earlier varicella infection (chicken pox) is reactivated.,VARICELLA ZOSTER VIRUS,ZOSTER (SHINGLES),RO-has_causative_agent
502904679,7/14/2014 10:21:07,,1322711316,7/14/2014 10:20:10,clixsense,0.7139,27871219,NLD,07,Amsterdam,87.210.207.223,VARICELLA ZOSTER VIRUS causes ZOSTER (SHINGLES),44,7,,65,24,causes,1.0,903737-FS1-4,Herpes ZOSTER (SHINGLES) is caused when the VARICELLA ZOSTER VIRUS that has remained latent since an earlier varicella infection (chicken pox) is reactivated.,VARICELLA ZOSTER VIRUS,ZOSTER (SHINGLES),RO-has_causative_agent
502904679,7/14/2014 10:21:25,,1322711599,7/14/2014 10:21:03,prodege,0.6625,27934334,GBR,Q2,Wokingham,86.166.73.21,VARICELLA ZOSTER VIRUS causes ZOSTER (SHINGLES),44,7,,65,24,causes,1.0,903737-FS1-4,Herpes ZOSTER (SHINGLES) is caused when the VARICELLA ZOSTER VIRUS that has remained latent since an earlier varicella infection (chicken pox) is reactivated.,VARICELLA ZOSTER VIRUS,ZOSTER (SHINGLES),RO-has_causative_agent
502904679,7/14/2014 10:58:52,,1322738322,7/14/2014 10:58:23,instagc,0.4815,23149109,USA,NC,Durham,75.189.206.205,VARICELLA ZOSTER VIRUS causes ZOSTER (SHINGLES),44,7,,65,24,causes,1.0,903737-FS1-4,Herpes ZOSTER (SHINGLES) is caused when the VARICELLA ZOSTER VIRUS that has remained latent since an earlier varicella infection (chicken pox) is reactivated.,VARICELLA ZOSTER VIRUS,ZOSTER (SHINGLES),RO-has_causative_agent
502904679,7/14/2014 11:05:46,,1322742732,7/14/2014 11:05:28,clixsense,0.5853,27969116,NLD,,,91.213.37.165,VARICELLA ZOSTER VIRUS causes ZOSTER (SHINGLES),44,7,,65,24,causes,1.0,903737-FS1-4,Herpes ZOSTER (SHINGLES) is caused when the VARICELLA ZOSTER VIRUS that has remained latent since an earlier varicella infection (chicken pox) is reactivated.,VARICELLA ZOSTER VIRUS,ZOSTER (SHINGLES),RO-has_causative_agent
502904679,7/14/2014 12:13:06,,1322789765,7/14/2014 12:12:11,clixsense,0.6319,8100278,USA,FL,Orlando,98.70.77.97,VARICELLA ZOSTER VIRUS causes ZOSTER (SHINGLES),44,7,,65,24,causes,1.0,903737-FS1-4,Herpes ZOSTER (SHINGLES) is caused when the VARICELLA ZOSTER VIRUS that has remained latent since an earlier varicella infection (chicken pox) is reactivated.,VARICELLA ZOSTER VIRUS,ZOSTER (SHINGLES),RO-has_causative_agent
502904679,7/14/2014 12:19:12,,1322793515,7/14/2014 12:18:45,prodege,0.6286,24913101,GBR,,,146.90.205.21,VARICELLA ZOSTER VIRUS causes ZOSTER (SHINGLES),44,7,,65,24,causes,1.0,903737-FS1-4,Herpes ZOSTER (SHINGLES) is caused when the VARICELLA ZOSTER VIRUS that has remained latent since an earlier varicella infection (chicken pox) is reactivated.,VARICELLA ZOSTER VIRUS,ZOSTER (SHINGLES),RO-has_causative_agent
502904684,7/14/2014 10:09:10,,1322702827,7/14/2014 10:08:53,clixsense,0.8056,19803139,NLD,11,Leiden,82.139.76.131,ANTIARRHYTHMIC THERAPY treats ARRHYTHMIA,35,78,,44,100,treats,0.979957887012223,907383-FS1-2,All patients have remained free of ARRHYTHMIA recurrence and have required no ANTIARRHYTHMIC THERAPY after a follow up of 5 to 28 months (mean 14.,ARRHYTHMIA,ANTIARRHYTHMIC THERAPY,RO-may_prevent
502904684,7/14/2014 11:47:15,,1322772664,7/14/2014 11:46:34,rewardsspot,0.5710000000000001,24482174,GBR,H9,London,46.23.68.180,ANTIARRHYTHMIC THERAPY treats ARRHYTHMIA,35,78,,44,100,treats,0.979957887012223,907383-FS1-2,All patients have remained free of ARRHYTHMIA recurrence and have required no ANTIARRHYTHMIC THERAPY after a follow up of 5 to 28 months (mean 14.,ARRHYTHMIA,ANTIARRHYTHMIC THERAPY,RO-may_prevent
502904684,7/14/2014 12:15:23,,1322791250,7/14/2014 12:14:21,prodege,0.6286,24913101,GBR,,,146.90.205.21,ANTIARRHYTHMIC THERAPY treats ARRHYTHMIA,35,78,,44,100,treats,0.979957887012223,907383-FS1-2,All patients have remained free of ARRHYTHMIA recurrence and have required no ANTIARRHYTHMIC THERAPY after a follow up of 5 to 28 months (mean 14.,ARRHYTHMIA,ANTIARRHYTHMIC THERAPY,RO-may_prevent
502904684,7/14/2014 12:44:30,,1322811011,7/14/2014 12:44:25,clixsense,0.4054,25419319,GBR,H8,Liverpool,94.4.192.228,ANTIARRHYTHMIC THERAPY treats ARRHYTHMIA,35,78,,44,100,treats,0.979957887012223,907383-FS1-2,All patients have remained free of ARRHYTHMIA recurrence and have required no ANTIARRHYTHMIC THERAPY after a follow up of 5 to 28 months (mean 14.,ARRHYTHMIA,ANTIARRHYTHMIC THERAPY,RO-may_prevent
502904684,7/14/2014 12:55:48,,1322818683,7/14/2014 12:55:06,instagc,0.72,16334880,USA,PA,Saint Marys,98.21.77.53,ANTIARRHYTHMIC THERAPY treats ARRHYTHMIA,35,78,,44,100,treats,0.979957887012223,907383-FS1-2,All patients have remained free of ARRHYTHMIA recurrence and have required no ANTIARRHYTHMIC THERAPY after a follow up of 5 to 28 months (mean 14.,ARRHYTHMIA,ANTIARRHYTHMIC THERAPY,RO-may_prevent
502904684,7/14/2014 13:02:47,,1322823302,7/14/2014 13:02:33,prodege,0.8571,7664351,USA,NY,Cicero,74.111.0.21,ANTIARRHYTHMIC THERAPY treats ARRHYTHMIA,35,78,,44,100,treats,0.979957887012223,907383-FS1-2,All patients have remained free of ARRHYTHMIA recurrence and have required no ANTIARRHYTHMIC THERAPY after a follow up of 5 to 28 months (mean 14.,ARRHYTHMIA,ANTIARRHYTHMIC THERAPY,RO-may_prevent
502904684,7/14/2014 13:53:17,,1322858837,7/14/2014 13:53:04,clixsense,1.0,25402344,CAN,ON,Wawa,24.109.124.45,ANTIARRHYTHMIC THERAPY treats ARRHYTHMIA,35,78,,44,100,treats,0.979957887012223,907383-FS1-2,All patients have remained free of ARRHYTHMIA recurrence and have required no ANTIARRHYTHMIC THERAPY after a follow up of 5 to 28 months (mean 14.,ARRHYTHMIA,ANTIARRHYTHMIC THERAPY,RO-may_prevent
502904686,7/14/2014 10:22:31,,1322712329,7/14/2014 10:21:53,prodege,0.6625,27934334,GBR,Q2,Wokingham,86.166.73.21,CUSHING'S SYNDROME diagnosed by DEXAMETHASONE AND METYRAPONE TESTS,118,55,,135,89,diagnosed by,0.8082903768654759,906906-FS1-13,This study prospectively evaluated the accuracy of the DEXAMETHASONE AND METYRAPONE TESTS in determining the cause of CUSHING'S SYNDROME in a series of 25 unselected patients.,CUSHING'S SYNDROME,DEXAMETHASONE AND METYRAPONE TESTS,RO-may_diagnose
502904686,7/14/2014 10:27:47,,1322716088,7/14/2014 10:27:39,instagc,0.7986,27753923,GBR,,,188.30.192.65,CUSHING'S SYNDROME diagnosed by DEXAMETHASONE AND METYRAPONE TESTS,118,55,,135,89,diagnosed by,0.8082903768654759,906906-FS1-13,This study prospectively evaluated the accuracy of the DEXAMETHASONE AND METYRAPONE TESTS in determining the cause of CUSHING'S SYNDROME in a series of 25 unselected patients.,CUSHING'S SYNDROME,DEXAMETHASONE AND METYRAPONE TESTS,RO-may_diagnose
502904686,7/14/2014 10:36:58,,1322722548,7/14/2014 10:35:59,clixsense,0.625,6344740,USA,WA,Longview,71.193.162.200,CUSHING'S SYNDROME diagnosed by DEXAMETHASONE AND METYRAPONE TESTS,118,55,,135,89,diagnosed by,0.8082903768654759,906906-FS1-13,This study prospectively evaluated the accuracy of the DEXAMETHASONE AND METYRAPONE TESTS in determining the cause of CUSHING'S SYNDROME in a series of 25 unselected patients.,CUSHING'S SYNDROME,DEXAMETHASONE AND METYRAPONE TESTS,RO-may_diagnose
502904686,7/14/2014 10:53:23,,1322734569,7/14/2014 10:53:07,clixsense,0.5597,27793793,GBR,C5,Chester,151.230.27.155,DEXAMETHASONE AND METYRAPONE TESTS diagnosed by CUSHING'S SYNDROME,118,55,,135,89,diagnosed by,0.8082903768654759,906906-FS1-13,This study prospectively evaluated the accuracy of the DEXAMETHASONE AND METYRAPONE TESTS in determining the cause of CUSHING'S SYNDROME in a series of 25 unselected patients.,CUSHING'S SYNDROME,DEXAMETHASONE AND METYRAPONE TESTS,RO-may_diagnose
502904686,7/14/2014 11:01:02,,1322739679,7/14/2014 11:00:33,instagc,0.5532,28301350,GBR,K4,Plymouth,78.145.138.150,CUSHING'S SYNDROME diagnosed by DEXAMETHASONE AND METYRAPONE TESTS,118,55,,135,89,diagnosed by,0.8082903768654759,906906-FS1-13,This study prospectively evaluated the accuracy of the DEXAMETHASONE AND METYRAPONE TESTS in determining the cause of CUSHING'S SYNDROME in a series of 25 unselected patients.,CUSHING'S SYNDROME,DEXAMETHASONE AND METYRAPONE TESTS,RO-may_diagnose
502904686,7/14/2014 11:49:37,,1322774311,7/14/2014 11:49:14,clixsense,0.3881,24763049,GBR,,,86.133.47.213,DEXAMETHASONE AND METYRAPONE TESTS diagnosed by CUSHING'S SYNDROME,118,55,,135,89,diagnosed by,0.8082903768654759,906906-FS1-13,This study prospectively evaluated the accuracy of the DEXAMETHASONE AND METYRAPONE TESTS in determining the cause of CUSHING'S SYNDROME in a series of 25 unselected patients.,CUSHING'S SYNDROME,DEXAMETHASONE AND METYRAPONE TESTS,RO-may_diagnose
502904686,7/14/2014 12:07:11,,1322785881,7/14/2014 12:06:38,prodege,0.4702,28039757,GBR,L8,Southport,109.155.158.54,CUSHING'S SYNDROME diagnosed by DEXAMETHASONE AND METYRAPONE TESTS,118,55,,135,89,diagnosed by,0.8082903768654759,906906-FS1-13,This study prospectively evaluated the accuracy of the DEXAMETHASONE AND METYRAPONE TESTS in determining the cause of CUSHING'S SYNDROME in a series of 25 unselected patients.,CUSHING'S SYNDROME,DEXAMETHASONE AND METYRAPONE TESTS,RO-may_diagnose
502904691,7/14/2014 10:08:14,,1322702226,7/14/2014 10:07:24,prodege,0.8056,21891314,AUS,07,Glen Iris,58.6.248.249,EXPERIMENTAL FORMS OF HYPERTENSION causes BLOOD PRESSURE ELEVATION,232,78,,255,112,causes,0.98058067569092,904736-FS1-4,"There is some evidence for a role of ET 1 in blood pressure elevation in some EXPERIMENTAL FORMS OF HYPERTENSION particularly severe, sodium sensitive hypertension, in which it may play a role in accentuating rather than initiating BLOOD PRESSURE ELEVATION.",BLOOD PRESSURE ELEVATION,EXPERIMENTAL FORMS OF HYPERTENSION,RO-has_definitional_manifestation
502904691,7/14/2014 10:08:52,,1322702698,7/14/2014 10:08:39,clixsense,0.8056,19803139,NLD,11,Leiden,82.139.76.131,BLOOD PRESSURE ELEVATION causes EXPERIMENTAL FORMS OF HYPERTENSION,232,78,,255,112,causes,0.98058067569092,904736-FS1-4,"There is some evidence for a role of ET 1 in blood pressure elevation in some EXPERIMENTAL FORMS OF HYPERTENSION particularly severe, sodium sensitive hypertension, in which it may play a role in accentuating rather than initiating BLOOD PRESSURE ELEVATION.",BLOOD PRESSURE ELEVATION,EXPERIMENTAL FORMS OF HYPERTENSION,RO-has_definitional_manifestation
502904691,7/14/2014 10:20:26,,1322710698,7/14/2014 10:19:37,prodege,0.6625,27934334,GBR,Q2,Wokingham,86.166.73.21,no_relation,232,78,,255,112,causes,0.98058067569092,904736-FS1-4,"There is some evidence for a role of ET 1 in blood pressure elevation in some EXPERIMENTAL FORMS OF HYPERTENSION particularly severe, sodium sensitive hypertension, in which it may play a role in accentuating rather than initiating BLOOD PRESSURE ELEVATION.",BLOOD PRESSURE ELEVATION,EXPERIMENTAL FORMS OF HYPERTENSION,RO-has_definitional_manifestation
502904691,7/14/2014 10:51:02,,1322732923,7/14/2014 10:50:34,prodege,0.5599,15439740,AUS,02,Jannali,27.96.208.89,EXPERIMENTAL FORMS OF HYPERTENSION causes BLOOD PRESSURE ELEVATION,232,78,,255,112,causes,0.98058067569092,904736-FS1-4,"There is some evidence for a role of ET 1 in blood pressure elevation in some EXPERIMENTAL FORMS OF HYPERTENSION particularly severe, sodium sensitive hypertension, in which it may play a role in accentuating rather than initiating BLOOD PRESSURE ELEVATION.",BLOOD PRESSURE ELEVATION,EXPERIMENTAL FORMS OF HYPERTENSION,RO-has_definitional_manifestation
502904691,7/14/2014 10:53:34,,1322734674,7/14/2014 10:53:24,clixsense,0.5597,27793793,GBR,C5,Chester,151.230.27.155,BLOOD PRESSURE ELEVATION causes EXPERIMENTAL FORMS OF HYPERTENSION,232,78,,255,112,causes,0.98058067569092,904736-FS1-4,"There is some evidence for a role of ET 1 in blood pressure elevation in some EXPERIMENTAL FORMS OF HYPERTENSION particularly severe, sodium sensitive hypertension, in which it may play a role in accentuating rather than initiating BLOOD PRESSURE ELEVATION.",BLOOD PRESSURE ELEVATION,EXPERIMENTAL FORMS OF HYPERTENSION,RO-has_definitional_manifestation
502904691,7/14/2014 11:01:02,,1322739675,7/14/2014 11:00:33,instagc,0.5532,28301350,GBR,K4,Plymouth,78.145.138.150,EXPERIMENTAL FORMS OF HYPERTENSION causes BLOOD PRESSURE ELEVATION,232,78,,255,112,causes,0.98058067569092,904736-FS1-4,"There is some evidence for a role of ET 1 in blood pressure elevation in some EXPERIMENTAL FORMS OF HYPERTENSION particularly severe, sodium sensitive hypertension, in which it may play a role in accentuating rather than initiating BLOOD PRESSURE ELEVATION.",BLOOD PRESSURE ELEVATION,EXPERIMENTAL FORMS OF HYPERTENSION,RO-has_definitional_manifestation
502904691,7/14/2014 11:03:12,,1322740933,7/14/2014 11:02:49,gifthulk,0.7087,21916793,GBR,,,87.113.87.199,EXPERIMENTAL FORMS OF HYPERTENSION causes BLOOD PRESSURE ELEVATION,232,78,,255,112,causes,0.98058067569092,904736-FS1-4,"There is some evidence for a role of ET 1 in blood pressure elevation in some EXPERIMENTAL FORMS OF HYPERTENSION particularly severe, sodium sensitive hypertension, in which it may play a role in accentuating rather than initiating BLOOD PRESSURE ELEVATION.",BLOOD PRESSURE ELEVATION,EXPERIMENTAL FORMS OF HYPERTENSION,RO-has_definitional_manifestation
502904696,7/14/2014 10:07:47,,1322701844,7/14/2014 10:07:09,clixsense,0.9722,15189335,GBR,K3,Peterborough,81.156.166.189,DEFECTIVE MOBILIZATION OF VITAMIN A FROM THE LIVER causes VITAMIN A DEFICIENCY,110,153,,129,203,causes,0.5303300858899109,907453-FS1-4,The results suggest that the low serum vitamin A levels in primary biliary cirrhosis are not a consequence of VITAMIN A DEFICIENCY but instead reflect a DEFECTIVE MOBILIZATION OF VITAMIN A FROM THE LIVER.,VITAMIN A DEFICIENCY,DEFECTIVE MOBILIZATION OF VITAMIN A FROM THE LIVER,RO-may_prevent
502904696,7/14/2014 10:09:39,,1322703268,7/14/2014 10:08:57,instagc,0.8889,25901556,GBR,C3,Saint Ives,82.9.129.2,no_relation,110,153,,129,203,causes,0.5303300858899109,907453-FS1-4,The results suggest that the low serum vitamin A levels in primary biliary cirrhosis are not a consequence of VITAMIN A DEFICIENCY but instead reflect a DEFECTIVE MOBILIZATION OF VITAMIN A FROM THE LIVER.,VITAMIN A DEFICIENCY,DEFECTIVE MOBILIZATION OF VITAMIN A FROM THE LIVER,RO-may_prevent
502904696,7/14/2014 10:18:21,,1322709254,7/14/2014 10:17:19,clixsense,0.7139,27871219,NLD,07,Amsterdam,87.210.207.223,DEFECTIVE MOBILIZATION OF VITAMIN A FROM THE LIVER causes VITAMIN A DEFICIENCY,110,153,,129,203,causes,0.5303300858899109,907453-FS1-4,The results suggest that the low serum vitamin A levels in primary biliary cirrhosis are not a consequence of VITAMIN A DEFICIENCY but instead reflect a DEFECTIVE MOBILIZATION OF VITAMIN A FROM THE LIVER.,VITAMIN A DEFICIENCY,DEFECTIVE MOBILIZATION OF VITAMIN A FROM THE LIVER,RO-may_prevent
502904696,7/14/2014 10:22:31,,1322712331,7/14/2014 10:21:53,prodege,0.6625,27934334,GBR,Q2,Wokingham,86.166.73.21,no_relation,110,153,,129,203,causes,0.5303300858899109,907453-FS1-4,The results suggest that the low serum vitamin A levels in primary biliary cirrhosis are not a consequence of VITAMIN A DEFICIENCY but instead reflect a DEFECTIVE MOBILIZATION OF VITAMIN A FROM THE LIVER.,VITAMIN A DEFICIENCY,DEFECTIVE MOBILIZATION OF VITAMIN A FROM THE LIVER,RO-may_prevent
502904696,7/14/2014 10:49:35,,1322731950,7/14/2014 10:48:45,elite,0.6026,28397222,GBR,Y4,Usk,31.50.223.75,no_relation,110,153,,129,203,causes,0.5303300858899109,907453-FS1-4,The results suggest that the low serum vitamin A levels in primary biliary cirrhosis are not a consequence of VITAMIN A DEFICIENCY but instead reflect a DEFECTIVE MOBILIZATION OF VITAMIN A FROM THE LIVER.,VITAMIN A DEFICIENCY,DEFECTIVE MOBILIZATION OF VITAMIN A FROM THE LIVER,RO-may_prevent
502904696,7/14/2014 10:55:05,,1322735643,7/14/2014 10:54:40,prodege,0.5599,15439740,AUS,02,Jannali,27.96.208.89,no_relation,110,153,,129,203,causes,0.5303300858899109,907453-FS1-4,The results suggest that the low serum vitamin A levels in primary biliary cirrhosis are not a consequence of VITAMIN A DEFICIENCY but instead reflect a DEFECTIVE MOBILIZATION OF VITAMIN A FROM THE LIVER.,VITAMIN A DEFICIENCY,DEFECTIVE MOBILIZATION OF VITAMIN A FROM THE LIVER,RO-may_prevent
502904696,7/14/2014 11:01:56,,1322740205,7/14/2014 11:01:16,instagc,0.4815,23149109,USA,NC,Durham,75.189.206.205,DEFECTIVE MOBILIZATION OF VITAMIN A FROM THE LIVER causes VITAMIN A DEFICIENCY,110,153,,129,203,causes,0.5303300858899109,907453-FS1-4,The results suggest that the low serum vitamin A levels in primary biliary cirrhosis are not a consequence of VITAMIN A DEFICIENCY but instead reflect a DEFECTIVE MOBILIZATION OF VITAMIN A FROM THE LIVER.,VITAMIN A DEFICIENCY,DEFECTIVE MOBILIZATION OF VITAMIN A FROM THE LIVER,RO-may_prevent
502904700,7/14/2014 10:10:36,,1322703986,7/14/2014 10:10:04,instagc,0.7903,24252915,GBR,B7,Bristol,77.98.139.82,PALMAR LICHEN NITIDUS causes NORMAL PALMAR SKIN,135,49,,152,70,causes,0.881917103688197,905453-FS1-4,We conclude that this histopathologic feature in PALMAR LICHEN NITIDUS could be the result of the superimposition of lichen nitidus on NORMAL PALMAR SKIN resulting in a picture resembling hypertrophic lichen planus.,NORMAL PALMAR SKIN,PALMAR LICHEN NITIDUS,RO-has_finding_site
502904700,7/14/2014 10:42:54,,1322727157,7/14/2014 10:42:16,prodege,0.5958,24403612,CAN,ON,Ajax,99.242.234.239,no_relation,135,49,,152,70,causes,0.881917103688197,905453-FS1-4,We conclude that this histopathologic feature in PALMAR LICHEN NITIDUS could be the result of the superimposition of lichen nitidus on NORMAL PALMAR SKIN resulting in a picture resembling hypertrophic lichen planus.,NORMAL PALMAR SKIN,PALMAR LICHEN NITIDUS,RO-has_finding_site
502904700,7/14/2014 10:59:33,,1322738680,7/14/2014 10:59:12,instagc,0.5532,28301350,GBR,K4,Plymouth,78.145.138.150,no_relation,135,49,,152,70,causes,0.881917103688197,905453-FS1-4,We conclude that this histopathologic feature in PALMAR LICHEN NITIDUS could be the result of the superimposition of lichen nitidus on NORMAL PALMAR SKIN resulting in a picture resembling hypertrophic lichen planus.,NORMAL PALMAR SKIN,PALMAR LICHEN NITIDUS,RO-has_finding_site
502904700,7/14/2014 11:00:27,,1322739212,7/14/2014 10:59:37,instagc,0.4815,23149109,USA,NC,Durham,75.189.206.205,NORMAL PALMAR SKIN causes PALMAR LICHEN NITIDUS,135,49,,152,70,causes,0.881917103688197,905453-FS1-4,We conclude that this histopathologic feature in PALMAR LICHEN NITIDUS could be the result of the superimposition of lichen nitidus on NORMAL PALMAR SKIN resulting in a picture resembling hypertrophic lichen planus.,NORMAL PALMAR SKIN,PALMAR LICHEN NITIDUS,RO-has_finding_site
502904700,7/14/2014 11:04:26,,1322741781,7/14/2014 11:04:04,gifthulk,0.7087,21916793,GBR,,,87.113.87.199,no_relation,135,49,,152,70,causes,0.881917103688197,905453-FS1-4,We conclude that this histopathologic feature in PALMAR LICHEN NITIDUS could be the result of the superimposition of lichen nitidus on NORMAL PALMAR SKIN resulting in a picture resembling hypertrophic lichen planus.,NORMAL PALMAR SKIN,PALMAR LICHEN NITIDUS,RO-has_finding_site
502904700,7/14/2014 12:44:23,,1322810946,7/14/2014 12:44:18,clixsense,0.4054,25419319,GBR,H8,Liverpool,94.4.192.228,NORMAL PALMAR SKIN causes PALMAR LICHEN NITIDUS,135,49,,152,70,causes,0.881917103688197,905453-FS1-4,We conclude that this histopathologic feature in PALMAR LICHEN NITIDUS could be the result of the superimposition of lichen nitidus on NORMAL PALMAR SKIN resulting in a picture resembling hypertrophic lichen planus.,NORMAL PALMAR SKIN,PALMAR LICHEN NITIDUS,RO-has_finding_site
502904700,7/14/2014 12:57:09,,1322819581,7/14/2014 12:56:30,instagc,0.72,16334880,USA,PA,Saint Marys,98.21.77.53,NORMAL PALMAR SKIN causes PALMAR LICHEN NITIDUS,135,49,,152,70,causes,0.881917103688197,905453-FS1-4,We conclude that this histopathologic feature in PALMAR LICHEN NITIDUS could be the result of the superimposition of lichen nitidus on NORMAL PALMAR SKIN resulting in a picture resembling hypertrophic lichen planus.,NORMAL PALMAR SKIN,PALMAR LICHEN NITIDUS,RO-has_finding_site
502904703,7/14/2014 10:08:14,,1322702216,7/14/2014 10:07:49,clixsense,0.8056,19803139,NLD,11,Leiden,82.139.76.131,no_relation,71,120,,78,124,causes,0.547722557505166,901513-FS1-4,Xenograft histology following radioimmunotherapy showed large areas of NECROSIS fibrosis and very few residual cells of SCLC origin.,NECROSIS,SCLC,RO-disease_has_finding
502904703,7/14/2014 10:10:36,,1322703987,7/14/2014 10:10:04,instagc,0.7903,24252915,GBR,B7,Bristol,77.98.139.82,no_relation,71,120,,78,124,causes,0.547722557505166,901513-FS1-4,Xenograft histology following radioimmunotherapy showed large areas of NECROSIS fibrosis and very few residual cells of SCLC origin.,NECROSIS,SCLC,RO-disease_has_finding
502904703,7/14/2014 10:11:09,,1322704479,7/14/2014 10:10:04,prodege,0.8056,21891314,AUS,07,Glen Iris,58.6.248.249,no_relation,71,120,,78,124,causes,0.547722557505166,901513-FS1-4,Xenograft histology following radioimmunotherapy showed large areas of NECROSIS fibrosis and very few residual cells of SCLC origin.,NECROSIS,SCLC,RO-disease_has_finding
502904703,7/14/2014 10:12:54,,1322705593,7/14/2014 10:12:47,neodev,0.6944,17610000,GBR,I2,Manchester,90.200.140.201,NECROSIS causes SCLC,71,120,,78,124,causes,0.547722557505166,901513-FS1-4,Xenograft histology following radioimmunotherapy showed large areas of NECROSIS fibrosis and very few residual cells of SCLC origin.,NECROSIS,SCLC,RO-disease_has_finding
502904703,7/14/2014 10:43:59,,1322727831,7/14/2014 10:43:31,prodege,0.5958,24403612,CAN,ON,Ajax,99.242.234.239,no_relation,71,120,,78,124,causes,0.547722557505166,901513-FS1-4,Xenograft histology following radioimmunotherapy showed large areas of NECROSIS fibrosis and very few residual cells of SCLC origin.,NECROSIS,SCLC,RO-disease_has_finding
502904703,7/14/2014 10:51:02,,1322732933,7/14/2014 10:50:34,prodege,0.5599,15439740,AUS,02,Jannali,27.96.208.89,NECROSIS causes SCLC,71,120,,78,124,causes,0.547722557505166,901513-FS1-4,Xenograft histology following radioimmunotherapy showed large areas of NECROSIS fibrosis and very few residual cells of SCLC origin.,NECROSIS,SCLC,RO-disease_has_finding
502904703,7/14/2014 10:51:58,,1322733507,7/14/2014 10:51:28,elite,0.6026,28397222,GBR,Y4,Usk,31.50.223.75,no_relation,71,120,,78,124,causes,0.547722557505166,901513-FS1-4,Xenograft histology following radioimmunotherapy showed large areas of NECROSIS fibrosis and very few residual cells of SCLC origin.,NECROSIS,SCLC,RO-disease_has_finding
502904707,7/14/2014 10:13:07,,1322705752,7/14/2014 10:13:01,neodev,0.6944,17610000,GBR,I2,Manchester,90.200.140.201,OSTEOARTHRITIS treats PIROXICAM,69,0,,82,9,treats,0.7559289460184542,908057-FS1-2,PIROXICAM in 211 patients with rheumatoid arthritis (RA) (n = 95) or OSTEOARTHRITIS (OA) (n = 116.,OSTEOARTHRITIS,PIROXICAM,RO-may_treat
502904707,7/14/2014 10:21:55,,1322711930,7/14/2014 10:21:39,clixsense,0.7139,27871219,NLD,07,Amsterdam,87.210.207.223,PIROXICAM treats OSTEOARTHRITIS,69,0,,82,9,treats,0.7559289460184542,908057-FS1-2,PIROXICAM in 211 patients with rheumatoid arthritis (RA) (n = 95) or OSTEOARTHRITIS (OA) (n = 116.,OSTEOARTHRITIS,PIROXICAM,RO-may_treat
502904707,7/14/2014 10:27:18,,1322715815,7/14/2014 10:27:13,instagc,0.7986,27753923,GBR,,,188.30.192.65,OSTEOARTHRITIS treats PIROXICAM,69,0,,82,9,treats,0.7559289460184542,908057-FS1-2,PIROXICAM in 211 patients with rheumatoid arthritis (RA) (n = 95) or OSTEOARTHRITIS (OA) (n = 116.,OSTEOARTHRITIS,PIROXICAM,RO-may_treat
502904707,7/14/2014 11:00:32,,1322739284,7/14/2014 11:00:14,instagc,0.5532,28301350,GBR,K4,Plymouth,78.145.138.150,PIROXICAM treats OSTEOARTHRITIS,69,0,,82,9,treats,0.7559289460184542,908057-FS1-2,PIROXICAM in 211 patients with rheumatoid arthritis (RA) (n = 95) or OSTEOARTHRITIS (OA) (n = 116.,OSTEOARTHRITIS,PIROXICAM,RO-may_treat
502904707,7/14/2014 11:35:23,,1322764324,7/14/2014 11:34:43,clixsense,0.4976,21689102,CAN,ON,Oshawa,70.24.112.89,PIROXICAM treats OSTEOARTHRITIS,69,0,,82,9,treats,0.7559289460184542,908057-FS1-2,PIROXICAM in 211 patients with rheumatoid arthritis (RA) (n = 95) or OSTEOARTHRITIS (OA) (n = 116.,OSTEOARTHRITIS,PIROXICAM,RO-may_treat
502904707,7/14/2014 11:38:13,,1322766331,7/14/2014 11:38:02,instagc,0.4613,15445601,USA,FL,Jacksonville,24.129.68.254,no_relation,69,0,,82,9,treats,0.7559289460184542,908057-FS1-2,PIROXICAM in 211 patients with rheumatoid arthritis (RA) (n = 95) or OSTEOARTHRITIS (OA) (n = 116.,OSTEOARTHRITIS,PIROXICAM,RO-may_treat
502904707,7/14/2014 12:18:44,,1322793191,7/14/2014 12:18:12,prodege,0.6286,24913101,GBR,,,146.90.205.21,no_relation,69,0,,82,9,treats,0.7559289460184542,908057-FS1-2,PIROXICAM in 211 patients with rheumatoid arthritis (RA) (n = 95) or OSTEOARTHRITIS (OA) (n = 116.,OSTEOARTHRITIS,PIROXICAM,RO-may_treat
502904708,7/14/2014 10:13:15,,1322705881,7/14/2014 10:13:09,neodev,0.6944,17610000,GBR,I2,Manchester,90.200.140.201,NECROSIS is location of SCLC,71,120,,78,124,is location of,0.36514837167011105,901513-FS1-9,Xenograft histology following radioimmunotherapy showed large areas of NECROSIS fibrosis and very few residual cells of SCLC origin.,NECROSIS,SCLC,RO-disease_has_finding
502904708,7/14/2014 10:42:15,,1322726560,7/14/2014 10:41:39,prodege,0.5958,24403612,CAN,ON,Ajax,99.242.234.239,no_relation,71,120,,78,124,is location of,0.36514837167011105,901513-FS1-9,Xenograft histology following radioimmunotherapy showed large areas of NECROSIS fibrosis and very few residual cells of SCLC origin.,NECROSIS,SCLC,RO-disease_has_finding
502904708,7/14/2014 11:08:30,,1322744735,7/14/2014 11:07:47,clixsense,0.5853,27969116,NLD,,,91.213.37.165,SCLC is location of NECROSIS,71,120,,78,124,is location of,0.36514837167011105,901513-FS1-9,Xenograft histology following radioimmunotherapy showed large areas of NECROSIS fibrosis and very few residual cells of SCLC origin.,NECROSIS,SCLC,RO-disease_has_finding
502904708,7/14/2014 11:38:41,,1322766749,7/14/2014 11:38:31,instagc,0.4613,15445601,USA,FL,Jacksonville,24.129.68.254,no_relation,71,120,,78,124,is location of,0.36514837167011105,901513-FS1-9,Xenograft histology following radioimmunotherapy showed large areas of NECROSIS fibrosis and very few residual cells of SCLC origin.,NECROSIS,SCLC,RO-disease_has_finding
502904708,7/14/2014 12:06:37,,1322785462,7/14/2014 12:06:04,prodege,0.4702,28039757,GBR,L8,Southport,109.155.158.54,SCLC is location of NECROSIS,71,120,,78,124,is location of,0.36514837167011105,901513-FS1-9,Xenograft histology following radioimmunotherapy showed large areas of NECROSIS fibrosis and very few residual cells of SCLC origin.,NECROSIS,SCLC,RO-disease_has_finding
502904708,7/14/2014 12:14:11,,1322790384,7/14/2014 12:13:07,clixsense,0.6319,8100278,USA,FL,Orlando,98.70.77.97,no_relation,71,120,,78,124,is location of,0.36514837167011105,901513-FS1-9,Xenograft histology following radioimmunotherapy showed large areas of NECROSIS fibrosis and very few residual cells of SCLC origin.,NECROSIS,SCLC,RO-disease_has_finding
502904708,7/14/2014 12:44:36,,1322811080,7/14/2014 12:44:30,clixsense,0.4054,25419319,GBR,H8,Liverpool,94.4.192.228,NECROSIS is location of SCLC,71,120,,78,124,is location of,0.36514837167011105,901513-FS1-9,Xenograft histology following radioimmunotherapy showed large areas of NECROSIS fibrosis and very few residual cells of SCLC origin.,NECROSIS,SCLC,RO-disease_has_finding
502912470,7/14/2014 15:05:02,,1322906497,7/14/2014 15:04:47,neodev,0.7190000000000001,18755947,GBR,H2,Accrington,80.47.185.52,BONE is location of BONE LOSS,67,67,,70,76,is location of,0.609994281330419,905117-FS1-9,"In contrast, all ITAM adapter deficient mice responded to OVX with BONE LOSS in both femur and tibia of approximately 40%, relative to basal BONE volumes.",BONE,BONE LOSS,RO-has_finding_site
502912470,7/14/2014 15:05:58,,1322906901,7/14/2014 15:05:07,instagc,0.7125,28519532,USA,IA,Honey Creek,12.73.110.26,no_relation,67,67,,70,76,is location of,0.609994281330419,905117-FS1-9,"In contrast, all ITAM adapter deficient mice responded to OVX with BONE LOSS in both femur and tibia of approximately 40%, relative to basal BONE volumes.",BONE,BONE LOSS,RO-has_finding_site
502912470,7/14/2014 15:10:10,,1322909243,7/14/2014 15:09:45,clixsense,0.5718,19803139,NLD,06,Veldhoven,212.61.84.196,BONE is location of BONE LOSS,67,67,,70,76,is location of,0.609994281330419,905117-FS1-9,"In contrast, all ITAM adapter deficient mice responded to OVX with BONE LOSS in both femur and tibia of approximately 40%, relative to basal BONE volumes.",BONE,BONE LOSS,RO-has_finding_site
502912470,7/14/2014 15:18:49,,1322913590,7/14/2014 15:18:43,clixsense,0.4823,19162475,GBR,M3,Frome,82.33.126.30,BONE is location of BONE LOSS,67,67,,70,76,is location of,0.609994281330419,905117-FS1-9,"In contrast, all ITAM adapter deficient mice responded to OVX with BONE LOSS in both femur and tibia of approximately 40%, relative to basal BONE volumes.",BONE,BONE LOSS,RO-has_finding_site
502912470,7/14/2014 15:22:33,,1322915885,7/14/2014 15:21:32,clixsense,0.4244,26889820,GBR,C3,Shelford,92.18.120.203,no_relation,67,67,,70,76,is location of,0.609994281330419,905117-FS1-9,"In contrast, all ITAM adapter deficient mice responded to OVX with BONE LOSS in both femur and tibia of approximately 40%, relative to basal BONE volumes.",BONE,BONE LOSS,RO-has_finding_site
502912470,7/14/2014 15:28:34,,1322919429,7/14/2014 15:28:23,gifthulk,0.6484,21916793,GBR,,,87.113.87.199,BONE is location of BONE LOSS,67,67,,70,76,is location of,0.609994281330419,905117-FS1-9,"In contrast, all ITAM adapter deficient mice responded to OVX with BONE LOSS in both femur and tibia of approximately 40%, relative to basal BONE volumes.",BONE,BONE LOSS,RO-has_finding_site
502912470,7/14/2014 15:33:29,,1322922447,7/14/2014 15:33:12,neodev,0.5101,21405167,USA,MD,Glen Burnie,69.137.237.73,BONE is location of BONE LOSS,67,67,,70,76,is location of,0.609994281330419,905117-FS1-9,"In contrast, all ITAM adapter deficient mice responded to OVX with BONE LOSS in both femur and tibia of approximately 40%, relative to basal BONE volumes.",BONE,BONE LOSS,RO-has_finding_site
502912475,7/14/2014 13:08:06,,1322826854,7/14/2014 13:07:40,prodege,0.6278,11616695,GBR,P7,Wigan,92.29.199.166,no_relation,63,13,,67,24,causes,0.643267520902677,905480-FS1-4,Infants with ANENCEPHALY are born without all or most of their BRAIN and die within a few days of life.,BRAIN,ANENCEPHALY,RO-has_finding_site
502912475,7/14/2014 13:19:11,,1322834332,7/14/2014 13:18:21,clixsense,0.7,24896327,GBR,V2,Glasgow,94.2.231.4,no_relation,63,13,,67,24,causes,0.643267520902677,905480-FS1-4,Infants with ANENCEPHALY are born without all or most of their BRAIN and die within a few days of life.,BRAIN,ANENCEPHALY,RO-has_finding_site
502912475,7/14/2014 13:54:28,,1322859644,7/14/2014 13:54:08,zoombucks,0.7764,5919735,USA,PA,Doylestown,173.49.91.231,no_relation,63,13,,67,24,causes,0.643267520902677,905480-FS1-4,Infants with ANENCEPHALY are born without all or most of their BRAIN and die within a few days of life.,BRAIN,ANENCEPHALY,RO-has_finding_site
502912475,7/14/2014 14:31:46,,1322885440,7/14/2014 14:31:33,clixsense,0.5125,7415230,GBR,A7,Birmingham,147.188.47.242,no_relation,63,13,,67,24,causes,0.643267520902677,905480-FS1-4,Infants with ANENCEPHALY are born without all or most of their BRAIN and die within a few days of life.,BRAIN,ANENCEPHALY,RO-has_finding_site
502912475,7/14/2014 14:55:08,,1322900440,7/14/2014 14:54:45,instagc,0.6593,13763729,USA,,,75.182.89.225,no_relation,63,13,,67,24,causes,0.643267520902677,905480-FS1-4,Infants with ANENCEPHALY are born without all or most of their BRAIN and die within a few days of life.,BRAIN,ANENCEPHALY,RO-has_finding_site
502912475,7/14/2014 14:57:27,,1322901971,7/14/2014 14:57:10,elite,0.4302,28276268,USA,MI,Taylor,67.149.247.166,ANENCEPHALY causes BRAIN,63,13,,67,24,causes,0.643267520902677,905480-FS1-4,Infants with ANENCEPHALY are born without all or most of their BRAIN and die within a few days of life.,BRAIN,ANENCEPHALY,RO-has_finding_site
502912475,7/14/2014 15:00:49,,1322904043,7/14/2014 15:00:28,instagc,0.5536,18960682,GBR,,,86.29.147.112,no_relation,63,13,,67,24,causes,0.643267520902677,905480-FS1-4,Infants with ANENCEPHALY are born without all or most of their BRAIN and die within a few days of life.,BRAIN,ANENCEPHALY,RO-has_finding_site
502912479,7/14/2014 12:35:00,,1322804553,7/14/2014 12:34:41,clixsense,0.9583,27871219,NLD,07,Amsterdam,87.210.207.223,MICROVASCULAR PROLIFERATION causes GLIOBLASTOMA MULTIFORME,16,83,,42,106,causes,0.8,901588-FS1-4,The presence of MICROVASCULAR PROLIFERATION leads to the histological diagnosis of GLIOBLASTOMA MULTIFORME.,MICROVASCULAR PROLIFERATION,GLIOBLASTOMA MULTIFORME,RO-disease_has_finding
502912479,7/14/2014 13:53:45,,1322859108,7/14/2014 13:53:25,zoombucks,0.7764,5919735,USA,PA,Doylestown,173.49.91.231,MICROVASCULAR PROLIFERATION causes GLIOBLASTOMA MULTIFORME,16,83,,42,106,causes,0.8,901588-FS1-4,The presence of MICROVASCULAR PROLIFERATION leads to the histological diagnosis of GLIOBLASTOMA MULTIFORME.,MICROVASCULAR PROLIFERATION,GLIOBLASTOMA MULTIFORME,RO-disease_has_finding
502912479,7/14/2014 14:57:08,,1322901787,7/14/2014 14:56:52,elite,0.4302,28276268,USA,MI,Taylor,67.149.247.166,MICROVASCULAR PROLIFERATION causes GLIOBLASTOMA MULTIFORME,16,83,,42,106,causes,0.8,901588-FS1-4,The presence of MICROVASCULAR PROLIFERATION leads to the histological diagnosis of GLIOBLASTOMA MULTIFORME.,MICROVASCULAR PROLIFERATION,GLIOBLASTOMA MULTIFORME,RO-disease_has_finding
502912479,7/14/2014 15:00:27,,1322903752,7/14/2014 15:00:14,instagc,0.5536,18960682,GBR,,,86.29.147.112,GLIOBLASTOMA MULTIFORME causes MICROVASCULAR PROLIFERATION,16,83,,42,106,causes,0.8,901588-FS1-4,The presence of MICROVASCULAR PROLIFERATION leads to the histological diagnosis of GLIOBLASTOMA MULTIFORME.,MICROVASCULAR PROLIFERATION,GLIOBLASTOMA MULTIFORME,RO-disease_has_finding
502912479,7/14/2014 15:20:04,,1322914316,7/14/2014 15:19:31,prodege,0.639,27996604,CAN,QC,Boucherville,24.201.21.27,MICROVASCULAR PROLIFERATION causes GLIOBLASTOMA MULTIFORME,16,83,,42,106,causes,0.8,901588-FS1-4,The presence of MICROVASCULAR PROLIFERATION leads to the histological diagnosis of GLIOBLASTOMA MULTIFORME.,MICROVASCULAR PROLIFERATION,GLIOBLASTOMA MULTIFORME,RO-disease_has_finding
502912479,7/14/2014 15:33:51,,1322922691,7/14/2014 15:33:30,neodev,0.5101,21405167,USA,MD,Glen Burnie,69.137.237.73,GLIOBLASTOMA MULTIFORME causes MICROVASCULAR PROLIFERATION,16,83,,42,106,causes,0.8,901588-FS1-4,The presence of MICROVASCULAR PROLIFERATION leads to the histological diagnosis of GLIOBLASTOMA MULTIFORME.,MICROVASCULAR PROLIFERATION,GLIOBLASTOMA MULTIFORME,RO-disease_has_finding
502912479,7/14/2014 15:56:36,,1322935369,7/14/2014 15:55:53,instagc,0.3429,18985376,GBR,D2,Derby,86.5.192.8,no_relation,16,83,,42,106,causes,0.8,901588-FS1-4,The presence of MICROVASCULAR PROLIFERATION leads to the histological diagnosis of GLIOBLASTOMA MULTIFORME.,MICROVASCULAR PROLIFERATION,GLIOBLASTOMA MULTIFORME,RO-disease_has_finding
502912481,7/14/2014 12:33:53,,1322803833,7/14/2014 12:33:17,clixsense,0.9583,27871219,NLD,07,Amsterdam,87.210.207.223,HYPERTENSION causes INCREASED BLOOD PRESSURE,120,44,,143,56,causes,0.610847221781526,904726-FS1-4,The number of patients with well controlled HYPERTENSION is alarmingly low worldwide and new approaches to treatment of INCREASED BLOOD PRESSURE (BP) are being sought.,INCREASED BLOOD PRESSURE,HYPERTENSION,RO-has_definitional_manifestation
502912481,7/14/2014 12:56:13,,1322819025,7/14/2014 12:55:40,clixsense,0.8194,15189335,GBR,K3,Peterborough,81.156.166.189,INCREASED BLOOD PRESSURE causes HYPERTENSION,120,44,,143,56,causes,0.610847221781526,904726-FS1-4,The number of patients with well controlled HYPERTENSION is alarmingly low worldwide and new approaches to treatment of INCREASED BLOOD PRESSURE (BP) are being sought.,INCREASED BLOOD PRESSURE,HYPERTENSION,RO-has_definitional_manifestation
502912481,7/14/2014 13:00:28,,1322821827,7/14/2014 12:59:57,prodege,0.7639,7664351,USA,NY,Cicero,74.111.0.21,INCREASED BLOOD PRESSURE causes HYPERTENSION,120,44,,143,56,causes,0.610847221781526,904726-FS1-4,The number of patients with well controlled HYPERTENSION is alarmingly low worldwide and new approaches to treatment of INCREASED BLOOD PRESSURE (BP) are being sought.,INCREASED BLOOD PRESSURE,HYPERTENSION,RO-has_definitional_manifestation
502912481,7/14/2014 14:23:48,,1322879453,7/14/2014 14:23:41,neodev,0.3792,25224036,CAN,ON,Sudbury,67.204.218.187,HYPERTENSION causes INCREASED BLOOD PRESSURE,120,44,,143,56,causes,0.610847221781526,904726-FS1-4,The number of patients with well controlled HYPERTENSION is alarmingly low worldwide and new approaches to treatment of INCREASED BLOOD PRESSURE (BP) are being sought.,INCREASED BLOOD PRESSURE,HYPERTENSION,RO-has_definitional_manifestation
502912481,7/14/2014 14:31:51,,1322885507,7/14/2014 14:31:46,instagc,0.644,15445601,USA,FL,Jacksonville,24.129.68.254,no_relation,120,44,,143,56,causes,0.610847221781526,904726-FS1-4,The number of patients with well controlled HYPERTENSION is alarmingly low worldwide and new approaches to treatment of INCREASED BLOOD PRESSURE (BP) are being sought.,INCREASED BLOOD PRESSURE,HYPERTENSION,RO-has_definitional_manifestation
502912481,7/14/2014 14:45:59,,1322895011,7/14/2014 14:45:52,instagc,0.4611,27753923,GBR,,,188.30.192.65,INCREASED BLOOD PRESSURE causes HYPERTENSION,120,44,,143,56,causes,0.610847221781526,904726-FS1-4,The number of patients with well controlled HYPERTENSION is alarmingly low worldwide and new approaches to treatment of INCREASED BLOOD PRESSURE (BP) are being sought.,INCREASED BLOOD PRESSURE,HYPERTENSION,RO-has_definitional_manifestation
502912481,7/14/2014 14:56:59,,1322901702,7/14/2014 14:56:26,instagc,0.6593,13763729,USA,,,75.182.89.225,HYPERTENSION causes INCREASED BLOOD PRESSURE,120,44,,143,56,causes,0.610847221781526,904726-FS1-4,The number of patients with well controlled HYPERTENSION is alarmingly low worldwide and new approaches to treatment of INCREASED BLOOD PRESSURE (BP) are being sought.,INCREASED BLOOD PRESSURE,HYPERTENSION,RO-has_definitional_manifestation
502912482,7/14/2014 12:34:36,,1322804335,7/14/2014 12:34:29,neodev,0.9583,17610000,GBR,I2,Manchester,90.200.140.201,MULTIPLE SCLEROSIS treats ORAL CLADRIBINE,99,69,,116,84,treats,0.9594032236002471,907766-FS1-2,New Reference of Interest  2010 02 04  A placebo controlled trial of ORAL CLADRIBINE for relapsing MULTIPLE SCLEROSIS,MULTIPLE SCLEROSIS,ORAL CLADRIBINE,RO-may_treat
502912482,7/14/2014 12:44:23,,1322810930,7/14/2014 12:43:21,elite,0.75,27433978,AUS,05,Plympton,110.174.120.88,ORAL CLADRIBINE treats MULTIPLE SCLEROSIS,99,69,,116,84,treats,0.9594032236002471,907766-FS1-2,New Reference of Interest  2010 02 04  A placebo controlled trial of ORAL CLADRIBINE for relapsing MULTIPLE SCLEROSIS,MULTIPLE SCLEROSIS,ORAL CLADRIBINE,RO-may_treat
502912482,7/14/2014 13:53:24,,1322858898,7/14/2014 13:53:01,zoombucks,0.7764,5919735,USA,PA,Doylestown,173.49.91.231,ORAL CLADRIBINE treats MULTIPLE SCLEROSIS,99,69,,116,84,treats,0.9594032236002471,907766-FS1-2,New Reference of Interest  2010 02 04  A placebo controlled trial of ORAL CLADRIBINE for relapsing MULTIPLE SCLEROSIS,MULTIPLE SCLEROSIS,ORAL CLADRIBINE,RO-may_treat
502912482,7/14/2014 14:45:39,,1322894831,7/14/2014 14:45:34,instagc,0.4611,27753923,GBR,,,188.30.192.65,MULTIPLE SCLEROSIS treats ORAL CLADRIBINE,99,69,,116,84,treats,0.9594032236002471,907766-FS1-2,New Reference of Interest  2010 02 04  A placebo controlled trial of ORAL CLADRIBINE for relapsing MULTIPLE SCLEROSIS,MULTIPLE SCLEROSIS,ORAL CLADRIBINE,RO-may_treat
502912482,7/14/2014 15:04:29,,1322906179,7/14/2014 15:03:54,instagc,0.7125,28519532,USA,IA,Honey Creek,12.73.110.26,ORAL CLADRIBINE treats MULTIPLE SCLEROSIS,99,69,,116,84,treats,0.9594032236002471,907766-FS1-2,New Reference of Interest  2010 02 04  A placebo controlled trial of ORAL CLADRIBINE for relapsing MULTIPLE SCLEROSIS,MULTIPLE SCLEROSIS,ORAL CLADRIBINE,RO-may_treat
502912482,7/14/2014 15:10:10,,1322909242,7/14/2014 15:09:45,clixsense,0.5718,19803139,NLD,06,Veldhoven,212.61.84.196,ORAL CLADRIBINE treats MULTIPLE SCLEROSIS,99,69,,116,84,treats,0.9594032236002471,907766-FS1-2,New Reference of Interest  2010 02 04  A placebo controlled trial of ORAL CLADRIBINE for relapsing MULTIPLE SCLEROSIS,MULTIPLE SCLEROSIS,ORAL CLADRIBINE,RO-may_treat
502912482,7/14/2014 15:34:10,,1322922913,7/14/2014 15:33:52,neodev,0.5101,21405167,USA,MD,Glen Burnie,69.137.237.73,ORAL CLADRIBINE treats MULTIPLE SCLEROSIS,99,69,,116,84,treats,0.9594032236002471,907766-FS1-2,New Reference of Interest  2010 02 04  A placebo controlled trial of ORAL CLADRIBINE for relapsing MULTIPLE SCLEROSIS,MULTIPLE SCLEROSIS,ORAL CLADRIBINE,RO-may_treat
502912484,7/14/2014 12:54:56,,1322818151,7/14/2014 12:54:37,clixsense,0.8194,15189335,GBR,K3,Peterborough,81.156.166.189,NEPHROBLASTOMA diagnosed by HYPERTENSION,65,0,,76,14,diagnosed by,0.6837634587578281,902706-FS1-13,"NEPHROBLASTOMA must be included in the differential diagnosis of HYPERTENSION associated with increased renin concentrations, even in the absence of an abdominal mass..",HYPERTENSION,NEPHROBLASTOMA,RO-disease_may_have_finding
502912484,7/14/2014 14:09:43,,1322869768,7/14/2014 14:09:28,clixsense,0.7708,27793793,GBR,C5,Chester,151.230.27.155,HYPERTENSION diagnosed by NEPHROBLASTOMA,65,0,,76,14,diagnosed by,0.6837634587578281,902706-FS1-13,"NEPHROBLASTOMA must be included in the differential diagnosis of HYPERTENSION associated with increased renin concentrations, even in the absence of an abdominal mass..",HYPERTENSION,NEPHROBLASTOMA,RO-disease_may_have_finding
502912484,7/14/2014 15:01:10,,1322904216,7/14/2014 15:00:50,instagc,0.5536,18960682,GBR,,,86.29.147.112,NEPHROBLASTOMA diagnosed by HYPERTENSION,65,0,,76,14,diagnosed by,0.6837634587578281,902706-FS1-13,"NEPHROBLASTOMA must be included in the differential diagnosis of HYPERTENSION associated with increased renin concentrations, even in the absence of an abdominal mass..",HYPERTENSION,NEPHROBLASTOMA,RO-disease_may_have_finding
502912484,7/14/2014 15:13:45,,1322910800,7/14/2014 15:12:55,elite,0.4429,28322695,GBR,A3,Barnsley,217.44.205.195,no_relation,65,0,,76,14,diagnosed by,0.6837634587578281,902706-FS1-13,"NEPHROBLASTOMA must be included in the differential diagnosis of HYPERTENSION associated with increased renin concentrations, even in the absence of an abdominal mass..",HYPERTENSION,NEPHROBLASTOMA,RO-disease_may_have_finding
502912484,7/14/2014 15:18:23,,1322913335,7/14/2014 15:18:15,clixsense,0.4823,19162475,GBR,M3,Frome,82.33.126.30,HYPERTENSION diagnosed by NEPHROBLASTOMA,65,0,,76,14,diagnosed by,0.6837634587578281,902706-FS1-13,"NEPHROBLASTOMA must be included in the differential diagnosis of HYPERTENSION associated with increased renin concentrations, even in the absence of an abdominal mass..",HYPERTENSION,NEPHROBLASTOMA,RO-disease_may_have_finding
502912484,7/14/2014 15:18:32,,1322913422,7/14/2014 15:17:59,prodege,0.639,27996604,CAN,QC,Boucherville,24.201.21.27,NEPHROBLASTOMA diagnosed by HYPERTENSION,65,0,,76,14,diagnosed by,0.6837634587578281,902706-FS1-13,"NEPHROBLASTOMA must be included in the differential diagnosis of HYPERTENSION associated with increased renin concentrations, even in the absence of an abdominal mass..",HYPERTENSION,NEPHROBLASTOMA,RO-disease_may_have_finding
502912484,7/14/2014 15:27:42,,1322918915,7/14/2014 15:27:22,instagc,0.3552,19004168,GBR,H2,Accrington,80.47.185.52,no_relation,65,0,,76,14,diagnosed by,0.6837634587578281,902706-FS1-13,"NEPHROBLASTOMA must be included in the differential diagnosis of HYPERTENSION associated with increased renin concentrations, even in the absence of an abdominal mass..",HYPERTENSION,NEPHROBLASTOMA,RO-disease_may_have_finding
502912486,7/14/2014 14:10:05,,1322869975,7/14/2014 14:09:56,clixsense,0.7708,27793793,GBR,C5,Chester,151.230.27.155,GLIOBLASTOMA diagnosed by DEDIFFERENTIATION,158,72,,174,84,diagnosed by,0.30151134457776396,901970-FS1-13,The results of modern neuro oncology support the pathogenetic view that GLIOBLASTOMA results from neoplastic transformation of glial elements with continuing DEDIFFERENTIATION,DEDIFFERENTIATION,GLIOBLASTOMA,RO-disease_has_finding
502912486,7/14/2014 14:16:57,,1322874737,7/14/2014 14:16:48,clixsense,0.5125,7415230,GBR,A7,Birmingham,147.188.47.242,no_relation,158,72,,174,84,diagnosed by,0.30151134457776396,901970-FS1-13,The results of modern neuro oncology support the pathogenetic view that GLIOBLASTOMA results from neoplastic transformation of glial elements with continuing DEDIFFERENTIATION,DEDIFFERENTIATION,GLIOBLASTOMA,RO-disease_has_finding
502912486,7/14/2014 14:30:59,,1322884848,7/14/2014 14:30:34,instagc,0.644,15445601,USA,FL,Jacksonville,24.129.68.254,GLIOBLASTOMA diagnosed by DEDIFFERENTIATION,158,72,,174,84,diagnosed by,0.30151134457776396,901970-FS1-13,The results of modern neuro oncology support the pathogenetic view that GLIOBLASTOMA results from neoplastic transformation of glial elements with continuing DEDIFFERENTIATION,DEDIFFERENTIATION,GLIOBLASTOMA,RO-disease_has_finding
502912486,7/14/2014 15:02:22,,1322904880,7/14/2014 15:01:42,vivatic,0.5339,25451531,GBR,,,83.67.28.193,DEDIFFERENTIATION diagnosed by GLIOBLASTOMA,158,72,,174,84,diagnosed by,0.30151134457776396,901970-FS1-13,The results of modern neuro oncology support the pathogenetic view that GLIOBLASTOMA results from neoplastic transformation of glial elements with continuing DEDIFFERENTIATION,DEDIFFERENTIATION,GLIOBLASTOMA,RO-disease_has_finding
502912486,7/14/2014 15:09:44,,1322909026,7/14/2014 15:09:17,clixsense,0.5718,19803139,NLD,06,Veldhoven,212.61.84.196,GLIOBLASTOMA diagnosed by DEDIFFERENTIATION,158,72,,174,84,diagnosed by,0.30151134457776396,901970-FS1-13,The results of modern neuro oncology support the pathogenetic view that GLIOBLASTOMA results from neoplastic transformation of glial elements with continuing DEDIFFERENTIATION,DEDIFFERENTIATION,GLIOBLASTOMA,RO-disease_has_finding
502912486,7/14/2014 15:18:42,,1322913530,7/14/2014 15:18:32,clixsense,0.4823,19162475,GBR,M3,Frome,82.33.126.30,GLIOBLASTOMA diagnosed by DEDIFFERENTIATION,158,72,,174,84,diagnosed by,0.30151134457776396,901970-FS1-13,The results of modern neuro oncology support the pathogenetic view that GLIOBLASTOMA results from neoplastic transformation of glial elements with continuing DEDIFFERENTIATION,DEDIFFERENTIATION,GLIOBLASTOMA,RO-disease_has_finding
502912486,7/14/2014 15:27:21,,1322918664,7/14/2014 15:27:02,instagc,0.3552,19004168,GBR,H2,Accrington,80.47.185.52,no_relation,158,72,,174,84,diagnosed by,0.30151134457776396,901970-FS1-13,The results of modern neuro oncology support the pathogenetic view that GLIOBLASTOMA results from neoplastic transformation of glial elements with continuing DEDIFFERENTIATION,DEDIFFERENTIATION,GLIOBLASTOMA,RO-disease_has_finding
502912491,7/14/2014 12:51:41,,1322815921,7/14/2014 12:50:47,clixsense,0.8194,15189335,GBR,K3,Peterborough,81.156.166.189,GLIOBLASTOMA causes DEDIFFERENTIATION,158,72,,174,84,causes,0.9045340337332909,901970-FS1-4,The results of modern neuro oncology support the pathogenetic view that GLIOBLASTOMA results from neoplastic transformation of glial elements with continuing DEDIFFERENTIATION,DEDIFFERENTIATION,GLIOBLASTOMA,RO-disease_has_finding
502912491,7/14/2014 13:01:21,,1322822377,7/14/2014 13:00:47,rewardsspot,0.7153,24482174,GBR,H9,London,46.23.68.180,DEDIFFERENTIATION causes GLIOBLASTOMA,158,72,,174,84,causes,0.9045340337332909,901970-FS1-4,The results of modern neuro oncology support the pathogenetic view that GLIOBLASTOMA results from neoplastic transformation of glial elements with continuing DEDIFFERENTIATION,DEDIFFERENTIATION,GLIOBLASTOMA,RO-disease_has_finding
502912491,7/14/2014 14:55:53,,1322900871,7/14/2014 14:55:31,instagc,0.6593,13763729,USA,,,75.182.89.225,DEDIFFERENTIATION causes GLIOBLASTOMA,158,72,,174,84,causes,0.9045340337332909,901970-FS1-4,The results of modern neuro oncology support the pathogenetic view that GLIOBLASTOMA results from neoplastic transformation of glial elements with continuing DEDIFFERENTIATION,DEDIFFERENTIATION,GLIOBLASTOMA,RO-disease_has_finding
502912491,7/14/2014 15:01:07,,1322904200,7/14/2014 15:00:30,vivatic,0.5339,25451531,GBR,,,83.67.28.193,GLIOBLASTOMA causes DEDIFFERENTIATION,158,72,,174,84,causes,0.9045340337332909,901970-FS1-4,The results of modern neuro oncology support the pathogenetic view that GLIOBLASTOMA results from neoplastic transformation of glial elements with continuing DEDIFFERENTIATION,DEDIFFERENTIATION,GLIOBLASTOMA,RO-disease_has_finding
502912491,7/14/2014 15:06:46,,1322907291,7/14/2014 15:06:03,instagc,0.7125,28519532,USA,IA,Honey Creek,12.73.110.26,DEDIFFERENTIATION causes GLIOBLASTOMA,158,72,,174,84,causes,0.9045340337332909,901970-FS1-4,The results of modern neuro oncology support the pathogenetic view that GLIOBLASTOMA results from neoplastic transformation of glial elements with continuing DEDIFFERENTIATION,DEDIFFERENTIATION,GLIOBLASTOMA,RO-disease_has_finding
502912491,7/14/2014 15:09:16,,1322908730,7/14/2014 15:08:49,clixsense,0.5718,19803139,NLD,06,Veldhoven,212.61.84.196,GLIOBLASTOMA causes DEDIFFERENTIATION,158,72,,174,84,causes,0.9045340337332909,901970-FS1-4,The results of modern neuro oncology support the pathogenetic view that GLIOBLASTOMA results from neoplastic transformation of glial elements with continuing DEDIFFERENTIATION,DEDIFFERENTIATION,GLIOBLASTOMA,RO-disease_has_finding
502912491,7/14/2014 15:18:04,,1322913147,7/14/2014 15:17:54,clixsense,0.4823,19162475,GBR,M3,Frome,82.33.126.30,DEDIFFERENTIATION causes GLIOBLASTOMA,158,72,,174,84,causes,0.9045340337332909,901970-FS1-4,The results of modern neuro oncology support the pathogenetic view that GLIOBLASTOMA results from neoplastic transformation of glial elements with continuing DEDIFFERENTIATION,DEDIFFERENTIATION,GLIOBLASTOMA,RO-disease_has_finding
502912505,7/14/2014 12:49:46,,1322814556,7/14/2014 12:49:11,elite,0.75,27433978,AUS,05,Plympton,110.174.120.88,no_relation,120,44,,143,56,treats,0.7330166661378309,904726-FS1-2,The number of patients with well controlled HYPERTENSION is alarmingly low worldwide and new approaches to treatment of INCREASED BLOOD PRESSURE (BP) are being sought.,INCREASED BLOOD PRESSURE,HYPERTENSION,RO-has_definitional_manifestation
502912505,7/14/2014 12:57:06,,1322819539,7/14/2014 12:56:15,clixsense,0.8194,15189335,GBR,K3,Peterborough,81.156.166.189,no_relation,120,44,,143,56,treats,0.7330166661378309,904726-FS1-2,The number of patients with well controlled HYPERTENSION is alarmingly low worldwide and new approaches to treatment of INCREASED BLOOD PRESSURE (BP) are being sought.,INCREASED BLOOD PRESSURE,HYPERTENSION,RO-has_definitional_manifestation
502912505,7/14/2014 13:50:45,,1322856910,7/14/2014 13:50:16,clixsense,0.4042,25402344,CAN,ON,Wawa,24.109.124.45,HYPERTENSION treats INCREASED BLOOD PRESSURE,120,44,,143,56,treats,0.7330166661378309,904726-FS1-2,The number of patients with well controlled HYPERTENSION is alarmingly low worldwide and new approaches to treatment of INCREASED BLOOD PRESSURE (BP) are being sought.,INCREASED BLOOD PRESSURE,HYPERTENSION,RO-has_definitional_manifestation
502912505,7/14/2014 13:53:24,,1322858900,7/14/2014 13:53:01,zoombucks,0.7764,5919735,USA,PA,Doylestown,173.49.91.231,no_relation,120,44,,143,56,treats,0.7330166661378309,904726-FS1-2,The number of patients with well controlled HYPERTENSION is alarmingly low worldwide and new approaches to treatment of INCREASED BLOOD PRESSURE (BP) are being sought.,INCREASED BLOOD PRESSURE,HYPERTENSION,RO-has_definitional_manifestation
502912505,7/14/2014 14:23:16,,1322879058,7/14/2014 14:23:10,neodev,0.3792,25224036,CAN,ON,Sudbury,67.204.218.187,INCREASED BLOOD PRESSURE treats HYPERTENSION,120,44,,143,56,treats,0.7330166661378309,904726-FS1-2,The number of patients with well controlled HYPERTENSION is alarmingly low worldwide and new approaches to treatment of INCREASED BLOOD PRESSURE (BP) are being sought.,INCREASED BLOOD PRESSURE,HYPERTENSION,RO-has_definitional_manifestation
502912505,7/14/2014 14:57:27,,1322901969,7/14/2014 14:57:10,elite,0.4302,28276268,USA,MI,Taylor,67.149.247.166,HYPERTENSION treats INCREASED BLOOD PRESSURE,120,44,,143,56,treats,0.7330166661378309,904726-FS1-2,The number of patients with well controlled HYPERTENSION is alarmingly low worldwide and new approaches to treatment of INCREASED BLOOD PRESSURE (BP) are being sought.,INCREASED BLOOD PRESSURE,HYPERTENSION,RO-has_definitional_manifestation
502912505,7/14/2014 15:01:41,,1322904539,7/14/2014 15:01:08,vivatic,0.5339,25451531,GBR,,,83.67.28.193,no_relation,120,44,,143,56,treats,0.7330166661378309,904726-FS1-2,The number of patients with well controlled HYPERTENSION is alarmingly low worldwide and new approaches to treatment of INCREASED BLOOD PRESSURE (BP) are being sought.,INCREASED BLOOD PRESSURE,HYPERTENSION,RO-has_definitional_manifestation
502932175,7/14/2014 16:58:36,,1322962405,7/14/2014 16:58:31,instagc,1.0,27753923,GBR,,,94.196.229.196,GLUTEN FREE DIET treats COELIAC DISEASE,262,231,,277,246,treats,1.0,903747-FS1-2,The 5 HT level in PPP was significantly increased in patients with coeliac disease in whom the disease was untreated or treated with gluten free diet for less than a year (p less than 0.01) but also compared with the patients with COELIAC DISEASE treated with a GLUTEN FREE DIET for more than a year (p less than 0.01.,GLUTEN FREE DIET,COELIAC DISEASE,RO-has_causative_agent
502932175,7/14/2014 17:04:42,,1322965363,7/14/2014 17:04:33,clixsense,0.6944,27793793,GBR,C5,Chester,151.230.27.155,GLUTEN FREE DIET treats COELIAC DISEASE,262,231,,277,246,treats,1.0,903747-FS1-2,The 5 HT level in PPP was significantly increased in patients with coeliac disease in whom the disease was untreated or treated with gluten free diet for less than a year (p less than 0.01) but also compared with the patients with COELIAC DISEASE treated with a GLUTEN FREE DIET for more than a year (p less than 0.01.,GLUTEN FREE DIET,COELIAC DISEASE,RO-has_causative_agent
502932175,7/14/2014 17:06:13,,1322966142,7/14/2014 17:05:47,instagc,0.8889,19636746,USA,NY,Andover,192.182.216.225,GLUTEN FREE DIET treats COELIAC DISEASE,262,231,,277,246,treats,1.0,903747-FS1-2,The 5 HT level in PPP was significantly increased in patients with coeliac disease in whom the disease was untreated or treated with gluten free diet for less than a year (p less than 0.01) but also compared with the patients with COELIAC DISEASE treated with a GLUTEN FREE DIET for more than a year (p less than 0.01.,GLUTEN FREE DIET,COELIAC DISEASE,RO-has_causative_agent
502932175,7/14/2014 18:10:57,,1323007680,7/14/2014 18:10:20,quickrewards,0.7448,20452113,USA,NY,Port Henry,108.176.206.207,GLUTEN FREE DIET treats COELIAC DISEASE,262,231,,277,246,treats,1.0,903747-FS1-2,The 5 HT level in PPP was significantly increased in patients with coeliac disease in whom the disease was untreated or treated with gluten free diet for less than a year (p less than 0.01) but also compared with the patients with COELIAC DISEASE treated with a GLUTEN FREE DIET for more than a year (p less than 0.01.,GLUTEN FREE DIET,COELIAC DISEASE,RO-has_causative_agent
502932175,7/14/2014 18:35:33,,1323018260,7/14/2014 18:35:26,clixsense,0.5347,16827630,GBR,A7,Birmingham,86.146.169.103,GLUTEN FREE DIET treats COELIAC DISEASE,262,231,,277,246,treats,1.0,903747-FS1-2,The 5 HT level in PPP was significantly increased in patients with coeliac disease in whom the disease was untreated or treated with gluten free diet for less than a year (p less than 0.01) but also compared with the patients with COELIAC DISEASE treated with a GLUTEN FREE DIET for more than a year (p less than 0.01.,GLUTEN FREE DIET,COELIAC DISEASE,RO-has_causative_agent
502932175,7/14/2014 18:48:21,,1323024392,7/14/2014 18:48:10,instagc,0.5032,25990856,USA,NV,Las Vegas,68.108.98.78,GLUTEN FREE DIET treats COELIAC DISEASE,262,231,,277,246,treats,1.0,903747-FS1-2,The 5 HT level in PPP was significantly increased in patients with coeliac disease in whom the disease was untreated or treated with gluten free diet for less than a year (p less than 0.01) but also compared with the patients with COELIAC DISEASE treated with a GLUTEN FREE DIET for more than a year (p less than 0.01.,GLUTEN FREE DIET,COELIAC DISEASE,RO-has_causative_agent
502932175,7/14/2014 19:03:08,,1323033723,7/14/2014 19:02:17,instagc,0.6101,19686223,CAN,BC,Surrey,184.65.16.6,GLUTEN FREE DIET treats COELIAC DISEASE,262,231,,277,246,treats,1.0,903747-FS1-2,The 5 HT level in PPP was significantly increased in patients with coeliac disease in whom the disease was untreated or treated with gluten free diet for less than a year (p less than 0.01) but also compared with the patients with COELIAC DISEASE treated with a GLUTEN FREE DIET for more than a year (p less than 0.01.,GLUTEN FREE DIET,COELIAC DISEASE,RO-has_causative_agent
502932192,7/14/2014 18:15:04,,1323009520,7/14/2014 18:14:19,vivatic,0.5669,25451531,GBR,,,83.67.28.193,no_relation,84,32,,115,42,treats,1.0,907062-FS1-2,"Misoprostol, H2 antagonists and SUCRALFATE are of similar efficacy in prevention of NSAID ASSOCIATED DUODENAL ULCERS but misoprostol is more effective in prevention of gastric ulcers.",NSAID ASSOCIATED DUODENAL ULCERS,SUCRALFATE,RO-may_prevent
502932192,7/14/2014 18:36:43,,1323018715,7/14/2014 18:36:22,instagc,0.5702,28524232,CAN,ON,Toronto,99.244.116.246,no_relation,84,32,,115,42,treats,1.0,907062-FS1-2,"Misoprostol, H2 antagonists and SUCRALFATE are of similar efficacy in prevention of NSAID ASSOCIATED DUODENAL ULCERS but misoprostol is more effective in prevention of gastric ulcers.",NSAID ASSOCIATED DUODENAL ULCERS,SUCRALFATE,RO-may_prevent
502932192,7/14/2014 18:49:59,,1323025288,7/14/2014 18:49:53,clixsense,0.2853,19162475,GBR,M3,Frome,82.33.126.30,NSAID ASSOCIATED DUODENAL ULCERS treats SUCRALFATE,84,32,,115,42,treats,1.0,907062-FS1-2,"Misoprostol, H2 antagonists and SUCRALFATE are of similar efficacy in prevention of NSAID ASSOCIATED DUODENAL ULCERS but misoprostol is more effective in prevention of gastric ulcers.",NSAID ASSOCIATED DUODENAL ULCERS,SUCRALFATE,RO-may_prevent
502932192,7/14/2014 19:17:09,,1323041396,7/14/2014 19:16:36,elite,0.5323,28503042,USA,NJ,Woodbridge,54.191.150.115,SUCRALFATE treats NSAID ASSOCIATED DUODENAL ULCERS,84,32,,115,42,treats,1.0,907062-FS1-2,"Misoprostol, H2 antagonists and SUCRALFATE are of similar efficacy in prevention of NSAID ASSOCIATED DUODENAL ULCERS but misoprostol is more effective in prevention of gastric ulcers.",NSAID ASSOCIATED DUODENAL ULCERS,SUCRALFATE,RO-may_prevent
502932192,7/14/2014 19:27:33,,1323047872,7/14/2014 19:27:08,neodev,0.4529,14861092,GBR,I2,Manchester,90.194.137.76,SUCRALFATE treats NSAID ASSOCIATED DUODENAL ULCERS,84,32,,115,42,treats,1.0,907062-FS1-2,"Misoprostol, H2 antagonists and SUCRALFATE are of similar efficacy in prevention of NSAID ASSOCIATED DUODENAL ULCERS but misoprostol is more effective in prevention of gastric ulcers.",NSAID ASSOCIATED DUODENAL ULCERS,SUCRALFATE,RO-may_prevent
502932192,7/14/2014 19:27:57,,1323048155,7/14/2014 19:27:35,clixsense,0.3805,15189335,GBR,A7,Birmingham,94.197.121.232,SUCRALFATE treats NSAID ASSOCIATED DUODENAL ULCERS,84,32,,115,42,treats,1.0,907062-FS1-2,"Misoprostol, H2 antagonists and SUCRALFATE are of similar efficacy in prevention of NSAID ASSOCIATED DUODENAL ULCERS but misoprostol is more effective in prevention of gastric ulcers.",NSAID ASSOCIATED DUODENAL ULCERS,SUCRALFATE,RO-may_prevent
502932192,7/14/2014 19:36:42,,1323053740,7/14/2014 19:35:53,prodege,0.3393,22360212,GBR,I1,Luton,82.6.41.191,no_relation,84,32,,115,42,treats,1.0,907062-FS1-2,"Misoprostol, H2 antagonists and SUCRALFATE are of similar efficacy in prevention of NSAID ASSOCIATED DUODENAL ULCERS but misoprostol is more effective in prevention of gastric ulcers.",NSAID ASSOCIATED DUODENAL ULCERS,SUCRALFATE,RO-may_prevent
502932202,7/14/2014 17:04:42,,1322965364,7/14/2014 17:04:33,clixsense,0.6944,27793793,GBR,C5,Chester,151.230.27.155,TUMOR CAUSES BLOODY ASCITES SHOCK OR PERITONITIS causes HEPATOCELLULAR CARCINOMA,32,121,,79,145,causes,1.0,902829-FS1-4,"Occasionally, hemorrhage of the TUMOR CAUSES BLOODY ASCITES SHOCK OR PERITONITIS which may be the first manifestation of HEPATOCELLULAR CARCINOMA",TUMOR CAUSES BLOODY ASCITES SHOCK OR PERITONITIS,HEPATOCELLULAR CARCINOMA,RO-disease_may_have_finding
502932202,7/14/2014 17:07:50,,1322966962,7/14/2014 17:07:44,neodev,0.6806,25224036,CAN,ON,Sudbury,67.204.218.187,HEPATOCELLULAR CARCINOMA causes TUMOR CAUSES BLOODY ASCITES SHOCK OR PERITONITIS,32,121,,79,145,causes,1.0,902829-FS1-4,"Occasionally, hemorrhage of the TUMOR CAUSES BLOODY ASCITES SHOCK OR PERITONITIS which may be the first manifestation of HEPATOCELLULAR CARCINOMA",TUMOR CAUSES BLOODY ASCITES SHOCK OR PERITONITIS,HEPATOCELLULAR CARCINOMA,RO-disease_may_have_finding
502932202,7/14/2014 17:13:51,,1322970111,7/14/2014 17:13:08,prodege,0.7431,2767509,CAN,BC,Victoria,96.54.172.117,no_relation,32,121,,79,145,causes,1.0,902829-FS1-4,"Occasionally, hemorrhage of the TUMOR CAUSES BLOODY ASCITES SHOCK OR PERITONITIS which may be the first manifestation of HEPATOCELLULAR CARCINOMA",TUMOR CAUSES BLOODY ASCITES SHOCK OR PERITONITIS,HEPATOCELLULAR CARCINOMA,RO-disease_may_have_finding
502932202,7/14/2014 17:47:11,,1322995403,7/14/2014 17:46:50,neodev,0.4944,11014534,GBR,B8,West Wickham,86.18.149.6,no_relation,32,121,,79,145,causes,1.0,902829-FS1-4,"Occasionally, hemorrhage of the TUMOR CAUSES BLOODY ASCITES SHOCK OR PERITONITIS which may be the first manifestation of HEPATOCELLULAR CARCINOMA",TUMOR CAUSES BLOODY ASCITES SHOCK OR PERITONITIS,HEPATOCELLULAR CARCINOMA,RO-disease_may_have_finding
502932202,7/14/2014 18:03:11,,1323002646,7/14/2014 18:02:22,prodege,0.5258,7899370,USA,MI,Bay City,71.13.81.162,HEPATOCELLULAR CARCINOMA causes TUMOR CAUSES BLOODY ASCITES SHOCK OR PERITONITIS,32,121,,79,145,causes,1.0,902829-FS1-4,"Occasionally, hemorrhage of the TUMOR CAUSES BLOODY ASCITES SHOCK OR PERITONITIS which may be the first manifestation of HEPATOCELLULAR CARCINOMA",TUMOR CAUSES BLOODY ASCITES SHOCK OR PERITONITIS,HEPATOCELLULAR CARCINOMA,RO-disease_may_have_finding
502932202,7/14/2014 18:48:21,,1323024387,7/14/2014 18:48:10,instagc,0.5032,25990856,USA,NV,Las Vegas,68.108.98.78,TUMOR CAUSES BLOODY ASCITES SHOCK OR PERITONITIS causes HEPATOCELLULAR CARCINOMA,32,121,,79,145,causes,1.0,902829-FS1-4,"Occasionally, hemorrhage of the TUMOR CAUSES BLOODY ASCITES SHOCK OR PERITONITIS which may be the first manifestation of HEPATOCELLULAR CARCINOMA",TUMOR CAUSES BLOODY ASCITES SHOCK OR PERITONITIS,HEPATOCELLULAR CARCINOMA,RO-disease_may_have_finding
502932202,7/14/2014 18:50:06,,1323025335,7/14/2014 18:50:01,clixsense,0.2853,19162475,GBR,M3,Frome,82.33.126.30,HEPATOCELLULAR CARCINOMA causes TUMOR CAUSES BLOODY ASCITES SHOCK OR PERITONITIS,32,121,,79,145,causes,1.0,902829-FS1-4,"Occasionally, hemorrhage of the TUMOR CAUSES BLOODY ASCITES SHOCK OR PERITONITIS which may be the first manifestation of HEPATOCELLULAR CARCINOMA",TUMOR CAUSES BLOODY ASCITES SHOCK OR PERITONITIS,HEPATOCELLULAR CARCINOMA,RO-disease_may_have_finding
502932209,7/14/2014 17:15:30,,1322970942,7/14/2014 17:14:55,prodege,0.7431,2767509,CAN,BC,Victoria,96.54.172.117,no_relation,262,196,,278,239,causes,0.41702882811415004,903575-FS1-4,"To evaluate the utility of this system we constructed DeltaE1/DeltaE2 vector carrying different classes of protein, that is, the gene coding for spike protein derived from the Coronavirus causing SEVERE ACUTE RESPIRATORY SYNDROME (SARS COV a gene coding for the SARS COV RECEPTOR or the genes coding for an antibody shown to bind and neutralize SARS CoV (SARS AB.",SARS COV RECEPTOR,SEVERE ACUTE RESPIRATORY SYNDROME (SARS COV,RO-has_causative_agent
502932209,7/14/2014 17:25:23,,1322976141,7/14/2014 17:25:07,pokerowned,0.5625,18747884,USA,MI,Snover,209.40.219.170,SARS COV RECEPTOR causes SEVERE ACUTE RESPIRATORY SYNDROME (SARS COV,262,196,,278,239,causes,0.41702882811415004,903575-FS1-4,"To evaluate the utility of this system we constructed DeltaE1/DeltaE2 vector carrying different classes of protein, that is, the gene coding for spike protein derived from the Coronavirus causing SEVERE ACUTE RESPIRATORY SYNDROME (SARS COV a gene coding for the SARS COV RECEPTOR or the genes coding for an antibody shown to bind and neutralize SARS CoV (SARS AB.",SARS COV RECEPTOR,SEVERE ACUTE RESPIRATORY SYNDROME (SARS COV,RO-has_causative_agent
502932209,7/14/2014 17:46:49,,1322995274,7/14/2014 17:46:20,neodev,0.4944,11014534,GBR,B8,West Wickham,86.18.149.6,no_relation,262,196,,278,239,causes,0.41702882811415004,903575-FS1-4,"To evaluate the utility of this system we constructed DeltaE1/DeltaE2 vector carrying different classes of protein, that is, the gene coding for spike protein derived from the Coronavirus causing SEVERE ACUTE RESPIRATORY SYNDROME (SARS COV a gene coding for the SARS COV RECEPTOR or the genes coding for an antibody shown to bind and neutralize SARS CoV (SARS AB.",SARS COV RECEPTOR,SEVERE ACUTE RESPIRATORY SYNDROME (SARS COV,RO-has_causative_agent
502932209,7/14/2014 17:48:27,,1322995974,7/14/2014 17:48:16,prodege,0.4458,2143114,CAN,BC,Vancouver,24.84.160.12,SARS COV RECEPTOR causes SEVERE ACUTE RESPIRATORY SYNDROME (SARS COV,262,196,,278,239,causes,0.41702882811415004,903575-FS1-4,"To evaluate the utility of this system we constructed DeltaE1/DeltaE2 vector carrying different classes of protein, that is, the gene coding for spike protein derived from the Coronavirus causing SEVERE ACUTE RESPIRATORY SYNDROME (SARS COV a gene coding for the SARS COV RECEPTOR or the genes coding for an antibody shown to bind and neutralize SARS CoV (SARS AB.",SARS COV RECEPTOR,SEVERE ACUTE RESPIRATORY SYNDROME (SARS COV,RO-has_causative_agent
502932209,7/14/2014 17:52:10,,1322997749,7/14/2014 17:51:14,neodev,0.5569,28269997,GBR,H9,London,151.224.171.48,no_relation,262,196,,278,239,causes,0.41702882811415004,903575-FS1-4,"To evaluate the utility of this system we constructed DeltaE1/DeltaE2 vector carrying different classes of protein, that is, the gene coding for spike protein derived from the Coronavirus causing SEVERE ACUTE RESPIRATORY SYNDROME (SARS COV a gene coding for the SARS COV RECEPTOR or the genes coding for an antibody shown to bind and neutralize SARS CoV (SARS AB.",SARS COV RECEPTOR,SEVERE ACUTE RESPIRATORY SYNDROME (SARS COV,RO-has_causative_agent
502932209,7/14/2014 18:03:11,,1323002644,7/14/2014 18:02:22,prodege,0.5258,7899370,USA,MI,Bay City,71.13.81.162,no_relation,262,196,,278,239,causes,0.41702882811415004,903575-FS1-4,"To evaluate the utility of this system we constructed DeltaE1/DeltaE2 vector carrying different classes of protein, that is, the gene coding for spike protein derived from the Coronavirus causing SEVERE ACUTE RESPIRATORY SYNDROME (SARS COV a gene coding for the SARS COV RECEPTOR or the genes coding for an antibody shown to bind and neutralize SARS CoV (SARS AB.",SARS COV RECEPTOR,SEVERE ACUTE RESPIRATORY SYNDROME (SARS COV,RO-has_causative_agent
502932209,7/14/2014 18:22:26,,1323012708,7/14/2014 18:22:07,neodev,0.4456,21515166,NLD,11,Nootdorp,83.86.58.179,SARS COV RECEPTOR causes SEVERE ACUTE RESPIRATORY SYNDROME (SARS COV,262,196,,278,239,causes,0.41702882811415004,903575-FS1-4,"To evaluate the utility of this system we constructed DeltaE1/DeltaE2 vector carrying different classes of protein, that is, the gene coding for spike protein derived from the Coronavirus causing SEVERE ACUTE RESPIRATORY SYNDROME (SARS COV a gene coding for the SARS COV RECEPTOR or the genes coding for an antibody shown to bind and neutralize SARS CoV (SARS AB.",SARS COV RECEPTOR,SEVERE ACUTE RESPIRATORY SYNDROME (SARS COV,RO-has_causative_agent
502932210,7/14/2014 16:58:50,,1322962506,7/14/2014 16:58:44,instagc,1.0,27753923,GBR,,,94.196.229.196,BONE MINERAL METABOLISM diagnosed by OSTEOPOROSIS,172,220,,194,232,diagnosed by,0.577350269189626,902487-FS1-13,"Our results indicate, for the first time, an association between Graves' disease and a VDR polymorphism in the Japanese and suggest that a VDR FokI polymorphism may affect BONE MINERAL METABOLISM and can predict risk of OSTEOPOROSIS as a complication of Graves' disease in patients in remission.",BONE MINERAL METABOLISM,OSTEOPOROSIS,RO-disease_has_primary_anatomic_site
502932210,7/14/2014 17:00:20,,1322963188,7/14/2014 17:00:13,neodev,1.0,17610000,GBR,I2,Manchester,90.200.140.201,BONE MINERAL METABOLISM diagnosed by OSTEOPOROSIS,172,220,,194,232,diagnosed by,0.577350269189626,902487-FS1-13,"Our results indicate, for the first time, an association between Graves' disease and a VDR polymorphism in the Japanese and suggest that a VDR FokI polymorphism may affect BONE MINERAL METABOLISM and can predict risk of OSTEOPOROSIS as a complication of Graves' disease in patients in remission.",BONE MINERAL METABOLISM,OSTEOPOROSIS,RO-disease_has_primary_anatomic_site
502932210,7/14/2014 17:04:04,,1322965091,7/14/2014 17:03:51,clixsense,0.6944,27793793,GBR,C5,Chester,151.230.27.155,OSTEOPOROSIS diagnosed by BONE MINERAL METABOLISM,172,220,,194,232,diagnosed by,0.577350269189626,902487-FS1-13,"Our results indicate, for the first time, an association between Graves' disease and a VDR polymorphism in the Japanese and suggest that a VDR FokI polymorphism may affect BONE MINERAL METABOLISM and can predict risk of OSTEOPOROSIS as a complication of Graves' disease in patients in remission.",BONE MINERAL METABOLISM,OSTEOPOROSIS,RO-disease_has_primary_anatomic_site
502932210,7/14/2014 17:20:50,,1322973469,7/14/2014 17:20:30,instagc,0.5917,18960682,GBR,,,86.29.147.112,OSTEOPOROSIS diagnosed by BONE MINERAL METABOLISM,172,220,,194,232,diagnosed by,0.577350269189626,902487-FS1-13,"Our results indicate, for the first time, an association between Graves' disease and a VDR polymorphism in the Japanese and suggest that a VDR FokI polymorphism may affect BONE MINERAL METABOLISM and can predict risk of OSTEOPOROSIS as a complication of Graves' disease in patients in remission.",BONE MINERAL METABOLISM,OSTEOPOROSIS,RO-disease_has_primary_anatomic_site
502932210,7/14/2014 17:25:23,,1322976156,7/14/2014 17:25:03,elite,0.6415,28276268,USA,MI,Taylor,67.149.247.166,BONE MINERAL METABOLISM diagnosed by OSTEOPOROSIS,172,220,,194,232,diagnosed by,0.577350269189626,902487-FS1-13,"Our results indicate, for the first time, an association between Graves' disease and a VDR polymorphism in the Japanese and suggest that a VDR FokI polymorphism may affect BONE MINERAL METABOLISM and can predict risk of OSTEOPOROSIS as a complication of Graves' disease in patients in remission.",BONE MINERAL METABOLISM,OSTEOPOROSIS,RO-disease_has_primary_anatomic_site
502932210,7/14/2014 18:02:22,,1323002270,7/14/2014 18:01:45,prodege,0.5258,7899370,USA,MI,Bay City,71.13.81.162,OSTEOPOROSIS diagnosed by BONE MINERAL METABOLISM,172,220,,194,232,diagnosed by,0.577350269189626,902487-FS1-13,"Our results indicate, for the first time, an association between Graves' disease and a VDR polymorphism in the Japanese and suggest that a VDR FokI polymorphism may affect BONE MINERAL METABOLISM and can predict risk of OSTEOPOROSIS as a complication of Graves' disease in patients in remission.",BONE MINERAL METABOLISM,OSTEOPOROSIS,RO-disease_has_primary_anatomic_site
502932210,7/14/2014 18:02:28,,1323002335,7/14/2014 18:01:57,prodege,0.4377,12944140,GBR,I4,Mitcham,92.21.55.247,OSTEOPOROSIS diagnosed by BONE MINERAL METABOLISM,172,220,,194,232,diagnosed by,0.577350269189626,902487-FS1-13,"Our results indicate, for the first time, an association between Graves' disease and a VDR polymorphism in the Japanese and suggest that a VDR FokI polymorphism may affect BONE MINERAL METABOLISM and can predict risk of OSTEOPOROSIS as a complication of Graves' disease in patients in remission.",BONE MINERAL METABOLISM,OSTEOPOROSIS,RO-disease_has_primary_anatomic_site
502932216,7/14/2014 17:05:22,,1322965712,7/14/2014 17:04:41,instagc,0.8889,19636746,USA,NY,Andover,192.182.216.225,EXERCISE INDUCED ANGINA causes PAINS,149,194,,153,217,causes,0.9284766908852591,904623-FS1-4,"Results showed near zero correlations between measures of heat, cold, ischemic, and electrical laboratory pains, as well as between these laboratory PAINS and an idiopathic pain, the latency to EXERCISE INDUCED ANGINA in the patients.",PAINS,EXERCISE INDUCED ANGINA,RO-has_definitional_manifestation
502932216,7/14/2014 17:05:58,,1322966010,7/14/2014 17:05:36,clixsense,0.7639,27871219,NLD,07,Amsterdam,87.210.207.223,EXERCISE INDUCED ANGINA causes PAINS,149,194,,153,217,causes,0.9284766908852591,904623-FS1-4,"Results showed near zero correlations between measures of heat, cold, ischemic, and electrical laboratory pains, as well as between these laboratory PAINS and an idiopathic pain, the latency to EXERCISE INDUCED ANGINA in the patients.",PAINS,EXERCISE INDUCED ANGINA,RO-has_definitional_manifestation
502932216,7/14/2014 17:53:41,,1322998475,7/14/2014 17:52:49,neodev,0.5569,28269997,GBR,H9,London,151.224.171.48,EXERCISE INDUCED ANGINA causes PAINS,149,194,,153,217,causes,0.9284766908852591,904623-FS1-4,"Results showed near zero correlations between measures of heat, cold, ischemic, and electrical laboratory pains, as well as between these laboratory PAINS and an idiopathic pain, the latency to EXERCISE INDUCED ANGINA in the patients.",PAINS,EXERCISE INDUCED ANGINA,RO-has_definitional_manifestation
502932216,7/14/2014 18:10:20,,1323007310,7/14/2014 18:09:37,quickrewards,0.7448,20452113,USA,NY,Port Henry,108.176.206.207,EXERCISE INDUCED ANGINA causes PAINS,149,194,,153,217,causes,0.9284766908852591,904623-FS1-4,"Results showed near zero correlations between measures of heat, cold, ischemic, and electrical laboratory pains, as well as between these laboratory PAINS and an idiopathic pain, the latency to EXERCISE INDUCED ANGINA in the patients.",PAINS,EXERCISE INDUCED ANGINA,RO-has_definitional_manifestation
502932216,7/14/2014 18:13:15,,1323008671,7/14/2014 18:12:32,vivatic,0.5669,25451531,GBR,,,83.67.28.193,EXERCISE INDUCED ANGINA causes PAINS,149,194,,153,217,causes,0.9284766908852591,904623-FS1-4,"Results showed near zero correlations between measures of heat, cold, ischemic, and electrical laboratory pains, as well as between these laboratory PAINS and an idiopathic pain, the latency to EXERCISE INDUCED ANGINA in the patients.",PAINS,EXERCISE INDUCED ANGINA,RO-has_definitional_manifestation
502932216,7/14/2014 18:20:31,,1323011900,7/14/2014 18:20:08,prodege,0.6105,28039757,GBR,L8,Southport,109.155.158.54,EXERCISE INDUCED ANGINA causes PAINS,149,194,,153,217,causes,0.9284766908852591,904623-FS1-4,"Results showed near zero correlations between measures of heat, cold, ischemic, and electrical laboratory pains, as well as between these laboratory PAINS and an idiopathic pain, the latency to EXERCISE INDUCED ANGINA in the patients.",PAINS,EXERCISE INDUCED ANGINA,RO-has_definitional_manifestation
502932216,7/14/2014 18:35:03,,1323018026,7/14/2014 18:34:52,clixsense,0.5347,16827630,GBR,A7,Birmingham,86.146.169.103,EXERCISE INDUCED ANGINA causes PAINS,149,194,,153,217,causes,0.9284766908852591,904623-FS1-4,"Results showed near zero correlations between measures of heat, cold, ischemic, and electrical laboratory pains, as well as between these laboratory PAINS and an idiopathic pain, the latency to EXERCISE INDUCED ANGINA in the patients.",PAINS,EXERCISE INDUCED ANGINA,RO-has_definitional_manifestation
502932217,7/14/2014 17:04:00,,1322965057,7/14/2014 17:03:27,clixsense,0.7639,27871219,NLD,07,Amsterdam,87.210.207.223,no_relation,142,98,,162,115,causes,0.790569415042095,900112-FS1-4,"Hyperglycemic Effects  Hyperglycemia, new onset diabetes mellitus, or exacerbation of preexisting DIABETES MELLITUS reported with use of PIs; DIABETIC KETOACIDOSIS has occurred.",DIABETIC KETOACIDOSIS,DIABETES MELLITUS,RO-cause_of
502932217,7/14/2014 17:04:04,,1322965088,7/14/2014 17:03:51,clixsense,0.6944,27793793,GBR,C5,Chester,151.230.27.155,DIABETIC KETOACIDOSIS causes DIABETES MELLITUS,142,98,,162,115,causes,0.790569415042095,900112-FS1-4,"Hyperglycemic Effects  Hyperglycemia, new onset diabetes mellitus, or exacerbation of preexisting DIABETES MELLITUS reported with use of PIs; DIABETIC KETOACIDOSIS has occurred.",DIABETIC KETOACIDOSIS,DIABETES MELLITUS,RO-cause_of
502932217,7/14/2014 18:22:06,,1323012570,7/14/2014 18:21:43,neodev,0.4456,21515166,NLD,11,Nootdorp,83.86.58.179,DIABETIC KETOACIDOSIS causes DIABETES MELLITUS,142,98,,162,115,causes,0.790569415042095,900112-FS1-4,"Hyperglycemic Effects  Hyperglycemia, new onset diabetes mellitus, or exacerbation of preexisting DIABETES MELLITUS reported with use of PIs; DIABETIC KETOACIDOSIS has occurred.",DIABETIC KETOACIDOSIS,DIABETES MELLITUS,RO-cause_of
502932217,7/14/2014 18:35:24,,1323018179,7/14/2014 18:35:15,clixsense,0.5347,16827630,GBR,A7,Birmingham,86.146.169.103,no_relation,142,98,,162,115,causes,0.790569415042095,900112-FS1-4,"Hyperglycemic Effects  Hyperglycemia, new onset diabetes mellitus, or exacerbation of preexisting DIABETES MELLITUS reported with use of PIs; DIABETIC KETOACIDOSIS has occurred.",DIABETIC KETOACIDOSIS,DIABETES MELLITUS,RO-cause_of
502932217,7/14/2014 18:46:44,,1323023507,7/14/2014 18:46:23,instagc,0.5032,25990856,USA,NV,Las Vegas,68.108.98.78,no_relation,142,98,,162,115,causes,0.790569415042095,900112-FS1-4,"Hyperglycemic Effects  Hyperglycemia, new onset diabetes mellitus, or exacerbation of preexisting DIABETES MELLITUS reported with use of PIs; DIABETIC KETOACIDOSIS has occurred.",DIABETIC KETOACIDOSIS,DIABETES MELLITUS,RO-cause_of
502932217,7/14/2014 19:01:39,,1323032716,7/14/2014 19:01:06,instagc,0.6101,19686223,CAN,BC,Surrey,184.65.16.6,no_relation,142,98,,162,115,causes,0.790569415042095,900112-FS1-4,"Hyperglycemic Effects  Hyperglycemia, new onset diabetes mellitus, or exacerbation of preexisting DIABETES MELLITUS reported with use of PIs; DIABETIC KETOACIDOSIS has occurred.",DIABETIC KETOACIDOSIS,DIABETES MELLITUS,RO-cause_of
502932217,7/14/2014 19:14:57,,1323040150,7/14/2014 19:14:26,clixsense,0.4911,25595227,CAN,SK,North Battleford,24.72.96.119,DIABETES MELLITUS causes DIABETIC KETOACIDOSIS,142,98,,162,115,causes,0.790569415042095,900112-FS1-4,"Hyperglycemic Effects  Hyperglycemia, new onset diabetes mellitus, or exacerbation of preexisting DIABETES MELLITUS reported with use of PIs; DIABETIC KETOACIDOSIS has occurred.",DIABETIC KETOACIDOSIS,DIABETES MELLITUS,RO-cause_of
502932219,7/14/2014 16:58:42,,1322962441,7/14/2014 16:58:38,instagc,1.0,27753923,GBR,,,94.196.229.196,USDA TUBERCULIN diagnosed by TUBERCULOSIS,59,98,,70,113,diagnosed by,0.549442255794756,906772-FS1-13,In a comparison group of 70 dogs without knwon exposure to TUBERCULOSIS two positive responses to USDA TUBERCULIN were demonstrated and none to PPD.,TUBERCULOSIS,USDA TUBERCULIN,RO-may_diagnose
502932219,7/14/2014 17:04:00,,1322965058,7/14/2014 17:03:27,clixsense,0.7639,27871219,NLD,07,Amsterdam,87.210.207.223,TUBERCULOSIS diagnosed by USDA TUBERCULIN,59,98,,70,113,diagnosed by,0.549442255794756,906772-FS1-13,In a comparison group of 70 dogs without knwon exposure to TUBERCULOSIS two positive responses to USDA TUBERCULIN were demonstrated and none to PPD.,TUBERCULOSIS,USDA TUBERCULIN,RO-may_diagnose
502932219,7/14/2014 17:04:54,,1322965455,7/14/2014 17:04:44,clixsense,0.6944,27793793,GBR,C5,Chester,151.230.27.155,TUBERCULOSIS diagnosed by USDA TUBERCULIN,59,98,,70,113,diagnosed by,0.549442255794756,906772-FS1-13,In a comparison group of 70 dogs without knwon exposure to TUBERCULOSIS two positive responses to USDA TUBERCULIN were demonstrated and none to PPD.,TUBERCULOSIS,USDA TUBERCULIN,RO-may_diagnose
502932219,7/14/2014 17:14:29,,1322970491,7/14/2014 17:13:53,prodege,0.7431,2767509,CAN,BC,Victoria,96.54.172.117,no_relation,59,98,,70,113,diagnosed by,0.549442255794756,906772-FS1-13,In a comparison group of 70 dogs without knwon exposure to TUBERCULOSIS two positive responses to USDA TUBERCULIN were demonstrated and none to PPD.,TUBERCULOSIS,USDA TUBERCULIN,RO-may_diagnose
502932219,7/14/2014 17:21:13,,1322973666,7/14/2014 17:20:51,instagc,0.5917,18960682,GBR,,,86.29.147.112,TUBERCULOSIS diagnosed by USDA TUBERCULIN,59,98,,70,113,diagnosed by,0.549442255794756,906772-FS1-13,In a comparison group of 70 dogs without knwon exposure to TUBERCULOSIS two positive responses to USDA TUBERCULIN were demonstrated and none to PPD.,TUBERCULOSIS,USDA TUBERCULIN,RO-may_diagnose
502932219,7/14/2014 17:25:50,,1322976423,7/14/2014 17:25:35,pokerowned,0.5625,18747884,USA,MI,Snover,209.40.219.170,TUBERCULOSIS diagnosed by USDA TUBERCULIN,59,98,,70,113,diagnosed by,0.549442255794756,906772-FS1-13,In a comparison group of 70 dogs without knwon exposure to TUBERCULOSIS two positive responses to USDA TUBERCULIN were demonstrated and none to PPD.,TUBERCULOSIS,USDA TUBERCULIN,RO-may_diagnose
502932219,7/14/2014 17:26:42,,1322977044,7/14/2014 17:26:21,elite,0.6415,28276268,USA,MI,Taylor,67.149.247.166,TUBERCULOSIS diagnosed by USDA TUBERCULIN,59,98,,70,113,diagnosed by,0.549442255794756,906772-FS1-13,In a comparison group of 70 dogs without knwon exposure to TUBERCULOSIS two positive responses to USDA TUBERCULIN were demonstrated and none to PPD.,TUBERCULOSIS,USDA TUBERCULIN,RO-may_diagnose
502932223,7/14/2014 17:00:11,,1322963100,7/14/2014 17:00:03,neodev,1.0,17610000,GBR,I2,Manchester,90.200.140.201,ACUTE MYELOCYTIC LEUKEMIA diagnosed by CYTOSINE ARABINOSIDE,38,196,,62,216,diagnosed by,0.312347523777212,907921-FS1-13,"CASE SCENARIO  A 30 year old man with ACUTE MYELOCYTIC LEUKEMIA failed to respond to induction therapy with cytosine arabinoside and idarubicin and received salvage chemotherapy with fludarabine, CYTOSINE ARABINOSIDE, G CSF, and idarubicin.",ACUTE MYELOCYTIC LEUKEMIA,CYTOSINE ARABINOSIDE,RO-may_treat
502932223,7/14/2014 17:21:47,,1322973956,7/14/2014 17:21:28,instagc,0.5917,18960682,GBR,,,86.29.147.112,no_relation,38,196,,62,216,diagnosed by,0.312347523777212,907921-FS1-13,"CASE SCENARIO  A 30 year old man with ACUTE MYELOCYTIC LEUKEMIA failed to respond to induction therapy with cytosine arabinoside and idarubicin and received salvage chemotherapy with fludarabine, CYTOSINE ARABINOSIDE, G CSF, and idarubicin.",ACUTE MYELOCYTIC LEUKEMIA,CYTOSINE ARABINOSIDE,RO-may_treat
502932223,7/14/2014 18:03:23,,1323002733,7/14/2014 18:03:11,prodege,0.4377,12944140,GBR,I4,Mitcham,92.21.55.247,no_relation,38,196,,62,216,diagnosed by,0.312347523777212,907921-FS1-13,"CASE SCENARIO  A 30 year old man with ACUTE MYELOCYTIC LEUKEMIA failed to respond to induction therapy with cytosine arabinoside and idarubicin and received salvage chemotherapy with fludarabine, CYTOSINE ARABINOSIDE, G CSF, and idarubicin.",ACUTE MYELOCYTIC LEUKEMIA,CYTOSINE ARABINOSIDE,RO-may_treat
502932223,7/14/2014 18:20:07,,1323011699,7/14/2014 18:19:36,prodege,0.6105,28039757,GBR,L8,Southport,109.155.158.54,no_relation,38,196,,62,216,diagnosed by,0.312347523777212,907921-FS1-13,"CASE SCENARIO  A 30 year old man with ACUTE MYELOCYTIC LEUKEMIA failed to respond to induction therapy with cytosine arabinoside and idarubicin and received salvage chemotherapy with fludarabine, CYTOSINE ARABINOSIDE, G CSF, and idarubicin.",ACUTE MYELOCYTIC LEUKEMIA,CYTOSINE ARABINOSIDE,RO-may_treat
502932223,7/14/2014 18:34:51,,1323017920,7/14/2014 18:34:41,clixsense,0.5347,16827630,GBR,A7,Birmingham,86.146.169.103,ACUTE MYELOCYTIC LEUKEMIA diagnosed by CYTOSINE ARABINOSIDE,38,196,,62,216,diagnosed by,0.312347523777212,907921-FS1-13,"CASE SCENARIO  A 30 year old man with ACUTE MYELOCYTIC LEUKEMIA failed to respond to induction therapy with cytosine arabinoside and idarubicin and received salvage chemotherapy with fludarabine, CYTOSINE ARABINOSIDE, G CSF, and idarubicin.",ACUTE MYELOCYTIC LEUKEMIA,CYTOSINE ARABINOSIDE,RO-may_treat
502932223,7/14/2014 18:39:13,,1323019840,7/14/2014 18:38:49,instagc,0.5702,28524232,CAN,ON,Toronto,99.244.116.246,no_relation,38,196,,62,216,diagnosed by,0.312347523777212,907921-FS1-13,"CASE SCENARIO  A 30 year old man with ACUTE MYELOCYTIC LEUKEMIA failed to respond to induction therapy with cytosine arabinoside and idarubicin and received salvage chemotherapy with fludarabine, CYTOSINE ARABINOSIDE, G CSF, and idarubicin.",ACUTE MYELOCYTIC LEUKEMIA,CYTOSINE ARABINOSIDE,RO-may_treat
502932223,7/14/2014 19:17:56,,1323041939,7/14/2014 19:16:54,clixsense,0.4911,25595227,CAN,SK,North Battleford,24.72.96.119,no_relation,38,196,,62,216,diagnosed by,0.312347523777212,907921-FS1-13,"CASE SCENARIO  A 30 year old man with ACUTE MYELOCYTIC LEUKEMIA failed to respond to induction therapy with cytosine arabinoside and idarubicin and received salvage chemotherapy with fludarabine, CYTOSINE ARABINOSIDE, G CSF, and idarubicin.",ACUTE MYELOCYTIC LEUKEMIA,CYTOSINE ARABINOSIDE,RO-may_treat
502934678,7/14/2014 17:51:19,,1322997292,7/14/2014 17:50:59,clixsense,0.6389,19803139,NLD,06,Veldhoven,212.61.84.196,GASTRO INTESTINAL POLYPS causes POLYPOID LESION,106,33,,120,57,causes,0.577350269189626,901529-FS1-4,"Although, according to T.Yamada, GASTRO INTESTINAL POLYPS are described with respect to shape and size of POLYPOID LESION only, microscopic structure of polyps manages to find its reflection to a considerable degree too: type I predominantly embraces hypertrophic folds of mucosa as well as non tumor polyps, both hyperplastic and inflammatory, while, at more advanced stages (II IV), tubular and tubulo villose adenomas and villose tumors prevail.",POLYPOID LESION,GASTRO INTESTINAL POLYPS,RO-disease_has_finding
502934678,7/14/2014 18:14:37,,1323009331,7/14/2014 18:13:55,instagc,0.4639,28519532,USA,IA,Honey Creek,12.73.110.131,no_relation,106,33,,120,57,causes,0.577350269189626,901529-FS1-4,"Although, according to T.Yamada, GASTRO INTESTINAL POLYPS are described with respect to shape and size of POLYPOID LESION only, microscopic structure of polyps manages to find its reflection to a considerable degree too: type I predominantly embraces hypertrophic folds of mucosa as well as non tumor polyps, both hyperplastic and inflammatory, while, at more advanced stages (II IV), tubular and tubulo villose adenomas and villose tumors prevail.",POLYPOID LESION,GASTRO INTESTINAL POLYPS,RO-disease_has_finding
502934678,7/14/2014 18:56:37,,1323029095,7/14/2014 18:55:57,instagc,0.5877,19686223,CAN,BC,Surrey,184.65.16.6,no_relation,106,33,,120,57,causes,0.577350269189626,901529-FS1-4,"Although, according to T.Yamada, GASTRO INTESTINAL POLYPS are described with respect to shape and size of POLYPOID LESION only, microscopic structure of polyps manages to find its reflection to a considerable degree too: type I predominantly embraces hypertrophic folds of mucosa as well as non tumor polyps, both hyperplastic and inflammatory, while, at more advanced stages (II IV), tubular and tubulo villose adenomas and villose tumors prevail.",POLYPOID LESION,GASTRO INTESTINAL POLYPS,RO-disease_has_finding
502934678,7/14/2014 19:30:23,,1323049718,7/14/2014 19:29:59,neodev,0.6472,14861092,GBR,I2,Manchester,90.194.137.76,GASTRO INTESTINAL POLYPS causes POLYPOID LESION,106,33,,120,57,causes,0.577350269189626,901529-FS1-4,"Although, according to T.Yamada, GASTRO INTESTINAL POLYPS are described with respect to shape and size of POLYPOID LESION only, microscopic structure of polyps manages to find its reflection to a considerable degree too: type I predominantly embraces hypertrophic folds of mucosa as well as non tumor polyps, both hyperplastic and inflammatory, while, at more advanced stages (II IV), tubular and tubulo villose adenomas and villose tumors prevail.",POLYPOID LESION,GASTRO INTESTINAL POLYPS,RO-disease_has_finding
502934678,7/14/2014 19:32:39,,1323051248,7/14/2014 19:31:35,neodev,0.7222,21752395,USA,,,173.23.121.63,no_relation,106,33,,120,57,causes,0.577350269189626,901529-FS1-4,"Although, according to T.Yamada, GASTRO INTESTINAL POLYPS are described with respect to shape and size of POLYPOID LESION only, microscopic structure of polyps manages to find its reflection to a considerable degree too: type I predominantly embraces hypertrophic folds of mucosa as well as non tumor polyps, both hyperplastic and inflammatory, while, at more advanced stages (II IV), tubular and tubulo villose adenomas and villose tumors prevail.",POLYPOID LESION,GASTRO INTESTINAL POLYPS,RO-disease_has_finding
502934678,7/14/2014 19:33:03,,1323051473,7/14/2014 19:32:40,eup_slw,0.5952,20818028,GBR,A7,Birmingham,92.232.139.254,no_relation,106,33,,120,57,causes,0.577350269189626,901529-FS1-4,"Although, according to T.Yamada, GASTRO INTESTINAL POLYPS are described with respect to shape and size of POLYPOID LESION only, microscopic structure of polyps manages to find its reflection to a considerable degree too: type I predominantly embraces hypertrophic folds of mucosa as well as non tumor polyps, both hyperplastic and inflammatory, while, at more advanced stages (II IV), tubular and tubulo villose adenomas and villose tumors prevail.",POLYPOID LESION,GASTRO INTESTINAL POLYPS,RO-disease_has_finding
502934678,7/14/2014 19:40:35,,1323055930,7/14/2014 19:39:51,prodege,0.6667,22360212,GBR,I1,Luton,82.6.41.191,no_relation,106,33,,120,57,causes,0.577350269189626,901529-FS1-4,"Although, according to T.Yamada, GASTRO INTESTINAL POLYPS are described with respect to shape and size of POLYPOID LESION only, microscopic structure of polyps manages to find its reflection to a considerable degree too: type I predominantly embraces hypertrophic folds of mucosa as well as non tumor polyps, both hyperplastic and inflammatory, while, at more advanced stages (II IV), tubular and tubulo villose adenomas and villose tumors prevail.",POLYPOID LESION,GASTRO INTESTINAL POLYPS,RO-disease_has_finding
502934679,7/14/2014 17:01:30,,1322963995,7/14/2014 17:01:22,neodev,0.875,17610000,GBR,I2,Manchester,90.200.140.201,TUMOR (NEUROFIBROMA causes NEUROFIBROMATOSIS TYPE 1,96,0,,114,24,causes,0.987878339907213,906112-FS1-4,NEUROFIBROMATOSIS TYPE 1 (NF1) is a common autosomal dominant condition characterized by benign TUMOR (NEUROFIBROMA) growth and increased risk of malignancy.,TUMOR (NEUROFIBROMA,NEUROFIBROMATOSIS TYPE 1,RO-has_manifestation
502934679,7/14/2014 17:02:08,,1322964225,7/14/2014 17:01:49,clixsense,0.8194,27793793,GBR,C5,Chester,151.230.27.155,no_relation,96,0,,114,24,causes,0.987878339907213,906112-FS1-4,NEUROFIBROMATOSIS TYPE 1 (NF1) is a common autosomal dominant condition characterized by benign TUMOR (NEUROFIBROMA) growth and increased risk of malignancy.,TUMOR (NEUROFIBROMA,NEUROFIBROMATOSIS TYPE 1,RO-has_manifestation
502934679,7/14/2014 17:08:54,,1322967510,7/14/2014 17:08:48,neodev,0.6389,25224036,CAN,ON,Sudbury,67.204.218.187,TUMOR (NEUROFIBROMA causes NEUROFIBROMATOSIS TYPE 1,96,0,,114,24,causes,0.987878339907213,906112-FS1-4,NEUROFIBROMATOSIS TYPE 1 (NF1) is a common autosomal dominant condition characterized by benign TUMOR (NEUROFIBROMA) growth and increased risk of malignancy.,TUMOR (NEUROFIBROMA,NEUROFIBROMATOSIS TYPE 1,RO-has_manifestation
502934679,7/14/2014 17:28:13,,1322978201,7/14/2014 17:27:31,elite,0.5833,28276268,USA,MI,Taylor,67.149.247.166,NEUROFIBROMATOSIS TYPE 1 causes TUMOR (NEUROFIBROMA,96,0,,114,24,causes,0.987878339907213,906112-FS1-4,NEUROFIBROMATOSIS TYPE 1 (NF1) is a common autosomal dominant condition characterized by benign TUMOR (NEUROFIBROMA) growth and increased risk of malignancy.,TUMOR (NEUROFIBROMA,NEUROFIBROMATOSIS TYPE 1,RO-has_manifestation
502934679,7/14/2014 18:27:57,,1323014970,7/14/2014 18:27:38,neodev,0.6095,21515166,NLD,11,Nootdorp,83.86.58.179,NEUROFIBROMATOSIS TYPE 1 causes TUMOR (NEUROFIBROMA,96,0,,114,24,causes,0.987878339907213,906112-FS1-4,NEUROFIBROMATOSIS TYPE 1 (NF1) is a common autosomal dominant condition characterized by benign TUMOR (NEUROFIBROMA) growth and increased risk of malignancy.,TUMOR (NEUROFIBROMA,NEUROFIBROMATOSIS TYPE 1,RO-has_manifestation
502934679,7/14/2014 18:30:00,,1323015834,7/14/2014 18:29:33,instagc,0.6187,28524232,CAN,ON,Toronto,99.244.116.246,NEUROFIBROMATOSIS TYPE 1 causes TUMOR (NEUROFIBROMA,96,0,,114,24,causes,0.987878339907213,906112-FS1-4,NEUROFIBROMATOSIS TYPE 1 (NF1) is a common autosomal dominant condition characterized by benign TUMOR (NEUROFIBROMA) growth and increased risk of malignancy.,TUMOR (NEUROFIBROMA,NEUROFIBROMATOSIS TYPE 1,RO-has_manifestation
502934679,7/14/2014 18:49:41,,1323025099,7/14/2014 18:49:36,clixsense,0.4121,19162475,GBR,M3,Frome,82.33.126.30,NEUROFIBROMATOSIS TYPE 1 causes TUMOR (NEUROFIBROMA,96,0,,114,24,causes,0.987878339907213,906112-FS1-4,NEUROFIBROMATOSIS TYPE 1 (NF1) is a common autosomal dominant condition characterized by benign TUMOR (NEUROFIBROMA) growth and increased risk of malignancy.,TUMOR (NEUROFIBROMA,NEUROFIBROMATOSIS TYPE 1,RO-has_manifestation
502934680,7/14/2014 17:00:52,,1322963547,7/14/2014 17:00:32,clixsense,0.8611,27871219,NLD,07,Amsterdam,87.210.207.223,MIGRAINE causes TENSION TYPE HEADACHE,14,163,,34,171,causes,0.557086014531156,904906-FS1-4,"Migraine with TENSION TYPE HEADACHE differs from pure migraine in respect of more numerous attacks within 1 year among females, and of more frequent occurrence of MIGRAINE with sensory aura among males.",TENSION TYPE HEADACHE,MIGRAINE,RO-has_definitional_manifestation
502934680,7/14/2014 17:01:21,,1322963905,7/14/2014 17:01:15,neodev,0.875,17610000,GBR,I2,Manchester,90.200.140.201,TENSION TYPE HEADACHE causes MIGRAINE,14,163,,34,171,causes,0.557086014531156,904906-FS1-4,"Migraine with TENSION TYPE HEADACHE differs from pure migraine in respect of more numerous attacks within 1 year among females, and of more frequent occurrence of MIGRAINE with sensory aura among males.",TENSION TYPE HEADACHE,MIGRAINE,RO-has_definitional_manifestation
502934680,7/14/2014 17:01:48,,1322964154,7/14/2014 17:01:33,clixsense,0.8194,27793793,GBR,C5,Chester,151.230.27.155,MIGRAINE causes TENSION TYPE HEADACHE,14,163,,34,171,causes,0.557086014531156,904906-FS1-4,"Migraine with TENSION TYPE HEADACHE differs from pure migraine in respect of more numerous attacks within 1 year among females, and of more frequent occurrence of MIGRAINE with sensory aura among males.",TENSION TYPE HEADACHE,MIGRAINE,RO-has_definitional_manifestation
502934680,7/14/2014 17:11:16,,1322968811,7/14/2014 17:10:50,instagc,0.5208,19636746,USA,NY,Andover,192.182.216.225,no_relation,14,163,,34,171,causes,0.557086014531156,904906-FS1-4,"Migraine with TENSION TYPE HEADACHE differs from pure migraine in respect of more numerous attacks within 1 year among females, and of more frequent occurrence of MIGRAINE with sensory aura among males.",TENSION TYPE HEADACHE,MIGRAINE,RO-has_definitional_manifestation
502934680,7/14/2014 17:49:22,,1322996403,7/14/2014 17:48:54,prodege,0.6667,2143114,CAN,BC,Vancouver,24.84.160.12,TENSION TYPE HEADACHE causes MIGRAINE,14,163,,34,171,causes,0.557086014531156,904906-FS1-4,"Migraine with TENSION TYPE HEADACHE differs from pure migraine in respect of more numerous attacks within 1 year among females, and of more frequent occurrence of MIGRAINE with sensory aura among males.",TENSION TYPE HEADACHE,MIGRAINE,RO-has_definitional_manifestation
502934680,7/14/2014 17:49:53,,1322996599,7/14/2014 17:49:33,clixsense,0.6389,19803139,NLD,06,Veldhoven,212.61.84.196,TENSION TYPE HEADACHE causes MIGRAINE,14,163,,34,171,causes,0.557086014531156,904906-FS1-4,"Migraine with TENSION TYPE HEADACHE differs from pure migraine in respect of more numerous attacks within 1 year among females, and of more frequent occurrence of MIGRAINE with sensory aura among males.",TENSION TYPE HEADACHE,MIGRAINE,RO-has_definitional_manifestation
502934680,7/14/2014 17:59:59,,1323001190,7/14/2014 17:59:27,neodev,0.6641,28269997,GBR,H9,London,151.224.171.48,no_relation,14,163,,34,171,causes,0.557086014531156,904906-FS1-4,"Migraine with TENSION TYPE HEADACHE differs from pure migraine in respect of more numerous attacks within 1 year among females, and of more frequent occurrence of MIGRAINE with sensory aura among males.",TENSION TYPE HEADACHE,MIGRAINE,RO-has_definitional_manifestation
502934681,7/14/2014 16:59:11,,1322962637,7/14/2014 16:59:07,instagc,1.0,27753923,GBR,,,94.196.229.196,DRUG RESISTANT EPILEPSY causes ANTIEPILEPTIC DRUGS (AEDS),94,32,,116,58,causes,0.404519917477945,908168-FS1-4,"In spite of the large number of ANTIEPILEPTIC DRUGS (AEDS) actually available, the problem of DRUG RESISTANT EPILEPSY has not been solved.",DRUG RESISTANT EPILEPSY,ANTIEPILEPTIC DRUGS (AEDS),RO-may_treat
502934681,7/14/2014 17:26:24,,1322976815,7/14/2014 17:26:08,pokerowned,0.5639,18747884,USA,MI,Snover,209.40.219.170,ANTIEPILEPTIC DRUGS (AEDS) causes DRUG RESISTANT EPILEPSY,94,32,,116,58,causes,0.404519917477945,908168-FS1-4,"In spite of the large number of ANTIEPILEPTIC DRUGS (AEDS) actually available, the problem of DRUG RESISTANT EPILEPSY has not been solved.",DRUG RESISTANT EPILEPSY,ANTIEPILEPTIC DRUGS (AEDS),RO-may_treat
502934681,7/14/2014 17:50:05,,1322996677,7/14/2014 17:49:57,prodege,0.6667,2143114,CAN,BC,Vancouver,24.84.160.12,ANTIEPILEPTIC DRUGS (AEDS) causes DRUG RESISTANT EPILEPSY,94,32,,116,58,causes,0.404519917477945,908168-FS1-4,"In spite of the large number of ANTIEPILEPTIC DRUGS (AEDS) actually available, the problem of DRUG RESISTANT EPILEPSY has not been solved.",DRUG RESISTANT EPILEPSY,ANTIEPILEPTIC DRUGS (AEDS),RO-may_treat
502934681,7/14/2014 17:50:12,,1322996729,7/14/2014 17:49:54,clixsense,0.6389,19803139,NLD,06,Veldhoven,212.61.84.196,ANTIEPILEPTIC DRUGS (AEDS) causes DRUG RESISTANT EPILEPSY,94,32,,116,58,causes,0.404519917477945,908168-FS1-4,"In spite of the large number of ANTIEPILEPTIC DRUGS (AEDS) actually available, the problem of DRUG RESISTANT EPILEPSY has not been solved.",DRUG RESISTANT EPILEPSY,ANTIEPILEPTIC DRUGS (AEDS),RO-may_treat
502934681,7/14/2014 18:48:51,,1323024646,7/14/2014 18:48:32,instagc,0.5869,25990856,USA,NV,Las Vegas,68.108.98.78,no_relation,94,32,,116,58,causes,0.404519917477945,908168-FS1-4,"In spite of the large number of ANTIEPILEPTIC DRUGS (AEDS) actually available, the problem of DRUG RESISTANT EPILEPSY has not been solved.",DRUG RESISTANT EPILEPSY,ANTIEPILEPTIC DRUGS (AEDS),RO-may_treat
502934681,7/14/2014 18:57:05,,1323029465,7/14/2014 18:56:38,instagc,0.5877,19686223,CAN,BC,Surrey,184.65.16.6,no_relation,94,32,,116,58,causes,0.404519917477945,908168-FS1-4,"In spite of the large number of ANTIEPILEPTIC DRUGS (AEDS) actually available, the problem of DRUG RESISTANT EPILEPSY has not been solved.",DRUG RESISTANT EPILEPSY,ANTIEPILEPTIC DRUGS (AEDS),RO-may_treat
502934681,7/14/2014 19:17:58,,1323041965,7/14/2014 19:17:33,instagc,0.7278,13763729,USA,,,75.182.89.225,no_relation,94,32,,116,58,causes,0.404519917477945,908168-FS1-4,"In spite of the large number of ANTIEPILEPTIC DRUGS (AEDS) actually available, the problem of DRUG RESISTANT EPILEPSY has not been solved.",DRUG RESISTANT EPILEPSY,ANTIEPILEPTIC DRUGS (AEDS),RO-may_treat
502934696,7/14/2014 17:01:22,,1322963922,7/14/2014 17:00:53,clixsense,0.8611,27871219,NLD,07,Amsterdam,87.210.207.223,no_relation,132,85,,173,103,causes,0.36514837167011105,906409-FS1-4,These endogenous erythroid colonies (EEC) are seen in the great majority of cases of POLYCYTHAEMIA VERA as well as in some cases of THROMBOCYTHAEMIA CHRONIC MYELOID LEUKAEMIA and idiopathic myelofibrosis.,THROMBOCYTHAEMIA CHRONIC MYELOID LEUKAEMIA,POLYCYTHAEMIA VERA,RO-has_manifestation
502934696,7/14/2014 18:10:47,,1323007587,7/14/2014 18:10:19,vivatic,0.605,25451531,GBR,,,83.67.28.193,no_relation,132,85,,173,103,causes,0.36514837167011105,906409-FS1-4,These endogenous erythroid colonies (EEC) are seen in the great majority of cases of POLYCYTHAEMIA VERA as well as in some cases of THROMBOCYTHAEMIA CHRONIC MYELOID LEUKAEMIA and idiopathic myelofibrosis.,THROMBOCYTHAEMIA CHRONIC MYELOID LEUKAEMIA,POLYCYTHAEMIA VERA,RO-has_manifestation
502934696,7/14/2014 18:28:13,,1323015102,7/14/2014 18:27:58,neodev,0.6095,21515166,NLD,11,Nootdorp,83.86.58.179,POLYCYTHAEMIA VERA causes THROMBOCYTHAEMIA CHRONIC MYELOID LEUKAEMIA,132,85,,173,103,causes,0.36514837167011105,906409-FS1-4,These endogenous erythroid colonies (EEC) are seen in the great majority of cases of POLYCYTHAEMIA VERA as well as in some cases of THROMBOCYTHAEMIA CHRONIC MYELOID LEUKAEMIA and idiopathic myelofibrosis.,THROMBOCYTHAEMIA CHRONIC MYELOID LEUKAEMIA,POLYCYTHAEMIA VERA,RO-has_manifestation
502934696,7/14/2014 18:50:38,,1323025631,7/14/2014 18:50:14,instagc,0.5869,25990856,USA,NV,Las Vegas,68.108.98.78,no_relation,132,85,,173,103,causes,0.36514837167011105,906409-FS1-4,These endogenous erythroid colonies (EEC) are seen in the great majority of cases of POLYCYTHAEMIA VERA as well as in some cases of THROMBOCYTHAEMIA CHRONIC MYELOID LEUKAEMIA and idiopathic myelofibrosis.,THROMBOCYTHAEMIA CHRONIC MYELOID LEUKAEMIA,POLYCYTHAEMIA VERA,RO-has_manifestation
502934696,7/14/2014 19:15:30,,1323040432,7/14/2014 19:15:12,elite,0.6234,28503042,USA,NJ,Woodbridge,54.191.150.115,no_relation,132,85,,173,103,causes,0.36514837167011105,906409-FS1-4,These endogenous erythroid colonies (EEC) are seen in the great majority of cases of POLYCYTHAEMIA VERA as well as in some cases of THROMBOCYTHAEMIA CHRONIC MYELOID LEUKAEMIA and idiopathic myelofibrosis.,THROMBOCYTHAEMIA CHRONIC MYELOID LEUKAEMIA,POLYCYTHAEMIA VERA,RO-has_manifestation
502934696,7/14/2014 19:30:53,,1323049973,7/14/2014 19:30:31,clixsense,0.3921,15189335,GBR,A7,Birmingham,94.197.121.232,POLYCYTHAEMIA VERA causes THROMBOCYTHAEMIA CHRONIC MYELOID LEUKAEMIA,132,85,,173,103,causes,0.36514837167011105,906409-FS1-4,These endogenous erythroid colonies (EEC) are seen in the great majority of cases of POLYCYTHAEMIA VERA as well as in some cases of THROMBOCYTHAEMIA CHRONIC MYELOID LEUKAEMIA and idiopathic myelofibrosis.,THROMBOCYTHAEMIA CHRONIC MYELOID LEUKAEMIA,POLYCYTHAEMIA VERA,RO-has_manifestation
502934696,7/14/2014 19:33:28,,1323051694,7/14/2014 19:33:05,eup_slw,0.5952,20818028,GBR,A7,Birmingham,92.232.139.254,no_relation,132,85,,173,103,causes,0.36514837167011105,906409-FS1-4,These endogenous erythroid colonies (EEC) are seen in the great majority of cases of POLYCYTHAEMIA VERA as well as in some cases of THROMBOCYTHAEMIA CHRONIC MYELOID LEUKAEMIA and idiopathic myelofibrosis.,THROMBOCYTHAEMIA CHRONIC MYELOID LEUKAEMIA,POLYCYTHAEMIA VERA,RO-has_manifestation
502934704,7/14/2014 17:23:48,,1322975120,7/14/2014 17:23:33,instagc,0.8125,18960682,GBR,,,86.29.147.112,OCA2 causes SKIN AND HAIR PIGMENTATION,122,29,,147,33,causes,0.31622776601683805,905331-FS1-4,"Although the function of the OCA2 gene product has not been totally clarified, variation in OCA2 has been associated with SKIN AND HAIR PIGMENTATION in human and mouse.",SKIN AND HAIR PIGMENTATION,OCA2,RO-has_finding_site
502934704,7/14/2014 17:30:29,,1322980104,7/14/2014 17:29:50,elite,0.5833,28276268,USA,MI,Taylor,67.149.247.166,OCA2 causes SKIN AND HAIR PIGMENTATION,122,29,,147,33,causes,0.31622776601683805,905331-FS1-4,"Although the function of the OCA2 gene product has not been totally clarified, variation in OCA2 has been associated with SKIN AND HAIR PIGMENTATION in human and mouse.",SKIN AND HAIR PIGMENTATION,OCA2,RO-has_finding_site
502934704,7/14/2014 17:58:39,,1323000663,7/14/2014 17:58:04,neodev,0.6641,28269997,GBR,H9,London,151.224.171.48,OCA2 causes SKIN AND HAIR PIGMENTATION,122,29,,147,33,causes,0.31622776601683805,905331-FS1-4,"Although the function of the OCA2 gene product has not been totally clarified, variation in OCA2 has been associated with SKIN AND HAIR PIGMENTATION in human and mouse.",SKIN AND HAIR PIGMENTATION,OCA2,RO-has_finding_site
502934704,7/14/2014 18:02:58,,1323002567,7/14/2014 18:02:46,prodege,0.4264,12944140,GBR,I4,Mitcham,92.21.55.247,no_relation,122,29,,147,33,causes,0.31622776601683805,905331-FS1-4,"Although the function of the OCA2 gene product has not been totally clarified, variation in OCA2 has been associated with SKIN AND HAIR PIGMENTATION in human and mouse.",SKIN AND HAIR PIGMENTATION,OCA2,RO-has_finding_site
502934704,7/14/2014 18:08:17,,1323006334,7/14/2014 18:07:42,vivatic,0.605,25451531,GBR,,,83.67.28.193,OCA2 causes SKIN AND HAIR PIGMENTATION,122,29,,147,33,causes,0.31622776601683805,905331-FS1-4,"Although the function of the OCA2 gene product has not been totally clarified, variation in OCA2 has been associated with SKIN AND HAIR PIGMENTATION in human and mouse.",SKIN AND HAIR PIGMENTATION,OCA2,RO-has_finding_site
502934704,7/14/2014 18:28:54,,1323015407,7/14/2014 18:28:34,neodev,0.6095,21515166,NLD,11,Nootdorp,83.86.58.179,OCA2 causes SKIN AND HAIR PIGMENTATION,122,29,,147,33,causes,0.31622776601683805,905331-FS1-4,"Although the function of the OCA2 gene product has not been totally clarified, variation in OCA2 has been associated with SKIN AND HAIR PIGMENTATION in human and mouse.",SKIN AND HAIR PIGMENTATION,OCA2,RO-has_finding_site
502934704,7/14/2014 18:47:10,,1323023817,7/14/2014 18:47:04,clixsense,0.4121,19162475,GBR,M3,Frome,82.33.126.30,SKIN AND HAIR PIGMENTATION causes OCA2,122,29,,147,33,causes,0.31622776601683805,905331-FS1-4,"Although the function of the OCA2 gene product has not been totally clarified, variation in OCA2 has been associated with SKIN AND HAIR PIGMENTATION in human and mouse.",SKIN AND HAIR PIGMENTATION,OCA2,RO-has_finding_site
502934705,7/14/2014 17:01:14,,1322963812,7/14/2014 17:01:09,neodev,0.875,17610000,GBR,I2,Manchester,90.200.140.201,BRONCHIAL HYPERREACTIVITY treats SINGLE METHACHOLINE STIMULATION,201,133,,225,164,treats,0.32444284226152503,906678-FS1-2,"In the presence of extracellular Ca(2+), simultaneous exposure to TDI and methacholine led a higher level of [Ca(2+)](c) compared to SINGLE METHACHOLINE STIMULATION that might explain that TDI induces BRONCHIAL HYPERREACTIVITY to methacholine.",BRONCHIAL HYPERREACTIVITY,SINGLE METHACHOLINE STIMULATION,RO-may_diagnose
502934705,7/14/2014 17:23:32,,1322974920,7/14/2014 17:23:22,instagc,0.8125,18960682,GBR,,,86.29.147.112,no_relation,201,133,,225,164,treats,0.32444284226152503,906678-FS1-2,"In the presence of extracellular Ca(2+), simultaneous exposure to TDI and methacholine led a higher level of [Ca(2+)](c) compared to SINGLE METHACHOLINE STIMULATION that might explain that TDI induces BRONCHIAL HYPERREACTIVITY to methacholine.",BRONCHIAL HYPERREACTIVITY,SINGLE METHACHOLINE STIMULATION,RO-may_diagnose
502934705,7/14/2014 17:58:03,,1323000451,7/14/2014 17:56:59,neodev,0.6641,28269997,GBR,H9,London,151.224.171.48,no_relation,201,133,,225,164,treats,0.32444284226152503,906678-FS1-2,"In the presence of extracellular Ca(2+), simultaneous exposure to TDI and methacholine led a higher level of [Ca(2+)](c) compared to SINGLE METHACHOLINE STIMULATION that might explain that TDI induces BRONCHIAL HYPERREACTIVITY to methacholine.",BRONCHIAL HYPERREACTIVITY,SINGLE METHACHOLINE STIMULATION,RO-may_diagnose
502934705,7/14/2014 18:07:54,,1323006122,7/14/2014 18:06:59,prodege,0.5502,7899370,USA,MI,Bay City,71.13.81.162,SINGLE METHACHOLINE STIMULATION treats BRONCHIAL HYPERREACTIVITY,201,133,,225,164,treats,0.32444284226152503,906678-FS1-2,"In the presence of extracellular Ca(2+), simultaneous exposure to TDI and methacholine led a higher level of [Ca(2+)](c) compared to SINGLE METHACHOLINE STIMULATION that might explain that TDI induces BRONCHIAL HYPERREACTIVITY to methacholine.",BRONCHIAL HYPERREACTIVITY,SINGLE METHACHOLINE STIMULATION,RO-may_diagnose
502934705,7/14/2014 18:32:49,,1323017090,7/14/2014 18:32:30,clixsense,0.7071,16827630,GBR,A7,Birmingham,86.146.169.103,no_relation,201,133,,225,164,treats,0.32444284226152503,906678-FS1-2,"In the presence of extracellular Ca(2+), simultaneous exposure to TDI and methacholine led a higher level of [Ca(2+)](c) compared to SINGLE METHACHOLINE STIMULATION that might explain that TDI induces BRONCHIAL HYPERREACTIVITY to methacholine.",BRONCHIAL HYPERREACTIVITY,SINGLE METHACHOLINE STIMULATION,RO-may_diagnose
502934705,7/14/2014 19:29:58,,1323049399,7/14/2014 19:29:21,neodev,0.6472,14861092,GBR,I2,Manchester,90.194.137.76,SINGLE METHACHOLINE STIMULATION treats BRONCHIAL HYPERREACTIVITY,201,133,,225,164,treats,0.32444284226152503,906678-FS1-2,"In the presence of extracellular Ca(2+), simultaneous exposure to TDI and methacholine led a higher level of [Ca(2+)](c) compared to SINGLE METHACHOLINE STIMULATION that might explain that TDI induces BRONCHIAL HYPERREACTIVITY to methacholine.",BRONCHIAL HYPERREACTIVITY,SINGLE METHACHOLINE STIMULATION,RO-may_diagnose
502934705,7/14/2014 19:30:13,,1323049613,7/14/2014 19:29:50,clixsense,0.3921,15189335,GBR,A7,Birmingham,94.197.121.232,SINGLE METHACHOLINE STIMULATION treats BRONCHIAL HYPERREACTIVITY,201,133,,225,164,treats,0.32444284226152503,906678-FS1-2,"In the presence of extracellular Ca(2+), simultaneous exposure to TDI and methacholine led a higher level of [Ca(2+)](c) compared to SINGLE METHACHOLINE STIMULATION that might explain that TDI induces BRONCHIAL HYPERREACTIVITY to methacholine.",BRONCHIAL HYPERREACTIVITY,SINGLE METHACHOLINE STIMULATION,RO-may_diagnose
502934708,7/14/2014 16:59:11,,1322962638,7/14/2014 16:59:07,instagc,1.0,27753923,GBR,,,94.196.229.196,END STAGE RENAL DISEASE causes RENAL OSTEODYSTROPHY,0,76,,19,99,causes,0.964901281354015,900397-FS1-4,RENAL OSTEODYSTROPHY is a general complication of chronic renal failure and END STAGE RENAL DISEASE,RENAL OSTEODYSTROPHY,END STAGE RENAL DISEASE,RO-cause_of
502934708,7/14/2014 17:01:02,,1322963647,7/14/2014 17:00:56,neodev,0.875,17610000,GBR,I2,Manchester,90.200.140.201,RENAL OSTEODYSTROPHY causes END STAGE RENAL DISEASE,0,76,,19,99,causes,0.964901281354015,900397-FS1-4,RENAL OSTEODYSTROPHY is a general complication of chronic renal failure and END STAGE RENAL DISEASE,RENAL OSTEODYSTROPHY,END STAGE RENAL DISEASE,RO-cause_of
502934708,7/14/2014 18:08:39,,1323006509,7/14/2014 18:08:01,instagc,0.4639,28519532,USA,IA,Honey Creek,12.73.110.131,no_relation,0,76,,19,99,causes,0.964901281354015,900397-FS1-4,RENAL OSTEODYSTROPHY is a general complication of chronic renal failure and END STAGE RENAL DISEASE,RENAL OSTEODYSTROPHY,END STAGE RENAL DISEASE,RO-cause_of
502934708,7/14/2014 19:18:27,,1323042301,7/14/2014 19:17:58,instagc,0.7278,13763729,USA,,,75.182.89.225,no_relation,0,76,,19,99,causes,0.964901281354015,900397-FS1-4,RENAL OSTEODYSTROPHY is a general complication of chronic renal failure and END STAGE RENAL DISEASE,RENAL OSTEODYSTROPHY,END STAGE RENAL DISEASE,RO-cause_of
502934708,7/14/2014 19:29:48,,1323049331,7/14/2014 19:29:22,clixsense,0.3921,15189335,GBR,A7,Birmingham,94.197.121.232,RENAL OSTEODYSTROPHY causes END STAGE RENAL DISEASE,0,76,,19,99,causes,0.964901281354015,900397-FS1-4,RENAL OSTEODYSTROPHY is a general complication of chronic renal failure and END STAGE RENAL DISEASE,RENAL OSTEODYSTROPHY,END STAGE RENAL DISEASE,RO-cause_of
502934708,7/14/2014 19:32:39,,1323051264,7/14/2014 19:32:17,eup_slw,0.5952,20818028,GBR,A7,Birmingham,92.232.139.254,END STAGE RENAL DISEASE causes RENAL OSTEODYSTROPHY,0,76,,19,99,causes,0.964901281354015,900397-FS1-4,RENAL OSTEODYSTROPHY is a general complication of chronic renal failure and END STAGE RENAL DISEASE,RENAL OSTEODYSTROPHY,END STAGE RENAL DISEASE,RO-cause_of
502934708,7/14/2014 19:33:07,,1323051503,7/14/2014 19:32:40,neodev,0.7222,21752395,USA,,,173.23.121.63,END STAGE RENAL DISEASE causes RENAL OSTEODYSTROPHY,0,76,,19,99,causes,0.964901281354015,900397-FS1-4,RENAL OSTEODYSTROPHY is a general complication of chronic renal failure and END STAGE RENAL DISEASE,RENAL OSTEODYSTROPHY,END STAGE RENAL DISEASE,RO-cause_of
502934712,7/14/2014 17:11:45,,1322969093,7/14/2014 17:11:17,instagc,0.5208,19636746,USA,NY,Andover,192.182.216.225,no_relation,253,196,,268,219,causes,0.4472135954999579,906130-FS1-4,"Crouzon's disease    (              audio )  [Octave Crouzon, Fr. neurologist, 1874 1938] An autosomal dominantly inherited congenital disease characterized by hypertelorism (widely spaced eyes), CRANIOFACIAL DYSOSTOSIS exophthalmos, optic atrophy, and DIVERGENT SQUINT",DIVERGENT SQUINT,CRANIOFACIAL DYSOSTOSIS,RO-has_manifestation
502934712,7/14/2014 17:49:22,,1322996402,7/14/2014 17:48:54,prodege,0.6667,2143114,CAN,BC,Vancouver,24.84.160.12,CRANIOFACIAL DYSOSTOSIS causes DIVERGENT SQUINT,253,196,,268,219,causes,0.4472135954999579,906130-FS1-4,"Crouzon's disease    (              audio )  [Octave Crouzon, Fr. neurologist, 1874 1938] An autosomal dominantly inherited congenital disease characterized by hypertelorism (widely spaced eyes), CRANIOFACIAL DYSOSTOSIS exophthalmos, optic atrophy, and DIVERGENT SQUINT",DIVERGENT SQUINT,CRANIOFACIAL DYSOSTOSIS,RO-has_manifestation
502934712,7/14/2014 17:58:03,,1323000452,7/14/2014 17:56:59,neodev,0.6641,28269997,GBR,H9,London,151.224.171.48,no_relation,253,196,,268,219,causes,0.4472135954999579,906130-FS1-4,"Crouzon's disease    (              audio )  [Octave Crouzon, Fr. neurologist, 1874 1938] An autosomal dominantly inherited congenital disease characterized by hypertelorism (widely spaced eyes), CRANIOFACIAL DYSOSTOSIS exophthalmos, optic atrophy, and DIVERGENT SQUINT",DIVERGENT SQUINT,CRANIOFACIAL DYSOSTOSIS,RO-has_manifestation
502934712,7/14/2014 18:46:23,,1323023343,7/14/2014 18:46:14,clixsense,0.4121,19162475,GBR,M3,Frome,82.33.126.30,DIVERGENT SQUINT causes CRANIOFACIAL DYSOSTOSIS,253,196,,268,219,causes,0.4472135954999579,906130-FS1-4,"Crouzon's disease    (              audio )  [Octave Crouzon, Fr. neurologist, 1874 1938] An autosomal dominantly inherited congenital disease characterized by hypertelorism (widely spaced eyes), CRANIOFACIAL DYSOSTOSIS exophthalmos, optic atrophy, and DIVERGENT SQUINT",DIVERGENT SQUINT,CRANIOFACIAL DYSOSTOSIS,RO-has_manifestation
502934712,7/14/2014 18:57:05,,1323029463,7/14/2014 18:56:38,instagc,0.5877,19686223,CAN,BC,Surrey,184.65.16.6,no_relation,253,196,,268,219,causes,0.4472135954999579,906130-FS1-4,"Crouzon's disease    (              audio )  [Octave Crouzon, Fr. neurologist, 1874 1938] An autosomal dominantly inherited congenital disease characterized by hypertelorism (widely spaced eyes), CRANIOFACIAL DYSOSTOSIS exophthalmos, optic atrophy, and DIVERGENT SQUINT",DIVERGENT SQUINT,CRANIOFACIAL DYSOSTOSIS,RO-has_manifestation
502934712,7/14/2014 19:13:38,,1323039436,7/14/2014 19:13:12,elite,0.6234,28503042,USA,NJ,Woodbridge,54.191.150.115,no_relation,253,196,,268,219,causes,0.4472135954999579,906130-FS1-4,"Crouzon's disease    (              audio )  [Octave Crouzon, Fr. neurologist, 1874 1938] An autosomal dominantly inherited congenital disease characterized by hypertelorism (widely spaced eyes), CRANIOFACIAL DYSOSTOSIS exophthalmos, optic atrophy, and DIVERGENT SQUINT",DIVERGENT SQUINT,CRANIOFACIAL DYSOSTOSIS,RO-has_manifestation
502934712,7/14/2014 19:31:01,,1323050046,7/14/2014 19:30:45,neodev,0.6472,14861092,GBR,I2,Manchester,90.194.137.76,no_relation,253,196,,268,219,causes,0.4472135954999579,906130-FS1-4,"Crouzon's disease    (              audio )  [Octave Crouzon, Fr. neurologist, 1874 1938] An autosomal dominantly inherited congenital disease characterized by hypertelorism (widely spaced eyes), CRANIOFACIAL DYSOSTOSIS exophthalmos, optic atrophy, and DIVERGENT SQUINT",DIVERGENT SQUINT,CRANIOFACIAL DYSOSTOSIS,RO-has_manifestation
502934717,7/14/2014 17:50:05,,1322996690,7/14/2014 17:49:57,prodege,0.6667,2143114,CAN,BC,Vancouver,24.84.160.12,INTRAVENOUS DANTROLENE causes MALIGNANT HYPERTHERMIA,39,87,,60,109,causes,0.371390676354104,908181-FS1-4,In one group of four pigs sensitive to MALIGNANT HYPERTHERMIA (MHS) a dose response to INTRAVENOUS DANTROLENE was determined by quantitation of toe twitch tension.,MALIGNANT HYPERTHERMIA,INTRAVENOUS DANTROLENE,RO-may_treat
502934717,7/14/2014 18:00:33,,1323001463,7/14/2014 18:00:00,neodev,0.6641,28269997,GBR,H9,London,151.224.171.48,MALIGNANT HYPERTHERMIA causes INTRAVENOUS DANTROLENE,39,87,,60,109,causes,0.371390676354104,908181-FS1-4,In one group of four pigs sensitive to MALIGNANT HYPERTHERMIA (MHS) a dose response to INTRAVENOUS DANTROLENE was determined by quantitation of toe twitch tension.,MALIGNANT HYPERTHERMIA,INTRAVENOUS DANTROLENE,RO-may_treat
502934717,7/14/2014 18:03:05,,1323002591,7/14/2014 18:02:59,prodege,0.4264,12944140,GBR,I4,Mitcham,92.21.55.247,no_relation,39,87,,60,109,causes,0.371390676354104,908181-FS1-4,In one group of four pigs sensitive to MALIGNANT HYPERTHERMIA (MHS) a dose response to INTRAVENOUS DANTROLENE was determined by quantitation of toe twitch tension.,MALIGNANT HYPERTHERMIA,INTRAVENOUS DANTROLENE,RO-may_treat
502934717,7/14/2014 18:09:13,,1323006803,7/14/2014 18:08:44,instagc,0.4639,28519532,USA,IA,Honey Creek,12.73.110.131,no_relation,39,87,,60,109,causes,0.371390676354104,908181-FS1-4,In one group of four pigs sensitive to MALIGNANT HYPERTHERMIA (MHS) a dose response to INTRAVENOUS DANTROLENE was determined by quantitation of toe twitch tension.,MALIGNANT HYPERTHERMIA,INTRAVENOUS DANTROLENE,RO-may_treat
502934717,7/14/2014 18:28:33,,1323015273,7/14/2014 18:28:13,neodev,0.6095,21515166,NLD,11,Nootdorp,83.86.58.179,INTRAVENOUS DANTROLENE causes MALIGNANT HYPERTHERMIA,39,87,,60,109,causes,0.371390676354104,908181-FS1-4,In one group of four pigs sensitive to MALIGNANT HYPERTHERMIA (MHS) a dose response to INTRAVENOUS DANTROLENE was determined by quantitation of toe twitch tension.,MALIGNANT HYPERTHERMIA,INTRAVENOUS DANTROLENE,RO-may_treat
502934717,7/14/2014 18:56:37,,1323029097,7/14/2014 18:55:57,instagc,0.5877,19686223,CAN,BC,Surrey,184.65.16.6,MALIGNANT HYPERTHERMIA causes INTRAVENOUS DANTROLENE,39,87,,60,109,causes,0.371390676354104,908181-FS1-4,In one group of four pigs sensitive to MALIGNANT HYPERTHERMIA (MHS) a dose response to INTRAVENOUS DANTROLENE was determined by quantitation of toe twitch tension.,MALIGNANT HYPERTHERMIA,INTRAVENOUS DANTROLENE,RO-may_treat
502934717,7/14/2014 19:13:10,,1323039171,7/14/2014 19:12:40,elite,0.6234,28503042,USA,NJ,Woodbridge,54.191.150.115,no_relation,39,87,,60,109,causes,0.371390676354104,908181-FS1-4,In one group of four pigs sensitive to MALIGNANT HYPERTHERMIA (MHS) a dose response to INTRAVENOUS DANTROLENE was determined by quantitation of toe twitch tension.,MALIGNANT HYPERTHERMIA,INTRAVENOUS DANTROLENE,RO-may_treat
503007613,7/14/2014 20:43:23,,1323087353,7/14/2014 20:42:57,elite,0.875,28503042,USA,NJ,Woodbridge,54.191.150.115,ACETAMINOPHEN treats PAIN,81,32,,84,45,treats,0.993883734673619,907827-FS1-2,"She is given a prescription for ACETAMINOPHEN with codeine to take as needed for PAIN the week before surgery, and she is instructed to take her atenolol the morning of surgery with a sip of water.",PAIN,ACETAMINOPHEN,RO-may_treat
503007613,7/14/2014 20:45:46,,1323088552,7/14/2014 20:45:43,instagc,0.6111,25990856,USA,NV,Las Vegas,68.108.98.78,PAIN treats ACETAMINOPHEN,81,32,,84,45,treats,0.993883734673619,907827-FS1-2,"She is given a prescription for ACETAMINOPHEN with codeine to take as needed for PAIN the week before surgery, and she is instructed to take her atenolol the morning of surgery with a sip of water.",PAIN,ACETAMINOPHEN,RO-may_treat
503007613,7/14/2014 21:17:02,,1323104361,7/14/2014 21:16:29,prodege,0.7639,28255346,GBR,L9,Sheffield,2.125.183.137,ACETAMINOPHEN treats PAIN,81,32,,84,45,treats,0.993883734673619,907827-FS1-2,"She is given a prescription for ACETAMINOPHEN with codeine to take as needed for PAIN the week before surgery, and she is instructed to take her atenolol the morning of surgery with a sip of water.",PAIN,ACETAMINOPHEN,RO-may_treat
503007613,7/14/2014 21:27:11,,1323109129,7/14/2014 21:27:03,prodege,0.7306,23541832,USA,AZ,Tempe,149.169.129.225,ACETAMINOPHEN treats PAIN,81,32,,84,45,treats,0.993883734673619,907827-FS1-2,"She is given a prescription for ACETAMINOPHEN with codeine to take as needed for PAIN the week before surgery, and she is instructed to take her atenolol the morning of surgery with a sip of water.",PAIN,ACETAMINOPHEN,RO-may_treat
503007613,7/14/2014 21:36:19,,1323114180,7/14/2014 21:35:54,clixsense,0.5974,19803139,NLD,06,Veldhoven,212.61.84.196,ACETAMINOPHEN treats PAIN,81,32,,84,45,treats,0.993883734673619,907827-FS1-2,"She is given a prescription for ACETAMINOPHEN with codeine to take as needed for PAIN the week before surgery, and she is instructed to take her atenolol the morning of surgery with a sip of water.",PAIN,ACETAMINOPHEN,RO-may_treat
503007613,7/14/2014 22:29:28,,1323145773,7/14/2014 22:29:01,instagc,0.5867,23149109,USA,NC,Durham,75.189.206.205,ACETAMINOPHEN treats PAIN,81,32,,84,45,treats,0.993883734673619,907827-FS1-2,"She is given a prescription for ACETAMINOPHEN with codeine to take as needed for PAIN the week before surgery, and she is instructed to take her atenolol the morning of surgery with a sip of water.",PAIN,ACETAMINOPHEN,RO-may_treat
503007613,7/14/2014 22:32:08,,1323146951,7/14/2014 22:32:03,clixsense,0.3016,25419319,GBR,H8,Liverpool,94.4.192.228,PAIN treats ACETAMINOPHEN,81,32,,84,45,treats,0.993883734673619,907827-FS1-2,"She is given a prescription for ACETAMINOPHEN with codeine to take as needed for PAIN the week before surgery, and she is instructed to take her atenolol the morning of surgery with a sip of water.",PAIN,ACETAMINOPHEN,RO-may_treat
503007615,7/14/2014 20:33:05,,1323082232,7/14/2014 20:32:48,clixsense,0.9583,27871219,NLD,07,Amsterdam,87.210.207.223,DEFERIPRONE AND DEFEROXAMINE (DFO) treats MYOCARDIAL IRON OVERLOAD,134,77,,157,111,treats,1.0,907233-FS1-2,"Regarding iron chelation treatment, patients receiving combined therapy with DEFERIPRONE AND DEFEROXAMINE (DFO) significantly reduced MYOCARDIAL IRON OVERLOAD during the 4 yr study period, whilst patients in monotherapy with DFO showed a significant increase in LIC.",MYOCARDIAL IRON OVERLOAD,DEFERIPRONE AND DEFEROXAMINE (DFO),RO-may_prevent
503007615,7/14/2014 20:34:46,,1323083033,7/14/2014 20:34:31,neodev,0.9583,21515166,NLD,11,Nootdorp,83.86.58.179,DEFERIPRONE AND DEFEROXAMINE (DFO) treats MYOCARDIAL IRON OVERLOAD,134,77,,157,111,treats,1.0,907233-FS1-2,"Regarding iron chelation treatment, patients receiving combined therapy with DEFERIPRONE AND DEFEROXAMINE (DFO) significantly reduced MYOCARDIAL IRON OVERLOAD during the 4 yr study period, whilst patients in monotherapy with DFO showed a significant increase in LIC.",MYOCARDIAL IRON OVERLOAD,DEFERIPRONE AND DEFEROXAMINE (DFO),RO-may_prevent
503007615,7/14/2014 20:48:20,,1323089843,7/14/2014 20:47:54,zoombucks,0.875,28232452,USA,NC,Cary,174.97.217.113,DEFERIPRONE AND DEFEROXAMINE (DFO) treats MYOCARDIAL IRON OVERLOAD,134,77,,157,111,treats,1.0,907233-FS1-2,"Regarding iron chelation treatment, patients receiving combined therapy with DEFERIPRONE AND DEFEROXAMINE (DFO) significantly reduced MYOCARDIAL IRON OVERLOAD during the 4 yr study period, whilst patients in monotherapy with DFO showed a significant increase in LIC.",MYOCARDIAL IRON OVERLOAD,DEFERIPRONE AND DEFEROXAMINE (DFO),RO-may_prevent
503007615,7/14/2014 21:14:11,,1323103026,7/14/2014 21:13:49,elite,0.8694,28276268,USA,MI,Taylor,67.149.247.166,DEFERIPRONE AND DEFEROXAMINE (DFO) treats MYOCARDIAL IRON OVERLOAD,134,77,,157,111,treats,1.0,907233-FS1-2,"Regarding iron chelation treatment, patients receiving combined therapy with DEFERIPRONE AND DEFEROXAMINE (DFO) significantly reduced MYOCARDIAL IRON OVERLOAD during the 4 yr study period, whilst patients in monotherapy with DFO showed a significant increase in LIC.",MYOCARDIAL IRON OVERLOAD,DEFERIPRONE AND DEFEROXAMINE (DFO),RO-may_prevent
503007615,7/14/2014 21:40:55,,1323117316,7/14/2014 21:40:18,instagc,0.7958,28301350,GBR,K4,Plymouth,92.28.215.248,DEFERIPRONE AND DEFEROXAMINE (DFO) treats MYOCARDIAL IRON OVERLOAD,134,77,,157,111,treats,1.0,907233-FS1-2,"Regarding iron chelation treatment, patients receiving combined therapy with DEFERIPRONE AND DEFEROXAMINE (DFO) significantly reduced MYOCARDIAL IRON OVERLOAD during the 4 yr study period, whilst patients in monotherapy with DFO showed a significant increase in LIC.",MYOCARDIAL IRON OVERLOAD,DEFERIPRONE AND DEFEROXAMINE (DFO),RO-may_prevent
503007615,7/14/2014 21:51:43,,1323124746,7/14/2014 21:51:01,clixsense,0.5155,26889820,GBR,C3,Shelford,92.18.120.203,no_relation,134,77,,157,111,treats,1.0,907233-FS1-2,"Regarding iron chelation treatment, patients receiving combined therapy with DEFERIPRONE AND DEFEROXAMINE (DFO) significantly reduced MYOCARDIAL IRON OVERLOAD during the 4 yr study period, whilst patients in monotherapy with DFO showed a significant increase in LIC.",MYOCARDIAL IRON OVERLOAD,DEFERIPRONE AND DEFEROXAMINE (DFO),RO-may_prevent
503007615,7/14/2014 22:07:31,,1323132443,7/14/2014 22:07:17,instagc,0.5915,18960682,GBR,,,86.29.147.112,DEFERIPRONE AND DEFEROXAMINE (DFO) treats MYOCARDIAL IRON OVERLOAD,134,77,,157,111,treats,1.0,907233-FS1-2,"Regarding iron chelation treatment, patients receiving combined therapy with DEFERIPRONE AND DEFEROXAMINE (DFO) significantly reduced MYOCARDIAL IRON OVERLOAD during the 4 yr study period, whilst patients in monotherapy with DFO showed a significant increase in LIC.",MYOCARDIAL IRON OVERLOAD,DEFERIPRONE AND DEFEROXAMINE (DFO),RO-may_prevent
503007619,7/14/2014 20:45:51,,1323088608,7/14/2014 20:45:48,instagc,0.6111,25990856,USA,NV,Las Vegas,68.108.98.78,OSTEOARTHRITIS THAT INVOLVES JOINTS is location of OSTEOARTHRITIS,234,234,,268,248,is location of,0.480384461415261,902437-FS1-9,C]  Specific recommendation: ? Consider referral to a rheumatologist for diagnostic consultation for CPPD disease/pseudogout in patients with: ? Inflammatory arthritis ? Osteoarthritis that appears to have an inflammatory component ? OSTEOARTHRITIS THAT INVOLVES JOINTS that are not usually affected by OSTEOARTHRITIS ? Consider referral to other specialists for patients with signs and symptoms of other underlying diseases such as: ? Hemochromatosis ? Hyperparathyroidism ? Acromegaly ? See module  Osteoarthritis.,OSTEOARTHRITIS THAT INVOLVES JOINTS,OSTEOARTHRITIS,RO-disease_has_primary_anatomic_site
503007619,7/14/2014 21:13:08,,1323102568,7/14/2014 21:12:39,elite,0.8694,28276268,USA,MI,Taylor,67.149.247.166,OSTEOARTHRITIS THAT INVOLVES JOINTS is location of OSTEOARTHRITIS,234,234,,268,248,is location of,0.480384461415261,902437-FS1-9,C]  Specific recommendation: ? Consider referral to a rheumatologist for diagnostic consultation for CPPD disease/pseudogout in patients with: ? Inflammatory arthritis ? Osteoarthritis that appears to have an inflammatory component ? OSTEOARTHRITIS THAT INVOLVES JOINTS that are not usually affected by OSTEOARTHRITIS ? Consider referral to other specialists for patients with signs and symptoms of other underlying diseases such as: ? Hemochromatosis ? Hyperparathyroidism ? Acromegaly ? See module  Osteoarthritis.,OSTEOARTHRITIS THAT INVOLVES JOINTS,OSTEOARTHRITIS,RO-disease_has_primary_anatomic_site
503007619,7/14/2014 21:31:15,,1323111418,7/14/2014 21:30:45,instagc,0.6498,19602039,USA,WA,Bellevue,50.135.214.140,no_relation,234,234,,268,248,is location of,0.480384461415261,902437-FS1-9,C]  Specific recommendation: ? Consider referral to a rheumatologist for diagnostic consultation for CPPD disease/pseudogout in patients with: ? Inflammatory arthritis ? Osteoarthritis that appears to have an inflammatory component ? OSTEOARTHRITIS THAT INVOLVES JOINTS that are not usually affected by OSTEOARTHRITIS ? Consider referral to other specialists for patients with signs and symptoms of other underlying diseases such as: ? Hemochromatosis ? Hyperparathyroidism ? Acromegaly ? See module  Osteoarthritis.,OSTEOARTHRITIS THAT INVOLVES JOINTS,OSTEOARTHRITIS,RO-disease_has_primary_anatomic_site
503007619,7/14/2014 21:32:05,,1323111852,7/14/2014 21:31:40,tremorgames,0.5903,28013393,USA,CA,Rancho Cordova,71.197.67.37,OSTEOARTHRITIS THAT INVOLVES JOINTS is location of OSTEOARTHRITIS,234,234,,268,248,is location of,0.480384461415261,902437-FS1-9,C]  Specific recommendation: ? Consider referral to a rheumatologist for diagnostic consultation for CPPD disease/pseudogout in patients with: ? Inflammatory arthritis ? Osteoarthritis that appears to have an inflammatory component ? OSTEOARTHRITIS THAT INVOLVES JOINTS that are not usually affected by OSTEOARTHRITIS ? Consider referral to other specialists for patients with signs and symptoms of other underlying diseases such as: ? Hemochromatosis ? Hyperparathyroidism ? Acromegaly ? See module  Osteoarthritis.,OSTEOARTHRITIS THAT INVOLVES JOINTS,OSTEOARTHRITIS,RO-disease_has_primary_anatomic_site
503007619,7/14/2014 21:44:24,,1323120073,7/14/2014 21:44:12,prodege,0.5819,2143114,CAN,BC,Vancouver,24.84.160.12,OSTEOARTHRITIS is location of OSTEOARTHRITIS THAT INVOLVES JOINTS,234,234,,268,248,is location of,0.480384461415261,902437-FS1-9,C]  Specific recommendation: ? Consider referral to a rheumatologist for diagnostic consultation for CPPD disease/pseudogout in patients with: ? Inflammatory arthritis ? Osteoarthritis that appears to have an inflammatory component ? OSTEOARTHRITIS THAT INVOLVES JOINTS that are not usually affected by OSTEOARTHRITIS ? Consider referral to other specialists for patients with signs and symptoms of other underlying diseases such as: ? Hemochromatosis ? Hyperparathyroidism ? Acromegaly ? See module  Osteoarthritis.,OSTEOARTHRITIS THAT INVOLVES JOINTS,OSTEOARTHRITIS,RO-disease_has_primary_anatomic_site
503007619,7/14/2014 21:47:46,,1323122694,7/14/2014 21:46:59,instagc,0.6292,21551272,GBR,E6,Chipping Campden,78.145.193.123,no_relation,234,234,,268,248,is location of,0.480384461415261,902437-FS1-9,C]  Specific recommendation: ? Consider referral to a rheumatologist for diagnostic consultation for CPPD disease/pseudogout in patients with: ? Inflammatory arthritis ? Osteoarthritis that appears to have an inflammatory component ? OSTEOARTHRITIS THAT INVOLVES JOINTS that are not usually affected by OSTEOARTHRITIS ? Consider referral to other specialists for patients with signs and symptoms of other underlying diseases such as: ? Hemochromatosis ? Hyperparathyroidism ? Acromegaly ? See module  Osteoarthritis.,OSTEOARTHRITIS THAT INVOLVES JOINTS,OSTEOARTHRITIS,RO-disease_has_primary_anatomic_site
503007619,7/14/2014 22:07:17,,1323132245,7/14/2014 22:06:56,instagc,0.5915,18960682,GBR,,,86.29.147.112,no_relation,234,234,,268,248,is location of,0.480384461415261,902437-FS1-9,C]  Specific recommendation: ? Consider referral to a rheumatologist for diagnostic consultation for CPPD disease/pseudogout in patients with: ? Inflammatory arthritis ? Osteoarthritis that appears to have an inflammatory component ? OSTEOARTHRITIS THAT INVOLVES JOINTS that are not usually affected by OSTEOARTHRITIS ? Consider referral to other specialists for patients with signs and symptoms of other underlying diseases such as: ? Hemochromatosis ? Hyperparathyroidism ? Acromegaly ? See module  Osteoarthritis.,OSTEOARTHRITIS THAT INVOLVES JOINTS,OSTEOARTHRITIS,RO-disease_has_primary_anatomic_site
503007635,7/14/2014 20:42:40,,1323086991,7/14/2014 20:41:50,elite,0.875,28503042,USA,NJ,Woodbridge,54.191.150.115,no_relation,63,208,,80,228,diagnosed by,0.937042571331636,902099-FS1-13,"In conclusion, NSE was considered to be very useful as a tumor MARKER OF THE LUNG especially in small cell carcinoma for diagnosis and determination of disease extent and response to therapy, and also in non SMALL CELL CARCINOMA for the evaluation of treatment effectiveness.",MARKER OF THE LUNG,SMALL CELL CARCINOMA,RO-disease_has_primary_anatomic_site
503007635,7/14/2014 21:23:37,,1323107251,7/14/2014 21:23:27,clixsense,0.5625,16827630,GBR,A7,Birmingham,86.146.169.103,SMALL CELL CARCINOMA diagnosed by MARKER OF THE LUNG,63,208,,80,228,diagnosed by,0.937042571331636,902099-FS1-13,"In conclusion, NSE was considered to be very useful as a tumor MARKER OF THE LUNG especially in small cell carcinoma for diagnosis and determination of disease extent and response to therapy, and also in non SMALL CELL CARCINOMA for the evaluation of treatment effectiveness.",MARKER OF THE LUNG,SMALL CELL CARCINOMA,RO-disease_has_primary_anatomic_site
503007635,7/14/2014 21:26:16,,1323108639,7/14/2014 21:26:06,prodege,0.7306,23541832,USA,AZ,Tempe,149.169.129.225,SMALL CELL CARCINOMA diagnosed by MARKER OF THE LUNG,63,208,,80,228,diagnosed by,0.937042571331636,902099-FS1-13,"In conclusion, NSE was considered to be very useful as a tumor MARKER OF THE LUNG especially in small cell carcinoma for diagnosis and determination of disease extent and response to therapy, and also in non SMALL CELL CARCINOMA for the evaluation of treatment effectiveness.",MARKER OF THE LUNG,SMALL CELL CARCINOMA,RO-disease_has_primary_anatomic_site
503007635,7/14/2014 21:30:07,,1323110806,7/14/2014 21:29:11,instagc,0.6498,19602039,USA,WA,Bellevue,50.135.214.140,no_relation,63,208,,80,228,diagnosed by,0.937042571331636,902099-FS1-13,"In conclusion, NSE was considered to be very useful as a tumor MARKER OF THE LUNG especially in small cell carcinoma for diagnosis and determination of disease extent and response to therapy, and also in non SMALL CELL CARCINOMA for the evaluation of treatment effectiveness.",MARKER OF THE LUNG,SMALL CELL CARCINOMA,RO-disease_has_primary_anatomic_site
503007635,7/14/2014 21:37:20,,1323114750,7/14/2014 21:37:14,clixsense,0.4925,19162475,GBR,M3,Frome,82.33.126.30,SMALL CELL CARCINOMA diagnosed by MARKER OF THE LUNG,63,208,,80,228,diagnosed by,0.937042571331636,902099-FS1-13,"In conclusion, NSE was considered to be very useful as a tumor MARKER OF THE LUNG especially in small cell carcinoma for diagnosis and determination of disease extent and response to therapy, and also in non SMALL CELL CARCINOMA for the evaluation of treatment effectiveness.",MARKER OF THE LUNG,SMALL CELL CARCINOMA,RO-disease_has_primary_anatomic_site
503007635,7/14/2014 21:44:20,,1323120010,7/14/2014 21:44:00,neodev,0.6153,27597779,CAN,AB,Calgary,72.29.251.209,no_relation,63,208,,80,228,diagnosed by,0.937042571331636,902099-FS1-13,"In conclusion, NSE was considered to be very useful as a tumor MARKER OF THE LUNG especially in small cell carcinoma for diagnosis and determination of disease extent and response to therapy, and also in non SMALL CELL CARCINOMA for the evaluation of treatment effectiveness.",MARKER OF THE LUNG,SMALL CELL CARCINOMA,RO-disease_has_primary_anatomic_site
503007635,7/14/2014 22:29:18,,1323145694,7/14/2014 22:28:30,clixsense,0.5752,15189335,GBR,K3,Peterborough,81.156.166.189,SMALL CELL CARCINOMA diagnosed by MARKER OF THE LUNG,63,208,,80,228,diagnosed by,0.937042571331636,902099-FS1-13,"In conclusion, NSE was considered to be very useful as a tumor MARKER OF THE LUNG especially in small cell carcinoma for diagnosis and determination of disease extent and response to therapy, and also in non SMALL CELL CARCINOMA for the evaluation of treatment effectiveness.",MARKER OF THE LUNG,SMALL CELL CARCINOMA,RO-disease_has_primary_anatomic_site
503007642,7/14/2014 20:34:15,,1323082798,7/14/2014 20:33:57,clixsense,0.9583,27871219,NLD,07,Amsterdam,87.210.207.223,BONE is location of OSTEOMYELITIS,99,66,,102,79,is location of,0.824163383692134,902221-FS1-9,"In a 5 1/2 year retrospective study of hospitalized children with OSTEOMYELITIS who had technetium BONE scans, we found that 32 of 38 (84%) had increased radionuclide uptake, 4 (11%) had normal uptake and 2 (5%) had decreased uptake.",BONE,OSTEOMYELITIS,RO-disease_has_primary_anatomic_site
503007642,7/14/2014 20:49:01,,1323090218,7/14/2014 20:48:42,zoombucks,0.875,28232452,USA,NC,Cary,174.97.217.113,BONE is location of OSTEOMYELITIS,99,66,,102,79,is location of,0.824163383692134,902221-FS1-9,"In a 5 1/2 year retrospective study of hospitalized children with OSTEOMYELITIS who had technetium BONE scans, we found that 32 of 38 (84%) had increased radionuclide uptake, 4 (11%) had normal uptake and 2 (5%) had decreased uptake.",BONE,OSTEOMYELITIS,RO-disease_has_primary_anatomic_site
503007642,7/14/2014 21:37:40,,1323114958,7/14/2014 21:37:35,clixsense,0.4925,19162475,GBR,M3,Frome,82.33.126.30,OSTEOMYELITIS is location of BONE,99,66,,102,79,is location of,0.824163383692134,902221-FS1-9,"In a 5 1/2 year retrospective study of hospitalized children with OSTEOMYELITIS who had technetium BONE scans, we found that 32 of 38 (84%) had increased radionuclide uptake, 4 (11%) had normal uptake and 2 (5%) had decreased uptake.",BONE,OSTEOMYELITIS,RO-disease_has_primary_anatomic_site
503007642,7/14/2014 21:44:37,,1323120386,7/14/2014 21:44:21,neodev,0.6153,27597779,CAN,AB,Calgary,72.29.251.209,BONE is location of OSTEOMYELITIS,99,66,,102,79,is location of,0.824163383692134,902221-FS1-9,"In a 5 1/2 year retrospective study of hospitalized children with OSTEOMYELITIS who had technetium BONE scans, we found that 32 of 38 (84%) had increased radionuclide uptake, 4 (11%) had normal uptake and 2 (5%) had decreased uptake.",BONE,OSTEOMYELITIS,RO-disease_has_primary_anatomic_site
503007642,7/14/2014 21:47:46,,1323122691,7/14/2014 21:46:59,instagc,0.6292,21551272,GBR,E6,Chipping Campden,78.145.193.123,BONE is location of OSTEOMYELITIS,99,66,,102,79,is location of,0.824163383692134,902221-FS1-9,"In a 5 1/2 year retrospective study of hospitalized children with OSTEOMYELITIS who had technetium BONE scans, we found that 32 of 38 (84%) had increased radionuclide uptake, 4 (11%) had normal uptake and 2 (5%) had decreased uptake.",BONE,OSTEOMYELITIS,RO-disease_has_primary_anatomic_site
503007642,7/14/2014 22:28:28,,1323145365,7/14/2014 22:28:13,clixsense,0.5752,15189335,GBR,K3,Peterborough,81.156.166.189,BONE is location of OSTEOMYELITIS,99,66,,102,79,is location of,0.824163383692134,902221-FS1-9,"In a 5 1/2 year retrospective study of hospitalized children with OSTEOMYELITIS who had technetium BONE scans, we found that 32 of 38 (84%) had increased radionuclide uptake, 4 (11%) had normal uptake and 2 (5%) had decreased uptake.",BONE,OSTEOMYELITIS,RO-disease_has_primary_anatomic_site
503007642,7/14/2014 22:32:20,,1323147017,7/14/2014 22:32:15,clixsense,0.3016,25419319,GBR,H8,Liverpool,94.4.192.228,OSTEOMYELITIS is location of BONE,99,66,,102,79,is location of,0.824163383692134,902221-FS1-9,"In a 5 1/2 year retrospective study of hospitalized children with OSTEOMYELITIS who had technetium BONE scans, we found that 32 of 38 (84%) had increased radionuclide uptake, 4 (11%) had normal uptake and 2 (5%) had decreased uptake.",BONE,OSTEOMYELITIS,RO-disease_has_primary_anatomic_site
503223341,7/15/2014 10:26:02,,1323486534,7/15/2014 10:25:36,rewardsspot,0.8889,24482174,GBR,H9,London,46.23.68.180,PREGNANCY contraindicates CAPTOPRIL,41,6,,49,15,contraindicates,0.9707253433941508,901494-FS1-10,"?  If PREGNANCY is detected, discontinue CAPTOPRIL as soon as possible.",CAPTOPRIL,PREGNANCY,RO-contraindicated_drug
503223341,7/15/2014 10:52:42,,1323504934,7/15/2014 10:52:15,rewardsspot,0.6319,17763704,USA,VA,Manassas,198.7.62.204,CAPTOPRIL contraindicates PREGNANCY,41,6,,49,15,contraindicates,0.9707253433941508,901494-FS1-10,"?  If PREGNANCY is detected, discontinue CAPTOPRIL as soon as possible.",CAPTOPRIL,PREGNANCY,RO-contraindicated_drug
503223341,7/15/2014 11:03:55,,1323511882,7/15/2014 11:03:34,prodege,0.6528,28039757,GBR,L8,Southport,109.155.158.54,no_relation,41,6,,49,15,contraindicates,0.9707253433941508,901494-FS1-10,"?  If PREGNANCY is detected, discontinue CAPTOPRIL as soon as possible.",CAPTOPRIL,PREGNANCY,RO-contraindicated_drug
503223341,7/15/2014 11:11:43,,1323518563,7/15/2014 11:11:05,elite,0.7417,28397222,GBR,Y4,Usk,31.50.223.75,PREGNANCY contraindicates CAPTOPRIL,41,6,,49,15,contraindicates,0.9707253433941508,901494-FS1-10,"?  If PREGNANCY is detected, discontinue CAPTOPRIL as soon as possible.",CAPTOPRIL,PREGNANCY,RO-contraindicated_drug
503223341,7/15/2014 11:12:25,,1323519099,7/15/2014 11:11:59,prodege,0.7681,11864493,GBR,Z4,Wrexham,212.219.196.69,no_relation,41,6,,49,15,contraindicates,0.9707253433941508,901494-FS1-10,"?  If PREGNANCY is detected, discontinue CAPTOPRIL as soon as possible.",CAPTOPRIL,PREGNANCY,RO-contraindicated_drug
503223341,7/15/2014 11:48:29,,1323540105,7/15/2014 11:48:15,neodev,0.6637,21515166,NLD,11,Nootdorp,83.86.58.179,CAPTOPRIL contraindicates PREGNANCY,41,6,,49,15,contraindicates,0.9707253433941508,901494-FS1-10,"?  If PREGNANCY is detected, discontinue CAPTOPRIL as soon as possible.",CAPTOPRIL,PREGNANCY,RO-contraindicated_drug
503223341,7/15/2014 13:50:10,,1323586788,7/15/2014 13:49:47,prodege,0.6706,13795372,CAN,NS,Dartmouth,142.68.155.182,no_relation,41,6,,49,15,contraindicates,0.9707253433941508,901494-FS1-10,"?  If PREGNANCY is detected, discontinue CAPTOPRIL as soon as possible.",CAPTOPRIL,PREGNANCY,RO-contraindicated_drug
503223342,7/15/2014 11:51:46,,1323542305,7/15/2014 11:51:12,neodev,0.6736,24578640,USA,IL,Chicago,65.60.20.66,TRICHOFOLLICULOMA contraindicates FOLLICULAR DIFFERENTIATION,87,171,,112,188,contraindicates,0.4,901731-FS1-10,We report a nodular lesion that was identified histopathologically as a hamartoma with FOLLICULAR DIFFERENTIATION and that systematic serial sectioning showed not to be a TRICHOFOLLICULOMA,FOLLICULAR DIFFERENTIATION,TRICHOFOLLICULOMA,RO-disease_has_finding
503223342,7/15/2014 12:39:57,,1323561739,7/15/2014 12:39:41,instagc,0.7472,18960682,GBR,,,86.29.147.112,FOLLICULAR DIFFERENTIATION contraindicates TRICHOFOLLICULOMA,87,171,,112,188,contraindicates,0.4,901731-FS1-10,We report a nodular lesion that was identified histopathologically as a hamartoma with FOLLICULAR DIFFERENTIATION and that systematic serial sectioning showed not to be a TRICHOFOLLICULOMA,FOLLICULAR DIFFERENTIATION,TRICHOFOLLICULOMA,RO-disease_has_finding
503223342,7/15/2014 13:47:28,,1323586075,7/15/2014 13:46:56,prodege,0.6706,13795372,CAN,NS,Dartmouth,142.68.155.182,FOLLICULAR DIFFERENTIATION contraindicates TRICHOFOLLICULOMA,87,171,,112,188,contraindicates,0.4,901731-FS1-10,We report a nodular lesion that was identified histopathologically as a hamartoma with FOLLICULAR DIFFERENTIATION and that systematic serial sectioning showed not to be a TRICHOFOLLICULOMA,FOLLICULAR DIFFERENTIATION,TRICHOFOLLICULOMA,RO-disease_has_finding
503223342,7/15/2014 14:29:03,,1323597929,7/15/2014 14:28:47,elite,0.6381,28276268,USA,FL,Boynton Beach,99.114.225.45,FOLLICULAR DIFFERENTIATION contraindicates TRICHOFOLLICULOMA,87,171,,112,188,contraindicates,0.4,901731-FS1-10,We report a nodular lesion that was identified histopathologically as a hamartoma with FOLLICULAR DIFFERENTIATION and that systematic serial sectioning showed not to be a TRICHOFOLLICULOMA,FOLLICULAR DIFFERENTIATION,TRICHOFOLLICULOMA,RO-disease_has_finding
503223342,7/15/2014 14:32:41,,1323599028,7/15/2014 14:32:36,neodev,0.3913,25224036,CAN,ON,Sudbury,67.204.218.187,FOLLICULAR DIFFERENTIATION contraindicates TRICHOFOLLICULOMA,87,171,,112,188,contraindicates,0.4,901731-FS1-10,We report a nodular lesion that was identified histopathologically as a hamartoma with FOLLICULAR DIFFERENTIATION and that systematic serial sectioning showed not to be a TRICHOFOLLICULOMA,FOLLICULAR DIFFERENTIATION,TRICHOFOLLICULOMA,RO-disease_has_finding
503223342,7/15/2014 16:25:16,,1323671678,7/15/2014 16:25:03,clixsense,0.475,16827630,GBR,A7,Birmingham,86.146.169.103,FOLLICULAR DIFFERENTIATION contraindicates TRICHOFOLLICULOMA,87,171,,112,188,contraindicates,0.4,901731-FS1-10,We report a nodular lesion that was identified histopathologically as a hamartoma with FOLLICULAR DIFFERENTIATION and that systematic serial sectioning showed not to be a TRICHOFOLLICULOMA,FOLLICULAR DIFFERENTIATION,TRICHOFOLLICULOMA,RO-disease_has_finding
503223342,7/15/2014 16:45:38,,1323696032,7/15/2014 16:45:30,prodege,0.474,2143114,CAN,BC,Vancouver,24.84.160.12,TRICHOFOLLICULOMA contraindicates FOLLICULAR DIFFERENTIATION,87,171,,112,188,contraindicates,0.4,901731-FS1-10,We report a nodular lesion that was identified histopathologically as a hamartoma with FOLLICULAR DIFFERENTIATION and that systematic serial sectioning showed not to be a TRICHOFOLLICULOMA,FOLLICULAR DIFFERENTIATION,TRICHOFOLLICULOMA,RO-disease_has_finding
503223348,7/15/2014 10:29:09,,1323488646,7/15/2014 10:28:26,vivatic,0.8056,25451531,GBR,,,83.67.28.193,THE TREATMENT OF VULVODYNIA FOUND THAT 17 causes ROBUST REDUCTION IN PAIN,124,49,,147,90,causes,0.42426406871192895,904958-FS1-4,"? An open label, 8 week trial of lamotrigine for THE TREATMENT OF VULVODYNIA FOUND THAT 17 of 31 participants experienced a ROBUST REDUCTION IN PAIN ( 55.",ROBUST REDUCTION IN PAIN,THE TREATMENT OF VULVODYNIA FOUND THAT 17,RO-has_definitional_manifestation
503223348,7/15/2014 10:30:58,,1323489844,7/15/2014 10:30:50,clixsense,0.6875,19162475,GBR,M3,Frome,82.33.126.30,ROBUST REDUCTION IN PAIN causes THE TREATMENT OF VULVODYNIA FOUND THAT 17,124,49,,147,90,causes,0.42426406871192895,904958-FS1-4,"? An open label, 8 week trial of lamotrigine for THE TREATMENT OF VULVODYNIA FOUND THAT 17 of 31 participants experienced a ROBUST REDUCTION IN PAIN ( 55.",ROBUST REDUCTION IN PAIN,THE TREATMENT OF VULVODYNIA FOUND THAT 17,RO-has_definitional_manifestation
503223348,7/15/2014 11:15:18,,1323520845,7/15/2014 11:15:03,clixsense,0.8306,27871219,NLD,07,Amsterdam,87.210.207.223,THE TREATMENT OF VULVODYNIA FOUND THAT 17 causes ROBUST REDUCTION IN PAIN,124,49,,147,90,causes,0.42426406871192895,904958-FS1-4,"? An open label, 8 week trial of lamotrigine for THE TREATMENT OF VULVODYNIA FOUND THAT 17 of 31 participants experienced a ROBUST REDUCTION IN PAIN ( 55.",ROBUST REDUCTION IN PAIN,THE TREATMENT OF VULVODYNIA FOUND THAT 17,RO-has_definitional_manifestation
503223348,7/15/2014 11:18:32,,1323523008,7/15/2014 11:18:02,instagc,0.7264,24252915,GBR,B7,Bristol,77.98.139.82,THE TREATMENT OF VULVODYNIA FOUND THAT 17 causes ROBUST REDUCTION IN PAIN,124,49,,147,90,causes,0.42426406871192895,904958-FS1-4,"? An open label, 8 week trial of lamotrigine for THE TREATMENT OF VULVODYNIA FOUND THAT 17 of 31 participants experienced a ROBUST REDUCTION IN PAIN ( 55.",ROBUST REDUCTION IN PAIN,THE TREATMENT OF VULVODYNIA FOUND THAT 17,RO-has_definitional_manifestation
503223348,7/15/2014 11:20:24,,1323524124,7/15/2014 11:20:07,instagc,0.8431,13763729,USA,,,75.182.89.225,no_relation,124,49,,147,90,causes,0.42426406871192895,904958-FS1-4,"? An open label, 8 week trial of lamotrigine for THE TREATMENT OF VULVODYNIA FOUND THAT 17 of 31 participants experienced a ROBUST REDUCTION IN PAIN ( 55.",ROBUST REDUCTION IN PAIN,THE TREATMENT OF VULVODYNIA FOUND THAT 17,RO-has_definitional_manifestation
503223348,7/15/2014 11:27:54,,1323528271,7/15/2014 11:27:20,elite,0.7417,28397222,GBR,Y4,Usk,31.50.223.75,no_relation,124,49,,147,90,causes,0.42426406871192895,904958-FS1-4,"? An open label, 8 week trial of lamotrigine for THE TREATMENT OF VULVODYNIA FOUND THAT 17 of 31 participants experienced a ROBUST REDUCTION IN PAIN ( 55.",ROBUST REDUCTION IN PAIN,THE TREATMENT OF VULVODYNIA FOUND THAT 17,RO-has_definitional_manifestation
503223348,7/15/2014 11:38:25,,1323534406,7/15/2014 11:37:56,clixsense,0.5726,23233834,GBR,N6,Sunderland,86.17.58.181,THE TREATMENT OF VULVODYNIA FOUND THAT 17 causes ROBUST REDUCTION IN PAIN,124,49,,147,90,causes,0.42426406871192895,904958-FS1-4,"? An open label, 8 week trial of lamotrigine for THE TREATMENT OF VULVODYNIA FOUND THAT 17 of 31 participants experienced a ROBUST REDUCTION IN PAIN ( 55.",ROBUST REDUCTION IN PAIN,THE TREATMENT OF VULVODYNIA FOUND THAT 17,RO-has_definitional_manifestation
503223350,7/15/2014 11:11:04,,1323518052,7/15/2014 11:10:08,elite,0.7417,28397222,GBR,Y4,Usk,31.50.223.75,DIABETES causes DIABETIC NEUROPATHY,105,44,,123,52,causes,0.977355554850442,900157-FS1-4,"The physician should ask about a history of DIABETES of long duration, including other manifestations of DIABETIC NEUROPATHY",DIABETIC NEUROPATHY,DIABETES,RO-cause_of
503223350,7/15/2014 11:20:30,,1323524211,7/15/2014 11:20:05,instagc,0.7264,24252915,GBR,B7,Bristol,77.98.139.82,DIABETIC NEUROPATHY causes DIABETES,105,44,,123,52,causes,0.977355554850442,900157-FS1-4,"The physician should ask about a history of DIABETES of long duration, including other manifestations of DIABETIC NEUROPATHY",DIABETIC NEUROPATHY,DIABETES,RO-cause_of
503223350,7/15/2014 12:23:52,,1323555752,7/15/2014 12:23:23,paiddailysurveys,0.6127,11786001,USA,NC,Charlotte,71.28.89.238,DIABETES causes DIABETIC NEUROPATHY,105,44,,123,52,causes,0.977355554850442,900157-FS1-4,"The physician should ask about a history of DIABETES of long duration, including other manifestations of DIABETIC NEUROPATHY",DIABETIC NEUROPATHY,DIABETES,RO-cause_of
503223350,7/15/2014 12:36:57,,1323560598,7/15/2014 12:36:40,prodege,0.5236,1852770,USA,TX,Abilene,76.198.102.54,DIABETES causes DIABETIC NEUROPATHY,105,44,,123,52,causes,0.977355554850442,900157-FS1-4,"The physician should ask about a history of DIABETES of long duration, including other manifestations of DIABETIC NEUROPATHY",DIABETIC NEUROPATHY,DIABETES,RO-cause_of
503223350,7/15/2014 13:30:01,,1323580301,7/15/2014 13:29:39,instagc,0.5063,23149109,USA,NC,Cary,24.206.38.18,DIABETIC NEUROPATHY causes DIABETES,105,44,,123,52,causes,0.977355554850442,900157-FS1-4,"The physician should ask about a history of DIABETES of long duration, including other manifestations of DIABETIC NEUROPATHY",DIABETIC NEUROPATHY,DIABETES,RO-cause_of
503223350,7/15/2014 14:32:56,,1323599145,7/15/2014 14:32:50,neodev,0.3913,25224036,CAN,ON,Sudbury,67.204.218.187,DIABETIC NEUROPATHY causes DIABETES,105,44,,123,52,causes,0.977355554850442,900157-FS1-4,"The physician should ask about a history of DIABETES of long duration, including other manifestations of DIABETIC NEUROPATHY",DIABETIC NEUROPATHY,DIABETES,RO-cause_of
503223350,7/15/2014 15:53:15,,1323643735,7/15/2014 15:53:01,neodev,0.624,14861092,GBR,I2,Manchester,90.194.137.76,DIABETES causes DIABETIC NEUROPATHY,105,44,,123,52,causes,0.977355554850442,900157-FS1-4,"The physician should ask about a history of DIABETES of long duration, including other manifestations of DIABETIC NEUROPATHY",DIABETIC NEUROPATHY,DIABETES,RO-cause_of
503223355,7/15/2014 10:28:36,,1323488307,7/15/2014 10:28:14,clixsense,0.8472,19803139,NLD,06,Veldhoven,212.61.84.196,ELEVATED BLOOD PRESSURE causes THE ACCELERATION OF HYPERTENSION,165,216,,187,248,causes,0.971285862357264,904990-FS1-4,"In addition, the decrease in granularity of the RIC in the presence of extensive renal arteriolar and arterial damage suggests reduced ability to compensate for the ELEVATED BLOOD PRESSURE and thus may contribute to THE ACCELERATION OF HYPERTENSION",ELEVATED BLOOD PRESSURE,THE ACCELERATION OF HYPERTENSION,RO-has_definitional_manifestation
503223355,7/15/2014 10:31:36,,1323490268,7/15/2014 10:31:28,clixsense,0.6875,19162475,GBR,M3,Frome,82.33.126.30,ELEVATED BLOOD PRESSURE causes THE ACCELERATION OF HYPERTENSION,165,216,,187,248,causes,0.971285862357264,904990-FS1-4,"In addition, the decrease in granularity of the RIC in the presence of extensive renal arteriolar and arterial damage suggests reduced ability to compensate for the ELEVATED BLOOD PRESSURE and thus may contribute to THE ACCELERATION OF HYPERTENSION",ELEVATED BLOOD PRESSURE,THE ACCELERATION OF HYPERTENSION,RO-has_definitional_manifestation
503223355,7/15/2014 10:51:17,,1323503984,7/15/2014 10:51:01,rewardsspot,0.6319,17763704,USA,VA,Manassas,198.7.62.204,ELEVATED BLOOD PRESSURE causes THE ACCELERATION OF HYPERTENSION,165,216,,187,248,causes,0.971285862357264,904990-FS1-4,"In addition, the decrease in granularity of the RIC in the presence of extensive renal arteriolar and arterial damage suggests reduced ability to compensate for the ELEVATED BLOOD PRESSURE and thus may contribute to THE ACCELERATION OF HYPERTENSION",ELEVATED BLOOD PRESSURE,THE ACCELERATION OF HYPERTENSION,RO-has_definitional_manifestation
503223355,7/15/2014 11:25:17,,1323526797,7/15/2014 11:24:48,prodege,0.7792,15439740,AUS,02,Jannali,27.96.208.89,ELEVATED BLOOD PRESSURE causes THE ACCELERATION OF HYPERTENSION,165,216,,187,248,causes,0.971285862357264,904990-FS1-4,"In addition, the decrease in granularity of the RIC in the presence of extensive renal arteriolar and arterial damage suggests reduced ability to compensate for the ELEVATED BLOOD PRESSURE and thus may contribute to THE ACCELERATION OF HYPERTENSION",ELEVATED BLOOD PRESSURE,THE ACCELERATION OF HYPERTENSION,RO-has_definitional_manifestation
503223355,7/15/2014 12:40:12,,1323561782,7/15/2014 12:39:58,instagc,0.7472,18960682,GBR,,,86.29.147.112,ELEVATED BLOOD PRESSURE causes THE ACCELERATION OF HYPERTENSION,165,216,,187,248,causes,0.971285862357264,904990-FS1-4,"In addition, the decrease in granularity of the RIC in the presence of extensive renal arteriolar and arterial damage suggests reduced ability to compensate for the ELEVATED BLOOD PRESSURE and thus may contribute to THE ACCELERATION OF HYPERTENSION",ELEVATED BLOOD PRESSURE,THE ACCELERATION OF HYPERTENSION,RO-has_definitional_manifestation
503223355,7/15/2014 13:05:01,,1323571645,7/15/2014 13:04:52,clixsense,0.601,20614047,USA,ID,Priest River,174.32.160.124,ELEVATED BLOOD PRESSURE causes THE ACCELERATION OF HYPERTENSION,165,216,,187,248,causes,0.971285862357264,904990-FS1-4,"In addition, the decrease in granularity of the RIC in the presence of extensive renal arteriolar and arterial damage suggests reduced ability to compensate for the ELEVATED BLOOD PRESSURE and thus may contribute to THE ACCELERATION OF HYPERTENSION",ELEVATED BLOOD PRESSURE,THE ACCELERATION OF HYPERTENSION,RO-has_definitional_manifestation
503223355,7/15/2014 15:31:05,,1323627270,7/15/2014 15:30:56,tremorgames,0.5508,24449707,CAN,QC,Laval,96.21.249.72,THE ACCELERATION OF HYPERTENSION causes ELEVATED BLOOD PRESSURE,165,216,,187,248,causes,0.971285862357264,904990-FS1-4,"In addition, the decrease in granularity of the RIC in the presence of extensive renal arteriolar and arterial damage suggests reduced ability to compensate for the ELEVATED BLOOD PRESSURE and thus may contribute to THE ACCELERATION OF HYPERTENSION",ELEVATED BLOOD PRESSURE,THE ACCELERATION OF HYPERTENSION,RO-has_definitional_manifestation
503223356,7/15/2014 10:18:14,,1323481565,7/15/2014 10:17:19,gifthulk,0.9583,22144176,GBR,U8,Edinburgh,129.215.149.99,no_relation,37,108,,90,120,causes,0.5303300858899109,902461-FS1-4,"The alterations found in bone matrix CONSTITUENTS IN OSTEOPOROTIC BONE RELATIVE TO CONTROLS suggest that in OSTEOPOROSIS and fractures, not only bone mass changes, but also bone quality changes play a role in bone strength.",CONSTITUENTS IN OSTEOPOROTIC BONE RELATIVE TO CONTROLS,OSTEOPOROSIS,RO-disease_has_primary_anatomic_site
503223356,7/15/2014 11:24:45,,1323526567,7/15/2014 11:24:27,prodege,0.7792,15439740,AUS,02,Jannali,27.96.208.89,OSTEOPOROSIS causes CONSTITUENTS IN OSTEOPOROTIC BONE RELATIVE TO CONTROLS,37,108,,90,120,causes,0.5303300858899109,902461-FS1-4,"The alterations found in bone matrix CONSTITUENTS IN OSTEOPOROTIC BONE RELATIVE TO CONTROLS suggest that in OSTEOPOROSIS and fractures, not only bone mass changes, but also bone quality changes play a role in bone strength.",CONSTITUENTS IN OSTEOPOROTIC BONE RELATIVE TO CONTROLS,OSTEOPOROSIS,RO-disease_has_primary_anatomic_site
503223356,7/15/2014 12:27:08,,1323557016,7/15/2014 12:26:29,prodege,0.6058,27934334,GBR,B9,High Wycombe,86.166.72.139,no_relation,37,108,,90,120,causes,0.5303300858899109,902461-FS1-4,"The alterations found in bone matrix CONSTITUENTS IN OSTEOPOROTIC BONE RELATIVE TO CONTROLS suggest that in OSTEOPOROSIS and fractures, not only bone mass changes, but also bone quality changes play a role in bone strength.",CONSTITUENTS IN OSTEOPOROTIC BONE RELATIVE TO CONTROLS,OSTEOPOROSIS,RO-disease_has_primary_anatomic_site
503223356,7/15/2014 13:04:49,,1323571572,7/15/2014 13:04:39,clixsense,0.601,20614047,USA,ID,Priest River,174.32.160.124,no_relation,37,108,,90,120,causes,0.5303300858899109,902461-FS1-4,"The alterations found in bone matrix CONSTITUENTS IN OSTEOPOROTIC BONE RELATIVE TO CONTROLS suggest that in OSTEOPOROSIS and fractures, not only bone mass changes, but also bone quality changes play a role in bone strength.",CONSTITUENTS IN OSTEOPOROTIC BONE RELATIVE TO CONTROLS,OSTEOPOROSIS,RO-disease_has_primary_anatomic_site
503223356,7/15/2014 13:10:33,,1323573705,7/15/2014 13:10:06,neodev,0.4365,28336203,USA,PA,Harrisburg,50.149.53.150,no_relation,37,108,,90,120,causes,0.5303300858899109,902461-FS1-4,"The alterations found in bone matrix CONSTITUENTS IN OSTEOPOROTIC BONE RELATIVE TO CONTROLS suggest that in OSTEOPOROSIS and fractures, not only bone mass changes, but also bone quality changes play a role in bone strength.",CONSTITUENTS IN OSTEOPOROTIC BONE RELATIVE TO CONTROLS,OSTEOPOROSIS,RO-disease_has_primary_anatomic_site
503223356,7/15/2014 16:46:08,,1323696629,7/15/2014 16:46:02,prodege,0.474,2143114,CAN,BC,Vancouver,24.84.160.12,CONSTITUENTS IN OSTEOPOROTIC BONE RELATIVE TO CONTROLS causes OSTEOPOROSIS,37,108,,90,120,causes,0.5303300858899109,902461-FS1-4,"The alterations found in bone matrix CONSTITUENTS IN OSTEOPOROTIC BONE RELATIVE TO CONTROLS suggest that in OSTEOPOROSIS and fractures, not only bone mass changes, but also bone quality changes play a role in bone strength.",CONSTITUENTS IN OSTEOPOROTIC BONE RELATIVE TO CONTROLS,OSTEOPOROSIS,RO-disease_has_primary_anatomic_site
503223356,7/15/2014 16:49:26,,1323700213,7/15/2014 16:48:47,prodege,0.5758,23541832,USA,AZ,Tempe,149.169.145.144,no_relation,37,108,,90,120,causes,0.5303300858899109,902461-FS1-4,"The alterations found in bone matrix CONSTITUENTS IN OSTEOPOROTIC BONE RELATIVE TO CONTROLS suggest that in OSTEOPOROSIS and fractures, not only bone mass changes, but also bone quality changes play a role in bone strength.",CONSTITUENTS IN OSTEOPOROTIC BONE RELATIVE TO CONTROLS,OSTEOPOROSIS,RO-disease_has_primary_anatomic_site
503223364,7/15/2014 10:06:49,,1323474854,7/15/2014 10:06:05,eup_slw,0.9167,20818028,GBR,A7,Birmingham,92.232.139.254,no_relation,87,18,,109,31,causes,0.9704949588309459,903519-FS1-4,"Two patients with MONONUCLEOSIS one due to cytomegalovirus (CMV), and the other due to EPSTEIN BARR VIRUS (EBV presenting with high fever, malaise and hepatitis, had granulomas in the bone marrow but not in the liver.",EPSTEIN BARR VIRUS (EBV,MONONUCLEOSIS,RO-has_causative_agent
503223364,7/15/2014 10:08:52,,1323475968,7/15/2014 10:08:31,clixsense,0.875,15189335,GBR,E4,Colchester,5.67.141.89,MONONUCLEOSIS causes EPSTEIN BARR VIRUS (EBV,87,18,,109,31,causes,0.9704949588309459,903519-FS1-4,"Two patients with MONONUCLEOSIS one due to cytomegalovirus (CMV), and the other due to EPSTEIN BARR VIRUS (EBV presenting with high fever, malaise and hepatitis, had granulomas in the bone marrow but not in the liver.",EPSTEIN BARR VIRUS (EBV,MONONUCLEOSIS,RO-has_causative_agent
503223364,7/15/2014 10:52:42,,1323504933,7/15/2014 10:52:15,rewardsspot,0.6319,17763704,USA,VA,Manassas,198.7.62.204,EPSTEIN BARR VIRUS (EBV causes MONONUCLEOSIS,87,18,,109,31,causes,0.9704949588309459,903519-FS1-4,"Two patients with MONONUCLEOSIS one due to cytomegalovirus (CMV), and the other due to EPSTEIN BARR VIRUS (EBV presenting with high fever, malaise and hepatitis, had granulomas in the bone marrow but not in the liver.",EPSTEIN BARR VIRUS (EBV,MONONUCLEOSIS,RO-has_causative_agent
503223364,7/15/2014 12:12:14,,1323551174,7/15/2014 12:11:45,paiddailysurveys,0.6127,11786001,USA,NC,Charlotte,71.28.89.238,MONONUCLEOSIS causes EPSTEIN BARR VIRUS (EBV,87,18,,109,31,causes,0.9704949588309459,903519-FS1-4,"Two patients with MONONUCLEOSIS one due to cytomegalovirus (CMV), and the other due to EPSTEIN BARR VIRUS (EBV presenting with high fever, malaise and hepatitis, had granulomas in the bone marrow but not in the liver.",EPSTEIN BARR VIRUS (EBV,MONONUCLEOSIS,RO-has_causative_agent
503223364,7/15/2014 12:36:57,,1323560596,7/15/2014 12:36:40,prodege,0.5236,1852770,USA,TX,Abilene,76.198.102.54,EPSTEIN BARR VIRUS (EBV causes MONONUCLEOSIS,87,18,,109,31,causes,0.9704949588309459,903519-FS1-4,"Two patients with MONONUCLEOSIS one due to cytomegalovirus (CMV), and the other due to EPSTEIN BARR VIRUS (EBV presenting with high fever, malaise and hepatitis, had granulomas in the bone marrow but not in the liver.",EPSTEIN BARR VIRUS (EBV,MONONUCLEOSIS,RO-has_causative_agent
503223364,7/15/2014 13:46:49,,1323585933,7/15/2014 13:46:20,prodege,0.6706,13795372,CAN,NS,Dartmouth,142.68.155.182,no_relation,87,18,,109,31,causes,0.9704949588309459,903519-FS1-4,"Two patients with MONONUCLEOSIS one due to cytomegalovirus (CMV), and the other due to EPSTEIN BARR VIRUS (EBV presenting with high fever, malaise and hepatitis, had granulomas in the bone marrow but not in the liver.",EPSTEIN BARR VIRUS (EBV,MONONUCLEOSIS,RO-has_causative_agent
503223364,7/15/2014 15:51:47,,1323642670,7/15/2014 15:51:26,neodev,0.624,14861092,GBR,I2,Manchester,90.194.137.76,EPSTEIN BARR VIRUS (EBV causes MONONUCLEOSIS,87,18,,109,31,causes,0.9704949588309459,903519-FS1-4,"Two patients with MONONUCLEOSIS one due to cytomegalovirus (CMV), and the other due to EPSTEIN BARR VIRUS (EBV presenting with high fever, malaise and hepatitis, had granulomas in the bone marrow but not in the liver.",EPSTEIN BARR VIRUS (EBV,MONONUCLEOSIS,RO-has_causative_agent
503223369,7/15/2014 11:13:09,,1323519562,7/15/2014 11:12:26,prodege,0.7681,11864493,GBR,Z4,Wrexham,212.219.196.69,FIRST PROTEASOME INHIBITOR BORTEZOMIB FOR THE TREATMENT treats MULTIPLE MYELOMA,180,101,,195,156,treats,0.981980506061966,908005-FS1-2,The clinical applicability of targeting proteasomes is exemplified by the recent FDA approval of the FIRST PROTEASOME INHIBITOR BORTEZOMIB FOR THE TREATMENT of relapsed/refractory MULTIPLE MYELOMA,MULTIPLE MYELOMA,FIRST PROTEASOME INHIBITOR BORTEZOMIB FOR THE TREATMENT,RO-may_treat
503223369,7/15/2014 13:49:32,,1323586616,7/15/2014 13:48:52,prodege,0.6706,13795372,CAN,NS,Dartmouth,142.68.155.182,FIRST PROTEASOME INHIBITOR BORTEZOMIB FOR THE TREATMENT treats MULTIPLE MYELOMA,180,101,,195,156,treats,0.981980506061966,908005-FS1-2,The clinical applicability of targeting proteasomes is exemplified by the recent FDA approval of the FIRST PROTEASOME INHIBITOR BORTEZOMIB FOR THE TREATMENT of relapsed/refractory MULTIPLE MYELOMA,MULTIPLE MYELOMA,FIRST PROTEASOME INHIBITOR BORTEZOMIB FOR THE TREATMENT,RO-may_treat
503223369,7/15/2014 14:11:27,,1323592769,7/15/2014 14:11:07,neodev,0.4365,28336203,USA,PA,Harrisburg,50.149.53.150,no_relation,180,101,,195,156,treats,0.981980506061966,908005-FS1-2,The clinical applicability of targeting proteasomes is exemplified by the recent FDA approval of the FIRST PROTEASOME INHIBITOR BORTEZOMIB FOR THE TREATMENT of relapsed/refractory MULTIPLE MYELOMA,MULTIPLE MYELOMA,FIRST PROTEASOME INHIBITOR BORTEZOMIB FOR THE TREATMENT,RO-may_treat
503223369,7/15/2014 14:20:09,,1323595310,7/15/2014 14:19:44,instagc,0.6554,19636746,USA,NY,Andover,192.182.216.225,FIRST PROTEASOME INHIBITOR BORTEZOMIB FOR THE TREATMENT treats MULTIPLE MYELOMA,180,101,,195,156,treats,0.981980506061966,908005-FS1-2,The clinical applicability of targeting proteasomes is exemplified by the recent FDA approval of the FIRST PROTEASOME INHIBITOR BORTEZOMIB FOR THE TREATMENT of relapsed/refractory MULTIPLE MYELOMA,MULTIPLE MYELOMA,FIRST PROTEASOME INHIBITOR BORTEZOMIB FOR THE TREATMENT,RO-may_treat
503223369,7/15/2014 14:27:21,,1323597372,7/15/2014 14:26:59,elite,0.6381,28276268,USA,FL,Boynton Beach,99.114.225.45,FIRST PROTEASOME INHIBITOR BORTEZOMIB FOR THE TREATMENT treats MULTIPLE MYELOMA,180,101,,195,156,treats,0.981980506061966,908005-FS1-2,The clinical applicability of targeting proteasomes is exemplified by the recent FDA approval of the FIRST PROTEASOME INHIBITOR BORTEZOMIB FOR THE TREATMENT of relapsed/refractory MULTIPLE MYELOMA,MULTIPLE MYELOMA,FIRST PROTEASOME INHIBITOR BORTEZOMIB FOR THE TREATMENT,RO-may_treat
503223369,7/15/2014 15:30:03,,1323626466,7/15/2014 15:29:43,tremorgames,0.5508,24449707,CAN,QC,Laval,96.21.249.72,no_relation,180,101,,195,156,treats,0.981980506061966,908005-FS1-2,The clinical applicability of targeting proteasomes is exemplified by the recent FDA approval of the FIRST PROTEASOME INHIBITOR BORTEZOMIB FOR THE TREATMENT of relapsed/refractory MULTIPLE MYELOMA,MULTIPLE MYELOMA,FIRST PROTEASOME INHIBITOR BORTEZOMIB FOR THE TREATMENT,RO-may_treat
503223369,7/15/2014 16:25:57,,1323672417,7/15/2014 16:25:48,clixsense,0.475,16827630,GBR,A7,Birmingham,86.146.169.103,no_relation,180,101,,195,156,treats,0.981980506061966,908005-FS1-2,The clinical applicability of targeting proteasomes is exemplified by the recent FDA approval of the FIRST PROTEASOME INHIBITOR BORTEZOMIB FOR THE TREATMENT of relapsed/refractory MULTIPLE MYELOMA,MULTIPLE MYELOMA,FIRST PROTEASOME INHIBITOR BORTEZOMIB FOR THE TREATMENT,RO-may_treat
503223370,7/15/2014 10:06:49,,1323474851,7/15/2014 10:06:05,eup_slw,0.9167,20818028,GBR,A7,Birmingham,92.232.139.254,ECTOPIC PREGNANCY causes COMPLICATIONS OF PREGNANCY,38,0,,63,17,causes,0.7875615306482171,901953-FS1-4,ECTOPIC PREGNANCY is one of the major COMPLICATIONS OF PREGNANCY,COMPLICATIONS OF PREGNANCY,ECTOPIC PREGNANCY,RO-disease_has_finding
503223370,7/15/2014 10:06:50,,1323474870,7/15/2014 10:06:29,clixsense,0.875,15189335,GBR,E4,Colchester,5.67.141.89,ECTOPIC PREGNANCY causes COMPLICATIONS OF PREGNANCY,38,0,,63,17,causes,0.7875615306482171,901953-FS1-4,ECTOPIC PREGNANCY is one of the major COMPLICATIONS OF PREGNANCY,COMPLICATIONS OF PREGNANCY,ECTOPIC PREGNANCY,RO-disease_has_finding
503223370,7/15/2014 10:31:44,,1323490372,7/15/2014 10:31:37,clixsense,0.6875,19162475,GBR,M3,Frome,82.33.126.30,COMPLICATIONS OF PREGNANCY causes ECTOPIC PREGNANCY,38,0,,63,17,causes,0.7875615306482171,901953-FS1-4,ECTOPIC PREGNANCY is one of the major COMPLICATIONS OF PREGNANCY,COMPLICATIONS OF PREGNANCY,ECTOPIC PREGNANCY,RO-disease_has_finding
503223370,7/15/2014 10:51:51,,1323504425,7/15/2014 10:51:39,clixsense,0.8486,27793793,GBR,C5,Chester,151.230.27.155,ECTOPIC PREGNANCY causes COMPLICATIONS OF PREGNANCY,38,0,,63,17,causes,0.7875615306482171,901953-FS1-4,ECTOPIC PREGNANCY is one of the major COMPLICATIONS OF PREGNANCY,COMPLICATIONS OF PREGNANCY,ECTOPIC PREGNANCY,RO-disease_has_finding
503223370,7/15/2014 11:19:02,,1323523370,7/15/2014 11:18:33,instagc,0.7264,24252915,GBR,B7,Bristol,77.98.139.82,ECTOPIC PREGNANCY causes COMPLICATIONS OF PREGNANCY,38,0,,63,17,causes,0.7875615306482171,901953-FS1-4,ECTOPIC PREGNANCY is one of the major COMPLICATIONS OF PREGNANCY,COMPLICATIONS OF PREGNANCY,ECTOPIC PREGNANCY,RO-disease_has_finding
503223370,7/15/2014 11:38:25,,1323534407,7/15/2014 11:37:56,clixsense,0.5726,23233834,GBR,N6,Sunderland,86.17.58.181,ECTOPIC PREGNANCY causes COMPLICATIONS OF PREGNANCY,38,0,,63,17,causes,0.7875615306482171,901953-FS1-4,ECTOPIC PREGNANCY is one of the major COMPLICATIONS OF PREGNANCY,COMPLICATIONS OF PREGNANCY,ECTOPIC PREGNANCY,RO-disease_has_finding
503223370,7/15/2014 13:30:41,,1323580502,7/15/2014 13:30:02,instagc,0.5063,23149109,USA,NC,Cary,24.206.38.18,ECTOPIC PREGNANCY causes COMPLICATIONS OF PREGNANCY,38,0,,63,17,causes,0.7875615306482171,901953-FS1-4,ECTOPIC PREGNANCY is one of the major COMPLICATIONS OF PREGNANCY,COMPLICATIONS OF PREGNANCY,ECTOPIC PREGNANCY,RO-disease_has_finding
503223374,7/15/2014 11:19:02,,1323523384,7/15/2014 11:18:33,instagc,0.7264,24252915,GBR,B7,Bristol,77.98.139.82,ADMINISTRATION OF THE DRUG AFTER THE TEST causes AN UNINTOXICATED STATE TOLERANCE IS LOST EVEN,153,68,,193,113,causes,0.371390676354104,903512-FS1-4,When tolerant rats are later allowed to drink milk from a bottle in AN UNINTOXICATED STATE TOLERANCE IS LOST EVEN when drug exposure is held constant by ADMINISTRATION OF THE DRUG AFTER THE TEST.,ADMINISTRATION OF THE DRUG AFTER THE TEST,AN UNINTOXICATED STATE TOLERANCE IS LOST EVEN,RO-has_causative_agent
503223374,7/15/2014 11:19:46,,1323523780,7/15/2014 11:19:01,instagc,0.8431,13763729,USA,,,75.182.89.225,no_relation,153,68,,193,113,causes,0.371390676354104,903512-FS1-4,When tolerant rats are later allowed to drink milk from a bottle in AN UNINTOXICATED STATE TOLERANCE IS LOST EVEN when drug exposure is held constant by ADMINISTRATION OF THE DRUG AFTER THE TEST.,ADMINISTRATION OF THE DRUG AFTER THE TEST,AN UNINTOXICATED STATE TOLERANCE IS LOST EVEN,RO-has_causative_agent
503223374,7/15/2014 12:22:34,,1323555301,7/15/2014 12:21:40,paiddailysurveys,0.6127,11786001,USA,NC,Charlotte,71.28.89.238,AN UNINTOXICATED STATE TOLERANCE IS LOST EVEN causes ADMINISTRATION OF THE DRUG AFTER THE TEST,153,68,,193,113,causes,0.371390676354104,903512-FS1-4,When tolerant rats are later allowed to drink milk from a bottle in AN UNINTOXICATED STATE TOLERANCE IS LOST EVEN when drug exposure is held constant by ADMINISTRATION OF THE DRUG AFTER THE TEST.,ADMINISTRATION OF THE DRUG AFTER THE TEST,AN UNINTOXICATED STATE TOLERANCE IS LOST EVEN,RO-has_causative_agent
503223374,7/15/2014 15:52:08,,1323642980,7/15/2014 15:51:48,neodev,0.624,14861092,GBR,I2,Manchester,90.194.137.76,no_relation,153,68,,193,113,causes,0.371390676354104,903512-FS1-4,When tolerant rats are later allowed to drink milk from a bottle in AN UNINTOXICATED STATE TOLERANCE IS LOST EVEN when drug exposure is held constant by ADMINISTRATION OF THE DRUG AFTER THE TEST.,ADMINISTRATION OF THE DRUG AFTER THE TEST,AN UNINTOXICATED STATE TOLERANCE IS LOST EVEN,RO-has_causative_agent
503223374,7/15/2014 16:45:49,,1323696290,7/15/2014 16:45:39,prodege,0.474,2143114,CAN,BC,Vancouver,24.84.160.12,ADMINISTRATION OF THE DRUG AFTER THE TEST causes AN UNINTOXICATED STATE TOLERANCE IS LOST EVEN,153,68,,193,113,causes,0.371390676354104,903512-FS1-4,When tolerant rats are later allowed to drink milk from a bottle in AN UNINTOXICATED STATE TOLERANCE IS LOST EVEN when drug exposure is held constant by ADMINISTRATION OF THE DRUG AFTER THE TEST.,ADMINISTRATION OF THE DRUG AFTER THE TEST,AN UNINTOXICATED STATE TOLERANCE IS LOST EVEN,RO-has_causative_agent
503223374,7/15/2014 16:49:26,,1323700210,7/15/2014 16:48:47,prodege,0.5758,23541832,USA,AZ,Tempe,149.169.145.144,no_relation,153,68,,193,113,causes,0.371390676354104,903512-FS1-4,When tolerant rats are later allowed to drink milk from a bottle in AN UNINTOXICATED STATE TOLERANCE IS LOST EVEN when drug exposure is held constant by ADMINISTRATION OF THE DRUG AFTER THE TEST.,ADMINISTRATION OF THE DRUG AFTER THE TEST,AN UNINTOXICATED STATE TOLERANCE IS LOST EVEN,RO-has_causative_agent
503223374,7/15/2014 16:59:26,,1323711648,7/15/2014 16:59:00,neodev,0.6701,18755947,GBR,H2,Accrington,80.47.185.52,no_relation,153,68,,193,113,causes,0.371390676354104,903512-FS1-4,When tolerant rats are later allowed to drink milk from a bottle in AN UNINTOXICATED STATE TOLERANCE IS LOST EVEN when drug exposure is held constant by ADMINISTRATION OF THE DRUG AFTER THE TEST.,ADMINISTRATION OF THE DRUG AFTER THE TEST,AN UNINTOXICATED STATE TOLERANCE IS LOST EVEN,RO-has_causative_agent
503223377,7/15/2014 10:27:06,,1323487196,7/15/2014 10:26:36,vivatic,0.8056,25451531,GBR,,,83.67.28.193,no_relation,91,32,,101,44,treats,0.9354143466934849,907851-FS1-2,1 trial comparing tramadol with CLOMIPRAMINE with or without levomepromazine showed better PAIN RELIEF with tramadol but no difference in pain intensity between groups.,PAIN RELIEF,CLOMIPRAMINE,RO-may_treat
503223377,7/15/2014 12:22:34,,1323555299,7/15/2014 12:21:40,paiddailysurveys,0.6127,11786001,USA,NC,Charlotte,71.28.89.238,CLOMIPRAMINE treats PAIN RELIEF,91,32,,101,44,treats,0.9354143466934849,907851-FS1-2,1 trial comparing tramadol with CLOMIPRAMINE with or without levomepromazine showed better PAIN RELIEF with tramadol but no difference in pain intensity between groups.,PAIN RELIEF,CLOMIPRAMINE,RO-may_treat
503223377,7/15/2014 14:18:18,,1323594790,7/15/2014 14:17:45,instagc,0.6554,19636746,USA,NY,Andover,192.182.216.225,no_relation,91,32,,101,44,treats,0.9354143466934849,907851-FS1-2,1 trial comparing tramadol with CLOMIPRAMINE with or without levomepromazine showed better PAIN RELIEF with tramadol but no difference in pain intensity between groups.,PAIN RELIEF,CLOMIPRAMINE,RO-may_treat
503223377,7/15/2014 14:27:21,,1323597371,7/15/2014 14:26:59,elite,0.6381,28276268,USA,FL,Boynton Beach,99.114.225.45,CLOMIPRAMINE treats PAIN RELIEF,91,32,,101,44,treats,0.9354143466934849,907851-FS1-2,1 trial comparing tramadol with CLOMIPRAMINE with or without levomepromazine showed better PAIN RELIEF with tramadol but no difference in pain intensity between groups.,PAIN RELIEF,CLOMIPRAMINE,RO-may_treat
503223377,7/15/2014 14:32:35,,1323599001,7/15/2014 14:32:30,neodev,0.3913,25224036,CAN,ON,Sudbury,67.204.218.187,PAIN RELIEF treats CLOMIPRAMINE,91,32,,101,44,treats,0.9354143466934849,907851-FS1-2,1 trial comparing tramadol with CLOMIPRAMINE with or without levomepromazine showed better PAIN RELIEF with tramadol but no difference in pain intensity between groups.,PAIN RELIEF,CLOMIPRAMINE,RO-may_treat
503223377,7/15/2014 15:31:21,,1323627456,7/15/2014 15:31:06,tremorgames,0.5508,24449707,CAN,QC,Laval,96.21.249.72,CLOMIPRAMINE treats PAIN RELIEF,91,32,,101,44,treats,0.9354143466934849,907851-FS1-2,1 trial comparing tramadol with CLOMIPRAMINE with or without levomepromazine showed better PAIN RELIEF with tramadol but no difference in pain intensity between groups.,PAIN RELIEF,CLOMIPRAMINE,RO-may_treat
503223377,7/15/2014 15:49:07,,1323640572,7/15/2014 15:48:52,clixsense,0.6403,7265596,USA,IA,Neola,199.120.116.136,CLOMIPRAMINE treats PAIN RELIEF,91,32,,101,44,treats,0.9354143466934849,907851-FS1-2,1 trial comparing tramadol with CLOMIPRAMINE with or without levomepromazine showed better PAIN RELIEF with tramadol but no difference in pain intensity between groups.,PAIN RELIEF,CLOMIPRAMINE,RO-may_treat
503223379,7/15/2014 10:27:32,,1323487472,7/15/2014 10:27:13,clixsense,0.8472,19803139,NLD,06,Veldhoven,212.61.84.196,IVERMECTIN treats ONCHOCERCIASIS,69,14,,82,24,treats,1.0,907881-FS1-2,Comparison of IVERMECTIN and diethylcarbamazine for the treatment of ONCHOCERCIASIS,ONCHOCERCIASIS,IVERMECTIN,RO-may_treat
503223379,7/15/2014 10:31:36,,1323490265,7/15/2014 10:31:28,clixsense,0.6875,19162475,GBR,M3,Frome,82.33.126.30,ONCHOCERCIASIS treats IVERMECTIN,69,14,,82,24,treats,1.0,907881-FS1-2,Comparison of IVERMECTIN and diethylcarbamazine for the treatment of ONCHOCERCIASIS,ONCHOCERCIASIS,IVERMECTIN,RO-may_treat
503223379,7/15/2014 10:50:57,,1323503714,7/15/2014 10:50:01,rewardsspot,0.6319,17763704,USA,VA,Manassas,198.7.62.204,IVERMECTIN treats ONCHOCERCIASIS,69,14,,82,24,treats,1.0,907881-FS1-2,Comparison of IVERMECTIN and diethylcarbamazine for the treatment of ONCHOCERCIASIS,ONCHOCERCIASIS,IVERMECTIN,RO-may_treat
503223379,7/15/2014 10:52:01,,1323504531,7/15/2014 10:51:52,clixsense,0.8486,27793793,GBR,C5,Chester,151.230.27.155,IVERMECTIN treats ONCHOCERCIASIS,69,14,,82,24,treats,1.0,907881-FS1-2,Comparison of IVERMECTIN and diethylcarbamazine for the treatment of ONCHOCERCIASIS,ONCHOCERCIASIS,IVERMECTIN,RO-may_treat
503223379,7/15/2014 11:05:10,,1323512950,7/15/2014 11:04:45,prodege,0.6528,28039757,GBR,L8,Southport,109.155.158.54,IVERMECTIN treats ONCHOCERCIASIS,69,14,,82,24,treats,1.0,907881-FS1-2,Comparison of IVERMECTIN and diethylcarbamazine for the treatment of ONCHOCERCIASIS,ONCHOCERCIASIS,IVERMECTIN,RO-may_treat
503223379,7/15/2014 11:50:11,,1323541182,7/15/2014 11:49:45,neodev,0.6637,21515166,NLD,11,Nootdorp,83.86.58.179,IVERMECTIN treats ONCHOCERCIASIS,69,14,,82,24,treats,1.0,907881-FS1-2,Comparison of IVERMECTIN and diethylcarbamazine for the treatment of ONCHOCERCIASIS,ONCHOCERCIASIS,IVERMECTIN,RO-may_treat
503223379,7/15/2014 14:10:54,,1323592694,7/15/2014 14:10:33,neodev,0.4365,28336203,USA,PA,Harrisburg,50.149.53.150,IVERMECTIN treats ONCHOCERCIASIS,69,14,,82,24,treats,1.0,907881-FS1-2,Comparison of IVERMECTIN and diethylcarbamazine for the treatment of ONCHOCERCIASIS,ONCHOCERCIASIS,IVERMECTIN,RO-may_treat
503223380,7/15/2014 12:37:39,,1323560878,7/15/2014 12:37:00,prodege,0.5236,1852770,USA,TX,Abilene,76.198.102.54,no_relation,248,273,,263,299,causes,0.617213399848368,901857-FS1-4,"Follow up was available on 63 cases: Seven had negative follow up smears for at least 2 years, 15 had negative biopsies, seven had endocervical polyps, two had endometrial hyperplasia, eight had mild dysplasia, five had moderate dysplasia, six had SEVERE DYSPLASIA six had SQUAMOUS CARCINOMA IN SITU five had adenocarcinoma in situ, and two had invasive adenocarcinoma.",SEVERE DYSPLASIA,SQUAMOUS CARCINOMA IN SITU,RO-disease_has_finding
503223380,7/15/2014 12:58:18,,1323568969,7/15/2014 12:58:00,elite,0.8028,28503042,USA,NJ,Woodbridge,54.191.150.115,no_relation,248,273,,263,299,causes,0.617213399848368,901857-FS1-4,"Follow up was available on 63 cases: Seven had negative follow up smears for at least 2 years, 15 had negative biopsies, seven had endocervical polyps, two had endometrial hyperplasia, eight had mild dysplasia, five had moderate dysplasia, six had SEVERE DYSPLASIA six had SQUAMOUS CARCINOMA IN SITU five had adenocarcinoma in situ, and two had invasive adenocarcinoma.",SEVERE DYSPLASIA,SQUAMOUS CARCINOMA IN SITU,RO-disease_has_finding
503223380,7/15/2014 13:10:33,,1323573699,7/15/2014 13:10:06,neodev,0.4365,28336203,USA,PA,Harrisburg,50.149.53.150,SQUAMOUS CARCINOMA IN SITU causes SEVERE DYSPLASIA,248,273,,263,299,causes,0.617213399848368,901857-FS1-4,"Follow up was available on 63 cases: Seven had negative follow up smears for at least 2 years, 15 had negative biopsies, seven had endocervical polyps, two had endometrial hyperplasia, eight had mild dysplasia, five had moderate dysplasia, six had SEVERE DYSPLASIA six had SQUAMOUS CARCINOMA IN SITU five had adenocarcinoma in situ, and two had invasive adenocarcinoma.",SEVERE DYSPLASIA,SQUAMOUS CARCINOMA IN SITU,RO-disease_has_finding
503223380,7/15/2014 13:49:47,,1323586730,7/15/2014 13:49:18,neodev,0.4671,18339121,USA,SC,Sumter,173.93.188.194,SEVERE DYSPLASIA causes SQUAMOUS CARCINOMA IN SITU,248,273,,263,299,causes,0.617213399848368,901857-FS1-4,"Follow up was available on 63 cases: Seven had negative follow up smears for at least 2 years, 15 had negative biopsies, seven had endocervical polyps, two had endometrial hyperplasia, eight had mild dysplasia, five had moderate dysplasia, six had SEVERE DYSPLASIA six had SQUAMOUS CARCINOMA IN SITU five had adenocarcinoma in situ, and two had invasive adenocarcinoma.",SEVERE DYSPLASIA,SQUAMOUS CARCINOMA IN SITU,RO-disease_has_finding
503223380,7/15/2014 15:20:35,,1323619847,7/15/2014 15:20:09,prodege,0.5683,7899370,USA,MI,Bay City,71.13.81.162,no_relation,248,273,,263,299,causes,0.617213399848368,901857-FS1-4,"Follow up was available on 63 cases: Seven had negative follow up smears for at least 2 years, 15 had negative biopsies, seven had endocervical polyps, two had endometrial hyperplasia, eight had mild dysplasia, five had moderate dysplasia, six had SEVERE DYSPLASIA six had SQUAMOUS CARCINOMA IN SITU five had adenocarcinoma in situ, and two had invasive adenocarcinoma.",SEVERE DYSPLASIA,SQUAMOUS CARCINOMA IN SITU,RO-disease_has_finding
503223380,7/15/2014 15:30:55,,1323627127,7/15/2014 15:30:44,tremorgames,0.5508,24449707,CAN,QC,Laval,96.21.249.72,no_relation,248,273,,263,299,causes,0.617213399848368,901857-FS1-4,"Follow up was available on 63 cases: Seven had negative follow up smears for at least 2 years, 15 had negative biopsies, seven had endocervical polyps, two had endometrial hyperplasia, eight had mild dysplasia, five had moderate dysplasia, six had SEVERE DYSPLASIA six had SQUAMOUS CARCINOMA IN SITU five had adenocarcinoma in situ, and two had invasive adenocarcinoma.",SEVERE DYSPLASIA,SQUAMOUS CARCINOMA IN SITU,RO-disease_has_finding
503223380,7/15/2014 16:25:57,,1323672418,7/15/2014 16:25:48,clixsense,0.475,16827630,GBR,A7,Birmingham,86.146.169.103,no_relation,248,273,,263,299,causes,0.617213399848368,901857-FS1-4,"Follow up was available on 63 cases: Seven had negative follow up smears for at least 2 years, 15 had negative biopsies, seven had endocervical polyps, two had endometrial hyperplasia, eight had mild dysplasia, five had moderate dysplasia, six had SEVERE DYSPLASIA six had SQUAMOUS CARCINOMA IN SITU five had adenocarcinoma in situ, and two had invasive adenocarcinoma.",SEVERE DYSPLASIA,SQUAMOUS CARCINOMA IN SITU,RO-disease_has_finding
503223382,7/15/2014 10:06:50,,1323474878,7/15/2014 10:06:29,clixsense,0.875,15189335,GBR,E4,Colchester,5.67.141.89,CALCIFICATION causes PILOMATRICOMA,137,58,,149,71,causes,0.589767824619588,902676-FS1-4,Amyloid deposition was encountered in 10 of 16 samples of PILOMATRICOMA indicating that the deposition of amyloid is nearly as common as CALCIFICATION in pilomatricoma.,CALCIFICATION,PILOMATRICOMA,RO-disease_may_have_finding
503223382,7/15/2014 10:29:24,,1323488764,7/15/2014 10:28:55,clixsense,0.8472,19803139,NLD,06,Veldhoven,212.61.84.196,PILOMATRICOMA causes CALCIFICATION,137,58,,149,71,causes,0.589767824619588,902676-FS1-4,Amyloid deposition was encountered in 10 of 16 samples of PILOMATRICOMA indicating that the deposition of amyloid is nearly as common as CALCIFICATION in pilomatricoma.,CALCIFICATION,PILOMATRICOMA,RO-disease_may_have_finding
503223382,7/15/2014 11:15:02,,1323520691,7/15/2014 11:14:30,clixsense,0.8306,27871219,NLD,07,Amsterdam,87.210.207.223,CALCIFICATION causes PILOMATRICOMA,137,58,,149,71,causes,0.589767824619588,902676-FS1-4,Amyloid deposition was encountered in 10 of 16 samples of PILOMATRICOMA indicating that the deposition of amyloid is nearly as common as CALCIFICATION in pilomatricoma.,CALCIFICATION,PILOMATRICOMA,RO-disease_may_have_finding
503223382,7/15/2014 11:26:51,,1323527620,7/15/2014 11:26:32,instagc,0.7611,28301350,GBR,K4,Plymouth,92.28.215.248,no_relation,137,58,,149,71,causes,0.589767824619588,902676-FS1-4,Amyloid deposition was encountered in 10 of 16 samples of PILOMATRICOMA indicating that the deposition of amyloid is nearly as common as CALCIFICATION in pilomatricoma.,CALCIFICATION,PILOMATRICOMA,RO-disease_may_have_finding
503223382,7/15/2014 11:39:13,,1323534824,7/15/2014 11:38:49,clixsense,0.5726,23233834,GBR,N6,Sunderland,86.17.58.181,CALCIFICATION causes PILOMATRICOMA,137,58,,149,71,causes,0.589767824619588,902676-FS1-4,Amyloid deposition was encountered in 10 of 16 samples of PILOMATRICOMA indicating that the deposition of amyloid is nearly as common as CALCIFICATION in pilomatricoma.,CALCIFICATION,PILOMATRICOMA,RO-disease_may_have_finding
503223382,7/15/2014 12:04:58,,1323548696,7/15/2014 12:04:31,prodege,0.35,7664351,USA,NY,Cicero,74.111.0.21,no_relation,137,58,,149,71,causes,0.589767824619588,902676-FS1-4,Amyloid deposition was encountered in 10 of 16 samples of PILOMATRICOMA indicating that the deposition of amyloid is nearly as common as CALCIFICATION in pilomatricoma.,CALCIFICATION,PILOMATRICOMA,RO-disease_may_have_finding
503223382,7/15/2014 12:12:36,,1323551380,7/15/2014 12:12:15,paiddailysurveys,0.6127,11786001,USA,NC,Charlotte,71.28.89.238,PILOMATRICOMA causes CALCIFICATION,137,58,,149,71,causes,0.589767824619588,902676-FS1-4,Amyloid deposition was encountered in 10 of 16 samples of PILOMATRICOMA indicating that the deposition of amyloid is nearly as common as CALCIFICATION in pilomatricoma.,CALCIFICATION,PILOMATRICOMA,RO-disease_may_have_finding
503223387,7/15/2014 10:08:03,,1323475548,7/15/2014 10:07:28,clixsense,0.875,15189335,GBR,E4,Colchester,5.67.141.89,TRICHOFOLLICULOMA diagnosed by FOLLICULAR DIFFERENTIATION,87,171,,112,188,diagnosed by,0.4,901731-FS1-13,We report a nodular lesion that was identified histopathologically as a hamartoma with FOLLICULAR DIFFERENTIATION and that systematic serial sectioning showed not to be a TRICHOFOLLICULOMA,FOLLICULAR DIFFERENTIATION,TRICHOFOLLICULOMA,RO-disease_has_finding
503223387,7/15/2014 10:18:32,,1323481796,7/15/2014 10:18:15,gifthulk,0.9583,22144176,GBR,U8,Edinburgh,129.215.149.99,no_relation,87,171,,112,188,diagnosed by,0.4,901731-FS1-13,We report a nodular lesion that was identified histopathologically as a hamartoma with FOLLICULAR DIFFERENTIATION and that systematic serial sectioning showed not to be a TRICHOFOLLICULOMA,FOLLICULAR DIFFERENTIATION,TRICHOFOLLICULOMA,RO-disease_has_finding
503223387,7/15/2014 10:51:51,,1323504421,7/15/2014 10:51:39,clixsense,0.8486,27793793,GBR,C5,Chester,151.230.27.155,no_relation,87,171,,112,188,diagnosed by,0.4,901731-FS1-13,We report a nodular lesion that was identified histopathologically as a hamartoma with FOLLICULAR DIFFERENTIATION and that systematic serial sectioning showed not to be a TRICHOFOLLICULOMA,FOLLICULAR DIFFERENTIATION,TRICHOFOLLICULOMA,RO-disease_has_finding
503223387,7/15/2014 11:03:03,,1323511248,7/15/2014 11:02:32,prodege,0.6528,28039757,GBR,L8,Southport,109.155.158.54,no_relation,87,171,,112,188,diagnosed by,0.4,901731-FS1-13,We report a nodular lesion that was identified histopathologically as a hamartoma with FOLLICULAR DIFFERENTIATION and that systematic serial sectioning showed not to be a TRICHOFOLLICULOMA,FOLLICULAR DIFFERENTIATION,TRICHOFOLLICULOMA,RO-disease_has_finding
503223387,7/15/2014 11:13:53,,1323520045,7/15/2014 11:13:23,clixsense,0.8306,27871219,NLD,07,Amsterdam,87.210.207.223,no_relation,87,171,,112,188,diagnosed by,0.4,901731-FS1-13,We report a nodular lesion that was identified histopathologically as a hamartoma with FOLLICULAR DIFFERENTIATION and that systematic serial sectioning showed not to be a TRICHOFOLLICULOMA,FOLLICULAR DIFFERENTIATION,TRICHOFOLLICULOMA,RO-disease_has_finding
503223387,7/15/2014 12:57:17,,1323568524,7/15/2014 12:56:44,elite,0.8028,28503042,USA,NJ,Woodbridge,54.191.150.115,TRICHOFOLLICULOMA diagnosed by FOLLICULAR DIFFERENTIATION,87,171,,112,188,diagnosed by,0.4,901731-FS1-13,We report a nodular lesion that was identified histopathologically as a hamartoma with FOLLICULAR DIFFERENTIATION and that systematic serial sectioning showed not to be a TRICHOFOLLICULOMA,FOLLICULAR DIFFERENTIATION,TRICHOFOLLICULOMA,RO-disease_has_finding
503223387,7/15/2014 13:05:01,,1323571640,7/15/2014 13:04:52,clixsense,0.601,20614047,USA,ID,Priest River,174.32.160.124,TRICHOFOLLICULOMA diagnosed by FOLLICULAR DIFFERENTIATION,87,171,,112,188,diagnosed by,0.4,901731-FS1-13,We report a nodular lesion that was identified histopathologically as a hamartoma with FOLLICULAR DIFFERENTIATION and that systematic serial sectioning showed not to be a TRICHOFOLLICULOMA,FOLLICULAR DIFFERENTIATION,TRICHOFOLLICULOMA,RO-disease_has_finding
503223396,7/15/2014 10:18:50,,1323481999,7/15/2014 10:18:33,gifthulk,0.9583,22144176,GBR,U8,Edinburgh,129.215.149.99,no_relation,0,47,,13,75,causes,0.9950371902099889,906433-FS1-4,HYPERAMMONEMIA is one of the major symptoms of PRIMARY CARNITINE DEFICIENCY,HYPERAMMONEMIA,PRIMARY CARNITINE DEFICIENCY,RO-has_manifestation
503223396,7/15/2014 10:53:18,,1323505325,7/15/2014 10:52:46,rewardsspot,0.6319,17763704,USA,VA,Manassas,198.7.62.204,PRIMARY CARNITINE DEFICIENCY causes HYPERAMMONEMIA,0,47,,13,75,causes,0.9950371902099889,906433-FS1-4,HYPERAMMONEMIA is one of the major symptoms of PRIMARY CARNITINE DEFICIENCY,HYPERAMMONEMIA,PRIMARY CARNITINE DEFICIENCY,RO-has_manifestation
503223396,7/15/2014 11:18:02,,1323522686,7/15/2014 11:17:33,instagc,0.7264,24252915,GBR,B7,Bristol,77.98.139.82,PRIMARY CARNITINE DEFICIENCY causes HYPERAMMONEMIA,0,47,,13,75,causes,0.9950371902099889,906433-FS1-4,HYPERAMMONEMIA is one of the major symptoms of PRIMARY CARNITINE DEFICIENCY,HYPERAMMONEMIA,PRIMARY CARNITINE DEFICIENCY,RO-has_manifestation
503223396,7/15/2014 11:24:45,,1323526568,7/15/2014 11:24:27,prodege,0.7792,15439740,AUS,02,Jannali,27.96.208.89,PRIMARY CARNITINE DEFICIENCY causes HYPERAMMONEMIA,0,47,,13,75,causes,0.9950371902099889,906433-FS1-4,HYPERAMMONEMIA is one of the major symptoms of PRIMARY CARNITINE DEFICIENCY,HYPERAMMONEMIA,PRIMARY CARNITINE DEFICIENCY,RO-has_manifestation
503223396,7/15/2014 11:27:06,,1323527793,7/15/2014 11:26:53,instagc,0.7611,28301350,GBR,K4,Plymouth,92.28.215.248,PRIMARY CARNITINE DEFICIENCY causes HYPERAMMONEMIA,0,47,,13,75,causes,0.9950371902099889,906433-FS1-4,HYPERAMMONEMIA is one of the major symptoms of PRIMARY CARNITINE DEFICIENCY,HYPERAMMONEMIA,PRIMARY CARNITINE DEFICIENCY,RO-has_manifestation
503223396,7/15/2014 11:53:31,,1323543631,7/15/2014 11:53:13,neodev,0.6736,24578640,USA,IL,Chicago,65.60.20.66,PRIMARY CARNITINE DEFICIENCY causes HYPERAMMONEMIA,0,47,,13,75,causes,0.9950371902099889,906433-FS1-4,HYPERAMMONEMIA is one of the major symptoms of PRIMARY CARNITINE DEFICIENCY,HYPERAMMONEMIA,PRIMARY CARNITINE DEFICIENCY,RO-has_manifestation
503223396,7/15/2014 14:33:03,,1323599186,7/15/2014 14:32:57,neodev,0.3913,25224036,CAN,ON,Sudbury,67.204.218.187,HYPERAMMONEMIA causes PRIMARY CARNITINE DEFICIENCY,0,47,,13,75,causes,0.9950371902099889,906433-FS1-4,HYPERAMMONEMIA is one of the major symptoms of PRIMARY CARNITINE DEFICIENCY,HYPERAMMONEMIA,PRIMARY CARNITINE DEFICIENCY,RO-has_manifestation
503223397,7/15/2014 10:31:07,,1323489943,7/15/2014 10:30:59,clixsense,0.6875,19162475,GBR,M3,Frome,82.33.126.30,MENTAL RETARDATION causes X LINKED HYDROCEPHALUS/HSAS (HYDROCEPHALUS,177,75,,194,117,causes,0.589767824619588,906021-FS1-4,"Mutations in the L1CAM gene are responsible for four related L1 disorders; X LINKED HYDROCEPHALUS/HSAS (HYDROCEPHALUS as a result of Stenosis of the Aqueduct of Sylvius), MASA (MENTAL RETARDATION Aphasia, Shuffling gait, and Adducted thumbs) syndrome, X linked complicated spastic paraplegia type I (SPG1) and X linked Agenesis of the Corpus Callosum (ACC.",MENTAL RETARDATION,X LINKED HYDROCEPHALUS/HSAS (HYDROCEPHALUS,RO-has_manifestation
503223397,7/15/2014 14:32:49,,1323599088,7/15/2014 14:32:43,neodev,0.3913,25224036,CAN,ON,Sudbury,67.204.218.187,X LINKED HYDROCEPHALUS/HSAS (HYDROCEPHALUS causes MENTAL RETARDATION,177,75,,194,117,causes,0.589767824619588,906021-FS1-4,"Mutations in the L1CAM gene are responsible for four related L1 disorders; X LINKED HYDROCEPHALUS/HSAS (HYDROCEPHALUS as a result of Stenosis of the Aqueduct of Sylvius), MASA (MENTAL RETARDATION Aphasia, Shuffling gait, and Adducted thumbs) syndrome, X linked complicated spastic paraplegia type I (SPG1) and X linked Agenesis of the Corpus Callosum (ACC.",MENTAL RETARDATION,X LINKED HYDROCEPHALUS/HSAS (HYDROCEPHALUS,RO-has_manifestation
503223397,7/15/2014 15:19:46,,1323619399,7/15/2014 15:19:11,prodege,0.5683,7899370,USA,MI,Bay City,71.13.81.162,no_relation,177,75,,194,117,causes,0.589767824619588,906021-FS1-4,"Mutations in the L1CAM gene are responsible for four related L1 disorders; X LINKED HYDROCEPHALUS/HSAS (HYDROCEPHALUS as a result of Stenosis of the Aqueduct of Sylvius), MASA (MENTAL RETARDATION Aphasia, Shuffling gait, and Adducted thumbs) syndrome, X linked complicated spastic paraplegia type I (SPG1) and X linked Agenesis of the Corpus Callosum (ACC.",MENTAL RETARDATION,X LINKED HYDROCEPHALUS/HSAS (HYDROCEPHALUS,RO-has_manifestation
503223397,7/15/2014 15:48:50,,1323640400,7/15/2014 15:48:37,clixsense,0.6403,7265596,USA,IA,Neola,199.120.116.136,X LINKED HYDROCEPHALUS/HSAS (HYDROCEPHALUS causes MENTAL RETARDATION,177,75,,194,117,causes,0.589767824619588,906021-FS1-4,"Mutations in the L1CAM gene are responsible for four related L1 disorders; X LINKED HYDROCEPHALUS/HSAS (HYDROCEPHALUS as a result of Stenosis of the Aqueduct of Sylvius), MASA (MENTAL RETARDATION Aphasia, Shuffling gait, and Adducted thumbs) syndrome, X linked complicated spastic paraplegia type I (SPG1) and X linked Agenesis of the Corpus Callosum (ACC.",MENTAL RETARDATION,X LINKED HYDROCEPHALUS/HSAS (HYDROCEPHALUS,RO-has_manifestation
503223397,7/15/2014 15:52:37,,1323643303,7/15/2014 15:52:09,neodev,0.624,14861092,GBR,I2,Manchester,90.194.137.76,X LINKED HYDROCEPHALUS/HSAS (HYDROCEPHALUS causes MENTAL RETARDATION,177,75,,194,117,causes,0.589767824619588,906021-FS1-4,"Mutations in the L1CAM gene are responsible for four related L1 disorders; X LINKED HYDROCEPHALUS/HSAS (HYDROCEPHALUS as a result of Stenosis of the Aqueduct of Sylvius), MASA (MENTAL RETARDATION Aphasia, Shuffling gait, and Adducted thumbs) syndrome, X linked complicated spastic paraplegia type I (SPG1) and X linked Agenesis of the Corpus Callosum (ACC.",MENTAL RETARDATION,X LINKED HYDROCEPHALUS/HSAS (HYDROCEPHALUS,RO-has_manifestation
503223397,7/15/2014 16:25:36,,1323672108,7/15/2014 16:25:18,clixsense,0.475,16827630,GBR,A7,Birmingham,86.146.169.103,no_relation,177,75,,194,117,causes,0.589767824619588,906021-FS1-4,"Mutations in the L1CAM gene are responsible for four related L1 disorders; X LINKED HYDROCEPHALUS/HSAS (HYDROCEPHALUS as a result of Stenosis of the Aqueduct of Sylvius), MASA (MENTAL RETARDATION Aphasia, Shuffling gait, and Adducted thumbs) syndrome, X linked complicated spastic paraplegia type I (SPG1) and X linked Agenesis of the Corpus Callosum (ACC.",MENTAL RETARDATION,X LINKED HYDROCEPHALUS/HSAS (HYDROCEPHALUS,RO-has_manifestation
503223397,7/15/2014 16:45:28,,1323695797,7/15/2014 16:45:20,prodege,0.474,2143114,CAN,BC,Vancouver,24.84.160.12,MENTAL RETARDATION causes X LINKED HYDROCEPHALUS/HSAS (HYDROCEPHALUS,177,75,,194,117,causes,0.589767824619588,906021-FS1-4,"Mutations in the L1CAM gene are responsible for four related L1 disorders; X LINKED HYDROCEPHALUS/HSAS (HYDROCEPHALUS as a result of Stenosis of the Aqueduct of Sylvius), MASA (MENTAL RETARDATION Aphasia, Shuffling gait, and Adducted thumbs) syndrome, X linked complicated spastic paraplegia type I (SPG1) and X linked Agenesis of the Corpus Callosum (ACC.",MENTAL RETARDATION,X LINKED HYDROCEPHALUS/HSAS (HYDROCEPHALUS,RO-has_manifestation
503223401,7/15/2014 10:06:03,,1323474389,7/15/2014 10:05:09,eup_slw,0.9167,20818028,GBR,A7,Birmingham,92.232.139.254,CLOMIPRAMINE treats PANIC DISORDER,64,36,,77,48,treats,0.981980506061966,907891-FS1-2,"Long term evaluation of paroxetine, CLOMIPRAMINE and placebo in PANIC DISORDER",PANIC DISORDER,CLOMIPRAMINE,RO-may_treat
503223401,7/15/2014 10:07:27,,1323475169,7/15/2014 10:06:51,clixsense,0.875,15189335,GBR,E4,Colchester,5.67.141.89,CLOMIPRAMINE treats PANIC DISORDER,64,36,,77,48,treats,0.981980506061966,907891-FS1-2,"Long term evaluation of paroxetine, CLOMIPRAMINE and placebo in PANIC DISORDER",PANIC DISORDER,CLOMIPRAMINE,RO-may_treat
503223401,7/15/2014 10:31:28,,1323490199,7/15/2014 10:31:07,clixsense,0.6875,19162475,GBR,M3,Frome,82.33.126.30,CLOMIPRAMINE treats PANIC DISORDER,64,36,,77,48,treats,0.981980506061966,907891-FS1-2,"Long term evaluation of paroxetine, CLOMIPRAMINE and placebo in PANIC DISORDER",PANIC DISORDER,CLOMIPRAMINE,RO-may_treat
503223401,7/15/2014 11:11:58,,1323518758,7/15/2014 11:11:17,prodege,0.7681,11864493,GBR,Z4,Wrexham,212.219.196.69,no_relation,64,36,,77,48,treats,0.981980506061966,907891-FS1-2,"Long term evaluation of paroxetine, CLOMIPRAMINE and placebo in PANIC DISORDER",PANIC DISORDER,CLOMIPRAMINE,RO-may_treat
503223401,7/15/2014 13:05:16,,1323571746,7/15/2014 13:05:04,clixsense,0.601,20614047,USA,ID,Priest River,174.32.160.124,PANIC DISORDER treats CLOMIPRAMINE,64,36,,77,48,treats,0.981980506061966,907891-FS1-2,"Long term evaluation of paroxetine, CLOMIPRAMINE and placebo in PANIC DISORDER",PANIC DISORDER,CLOMIPRAMINE,RO-may_treat
503223401,7/15/2014 13:49:47,,1323586729,7/15/2014 13:49:18,neodev,0.4671,18339121,USA,SC,Sumter,173.93.188.194,CLOMIPRAMINE treats PANIC DISORDER,64,36,,77,48,treats,0.981980506061966,907891-FS1-2,"Long term evaluation of paroxetine, CLOMIPRAMINE and placebo in PANIC DISORDER",PANIC DISORDER,CLOMIPRAMINE,RO-may_treat
503223401,7/15/2014 16:25:47,,1323672293,7/15/2014 16:25:37,clixsense,0.475,16827630,GBR,A7,Birmingham,86.146.169.103,CLOMIPRAMINE treats PANIC DISORDER,64,36,,77,48,treats,0.981980506061966,907891-FS1-2,"Long term evaluation of paroxetine, CLOMIPRAMINE and placebo in PANIC DISORDER",PANIC DISORDER,CLOMIPRAMINE,RO-may_treat
503223406,7/15/2014 10:09:04,,1323476117,7/15/2014 10:08:20,eup_slw,0.9167,20818028,GBR,A7,Birmingham,92.232.139.254,no_relation,19,119,,56,148,causes,0.9258200997725509,900203-FS1-4,Gilliam recognized SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS (SCLE) as a lupus specific eruption that identifies a unique SUBSET OF LUPUS ERYTHEMATOSUS.,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,SUBSET OF LUPUS ERYTHEMATOSUS,RO-cause_of
503223406,7/15/2014 11:15:43,,1323521102,7/15/2014 11:15:19,clixsense,0.8306,27871219,NLD,07,Amsterdam,87.210.207.223,no_relation,19,119,,56,148,causes,0.9258200997725509,900203-FS1-4,Gilliam recognized SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS (SCLE) as a lupus specific eruption that identifies a unique SUBSET OF LUPUS ERYTHEMATOSUS.,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,SUBSET OF LUPUS ERYTHEMATOSUS,RO-cause_of
503223406,7/15/2014 12:24:45,,1323556091,7/15/2014 12:23:54,paiddailysurveys,0.6127,11786001,USA,NC,Charlotte,71.28.89.238,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS causes SUBSET OF LUPUS ERYTHEMATOSUS,19,119,,56,148,causes,0.9258200997725509,900203-FS1-4,Gilliam recognized SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS (SCLE) as a lupus specific eruption that identifies a unique SUBSET OF LUPUS ERYTHEMATOSUS.,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,SUBSET OF LUPUS ERYTHEMATOSUS,RO-cause_of
503223406,7/15/2014 12:27:08,,1323557036,7/15/2014 12:26:29,prodege,0.6058,27934334,GBR,B9,High Wycombe,86.166.72.139,no_relation,19,119,,56,148,causes,0.9258200997725509,900203-FS1-4,Gilliam recognized SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS (SCLE) as a lupus specific eruption that identifies a unique SUBSET OF LUPUS ERYTHEMATOSUS.,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,SUBSET OF LUPUS ERYTHEMATOSUS,RO-cause_of
503223406,7/15/2014 13:29:38,,1323580208,7/15/2014 13:28:59,instagc,0.5063,23149109,USA,NC,Cary,24.206.38.18,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS causes SUBSET OF LUPUS ERYTHEMATOSUS,19,119,,56,148,causes,0.9258200997725509,900203-FS1-4,Gilliam recognized SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS (SCLE) as a lupus specific eruption that identifies a unique SUBSET OF LUPUS ERYTHEMATOSUS.,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,SUBSET OF LUPUS ERYTHEMATOSUS,RO-cause_of
503223406,7/15/2014 13:47:28,,1323586074,7/15/2014 13:46:56,prodege,0.6706,13795372,CAN,NS,Dartmouth,142.68.155.182,no_relation,19,119,,56,148,causes,0.9258200997725509,900203-FS1-4,Gilliam recognized SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS (SCLE) as a lupus specific eruption that identifies a unique SUBSET OF LUPUS ERYTHEMATOSUS.,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,SUBSET OF LUPUS ERYTHEMATOSUS,RO-cause_of
503223406,7/15/2014 15:48:50,,1323640402,7/15/2014 15:48:37,clixsense,0.6403,7265596,USA,IA,Neola,199.120.116.136,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS causes SUBSET OF LUPUS ERYTHEMATOSUS,19,119,,56,148,causes,0.9258200997725509,900203-FS1-4,Gilliam recognized SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS (SCLE) as a lupus specific eruption that identifies a unique SUBSET OF LUPUS ERYTHEMATOSUS.,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,SUBSET OF LUPUS ERYTHEMATOSUS,RO-cause_of
503223451,7/15/2014 10:10:55,,1323477055,7/15/2014 10:10:34,clixsense,0.9583,15189335,GBR,E4,Colchester,5.67.141.89,TUBERCULIN treats TUBERCULOSIS,137,84,,148,94,treats,0.6741998624632421,906630-FS1-2,"Whereas only 15% to 20% of persons showed a significant (10 mm or more) reaction to TUBERCULIN on admission, 2% to 3% of these developed TUBERCULOSIS",TUBERCULOSIS,TUBERCULIN,RO-may_diagnose
503223451,7/15/2014 11:25:02,,1323526696,7/15/2014 11:24:09,elite,0.8264,28397222,GBR,Y4,Usk,31.50.223.75,no_relation,137,84,,148,94,treats,0.6741998624632421,906630-FS1-2,"Whereas only 15% to 20% of persons showed a significant (10 mm or more) reaction to TUBERCULIN on admission, 2% to 3% of these developed TUBERCULOSIS",TUBERCULOSIS,TUBERCULIN,RO-may_diagnose
503223451,7/15/2014 12:15:27,,1323552505,7/15/2014 12:14:59,paiddailysurveys,0.6292,11786001,USA,NC,Charlotte,71.28.89.238,TUBERCULIN treats TUBERCULOSIS,137,84,,148,94,treats,0.6741998624632421,906630-FS1-2,"Whereas only 15% to 20% of persons showed a significant (10 mm or more) reaction to TUBERCULIN on admission, 2% to 3% of these developed TUBERCULOSIS",TUBERCULOSIS,TUBERCULIN,RO-may_diagnose
503223451,7/15/2014 15:17:34,,1323618150,7/15/2014 15:16:42,prodege,0.7067,27934334,GBR,B9,High Wycombe,86.166.72.139,no_relation,137,84,,148,94,treats,0.6741998624632421,906630-FS1-2,"Whereas only 15% to 20% of persons showed a significant (10 mm or more) reaction to TUBERCULIN on admission, 2% to 3% of these developed TUBERCULOSIS",TUBERCULOSIS,TUBERCULIN,RO-may_diagnose
503223451,7/15/2014 17:00:05,,1323712291,7/15/2014 16:59:50,neodev,0.7097,18755947,GBR,H2,Accrington,80.47.185.52,no_relation,137,84,,148,94,treats,0.6741998624632421,906630-FS1-2,"Whereas only 15% to 20% of persons showed a significant (10 mm or more) reaction to TUBERCULIN on admission, 2% to 3% of these developed TUBERCULOSIS",TUBERCULOSIS,TUBERCULIN,RO-may_diagnose
503223451,7/15/2014 18:54:38,,1323784682,7/15/2014 18:54:34,prodege,0.4899,12944140,GBR,C8,Thornton Heath,92.21.6.167,TUBERCULIN treats TUBERCULOSIS,137,84,,148,94,treats,0.6741998624632421,906630-FS1-2,"Whereas only 15% to 20% of persons showed a significant (10 mm or more) reaction to TUBERCULIN on admission, 2% to 3% of these developed TUBERCULOSIS",TUBERCULOSIS,TUBERCULIN,RO-may_diagnose
503223451,7/15/2014 19:13:34,,1323794909,7/15/2014 19:13:03,prodege,0.5528,17932518,GBR,L5,Salford,95.151.167.238,no_relation,137,84,,148,94,treats,0.6741998624632421,906630-FS1-2,"Whereas only 15% to 20% of persons showed a significant (10 mm or more) reaction to TUBERCULIN on admission, 2% to 3% of these developed TUBERCULOSIS",TUBERCULOSIS,TUBERCULIN,RO-may_diagnose
503223455,7/15/2014 11:16:42,,1323521672,7/15/2014 11:16:11,prodege,0.7986,11864493,GBR,Z4,Wrexham,212.219.196.69,PHENTERMINE treats EXOGENOUS OBESITY,63,152,,79,163,treats,0.9830783046228491,907893-FS1-2,"3 ,   39 ,   40  Obesity  Not  indicated for the management of EXOGENOUS OBESITY   +    (either alone or in combination with weight loss agents such as PHENTERMINE although weight loss reported in some patients receiving the drug for other disorders.",EXOGENOUS OBESITY,PHENTERMINE,RO-may_treat
503223455,7/15/2014 15:23:28,,1323621893,7/15/2014 15:23:06,prodege,0.7167,7899370,USA,MI,Bay City,71.13.81.162,PHENTERMINE treats EXOGENOUS OBESITY,63,152,,79,163,treats,0.9830783046228491,907893-FS1-2,"3 ,   39 ,   40  Obesity  Not  indicated for the management of EXOGENOUS OBESITY   +    (either alone or in combination with weight loss agents such as PHENTERMINE although weight loss reported in some patients receiving the drug for other disorders.",EXOGENOUS OBESITY,PHENTERMINE,RO-may_treat
503223455,7/15/2014 15:44:48,,1323637493,7/15/2014 15:44:19,clixsense,0.6496,7265596,USA,IA,Neola,199.120.116.136,PHENTERMINE treats EXOGENOUS OBESITY,63,152,,79,163,treats,0.9830783046228491,907893-FS1-2,"3 ,   39 ,   40  Obesity  Not  indicated for the management of EXOGENOUS OBESITY   +    (either alone or in combination with weight loss agents such as PHENTERMINE although weight loss reported in some patients receiving the drug for other disorders.",EXOGENOUS OBESITY,PHENTERMINE,RO-may_treat
503223455,7/15/2014 17:57:30,,1323760320,7/15/2014 17:57:14,clixsense,0.4097,17722340,CAN,BC,Mission,50.98.185.25,EXOGENOUS OBESITY treats PHENTERMINE,63,152,,79,163,treats,0.9830783046228491,907893-FS1-2,"3 ,   39 ,   40  Obesity  Not  indicated for the management of EXOGENOUS OBESITY   +    (either alone or in combination with weight loss agents such as PHENTERMINE although weight loss reported in some patients receiving the drug for other disorders.",EXOGENOUS OBESITY,PHENTERMINE,RO-may_treat
503223455,7/15/2014 22:41:53,,1323881807,7/15/2014 22:41:45,instagc,0.4595,15445601,USA,FL,Jacksonville,24.129.68.254,no_relation,63,152,,79,163,treats,0.9830783046228491,907893-FS1-2,"3 ,   39 ,   40  Obesity  Not  indicated for the management of EXOGENOUS OBESITY   +    (either alone or in combination with weight loss agents such as PHENTERMINE although weight loss reported in some patients receiving the drug for other disorders.",EXOGENOUS OBESITY,PHENTERMINE,RO-may_treat
503223455,7/16/2014 00:39:30,,1323945600,7/16/2014 00:38:30,superrewards,0.4976,27577220,USA,NY,Brooklyn,98.116.119.6,PHENTERMINE treats EXOGENOUS OBESITY,63,152,,79,163,treats,0.9830783046228491,907893-FS1-2,"3 ,   39 ,   40  Obesity  Not  indicated for the management of EXOGENOUS OBESITY   +    (either alone or in combination with weight loss agents such as PHENTERMINE although weight loss reported in some patients receiving the drug for other disorders.",EXOGENOUS OBESITY,PHENTERMINE,RO-may_treat
503223455,7/16/2014 01:09:44,,1323962528,7/16/2014 01:09:25,bitcoinget,0.6825,28377798,GBR,,,195.166.117.126,PHENTERMINE treats EXOGENOUS OBESITY,63,152,,79,163,treats,0.9830783046228491,907893-FS1-2,"3 ,   39 ,   40  Obesity  Not  indicated for the management of EXOGENOUS OBESITY   +    (either alone or in combination with weight loss agents such as PHENTERMINE although weight loss reported in some patients receiving the drug for other disorders.",EXOGENOUS OBESITY,PHENTERMINE,RO-may_treat
503223458,7/15/2014 10:32:02,,1323490539,7/15/2014 10:31:20,vivatic,0.7917,25451531,GBR,,,83.67.28.193,no_relation,111,137,,131,167,causes,0.371390676354104,901591-FS1-4,"The clinicopathologic features of intestinal type adenocarcinoma have been well documented in the stomach, and INTESTINAL METAPLASIA and INTESTINAL TYPE ADENOCARCINOMA has also been reported in the gallbladder.",INTESTINAL METAPLASIA,INTESTINAL TYPE ADENOCARCINOMA,RO-disease_has_finding
503223458,7/15/2014 11:35:15,,1323532540,7/15/2014 11:34:54,prodege,0.6514,28039757,GBR,L8,Southport,109.155.158.54,no_relation,111,137,,131,167,causes,0.371390676354104,901591-FS1-4,"The clinicopathologic features of intestinal type adenocarcinoma have been well documented in the stomach, and INTESTINAL METAPLASIA and INTESTINAL TYPE ADENOCARCINOMA has also been reported in the gallbladder.",INTESTINAL METAPLASIA,INTESTINAL TYPE ADENOCARCINOMA,RO-disease_has_finding
503223458,7/15/2014 15:31:57,,1323627814,7/15/2014 15:31:41,tremorgames,0.8357,24449707,CAN,QC,Laval,96.21.249.72,no_relation,111,137,,131,167,causes,0.371390676354104,901591-FS1-4,"The clinicopathologic features of intestinal type adenocarcinoma have been well documented in the stomach, and INTESTINAL METAPLASIA and INTESTINAL TYPE ADENOCARCINOMA has also been reported in the gallbladder.",INTESTINAL METAPLASIA,INTESTINAL TYPE ADENOCARCINOMA,RO-disease_has_finding
503223458,7/15/2014 16:53:42,,1323704770,7/15/2014 16:53:07,prodege,0.7147,23541832,USA,AZ,Tempe,149.169.145.144,no_relation,111,137,,131,167,causes,0.371390676354104,901591-FS1-4,"The clinicopathologic features of intestinal type adenocarcinoma have been well documented in the stomach, and INTESTINAL METAPLASIA and INTESTINAL TYPE ADENOCARCINOMA has also been reported in the gallbladder.",INTESTINAL METAPLASIA,INTESTINAL TYPE ADENOCARCINOMA,RO-disease_has_finding
503223458,7/15/2014 18:48:46,,1323781550,7/15/2014 18:48:23,clixsense,0.7143,6355977,NLD,07,Amsterdam,46.129.42.165,no_relation,111,137,,131,167,causes,0.371390676354104,901591-FS1-4,"The clinicopathologic features of intestinal type adenocarcinoma have been well documented in the stomach, and INTESTINAL METAPLASIA and INTESTINAL TYPE ADENOCARCINOMA has also been reported in the gallbladder.",INTESTINAL METAPLASIA,INTESTINAL TYPE ADENOCARCINOMA,RO-disease_has_finding
503223458,7/16/2014 00:45:14,,1323948209,7/16/2014 00:44:41,neodev,0.7216,11460728,CAN,BC,Burnaby,70.79.16.165,no_relation,111,137,,131,167,causes,0.371390676354104,901591-FS1-4,"The clinicopathologic features of intestinal type adenocarcinoma have been well documented in the stomach, and INTESTINAL METAPLASIA and INTESTINAL TYPE ADENOCARCINOMA has also been reported in the gallbladder.",INTESTINAL METAPLASIA,INTESTINAL TYPE ADENOCARCINOMA,RO-disease_has_finding
503223458,7/16/2014 01:10:17,,1323962868,7/16/2014 01:09:45,bitcoinget,0.6825,28377798,GBR,,,195.166.117.126,no_relation,111,137,,131,167,causes,0.371390676354104,901591-FS1-4,"The clinicopathologic features of intestinal type adenocarcinoma have been well documented in the stomach, and INTESTINAL METAPLASIA and INTESTINAL TYPE ADENOCARCINOMA has also been reported in the gallbladder.",INTESTINAL METAPLASIA,INTESTINAL TYPE ADENOCARCINOMA,RO-disease_has_finding
503223463,7/15/2014 11:23:25,,1323525755,7/15/2014 11:23:01,instagc,0.9417,13763729,USA,,,75.182.89.225,DEFICIENCY OF SULFUR AMINO causes PROTEIN CALORIE MALNUTRITION,85,0,,112,26,causes,0.997054485501582,900213-FS1-4,DEFICIENCY OF SULFUR AMINO acids occurs in certain pathophysiological states such as PROTEIN CALORIE MALNUTRITION,PROTEIN CALORIE MALNUTRITION,DEFICIENCY OF SULFUR AMINO,RO-cause_of
503223463,7/15/2014 17:00:44,,1323712929,7/15/2014 17:00:29,neodev,0.7097,18755947,GBR,H2,Accrington,80.47.185.52,PROTEIN CALORIE MALNUTRITION causes DEFICIENCY OF SULFUR AMINO,85,0,,112,26,causes,0.997054485501582,900213-FS1-4,DEFICIENCY OF SULFUR AMINO acids occurs in certain pathophysiological states such as PROTEIN CALORIE MALNUTRITION,PROTEIN CALORIE MALNUTRITION,DEFICIENCY OF SULFUR AMINO,RO-cause_of
503223463,7/15/2014 17:23:41,,1323729124,7/15/2014 17:23:13,instagc,0.531,28519532,USA,IA,Honey Creek,12.73.110.41,PROTEIN CALORIE MALNUTRITION causes DEFICIENCY OF SULFUR AMINO,85,0,,112,26,causes,0.997054485501582,900213-FS1-4,DEFICIENCY OF SULFUR AMINO acids occurs in certain pathophysiological states such as PROTEIN CALORIE MALNUTRITION,PROTEIN CALORIE MALNUTRITION,DEFICIENCY OF SULFUR AMINO,RO-cause_of
503223463,7/15/2014 19:12:37,,1323794449,7/15/2014 19:11:51,prodege,0.5528,17932518,GBR,L5,Salford,95.151.167.238,DEFICIENCY OF SULFUR AMINO causes PROTEIN CALORIE MALNUTRITION,85,0,,112,26,causes,0.997054485501582,900213-FS1-4,DEFICIENCY OF SULFUR AMINO acids occurs in certain pathophysiological states such as PROTEIN CALORIE MALNUTRITION,PROTEIN CALORIE MALNUTRITION,DEFICIENCY OF SULFUR AMINO,RO-cause_of
503223463,7/15/2014 19:36:46,,1323805445,7/15/2014 19:36:23,gifthulk,0.6774,21916793,GBR,,,87.113.87.199,PROTEIN CALORIE MALNUTRITION causes DEFICIENCY OF SULFUR AMINO,85,0,,112,26,causes,0.997054485501582,900213-FS1-4,DEFICIENCY OF SULFUR AMINO acids occurs in certain pathophysiological states such as PROTEIN CALORIE MALNUTRITION,PROTEIN CALORIE MALNUTRITION,DEFICIENCY OF SULFUR AMINO,RO-cause_of
503223463,7/15/2014 22:16:35,,1323869566,7/15/2014 22:16:07,instagc,0.6571,26706653,USA,IL,Elk Grove Village,99.99.9.247,DEFICIENCY OF SULFUR AMINO causes PROTEIN CALORIE MALNUTRITION,85,0,,112,26,causes,0.997054485501582,900213-FS1-4,DEFICIENCY OF SULFUR AMINO acids occurs in certain pathophysiological states such as PROTEIN CALORIE MALNUTRITION,PROTEIN CALORIE MALNUTRITION,DEFICIENCY OF SULFUR AMINO,RO-cause_of
503223463,7/16/2014 01:09:25,,1323962341,7/16/2014 01:09:04,bitcoinget,0.6825,28377798,GBR,,,195.166.117.126,PROTEIN CALORIE MALNUTRITION causes DEFICIENCY OF SULFUR AMINO,85,0,,112,26,causes,0.997054485501582,900213-FS1-4,DEFICIENCY OF SULFUR AMINO acids occurs in certain pathophysiological states such as PROTEIN CALORIE MALNUTRITION,PROTEIN CALORIE MALNUTRITION,DEFICIENCY OF SULFUR AMINO,RO-cause_of
503223475,7/15/2014 11:34:46,,1323532259,7/15/2014 11:34:12,clixsense,0.8514,8888883,USA,FL,Orlando,76.26.232.146,no_relation,61,0,,86,21,treats,0.338061701891407,903610-FS1-2,"FORMALDEHYDE TOXICITY was partly reversible because once the FORMALDEHYDE CONCENTRATION was extremely low or virtually removed from the system, the methane production rate was partially recovered.",FORMALDEHYDE CONCENTRATION,FORMALDEHYDE TOXICITY,RO-has_causative_agent
503223475,7/15/2014 12:42:44,,1323562724,7/15/2014 12:42:23,prodege,0.7631,1852770,USA,TX,Abilene,76.198.102.54,no_relation,61,0,,86,21,treats,0.338061701891407,903610-FS1-2,"FORMALDEHYDE TOXICITY was partly reversible because once the FORMALDEHYDE CONCENTRATION was extremely low or virtually removed from the system, the methane production rate was partially recovered.",FORMALDEHYDE CONCENTRATION,FORMALDEHYDE TOXICITY,RO-has_causative_agent
503223475,7/15/2014 13:35:38,,1323582202,7/15/2014 13:34:54,instagc,0.6153,23149109,USA,NC,Cary,24.206.38.18,FORMALDEHYDE CONCENTRATION treats FORMALDEHYDE TOXICITY,61,0,,86,21,treats,0.338061701891407,903610-FS1-2,"FORMALDEHYDE TOXICITY was partly reversible because once the FORMALDEHYDE CONCENTRATION was extremely low or virtually removed from the system, the methane production rate was partially recovered.",FORMALDEHYDE CONCENTRATION,FORMALDEHYDE TOXICITY,RO-has_causative_agent
503223475,7/15/2014 13:55:38,,1323588387,7/15/2014 13:55:15,neodev,0.4998,18339121,USA,SC,Sumter,173.93.188.194,FORMALDEHYDE CONCENTRATION treats FORMALDEHYDE TOXICITY,61,0,,86,21,treats,0.338061701891407,903610-FS1-2,"FORMALDEHYDE TOXICITY was partly reversible because once the FORMALDEHYDE CONCENTRATION was extremely low or virtually removed from the system, the methane production rate was partially recovered.",FORMALDEHYDE CONCENTRATION,FORMALDEHYDE TOXICITY,RO-has_causative_agent
503223475,7/15/2014 14:14:38,,1323593581,7/15/2014 14:13:58,neodev,0.8179,28336203,USA,PA,Harrisburg,50.149.53.150,FORMALDEHYDE CONCENTRATION treats FORMALDEHYDE TOXICITY,61,0,,86,21,treats,0.338061701891407,903610-FS1-2,"FORMALDEHYDE TOXICITY was partly reversible because once the FORMALDEHYDE CONCENTRATION was extremely low or virtually removed from the system, the methane production rate was partially recovered.",FORMALDEHYDE CONCENTRATION,FORMALDEHYDE TOXICITY,RO-has_causative_agent
503223475,7/15/2014 15:24:13,,1323622384,7/15/2014 15:23:49,prodege,0.7167,7899370,USA,MI,Bay City,71.13.81.162,no_relation,61,0,,86,21,treats,0.338061701891407,903610-FS1-2,"FORMALDEHYDE TOXICITY was partly reversible because once the FORMALDEHYDE CONCENTRATION was extremely low or virtually removed from the system, the methane production rate was partially recovered.",FORMALDEHYDE CONCENTRATION,FORMALDEHYDE TOXICITY,RO-has_causative_agent
503223475,7/15/2014 15:31:39,,1323627595,7/15/2014 15:31:25,tremorgames,0.8357,24449707,CAN,QC,Laval,96.21.249.72,FORMALDEHYDE CONCENTRATION treats FORMALDEHYDE TOXICITY,61,0,,86,21,treats,0.338061701891407,903610-FS1-2,"FORMALDEHYDE TOXICITY was partly reversible because once the FORMALDEHYDE CONCENTRATION was extremely low or virtually removed from the system, the methane production rate was partially recovered.",FORMALDEHYDE CONCENTRATION,FORMALDEHYDE TOXICITY,RO-has_causative_agent
503223478,7/15/2014 11:33:14,,1323531277,7/15/2014 11:32:25,clixsense,0.8514,8888883,USA,FL,Orlando,76.26.232.146,PREECLAMPSIA causes PREGNANCY COMPLICATION,18,0,,39,12,causes,0.854242196177249,901534-FS1-4,"PREECLAMPSIA is a PREGNANCY COMPLICATION diagnosed by hypertension and proteinuria, characterized by endothelial dysfunction, and supposedly caused by compounds from hypoxic uteroplacental tissues.",PREGNANCY COMPLICATION,PREECLAMPSIA,RO-disease_has_finding
503223478,7/15/2014 11:34:52,,1323532317,7/15/2014 11:34:20,prodege,0.6514,28039757,GBR,L8,Southport,109.155.158.54,PREGNANCY COMPLICATION causes PREECLAMPSIA,18,0,,39,12,causes,0.854242196177249,901534-FS1-4,"PREECLAMPSIA is a PREGNANCY COMPLICATION diagnosed by hypertension and proteinuria, characterized by endothelial dysfunction, and supposedly caused by compounds from hypoxic uteroplacental tissues.",PREGNANCY COMPLICATION,PREECLAMPSIA,RO-disease_has_finding
503223478,7/15/2014 12:15:27,,1323552513,7/15/2014 12:14:59,paiddailysurveys,0.6292,11786001,USA,NC,Charlotte,71.28.89.238,PREECLAMPSIA causes PREGNANCY COMPLICATION,18,0,,39,12,causes,0.854242196177249,901534-FS1-4,"PREECLAMPSIA is a PREGNANCY COMPLICATION diagnosed by hypertension and proteinuria, characterized by endothelial dysfunction, and supposedly caused by compounds from hypoxic uteroplacental tissues.",PREGNANCY COMPLICATION,PREECLAMPSIA,RO-disease_has_finding
503223478,7/15/2014 13:07:46,,1323572695,7/15/2014 13:07:36,clixsense,0.4944,20614047,USA,ID,Priest River,174.32.160.124,PREGNANCY COMPLICATION causes PREECLAMPSIA,18,0,,39,12,causes,0.854242196177249,901534-FS1-4,"PREECLAMPSIA is a PREGNANCY COMPLICATION diagnosed by hypertension and proteinuria, characterized by endothelial dysfunction, and supposedly caused by compounds from hypoxic uteroplacental tissues.",PREGNANCY COMPLICATION,PREECLAMPSIA,RO-disease_has_finding
503223478,7/15/2014 13:33:50,,1323581663,7/15/2014 13:33:36,instagc,0.6153,23149109,USA,NC,Cary,24.206.38.18,PREECLAMPSIA causes PREGNANCY COMPLICATION,18,0,,39,12,causes,0.854242196177249,901534-FS1-4,"PREECLAMPSIA is a PREGNANCY COMPLICATION diagnosed by hypertension and proteinuria, characterized by endothelial dysfunction, and supposedly caused by compounds from hypoxic uteroplacental tissues.",PREGNANCY COMPLICATION,PREECLAMPSIA,RO-disease_has_finding
503223478,7/15/2014 16:47:06,,1323697768,7/15/2014 16:46:58,prodege,0.5014,2143114,CAN,BC,Vancouver,24.84.160.12,PREECLAMPSIA causes PREGNANCY COMPLICATION,18,0,,39,12,causes,0.854242196177249,901534-FS1-4,"PREECLAMPSIA is a PREGNANCY COMPLICATION diagnosed by hypertension and proteinuria, characterized by endothelial dysfunction, and supposedly caused by compounds from hypoxic uteroplacental tissues.",PREGNANCY COMPLICATION,PREECLAMPSIA,RO-disease_has_finding
503223478,7/15/2014 19:52:04,,1323811125,7/15/2014 19:51:26,clixsense,0.4819,6714657,USA,CT,Groton,71.235.184.32,PREECLAMPSIA causes PREGNANCY COMPLICATION,18,0,,39,12,causes,0.854242196177249,901534-FS1-4,"PREECLAMPSIA is a PREGNANCY COMPLICATION diagnosed by hypertension and proteinuria, characterized by endothelial dysfunction, and supposedly caused by compounds from hypoxic uteroplacental tissues.",PREGNANCY COMPLICATION,PREECLAMPSIA,RO-disease_has_finding
503223484,7/15/2014 10:52:54,,1323505056,7/15/2014 10:52:43,clixsense,1.0,27793793,GBR,C5,Chester,151.230.27.155,FETAL FLUORIDE treats CARIES,3,35,,8,49,treats,0.917662935482247,907148-FS1-2,"No CARIES protective effect of the FETAL FLUORIDE however, has been substantiated by pertinent research.",CARIES,FETAL FLUORIDE,RO-may_prevent
503223484,7/15/2014 11:22:41,,1323525292,7/15/2014 11:22:01,elite,0.8264,28397222,GBR,Y4,Usk,31.50.223.75,FETAL FLUORIDE treats CARIES,3,35,,8,49,treats,0.917662935482247,907148-FS1-2,"No CARIES protective effect of the FETAL FLUORIDE however, has been substantiated by pertinent research.",CARIES,FETAL FLUORIDE,RO-may_prevent
503223484,7/15/2014 11:34:18,,1323532012,7/15/2014 11:33:54,prodege,0.6514,28039757,GBR,L8,Southport,109.155.158.54,no_relation,3,35,,8,49,treats,0.917662935482247,907148-FS1-2,"No CARIES protective effect of the FETAL FLUORIDE however, has been substantiated by pertinent research.",CARIES,FETAL FLUORIDE,RO-may_prevent
503223484,7/15/2014 17:58:41,,1323761155,7/15/2014 17:58:22,tremorgames,0.5768,28013393,USA,CA,Rancho Cordova,71.197.67.37,CARIES treats FETAL FLUORIDE,3,35,,8,49,treats,0.917662935482247,907148-FS1-2,"No CARIES protective effect of the FETAL FLUORIDE however, has been substantiated by pertinent research.",CARIES,FETAL FLUORIDE,RO-may_prevent
503223484,7/15/2014 19:54:52,,1323812038,7/15/2014 19:54:17,clixsense,0.4819,6714657,USA,CT,Groton,71.235.184.32,no_relation,3,35,,8,49,treats,0.917662935482247,907148-FS1-2,"No CARIES protective effect of the FETAL FLUORIDE however, has been substantiated by pertinent research.",CARIES,FETAL FLUORIDE,RO-may_prevent
503223484,7/15/2014 20:24:38,,1323824119,7/15/2014 20:23:41,clixsense,0.5208,25399403,GBR,,,188.29.96.57,no_relation,3,35,,8,49,treats,0.917662935482247,907148-FS1-2,"No CARIES protective effect of the FETAL FLUORIDE however, has been substantiated by pertinent research.",CARIES,FETAL FLUORIDE,RO-may_prevent
503223484,7/16/2014 02:17:14,,1323995900,7/16/2014 02:17:09,neodev,0.523,22098386,USA,NY,Greenwich,67.248.253.125,FETAL FLUORIDE treats CARIES,3,35,,8,49,treats,0.917662935482247,907148-FS1-2,"No CARIES protective effect of the FETAL FLUORIDE however, has been substantiated by pertinent research.",CARIES,FETAL FLUORIDE,RO-may_prevent
503223497,7/15/2014 10:11:10,,1323477161,7/15/2014 10:10:41,eup_slw,0.9583,20818028,GBR,A7,Birmingham,92.232.139.254,PHEOCHROMOCYTOMA causes HYPERTENSION,64,131,,75,147,causes,0.5393598899705939,902674-FS1-4,C]  4.1 Consider consulting an endocrinologist or specialist in HYPERTENSION to assist in confirming or excluding the diagnosis of PHEOCHROMOCYTOMA,HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
503223497,7/15/2014 11:10:22,,1323517528,7/15/2014 11:10:03,instagc,0.7778,24252915,GBR,B7,Bristol,77.98.139.82,PHEOCHROMOCYTOMA causes HYPERTENSION,64,131,,75,147,causes,0.5393598899705939,902674-FS1-4,C]  4.1 Consider consulting an endocrinologist or specialist in HYPERTENSION to assist in confirming or excluding the diagnosis of PHEOCHROMOCYTOMA,HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
503223497,7/15/2014 11:40:19,,1323535424,7/15/2014 11:39:53,clixsense,0.5,23233834,GBR,N6,Sunderland,86.17.58.181,HYPERTENSION causes PHEOCHROMOCYTOMA,64,131,,75,147,causes,0.5393598899705939,902674-FS1-4,C]  4.1 Consider consulting an endocrinologist or specialist in HYPERTENSION to assist in confirming or excluding the diagnosis of PHEOCHROMOCYTOMA,HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
503223497,7/15/2014 13:55:38,,1323588392,7/15/2014 13:55:15,neodev,0.4998,18339121,USA,SC,Sumter,173.93.188.194,PHEOCHROMOCYTOMA causes HYPERTENSION,64,131,,75,147,causes,0.5393598899705939,902674-FS1-4,C]  4.1 Consider consulting an endocrinologist or specialist in HYPERTENSION to assist in confirming or excluding the diagnosis of PHEOCHROMOCYTOMA,HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
503223497,7/15/2014 15:32:05,,1323627917,7/15/2014 15:31:58,tremorgames,0.8357,24449707,CAN,QC,Laval,96.21.249.72,PHEOCHROMOCYTOMA causes HYPERTENSION,64,131,,75,147,causes,0.5393598899705939,902674-FS1-4,C]  4.1 Consider consulting an endocrinologist or specialist in HYPERTENSION to assist in confirming or excluding the diagnosis of PHEOCHROMOCYTOMA,HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
503223497,7/15/2014 19:42:04,,1323807727,7/15/2014 19:41:44,clixsense,0.6984,24429778,AUS,,,121.211.19.218,PHEOCHROMOCYTOMA causes HYPERTENSION,64,131,,75,147,causes,0.5393598899705939,902674-FS1-4,C]  4.1 Consider consulting an endocrinologist or specialist in HYPERTENSION to assist in confirming or excluding the diagnosis of PHEOCHROMOCYTOMA,HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
503223497,7/15/2014 21:31:44,,1323852052,7/15/2014 21:31:23,clixsense,0.7169,25595227,CAN,SK,North Battleford,24.72.96.119,PHEOCHROMOCYTOMA causes HYPERTENSION,64,131,,75,147,causes,0.5393598899705939,902674-FS1-4,C]  4.1 Consider consulting an endocrinologist or specialist in HYPERTENSION to assist in confirming or excluding the diagnosis of PHEOCHROMOCYTOMA,HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
503223503,7/15/2014 11:25:05,,1323526743,7/15/2014 11:24:52,instagc,0.7528,28301350,GBR,K4,Plymouth,92.28.215.248,DEFEROXAMINE treats IRON OVERLOAD,79,25,,91,37,treats,0.997054485501582,907321-FS1-2,"Despite the successes of DEFEROXAMINE (DFO) in the treatment and prevention of IRON OVERLOAD an effective orally available iron chelating drug is needed, since erratic compliance with irritating, cumbersome parenteral infusions still results in fatal iron accumulation in many patients.",IRON OVERLOAD,DEFEROXAMINE,RO-may_prevent
503223503,7/15/2014 11:27:40,,1323528160,7/15/2014 11:27:27,prodege,0.6917,15439740,AUS,02,Jannali,27.96.208.89,DEFEROXAMINE treats IRON OVERLOAD,79,25,,91,37,treats,0.997054485501582,907321-FS1-2,"Despite the successes of DEFEROXAMINE (DFO) in the treatment and prevention of IRON OVERLOAD an effective orally available iron chelating drug is needed, since erratic compliance with irritating, cumbersome parenteral infusions still results in fatal iron accumulation in many patients.",IRON OVERLOAD,DEFEROXAMINE,RO-may_prevent
503223503,7/15/2014 11:33:40,,1323531609,7/15/2014 11:33:14,clixsense,0.8514,8888883,USA,FL,Orlando,76.26.232.146,DEFEROXAMINE treats IRON OVERLOAD,79,25,,91,37,treats,0.997054485501582,907321-FS1-2,"Despite the successes of DEFEROXAMINE (DFO) in the treatment and prevention of IRON OVERLOAD an effective orally available iron chelating drug is needed, since erratic compliance with irritating, cumbersome parenteral infusions still results in fatal iron accumulation in many patients.",IRON OVERLOAD,DEFEROXAMINE,RO-may_prevent
503223503,7/15/2014 12:43:07,,1323562858,7/15/2014 12:42:45,prodege,0.7631,1852770,USA,TX,Abilene,76.198.102.54,DEFEROXAMINE treats IRON OVERLOAD,79,25,,91,37,treats,0.997054485501582,907321-FS1-2,"Despite the successes of DEFEROXAMINE (DFO) in the treatment and prevention of IRON OVERLOAD an effective orally available iron chelating drug is needed, since erratic compliance with irritating, cumbersome parenteral infusions still results in fatal iron accumulation in many patients.",IRON OVERLOAD,DEFEROXAMINE,RO-may_prevent
503223503,7/15/2014 13:07:46,,1323572696,7/15/2014 13:07:36,clixsense,0.4944,20614047,USA,ID,Priest River,174.32.160.124,no_relation,79,25,,91,37,treats,0.997054485501582,907321-FS1-2,"Despite the successes of DEFEROXAMINE (DFO) in the treatment and prevention of IRON OVERLOAD an effective orally available iron chelating drug is needed, since erratic compliance with irritating, cumbersome parenteral infusions still results in fatal iron accumulation in many patients.",IRON OVERLOAD,DEFEROXAMINE,RO-may_prevent
503223503,7/15/2014 13:35:58,,1323582387,7/15/2014 13:35:45,instagc,0.6153,23149109,USA,NC,Cary,24.206.38.18,DEFEROXAMINE treats IRON OVERLOAD,79,25,,91,37,treats,0.997054485501582,907321-FS1-2,"Despite the successes of DEFEROXAMINE (DFO) in the treatment and prevention of IRON OVERLOAD an effective orally available iron chelating drug is needed, since erratic compliance with irritating, cumbersome parenteral infusions still results in fatal iron accumulation in many patients.",IRON OVERLOAD,DEFEROXAMINE,RO-may_prevent
503223503,7/15/2014 15:31:57,,1323627810,7/15/2014 15:31:41,tremorgames,0.8357,24449707,CAN,QC,Laval,96.21.249.72,DEFEROXAMINE treats IRON OVERLOAD,79,25,,91,37,treats,0.997054485501582,907321-FS1-2,"Despite the successes of DEFEROXAMINE (DFO) in the treatment and prevention of IRON OVERLOAD an effective orally available iron chelating drug is needed, since erratic compliance with irritating, cumbersome parenteral infusions still results in fatal iron accumulation in many patients.",IRON OVERLOAD,DEFEROXAMINE,RO-may_prevent
503223511,7/15/2014 11:16:09,,1323521346,7/15/2014 11:15:30,prodege,0.7986,11864493,GBR,Z4,Wrexham,212.219.196.69,TUBERCULOSIS diagnosed by PPD INTRADERMAL,196,142,,207,157,diagnosed by,0.99654575824488,906599-FS1-13,"Health Canada/Canadian Lung Association/Canadian Thoracic Society, 2007  Canadian tuberculosis standards  The Mantoux using 0.1 mL of 5 TU of PPD INTRADERMAL is the recommended test to screen for TUBERCULOSIS infection.",TUBERCULOSIS,PPD INTRADERMAL,RO-may_diagnose
503223511,7/15/2014 13:15:51,,1323575487,7/15/2014 13:15:10,prodege,0.6865,21891314,AUS,07,Glen Iris,58.6.248.249,TUBERCULOSIS diagnosed by PPD INTRADERMAL,196,142,,207,157,diagnosed by,0.99654575824488,906599-FS1-13,"Health Canada/Canadian Lung Association/Canadian Thoracic Society, 2007  Canadian tuberculosis standards  The Mantoux using 0.1 mL of 5 TU of PPD INTRADERMAL is the recommended test to screen for TUBERCULOSIS infection.",TUBERCULOSIS,PPD INTRADERMAL,RO-may_diagnose
503223511,7/15/2014 17:09:13,,1323720842,7/15/2014 17:08:33,clixsense,0.5345,6574199,USA,TX,San Antonio,207.230.144.242,TUBERCULOSIS diagnosed by PPD INTRADERMAL,196,142,,207,157,diagnosed by,0.99654575824488,906599-FS1-13,"Health Canada/Canadian Lung Association/Canadian Thoracic Society, 2007  Canadian tuberculosis standards  The Mantoux using 0.1 mL of 5 TU of PPD INTRADERMAL is the recommended test to screen for TUBERCULOSIS infection.",TUBERCULOSIS,PPD INTRADERMAL,RO-may_diagnose
503223511,7/15/2014 19:36:22,,1323805293,7/15/2014 19:36:07,gifthulk,0.6774,21916793,GBR,,,87.113.87.199,TUBERCULOSIS diagnosed by PPD INTRADERMAL,196,142,,207,157,diagnosed by,0.99654575824488,906599-FS1-13,"Health Canada/Canadian Lung Association/Canadian Thoracic Society, 2007  Canadian tuberculosis standards  The Mantoux using 0.1 mL of 5 TU of PPD INTRADERMAL is the recommended test to screen for TUBERCULOSIS infection.",TUBERCULOSIS,PPD INTRADERMAL,RO-may_diagnose
503223511,7/15/2014 19:53:33,,1323811605,7/15/2014 19:52:47,clixsense,0.4819,6714657,USA,CT,Groton,71.235.184.32,TUBERCULOSIS diagnosed by PPD INTRADERMAL,196,142,,207,157,diagnosed by,0.99654575824488,906599-FS1-13,"Health Canada/Canadian Lung Association/Canadian Thoracic Society, 2007  Canadian tuberculosis standards  The Mantoux using 0.1 mL of 5 TU of PPD INTRADERMAL is the recommended test to screen for TUBERCULOSIS infection.",TUBERCULOSIS,PPD INTRADERMAL,RO-may_diagnose
503223511,7/16/2014 01:43:44,,1323979654,7/16/2014 01:43:18,clixsense,0.7798,19638651,USA,,,173.23.121.63,TUBERCULOSIS diagnosed by PPD INTRADERMAL,196,142,,207,157,diagnosed by,0.99654575824488,906599-FS1-13,"Health Canada/Canadian Lung Association/Canadian Thoracic Society, 2007  Canadian tuberculosis standards  The Mantoux using 0.1 mL of 5 TU of PPD INTRADERMAL is the recommended test to screen for TUBERCULOSIS infection.",TUBERCULOSIS,PPD INTRADERMAL,RO-may_diagnose
503223511,7/16/2014 02:17:14,,1323995908,7/16/2014 02:17:09,neodev,0.523,22098386,USA,NY,Greenwich,67.248.253.125,TUBERCULOSIS diagnosed by PPD INTRADERMAL,196,142,,207,157,diagnosed by,0.99654575824488,906599-FS1-13,"Health Canada/Canadian Lung Association/Canadian Thoracic Society, 2007  Canadian tuberculosis standards  The Mantoux using 0.1 mL of 5 TU of PPD INTRADERMAL is the recommended test to screen for TUBERCULOSIS infection.",TUBERCULOSIS,PPD INTRADERMAL,RO-may_diagnose
503223514,7/15/2014 10:32:36,,1323490894,7/15/2014 10:32:04,vivatic,0.7917,25451531,GBR,,,83.67.28.193,no_relation,77,113,,94,129,causes,0.985329278164293,901605-FS1-4,Twenty one primary lesions in patients without metastasis and 26 primary and METASTATIC LESIONS in patients with LIVER METASTASIS were studied.,METASTATIC LESIONS,LIVER METASTASIS,RO-disease_has_finding
503223514,7/15/2014 10:54:34,,1323506183,7/15/2014 10:54:08,rewardsspot,0.8542,17763704,USA,VA,Manassas,198.7.62.204,METASTATIC LESIONS causes LIVER METASTASIS,77,113,,94,129,causes,0.985329278164293,901605-FS1-4,Twenty one primary lesions in patients without metastasis and 26 primary and METASTATIC LESIONS in patients with LIVER METASTASIS were studied.,METASTATIC LESIONS,LIVER METASTASIS,RO-disease_has_finding
503223514,7/15/2014 17:10:07,,1323721492,7/15/2014 17:09:42,clixsense,0.5345,6574199,USA,TX,San Antonio,207.230.144.242,LIVER METASTASIS causes METASTATIC LESIONS,77,113,,94,129,causes,0.985329278164293,901605-FS1-4,Twenty one primary lesions in patients without metastasis and 26 primary and METASTATIC LESIONS in patients with LIVER METASTASIS were studied.,METASTATIC LESIONS,LIVER METASTASIS,RO-disease_has_finding
503223514,7/15/2014 20:33:55,,1323828043,7/15/2014 20:32:44,prodege,0.5694,28255346,GBR,L9,Sheffield,2.125.183.137,LIVER METASTASIS causes METASTATIC LESIONS,77,113,,94,129,causes,0.985329278164293,901605-FS1-4,Twenty one primary lesions in patients without metastasis and 26 primary and METASTATIC LESIONS in patients with LIVER METASTASIS were studied.,METASTATIC LESIONS,LIVER METASTASIS,RO-disease_has_finding
503223514,7/16/2014 00:40:32,,1323946073,7/16/2014 00:39:30,superrewards,0.4976,27577220,USA,NY,Brooklyn,98.116.119.6,METASTATIC LESIONS causes LIVER METASTASIS,77,113,,94,129,causes,0.985329278164293,901605-FS1-4,Twenty one primary lesions in patients without metastasis and 26 primary and METASTATIC LESIONS in patients with LIVER METASTASIS were studied.,METASTATIC LESIONS,LIVER METASTASIS,RO-disease_has_finding
503223514,7/16/2014 01:10:17,,1323962870,7/16/2014 01:09:45,bitcoinget,0.6825,28377798,GBR,,,195.166.117.126,LIVER METASTASIS causes METASTATIC LESIONS,77,113,,94,129,causes,0.985329278164293,901605-FS1-4,Twenty one primary lesions in patients without metastasis and 26 primary and METASTATIC LESIONS in patients with LIVER METASTASIS were studied.,METASTATIC LESIONS,LIVER METASTASIS,RO-disease_has_finding
503223514,7/16/2014 01:43:44,,1323979655,7/16/2014 01:43:18,clixsense,0.7798,19638651,USA,,,173.23.121.63,LIVER METASTASIS causes METASTATIC LESIONS,77,113,,94,129,causes,0.985329278164293,901605-FS1-4,Twenty one primary lesions in patients without metastasis and 26 primary and METASTATIC LESIONS in patients with LIVER METASTASIS were studied.,METASTATIC LESIONS,LIVER METASTASIS,RO-disease_has_finding
503223519,7/15/2014 12:40:42,,1323561958,7/15/2014 12:40:33,instagc,0.7417,18960682,GBR,,,86.29.147.112,BRAIN is location of MULTIFOCAL LEUKOENCEPHALOPATHY,33,62,,37,92,is location of,0.9434563530497259,902284-FS1-9,Neurotropic JC virus reaches the BRAIN and causes progressive MULTIFOCAL LEUKOENCEPHALOPATHY a demyelinating disease of the central nervous system with a high mortality rate.,BRAIN,MULTIFOCAL LEUKOENCEPHALOPATHY,RO-disease_has_primary_anatomic_site
503223519,7/15/2014 13:03:42,,1323571256,7/15/2014 13:03:06,prodege,0.875,19192508,USA,OK,Broken Arrow,70.177.111.89,BRAIN is location of MULTIFOCAL LEUKOENCEPHALOPATHY,33,62,,37,92,is location of,0.9434563530497259,902284-FS1-9,Neurotropic JC virus reaches the BRAIN and causes progressive MULTIFOCAL LEUKOENCEPHALOPATHY a demyelinating disease of the central nervous system with a high mortality rate.,BRAIN,MULTIFOCAL LEUKOENCEPHALOPATHY,RO-disease_has_primary_anatomic_site
503223519,7/15/2014 15:24:13,,1323622383,7/15/2014 15:23:49,prodege,0.7167,7899370,USA,MI,Bay City,71.13.81.162,BRAIN is location of MULTIFOCAL LEUKOENCEPHALOPATHY,33,62,,37,92,is location of,0.9434563530497259,902284-FS1-9,Neurotropic JC virus reaches the BRAIN and causes progressive MULTIFOCAL LEUKOENCEPHALOPATHY a demyelinating disease of the central nervous system with a high mortality rate.,BRAIN,MULTIFOCAL LEUKOENCEPHALOPATHY,RO-disease_has_primary_anatomic_site
503223519,7/15/2014 16:25:10,,1323671557,7/15/2014 16:24:55,clixsense,0.6252,16827630,GBR,A7,Birmingham,86.146.169.103,BRAIN is location of MULTIFOCAL LEUKOENCEPHALOPATHY,33,62,,37,92,is location of,0.9434563530497259,902284-FS1-9,Neurotropic JC virus reaches the BRAIN and causes progressive MULTIFOCAL LEUKOENCEPHALOPATHY a demyelinating disease of the central nervous system with a high mortality rate.,BRAIN,MULTIFOCAL LEUKOENCEPHALOPATHY,RO-disease_has_primary_anatomic_site
503223519,7/15/2014 16:53:53,,1323704964,7/15/2014 16:53:44,prodege,0.7147,23541832,USA,AZ,Tempe,149.169.145.144,BRAIN is location of MULTIFOCAL LEUKOENCEPHALOPATHY,33,62,,37,92,is location of,0.9434563530497259,902284-FS1-9,Neurotropic JC virus reaches the BRAIN and causes progressive MULTIFOCAL LEUKOENCEPHALOPATHY a demyelinating disease of the central nervous system with a high mortality rate.,BRAIN,MULTIFOCAL LEUKOENCEPHALOPATHY,RO-disease_has_primary_anatomic_site
503223519,7/15/2014 17:00:57,,1323713197,7/15/2014 17:00:45,neodev,0.7097,18755947,GBR,H2,Accrington,80.47.185.52,BRAIN is location of MULTIFOCAL LEUKOENCEPHALOPATHY,33,62,,37,92,is location of,0.9434563530497259,902284-FS1-9,Neurotropic JC virus reaches the BRAIN and causes progressive MULTIFOCAL LEUKOENCEPHALOPATHY a demyelinating disease of the central nervous system with a high mortality rate.,BRAIN,MULTIFOCAL LEUKOENCEPHALOPATHY,RO-disease_has_primary_anatomic_site
503223519,7/15/2014 17:24:18,,1323729405,7/15/2014 17:23:47,instagc,0.531,28519532,USA,IA,Honey Creek,12.73.110.41,BRAIN is location of MULTIFOCAL LEUKOENCEPHALOPATHY,33,62,,37,92,is location of,0.9434563530497259,902284-FS1-9,Neurotropic JC virus reaches the BRAIN and causes progressive MULTIFOCAL LEUKOENCEPHALOPATHY a demyelinating disease of the central nervous system with a high mortality rate.,BRAIN,MULTIFOCAL LEUKOENCEPHALOPATHY,RO-disease_has_primary_anatomic_site
503223525,7/15/2014 11:54:03,,1323543919,7/15/2014 11:53:45,neodev,0.7083,24578640,USA,IL,Chicago,65.60.20.66,NEUROFIBROMATOSIS is location of NERVOUS SYSTEM,108,0,,121,17,is location of,0.7559289460184542,905210-FS1-9,"NEUROFIBROMATOSIS Huntington's disease, and myotonic dystrophy are three hereditary disorders affecting the NERVOUS SYSTEM",NERVOUS SYSTEM,NEUROFIBROMATOSIS,RO-has_finding_site
503223525,7/15/2014 15:23:28,,1323621892,7/15/2014 15:23:06,prodege,0.7167,7899370,USA,MI,Bay City,71.13.81.162,NERVOUS SYSTEM is location of NEUROFIBROMATOSIS,108,0,,121,17,is location of,0.7559289460184542,905210-FS1-9,"NEUROFIBROMATOSIS Huntington's disease, and myotonic dystrophy are three hereditary disorders affecting the NERVOUS SYSTEM",NERVOUS SYSTEM,NEUROFIBROMATOSIS,RO-has_finding_site
503223525,7/15/2014 17:11:37,,1323722577,7/15/2014 17:10:53,clixsense,0.5345,6574199,USA,TX,San Antonio,207.230.144.242,no_relation,108,0,,121,17,is location of,0.7559289460184542,905210-FS1-9,"NEUROFIBROMATOSIS Huntington's disease, and myotonic dystrophy are three hereditary disorders affecting the NERVOUS SYSTEM",NERVOUS SYSTEM,NEUROFIBROMATOSIS,RO-has_finding_site
503223525,7/15/2014 19:36:06,,1323805154,7/15/2014 19:35:45,gifthulk,0.6774,21916793,GBR,,,87.113.87.199,NERVOUS SYSTEM is location of NEUROFIBROMATOSIS,108,0,,121,17,is location of,0.7559289460184542,905210-FS1-9,"NEUROFIBROMATOSIS Huntington's disease, and myotonic dystrophy are three hereditary disorders affecting the NERVOUS SYSTEM",NERVOUS SYSTEM,NEUROFIBROMATOSIS,RO-has_finding_site
503223525,7/15/2014 21:32:42,,1323852419,7/15/2014 21:32:22,clixsense,0.7169,25595227,CAN,SK,North Battleford,24.72.96.119,NERVOUS SYSTEM is location of NEUROFIBROMATOSIS,108,0,,121,17,is location of,0.7559289460184542,905210-FS1-9,"NEUROFIBROMATOSIS Huntington's disease, and myotonic dystrophy are three hereditary disorders affecting the NERVOUS SYSTEM",NERVOUS SYSTEM,NEUROFIBROMATOSIS,RO-has_finding_site
503223525,7/16/2014 00:37:34,,1323944688,7/16/2014 00:36:32,superrewards,0.4976,27577220,USA,NY,Brooklyn,98.116.119.6,NERVOUS SYSTEM is location of NEUROFIBROMATOSIS,108,0,,121,17,is location of,0.7559289460184542,905210-FS1-9,"NEUROFIBROMATOSIS Huntington's disease, and myotonic dystrophy are three hereditary disorders affecting the NERVOUS SYSTEM",NERVOUS SYSTEM,NEUROFIBROMATOSIS,RO-has_finding_site
503223525,7/16/2014 01:09:03,,1323962087,7/16/2014 01:08:42,bitcoinget,0.6825,28377798,GBR,,,195.166.117.126,no_relation,108,0,,121,17,is location of,0.7559289460184542,905210-FS1-9,"NEUROFIBROMATOSIS Huntington's disease, and myotonic dystrophy are three hereditary disorders affecting the NERVOUS SYSTEM",NERVOUS SYSTEM,NEUROFIBROMATOSIS,RO-has_finding_site
503223528,7/15/2014 10:30:04,,1323489199,7/15/2014 10:29:51,clixsense,0.9722,19803139,NLD,06,Veldhoven,212.61.84.196,INFECTIOUS MONONUCLEOSIS causes FEVER,99,62,,103,86,causes,0.9701425001453321,901550-FS1-4,"We describe a case of a 29 year old patient with a history of INFECTIOUS MONONUCLEOSIS followed by FEVER weight loss, and splenomegaly.",FEVER,INFECTIOUS MONONUCLEOSIS,RO-disease_has_finding
503223528,7/15/2014 11:23:41,,1323525904,7/15/2014 11:23:07,elite,0.8264,28397222,GBR,Y4,Usk,31.50.223.75,INFECTIOUS MONONUCLEOSIS causes FEVER,99,62,,103,86,causes,0.9701425001453321,901550-FS1-4,"We describe a case of a 29 year old patient with a history of INFECTIOUS MONONUCLEOSIS followed by FEVER weight loss, and splenomegaly.",FEVER,INFECTIOUS MONONUCLEOSIS,RO-disease_has_finding
503223528,7/15/2014 11:54:33,,1323544095,7/15/2014 11:54:17,neodev,0.7083,24578640,USA,IL,Chicago,65.60.20.66,FEVER causes INFECTIOUS MONONUCLEOSIS,99,62,,103,86,causes,0.9701425001453321,901550-FS1-4,"We describe a case of a 29 year old patient with a history of INFECTIOUS MONONUCLEOSIS followed by FEVER weight loss, and splenomegaly.",FEVER,INFECTIOUS MONONUCLEOSIS,RO-disease_has_finding
503223528,7/15/2014 13:35:58,,1323582388,7/15/2014 13:35:45,instagc,0.6153,23149109,USA,NC,Cary,24.206.38.18,INFECTIOUS MONONUCLEOSIS causes FEVER,99,62,,103,86,causes,0.9701425001453321,901550-FS1-4,"We describe a case of a 29 year old patient with a history of INFECTIOUS MONONUCLEOSIS followed by FEVER weight loss, and splenomegaly.",FEVER,INFECTIOUS MONONUCLEOSIS,RO-disease_has_finding
503223528,7/15/2014 16:54:22,,1323705469,7/15/2014 16:54:06,prodege,0.7147,23541832,USA,AZ,Tempe,149.169.145.144,INFECTIOUS MONONUCLEOSIS causes FEVER,99,62,,103,86,causes,0.9701425001453321,901550-FS1-4,"We describe a case of a 29 year old patient with a history of INFECTIOUS MONONUCLEOSIS followed by FEVER weight loss, and splenomegaly.",FEVER,INFECTIOUS MONONUCLEOSIS,RO-disease_has_finding
503223528,7/15/2014 18:45:32,,1323779808,7/15/2014 18:44:27,clixsense,0.7143,6355977,NLD,07,Amsterdam,46.129.42.165,INFECTIOUS MONONUCLEOSIS causes FEVER,99,62,,103,86,causes,0.9701425001453321,901550-FS1-4,"We describe a case of a 29 year old patient with a history of INFECTIOUS MONONUCLEOSIS followed by FEVER weight loss, and splenomegaly.",FEVER,INFECTIOUS MONONUCLEOSIS,RO-disease_has_finding
503223528,7/15/2014 19:13:02,,1323794636,7/15/2014 19:12:39,prodege,0.5528,17932518,GBR,L5,Salford,95.151.167.238,INFECTIOUS MONONUCLEOSIS causes FEVER,99,62,,103,86,causes,0.9701425001453321,901550-FS1-4,"We describe a case of a 29 year old patient with a history of INFECTIOUS MONONUCLEOSIS followed by FEVER weight loss, and splenomegaly.",FEVER,INFECTIOUS MONONUCLEOSIS,RO-disease_has_finding
503223529,7/15/2014 10:10:15,,1323476701,7/15/2014 10:09:26,eup_slw,0.9583,20818028,GBR,A7,Birmingham,92.232.139.254,PULMONARY METASTASES causes METASTATIC LESIONS,41,117,,58,137,causes,0.9931270663228409,901700-FS1-4,"Between May 1969 and September 1989, 677 METASTATIC LESIONS were resected during 107 operations in 100 patients with PULMONARY METASTASES from various primary sites at the Center for Adult Diseases, Osaka, Japan.",METASTATIC LESIONS,PULMONARY METASTASES,RO-disease_has_finding
503223529,7/15/2014 10:11:30,,1323477321,7/15/2014 10:10:56,clixsense,0.9583,15189335,GBR,E4,Colchester,5.67.141.89,PULMONARY METASTASES causes METASTATIC LESIONS,41,117,,58,137,causes,0.9931270663228409,901700-FS1-4,"Between May 1969 and September 1989, 677 METASTATIC LESIONS were resected during 107 operations in 100 patients with PULMONARY METASTASES from various primary sites at the Center for Adult Diseases, Osaka, Japan.",METASTATIC LESIONS,PULMONARY METASTASES,RO-disease_has_finding
503223529,7/15/2014 11:17:11,,1323522081,7/15/2014 11:16:27,clixsense,0.7361,27871219,NLD,07,Amsterdam,87.210.207.223,PULMONARY METASTASES causes METASTATIC LESIONS,41,117,,58,137,causes,0.9931270663228409,901700-FS1-4,"Between May 1969 and September 1989, 677 METASTATIC LESIONS were resected during 107 operations in 100 patients with PULMONARY METASTASES from various primary sites at the Center for Adult Diseases, Osaka, Japan.",METASTATIC LESIONS,PULMONARY METASTASES,RO-disease_has_finding
503223529,7/15/2014 13:07:57,,1323572722,7/15/2014 13:07:49,clixsense,0.4944,20614047,USA,ID,Priest River,174.32.160.124,METASTATIC LESIONS causes PULMONARY METASTASES,41,117,,58,137,causes,0.9931270663228409,901700-FS1-4,"Between May 1969 and September 1989, 677 METASTATIC LESIONS were resected during 107 operations in 100 patients with PULMONARY METASTASES from various primary sites at the Center for Adult Diseases, Osaka, Japan.",METASTATIC LESIONS,PULMONARY METASTASES,RO-disease_has_finding
503223529,7/15/2014 16:46:49,,1323697377,7/15/2014 16:46:42,prodege,0.5014,2143114,CAN,BC,Vancouver,24.84.160.12,METASTATIC LESIONS causes PULMONARY METASTASES,41,117,,58,137,causes,0.9931270663228409,901700-FS1-4,"Between May 1969 and September 1989, 677 METASTATIC LESIONS were resected during 107 operations in 100 patients with PULMONARY METASTASES from various primary sites at the Center for Adult Diseases, Osaka, Japan.",METASTATIC LESIONS,PULMONARY METASTASES,RO-disease_has_finding
503223529,7/15/2014 19:36:46,,1323805444,7/15/2014 19:36:23,gifthulk,0.6774,21916793,GBR,,,87.113.87.199,PULMONARY METASTASES causes METASTATIC LESIONS,41,117,,58,137,causes,0.9931270663228409,901700-FS1-4,"Between May 1969 and September 1989, 677 METASTATIC LESIONS were resected during 107 operations in 100 patients with PULMONARY METASTASES from various primary sites at the Center for Adult Diseases, Osaka, Japan.",METASTATIC LESIONS,PULMONARY METASTASES,RO-disease_has_finding
503223529,7/15/2014 22:40:17,,1323881184,7/15/2014 22:40:11,instagc,0.4595,15445601,USA,FL,Jacksonville,24.129.68.254,no_relation,41,117,,58,137,causes,0.9931270663228409,901700-FS1-4,"Between May 1969 and September 1989, 677 METASTATIC LESIONS were resected during 107 operations in 100 patients with PULMONARY METASTASES from various primary sites at the Center for Adult Diseases, Osaka, Japan.",METASTATIC LESIONS,PULMONARY METASTASES,RO-disease_has_finding
503223530,7/15/2014 10:32:01,,1323490514,7/15/2014 10:31:36,rewardsspot,0.8889,24482174,GBR,H9,London,46.23.68.180,PV causes THROMBOSIS,117,131,,126,133,causes,0.753778361444409,906362-FS1-4,Rationale: ? History of thrombosis and advanced age have been significantly associated with a high risk of recurrent THROMBOSIS in PV,THROMBOSIS,PV,RO-has_manifestation
503223530,7/15/2014 10:33:58,,1323491773,7/15/2014 10:33:20,vivatic,0.7917,25451531,GBR,,,83.67.28.193,no_relation,117,131,,126,133,causes,0.753778361444409,906362-FS1-4,Rationale: ? History of thrombosis and advanced age have been significantly associated with a high risk of recurrent THROMBOSIS in PV,THROMBOSIS,PV,RO-has_manifestation
503223530,7/15/2014 11:27:40,,1323528164,7/15/2014 11:27:27,prodege,0.6917,15439740,AUS,02,Jannali,27.96.208.89,no_relation,117,131,,126,133,causes,0.753778361444409,906362-FS1-4,Rationale: ? History of thrombosis and advanced age have been significantly associated with a high risk of recurrent THROMBOSIS in PV,THROMBOSIS,PV,RO-has_manifestation
503223530,7/15/2014 15:54:32,,1323644771,7/15/2014 15:54:16,neodev,0.4345,14861092,GBR,I2,Manchester,90.194.137.76,PV causes THROMBOSIS,117,131,,126,133,causes,0.753778361444409,906362-FS1-4,Rationale: ? History of thrombosis and advanced age have been significantly associated with a high risk of recurrent THROMBOSIS in PV,THROMBOSIS,PV,RO-has_manifestation
503223530,7/15/2014 15:56:23,,1323646174,7/15/2014 15:55:50,instagc,0.628,25901556,GBR,C3,Saint Ives,82.9.129.2,PV causes THROMBOSIS,117,131,,126,133,causes,0.753778361444409,906362-FS1-4,Rationale: ? History of thrombosis and advanced age have been significantly associated with a high risk of recurrent THROMBOSIS in PV,THROMBOSIS,PV,RO-has_manifestation
503223530,7/15/2014 16:46:57,,1323697642,7/15/2014 16:46:50,prodege,0.5014,2143114,CAN,BC,Vancouver,24.84.160.12,THROMBOSIS causes PV,117,131,,126,133,causes,0.753778361444409,906362-FS1-4,Rationale: ? History of thrombosis and advanced age have been significantly associated with a high risk of recurrent THROMBOSIS in PV,THROMBOSIS,PV,RO-has_manifestation
503223530,7/15/2014 16:52:22,,1323703469,7/15/2014 16:51:57,prodege,0.7147,23541832,USA,AZ,Tempe,149.169.145.144,no_relation,117,131,,126,133,causes,0.753778361444409,906362-FS1-4,Rationale: ? History of thrombosis and advanced age have been significantly associated with a high risk of recurrent THROMBOSIS in PV,THROMBOSIS,PV,RO-has_manifestation
503223531,7/15/2014 10:31:39,,1323490296,7/15/2014 10:31:20,clixsense,0.9722,19803139,NLD,06,Veldhoven,212.61.84.196,HEMOCHROMATOSIS contraindicates IRON,51,94,,65,98,contraindicates,0.6974858324629161,901227-FS1-10,A high intake of iron is harmful for patients with HEMOCHROMATOSIS and for others at risk for IRON overload.,HEMOCHROMATOSIS,IRON,RO-contraindicated_drug
503223531,7/15/2014 11:18:18,,1323522884,7/15/2014 11:17:46,prodege,0.7986,11864493,GBR,Z4,Wrexham,212.219.196.69,no_relation,51,94,,65,98,contraindicates,0.6974858324629161,901227-FS1-10,A high intake of iron is harmful for patients with HEMOCHROMATOSIS and for others at risk for IRON overload.,HEMOCHROMATOSIS,IRON,RO-contraindicated_drug
503223531,7/15/2014 14:34:03,,1323599520,7/15/2014 14:33:58,neodev,0.5833,25224036,CAN,ON,Sudbury,67.204.218.187,HEMOCHROMATOSIS contraindicates IRON,51,94,,65,98,contraindicates,0.6974858324629161,901227-FS1-10,A high intake of iron is harmful for patients with HEMOCHROMATOSIS and for others at risk for IRON overload.,HEMOCHROMATOSIS,IRON,RO-contraindicated_drug
503223531,7/15/2014 17:15:33,,1323725004,7/15/2014 17:14:59,instagc,0.531,28519532,USA,IA,Honey Creek,12.73.110.41,IRON contraindicates HEMOCHROMATOSIS,51,94,,65,98,contraindicates,0.6974858324629161,901227-FS1-10,A high intake of iron is harmful for patients with HEMOCHROMATOSIS and for others at risk for IRON overload.,HEMOCHROMATOSIS,IRON,RO-contraindicated_drug
503223531,7/15/2014 17:57:49,,1323760648,7/15/2014 17:57:32,clixsense,0.4097,17722340,CAN,BC,Mission,50.98.185.25,HEMOCHROMATOSIS contraindicates IRON,51,94,,65,98,contraindicates,0.6974858324629161,901227-FS1-10,A high intake of iron is harmful for patients with HEMOCHROMATOSIS and for others at risk for IRON overload.,HEMOCHROMATOSIS,IRON,RO-contraindicated_drug
503223531,7/15/2014 18:54:47,,1323784752,7/15/2014 18:54:44,prodege,0.4899,12944140,GBR,C8,Thornton Heath,92.21.6.167,HEMOCHROMATOSIS contraindicates IRON,51,94,,65,98,contraindicates,0.6974858324629161,901227-FS1-10,A high intake of iron is harmful for patients with HEMOCHROMATOSIS and for others at risk for IRON overload.,HEMOCHROMATOSIS,IRON,RO-contraindicated_drug
503223531,7/15/2014 19:54:52,,1323812034,7/15/2014 19:54:17,clixsense,0.4819,6714657,USA,CT,Groton,71.235.184.32,IRON contraindicates HEMOCHROMATOSIS,51,94,,65,98,contraindicates,0.6974858324629161,901227-FS1-10,A high intake of iron is harmful for patients with HEMOCHROMATOSIS and for others at risk for IRON overload.,HEMOCHROMATOSIS,IRON,RO-contraindicated_drug
503223536,7/15/2014 10:26:52,,1323487008,7/15/2014 10:26:17,rewardsspot,0.8889,24482174,GBR,H9,London,46.23.68.180,BUMETANIDE treats EDEMA,70,87,,74,97,treats,0.875,908056-FS1-2,"Slight stria edema was present at 10 min, marked edema at 1 hr and no EDEMA 24 h after BUMETANIDE",EDEMA,BUMETANIDE,RO-may_treat
503223536,7/15/2014 10:53:04,,1323505176,7/15/2014 10:52:55,clixsense,1.0,27793793,GBR,C5,Chester,151.230.27.155,BUMETANIDE treats EDEMA,70,87,,74,97,treats,0.875,908056-FS1-2,"Slight stria edema was present at 10 min, marked edema at 1 hr and no EDEMA 24 h after BUMETANIDE",EDEMA,BUMETANIDE,RO-may_treat
503223536,7/15/2014 11:16:42,,1323521671,7/15/2014 11:16:11,prodege,0.7986,11864493,GBR,Z4,Wrexham,212.219.196.69,no_relation,70,87,,74,97,treats,0.875,908056-FS1-2,"Slight stria edema was present at 10 min, marked edema at 1 hr and no EDEMA 24 h after BUMETANIDE",EDEMA,BUMETANIDE,RO-may_treat
503223536,7/15/2014 11:18:32,,1323523019,7/15/2014 11:18:00,clixsense,0.7361,27871219,NLD,07,Amsterdam,87.210.207.223,BUMETANIDE treats EDEMA,70,87,,74,97,treats,0.875,908056-FS1-2,"Slight stria edema was present at 10 min, marked edema at 1 hr and no EDEMA 24 h after BUMETANIDE",EDEMA,BUMETANIDE,RO-may_treat
503223536,7/15/2014 11:23:25,,1323525758,7/15/2014 11:23:01,instagc,0.9417,13763729,USA,,,75.182.89.225,BUMETANIDE treats EDEMA,70,87,,74,97,treats,0.875,908056-FS1-2,"Slight stria edema was present at 10 min, marked edema at 1 hr and no EDEMA 24 h after BUMETANIDE",EDEMA,BUMETANIDE,RO-may_treat
503223536,7/15/2014 11:24:07,,1323526203,7/15/2014 11:23:42,elite,0.8264,28397222,GBR,Y4,Usk,31.50.223.75,BUMETANIDE treats EDEMA,70,87,,74,97,treats,0.875,908056-FS1-2,"Slight stria edema was present at 10 min, marked edema at 1 hr and no EDEMA 24 h after BUMETANIDE",EDEMA,BUMETANIDE,RO-may_treat
503223536,7/15/2014 12:40:50,,1323562008,7/15/2014 12:39:41,prodege,0.7631,1852770,USA,TX,Abilene,76.198.102.54,BUMETANIDE treats EDEMA,70,87,,74,97,treats,0.875,908056-FS1-2,"Slight stria edema was present at 10 min, marked edema at 1 hr and no EDEMA 24 h after BUMETANIDE",EDEMA,BUMETANIDE,RO-may_treat
503223539,7/15/2014 10:31:19,,1323490076,7/15/2014 10:30:44,vivatic,0.7917,25451531,GBR,,,83.67.28.193,no_relation,96,96,,103,114,causes,0.905821627315676,903591-FS1-4,Greater knowledge of the effects of nicotine addiction and employment in programs that provided NICOTINE ADDICTION education or treatment increased the odds of counselors' providing NICOTINE counseling.,NICOTINE,NICOTINE ADDICTION,RO-has_causative_agent
503223539,7/15/2014 11:19:15,,1323523504,7/15/2014 11:18:46,clixsense,0.7361,27871219,NLD,07,Amsterdam,87.210.207.223,NICOTINE causes NICOTINE ADDICTION,96,96,,103,114,causes,0.905821627315676,903591-FS1-4,Greater knowledge of the effects of nicotine addiction and employment in programs that provided NICOTINE ADDICTION education or treatment increased the odds of counselors' providing NICOTINE counseling.,NICOTINE,NICOTINE ADDICTION,RO-has_causative_agent
503223539,7/15/2014 12:40:50,,1323562006,7/15/2014 12:39:41,prodege,0.7631,1852770,USA,TX,Abilene,76.198.102.54,NICOTINE causes NICOTINE ADDICTION,96,96,,103,114,causes,0.905821627315676,903591-FS1-4,Greater knowledge of the effects of nicotine addiction and employment in programs that provided NICOTINE ADDICTION education or treatment increased the odds of counselors' providing NICOTINE counseling.,NICOTINE,NICOTINE ADDICTION,RO-has_causative_agent
503223539,7/15/2014 14:22:12,,1323595834,7/15/2014 14:21:50,instagc,0.7347,19636746,USA,NY,Andover,192.182.216.225,NICOTINE causes NICOTINE ADDICTION,96,96,,103,114,causes,0.905821627315676,903591-FS1-4,Greater knowledge of the effects of nicotine addiction and employment in programs that provided NICOTINE ADDICTION education or treatment increased the odds of counselors' providing NICOTINE counseling.,NICOTINE,NICOTINE ADDICTION,RO-has_causative_agent
503223539,7/15/2014 15:56:50,,1323646498,7/15/2014 15:56:25,instagc,0.628,25901556,GBR,C3,Saint Ives,82.9.129.2,NICOTINE causes NICOTINE ADDICTION,96,96,,103,114,causes,0.905821627315676,903591-FS1-4,Greater knowledge of the effects of nicotine addiction and employment in programs that provided NICOTINE ADDICTION education or treatment increased the odds of counselors' providing NICOTINE counseling.,NICOTINE,NICOTINE ADDICTION,RO-has_causative_agent
503223539,7/15/2014 17:58:45,,1323761193,7/15/2014 17:58:25,clixsense,0.4097,17722340,CAN,BC,Mission,50.98.185.25,NICOTINE causes NICOTINE ADDICTION,96,96,,103,114,causes,0.905821627315676,903591-FS1-4,Greater knowledge of the effects of nicotine addiction and employment in programs that provided NICOTINE ADDICTION education or treatment increased the odds of counselors' providing NICOTINE counseling.,NICOTINE,NICOTINE ADDICTION,RO-has_causative_agent
503223539,7/15/2014 18:45:32,,1323779807,7/15/2014 18:44:27,clixsense,0.7143,6355977,NLD,07,Amsterdam,46.129.42.165,no_relation,96,96,,103,114,causes,0.905821627315676,903591-FS1-4,Greater knowledge of the effects of nicotine addiction and employment in programs that provided NICOTINE ADDICTION education or treatment increased the odds of counselors' providing NICOTINE counseling.,NICOTINE,NICOTINE ADDICTION,RO-has_causative_agent
503223540,7/15/2014 10:30:20,,1323489343,7/15/2014 10:30:13,clixsense,0.9583,19162475,GBR,M3,Frome,82.33.126.30,BOVINE TUBERCULOSIS (BTB) causes MYCOBACTERIUM BOVIS,76,166,,94,191,causes,0.9491579957524989,903869-FS1-4,Concurrent infection of cattle with bovine viral diarrhoea virus (BVDV) and MYCOBACTERIUM BOVIS is considered to be a possible risk factor for onward transmission of BOVINE TUBERCULOSIS (BTB) in infected cattle and is known to compromise diagnostic tests.,MYCOBACTERIUM BOVIS,BOVINE TUBERCULOSIS (BTB),RO-has_causative_agent
503223540,7/15/2014 10:32:01,,1323490513,7/15/2014 10:31:36,rewardsspot,0.8889,24482174,GBR,H9,London,46.23.68.180,MYCOBACTERIUM BOVIS causes BOVINE TUBERCULOSIS (BTB),76,166,,94,191,causes,0.9491579957524989,903869-FS1-4,Concurrent infection of cattle with bovine viral diarrhoea virus (BVDV) and MYCOBACTERIUM BOVIS is considered to be a possible risk factor for onward transmission of BOVINE TUBERCULOSIS (BTB) in infected cattle and is known to compromise diagnostic tests.,MYCOBACTERIUM BOVIS,BOVINE TUBERCULOSIS (BTB),RO-has_causative_agent
503223540,7/15/2014 11:23:41,,1323525903,7/15/2014 11:23:07,elite,0.8264,28397222,GBR,Y4,Usk,31.50.223.75,MYCOBACTERIUM BOVIS causes BOVINE TUBERCULOSIS (BTB),76,166,,94,191,causes,0.9491579957524989,903869-FS1-4,Concurrent infection of cattle with bovine viral diarrhoea virus (BVDV) and MYCOBACTERIUM BOVIS is considered to be a possible risk factor for onward transmission of BOVINE TUBERCULOSIS (BTB) in infected cattle and is known to compromise diagnostic tests.,MYCOBACTERIUM BOVIS,BOVINE TUBERCULOSIS (BTB),RO-has_causative_agent
503223540,7/15/2014 13:34:24,,1323581838,7/15/2014 13:34:06,instagc,0.6153,23149109,USA,NC,Cary,24.206.38.18,BOVINE TUBERCULOSIS (BTB) causes MYCOBACTERIUM BOVIS,76,166,,94,191,causes,0.9491579957524989,903869-FS1-4,Concurrent infection of cattle with bovine viral diarrhoea virus (BVDV) and MYCOBACTERIUM BOVIS is considered to be a possible risk factor for onward transmission of BOVINE TUBERCULOSIS (BTB) in infected cattle and is known to compromise diagnostic tests.,MYCOBACTERIUM BOVIS,BOVINE TUBERCULOSIS (BTB),RO-has_causative_agent
503223540,7/15/2014 15:32:41,,1323628397,7/15/2014 15:32:25,tremorgames,0.8357,24449707,CAN,QC,Laval,96.21.249.72,MYCOBACTERIUM BOVIS causes BOVINE TUBERCULOSIS (BTB),76,166,,94,191,causes,0.9491579957524989,903869-FS1-4,Concurrent infection of cattle with bovine viral diarrhoea virus (BVDV) and MYCOBACTERIUM BOVIS is considered to be a possible risk factor for onward transmission of BOVINE TUBERCULOSIS (BTB) in infected cattle and is known to compromise diagnostic tests.,MYCOBACTERIUM BOVIS,BOVINE TUBERCULOSIS (BTB),RO-has_causative_agent
503223540,7/15/2014 16:56:52,,1323708375,7/15/2014 16:56:34,prodege,0.544,9525153,CAN,ON,Toronto,65.95.187.40,MYCOBACTERIUM BOVIS causes BOVINE TUBERCULOSIS (BTB),76,166,,94,191,causes,0.9491579957524989,903869-FS1-4,Concurrent infection of cattle with bovine viral diarrhoea virus (BVDV) and MYCOBACTERIUM BOVIS is considered to be a possible risk factor for onward transmission of BOVINE TUBERCULOSIS (BTB) in infected cattle and is known to compromise diagnostic tests.,MYCOBACTERIUM BOVIS,BOVINE TUBERCULOSIS (BTB),RO-has_causative_agent
503223540,7/15/2014 18:54:57,,1323784829,7/15/2014 18:54:53,prodege,0.4899,12944140,GBR,C8,Thornton Heath,92.21.6.167,MYCOBACTERIUM BOVIS causes BOVINE TUBERCULOSIS (BTB),76,166,,94,191,causes,0.9491579957524989,903869-FS1-4,Concurrent infection of cattle with bovine viral diarrhoea virus (BVDV) and MYCOBACTERIUM BOVIS is considered to be a possible risk factor for onward transmission of BOVINE TUBERCULOSIS (BTB) in infected cattle and is known to compromise diagnostic tests.,MYCOBACTERIUM BOVIS,BOVINE TUBERCULOSIS (BTB),RO-has_causative_agent
503223545,7/15/2014 10:10:39,,1323476916,7/15/2014 10:10:16,eup_slw,0.9583,20818028,GBR,A7,Birmingham,92.232.139.254,no_relation,85,42,,102,52,treats,0.977355554850442,907599-FS1-2,Safety and efficacy of controlled release MESALAMINE for maintenance of remission in ULCERATIVE COLITIS,ULCERATIVE COLITIS,MESALAMINE,RO-may_treat
503223545,7/15/2014 11:10:02,,1323517349,7/15/2014 11:09:26,instagc,0.7778,24252915,GBR,B7,Bristol,77.98.139.82,MESALAMINE treats ULCERATIVE COLITIS,85,42,,102,52,treats,0.977355554850442,907599-FS1-2,Safety and efficacy of controlled release MESALAMINE for maintenance of remission in ULCERATIVE COLITIS,ULCERATIVE COLITIS,MESALAMINE,RO-may_treat
503223545,7/15/2014 11:21:59,,1323524986,7/15/2014 11:21:38,elite,0.8264,28397222,GBR,Y4,Usk,31.50.223.75,MESALAMINE treats ULCERATIVE COLITIS,85,42,,102,52,treats,0.977355554850442,907599-FS1-2,Safety and efficacy of controlled release MESALAMINE for maintenance of remission in ULCERATIVE COLITIS,ULCERATIVE COLITIS,MESALAMINE,RO-may_treat
503223545,7/15/2014 13:33:50,,1323581658,7/15/2014 13:33:36,instagc,0.6153,23149109,USA,NC,Cary,24.206.38.18,MESALAMINE treats ULCERATIVE COLITIS,85,42,,102,52,treats,0.977355554850442,907599-FS1-2,Safety and efficacy of controlled release MESALAMINE for maintenance of remission in ULCERATIVE COLITIS,ULCERATIVE COLITIS,MESALAMINE,RO-may_treat
503223545,7/15/2014 13:56:44,,1323588759,7/15/2014 13:55:41,clixsense,0.5419,6334612,USA,OH,Cleveland,108.225.254.58,MESALAMINE treats ULCERATIVE COLITIS,85,42,,102,52,treats,0.977355554850442,907599-FS1-2,Safety and efficacy of controlled release MESALAMINE for maintenance of remission in ULCERATIVE COLITIS,ULCERATIVE COLITIS,MESALAMINE,RO-may_treat
503223545,7/15/2014 22:15:40,,1323869113,7/15/2014 22:15:25,instagc,0.6571,26706653,USA,IL,Elk Grove Village,99.99.9.247,ULCERATIVE COLITIS treats MESALAMINE,85,42,,102,52,treats,0.977355554850442,907599-FS1-2,Safety and efficacy of controlled release MESALAMINE for maintenance of remission in ULCERATIVE COLITIS,ULCERATIVE COLITIS,MESALAMINE,RO-may_treat
503223545,7/16/2014 01:08:41,,1323961871,7/16/2014 01:08:24,bitcoinget,0.6825,28377798,GBR,,,195.166.117.126,MESALAMINE treats ULCERATIVE COLITIS,85,42,,102,52,treats,0.977355554850442,907599-FS1-2,Safety and efficacy of controlled release MESALAMINE for maintenance of remission in ULCERATIVE COLITIS,ULCERATIVE COLITIS,MESALAMINE,RO-may_treat
503223547,7/15/2014 10:27:30,,1323487449,7/15/2014 10:27:21,clixsense,0.9583,19162475,GBR,M3,Frome,82.33.126.30,ACUTE TOLERANCE diagnosed by DRUG NAIVE ANIMALS,109,40,,126,55,diagnosed by,0.7624928516630229,903964-FS1-13,"In the OF experiment, the occurrence of ACUTE TOLERANCE was examined for different spontaneous behaviours in DRUG NAIVE ANIMALS.",DRUG NAIVE ANIMALS,ACUTE TOLERANCE,RO-has_causative_agent
503223547,7/15/2014 10:28:30,,1323488251,7/15/2014 10:27:39,rewardsspot,0.8889,24482174,GBR,H9,London,46.23.68.180,DRUG NAIVE ANIMALS diagnosed by ACUTE TOLERANCE,109,40,,126,55,diagnosed by,0.7624928516630229,903964-FS1-13,"In the OF experiment, the occurrence of ACUTE TOLERANCE was examined for different spontaneous behaviours in DRUG NAIVE ANIMALS.",DRUG NAIVE ANIMALS,ACUTE TOLERANCE,RO-has_causative_agent
503223547,7/15/2014 10:31:00,,1323489832,7/15/2014 10:30:32,clixsense,0.9722,19803139,NLD,06,Veldhoven,212.61.84.196,DRUG NAIVE ANIMALS diagnosed by ACUTE TOLERANCE,109,40,,126,55,diagnosed by,0.7624928516630229,903964-FS1-13,"In the OF experiment, the occurrence of ACUTE TOLERANCE was examined for different spontaneous behaviours in DRUG NAIVE ANIMALS.",DRUG NAIVE ANIMALS,ACUTE TOLERANCE,RO-has_causative_agent
503223547,7/15/2014 11:17:42,,1323522490,7/15/2014 11:17:12,clixsense,0.7361,27871219,NLD,07,Amsterdam,87.210.207.223,DRUG NAIVE ANIMALS diagnosed by ACUTE TOLERANCE,109,40,,126,55,diagnosed by,0.7624928516630229,903964-FS1-13,"In the OF experiment, the occurrence of ACUTE TOLERANCE was examined for different spontaneous behaviours in DRUG NAIVE ANIMALS.",DRUG NAIVE ANIMALS,ACUTE TOLERANCE,RO-has_causative_agent
503223547,7/15/2014 11:24:50,,1323526605,7/15/2014 11:24:31,instagc,0.7528,28301350,GBR,K4,Plymouth,92.28.215.248,no_relation,109,40,,126,55,diagnosed by,0.7624928516630229,903964-FS1-13,"In the OF experiment, the occurrence of ACUTE TOLERANCE was examined for different spontaneous behaviours in DRUG NAIVE ANIMALS.",DRUG NAIVE ANIMALS,ACUTE TOLERANCE,RO-has_causative_agent
503223547,7/15/2014 11:33:27,,1323531430,7/15/2014 11:33:04,prodege,0.6514,28039757,GBR,L8,Southport,109.155.158.54,no_relation,109,40,,126,55,diagnosed by,0.7624928516630229,903964-FS1-13,"In the OF experiment, the occurrence of ACUTE TOLERANCE was examined for different spontaneous behaviours in DRUG NAIVE ANIMALS.",DRUG NAIVE ANIMALS,ACUTE TOLERANCE,RO-has_causative_agent
503223547,7/15/2014 13:15:09,,1323575227,7/15/2014 13:14:18,prodege,0.6865,21891314,AUS,07,Glen Iris,58.6.248.249,ACUTE TOLERANCE diagnosed by DRUG NAIVE ANIMALS,109,40,,126,55,diagnosed by,0.7624928516630229,903964-FS1-13,"In the OF experiment, the occurrence of ACUTE TOLERANCE was examined for different spontaneous behaviours in DRUG NAIVE ANIMALS.",DRUG NAIVE ANIMALS,ACUTE TOLERANCE,RO-has_causative_agent
503223548,7/15/2014 11:22:33,,1323525215,7/15/2014 11:22:07,instagc,0.9417,13763729,USA,,,75.182.89.225,SERUM DIGOXIN CONCENTRATION causes SUICIDAL DIGOXIN POISONING,73,21,,99,47,causes,0.7022468831767831,903566-FS1-4,In two patients with SUICIDAL DIGOXIN POISONING the correlations between SERUM DIGOXIN CONCENTRATION and changes in the duration of QTc and the flattening of the T waves were studied.,SERUM DIGOXIN CONCENTRATION,SUICIDAL DIGOXIN POISONING,RO-has_causative_agent
503223548,7/15/2014 17:10:50,,1323722048,7/15/2014 17:10:08,clixsense,0.5345,6574199,USA,TX,San Antonio,207.230.144.242,SERUM DIGOXIN CONCENTRATION causes SUICIDAL DIGOXIN POISONING,73,21,,99,47,causes,0.7022468831767831,903566-FS1-4,In two patients with SUICIDAL DIGOXIN POISONING the correlations between SERUM DIGOXIN CONCENTRATION and changes in the duration of QTc and the flattening of the T waves were studied.,SERUM DIGOXIN CONCENTRATION,SUICIDAL DIGOXIN POISONING,RO-has_causative_agent
503223548,7/15/2014 17:23:09,,1323728820,7/15/2014 17:22:42,instagc,0.531,28519532,USA,IA,Honey Creek,12.73.110.41,SUICIDAL DIGOXIN POISONING causes SERUM DIGOXIN CONCENTRATION,73,21,,99,47,causes,0.7022468831767831,903566-FS1-4,In two patients with SUICIDAL DIGOXIN POISONING the correlations between SERUM DIGOXIN CONCENTRATION and changes in the duration of QTc and the flattening of the T waves were studied.,SERUM DIGOXIN CONCENTRATION,SUICIDAL DIGOXIN POISONING,RO-has_causative_agent
503223548,7/15/2014 18:50:54,,1323782642,7/15/2014 18:50:50,instagc,0.578,25990856,USA,NV,Las Vegas,68.108.98.78,SERUM DIGOXIN CONCENTRATION causes SUICIDAL DIGOXIN POISONING,73,21,,99,47,causes,0.7022468831767831,903566-FS1-4,In two patients with SUICIDAL DIGOXIN POISONING the correlations between SERUM DIGOXIN CONCENTRATION and changes in the duration of QTc and the flattening of the T waves were studied.,SERUM DIGOXIN CONCENTRATION,SUICIDAL DIGOXIN POISONING,RO-has_causative_agent
503223548,7/15/2014 19:42:04,,1323807733,7/15/2014 19:41:44,clixsense,0.6984,24429778,AUS,,,121.211.19.218,SUICIDAL DIGOXIN POISONING causes SERUM DIGOXIN CONCENTRATION,73,21,,99,47,causes,0.7022468831767831,903566-FS1-4,In two patients with SUICIDAL DIGOXIN POISONING the correlations between SERUM DIGOXIN CONCENTRATION and changes in the duration of QTc and the flattening of the T waves were studied.,SERUM DIGOXIN CONCENTRATION,SUICIDAL DIGOXIN POISONING,RO-has_causative_agent
503223548,7/15/2014 20:37:13,,1323829342,7/15/2014 20:36:36,prodege,0.5694,28255346,GBR,L9,Sheffield,2.125.183.137,SUICIDAL DIGOXIN POISONING causes SERUM DIGOXIN CONCENTRATION,73,21,,99,47,causes,0.7022468831767831,903566-FS1-4,In two patients with SUICIDAL DIGOXIN POISONING the correlations between SERUM DIGOXIN CONCENTRATION and changes in the duration of QTc and the flattening of the T waves were studied.,SERUM DIGOXIN CONCENTRATION,SUICIDAL DIGOXIN POISONING,RO-has_causative_agent
503223548,7/15/2014 21:32:21,,1323852278,7/15/2014 21:31:45,clixsense,0.7169,25595227,CAN,SK,North Battleford,24.72.96.119,SUICIDAL DIGOXIN POISONING causes SERUM DIGOXIN CONCENTRATION,73,21,,99,47,causes,0.7022468831767831,903566-FS1-4,In two patients with SUICIDAL DIGOXIN POISONING the correlations between SERUM DIGOXIN CONCENTRATION and changes in the duration of QTc and the flattening of the T waves were studied.,SERUM DIGOXIN CONCENTRATION,SUICIDAL DIGOXIN POISONING,RO-has_causative_agent
503223553,7/15/2014 11:24:13,,1323526256,7/15/2014 11:23:58,instagc,0.7528,28301350,GBR,K4,Plymouth,92.28.215.248,LIVER is location of LIVER FAILURE,60,74,,64,87,is location of,0.9383148632568359,902160-FS1-9,"Protoporphyrins sometimes accumulate to toxic levels in the LIVER causing LIVER FAILURE; if this occurs, a liver transplant becomes necessary.",LIVER,LIVER FAILURE,RO-disease_has_primary_anatomic_site
503223553,7/15/2014 17:01:18,,1323713479,7/15/2014 17:00:58,neodev,0.7097,18755947,GBR,H2,Accrington,80.47.185.52,LIVER is location of LIVER FAILURE,60,74,,64,87,is location of,0.9383148632568359,902160-FS1-9,"Protoporphyrins sometimes accumulate to toxic levels in the LIVER causing LIVER FAILURE; if this occurs, a liver transplant becomes necessary.",LIVER,LIVER FAILURE,RO-disease_has_primary_anatomic_site
503223553,7/15/2014 17:57:13,,1323760041,7/15/2014 17:56:57,clixsense,0.4097,17722340,CAN,BC,Mission,50.98.185.25,LIVER FAILURE is location of LIVER,60,74,,64,87,is location of,0.9383148632568359,902160-FS1-9,"Protoporphyrins sometimes accumulate to toxic levels in the LIVER causing LIVER FAILURE; if this occurs, a liver transplant becomes necessary.",LIVER,LIVER FAILURE,RO-disease_has_primary_anatomic_site
503223553,7/15/2014 17:58:21,,1323760971,7/15/2014 17:58:13,tremorgames,0.5768,28013393,USA,CA,Rancho Cordova,71.197.67.37,LIVER is location of LIVER FAILURE,60,74,,64,87,is location of,0.9383148632568359,902160-FS1-9,"Protoporphyrins sometimes accumulate to toxic levels in the LIVER causing LIVER FAILURE; if this occurs, a liver transplant becomes necessary.",LIVER,LIVER FAILURE,RO-disease_has_primary_anatomic_site
503223553,7/15/2014 19:06:36,,1323791228,7/15/2014 19:05:56,prodege,0.5528,17932518,GBR,L5,Salford,95.151.167.238,no_relation,60,74,,64,87,is location of,0.9383148632568359,902160-FS1-9,"Protoporphyrins sometimes accumulate to toxic levels in the LIVER causing LIVER FAILURE; if this occurs, a liver transplant becomes necessary.",LIVER,LIVER FAILURE,RO-disease_has_primary_anatomic_site
503223553,7/15/2014 19:22:43,,1323799396,7/15/2014 19:22:09,clixsense,0.4583,11338264,CAN,ON,Aurora,184.148.114.225,LIVER is location of LIVER FAILURE,60,74,,64,87,is location of,0.9383148632568359,902160-FS1-9,"Protoporphyrins sometimes accumulate to toxic levels in the LIVER causing LIVER FAILURE; if this occurs, a liver transplant becomes necessary.",LIVER,LIVER FAILURE,RO-disease_has_primary_anatomic_site
503223553,7/15/2014 21:32:57,,1323852462,7/15/2014 21:32:42,clixsense,0.7169,25595227,CAN,SK,North Battleford,24.72.96.119,LIVER is location of LIVER FAILURE,60,74,,64,87,is location of,0.9383148632568359,902160-FS1-9,"Protoporphyrins sometimes accumulate to toxic levels in the LIVER causing LIVER FAILURE; if this occurs, a liver transplant becomes necessary.",LIVER,LIVER FAILURE,RO-disease_has_primary_anatomic_site
503223554,7/15/2014 10:30:30,,1323489477,7/15/2014 10:30:21,clixsense,0.9583,19162475,GBR,M3,Frome,82.33.126.30,SKIN is location of HIVES,19,61,,22,66,is location of,0.905821627315676,905314-FS1-9,"Involvement of the SKIN or mucosal tissue (e.g., generalized HIVES; itching or flushing; swollen lips, tongue, or uvula)  b.",SKIN,HIVES,RO-has_finding_site
503223554,7/15/2014 10:34:30,,1323492092,7/15/2014 10:33:59,vivatic,0.7917,25451531,GBR,,,83.67.28.193,SKIN is location of HIVES,19,61,,22,66,is location of,0.905821627315676,905314-FS1-9,"Involvement of the SKIN or mucosal tissue (e.g., generalized HIVES; itching or flushing; swollen lips, tongue, or uvula)  b.",SKIN,HIVES,RO-has_finding_site
503223554,7/15/2014 15:19:15,,1323619049,7/15/2014 15:18:46,prodege,0.7067,27934334,GBR,B9,High Wycombe,86.166.72.139,no_relation,19,61,,22,66,is location of,0.905821627315676,905314-FS1-9,"Involvement of the SKIN or mucosal tissue (e.g., generalized HIVES; itching or flushing; swollen lips, tongue, or uvula)  b.",SKIN,HIVES,RO-has_finding_site
503223554,7/15/2014 15:23:48,,1323622080,7/15/2014 15:23:30,prodege,0.7167,7899370,USA,MI,Bay City,71.13.81.162,SKIN is location of HIVES,19,61,,22,66,is location of,0.905821627315676,905314-FS1-9,"Involvement of the SKIN or mucosal tissue (e.g., generalized HIVES; itching or flushing; swollen lips, tongue, or uvula)  b.",SKIN,HIVES,RO-has_finding_site
503223554,7/15/2014 16:52:33,,1323703646,7/15/2014 16:52:16,clixsense,0.6852,6455807,CAN,BC,Victoria,96.54.172.117,SKIN is location of HIVES,19,61,,22,66,is location of,0.905821627315676,905314-FS1-9,"Involvement of the SKIN or mucosal tissue (e.g., generalized HIVES; itching or flushing; swollen lips, tongue, or uvula)  b.",SKIN,HIVES,RO-has_finding_site
503223554,7/15/2014 18:50:54,,1323782641,7/15/2014 18:50:50,instagc,0.578,25990856,USA,NV,Las Vegas,68.108.98.78,no_relation,19,61,,22,66,is location of,0.905821627315676,905314-FS1-9,"Involvement of the SKIN or mucosal tissue (e.g., generalized HIVES; itching or flushing; swollen lips, tongue, or uvula)  b.",SKIN,HIVES,RO-has_finding_site
503223554,7/16/2014 01:45:19,,1323980164,7/16/2014 01:45:00,clixsense,0.7798,19638651,USA,,,173.23.121.63,SKIN is location of HIVES,19,61,,22,66,is location of,0.905821627315676,905314-FS1-9,"Involvement of the SKIN or mucosal tissue (e.g., generalized HIVES; itching or flushing; swollen lips, tongue, or uvula)  b.",SKIN,HIVES,RO-has_finding_site
503223555,7/15/2014 10:26:52,,1323487007,7/15/2014 10:26:17,rewardsspot,0.8889,24482174,GBR,H9,London,46.23.68.180,STURGE WEBER SYNDROME causes SEIZURE DISORDERS,92,127,,108,148,causes,0.985329278164293,906322-FS1-4,Different degrees of cerebral calcifications together with encephalofacial angiomatosis and SEIZURE DISORDERS characterize the STURGE WEBER SYNDROME,SEIZURE DISORDERS,STURGE WEBER SYNDROME,RO-has_manifestation
503223555,7/15/2014 11:18:50,,1323523235,7/15/2014 11:18:20,prodege,0.7986,11864493,GBR,Z4,Wrexham,212.219.196.69,STURGE WEBER SYNDROME causes SEIZURE DISORDERS,92,127,,108,148,causes,0.985329278164293,906322-FS1-4,Different degrees of cerebral calcifications together with encephalofacial angiomatosis and SEIZURE DISORDERS characterize the STURGE WEBER SYNDROME,SEIZURE DISORDERS,STURGE WEBER SYNDROME,RO-has_manifestation
503223555,7/15/2014 11:24:13,,1323526254,7/15/2014 11:23:58,instagc,0.7528,28301350,GBR,K4,Plymouth,92.28.215.248,STURGE WEBER SYNDROME causes SEIZURE DISORDERS,92,127,,108,148,causes,0.985329278164293,906322-FS1-4,Different degrees of cerebral calcifications together with encephalofacial angiomatosis and SEIZURE DISORDERS characterize the STURGE WEBER SYNDROME,SEIZURE DISORDERS,STURGE WEBER SYNDROME,RO-has_manifestation
503223555,7/15/2014 14:12:43,,1323593113,7/15/2014 14:12:23,neodev,0.8179,28336203,USA,PA,Harrisburg,50.149.53.150,STURGE WEBER SYNDROME causes SEIZURE DISORDERS,92,127,,108,148,causes,0.985329278164293,906322-FS1-4,Different degrees of cerebral calcifications together with encephalofacial angiomatosis and SEIZURE DISORDERS characterize the STURGE WEBER SYNDROME,SEIZURE DISORDERS,STURGE WEBER SYNDROME,RO-has_manifestation
503223555,7/15/2014 15:18:11,,1323618479,7/15/2014 15:17:35,prodege,0.7067,27934334,GBR,B9,High Wycombe,86.166.72.139,STURGE WEBER SYNDROME causes SEIZURE DISORDERS,92,127,,108,148,causes,0.985329278164293,906322-FS1-4,Different degrees of cerebral calcifications together with encephalofacial angiomatosis and SEIZURE DISORDERS characterize the STURGE WEBER SYNDROME,SEIZURE DISORDERS,STURGE WEBER SYNDROME,RO-has_manifestation
503223555,7/15/2014 15:31:39,,1323627609,7/15/2014 15:31:25,tremorgames,0.8357,24449707,CAN,QC,Laval,96.21.249.72,STURGE WEBER SYNDROME causes SEIZURE DISORDERS,92,127,,108,148,causes,0.985329278164293,906322-FS1-4,Different degrees of cerebral calcifications together with encephalofacial angiomatosis and SEIZURE DISORDERS characterize the STURGE WEBER SYNDROME,SEIZURE DISORDERS,STURGE WEBER SYNDROME,RO-has_manifestation
503223555,7/15/2014 16:46:41,,1323697196,7/15/2014 16:46:29,prodege,0.5014,2143114,CAN,BC,Vancouver,24.84.160.12,STURGE WEBER SYNDROME causes SEIZURE DISORDERS,92,127,,108,148,causes,0.985329278164293,906322-FS1-4,Different degrees of cerebral calcifications together with encephalofacial angiomatosis and SEIZURE DISORDERS characterize the STURGE WEBER SYNDROME,SEIZURE DISORDERS,STURGE WEBER SYNDROME,RO-has_manifestation
503335428,7/15/2014 21:07:36,,1323841998,7/15/2014 21:07:33,instagc,0.6944,25990856,USA,NV,Las Vegas,68.108.98.78,no_relation,99,20,,111,32,is location of,0.8728715609439692,902202-FS1-9,"In the oral cavity, LYMPHANGIOMA is a rare, non odontogenic, benign neoplasm which originates from LYMPH VESSELS",LYMPH VESSELS,LYMPHANGIOMA,RO-disease_has_primary_anatomic_site
503335428,7/15/2014 21:30:33,,1323851615,7/15/2014 21:30:17,instagc,0.6917,28301350,GBR,O4,Torquay,89.241.101.166,LYMPH VESSELS is location of LYMPHANGIOMA,99,20,,111,32,is location of,0.8728715609439692,902202-FS1-9,"In the oral cavity, LYMPHANGIOMA is a rare, non odontogenic, benign neoplasm which originates from LYMPH VESSELS",LYMPH VESSELS,LYMPHANGIOMA,RO-disease_has_primary_anatomic_site
503335428,7/16/2014 00:09:19,,1323929250,7/16/2014 00:09:07,clixsense,0.4942,20614047,USA,MO,Maryville,174.32.162.147,LYMPH VESSELS is location of LYMPHANGIOMA,99,20,,111,32,is location of,0.8728715609439692,902202-FS1-9,"In the oral cavity, LYMPHANGIOMA is a rare, non odontogenic, benign neoplasm which originates from LYMPH VESSELS",LYMPH VESSELS,LYMPHANGIOMA,RO-disease_has_primary_anatomic_site
503335428,7/16/2014 02:26:36,,1323999907,7/16/2014 02:26:24,clixsense,0.6681,27793793,GBR,C5,Chester,151.230.27.155,LYMPH VESSELS is location of LYMPHANGIOMA,99,20,,111,32,is location of,0.8728715609439692,902202-FS1-9,"In the oral cavity, LYMPHANGIOMA is a rare, non odontogenic, benign neoplasm which originates from LYMPH VESSELS",LYMPH VESSELS,LYMPHANGIOMA,RO-disease_has_primary_anatomic_site
503335428,7/16/2014 07:10:31,,1324100868,7/16/2014 07:10:16,instagc,0.6093,18960682,GBR,,,86.29.147.112,LYMPH VESSELS is location of LYMPHANGIOMA,99,20,,111,32,is location of,0.8728715609439692,902202-FS1-9,"In the oral cavity, LYMPHANGIOMA is a rare, non odontogenic, benign neoplasm which originates from LYMPH VESSELS",LYMPH VESSELS,LYMPHANGIOMA,RO-disease_has_primary_anatomic_site
503335428,7/16/2014 07:30:40,,1324107235,7/16/2014 07:30:16,vivatic,0.6569,25451531,GBR,,,83.67.28.193,LYMPH VESSELS is location of LYMPHANGIOMA,99,20,,111,32,is location of,0.8728715609439692,902202-FS1-9,"In the oral cavity, LYMPHANGIOMA is a rare, non odontogenic, benign neoplasm which originates from LYMPH VESSELS",LYMPH VESSELS,LYMPHANGIOMA,RO-disease_has_primary_anatomic_site
503335428,7/16/2014 10:32:31,,1324185409,7/16/2014 10:31:44,prodege,0.6647,23999031,AUS,08,Perth,203.59.238.194,LYMPH VESSELS is location of LYMPHANGIOMA,99,20,,111,32,is location of,0.8728715609439692,902202-FS1-9,"In the oral cavity, LYMPHANGIOMA is a rare, non odontogenic, benign neoplasm which originates from LYMPH VESSELS",LYMPH VESSELS,LYMPHANGIOMA,RO-disease_has_primary_anatomic_site
503335429,7/15/2014 20:53:24,,1323835701,7/15/2014 20:52:46,instagc,0.9583,24252915,GBR,B7,Bristol,77.98.139.82,ESSENTIAL THROMBOCYTHEMIA causes THROMBOCYTOSIS,100,156,,113,181,causes,0.889000889001333,901650-FS1-4,"Improvement of polycythemia was observed in all 5 patients with polycythemia vera, and reduction of THROMBOCYTOSIS was observed in 5 out of 6 patients with ESSENTIAL THROMBOCYTHEMIA and myelofibrosis.",THROMBOCYTOSIS,ESSENTIAL THROMBOCYTHEMIA,RO-disease_has_finding
503335429,7/15/2014 21:22:12,,1323848104,7/15/2014 21:21:35,neodev,0.6597,21515166,NLD,11,Nootdorp,83.86.58.179,ESSENTIAL THROMBOCYTHEMIA causes THROMBOCYTOSIS,100,156,,113,181,causes,0.889000889001333,901650-FS1-4,"Improvement of polycythemia was observed in all 5 patients with polycythemia vera, and reduction of THROMBOCYTOSIS was observed in 5 out of 6 patients with ESSENTIAL THROMBOCYTHEMIA and myelofibrosis.",THROMBOCYTOSIS,ESSENTIAL THROMBOCYTHEMIA,RO-disease_has_finding
503335429,7/15/2014 21:27:23,,1323850383,7/15/2014 21:26:29,clixsense,0.7986,19803139,NLD,06,Veldhoven,212.61.84.196,ESSENTIAL THROMBOCYTHEMIA causes THROMBOCYTOSIS,100,156,,113,181,causes,0.889000889001333,901650-FS1-4,"Improvement of polycythemia was observed in all 5 patients with polycythemia vera, and reduction of THROMBOCYTOSIS was observed in 5 out of 6 patients with ESSENTIAL THROMBOCYTHEMIA and myelofibrosis.",THROMBOCYTOSIS,ESSENTIAL THROMBOCYTHEMIA,RO-disease_has_finding
503335429,7/15/2014 22:14:39,,1323868615,7/15/2014 22:14:28,instagc,0.4861,26706653,USA,IL,Elk Grove Village,99.99.9.247,ESSENTIAL THROMBOCYTHEMIA causes THROMBOCYTOSIS,100,156,,113,181,causes,0.889000889001333,901650-FS1-4,"Improvement of polycythemia was observed in all 5 patients with polycythemia vera, and reduction of THROMBOCYTOSIS was observed in 5 out of 6 patients with ESSENTIAL THROMBOCYTHEMIA and myelofibrosis.",THROMBOCYTOSIS,ESSENTIAL THROMBOCYTHEMIA,RO-disease_has_finding
503335429,7/16/2014 01:24:34,,1323971657,7/16/2014 01:24:29,tremorgames,0.6371,28013393,USA,CA,Rancho Cordova,71.197.67.37,THROMBOCYTOSIS causes ESSENTIAL THROMBOCYTHEMIA,100,156,,113,181,causes,0.889000889001333,901650-FS1-4,"Improvement of polycythemia was observed in all 5 patients with polycythemia vera, and reduction of THROMBOCYTOSIS was observed in 5 out of 6 patients with ESSENTIAL THROMBOCYTHEMIA and myelofibrosis.",THROMBOCYTOSIS,ESSENTIAL THROMBOCYTHEMIA,RO-disease_has_finding
503335429,7/16/2014 02:26:04,,1323999681,7/16/2014 02:25:55,clixsense,0.6681,27793793,GBR,C5,Chester,151.230.27.155,THROMBOCYTOSIS causes ESSENTIAL THROMBOCYTHEMIA,100,156,,113,181,causes,0.889000889001333,901650-FS1-4,"Improvement of polycythemia was observed in all 5 patients with polycythemia vera, and reduction of THROMBOCYTOSIS was observed in 5 out of 6 patients with ESSENTIAL THROMBOCYTHEMIA and myelofibrosis.",THROMBOCYTOSIS,ESSENTIAL THROMBOCYTHEMIA,RO-disease_has_finding
503335429,7/16/2014 08:27:35,,1324123773,7/16/2014 08:26:51,cotter,0.54,7461147,USA,VA,Saluda,71.253.203.209,no_relation,100,156,,113,181,causes,0.889000889001333,901650-FS1-4,"Improvement of polycythemia was observed in all 5 patients with polycythemia vera, and reduction of THROMBOCYTOSIS was observed in 5 out of 6 patients with ESSENTIAL THROMBOCYTHEMIA and myelofibrosis.",THROMBOCYTOSIS,ESSENTIAL THROMBOCYTHEMIA,RO-disease_has_finding
503335445,7/15/2014 21:04:44,,1323840720,7/15/2014 21:04:11,clixsense,0.7153,6564572,USA,MI,Kalamazoo,173.46.248.170,THYROID DISEASE diagnosed by TOTAL THYROXINE,154,203,,168,218,diagnosed by,0.629940788348712,906870-FS1-13,"Each patient had a physical examination performed by his or her primary care provider, was given a standardized questionnaire that focused on symptoms of THYROID DISEASE and underwent a venipuncture for TOTAL THYROXINE triiodothyronine resin uptake and thyrotropin (TSH) concentration.",THYROID DISEASE,TOTAL THYROXINE,RO-may_diagnose
503335445,7/15/2014 22:08:57,,1323866133,7/15/2014 22:08:17,neodev,0.6528,11087793,GBR,K6,Southsea,82.24.115.185,THYROID DISEASE diagnosed by TOTAL THYROXINE,154,203,,168,218,diagnosed by,0.629940788348712,906870-FS1-13,"Each patient had a physical examination performed by his or her primary care provider, was given a standardized questionnaire that focused on symptoms of THYROID DISEASE and underwent a venipuncture for TOTAL THYROXINE triiodothyronine resin uptake and thyrotropin (TSH) concentration.",THYROID DISEASE,TOTAL THYROXINE,RO-may_diagnose
503335445,7/16/2014 01:24:41,,1323971710,7/16/2014 01:24:35,tremorgames,0.6371,28013393,USA,CA,Rancho Cordova,71.197.67.37,THYROID DISEASE diagnosed by TOTAL THYROXINE,154,203,,168,218,diagnosed by,0.629940788348712,906870-FS1-13,"Each patient had a physical examination performed by his or her primary care provider, was given a standardized questionnaire that focused on symptoms of THYROID DISEASE and underwent a venipuncture for TOTAL THYROXINE triiodothyronine resin uptake and thyrotropin (TSH) concentration.",THYROID DISEASE,TOTAL THYROXINE,RO-may_diagnose
503335445,7/16/2014 02:18:04,,1323996352,7/16/2014 02:18:00,neodev,0.4899,22098386,USA,NY,Greenwich,67.248.253.125,THYROID DISEASE diagnosed by TOTAL THYROXINE,154,203,,168,218,diagnosed by,0.629940788348712,906870-FS1-13,"Each patient had a physical examination performed by his or her primary care provider, was given a standardized questionnaire that focused on symptoms of THYROID DISEASE and underwent a venipuncture for TOTAL THYROXINE triiodothyronine resin uptake and thyrotropin (TSH) concentration.",THYROID DISEASE,TOTAL THYROXINE,RO-may_diagnose
503335445,7/16/2014 10:54:45,,1324195565,7/16/2014 10:54:12,clixsense,0.6653,24896327,GBR,V2,Glasgow,94.2.231.4,no_relation,154,203,,168,218,diagnosed by,0.629940788348712,906870-FS1-13,"Each patient had a physical examination performed by his or her primary care provider, was given a standardized questionnaire that focused on symptoms of THYROID DISEASE and underwent a venipuncture for TOTAL THYROXINE triiodothyronine resin uptake and thyrotropin (TSH) concentration.",THYROID DISEASE,TOTAL THYROXINE,RO-may_diagnose
503335445,7/16/2014 11:29:39,,1324207464,7/16/2014 11:29:12,vivatic,0.4931,24842942,GBR,H9,London,149.254.51.63,no_relation,154,203,,168,218,diagnosed by,0.629940788348712,906870-FS1-13,"Each patient had a physical examination performed by his or her primary care provider, was given a standardized questionnaire that focused on symptoms of THYROID DISEASE and underwent a venipuncture for TOTAL THYROXINE triiodothyronine resin uptake and thyrotropin (TSH) concentration.",THYROID DISEASE,TOTAL THYROXINE,RO-may_diagnose
503335445,7/16/2014 11:47:32,,1324213622,7/16/2014 11:46:52,prodege,0.5516,28039757,GBR,L8,Southport,109.155.158.54,THYROID DISEASE diagnosed by TOTAL THYROXINE,154,203,,168,218,diagnosed by,0.629940788348712,906870-FS1-13,"Each patient had a physical examination performed by his or her primary care provider, was given a standardized questionnaire that focused on symptoms of THYROID DISEASE and underwent a venipuncture for TOTAL THYROXINE triiodothyronine resin uptake and thyrotropin (TSH) concentration.",THYROID DISEASE,TOTAL THYROXINE,RO-may_diagnose
503335446,7/15/2014 21:01:48,,1323839339,7/15/2014 21:01:41,neodev,0.875,25224036,CAN,ON,Sudbury,67.204.218.187,ACQUIRED IMMUNE DEFICIENCY SYNDROME causes HUMAN IMMUNODEFICIENCY VIRUS (HIV),30,88,,63,123,causes,0.9761870601839531,903982-FS1-4,Current models of the role of HUMAN IMMUNODEFICIENCY VIRUS (HIV) in the pathogenesis of ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS) are inadequate and inconsistent with the literature.,HUMAN IMMUNODEFICIENCY VIRUS (HIV),ACQUIRED IMMUNE DEFICIENCY SYNDROME,RO-has_causative_agent
503335446,7/15/2014 21:26:13,,1323849885,7/15/2014 21:25:48,neodev,0.8056,18755947,GBR,H2,Accrington,80.47.185.52,HUMAN IMMUNODEFICIENCY VIRUS (HIV) causes ACQUIRED IMMUNE DEFICIENCY SYNDROME,30,88,,63,123,causes,0.9761870601839531,903982-FS1-4,Current models of the role of HUMAN IMMUNODEFICIENCY VIRUS (HIV) in the pathogenesis of ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS) are inadequate and inconsistent with the literature.,HUMAN IMMUNODEFICIENCY VIRUS (HIV),ACQUIRED IMMUNE DEFICIENCY SYNDROME,RO-has_causative_agent
503335446,7/15/2014 21:46:27,,1323856817,7/15/2014 21:45:53,clixsense,0.6875,19638651,USA,,,173.23.121.63,no_relation,30,88,,63,123,causes,0.9761870601839531,903982-FS1-4,Current models of the role of HUMAN IMMUNODEFICIENCY VIRUS (HIV) in the pathogenesis of ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS) are inadequate and inconsistent with the literature.,HUMAN IMMUNODEFICIENCY VIRUS (HIV),ACQUIRED IMMUNE DEFICIENCY SYNDROME,RO-has_causative_agent
503335446,7/16/2014 02:17:44,,1323996181,7/16/2014 02:17:40,neodev,0.4899,22098386,USA,NY,Greenwich,67.248.253.125,HUMAN IMMUNODEFICIENCY VIRUS (HIV) causes ACQUIRED IMMUNE DEFICIENCY SYNDROME,30,88,,63,123,causes,0.9761870601839531,903982-FS1-4,Current models of the role of HUMAN IMMUNODEFICIENCY VIRUS (HIV) in the pathogenesis of ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS) are inadequate and inconsistent with the literature.,HUMAN IMMUNODEFICIENCY VIRUS (HIV),ACQUIRED IMMUNE DEFICIENCY SYNDROME,RO-has_causative_agent
503335446,7/16/2014 02:27:29,,1324000210,7/16/2014 02:26:42,instagc,0.7429,28519532,USA,IA,Honey Creek,12.73.110.156,HUMAN IMMUNODEFICIENCY VIRUS (HIV) causes ACQUIRED IMMUNE DEFICIENCY SYNDROME,30,88,,63,123,causes,0.9761870601839531,903982-FS1-4,Current models of the role of HUMAN IMMUNODEFICIENCY VIRUS (HIV) in the pathogenesis of ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS) are inadequate and inconsistent with the literature.,HUMAN IMMUNODEFICIENCY VIRUS (HIV),ACQUIRED IMMUNE DEFICIENCY SYNDROME,RO-has_causative_agent
503335446,7/16/2014 02:48:54,,1324007524,7/16/2014 02:48:21,rewardsspot,0.7526,24482174,GBR,H9,London,46.23.68.180,HUMAN IMMUNODEFICIENCY VIRUS (HIV) causes ACQUIRED IMMUNE DEFICIENCY SYNDROME,30,88,,63,123,causes,0.9761870601839531,903982-FS1-4,Current models of the role of HUMAN IMMUNODEFICIENCY VIRUS (HIV) in the pathogenesis of ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS) are inadequate and inconsistent with the literature.,HUMAN IMMUNODEFICIENCY VIRUS (HIV),ACQUIRED IMMUNE DEFICIENCY SYNDROME,RO-has_causative_agent
503335446,7/16/2014 04:22:19,,1324044965,7/16/2014 04:21:54,instagc,0.6288,27770607,USA,TX,El Paso,72.183.248.75,no_relation,30,88,,63,123,causes,0.9761870601839531,903982-FS1-4,Current models of the role of HUMAN IMMUNODEFICIENCY VIRUS (HIV) in the pathogenesis of ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS) are inadequate and inconsistent with the literature.,HUMAN IMMUNODEFICIENCY VIRUS (HIV),ACQUIRED IMMUNE DEFICIENCY SYNDROME,RO-has_causative_agent
503335449,7/15/2014 21:07:23,,1323841893,7/15/2014 21:07:19,instagc,0.6944,25990856,USA,NV,Las Vegas,68.108.98.78,PAPAVERINE treats ERECTILE DYSFUNCTION,3,140,,22,150,treats,0.8728715609439692,906641-FS1-2,"In ERECTILE DYSFUNCTION formerly, for both diagnostic and therapeutic purposes, intracavernous injections of papaverine and the combination PAPAVERINE/phentolamine were employed.",ERECTILE DYSFUNCTION,PAPAVERINE,RO-may_diagnose
503335449,7/16/2014 02:21:21,,1323997714,7/16/2014 02:20:23,zoombucks,0.5502,4688131,CAN,BC,Vancouver,108.180.143.28,PAPAVERINE treats ERECTILE DYSFUNCTION,3,140,,22,150,treats,0.8728715609439692,906641-FS1-2,"In ERECTILE DYSFUNCTION formerly, for both diagnostic and therapeutic purposes, intracavernous injections of papaverine and the combination PAPAVERINE/phentolamine were employed.",ERECTILE DYSFUNCTION,PAPAVERINE,RO-may_diagnose
503335449,7/16/2014 02:46:23,,1324006682,7/16/2014 02:45:57,rewardsspot,0.7526,24482174,GBR,H9,London,46.23.68.180,PAPAVERINE treats ERECTILE DYSFUNCTION,3,140,,22,150,treats,0.8728715609439692,906641-FS1-2,"In ERECTILE DYSFUNCTION formerly, for both diagnostic and therapeutic purposes, intracavernous injections of papaverine and the combination PAPAVERINE/phentolamine were employed.",ERECTILE DYSFUNCTION,PAPAVERINE,RO-may_diagnose
503335449,7/16/2014 05:04:56,,1324059586,7/16/2014 05:04:20,eup_slw,0.7258,28186528,USA,IN,Bloomington,74.204.124.9,PAPAVERINE treats ERECTILE DYSFUNCTION,3,140,,22,150,treats,0.8728715609439692,906641-FS1-2,"In ERECTILE DYSFUNCTION formerly, for both diagnostic and therapeutic purposes, intracavernous injections of papaverine and the combination PAPAVERINE/phentolamine were employed.",ERECTILE DYSFUNCTION,PAPAVERINE,RO-may_diagnose
503335449,7/16/2014 05:42:06,,1324070808,7/16/2014 05:41:44,sendearnings,0.5972,20717796,USA,CA,San Jose,99.27.90.128,PAPAVERINE treats ERECTILE DYSFUNCTION,3,140,,22,150,treats,0.8728715609439692,906641-FS1-2,"In ERECTILE DYSFUNCTION formerly, for both diagnostic and therapeutic purposes, intracavernous injections of papaverine and the combination PAPAVERINE/phentolamine were employed.",ERECTILE DYSFUNCTION,PAPAVERINE,RO-may_diagnose
503335449,7/16/2014 07:52:12,,1324112797,7/16/2014 07:51:42,prodege,0.5324,9559045,USA,TX,Katy,107.204.186.172,PAPAVERINE treats ERECTILE DYSFUNCTION,3,140,,22,150,treats,0.8728715609439692,906641-FS1-2,"In ERECTILE DYSFUNCTION formerly, for both diagnostic and therapeutic purposes, intracavernous injections of papaverine and the combination PAPAVERINE/phentolamine were employed.",ERECTILE DYSFUNCTION,PAPAVERINE,RO-may_diagnose
503335449,7/16/2014 08:07:45,,1324117704,7/16/2014 08:07:34,instagc,0.6736,20183814,USA,,,166.182.83.84,PAPAVERINE treats ERECTILE DYSFUNCTION,3,140,,22,150,treats,0.8728715609439692,906641-FS1-2,"In ERECTILE DYSFUNCTION formerly, for both diagnostic and therapeutic purposes, intracavernous injections of papaverine and the combination PAPAVERINE/phentolamine were employed.",ERECTILE DYSFUNCTION,PAPAVERINE,RO-may_diagnose
503335451,7/15/2014 20:53:24,,1323835700,7/15/2014 20:52:46,instagc,0.9583,24252915,GBR,B7,Bristol,77.98.139.82,GLUTEN SENSITIVITY diagnosed by RECTAL GLUTEN CHALLENGE,0,64,,22,82,diagnosed by,0.9704949588309459,903521-FS1-13,"RECTAL GLUTEN CHALLENGE is a simple, safe, and reliable test of GLUTEN SENSITIVITY both as a screening test for untreated coeliac disease and as a confirmatory test in patients with treated coeliac disease.",RECTAL GLUTEN CHALLENGE,GLUTEN SENSITIVITY,RO-has_causative_agent
503335451,7/15/2014 20:53:30,,1323835739,7/15/2014 20:53:06,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,GLUTEN SENSITIVITY diagnosed by RECTAL GLUTEN CHALLENGE,0,64,,22,82,diagnosed by,0.9704949588309459,903521-FS1-13,"RECTAL GLUTEN CHALLENGE is a simple, safe, and reliable test of GLUTEN SENSITIVITY both as a screening test for untreated coeliac disease and as a confirmatory test in patients with treated coeliac disease.",RECTAL GLUTEN CHALLENGE,GLUTEN SENSITIVITY,RO-has_causative_agent
503335451,7/15/2014 21:04:44,,1323840721,7/15/2014 21:04:11,clixsense,0.7153,6564572,USA,MI,Kalamazoo,173.46.248.170,GLUTEN SENSITIVITY diagnosed by RECTAL GLUTEN CHALLENGE,0,64,,22,82,diagnosed by,0.9704949588309459,903521-FS1-13,"RECTAL GLUTEN CHALLENGE is a simple, safe, and reliable test of GLUTEN SENSITIVITY both as a screening test for untreated coeliac disease and as a confirmatory test in patients with treated coeliac disease.",RECTAL GLUTEN CHALLENGE,GLUTEN SENSITIVITY,RO-has_causative_agent
503335451,7/15/2014 21:07:36,,1323841997,7/15/2014 21:07:33,instagc,0.6944,25990856,USA,NV,Las Vegas,68.108.98.78,RECTAL GLUTEN CHALLENGE diagnosed by GLUTEN SENSITIVITY,0,64,,22,82,diagnosed by,0.9704949588309459,903521-FS1-13,"RECTAL GLUTEN CHALLENGE is a simple, safe, and reliable test of GLUTEN SENSITIVITY both as a screening test for untreated coeliac disease and as a confirmatory test in patients with treated coeliac disease.",RECTAL GLUTEN CHALLENGE,GLUTEN SENSITIVITY,RO-has_causative_agent
503335451,7/15/2014 21:30:16,,1323851554,7/15/2014 21:29:58,instagc,0.6917,28301350,GBR,O4,Torquay,89.241.101.166,GLUTEN SENSITIVITY diagnosed by RECTAL GLUTEN CHALLENGE,0,64,,22,82,diagnosed by,0.9704949588309459,903521-FS1-13,"RECTAL GLUTEN CHALLENGE is a simple, safe, and reliable test of GLUTEN SENSITIVITY both as a screening test for untreated coeliac disease and as a confirmatory test in patients with treated coeliac disease.",RECTAL GLUTEN CHALLENGE,GLUTEN SENSITIVITY,RO-has_causative_agent
503335451,7/15/2014 22:28:01,,1323874801,7/15/2014 22:27:50,clixsense,0.7236,7265596,USA,IA,Neola,199.120.116.136,GLUTEN SENSITIVITY diagnosed by RECTAL GLUTEN CHALLENGE,0,64,,22,82,diagnosed by,0.9704949588309459,903521-FS1-13,"RECTAL GLUTEN CHALLENGE is a simple, safe, and reliable test of GLUTEN SENSITIVITY both as a screening test for untreated coeliac disease and as a confirmatory test in patients with treated coeliac disease.",RECTAL GLUTEN CHALLENGE,GLUTEN SENSITIVITY,RO-has_causative_agent
503335451,7/15/2014 22:39:23,,1323880722,7/15/2014 22:38:58,instagc,0.6089,13763729,USA,,,75.182.89.225,GLUTEN SENSITIVITY diagnosed by RECTAL GLUTEN CHALLENGE,0,64,,22,82,diagnosed by,0.9704949588309459,903521-FS1-13,"RECTAL GLUTEN CHALLENGE is a simple, safe, and reliable test of GLUTEN SENSITIVITY both as a screening test for untreated coeliac disease and as a confirmatory test in patients with treated coeliac disease.",RECTAL GLUTEN CHALLENGE,GLUTEN SENSITIVITY,RO-has_causative_agent
503335459,7/15/2014 21:36:08,,1323853473,7/15/2014 21:35:29,clixsense,0.8861,25595227,CAN,SK,North Battleford,24.72.96.119,CHARCOAL treats ACETAMINOPHEN OVERDOSE,93,52,,114,60,treats,0.881917103688197,907670-FS1-2,A prospective evaluation of the effect of activated CHARCOAL before oral N acetylcysteine in ACETAMINOPHEN OVERDOSE,ACETAMINOPHEN OVERDOSE,CHARCOAL,RO-may_treat
503335459,7/15/2014 22:27:49,,1323874664,7/15/2014 22:27:35,clixsense,0.7236,7265596,USA,IA,Neola,199.120.116.136,CHARCOAL treats ACETAMINOPHEN OVERDOSE,93,52,,114,60,treats,0.881917103688197,907670-FS1-2,A prospective evaluation of the effect of activated CHARCOAL before oral N acetylcysteine in ACETAMINOPHEN OVERDOSE,ACETAMINOPHEN OVERDOSE,CHARCOAL,RO-may_treat
503335459,7/16/2014 00:38:38,,1323945156,7/16/2014 00:37:59,neodev,0.7873,11460728,CAN,BC,Burnaby,70.79.16.165,CHARCOAL treats ACETAMINOPHEN OVERDOSE,93,52,,114,60,treats,0.881917103688197,907670-FS1-2,A prospective evaluation of the effect of activated CHARCOAL before oral N acetylcysteine in ACETAMINOPHEN OVERDOSE,ACETAMINOPHEN OVERDOSE,CHARCOAL,RO-may_treat
503335459,7/16/2014 01:33:18,,1323975864,7/16/2014 01:32:58,rewardsspot,0.5907,17763704,USA,VA,Manassas,198.7.62.204,no_relation,93,52,,114,60,treats,0.881917103688197,907670-FS1-2,A prospective evaluation of the effect of activated CHARCOAL before oral N acetylcysteine in ACETAMINOPHEN OVERDOSE,ACETAMINOPHEN OVERDOSE,CHARCOAL,RO-may_treat
503335459,7/16/2014 07:11:11,,1324101113,7/16/2014 07:10:57,instagc,0.6093,18960682,GBR,,,86.29.147.112,CHARCOAL treats ACETAMINOPHEN OVERDOSE,93,52,,114,60,treats,0.881917103688197,907670-FS1-2,A prospective evaluation of the effect of activated CHARCOAL before oral N acetylcysteine in ACETAMINOPHEN OVERDOSE,ACETAMINOPHEN OVERDOSE,CHARCOAL,RO-may_treat
503335459,7/16/2014 08:05:51,,1324117161,7/16/2014 08:05:12,instagc,0.6736,20183814,USA,,,166.182.83.84,no_relation,93,52,,114,60,treats,0.881917103688197,907670-FS1-2,A prospective evaluation of the effect of activated CHARCOAL before oral N acetylcysteine in ACETAMINOPHEN OVERDOSE,ACETAMINOPHEN OVERDOSE,CHARCOAL,RO-may_treat
503335459,7/16/2014 08:25:44,,1324123189,7/16/2014 08:24:41,cotter,0.54,7461147,USA,VA,Saluda,71.253.203.209,CHARCOAL treats ACETAMINOPHEN OVERDOSE,93,52,,114,60,treats,0.881917103688197,907670-FS1-2,A prospective evaluation of the effect of activated CHARCOAL before oral N acetylcysteine in ACETAMINOPHEN OVERDOSE,ACETAMINOPHEN OVERDOSE,CHARCOAL,RO-may_treat
503335464,7/15/2014 22:42:17,,1323882036,7/15/2014 22:41:59,instagc,0.6708,15445601,USA,FL,Jacksonville,24.129.68.254,no_relation,222,91,,231,115,diagnosed by,0.911684611677103,902786-FS1-13,A retrospective review of 64 patients with haematuria and subsequent histologically proven CARCINOMA OF THE BLADDER revealed that bladder tumours could be diagnosed pre operatively in 34 of 46 (76%) of patients with gross HAEMATURIA and 12 of of 18 (67%) of those with microhaematuria.,HAEMATURIA,CARCINOMA OF THE BLADDER,RO-disease_may_have_finding
503335464,7/16/2014 00:39:19,,1323945502,7/16/2014 00:38:40,neodev,0.7873,11460728,CAN,BC,Burnaby,70.79.16.165,HAEMATURIA diagnosed by CARCINOMA OF THE BLADDER,222,91,,231,115,diagnosed by,0.911684611677103,902786-FS1-13,A retrospective review of 64 patients with haematuria and subsequent histologically proven CARCINOMA OF THE BLADDER revealed that bladder tumours could be diagnosed pre operatively in 34 of 46 (76%) of patients with gross HAEMATURIA and 12 of of 18 (67%) of those with microhaematuria.,HAEMATURIA,CARCINOMA OF THE BLADDER,RO-disease_may_have_finding
503335464,7/16/2014 02:17:29,,1323996030,7/16/2014 02:16:55,neodev,0.4899,22098386,USA,NY,Greenwich,67.248.253.125,HAEMATURIA diagnosed by CARCINOMA OF THE BLADDER,222,91,,231,115,diagnosed by,0.911684611677103,902786-FS1-13,A retrospective review of 64 patients with haematuria and subsequent histologically proven CARCINOMA OF THE BLADDER revealed that bladder tumours could be diagnosed pre operatively in 34 of 46 (76%) of patients with gross HAEMATURIA and 12 of of 18 (67%) of those with microhaematuria.,HAEMATURIA,CARCINOMA OF THE BLADDER,RO-disease_may_have_finding
503335464,7/16/2014 10:30:10,,1324184650,7/16/2014 10:29:24,superrewards,0.4901,26561650,NLD,06,Tilburg,84.87.179.65,CARCINOMA OF THE BLADDER diagnosed by HAEMATURIA,222,91,,231,115,diagnosed by,0.911684611677103,902786-FS1-13,A retrospective review of 64 patients with haematuria and subsequent histologically proven CARCINOMA OF THE BLADDER revealed that bladder tumours could be diagnosed pre operatively in 34 of 46 (76%) of patients with gross HAEMATURIA and 12 of of 18 (67%) of those with microhaematuria.,HAEMATURIA,CARCINOMA OF THE BLADDER,RO-disease_may_have_finding
503335464,7/16/2014 10:34:07,,1324185941,7/16/2014 10:33:19,prodege,0.6647,23999031,AUS,08,Perth,203.59.238.194,no_relation,222,91,,231,115,diagnosed by,0.911684611677103,902786-FS1-13,A retrospective review of 64 patients with haematuria and subsequent histologically proven CARCINOMA OF THE BLADDER revealed that bladder tumours could be diagnosed pre operatively in 34 of 46 (76%) of patients with gross HAEMATURIA and 12 of of 18 (67%) of those with microhaematuria.,HAEMATURIA,CARCINOMA OF THE BLADDER,RO-disease_may_have_finding
503335464,7/16/2014 11:30:59,,1324207886,7/16/2014 11:29:42,vivatic,0.4931,24842942,GBR,H9,London,149.254.51.63,CARCINOMA OF THE BLADDER diagnosed by HAEMATURIA,222,91,,231,115,diagnosed by,0.911684611677103,902786-FS1-13,A retrospective review of 64 patients with haematuria and subsequent histologically proven CARCINOMA OF THE BLADDER revealed that bladder tumours could be diagnosed pre operatively in 34 of 46 (76%) of patients with gross HAEMATURIA and 12 of of 18 (67%) of those with microhaematuria.,HAEMATURIA,CARCINOMA OF THE BLADDER,RO-disease_may_have_finding
503335464,7/16/2014 11:47:32,,1324213621,7/16/2014 11:46:52,prodege,0.5516,28039757,GBR,L8,Southport,109.155.158.54,CARCINOMA OF THE BLADDER diagnosed by HAEMATURIA,222,91,,231,115,diagnosed by,0.911684611677103,902786-FS1-13,A retrospective review of 64 patients with haematuria and subsequent histologically proven CARCINOMA OF THE BLADDER revealed that bladder tumours could be diagnosed pre operatively in 34 of 46 (76%) of patients with gross HAEMATURIA and 12 of of 18 (67%) of those with microhaematuria.,HAEMATURIA,CARCINOMA OF THE BLADDER,RO-disease_may_have_finding
503335468,7/15/2014 22:37:30,,1323879726,7/15/2014 22:37:02,instagc,0.6089,13763729,USA,,,75.182.89.225,SEIZURES causes STATUS EPILEPTICUS,0,33,,7,51,causes,0.918558653543692,904791-FS1-4,"SEIZURES can rapidly progress to STATUS EPILEPTICUS contributing to mortality and, in survivors, to neuronal damage and neurological impairment.",SEIZURES,STATUS EPILEPTICUS,RO-has_definitional_manifestation
503335468,7/16/2014 01:06:11,,1323960192,7/16/2014 01:05:25,bitcoinget,0.6514,28377798,GBR,,,195.166.117.126,SEIZURES causes STATUS EPILEPTICUS,0,33,,7,51,causes,0.918558653543692,904791-FS1-4,"SEIZURES can rapidly progress to STATUS EPILEPTICUS contributing to mortality and, in survivors, to neuronal damage and neurological impairment.",SEIZURES,STATUS EPILEPTICUS,RO-has_definitional_manifestation
503335468,7/16/2014 01:40:16,,1323978440,7/16/2014 01:39:58,instagc,0.5153,23149109,USA,NC,Durham,75.189.206.205,STATUS EPILEPTICUS causes SEIZURES,0,33,,7,51,causes,0.918558653543692,904791-FS1-4,"SEIZURES can rapidly progress to STATUS EPILEPTICUS contributing to mortality and, in survivors, to neuronal damage and neurological impairment.",SEIZURES,STATUS EPILEPTICUS,RO-has_definitional_manifestation
503335468,7/16/2014 02:35:15,,1324003095,7/16/2014 02:34:12,zoombucks,0.5502,4688131,CAN,BC,Vancouver,108.180.143.28,no_relation,0,33,,7,51,causes,0.918558653543692,904791-FS1-4,"SEIZURES can rapidly progress to STATUS EPILEPTICUS contributing to mortality and, in survivors, to neuronal damage and neurological impairment.",SEIZURES,STATUS EPILEPTICUS,RO-has_definitional_manifestation
503335468,7/16/2014 08:36:09,,1324125896,7/16/2014 08:35:29,eup_slw,0.6377,20818028,GBR,A7,Birmingham,92.232.139.254,SEIZURES causes STATUS EPILEPTICUS,0,33,,7,51,causes,0.918558653543692,904791-FS1-4,"SEIZURES can rapidly progress to STATUS EPILEPTICUS contributing to mortality and, in survivors, to neuronal damage and neurological impairment.",SEIZURES,STATUS EPILEPTICUS,RO-has_definitional_manifestation
503335468,7/16/2014 09:04:14,,1324133740,7/16/2014 09:04:09,clixsense,0.4962,19162475,GBR,M3,Frome,82.33.126.30,SEIZURES causes STATUS EPILEPTICUS,0,33,,7,51,causes,0.918558653543692,904791-FS1-4,"SEIZURES can rapidly progress to STATUS EPILEPTICUS contributing to mortality and, in survivors, to neuronal damage and neurological impairment.",SEIZURES,STATUS EPILEPTICUS,RO-has_definitional_manifestation
503335468,7/16/2014 09:32:05,,1324150101,7/16/2014 09:31:39,prodege,0.7222,27934334,GBR,Q2,Wokingham,86.166.73.7,no_relation,0,33,,7,51,causes,0.918558653543692,904791-FS1-4,"SEIZURES can rapidly progress to STATUS EPILEPTICUS contributing to mortality and, in survivors, to neuronal damage and neurological impairment.",SEIZURES,STATUS EPILEPTICUS,RO-has_definitional_manifestation
503335475,7/15/2014 21:01:58,,1323839403,7/15/2014 21:01:50,neodev,0.875,25224036,CAN,ON,Sudbury,67.204.218.187,AGENTS (ATROPINE treats ARREST ARRHYTHMIA,248,224,,264,240,treats,0.676123403782813,907823-FS1-2,"The commonly used medications in cardiac resuscitation may be grouped into the following general categories: vasopressors (epinephrine or vasopressin), antiarrhythmics (amiodarone, lidocaine, and magnesium), anticholinergic AGENTS (ATROPINE if the ARREST ARRHYTHMIA is asystole or PEA is slow), and miscellaneous drugs used to treat specific problems contributing to the arrest state, such as sodium bicarbonate (for severe metabolic acidosis, hyperkalemia, and certain drug overdoses) and calcium chloride (for hyperkalemia, calcium channel blocker drug overdose, or severe hypocalcemia) [ see.",ARREST ARRHYTHMIA,AGENTS (ATROPINE,RO-may_treat
503335475,7/15/2014 21:04:39,,1323840693,7/15/2014 21:03:34,elite,0.8125,28276268,USA,MI,Taylor,67.149.247.166,AGENTS (ATROPINE treats ARREST ARRHYTHMIA,248,224,,264,240,treats,0.676123403782813,907823-FS1-2,"The commonly used medications in cardiac resuscitation may be grouped into the following general categories: vasopressors (epinephrine or vasopressin), antiarrhythmics (amiodarone, lidocaine, and magnesium), anticholinergic AGENTS (ATROPINE if the ARREST ARRHYTHMIA is asystole or PEA is slow), and miscellaneous drugs used to treat specific problems contributing to the arrest state, such as sodium bicarbonate (for severe metabolic acidosis, hyperkalemia, and certain drug overdoses) and calcium chloride (for hyperkalemia, calcium channel blocker drug overdose, or severe hypocalcemia) [ see.",ARREST ARRHYTHMIA,AGENTS (ATROPINE,RO-may_treat
503335475,7/15/2014 21:27:23,,1323850386,7/15/2014 21:26:40,neodev,0.8056,18755947,GBR,H2,Accrington,80.47.185.52,AGENTS (ATROPINE treats ARREST ARRHYTHMIA,248,224,,264,240,treats,0.676123403782813,907823-FS1-2,"The commonly used medications in cardiac resuscitation may be grouped into the following general categories: vasopressors (epinephrine or vasopressin), antiarrhythmics (amiodarone, lidocaine, and magnesium), anticholinergic AGENTS (ATROPINE if the ARREST ARRHYTHMIA is asystole or PEA is slow), and miscellaneous drugs used to treat specific problems contributing to the arrest state, such as sodium bicarbonate (for severe metabolic acidosis, hyperkalemia, and certain drug overdoses) and calcium chloride (for hyperkalemia, calcium channel blocker drug overdose, or severe hypocalcemia) [ see.",ARREST ARRHYTHMIA,AGENTS (ATROPINE,RO-may_treat
503335475,7/15/2014 21:31:57,,1323852149,7/15/2014 21:31:34,instagc,0.6917,28301350,GBR,O4,Torquay,89.241.101.166,AGENTS (ATROPINE treats ARREST ARRHYTHMIA,248,224,,264,240,treats,0.676123403782813,907823-FS1-2,"The commonly used medications in cardiac resuscitation may be grouped into the following general categories: vasopressors (epinephrine or vasopressin), antiarrhythmics (amiodarone, lidocaine, and magnesium), anticholinergic AGENTS (ATROPINE if the ARREST ARRHYTHMIA is asystole or PEA is slow), and miscellaneous drugs used to treat specific problems contributing to the arrest state, such as sodium bicarbonate (for severe metabolic acidosis, hyperkalemia, and certain drug overdoses) and calcium chloride (for hyperkalemia, calcium channel blocker drug overdose, or severe hypocalcemia) [ see.",ARREST ARRHYTHMIA,AGENTS (ATROPINE,RO-may_treat
503335475,7/15/2014 21:45:20,,1323856468,7/15/2014 21:44:30,clixsense,0.6875,19638651,USA,,,173.23.121.63,AGENTS (ATROPINE treats ARREST ARRHYTHMIA,248,224,,264,240,treats,0.676123403782813,907823-FS1-2,"The commonly used medications in cardiac resuscitation may be grouped into the following general categories: vasopressors (epinephrine or vasopressin), antiarrhythmics (amiodarone, lidocaine, and magnesium), anticholinergic AGENTS (ATROPINE if the ARREST ARRHYTHMIA is asystole or PEA is slow), and miscellaneous drugs used to treat specific problems contributing to the arrest state, such as sodium bicarbonate (for severe metabolic acidosis, hyperkalemia, and certain drug overdoses) and calcium chloride (for hyperkalemia, calcium channel blocker drug overdose, or severe hypocalcemia) [ see.",ARREST ARRHYTHMIA,AGENTS (ATROPINE,RO-may_treat
503335475,7/16/2014 00:33:32,,1323942787,7/16/2014 00:33:19,prodege,0.6712,15439740,AUS,02,Jannali,27.96.208.89,no_relation,248,224,,264,240,treats,0.676123403782813,907823-FS1-2,"The commonly used medications in cardiac resuscitation may be grouped into the following general categories: vasopressors (epinephrine or vasopressin), antiarrhythmics (amiodarone, lidocaine, and magnesium), anticholinergic AGENTS (ATROPINE if the ARREST ARRHYTHMIA is asystole or PEA is slow), and miscellaneous drugs used to treat specific problems contributing to the arrest state, such as sodium bicarbonate (for severe metabolic acidosis, hyperkalemia, and certain drug overdoses) and calcium chloride (for hyperkalemia, calcium channel blocker drug overdose, or severe hypocalcemia) [ see.",ARREST ARRHYTHMIA,AGENTS (ATROPINE,RO-may_treat
503335475,7/16/2014 05:41:05,,1324070543,7/16/2014 05:40:23,sendearnings,0.5972,20717796,USA,CA,San Jose,99.27.90.128,ARREST ARRHYTHMIA treats AGENTS (ATROPINE,248,224,,264,240,treats,0.676123403782813,907823-FS1-2,"The commonly used medications in cardiac resuscitation may be grouped into the following general categories: vasopressors (epinephrine or vasopressin), antiarrhythmics (amiodarone, lidocaine, and magnesium), anticholinergic AGENTS (ATROPINE if the ARREST ARRHYTHMIA is asystole or PEA is slow), and miscellaneous drugs used to treat specific problems contributing to the arrest state, such as sodium bicarbonate (for severe metabolic acidosis, hyperkalemia, and certain drug overdoses) and calcium chloride (for hyperkalemia, calcium channel blocker drug overdose, or severe hypocalcemia) [ see.",ARREST ARRHYTHMIA,AGENTS (ATROPINE,RO-may_treat
503335481,7/15/2014 21:06:15,,1323841464,7/15/2014 21:06:01,prodege,0.9167,2143114,CAN,BC,Vancouver,24.84.160.12,THYROTOXICOSIS causes GRAVES' DISEASE,18,135,,32,149,causes,0.4472135954999579,900105-FS1-4,Thyrotoxicosis in GRAVES' DISEASE is often aggravated in early pregnancy and this aggravation is associated with postpartum relapse of THYROTOXICOSIS.,GRAVES' DISEASE,THYROTOXICOSIS,RO-cause_of
503335481,7/15/2014 21:24:30,,1323849137,7/15/2014 21:23:50,clixsense,0.7986,19803139,NLD,06,Veldhoven,212.61.84.196,GRAVES' DISEASE causes THYROTOXICOSIS,18,135,,32,149,causes,0.4472135954999579,900105-FS1-4,Thyrotoxicosis in GRAVES' DISEASE is often aggravated in early pregnancy and this aggravation is associated with postpartum relapse of THYROTOXICOSIS.,GRAVES' DISEASE,THYROTOXICOSIS,RO-cause_of
503335481,7/15/2014 23:31:43,,1323908571,7/15/2014 23:30:47,elite,0.6665,28397222,GBR,Y4,Usk,31.50.223.75,GRAVES' DISEASE causes THYROTOXICOSIS,18,135,,32,149,causes,0.4472135954999579,900105-FS1-4,Thyrotoxicosis in GRAVES' DISEASE is often aggravated in early pregnancy and this aggravation is associated with postpartum relapse of THYROTOXICOSIS.,GRAVES' DISEASE,THYROTOXICOSIS,RO-cause_of
503335481,7/16/2014 01:25:04,,1323972055,7/16/2014 01:24:57,tremorgames,0.6371,28013393,USA,CA,Rancho Cordova,71.197.67.37,THYROTOXICOSIS causes GRAVES' DISEASE,18,135,,32,149,causes,0.4472135954999579,900105-FS1-4,Thyrotoxicosis in GRAVES' DISEASE is often aggravated in early pregnancy and this aggravation is associated with postpartum relapse of THYROTOXICOSIS.,GRAVES' DISEASE,THYROTOXICOSIS,RO-cause_of
503335481,7/16/2014 04:23:01,,1324045167,7/16/2014 04:22:19,instagc,0.6288,27770607,USA,TX,El Paso,72.183.248.75,GRAVES' DISEASE causes THYROTOXICOSIS,18,135,,32,149,causes,0.4472135954999579,900105-FS1-4,Thyrotoxicosis in GRAVES' DISEASE is often aggravated in early pregnancy and this aggravation is associated with postpartum relapse of THYROTOXICOSIS.,GRAVES' DISEASE,THYROTOXICOSIS,RO-cause_of
503335481,7/16/2014 07:29:32,,1324106900,7/16/2014 07:29:01,vivatic,0.6569,25451531,GBR,,,83.67.28.193,THYROTOXICOSIS causes GRAVES' DISEASE,18,135,,32,149,causes,0.4472135954999579,900105-FS1-4,Thyrotoxicosis in GRAVES' DISEASE is often aggravated in early pregnancy and this aggravation is associated with postpartum relapse of THYROTOXICOSIS.,GRAVES' DISEASE,THYROTOXICOSIS,RO-cause_of
503335481,7/16/2014 09:17:28,,1324138437,7/16/2014 09:16:23,clixsense,0.6071,27969116,NLD,04,Veendam,185.12.216.74,THYROTOXICOSIS causes GRAVES' DISEASE,18,135,,32,149,causes,0.4472135954999579,900105-FS1-4,Thyrotoxicosis in GRAVES' DISEASE is often aggravated in early pregnancy and this aggravation is associated with postpartum relapse of THYROTOXICOSIS.,GRAVES' DISEASE,THYROTOXICOSIS,RO-cause_of
503335484,7/15/2014 21:01:40,,1323839266,7/15/2014 21:01:35,neodev,0.875,25224036,CAN,ON,Sudbury,67.204.218.187,CUSHING'S SYNDROME diagnosed by AFTER AN OVERNIGHT DEXAMETHASONE ADMINISTRATION,52,115,,69,162,diagnosed by,0.639602149066831,906655-FS1-13,Although she had no characteristic feature of overt CUSHING'S SYNDROME her serum cortisol level was not suppressed AFTER AN OVERNIGHT DEXAMETHASONE ADMINISTRATION.,CUSHING'S SYNDROME,AFTER AN OVERNIGHT DEXAMETHASONE ADMINISTRATION,RO-may_diagnose
503335484,7/15/2014 21:05:59,,1323841278,7/15/2014 21:05:44,prodege,0.9167,2143114,CAN,BC,Vancouver,24.84.160.12,CUSHING'S SYNDROME diagnosed by AFTER AN OVERNIGHT DEXAMETHASONE ADMINISTRATION,52,115,,69,162,diagnosed by,0.639602149066831,906655-FS1-13,Although she had no characteristic feature of overt CUSHING'S SYNDROME her serum cortisol level was not suppressed AFTER AN OVERNIGHT DEXAMETHASONE ADMINISTRATION.,CUSHING'S SYNDROME,AFTER AN OVERNIGHT DEXAMETHASONE ADMINISTRATION,RO-may_diagnose
503335484,7/15/2014 21:39:27,,1323854489,7/15/2014 21:39:04,tremorgames,0.6875,24449707,CAN,QC,Laval,96.21.249.72,no_relation,52,115,,69,162,diagnosed by,0.639602149066831,906655-FS1-13,Although she had no characteristic feature of overt CUSHING'S SYNDROME her serum cortisol level was not suppressed AFTER AN OVERNIGHT DEXAMETHASONE ADMINISTRATION.,CUSHING'S SYNDROME,AFTER AN OVERNIGHT DEXAMETHASONE ADMINISTRATION,RO-may_diagnose
503335484,7/15/2014 22:02:16,,1323863099,7/15/2014 22:01:26,elite,0.5972,28465503,CAN,QC,Boucherville,24.201.21.27,no_relation,52,115,,69,162,diagnosed by,0.639602149066831,906655-FS1-13,Although she had no characteristic feature of overt CUSHING'S SYNDROME her serum cortisol level was not suppressed AFTER AN OVERNIGHT DEXAMETHASONE ADMINISTRATION.,CUSHING'S SYNDROME,AFTER AN OVERNIGHT DEXAMETHASONE ADMINISTRATION,RO-may_diagnose
503335484,7/15/2014 22:14:06,,1323868326,7/15/2014 22:14:00,instagc,0.4861,26706653,USA,IL,Elk Grove Village,99.99.9.247,CUSHING'S SYNDROME diagnosed by AFTER AN OVERNIGHT DEXAMETHASONE ADMINISTRATION,52,115,,69,162,diagnosed by,0.639602149066831,906655-FS1-13,Although she had no characteristic feature of overt CUSHING'S SYNDROME her serum cortisol level was not suppressed AFTER AN OVERNIGHT DEXAMETHASONE ADMINISTRATION.,CUSHING'S SYNDROME,AFTER AN OVERNIGHT DEXAMETHASONE ADMINISTRATION,RO-may_diagnose
503335484,7/15/2014 22:43:11,,1323882465,7/15/2014 22:42:58,instagc,0.6708,15445601,USA,FL,Jacksonville,24.129.68.254,no_relation,52,115,,69,162,diagnosed by,0.639602149066831,906655-FS1-13,Although she had no characteristic feature of overt CUSHING'S SYNDROME her serum cortisol level was not suppressed AFTER AN OVERNIGHT DEXAMETHASONE ADMINISTRATION.,CUSHING'S SYNDROME,AFTER AN OVERNIGHT DEXAMETHASONE ADMINISTRATION,RO-may_diagnose
503335484,7/16/2014 00:32:51,,1323942449,7/16/2014 00:32:28,prodege,0.6712,15439740,AUS,02,Jannali,27.96.208.89,no_relation,52,115,,69,162,diagnosed by,0.639602149066831,906655-FS1-13,Although she had no characteristic feature of overt CUSHING'S SYNDROME her serum cortisol level was not suppressed AFTER AN OVERNIGHT DEXAMETHASONE ADMINISTRATION.,CUSHING'S SYNDROME,AFTER AN OVERNIGHT DEXAMETHASONE ADMINISTRATION,RO-may_diagnose
503335488,7/15/2014 20:54:00,,1323835855,7/15/2014 20:53:32,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,DEDIFFERENTIATION causes GLIOBLASTOMA,0,36,,16,48,causes,0.35921060405355,901662-FS1-4,DEDIFFERENTIATION of astrocytoma to GLIOBLASTOMA and the role of radiation therapy are discussed.,DEDIFFERENTIATION,GLIOBLASTOMA,RO-disease_has_finding
503335488,7/15/2014 21:07:23,,1323841894,7/15/2014 21:07:19,instagc,0.6944,25990856,USA,NV,Las Vegas,68.108.98.78,DEDIFFERENTIATION causes GLIOBLASTOMA,0,36,,16,48,causes,0.35921060405355,901662-FS1-4,DEDIFFERENTIATION of astrocytoma to GLIOBLASTOMA and the role of radiation therapy are discussed.,DEDIFFERENTIATION,GLIOBLASTOMA,RO-disease_has_finding
503335488,7/15/2014 21:18:57,,1323846788,7/15/2014 21:18:41,elite,0.6944,28503042,USA,NJ,Woodbridge,54.191.150.115,no_relation,0,36,,16,48,causes,0.35921060405355,901662-FS1-4,DEDIFFERENTIATION of astrocytoma to GLIOBLASTOMA and the role of radiation therapy are discussed.,DEDIFFERENTIATION,GLIOBLASTOMA,RO-disease_has_finding
503335488,7/15/2014 21:20:38,,1323847422,7/15/2014 21:20:02,neodev,0.6597,21515166,NLD,11,Nootdorp,83.86.58.179,GLIOBLASTOMA causes DEDIFFERENTIATION,0,36,,16,48,causes,0.35921060405355,901662-FS1-4,DEDIFFERENTIATION of astrocytoma to GLIOBLASTOMA and the role of radiation therapy are discussed.,DEDIFFERENTIATION,GLIOBLASTOMA,RO-disease_has_finding
503335488,7/15/2014 22:37:02,,1323879510,7/15/2014 22:36:39,instagc,0.6089,13763729,USA,,,75.182.89.225,no_relation,0,36,,16,48,causes,0.35921060405355,901662-FS1-4,DEDIFFERENTIATION of astrocytoma to GLIOBLASTOMA and the role of radiation therapy are discussed.,DEDIFFERENTIATION,GLIOBLASTOMA,RO-disease_has_finding
503335488,7/16/2014 02:47:25,,1324007006,7/16/2014 02:46:59,rewardsspot,0.7526,24482174,GBR,H9,London,46.23.68.180,DEDIFFERENTIATION causes GLIOBLASTOMA,0,36,,16,48,causes,0.35921060405355,901662-FS1-4,DEDIFFERENTIATION of astrocytoma to GLIOBLASTOMA and the role of radiation therapy are discussed.,DEDIFFERENTIATION,GLIOBLASTOMA,RO-disease_has_finding
503335488,7/16/2014 06:22:53,,1324083803,7/16/2014 06:22:39,clixsense,0.4766,17722340,CAN,BC,Mission,50.98.185.25,GLIOBLASTOMA causes DEDIFFERENTIATION,0,36,,16,48,causes,0.35921060405355,901662-FS1-4,DEDIFFERENTIATION of astrocytoma to GLIOBLASTOMA and the role of radiation therapy are discussed.,DEDIFFERENTIATION,GLIOBLASTOMA,RO-disease_has_finding
503335492,7/15/2014 21:01:40,,1323839265,7/15/2014 21:01:35,neodev,0.875,25224036,CAN,ON,Sudbury,67.204.218.187,PHLEBITIS is location of VARICES,150,64,,156,73,is location of,0.462910049886276,901829-FS1-9,The author begins with a brief discussion of the terminology of PHLEBITIS and then elucidated the significance of the deep veins and of the secondary VARICES in connection with the post thrombotic syndroms.,VARICES,PHLEBITIS,RO-disease_has_finding
503335492,7/15/2014 21:31:11,,1323851837,7/15/2014 21:30:48,instagc,0.6917,28301350,GBR,O4,Torquay,89.241.101.166,VARICES is location of PHLEBITIS,150,64,,156,73,is location of,0.462910049886276,901829-FS1-9,The author begins with a brief discussion of the terminology of PHLEBITIS and then elucidated the significance of the deep veins and of the secondary VARICES in connection with the post thrombotic syndroms.,VARICES,PHLEBITIS,RO-disease_has_finding
503335492,7/15/2014 22:38:57,,1323880525,7/15/2014 22:38:35,instagc,0.6089,13763729,USA,,,75.182.89.225,VARICES is location of PHLEBITIS,150,64,,156,73,is location of,0.462910049886276,901829-FS1-9,The author begins with a brief discussion of the terminology of PHLEBITIS and then elucidated the significance of the deep veins and of the secondary VARICES in connection with the post thrombotic syndroms.,VARICES,PHLEBITIS,RO-disease_has_finding
503335492,7/15/2014 22:42:41,,1323882237,7/15/2014 22:42:27,instagc,0.6708,15445601,USA,FL,Jacksonville,24.129.68.254,no_relation,150,64,,156,73,is location of,0.462910049886276,901829-FS1-9,The author begins with a brief discussion of the terminology of PHLEBITIS and then elucidated the significance of the deep veins and of the secondary VARICES in connection with the post thrombotic syndroms.,VARICES,PHLEBITIS,RO-disease_has_finding
503335492,7/16/2014 01:32:32,,1323975558,7/16/2014 01:32:02,rewardsspot,0.5907,17763704,USA,VA,Manassas,198.7.62.204,VARICES is location of PHLEBITIS,150,64,,156,73,is location of,0.462910049886276,901829-FS1-9,The author begins with a brief discussion of the terminology of PHLEBITIS and then elucidated the significance of the deep veins and of the secondary VARICES in connection with the post thrombotic syndroms.,VARICES,PHLEBITIS,RO-disease_has_finding
503335492,7/16/2014 08:33:26,,1324125284,7/16/2014 08:32:54,eup_slw,0.6377,20818028,GBR,A7,Birmingham,92.232.139.254,no_relation,150,64,,156,73,is location of,0.462910049886276,901829-FS1-9,The author begins with a brief discussion of the terminology of PHLEBITIS and then elucidated the significance of the deep veins and of the secondary VARICES in connection with the post thrombotic syndroms.,VARICES,PHLEBITIS,RO-disease_has_finding
503335492,7/16/2014 09:04:08,,1324133689,7/16/2014 09:04:02,clixsense,0.4962,19162475,GBR,M3,Frome,82.33.126.30,PHLEBITIS is location of VARICES,150,64,,156,73,is location of,0.462910049886276,901829-FS1-9,The author begins with a brief discussion of the terminology of PHLEBITIS and then elucidated the significance of the deep veins and of the secondary VARICES in connection with the post thrombotic syndroms.,VARICES,PHLEBITIS,RO-disease_has_finding
503335493,7/15/2014 20:54:40,,1323836168,7/15/2014 20:54:09,clixsense,0.9583,15189335,GBR,H9,London,188.29.165.120,BORRELIA BURGDORFERI causes LYME DISEASE,65,145,,84,157,causes,0.371390676354104,903632-FS1-4,The results of the study of the prevalence of antibodies against BORRELIA BURGDORFERI in three categories of subjects from the endemic region of LYME DISEASE in the northeast Croatia are reported.,BORRELIA BURGDORFERI,LYME DISEASE,RO-has_causative_agent
503335493,7/15/2014 20:55:03,,1323836302,7/15/2014 20:54:32,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,BORRELIA BURGDORFERI causes LYME DISEASE,65,145,,84,157,causes,0.371390676354104,903632-FS1-4,The results of the study of the prevalence of antibodies against BORRELIA BURGDORFERI in three categories of subjects from the endemic region of LYME DISEASE in the northeast Croatia are reported.,BORRELIA BURGDORFERI,LYME DISEASE,RO-has_causative_agent
503335493,7/15/2014 21:05:39,,1323841143,7/15/2014 21:04:47,clixsense,0.7153,6564572,USA,MI,Kalamazoo,173.46.248.170,LYME DISEASE causes BORRELIA BURGDORFERI,65,145,,84,157,causes,0.371390676354104,903632-FS1-4,The results of the study of the prevalence of antibodies against BORRELIA BURGDORFERI in three categories of subjects from the endemic region of LYME DISEASE in the northeast Croatia are reported.,BORRELIA BURGDORFERI,LYME DISEASE,RO-has_causative_agent
503335493,7/15/2014 21:34:53,,1323853042,7/15/2014 21:34:00,clixsense,0.8861,25595227,CAN,SK,North Battleford,24.72.96.119,LYME DISEASE causes BORRELIA BURGDORFERI,65,145,,84,157,causes,0.371390676354104,903632-FS1-4,The results of the study of the prevalence of antibodies against BORRELIA BURGDORFERI in three categories of subjects from the endemic region of LYME DISEASE in the northeast Croatia are reported.,BORRELIA BURGDORFERI,LYME DISEASE,RO-has_causative_agent
503335493,7/15/2014 22:37:30,,1323879725,7/15/2014 22:37:02,instagc,0.6089,13763729,USA,,,75.182.89.225,BORRELIA BURGDORFERI causes LYME DISEASE,65,145,,84,157,causes,0.371390676354104,903632-FS1-4,The results of the study of the prevalence of antibodies against BORRELIA BURGDORFERI in three categories of subjects from the endemic region of LYME DISEASE in the northeast Croatia are reported.,BORRELIA BURGDORFERI,LYME DISEASE,RO-has_causative_agent
503335493,7/15/2014 23:46:58,,1323916293,7/15/2014 23:45:58,elite,0.6665,28397222,GBR,Y4,Usk,31.50.223.75,BORRELIA BURGDORFERI causes LYME DISEASE,65,145,,84,157,causes,0.371390676354104,903632-FS1-4,The results of the study of the prevalence of antibodies against BORRELIA BURGDORFERI in three categories of subjects from the endemic region of LYME DISEASE in the northeast Croatia are reported.,BORRELIA BURGDORFERI,LYME DISEASE,RO-has_causative_agent
503335493,7/16/2014 00:09:51,,1323929623,7/16/2014 00:09:23,clixsense,0.4942,20614047,USA,MO,Maryville,174.32.162.147,BORRELIA BURGDORFERI causes LYME DISEASE,65,145,,84,157,causes,0.371390676354104,903632-FS1-4,The results of the study of the prevalence of antibodies against BORRELIA BURGDORFERI in three categories of subjects from the endemic region of LYME DISEASE in the northeast Croatia are reported.,BORRELIA BURGDORFERI,LYME DISEASE,RO-has_causative_agent
503335497,7/15/2014 21:04:09,,1323840487,7/15/2014 21:03:07,clixsense,0.7153,6564572,USA,MI,Kalamazoo,173.46.248.170,ALLERGIC REACTIONS causes ALLERGIC ASTHMA,149,79,,163,97,causes,0.583459965991578,900154-FS1-4,These results showed that STA 1 could effectively suppress the Der p 5 induced ALLERGIC REACTIONS and the availability of STA 1 for the treatment of ALLERGIC ASTHMA was demonstrated in this study.,ALLERGIC ASTHMA,ALLERGIC REACTIONS,RO-cause_of
503335497,7/15/2014 21:06:57,,1323841772,7/15/2014 21:06:46,prodege,0.9167,2143114,CAN,BC,Vancouver,24.84.160.12,ALLERGIC ASTHMA causes ALLERGIC REACTIONS,149,79,,163,97,causes,0.583459965991578,900154-FS1-4,These results showed that STA 1 could effectively suppress the Der p 5 induced ALLERGIC REACTIONS and the availability of STA 1 for the treatment of ALLERGIC ASTHMA was demonstrated in this study.,ALLERGIC ASTHMA,ALLERGIC REACTIONS,RO-cause_of
503335497,7/15/2014 21:21:34,,1323847770,7/15/2014 21:21:06,neodev,0.6597,21515166,NLD,11,Nootdorp,83.86.58.179,ALLERGIC REACTIONS causes ALLERGIC ASTHMA,149,79,,163,97,causes,0.583459965991578,900154-FS1-4,These results showed that STA 1 could effectively suppress the Der p 5 induced ALLERGIC REACTIONS and the availability of STA 1 for the treatment of ALLERGIC ASTHMA was demonstrated in this study.,ALLERGIC ASTHMA,ALLERGIC REACTIONS,RO-cause_of
503335497,7/15/2014 21:56:20,,1323860347,7/15/2014 21:55:41,prodege,0.7389,28255346,GBR,L9,Sheffield,2.125.183.137,no_relation,149,79,,163,97,causes,0.583459965991578,900154-FS1-4,These results showed that STA 1 could effectively suppress the Der p 5 induced ALLERGIC REACTIONS and the availability of STA 1 for the treatment of ALLERGIC ASTHMA was demonstrated in this study.,ALLERGIC ASTHMA,ALLERGIC REACTIONS,RO-cause_of
503335497,7/15/2014 22:00:33,,1323862333,7/15/2014 21:59:34,elite,0.5972,28465503,CAN,QC,Boucherville,24.201.21.27,ALLERGIC ASTHMA causes ALLERGIC REACTIONS,149,79,,163,97,causes,0.583459965991578,900154-FS1-4,These results showed that STA 1 could effectively suppress the Der p 5 induced ALLERGIC REACTIONS and the availability of STA 1 for the treatment of ALLERGIC ASTHMA was demonstrated in this study.,ALLERGIC ASTHMA,ALLERGIC REACTIONS,RO-cause_of
503335497,7/15/2014 22:27:49,,1323874663,7/15/2014 22:27:35,clixsense,0.7236,7265596,USA,IA,Neola,199.120.116.136,ALLERGIC REACTIONS causes ALLERGIC ASTHMA,149,79,,163,97,causes,0.583459965991578,900154-FS1-4,These results showed that STA 1 could effectively suppress the Der p 5 induced ALLERGIC REACTIONS and the availability of STA 1 for the treatment of ALLERGIC ASTHMA was demonstrated in this study.,ALLERGIC ASTHMA,ALLERGIC REACTIONS,RO-cause_of
503335497,7/16/2014 01:32:57,,1323975743,7/16/2014 01:32:34,rewardsspot,0.5907,17763704,USA,VA,Manassas,198.7.62.204,ALLERGIC REACTIONS causes ALLERGIC ASTHMA,149,79,,163,97,causes,0.583459965991578,900154-FS1-4,These results showed that STA 1 could effectively suppress the Der p 5 induced ALLERGIC REACTIONS and the availability of STA 1 for the treatment of ALLERGIC ASTHMA was demonstrated in this study.,ALLERGIC ASTHMA,ALLERGIC REACTIONS,RO-cause_of
503335502,7/16/2014 02:28:36,,1324000761,7/16/2014 02:28:08,instagc,0.7429,28519532,USA,IA,Honey Creek,12.73.110.156,no_relation,126,211,,152,251,causes,0.45749571099781394,906758-FS1-4,The response of urethral pressure to administration of an alpha stimulant was compared between a group of eight patients with CHRONIC NEUROGENIC BLADDERS as evidenced by positive denervation supersensitivity to PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE and a group of ten control patients.,CHRONIC NEUROGENIC BLADDERS,PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE,RO-may_diagnose
503335502,7/16/2014 02:53:36,,1324008901,7/16/2014 02:52:48,clixsense,0.5768,23398628,USA,WA,Spanaway,50.149.99.43,CHRONIC NEUROGENIC BLADDERS causes PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE,126,211,,152,251,causes,0.45749571099781394,906758-FS1-4,The response of urethral pressure to administration of an alpha stimulant was compared between a group of eight patients with CHRONIC NEUROGENIC BLADDERS as evidenced by positive denervation supersensitivity to PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE and a group of ten control patients.,CHRONIC NEUROGENIC BLADDERS,PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE,RO-may_diagnose
503335502,7/16/2014 07:28:05,,1324106375,7/16/2014 07:27:30,vivatic,0.6569,25451531,GBR,,,83.67.28.193,no_relation,126,211,,152,251,causes,0.45749571099781394,906758-FS1-4,The response of urethral pressure to administration of an alpha stimulant was compared between a group of eight patients with CHRONIC NEUROGENIC BLADDERS as evidenced by positive denervation supersensitivity to PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE and a group of ten control patients.,CHRONIC NEUROGENIC BLADDERS,PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE,RO-may_diagnose
503335502,7/16/2014 09:04:01,,1324133654,7/16/2014 09:03:56,clixsense,0.4962,19162475,GBR,M3,Frome,82.33.126.30,PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE causes CHRONIC NEUROGENIC BLADDERS,126,211,,152,251,causes,0.45749571099781394,906758-FS1-4,The response of urethral pressure to administration of an alpha stimulant was compared between a group of eight patients with CHRONIC NEUROGENIC BLADDERS as evidenced by positive denervation supersensitivity to PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE and a group of ten control patients.,CHRONIC NEUROGENIC BLADDERS,PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE,RO-may_diagnose
503335502,7/16/2014 10:33:17,,1324185685,7/16/2014 10:32:33,prodege,0.6647,23999031,AUS,08,Perth,203.59.238.194,no_relation,126,211,,152,251,causes,0.45749571099781394,906758-FS1-4,The response of urethral pressure to administration of an alpha stimulant was compared between a group of eight patients with CHRONIC NEUROGENIC BLADDERS as evidenced by positive denervation supersensitivity to PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE and a group of ten control patients.,CHRONIC NEUROGENIC BLADDERS,PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE,RO-may_diagnose
503335502,7/16/2014 10:56:45,,1324196268,7/16/2014 10:55:51,clixsense,0.6653,24896327,GBR,V2,Glasgow,94.2.231.4,PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE causes CHRONIC NEUROGENIC BLADDERS,126,211,,152,251,causes,0.45749571099781394,906758-FS1-4,The response of urethral pressure to administration of an alpha stimulant was compared between a group of eight patients with CHRONIC NEUROGENIC BLADDERS as evidenced by positive denervation supersensitivity to PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE and a group of ten control patients.,CHRONIC NEUROGENIC BLADDERS,PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE,RO-may_diagnose
503335502,7/16/2014 11:29:10,,1324207285,7/16/2014 11:28:41,vivatic,0.4931,24842942,GBR,H9,London,149.254.51.63,no_relation,126,211,,152,251,causes,0.45749571099781394,906758-FS1-4,The response of urethral pressure to administration of an alpha stimulant was compared between a group of eight patients with CHRONIC NEUROGENIC BLADDERS as evidenced by positive denervation supersensitivity to PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE and a group of ten control patients.,CHRONIC NEUROGENIC BLADDERS,PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE,RO-may_diagnose
503335508,7/15/2014 21:45:52,,1323856671,7/15/2014 21:45:22,clixsense,0.6875,19638651,USA,,,173.23.121.63,no_relation,121,85,,161,120,causes,0.6859943405700349,902448-FS1-4,"Because of the extreme sensitivity of the thyroid gland in children, there is a risk OF RADIATION INDUCED THYROID CANCER EVEN WHEN THE THYROID GLAND IS OUTSIDE OF the irradiated field.",EVEN WHEN THE THYROID GLAND IS OUTSIDE OF,OF RADIATION INDUCED THYROID CANCER,RO-disease_has_primary_anatomic_site
503335508,7/15/2014 21:57:35,,1323860854,7/15/2014 21:57:03,prodege,0.7389,28255346,GBR,L9,Sheffield,2.125.183.137,no_relation,121,85,,161,120,causes,0.6859943405700349,902448-FS1-4,"Because of the extreme sensitivity of the thyroid gland in children, there is a risk OF RADIATION INDUCED THYROID CANCER EVEN WHEN THE THYROID GLAND IS OUTSIDE OF the irradiated field.",EVEN WHEN THE THYROID GLAND IS OUTSIDE OF,OF RADIATION INDUCED THYROID CANCER,RO-disease_has_primary_anatomic_site
503335508,7/16/2014 00:33:32,,1323942789,7/16/2014 00:33:19,prodege,0.6712,15439740,AUS,02,Jannali,27.96.208.89,no_relation,121,85,,161,120,causes,0.6859943405700349,902448-FS1-4,"Because of the extreme sensitivity of the thyroid gland in children, there is a risk OF RADIATION INDUCED THYROID CANCER EVEN WHEN THE THYROID GLAND IS OUTSIDE OF the irradiated field.",EVEN WHEN THE THYROID GLAND IS OUTSIDE OF,OF RADIATION INDUCED THYROID CANCER,RO-disease_has_primary_anatomic_site
503335508,7/16/2014 06:16:27,,1324081581,7/16/2014 06:16:01,clixsense,0.6893,15117831,GBR,H9,London,90.194.156.173,no_relation,121,85,,161,120,causes,0.6859943405700349,902448-FS1-4,"Because of the extreme sensitivity of the thyroid gland in children, there is a risk OF RADIATION INDUCED THYROID CANCER EVEN WHEN THE THYROID GLAND IS OUTSIDE OF the irradiated field.",EVEN WHEN THE THYROID GLAND IS OUTSIDE OF,OF RADIATION INDUCED THYROID CANCER,RO-disease_has_primary_anatomic_site
503335508,7/16/2014 07:52:59,,1324113024,7/16/2014 07:52:34,prodege,0.5324,9559045,USA,TX,Katy,107.204.186.172,OF RADIATION INDUCED THYROID CANCER causes EVEN WHEN THE THYROID GLAND IS OUTSIDE OF,121,85,,161,120,causes,0.6859943405700349,902448-FS1-4,"Because of the extreme sensitivity of the thyroid gland in children, there is a risk OF RADIATION INDUCED THYROID CANCER EVEN WHEN THE THYROID GLAND IS OUTSIDE OF the irradiated field.",EVEN WHEN THE THYROID GLAND IS OUTSIDE OF,OF RADIATION INDUCED THYROID CANCER,RO-disease_has_primary_anatomic_site
503335508,7/16/2014 09:32:05,,1324150102,7/16/2014 09:31:39,prodege,0.7222,27934334,GBR,Q2,Wokingham,86.166.73.7,no_relation,121,85,,161,120,causes,0.6859943405700349,902448-FS1-4,"Because of the extreme sensitivity of the thyroid gland in children, there is a risk OF RADIATION INDUCED THYROID CANCER EVEN WHEN THE THYROID GLAND IS OUTSIDE OF the irradiated field.",EVEN WHEN THE THYROID GLAND IS OUTSIDE OF,OF RADIATION INDUCED THYROID CANCER,RO-disease_has_primary_anatomic_site
503335508,7/16/2014 10:34:37,,1324186106,7/16/2014 10:34:09,prodege,0.6647,23999031,AUS,08,Perth,203.59.238.194,EVEN WHEN THE THYROID GLAND IS OUTSIDE OF causes OF RADIATION INDUCED THYROID CANCER,121,85,,161,120,causes,0.6859943405700349,902448-FS1-4,"Because of the extreme sensitivity of the thyroid gland in children, there is a risk OF RADIATION INDUCED THYROID CANCER EVEN WHEN THE THYROID GLAND IS OUTSIDE OF the irradiated field.",EVEN WHEN THE THYROID GLAND IS OUTSIDE OF,OF RADIATION INDUCED THYROID CANCER,RO-disease_has_primary_anatomic_site
503335511,7/15/2014 20:54:39,,1323836169,7/15/2014 20:53:59,instagc,0.9583,24252915,GBR,B7,Bristol,77.98.139.82,OSTEOID OSTEOMA causes PAIN,59,20,,62,35,causes,0.830747160735697,901848-FS1-4,In the diagnosis of OSTEOID OSTEOMA a history of relief of PAIN with aspirin is important.,PAIN,OSTEOID OSTEOMA,RO-disease_has_finding
503335511,7/15/2014 21:01:27,,1323839142,7/15/2014 21:01:19,neodev,0.875,25224036,CAN,ON,Sudbury,67.204.218.187,PAIN causes OSTEOID OSTEOMA,59,20,,62,35,causes,0.830747160735697,901848-FS1-4,In the diagnosis of OSTEOID OSTEOMA a history of relief of PAIN with aspirin is important.,PAIN,OSTEOID OSTEOMA,RO-disease_has_finding
503335511,7/15/2014 21:24:58,,1323849341,7/15/2014 21:24:31,clixsense,0.7986,19803139,NLD,06,Veldhoven,212.61.84.196,OSTEOID OSTEOMA causes PAIN,59,20,,62,35,causes,0.830747160735697,901848-FS1-4,In the diagnosis of OSTEOID OSTEOMA a history of relief of PAIN with aspirin is important.,PAIN,OSTEOID OSTEOMA,RO-disease_has_finding
503335511,7/16/2014 00:33:17,,1323942668,7/16/2014 00:32:53,prodege,0.6712,15439740,AUS,02,Jannali,27.96.208.89,OSTEOID OSTEOMA causes PAIN,59,20,,62,35,causes,0.830747160735697,901848-FS1-4,In the diagnosis of OSTEOID OSTEOMA a history of relief of PAIN with aspirin is important.,PAIN,OSTEOID OSTEOMA,RO-disease_has_finding
503335511,7/16/2014 06:15:25,,1324081207,7/16/2014 06:15:02,clixsense,0.6893,15117831,GBR,H9,London,90.194.156.173,no_relation,59,20,,62,35,causes,0.830747160735697,901848-FS1-4,In the diagnosis of OSTEOID OSTEOMA a history of relief of PAIN with aspirin is important.,PAIN,OSTEOID OSTEOMA,RO-disease_has_finding
503335511,7/16/2014 08:07:33,,1324117662,7/16/2014 08:07:01,instagc,0.6736,20183814,USA,,,166.182.83.84,OSTEOID OSTEOMA causes PAIN,59,20,,62,35,causes,0.830747160735697,901848-FS1-4,In the diagnosis of OSTEOID OSTEOMA a history of relief of PAIN with aspirin is important.,PAIN,OSTEOID OSTEOMA,RO-disease_has_finding
503335511,7/16/2014 08:33:53,,1324125399,7/16/2014 08:33:27,eup_slw,0.6377,20818028,GBR,A7,Birmingham,92.232.139.254,OSTEOID OSTEOMA causes PAIN,59,20,,62,35,causes,0.830747160735697,901848-FS1-4,In the diagnosis of OSTEOID OSTEOMA a history of relief of PAIN with aspirin is important.,PAIN,OSTEOID OSTEOMA,RO-disease_has_finding
503460422,7/16/2014 13:07:34,,1324244333,7/16/2014 13:07:18,clixsense,1.0,19803139,NLD,06,Veldhoven,212.61.84.196,ACTIVE FORM OF VITAMIN D treats OSTEOPOROSIS,117,71,,128,95,treats,1.0,907445-FS1-2,Some misunderstandings exist internationally about the efficacy of the ACTIVE FORM OF VITAMIN D for the treatment of OSTEOPOROSIS,OSTEOPOROSIS,ACTIVE FORM OF VITAMIN D,RO-may_prevent
503460422,7/16/2014 13:26:30,,1324252000,7/16/2014 13:26:04,neodev,0.8806,21515166,NLD,11,Nootdorp,83.86.58.179,ACTIVE FORM OF VITAMIN D treats OSTEOPOROSIS,117,71,,128,95,treats,1.0,907445-FS1-2,Some misunderstandings exist internationally about the efficacy of the ACTIVE FORM OF VITAMIN D for the treatment of OSTEOPOROSIS,OSTEOPOROSIS,ACTIVE FORM OF VITAMIN D,RO-may_prevent
503460422,7/16/2014 15:00:43,,1324288251,7/16/2014 15:00:11,prodege,0.6956,17780691,CAN,ON,Toronto,24.114.226.82,ACTIVE FORM OF VITAMIN D treats OSTEOPOROSIS,117,71,,128,95,treats,1.0,907445-FS1-2,Some misunderstandings exist internationally about the efficacy of the ACTIVE FORM OF VITAMIN D for the treatment of OSTEOPOROSIS,OSTEOPOROSIS,ACTIVE FORM OF VITAMIN D,RO-may_prevent
503460422,7/16/2014 15:41:25,,1324302587,7/16/2014 15:40:41,prodege,0.5256,15220325,USA,PA,Troy,24.229.175.37,ACTIVE FORM OF VITAMIN D treats OSTEOPOROSIS,117,71,,128,95,treats,1.0,907445-FS1-2,Some misunderstandings exist internationally about the efficacy of the ACTIVE FORM OF VITAMIN D for the treatment of OSTEOPOROSIS,OSTEOPOROSIS,ACTIVE FORM OF VITAMIN D,RO-may_prevent
503460422,7/16/2014 17:21:08,,1324344691,7/16/2014 17:20:30,prodege,0.521,19026375,GBR,Z1,Swansea,92.26.69.100,ACTIVE FORM OF VITAMIN D treats OSTEOPOROSIS,117,71,,128,95,treats,1.0,907445-FS1-2,Some misunderstandings exist internationally about the efficacy of the ACTIVE FORM OF VITAMIN D for the treatment of OSTEOPOROSIS,OSTEOPOROSIS,ACTIVE FORM OF VITAMIN D,RO-may_prevent
503460422,7/16/2014 18:23:00,,1324399223,7/16/2014 18:22:47,gifthulk,0.6992,21916793,GBR,,,87.113.87.199,ACTIVE FORM OF VITAMIN D treats OSTEOPOROSIS,117,71,,128,95,treats,1.0,907445-FS1-2,Some misunderstandings exist internationally about the efficacy of the ACTIVE FORM OF VITAMIN D for the treatment of OSTEOPOROSIS,OSTEOPOROSIS,ACTIVE FORM OF VITAMIN D,RO-may_prevent
503460422,7/16/2014 18:34:40,,1324404351,7/16/2014 18:34:31,instagc,0.4563,15445601,USA,FL,Jacksonville,24.129.68.254,no_relation,117,71,,128,95,treats,1.0,907445-FS1-2,Some misunderstandings exist internationally about the efficacy of the ACTIVE FORM OF VITAMIN D for the treatment of OSTEOPOROSIS,OSTEOPOROSIS,ACTIVE FORM OF VITAMIN D,RO-may_prevent
503460423,7/16/2014 13:11:49,,1324246021,7/16/2014 13:11:38,clixsense,0.9167,20614047,USA,MO,Maryville,174.32.162.147,PEMPHIGUS VULGARIS is location of DISEASE OF THE SKIN AND MUCOUS MEMBRANES,47,0,,86,18,is location of,0.8006407690254359,902397-FS1-9,PEMPHIGUS VULGARIS is an autoimmune blistering DISEASE OF THE SKIN AND MUCOUS MEMBRANES that is caused by anti desmoglein 3 IgG autoantibodies.,DISEASE OF THE SKIN AND MUCOUS MEMBRANES,PEMPHIGUS VULGARIS,RO-disease_has_primary_anatomic_site
503460423,7/16/2014 13:33:20,,1324255058,7/16/2014 13:32:41,clixsense,0.7278,24896327,GBR,V2,Glasgow,94.2.231.4,no_relation,47,0,,86,18,is location of,0.8006407690254359,902397-FS1-9,PEMPHIGUS VULGARIS is an autoimmune blistering DISEASE OF THE SKIN AND MUCOUS MEMBRANES that is caused by anti desmoglein 3 IgG autoantibodies.,DISEASE OF THE SKIN AND MUCOUS MEMBRANES,PEMPHIGUS VULGARIS,RO-disease_has_primary_anatomic_site
503460423,7/16/2014 14:42:53,,1324282454,7/16/2014 14:42:18,fusioncash,0.6587,7012325,USA,CT,Stamford,24.185.182.15,no_relation,47,0,,86,18,is location of,0.8006407690254359,902397-FS1-9,PEMPHIGUS VULGARIS is an autoimmune blistering DISEASE OF THE SKIN AND MUCOUS MEMBRANES that is caused by anti desmoglein 3 IgG autoantibodies.,DISEASE OF THE SKIN AND MUCOUS MEMBRANES,PEMPHIGUS VULGARIS,RO-disease_has_primary_anatomic_site
503460423,7/16/2014 15:01:18,,1324288448,7/16/2014 15:00:44,prodege,0.6956,17780691,CAN,ON,Toronto,24.114.226.82,PEMPHIGUS VULGARIS is location of DISEASE OF THE SKIN AND MUCOUS MEMBRANES,47,0,,86,18,is location of,0.8006407690254359,902397-FS1-9,PEMPHIGUS VULGARIS is an autoimmune blistering DISEASE OF THE SKIN AND MUCOUS MEMBRANES that is caused by anti desmoglein 3 IgG autoantibodies.,DISEASE OF THE SKIN AND MUCOUS MEMBRANES,PEMPHIGUS VULGARIS,RO-disease_has_primary_anatomic_site
503460423,7/16/2014 15:48:34,,1324305626,7/16/2014 15:48:22,clixsense,0.58,16827630,GBR,A7,Birmingham,86.146.169.103,no_relation,47,0,,86,18,is location of,0.8006407690254359,902397-FS1-9,PEMPHIGUS VULGARIS is an autoimmune blistering DISEASE OF THE SKIN AND MUCOUS MEMBRANES that is caused by anti desmoglein 3 IgG autoantibodies.,DISEASE OF THE SKIN AND MUCOUS MEMBRANES,PEMPHIGUS VULGARIS,RO-disease_has_primary_anatomic_site
503460423,7/16/2014 16:56:11,,1324336776,7/16/2014 16:55:13,instagc,0.6306,14941596,USA,KY,Erlanger,74.140.124.145,no_relation,47,0,,86,18,is location of,0.8006407690254359,902397-FS1-9,PEMPHIGUS VULGARIS is an autoimmune blistering DISEASE OF THE SKIN AND MUCOUS MEMBRANES that is caused by anti desmoglein 3 IgG autoantibodies.,DISEASE OF THE SKIN AND MUCOUS MEMBRANES,PEMPHIGUS VULGARIS,RO-disease_has_primary_anatomic_site
503460423,7/16/2014 17:28:40,,1324348328,7/16/2014 17:28:14,clixsense,0.6583,25595227,CAN,SK,North Battleford,24.72.96.119,DISEASE OF THE SKIN AND MUCOUS MEMBRANES is location of PEMPHIGUS VULGARIS,47,0,,86,18,is location of,0.8006407690254359,902397-FS1-9,PEMPHIGUS VULGARIS is an autoimmune blistering DISEASE OF THE SKIN AND MUCOUS MEMBRANES that is caused by anti desmoglein 3 IgG autoantibodies.,DISEASE OF THE SKIN AND MUCOUS MEMBRANES,PEMPHIGUS VULGARIS,RO-disease_has_primary_anatomic_site
503460429,7/16/2014 13:20:13,,1324249412,7/16/2014 13:20:05,neodev,0.7306,25224036,CAN,ON,Sudbury,67.204.218.187,SCHIZOPHRENIA treats RISPERIDONE,104,0,,116,11,treats,0.911684611677103,907998-FS1-2,RISPERIDONE is an atypical antipsychotic agent with efficacy for both positive and negative symptoms of SCHIZOPHRENIA,SCHIZOPHRENIA,RISPERIDONE,RO-may_treat
503460429,7/16/2014 13:22:21,,1324250287,7/16/2014 13:22:00,prodege,0.6875,22031444,GBR,B7,Bristol,77.98.139.82,RISPERIDONE treats SCHIZOPHRENIA,104,0,,116,11,treats,0.911684611677103,907998-FS1-2,RISPERIDONE is an atypical antipsychotic agent with efficacy for both positive and negative symptoms of SCHIZOPHRENIA,SCHIZOPHRENIA,RISPERIDONE,RO-may_treat
503460429,7/16/2014 13:38:24,,1324257028,7/16/2014 13:38:01,prodege,0.5958,1852770,USA,TX,Abilene,76.198.102.54,RISPERIDONE treats SCHIZOPHRENIA,104,0,,116,11,treats,0.911684611677103,907998-FS1-2,RISPERIDONE is an atypical antipsychotic agent with efficacy for both positive and negative symptoms of SCHIZOPHRENIA,SCHIZOPHRENIA,RISPERIDONE,RO-may_treat
503460429,7/16/2014 15:10:01,,1324291969,7/16/2014 15:09:55,clixsense,0.6313,19162475,GBR,M3,Frome,82.33.126.30,RISPERIDONE treats SCHIZOPHRENIA,104,0,,116,11,treats,0.911684611677103,907998-FS1-2,RISPERIDONE is an atypical antipsychotic agent with efficacy for both positive and negative symptoms of SCHIZOPHRENIA,SCHIZOPHRENIA,RISPERIDONE,RO-may_treat
503460429,7/16/2014 15:13:27,,1324293086,7/16/2014 15:12:46,elite,0.5194,28276268,USA,MI,Fenton,68.188.185.225,RISPERIDONE treats SCHIZOPHRENIA,104,0,,116,11,treats,0.911684611677103,907998-FS1-2,RISPERIDONE is an atypical antipsychotic agent with efficacy for both positive and negative symptoms of SCHIZOPHRENIA,SCHIZOPHRENIA,RISPERIDONE,RO-may_treat
503460429,7/16/2014 17:06:15,,1324339980,7/16/2014 17:05:50,instagc,0.5901,23149109,USA,NC,Cary,24.206.38.18,RISPERIDONE treats SCHIZOPHRENIA,104,0,,116,11,treats,0.911684611677103,907998-FS1-2,RISPERIDONE is an atypical antipsychotic agent with efficacy for both positive and negative symptoms of SCHIZOPHRENIA,SCHIZOPHRENIA,RISPERIDONE,RO-may_treat
503460429,7/16/2014 17:17:09,,1324343588,7/16/2014 17:16:52,clixsense,0.6583,25595227,CAN,SK,North Battleford,24.72.96.119,RISPERIDONE treats SCHIZOPHRENIA,104,0,,116,11,treats,0.911684611677103,907998-FS1-2,RISPERIDONE is an atypical antipsychotic agent with efficacy for both positive and negative symptoms of SCHIZOPHRENIA,SCHIZOPHRENIA,RISPERIDONE,RO-may_treat
503460435,7/16/2014 13:07:33,,1324244320,7/16/2014 13:07:15,tremorgames,0.8889,24449707,CAN,QC,Laval,96.21.249.72,HAEMOPHILIA A treats HUMAN FACTOR VIII (FVIII),0,36,,12,61,treats,0.98058067569092,908174-FS1-2,HAEMOPHILIA A patients treated with HUMAN FACTOR VIII (FVIII) may develop antibody (Ab) inhibitors to fVIII.,HAEMOPHILIA A,HUMAN FACTOR VIII (FVIII),RO-may_treat
503460435,7/16/2014 13:08:38,,1324244824,7/16/2014 13:08:10,neodev,0.8194,18339121,USA,SC,Sumter,173.93.188.194,HAEMOPHILIA A treats HUMAN FACTOR VIII (FVIII),0,36,,12,61,treats,0.98058067569092,908174-FS1-2,HAEMOPHILIA A patients treated with HUMAN FACTOR VIII (FVIII) may develop antibody (Ab) inhibitors to fVIII.,HAEMOPHILIA A,HUMAN FACTOR VIII (FVIII),RO-may_treat
503460435,7/16/2014 14:26:55,,1324276223,7/16/2014 14:26:29,rewardsspot,0.6855,17763704,USA,VA,Manassas,198.7.62.204,HAEMOPHILIA A treats HUMAN FACTOR VIII (FVIII),0,36,,12,61,treats,0.98058067569092,908174-FS1-2,HAEMOPHILIA A patients treated with HUMAN FACTOR VIII (FVIII) may develop antibody (Ab) inhibitors to fVIII.,HAEMOPHILIA A,HUMAN FACTOR VIII (FVIII),RO-may_treat
503460435,7/16/2014 16:40:10,,1324330758,7/16/2014 16:39:49,neodev,0.5359,14861092,GBR,H9,London,90.194.156.173,HUMAN FACTOR VIII (FVIII) treats HAEMOPHILIA A,0,36,,12,61,treats,0.98058067569092,908174-FS1-2,HAEMOPHILIA A patients treated with HUMAN FACTOR VIII (FVIII) may develop antibody (Ab) inhibitors to fVIII.,HAEMOPHILIA A,HUMAN FACTOR VIII (FVIII),RO-may_treat
503460435,7/16/2014 18:02:11,,1324380033,7/16/2014 18:01:51,instagc,0.5512,28157545,USA,OR,Mcminnville,76.115.153.186,HUMAN FACTOR VIII (FVIII) treats HAEMOPHILIA A,0,36,,12,61,treats,0.98058067569092,908174-FS1-2,HAEMOPHILIA A patients treated with HUMAN FACTOR VIII (FVIII) may develop antibody (Ab) inhibitors to fVIII.,HAEMOPHILIA A,HUMAN FACTOR VIII (FVIII),RO-may_treat
503460435,7/16/2014 18:07:27,,1324385391,7/16/2014 18:07:05,clixsense,0.4083,6451515,USA,MN,Minneapolis,75.144.36.177,HUMAN FACTOR VIII (FVIII) treats HAEMOPHILIA A,0,36,,12,61,treats,0.98058067569092,908174-FS1-2,HAEMOPHILIA A patients treated with HUMAN FACTOR VIII (FVIII) may develop antibody (Ab) inhibitors to fVIII.,HAEMOPHILIA A,HUMAN FACTOR VIII (FVIII),RO-may_treat
503460435,7/16/2014 18:22:46,,1324399110,7/16/2014 18:22:37,gifthulk,0.6992,21916793,GBR,,,87.113.87.199,HUMAN FACTOR VIII (FVIII) treats HAEMOPHILIA A,0,36,,12,61,treats,0.98058067569092,908174-FS1-2,HAEMOPHILIA A patients treated with HUMAN FACTOR VIII (FVIII) may develop antibody (Ab) inhibitors to fVIII.,HAEMOPHILIA A,HUMAN FACTOR VIII (FVIII),RO-may_treat
503460436,7/16/2014 13:20:13,,1324249407,7/16/2014 13:20:05,neodev,0.7306,25224036,CAN,ON,Sudbury,67.204.218.187,FISTULA TRACT is location of CASE OF SEVERE CROHN'S DISEASE WITH AN ESOPHAGOBRONCHIAL,117,18,,129,74,is location of,0.9494253265550829,906096-FS1-9,We here present a CASE OF SEVERE CROHN'S DISEASE WITH AN ESOPHAGOBRONCHIAL fistula and the successful closure of the FISTULA TRACT with the novel liquid polymer sealant Onyx.,FISTULA TRACT,CASE OF SEVERE CROHN'S DISEASE WITH AN ESOPHAGOBRONCHIAL,RO-has_manifestation
503460436,7/16/2014 15:09:54,,1324291944,7/16/2014 15:09:48,clixsense,0.6313,19162475,GBR,M3,Frome,82.33.126.30,CASE OF SEVERE CROHN'S DISEASE WITH AN ESOPHAGOBRONCHIAL is location of FISTULA TRACT,117,18,,129,74,is location of,0.9494253265550829,906096-FS1-9,We here present a CASE OF SEVERE CROHN'S DISEASE WITH AN ESOPHAGOBRONCHIAL fistula and the successful closure of the FISTULA TRACT with the novel liquid polymer sealant Onyx.,FISTULA TRACT,CASE OF SEVERE CROHN'S DISEASE WITH AN ESOPHAGOBRONCHIAL,RO-has_manifestation
503460436,7/16/2014 17:45:09,,1324362104,7/16/2014 17:44:41,clixsense,0.6621,23398628,USA,WA,Spanaway,50.149.99.43,FISTULA TRACT is location of CASE OF SEVERE CROHN'S DISEASE WITH AN ESOPHAGOBRONCHIAL,117,18,,129,74,is location of,0.9494253265550829,906096-FS1-9,We here present a CASE OF SEVERE CROHN'S DISEASE WITH AN ESOPHAGOBRONCHIAL fistula and the successful closure of the FISTULA TRACT with the novel liquid polymer sealant Onyx.,FISTULA TRACT,CASE OF SEVERE CROHN'S DISEASE WITH AN ESOPHAGOBRONCHIAL,RO-has_manifestation
503460436,7/16/2014 17:59:26,,1324377278,7/16/2014 17:58:50,instagc,0.5512,28157545,USA,OR,Mcminnville,76.115.153.186,FISTULA TRACT is location of CASE OF SEVERE CROHN'S DISEASE WITH AN ESOPHAGOBRONCHIAL,117,18,,129,74,is location of,0.9494253265550829,906096-FS1-9,We here present a CASE OF SEVERE CROHN'S DISEASE WITH AN ESOPHAGOBRONCHIAL fistula and the successful closure of the FISTULA TRACT with the novel liquid polymer sealant Onyx.,FISTULA TRACT,CASE OF SEVERE CROHN'S DISEASE WITH AN ESOPHAGOBRONCHIAL,RO-has_manifestation
503460436,7/16/2014 18:23:43,,1324399459,7/16/2014 18:23:21,gifthulk,0.6992,21916793,GBR,,,87.113.87.199,FISTULA TRACT is location of CASE OF SEVERE CROHN'S DISEASE WITH AN ESOPHAGOBRONCHIAL,117,18,,129,74,is location of,0.9494253265550829,906096-FS1-9,We here present a CASE OF SEVERE CROHN'S DISEASE WITH AN ESOPHAGOBRONCHIAL fistula and the successful closure of the FISTULA TRACT with the novel liquid polymer sealant Onyx.,FISTULA TRACT,CASE OF SEVERE CROHN'S DISEASE WITH AN ESOPHAGOBRONCHIAL,RO-has_manifestation
503460436,7/16/2014 18:34:02,,1324404057,7/16/2014 18:33:49,instagc,0.4563,15445601,USA,FL,Jacksonville,24.129.68.254,no_relation,117,18,,129,74,is location of,0.9494253265550829,906096-FS1-9,We here present a CASE OF SEVERE CROHN'S DISEASE WITH AN ESOPHAGOBRONCHIAL fistula and the successful closure of the FISTULA TRACT with the novel liquid polymer sealant Onyx.,FISTULA TRACT,CASE OF SEVERE CROHN'S DISEASE WITH AN ESOPHAGOBRONCHIAL,RO-has_manifestation
503460436,7/16/2014 18:47:19,,1324410908,7/16/2014 18:46:44,eup_slw,0.5873,28186528,USA,IN,Bloomington,74.204.124.9,CASE OF SEVERE CROHN'S DISEASE WITH AN ESOPHAGOBRONCHIAL is location of FISTULA TRACT,117,18,,129,74,is location of,0.9494253265550829,906096-FS1-9,We here present a CASE OF SEVERE CROHN'S DISEASE WITH AN ESOPHAGOBRONCHIAL fistula and the successful closure of the FISTULA TRACT with the novel liquid polymer sealant Onyx.,FISTULA TRACT,CASE OF SEVERE CROHN'S DISEASE WITH AN ESOPHAGOBRONCHIAL,RO-has_manifestation
503460437,7/16/2014 13:13:06,,1324246569,7/16/2014 13:12:26,instagc,0.7222,14378608,USA,NY,Brooklyn,24.189.101.95,VITILIGO is location of SKIN,562,534,,565,542,is location of,0.942809041582064,902476-FS1-9,"? An artificial tanning preparation containing dihydroxyacetone (DHA) to help mask the extent of vitiligo for several days (most appropriate for skin with a yellow hue) ? Cosmetic tattooing in darker skinned patients with localized, stable vitiligo in whom repigmentation is unlikely (most effective for involvement of the lips) ? Recommend regular sunscreen use in all vitiligo patients, both to prevent burning of depigmented areas and to prevent tanning of normally pigmented skin and the resulting enhancement of contrast between VITILIGO patches and normal SKIN.",SKIN,VITILIGO,RO-disease_has_primary_anatomic_site
503460437,7/16/2014 13:19:57,,1324249301,7/16/2014 13:19:50,neodev,0.7306,25224036,CAN,ON,Sudbury,67.204.218.187,VITILIGO is location of SKIN,562,534,,565,542,is location of,0.942809041582064,902476-FS1-9,"? An artificial tanning preparation containing dihydroxyacetone (DHA) to help mask the extent of vitiligo for several days (most appropriate for skin with a yellow hue) ? Cosmetic tattooing in darker skinned patients with localized, stable vitiligo in whom repigmentation is unlikely (most effective for involvement of the lips) ? Recommend regular sunscreen use in all vitiligo patients, both to prevent burning of depigmented areas and to prevent tanning of normally pigmented skin and the resulting enhancement of contrast between VITILIGO patches and normal SKIN.",SKIN,VITILIGO,RO-disease_has_primary_anatomic_site
503460437,7/16/2014 13:23:29,,1324250632,7/16/2014 13:22:43,neodev,0.6722,12115558,USA,OH,Twinsburg,75.187.196.41,SKIN is location of VITILIGO,562,534,,565,542,is location of,0.942809041582064,902476-FS1-9,"? An artificial tanning preparation containing dihydroxyacetone (DHA) to help mask the extent of vitiligo for several days (most appropriate for skin with a yellow hue) ? Cosmetic tattooing in darker skinned patients with localized, stable vitiligo in whom repigmentation is unlikely (most effective for involvement of the lips) ? Recommend regular sunscreen use in all vitiligo patients, both to prevent burning of depigmented areas and to prevent tanning of normally pigmented skin and the resulting enhancement of contrast between VITILIGO patches and normal SKIN.",SKIN,VITILIGO,RO-disease_has_primary_anatomic_site
503460437,7/16/2014 13:34:22,,1324255524,7/16/2014 13:33:57,prodege,0.5958,1852770,USA,TX,Abilene,76.198.102.54,SKIN is location of VITILIGO,562,534,,565,542,is location of,0.942809041582064,902476-FS1-9,"? An artificial tanning preparation containing dihydroxyacetone (DHA) to help mask the extent of vitiligo for several days (most appropriate for skin with a yellow hue) ? Cosmetic tattooing in darker skinned patients with localized, stable vitiligo in whom repigmentation is unlikely (most effective for involvement of the lips) ? Recommend regular sunscreen use in all vitiligo patients, both to prevent burning of depigmented areas and to prevent tanning of normally pigmented skin and the resulting enhancement of contrast between VITILIGO patches and normal SKIN.",SKIN,VITILIGO,RO-disease_has_primary_anatomic_site
503460437,7/16/2014 14:27:05,,1324276302,7/16/2014 14:26:23,fusioncash,0.6587,7012325,USA,CT,Stamford,24.185.182.15,no_relation,562,534,,565,542,is location of,0.942809041582064,902476-FS1-9,"? An artificial tanning preparation containing dihydroxyacetone (DHA) to help mask the extent of vitiligo for several days (most appropriate for skin with a yellow hue) ? Cosmetic tattooing in darker skinned patients with localized, stable vitiligo in whom repigmentation is unlikely (most effective for involvement of the lips) ? Recommend regular sunscreen use in all vitiligo patients, both to prevent burning of depigmented areas and to prevent tanning of normally pigmented skin and the resulting enhancement of contrast between VITILIGO patches and normal SKIN.",SKIN,VITILIGO,RO-disease_has_primary_anatomic_site
503460437,7/16/2014 14:44:19,,1324282833,7/16/2014 14:43:50,clixsense,0.6742,28324391,NLD,11,Hazerswoude-rijndijk,94.208.82.215,VITILIGO is location of SKIN,562,534,,565,542,is location of,0.942809041582064,902476-FS1-9,"? An artificial tanning preparation containing dihydroxyacetone (DHA) to help mask the extent of vitiligo for several days (most appropriate for skin with a yellow hue) ? Cosmetic tattooing in darker skinned patients with localized, stable vitiligo in whom repigmentation is unlikely (most effective for involvement of the lips) ? Recommend regular sunscreen use in all vitiligo patients, both to prevent burning of depigmented areas and to prevent tanning of normally pigmented skin and the resulting enhancement of contrast between VITILIGO patches and normal SKIN.",SKIN,VITILIGO,RO-disease_has_primary_anatomic_site
503460437,7/16/2014 15:42:50,,1324303128,7/16/2014 15:42:22,prodege,0.6956,17780691,CAN,ON,Toronto,24.114.226.82,SKIN is location of VITILIGO,562,534,,565,542,is location of,0.942809041582064,902476-FS1-9,"? An artificial tanning preparation containing dihydroxyacetone (DHA) to help mask the extent of vitiligo for several days (most appropriate for skin with a yellow hue) ? Cosmetic tattooing in darker skinned patients with localized, stable vitiligo in whom repigmentation is unlikely (most effective for involvement of the lips) ? Recommend regular sunscreen use in all vitiligo patients, both to prevent burning of depigmented areas and to prevent tanning of normally pigmented skin and the resulting enhancement of contrast between VITILIGO patches and normal SKIN.",SKIN,VITILIGO,RO-disease_has_primary_anatomic_site
503460442,7/16/2014 13:14:21,,1324247121,7/16/2014 13:13:07,instagc,0.7222,14378608,USA,NY,Brooklyn,24.189.101.95,FISH OIL treats CARDIAC ARRHYTHMIAS,14,78,,32,86,treats,0.975900072948533,907011-FS1-2,Prevention of CARDIAC ARRHYTHMIAS and sudden death is demonstrable at fish or FISH OIL intakes that have little or no effect on blood pressure or plasma lipids.,CARDIAC ARRHYTHMIAS,FISH OIL,RO-may_prevent
503460442,7/16/2014 13:22:21,,1324250286,7/16/2014 13:22:00,prodege,0.6875,22031444,GBR,B7,Bristol,77.98.139.82,FISH OIL treats CARDIAC ARRHYTHMIAS,14,78,,32,86,treats,0.975900072948533,907011-FS1-2,Prevention of CARDIAC ARRHYTHMIAS and sudden death is demonstrable at fish or FISH OIL intakes that have little or no effect on blood pressure or plasma lipids.,CARDIAC ARRHYTHMIAS,FISH OIL,RO-may_prevent
503460442,7/16/2014 13:51:54,,1324261769,7/16/2014 13:51:21,instagc,0.7333,13763729,USA,,,75.182.89.225,FISH OIL treats CARDIAC ARRHYTHMIAS,14,78,,32,86,treats,0.975900072948533,907011-FS1-2,Prevention of CARDIAC ARRHYTHMIAS and sudden death is demonstrable at fish or FISH OIL intakes that have little or no effect on blood pressure or plasma lipids.,CARDIAC ARRHYTHMIAS,FISH OIL,RO-may_prevent
503460442,7/16/2014 14:25:14,,1324275635,7/16/2014 14:24:44,rewardsspot,0.6855,17763704,USA,VA,Manassas,198.7.62.204,FISH OIL treats CARDIAC ARRHYTHMIAS,14,78,,32,86,treats,0.975900072948533,907011-FS1-2,Prevention of CARDIAC ARRHYTHMIAS and sudden death is demonstrable at fish or FISH OIL intakes that have little or no effect on blood pressure or plasma lipids.,CARDIAC ARRHYTHMIAS,FISH OIL,RO-may_prevent
503460442,7/16/2014 15:02:43,,1324289128,7/16/2014 15:02:10,prodege,0.6956,17780691,CAN,ON,Toronto,24.114.226.82,FISH OIL treats CARDIAC ARRHYTHMIAS,14,78,,32,86,treats,0.975900072948533,907011-FS1-2,Prevention of CARDIAC ARRHYTHMIAS and sudden death is demonstrable at fish or FISH OIL intakes that have little or no effect on blood pressure or plasma lipids.,CARDIAC ARRHYTHMIAS,FISH OIL,RO-may_prevent
503460442,7/16/2014 15:35:50,,1324300295,7/16/2014 15:35:07,instagc,0.7538,19636746,USA,NY,Andover,192.182.216.225,no_relation,14,78,,32,86,treats,0.975900072948533,907011-FS1-2,Prevention of CARDIAC ARRHYTHMIAS and sudden death is demonstrable at fish or FISH OIL intakes that have little or no effect on blood pressure or plasma lipids.,CARDIAC ARRHYTHMIAS,FISH OIL,RO-may_prevent
503460442,7/16/2014 15:37:07,,1324300775,7/16/2014 15:36:48,prodege,0.5498,23541832,USA,AZ,Tempe,149.169.143.104,no_relation,14,78,,32,86,treats,0.975900072948533,907011-FS1-2,Prevention of CARDIAC ARRHYTHMIAS and sudden death is demonstrable at fish or FISH OIL intakes that have little or no effect on blood pressure or plasma lipids.,CARDIAC ARRHYTHMIAS,FISH OIL,RO-may_prevent
503460444,7/16/2014 13:06:16,,1324243827,7/16/2014 13:05:51,prodege,0.9167,7664351,USA,NY,Cicero,74.111.0.21,SKIN is location of INFLAMMATORY DERMATOSES,156,100,,159,123,is location of,0.975900072948533,902112-FS1-9,The distribution of OKM 5 positive dendritic cells in the epidermis was investigated in 75 cases of INFLAMMATORY DERMATOSES and in 14 cases of normal human SKIN by immunohistochemical and morphometric methods.,SKIN,INFLAMMATORY DERMATOSES,RO-disease_has_primary_anatomic_site
503460444,7/16/2014 13:08:20,,1324244701,7/16/2014 13:07:58,clixsense,0.9583,27871219,NLD,07,Amsterdam,87.210.207.223,SKIN is location of INFLAMMATORY DERMATOSES,156,100,,159,123,is location of,0.975900072948533,902112-FS1-9,The distribution of OKM 5 positive dendritic cells in the epidermis was investigated in 75 cases of INFLAMMATORY DERMATOSES and in 14 cases of normal human SKIN by immunohistochemical and morphometric methods.,SKIN,INFLAMMATORY DERMATOSES,RO-disease_has_primary_anatomic_site
503460444,7/16/2014 13:16:14,,1324247802,7/16/2014 13:15:51,prodege,0.7917,9525153,CAN,ON,Toronto,65.95.94.44,SKIN is location of INFLAMMATORY DERMATOSES,156,100,,159,123,is location of,0.975900072948533,902112-FS1-9,The distribution of OKM 5 positive dendritic cells in the epidermis was investigated in 75 cases of INFLAMMATORY DERMATOSES and in 14 cases of normal human SKIN by immunohistochemical and morphometric methods.,SKIN,INFLAMMATORY DERMATOSES,RO-disease_has_primary_anatomic_site
503460444,7/16/2014 13:26:46,,1324252122,7/16/2014 13:26:18,clixsense,0.8056,15189335,GBR,I9,Bury Saint Edmunds,81.155.129.231,SKIN is location of INFLAMMATORY DERMATOSES,156,100,,159,123,is location of,0.975900072948533,902112-FS1-9,The distribution of OKM 5 positive dendritic cells in the epidermis was investigated in 75 cases of INFLAMMATORY DERMATOSES and in 14 cases of normal human SKIN by immunohistochemical and morphometric methods.,SKIN,INFLAMMATORY DERMATOSES,RO-disease_has_primary_anatomic_site
503460444,7/16/2014 13:52:17,,1324261889,7/16/2014 13:51:55,instagc,0.7333,13763729,USA,,,75.182.89.225,SKIN is location of INFLAMMATORY DERMATOSES,156,100,,159,123,is location of,0.975900072948533,902112-FS1-9,The distribution of OKM 5 positive dendritic cells in the epidermis was investigated in 75 cases of INFLAMMATORY DERMATOSES and in 14 cases of normal human SKIN by immunohistochemical and morphometric methods.,SKIN,INFLAMMATORY DERMATOSES,RO-disease_has_primary_anatomic_site
503460444,7/16/2014 14:17:26,,1324272496,7/16/2014 14:17:06,instagc,0.7677,28301350,GBR,K4,Plymouth,92.28.208.109,SKIN is location of INFLAMMATORY DERMATOSES,156,100,,159,123,is location of,0.975900072948533,902112-FS1-9,The distribution of OKM 5 positive dendritic cells in the epidermis was investigated in 75 cases of INFLAMMATORY DERMATOSES and in 14 cases of normal human SKIN by immunohistochemical and morphometric methods.,SKIN,INFLAMMATORY DERMATOSES,RO-disease_has_primary_anatomic_site
503460444,7/16/2014 14:53:37,,1324285583,7/16/2014 14:53:00,prodege,0.505,28039757,GBR,L8,Southport,109.155.158.54,no_relation,156,100,,159,123,is location of,0.975900072948533,902112-FS1-9,The distribution of OKM 5 positive dendritic cells in the epidermis was investigated in 75 cases of INFLAMMATORY DERMATOSES and in 14 cases of normal human SKIN by immunohistochemical and morphometric methods.,SKIN,INFLAMMATORY DERMATOSES,RO-disease_has_primary_anatomic_site
503460448,7/16/2014 13:14:01,,1324246990,7/16/2014 13:13:38,instagc,0.7083,18960682,GBR,,,86.29.147.112,no_relation,159,196,,174,230,diagnosed by,0.753778361444409,901897-FS1-13,"On the basis of progressive hyperferritinemia (1323 ng/ml), anemia (hemoglobin: 5.2 g/dl), hypertriglyceridemia (547 mg/dl) and increased LDH (1063 IU/l) with HEMOPHAGOCYTOSIS in the bone marrow, HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS was diagnosed.",HEMOPHAGOCYTOSIS,HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS,RO-disease_has_finding
503460448,7/16/2014 13:19:25,,1324249074,7/16/2014 13:18:57,elite,0.7917,28503042,USA,NJ,Woodbridge,54.191.150.115,HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS diagnosed by HEMOPHAGOCYTOSIS,159,196,,174,230,diagnosed by,0.753778361444409,901897-FS1-13,"On the basis of progressive hyperferritinemia (1323 ng/ml), anemia (hemoglobin: 5.2 g/dl), hypertriglyceridemia (547 mg/dl) and increased LDH (1063 IU/l) with HEMOPHAGOCYTOSIS in the bone marrow, HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS was diagnosed.",HEMOPHAGOCYTOSIS,HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS,RO-disease_has_finding
503460448,7/16/2014 13:21:59,,1324250135,7/16/2014 13:21:24,prodege,0.6875,22031444,GBR,B7,Bristol,77.98.139.82,HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS diagnosed by HEMOPHAGOCYTOSIS,159,196,,174,230,diagnosed by,0.753778361444409,901897-FS1-13,"On the basis of progressive hyperferritinemia (1323 ng/ml), anemia (hemoglobin: 5.2 g/dl), hypertriglyceridemia (547 mg/dl) and increased LDH (1063 IU/l) with HEMOPHAGOCYTOSIS in the bone marrow, HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS was diagnosed.",HEMOPHAGOCYTOSIS,HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS,RO-disease_has_finding
503460448,7/16/2014 13:32:50,,1324254799,7/16/2014 13:32:18,clixsense,0.7708,6564572,USA,MI,Kalamazoo,173.46.248.170,HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS diagnosed by HEMOPHAGOCYTOSIS,159,196,,174,230,diagnosed by,0.753778361444409,901897-FS1-13,"On the basis of progressive hyperferritinemia (1323 ng/ml), anemia (hemoglobin: 5.2 g/dl), hypertriglyceridemia (547 mg/dl) and increased LDH (1063 IU/l) with HEMOPHAGOCYTOSIS in the bone marrow, HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS was diagnosed.",HEMOPHAGOCYTOSIS,HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS,RO-disease_has_finding
503460448,7/16/2014 14:29:07,,1324277212,7/16/2014 14:28:28,vivatic,0.5899,25451531,GBR,,,83.67.28.193,HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS diagnosed by HEMOPHAGOCYTOSIS,159,196,,174,230,diagnosed by,0.753778361444409,901897-FS1-13,"On the basis of progressive hyperferritinemia (1323 ng/ml), anemia (hemoglobin: 5.2 g/dl), hypertriglyceridemia (547 mg/dl) and increased LDH (1063 IU/l) with HEMOPHAGOCYTOSIS in the bone marrow, HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS was diagnosed.",HEMOPHAGOCYTOSIS,HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS,RO-disease_has_finding
503460448,7/16/2014 14:30:50,,1324278047,7/16/2014 14:30:32,clixsense,0.6486,17722340,CAN,BC,Mission,50.98.185.25,HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS diagnosed by HEMOPHAGOCYTOSIS,159,196,,174,230,diagnosed by,0.753778361444409,901897-FS1-13,"On the basis of progressive hyperferritinemia (1323 ng/ml), anemia (hemoglobin: 5.2 g/dl), hypertriglyceridemia (547 mg/dl) and increased LDH (1063 IU/l) with HEMOPHAGOCYTOSIS in the bone marrow, HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS was diagnosed.",HEMOPHAGOCYTOSIS,HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS,RO-disease_has_finding
503460448,7/16/2014 14:45:33,,1324283118,7/16/2014 14:44:56,clixsense,0.6742,28324391,NLD,11,Hazerswoude-rijndijk,94.208.82.215,HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS diagnosed by HEMOPHAGOCYTOSIS,159,196,,174,230,diagnosed by,0.753778361444409,901897-FS1-13,"On the basis of progressive hyperferritinemia (1323 ng/ml), anemia (hemoglobin: 5.2 g/dl), hypertriglyceridemia (547 mg/dl) and increased LDH (1063 IU/l) with HEMOPHAGOCYTOSIS in the bone marrow, HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS was diagnosed.",HEMOPHAGOCYTOSIS,HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS,RO-disease_has_finding
503460456,7/16/2014 13:09:46,,1324245239,7/16/2014 13:09:10,neodev,0.8194,18339121,USA,SC,Sumter,173.93.188.194,PODOPHYLLOTOXIN treats PENILE WARTS,151,104,,162,119,treats,0.9958932064677041,907713-FS1-2,"1]  White DJ, Billingham C, Chapman S, Drake S, Jayaweera D, Jones S, et al. Podophyllin 0.5% or 2.0% v PODOPHYLLOTOXIN 0.5% for the self treatment of PENILE WARTS: a double blind randomised study.",PENILE WARTS,PODOPHYLLOTOXIN,RO-may_treat
503460456,7/16/2014 13:11:05,,1324245750,7/16/2014 13:10:52,clixsense,0.9167,20614047,USA,MO,Maryville,174.32.162.147,no_relation,151,104,,162,119,treats,0.9958932064677041,907713-FS1-2,"1]  White DJ, Billingham C, Chapman S, Drake S, Jayaweera D, Jones S, et al. Podophyllin 0.5% or 2.0% v PODOPHYLLOTOXIN 0.5% for the self treatment of PENILE WARTS: a double blind randomised study.",PENILE WARTS,PODOPHYLLOTOXIN,RO-may_treat
503460456,7/16/2014 13:14:16,,1324247066,7/16/2014 13:14:02,instagc,0.7083,18960682,GBR,,,86.29.147.112,PODOPHYLLOTOXIN treats PENILE WARTS,151,104,,162,119,treats,0.9958932064677041,907713-FS1-2,"1]  White DJ, Billingham C, Chapman S, Drake S, Jayaweera D, Jones S, et al. Podophyllin 0.5% or 2.0% v PODOPHYLLOTOXIN 0.5% for the self treatment of PENILE WARTS: a double blind randomised study.",PENILE WARTS,PODOPHYLLOTOXIN,RO-may_treat
503460456,7/16/2014 14:27:21,,1324276389,7/16/2014 14:26:57,rewardsspot,0.6855,17763704,USA,VA,Manassas,198.7.62.204,PODOPHYLLOTOXIN treats PENILE WARTS,151,104,,162,119,treats,0.9958932064677041,907713-FS1-2,"1]  White DJ, Billingham C, Chapman S, Drake S, Jayaweera D, Jones S, et al. Podophyllin 0.5% or 2.0% v PODOPHYLLOTOXIN 0.5% for the self treatment of PENILE WARTS: a double blind randomised study.",PENILE WARTS,PODOPHYLLOTOXIN,RO-may_treat
503460456,7/16/2014 14:31:44,,1324278355,7/16/2014 14:30:51,clixsense,0.6486,17722340,CAN,BC,Mission,50.98.185.25,PENILE WARTS treats PODOPHYLLOTOXIN,151,104,,162,119,treats,0.9958932064677041,907713-FS1-2,"1]  White DJ, Billingham C, Chapman S, Drake S, Jayaweera D, Jones S, et al. Podophyllin 0.5% or 2.0% v PODOPHYLLOTOXIN 0.5% for the self treatment of PENILE WARTS: a double blind randomised study.",PENILE WARTS,PODOPHYLLOTOXIN,RO-may_treat
503460456,7/16/2014 15:44:01,,1324303691,7/16/2014 15:43:53,neodev,0.6659,27597779,CAN,AB,Calgary,72.29.251.209,PODOPHYLLOTOXIN treats PENILE WARTS,151,104,,162,119,treats,0.9958932064677041,907713-FS1-2,"1]  White DJ, Billingham C, Chapman S, Drake S, Jayaweera D, Jones S, et al. Podophyllin 0.5% or 2.0% v PODOPHYLLOTOXIN 0.5% for the self treatment of PENILE WARTS: a double blind randomised study.",PENILE WARTS,PODOPHYLLOTOXIN,RO-may_treat
503460456,7/16/2014 16:39:01,,1324330120,7/16/2014 16:38:39,neodev,0.5359,14861092,GBR,H9,London,90.194.156.173,PODOPHYLLOTOXIN treats PENILE WARTS,151,104,,162,119,treats,0.9958932064677041,907713-FS1-2,"1]  White DJ, Billingham C, Chapman S, Drake S, Jayaweera D, Jones S, et al. Podophyllin 0.5% or 2.0% v PODOPHYLLOTOXIN 0.5% for the self treatment of PENILE WARTS: a double blind randomised study.",PENILE WARTS,PODOPHYLLOTOXIN,RO-may_treat
503460458,7/16/2014 13:19:34,,1324249147,7/16/2014 13:19:24,neodev,0.7306,25224036,CAN,ON,Sudbury,67.204.218.187,PARACETAMOL treats MINOR PAIN,74,0,,83,11,treats,0.9363291775690441,908294-FS1-2,PARACETAMOL (acetaminophen) was the most common alternative analgesic for MINOR PAIN,MINOR PAIN,PARACETAMOL,RO-may_treat
503460458,7/16/2014 15:00:43,,1324288219,7/16/2014 15:00:11,prodege,0.6956,17780691,CAN,ON,Toronto,24.114.226.82,PARACETAMOL treats MINOR PAIN,74,0,,83,11,treats,0.9363291775690441,908294-FS1-2,PARACETAMOL (acetaminophen) was the most common alternative analgesic for MINOR PAIN,MINOR PAIN,PARACETAMOL,RO-may_treat
503460458,7/16/2014 15:09:33,,1324291826,7/16/2014 15:09:22,clixsense,0.6313,19162475,GBR,M3,Frome,82.33.126.30,PARACETAMOL treats MINOR PAIN,74,0,,83,11,treats,0.9363291775690441,908294-FS1-2,PARACETAMOL (acetaminophen) was the most common alternative analgesic for MINOR PAIN,MINOR PAIN,PARACETAMOL,RO-may_treat
503460458,7/16/2014 15:34:34,,1324299856,7/16/2014 15:34:18,instagc,0.7538,19636746,USA,NY,Andover,192.182.216.225,PARACETAMOL treats MINOR PAIN,74,0,,83,11,treats,0.9363291775690441,908294-FS1-2,PARACETAMOL (acetaminophen) was the most common alternative analgesic for MINOR PAIN,MINOR PAIN,PARACETAMOL,RO-may_treat
503460458,7/16/2014 17:17:09,,1324343590,7/16/2014 17:16:52,clixsense,0.6583,25595227,CAN,SK,North Battleford,24.72.96.119,PARACETAMOL treats MINOR PAIN,74,0,,83,11,treats,0.9363291775690441,908294-FS1-2,PARACETAMOL (acetaminophen) was the most common alternative analgesic for MINOR PAIN,MINOR PAIN,PARACETAMOL,RO-may_treat
503460458,7/16/2014 17:17:43,,1324343757,7/16/2014 17:17:24,prodege,0.521,19026375,GBR,Z1,Swansea,92.26.69.100,PARACETAMOL treats MINOR PAIN,74,0,,83,11,treats,0.9363291775690441,908294-FS1-2,PARACETAMOL (acetaminophen) was the most common alternative analgesic for MINOR PAIN,MINOR PAIN,PARACETAMOL,RO-may_treat
503460458,7/16/2014 17:45:09,,1324362101,7/16/2014 17:44:41,clixsense,0.6621,23398628,USA,WA,Spanaway,50.149.99.43,PARACETAMOL treats MINOR PAIN,74,0,,83,11,treats,0.9363291775690441,908294-FS1-2,PARACETAMOL (acetaminophen) was the most common alternative analgesic for MINOR PAIN,MINOR PAIN,PARACETAMOL,RO-may_treat
503460459,7/16/2014 13:06:44,,1324244034,7/16/2014 13:06:25,clixsense,0.9583,27871219,NLD,07,Amsterdam,87.210.207.223,HYPERTENSION diagnosed by BLOOD PRESSURE ELEVATION,92,76,,115,88,diagnosed by,0.35921060405355,904546-FS1-13,The objective of the present study was to assess the impact of a history of HYPERTENSION or BLOOD PRESSURE ELEVATION on admission on the diagnostic performance of BNP in the diagnosis of heart failure (HF) in patients with acute dyspnea.,BLOOD PRESSURE ELEVATION,HYPERTENSION,RO-has_definitional_manifestation
503460459,7/16/2014 13:14:21,,1324247122,7/16/2014 13:13:07,instagc,0.7222,14378608,USA,NY,Brooklyn,24.189.101.95,no_relation,92,76,,115,88,diagnosed by,0.35921060405355,904546-FS1-13,The objective of the present study was to assess the impact of a history of HYPERTENSION or BLOOD PRESSURE ELEVATION on admission on the diagnostic performance of BNP in the diagnosis of heart failure (HF) in patients with acute dyspnea.,BLOOD PRESSURE ELEVATION,HYPERTENSION,RO-has_definitional_manifestation
503460459,7/16/2014 13:19:14,,1324249009,7/16/2014 13:19:06,neodev,0.7833,25804244,USA,IL,Chicago,99.198.108.116,HYPERTENSION diagnosed by BLOOD PRESSURE ELEVATION,92,76,,115,88,diagnosed by,0.35921060405355,904546-FS1-13,The objective of the present study was to assess the impact of a history of HYPERTENSION or BLOOD PRESSURE ELEVATION on admission on the diagnostic performance of BNP in the diagnosis of heart failure (HF) in patients with acute dyspnea.,BLOOD PRESSURE ELEVATION,HYPERTENSION,RO-has_definitional_manifestation
503460459,7/16/2014 13:23:23,,1324250609,7/16/2014 13:23:03,clixsense,0.8056,15189335,GBR,I9,Bury Saint Edmunds,81.155.129.231,BLOOD PRESSURE ELEVATION diagnosed by HYPERTENSION,92,76,,115,88,diagnosed by,0.35921060405355,904546-FS1-13,The objective of the present study was to assess the impact of a history of HYPERTENSION or BLOOD PRESSURE ELEVATION on admission on the diagnostic performance of BNP in the diagnosis of heart failure (HF) in patients with acute dyspnea.,BLOOD PRESSURE ELEVATION,HYPERTENSION,RO-has_definitional_manifestation
503460459,7/16/2014 13:24:52,,1324251246,7/16/2014 13:24:24,neodev,0.8806,21515166,NLD,11,Nootdorp,83.86.58.179,BLOOD PRESSURE ELEVATION diagnosed by HYPERTENSION,92,76,,115,88,diagnosed by,0.35921060405355,904546-FS1-13,The objective of the present study was to assess the impact of a history of HYPERTENSION or BLOOD PRESSURE ELEVATION on admission on the diagnostic performance of BNP in the diagnosis of heart failure (HF) in patients with acute dyspnea.,BLOOD PRESSURE ELEVATION,HYPERTENSION,RO-has_definitional_manifestation
503460459,7/16/2014 13:29:03,,1324253082,7/16/2014 13:28:22,rewardsspot,0.5306,24482174,GBR,H9,London,46.23.68.180,no_relation,92,76,,115,88,diagnosed by,0.35921060405355,904546-FS1-13,The objective of the present study was to assess the impact of a history of HYPERTENSION or BLOOD PRESSURE ELEVATION on admission on the diagnostic performance of BNP in the diagnosis of heart failure (HF) in patients with acute dyspnea.,BLOOD PRESSURE ELEVATION,HYPERTENSION,RO-has_definitional_manifestation
503460459,7/16/2014 14:27:33,,1324276508,7/16/2014 14:26:42,vivatic,0.5899,25451531,GBR,,,83.67.28.193,no_relation,92,76,,115,88,diagnosed by,0.35921060405355,904546-FS1-13,The objective of the present study was to assess the impact of a history of HYPERTENSION or BLOOD PRESSURE ELEVATION on admission on the diagnostic performance of BNP in the diagnosis of heart failure (HF) in patients with acute dyspnea.,BLOOD PRESSURE ELEVATION,HYPERTENSION,RO-has_definitional_manifestation
503460463,7/16/2014 13:22:23,,1324250290,7/16/2014 13:22:13,clixsense,0.7208,27793793,GBR,C5,Chester,151.230.27.155,FREE LUNG CELLS is location of BRONCHIAL CARCINOMA,265,289,,279,308,is location of,0.38490017945974997,902226-FS1-9,"Such studies are of particular interest in patients with recurrent chest infections, to detect abnormalities of local cellular immunity; in pulmonary fibrosis to assess activity of the disease and effect of treatment by observing morphology and testing function of FREE LUNG CELLS; and in BRONCHIAL CARCINOMA to investigate local immune responses to the tumour.",FREE LUNG CELLS,BRONCHIAL CARCINOMA,RO-disease_has_primary_anatomic_site
503460463,7/16/2014 13:30:14,,1324253592,7/16/2014 13:29:08,rewardsspot,0.5306,24482174,GBR,H9,London,46.23.68.180,FREE LUNG CELLS is location of BRONCHIAL CARCINOMA,265,289,,279,308,is location of,0.38490017945974997,902226-FS1-9,"Such studies are of particular interest in patients with recurrent chest infections, to detect abnormalities of local cellular immunity; in pulmonary fibrosis to assess activity of the disease and effect of treatment by observing morphology and testing function of FREE LUNG CELLS; and in BRONCHIAL CARCINOMA to investigate local immune responses to the tumour.",FREE LUNG CELLS,BRONCHIAL CARCINOMA,RO-disease_has_primary_anatomic_site
503460463,7/16/2014 14:32:07,,1324278476,7/16/2014 14:31:45,clixsense,0.6486,17722340,CAN,BC,Mission,50.98.185.25,FREE LUNG CELLS is location of BRONCHIAL CARCINOMA,265,289,,279,308,is location of,0.38490017945974997,902226-FS1-9,"Such studies are of particular interest in patients with recurrent chest infections, to detect abnormalities of local cellular immunity; in pulmonary fibrosis to assess activity of the disease and effect of treatment by observing morphology and testing function of FREE LUNG CELLS; and in BRONCHIAL CARCINOMA to investigate local immune responses to the tumour.",FREE LUNG CELLS,BRONCHIAL CARCINOMA,RO-disease_has_primary_anatomic_site
503460463,7/16/2014 15:09:54,,1324291943,7/16/2014 15:09:48,clixsense,0.6313,19162475,GBR,M3,Frome,82.33.126.30,FREE LUNG CELLS is location of BRONCHIAL CARCINOMA,265,289,,279,308,is location of,0.38490017945974997,902226-FS1-9,"Such studies are of particular interest in patients with recurrent chest infections, to detect abnormalities of local cellular immunity; in pulmonary fibrosis to assess activity of the disease and effect of treatment by observing morphology and testing function of FREE LUNG CELLS; and in BRONCHIAL CARCINOMA to investigate local immune responses to the tumour.",FREE LUNG CELLS,BRONCHIAL CARCINOMA,RO-disease_has_primary_anatomic_site
503460463,7/16/2014 15:36:24,,1324300531,7/16/2014 15:36:17,prodege,0.5498,23541832,USA,AZ,Tempe,149.169.143.104,BRONCHIAL CARCINOMA is location of FREE LUNG CELLS,265,289,,279,308,is location of,0.38490017945974997,902226-FS1-9,"Such studies are of particular interest in patients with recurrent chest infections, to detect abnormalities of local cellular immunity; in pulmonary fibrosis to assess activity of the disease and effect of treatment by observing morphology and testing function of FREE LUNG CELLS; and in BRONCHIAL CARCINOMA to investigate local immune responses to the tumour.",FREE LUNG CELLS,BRONCHIAL CARCINOMA,RO-disease_has_primary_anatomic_site
503460463,7/16/2014 17:09:43,,1324341287,7/16/2014 17:09:08,clixsense,0.5952,19638651,USA,,,173.23.121.63,FREE LUNG CELLS is location of BRONCHIAL CARCINOMA,265,289,,279,308,is location of,0.38490017945974997,902226-FS1-9,"Such studies are of particular interest in patients with recurrent chest infections, to detect abnormalities of local cellular immunity; in pulmonary fibrosis to assess activity of the disease and effect of treatment by observing morphology and testing function of FREE LUNG CELLS; and in BRONCHIAL CARCINOMA to investigate local immune responses to the tumour.",FREE LUNG CELLS,BRONCHIAL CARCINOMA,RO-disease_has_primary_anatomic_site
503460463,7/16/2014 17:18:03,,1324343864,7/16/2014 17:17:32,clixsense,0.6583,25595227,CAN,SK,North Battleford,24.72.96.119,FREE LUNG CELLS is location of BRONCHIAL CARCINOMA,265,289,,279,308,is location of,0.38490017945974997,902226-FS1-9,"Such studies are of particular interest in patients with recurrent chest infections, to detect abnormalities of local cellular immunity; in pulmonary fibrosis to assess activity of the disease and effect of treatment by observing morphology and testing function of FREE LUNG CELLS; and in BRONCHIAL CARCINOMA to investigate local immune responses to the tumour.",FREE LUNG CELLS,BRONCHIAL CARCINOMA,RO-disease_has_primary_anatomic_site
503460482,7/16/2014 13:25:28,,1324251569,7/16/2014 13:25:05,neodev,0.6722,12115558,USA,OH,Twinsburg,75.187.196.41,no_relation,91,63,,109,73,causes,0.848528137423857,906133-FS1-4,This study expands the geographical map of the distribution of BCL 2 GENE rearrangement in FOLLICULAR LYMPHOMA patients in the Middle East region.,FOLLICULAR LYMPHOMA,BCL 2 GENE,RO-has_manifestation
503460482,7/16/2014 13:38:48,,1324257189,7/16/2014 13:38:25,prodege,0.5958,1852770,USA,TX,Abilene,76.198.102.54,no_relation,91,63,,109,73,causes,0.848528137423857,906133-FS1-4,This study expands the geographical map of the distribution of BCL 2 GENE rearrangement in FOLLICULAR LYMPHOMA patients in the Middle East region.,FOLLICULAR LYMPHOMA,BCL 2 GENE,RO-has_manifestation
503460482,7/16/2014 13:51:20,,1324261589,7/16/2014 13:50:45,instagc,0.7333,13763729,USA,,,75.182.89.225,BCL 2 GENE causes FOLLICULAR LYMPHOMA,91,63,,109,73,causes,0.848528137423857,906133-FS1-4,This study expands the geographical map of the distribution of BCL 2 GENE rearrangement in FOLLICULAR LYMPHOMA patients in the Middle East region.,FOLLICULAR LYMPHOMA,BCL 2 GENE,RO-has_manifestation
503460482,7/16/2014 15:10:01,,1324291965,7/16/2014 15:09:55,clixsense,0.6313,19162475,GBR,M3,Frome,82.33.126.30,FOLLICULAR LYMPHOMA causes BCL 2 GENE,91,63,,109,73,causes,0.848528137423857,906133-FS1-4,This study expands the geographical map of the distribution of BCL 2 GENE rearrangement in FOLLICULAR LYMPHOMA patients in the Middle East region.,FOLLICULAR LYMPHOMA,BCL 2 GENE,RO-has_manifestation
503460482,7/16/2014 15:36:09,,1324300397,7/16/2014 15:35:58,prodege,0.5498,23541832,USA,AZ,Tempe,149.169.143.104,BCL 2 GENE causes FOLLICULAR LYMPHOMA,91,63,,109,73,causes,0.848528137423857,906133-FS1-4,This study expands the geographical map of the distribution of BCL 2 GENE rearrangement in FOLLICULAR LYMPHOMA patients in the Middle East region.,FOLLICULAR LYMPHOMA,BCL 2 GENE,RO-has_manifestation
503460482,7/16/2014 15:49:08,,1324305822,7/16/2014 15:48:58,clixsense,0.58,16827630,GBR,A7,Birmingham,86.146.169.103,no_relation,91,63,,109,73,causes,0.848528137423857,906133-FS1-4,This study expands the geographical map of the distribution of BCL 2 GENE rearrangement in FOLLICULAR LYMPHOMA patients in the Middle East region.,FOLLICULAR LYMPHOMA,BCL 2 GENE,RO-has_manifestation
503460482,7/16/2014 17:04:50,,1324339702,7/16/2014 17:04:22,prodege,0.4233,12944140,GBR,C8,Croydon,92.21.8.174,BCL 2 GENE causes FOLLICULAR LYMPHOMA,91,63,,109,73,causes,0.848528137423857,906133-FS1-4,This study expands the geographical map of the distribution of BCL 2 GENE rearrangement in FOLLICULAR LYMPHOMA patients in the Middle East region.,FOLLICULAR LYMPHOMA,BCL 2 GENE,RO-has_manifestation
503460489,7/16/2014 13:07:17,,1324244204,7/16/2014 13:06:48,clixsense,1.0,19803139,NLD,06,Veldhoven,212.61.84.196,no_relation,44,116,,67,125,treats,0.790569415042095,907551-FS1-2,Effects of enalapril on mortality in severe CONGESTIVE HEART FAILURE: results of the cooperative North Scandinavian ENALAPRIL survival study (consensus.,CONGESTIVE HEART FAILURE,ENALAPRIL,RO-may_treat
503460489,7/16/2014 13:13:25,,1324246715,7/16/2014 13:13:05,instagc,0.7083,18960682,GBR,,,86.29.147.112,ENALAPRIL treats CONGESTIVE HEART FAILURE,44,116,,67,125,treats,0.790569415042095,907551-FS1-2,Effects of enalapril on mortality in severe CONGESTIVE HEART FAILURE: results of the cooperative North Scandinavian ENALAPRIL survival study (consensus.,CONGESTIVE HEART FAILURE,ENALAPRIL,RO-may_treat
503460489,7/16/2014 13:19:39,,1324249166,7/16/2014 13:19:25,neodev,0.7833,25804244,USA,IL,Chicago,99.198.108.116,ENALAPRIL treats CONGESTIVE HEART FAILURE,44,116,,67,125,treats,0.790569415042095,907551-FS1-2,Effects of enalapril on mortality in severe CONGESTIVE HEART FAILURE: results of the cooperative North Scandinavian ENALAPRIL survival study (consensus.,CONGESTIVE HEART FAILURE,ENALAPRIL,RO-may_treat
503460489,7/16/2014 13:21:23,,1324249871,7/16/2014 13:20:53,prodege,0.6875,22031444,GBR,B7,Bristol,77.98.139.82,ENALAPRIL treats CONGESTIVE HEART FAILURE,44,116,,67,125,treats,0.790569415042095,907551-FS1-2,Effects of enalapril on mortality in severe CONGESTIVE HEART FAILURE: results of the cooperative North Scandinavian ENALAPRIL survival study (consensus.,CONGESTIVE HEART FAILURE,ENALAPRIL,RO-may_treat
503460489,7/16/2014 13:38:48,,1324257188,7/16/2014 13:38:25,prodege,0.5958,1852770,USA,TX,Abilene,76.198.102.54,ENALAPRIL treats CONGESTIVE HEART FAILURE,44,116,,67,125,treats,0.790569415042095,907551-FS1-2,Effects of enalapril on mortality in severe CONGESTIVE HEART FAILURE: results of the cooperative North Scandinavian ENALAPRIL survival study (consensus.,CONGESTIVE HEART FAILURE,ENALAPRIL,RO-may_treat
503460489,7/16/2014 15:36:15,,1324300451,7/16/2014 15:36:09,prodege,0.5498,23541832,USA,AZ,Tempe,149.169.143.104,ENALAPRIL treats CONGESTIVE HEART FAILURE,44,116,,67,125,treats,0.790569415042095,907551-FS1-2,Effects of enalapril on mortality in severe CONGESTIVE HEART FAILURE: results of the cooperative North Scandinavian ENALAPRIL survival study (consensus.,CONGESTIVE HEART FAILURE,ENALAPRIL,RO-may_treat
503460489,7/16/2014 17:17:22,,1324343613,7/16/2014 17:16:22,prodege,0.521,19026375,GBR,Z1,Swansea,92.26.69.100,ENALAPRIL treats CONGESTIVE HEART FAILURE,44,116,,67,125,treats,0.790569415042095,907551-FS1-2,Effects of enalapril on mortality in severe CONGESTIVE HEART FAILURE: results of the cooperative North Scandinavian ENALAPRIL survival study (consensus.,CONGESTIVE HEART FAILURE,ENALAPRIL,RO-may_treat
503460490,7/16/2014 13:11:35,,1324245934,7/16/2014 13:11:22,clixsense,0.9167,20614047,USA,MO,Maryville,174.32.162.147,ARRHYTHMIAS contraindicates ANTIARRHYTHMIC DRUG EFFICACY,213,88,,223,116,contraindicates,0.304997140665209,907090-FS1-10,While maximal exercise testing is useful for detection of arrhythmias and assessment of ANTIARRHYTHMIC DRUG EFFICACY few reports have documented the safety of this procedure in patients with malignant ventricular ARRHYTHMIAS.,ARRHYTHMIAS,ANTIARRHYTHMIC DRUG EFFICACY,RO-may_prevent
503460490,7/16/2014 16:39:06,,1324330156,7/16/2014 16:38:57,prodege,0.5183,2143114,CAN,BC,Vancouver,24.84.160.12,ANTIARRHYTHMIC DRUG EFFICACY contraindicates ARRHYTHMIAS,213,88,,223,116,contraindicates,0.304997140665209,907090-FS1-10,While maximal exercise testing is useful for detection of arrhythmias and assessment of ANTIARRHYTHMIC DRUG EFFICACY few reports have documented the safety of this procedure in patients with malignant ventricular ARRHYTHMIAS.,ARRHYTHMIAS,ANTIARRHYTHMIC DRUG EFFICACY,RO-may_prevent
503460490,7/16/2014 18:34:40,,1324404352,7/16/2014 18:34:31,instagc,0.4563,15445601,USA,FL,Jacksonville,24.129.68.254,no_relation,213,88,,223,116,contraindicates,0.304997140665209,907090-FS1-10,While maximal exercise testing is useful for detection of arrhythmias and assessment of ANTIARRHYTHMIC DRUG EFFICACY few reports have documented the safety of this procedure in patients with malignant ventricular ARRHYTHMIAS.,ARRHYTHMIAS,ANTIARRHYTHMIC DRUG EFFICACY,RO-may_prevent
503460490,7/16/2014 18:48:19,,1324411496,7/16/2014 18:47:19,eup_slw,0.5873,28186528,USA,IN,Bloomington,74.204.124.9,ARRHYTHMIAS contraindicates ANTIARRHYTHMIC DRUG EFFICACY,213,88,,223,116,contraindicates,0.304997140665209,907090-FS1-10,While maximal exercise testing is useful for detection of arrhythmias and assessment of ANTIARRHYTHMIC DRUG EFFICACY few reports have documented the safety of this procedure in patients with malignant ventricular ARRHYTHMIAS.,ARRHYTHMIAS,ANTIARRHYTHMIC DRUG EFFICACY,RO-may_prevent
503460490,7/16/2014 19:29:04,,1324434073,7/16/2014 19:28:24,clixsense,0.5333,6714657,USA,CT,Groton,71.235.184.32,ANTIARRHYTHMIC DRUG EFFICACY contraindicates ARRHYTHMIAS,213,88,,223,116,contraindicates,0.304997140665209,907090-FS1-10,While maximal exercise testing is useful for detection of arrhythmias and assessment of ANTIARRHYTHMIC DRUG EFFICACY few reports have documented the safety of this procedure in patients with malignant ventricular ARRHYTHMIAS.,ARRHYTHMIAS,ANTIARRHYTHMIC DRUG EFFICACY,RO-may_prevent
503460490,7/16/2014 19:44:20,,1324441363,7/16/2014 19:43:28,prodege,0.3333,13391452,GBR,B7,Bristol,90.213.30.203,no_relation,213,88,,223,116,contraindicates,0.304997140665209,907090-FS1-10,While maximal exercise testing is useful for detection of arrhythmias and assessment of ANTIARRHYTHMIC DRUG EFFICACY few reports have documented the safety of this procedure in patients with malignant ventricular ARRHYTHMIAS.,ARRHYTHMIAS,ANTIARRHYTHMIC DRUG EFFICACY,RO-may_prevent
503460490,7/16/2014 19:56:33,,1324447192,7/16/2014 19:56:19,neodev,0.4286,18755947,GBR,H2,Accrington,80.47.185.52,no_relation,213,88,,223,116,contraindicates,0.304997140665209,907090-FS1-10,While maximal exercise testing is useful for detection of arrhythmias and assessment of ANTIARRHYTHMIC DRUG EFFICACY few reports have documented the safety of this procedure in patients with malignant ventricular ARRHYTHMIAS.,ARRHYTHMIAS,ANTIARRHYTHMIC DRUG EFFICACY,RO-may_prevent
503460491,7/16/2014 13:09:36,,1324245178,7/16/2014 13:09:18,tremorgames,0.8889,24449707,CAN,QC,Laval,96.21.249.72,no_relation,72,154,,92,166,treats,0.9704949588309459,907030-FS1-2,"In the trial based analysis, fondaparinux was estimated to prevent 15.1 THROMBOEMBOLIC EVENTS per 1000 patients at three months compared with enoxaparin; FONDAPARINUX produced cost savings per patient at 30 days, 3 months, and 5 years postdischarge.",THROMBOEMBOLIC EVENTS,FONDAPARINUX,RO-may_prevent
503460491,7/16/2014 13:16:41,,1324248032,7/16/2014 13:16:18,elite,0.7917,28503042,USA,NJ,Woodbridge,54.191.150.115,FONDAPARINUX treats THROMBOEMBOLIC EVENTS,72,154,,92,166,treats,0.9704949588309459,907030-FS1-2,"In the trial based analysis, fondaparinux was estimated to prevent 15.1 THROMBOEMBOLIC EVENTS per 1000 patients at three months compared with enoxaparin; FONDAPARINUX produced cost savings per patient at 30 days, 3 months, and 5 years postdischarge.",THROMBOEMBOLIC EVENTS,FONDAPARINUX,RO-may_prevent
503460491,7/16/2014 13:25:04,,1324251364,7/16/2014 13:24:48,neodev,0.6722,12115558,USA,OH,Twinsburg,75.187.196.41,FONDAPARINUX treats THROMBOEMBOLIC EVENTS,72,154,,92,166,treats,0.9704949588309459,907030-FS1-2,"In the trial based analysis, fondaparinux was estimated to prevent 15.1 THROMBOEMBOLIC EVENTS per 1000 patients at three months compared with enoxaparin; FONDAPARINUX produced cost savings per patient at 30 days, 3 months, and 5 years postdischarge.",THROMBOEMBOLIC EVENTS,FONDAPARINUX,RO-may_prevent
503460491,7/16/2014 13:33:23,,1324255066,7/16/2014 13:32:52,clixsense,0.7708,6564572,USA,MI,Kalamazoo,173.46.248.170,FONDAPARINUX treats THROMBOEMBOLIC EVENTS,72,154,,92,166,treats,0.9704949588309459,907030-FS1-2,"In the trial based analysis, fondaparinux was estimated to prevent 15.1 THROMBOEMBOLIC EVENTS per 1000 patients at three months compared with enoxaparin; FONDAPARINUX produced cost savings per patient at 30 days, 3 months, and 5 years postdischarge.",THROMBOEMBOLIC EVENTS,FONDAPARINUX,RO-may_prevent
503460491,7/16/2014 14:16:41,,1324272152,7/16/2014 14:16:20,instagc,0.7677,28301350,GBR,K4,Plymouth,92.28.208.109,FONDAPARINUX treats THROMBOEMBOLIC EVENTS,72,154,,92,166,treats,0.9704949588309459,907030-FS1-2,"In the trial based analysis, fondaparinux was estimated to prevent 15.1 THROMBOEMBOLIC EVENTS per 1000 patients at three months compared with enoxaparin; FONDAPARINUX produced cost savings per patient at 30 days, 3 months, and 5 years postdischarge.",THROMBOEMBOLIC EVENTS,FONDAPARINUX,RO-may_prevent
503460491,7/16/2014 14:54:22,,1324285797,7/16/2014 14:53:58,prodege,0.505,28039757,GBR,L8,Southport,109.155.158.54,THROMBOEMBOLIC EVENTS treats FONDAPARINUX,72,154,,92,166,treats,0.9704949588309459,907030-FS1-2,"In the trial based analysis, fondaparinux was estimated to prevent 15.1 THROMBOEMBOLIC EVENTS per 1000 patients at three months compared with enoxaparin; FONDAPARINUX produced cost savings per patient at 30 days, 3 months, and 5 years postdischarge.",THROMBOEMBOLIC EVENTS,FONDAPARINUX,RO-may_prevent
503460491,7/16/2014 16:39:49,,1324330524,7/16/2014 16:39:26,neodev,0.5359,14861092,GBR,H9,London,90.194.156.173,FONDAPARINUX treats THROMBOEMBOLIC EVENTS,72,154,,92,166,treats,0.9704949588309459,907030-FS1-2,"In the trial based analysis, fondaparinux was estimated to prevent 15.1 THROMBOEMBOLIC EVENTS per 1000 patients at three months compared with enoxaparin; FONDAPARINUX produced cost savings per patient at 30 days, 3 months, and 5 years postdischarge.",THROMBOEMBOLIC EVENTS,FONDAPARINUX,RO-may_prevent
503460498,7/16/2014 13:05:49,,1324243652,7/16/2014 13:05:33,clixsense,1.0,19803139,NLD,06,Veldhoven,212.61.84.196,ANGINA PECTORIS causes PAIN,5,40,,8,55,causes,0.875189948987367,904812-FS1-4,Such PAIN may be indistinguishable from ANGINA PECTORIS,PAIN,ANGINA PECTORIS,RO-has_definitional_manifestation
503460498,7/16/2014 13:34:39,,1324255686,7/16/2014 13:34:23,prodege,0.5958,1852770,USA,TX,Abilene,76.198.102.54,no_relation,5,40,,8,55,causes,0.875189948987367,904812-FS1-4,Such PAIN may be indistinguishable from ANGINA PECTORIS,PAIN,ANGINA PECTORIS,RO-has_definitional_manifestation
503460498,7/16/2014 14:54:45,,1324285930,7/16/2014 14:54:22,prodege,0.505,28039757,GBR,L8,Southport,109.155.158.54,no_relation,5,40,,8,55,causes,0.875189948987367,904812-FS1-4,Such PAIN may be indistinguishable from ANGINA PECTORIS,PAIN,ANGINA PECTORIS,RO-has_definitional_manifestation
503460498,7/16/2014 15:40:41,,1324302243,7/16/2014 15:40:17,prodege,0.5256,15220325,USA,PA,Troy,24.229.175.37,ANGINA PECTORIS causes PAIN,5,40,,8,55,causes,0.875189948987367,904812-FS1-4,Such PAIN may be indistinguishable from ANGINA PECTORIS,PAIN,ANGINA PECTORIS,RO-has_definitional_manifestation
503460498,7/16/2014 16:57:26,,1324337244,7/16/2014 16:56:54,instagc,0.6306,14941596,USA,KY,Erlanger,74.140.124.145,ANGINA PECTORIS causes PAIN,5,40,,8,55,causes,0.875189948987367,904812-FS1-4,Such PAIN may be indistinguishable from ANGINA PECTORIS,PAIN,ANGINA PECTORIS,RO-has_definitional_manifestation
503460498,7/16/2014 17:06:20,,1324340007,7/16/2014 17:06:14,prodege,0.4233,12944140,GBR,C8,Croydon,92.21.8.174,ANGINA PECTORIS causes PAIN,5,40,,8,55,causes,0.875189948987367,904812-FS1-4,Such PAIN may be indistinguishable from ANGINA PECTORIS,PAIN,ANGINA PECTORIS,RO-has_definitional_manifestation
503460498,7/16/2014 17:09:07,,1324341091,7/16/2014 17:08:43,clixsense,0.5952,19638651,USA,,,173.23.121.63,no_relation,5,40,,8,55,causes,0.875189948987367,904812-FS1-4,Such PAIN may be indistinguishable from ANGINA PECTORIS,PAIN,ANGINA PECTORIS,RO-has_definitional_manifestation
503468982,7/16/2014 15:32:19,,1324299133,7/16/2014 15:31:50,clixsense,0.9028,19803139,NLD,06,Veldhoven,212.61.84.196,no_relation,66,54,,84,62,causes,0.34815531191139604,907899-FS1-4,Lieberman A. Long term experience with selegiline and LEVODOPA in PARKINSON'S DISEASE,PARKINSON'S DISEASE,LEVODOPA,RO-may_treat
503468982,7/16/2014 15:36:40,,1324300618,7/16/2014 15:36:21,instagc,0.9028,13763729,USA,,,75.182.89.225,no_relation,66,54,,84,62,causes,0.34815531191139604,907899-FS1-4,Lieberman A. Long term experience with selegiline and LEVODOPA in PARKINSON'S DISEASE,PARKINSON'S DISEASE,LEVODOPA,RO-may_treat
503468982,7/16/2014 15:54:24,,1324308098,7/16/2014 15:53:49,rewardsspot,0.65,24482174,GBR,H9,London,46.23.68.180,LEVODOPA causes PARKINSON'S DISEASE,66,54,,84,62,causes,0.34815531191139604,907899-FS1-4,Lieberman A. Long term experience with selegiline and LEVODOPA in PARKINSON'S DISEASE,PARKINSON'S DISEASE,LEVODOPA,RO-may_treat
503468982,7/16/2014 16:15:27,,1324320175,7/16/2014 16:14:40,clixsense,0.4899,6574199,USA,TX,San Antonio,207.230.144.242,PARKINSON'S DISEASE causes LEVODOPA,66,54,,84,62,causes,0.34815531191139604,907899-FS1-4,Lieberman A. Long term experience with selegiline and LEVODOPA in PARKINSON'S DISEASE,PARKINSON'S DISEASE,LEVODOPA,RO-may_treat
503468982,7/16/2014 16:24:14,,1324323640,7/16/2014 16:23:47,neodev,0.5486,21515166,NLD,11,Nootdorp,83.86.58.179,LEVODOPA causes PARKINSON'S DISEASE,66,54,,84,62,causes,0.34815531191139604,907899-FS1-4,Lieberman A. Long term experience with selegiline and LEVODOPA in PARKINSON'S DISEASE,PARKINSON'S DISEASE,LEVODOPA,RO-may_treat
503468982,7/16/2014 17:02:24,,1324338927,7/16/2014 17:02:08,prodege,0.5583,12944140,GBR,C8,Croydon,92.21.8.174,LEVODOPA causes PARKINSON'S DISEASE,66,54,,84,62,causes,0.34815531191139604,907899-FS1-4,Lieberman A. Long term experience with selegiline and LEVODOPA in PARKINSON'S DISEASE,PARKINSON'S DISEASE,LEVODOPA,RO-may_treat
503468982,7/16/2014 18:18:53,,1324397399,7/16/2014 18:18:18,eup_slw,0.675,28186528,USA,IN,Bloomington,74.204.124.9,PARKINSON'S DISEASE causes LEVODOPA,66,54,,84,62,causes,0.34815531191139604,907899-FS1-4,Lieberman A. Long term experience with selegiline and LEVODOPA in PARKINSON'S DISEASE,PARKINSON'S DISEASE,LEVODOPA,RO-may_treat
503468983,7/16/2014 15:53:43,,1324307809,7/16/2014 15:53:18,rewardsspot,0.65,24482174,GBR,H9,London,46.23.68.180,HYPERTENSION treats CANDESARTAN CILEXETIL,117,61,,128,82,treats,0.975900072948533,907902-FS1-2,"Sever P, Holzgreve H. Long term efficacy and tolerability of CANDESARTAN CILEXETIL in patients with mild to moderate HYPERTENSION",HYPERTENSION,CANDESARTAN CILEXETIL,RO-may_treat
503468983,7/16/2014 16:51:28,,1324335116,7/16/2014 16:50:49,rewardsspot,0.6597,17763704,USA,VA,Manassas,198.7.62.204,HYPERTENSION treats CANDESARTAN CILEXETIL,117,61,,128,82,treats,0.975900072948533,907902-FS1-2,"Sever P, Holzgreve H. Long term efficacy and tolerability of CANDESARTAN CILEXETIL in patients with mild to moderate HYPERTENSION",HYPERTENSION,CANDESARTAN CILEXETIL,RO-may_treat
503468983,7/16/2014 17:29:58,,1324349316,7/16/2014 17:29:46,clixsense,0.6083,25595227,CAN,SK,North Battleford,24.72.96.119,CANDESARTAN CILEXETIL treats HYPERTENSION,117,61,,128,82,treats,0.975900072948533,907902-FS1-2,"Sever P, Holzgreve H. Long term efficacy and tolerability of CANDESARTAN CILEXETIL in patients with mild to moderate HYPERTENSION",HYPERTENSION,CANDESARTAN CILEXETIL,RO-may_treat
503468983,7/16/2014 20:36:26,,1324464812,7/16/2014 20:35:43,clixsense,0.4899,6574199,USA,TX,San Antonio,207.230.144.242,CANDESARTAN CILEXETIL treats HYPERTENSION,117,61,,128,82,treats,0.975900072948533,907902-FS1-2,"Sever P, Holzgreve H. Long term efficacy and tolerability of CANDESARTAN CILEXETIL in patients with mild to moderate HYPERTENSION",HYPERTENSION,CANDESARTAN CILEXETIL,RO-may_treat
503468983,7/16/2014 21:38:39,,1324493414,7/16/2014 21:38:14,clixsense,0.7516,24896327,GBR,V2,Glasgow,94.2.231.4,CANDESARTAN CILEXETIL treats HYPERTENSION,117,61,,128,82,treats,0.975900072948533,907902-FS1-2,"Sever P, Holzgreve H. Long term efficacy and tolerability of CANDESARTAN CILEXETIL in patients with mild to moderate HYPERTENSION",HYPERTENSION,CANDESARTAN CILEXETIL,RO-may_treat
503468983,7/16/2014 22:02:34,,1324502692,7/16/2014 22:02:03,clixsense,0.6754,6472283,USA,WI,Oak Creek,99.107.184.156,CANDESARTAN CILEXETIL treats HYPERTENSION,117,61,,128,82,treats,0.975900072948533,907902-FS1-2,"Sever P, Holzgreve H. Long term efficacy and tolerability of CANDESARTAN CILEXETIL in patients with mild to moderate HYPERTENSION",HYPERTENSION,CANDESARTAN CILEXETIL,RO-may_treat
503468983,7/16/2014 22:19:17,,1324508718,7/16/2014 22:18:46,clixsense,0.6101,19294877,USA,MA,Boston,96.233.18.114,CANDESARTAN CILEXETIL treats HYPERTENSION,117,61,,128,82,treats,0.975900072948533,907902-FS1-2,"Sever P, Holzgreve H. Long term efficacy and tolerability of CANDESARTAN CILEXETIL in patients with mild to moderate HYPERTENSION",HYPERTENSION,CANDESARTAN CILEXETIL,RO-may_treat
503468985,7/16/2014 15:29:08,,1324297987,7/16/2014 15:28:08,rewardsspot,0.65,24482174,GBR,H9,London,46.23.68.180,DRUG causes TOLERANCE,113,72,,116,81,causes,0.875189948987367,903548-FS1-4,The state of dependence was established by recording the development of TOLERANCE to the analgesic action of the DRUG and the effect of acute withdrawal of morphine and injection of nalorphine on one test group.2.,DRUG,TOLERANCE,RO-has_causative_agent
503468985,7/16/2014 15:29:29,,1324298116,7/16/2014 15:29:19,clixsense,0.9306,27793793,GBR,C5,Chester,151.230.27.155,DRUG causes TOLERANCE,113,72,,116,81,causes,0.875189948987367,903548-FS1-4,The state of dependence was established by recording the development of TOLERANCE to the analgesic action of the DRUG and the effect of acute withdrawal of morphine and injection of nalorphine on one test group.2.,DRUG,TOLERANCE,RO-has_causative_agent
503468985,7/16/2014 16:01:05,,1324311278,7/16/2014 16:00:49,clixsense,0.6111,17722340,CAN,BC,Mission,50.98.185.25,DRUG causes TOLERANCE,113,72,,116,81,causes,0.875189948987367,903548-FS1-4,The state of dependence was established by recording the development of TOLERANCE to the analgesic action of the DRUG and the effect of acute withdrawal of morphine and injection of nalorphine on one test group.2.,DRUG,TOLERANCE,RO-has_causative_agent
503468985,7/16/2014 16:41:22,,1324331433,7/16/2014 16:41:12,prodege,0.5091,2143114,CAN,BC,Vancouver,24.84.160.12,DRUG causes TOLERANCE,113,72,,116,81,causes,0.875189948987367,903548-FS1-4,The state of dependence was established by recording the development of TOLERANCE to the analgesic action of the DRUG and the effect of acute withdrawal of morphine and injection of nalorphine on one test group.2.,DRUG,TOLERANCE,RO-has_causative_agent
503468985,7/16/2014 16:48:35,,1324334200,7/16/2014 16:47:53,clixsense,0.7204,18647227,GBR,P3,Bulkington,2.216.185.243,no_relation,113,72,,116,81,causes,0.875189948987367,903548-FS1-4,The state of dependence was established by recording the development of TOLERANCE to the analgesic action of the DRUG and the effect of acute withdrawal of morphine and injection of nalorphine on one test group.2.,DRUG,TOLERANCE,RO-has_causative_agent
503468985,7/16/2014 20:43:57,,1324467733,7/16/2014 20:43:46,coinworker,0.4869,28394550,USA,PA,Marcus Hook,71.175.96.184,TOLERANCE causes DRUG,113,72,,116,81,causes,0.875189948987367,903548-FS1-4,The state of dependence was established by recording the development of TOLERANCE to the analgesic action of the DRUG and the effect of acute withdrawal of morphine and injection of nalorphine on one test group.2.,DRUG,TOLERANCE,RO-has_causative_agent
503468985,7/16/2014 21:38:12,,1324493263,7/16/2014 21:37:47,clixsense,0.7516,24896327,GBR,V2,Glasgow,94.2.231.4,no_relation,113,72,,116,81,causes,0.875189948987367,903548-FS1-4,The state of dependence was established by recording the development of TOLERANCE to the analgesic action of the DRUG and the effect of acute withdrawal of morphine and injection of nalorphine on one test group.2.,DRUG,TOLERANCE,RO-has_causative_agent
503468986,7/16/2014 15:38:14,,1324301181,7/16/2014 15:37:54,instagc,0.9028,13763729,USA,,,75.182.89.225,DIAZEPAM treats STATUS EPILEPTICUS,131,55,,148,63,treats,0.9363291775690441,908055-FS1-2,The effect of nimodipine alone and in combination with DIAZEPAM or phenytoin was tested in the electroshock induced mouse model of STATUS EPILEPTICUS,STATUS EPILEPTICUS,DIAZEPAM,RO-may_treat
503468986,7/16/2014 16:52:20,,1324335407,7/16/2014 16:51:47,clixsense,0.7204,18647227,GBR,P3,Bulkington,2.216.185.243,DIAZEPAM treats STATUS EPILEPTICUS,131,55,,148,63,treats,0.9363291775690441,908055-FS1-2,The effect of nimodipine alone and in combination with DIAZEPAM or phenytoin was tested in the electroshock induced mouse model of STATUS EPILEPTICUS,STATUS EPILEPTICUS,DIAZEPAM,RO-may_treat
503468986,7/16/2014 17:06:45,,1324340208,7/16/2014 17:06:29,instagc,0.6736,23149109,USA,NC,Cary,24.206.38.18,DIAZEPAM treats STATUS EPILEPTICUS,131,55,,148,63,treats,0.9363291775690441,908055-FS1-2,The effect of nimodipine alone and in combination with DIAZEPAM or phenytoin was tested in the electroshock induced mouse model of STATUS EPILEPTICUS,STATUS EPILEPTICUS,DIAZEPAM,RO-may_treat
503468986,7/16/2014 20:42:17,,1324467161,7/16/2014 20:41:59,prodege,0.6448,26325260,GBR,,,79.64.25.64,DIAZEPAM treats STATUS EPILEPTICUS,131,55,,148,63,treats,0.9363291775690441,908055-FS1-2,The effect of nimodipine alone and in combination with DIAZEPAM or phenytoin was tested in the electroshock induced mouse model of STATUS EPILEPTICUS,STATUS EPILEPTICUS,DIAZEPAM,RO-may_treat
503468986,7/16/2014 20:44:17,,1324467852,7/16/2014 20:44:13,coinworker,0.4869,28394550,USA,PA,Marcus Hook,71.175.96.184,STATUS EPILEPTICUS treats DIAZEPAM,131,55,,148,63,treats,0.9363291775690441,908055-FS1-2,The effect of nimodipine alone and in combination with DIAZEPAM or phenytoin was tested in the electroshock induced mouse model of STATUS EPILEPTICUS,STATUS EPILEPTICUS,DIAZEPAM,RO-may_treat
503468986,7/16/2014 22:55:47,,1324523740,7/16/2014 22:54:54,prodege,0.7282,12971342,USA,CA,Los Angeles,198.101.91.82,DIAZEPAM treats STATUS EPILEPTICUS,131,55,,148,63,treats,0.9363291775690441,908055-FS1-2,The effect of nimodipine alone and in combination with DIAZEPAM or phenytoin was tested in the electroshock induced mouse model of STATUS EPILEPTICUS,STATUS EPILEPTICUS,DIAZEPAM,RO-may_treat
503468986,7/16/2014 23:10:50,,1324528988,7/16/2014 23:10:27,instagc,0.6728,19636746,USA,NY,Andover,192.182.216.225,DIAZEPAM treats STATUS EPILEPTICUS,131,55,,148,63,treats,0.9363291775690441,908055-FS1-2,The effect of nimodipine alone and in combination with DIAZEPAM or phenytoin was tested in the electroshock induced mouse model of STATUS EPILEPTICUS,STATUS EPILEPTICUS,DIAZEPAM,RO-may_treat
503468988,7/16/2014 15:23:48,,1324296405,7/16/2014 15:23:33,tremorgames,1.0,24449707,CAN,QC,Laval,96.21.249.72,PYRIDOXINE treats PYRIDOXINE DEPENDENT SEIZURES,26,26,,54,36,treats,0.9901475429766742,908322-FS1-2,"In an infant with typical PYRIDOXINE DEPENDENT SEIZURES CSF GABA level, was determined before treatment with PYRIDOXINE",PYRIDOXINE DEPENDENT SEIZURES,PYRIDOXINE,RO-may_treat
503468988,7/16/2014 15:49:40,,1324306051,7/16/2014 15:49:18,clixsense,0.4792,16827630,GBR,A7,Birmingham,86.146.169.103,no_relation,26,26,,54,36,treats,0.9901475429766742,908322-FS1-2,"In an infant with typical PYRIDOXINE DEPENDENT SEIZURES CSF GABA level, was determined before treatment with PYRIDOXINE",PYRIDOXINE DEPENDENT SEIZURES,PYRIDOXINE,RO-may_treat
503468988,7/16/2014 15:52:33,,1324307339,7/16/2014 15:52:04,clixsense,0.775,27812714,NLD,06,Tilburg,84.31.160.155,PYRIDOXINE DEPENDENT SEIZURES treats PYRIDOXINE,26,26,,54,36,treats,0.9901475429766742,908322-FS1-2,"In an infant with typical PYRIDOXINE DEPENDENT SEIZURES CSF GABA level, was determined before treatment with PYRIDOXINE",PYRIDOXINE DEPENDENT SEIZURES,PYRIDOXINE,RO-may_treat
503468988,7/16/2014 17:06:45,,1324340212,7/16/2014 17:06:29,instagc,0.6736,23149109,USA,NC,Cary,24.206.38.18,PYRIDOXINE treats PYRIDOXINE DEPENDENT SEIZURES,26,26,,54,36,treats,0.9901475429766742,908322-FS1-2,"In an infant with typical PYRIDOXINE DEPENDENT SEIZURES CSF GABA level, was determined before treatment with PYRIDOXINE",PYRIDOXINE DEPENDENT SEIZURES,PYRIDOXINE,RO-may_treat
503468988,7/16/2014 19:30:43,,1324434769,7/16/2014 19:29:40,clixsense,0.6758,27871219,NLD,07,Amsterdam,87.210.207.223,PYRIDOXINE treats PYRIDOXINE DEPENDENT SEIZURES,26,26,,54,36,treats,0.9901475429766742,908322-FS1-2,"In an infant with typical PYRIDOXINE DEPENDENT SEIZURES CSF GABA level, was determined before treatment with PYRIDOXINE",PYRIDOXINE DEPENDENT SEIZURES,PYRIDOXINE,RO-may_treat
503468988,7/16/2014 22:53:14,,1324522599,7/16/2014 22:52:21,prodege,0.5665,28255346,GBR,L9,Sheffield,2.125.183.137,PYRIDOXINE treats PYRIDOXINE DEPENDENT SEIZURES,26,26,,54,36,treats,0.9901475429766742,908322-FS1-2,"In an infant with typical PYRIDOXINE DEPENDENT SEIZURES CSF GABA level, was determined before treatment with PYRIDOXINE",PYRIDOXINE DEPENDENT SEIZURES,PYRIDOXINE,RO-may_treat
503468988,7/16/2014 22:56:58,,1324524241,7/16/2014 22:56:28,prodege,0.7282,12971342,USA,CA,Los Angeles,198.101.91.82,PYRIDOXINE treats PYRIDOXINE DEPENDENT SEIZURES,26,26,,54,36,treats,0.9901475429766742,908322-FS1-2,"In an infant with typical PYRIDOXINE DEPENDENT SEIZURES CSF GABA level, was determined before treatment with PYRIDOXINE",PYRIDOXINE DEPENDENT SEIZURES,PYRIDOXINE,RO-may_treat
503468989,7/16/2014 15:23:33,,1324296343,7/16/2014 15:23:15,tremorgames,1.0,24449707,CAN,QC,Laval,96.21.249.72,PREECLAMPSIA causes COMPLICATION OF PREGNANCY,22,0,,46,12,causes,0.8955334711889901,901620-FS1-4,PREECLAMPSIA a common COMPLICATION OF PREGNANCY is associated with alteration in the concentration of leptin in maternal blood.,COMPLICATION OF PREGNANCY,PREECLAMPSIA,RO-disease_has_finding
503468989,7/16/2014 15:29:29,,1324298130,7/16/2014 15:29:19,clixsense,0.9306,27793793,GBR,C5,Chester,151.230.27.155,PREECLAMPSIA causes COMPLICATION OF PREGNANCY,22,0,,46,12,causes,0.8955334711889901,901620-FS1-4,PREECLAMPSIA a common COMPLICATION OF PREGNANCY is associated with alteration in the concentration of leptin in maternal blood.,COMPLICATION OF PREGNANCY,PREECLAMPSIA,RO-disease_has_finding
503468989,7/16/2014 15:31:51,,1324298987,7/16/2014 15:31:37,instagc,0.8611,24252915,GBR,B7,Bristol,77.98.139.82,PREECLAMPSIA causes COMPLICATION OF PREGNANCY,22,0,,46,12,causes,0.8955334711889901,901620-FS1-4,PREECLAMPSIA a common COMPLICATION OF PREGNANCY is associated with alteration in the concentration of leptin in maternal blood.,COMPLICATION OF PREGNANCY,PREECLAMPSIA,RO-disease_has_finding
503468989,7/16/2014 16:47:17,,1324333700,7/16/2014 16:47:11,clixsense,0.6125,19162475,GBR,M3,Frome,82.33.126.30,PREECLAMPSIA causes COMPLICATION OF PREGNANCY,22,0,,46,12,causes,0.8955334711889901,901620-FS1-4,PREECLAMPSIA a common COMPLICATION OF PREGNANCY is associated with alteration in the concentration of leptin in maternal blood.,COMPLICATION OF PREGNANCY,PREECLAMPSIA,RO-disease_has_finding
503468989,7/16/2014 17:02:30,,1324338940,7/16/2014 17:02:25,prodege,0.5583,12944140,GBR,C8,Croydon,92.21.8.174,COMPLICATION OF PREGNANCY causes PREECLAMPSIA,22,0,,46,12,causes,0.8955334711889901,901620-FS1-4,PREECLAMPSIA a common COMPLICATION OF PREGNANCY is associated with alteration in the concentration of leptin in maternal blood.,COMPLICATION OF PREGNANCY,PREECLAMPSIA,RO-disease_has_finding
503468989,7/16/2014 19:24:48,,1324431863,7/16/2014 19:24:20,clixsense,0.5444,6714657,USA,CT,Groton,71.235.184.32,PREECLAMPSIA causes COMPLICATION OF PREGNANCY,22,0,,46,12,causes,0.8955334711889901,901620-FS1-4,PREECLAMPSIA a common COMPLICATION OF PREGNANCY is associated with alteration in the concentration of leptin in maternal blood.,COMPLICATION OF PREGNANCY,PREECLAMPSIA,RO-disease_has_finding
503468989,7/16/2014 19:31:23,,1324435148,7/16/2014 19:30:45,clixsense,0.6758,27871219,NLD,07,Amsterdam,87.210.207.223,PREECLAMPSIA causes COMPLICATION OF PREGNANCY,22,0,,46,12,causes,0.8955334711889901,901620-FS1-4,PREECLAMPSIA a common COMPLICATION OF PREGNANCY is associated with alteration in the concentration of leptin in maternal blood.,COMPLICATION OF PREGNANCY,PREECLAMPSIA,RO-disease_has_finding
503468996,7/16/2014 15:49:55,,1324306199,7/16/2014 15:49:46,prodege,0.7083,9525153,CAN,ON,Toronto,65.95.94.44,DCIS diagnosed by CALCIFICATIONS,38,61,,51,65,diagnosed by,0.7022468831767831,902978-FS1-13,C. Excisional biopsy of the remaining CALCIFICATIONS reveals DCIS,CALCIFICATIONS,DCIS,RO-disease_may_have_finding
503468996,7/16/2014 16:20:15,,1324322087,7/16/2014 16:19:49,clixsense,0.7708,28324391,NLD,11,Hazerswoude-rijndijk,94.208.82.215,DCIS diagnosed by CALCIFICATIONS,38,61,,51,65,diagnosed by,0.7022468831767831,902978-FS1-13,C. Excisional biopsy of the remaining CALCIFICATIONS reveals DCIS,CALCIFICATIONS,DCIS,RO-disease_may_have_finding
503468996,7/16/2014 16:22:22,,1324322885,7/16/2014 16:21:45,prodege,0.6736,13300986,CAN,AB,Edmonton,68.150.33.230,DCIS diagnosed by CALCIFICATIONS,38,61,,51,65,diagnosed by,0.7022468831767831,902978-FS1-13,C. Excisional biopsy of the remaining CALCIFICATIONS reveals DCIS,CALCIFICATIONS,DCIS,RO-disease_may_have_finding
503468996,7/16/2014 18:16:50,,1324395480,7/16/2014 18:16:08,eup_slw,0.675,28186528,USA,IN,Bloomington,74.204.124.9,DCIS diagnosed by CALCIFICATIONS,38,61,,51,65,diagnosed by,0.7022468831767831,902978-FS1-13,C. Excisional biopsy of the remaining CALCIFICATIONS reveals DCIS,CALCIFICATIONS,DCIS,RO-disease_may_have_finding
503468996,7/16/2014 20:10:18,,1324452901,7/16/2014 20:10:12,tremorgames,0.6605,28013393,USA,CA,Rancho Cordova,71.197.67.37,DCIS diagnosed by CALCIFICATIONS,38,61,,51,65,diagnosed by,0.7022468831767831,902978-FS1-13,C. Excisional biopsy of the remaining CALCIFICATIONS reveals DCIS,CALCIFICATIONS,DCIS,RO-disease_may_have_finding
503468996,7/16/2014 20:36:15,,1324464713,7/16/2014 20:35:40,bitcoinget,0.8333,27766138,USA,AL,Birmingham,12.208.238.130,DCIS diagnosed by CALCIFICATIONS,38,61,,51,65,diagnosed by,0.7022468831767831,902978-FS1-13,C. Excisional biopsy of the remaining CALCIFICATIONS reveals DCIS,CALCIFICATIONS,DCIS,RO-disease_may_have_finding
503468996,7/16/2014 20:44:30,,1324467954,7/16/2014 20:44:25,coinworker,0.4869,28394550,USA,PA,Marcus Hook,71.175.96.184,CALCIFICATIONS diagnosed by DCIS,38,61,,51,65,diagnosed by,0.7022468831767831,902978-FS1-13,C. Excisional biopsy of the remaining CALCIFICATIONS reveals DCIS,CALCIFICATIONS,DCIS,RO-disease_may_have_finding
503469001,7/16/2014 15:31:36,,1324298900,7/16/2014 15:31:08,instagc,0.8611,24252915,GBR,B7,Bristol,77.98.139.82,no_relation,46,89,,67,110,diagnosed by,0.320256307610174,900492-FS1-13,It also allowed to predict the development of POSTTRAUMATIC EPILEPSY in individuals with CRANIOCEREBRAL TRAUMA in the past.,POSTTRAUMATIC EPILEPSY,CRANIOCEREBRAL TRAUMA,RO-cause_of
503469001,7/16/2014 15:40:25,,1324302140,7/16/2014 15:39:47,clixsense,0.8333,15189335,GBR,I9,Bury Saint Edmunds,81.155.129.231,POSTTRAUMATIC EPILEPSY diagnosed by CRANIOCEREBRAL TRAUMA,46,89,,67,110,diagnosed by,0.320256307610174,900492-FS1-13,It also allowed to predict the development of POSTTRAUMATIC EPILEPSY in individuals with CRANIOCEREBRAL TRAUMA in the past.,POSTTRAUMATIC EPILEPSY,CRANIOCEREBRAL TRAUMA,RO-cause_of
503469001,7/16/2014 15:49:19,,1324305899,7/16/2014 15:49:10,prodege,0.7083,9525153,CAN,ON,Toronto,65.95.94.44,CRANIOCEREBRAL TRAUMA diagnosed by POSTTRAUMATIC EPILEPSY,46,89,,67,110,diagnosed by,0.320256307610174,900492-FS1-13,It also allowed to predict the development of POSTTRAUMATIC EPILEPSY in individuals with CRANIOCEREBRAL TRAUMA in the past.,POSTTRAUMATIC EPILEPSY,CRANIOCEREBRAL TRAUMA,RO-cause_of
503469001,7/16/2014 17:09:00,,1324341036,7/16/2014 17:08:42,neodev,0.5903,18339121,USA,SC,Sumter,173.93.188.194,CRANIOCEREBRAL TRAUMA diagnosed by POSTTRAUMATIC EPILEPSY,46,89,,67,110,diagnosed by,0.320256307610174,900492-FS1-13,It also allowed to predict the development of POSTTRAUMATIC EPILEPSY in individuals with CRANIOCEREBRAL TRAUMA in the past.,POSTTRAUMATIC EPILEPSY,CRANIOCEREBRAL TRAUMA,RO-cause_of
503469001,7/16/2014 17:19:50,,1324344347,7/16/2014 17:19:32,prodege,0.6046,23541832,USA,AZ,Tempe,149.169.143.104,CRANIOCEREBRAL TRAUMA diagnosed by POSTTRAUMATIC EPILEPSY,46,89,,67,110,diagnosed by,0.320256307610174,900492-FS1-13,It also allowed to predict the development of POSTTRAUMATIC EPILEPSY in individuals with CRANIOCEREBRAL TRAUMA in the past.,POSTTRAUMATIC EPILEPSY,CRANIOCEREBRAL TRAUMA,RO-cause_of
503469001,7/16/2014 17:30:21,,1324349566,7/16/2014 17:29:59,clixsense,0.6083,25595227,CAN,SK,North Battleford,24.72.96.119,no_relation,46,89,,67,110,diagnosed by,0.320256307610174,900492-FS1-13,It also allowed to predict the development of POSTTRAUMATIC EPILEPSY in individuals with CRANIOCEREBRAL TRAUMA in the past.,POSTTRAUMATIC EPILEPSY,CRANIOCEREBRAL TRAUMA,RO-cause_of
503469001,7/16/2014 19:29:39,,1324434325,7/16/2014 19:28:58,clixsense,0.6758,27871219,NLD,07,Amsterdam,87.210.207.223,POSTTRAUMATIC EPILEPSY diagnosed by CRANIOCEREBRAL TRAUMA,46,89,,67,110,diagnosed by,0.320256307610174,900492-FS1-13,It also allowed to predict the development of POSTTRAUMATIC EPILEPSY in individuals with CRANIOCEREBRAL TRAUMA in the past.,POSTTRAUMATIC EPILEPSY,CRANIOCEREBRAL TRAUMA,RO-cause_of
503469006,7/16/2014 15:23:48,,1324296401,7/16/2014 15:23:33,tremorgames,1.0,24449707,CAN,QC,Laval,96.21.249.72,no_relation,173,220,,178,235,diagnosed by,0.744208407535251,903990-FS1-13,The results highlight the importance of gluten challenge and intestinal biopsy in the diagnosis of coeliac disease and strongly suggest that a normal biopsy after a 3 month GLUTEN challenge (as described above) excludes COELIAC DISEASE.,GLUTEN,COELIAC DISEASE,RO-has_causative_agent
503469006,7/16/2014 15:49:40,,1324306052,7/16/2014 15:49:18,clixsense,0.4792,16827630,GBR,A7,Birmingham,86.146.169.103,no_relation,173,220,,178,235,diagnosed by,0.744208407535251,903990-FS1-13,The results highlight the importance of gluten challenge and intestinal biopsy in the diagnosis of coeliac disease and strongly suggest that a normal biopsy after a 3 month GLUTEN challenge (as described above) excludes COELIAC DISEASE.,GLUTEN,COELIAC DISEASE,RO-has_causative_agent
503469006,7/16/2014 17:45:51,,1324362974,7/16/2014 17:45:24,gifthulk,0.7524,21916793,GBR,,,87.113.87.199,no_relation,173,220,,178,235,diagnosed by,0.744208407535251,903990-FS1-13,The results highlight the importance of gluten challenge and intestinal biopsy in the diagnosis of coeliac disease and strongly suggest that a normal biopsy after a 3 month GLUTEN challenge (as described above) excludes COELIAC DISEASE.,GLUTEN,COELIAC DISEASE,RO-has_causative_agent
503469006,7/16/2014 18:17:32,,1324396264,7/16/2014 18:16:51,eup_slw,0.675,28186528,USA,IN,Bloomington,74.204.124.9,no_relation,173,220,,178,235,diagnosed by,0.744208407535251,903990-FS1-13,The results highlight the importance of gluten challenge and intestinal biopsy in the diagnosis of coeliac disease and strongly suggest that a normal biopsy after a 3 month GLUTEN challenge (as described above) excludes COELIAC DISEASE.,GLUTEN,COELIAC DISEASE,RO-has_causative_agent
503469006,7/16/2014 19:08:44,,1324423792,7/16/2014 19:07:49,vivatic,0.6952,25451531,GBR,,,83.67.28.193,COELIAC DISEASE diagnosed by GLUTEN,173,220,,178,235,diagnosed by,0.744208407535251,903990-FS1-13,The results highlight the importance of gluten challenge and intestinal biopsy in the diagnosis of coeliac disease and strongly suggest that a normal biopsy after a 3 month GLUTEN challenge (as described above) excludes COELIAC DISEASE.,GLUTEN,COELIAC DISEASE,RO-has_causative_agent
503469006,7/16/2014 20:34:56,,1324464173,7/16/2014 20:34:13,clixsense,0.4899,6574199,USA,TX,San Antonio,207.230.144.242,no_relation,173,220,,178,235,diagnosed by,0.744208407535251,903990-FS1-13,The results highlight the importance of gluten challenge and intestinal biopsy in the diagnosis of coeliac disease and strongly suggest that a normal biopsy after a 3 month GLUTEN challenge (as described above) excludes COELIAC DISEASE.,GLUTEN,COELIAC DISEASE,RO-has_causative_agent
503469006,7/16/2014 20:41:15,,1324466780,7/16/2014 20:40:22,prodege,0.6448,26325260,GBR,,,79.64.25.64,COELIAC DISEASE diagnosed by GLUTEN,173,220,,178,235,diagnosed by,0.744208407535251,903990-FS1-13,The results highlight the importance of gluten challenge and intestinal biopsy in the diagnosis of coeliac disease and strongly suggest that a normal biopsy after a 3 month GLUTEN challenge (as described above) excludes COELIAC DISEASE.,GLUTEN,COELIAC DISEASE,RO-has_causative_agent
503469007,7/16/2014 15:25:37,,1324296984,7/16/2014 15:25:24,clixsense,0.9028,20614047,USA,MO,Maryville,174.32.162.147,VENTRICULAR TACHYCARDIA causes ATRIOVENTRICULAR NODAL REENTRANT TACHYCARDIA,234,189,,277,212,causes,0.8164965809277259,904794-FS1-4,Radiofrequency catheter ablation of the slow atrioventricular nodal pathway resulted in cure of atrioventricular nodal reentrant tachycardia and the prevention of spontaneous recurrence of VENTRICULAR TACHYCARDIA suggesting a role of ATRIOVENTRICULAR NODAL REENTRANT TACHYCARDIA in triggering the clinical episodes of ventricular tachycardia.,ATRIOVENTRICULAR NODAL REENTRANT TACHYCARDIA,VENTRICULAR TACHYCARDIA,RO-has_definitional_manifestation
503469007,7/16/2014 15:36:59,,1324300737,7/16/2014 15:36:41,instagc,0.9028,13763729,USA,,,75.182.89.225,ATRIOVENTRICULAR NODAL REENTRANT TACHYCARDIA causes VENTRICULAR TACHYCARDIA,234,189,,277,212,causes,0.8164965809277259,904794-FS1-4,Radiofrequency catheter ablation of the slow atrioventricular nodal pathway resulted in cure of atrioventricular nodal reentrant tachycardia and the prevention of spontaneous recurrence of VENTRICULAR TACHYCARDIA suggesting a role of ATRIOVENTRICULAR NODAL REENTRANT TACHYCARDIA in triggering the clinical episodes of ventricular tachycardia.,ATRIOVENTRICULAR NODAL REENTRANT TACHYCARDIA,VENTRICULAR TACHYCARDIA,RO-has_definitional_manifestation
503469007,7/16/2014 15:43:51,,1324303633,7/16/2014 15:43:36,instagc,0.8194,18960682,GBR,,,86.29.147.112,VENTRICULAR TACHYCARDIA causes ATRIOVENTRICULAR NODAL REENTRANT TACHYCARDIA,234,189,,277,212,causes,0.8164965809277259,904794-FS1-4,Radiofrequency catheter ablation of the slow atrioventricular nodal pathway resulted in cure of atrioventricular nodal reentrant tachycardia and the prevention of spontaneous recurrence of VENTRICULAR TACHYCARDIA suggesting a role of ATRIOVENTRICULAR NODAL REENTRANT TACHYCARDIA in triggering the clinical episodes of ventricular tachycardia.,ATRIOVENTRICULAR NODAL REENTRANT TACHYCARDIA,VENTRICULAR TACHYCARDIA,RO-has_definitional_manifestation
503469007,7/16/2014 16:23:24,,1324323310,7/16/2014 16:22:47,neodev,0.5486,21515166,NLD,11,Nootdorp,83.86.58.179,VENTRICULAR TACHYCARDIA causes ATRIOVENTRICULAR NODAL REENTRANT TACHYCARDIA,234,189,,277,212,causes,0.8164965809277259,904794-FS1-4,Radiofrequency catheter ablation of the slow atrioventricular nodal pathway resulted in cure of atrioventricular nodal reentrant tachycardia and the prevention of spontaneous recurrence of VENTRICULAR TACHYCARDIA suggesting a role of ATRIOVENTRICULAR NODAL REENTRANT TACHYCARDIA in triggering the clinical episodes of ventricular tachycardia.,ATRIOVENTRICULAR NODAL REENTRANT TACHYCARDIA,VENTRICULAR TACHYCARDIA,RO-has_definitional_manifestation
503469007,7/16/2014 17:06:04,,1324339931,7/16/2014 17:05:26,clixsense,0.5597,19638651,USA,,,173.23.121.63,ATRIOVENTRICULAR NODAL REENTRANT TACHYCARDIA causes VENTRICULAR TACHYCARDIA,234,189,,277,212,causes,0.8164965809277259,904794-FS1-4,Radiofrequency catheter ablation of the slow atrioventricular nodal pathway resulted in cure of atrioventricular nodal reentrant tachycardia and the prevention of spontaneous recurrence of VENTRICULAR TACHYCARDIA suggesting a role of ATRIOVENTRICULAR NODAL REENTRANT TACHYCARDIA in triggering the clinical episodes of ventricular tachycardia.,ATRIOVENTRICULAR NODAL REENTRANT TACHYCARDIA,VENTRICULAR TACHYCARDIA,RO-has_definitional_manifestation
503469007,7/16/2014 17:41:06,,1324358129,7/16/2014 17:40:27,clixsense,0.5657,23398628,USA,WA,Spanaway,50.149.99.43,VENTRICULAR TACHYCARDIA causes ATRIOVENTRICULAR NODAL REENTRANT TACHYCARDIA,234,189,,277,212,causes,0.8164965809277259,904794-FS1-4,Radiofrequency catheter ablation of the slow atrioventricular nodal pathway resulted in cure of atrioventricular nodal reentrant tachycardia and the prevention of spontaneous recurrence of VENTRICULAR TACHYCARDIA suggesting a role of ATRIOVENTRICULAR NODAL REENTRANT TACHYCARDIA in triggering the clinical episodes of ventricular tachycardia.,ATRIOVENTRICULAR NODAL REENTRANT TACHYCARDIA,VENTRICULAR TACHYCARDIA,RO-has_definitional_manifestation
503469007,7/16/2014 20:41:57,,1324467071,7/16/2014 20:41:16,prodege,0.6448,26325260,GBR,,,79.64.25.64,VENTRICULAR TACHYCARDIA causes ATRIOVENTRICULAR NODAL REENTRANT TACHYCARDIA,234,189,,277,212,causes,0.8164965809277259,904794-FS1-4,Radiofrequency catheter ablation of the slow atrioventricular nodal pathway resulted in cure of atrioventricular nodal reentrant tachycardia and the prevention of spontaneous recurrence of VENTRICULAR TACHYCARDIA suggesting a role of ATRIOVENTRICULAR NODAL REENTRANT TACHYCARDIA in triggering the clinical episodes of ventricular tachycardia.,ATRIOVENTRICULAR NODAL REENTRANT TACHYCARDIA,VENTRICULAR TACHYCARDIA,RO-has_definitional_manifestation
503469010,7/16/2014 15:24:14,,1324296570,7/16/2014 15:23:49,tremorgames,1.0,24449707,CAN,QC,Laval,96.21.249.72,PAROXETINE treats PANIC DISORDER,112,142,,125,152,treats,0.9701425001453321,907829-FS1-2,"Lecrubier Y, Bakker A, Dunbar G et al. A comparison of paroxetine, clomipramine and placebo in the treatment of PANIC DISORDER: Collaborative PAROXETINE Panic Study Investigators.",PANIC DISORDER,PAROXETINE,RO-may_treat
503469010,7/16/2014 15:30:45,,1324298608,7/16/2014 15:30:19,clixsense,0.9028,19803139,NLD,06,Veldhoven,212.61.84.196,PAROXETINE treats PANIC DISORDER,112,142,,125,152,treats,0.9701425001453321,907829-FS1-2,"Lecrubier Y, Bakker A, Dunbar G et al. A comparison of paroxetine, clomipramine and placebo in the treatment of PANIC DISORDER: Collaborative PAROXETINE Panic Study Investigators.",PANIC DISORDER,PAROXETINE,RO-may_treat
503469010,7/16/2014 16:21:07,,1324322426,7/16/2014 16:20:27,instagc,0.5972,19436046,GBR,U3,Dundee,82.36.106.184,PAROXETINE treats PANIC DISORDER,112,142,,125,152,treats,0.9701425001453321,907829-FS1-2,"Lecrubier Y, Bakker A, Dunbar G et al. A comparison of paroxetine, clomipramine and placebo in the treatment of PANIC DISORDER: Collaborative PAROXETINE Panic Study Investigators.",PANIC DISORDER,PAROXETINE,RO-may_treat
503469010,7/16/2014 17:08:38,,1324340914,7/16/2014 17:08:18,neodev,0.5903,18339121,USA,SC,Sumter,173.93.188.194,PAROXETINE treats PANIC DISORDER,112,142,,125,152,treats,0.9701425001453321,907829-FS1-2,"Lecrubier Y, Bakker A, Dunbar G et al. A comparison of paroxetine, clomipramine and placebo in the treatment of PANIC DISORDER: Collaborative PAROXETINE Panic Study Investigators.",PANIC DISORDER,PAROXETINE,RO-may_treat
503469010,7/16/2014 19:29:39,,1324434327,7/16/2014 19:28:58,clixsense,0.6758,27871219,NLD,07,Amsterdam,87.210.207.223,PAROXETINE treats PANIC DISORDER,112,142,,125,152,treats,0.9701425001453321,907829-FS1-2,"Lecrubier Y, Bakker A, Dunbar G et al. A comparison of paroxetine, clomipramine and placebo in the treatment of PANIC DISORDER: Collaborative PAROXETINE Panic Study Investigators.",PANIC DISORDER,PAROXETINE,RO-may_treat
503469010,7/16/2014 19:46:33,,1324442533,7/16/2014 19:46:10,prodege,0.4306,13391452,GBR,B7,Bristol,90.213.30.203,no_relation,112,142,,125,152,treats,0.9701425001453321,907829-FS1-2,"Lecrubier Y, Bakker A, Dunbar G et al. A comparison of paroxetine, clomipramine and placebo in the treatment of PANIC DISORDER: Collaborative PAROXETINE Panic Study Investigators.",PANIC DISORDER,PAROXETINE,RO-may_treat
503469010,7/16/2014 23:30:29,,1324537742,7/16/2014 23:30:00,zoombucks,0.7409,4688131,CAN,BC,Vancouver,108.180.143.28,PAROXETINE treats PANIC DISORDER,112,142,,125,152,treats,0.9701425001453321,907829-FS1-2,"Lecrubier Y, Bakker A, Dunbar G et al. A comparison of paroxetine, clomipramine and placebo in the treatment of PANIC DISORDER: Collaborative PAROXETINE Panic Study Investigators.",PANIC DISORDER,PAROXETINE,RO-may_treat
503469018,7/16/2014 15:44:12,,1324303756,7/16/2014 15:44:00,instagc,0.8194,18960682,GBR,,,86.29.147.112,AMLODIPINE treats HYPERTENSION,62,111,,73,121,treats,0.984731927834662,907516-FS1-2,"11  >     Benazepril/Amlodipine Fixed combination Therapy for HYPERTENSION  Oral:  In studies using benazepril/AMLODIPINE fixed combination in dosages of benazepril hydrochloride 10 40 mg daily and amlodipine 2.5 10 mg daily, BP response increased with increasing amlodipine dosage in all patient groups and increased with increasing benazepril dosage in nonblack patient groups.",HYPERTENSION,AMLODIPINE,RO-may_treat
503469018,7/16/2014 16:48:35,,1324334199,7/16/2014 16:47:53,clixsense,0.7204,18647227,GBR,P3,Bulkington,2.216.185.243,AMLODIPINE treats HYPERTENSION,62,111,,73,121,treats,0.984731927834662,907516-FS1-2,"11  >     Benazepril/Amlodipine Fixed combination Therapy for HYPERTENSION  Oral:  In studies using benazepril/AMLODIPINE fixed combination in dosages of benazepril hydrochloride 10 40 mg daily and amlodipine 2.5 10 mg daily, BP response increased with increasing amlodipine dosage in all patient groups and increased with increasing benazepril dosage in nonblack patient groups.",HYPERTENSION,AMLODIPINE,RO-may_treat
503469018,7/16/2014 18:16:06,,1324394648,7/16/2014 18:15:35,eup_slw,0.675,28186528,USA,IN,Bloomington,74.204.124.9,AMLODIPINE treats HYPERTENSION,62,111,,73,121,treats,0.984731927834662,907516-FS1-2,"11  >     Benazepril/Amlodipine Fixed combination Therapy for HYPERTENSION  Oral:  In studies using benazepril/AMLODIPINE fixed combination in dosages of benazepril hydrochloride 10 40 mg daily and amlodipine 2.5 10 mg daily, BP response increased with increasing amlodipine dosage in all patient groups and increased with increasing benazepril dosage in nonblack patient groups.",HYPERTENSION,AMLODIPINE,RO-may_treat
503469018,7/16/2014 22:02:34,,1324502693,7/16/2014 22:02:03,clixsense,0.6754,6472283,USA,WI,Oak Creek,99.107.184.156,AMLODIPINE treats HYPERTENSION,62,111,,73,121,treats,0.984731927834662,907516-FS1-2,"11  >     Benazepril/Amlodipine Fixed combination Therapy for HYPERTENSION  Oral:  In studies using benazepril/AMLODIPINE fixed combination in dosages of benazepril hydrochloride 10 40 mg daily and amlodipine 2.5 10 mg daily, BP response increased with increasing amlodipine dosage in all patient groups and increased with increasing benazepril dosage in nonblack patient groups.",HYPERTENSION,AMLODIPINE,RO-may_treat
503469018,7/16/2014 23:49:34,,1324545516,7/16/2014 23:49:21,clixsense,0.6734,23585686,GBR,H9,London,31.51.221.173,AMLODIPINE treats HYPERTENSION,62,111,,73,121,treats,0.984731927834662,907516-FS1-2,"11  >     Benazepril/Amlodipine Fixed combination Therapy for HYPERTENSION  Oral:  In studies using benazepril/AMLODIPINE fixed combination in dosages of benazepril hydrochloride 10 40 mg daily and amlodipine 2.5 10 mg daily, BP response increased with increasing amlodipine dosage in all patient groups and increased with increasing benazepril dosage in nonblack patient groups.",HYPERTENSION,AMLODIPINE,RO-may_treat
503469018,7/17/2014 00:27:15,,1324563531,7/17/2014 00:26:28,prodege,0.335,24403612,CAN,ON,Ajax,99.242.234.239,no_relation,62,111,,73,121,treats,0.984731927834662,907516-FS1-2,"11  >     Benazepril/Amlodipine Fixed combination Therapy for HYPERTENSION  Oral:  In studies using benazepril/AMLODIPINE fixed combination in dosages of benazepril hydrochloride 10 40 mg daily and amlodipine 2.5 10 mg daily, BP response increased with increasing amlodipine dosage in all patient groups and increased with increasing benazepril dosage in nonblack patient groups.",HYPERTENSION,AMLODIPINE,RO-may_treat
503469018,7/17/2014 02:20:32,,1324672641,7/17/2014 02:20:24,pokerowned,0.5583,18747884,USA,MI,Saginaw,74.85.192.98,AMLODIPINE treats HYPERTENSION,62,111,,73,121,treats,0.984731927834662,907516-FS1-2,"11  >     Benazepril/Amlodipine Fixed combination Therapy for HYPERTENSION  Oral:  In studies using benazepril/AMLODIPINE fixed combination in dosages of benazepril hydrochloride 10 40 mg daily and amlodipine 2.5 10 mg daily, BP response increased with increasing amlodipine dosage in all patient groups and increased with increasing benazepril dosage in nonblack patient groups.",HYPERTENSION,AMLODIPINE,RO-may_treat
503469019,7/16/2014 15:29:46,,1324298246,7/16/2014 15:29:38,clixsense,0.9306,27793793,GBR,C5,Chester,151.230.27.155,NICOTINE causes NICOTINE WITHDRAWAL,17,17,,24,36,causes,0.7453559924999301,903555-FS1-4,"Animal models of NICOTINE WITHDRAWAL indicate involvement of striatal serotonin (5 HT) systems in NICOTINE reward, withdrawal and craving.",NICOTINE,NICOTINE WITHDRAWAL,RO-has_causative_agent
503469019,7/16/2014 15:29:55,,1324298289,7/16/2014 15:29:32,clixsense,0.9028,19803139,NLD,06,Veldhoven,212.61.84.196,no_relation,17,17,,24,36,causes,0.7453559924999301,903555-FS1-4,"Animal models of NICOTINE WITHDRAWAL indicate involvement of striatal serotonin (5 HT) systems in NICOTINE reward, withdrawal and craving.",NICOTINE,NICOTINE WITHDRAWAL,RO-has_causative_agent
503469019,7/16/2014 15:55:46,,1324308655,7/16/2014 15:55:10,rewardsspot,0.65,24482174,GBR,H9,London,46.23.68.180,no_relation,17,17,,24,36,causes,0.7453559924999301,903555-FS1-4,"Animal models of NICOTINE WITHDRAWAL indicate involvement of striatal serotonin (5 HT) systems in NICOTINE reward, withdrawal and craving.",NICOTINE,NICOTINE WITHDRAWAL,RO-has_causative_agent
503469019,7/16/2014 16:20:46,,1324322262,7/16/2014 16:20:16,clixsense,0.7708,28324391,NLD,11,Hazerswoude-rijndijk,94.208.82.215,NICOTINE causes NICOTINE WITHDRAWAL,17,17,,24,36,causes,0.7453559924999301,903555-FS1-4,"Animal models of NICOTINE WITHDRAWAL indicate involvement of striatal serotonin (5 HT) systems in NICOTINE reward, withdrawal and craving.",NICOTINE,NICOTINE WITHDRAWAL,RO-has_causative_agent
503469019,7/16/2014 18:18:53,,1324397400,7/16/2014 18:18:18,eup_slw,0.675,28186528,USA,IN,Bloomington,74.204.124.9,no_relation,17,17,,24,36,causes,0.7453559924999301,903555-FS1-4,"Animal models of NICOTINE WITHDRAWAL indicate involvement of striatal serotonin (5 HT) systems in NICOTINE reward, withdrawal and craving.",NICOTINE,NICOTINE WITHDRAWAL,RO-has_causative_agent
503469019,7/16/2014 18:36:07,,1324405122,7/16/2014 18:35:59,instagc,0.5736,15445601,USA,FL,Jacksonville,24.129.68.254,NICOTINE causes NICOTINE WITHDRAWAL,17,17,,24,36,causes,0.7453559924999301,903555-FS1-4,"Animal models of NICOTINE WITHDRAWAL indicate involvement of striatal serotonin (5 HT) systems in NICOTINE reward, withdrawal and craving.",NICOTINE,NICOTINE WITHDRAWAL,RO-has_causative_agent
503469019,7/16/2014 20:02:39,,1324449496,7/16/2014 20:02:12,neodev,0.6433,18755947,GBR,H2,Accrington,80.47.185.52,NICOTINE causes NICOTINE WITHDRAWAL,17,17,,24,36,causes,0.7453559924999301,903555-FS1-4,"Animal models of NICOTINE WITHDRAWAL indicate involvement of striatal serotonin (5 HT) systems in NICOTINE reward, withdrawal and craving.",NICOTINE,NICOTINE WITHDRAWAL,RO-has_causative_agent
503469024,7/16/2014 15:43:35,,1324303472,7/16/2014 15:43:22,instagc,0.8194,18960682,GBR,,,86.29.147.112,no_relation,41,164,,44,184,causes,0.7293249574894731,900196-FS1-4,"Identification of more LQTS mutations in SIDS cases could provide new insights into the pathophysiology of SIDS and, consequently, reduce the number of unexplained SUDDEN INFANT DEATHS",SIDS,SUDDEN INFANT DEATHS,RO-cause_of
503469024,7/16/2014 17:29:58,,1324349314,7/16/2014 17:29:46,clixsense,0.6083,25595227,CAN,SK,North Battleford,24.72.96.119,SIDS causes SUDDEN INFANT DEATHS,41,164,,44,184,causes,0.7293249574894731,900196-FS1-4,"Identification of more LQTS mutations in SIDS cases could provide new insights into the pathophysiology of SIDS and, consequently, reduce the number of unexplained SUDDEN INFANT DEATHS",SIDS,SUDDEN INFANT DEATHS,RO-cause_of
503469024,7/16/2014 23:08:47,,1324528253,7/16/2014 23:08:01,instagc,0.6728,19636746,USA,NY,Andover,192.182.216.225,no_relation,41,164,,44,184,causes,0.7293249574894731,900196-FS1-4,"Identification of more LQTS mutations in SIDS cases could provide new insights into the pathophysiology of SIDS and, consequently, reduce the number of unexplained SUDDEN INFANT DEATHS",SIDS,SUDDEN INFANT DEATHS,RO-cause_of
503469024,7/16/2014 23:29:06,,1324537247,7/16/2014 23:28:41,zoombucks,0.7409,4688131,CAN,BC,Vancouver,108.180.143.28,no_relation,41,164,,44,184,causes,0.7293249574894731,900196-FS1-4,"Identification of more LQTS mutations in SIDS cases could provide new insights into the pathophysiology of SIDS and, consequently, reduce the number of unexplained SUDDEN INFANT DEATHS",SIDS,SUDDEN INFANT DEATHS,RO-cause_of
503469024,7/17/2014 02:20:23,,1324672398,7/17/2014 02:20:06,pokerowned,0.5583,18747884,USA,MI,Saginaw,74.85.192.98,SIDS causes SUDDEN INFANT DEATHS,41,164,,44,184,causes,0.7293249574894731,900196-FS1-4,"Identification of more LQTS mutations in SIDS cases could provide new insights into the pathophysiology of SIDS and, consequently, reduce the number of unexplained SUDDEN INFANT DEATHS",SIDS,SUDDEN INFANT DEATHS,RO-cause_of
503469024,7/17/2014 02:31:55,,1324683928,7/17/2014 02:31:12,neodev,0.7012,11460728,CAN,BC,Burnaby,70.79.16.165,no_relation,41,164,,44,184,causes,0.7293249574894731,900196-FS1-4,"Identification of more LQTS mutations in SIDS cases could provide new insights into the pathophysiology of SIDS and, consequently, reduce the number of unexplained SUDDEN INFANT DEATHS",SIDS,SUDDEN INFANT DEATHS,RO-cause_of
503469024,7/17/2014 03:07:59,,1324720630,7/17/2014 03:07:39,cotter,0.5675,7287927,USA,CA,San Jose,99.27.90.128,SIDS causes SUDDEN INFANT DEATHS,41,164,,44,184,causes,0.7293249574894731,900196-FS1-4,"Identification of more LQTS mutations in SIDS cases could provide new insights into the pathophysiology of SIDS and, consequently, reduce the number of unexplained SUDDEN INFANT DEATHS",SIDS,SUDDEN INFANT DEATHS,RO-cause_of
503469025,7/16/2014 15:25:21,,1324296924,7/16/2014 15:25:08,clixsense,0.9028,20614047,USA,MO,Maryville,174.32.162.147,no_relation,0,70,,8,78,causes,0.768221279597376,904999-FS1-4,HEADACHES associated with acute illnesses may be a precursor to later MIGRAINE,HEADACHES,MIGRAINE,RO-has_definitional_manifestation
503469025,7/16/2014 15:27:35,,1324297471,7/16/2014 15:27:13,elite,0.8472,28503042,USA,NJ,Woodbridge,54.191.150.115,HEADACHES causes MIGRAINE,0,70,,8,78,causes,0.768221279597376,904999-FS1-4,HEADACHES associated with acute illnesses may be a precursor to later MIGRAINE,HEADACHES,MIGRAINE,RO-has_definitional_manifestation
503469025,7/16/2014 15:38:14,,1324301182,7/16/2014 15:37:54,instagc,0.9028,13763729,USA,,,75.182.89.225,no_relation,0,70,,8,78,causes,0.768221279597376,904999-FS1-4,HEADACHES associated with acute illnesses may be a precursor to later MIGRAINE,HEADACHES,MIGRAINE,RO-has_definitional_manifestation
503469025,7/16/2014 15:53:26,,1324307659,7/16/2014 15:52:59,clixsense,0.775,27812714,NLD,06,Tilburg,84.31.160.155,no_relation,0,70,,8,78,causes,0.768221279597376,904999-FS1-4,HEADACHES associated with acute illnesses may be a precursor to later MIGRAINE,HEADACHES,MIGRAINE,RO-has_definitional_manifestation
503469025,7/16/2014 15:54:24,,1324308096,7/16/2014 15:53:49,rewardsspot,0.65,24482174,GBR,H9,London,46.23.68.180,no_relation,0,70,,8,78,causes,0.768221279597376,904999-FS1-4,HEADACHES associated with acute illnesses may be a precursor to later MIGRAINE,HEADACHES,MIGRAINE,RO-has_definitional_manifestation
503469025,7/16/2014 16:38:03,,1324329389,7/16/2014 16:37:49,neodev,0.8542,14861092,GBR,H9,London,90.194.156.173,no_relation,0,70,,8,78,causes,0.768221279597376,904999-FS1-4,HEADACHES associated with acute illnesses may be a precursor to later MIGRAINE,HEADACHES,MIGRAINE,RO-has_definitional_manifestation
503469025,7/16/2014 16:40:31,,1324330971,7/16/2014 16:40:02,prodege,0.5091,2143114,CAN,BC,Vancouver,24.84.160.12,MIGRAINE causes HEADACHES,0,70,,8,78,causes,0.768221279597376,904999-FS1-4,HEADACHES associated with acute illnesses may be a precursor to later MIGRAINE,HEADACHES,MIGRAINE,RO-has_definitional_manifestation
503469028,7/16/2014 19:27:17,,1324433105,7/16/2014 19:26:18,clixsense,0.5444,6714657,USA,CT,Groton,71.235.184.32,HEMORRHAGIC FEVER WITH RENAL SYNDROME causes HANTAAN VIRUS,209,43,,221,80,causes,0.452267016866645,903692-FS1-4,"Convalescent phase sera from patients with HEMORRHAGIC FEVER WITH RENAL SYNDROME (HFRS) having higher IF antibody titers to Hantaan virus than to nephropathia epidemica (NE) virus were capable of neutralizing HANTAAN VIRUS, while sera from patients with higher IF antibody titers to NE virus than Hantaan virus did not contain neutralizing antibody to Hantaan virus.",HANTAAN VIRUS,HEMORRHAGIC FEVER WITH RENAL SYNDROME,RO-has_causative_agent
503469028,7/16/2014 20:40:05,,1324466274,7/16/2014 20:39:21,prodege,0.6448,26325260,GBR,,,79.64.25.64,HANTAAN VIRUS causes HEMORRHAGIC FEVER WITH RENAL SYNDROME,209,43,,221,80,causes,0.452267016866645,903692-FS1-4,"Convalescent phase sera from patients with HEMORRHAGIC FEVER WITH RENAL SYNDROME (HFRS) having higher IF antibody titers to Hantaan virus than to nephropathia epidemica (NE) virus were capable of neutralizing HANTAAN VIRUS, while sera from patients with higher IF antibody titers to NE virus than Hantaan virus did not contain neutralizing antibody to Hantaan virus.",HANTAAN VIRUS,HEMORRHAGIC FEVER WITH RENAL SYNDROME,RO-has_causative_agent
503469028,7/16/2014 22:54:37,,1324523276,7/16/2014 22:54:07,prodege,0.7282,12971342,USA,CA,Los Angeles,198.101.91.82,HANTAAN VIRUS causes HEMORRHAGIC FEVER WITH RENAL SYNDROME,209,43,,221,80,causes,0.452267016866645,903692-FS1-4,"Convalescent phase sera from patients with HEMORRHAGIC FEVER WITH RENAL SYNDROME (HFRS) having higher IF antibody titers to Hantaan virus than to nephropathia epidemica (NE) virus were capable of neutralizing HANTAAN VIRUS, while sera from patients with higher IF antibody titers to NE virus than Hantaan virus did not contain neutralizing antibody to Hantaan virus.",HANTAAN VIRUS,HEMORRHAGIC FEVER WITH RENAL SYNDROME,RO-has_causative_agent
503469028,7/16/2014 23:10:26,,1324528827,7/16/2014 23:10:02,instagc,0.6728,19636746,USA,NY,Andover,192.182.216.225,no_relation,209,43,,221,80,causes,0.452267016866645,903692-FS1-4,"Convalescent phase sera from patients with HEMORRHAGIC FEVER WITH RENAL SYNDROME (HFRS) having higher IF antibody titers to Hantaan virus than to nephropathia epidemica (NE) virus were capable of neutralizing HANTAAN VIRUS, while sera from patients with higher IF antibody titers to NE virus than Hantaan virus did not contain neutralizing antibody to Hantaan virus.",HANTAAN VIRUS,HEMORRHAGIC FEVER WITH RENAL SYNDROME,RO-has_causative_agent
503469028,7/16/2014 23:31:08,,1324538064,7/16/2014 23:30:31,zoombucks,0.7409,4688131,CAN,BC,Vancouver,108.180.143.28,no_relation,209,43,,221,80,causes,0.452267016866645,903692-FS1-4,"Convalescent phase sera from patients with HEMORRHAGIC FEVER WITH RENAL SYNDROME (HFRS) having higher IF antibody titers to Hantaan virus than to nephropathia epidemica (NE) virus were capable of neutralizing HANTAAN VIRUS, while sera from patients with higher IF antibody titers to NE virus than Hantaan virus did not contain neutralizing antibody to Hantaan virus.",HANTAAN VIRUS,HEMORRHAGIC FEVER WITH RENAL SYNDROME,RO-has_causative_agent
503469028,7/16/2014 23:34:23,,1324539431,7/16/2014 23:34:01,neodev,0.6766,15848372,AUS,02,Jannali,27.96.208.89,no_relation,209,43,,221,80,causes,0.452267016866645,903692-FS1-4,"Convalescent phase sera from patients with HEMORRHAGIC FEVER WITH RENAL SYNDROME (HFRS) having higher IF antibody titers to Hantaan virus than to nephropathia epidemica (NE) virus were capable of neutralizing HANTAAN VIRUS, while sera from patients with higher IF antibody titers to NE virus than Hantaan virus did not contain neutralizing antibody to Hantaan virus.",HANTAAN VIRUS,HEMORRHAGIC FEVER WITH RENAL SYNDROME,RO-has_causative_agent
503469028,7/17/2014 00:59:59,,1324594144,7/17/2014 00:59:29,prodege,0.5889,2767509,CAN,BC,Victoria,96.54.172.117,HANTAAN VIRUS causes HEMORRHAGIC FEVER WITH RENAL SYNDROME,209,43,,221,80,causes,0.452267016866645,903692-FS1-4,"Convalescent phase sera from patients with HEMORRHAGIC FEVER WITH RENAL SYNDROME (HFRS) having higher IF antibody titers to Hantaan virus than to nephropathia epidemica (NE) virus were capable of neutralizing HANTAAN VIRUS, while sera from patients with higher IF antibody titers to NE virus than Hantaan virus did not contain neutralizing antibody to Hantaan virus.",HANTAAN VIRUS,HEMORRHAGIC FEVER WITH RENAL SYNDROME,RO-has_causative_agent
503469031,7/16/2014 15:22:52,,1324296139,7/16/2014 15:22:29,tremorgames,1.0,24449707,CAN,QC,Laval,96.21.249.72,SCABIES causes MITES,116,94,,120,101,causes,0.9647638212377321,903877-FS1-4,"? Investigations of the prevalence of mites in the personal environment of 37 cases of normal SCABIES revealed live MITES from dust samples taken from bedroom floors, overstuffed chairs, and couches in all 37 cases ( 11.",MITES,SCABIES,RO-has_causative_agent
503469031,7/16/2014 15:26:33,,1324297235,7/16/2014 15:26:12,elite,0.8472,28503042,USA,NJ,Woodbridge,54.191.150.115,MITES causes SCABIES,116,94,,120,101,causes,0.9647638212377321,903877-FS1-4,"? Investigations of the prevalence of mites in the personal environment of 37 cases of normal SCABIES revealed live MITES from dust samples taken from bedroom floors, overstuffed chairs, and couches in all 37 cases ( 11.",MITES,SCABIES,RO-has_causative_agent
503469031,7/16/2014 15:33:37,,1324299496,7/16/2014 15:33:13,neodev,0.8472,27597779,CAN,AB,Calgary,72.29.251.209,MITES causes SCABIES,116,94,,120,101,causes,0.9647638212377321,903877-FS1-4,"? Investigations of the prevalence of mites in the personal environment of 37 cases of normal SCABIES revealed live MITES from dust samples taken from bedroom floors, overstuffed chairs, and couches in all 37 cases ( 11.",MITES,SCABIES,RO-has_causative_agent
503469031,7/16/2014 16:20:46,,1324322254,7/16/2014 16:20:16,clixsense,0.7708,28324391,NLD,11,Hazerswoude-rijndijk,94.208.82.215,MITES causes SCABIES,116,94,,120,101,causes,0.9647638212377321,903877-FS1-4,"? Investigations of the prevalence of mites in the personal environment of 37 cases of normal SCABIES revealed live MITES from dust samples taken from bedroom floors, overstuffed chairs, and couches in all 37 cases ( 11.",MITES,SCABIES,RO-has_causative_agent
503469031,7/16/2014 16:51:28,,1324335119,7/16/2014 16:50:49,rewardsspot,0.6597,17763704,USA,VA,Manassas,198.7.62.204,MITES causes SCABIES,116,94,,120,101,causes,0.9647638212377321,903877-FS1-4,"? Investigations of the prevalence of mites in the personal environment of 37 cases of normal SCABIES revealed live MITES from dust samples taken from bedroom floors, overstuffed chairs, and couches in all 37 cases ( 11.",MITES,SCABIES,RO-has_causative_agent
503469031,7/16/2014 19:28:56,,1324433996,7/16/2014 19:27:41,clixsense,0.6758,27871219,NLD,07,Amsterdam,87.210.207.223,MITES causes SCABIES,116,94,,120,101,causes,0.9647638212377321,903877-FS1-4,"? Investigations of the prevalence of mites in the personal environment of 37 cases of normal SCABIES revealed live MITES from dust samples taken from bedroom floors, overstuffed chairs, and couches in all 37 cases ( 11.",MITES,SCABIES,RO-has_causative_agent
503469031,7/16/2014 19:39:53,,1324439046,7/16/2014 19:39:15,fusioncash,0.506,7012325,USA,CT,Stamford,24.185.182.15,MITES causes SCABIES,116,94,,120,101,causes,0.9647638212377321,903877-FS1-4,"? Investigations of the prevalence of mites in the personal environment of 37 cases of normal SCABIES revealed live MITES from dust samples taken from bedroom floors, overstuffed chairs, and couches in all 37 cases ( 11.",MITES,SCABIES,RO-has_causative_agent
503469032,7/16/2014 16:51:44,,1324335217,7/16/2014 16:50:57,clixsense,0.7204,18647227,GBR,P3,Bulkington,2.216.185.243,GANGLIOGLIOMAS causes SEIZURE,5,50,,11,64,causes,0.986393923832143,902773-FS1-4,"Good SEIZURE outcome is expected in patients with GANGLIOGLIOMAS despite years of medically intractable epilepsy, once the tumor is resected.",SEIZURE,GANGLIOGLIOMAS,RO-disease_may_have_finding
503469032,7/16/2014 17:43:17,,1324360277,7/16/2014 17:42:43,clixsense,0.5657,23398628,USA,WA,Spanaway,50.149.99.43,no_relation,5,50,,11,64,causes,0.986393923832143,902773-FS1-4,"Good SEIZURE outcome is expected in patients with GANGLIOGLIOMAS despite years of medically intractable epilepsy, once the tumor is resected.",SEIZURE,GANGLIOGLIOMAS,RO-disease_may_have_finding
503469032,7/16/2014 19:24:48,,1324431864,7/16/2014 19:24:20,clixsense,0.5444,6714657,USA,CT,Groton,71.235.184.32,GANGLIOGLIOMAS causes SEIZURE,5,50,,11,64,causes,0.986393923832143,902773-FS1-4,"Good SEIZURE outcome is expected in patients with GANGLIOGLIOMAS despite years of medically intractable epilepsy, once the tumor is resected.",SEIZURE,GANGLIOGLIOMAS,RO-disease_may_have_finding
503469032,7/16/2014 20:01:42,,1324449189,7/16/2014 20:01:18,neodev,0.6433,18755947,GBR,H2,Accrington,80.47.185.52,GANGLIOGLIOMAS causes SEIZURE,5,50,,11,64,causes,0.986393923832143,902773-FS1-4,"Good SEIZURE outcome is expected in patients with GANGLIOGLIOMAS despite years of medically intractable epilepsy, once the tumor is resected.",SEIZURE,GANGLIOGLIOMAS,RO-disease_may_have_finding
503469032,7/16/2014 22:04:01,,1324503296,7/16/2014 22:03:07,clixsense,0.6754,6472283,USA,WI,Oak Creek,99.107.184.156,GANGLIOGLIOMAS causes SEIZURE,5,50,,11,64,causes,0.986393923832143,902773-FS1-4,"Good SEIZURE outcome is expected in patients with GANGLIOGLIOMAS despite years of medically intractable epilepsy, once the tumor is resected.",SEIZURE,GANGLIOGLIOMAS,RO-disease_may_have_finding
503469032,7/16/2014 22:54:53,,1324523383,7/16/2014 22:54:38,prodege,0.7282,12971342,USA,CA,Los Angeles,198.101.91.82,GANGLIOGLIOMAS causes SEIZURE,5,50,,11,64,causes,0.986393923832143,902773-FS1-4,"Good SEIZURE outcome is expected in patients with GANGLIOGLIOMAS despite years of medically intractable epilepsy, once the tumor is resected.",SEIZURE,GANGLIOGLIOMAS,RO-disease_may_have_finding
503469032,7/16/2014 23:09:00,,1324528312,7/16/2014 23:08:33,eup_slw,0.7077,20818028,GBR,A7,Birmingham,92.232.139.254,GANGLIOGLIOMAS causes SEIZURE,5,50,,11,64,causes,0.986393923832143,902773-FS1-4,"Good SEIZURE outcome is expected in patients with GANGLIOGLIOMAS despite years of medically intractable epilepsy, once the tumor is resected.",SEIZURE,GANGLIOGLIOMAS,RO-disease_may_have_finding
503469036,7/16/2014 16:47:39,,1324333829,7/16/2014 16:47:34,clixsense,0.6125,19162475,GBR,M3,Frome,82.33.126.30,LENS is location of CATARACT FORMATION,177,198,,180,216,is location of,0.560112033611204,905038-FS1-9,The evidence reviewed here supports the hypothesis that metal catalyzed oxidation reactions occur in the lens and may make a significant contribution to the changes seen in the LENS with age and in CATARACT FORMATION.,LENS,CATARACT FORMATION,RO-has_finding_site
503469036,7/16/2014 16:49:23,,1324334477,7/16/2014 16:48:36,clixsense,0.7204,18647227,GBR,P3,Bulkington,2.216.185.243,no_relation,177,198,,180,216,is location of,0.560112033611204,905038-FS1-9,The evidence reviewed here supports the hypothesis that metal catalyzed oxidation reactions occur in the lens and may make a significant contribution to the changes seen in the LENS with age and in CATARACT FORMATION.,LENS,CATARACT FORMATION,RO-has_finding_site
503469036,7/16/2014 18:18:17,,1324397068,7/16/2014 18:17:33,eup_slw,0.675,28186528,USA,IN,Bloomington,74.204.124.9,LENS is location of CATARACT FORMATION,177,198,,180,216,is location of,0.560112033611204,905038-FS1-9,The evidence reviewed here supports the hypothesis that metal catalyzed oxidation reactions occur in the lens and may make a significant contribution to the changes seen in the LENS with age and in CATARACT FORMATION.,LENS,CATARACT FORMATION,RO-has_finding_site
503469036,7/16/2014 20:09:45,,1324452602,7/16/2014 20:09:38,tremorgames,0.6605,28013393,USA,CA,Rancho Cordova,71.197.67.37,LENS is location of CATARACT FORMATION,177,198,,180,216,is location of,0.560112033611204,905038-FS1-9,The evidence reviewed here supports the hypothesis that metal catalyzed oxidation reactions occur in the lens and may make a significant contribution to the changes seen in the LENS with age and in CATARACT FORMATION.,LENS,CATARACT FORMATION,RO-has_finding_site
503469036,7/16/2014 22:50:41,,1324521496,7/16/2014 22:49:47,prodege,0.5665,28255346,GBR,L9,Sheffield,2.125.183.137,CATARACT FORMATION is location of LENS,177,198,,180,216,is location of,0.560112033611204,905038-FS1-9,The evidence reviewed here supports the hypothesis that metal catalyzed oxidation reactions occur in the lens and may make a significant contribution to the changes seen in the LENS with age and in CATARACT FORMATION.,LENS,CATARACT FORMATION,RO-has_finding_site
503469036,7/17/2014 00:28:11,,1324564409,7/17/2014 00:27:47,prodege,0.335,24403612,CAN,ON,Ajax,99.242.234.239,no_relation,177,198,,180,216,is location of,0.560112033611204,905038-FS1-9,The evidence reviewed here supports the hypothesis that metal catalyzed oxidation reactions occur in the lens and may make a significant contribution to the changes seen in the LENS with age and in CATARACT FORMATION.,LENS,CATARACT FORMATION,RO-has_finding_site
503469036,7/17/2014 02:21:32,,1324673499,7/17/2014 02:20:30,clixsense,0.5607,6520576,USA,OH,Springfield,71.79.14.94,LENS is location of CATARACT FORMATION,177,198,,180,216,is location of,0.560112033611204,905038-FS1-9,The evidence reviewed here supports the hypothesis that metal catalyzed oxidation reactions occur in the lens and may make a significant contribution to the changes seen in the LENS with age and in CATARACT FORMATION.,LENS,CATARACT FORMATION,RO-has_finding_site
503469039,7/16/2014 17:02:24,,1324338928,7/16/2014 17:02:08,prodege,0.5583,12944140,GBR,C8,Croydon,92.21.8.174,PATHOLOGIC FRACTURES causes SOLITARY BONE METASTASIS,149,81,,168,105,causes,0.5547001962252289,902860-FS1-4,"A favorable prognosis was more likely in women and patients with adenocarcinoma, SOLITARY BONE METASTASIS no metastases to the appendicular bone, no PATHOLOGIC FRACTURES performance status 1 or less, use of systemic chemotherapy, and use of an epithelial growth factor receptor inhibitor.",PATHOLOGIC FRACTURES,SOLITARY BONE METASTASIS,RO-disease_may_have_finding
503469039,7/16/2014 21:38:39,,1324493413,7/16/2014 21:38:14,clixsense,0.7516,24896327,GBR,V2,Glasgow,94.2.231.4,no_relation,149,81,,168,105,causes,0.5547001962252289,902860-FS1-4,"A favorable prognosis was more likely in women and patients with adenocarcinoma, SOLITARY BONE METASTASIS no metastases to the appendicular bone, no PATHOLOGIC FRACTURES performance status 1 or less, use of systemic chemotherapy, and use of an epithelial growth factor receptor inhibitor.",PATHOLOGIC FRACTURES,SOLITARY BONE METASTASIS,RO-disease_may_have_finding
503469039,7/16/2014 22:56:27,,1324524016,7/16/2014 22:56:11,prodege,0.7282,12971342,USA,CA,Los Angeles,198.101.91.82,no_relation,149,81,,168,105,causes,0.5547001962252289,902860-FS1-4,"A favorable prognosis was more likely in women and patients with adenocarcinoma, SOLITARY BONE METASTASIS no metastases to the appendicular bone, no PATHOLOGIC FRACTURES performance status 1 or less, use of systemic chemotherapy, and use of an epithelial growth factor receptor inhibitor.",PATHOLOGIC FRACTURES,SOLITARY BONE METASTASIS,RO-disease_may_have_finding
503469039,7/16/2014 23:11:14,,1324529145,7/16/2014 23:10:47,eup_slw,0.7077,20818028,GBR,A7,Birmingham,92.232.139.254,no_relation,149,81,,168,105,causes,0.5547001962252289,902860-FS1-4,"A favorable prognosis was more likely in women and patients with adenocarcinoma, SOLITARY BONE METASTASIS no metastases to the appendicular bone, no PATHOLOGIC FRACTURES performance status 1 or less, use of systemic chemotherapy, and use of an epithelial growth factor receptor inhibitor.",PATHOLOGIC FRACTURES,SOLITARY BONE METASTASIS,RO-disease_may_have_finding
503469039,7/16/2014 23:30:29,,1324537767,7/16/2014 23:30:00,zoombucks,0.7409,4688131,CAN,BC,Vancouver,108.180.143.28,no_relation,149,81,,168,105,causes,0.5547001962252289,902860-FS1-4,"A favorable prognosis was more likely in women and patients with adenocarcinoma, SOLITARY BONE METASTASIS no metastases to the appendicular bone, no PATHOLOGIC FRACTURES performance status 1 or less, use of systemic chemotherapy, and use of an epithelial growth factor receptor inhibitor.",PATHOLOGIC FRACTURES,SOLITARY BONE METASTASIS,RO-disease_may_have_finding
503469039,7/17/2014 00:50:28,,1324584510,7/17/2014 00:49:28,neodev,0.7012,11460728,CAN,BC,Burnaby,70.79.16.165,no_relation,149,81,,168,105,causes,0.5547001962252289,902860-FS1-4,"A favorable prognosis was more likely in women and patients with adenocarcinoma, SOLITARY BONE METASTASIS no metastases to the appendicular bone, no PATHOLOGIC FRACTURES performance status 1 or less, use of systemic chemotherapy, and use of an epithelial growth factor receptor inhibitor.",PATHOLOGIC FRACTURES,SOLITARY BONE METASTASIS,RO-disease_may_have_finding
503469039,7/17/2014 02:22:13,,1324674192,7/17/2014 02:21:33,clixsense,0.5607,6520576,USA,OH,Springfield,71.79.14.94,SOLITARY BONE METASTASIS causes PATHOLOGIC FRACTURES,149,81,,168,105,causes,0.5547001962252289,902860-FS1-4,"A favorable prognosis was more likely in women and patients with adenocarcinoma, SOLITARY BONE METASTASIS no metastases to the appendicular bone, no PATHOLOGIC FRACTURES performance status 1 or less, use of systemic chemotherapy, and use of an epithelial growth factor receptor inhibitor.",PATHOLOGIC FRACTURES,SOLITARY BONE METASTASIS,RO-disease_may_have_finding
503469048,7/16/2014 15:28:49,,1324297893,7/16/2014 15:28:07,neodev,0.8472,27597779,CAN,AB,Calgary,72.29.251.209,HYDROQUINONE treats HYPERPIGMENTATION,24,54,,40,66,treats,0.99654575824488,907808-FS1-2,"Treatment  Treatment of HYPERPIGMENTATION may include HYDROQUINONE kojic acid, alpha hydroxy acids, azelaic acid, ascorbic acid, tretinoin (Retinol), topical glucocorticoids, and licorice extract.",HYPERPIGMENTATION,HYDROQUINONE,RO-may_treat
503469048,7/16/2014 17:07:22,,1324340504,7/16/2014 17:06:11,neodev,0.5903,18339121,USA,SC,Sumter,173.93.188.194,HYPERPIGMENTATION treats HYDROQUINONE,24,54,,40,66,treats,0.99654575824488,907808-FS1-2,"Treatment  Treatment of HYPERPIGMENTATION may include HYDROQUINONE kojic acid, alpha hydroxy acids, azelaic acid, ascorbic acid, tretinoin (Retinol), topical glucocorticoids, and licorice extract.",HYPERPIGMENTATION,HYDROQUINONE,RO-may_treat
503469048,7/16/2014 17:18:16,,1324343900,7/16/2014 17:18:02,prodege,0.6046,23541832,USA,AZ,Tempe,149.169.143.104,HYDROQUINONE treats HYPERPIGMENTATION,24,54,,40,66,treats,0.99654575824488,907808-FS1-2,"Treatment  Treatment of HYPERPIGMENTATION may include HYDROQUINONE kojic acid, alpha hydroxy acids, azelaic acid, ascorbic acid, tretinoin (Retinol), topical glucocorticoids, and licorice extract.",HYPERPIGMENTATION,HYDROQUINONE,RO-may_treat
503469048,7/16/2014 18:04:10,,1324382129,7/16/2014 18:03:59,instagc,0.7462,28157545,USA,OR,Mcminnville,76.115.153.186,HYDROQUINONE treats HYPERPIGMENTATION,24,54,,40,66,treats,0.99654575824488,907808-FS1-2,"Treatment  Treatment of HYPERPIGMENTATION may include HYDROQUINONE kojic acid, alpha hydroxy acids, azelaic acid, ascorbic acid, tretinoin (Retinol), topical glucocorticoids, and licorice extract.",HYPERPIGMENTATION,HYDROQUINONE,RO-may_treat
503469048,7/16/2014 18:35:48,,1324404954,7/16/2014 18:35:38,instagc,0.5736,15445601,USA,FL,Jacksonville,24.129.68.254,no_relation,24,54,,40,66,treats,0.99654575824488,907808-FS1-2,"Treatment  Treatment of HYPERPIGMENTATION may include HYDROQUINONE kojic acid, alpha hydroxy acids, azelaic acid, ascorbic acid, tretinoin (Retinol), topical glucocorticoids, and licorice extract.",HYPERPIGMENTATION,HYDROQUINONE,RO-may_treat
503469048,7/16/2014 23:10:50,,1324528982,7/16/2014 23:10:27,instagc,0.6728,19636746,USA,NY,Andover,192.182.216.225,HYDROQUINONE treats HYPERPIGMENTATION,24,54,,40,66,treats,0.99654575824488,907808-FS1-2,"Treatment  Treatment of HYPERPIGMENTATION may include HYDROQUINONE kojic acid, alpha hydroxy acids, azelaic acid, ascorbic acid, tretinoin (Retinol), topical glucocorticoids, and licorice extract.",HYPERPIGMENTATION,HYDROQUINONE,RO-may_treat
503469048,7/16/2014 23:11:46,,1324529353,7/16/2014 23:11:15,eup_slw,0.7077,20818028,GBR,A7,Birmingham,92.232.139.254,HYDROQUINONE treats HYPERPIGMENTATION,24,54,,40,66,treats,0.99654575824488,907808-FS1-2,"Treatment  Treatment of HYPERPIGMENTATION may include HYDROQUINONE kojic acid, alpha hydroxy acids, azelaic acid, ascorbic acid, tretinoin (Retinol), topical glucocorticoids, and licorice extract.",HYPERPIGMENTATION,HYDROQUINONE,RO-may_treat
503469051,7/16/2014 15:28:16,,1324297711,7/16/2014 15:27:36,elite,0.8472,28503042,USA,NJ,Woodbridge,54.191.150.115,no_relation,337,372,,340,381,causes,0.4472135954999579,905203-FS1-4,"Note medications that can induce cytopenias Physical exam  Oral exam  Look for mucosal ulceration Physical exam  Eye exam  Look for presence of vascularization of the conjunctivae Physical exam  Cardiac exam  Look for presence of murmurs or tachycardia Physical exam  Abdominal exam  Look for the presence of organomegaly Physical exam  SKIN exam  Look for ecchymosis and PETECHIAE   Differential Diagnosis of Myelodysplastic Syndrome  Normal;           Differential Diagnosis of Myelodysplastic Syndrome Disease  Characteristics  Notes Vitamin B12 deficiency  Macrocytic anemia with megaloblastic bone marrow abnormalities  Usually pernicious anemia, patients with a history of gastrectomy, or diseases that affect the terminal ileum.",SKIN,PETECHIAE,RO-has_finding_site
503469051,7/16/2014 15:41:31,,1324302661,7/16/2014 15:40:59,clixsense,0.8333,15189335,GBR,I9,Bury Saint Edmunds,81.155.129.231,no_relation,337,372,,340,381,causes,0.4472135954999579,905203-FS1-4,"Note medications that can induce cytopenias Physical exam  Oral exam  Look for mucosal ulceration Physical exam  Eye exam  Look for presence of vascularization of the conjunctivae Physical exam  Cardiac exam  Look for presence of murmurs or tachycardia Physical exam  Abdominal exam  Look for the presence of organomegaly Physical exam  SKIN exam  Look for ecchymosis and PETECHIAE   Differential Diagnosis of Myelodysplastic Syndrome  Normal;           Differential Diagnosis of Myelodysplastic Syndrome Disease  Characteristics  Notes Vitamin B12 deficiency  Macrocytic anemia with megaloblastic bone marrow abnormalities  Usually pernicious anemia, patients with a history of gastrectomy, or diseases that affect the terminal ileum.",SKIN,PETECHIAE,RO-has_finding_site
503469051,7/16/2014 16:04:38,,1324313400,7/16/2014 16:04:03,eup_slw,0.6538,18329415,USA,PA,Folcroft,64.121.230.236,no_relation,337,372,,340,381,causes,0.4472135954999579,905203-FS1-4,"Note medications that can induce cytopenias Physical exam  Oral exam  Look for mucosal ulceration Physical exam  Eye exam  Look for presence of vascularization of the conjunctivae Physical exam  Cardiac exam  Look for presence of murmurs or tachycardia Physical exam  Abdominal exam  Look for the presence of organomegaly Physical exam  SKIN exam  Look for ecchymosis and PETECHIAE   Differential Diagnosis of Myelodysplastic Syndrome  Normal;           Differential Diagnosis of Myelodysplastic Syndrome Disease  Characteristics  Notes Vitamin B12 deficiency  Macrocytic anemia with megaloblastic bone marrow abnormalities  Usually pernicious anemia, patients with a history of gastrectomy, or diseases that affect the terminal ileum.",SKIN,PETECHIAE,RO-has_finding_site
503469051,7/16/2014 16:24:45,,1324323852,7/16/2014 16:24:08,prodege,0.6736,13300986,CAN,AB,Edmonton,68.150.33.230,no_relation,337,372,,340,381,causes,0.4472135954999579,905203-FS1-4,"Note medications that can induce cytopenias Physical exam  Oral exam  Look for mucosal ulceration Physical exam  Eye exam  Look for presence of vascularization of the conjunctivae Physical exam  Cardiac exam  Look for presence of murmurs or tachycardia Physical exam  Abdominal exam  Look for the presence of organomegaly Physical exam  SKIN exam  Look for ecchymosis and PETECHIAE   Differential Diagnosis of Myelodysplastic Syndrome  Normal;           Differential Diagnosis of Myelodysplastic Syndrome Disease  Characteristics  Notes Vitamin B12 deficiency  Macrocytic anemia with megaloblastic bone marrow abnormalities  Usually pernicious anemia, patients with a history of gastrectomy, or diseases that affect the terminal ileum.",SKIN,PETECHIAE,RO-has_finding_site
503469051,7/16/2014 17:02:07,,1324338854,7/16/2014 17:02:03,prodege,0.5583,12944140,GBR,C8,Croydon,92.21.8.174,SKIN causes PETECHIAE,337,372,,340,381,causes,0.4472135954999579,905203-FS1-4,"Note medications that can induce cytopenias Physical exam  Oral exam  Look for mucosal ulceration Physical exam  Eye exam  Look for presence of vascularization of the conjunctivae Physical exam  Cardiac exam  Look for presence of murmurs or tachycardia Physical exam  Abdominal exam  Look for the presence of organomegaly Physical exam  SKIN exam  Look for ecchymosis and PETECHIAE   Differential Diagnosis of Myelodysplastic Syndrome  Normal;           Differential Diagnosis of Myelodysplastic Syndrome Disease  Characteristics  Notes Vitamin B12 deficiency  Macrocytic anemia with megaloblastic bone marrow abnormalities  Usually pernicious anemia, patients with a history of gastrectomy, or diseases that affect the terminal ileum.",SKIN,PETECHIAE,RO-has_finding_site
503469051,7/16/2014 18:36:07,,1324405125,7/16/2014 18:35:59,instagc,0.5736,15445601,USA,FL,Jacksonville,24.129.68.254,no_relation,337,372,,340,381,causes,0.4472135954999579,905203-FS1-4,"Note medications that can induce cytopenias Physical exam  Oral exam  Look for mucosal ulceration Physical exam  Eye exam  Look for presence of vascularization of the conjunctivae Physical exam  Cardiac exam  Look for presence of murmurs or tachycardia Physical exam  Abdominal exam  Look for the presence of organomegaly Physical exam  SKIN exam  Look for ecchymosis and PETECHIAE   Differential Diagnosis of Myelodysplastic Syndrome  Normal;           Differential Diagnosis of Myelodysplastic Syndrome Disease  Characteristics  Notes Vitamin B12 deficiency  Macrocytic anemia with megaloblastic bone marrow abnormalities  Usually pernicious anemia, patients with a history of gastrectomy, or diseases that affect the terminal ileum.",SKIN,PETECHIAE,RO-has_finding_site
503469051,7/16/2014 19:27:03,,1324433000,7/16/2014 19:26:25,clixsense,0.6758,27871219,NLD,07,Amsterdam,87.210.207.223,no_relation,337,372,,340,381,causes,0.4472135954999579,905203-FS1-4,"Note medications that can induce cytopenias Physical exam  Oral exam  Look for mucosal ulceration Physical exam  Eye exam  Look for presence of vascularization of the conjunctivae Physical exam  Cardiac exam  Look for presence of murmurs or tachycardia Physical exam  Abdominal exam  Look for the presence of organomegaly Physical exam  SKIN exam  Look for ecchymosis and PETECHIAE   Differential Diagnosis of Myelodysplastic Syndrome  Normal;           Differential Diagnosis of Myelodysplastic Syndrome Disease  Characteristics  Notes Vitamin B12 deficiency  Macrocytic anemia with megaloblastic bone marrow abnormalities  Usually pernicious anemia, patients with a history of gastrectomy, or diseases that affect the terminal ileum.",SKIN,PETECHIAE,RO-has_finding_site
503469059,7/16/2014 15:29:46,,1324298240,7/16/2014 15:29:38,clixsense,0.9306,27793793,GBR,C5,Chester,151.230.27.155,HEADACHE causes CHRONIC MIGRAINE,70,0,,77,16,causes,0.474712663277541,904636-FS1-4,CHRONIC MIGRAINE is a common form of disabling headache presenting in HEADACHE subspecialty practice.,HEADACHE,CHRONIC MIGRAINE,RO-has_definitional_manifestation
503469059,7/16/2014 15:31:07,,1324298740,7/16/2014 15:30:42,instagc,0.8611,24252915,GBR,B7,Bristol,77.98.139.82,CHRONIC MIGRAINE causes HEADACHE,70,0,,77,16,causes,0.474712663277541,904636-FS1-4,CHRONIC MIGRAINE is a common form of disabling headache presenting in HEADACHE subspecialty practice.,HEADACHE,CHRONIC MIGRAINE,RO-has_definitional_manifestation
503469059,7/16/2014 15:33:37,,1324299495,7/16/2014 15:33:13,neodev,0.8472,27597779,CAN,AB,Calgary,72.29.251.209,HEADACHE causes CHRONIC MIGRAINE,70,0,,77,16,causes,0.474712663277541,904636-FS1-4,CHRONIC MIGRAINE is a common form of disabling headache presenting in HEADACHE subspecialty practice.,HEADACHE,CHRONIC MIGRAINE,RO-has_definitional_manifestation
503469059,7/16/2014 15:49:16,,1324305878,7/16/2014 15:49:05,clixsense,0.4792,16827630,GBR,A7,Birmingham,86.146.169.103,CHRONIC MIGRAINE causes HEADACHE,70,0,,77,16,causes,0.474712663277541,904636-FS1-4,CHRONIC MIGRAINE is a common form of disabling headache presenting in HEADACHE subspecialty practice.,HEADACHE,CHRONIC MIGRAINE,RO-has_definitional_manifestation
503469059,7/16/2014 16:22:50,,1324323061,7/16/2014 16:22:23,prodege,0.6736,13300986,CAN,AB,Edmonton,68.150.33.230,no_relation,70,0,,77,16,causes,0.474712663277541,904636-FS1-4,CHRONIC MIGRAINE is a common form of disabling headache presenting in HEADACHE subspecialty practice.,HEADACHE,CHRONIC MIGRAINE,RO-has_definitional_manifestation
503469059,7/16/2014 17:07:35,,1324340573,7/16/2014 17:07:16,instagc,0.6736,23149109,USA,NC,Cary,24.206.38.18,CHRONIC MIGRAINE causes HEADACHE,70,0,,77,16,causes,0.474712663277541,904636-FS1-4,CHRONIC MIGRAINE is a common form of disabling headache presenting in HEADACHE subspecialty practice.,HEADACHE,CHRONIC MIGRAINE,RO-has_definitional_manifestation
503469059,7/16/2014 19:25:41,,1324432375,7/16/2014 19:24:49,clixsense,0.5444,6714657,USA,CT,Groton,71.235.184.32,no_relation,70,0,,77,16,causes,0.474712663277541,904636-FS1-4,CHRONIC MIGRAINE is a common form of disabling headache presenting in HEADACHE subspecialty practice.,HEADACHE,CHRONIC MIGRAINE,RO-has_definitional_manifestation
503469063,7/16/2014 15:30:01,,1324298306,7/16/2014 15:29:54,clixsense,0.9306,27793793,GBR,C5,Chester,151.230.27.155,GLUTEN causes COELIAC DISEASE,173,220,,178,235,causes,0.496138938356834,903990-FS1-4,The results highlight the importance of gluten challenge and intestinal biopsy in the diagnosis of coeliac disease and strongly suggest that a normal biopsy after a 3 month GLUTEN challenge (as described above) excludes COELIAC DISEASE.,GLUTEN,COELIAC DISEASE,RO-has_causative_agent
503469063,7/16/2014 15:43:20,,1324303327,7/16/2014 15:43:11,instagc,0.8194,18960682,GBR,,,86.29.147.112,GLUTEN causes COELIAC DISEASE,173,220,,178,235,causes,0.496138938356834,903990-FS1-4,The results highlight the importance of gluten challenge and intestinal biopsy in the diagnosis of coeliac disease and strongly suggest that a normal biopsy after a 3 month GLUTEN challenge (as described above) excludes COELIAC DISEASE.,GLUTEN,COELIAC DISEASE,RO-has_causative_agent
503469063,7/16/2014 15:59:59,,1324310687,7/16/2014 15:59:37,clixsense,0.6111,17722340,CAN,BC,Mission,50.98.185.25,GLUTEN causes COELIAC DISEASE,173,220,,178,235,causes,0.496138938356834,903990-FS1-4,The results highlight the importance of gluten challenge and intestinal biopsy in the diagnosis of coeliac disease and strongly suggest that a normal biopsy after a 3 month GLUTEN challenge (as described above) excludes COELIAC DISEASE.,GLUTEN,COELIAC DISEASE,RO-has_causative_agent
503469063,7/16/2014 17:08:16,,1324340758,7/16/2014 17:07:45,neodev,0.5903,18339121,USA,SC,Sumter,173.93.188.194,GLUTEN causes COELIAC DISEASE,173,220,,178,235,causes,0.496138938356834,903990-FS1-4,The results highlight the importance of gluten challenge and intestinal biopsy in the diagnosis of coeliac disease and strongly suggest that a normal biopsy after a 3 month GLUTEN challenge (as described above) excludes COELIAC DISEASE.,GLUTEN,COELIAC DISEASE,RO-has_causative_agent
503469063,7/16/2014 17:19:16,,1324344187,7/16/2014 17:18:53,prodege,0.6046,23541832,USA,AZ,Tempe,149.169.143.104,no_relation,173,220,,178,235,causes,0.496138938356834,903990-FS1-4,The results highlight the importance of gluten challenge and intestinal biopsy in the diagnosis of coeliac disease and strongly suggest that a normal biopsy after a 3 month GLUTEN challenge (as described above) excludes COELIAC DISEASE.,GLUTEN,COELIAC DISEASE,RO-has_causative_agent
503469063,7/16/2014 17:23:24,,1324345472,7/16/2014 17:22:39,prodege,0.7014,19026375,GBR,Z1,Swansea,92.26.69.100,GLUTEN causes COELIAC DISEASE,173,220,,178,235,causes,0.496138938356834,903990-FS1-4,The results highlight the importance of gluten challenge and intestinal biopsy in the diagnosis of coeliac disease and strongly suggest that a normal biopsy after a 3 month GLUTEN challenge (as described above) excludes COELIAC DISEASE.,GLUTEN,COELIAC DISEASE,RO-has_causative_agent
503469063,7/16/2014 18:18:17,,1324397079,7/16/2014 18:17:33,eup_slw,0.675,28186528,USA,IN,Bloomington,74.204.124.9,no_relation,173,220,,178,235,causes,0.496138938356834,903990-FS1-4,The results highlight the importance of gluten challenge and intestinal biopsy in the diagnosis of coeliac disease and strongly suggest that a normal biopsy after a 3 month GLUTEN challenge (as described above) excludes COELIAC DISEASE.,GLUTEN,COELIAC DISEASE,RO-has_causative_agent
503469065,7/16/2014 17:42:42,,1324359693,7/16/2014 17:42:11,clixsense,0.5657,23398628,USA,WA,Spanaway,50.149.99.43,DEXAMETHASONE treats HYPERCORTISOLISM,124,146,,139,159,treats,0.43301270189221897,906846-FS1-2,"A 49 year old man with classic manifestations of Cushing's syndrome had undetectable levels of ACTH, lack of suppression of HYPERCORTISOLISM with DEXAMETHASONE in doses of 2, 8, or 16 mg per day, bilaterally enlarged adrenal glands on MRI, and bilateral adrenal uptake of iodocholesterol.",HYPERCORTISOLISM,DEXAMETHASONE,RO-may_diagnose
503469065,7/16/2014 20:35:43,,1324464490,7/16/2014 20:34:57,clixsense,0.4899,6574199,USA,TX,San Antonio,207.230.144.242,no_relation,124,146,,139,159,treats,0.43301270189221897,906846-FS1-2,"A 49 year old man with classic manifestations of Cushing's syndrome had undetectable levels of ACTH, lack of suppression of HYPERCORTISOLISM with DEXAMETHASONE in doses of 2, 8, or 16 mg per day, bilaterally enlarged adrenal glands on MRI, and bilateral adrenal uptake of iodocholesterol.",HYPERCORTISOLISM,DEXAMETHASONE,RO-may_diagnose
503469065,7/16/2014 23:09:32,,1324528528,7/16/2014 23:08:48,instagc,0.6728,19636746,USA,NY,Andover,192.182.216.225,DEXAMETHASONE treats HYPERCORTISOLISM,124,146,,139,159,treats,0.43301270189221897,906846-FS1-2,"A 49 year old man with classic manifestations of Cushing's syndrome had undetectable levels of ACTH, lack of suppression of HYPERCORTISOLISM with DEXAMETHASONE in doses of 2, 8, or 16 mg per day, bilaterally enlarged adrenal glands on MRI, and bilateral adrenal uptake of iodocholesterol.",HYPERCORTISOLISM,DEXAMETHASONE,RO-may_diagnose
503469065,7/16/2014 23:31:08,,1324538075,7/16/2014 23:30:31,zoombucks,0.7409,4688131,CAN,BC,Vancouver,108.180.143.28,DEXAMETHASONE treats HYPERCORTISOLISM,124,146,,139,159,treats,0.43301270189221897,906846-FS1-2,"A 49 year old man with classic manifestations of Cushing's syndrome had undetectable levels of ACTH, lack of suppression of HYPERCORTISOLISM with DEXAMETHASONE in doses of 2, 8, or 16 mg per day, bilaterally enlarged adrenal glands on MRI, and bilateral adrenal uptake of iodocholesterol.",HYPERCORTISOLISM,DEXAMETHASONE,RO-may_diagnose
503469065,7/17/2014 00:28:58,,1324565142,7/17/2014 00:28:35,prodege,0.335,24403612,CAN,ON,Ajax,99.242.234.239,no_relation,124,146,,139,159,treats,0.43301270189221897,906846-FS1-2,"A 49 year old man with classic manifestations of Cushing's syndrome had undetectable levels of ACTH, lack of suppression of HYPERCORTISOLISM with DEXAMETHASONE in doses of 2, 8, or 16 mg per day, bilaterally enlarged adrenal glands on MRI, and bilateral adrenal uptake of iodocholesterol.",HYPERCORTISOLISM,DEXAMETHASONE,RO-may_diagnose
503469065,7/17/2014 02:19:22,,1324671423,7/17/2014 02:19:06,pokerowned,0.5583,18747884,USA,MI,Saginaw,74.85.192.98,DEXAMETHASONE treats HYPERCORTISOLISM,124,146,,139,159,treats,0.43301270189221897,906846-FS1-2,"A 49 year old man with classic manifestations of Cushing's syndrome had undetectable levels of ACTH, lack of suppression of HYPERCORTISOLISM with DEXAMETHASONE in doses of 2, 8, or 16 mg per day, bilaterally enlarged adrenal glands on MRI, and bilateral adrenal uptake of iodocholesterol.",HYPERCORTISOLISM,DEXAMETHASONE,RO-may_diagnose
503469065,7/17/2014 02:32:39,,1324684655,7/17/2014 02:31:56,neodev,0.7012,11460728,CAN,BC,Burnaby,70.79.16.165,DEXAMETHASONE treats HYPERCORTISOLISM,124,146,,139,159,treats,0.43301270189221897,906846-FS1-2,"A 49 year old man with classic manifestations of Cushing's syndrome had undetectable levels of ACTH, lack of suppression of HYPERCORTISOLISM with DEXAMETHASONE in doses of 2, 8, or 16 mg per day, bilaterally enlarged adrenal glands on MRI, and bilateral adrenal uptake of iodocholesterol.",HYPERCORTISOLISM,DEXAMETHASONE,RO-may_diagnose
503469066,7/16/2014 15:26:54,,1324297323,7/16/2014 15:26:35,clixsense,0.9028,20614047,USA,MO,Maryville,174.32.162.147,AGGRESSIVE CLINICAL COURSE causes PLASMA CELL LEUKAEMIA,63,17,,88,38,causes,0.609994281330419,902607-FS1-4,"The diagnosis of PLASMA CELL LEUKAEMIA a rare disorder with an AGGRESSIVE CLINICAL COURSE and poor prognosis, is not always straightforward and may be dependent on the results of immunophenotyping.",AGGRESSIVE CLINICAL COURSE,PLASMA CELL LEUKAEMIA,RO-disease_may_have_finding
503469066,7/16/2014 16:37:20,,1324328883,7/16/2014 16:37:07,neodev,0.8542,14861092,GBR,H9,London,90.194.156.173,PLASMA CELL LEUKAEMIA causes AGGRESSIVE CLINICAL COURSE,63,17,,88,38,causes,0.609994281330419,902607-FS1-4,"The diagnosis of PLASMA CELL LEUKAEMIA a rare disorder with an AGGRESSIVE CLINICAL COURSE and poor prognosis, is not always straightforward and may be dependent on the results of immunophenotyping.",AGGRESSIVE CLINICAL COURSE,PLASMA CELL LEUKAEMIA,RO-disease_may_have_finding
503469066,7/16/2014 16:52:23,,1324335433,7/16/2014 16:51:56,rewardsspot,0.6597,17763704,USA,VA,Manassas,198.7.62.204,AGGRESSIVE CLINICAL COURSE causes PLASMA CELL LEUKAEMIA,63,17,,88,38,causes,0.609994281330419,902607-FS1-4,"The diagnosis of PLASMA CELL LEUKAEMIA a rare disorder with an AGGRESSIVE CLINICAL COURSE and poor prognosis, is not always straightforward and may be dependent on the results of immunophenotyping.",AGGRESSIVE CLINICAL COURSE,PLASMA CELL LEUKAEMIA,RO-disease_may_have_finding
503469066,7/16/2014 23:48:32,,1324545086,7/16/2014 23:47:49,clixsense,0.6734,23585686,GBR,H9,London,31.51.221.173,PLASMA CELL LEUKAEMIA causes AGGRESSIVE CLINICAL COURSE,63,17,,88,38,causes,0.609994281330419,902607-FS1-4,"The diagnosis of PLASMA CELL LEUKAEMIA a rare disorder with an AGGRESSIVE CLINICAL COURSE and poor prognosis, is not always straightforward and may be dependent on the results of immunophenotyping.",AGGRESSIVE CLINICAL COURSE,PLASMA CELL LEUKAEMIA,RO-disease_may_have_finding
503469066,7/17/2014 00:59:11,,1324593236,7/17/2014 00:58:38,prodege,0.5889,2767509,CAN,BC,Victoria,96.54.172.117,no_relation,63,17,,88,38,causes,0.609994281330419,902607-FS1-4,"The diagnosis of PLASMA CELL LEUKAEMIA a rare disorder with an AGGRESSIVE CLINICAL COURSE and poor prognosis, is not always straightforward and may be dependent on the results of immunophenotyping.",AGGRESSIVE CLINICAL COURSE,PLASMA CELL LEUKAEMIA,RO-disease_may_have_finding
503469066,7/17/2014 02:20:23,,1324672426,7/17/2014 02:20:06,pokerowned,0.5583,18747884,USA,MI,Saginaw,74.85.192.98,PLASMA CELL LEUKAEMIA causes AGGRESSIVE CLINICAL COURSE,63,17,,88,38,causes,0.609994281330419,902607-FS1-4,"The diagnosis of PLASMA CELL LEUKAEMIA a rare disorder with an AGGRESSIVE CLINICAL COURSE and poor prognosis, is not always straightforward and may be dependent on the results of immunophenotyping.",AGGRESSIVE CLINICAL COURSE,PLASMA CELL LEUKAEMIA,RO-disease_may_have_finding
503469066,7/17/2014 02:23:09,,1324675133,7/17/2014 02:22:14,clixsense,0.5607,6520576,USA,OH,Springfield,71.79.14.94,no_relation,63,17,,88,38,causes,0.609994281330419,902607-FS1-4,"The diagnosis of PLASMA CELL LEUKAEMIA a rare disorder with an AGGRESSIVE CLINICAL COURSE and poor prognosis, is not always straightforward and may be dependent on the results of immunophenotyping.",AGGRESSIVE CLINICAL COURSE,PLASMA CELL LEUKAEMIA,RO-disease_may_have_finding
503469070,7/16/2014 15:34:18,,1324299736,7/16/2014 15:34:13,neodev,0.8472,27597779,CAN,AB,Calgary,72.29.251.209,METASTATIC MULTIPLE MYELOMA treats ZOLEDRONIC ACID,150,97,,176,112,treats,0.9036961141150641,908304-FS1-2,We collected resource use data prospectively for 930 patients alongside a multinational trial of ZOLEDRONIC ACID versus pamidronate for patients with METASTATIC MULTIPLE MYELOMA or breast cancer and > or =1 bone lesion.,METASTATIC MULTIPLE MYELOMA,ZOLEDRONIC ACID,RO-may_treat
503469070,7/16/2014 16:18:33,,1324321493,7/16/2014 16:18:08,elite,0.7361,28276268,USA,MI,Fenton,68.188.185.225,ZOLEDRONIC ACID treats METASTATIC MULTIPLE MYELOMA,150,97,,176,112,treats,0.9036961141150641,908304-FS1-2,We collected resource use data prospectively for 930 patients alongside a multinational trial of ZOLEDRONIC ACID versus pamidronate for patients with METASTATIC MULTIPLE MYELOMA or breast cancer and > or =1 bone lesion.,METASTATIC MULTIPLE MYELOMA,ZOLEDRONIC ACID,RO-may_treat
503469070,7/16/2014 16:21:37,,1324322631,7/16/2014 16:21:08,instagc,0.5972,19436046,GBR,U3,Dundee,82.36.106.184,ZOLEDRONIC ACID treats METASTATIC MULTIPLE MYELOMA,150,97,,176,112,treats,0.9036961141150641,908304-FS1-2,We collected resource use data prospectively for 930 patients alongside a multinational trial of ZOLEDRONIC ACID versus pamidronate for patients with METASTATIC MULTIPLE MYELOMA or breast cancer and > or =1 bone lesion.,METASTATIC MULTIPLE MYELOMA,ZOLEDRONIC ACID,RO-may_treat
503469070,7/16/2014 17:08:28,,1324340849,7/16/2014 17:08:08,instagc,0.6736,23149109,USA,NC,Cary,24.206.38.18,ZOLEDRONIC ACID treats METASTATIC MULTIPLE MYELOMA,150,97,,176,112,treats,0.9036961141150641,908304-FS1-2,We collected resource use data prospectively for 930 patients alongside a multinational trial of ZOLEDRONIC ACID versus pamidronate for patients with METASTATIC MULTIPLE MYELOMA or breast cancer and > or =1 bone lesion.,METASTATIC MULTIPLE MYELOMA,ZOLEDRONIC ACID,RO-may_treat
503469070,7/16/2014 17:44:11,,1324361140,7/16/2014 17:44:02,gifthulk,0.7524,21916793,GBR,,,87.113.87.199,ZOLEDRONIC ACID treats METASTATIC MULTIPLE MYELOMA,150,97,,176,112,treats,0.9036961141150641,908304-FS1-2,We collected resource use data prospectively for 930 patients alongside a multinational trial of ZOLEDRONIC ACID versus pamidronate for patients with METASTATIC MULTIPLE MYELOMA or breast cancer and > or =1 bone lesion.,METASTATIC MULTIPLE MYELOMA,ZOLEDRONIC ACID,RO-may_treat
503469070,7/16/2014 18:04:33,,1324382538,7/16/2014 18:04:11,instagc,0.7462,28157545,USA,OR,Mcminnville,76.115.153.186,ZOLEDRONIC ACID treats METASTATIC MULTIPLE MYELOMA,150,97,,176,112,treats,0.9036961141150641,908304-FS1-2,We collected resource use data prospectively for 930 patients alongside a multinational trial of ZOLEDRONIC ACID versus pamidronate for patients with METASTATIC MULTIPLE MYELOMA or breast cancer and > or =1 bone lesion.,METASTATIC MULTIPLE MYELOMA,ZOLEDRONIC ACID,RO-may_treat
503469070,7/16/2014 22:55:47,,1324523741,7/16/2014 22:54:54,prodege,0.7282,12971342,USA,CA,Los Angeles,198.101.91.82,ZOLEDRONIC ACID treats METASTATIC MULTIPLE MYELOMA,150,97,,176,112,treats,0.9036961141150641,908304-FS1-2,We collected resource use data prospectively for 930 patients alongside a multinational trial of ZOLEDRONIC ACID versus pamidronate for patients with METASTATIC MULTIPLE MYELOMA or breast cancer and > or =1 bone lesion.,METASTATIC MULTIPLE MYELOMA,ZOLEDRONIC ACID,RO-may_treat
503469073,7/16/2014 15:26:54,,1324297313,7/16/2014 15:26:35,clixsense,0.9028,20614047,USA,MO,Maryville,174.32.162.147,TUBERCULIN NEGATIVE causes TUBERCULOSIS,6,68,,17,87,causes,0.371390676354104,906819-FS1-4,A low TUBERCULOSIS risk differential was similarly observed between TUBERCULIN NEGATIVE and untreated tuberculin positive subjects in the historical cohort.,TUBERCULOSIS,TUBERCULIN NEGATIVE,RO-may_diagnose
503469073,7/16/2014 23:34:40,,1324539587,7/16/2014 23:34:25,neodev,0.6766,15848372,AUS,02,Jannali,27.96.208.89,no_relation,6,68,,17,87,causes,0.371390676354104,906819-FS1-4,A low TUBERCULOSIS risk differential was similarly observed between TUBERCULIN NEGATIVE and untreated tuberculin positive subjects in the historical cohort.,TUBERCULOSIS,TUBERCULIN NEGATIVE,RO-may_diagnose
503469073,7/16/2014 23:50:04,,1324545629,7/16/2014 23:49:35,clixsense,0.6734,23585686,GBR,H9,London,31.51.221.173,TUBERCULOSIS causes TUBERCULIN NEGATIVE,6,68,,17,87,causes,0.371390676354104,906819-FS1-4,A low TUBERCULOSIS risk differential was similarly observed between TUBERCULIN NEGATIVE and untreated tuberculin positive subjects in the historical cohort.,TUBERCULOSIS,TUBERCULIN NEGATIVE,RO-may_diagnose
503469073,7/17/2014 02:23:52,,1324675783,7/17/2014 02:23:32,clixsense,0.5607,6520576,USA,OH,Springfield,71.79.14.94,TUBERCULIN NEGATIVE causes TUBERCULOSIS,6,68,,17,87,causes,0.371390676354104,906819-FS1-4,A low TUBERCULOSIS risk differential was similarly observed between TUBERCULIN NEGATIVE and untreated tuberculin positive subjects in the historical cohort.,TUBERCULOSIS,TUBERCULIN NEGATIVE,RO-may_diagnose
503469073,7/17/2014 02:31:55,,1324683929,7/17/2014 02:31:12,neodev,0.7012,11460728,CAN,BC,Burnaby,70.79.16.165,no_relation,6,68,,17,87,causes,0.371390676354104,906819-FS1-4,A low TUBERCULOSIS risk differential was similarly observed between TUBERCULIN NEGATIVE and untreated tuberculin positive subjects in the historical cohort.,TUBERCULOSIS,TUBERCULIN NEGATIVE,RO-may_diagnose
503469073,7/17/2014 03:07:59,,1324720684,7/17/2014 03:07:39,cotter,0.5675,7287927,USA,CA,San Jose,99.27.90.128,TUBERCULIN NEGATIVE causes TUBERCULOSIS,6,68,,17,87,causes,0.371390676354104,906819-FS1-4,A low TUBERCULOSIS risk differential was similarly observed between TUBERCULIN NEGATIVE and untreated tuberculin positive subjects in the historical cohort.,TUBERCULOSIS,TUBERCULIN NEGATIVE,RO-may_diagnose
503469073,7/17/2014 03:39:44,,1324751265,7/17/2014 03:38:57,instagc,0.5238,20183814,USA,,,166.182.81.199,no_relation,6,68,,17,87,causes,0.371390676354104,906819-FS1-4,A low TUBERCULOSIS risk differential was similarly observed between TUBERCULIN NEGATIVE and untreated tuberculin positive subjects in the historical cohort.,TUBERCULOSIS,TUBERCULIN NEGATIVE,RO-may_diagnose
503469074,7/16/2014 15:55:04,,1324308363,7/16/2014 15:54:30,rewardsspot,0.65,24482174,GBR,H9,London,46.23.68.180,IRON causes IRON DEFICIENCY ANEMIA,96,96,,117,100,causes,0.48507125007266605,907379-FS1-4,"? Adherence to a gluten free diet in patients with celiac disease can lead to the correction of IRON DEFICIENCY ANEMIA and the replacement of iron stores, and it can prevent the recurrence of IRON deficiency.",IRON DEFICIENCY ANEMIA,IRON,RO-may_prevent
503469074,7/16/2014 18:35:38,,1324404896,7/16/2014 18:35:29,instagc,0.5736,15445601,USA,FL,Jacksonville,24.129.68.254,no_relation,96,96,,117,100,causes,0.48507125007266605,907379-FS1-4,"? Adherence to a gluten free diet in patients with celiac disease can lead to the correction of IRON DEFICIENCY ANEMIA and the replacement of iron stores, and it can prevent the recurrence of IRON deficiency.",IRON DEFICIENCY ANEMIA,IRON,RO-may_prevent
503469074,7/16/2014 21:39:42,,1324493889,7/16/2014 21:39:20,clixsense,0.7516,24896327,GBR,V2,Glasgow,94.2.231.4,no_relation,96,96,,117,100,causes,0.48507125007266605,907379-FS1-4,"? Adherence to a gluten free diet in patients with celiac disease can lead to the correction of IRON DEFICIENCY ANEMIA and the replacement of iron stores, and it can prevent the recurrence of IRON deficiency.",IRON DEFICIENCY ANEMIA,IRON,RO-may_prevent
503469074,7/16/2014 23:35:05,,1324539740,7/16/2014 23:34:42,neodev,0.6766,15848372,AUS,02,Jannali,27.96.208.89,no_relation,96,96,,117,100,causes,0.48507125007266605,907379-FS1-4,"? Adherence to a gluten free diet in patients with celiac disease can lead to the correction of IRON DEFICIENCY ANEMIA and the replacement of iron stores, and it can prevent the recurrence of IRON deficiency.",IRON DEFICIENCY ANEMIA,IRON,RO-may_prevent
503469074,7/17/2014 00:50:28,,1324584522,7/17/2014 00:49:28,neodev,0.7012,11460728,CAN,BC,Burnaby,70.79.16.165,no_relation,96,96,,117,100,causes,0.48507125007266605,907379-FS1-4,"? Adherence to a gluten free diet in patients with celiac disease can lead to the correction of IRON DEFICIENCY ANEMIA and the replacement of iron stores, and it can prevent the recurrence of IRON deficiency.",IRON DEFICIENCY ANEMIA,IRON,RO-may_prevent
503469074,7/17/2014 02:22:13,,1324674191,7/17/2014 02:21:33,clixsense,0.5607,6520576,USA,OH,Springfield,71.79.14.94,no_relation,96,96,,117,100,causes,0.48507125007266605,907379-FS1-4,"? Adherence to a gluten free diet in patients with celiac disease can lead to the correction of IRON DEFICIENCY ANEMIA and the replacement of iron stores, and it can prevent the recurrence of IRON deficiency.",IRON DEFICIENCY ANEMIA,IRON,RO-may_prevent
503469074,7/17/2014 03:07:37,,1324720207,7/17/2014 03:06:58,cotter,0.5675,7287927,USA,CA,San Jose,99.27.90.128,IRON causes IRON DEFICIENCY ANEMIA,96,96,,117,100,causes,0.48507125007266605,907379-FS1-4,"? Adherence to a gluten free diet in patients with celiac disease can lead to the correction of IRON DEFICIENCY ANEMIA and the replacement of iron stores, and it can prevent the recurrence of IRON deficiency.",IRON DEFICIENCY ANEMIA,IRON,RO-may_prevent
503469075,7/16/2014 15:30:45,,1324298607,7/16/2014 15:30:19,clixsense,0.9028,19803139,NLD,06,Veldhoven,212.61.84.196,LYMPHOMATOID PAPULOSIS causes PAPULES,164,67,,170,89,causes,0.98058067569092,902774-FS1-4,"In this review, we discuss the clinical and histologic features of LYMPHOMATOID PAPULOSIS a cutaneous disorder characterized by recurrent eruptions of self healing PAPULES and small nodules with histologic findings suggestive of malignant lymphoma.",PAPULES,LYMPHOMATOID PAPULOSIS,RO-disease_may_have_finding
503469075,7/16/2014 17:18:52,,1324344045,7/16/2014 17:18:38,prodege,0.6046,23541832,USA,AZ,Tempe,149.169.143.104,LYMPHOMATOID PAPULOSIS causes PAPULES,164,67,,170,89,causes,0.98058067569092,902774-FS1-4,"In this review, we discuss the clinical and histologic features of LYMPHOMATOID PAPULOSIS a cutaneous disorder characterized by recurrent eruptions of self healing PAPULES and small nodules with histologic findings suggestive of malignant lymphoma.",PAPULES,LYMPHOMATOID PAPULOSIS,RO-disease_may_have_finding
503469075,7/16/2014 18:03:58,,1324381892,7/16/2014 18:03:28,instagc,0.7462,28157545,USA,OR,Mcminnville,76.115.153.186,LYMPHOMATOID PAPULOSIS causes PAPULES,164,67,,170,89,causes,0.98058067569092,902774-FS1-4,"In this review, we discuss the clinical and histologic features of LYMPHOMATOID PAPULOSIS a cutaneous disorder characterized by recurrent eruptions of self healing PAPULES and small nodules with histologic findings suggestive of malignant lymphoma.",PAPULES,LYMPHOMATOID PAPULOSIS,RO-disease_may_have_finding
503469075,7/16/2014 18:26:24,,1324400587,7/16/2014 18:25:42,eup_slw,0.6538,18329415,USA,PA,Folcroft,64.121.230.236,no_relation,164,67,,170,89,causes,0.98058067569092,902774-FS1-4,"In this review, we discuss the clinical and histologic features of LYMPHOMATOID PAPULOSIS a cutaneous disorder characterized by recurrent eruptions of self healing PAPULES and small nodules with histologic findings suggestive of malignant lymphoma.",PAPULES,LYMPHOMATOID PAPULOSIS,RO-disease_may_have_finding
503469075,7/16/2014 20:09:54,,1324452655,7/16/2014 20:09:47,tremorgames,0.6605,28013393,USA,CA,Rancho Cordova,71.197.67.37,PAPULES causes LYMPHOMATOID PAPULOSIS,164,67,,170,89,causes,0.98058067569092,902774-FS1-4,"In this review, we discuss the clinical and histologic features of LYMPHOMATOID PAPULOSIS a cutaneous disorder characterized by recurrent eruptions of self healing PAPULES and small nodules with histologic findings suggestive of malignant lymphoma.",PAPULES,LYMPHOMATOID PAPULOSIS,RO-disease_may_have_finding
503469075,7/17/2014 00:28:35,,1324564769,7/17/2014 00:28:12,prodege,0.335,24403612,CAN,ON,Ajax,99.242.234.239,no_relation,164,67,,170,89,causes,0.98058067569092,902774-FS1-4,"In this review, we discuss the clinical and histologic features of LYMPHOMATOID PAPULOSIS a cutaneous disorder characterized by recurrent eruptions of self healing PAPULES and small nodules with histologic findings suggestive of malignant lymphoma.",PAPULES,LYMPHOMATOID PAPULOSIS,RO-disease_may_have_finding
503469075,7/17/2014 02:33:15,,1324685408,7/17/2014 02:32:40,neodev,0.7012,11460728,CAN,BC,Burnaby,70.79.16.165,LYMPHOMATOID PAPULOSIS causes PAPULES,164,67,,170,89,causes,0.98058067569092,902774-FS1-4,"In this review, we discuss the clinical and histologic features of LYMPHOMATOID PAPULOSIS a cutaneous disorder characterized by recurrent eruptions of self healing PAPULES and small nodules with histologic findings suggestive of malignant lymphoma.",PAPULES,LYMPHOMATOID PAPULOSIS,RO-disease_may_have_finding
503469077,7/16/2014 15:40:25,,1324302139,7/16/2014 15:39:47,clixsense,0.8333,15189335,GBR,I9,Bury Saint Edmunds,81.155.129.231,no_relation,62,86,,72,98,causes,0.404061017820884,904720-FS1-4,Alcohol sensitivity and alcohol use were both associated with ELEVATED BP and risk of HYPERTENSION in an older Chinese population.,ELEVATED BP,HYPERTENSION,RO-has_definitional_manifestation
503469077,7/16/2014 16:39:39,,1324330473,7/16/2014 16:39:31,prodege,0.5091,2143114,CAN,BC,Vancouver,24.84.160.12,HYPERTENSION causes ELEVATED BP,62,86,,72,98,causes,0.404061017820884,904720-FS1-4,Alcohol sensitivity and alcohol use were both associated with ELEVATED BP and risk of HYPERTENSION in an older Chinese population.,ELEVATED BP,HYPERTENSION,RO-has_definitional_manifestation
503469077,7/16/2014 17:03:40,,1324339267,7/16/2014 17:03:21,neodev,0.375,12218487,CAN,ON,Oshawa,174.117.79.122,no_relation,62,86,,72,98,causes,0.404061017820884,904720-FS1-4,Alcohol sensitivity and alcohol use were both associated with ELEVATED BP and risk of HYPERTENSION in an older Chinese population.,ELEVATED BP,HYPERTENSION,RO-has_definitional_manifestation
503469077,7/16/2014 17:05:24,,1324339812,7/16/2014 17:04:35,clixsense,0.5597,19638651,USA,,,173.23.121.63,no_relation,62,86,,72,98,causes,0.404061017820884,904720-FS1-4,Alcohol sensitivity and alcohol use were both associated with ELEVATED BP and risk of HYPERTENSION in an older Chinese population.,ELEVATED BP,HYPERTENSION,RO-has_definitional_manifestation
503469077,7/16/2014 17:45:22,,1324362347,7/16/2014 17:45:06,gifthulk,0.7524,21916793,GBR,,,87.113.87.199,ELEVATED BP causes HYPERTENSION,62,86,,72,98,causes,0.404061017820884,904720-FS1-4,Alcohol sensitivity and alcohol use were both associated with ELEVATED BP and risk of HYPERTENSION in an older Chinese population.,ELEVATED BP,HYPERTENSION,RO-has_definitional_manifestation
503469077,7/16/2014 18:15:34,,1324393878,7/16/2014 18:14:41,eup_slw,0.675,28186528,USA,IN,Bloomington,74.204.124.9,ELEVATED BP causes HYPERTENSION,62,86,,72,98,causes,0.404061017820884,904720-FS1-4,Alcohol sensitivity and alcohol use were both associated with ELEVATED BP and risk of HYPERTENSION in an older Chinese population.,ELEVATED BP,HYPERTENSION,RO-has_definitional_manifestation
503469077,7/16/2014 19:26:17,,1324432622,7/16/2014 19:25:42,clixsense,0.5444,6714657,USA,CT,Groton,71.235.184.32,no_relation,62,86,,72,98,causes,0.404061017820884,904720-FS1-4,Alcohol sensitivity and alcohol use were both associated with ELEVATED BP and risk of HYPERTENSION in an older Chinese population.,ELEVATED BP,HYPERTENSION,RO-has_definitional_manifestation
503729616,7/16/2014 22:23:21,,1324510481,7/16/2014 22:22:40,clixsense,1.0,21642428,NLD,11,Nootdorp,83.86.58.179,METHOTREXATE treats LEUKEMIA,28,60,,35,72,treats,0.9830783046228491,908155-FS1-2,We report two patients with LEUKEMIA treated with high dose METHOTREXATE,LEUKEMIA,METHOTREXATE,RO-may_treat
503729616,7/17/2014 01:32:22,,1324624961,7/17/2014 01:32:17,tremorgames,0.6667,28013393,USA,CA,Rancho Cordova,71.197.67.37,METHOTREXATE treats LEUKEMIA,28,60,,35,72,treats,0.9830783046228491,908155-FS1-2,We report two patients with LEUKEMIA treated with high dose METHOTREXATE,LEUKEMIA,METHOTREXATE,RO-may_treat
503729616,7/17/2014 03:08:26,,1324721086,7/17/2014 03:08:06,prodege,0.6565,6011370,CAN,BC,Richmond,70.79.45.148,METHOTREXATE treats LEUKEMIA,28,60,,35,72,treats,0.9830783046228491,908155-FS1-2,We report two patients with LEUKEMIA treated with high dose METHOTREXATE,LEUKEMIA,METHOTREXATE,RO-may_treat
503729616,7/17/2014 04:55:38,,1324820091,7/17/2014 04:55:06,prodege,0.7105,27934334,GBR,,,86.130.153.15,METHOTREXATE treats LEUKEMIA,28,60,,35,72,treats,0.9830783046228491,908155-FS1-2,We report two patients with LEUKEMIA treated with high dose METHOTREXATE,LEUKEMIA,METHOTREXATE,RO-may_treat
503729616,7/17/2014 06:05:06,,1324879056,7/17/2014 06:04:31,clixsense,0.6042,6472283,USA,WI,Oak Creek,99.107.184.156,METHOTREXATE treats LEUKEMIA,28,60,,35,72,treats,0.9830783046228491,908155-FS1-2,We report two patients with LEUKEMIA treated with high dose METHOTREXATE,LEUKEMIA,METHOTREXATE,RO-may_treat
503729616,7/17/2014 07:45:06,,1324979737,7/17/2014 07:44:55,instagc,0.698,18960682,GBR,,,86.29.147.112,METHOTREXATE treats LEUKEMIA,28,60,,35,72,treats,0.9830783046228491,908155-FS1-2,We report two patients with LEUKEMIA treated with high dose METHOTREXATE,LEUKEMIA,METHOTREXATE,RO-may_treat
503729616,7/17/2014 10:37:22,,1325144097,7/17/2014 10:37:08,prodege,0.652,9525153,CAN,ON,Toronto,65.95.92.180,METHOTREXATE treats LEUKEMIA,28,60,,35,72,treats,0.9830783046228491,908155-FS1-2,We report two patients with LEUKEMIA treated with high dose METHOTREXATE,LEUKEMIA,METHOTREXATE,RO-may_treat
503729617,7/16/2014 22:36:21,,1324516067,7/16/2014 22:36:02,tremorgames,0.8403,24449707,CAN,QC,Laval,96.21.249.72,CISAPRIDE causes FOOD STIMULATED GASTRO OESOPHAGEAL REFLUX MECHANISMS,30,17,,81,26,causes,0.560112033611204,908361-FS1-4,"The influence of CISAPRIDE on FOOD STIMULATED GASTRO OESOPHAGEAL REFLUX MECHANISMS was studied in a double blind cross over investigation in 24 consecutive patients selected by endoscopy, 12 with microscopical evidence of gastro oesophageal reflux and 12 with additional macroscopic oesophagitis.",FOOD STIMULATED GASTRO OESOPHAGEAL REFLUX MECHANISMS,CISAPRIDE,RO-may_treat
503729617,7/16/2014 22:45:06,,1324519368,7/16/2014 22:44:50,elite,0.8333,28276268,USA,CA,Daly City,24.6.249.44,CISAPRIDE causes FOOD STIMULATED GASTRO OESOPHAGEAL REFLUX MECHANISMS,30,17,,81,26,causes,0.560112033611204,908361-FS1-4,"The influence of CISAPRIDE on FOOD STIMULATED GASTRO OESOPHAGEAL REFLUX MECHANISMS was studied in a double blind cross over investigation in 24 consecutive patients selected by endoscopy, 12 with microscopical evidence of gastro oesophageal reflux and 12 with additional macroscopic oesophagitis.",FOOD STIMULATED GASTRO OESOPHAGEAL REFLUX MECHANISMS,CISAPRIDE,RO-may_treat
503729617,7/16/2014 23:11:23,,1324529206,7/16/2014 23:10:45,cotter,0.6014,7287927,USA,CA,San Jose,99.27.90.128,FOOD STIMULATED GASTRO OESOPHAGEAL REFLUX MECHANISMS causes CISAPRIDE,30,17,,81,26,causes,0.560112033611204,908361-FS1-4,"The influence of CISAPRIDE on FOOD STIMULATED GASTRO OESOPHAGEAL REFLUX MECHANISMS was studied in a double blind cross over investigation in 24 consecutive patients selected by endoscopy, 12 with microscopical evidence of gastro oesophageal reflux and 12 with additional macroscopic oesophagitis.",FOOD STIMULATED GASTRO OESOPHAGEAL REFLUX MECHANISMS,CISAPRIDE,RO-may_treat
503729617,7/16/2014 23:43:00,,1324543096,7/16/2014 23:42:08,clixsense,0.6403,23585686,GBR,H9,London,31.51.221.173,CISAPRIDE causes FOOD STIMULATED GASTRO OESOPHAGEAL REFLUX MECHANISMS,30,17,,81,26,causes,0.560112033611204,908361-FS1-4,"The influence of CISAPRIDE on FOOD STIMULATED GASTRO OESOPHAGEAL REFLUX MECHANISMS was studied in a double blind cross over investigation in 24 consecutive patients selected by endoscopy, 12 with microscopical evidence of gastro oesophageal reflux and 12 with additional macroscopic oesophagitis.",FOOD STIMULATED GASTRO OESOPHAGEAL REFLUX MECHANISMS,CISAPRIDE,RO-may_treat
503729617,7/17/2014 00:49:09,,1324583526,7/17/2014 00:49:05,coinworker,0.4226,28394550,USA,PA,Marcus Hook,71.175.96.184,FOOD STIMULATED GASTRO OESOPHAGEAL REFLUX MECHANISMS causes CISAPRIDE,30,17,,81,26,causes,0.560112033611204,908361-FS1-4,"The influence of CISAPRIDE on FOOD STIMULATED GASTRO OESOPHAGEAL REFLUX MECHANISMS was studied in a double blind cross over investigation in 24 consecutive patients selected by endoscopy, 12 with microscopical evidence of gastro oesophageal reflux and 12 with additional macroscopic oesophagitis.",FOOD STIMULATED GASTRO OESOPHAGEAL REFLUX MECHANISMS,CISAPRIDE,RO-may_treat
503729617,7/17/2014 01:24:51,,1324617124,7/17/2014 01:24:17,rewardsspot,0.5125,24482174,GBR,H9,London,46.23.68.180,FOOD STIMULATED GASTRO OESOPHAGEAL REFLUX MECHANISMS causes CISAPRIDE,30,17,,81,26,causes,0.560112033611204,908361-FS1-4,"The influence of CISAPRIDE on FOOD STIMULATED GASTRO OESOPHAGEAL REFLUX MECHANISMS was studied in a double blind cross over investigation in 24 consecutive patients selected by endoscopy, 12 with microscopical evidence of gastro oesophageal reflux and 12 with additional macroscopic oesophagitis.",FOOD STIMULATED GASTRO OESOPHAGEAL REFLUX MECHANISMS,CISAPRIDE,RO-may_treat
503729617,7/17/2014 06:03:06,,1324877514,7/17/2014 06:02:27,clixsense,0.6042,6472283,USA,WI,Oak Creek,99.107.184.156,CISAPRIDE causes FOOD STIMULATED GASTRO OESOPHAGEAL REFLUX MECHANISMS,30,17,,81,26,causes,0.560112033611204,908361-FS1-4,"The influence of CISAPRIDE on FOOD STIMULATED GASTRO OESOPHAGEAL REFLUX MECHANISMS was studied in a double blind cross over investigation in 24 consecutive patients selected by endoscopy, 12 with microscopical evidence of gastro oesophageal reflux and 12 with additional macroscopic oesophagitis.",FOOD STIMULATED GASTRO OESOPHAGEAL REFLUX MECHANISMS,CISAPRIDE,RO-may_treat
503729618,7/16/2014 22:37:24,,1324516560,7/16/2014 22:36:56,tremorgames,0.8403,24449707,CAN,QC,Laval,96.21.249.72,no_relation,146,201,,173,217,causes,0.7715167498104591,904937-FS1-4,"Essentially, the classification of chronic pain falls into 3 broad categories: (1) pain owing to tissue disease or damage (nociceptive pain), (2) PAIN CAUSED BY SOMATOSENSORY system disease or damage (NEUROPATHIC PAIN and (3) pain without a known somatic background.",PAIN CAUSED BY SOMATOSENSORY,NEUROPATHIC PAIN,RO-has_definitional_manifestation
503729618,7/16/2014 23:25:29,,1324535709,7/16/2014 23:25:02,instagc,0.7639,13763729,USA,,,75.182.89.225,NEUROPATHIC PAIN causes PAIN CAUSED BY SOMATOSENSORY,146,201,,173,217,causes,0.7715167498104591,904937-FS1-4,"Essentially, the classification of chronic pain falls into 3 broad categories: (1) pain owing to tissue disease or damage (nociceptive pain), (2) PAIN CAUSED BY SOMATOSENSORY system disease or damage (NEUROPATHIC PAIN and (3) pain without a known somatic background.",PAIN CAUSED BY SOMATOSENSORY,NEUROPATHIC PAIN,RO-has_definitional_manifestation
503729618,7/16/2014 23:43:33,,1324543271,7/16/2014 23:43:15,prodege,0.5722,2143114,CAN,BC,Vancouver,24.84.160.12,NEUROPATHIC PAIN causes PAIN CAUSED BY SOMATOSENSORY,146,201,,173,217,causes,0.7715167498104591,904937-FS1-4,"Essentially, the classification of chronic pain falls into 3 broad categories: (1) pain owing to tissue disease or damage (nociceptive pain), (2) PAIN CAUSED BY SOMATOSENSORY system disease or damage (NEUROPATHIC PAIN and (3) pain without a known somatic background.",PAIN CAUSED BY SOMATOSENSORY,NEUROPATHIC PAIN,RO-has_definitional_manifestation
503729618,7/17/2014 00:33:39,,1324568919,7/17/2014 00:32:55,eup_slw,0.5788,28186528,USA,IN,Bloomington,74.204.124.9,PAIN CAUSED BY SOMATOSENSORY causes NEUROPATHIC PAIN,146,201,,173,217,causes,0.7715167498104591,904937-FS1-4,"Essentially, the classification of chronic pain falls into 3 broad categories: (1) pain owing to tissue disease or damage (nociceptive pain), (2) PAIN CAUSED BY SOMATOSENSORY system disease or damage (NEUROPATHIC PAIN and (3) pain without a known somatic background.",PAIN CAUSED BY SOMATOSENSORY,NEUROPATHIC PAIN,RO-has_definitional_manifestation
503729618,7/17/2014 01:12:50,,1324605877,7/17/2014 01:11:49,prodege,0.649,2767509,CAN,BC,Victoria,96.54.172.117,PAIN CAUSED BY SOMATOSENSORY causes NEUROPATHIC PAIN,146,201,,173,217,causes,0.7715167498104591,904937-FS1-4,"Essentially, the classification of chronic pain falls into 3 broad categories: (1) pain owing to tissue disease or damage (nociceptive pain), (2) PAIN CAUSED BY SOMATOSENSORY system disease or damage (NEUROPATHIC PAIN and (3) pain without a known somatic background.",PAIN CAUSED BY SOMATOSENSORY,NEUROPATHIC PAIN,RO-has_definitional_manifestation
503729618,7/17/2014 01:39:41,,1324632556,7/17/2014 01:38:53,rewardsspot,0.6012,17763704,USA,IL,Chicago,67.212.175.123,no_relation,146,201,,173,217,causes,0.7715167498104591,904937-FS1-4,"Essentially, the classification of chronic pain falls into 3 broad categories: (1) pain owing to tissue disease or damage (nociceptive pain), (2) PAIN CAUSED BY SOMATOSENSORY system disease or damage (NEUROPATHIC PAIN and (3) pain without a known somatic background.",PAIN CAUSED BY SOMATOSENSORY,NEUROPATHIC PAIN,RO-has_definitional_manifestation
503729618,7/17/2014 10:32:57,,1325140414,7/17/2014 10:32:50,clixsense,0.5793,27793793,GBR,C5,Chester,151.230.27.155,NEUROPATHIC PAIN causes PAIN CAUSED BY SOMATOSENSORY,146,201,,173,217,causes,0.7715167498104591,904937-FS1-4,"Essentially, the classification of chronic pain falls into 3 broad categories: (1) pain owing to tissue disease or damage (nociceptive pain), (2) PAIN CAUSED BY SOMATOSENSORY system disease or damage (NEUROPATHIC PAIN and (3) pain without a known somatic background.",PAIN CAUSED BY SOMATOSENSORY,NEUROPATHIC PAIN,RO-has_definitional_manifestation
503729621,7/16/2014 22:34:20,,1324515013,7/16/2014 22:34:02,clixsense,0.875,15189335,GBR,H9,London,188.29.165.175,ATOPY causes HAY FEVER,99,154,,107,159,causes,0.488677777425221,900242-FS1-4,Malignancies were observed less frequently in the closest relatives of the patients suffering from HAY FEVER with the most proved hereditary liability of ATOPY than in the relatives of control groups.,HAY FEVER,ATOPY,RO-cause_of
503729621,7/16/2014 22:57:47,,1324524501,7/16/2014 22:57:01,prodege,0.8194,28255346,GBR,L9,Sheffield,2.125.183.137,ATOPY causes HAY FEVER,99,154,,107,159,causes,0.488677777425221,900242-FS1-4,Malignancies were observed less frequently in the closest relatives of the patients suffering from HAY FEVER with the most proved hereditary liability of ATOPY than in the relatives of control groups.,HAY FEVER,ATOPY,RO-cause_of
503729621,7/16/2014 23:00:24,,1324525353,7/16/2014 23:00:02,instagc,0.7361,15445601,USA,FL,Jacksonville,24.129.68.254,no_relation,99,154,,107,159,causes,0.488677777425221,900242-FS1-4,Malignancies were observed less frequently in the closest relatives of the patients suffering from HAY FEVER with the most proved hereditary liability of ATOPY than in the relatives of control groups.,HAY FEVER,ATOPY,RO-cause_of
503729621,7/16/2014 23:09:24,,1324528468,7/16/2014 23:08:39,clixsense,0.6278,18647227,GBR,P3,Bulkington,2.216.185.243,no_relation,99,154,,107,159,causes,0.488677777425221,900242-FS1-4,Malignancies were observed less frequently in the closest relatives of the patients suffering from HAY FEVER with the most proved hereditary liability of ATOPY than in the relatives of control groups.,HAY FEVER,ATOPY,RO-cause_of
503729621,7/16/2014 23:16:53,,1324531353,7/16/2014 23:15:59,eup_slw,0.7375,20818028,GBR,A7,Birmingham,92.232.139.254,ATOPY causes HAY FEVER,99,154,,107,159,causes,0.488677777425221,900242-FS1-4,Malignancies were observed less frequently in the closest relatives of the patients suffering from HAY FEVER with the most proved hereditary liability of ATOPY than in the relatives of control groups.,HAY FEVER,ATOPY,RO-cause_of
503729621,7/16/2014 23:26:15,,1324536049,7/16/2014 23:25:51,instagc,0.7639,13763729,USA,,,75.182.89.225,no_relation,99,154,,107,159,causes,0.488677777425221,900242-FS1-4,Malignancies were observed less frequently in the closest relatives of the patients suffering from HAY FEVER with the most proved hereditary liability of ATOPY than in the relatives of control groups.,HAY FEVER,ATOPY,RO-cause_of
503729621,7/17/2014 00:19:08,,1324558600,7/17/2014 00:18:50,prodege,0.555,13391452,GBR,B7,Bristol,90.213.30.203,no_relation,99,154,,107,159,causes,0.488677777425221,900242-FS1-4,Malignancies were observed less frequently in the closest relatives of the patients suffering from HAY FEVER with the most proved hereditary liability of ATOPY than in the relatives of control groups.,HAY FEVER,ATOPY,RO-cause_of
503729623,7/16/2014 22:28:59,,1324512897,7/16/2014 22:28:44,clixsense,0.9306,20614047,USA,MO,Maryville,174.32.162.147,PAIN causes CLUSTER HEADACHE,70,53,,73,69,causes,0.923380516876639,904783-FS1-4,"Although the pain in both disorders is excruciating, CLUSTER HEADACHE PAIN is episodic and unilateral, typically surrounds the eye, and lasts 15 to 180 minutes; the pain of trigeminal neuralgia lasts just seconds and is usually limited to the tissues overlying the maxillary and mandibular divisions of the trigeminal nerve.",PAIN,CLUSTER HEADACHE,RO-has_definitional_manifestation
503729623,7/16/2014 23:11:23,,1324529207,7/16/2014 23:10:45,cotter,0.6014,7287927,USA,CA,San Jose,99.27.90.128,CLUSTER HEADACHE causes PAIN,70,53,,73,69,causes,0.923380516876639,904783-FS1-4,"Although the pain in both disorders is excruciating, CLUSTER HEADACHE PAIN is episodic and unilateral, typically surrounds the eye, and lasts 15 to 180 minutes; the pain of trigeminal neuralgia lasts just seconds and is usually limited to the tissues overlying the maxillary and mandibular divisions of the trigeminal nerve.",PAIN,CLUSTER HEADACHE,RO-has_definitional_manifestation
503729623,7/16/2014 23:17:25,,1324531613,7/16/2014 23:16:55,eup_slw,0.7375,20818028,GBR,A7,Birmingham,92.232.139.254,CLUSTER HEADACHE causes PAIN,70,53,,73,69,causes,0.923380516876639,904783-FS1-4,"Although the pain in both disorders is excruciating, CLUSTER HEADACHE PAIN is episodic and unilateral, typically surrounds the eye, and lasts 15 to 180 minutes; the pain of trigeminal neuralgia lasts just seconds and is usually limited to the tissues overlying the maxillary and mandibular divisions of the trigeminal nerve.",PAIN,CLUSTER HEADACHE,RO-has_definitional_manifestation
503729623,7/16/2014 23:44:20,,1324543536,7/16/2014 23:43:46,prodege,0.5722,2143114,CAN,BC,Vancouver,24.84.160.12,CLUSTER HEADACHE causes PAIN,70,53,,73,69,causes,0.923380516876639,904783-FS1-4,"Although the pain in both disorders is excruciating, CLUSTER HEADACHE PAIN is episodic and unilateral, typically surrounds the eye, and lasts 15 to 180 minutes; the pain of trigeminal neuralgia lasts just seconds and is usually limited to the tissues overlying the maxillary and mandibular divisions of the trigeminal nerve.",PAIN,CLUSTER HEADACHE,RO-has_definitional_manifestation
503729623,7/17/2014 00:16:40,,1324557437,7/17/2014 00:16:19,prodege,0.555,13391452,GBR,B7,Bristol,90.213.30.203,no_relation,70,53,,73,69,causes,0.923380516876639,904783-FS1-4,"Although the pain in both disorders is excruciating, CLUSTER HEADACHE PAIN is episodic and unilateral, typically surrounds the eye, and lasts 15 to 180 minutes; the pain of trigeminal neuralgia lasts just seconds and is usually limited to the tissues overlying the maxillary and mandibular divisions of the trigeminal nerve.",PAIN,CLUSTER HEADACHE,RO-has_definitional_manifestation
503729623,7/17/2014 01:11:23,,1324604481,7/17/2014 01:11:05,prodege,0.649,2767509,CAN,BC,Victoria,96.54.172.117,CLUSTER HEADACHE causes PAIN,70,53,,73,69,causes,0.923380516876639,904783-FS1-4,"Although the pain in both disorders is excruciating, CLUSTER HEADACHE PAIN is episodic and unilateral, typically surrounds the eye, and lasts 15 to 180 minutes; the pain of trigeminal neuralgia lasts just seconds and is usually limited to the tissues overlying the maxillary and mandibular divisions of the trigeminal nerve.",PAIN,CLUSTER HEADACHE,RO-has_definitional_manifestation
503729623,7/17/2014 01:32:39,,1324625262,7/17/2014 01:32:33,tremorgames,0.6667,28013393,USA,CA,Rancho Cordova,71.197.67.37,CLUSTER HEADACHE causes PAIN,70,53,,73,69,causes,0.923380516876639,904783-FS1-4,"Although the pain in both disorders is excruciating, CLUSTER HEADACHE PAIN is episodic and unilateral, typically surrounds the eye, and lasts 15 to 180 minutes; the pain of trigeminal neuralgia lasts just seconds and is usually limited to the tissues overlying the maxillary and mandibular divisions of the trigeminal nerve.",PAIN,CLUSTER HEADACHE,RO-has_definitional_manifestation
503729624,7/16/2014 22:46:05,,1324519801,7/16/2014 22:45:50,elite,0.8333,28276268,USA,CA,Daly City,24.6.249.44,DIABETES treats ISLET CELL NEOGENESIS,91,79,,111,87,treats,0.99654575824488,902134-FS1-2,"If islet cell tolerance could be re induced, a major clinical hurdle to curing DIABETES by ISLET CELL NEOGENESIS may be overcome.",ISLET CELL NEOGENESIS,DIABETES,RO-disease_has_primary_anatomic_site
503729624,7/16/2014 23:09:56,,1324528680,7/16/2014 23:09:25,clixsense,0.6278,18647227,GBR,P3,Bulkington,2.216.185.243,ISLET CELL NEOGENESIS treats DIABETES,91,79,,111,87,treats,0.99654575824488,902134-FS1-2,"If islet cell tolerance could be re induced, a major clinical hurdle to curing DIABETES by ISLET CELL NEOGENESIS may be overcome.",ISLET CELL NEOGENESIS,DIABETES,RO-disease_has_primary_anatomic_site
503729624,7/16/2014 23:37:25,,1324540838,7/16/2014 23:36:53,neodev,0.7056,15848372,AUS,02,Jannali,27.96.208.89,ISLET CELL NEOGENESIS treats DIABETES,91,79,,111,87,treats,0.99654575824488,902134-FS1-2,"If islet cell tolerance could be re induced, a major clinical hurdle to curing DIABETES by ISLET CELL NEOGENESIS may be overcome.",ISLET CELL NEOGENESIS,DIABETES,RO-disease_has_primary_anatomic_site
503729624,7/16/2014 23:43:31,,1324543260,7/16/2014 23:43:02,clixsense,0.6403,23585686,GBR,H9,London,31.51.221.173,ISLET CELL NEOGENESIS treats DIABETES,91,79,,111,87,treats,0.99654575824488,902134-FS1-2,"If islet cell tolerance could be re induced, a major clinical hurdle to curing DIABETES by ISLET CELL NEOGENESIS may be overcome.",ISLET CELL NEOGENESIS,DIABETES,RO-disease_has_primary_anatomic_site
503729624,7/17/2014 00:48:57,,1324583355,7/17/2014 00:48:51,coinworker,0.4226,28394550,USA,PA,Marcus Hook,71.175.96.184,DIABETES treats ISLET CELL NEOGENESIS,91,79,,111,87,treats,0.99654575824488,902134-FS1-2,"If islet cell tolerance could be re induced, a major clinical hurdle to curing DIABETES by ISLET CELL NEOGENESIS may be overcome.",ISLET CELL NEOGENESIS,DIABETES,RO-disease_has_primary_anatomic_site
503729624,7/17/2014 01:13:46,,1324606707,7/17/2014 01:13:21,prodege,0.649,2767509,CAN,BC,Victoria,96.54.172.117,ISLET CELL NEOGENESIS treats DIABETES,91,79,,111,87,treats,0.99654575824488,902134-FS1-2,"If islet cell tolerance could be re induced, a major clinical hurdle to curing DIABETES by ISLET CELL NEOGENESIS may be overcome.",ISLET CELL NEOGENESIS,DIABETES,RO-disease_has_primary_anatomic_site
503729624,7/17/2014 01:26:55,,1324619122,7/17/2014 01:26:21,rewardsspot,0.5125,24482174,GBR,H9,London,46.23.68.180,ISLET CELL NEOGENESIS treats DIABETES,91,79,,111,87,treats,0.99654575824488,902134-FS1-2,"If islet cell tolerance could be re induced, a major clinical hurdle to curing DIABETES by ISLET CELL NEOGENESIS may be overcome.",ISLET CELL NEOGENESIS,DIABETES,RO-disease_has_primary_anatomic_site
503729627,7/16/2014 22:29:09,,1324512940,7/16/2014 22:28:52,clixsense,0.8194,16827630,GBR,A7,Birmingham,86.146.169.103,no_relation,78,157,,99,166,diagnosed by,0.9958932064677041,906943-FS1-13,In view of the wide spectrum of drug sensitivity characterizing subjects with MALIGNANT HYPERTHERMIA it is suggested that exposure to A23187 be added to the HALOTHANE and caffeine tests currently used to detect this disease.,MALIGNANT HYPERTHERMIA,HALOTHANE,RO-may_diagnose
503729627,7/16/2014 22:31:26,,1324513905,7/16/2014 22:30:48,clixsense,0.875,15189335,GBR,H9,London,188.29.165.175,MALIGNANT HYPERTHERMIA diagnosed by HALOTHANE,78,157,,99,166,diagnosed by,0.9958932064677041,906943-FS1-13,In view of the wide spectrum of drug sensitivity characterizing subjects with MALIGNANT HYPERTHERMIA it is suggested that exposure to A23187 be added to the HALOTHANE and caffeine tests currently used to detect this disease.,MALIGNANT HYPERTHERMIA,HALOTHANE,RO-may_diagnose
503729627,7/17/2014 00:49:09,,1324583525,7/17/2014 00:49:05,coinworker,0.4226,28394550,USA,PA,Marcus Hook,71.175.96.184,HALOTHANE diagnosed by MALIGNANT HYPERTHERMIA,78,157,,99,166,diagnosed by,0.9958932064677041,906943-FS1-13,In view of the wide spectrum of drug sensitivity characterizing subjects with MALIGNANT HYPERTHERMIA it is suggested that exposure to A23187 be added to the HALOTHANE and caffeine tests currently used to detect this disease.,MALIGNANT HYPERTHERMIA,HALOTHANE,RO-may_diagnose
503729627,7/17/2014 02:37:32,,1324690030,7/17/2014 02:36:49,neodev,0.7234,11460728,CAN,BC,Burnaby,70.79.16.165,no_relation,78,157,,99,166,diagnosed by,0.9958932064677041,906943-FS1-13,In view of the wide spectrum of drug sensitivity characterizing subjects with MALIGNANT HYPERTHERMIA it is suggested that exposure to A23187 be added to the HALOTHANE and caffeine tests currently used to detect this disease.,MALIGNANT HYPERTHERMIA,HALOTHANE,RO-may_diagnose
503729627,7/17/2014 03:09:52,,1324722431,7/17/2014 03:09:29,instagc,0.6704,24252915,GBR,B7,Bristol,77.98.139.82,MALIGNANT HYPERTHERMIA diagnosed by HALOTHANE,78,157,,99,166,diagnosed by,0.9958932064677041,906943-FS1-13,In view of the wide spectrum of drug sensitivity characterizing subjects with MALIGNANT HYPERTHERMIA it is suggested that exposure to A23187 be added to the HALOTHANE and caffeine tests currently used to detect this disease.,MALIGNANT HYPERTHERMIA,HALOTHANE,RO-may_diagnose
503729627,7/17/2014 07:05:26,,1324934915,7/17/2014 07:05:16,clixsense,0.5793,27793793,GBR,C5,Chester,151.230.27.155,no_relation,78,157,,99,166,diagnosed by,0.9958932064677041,906943-FS1-13,In view of the wide spectrum of drug sensitivity characterizing subjects with MALIGNANT HYPERTHERMIA it is suggested that exposure to A23187 be added to the HALOTHANE and caffeine tests currently used to detect this disease.,MALIGNANT HYPERTHERMIA,HALOTHANE,RO-may_diagnose
503729627,7/17/2014 07:44:28,,1324979040,7/17/2014 07:44:11,instagc,0.698,18960682,GBR,,,86.29.147.112,HALOTHANE diagnosed by MALIGNANT HYPERTHERMIA,78,157,,99,166,diagnosed by,0.9958932064677041,906943-FS1-13,In view of the wide spectrum of drug sensitivity characterizing subjects with MALIGNANT HYPERTHERMIA it is suggested that exposure to A23187 be added to the HALOTHANE and caffeine tests currently used to detect this disease.,MALIGNANT HYPERTHERMIA,HALOTHANE,RO-may_diagnose
503729628,7/16/2014 22:29:06,,1324512931,7/16/2014 22:28:43,clixsense,0.875,15189335,GBR,H9,London,188.29.165.175,LONG ACTING RISPERIDONE treats SCHIZOPHRENIA,96,13,,108,36,treats,0.9931270663228409,908025-FS1-2,CONCLUSIONS: LONG ACTING RISPERIDONE is effective and generally well tolerated in patients with SCHIZOPHRENIA including those patients with stable symptoms.,SCHIZOPHRENIA,LONG ACTING RISPERIDONE,RO-may_treat
503729628,7/16/2014 23:08:02,,1324528022,7/16/2014 23:07:37,clixsense,0.6278,18647227,GBR,P3,Bulkington,2.216.185.243,LONG ACTING RISPERIDONE treats SCHIZOPHRENIA,96,13,,108,36,treats,0.9931270663228409,908025-FS1-2,CONCLUSIONS: LONG ACTING RISPERIDONE is effective and generally well tolerated in patients with SCHIZOPHRENIA including those patients with stable symptoms.,SCHIZOPHRENIA,LONG ACTING RISPERIDONE,RO-may_treat
503729628,7/16/2014 23:14:49,,1324530533,7/16/2014 23:14:25,eup_slw,0.7375,20818028,GBR,A7,Birmingham,92.232.139.254,LONG ACTING RISPERIDONE treats SCHIZOPHRENIA,96,13,,108,36,treats,0.9931270663228409,908025-FS1-2,CONCLUSIONS: LONG ACTING RISPERIDONE is effective and generally well tolerated in patients with SCHIZOPHRENIA including those patients with stable symptoms.,SCHIZOPHRENIA,LONG ACTING RISPERIDONE,RO-may_treat
503729628,7/16/2014 23:33:20,,1324538990,7/16/2014 23:33:03,zoombucks,0.7236,4688131,CAN,BC,Vancouver,108.180.143.28,LONG ACTING RISPERIDONE treats SCHIZOPHRENIA,96,13,,108,36,treats,0.9931270663228409,908025-FS1-2,CONCLUSIONS: LONG ACTING RISPERIDONE is effective and generally well tolerated in patients with SCHIZOPHRENIA including those patients with stable symptoms.,SCHIZOPHRENIA,LONG ACTING RISPERIDONE,RO-may_treat
503729628,7/16/2014 23:43:44,,1324543348,7/16/2014 23:43:33,prodege,0.5722,2143114,CAN,BC,Vancouver,24.84.160.12,SCHIZOPHRENIA treats LONG ACTING RISPERIDONE,96,13,,108,36,treats,0.9931270663228409,908025-FS1-2,CONCLUSIONS: LONG ACTING RISPERIDONE is effective and generally well tolerated in patients with SCHIZOPHRENIA including those patients with stable symptoms.,SCHIZOPHRENIA,LONG ACTING RISPERIDONE,RO-may_treat
503729628,7/17/2014 06:04:30,,1324878544,7/17/2014 06:03:48,clixsense,0.6042,6472283,USA,WI,Oak Creek,99.107.184.156,LONG ACTING RISPERIDONE treats SCHIZOPHRENIA,96,13,,108,36,treats,0.9931270663228409,908025-FS1-2,CONCLUSIONS: LONG ACTING RISPERIDONE is effective and generally well tolerated in patients with SCHIZOPHRENIA including those patients with stable symptoms.,SCHIZOPHRENIA,LONG ACTING RISPERIDONE,RO-may_treat
503729628,7/17/2014 09:32:15,,1325086517,7/17/2014 09:31:47,prodege,0.6687,28039757,GBR,L8,Southport,109.155.158.54,LONG ACTING RISPERIDONE treats SCHIZOPHRENIA,96,13,,108,36,treats,0.9931270663228409,908025-FS1-2,CONCLUSIONS: LONG ACTING RISPERIDONE is effective and generally well tolerated in patients with SCHIZOPHRENIA including those patients with stable symptoms.,SCHIZOPHRENIA,LONG ACTING RISPERIDONE,RO-may_treat
503729631,7/17/2014 03:08:02,,1324720709,7/17/2014 03:07:38,prodege,0.6565,6011370,CAN,BC,Richmond,70.79.45.148,GLUCOSE IV treats SEVERE HYPOGLYCAEMIA (SH),95,136,,119,146,treats,0.913811548620257,908138-FS1-2,The objectives of the present analyses were to assess the association between HbA1c levels and SEVERE HYPOGLYCAEMIA (SH) treatment with GLUCOSE IV.,SEVERE HYPOGLYCAEMIA (SH),GLUCOSE IV,RO-may_treat
503729631,7/17/2014 07:32:05,,1324965372,7/17/2014 07:31:31,instagc,0.8278,25901556,GBR,C3,Saint Ives,82.9.129.2,GLUCOSE IV treats SEVERE HYPOGLYCAEMIA (SH),95,136,,119,146,treats,0.913811548620257,908138-FS1-2,The objectives of the present analyses were to assess the association between HbA1c levels and SEVERE HYPOGLYCAEMIA (SH) treatment with GLUCOSE IV.,SEVERE HYPOGLYCAEMIA (SH),GLUCOSE IV,RO-may_treat
503729631,7/17/2014 10:33:09,,1325140595,7/17/2014 10:32:59,clixsense,0.5793,27793793,GBR,C5,Chester,151.230.27.155,GLUCOSE IV treats SEVERE HYPOGLYCAEMIA (SH),95,136,,119,146,treats,0.913811548620257,908138-FS1-2,The objectives of the present analyses were to assess the association between HbA1c levels and SEVERE HYPOGLYCAEMIA (SH) treatment with GLUCOSE IV.,SEVERE HYPOGLYCAEMIA (SH),GLUCOSE IV,RO-may_treat
503729631,7/17/2014 10:34:31,,1325141784,7/17/2014 10:34:10,prodege,0.652,9525153,CAN,ON,Toronto,65.95.92.180,GLUCOSE IV treats SEVERE HYPOGLYCAEMIA (SH),95,136,,119,146,treats,0.913811548620257,908138-FS1-2,The objectives of the present analyses were to assess the association between HbA1c levels and SEVERE HYPOGLYCAEMIA (SH) treatment with GLUCOSE IV.,SEVERE HYPOGLYCAEMIA (SH),GLUCOSE IV,RO-may_treat
503729631,7/17/2014 10:36:28,,1325143452,7/17/2014 10:36:10,clixsense,0.6636,19803139,NLD,06,Veldhoven,212.61.84.196,GLUCOSE IV treats SEVERE HYPOGLYCAEMIA (SH),95,136,,119,146,treats,0.913811548620257,908138-FS1-2,The objectives of the present analyses were to assess the association between HbA1c levels and SEVERE HYPOGLYCAEMIA (SH) treatment with GLUCOSE IV.,SEVERE HYPOGLYCAEMIA (SH),GLUCOSE IV,RO-may_treat
503729631,7/17/2014 10:59:28,,1325160776,7/17/2014 10:58:54,elite,0.7556,28397222,GBR,Y4,Usk,31.50.223.75,GLUCOSE IV treats SEVERE HYPOGLYCAEMIA (SH),95,136,,119,146,treats,0.913811548620257,908138-FS1-2,The objectives of the present analyses were to assess the association between HbA1c levels and SEVERE HYPOGLYCAEMIA (SH) treatment with GLUCOSE IV.,SEVERE HYPOGLYCAEMIA (SH),GLUCOSE IV,RO-may_treat
503729631,7/17/2014 11:11:37,,1325170194,7/17/2014 11:11:10,prodege,0.5714,15439740,AUS,02,Jannali,27.96.208.89,GLUCOSE IV treats SEVERE HYPOGLYCAEMIA (SH),95,136,,119,146,treats,0.913811548620257,908138-FS1-2,The objectives of the present analyses were to assess the association between HbA1c levels and SEVERE HYPOGLYCAEMIA (SH) treatment with GLUCOSE IV.,SEVERE HYPOGLYCAEMIA (SH),GLUCOSE IV,RO-may_treat
503729632,7/16/2014 23:01:00,,1324525498,7/16/2014 23:00:50,instagc,0.7361,15445601,USA,FL,Jacksonville,24.129.68.254,no_relation,162,113,,177,138,causes,0.50709255283711,907131-FS1-4,"The object of the present investigation was to identify those who, among high risk patients, would break through LOW DOSE HEPARIN PROPHYLAxis and develop thromboeMBOLISM AFTER MAjor abdominal surgery.",MBOLISM AFTER MA,LOW DOSE HEPARIN PROPHYLA,RO-may_prevent
503729632,7/17/2014 02:34:19,,1324686575,7/17/2014 02:33:34,neodev,0.7234,11460728,CAN,BC,Burnaby,70.79.16.165,LOW DOSE HEPARIN PROPHYLA causes MBOLISM AFTER MA,162,113,,177,138,causes,0.50709255283711,907131-FS1-4,"The object of the present investigation was to identify those who, among high risk patients, would break through LOW DOSE HEPARIN PROPHYLAxis and develop thromboeMBOLISM AFTER MAjor abdominal surgery.",MBOLISM AFTER MA,LOW DOSE HEPARIN PROPHYLA,RO-may_prevent
503729632,7/17/2014 06:05:06,,1324879055,7/17/2014 06:04:31,clixsense,0.6042,6472283,USA,WI,Oak Creek,99.107.184.156,no_relation,162,113,,177,138,causes,0.50709255283711,907131-FS1-4,"The object of the present investigation was to identify those who, among high risk patients, would break through LOW DOSE HEPARIN PROPHYLAxis and develop thromboeMBOLISM AFTER MAjor abdominal surgery.",MBOLISM AFTER MA,LOW DOSE HEPARIN PROPHYLA,RO-may_prevent
503729632,7/17/2014 07:47:27,,1324982283,7/17/2014 07:46:44,vivatic,0.5413,25451531,GBR,,,83.67.28.193,no_relation,162,113,,177,138,causes,0.50709255283711,907131-FS1-4,"The object of the present investigation was to identify those who, among high risk patients, would break through LOW DOSE HEPARIN PROPHYLAxis and develop thromboeMBOLISM AFTER MAjor abdominal surgery.",MBOLISM AFTER MA,LOW DOSE HEPARIN PROPHYLA,RO-may_prevent
503729632,7/17/2014 07:58:20,,1324993571,7/17/2014 07:57:35,prodege,0.4905,19466267,GBR,Z5,Bedford,82.29.157.23,no_relation,162,113,,177,138,causes,0.50709255283711,907131-FS1-4,"The object of the present investigation was to identify those who, among high risk patients, would break through LOW DOSE HEPARIN PROPHYLAxis and develop thromboeMBOLISM AFTER MAjor abdominal surgery.",MBOLISM AFTER MA,LOW DOSE HEPARIN PROPHYLA,RO-may_prevent
503729632,7/17/2014 08:47:24,,1325044079,7/17/2014 08:47:05,neodev,0.5377,18339121,USA,SC,Sumter,173.93.188.194,MBOLISM AFTER MA causes LOW DOSE HEPARIN PROPHYLA,162,113,,177,138,causes,0.50709255283711,907131-FS1-4,"The object of the present investigation was to identify those who, among high risk patients, would break through LOW DOSE HEPARIN PROPHYLAxis and develop thromboeMBOLISM AFTER MAjor abdominal surgery.",MBOLISM AFTER MA,LOW DOSE HEPARIN PROPHYLA,RO-may_prevent
503729632,7/17/2014 10:32:27,,1325140008,7/17/2014 10:32:18,clixsense,0.5793,27793793,GBR,C5,Chester,151.230.27.155,no_relation,162,113,,177,138,causes,0.50709255283711,907131-FS1-4,"The object of the present investigation was to identify those who, among high risk patients, would break through LOW DOSE HEPARIN PROPHYLAxis and develop thromboeMBOLISM AFTER MAjor abdominal surgery.",MBOLISM AFTER MA,LOW DOSE HEPARIN PROPHYLA,RO-may_prevent
503729642,7/16/2014 22:36:55,,1324516279,7/16/2014 22:36:41,tremorgames,0.8403,24449707,CAN,QC,Laval,96.21.249.72,ATOPIC DIATHESIS causes ATOPIC DERMATITIS,0,56,,16,72,causes,0.9931270663228409,900179-FS1-4,ATOPIC DERMATITIS the dermatologic manifestation of the ATOPIC DIATHESIS has a variety of clinical presentations.,ATOPIC DERMATITIS,ATOPIC DIATHESIS,RO-cause_of
503729642,7/16/2014 23:43:14,,1324543166,7/16/2014 23:43:05,prodege,0.5722,2143114,CAN,BC,Vancouver,24.84.160.12,ATOPIC DERMATITIS causes ATOPIC DIATHESIS,0,56,,16,72,causes,0.9931270663228409,900179-FS1-4,ATOPIC DERMATITIS the dermatologic manifestation of the ATOPIC DIATHESIS has a variety of clinical presentations.,ATOPIC DERMATITIS,ATOPIC DIATHESIS,RO-cause_of
503729642,7/17/2014 00:48:43,,1324583170,7/17/2014 00:48:35,coinworker,0.4226,28394550,USA,PA,Marcus Hook,71.175.96.184,ATOPIC DIATHESIS causes ATOPIC DERMATITIS,0,56,,16,72,causes,0.9931270663228409,900179-FS1-4,ATOPIC DERMATITIS the dermatologic manifestation of the ATOPIC DIATHESIS has a variety of clinical presentations.,ATOPIC DERMATITIS,ATOPIC DIATHESIS,RO-cause_of
503729642,7/17/2014 01:23:12,,1324615460,7/17/2014 01:22:41,rewardsspot,0.5125,24482174,GBR,H9,London,46.23.68.180,no_relation,0,56,,16,72,causes,0.9931270663228409,900179-FS1-4,ATOPIC DERMATITIS the dermatologic manifestation of the ATOPIC DIATHESIS has a variety of clinical presentations.,ATOPIC DERMATITIS,ATOPIC DIATHESIS,RO-cause_of
503729642,7/17/2014 04:44:58,,1324810864,7/17/2014 04:44:34,clixsense,0.5202,27608125,CAN,AB,Calgary,68.146.86.137,ATOPIC DERMATITIS causes ATOPIC DIATHESIS,0,56,,16,72,causes,0.9931270663228409,900179-FS1-4,ATOPIC DERMATITIS the dermatologic manifestation of the ATOPIC DIATHESIS has a variety of clinical presentations.,ATOPIC DERMATITIS,ATOPIC DIATHESIS,RO-cause_of
503729642,7/17/2014 06:03:46,,1324878047,7/17/2014 06:03:06,clixsense,0.6042,6472283,USA,WI,Oak Creek,99.107.184.156,no_relation,0,56,,16,72,causes,0.9931270663228409,900179-FS1-4,ATOPIC DERMATITIS the dermatologic manifestation of the ATOPIC DIATHESIS has a variety of clinical presentations.,ATOPIC DERMATITIS,ATOPIC DIATHESIS,RO-cause_of
503729642,7/17/2014 06:06:04,,1324879920,7/17/2014 06:05:46,clixsense,0.6268,15117831,GBR,H9,London,90.194.156.173,ATOPIC DIATHESIS causes ATOPIC DERMATITIS,0,56,,16,72,causes,0.9931270663228409,900179-FS1-4,ATOPIC DERMATITIS the dermatologic manifestation of the ATOPIC DIATHESIS has a variety of clinical presentations.,ATOPIC DERMATITIS,ATOPIC DIATHESIS,RO-cause_of
503729644,7/16/2014 22:28:51,,1324512857,7/16/2014 22:28:37,clixsense,0.8194,16827630,GBR,A7,Birmingham,86.146.169.103,no_relation,162,113,,177,138,treats,0.338061701891407,907131-FS1-2,"The object of the present investigation was to identify those who, among high risk patients, would break through LOW DOSE HEPARIN PROPHYLAxis and develop thromboeMBOLISM AFTER MAjor abdominal surgery.",MBOLISM AFTER MA,LOW DOSE HEPARIN PROPHYLA,RO-may_prevent
503729644,7/16/2014 23:24:55,,1324535504,7/16/2014 23:24:34,instagc,0.5714,23149109,USA,NC,Durham,75.189.206.205,LOW DOSE HEPARIN PROPHYLA treats MBOLISM AFTER MA,162,113,,177,138,treats,0.338061701891407,907131-FS1-2,"The object of the present investigation was to identify those who, among high risk patients, would break through LOW DOSE HEPARIN PROPHYLAxis and develop thromboeMBOLISM AFTER MAjor abdominal surgery.",MBOLISM AFTER MA,LOW DOSE HEPARIN PROPHYLA,RO-may_prevent
503729644,7/17/2014 06:12:00,,1324885049,7/17/2014 06:11:42,clixsense,0.6401,17648398,GBR,O4,Torquay,92.23.66.130,no_relation,162,113,,177,138,treats,0.338061701891407,907131-FS1-2,"The object of the present investigation was to identify those who, among high risk patients, would break through LOW DOSE HEPARIN PROPHYLAxis and develop thromboeMBOLISM AFTER MAjor abdominal surgery.",MBOLISM AFTER MA,LOW DOSE HEPARIN PROPHYLA,RO-may_prevent
503729644,7/17/2014 07:04:50,,1324934322,7/17/2014 07:04:38,clixsense,0.5793,27793793,GBR,C5,Chester,151.230.27.155,LOW DOSE HEPARIN PROPHYLA treats MBOLISM AFTER MA,162,113,,177,138,treats,0.338061701891407,907131-FS1-2,"The object of the present investigation was to identify those who, among high risk patients, would break through LOW DOSE HEPARIN PROPHYLAxis and develop thromboeMBOLISM AFTER MAjor abdominal surgery.",MBOLISM AFTER MA,LOW DOSE HEPARIN PROPHYLA,RO-may_prevent
503729644,7/17/2014 10:34:51,,1325142033,7/17/2014 10:34:32,prodege,0.652,9525153,CAN,ON,Toronto,65.95.92.180,LOW DOSE HEPARIN PROPHYLA treats MBOLISM AFTER MA,162,113,,177,138,treats,0.338061701891407,907131-FS1-2,"The object of the present investigation was to identify those who, among high risk patients, would break through LOW DOSE HEPARIN PROPHYLAxis and develop thromboeMBOLISM AFTER MAjor abdominal surgery.",MBOLISM AFTER MA,LOW DOSE HEPARIN PROPHYLA,RO-may_prevent
503729644,7/17/2014 10:38:14,,1325144683,7/17/2014 10:37:53,clixsense,0.6636,19803139,NLD,06,Veldhoven,212.61.84.196,no_relation,162,113,,177,138,treats,0.338061701891407,907131-FS1-2,"The object of the present investigation was to identify those who, among high risk patients, would break through LOW DOSE HEPARIN PROPHYLAxis and develop thromboeMBOLISM AFTER MAjor abdominal surgery.",MBOLISM AFTER MA,LOW DOSE HEPARIN PROPHYLA,RO-may_prevent
503729644,7/17/2014 11:00:27,,1325161576,7/17/2014 10:59:58,elite,0.7556,28397222,GBR,Y4,Usk,31.50.223.75,no_relation,162,113,,177,138,treats,0.338061701891407,907131-FS1-2,"The object of the present investigation was to identify those who, among high risk patients, would break through LOW DOSE HEPARIN PROPHYLAxis and develop thromboeMBOLISM AFTER MAjor abdominal surgery.",MBOLISM AFTER MA,LOW DOSE HEPARIN PROPHYLA,RO-may_prevent
503729645,7/16/2014 22:25:19,,1324511165,7/16/2014 22:25:09,clixsense,1.0,24896327,GBR,V2,Glasgow,94.2.231.4,LIVER DISEASE causes INDOCYANINE GREEN (ICG UPTAKE EXCRETION,137,70,,149,109,causes,0.802955068546966,906957-FS1-4,The purpose of the present paper is to clarify the disturbance of the INDOCYANINE GREEN (ICG UPTAKE EXCRETION mechanism in patients with LIVER DISEASE,LIVER DISEASE,INDOCYANINE GREEN (ICG UPTAKE EXCRETION,RO-may_diagnose
503729645,7/16/2014 22:46:42,,1324520041,7/16/2014 22:46:24,elite,0.8333,28276268,USA,CA,Daly City,24.6.249.44,INDOCYANINE GREEN (ICG UPTAKE EXCRETION causes LIVER DISEASE,137,70,,149,109,causes,0.802955068546966,906957-FS1-4,The purpose of the present paper is to clarify the disturbance of the INDOCYANINE GREEN (ICG UPTAKE EXCRETION mechanism in patients with LIVER DISEASE,LIVER DISEASE,INDOCYANINE GREEN (ICG UPTAKE EXCRETION,RO-may_diagnose
503729645,7/16/2014 22:53:47,,1324522852,7/16/2014 22:53:22,prodege,0.8194,12971342,USA,CA,Los Angeles,198.101.91.82,LIVER DISEASE causes INDOCYANINE GREEN (ICG UPTAKE EXCRETION,137,70,,149,109,causes,0.802955068546966,906957-FS1-4,The purpose of the present paper is to clarify the disturbance of the INDOCYANINE GREEN (ICG UPTAKE EXCRETION mechanism in patients with LIVER DISEASE,LIVER DISEASE,INDOCYANINE GREEN (ICG UPTAKE EXCRETION,RO-may_diagnose
503729645,7/17/2014 00:09:30,,1324554668,7/17/2014 00:09:01,instagc,0.675,19636746,USA,NY,Andover,192.182.216.225,no_relation,137,70,,149,109,causes,0.802955068546966,906957-FS1-4,The purpose of the present paper is to clarify the disturbance of the INDOCYANINE GREEN (ICG UPTAKE EXCRETION mechanism in patients with LIVER DISEASE,LIVER DISEASE,INDOCYANINE GREEN (ICG UPTAKE EXCRETION,RO-may_diagnose
503729645,7/17/2014 03:06:05,,1324718644,7/17/2014 03:05:34,cotter,0.6014,7287927,USA,CA,San Jose,99.27.90.128,INDOCYANINE GREEN (ICG UPTAKE EXCRETION causes LIVER DISEASE,137,70,,149,109,causes,0.802955068546966,906957-FS1-4,The purpose of the present paper is to clarify the disturbance of the INDOCYANINE GREEN (ICG UPTAKE EXCRETION mechanism in patients with LIVER DISEASE,LIVER DISEASE,INDOCYANINE GREEN (ICG UPTAKE EXCRETION,RO-may_diagnose
503729645,7/17/2014 10:32:37,,1325140138,7/17/2014 10:32:28,clixsense,0.5793,27793793,GBR,C5,Chester,151.230.27.155,INDOCYANINE GREEN (ICG UPTAKE EXCRETION causes LIVER DISEASE,137,70,,149,109,causes,0.802955068546966,906957-FS1-4,The purpose of the present paper is to clarify the disturbance of the INDOCYANINE GREEN (ICG UPTAKE EXCRETION mechanism in patients with LIVER DISEASE,LIVER DISEASE,INDOCYANINE GREEN (ICG UPTAKE EXCRETION,RO-may_diagnose
503729645,7/17/2014 10:37:08,,1325143968,7/17/2014 10:36:45,prodege,0.652,9525153,CAN,ON,Toronto,65.95.92.180,INDOCYANINE GREEN (ICG UPTAKE EXCRETION causes LIVER DISEASE,137,70,,149,109,causes,0.802955068546966,906957-FS1-4,The purpose of the present paper is to clarify the disturbance of the INDOCYANINE GREEN (ICG UPTAKE EXCRETION mechanism in patients with LIVER DISEASE,LIVER DISEASE,INDOCYANINE GREEN (ICG UPTAKE EXCRETION,RO-may_diagnose
503729648,7/16/2014 22:24:57,,1324511018,7/16/2014 22:24:29,clixsense,1.0,21642428,NLD,11,Nootdorp,83.86.58.179,CATARACT FORMATION causes LENS TRANSPARENCY,64,18,,80,36,causes,0.9901475429766742,905456-FS1-4,The last stage of CATARACT FORMATION results in a total loss of LENS TRANSPARENCY and leakage of lens proteins.,LENS TRANSPARENCY,CATARACT FORMATION,RO-has_finding_site
503729648,7/16/2014 22:29:43,,1324513205,7/16/2014 22:29:07,clixsense,0.875,15189335,GBR,H9,London,188.29.165.175,no_relation,64,18,,80,36,causes,0.9901475429766742,905456-FS1-4,The last stage of CATARACT FORMATION results in a total loss of LENS TRANSPARENCY and leakage of lens proteins.,LENS TRANSPARENCY,CATARACT FORMATION,RO-has_finding_site
503729648,7/16/2014 23:09:47,,1324528603,7/16/2014 23:09:10,cotter,0.6014,7287927,USA,CA,San Jose,99.27.90.128,CATARACT FORMATION causes LENS TRANSPARENCY,64,18,,80,36,causes,0.9901475429766742,905456-FS1-4,The last stage of CATARACT FORMATION results in a total loss of LENS TRANSPARENCY and leakage of lens proteins.,LENS TRANSPARENCY,CATARACT FORMATION,RO-has_finding_site
503729648,7/16/2014 23:15:58,,1324530965,7/16/2014 23:15:26,eup_slw,0.7375,20818028,GBR,A7,Birmingham,92.232.139.254,CATARACT FORMATION causes LENS TRANSPARENCY,64,18,,80,36,causes,0.9901475429766742,905456-FS1-4,The last stage of CATARACT FORMATION results in a total loss of LENS TRANSPARENCY and leakage of lens proteins.,LENS TRANSPARENCY,CATARACT FORMATION,RO-has_finding_site
503729648,7/17/2014 00:18:48,,1324558427,7/17/2014 00:18:28,prodege,0.555,13391452,GBR,B7,Bristol,90.213.30.203,no_relation,64,18,,80,36,causes,0.9901475429766742,905456-FS1-4,The last stage of CATARACT FORMATION results in a total loss of LENS TRANSPARENCY and leakage of lens proteins.,LENS TRANSPARENCY,CATARACT FORMATION,RO-has_finding_site
503729648,7/17/2014 04:56:25,,1324820838,7/17/2014 04:55:39,prodege,0.7105,27934334,GBR,,,86.130.153.15,no_relation,64,18,,80,36,causes,0.9901475429766742,905456-FS1-4,The last stage of CATARACT FORMATION results in a total loss of LENS TRANSPARENCY and leakage of lens proteins.,LENS TRANSPARENCY,CATARACT FORMATION,RO-has_finding_site
503729648,7/17/2014 09:31:31,,1325085585,7/17/2014 09:30:56,prodege,0.5512,27990290,GBR,I9,Bury Saint Edmunds,86.142.231.81,CATARACT FORMATION causes LENS TRANSPARENCY,64,18,,80,36,causes,0.9901475429766742,905456-FS1-4,The last stage of CATARACT FORMATION results in a total loss of LENS TRANSPARENCY and leakage of lens proteins.,LENS TRANSPARENCY,CATARACT FORMATION,RO-has_finding_site
503729655,7/16/2014 23:26:14,,1324536040,7/16/2014 23:25:58,instagc,0.5714,23149109,USA,NC,Durham,75.189.206.205,EPILEPSY causes NUMBER OF SEIZURES,101,47,,118,55,causes,0.9045340337332909,904527-FS1-4,Menopause tends to occur earlier in women with EPILEPSY especially in the setting of a high lifetime NUMBER OF SEIZURES and lifetime use of multiple enzyme inducing AEDs.,NUMBER OF SEIZURES,EPILEPSY,RO-has_definitional_manifestation
503729655,7/16/2014 23:47:27,,1324544682,7/16/2014 23:46:16,clixsense,0.6403,23585686,GBR,H9,London,31.51.221.173,EPILEPSY causes NUMBER OF SEIZURES,101,47,,118,55,causes,0.9045340337332909,904527-FS1-4,Menopause tends to occur earlier in women with EPILEPSY especially in the setting of a high lifetime NUMBER OF SEIZURES and lifetime use of multiple enzyme inducing AEDs.,NUMBER OF SEIZURES,EPILEPSY,RO-has_definitional_manifestation
503729655,7/16/2014 23:54:59,,1324547590,7/16/2014 23:54:46,gifthulk,0.9056,21916793,GBR,,,87.115.178.12,EPILEPSY causes NUMBER OF SEIZURES,101,47,,118,55,causes,0.9045340337332909,904527-FS1-4,Menopause tends to occur earlier in women with EPILEPSY especially in the setting of a high lifetime NUMBER OF SEIZURES and lifetime use of multiple enzyme inducing AEDs.,NUMBER OF SEIZURES,EPILEPSY,RO-has_definitional_manifestation
503729655,7/17/2014 00:09:55,,1324554835,7/17/2014 00:09:31,instagc,0.675,19636746,USA,NY,Andover,192.182.216.225,no_relation,101,47,,118,55,causes,0.9045340337332909,904527-FS1-4,Menopause tends to occur earlier in women with EPILEPSY especially in the setting of a high lifetime NUMBER OF SEIZURES and lifetime use of multiple enzyme inducing AEDs.,NUMBER OF SEIZURES,EPILEPSY,RO-has_definitional_manifestation
503729655,7/17/2014 01:32:15,,1324624926,7/17/2014 01:32:10,tremorgames,0.6667,28013393,USA,CA,Rancho Cordova,71.197.67.37,NUMBER OF SEIZURES causes EPILEPSY,101,47,,118,55,causes,0.9045340337332909,904527-FS1-4,Menopause tends to occur earlier in women with EPILEPSY especially in the setting of a high lifetime NUMBER OF SEIZURES and lifetime use of multiple enzyme inducing AEDs.,NUMBER OF SEIZURES,EPILEPSY,RO-has_definitional_manifestation
503729655,7/17/2014 01:37:06,,1324629798,7/17/2014 01:36:24,rewardsspot,0.6012,17763704,USA,IL,Chicago,67.212.175.123,no_relation,101,47,,118,55,causes,0.9045340337332909,904527-FS1-4,Menopause tends to occur earlier in women with EPILEPSY especially in the setting of a high lifetime NUMBER OF SEIZURES and lifetime use of multiple enzyme inducing AEDs.,NUMBER OF SEIZURES,EPILEPSY,RO-has_definitional_manifestation
503729655,7/17/2014 07:48:15,,1324983134,7/17/2014 07:47:28,vivatic,0.5413,25451531,GBR,,,83.67.28.193,no_relation,101,47,,118,55,causes,0.9045340337332909,904527-FS1-4,Menopause tends to occur earlier in women with EPILEPSY especially in the setting of a high lifetime NUMBER OF SEIZURES and lifetime use of multiple enzyme inducing AEDs.,NUMBER OF SEIZURES,EPILEPSY,RO-has_definitional_manifestation
503729660,7/16/2014 22:26:51,,1324511896,7/16/2014 22:26:32,clixsense,0.6636,19803139,NLD,06,Veldhoven,212.61.84.196,CLINDAMYCIN treats BACTERIAL VAGINOSIS,53,0,,71,11,treats,0.9958932064677041,907536-FS1-2,CLINDAMYCIN versus metronidazole in the treatment of BACTERIAL VAGINOSIS,BACTERIAL VAGINOSIS,CLINDAMYCIN,RO-may_treat
503729660,7/17/2014 00:28:11,,1324564377,7/17/2014 00:27:51,elite,0.675,28503042,USA,OK,Watonga,65.255.78.241,CLINDAMYCIN treats BACTERIAL VAGINOSIS,53,0,,71,11,treats,0.9958932064677041,907536-FS1-2,CLINDAMYCIN versus metronidazole in the treatment of BACTERIAL VAGINOSIS,BACTERIAL VAGINOSIS,CLINDAMYCIN,RO-may_treat
503729660,7/17/2014 02:18:09,,1324670134,7/17/2014 02:17:56,pokerowned,0.6218,18747884,USA,MI,Saginaw,74.85.192.98,CLINDAMYCIN treats BACTERIAL VAGINOSIS,53,0,,71,11,treats,0.9958932064677041,907536-FS1-2,CLINDAMYCIN versus metronidazole in the treatment of BACTERIAL VAGINOSIS,BACTERIAL VAGINOSIS,CLINDAMYCIN,RO-may_treat
503729660,7/17/2014 03:06:34,,1324719151,7/17/2014 03:06:06,cotter,0.6014,7287927,USA,CA,San Jose,99.27.90.128,CLINDAMYCIN treats BACTERIAL VAGINOSIS,53,0,,71,11,treats,0.9958932064677041,907536-FS1-2,CLINDAMYCIN versus metronidazole in the treatment of BACTERIAL VAGINOSIS,BACTERIAL VAGINOSIS,CLINDAMYCIN,RO-may_treat
503729660,7/17/2014 07:04:58,,1324934504,7/17/2014 07:04:51,clixsense,0.5793,27793793,GBR,C5,Chester,151.230.27.155,CLINDAMYCIN treats BACTERIAL VAGINOSIS,53,0,,71,11,treats,0.9958932064677041,907536-FS1-2,CLINDAMYCIN versus metronidazole in the treatment of BACTERIAL VAGINOSIS,BACTERIAL VAGINOSIS,CLINDAMYCIN,RO-may_treat
503729660,7/17/2014 07:46:42,,1324981439,7/17/2014 07:46:08,vivatic,0.5413,25451531,GBR,,,83.67.28.193,CLINDAMYCIN treats BACTERIAL VAGINOSIS,53,0,,71,11,treats,0.9958932064677041,907536-FS1-2,CLINDAMYCIN versus metronidazole in the treatment of BACTERIAL VAGINOSIS,BACTERIAL VAGINOSIS,CLINDAMYCIN,RO-may_treat
503729660,7/17/2014 09:32:53,,1325087104,7/17/2014 09:32:35,prodege,0.6687,28039757,GBR,L8,Southport,109.155.158.54,CLINDAMYCIN treats BACTERIAL VAGINOSIS,53,0,,71,11,treats,0.9958932064677041,907536-FS1-2,CLINDAMYCIN versus metronidazole in the treatment of BACTERIAL VAGINOSIS,BACTERIAL VAGINOSIS,CLINDAMYCIN,RO-may_treat
503729666,7/16/2014 22:25:08,,1324511111,7/16/2014 22:24:50,clixsense,1.0,24896327,GBR,V2,Glasgow,94.2.231.4,ALUMINUM causes ALUMINUM INTOXICATION,0,0,,7,21,causes,0.843274042711568,903967-FS1-4,ALUMINUM INTOXICATION is common in patients with chronic renal failure because of absorption of aluminum during dialysis from ALUMINUM containing dyalysate water and ingestion of phosphate binders containing aluminum.,ALUMINUM,ALUMINUM INTOXICATION,RO-has_causative_agent
503729666,7/16/2014 22:55:26,,1324523601,7/16/2014 22:54:36,prodege,0.8194,28255346,GBR,L9,Sheffield,2.125.183.137,ALUMINUM causes ALUMINUM INTOXICATION,0,0,,7,21,causes,0.843274042711568,903967-FS1-4,ALUMINUM INTOXICATION is common in patients with chronic renal failure because of absorption of aluminum during dialysis from ALUMINUM containing dyalysate water and ingestion of phosphate binders containing aluminum.,ALUMINUM,ALUMINUM INTOXICATION,RO-has_causative_agent
503729666,7/17/2014 01:12:50,,1324605879,7/17/2014 01:11:49,prodege,0.649,2767509,CAN,BC,Victoria,96.54.172.117,ALUMINUM causes ALUMINUM INTOXICATION,0,0,,7,21,causes,0.843274042711568,903967-FS1-4,ALUMINUM INTOXICATION is common in patients with chronic renal failure because of absorption of aluminum during dialysis from ALUMINUM containing dyalysate water and ingestion of phosphate binders containing aluminum.,ALUMINUM,ALUMINUM INTOXICATION,RO-has_causative_agent
503729666,7/17/2014 02:17:55,,1324669907,7/17/2014 02:17:41,pokerowned,0.6218,18747884,USA,MI,Saginaw,74.85.192.98,ALUMINUM causes ALUMINUM INTOXICATION,0,0,,7,21,causes,0.843274042711568,903967-FS1-4,ALUMINUM INTOXICATION is common in patients with chronic renal failure because of absorption of aluminum during dialysis from ALUMINUM containing dyalysate water and ingestion of phosphate binders containing aluminum.,ALUMINUM,ALUMINUM INTOXICATION,RO-has_causative_agent
503729666,7/17/2014 02:36:20,,1324688836,7/17/2014 02:35:41,neodev,0.7234,11460728,CAN,BC,Burnaby,70.79.16.165,ALUMINUM causes ALUMINUM INTOXICATION,0,0,,7,21,causes,0.843274042711568,903967-FS1-4,ALUMINUM INTOXICATION is common in patients with chronic renal failure because of absorption of aluminum during dialysis from ALUMINUM containing dyalysate water and ingestion of phosphate binders containing aluminum.,ALUMINUM,ALUMINUM INTOXICATION,RO-has_causative_agent
503729666,7/17/2014 03:10:36,,1324723071,7/17/2014 03:10:21,prodege,0.6565,6011370,CAN,BC,Richmond,70.79.45.148,ALUMINUM INTOXICATION causes ALUMINUM,0,0,,7,21,causes,0.843274042711568,903967-FS1-4,ALUMINUM INTOXICATION is common in patients with chronic renal failure because of absorption of aluminum during dialysis from ALUMINUM containing dyalysate water and ingestion of phosphate binders containing aluminum.,ALUMINUM,ALUMINUM INTOXICATION,RO-has_causative_agent
503729666,7/17/2014 03:11:25,,1324723739,7/17/2014 03:10:46,instagc,0.6704,24252915,GBR,B7,Bristol,77.98.139.82,ALUMINUM causes ALUMINUM INTOXICATION,0,0,,7,21,causes,0.843274042711568,903967-FS1-4,ALUMINUM INTOXICATION is common in patients with chronic renal failure because of absorption of aluminum during dialysis from ALUMINUM containing dyalysate water and ingestion of phosphate binders containing aluminum.,ALUMINUM,ALUMINUM INTOXICATION,RO-has_causative_agent
503729671,7/16/2014 22:28:22,,1324512686,7/16/2014 22:28:14,clixsense,0.8194,16827630,GBR,A7,Birmingham,86.146.169.103,BONE METASTASES causes PATHOLOGIC FRACTURES,48,32,,67,47,causes,0.50709255283711,902836-FS1-4,"Outcomes:  Skeletal events (new BONE METASTASES PATHOLOGIC FRACTURES spinal cord compression, irradiation of or surgery on bone, development or progression of bone pain [and, in some studies, hypercalcemia]), quality of life, and survival.",PATHOLOGIC FRACTURES,BONE METASTASES,RO-disease_may_have_finding
503729671,7/16/2014 22:55:26,,1324523602,7/16/2014 22:54:36,prodege,0.8194,28255346,GBR,L9,Sheffield,2.125.183.137,no_relation,48,32,,67,47,causes,0.50709255283711,902836-FS1-4,"Outcomes:  Skeletal events (new BONE METASTASES PATHOLOGIC FRACTURES spinal cord compression, irradiation of or surgery on bone, development or progression of bone pain [and, in some studies, hypercalcemia]), quality of life, and survival.",PATHOLOGIC FRACTURES,BONE METASTASES,RO-disease_may_have_finding
503729671,7/16/2014 23:00:47,,1324525442,7/16/2014 23:00:36,instagc,0.7361,15445601,USA,FL,Jacksonville,24.129.68.254,no_relation,48,32,,67,47,causes,0.50709255283711,902836-FS1-4,"Outcomes:  Skeletal events (new BONE METASTASES PATHOLOGIC FRACTURES spinal cord compression, irradiation of or surgery on bone, development or progression of bone pain [and, in some studies, hypercalcemia]), quality of life, and survival.",PATHOLOGIC FRACTURES,BONE METASTASES,RO-disease_may_have_finding
503729671,7/16/2014 23:46:15,,1324544261,7/16/2014 23:45:06,clixsense,0.6403,23585686,GBR,H9,London,31.51.221.173,BONE METASTASES causes PATHOLOGIC FRACTURES,48,32,,67,47,causes,0.50709255283711,902836-FS1-4,"Outcomes:  Skeletal events (new BONE METASTASES PATHOLOGIC FRACTURES spinal cord compression, irradiation of or surgery on bone, development or progression of bone pain [and, in some studies, hypercalcemia]), quality of life, and survival.",PATHOLOGIC FRACTURES,BONE METASTASES,RO-disease_may_have_finding
503729671,7/17/2014 00:09:30,,1324554669,7/17/2014 00:09:01,instagc,0.675,19636746,USA,NY,Andover,192.182.216.225,no_relation,48,32,,67,47,causes,0.50709255283711,902836-FS1-4,"Outcomes:  Skeletal events (new BONE METASTASES PATHOLOGIC FRACTURES spinal cord compression, irradiation of or surgery on bone, development or progression of bone pain [and, in some studies, hypercalcemia]), quality of life, and survival.",PATHOLOGIC FRACTURES,BONE METASTASES,RO-disease_may_have_finding
503729671,7/17/2014 07:05:36,,1324935095,7/17/2014 07:05:27,clixsense,0.5793,27793793,GBR,C5,Chester,151.230.27.155,no_relation,48,32,,67,47,causes,0.50709255283711,902836-FS1-4,"Outcomes:  Skeletal events (new BONE METASTASES PATHOLOGIC FRACTURES spinal cord compression, irradiation of or surgery on bone, development or progression of bone pain [and, in some studies, hypercalcemia]), quality of life, and survival.",PATHOLOGIC FRACTURES,BONE METASTASES,RO-disease_may_have_finding
503729671,7/17/2014 09:30:20,,1325084172,7/17/2014 09:29:32,prodege,0.5512,27990290,GBR,I9,Bury Saint Edmunds,86.142.231.81,no_relation,48,32,,67,47,causes,0.50709255283711,902836-FS1-4,"Outcomes:  Skeletal events (new BONE METASTASES PATHOLOGIC FRACTURES spinal cord compression, irradiation of or surgery on bone, development or progression of bone pain [and, in some studies, hypercalcemia]), quality of life, and survival.",PATHOLOGIC FRACTURES,BONE METASTASES,RO-disease_may_have_finding
503729684,7/16/2014 23:37:46,,1324541081,7/16/2014 23:37:26,neodev,0.7056,15848372,AUS,02,Jannali,27.96.208.89,SEIZURE causes EPILEPSY,142,180,,148,188,causes,0.8888888888888891,904923-FS1-4,Epileptic women were found to have a 26.1% risk of seizure deterioration during pregnancy and the single most important factor for predicting SEIZURE prognosis was the severity of EPILEPSY prepregnancy.,SEIZURE,EPILEPSY,RO-has_definitional_manifestation
503729684,7/17/2014 00:47:36,,1324582169,7/17/2014 00:46:51,instagc,0.4167,19745059,CAN,ON,Saint Catharines,216.121.166.67,EPILEPSY causes SEIZURE,142,180,,148,188,causes,0.8888888888888891,904923-FS1-4,Epileptic women were found to have a 26.1% risk of seizure deterioration during pregnancy and the single most important factor for predicting SEIZURE prognosis was the severity of EPILEPSY prepregnancy.,SEIZURE,EPILEPSY,RO-has_definitional_manifestation
503729684,7/17/2014 02:18:55,,1324671045,7/17/2014 02:18:25,pokerowned,0.6218,18747884,USA,MI,Saginaw,74.85.192.98,EPILEPSY causes SEIZURE,142,180,,148,188,causes,0.8888888888888891,904923-FS1-4,Epileptic women were found to have a 26.1% risk of seizure deterioration during pregnancy and the single most important factor for predicting SEIZURE prognosis was the severity of EPILEPSY prepregnancy.,SEIZURE,EPILEPSY,RO-has_definitional_manifestation
503729684,7/17/2014 03:05:32,,1324718124,7/17/2014 03:05:04,cotter,0.6014,7287927,USA,CA,San Jose,99.27.90.128,EPILEPSY causes SEIZURE,142,180,,148,188,causes,0.8888888888888891,904923-FS1-4,Epileptic women were found to have a 26.1% risk of seizure deterioration during pregnancy and the single most important factor for predicting SEIZURE prognosis was the severity of EPILEPSY prepregnancy.,SEIZURE,EPILEPSY,RO-has_definitional_manifestation
503729684,7/17/2014 06:11:24,,1324884580,7/17/2014 06:11:00,clixsense,0.6401,17648398,GBR,O4,Torquay,92.23.66.130,EPILEPSY causes SEIZURE,142,180,,148,188,causes,0.8888888888888891,904923-FS1-4,Epileptic women were found to have a 26.1% risk of seizure deterioration during pregnancy and the single most important factor for predicting SEIZURE prognosis was the severity of EPILEPSY prepregnancy.,SEIZURE,EPILEPSY,RO-has_definitional_manifestation
503729684,7/17/2014 07:27:14,,1324959937,7/17/2014 07:27:00,clixsense,0.7143,28324391,NLD,11,Hazerswoude-rijndijk,94.208.82.215,EPILEPSY causes SEIZURE,142,180,,148,188,causes,0.8888888888888891,904923-FS1-4,Epileptic women were found to have a 26.1% risk of seizure deterioration during pregnancy and the single most important factor for predicting SEIZURE prognosis was the severity of EPILEPSY prepregnancy.,SEIZURE,EPILEPSY,RO-has_definitional_manifestation
503729684,7/17/2014 07:56:06,,1324991471,7/17/2014 07:55:30,prodege,0.4905,19466267,GBR,Z5,Bedford,82.29.157.23,EPILEPSY causes SEIZURE,142,180,,148,188,causes,0.8888888888888891,904923-FS1-4,Epileptic women were found to have a 26.1% risk of seizure deterioration during pregnancy and the single most important factor for predicting SEIZURE prognosis was the severity of EPILEPSY prepregnancy.,SEIZURE,EPILEPSY,RO-has_definitional_manifestation
503729685,7/16/2014 22:30:44,,1324513605,7/16/2014 22:30:20,clixsense,0.875,15189335,GBR,H9,London,188.29.165.175,no_relation,100,0,,108,23,causes,0.620173672946042,901910-FS1-4,ANAPLASTIC ASTROCYTOMAS and glioblastomas showed progressive reduction of parenchymal positivity as ANAPLASIA increased.,ANAPLASIA,ANAPLASTIC ASTROCYTOMAS,RO-disease_has_finding
503729685,7/16/2014 23:15:25,,1324530732,7/16/2014 23:14:51,eup_slw,0.7375,20818028,GBR,A7,Birmingham,92.232.139.254,ANAPLASTIC ASTROCYTOMAS causes ANAPLASIA,100,0,,108,23,causes,0.620173672946042,901910-FS1-4,ANAPLASTIC ASTROCYTOMAS and glioblastomas showed progressive reduction of parenchymal positivity as ANAPLASIA increased.,ANAPLASIA,ANAPLASTIC ASTROCYTOMAS,RO-disease_has_finding
503729685,7/16/2014 23:44:21,,1324543547,7/16/2014 23:43:32,clixsense,0.6403,23585686,GBR,H9,London,31.51.221.173,ANAPLASIA causes ANAPLASTIC ASTROCYTOMAS,100,0,,108,23,causes,0.620173672946042,901910-FS1-4,ANAPLASTIC ASTROCYTOMAS and glioblastomas showed progressive reduction of parenchymal positivity as ANAPLASIA increased.,ANAPLASIA,ANAPLASTIC ASTROCYTOMAS,RO-disease_has_finding
503729685,7/17/2014 06:40:27,,1324910146,7/17/2014 06:39:56,instagc,0.5978,18634892,USA,,,68.102.93.185,no_relation,100,0,,108,23,causes,0.620173672946042,901910-FS1-4,ANAPLASTIC ASTROCYTOMAS and glioblastomas showed progressive reduction of parenchymal positivity as ANAPLASIA increased.,ANAPLASIA,ANAPLASTIC ASTROCYTOMAS,RO-disease_has_finding
503729685,7/17/2014 07:46:06,,1324980806,7/17/2014 07:45:30,vivatic,0.5413,25451531,GBR,,,83.67.28.193,no_relation,100,0,,108,23,causes,0.620173672946042,901910-FS1-4,ANAPLASTIC ASTROCYTOMAS and glioblastomas showed progressive reduction of parenchymal positivity as ANAPLASIA increased.,ANAPLASIA,ANAPLASTIC ASTROCYTOMAS,RO-disease_has_finding
503729685,7/17/2014 07:57:01,,1324992309,7/17/2014 07:56:08,prodege,0.4905,19466267,GBR,Z5,Bedford,82.29.157.23,ANAPLASIA causes ANAPLASTIC ASTROCYTOMAS,100,0,,108,23,causes,0.620173672946042,901910-FS1-4,ANAPLASTIC ASTROCYTOMAS and glioblastomas showed progressive reduction of parenchymal positivity as ANAPLASIA increased.,ANAPLASIA,ANAPLASTIC ASTROCYTOMAS,RO-disease_has_finding
503729685,7/17/2014 08:48:30,,1325045134,7/17/2014 08:48:11,neodev,0.5377,18339121,USA,SC,Sumter,173.93.188.194,ANAPLASTIC ASTROCYTOMAS causes ANAPLASIA,100,0,,108,23,causes,0.620173672946042,901910-FS1-4,ANAPLASTIC ASTROCYTOMAS and glioblastomas showed progressive reduction of parenchymal positivity as ANAPLASIA increased.,ANAPLASIA,ANAPLASTIC ASTROCYTOMAS,RO-disease_has_finding
503729692,7/16/2014 23:15:25,,1324530734,7/16/2014 23:14:51,eup_slw,0.7375,20818028,GBR,A7,Birmingham,92.232.139.254,no_relation,82,105,,94,149,diagnosed by,0.304997140665209,901702-FS1-13,"11,12  DIFFERENTIAL DIAGNOSIS  The differential diagnosis of brucellosis includes ENTERIC FEVER malaria, INFECTIOUS MONONUCLEOSIS (EPSTEIN BARR VIRUS [EBV] infection), atypical mononucleosis (cytomegalovirus infection), Q fever, miliary tuberculosis, subacute bacterial endocarditis, HIV infection, and visceral leishmaniasis (kala azar.",ENTERIC FEVER,INFECTIOUS MONONUCLEOSIS (EPSTEIN BARR VIRUS,RO-disease_has_finding
503729692,7/16/2014 23:26:34,,1324536175,7/16/2014 23:26:16,instagc,0.7639,13763729,USA,,,75.182.89.225,no_relation,82,105,,94,149,diagnosed by,0.304997140665209,901702-FS1-13,"11,12  DIFFERENTIAL DIAGNOSIS  The differential diagnosis of brucellosis includes ENTERIC FEVER malaria, INFECTIOUS MONONUCLEOSIS (EPSTEIN BARR VIRUS [EBV] infection), atypical mononucleosis (cytomegalovirus infection), Q fever, miliary tuberculosis, subacute bacterial endocarditis, HIV infection, and visceral leishmaniasis (kala azar.",ENTERIC FEVER,INFECTIOUS MONONUCLEOSIS (EPSTEIN BARR VIRUS,RO-disease_has_finding
503729692,7/16/2014 23:35:42,,1324540058,7/16/2014 23:35:10,neodev,0.7056,15848372,AUS,02,Jannali,27.96.208.89,no_relation,82,105,,94,149,diagnosed by,0.304997140665209,901702-FS1-13,"11,12  DIFFERENTIAL DIAGNOSIS  The differential diagnosis of brucellosis includes ENTERIC FEVER malaria, INFECTIOUS MONONUCLEOSIS (EPSTEIN BARR VIRUS [EBV] infection), atypical mononucleosis (cytomegalovirus infection), Q fever, miliary tuberculosis, subacute bacterial endocarditis, HIV infection, and visceral leishmaniasis (kala azar.",ENTERIC FEVER,INFECTIOUS MONONUCLEOSIS (EPSTEIN BARR VIRUS,RO-disease_has_finding
503729692,7/16/2014 23:43:14,,1324543170,7/16/2014 23:43:05,prodege,0.5722,2143114,CAN,BC,Vancouver,24.84.160.12,ENTERIC FEVER diagnosed by INFECTIOUS MONONUCLEOSIS (EPSTEIN BARR VIRUS,82,105,,94,149,diagnosed by,0.304997140665209,901702-FS1-13,"11,12  DIFFERENTIAL DIAGNOSIS  The differential diagnosis of brucellosis includes ENTERIC FEVER malaria, INFECTIOUS MONONUCLEOSIS (EPSTEIN BARR VIRUS [EBV] infection), atypical mononucleosis (cytomegalovirus infection), Q fever, miliary tuberculosis, subacute bacterial endocarditis, HIV infection, and visceral leishmaniasis (kala azar.",ENTERIC FEVER,INFECTIOUS MONONUCLEOSIS (EPSTEIN BARR VIRUS,RO-disease_has_finding
503729692,7/17/2014 01:24:12,,1324616470,7/17/2014 01:23:29,rewardsspot,0.5125,24482174,GBR,H9,London,46.23.68.180,INFECTIOUS MONONUCLEOSIS (EPSTEIN BARR VIRUS diagnosed by ENTERIC FEVER,82,105,,94,149,diagnosed by,0.304997140665209,901702-FS1-13,"11,12  DIFFERENTIAL DIAGNOSIS  The differential diagnosis of brucellosis includes ENTERIC FEVER malaria, INFECTIOUS MONONUCLEOSIS (EPSTEIN BARR VIRUS [EBV] infection), atypical mononucleosis (cytomegalovirus infection), Q fever, miliary tuberculosis, subacute bacterial endocarditis, HIV infection, and visceral leishmaniasis (kala azar.",ENTERIC FEVER,INFECTIOUS MONONUCLEOSIS (EPSTEIN BARR VIRUS,RO-disease_has_finding
503729692,7/17/2014 07:30:38,,1324963865,7/17/2014 07:30:04,instagc,0.8278,25901556,GBR,C3,Saint Ives,82.9.129.2,no_relation,82,105,,94,149,diagnosed by,0.304997140665209,901702-FS1-13,"11,12  DIFFERENTIAL DIAGNOSIS  The differential diagnosis of brucellosis includes ENTERIC FEVER malaria, INFECTIOUS MONONUCLEOSIS (EPSTEIN BARR VIRUS [EBV] infection), atypical mononucleosis (cytomegalovirus infection), Q fever, miliary tuberculosis, subacute bacterial endocarditis, HIV infection, and visceral leishmaniasis (kala azar.",ENTERIC FEVER,INFECTIOUS MONONUCLEOSIS (EPSTEIN BARR VIRUS,RO-disease_has_finding
503729692,7/17/2014 08:49:09,,1325045643,7/17/2014 08:48:51,neodev,0.5377,18339121,USA,SC,Sumter,173.93.188.194,no_relation,82,105,,94,149,diagnosed by,0.304997140665209,901702-FS1-13,"11,12  DIFFERENTIAL DIAGNOSIS  The differential diagnosis of brucellosis includes ENTERIC FEVER malaria, INFECTIOUS MONONUCLEOSIS (EPSTEIN BARR VIRUS [EBV] infection), atypical mononucleosis (cytomegalovirus infection), Q fever, miliary tuberculosis, subacute bacterial endocarditis, HIV infection, and visceral leishmaniasis (kala azar.",ENTERIC FEVER,INFECTIOUS MONONUCLEOSIS (EPSTEIN BARR VIRUS,RO-disease_has_finding
503729695,7/16/2014 22:45:48,,1324519639,7/16/2014 22:45:30,elite,0.8333,28276268,USA,CA,Daly City,24.6.249.44,RESPIRATORY DISTRESS causes WET LUNG,68,91,,87,99,causes,0.845154254728516,901567-FS1-4,Tracheobronchial saline lavage to dislodge meconium may precipitate RESPIRATORY DISTRESS a WET LUNG appearance and respiratory failure.,RESPIRATORY DISTRESS,WET LUNG,RO-disease_has_finding
503729695,7/16/2014 23:45:05,,1324543796,7/16/2014 23:44:22,clixsense,0.6403,23585686,GBR,H9,London,31.51.221.173,WET LUNG causes RESPIRATORY DISTRESS,68,91,,87,99,causes,0.845154254728516,901567-FS1-4,Tracheobronchial saline lavage to dislodge meconium may precipitate RESPIRATORY DISTRESS a WET LUNG appearance and respiratory failure.,RESPIRATORY DISTRESS,WET LUNG,RO-disease_has_finding
503729695,7/17/2014 02:19:13,,1324671249,7/17/2014 02:18:56,pokerowned,0.6218,18747884,USA,MI,Saginaw,74.85.192.98,WET LUNG causes RESPIRATORY DISTRESS,68,91,,87,99,causes,0.845154254728516,901567-FS1-4,Tracheobronchial saline lavage to dislodge meconium may precipitate RESPIRATORY DISTRESS a WET LUNG appearance and respiratory failure.,RESPIRATORY DISTRESS,WET LUNG,RO-disease_has_finding
503729695,7/17/2014 07:05:26,,1324934927,7/17/2014 07:05:16,clixsense,0.5793,27793793,GBR,C5,Chester,151.230.27.155,WET LUNG causes RESPIRATORY DISTRESS,68,91,,87,99,causes,0.845154254728516,901567-FS1-4,Tracheobronchial saline lavage to dislodge meconium may precipitate RESPIRATORY DISTRESS a WET LUNG appearance and respiratory failure.,RESPIRATORY DISTRESS,WET LUNG,RO-disease_has_finding
503729695,7/17/2014 07:54:55,,1324990157,7/17/2014 07:54:04,prodege,0.4905,19466267,GBR,Z5,Bedford,82.29.157.23,no_relation,68,91,,87,99,causes,0.845154254728516,901567-FS1-4,Tracheobronchial saline lavage to dislodge meconium may precipitate RESPIRATORY DISTRESS a WET LUNG appearance and respiratory failure.,RESPIRATORY DISTRESS,WET LUNG,RO-disease_has_finding
503729695,7/17/2014 09:29:31,,1325083093,7/17/2014 09:28:15,prodege,0.5512,27990290,GBR,I9,Bury Saint Edmunds,86.142.231.81,no_relation,68,91,,87,99,causes,0.845154254728516,901567-FS1-4,Tracheobronchial saline lavage to dislodge meconium may precipitate RESPIRATORY DISTRESS a WET LUNG appearance and respiratory failure.,RESPIRATORY DISTRESS,WET LUNG,RO-disease_has_finding
503729695,7/17/2014 10:34:51,,1325142036,7/17/2014 10:34:32,prodege,0.652,9525153,CAN,ON,Toronto,65.95.92.180,WET LUNG causes RESPIRATORY DISTRESS,68,91,,87,99,causes,0.845154254728516,901567-FS1-4,Tracheobronchial saline lavage to dislodge meconium may precipitate RESPIRATORY DISTRESS a WET LUNG appearance and respiratory failure.,RESPIRATORY DISTRESS,WET LUNG,RO-disease_has_finding
503729696,7/16/2014 23:26:15,,1324536048,7/16/2014 23:25:51,instagc,0.7639,13763729,USA,,,75.182.89.225,ASPIRIN treats MI,84,44,,85,51,treats,0.9684959969581859,907404-FS1-2,"Rationale: ? The combination of heparin and ASPIRIN in ACS reduces the incidence of MI during the in hospital period, and LMWHs reduce cardiac events and the need for revascularization procedures.",MI,ASPIRIN,RO-may_prevent
503729696,7/17/2014 10:35:40,,1325142876,7/17/2014 10:35:26,prodege,0.652,9525153,CAN,ON,Toronto,65.95.92.180,ASPIRIN treats MI,84,44,,85,51,treats,0.9684959969581859,907404-FS1-2,"Rationale: ? The combination of heparin and ASPIRIN in ACS reduces the incidence of MI during the in hospital period, and LMWHs reduce cardiac events and the need for revascularization procedures.",MI,ASPIRIN,RO-may_prevent
503729696,7/17/2014 10:36:59,,1325143919,7/17/2014 10:36:29,clixsense,0.6636,19803139,NLD,06,Veldhoven,212.61.84.196,ASPIRIN treats MI,84,44,,85,51,treats,0.9684959969581859,907404-FS1-2,"Rationale: ? The combination of heparin and ASPIRIN in ACS reduces the incidence of MI during the in hospital period, and LMWHs reduce cardiac events and the need for revascularization procedures.",MI,ASPIRIN,RO-may_prevent
503729696,7/17/2014 10:58:26,,1325159961,7/17/2014 10:58:04,elite,0.7556,28397222,GBR,Y4,Usk,31.50.223.75,ASPIRIN treats MI,84,44,,85,51,treats,0.9684959969581859,907404-FS1-2,"Rationale: ? The combination of heparin and ASPIRIN in ACS reduces the incidence of MI during the in hospital period, and LMWHs reduce cardiac events and the need for revascularization procedures.",MI,ASPIRIN,RO-may_prevent
503729696,7/17/2014 11:11:28,,1325170014,7/17/2014 11:11:16,instagc,0.5714,23149109,USA,NC,Durham,75.189.206.205,ASPIRIN treats MI,84,44,,85,51,treats,0.9684959969581859,907404-FS1-2,"Rationale: ? The combination of heparin and ASPIRIN in ACS reduces the incidence of MI during the in hospital period, and LMWHs reduce cardiac events and the need for revascularization procedures.",MI,ASPIRIN,RO-may_prevent
503729696,7/17/2014 11:12:01,,1325170567,7/17/2014 11:11:39,prodege,0.5714,15439740,AUS,02,Jannali,27.96.208.89,ASPIRIN treats MI,84,44,,85,51,treats,0.9684959969581859,907404-FS1-2,"Rationale: ? The combination of heparin and ASPIRIN in ACS reduces the incidence of MI during the in hospital period, and LMWHs reduce cardiac events and the need for revascularization procedures.",MI,ASPIRIN,RO-may_prevent
503729696,7/17/2014 11:14:02,,1325172265,7/17/2014 11:13:51,clixsense,0.7143,28324391,NLD,11,Hazerswoude-rijndijk,94.208.82.215,ASPIRIN treats MI,84,44,,85,51,treats,0.9684959969581859,907404-FS1-2,"Rationale: ? The combination of heparin and ASPIRIN in ACS reduces the incidence of MI during the in hospital period, and LMWHs reduce cardiac events and the need for revascularization procedures.",MI,ASPIRIN,RO-may_prevent
503729699,7/16/2014 22:27:59,,1324512479,7/16/2014 22:27:41,clixsense,0.6636,19803139,NLD,06,Veldhoven,212.61.84.196,VIRUSES causes VIRAL INFECTION,124,143,,130,158,causes,0.9363291775690441,903536-FS1-4,"In order to determine the mode of antiviral action, the fragrant sumac extract was added at different times to the cells or VIRUSES during the VIRAL INFECTION cycle.",VIRUSES,VIRAL INFECTION,RO-has_causative_agent
503729699,7/16/2014 22:53:47,,1324522853,7/16/2014 22:53:22,prodege,0.8194,12971342,USA,CA,Los Angeles,198.101.91.82,VIRUSES causes VIRAL INFECTION,124,143,,130,158,causes,0.9363291775690441,903536-FS1-4,"In order to determine the mode of antiviral action, the fragrant sumac extract was added at different times to the cells or VIRUSES during the VIRAL INFECTION cycle.",VIRUSES,VIRAL INFECTION,RO-has_causative_agent
503729699,7/16/2014 23:10:23,,1324528795,7/16/2014 23:09:57,clixsense,0.6278,18647227,GBR,P3,Bulkington,2.216.185.243,no_relation,124,143,,130,158,causes,0.9363291775690441,903536-FS1-4,"In order to determine the mode of antiviral action, the fragrant sumac extract was added at different times to the cells or VIRUSES during the VIRAL INFECTION cycle.",VIRUSES,VIRAL INFECTION,RO-has_causative_agent
503729699,7/16/2014 23:33:53,,1324539213,7/16/2014 23:33:37,zoombucks,0.7236,4688131,CAN,BC,Vancouver,108.180.143.28,no_relation,124,143,,130,158,causes,0.9363291775690441,903536-FS1-4,"In order to determine the mode of antiviral action, the fragrant sumac extract was added at different times to the cells or VIRUSES during the VIRAL INFECTION cycle.",VIRUSES,VIRAL INFECTION,RO-has_causative_agent
503729699,7/16/2014 23:45:05,,1324543798,7/16/2014 23:44:22,clixsense,0.6403,23585686,GBR,H9,London,31.51.221.173,VIRUSES causes VIRAL INFECTION,124,143,,130,158,causes,0.9363291775690441,903536-FS1-4,"In order to determine the mode of antiviral action, the fragrant sumac extract was added at different times to the cells or VIRUSES during the VIRAL INFECTION cycle.",VIRUSES,VIRAL INFECTION,RO-has_causative_agent
503729699,7/17/2014 03:10:36,,1324723070,7/17/2014 03:10:21,prodege,0.6565,6011370,CAN,BC,Richmond,70.79.45.148,no_relation,124,143,,130,158,causes,0.9363291775690441,903536-FS1-4,"In order to determine the mode of antiviral action, the fragrant sumac extract was added at different times to the cells or VIRUSES during the VIRAL INFECTION cycle.",VIRUSES,VIRAL INFECTION,RO-has_causative_agent
503729699,7/17/2014 06:39:55,,1324909660,7/17/2014 06:39:31,instagc,0.5978,18634892,USA,,,68.102.93.185,VIRUSES causes VIRAL INFECTION,124,143,,130,158,causes,0.9363291775690441,903536-FS1-4,"In order to determine the mode of antiviral action, the fragrant sumac extract was added at different times to the cells or VIRUSES during the VIRAL INFECTION cycle.",VIRUSES,VIRAL INFECTION,RO-has_causative_agent
503729700,7/16/2014 22:24:48,,1324510968,7/16/2014 22:24:38,clixsense,1.0,24896327,GBR,V2,Glasgow,94.2.231.4,SKIN is location of DERMATOPHYTOSES,56,112,,59,127,is location of,0.981980506061966,902135-FS1-9,"Between 1994 and 1998, a total of 790 feather, hair and SKIN specimens from a variety of animals with suspected DERMATOPHYTOSES were studied, of which 248 (31.4%) yielded dermatophytes.",SKIN,DERMATOPHYTOSES,RO-disease_has_primary_anatomic_site
503729700,7/16/2014 23:10:44,,1324528932,7/16/2014 23:09:49,cotter,0.6014,7287927,USA,CA,San Jose,99.27.90.128,SKIN is location of DERMATOPHYTOSES,56,112,,59,127,is location of,0.981980506061966,902135-FS1-9,"Between 1994 and 1998, a total of 790 feather, hair and SKIN specimens from a variety of animals with suspected DERMATOPHYTOSES were studied, of which 248 (31.4%) yielded dermatophytes.",SKIN,DERMATOPHYTOSES,RO-disease_has_primary_anatomic_site
503729700,7/16/2014 23:37:46,,1324541085,7/16/2014 23:37:26,neodev,0.7056,15848372,AUS,02,Jannali,27.96.208.89,SKIN is location of DERMATOPHYTOSES,56,112,,59,127,is location of,0.981980506061966,902135-FS1-9,"Between 1994 and 1998, a total of 790 feather, hair and SKIN specimens from a variety of animals with suspected DERMATOPHYTOSES were studied, of which 248 (31.4%) yielded dermatophytes.",SKIN,DERMATOPHYTOSES,RO-disease_has_primary_anatomic_site
503729700,7/17/2014 00:34:39,,1324569624,7/17/2014 00:34:08,eup_slw,0.5788,28186528,USA,IN,Bloomington,74.204.124.9,SKIN is location of DERMATOPHYTOSES,56,112,,59,127,is location of,0.981980506061966,902135-FS1-9,"Between 1994 and 1998, a total of 790 feather, hair and SKIN specimens from a variety of animals with suspected DERMATOPHYTOSES were studied, of which 248 (31.4%) yielded dermatophytes.",SKIN,DERMATOPHYTOSES,RO-disease_has_primary_anatomic_site
503729700,7/17/2014 02:18:55,,1324671034,7/17/2014 02:18:25,pokerowned,0.6218,18747884,USA,MI,Saginaw,74.85.192.98,DERMATOPHYTOSES is location of SKIN,56,112,,59,127,is location of,0.981980506061966,902135-FS1-9,"Between 1994 and 1998, a total of 790 feather, hair and SKIN specimens from a variety of animals with suspected DERMATOPHYTOSES were studied, of which 248 (31.4%) yielded dermatophytes.",SKIN,DERMATOPHYTOSES,RO-disease_has_primary_anatomic_site
503729700,7/17/2014 06:02:26,,1324876938,7/17/2014 06:01:53,clixsense,0.6042,6472283,USA,WI,Oak Creek,99.107.184.156,DERMATOPHYTOSES is location of SKIN,56,112,,59,127,is location of,0.981980506061966,902135-FS1-9,"Between 1994 and 1998, a total of 790 feather, hair and SKIN specimens from a variety of animals with suspected DERMATOPHYTOSES were studied, of which 248 (31.4%) yielded dermatophytes.",SKIN,DERMATOPHYTOSES,RO-disease_has_primary_anatomic_site
503729700,7/17/2014 06:12:36,,1324885491,7/17/2014 06:12:19,clixsense,0.6401,17648398,GBR,O4,Torquay,92.23.66.130,SKIN is location of DERMATOPHYTOSES,56,112,,59,127,is location of,0.981980506061966,902135-FS1-9,"Between 1994 and 1998, a total of 790 feather, hair and SKIN specimens from a variety of animals with suspected DERMATOPHYTOSES were studied, of which 248 (31.4%) yielded dermatophytes.",SKIN,DERMATOPHYTOSES,RO-disease_has_primary_anatomic_site
503729707,7/16/2014 22:51:17,,1324521763,7/16/2014 22:50:49,clixsense,0.75,17722340,CAN,BC,Mission,50.98.185.25,CONDITION (BINGE) causes BINGE EATING,173,96,,184,113,causes,0.680413817439772,904730-FS1-4,"Primary end points included the Eating Disorders Inventory (EDI), the Severity Index of Bulimic CONDITION (BINGE) Clinical Global Impression (CGI) scores, and the number of BINGE EATING episodes per week.",BINGE EATING,CONDITION (BINGE),RO-has_definitional_manifestation
503729707,7/16/2014 23:25:50,,1324535871,7/16/2014 23:25:29,instagc,0.7639,13763729,USA,,,75.182.89.225,CONDITION (BINGE) causes BINGE EATING,173,96,,184,113,causes,0.680413817439772,904730-FS1-4,"Primary end points included the Eating Disorders Inventory (EDI), the Severity Index of Bulimic CONDITION (BINGE) Clinical Global Impression (CGI) scores, and the number of BINGE EATING episodes per week.",BINGE EATING,CONDITION (BINGE),RO-has_definitional_manifestation
503729707,7/16/2014 23:25:58,,1324535932,7/16/2014 23:25:41,instagc,0.5714,23149109,USA,NC,Durham,75.189.206.205,CONDITION (BINGE) causes BINGE EATING,173,96,,184,113,causes,0.680413817439772,904730-FS1-4,"Primary end points included the Eating Disorders Inventory (EDI), the Severity Index of Bulimic CONDITION (BINGE) Clinical Global Impression (CGI) scores, and the number of BINGE EATING episodes per week.",BINGE EATING,CONDITION (BINGE),RO-has_definitional_manifestation
503729707,7/17/2014 00:31:45,,1324567325,7/17/2014 00:31:10,eup_slw,0.5788,28186528,USA,IN,Bloomington,74.204.124.9,no_relation,173,96,,184,113,causes,0.680413817439772,904730-FS1-4,"Primary end points included the Eating Disorders Inventory (EDI), the Severity Index of Bulimic CONDITION (BINGE) Clinical Global Impression (CGI) scores, and the number of BINGE EATING episodes per week.",BINGE EATING,CONDITION (BINGE),RO-has_definitional_manifestation
503729707,7/17/2014 07:29:45,,1324962728,7/17/2014 07:29:16,instagc,0.8278,25901556,GBR,C3,Saint Ives,82.9.129.2,CONDITION (BINGE) causes BINGE EATING,173,96,,184,113,causes,0.680413817439772,904730-FS1-4,"Primary end points included the Eating Disorders Inventory (EDI), the Severity Index of Bulimic CONDITION (BINGE) Clinical Global Impression (CGI) scores, and the number of BINGE EATING episodes per week.",BINGE EATING,CONDITION (BINGE),RO-has_definitional_manifestation
503729707,7/17/2014 10:02:37,,1325115467,7/17/2014 10:02:19,prodege,0.7163,25949006,GBR,,,62.249.242.67,no_relation,173,96,,184,113,causes,0.680413817439772,904730-FS1-4,"Primary end points included the Eating Disorders Inventory (EDI), the Severity Index of Bulimic CONDITION (BINGE) Clinical Global Impression (CGI) scores, and the number of BINGE EATING episodes per week.",BINGE EATING,CONDITION (BINGE),RO-has_definitional_manifestation
503729707,7/17/2014 10:33:55,,1325141285,7/17/2014 10:33:30,prodege,0.652,9525153,CAN,ON,Toronto,65.95.92.180,CONDITION (BINGE) causes BINGE EATING,173,96,,184,113,causes,0.680413817439772,904730-FS1-4,"Primary end points included the Eating Disorders Inventory (EDI), the Severity Index of Bulimic CONDITION (BINGE) Clinical Global Impression (CGI) scores, and the number of BINGE EATING episodes per week.",BINGE EATING,CONDITION (BINGE),RO-has_definitional_manifestation
503729709,7/16/2014 22:28:36,,1324512775,7/16/2014 22:28:23,clixsense,0.8194,16827630,GBR,A7,Birmingham,86.146.169.103,STAPHYLOCOCCI causes STAPHYLOCOCCAL INFECTIONS,115,202,,127,227,causes,0.7624928516630229,903638-FS1-4,"1   If staphylococci resistant to penicillinase resistant penicillins (oxacillin resistant [methicillin resistant] STAPHYLOCOCCI are prevalent in the hospital or community, empiric therapy of suspected STAPHYLOCOCCAL INFECTIONS should include another appropriate anti infective (e.g., vancomycin.",STAPHYLOCOCCI,STAPHYLOCOCCAL INFECTIONS,RO-has_causative_agent
503729709,7/17/2014 01:32:32,,1324625141,7/17/2014 01:32:24,tremorgames,0.6667,28013393,USA,CA,Rancho Cordova,71.197.67.37,STAPHYLOCOCCI causes STAPHYLOCOCCAL INFECTIONS,115,202,,127,227,causes,0.7624928516630229,903638-FS1-4,"1   If staphylococci resistant to penicillinase resistant penicillins (oxacillin resistant [methicillin resistant] STAPHYLOCOCCI are prevalent in the hospital or community, empiric therapy of suspected STAPHYLOCOCCAL INFECTIONS should include another appropriate anti infective (e.g., vancomycin.",STAPHYLOCOCCI,STAPHYLOCOCCAL INFECTIONS,RO-has_causative_agent
503729709,7/17/2014 02:35:40,,1324688034,7/17/2014 02:35:02,neodev,0.7234,11460728,CAN,BC,Burnaby,70.79.16.165,STAPHYLOCOCCI causes STAPHYLOCOCCAL INFECTIONS,115,202,,127,227,causes,0.7624928516630229,903638-FS1-4,"1   If staphylococci resistant to penicillinase resistant penicillins (oxacillin resistant [methicillin resistant] STAPHYLOCOCCI are prevalent in the hospital or community, empiric therapy of suspected STAPHYLOCOCCAL INFECTIONS should include another appropriate anti infective (e.g., vancomycin.",STAPHYLOCOCCI,STAPHYLOCOCCAL INFECTIONS,RO-has_causative_agent
503729709,7/17/2014 03:10:44,,1324723257,7/17/2014 03:10:22,instagc,0.6704,24252915,GBR,B7,Bristol,77.98.139.82,no_relation,115,202,,127,227,causes,0.7624928516630229,903638-FS1-4,"1   If staphylococci resistant to penicillinase resistant penicillins (oxacillin resistant [methicillin resistant] STAPHYLOCOCCI are prevalent in the hospital or community, empiric therapy of suspected STAPHYLOCOCCAL INFECTIONS should include another appropriate anti infective (e.g., vancomycin.",STAPHYLOCOCCI,STAPHYLOCOCCAL INFECTIONS,RO-has_causative_agent
503729709,7/17/2014 04:58:19,,1324822683,7/17/2014 04:57:57,prodege,0.7105,27934334,GBR,,,86.130.153.15,STAPHYLOCOCCI causes STAPHYLOCOCCAL INFECTIONS,115,202,,127,227,causes,0.7624928516630229,903638-FS1-4,"1   If staphylococci resistant to penicillinase resistant penicillins (oxacillin resistant [methicillin resistant] STAPHYLOCOCCI are prevalent in the hospital or community, empiric therapy of suspected STAPHYLOCOCCAL INFECTIONS should include another appropriate anti infective (e.g., vancomycin.",STAPHYLOCOCCI,STAPHYLOCOCCAL INFECTIONS,RO-has_causative_agent
503729709,7/17/2014 07:30:03,,1324963124,7/17/2014 07:29:46,instagc,0.8278,25901556,GBR,C3,Saint Ives,82.9.129.2,STAPHYLOCOCCI causes STAPHYLOCOCCAL INFECTIONS,115,202,,127,227,causes,0.7624928516630229,903638-FS1-4,"1   If staphylococci resistant to penicillinase resistant penicillins (oxacillin resistant [methicillin resistant] STAPHYLOCOCCI are prevalent in the hospital or community, empiric therapy of suspected STAPHYLOCOCCAL INFECTIONS should include another appropriate anti infective (e.g., vancomycin.",STAPHYLOCOCCI,STAPHYLOCOCCAL INFECTIONS,RO-has_causative_agent
503729709,7/17/2014 07:55:28,,1324990762,7/17/2014 07:54:56,prodege,0.4905,19466267,GBR,Z5,Bedford,82.29.157.23,no_relation,115,202,,127,227,causes,0.7624928516630229,903638-FS1-4,"1   If staphylococci resistant to penicillinase resistant penicillins (oxacillin resistant [methicillin resistant] STAPHYLOCOCCI are prevalent in the hospital or community, empiric therapy of suspected STAPHYLOCOCCAL INFECTIONS should include another appropriate anti infective (e.g., vancomycin.",STAPHYLOCOCCI,STAPHYLOCOCCAL INFECTIONS,RO-has_causative_agent
503729714,7/16/2014 22:36:40,,1324516159,7/16/2014 22:36:22,tremorgames,0.8403,24449707,CAN,QC,Laval,96.21.249.72,ATROPINE treats BRADYCARDIA,81,116,,91,124,treats,0.9931270663228409,908049-FS1-2,Bilateral vagotomy also inhibited both effects whereas atropine only reduced the BRADYCARDIA but the combination of ATROPINE and tertatolol suppressed the bradycardia.,BRADYCARDIA,ATROPINE,RO-may_treat
503729714,7/17/2014 03:08:02,,1324720708,7/17/2014 03:07:38,prodege,0.6565,6011370,CAN,BC,Richmond,70.79.45.148,ATROPINE treats BRADYCARDIA,81,116,,91,124,treats,0.9931270663228409,908049-FS1-2,Bilateral vagotomy also inhibited both effects whereas atropine only reduced the BRADYCARDIA but the combination of ATROPINE and tertatolol suppressed the bradycardia.,BRADYCARDIA,ATROPINE,RO-may_treat
503729714,7/17/2014 06:38:15,,1324908080,7/17/2014 06:37:39,instagc,0.5978,18634892,USA,,,68.102.93.185,ATROPINE treats BRADYCARDIA,81,116,,91,124,treats,0.9931270663228409,908049-FS1-2,Bilateral vagotomy also inhibited both effects whereas atropine only reduced the BRADYCARDIA but the combination of ATROPINE and tertatolol suppressed the bradycardia.,BRADYCARDIA,ATROPINE,RO-may_treat
503729714,7/17/2014 10:33:35,,1325140965,7/17/2014 10:33:27,clixsense,0.5793,27793793,GBR,C5,Chester,151.230.27.155,ATROPINE treats BRADYCARDIA,81,116,,91,124,treats,0.9931270663228409,908049-FS1-2,Bilateral vagotomy also inhibited both effects whereas atropine only reduced the BRADYCARDIA but the combination of ATROPINE and tertatolol suppressed the bradycardia.,BRADYCARDIA,ATROPINE,RO-may_treat
503729714,7/17/2014 10:35:05,,1325142284,7/17/2014 10:34:52,prodege,0.652,9525153,CAN,ON,Toronto,65.95.92.180,ATROPINE treats BRADYCARDIA,81,116,,91,124,treats,0.9931270663228409,908049-FS1-2,Bilateral vagotomy also inhibited both effects whereas atropine only reduced the BRADYCARDIA but the combination of ATROPINE and tertatolol suppressed the bradycardia.,BRADYCARDIA,ATROPINE,RO-may_treat
503729714,7/17/2014 10:37:52,,1325144468,7/17/2014 10:37:26,clixsense,0.6636,19803139,NLD,06,Veldhoven,212.61.84.196,ATROPINE treats BRADYCARDIA,81,116,,91,124,treats,0.9931270663228409,908049-FS1-2,Bilateral vagotomy also inhibited both effects whereas atropine only reduced the BRADYCARDIA but the combination of ATROPINE and tertatolol suppressed the bradycardia.,BRADYCARDIA,ATROPINE,RO-may_treat
503729714,7/17/2014 10:59:57,,1325161208,7/17/2014 10:59:28,elite,0.7556,28397222,GBR,Y4,Usk,31.50.223.75,ATROPINE treats BRADYCARDIA,81,116,,91,124,treats,0.9931270663228409,908049-FS1-2,Bilateral vagotomy also inhibited both effects whereas atropine only reduced the BRADYCARDIA but the combination of ATROPINE and tertatolol suppressed the bradycardia.,BRADYCARDIA,ATROPINE,RO-may_treat
503729716,7/16/2014 22:24:28,,1324510858,7/16/2014 22:24:02,clixsense,1.0,21642428,NLD,11,Nootdorp,83.86.58.179,FUROSEMIDE treats ASCITES,100,69,,106,79,treats,1.0,907842-FS1-2,"Herlong HF, Hunter FM, Koff RS et al. A comparison of bumetanide and FUROSEMIDE in the treatment of ASCITES: cooperative study.",ASCITES,FUROSEMIDE,RO-may_treat
503729716,7/17/2014 01:32:22,,1324624970,7/17/2014 01:32:17,tremorgames,0.6667,28013393,USA,CA,Rancho Cordova,71.197.67.37,FUROSEMIDE treats ASCITES,100,69,,106,79,treats,1.0,907842-FS1-2,"Herlong HF, Hunter FM, Koff RS et al. A comparison of bumetanide and FUROSEMIDE in the treatment of ASCITES: cooperative study.",ASCITES,FUROSEMIDE,RO-may_treat
503729716,7/17/2014 06:01:52,,1324876483,7/17/2014 06:01:26,clixsense,0.6042,6472283,USA,WI,Oak Creek,99.107.184.156,ASCITES treats FUROSEMIDE,100,69,,106,79,treats,1.0,907842-FS1-2,"Herlong HF, Hunter FM, Koff RS et al. A comparison of bumetanide and FUROSEMIDE in the treatment of ASCITES: cooperative study.",ASCITES,FUROSEMIDE,RO-may_treat
503729716,7/17/2014 07:44:39,,1324979192,7/17/2014 07:44:29,instagc,0.698,18960682,GBR,,,86.29.147.112,FUROSEMIDE treats ASCITES,100,69,,106,79,treats,1.0,907842-FS1-2,"Herlong HF, Hunter FM, Koff RS et al. A comparison of bumetanide and FUROSEMIDE in the treatment of ASCITES: cooperative study.",ASCITES,FUROSEMIDE,RO-may_treat
503729716,7/17/2014 09:31:56,,1325086063,7/17/2014 09:31:33,prodege,0.5512,27990290,GBR,I9,Bury Saint Edmunds,86.142.231.81,FUROSEMIDE treats ASCITES,100,69,,106,79,treats,1.0,907842-FS1-2,"Herlong HF, Hunter FM, Koff RS et al. A comparison of bumetanide and FUROSEMIDE in the treatment of ASCITES: cooperative study.",ASCITES,FUROSEMIDE,RO-may_treat
503729716,7/17/2014 10:01:01,,1325114016,7/17/2014 10:00:34,prodege,0.7163,25949006,GBR,,,62.249.242.67,FUROSEMIDE treats ASCITES,100,69,,106,79,treats,1.0,907842-FS1-2,"Herlong HF, Hunter FM, Koff RS et al. A comparison of bumetanide and FUROSEMIDE in the treatment of ASCITES: cooperative study.",ASCITES,FUROSEMIDE,RO-may_treat
503729716,7/17/2014 10:34:09,,1325141472,7/17/2014 10:33:55,prodege,0.652,9525153,CAN,ON,Toronto,65.95.92.180,FUROSEMIDE treats ASCITES,100,69,,106,79,treats,1.0,907842-FS1-2,"Herlong HF, Hunter FM, Koff RS et al. A comparison of bumetanide and FUROSEMIDE in the treatment of ASCITES: cooperative study.",ASCITES,FUROSEMIDE,RO-may_treat
504169871,7/17/2014 10:26:43,,1325135256,7/17/2014 10:25:25,bitcoinget,1.0,28158287,USA,CA,San Jose,71.202.186.225,MYCOBACTERIUM LEPRAE causes LEPROSY,68,0,,87,7,causes,0.9594032236002471,903748-FS1-4,"LEPROSY is unique in terms of the nature of the causative organism (MYCOBACTERIUM LEPRAE the chronicity of the disease, its prolonged treatment and the definitions of cure and relapse.",MYCOBACTERIUM LEPRAE,LEPROSY,RO-has_causative_agent
504169871,7/17/2014 10:33:56,,1325141292,7/17/2014 10:33:42,instagc,0.8444,24252915,GBR,B7,Bristol,77.98.139.82,MYCOBACTERIUM LEPRAE causes LEPROSY,68,0,,87,7,causes,0.9594032236002471,903748-FS1-4,"LEPROSY is unique in terms of the nature of the causative organism (MYCOBACTERIUM LEPRAE the chronicity of the disease, its prolonged treatment and the definitions of cure and relapse.",MYCOBACTERIUM LEPRAE,LEPROSY,RO-has_causative_agent
504169871,7/17/2014 10:43:40,,1325148934,7/17/2014 10:43:14,clixsense,0.8083,19803139,NLD,06,Veldhoven,212.61.84.196,MYCOBACTERIUM LEPRAE causes LEPROSY,68,0,,87,7,causes,0.9594032236002471,903748-FS1-4,"LEPROSY is unique in terms of the nature of the causative organism (MYCOBACTERIUM LEPRAE the chronicity of the disease, its prolonged treatment and the definitions of cure and relapse.",MYCOBACTERIUM LEPRAE,LEPROSY,RO-has_causative_agent
504169871,7/17/2014 11:23:22,,1325179395,7/17/2014 11:22:53,prodege,0.5754,27934334,GBR,,,86.130.153.15,MYCOBACTERIUM LEPRAE causes LEPROSY,68,0,,87,7,causes,0.9594032236002471,903748-FS1-4,"LEPROSY is unique in terms of the nature of the causative organism (MYCOBACTERIUM LEPRAE the chronicity of the disease, its prolonged treatment and the definitions of cure and relapse.",MYCOBACTERIUM LEPRAE,LEPROSY,RO-has_causative_agent
504169871,7/17/2014 12:56:57,,1325252089,7/17/2014 12:56:50,clixsense,0.7115,16827630,GBR,A7,Birmingham,86.146.169.103,MYCOBACTERIUM LEPRAE causes LEPROSY,68,0,,87,7,causes,0.9594032236002471,903748-FS1-4,"LEPROSY is unique in terms of the nature of the causative organism (MYCOBACTERIUM LEPRAE the chronicity of the disease, its prolonged treatment and the definitions of cure and relapse.",MYCOBACTERIUM LEPRAE,LEPROSY,RO-has_causative_agent
504169871,7/17/2014 13:04:54,,1325259290,7/17/2014 13:04:29,neodev,0.6065,21515166,NLD,11,Nootdorp,83.86.58.179,MYCOBACTERIUM LEPRAE causes LEPROSY,68,0,,87,7,causes,0.9594032236002471,903748-FS1-4,"LEPROSY is unique in terms of the nature of the causative organism (MYCOBACTERIUM LEPRAE the chronicity of the disease, its prolonged treatment and the definitions of cure and relapse.",MYCOBACTERIUM LEPRAE,LEPROSY,RO-has_causative_agent
504169871,7/17/2014 14:01:09,,1325311860,7/17/2014 14:00:57,clixsense,0.6306,15189335,GBR,T5,Aberdeen,90.218.222.164,MYCOBACTERIUM LEPRAE causes LEPROSY,68,0,,87,7,causes,0.9594032236002471,903748-FS1-4,"LEPROSY is unique in terms of the nature of the causative organism (MYCOBACTERIUM LEPRAE the chronicity of the disease, its prolonged treatment and the definitions of cure and relapse.",MYCOBACTERIUM LEPRAE,LEPROSY,RO-has_causative_agent
504169877,7/17/2014 10:31:59,,1325139683,7/17/2014 10:31:37,clixsense,0.8667,19162475,GBR,M3,Frome,82.33.126.30,HEPATITIS B INFECTION treats HEPATITIS B VACCINE,218,151,,238,170,treats,0.9647638212377321,907208-FS1-2,"The protocols for the practical management of these cases, including the immunisation of susceptible non human primates and the staff with recombinant HEPATITIS B VACCINE are described, and the origin and evolution of HEPATITIS B INFECTION in primates are discussed.",HEPATITIS B INFECTION,HEPATITIS B VACCINE,RO-may_prevent
504169877,7/17/2014 10:35:15,,1325142509,7/17/2014 10:35:05,clixsense,0.8111,27793793,GBR,C5,Chester,151.230.27.155,HEPATITIS B VACCINE treats HEPATITIS B INFECTION,218,151,,238,170,treats,0.9647638212377321,907208-FS1-2,"The protocols for the practical management of these cases, including the immunisation of susceptible non human primates and the staff with recombinant HEPATITIS B VACCINE are described, and the origin and evolution of HEPATITIS B INFECTION in primates are discussed.",HEPATITIS B INFECTION,HEPATITIS B VACCINE,RO-may_prevent
504169877,7/17/2014 12:57:35,,1325252588,7/17/2014 12:57:25,clixsense,0.7115,16827630,GBR,A7,Birmingham,86.146.169.103,HEPATITIS B VACCINE treats HEPATITIS B INFECTION,218,151,,238,170,treats,0.9647638212377321,907208-FS1-2,"The protocols for the practical management of these cases, including the immunisation of susceptible non human primates and the staff with recombinant HEPATITIS B VACCINE are described, and the origin and evolution of HEPATITIS B INFECTION in primates are discussed.",HEPATITIS B INFECTION,HEPATITIS B VACCINE,RO-may_prevent
504169877,7/17/2014 13:21:50,,1325273540,7/17/2014 13:21:00,clixsense,0.5029,6334612,USA,OH,Cleveland,108.225.254.58,no_relation,218,151,,238,170,treats,0.9647638212377321,907208-FS1-2,"The protocols for the practical management of these cases, including the immunisation of susceptible non human primates and the staff with recombinant HEPATITIS B VACCINE are described, and the origin and evolution of HEPATITIS B INFECTION in primates are discussed.",HEPATITIS B INFECTION,HEPATITIS B VACCINE,RO-may_prevent
504169877,7/17/2014 13:36:51,,1325289203,7/17/2014 13:36:29,prodege,0.5459,28039757,GBR,L8,Southport,109.155.158.54,no_relation,218,151,,238,170,treats,0.9647638212377321,907208-FS1-2,"The protocols for the practical management of these cases, including the immunisation of susceptible non human primates and the staff with recombinant HEPATITIS B VACCINE are described, and the origin and evolution of HEPATITIS B INFECTION in primates are discussed.",HEPATITIS B INFECTION,HEPATITIS B VACCINE,RO-may_prevent
504169877,7/17/2014 13:54:31,,1325305509,7/17/2014 13:53:59,clixsense,0.619,6579377,CAN,BC,Richmond,174.6.142.227,HEPATITIS B VACCINE treats HEPATITIS B INFECTION,218,151,,238,170,treats,0.9647638212377321,907208-FS1-2,"The protocols for the practical management of these cases, including the immunisation of susceptible non human primates and the staff with recombinant HEPATITIS B VACCINE are described, and the origin and evolution of HEPATITIS B INFECTION in primates are discussed.",HEPATITIS B INFECTION,HEPATITIS B VACCINE,RO-may_prevent
504169877,7/17/2014 14:02:03,,1325312869,7/17/2014 14:01:44,clixsense,0.6306,15189335,GBR,T5,Aberdeen,90.218.222.164,no_relation,218,151,,238,170,treats,0.9647638212377321,907208-FS1-2,"The protocols for the practical management of these cases, including the immunisation of susceptible non human primates and the staff with recombinant HEPATITIS B VACCINE are described, and the origin and evolution of HEPATITIS B INFECTION in primates are discussed.",HEPATITIS B INFECTION,HEPATITIS B VACCINE,RO-may_prevent
504169880,7/17/2014 10:34:23,,1325141670,7/17/2014 10:33:57,instagc,0.8444,24252915,GBR,B7,Bristol,77.98.139.82,BRAIN is location of CEREBRAL ISCHEMIA,71,110,,75,127,is location of,0.9491579957524989,902113-FS1-9,The results indicate that the function of the inhibitory system in the BRAIN is selectively vulnerable during CEREBRAL ISCHEMIA,BRAIN,CEREBRAL ISCHEMIA,RO-disease_has_primary_anatomic_site
504169880,7/17/2014 10:45:20,,1325150140,7/17/2014 10:45:01,clixsense,0.8083,19803139,NLD,06,Veldhoven,212.61.84.196,BRAIN is location of CEREBRAL ISCHEMIA,71,110,,75,127,is location of,0.9491579957524989,902113-FS1-9,The results indicate that the function of the inhibitory system in the BRAIN is selectively vulnerable during CEREBRAL ISCHEMIA,BRAIN,CEREBRAL ISCHEMIA,RO-disease_has_primary_anatomic_site
504169880,7/17/2014 12:54:03,,1325249842,7/17/2014 12:53:53,clixsense,0.7115,16827630,GBR,A7,Birmingham,86.146.169.103,BRAIN is location of CEREBRAL ISCHEMIA,71,110,,75,127,is location of,0.9491579957524989,902113-FS1-9,The results indicate that the function of the inhibitory system in the BRAIN is selectively vulnerable during CEREBRAL ISCHEMIA,BRAIN,CEREBRAL ISCHEMIA,RO-disease_has_primary_anatomic_site
504169880,7/17/2014 13:18:45,,1325270804,7/17/2014 13:17:51,clixsense,0.5029,6334612,USA,OH,Cleveland,108.225.254.58,BRAIN is location of CEREBRAL ISCHEMIA,71,110,,75,127,is location of,0.9491579957524989,902113-FS1-9,The results indicate that the function of the inhibitory system in the BRAIN is selectively vulnerable during CEREBRAL ISCHEMIA,BRAIN,CEREBRAL ISCHEMIA,RO-disease_has_primary_anatomic_site
504169880,7/17/2014 13:22:57,,1325274524,7/17/2014 13:22:29,prodege,0.6851,24945126,GBR,F6,Romford,82.12.220.44,BRAIN is location of CEREBRAL ISCHEMIA,71,110,,75,127,is location of,0.9491579957524989,902113-FS1-9,The results indicate that the function of the inhibitory system in the BRAIN is selectively vulnerable during CEREBRAL ISCHEMIA,BRAIN,CEREBRAL ISCHEMIA,RO-disease_has_primary_anatomic_site
504169880,7/17/2014 13:32:17,,1325285351,7/17/2014 13:31:55,prodege,0.5459,28039757,GBR,L8,Southport,109.155.158.54,BRAIN is location of CEREBRAL ISCHEMIA,71,110,,75,127,is location of,0.9491579957524989,902113-FS1-9,The results indicate that the function of the inhibitory system in the BRAIN is selectively vulnerable during CEREBRAL ISCHEMIA,BRAIN,CEREBRAL ISCHEMIA,RO-disease_has_primary_anatomic_site
504169880,7/17/2014 13:58:30,,1325309286,7/17/2014 13:58:04,clixsense,0.619,6579377,CAN,BC,Richmond,174.6.142.227,no_relation,71,110,,75,127,is location of,0.9491579957524989,902113-FS1-9,The results indicate that the function of the inhibitory system in the BRAIN is selectively vulnerable during CEREBRAL ISCHEMIA,BRAIN,CEREBRAL ISCHEMIA,RO-disease_has_primary_anatomic_site
504169900,7/17/2014 10:31:01,,1325138775,7/17/2014 10:30:54,clixsense,0.8667,19162475,GBR,M3,Frome,82.33.126.30,BRONCHIAL HYPERREACTIVITY treats METHACHOLINE,225,266,,249,278,treats,0.693375245281537,906530-FS1-2,"We found that genetically mast cell deficient WBB6F(1) W/W(v) mice that were sensitized to ovalbumin (OVA) without adjuvant, then challenged repetitively with antigen intranasally, exhibited much weaker responses in terms of BRONCHIAL HYPERREACTIVITY to aerosolized METHACHOLINE lung tissue eosinophil infiltration, and numbers of proliferating cells within the airway epithelium than did identically treated WBB6F(1) +/+ normal mice.",BRONCHIAL HYPERREACTIVITY,METHACHOLINE,RO-may_diagnose
504169900,7/17/2014 11:14:14,,1325172424,7/17/2014 11:13:58,prodege,0.6456,15439740,AUS,02,Jannali,27.96.208.89,no_relation,225,266,,249,278,treats,0.693375245281537,906530-FS1-2,"We found that genetically mast cell deficient WBB6F(1) W/W(v) mice that were sensitized to ovalbumin (OVA) without adjuvant, then challenged repetitively with antigen intranasally, exhibited much weaker responses in terms of BRONCHIAL HYPERREACTIVITY to aerosolized METHACHOLINE lung tissue eosinophil infiltration, and numbers of proliferating cells within the airway epithelium than did identically treated WBB6F(1) +/+ normal mice.",BRONCHIAL HYPERREACTIVITY,METHACHOLINE,RO-may_diagnose
504169900,7/17/2014 11:31:01,,1325185094,7/17/2014 11:30:49,gifthulk,0.71,21916793,GBR,,,87.115.178.12,METHACHOLINE treats BRONCHIAL HYPERREACTIVITY,225,266,,249,278,treats,0.693375245281537,906530-FS1-2,"We found that genetically mast cell deficient WBB6F(1) W/W(v) mice that were sensitized to ovalbumin (OVA) without adjuvant, then challenged repetitively with antigen intranasally, exhibited much weaker responses in terms of BRONCHIAL HYPERREACTIVITY to aerosolized METHACHOLINE lung tissue eosinophil infiltration, and numbers of proliferating cells within the airway epithelium than did identically treated WBB6F(1) +/+ normal mice.",BRONCHIAL HYPERREACTIVITY,METHACHOLINE,RO-may_diagnose
504169900,7/17/2014 11:58:36,,1325205958,7/17/2014 11:58:15,tremorgames,0.5999,24449707,CAN,QC,Laval,96.21.249.72,METHACHOLINE treats BRONCHIAL HYPERREACTIVITY,225,266,,249,278,treats,0.693375245281537,906530-FS1-2,"We found that genetically mast cell deficient WBB6F(1) W/W(v) mice that were sensitized to ovalbumin (OVA) without adjuvant, then challenged repetitively with antigen intranasally, exhibited much weaker responses in terms of BRONCHIAL HYPERREACTIVITY to aerosolized METHACHOLINE lung tissue eosinophil infiltration, and numbers of proliferating cells within the airway epithelium than did identically treated WBB6F(1) +/+ normal mice.",BRONCHIAL HYPERREACTIVITY,METHACHOLINE,RO-may_diagnose
504169900,7/17/2014 12:25:47,,1325226423,7/17/2014 12:25:30,prodege,0.7034,7664351,USA,NY,Cicero,74.111.0.21,no_relation,225,266,,249,278,treats,0.693375245281537,906530-FS1-2,"We found that genetically mast cell deficient WBB6F(1) W/W(v) mice that were sensitized to ovalbumin (OVA) without adjuvant, then challenged repetitively with antigen intranasally, exhibited much weaker responses in terms of BRONCHIAL HYPERREACTIVITY to aerosolized METHACHOLINE lung tissue eosinophil infiltration, and numbers of proliferating cells within the airway epithelium than did identically treated WBB6F(1) +/+ normal mice.",BRONCHIAL HYPERREACTIVITY,METHACHOLINE,RO-may_diagnose
504169900,7/17/2014 12:56:49,,1325251976,7/17/2014 12:56:41,clixsense,0.7115,16827630,GBR,A7,Birmingham,86.146.169.103,METHACHOLINE treats BRONCHIAL HYPERREACTIVITY,225,266,,249,278,treats,0.693375245281537,906530-FS1-2,"We found that genetically mast cell deficient WBB6F(1) W/W(v) mice that were sensitized to ovalbumin (OVA) without adjuvant, then challenged repetitively with antigen intranasally, exhibited much weaker responses in terms of BRONCHIAL HYPERREACTIVITY to aerosolized METHACHOLINE lung tissue eosinophil infiltration, and numbers of proliferating cells within the airway epithelium than did identically treated WBB6F(1) +/+ normal mice.",BRONCHIAL HYPERREACTIVITY,METHACHOLINE,RO-may_diagnose
504169900,7/17/2014 13:01:53,,1325256483,7/17/2014 13:01:37,prodege,0.6851,24945126,GBR,F6,Romford,82.12.220.44,METHACHOLINE treats BRONCHIAL HYPERREACTIVITY,225,266,,249,278,treats,0.693375245281537,906530-FS1-2,"We found that genetically mast cell deficient WBB6F(1) W/W(v) mice that were sensitized to ovalbumin (OVA) without adjuvant, then challenged repetitively with antigen intranasally, exhibited much weaker responses in terms of BRONCHIAL HYPERREACTIVITY to aerosolized METHACHOLINE lung tissue eosinophil infiltration, and numbers of proliferating cells within the airway epithelium than did identically treated WBB6F(1) +/+ normal mice.",BRONCHIAL HYPERREACTIVITY,METHACHOLINE,RO-may_diagnose
504169903,7/17/2014 10:41:57,,1325147541,7/17/2014 10:41:45,prodege,0.7444,9525153,CAN,ON,Toronto,65.95.92.180,OSTEOPOROSIS causes BONE CELLS,112,170,,121,182,causes,0.529812942826018,902076-FS1-4,"Interleukin 6 (IL 6) is an attractive candidate gene for osteoporosis susceptibility, because it has effects on BONE CELLS and has been implicated in the pathogenesis of OSTEOPOROSIS",BONE CELLS,OSTEOPOROSIS,RO-disease_has_primary_anatomic_site
504169903,7/17/2014 11:27:39,,1325182294,7/17/2014 11:26:28,prodege,0.5754,27934334,GBR,,,86.130.153.15,no_relation,112,170,,121,182,causes,0.529812942826018,902076-FS1-4,"Interleukin 6 (IL 6) is an attractive candidate gene for osteoporosis susceptibility, because it has effects on BONE CELLS and has been implicated in the pathogenesis of OSTEOPOROSIS",BONE CELLS,OSTEOPOROSIS,RO-disease_has_primary_anatomic_site
504169903,7/17/2014 11:28:57,,1325183246,7/17/2014 11:28:12,vivatic,0.5949,25451531,GBR,,,83.67.28.193,no_relation,112,170,,121,182,causes,0.529812942826018,902076-FS1-4,"Interleukin 6 (IL 6) is an attractive candidate gene for osteoporosis susceptibility, because it has effects on BONE CELLS and has been implicated in the pathogenesis of OSTEOPOROSIS",BONE CELLS,OSTEOPOROSIS,RO-disease_has_primary_anatomic_site
504169903,7/17/2014 13:15:34,,1325268051,7/17/2014 13:14:39,clixsense,0.5029,6334612,USA,OH,Cleveland,108.225.254.58,OSTEOPOROSIS causes BONE CELLS,112,170,,121,182,causes,0.529812942826018,902076-FS1-4,"Interleukin 6 (IL 6) is an attractive candidate gene for osteoporosis susceptibility, because it has effects on BONE CELLS and has been implicated in the pathogenesis of OSTEOPOROSIS",BONE CELLS,OSTEOPOROSIS,RO-disease_has_primary_anatomic_site
504169903,7/17/2014 13:53:59,,1325305086,7/17/2014 13:53:28,clixsense,0.619,6579377,CAN,BC,Richmond,174.6.142.227,no_relation,112,170,,121,182,causes,0.529812942826018,902076-FS1-4,"Interleukin 6 (IL 6) is an attractive candidate gene for osteoporosis susceptibility, because it has effects on BONE CELLS and has been implicated in the pathogenesis of OSTEOPOROSIS",BONE CELLS,OSTEOPOROSIS,RO-disease_has_primary_anatomic_site
504169903,7/17/2014 14:00:56,,1325311636,7/17/2014 14:00:42,clixsense,0.6306,15189335,GBR,T5,Aberdeen,90.218.222.164,BONE CELLS causes OSTEOPOROSIS,112,170,,121,182,causes,0.529812942826018,902076-FS1-4,"Interleukin 6 (IL 6) is an attractive candidate gene for osteoporosis susceptibility, because it has effects on BONE CELLS and has been implicated in the pathogenesis of OSTEOPOROSIS",BONE CELLS,OSTEOPOROSIS,RO-disease_has_primary_anatomic_site
504169903,7/17/2014 14:03:32,,1325314191,7/17/2014 14:03:11,neodev,0.4184,18339121,USA,SC,Sumter,173.93.188.194,BONE CELLS causes OSTEOPOROSIS,112,170,,121,182,causes,0.529812942826018,902076-FS1-4,"Interleukin 6 (IL 6) is an attractive candidate gene for osteoporosis susceptibility, because it has effects on BONE CELLS and has been implicated in the pathogenesis of OSTEOPOROSIS",BONE CELLS,OSTEOPOROSIS,RO-disease_has_primary_anatomic_site
504169904,7/17/2014 10:21:25,,1325131259,7/17/2014 10:21:18,clixsense,0.8111,27793793,GBR,C5,Chester,151.230.27.155,no_relation,4,52,,10,60,causes,0.492365963917331,902866-FS1-4,"The ASCITES form of a chemically induced guinea pig HEPATOMA line 10, was resistant to killing in vitro by xenogeneic antibody and guinea pig complement.",ASCITES,HEPATOMA,RO-disease_may_have_finding
504169904,7/17/2014 10:35:24,,1325142633,7/17/2014 10:34:55,instagc,0.8444,24252915,GBR,B7,Bristol,77.98.139.82,no_relation,4,52,,10,60,causes,0.492365963917331,902866-FS1-4,"The ASCITES form of a chemically induced guinea pig HEPATOMA line 10, was resistant to killing in vitro by xenogeneic antibody and guinea pig complement.",ASCITES,HEPATOMA,RO-disease_may_have_finding
504169904,7/17/2014 10:42:52,,1325148255,7/17/2014 10:42:19,prodege,0.7444,9525153,CAN,ON,Toronto,65.95.92.180,HEPATOMA causes ASCITES,4,52,,10,60,causes,0.492365963917331,902866-FS1-4,"The ASCITES form of a chemically induced guinea pig HEPATOMA line 10, was resistant to killing in vitro by xenogeneic antibody and guinea pig complement.",ASCITES,HEPATOMA,RO-disease_may_have_finding
504169904,7/17/2014 11:13:11,,1325171587,7/17/2014 11:12:34,prodege,0.6456,15439740,AUS,02,Jannali,27.96.208.89,ASCITES causes HEPATOMA,4,52,,10,60,causes,0.492365963917331,902866-FS1-4,"The ASCITES form of a chemically induced guinea pig HEPATOMA line 10, was resistant to killing in vitro by xenogeneic antibody and guinea pig complement.",ASCITES,HEPATOMA,RO-disease_may_have_finding
504169904,7/17/2014 11:28:07,,1325182612,7/17/2014 11:27:49,gifthulk,0.71,21916793,GBR,,,87.115.178.12,no_relation,4,52,,10,60,causes,0.492365963917331,902866-FS1-4,"The ASCITES form of a chemically induced guinea pig HEPATOMA line 10, was resistant to killing in vitro by xenogeneic antibody and guinea pig complement.",ASCITES,HEPATOMA,RO-disease_may_have_finding
504169904,7/17/2014 11:46:11,,1325197382,7/17/2014 11:45:48,instagc,0.6489,13763729,USA,,,75.182.89.225,ASCITES causes HEPATOMA,4,52,,10,60,causes,0.492365963917331,902866-FS1-4,"The ASCITES form of a chemically induced guinea pig HEPATOMA line 10, was resistant to killing in vitro by xenogeneic antibody and guinea pig complement.",ASCITES,HEPATOMA,RO-disease_may_have_finding
504169904,7/17/2014 12:54:55,,1325250531,7/17/2014 12:54:45,clixsense,0.7115,16827630,GBR,A7,Birmingham,86.146.169.103,no_relation,4,52,,10,60,causes,0.492365963917331,902866-FS1-4,"The ASCITES form of a chemically induced guinea pig HEPATOMA line 10, was resistant to killing in vitro by xenogeneic antibody and guinea pig complement.",ASCITES,HEPATOMA,RO-disease_may_have_finding
504169907,7/17/2014 10:22:05,,1325131756,7/17/2014 10:21:55,clixsense,0.8111,27793793,GBR,C5,Chester,151.230.27.155,no_relation,82,131,,96,134,causes,0.33968311024337894,902686-FS1-4,"? In patients with rapidly advancing disease characterized by B symptoms, massive LYMPHADENOPATHY and hepatosplenomegaly, consider CLL transformation (see  disease specific drug treatment in patients with transformed CLL.",LYMPHADENOPATHY,CLL,RO-disease_may_have_finding
504169907,7/17/2014 10:40:19,,1325146322,7/17/2014 10:40:01,prodege,0.7444,9525153,CAN,ON,Toronto,65.95.92.180,CLL causes LYMPHADENOPATHY,82,131,,96,134,causes,0.33968311024337894,902686-FS1-4,"? In patients with rapidly advancing disease characterized by B symptoms, massive LYMPHADENOPATHY and hepatosplenomegaly, consider CLL transformation (see  disease specific drug treatment in patients with transformed CLL.",LYMPHADENOPATHY,CLL,RO-disease_may_have_finding
504169907,7/17/2014 11:06:45,,1325166209,7/17/2014 11:06:29,instagc,0.6656,23149109,USA,NC,Durham,75.189.206.205,LYMPHADENOPATHY causes CLL,82,131,,96,134,causes,0.33968311024337894,902686-FS1-4,"? In patients with rapidly advancing disease characterized by B symptoms, massive LYMPHADENOPATHY and hepatosplenomegaly, consider CLL transformation (see  disease specific drug treatment in patients with transformed CLL.",LYMPHADENOPATHY,CLL,RO-disease_may_have_finding
504169907,7/17/2014 11:20:33,,1325177248,7/17/2014 11:19:51,prodege,0.5754,27934334,GBR,,,86.130.153.15,CLL causes LYMPHADENOPATHY,82,131,,96,134,causes,0.33968311024337894,902686-FS1-4,"? In patients with rapidly advancing disease characterized by B symptoms, massive LYMPHADENOPATHY and hepatosplenomegaly, consider CLL transformation (see  disease specific drug treatment in patients with transformed CLL.",LYMPHADENOPATHY,CLL,RO-disease_may_have_finding
504169907,7/17/2014 11:33:24,,1325187544,7/17/2014 11:32:32,fusioncash,0.6519,7012325,USA,CT,Stamford,24.185.182.15,CLL causes LYMPHADENOPATHY,82,131,,96,134,causes,0.33968311024337894,902686-FS1-4,"? In patients with rapidly advancing disease characterized by B symptoms, massive LYMPHADENOPATHY and hepatosplenomegaly, consider CLL transformation (see  disease specific drug treatment in patients with transformed CLL.",LYMPHADENOPATHY,CLL,RO-disease_may_have_finding
504169907,7/17/2014 12:07:34,,1325212410,7/17/2014 12:07:09,elite,0.6437,28503042,USA,NJ,Woodbridge,54.191.150.115,LYMPHADENOPATHY causes CLL,82,131,,96,134,causes,0.33968311024337894,902686-FS1-4,"? In patients with rapidly advancing disease characterized by B symptoms, massive LYMPHADENOPATHY and hepatosplenomegaly, consider CLL transformation (see  disease specific drug treatment in patients with transformed CLL.",LYMPHADENOPATHY,CLL,RO-disease_may_have_finding
504169907,7/17/2014 13:23:08,,1325274654,7/17/2014 13:22:35,clixsense,0.5029,6334612,USA,OH,Cleveland,108.225.254.58,no_relation,82,131,,96,134,causes,0.33968311024337894,902686-FS1-4,"? In patients with rapidly advancing disease characterized by B symptoms, massive LYMPHADENOPATHY and hepatosplenomegaly, consider CLL transformation (see  disease specific drug treatment in patients with transformed CLL.",LYMPHADENOPATHY,CLL,RO-disease_may_have_finding
504169910,7/17/2014 10:21:33,,1325131352,7/17/2014 10:21:26,clixsense,0.8111,27793793,GBR,C5,Chester,151.230.27.155,no_relation,63,0,,94,34,is location of,0.384110639798688,901974-FS1-9,DPA INDUCED CICATRICIAL PEMPHIGOID is a severe disease of both MUCOUS AND CUTANEOUS INVOLVEMENT with a prognosis similar to the spontaneous disease.,MUCOUS AND CUTANEOUS INVOLVEMENT,DPA INDUCED CICATRICIAL PEMPHIGOID,RO-disease_has_finding
504169910,7/17/2014 10:32:29,,1325140025,7/17/2014 10:32:24,clixsense,0.8667,19162475,GBR,M3,Frome,82.33.126.30,DPA INDUCED CICATRICIAL PEMPHIGOID is location of MUCOUS AND CUTANEOUS INVOLVEMENT,63,0,,94,34,is location of,0.384110639798688,901974-FS1-9,DPA INDUCED CICATRICIAL PEMPHIGOID is a severe disease of both MUCOUS AND CUTANEOUS INVOLVEMENT with a prognosis similar to the spontaneous disease.,MUCOUS AND CUTANEOUS INVOLVEMENT,DPA INDUCED CICATRICIAL PEMPHIGOID,RO-disease_has_finding
504169910,7/17/2014 10:44:38,,1325149621,7/17/2014 10:44:14,clixsense,0.8083,19803139,NLD,06,Veldhoven,212.61.84.196,DPA INDUCED CICATRICIAL PEMPHIGOID is location of MUCOUS AND CUTANEOUS INVOLVEMENT,63,0,,94,34,is location of,0.384110639798688,901974-FS1-9,DPA INDUCED CICATRICIAL PEMPHIGOID is a severe disease of both MUCOUS AND CUTANEOUS INVOLVEMENT with a prognosis similar to the spontaneous disease.,MUCOUS AND CUTANEOUS INVOLVEMENT,DPA INDUCED CICATRICIAL PEMPHIGOID,RO-disease_has_finding
504169910,7/17/2014 11:05:37,,1325165354,7/17/2014 11:05:11,clixsense,0.6811,28324391,NLD,11,Hazerswoude-rijndijk,94.208.82.215,MUCOUS AND CUTANEOUS INVOLVEMENT is location of DPA INDUCED CICATRICIAL PEMPHIGOID,63,0,,94,34,is location of,0.384110639798688,901974-FS1-9,DPA INDUCED CICATRICIAL PEMPHIGOID is a severe disease of both MUCOUS AND CUTANEOUS INVOLVEMENT with a prognosis similar to the spontaneous disease.,MUCOUS AND CUTANEOUS INVOLVEMENT,DPA INDUCED CICATRICIAL PEMPHIGOID,RO-disease_has_finding
504169910,7/17/2014 11:06:29,,1325165960,7/17/2014 11:06:07,instagc,0.6656,23149109,USA,NC,Durham,75.189.206.205,MUCOUS AND CUTANEOUS INVOLVEMENT is location of DPA INDUCED CICATRICIAL PEMPHIGOID,63,0,,94,34,is location of,0.384110639798688,901974-FS1-9,DPA INDUCED CICATRICIAL PEMPHIGOID is a severe disease of both MUCOUS AND CUTANEOUS INVOLVEMENT with a prognosis similar to the spontaneous disease.,MUCOUS AND CUTANEOUS INVOLVEMENT,DPA INDUCED CICATRICIAL PEMPHIGOID,RO-disease_has_finding
504169910,7/17/2014 11:19:13,,1325176379,7/17/2014 11:18:57,prodege,0.6456,15439740,AUS,02,Jannali,27.96.208.89,no_relation,63,0,,94,34,is location of,0.384110639798688,901974-FS1-9,DPA INDUCED CICATRICIAL PEMPHIGOID is a severe disease of both MUCOUS AND CUTANEOUS INVOLVEMENT with a prognosis similar to the spontaneous disease.,MUCOUS AND CUTANEOUS INVOLVEMENT,DPA INDUCED CICATRICIAL PEMPHIGOID,RO-disease_has_finding
504169910,7/17/2014 11:21:21,,1325177923,7/17/2014 11:20:34,prodege,0.5754,27934334,GBR,,,86.130.153.15,no_relation,63,0,,94,34,is location of,0.384110639798688,901974-FS1-9,DPA INDUCED CICATRICIAL PEMPHIGOID is a severe disease of both MUCOUS AND CUTANEOUS INVOLVEMENT with a prognosis similar to the spontaneous disease.,MUCOUS AND CUTANEOUS INVOLVEMENT,DPA INDUCED CICATRICIAL PEMPHIGOID,RO-disease_has_finding
504169912,7/17/2014 11:07:07,,1325166398,7/17/2014 11:06:45,instagc,0.6656,23149109,USA,NC,Durham,75.189.206.205,SEVERE DYSPLASIA causes CARCINOMA IN SITU,165,78,,180,95,causes,0.50709255283711,901932-FS1-4,"Only two premalignant lesions showed absence of p16 expression, of which one (CARCINOMA IN SITU was hypermethylated at the p16(INK4a) promoter region and the other (SEVERE DYSPLASIA showed BMI 1 expression.",SEVERE DYSPLASIA,CARCINOMA IN SITU,RO-disease_has_finding
504169912,7/17/2014 12:11:47,,1325215796,7/17/2014 12:11:28,prodege,0.6851,24945126,GBR,F6,Romford,82.12.220.44,SEVERE DYSPLASIA causes CARCINOMA IN SITU,165,78,,180,95,causes,0.50709255283711,901932-FS1-4,"Only two premalignant lesions showed absence of p16 expression, of which one (CARCINOMA IN SITU was hypermethylated at the p16(INK4a) promoter region and the other (SEVERE DYSPLASIA showed BMI 1 expression.",SEVERE DYSPLASIA,CARCINOMA IN SITU,RO-disease_has_finding
504169912,7/17/2014 13:19:33,,1325271509,7/17/2014 13:18:45,clixsense,0.5029,6334612,USA,OH,Cleveland,108.225.254.58,no_relation,165,78,,180,95,causes,0.50709255283711,901932-FS1-4,"Only two premalignant lesions showed absence of p16 expression, of which one (CARCINOMA IN SITU was hypermethylated at the p16(INK4a) promoter region and the other (SEVERE DYSPLASIA showed BMI 1 expression.",SEVERE DYSPLASIA,CARCINOMA IN SITU,RO-disease_has_finding
504169912,7/17/2014 13:34:11,,1325287096,7/17/2014 13:33:50,prodege,0.5459,28039757,GBR,L8,Southport,109.155.158.54,no_relation,165,78,,180,95,causes,0.50709255283711,901932-FS1-4,"Only two premalignant lesions showed absence of p16 expression, of which one (CARCINOMA IN SITU was hypermethylated at the p16(INK4a) promoter region and the other (SEVERE DYSPLASIA showed BMI 1 expression.",SEVERE DYSPLASIA,CARCINOMA IN SITU,RO-disease_has_finding
504169912,7/17/2014 13:57:18,,1325307974,7/17/2014 13:56:59,clixsense,0.619,6579377,CAN,BC,Richmond,174.6.142.227,no_relation,165,78,,180,95,causes,0.50709255283711,901932-FS1-4,"Only two premalignant lesions showed absence of p16 expression, of which one (CARCINOMA IN SITU was hypermethylated at the p16(INK4a) promoter region and the other (SEVERE DYSPLASIA showed BMI 1 expression.",SEVERE DYSPLASIA,CARCINOMA IN SITU,RO-disease_has_finding
504169912,7/17/2014 14:03:20,,1325314066,7/17/2014 14:03:07,clixsense,0.6306,15189335,GBR,T5,Aberdeen,90.218.222.164,CARCINOMA IN SITU causes SEVERE DYSPLASIA,165,78,,180,95,causes,0.50709255283711,901932-FS1-4,"Only two premalignant lesions showed absence of p16 expression, of which one (CARCINOMA IN SITU was hypermethylated at the p16(INK4a) promoter region and the other (SEVERE DYSPLASIA showed BMI 1 expression.",SEVERE DYSPLASIA,CARCINOMA IN SITU,RO-disease_has_finding
504169912,7/17/2014 14:03:55,,1325314553,7/17/2014 14:03:32,neodev,0.4184,18339121,USA,SC,Sumter,173.93.188.194,CARCINOMA IN SITU causes SEVERE DYSPLASIA,165,78,,180,95,causes,0.50709255283711,901932-FS1-4,"Only two premalignant lesions showed absence of p16 expression, of which one (CARCINOMA IN SITU was hypermethylated at the p16(INK4a) promoter region and the other (SEVERE DYSPLASIA showed BMI 1 expression.",SEVERE DYSPLASIA,CARCINOMA IN SITU,RO-disease_has_finding
504169918,7/17/2014 11:08:27,,1325167603,7/17/2014 11:08:16,instagc,0.6656,23149109,USA,NC,Durham,75.189.206.205,GLUCAGON treats HYPOGLYCEMIA,55,100,,66,108,treats,1.0,907911-FS1-2,"For patients who are unconscious or unable to swallow, HYPOGLYCEMIA can be treated immediately with GLUCAGON 1 mg sc or IM or a 50% dextrose solution 50 mL IV (25 g), followed, if necessary, by IV infusion of a 5 or 10% dextrose solution to maintain adequate plasma glucose levels.",HYPOGLYCEMIA,GLUCAGON,RO-may_treat
504169918,7/17/2014 11:56:16,,1325204369,7/17/2014 11:55:52,tremorgames,0.5999,24449707,CAN,QC,Laval,96.21.249.72,GLUCAGON treats HYPOGLYCEMIA,55,100,,66,108,treats,1.0,907911-FS1-2,"For patients who are unconscious or unable to swallow, HYPOGLYCEMIA can be treated immediately with GLUCAGON 1 mg sc or IM or a 50% dextrose solution 50 mL IV (25 g), followed, if necessary, by IV infusion of a 5 or 10% dextrose solution to maintain adequate plasma glucose levels.",HYPOGLYCEMIA,GLUCAGON,RO-may_treat
504169918,7/17/2014 12:12:41,,1325216446,7/17/2014 12:11:48,prodege,0.6851,24945126,GBR,F6,Romford,82.12.220.44,GLUCAGON treats HYPOGLYCEMIA,55,100,,66,108,treats,1.0,907911-FS1-2,"For patients who are unconscious or unable to swallow, HYPOGLYCEMIA can be treated immediately with GLUCAGON 1 mg sc or IM or a 50% dextrose solution 50 mL IV (25 g), followed, if necessary, by IV infusion of a 5 or 10% dextrose solution to maintain adequate plasma glucose levels.",HYPOGLYCEMIA,GLUCAGON,RO-may_treat
504169918,7/17/2014 12:54:42,,1325250383,7/17/2014 12:54:32,clixsense,0.7115,16827630,GBR,A7,Birmingham,86.146.169.103,GLUCAGON treats HYPOGLYCEMIA,55,100,,66,108,treats,1.0,907911-FS1-2,"For patients who are unconscious or unable to swallow, HYPOGLYCEMIA can be treated immediately with GLUCAGON 1 mg sc or IM or a 50% dextrose solution 50 mL IV (25 g), followed, if necessary, by IV infusion of a 5 or 10% dextrose solution to maintain adequate plasma glucose levels.",HYPOGLYCEMIA,GLUCAGON,RO-may_treat
504169918,7/17/2014 13:08:55,,1325262448,7/17/2014 13:08:39,neodev,0.6065,21515166,NLD,11,Nootdorp,83.86.58.179,GLUCAGON treats HYPOGLYCEMIA,55,100,,66,108,treats,1.0,907911-FS1-2,"For patients who are unconscious or unable to swallow, HYPOGLYCEMIA can be treated immediately with GLUCAGON 1 mg sc or IM or a 50% dextrose solution 50 mL IV (25 g), followed, if necessary, by IV infusion of a 5 or 10% dextrose solution to maintain adequate plasma glucose levels.",HYPOGLYCEMIA,GLUCAGON,RO-may_treat
504169918,7/17/2014 13:32:39,,1325285694,7/17/2014 13:32:18,prodege,0.5459,28039757,GBR,L8,Southport,109.155.158.54,GLUCAGON treats HYPOGLYCEMIA,55,100,,66,108,treats,1.0,907911-FS1-2,"For patients who are unconscious or unable to swallow, HYPOGLYCEMIA can be treated immediately with GLUCAGON 1 mg sc or IM or a 50% dextrose solution 50 mL IV (25 g), followed, if necessary, by IV infusion of a 5 or 10% dextrose solution to maintain adequate plasma glucose levels.",HYPOGLYCEMIA,GLUCAGON,RO-may_treat
504169918,7/17/2014 13:53:59,,1325305064,7/17/2014 13:53:28,clixsense,0.619,6579377,CAN,BC,Richmond,174.6.142.227,GLUCAGON treats HYPOGLYCEMIA,55,100,,66,108,treats,1.0,907911-FS1-2,"For patients who are unconscious or unable to swallow, HYPOGLYCEMIA can be treated immediately with GLUCAGON 1 mg sc or IM or a 50% dextrose solution 50 mL IV (25 g), followed, if necessary, by IV infusion of a 5 or 10% dextrose solution to maintain adequate plasma glucose levels.",HYPOGLYCEMIA,GLUCAGON,RO-may_treat
504169923,7/17/2014 10:30:17,,1325138161,7/17/2014 10:29:57,instagc,0.8444,24252915,GBR,B7,Bristol,77.98.139.82,no_relation,227,142,,234,167,causes,0.412081691846067,904552-FS1-4,"Mutations in the X linked cyclin dependent kinase like 5 (CDKL5) gene have been identified in patients with Rett syndrome, West syndrome, and X LINKED INFANTILE SPASMS sharing the common features of generally intractable early SEIZURES and mental retardation.",SEIZURES,X LINKED INFANTILE SPASMS,RO-has_definitional_manifestation
504169923,7/17/2014 10:31:36,,1325139325,7/17/2014 10:31:32,clixsense,0.8667,19162475,GBR,M3,Frome,82.33.126.30,X LINKED INFANTILE SPASMS causes SEIZURES,227,142,,234,167,causes,0.412081691846067,904552-FS1-4,"Mutations in the X linked cyclin dependent kinase like 5 (CDKL5) gene have been identified in patients with Rett syndrome, West syndrome, and X LINKED INFANTILE SPASMS sharing the common features of generally intractable early SEIZURES and mental retardation.",SEIZURES,X LINKED INFANTILE SPASMS,RO-has_definitional_manifestation
504169923,7/17/2014 11:50:06,,1325200223,7/17/2014 11:49:42,instagc,0.6489,13763729,USA,,,75.182.89.225,no_relation,227,142,,234,167,causes,0.412081691846067,904552-FS1-4,"Mutations in the X linked cyclin dependent kinase like 5 (CDKL5) gene have been identified in patients with Rett syndrome, West syndrome, and X LINKED INFANTILE SPASMS sharing the common features of generally intractable early SEIZURES and mental retardation.",SEIZURES,X LINKED INFANTILE SPASMS,RO-has_definitional_manifestation
504169923,7/17/2014 11:59:25,,1325206567,7/17/2014 11:59:06,tremorgames,0.5999,24449707,CAN,QC,Laval,96.21.249.72,X LINKED INFANTILE SPASMS causes SEIZURES,227,142,,234,167,causes,0.412081691846067,904552-FS1-4,"Mutations in the X linked cyclin dependent kinase like 5 (CDKL5) gene have been identified in patients with Rett syndrome, West syndrome, and X LINKED INFANTILE SPASMS sharing the common features of generally intractable early SEIZURES and mental retardation.",SEIZURES,X LINKED INFANTILE SPASMS,RO-has_definitional_manifestation
504169923,7/17/2014 13:07:07,,1325261127,7/17/2014 13:06:33,neodev,0.6065,21515166,NLD,11,Nootdorp,83.86.58.179,X LINKED INFANTILE SPASMS causes SEIZURES,227,142,,234,167,causes,0.412081691846067,904552-FS1-4,"Mutations in the X linked cyclin dependent kinase like 5 (CDKL5) gene have been identified in patients with Rett syndrome, West syndrome, and X LINKED INFANTILE SPASMS sharing the common features of generally intractable early SEIZURES and mental retardation.",SEIZURES,X LINKED INFANTILE SPASMS,RO-has_definitional_manifestation
504169923,7/17/2014 13:24:21,,1325275663,7/17/2014 13:24:00,clixsense,0.5029,6334612,USA,OH,Cleveland,108.225.254.58,no_relation,227,142,,234,167,causes,0.412081691846067,904552-FS1-4,"Mutations in the X linked cyclin dependent kinase like 5 (CDKL5) gene have been identified in patients with Rett syndrome, West syndrome, and X LINKED INFANTILE SPASMS sharing the common features of generally intractable early SEIZURES and mental retardation.",SEIZURES,X LINKED INFANTILE SPASMS,RO-has_definitional_manifestation
504169923,7/17/2014 13:34:11,,1325287107,7/17/2014 13:33:50,prodege,0.5459,28039757,GBR,L8,Southport,109.155.158.54,no_relation,227,142,,234,167,causes,0.412081691846067,904552-FS1-4,"Mutations in the X linked cyclin dependent kinase like 5 (CDKL5) gene have been identified in patients with Rett syndrome, West syndrome, and X LINKED INFANTILE SPASMS sharing the common features of generally intractable early SEIZURES and mental retardation.",SEIZURES,X LINKED INFANTILE SPASMS,RO-has_definitional_manifestation
504169926,7/17/2014 10:32:16,,1325139883,7/17/2014 10:32:11,clixsense,0.8667,19162475,GBR,M3,Frome,82.33.126.30,BRONCHIECTASIS diagnosed by SEGMENTAL BRONCHI,11,94,,27,108,diagnosed by,0.620173672946042,905364-FS1-13,"Of the 101 SEGMENTAL BRONCHI showing bronchiectasis on bronchography, CT correctly identified BRONCHIECTASIS in 98 segments (97%.",SEGMENTAL BRONCHI,BRONCHIECTASIS,RO-has_finding_site
504169926,7/17/2014 10:34:03,,1325141416,7/17/2014 10:33:57,clixsense,0.8111,27793793,GBR,C5,Chester,151.230.27.155,no_relation,11,94,,27,108,diagnosed by,0.620173672946042,905364-FS1-13,"Of the 101 SEGMENTAL BRONCHI showing bronchiectasis on bronchography, CT correctly identified BRONCHIECTASIS in 98 segments (97%.",SEGMENTAL BRONCHI,BRONCHIECTASIS,RO-has_finding_site
504169926,7/17/2014 10:38:56,,1325145156,7/17/2014 10:38:37,prodege,0.7444,9525153,CAN,ON,Toronto,65.95.92.180,BRONCHIECTASIS diagnosed by SEGMENTAL BRONCHI,11,94,,27,108,diagnosed by,0.620173672946042,905364-FS1-13,"Of the 101 SEGMENTAL BRONCHI showing bronchiectasis on bronchography, CT correctly identified BRONCHIECTASIS in 98 segments (97%.",SEGMENTAL BRONCHI,BRONCHIECTASIS,RO-has_finding_site
504169926,7/17/2014 11:33:03,,1325187181,7/17/2014 11:32:18,vivatic,0.5949,25451531,GBR,,,83.67.28.193,no_relation,11,94,,27,108,diagnosed by,0.620173672946042,905364-FS1-13,"Of the 101 SEGMENTAL BRONCHI showing bronchiectasis on bronchography, CT correctly identified BRONCHIECTASIS in 98 segments (97%.",SEGMENTAL BRONCHI,BRONCHIECTASIS,RO-has_finding_site
504169926,7/17/2014 11:35:48,,1325189824,7/17/2014 11:35:17,fusioncash,0.6519,7012325,USA,CT,Stamford,24.185.182.15,BRONCHIECTASIS diagnosed by SEGMENTAL BRONCHI,11,94,,27,108,diagnosed by,0.620173672946042,905364-FS1-13,"Of the 101 SEGMENTAL BRONCHI showing bronchiectasis on bronchography, CT correctly identified BRONCHIECTASIS in 98 segments (97%.",SEGMENTAL BRONCHI,BRONCHIECTASIS,RO-has_finding_site
504169926,7/17/2014 11:51:29,,1325201136,7/17/2014 11:50:59,instagc,0.6489,13763729,USA,,,75.182.89.225,no_relation,11,94,,27,108,diagnosed by,0.620173672946042,905364-FS1-13,"Of the 101 SEGMENTAL BRONCHI showing bronchiectasis on bronchography, CT correctly identified BRONCHIECTASIS in 98 segments (97%.",SEGMENTAL BRONCHI,BRONCHIECTASIS,RO-has_finding_site
504169926,7/17/2014 13:06:32,,1325260674,7/17/2014 13:06:04,neodev,0.6065,21515166,NLD,11,Nootdorp,83.86.58.179,BRONCHIECTASIS diagnosed by SEGMENTAL BRONCHI,11,94,,27,108,diagnosed by,0.620173672946042,905364-FS1-13,"Of the 101 SEGMENTAL BRONCHI showing bronchiectasis on bronchography, CT correctly identified BRONCHIECTASIS in 98 segments (97%.",SEGMENTAL BRONCHI,BRONCHIECTASIS,RO-has_finding_site
504169928,7/17/2014 10:32:35,,1325140109,7/17/2014 10:32:30,clixsense,0.8667,19162475,GBR,M3,Frome,82.33.126.30,CHRONIC LYMPHOCYTIC LEUKAEMIA causes INGUINO CRURAL TENDER LYMPHADENOPATHY WITH PERIADENITIS,109,60,,163,89,causes,0.9830783046228491,902791-FS1-4,We report a case of a 68 years old male patient treated for CHRONIC LYMPHOCYTIC LEUKAEMIA presenting a right INGUINO CRURAL TENDER LYMPHADENOPATHY WITH PERIADENITIS.,INGUINO CRURAL TENDER LYMPHADENOPATHY WITH PERIADENITIS,CHRONIC LYMPHOCYTIC LEUKAEMIA,RO-disease_may_have_finding
504169928,7/17/2014 10:43:56,,1325149102,7/17/2014 10:43:41,clixsense,0.8083,19803139,NLD,06,Veldhoven,212.61.84.196,no_relation,109,60,,163,89,causes,0.9830783046228491,902791-FS1-4,We report a case of a 68 years old male patient treated for CHRONIC LYMPHOCYTIC LEUKAEMIA presenting a right INGUINO CRURAL TENDER LYMPHADENOPATHY WITH PERIADENITIS.,INGUINO CRURAL TENDER LYMPHADENOPATHY WITH PERIADENITIS,CHRONIC LYMPHOCYTIC LEUKAEMIA,RO-disease_may_have_finding
504169928,7/17/2014 11:09:32,,1325168395,7/17/2014 11:09:25,instagc,0.6656,23149109,USA,NC,Durham,75.189.206.205,CHRONIC LYMPHOCYTIC LEUKAEMIA causes INGUINO CRURAL TENDER LYMPHADENOPATHY WITH PERIADENITIS,109,60,,163,89,causes,0.9830783046228491,902791-FS1-4,We report a case of a 68 years old male patient treated for CHRONIC LYMPHOCYTIC LEUKAEMIA presenting a right INGUINO CRURAL TENDER LYMPHADENOPATHY WITH PERIADENITIS.,INGUINO CRURAL TENDER LYMPHADENOPATHY WITH PERIADENITIS,CHRONIC LYMPHOCYTIC LEUKAEMIA,RO-disease_may_have_finding
504169928,7/17/2014 11:28:11,,1325182691,7/17/2014 11:27:24,vivatic,0.5949,25451531,GBR,,,83.67.28.193,INGUINO CRURAL TENDER LYMPHADENOPATHY WITH PERIADENITIS causes CHRONIC LYMPHOCYTIC LEUKAEMIA,109,60,,163,89,causes,0.9830783046228491,902791-FS1-4,We report a case of a 68 years old male patient treated for CHRONIC LYMPHOCYTIC LEUKAEMIA presenting a right INGUINO CRURAL TENDER LYMPHADENOPATHY WITH PERIADENITIS.,INGUINO CRURAL TENDER LYMPHADENOPATHY WITH PERIADENITIS,CHRONIC LYMPHOCYTIC LEUKAEMIA,RO-disease_may_have_finding
504169928,7/17/2014 11:46:43,,1325197732,7/17/2014 11:46:11,instagc,0.6489,13763729,USA,,,75.182.89.225,no_relation,109,60,,163,89,causes,0.9830783046228491,902791-FS1-4,We report a case of a 68 years old male patient treated for CHRONIC LYMPHOCYTIC LEUKAEMIA presenting a right INGUINO CRURAL TENDER LYMPHADENOPATHY WITH PERIADENITIS.,INGUINO CRURAL TENDER LYMPHADENOPATHY WITH PERIADENITIS,CHRONIC LYMPHOCYTIC LEUKAEMIA,RO-disease_may_have_finding
504169928,7/17/2014 12:55:44,,1325251224,7/17/2014 12:55:17,clixsense,0.7115,16827630,GBR,A7,Birmingham,86.146.169.103,CHRONIC LYMPHOCYTIC LEUKAEMIA causes INGUINO CRURAL TENDER LYMPHADENOPATHY WITH PERIADENITIS,109,60,,163,89,causes,0.9830783046228491,902791-FS1-4,We report a case of a 68 years old male patient treated for CHRONIC LYMPHOCYTIC LEUKAEMIA presenting a right INGUINO CRURAL TENDER LYMPHADENOPATHY WITH PERIADENITIS.,INGUINO CRURAL TENDER LYMPHADENOPATHY WITH PERIADENITIS,CHRONIC LYMPHOCYTIC LEUKAEMIA,RO-disease_may_have_finding
504169928,7/17/2014 13:21:26,,1325273163,7/17/2014 13:20:57,prodege,0.6851,24945126,GBR,F6,Romford,82.12.220.44,no_relation,109,60,,163,89,causes,0.9830783046228491,902791-FS1-4,We report a case of a 68 years old male patient treated for CHRONIC LYMPHOCYTIC LEUKAEMIA presenting a right INGUINO CRURAL TENDER LYMPHADENOPATHY WITH PERIADENITIS.,INGUINO CRURAL TENDER LYMPHADENOPATHY WITH PERIADENITIS,CHRONIC LYMPHOCYTIC LEUKAEMIA,RO-disease_may_have_finding
504169938,7/17/2014 10:34:55,,1325142126,7/17/2014 10:34:47,clixsense,0.8111,27793793,GBR,C5,Chester,151.230.27.155,no_relation,0,80,,18,90,causes,0.31622776601683805,908309-FS1-4,"SALMONELLA ISOLATES were found to be susceptible to chloramphenicol, kanamycin, AMPICILLIN and tetracycline.",SALMONELLA ISOLATES,AMPICILLIN,RO-may_treat
504169938,7/17/2014 10:43:17,,1325148609,7/17/2014 10:42:53,prodege,0.7444,9525153,CAN,ON,Toronto,65.95.92.180,SALMONELLA ISOLATES causes AMPICILLIN,0,80,,18,90,causes,0.31622776601683805,908309-FS1-4,"SALMONELLA ISOLATES were found to be susceptible to chloramphenicol, kanamycin, AMPICILLIN and tetracycline.",SALMONELLA ISOLATES,AMPICILLIN,RO-may_treat
504169938,7/17/2014 11:15:07,,1325173120,7/17/2014 11:14:52,prodege,0.6456,15439740,AUS,02,Jannali,27.96.208.89,no_relation,0,80,,18,90,causes,0.31622776601683805,908309-FS1-4,"SALMONELLA ISOLATES were found to be susceptible to chloramphenicol, kanamycin, AMPICILLIN and tetracycline.",SALMONELLA ISOLATES,AMPICILLIN,RO-may_treat
504169938,7/17/2014 11:22:28,,1325178760,7/17/2014 11:22:05,prodege,0.5754,27934334,GBR,,,86.130.153.15,no_relation,0,80,,18,90,causes,0.31622776601683805,908309-FS1-4,"SALMONELLA ISOLATES were found to be susceptible to chloramphenicol, kanamycin, AMPICILLIN and tetracycline.",SALMONELLA ISOLATES,AMPICILLIN,RO-may_treat
504169938,7/17/2014 11:51:29,,1325201137,7/17/2014 11:50:59,instagc,0.6489,13763729,USA,,,75.182.89.225,no_relation,0,80,,18,90,causes,0.31622776601683805,908309-FS1-4,"SALMONELLA ISOLATES were found to be susceptible to chloramphenicol, kanamycin, AMPICILLIN and tetracycline.",SALMONELLA ISOLATES,AMPICILLIN,RO-may_treat
504169938,7/17/2014 11:59:05,,1325206377,7/17/2014 11:58:53,tremorgames,0.5999,24449707,CAN,QC,Laval,96.21.249.72,AMPICILLIN causes SALMONELLA ISOLATES,0,80,,18,90,causes,0.31622776601683805,908309-FS1-4,"SALMONELLA ISOLATES were found to be susceptible to chloramphenicol, kanamycin, AMPICILLIN and tetracycline.",SALMONELLA ISOLATES,AMPICILLIN,RO-may_treat
504169938,7/17/2014 12:56:40,,1325251893,7/17/2014 12:56:11,clixsense,0.7115,16827630,GBR,A7,Birmingham,86.146.169.103,no_relation,0,80,,18,90,causes,0.31622776601683805,908309-FS1-4,"SALMONELLA ISOLATES were found to be susceptible to chloramphenicol, kanamycin, AMPICILLIN and tetracycline.",SALMONELLA ISOLATES,AMPICILLIN,RO-may_treat
504169945,7/17/2014 11:15:45,,1325173680,7/17/2014 11:15:29,prodege,0.6456,15439740,AUS,02,Jannali,27.96.208.89,no_relation,82,131,,96,134,treats,0.905821627315676,902686-FS1-2,"? In patients with rapidly advancing disease characterized by B symptoms, massive LYMPHADENOPATHY and hepatosplenomegaly, consider CLL transformation (see  disease specific drug treatment in patients with transformed CLL.",LYMPHADENOPATHY,CLL,RO-disease_may_have_finding
504169945,7/17/2014 11:29:48,,1325184040,7/17/2014 11:29:17,fusioncash,0.6519,7012325,USA,CT,Stamford,24.185.182.15,no_relation,82,131,,96,134,treats,0.905821627315676,902686-FS1-2,"? In patients with rapidly advancing disease characterized by B symptoms, massive LYMPHADENOPATHY and hepatosplenomegaly, consider CLL transformation (see  disease specific drug treatment in patients with transformed CLL.",LYMPHADENOPATHY,CLL,RO-disease_may_have_finding
504169945,7/17/2014 11:50:06,,1325200224,7/17/2014 11:49:42,instagc,0.6489,13763729,USA,,,75.182.89.225,CLL treats LYMPHADENOPATHY,82,131,,96,134,treats,0.905821627315676,902686-FS1-2,"? In patients with rapidly advancing disease characterized by B symptoms, massive LYMPHADENOPATHY and hepatosplenomegaly, consider CLL transformation (see  disease specific drug treatment in patients with transformed CLL.",LYMPHADENOPATHY,CLL,RO-disease_may_have_finding
504169945,7/17/2014 12:11:28,,1325215469,7/17/2014 12:11:08,elite,0.6437,28503042,USA,NJ,Woodbridge,54.191.150.115,CLL treats LYMPHADENOPATHY,82,131,,96,134,treats,0.905821627315676,902686-FS1-2,"? In patients with rapidly advancing disease characterized by B symptoms, massive LYMPHADENOPATHY and hepatosplenomegaly, consider CLL transformation (see  disease specific drug treatment in patients with transformed CLL.",LYMPHADENOPATHY,CLL,RO-disease_may_have_finding
504169945,7/17/2014 12:24:06,,1325225099,7/17/2014 12:23:17,prodege,0.7034,7664351,USA,NY,Cicero,74.111.0.21,no_relation,82,131,,96,134,treats,0.905821627315676,902686-FS1-2,"? In patients with rapidly advancing disease characterized by B symptoms, massive LYMPHADENOPATHY and hepatosplenomegaly, consider CLL transformation (see  disease specific drug treatment in patients with transformed CLL.",LYMPHADENOPATHY,CLL,RO-disease_may_have_finding
504169945,7/17/2014 12:56:10,,1325251547,7/17/2014 12:55:46,clixsense,0.7115,16827630,GBR,A7,Birmingham,86.146.169.103,CLL treats LYMPHADENOPATHY,82,131,,96,134,treats,0.905821627315676,902686-FS1-2,"? In patients with rapidly advancing disease characterized by B symptoms, massive LYMPHADENOPATHY and hepatosplenomegaly, consider CLL transformation (see  disease specific drug treatment in patients with transformed CLL.",LYMPHADENOPATHY,CLL,RO-disease_may_have_finding
504169945,7/17/2014 13:22:02,,1325273724,7/17/2014 13:21:27,prodege,0.6851,24945126,GBR,F6,Romford,82.12.220.44,no_relation,82,131,,96,134,treats,0.905821627315676,902686-FS1-2,"? In patients with rapidly advancing disease characterized by B symptoms, massive LYMPHADENOPATHY and hepatosplenomegaly, consider CLL transformation (see  disease specific drug treatment in patients with transformed CLL.",LYMPHADENOPATHY,CLL,RO-disease_may_have_finding
504169953,7/17/2014 10:31:01,,1325138758,7/17/2014 10:30:54,clixsense,0.8667,19162475,GBR,M3,Frome,82.33.126.30,CIRRHOSIS treats MILK THISTLE,182,157,,190,169,treats,0.790569415042095,907669-FS1-2,"Alternative Therapies for Hepatitis     Normal; Alternative Therapies for Hepatitis  Therapy Best Evidencea Probably Usefulb Least Evidencec         Herbals MILK THISTLE (hepatitis, CIRRHOSIS 70 140 mg t.i.d.",CIRRHOSIS,MILK THISTLE,RO-may_treat
504169953,7/17/2014 10:35:04,,1325142275,7/17/2014 10:34:57,clixsense,0.8111,27793793,GBR,C5,Chester,151.230.27.155,MILK THISTLE treats CIRRHOSIS,182,157,,190,169,treats,0.790569415042095,907669-FS1-2,"Alternative Therapies for Hepatitis     Normal; Alternative Therapies for Hepatitis  Therapy Best Evidencea Probably Usefulb Least Evidencec         Herbals MILK THISTLE (hepatitis, CIRRHOSIS 70 140 mg t.i.d.",CIRRHOSIS,MILK THISTLE,RO-may_treat
504169953,7/17/2014 11:07:31,,1325166767,7/17/2014 11:06:38,clixsense,0.6811,28324391,NLD,11,Hazerswoude-rijndijk,94.208.82.215,no_relation,182,157,,190,169,treats,0.790569415042095,907669-FS1-2,"Alternative Therapies for Hepatitis     Normal; Alternative Therapies for Hepatitis  Therapy Best Evidencea Probably Usefulb Least Evidencec         Herbals MILK THISTLE (hepatitis, CIRRHOSIS 70 140 mg t.i.d.",CIRRHOSIS,MILK THISTLE,RO-may_treat
504169953,7/17/2014 11:14:51,,1325172935,7/17/2014 11:14:34,prodege,0.6456,15439740,AUS,02,Jannali,27.96.208.89,no_relation,182,157,,190,169,treats,0.790569415042095,907669-FS1-2,"Alternative Therapies for Hepatitis     Normal; Alternative Therapies for Hepatitis  Therapy Best Evidencea Probably Usefulb Least Evidencec         Herbals MILK THISTLE (hepatitis, CIRRHOSIS 70 140 mg t.i.d.",CIRRHOSIS,MILK THISTLE,RO-may_treat
504169953,7/17/2014 11:28:32,,1325182934,7/17/2014 11:27:40,prodege,0.5754,27934334,GBR,,,86.130.153.15,no_relation,182,157,,190,169,treats,0.790569415042095,907669-FS1-2,"Alternative Therapies for Hepatitis     Normal; Alternative Therapies for Hepatitis  Therapy Best Evidencea Probably Usefulb Least Evidencec         Herbals MILK THISTLE (hepatitis, CIRRHOSIS 70 140 mg t.i.d.",CIRRHOSIS,MILK THISTLE,RO-may_treat
504169953,7/17/2014 11:29:31,,1325183751,7/17/2014 11:29:16,gifthulk,0.71,21916793,GBR,,,87.115.178.12,MILK THISTLE treats CIRRHOSIS,182,157,,190,169,treats,0.790569415042095,907669-FS1-2,"Alternative Therapies for Hepatitis     Normal; Alternative Therapies for Hepatitis  Therapy Best Evidencea Probably Usefulb Least Evidencec         Herbals MILK THISTLE (hepatitis, CIRRHOSIS 70 140 mg t.i.d.",CIRRHOSIS,MILK THISTLE,RO-may_treat
504169953,7/17/2014 13:36:51,,1325289201,7/17/2014 13:36:29,prodege,0.5459,28039757,GBR,L8,Southport,109.155.158.54,no_relation,182,157,,190,169,treats,0.790569415042095,907669-FS1-2,"Alternative Therapies for Hepatitis     Normal; Alternative Therapies for Hepatitis  Therapy Best Evidencea Probably Usefulb Least Evidencec         Herbals MILK THISTLE (hepatitis, CIRRHOSIS 70 140 mg t.i.d.",CIRRHOSIS,MILK THISTLE,RO-may_treat
504169964,7/17/2014 10:30:54,,1325138636,7/17/2014 10:30:45,clixsense,0.8667,19162475,GBR,M3,Frome,82.33.126.30,HEART is location of MYOCARDIAL ISCHAEMIA,143,108,,147,128,is location of,0.9830783046228491,905220-FS1-9,"Functional and structural alterations of myocardial mitochondria were investigated after four conditions of MYOCARDIAL ISCHAEMIA in guinea pig HEART: (1) 45 min complete ischaemia, (2) 60 min low flow anoxic perfusion (0.3 ml/g wet weight per minute) with a modified Tyrode solution, (3) as (2) with 0.4 mM palmitic acid added to the perfusate, and (4) as (2) with 0.4 mM oleic acid added.",HEART,MYOCARDIAL ISCHAEMIA,RO-has_finding_site
504169964,7/17/2014 10:41:38,,1325147308,7/17/2014 10:41:21,clixsense,0.8083,19803139,NLD,06,Veldhoven,212.61.84.196,HEART is location of MYOCARDIAL ISCHAEMIA,143,108,,147,128,is location of,0.9830783046228491,905220-FS1-9,"Functional and structural alterations of myocardial mitochondria were investigated after four conditions of MYOCARDIAL ISCHAEMIA in guinea pig HEART: (1) 45 min complete ischaemia, (2) 60 min low flow anoxic perfusion (0.3 ml/g wet weight per minute) with a modified Tyrode solution, (3) as (2) with 0.4 mM palmitic acid added to the perfusate, and (4) as (2) with 0.4 mM oleic acid added.",HEART,MYOCARDIAL ISCHAEMIA,RO-has_finding_site
504169964,7/17/2014 12:08:34,,1325213079,7/17/2014 12:08:12,elite,0.6437,28503042,USA,NJ,Woodbridge,54.191.150.115,HEART is location of MYOCARDIAL ISCHAEMIA,143,108,,147,128,is location of,0.9830783046228491,905220-FS1-9,"Functional and structural alterations of myocardial mitochondria were investigated after four conditions of MYOCARDIAL ISCHAEMIA in guinea pig HEART: (1) 45 min complete ischaemia, (2) 60 min low flow anoxic perfusion (0.3 ml/g wet weight per minute) with a modified Tyrode solution, (3) as (2) with 0.4 mM palmitic acid added to the perfusate, and (4) as (2) with 0.4 mM oleic acid added.",HEART,MYOCARDIAL ISCHAEMIA,RO-has_finding_site
504169964,7/17/2014 12:25:47,,1325226424,7/17/2014 12:25:30,prodege,0.7034,7664351,USA,NY,Cicero,74.111.0.21,HEART is location of MYOCARDIAL ISCHAEMIA,143,108,,147,128,is location of,0.9830783046228491,905220-FS1-9,"Functional and structural alterations of myocardial mitochondria were investigated after four conditions of MYOCARDIAL ISCHAEMIA in guinea pig HEART: (1) 45 min complete ischaemia, (2) 60 min low flow anoxic perfusion (0.3 ml/g wet weight per minute) with a modified Tyrode solution, (3) as (2) with 0.4 mM palmitic acid added to the perfusate, and (4) as (2) with 0.4 mM oleic acid added.",HEART,MYOCARDIAL ISCHAEMIA,RO-has_finding_site
504169964,7/17/2014 12:56:57,,1325252090,7/17/2014 12:56:50,clixsense,0.7115,16827630,GBR,A7,Birmingham,86.146.169.103,HEART is location of MYOCARDIAL ISCHAEMIA,143,108,,147,128,is location of,0.9830783046228491,905220-FS1-9,"Functional and structural alterations of myocardial mitochondria were investigated after four conditions of MYOCARDIAL ISCHAEMIA in guinea pig HEART: (1) 45 min complete ischaemia, (2) 60 min low flow anoxic perfusion (0.3 ml/g wet weight per minute) with a modified Tyrode solution, (3) as (2) with 0.4 mM palmitic acid added to the perfusate, and (4) as (2) with 0.4 mM oleic acid added.",HEART,MYOCARDIAL ISCHAEMIA,RO-has_finding_site
504169964,7/17/2014 13:15:34,,1325268052,7/17/2014 13:14:39,clixsense,0.5029,6334612,USA,OH,Cleveland,108.225.254.58,no_relation,143,108,,147,128,is location of,0.9830783046228491,905220-FS1-9,"Functional and structural alterations of myocardial mitochondria were investigated after four conditions of MYOCARDIAL ISCHAEMIA in guinea pig HEART: (1) 45 min complete ischaemia, (2) 60 min low flow anoxic perfusion (0.3 ml/g wet weight per minute) with a modified Tyrode solution, (3) as (2) with 0.4 mM palmitic acid added to the perfusate, and (4) as (2) with 0.4 mM oleic acid added.",HEART,MYOCARDIAL ISCHAEMIA,RO-has_finding_site
504169964,7/17/2014 13:35:53,,1325288382,7/17/2014 13:35:34,prodege,0.5459,28039757,GBR,L8,Southport,109.155.158.54,HEART is location of MYOCARDIAL ISCHAEMIA,143,108,,147,128,is location of,0.9830783046228491,905220-FS1-9,"Functional and structural alterations of myocardial mitochondria were investigated after four conditions of MYOCARDIAL ISCHAEMIA in guinea pig HEART: (1) 45 min complete ischaemia, (2) 60 min low flow anoxic perfusion (0.3 ml/g wet weight per minute) with a modified Tyrode solution, (3) as (2) with 0.4 mM palmitic acid added to the perfusate, and (4) as (2) with 0.4 mM oleic acid added.",HEART,MYOCARDIAL ISCHAEMIA,RO-has_finding_site
504169965,7/17/2014 11:03:42,,1325164026,7/17/2014 11:03:09,clixsense,0.6811,28324391,NLD,11,Hazerswoude-rijndijk,94.208.82.215,HASHIMOTO'S THYROIDITIS is location of THYROID,28,16,,34,39,is location of,0.939793423488437,902140-FS1-9,Pathogenesis of HASHIMOTO'S THYROIDITIS is largely cell mediated immune destruction of the THYROID,THYROID,HASHIMOTO'S THYROIDITIS,RO-disease_has_primary_anatomic_site
504169965,7/17/2014 11:25:10,,1325180626,7/17/2014 11:24:43,prodege,0.5754,27934334,GBR,,,86.130.153.15,THYROID is location of HASHIMOTO'S THYROIDITIS,28,16,,34,39,is location of,0.939793423488437,902140-FS1-9,Pathogenesis of HASHIMOTO'S THYROIDITIS is largely cell mediated immune destruction of the THYROID,THYROID,HASHIMOTO'S THYROIDITIS,RO-disease_has_primary_anatomic_site
504169965,7/17/2014 11:30:48,,1325184868,7/17/2014 11:30:33,gifthulk,0.71,21916793,GBR,,,87.115.178.12,THYROID is location of HASHIMOTO'S THYROIDITIS,28,16,,34,39,is location of,0.939793423488437,902140-FS1-9,Pathogenesis of HASHIMOTO'S THYROIDITIS is largely cell mediated immune destruction of the THYROID,THYROID,HASHIMOTO'S THYROIDITIS,RO-disease_has_primary_anatomic_site
504169965,7/17/2014 11:56:37,,1325204543,7/17/2014 11:56:17,tremorgames,0.5999,24449707,CAN,QC,Laval,96.21.249.72,THYROID is location of HASHIMOTO'S THYROIDITIS,28,16,,34,39,is location of,0.939793423488437,902140-FS1-9,Pathogenesis of HASHIMOTO'S THYROIDITIS is largely cell mediated immune destruction of the THYROID,THYROID,HASHIMOTO'S THYROIDITIS,RO-disease_has_primary_anatomic_site
504169965,7/17/2014 13:03:54,,1325258327,7/17/2014 13:03:31,neodev,0.6065,21515166,NLD,11,Nootdorp,83.86.58.179,THYROID is location of HASHIMOTO'S THYROIDITIS,28,16,,34,39,is location of,0.939793423488437,902140-FS1-9,Pathogenesis of HASHIMOTO'S THYROIDITIS is largely cell mediated immune destruction of the THYROID,THYROID,HASHIMOTO'S THYROIDITIS,RO-disease_has_primary_anatomic_site
504169965,7/17/2014 13:22:28,,1325274080,7/17/2014 13:22:03,prodege,0.6851,24945126,GBR,F6,Romford,82.12.220.44,THYROID is location of HASHIMOTO'S THYROIDITIS,28,16,,34,39,is location of,0.939793423488437,902140-FS1-9,Pathogenesis of HASHIMOTO'S THYROIDITIS is largely cell mediated immune destruction of the THYROID,THYROID,HASHIMOTO'S THYROIDITIS,RO-disease_has_primary_anatomic_site
504169965,7/17/2014 13:54:54,,1325305731,7/17/2014 13:54:32,clixsense,0.619,6579377,CAN,BC,Richmond,174.6.142.227,no_relation,28,16,,34,39,is location of,0.939793423488437,902140-FS1-9,Pathogenesis of HASHIMOTO'S THYROIDITIS is largely cell mediated immune destruction of the THYROID,THYROID,HASHIMOTO'S THYROIDITIS,RO-disease_has_primary_anatomic_site
504170009,7/17/2014 10:27:05,,1325135436,7/17/2014 10:26:45,instagc,0.9583,24252915,GBR,B7,Bristol,77.98.139.82,THALIDOMIDE treats REFRACTORY MYELOMA,41,0,,58,11,treats,0.9701425001453321,908083-FS1-2,THALIDOMIDE was used in 73 patients with REFRACTORY MYELOMA in 15 of 45 institutes participating in the Japan Myeloma Study Group.,REFRACTORY MYELOMA,THALIDOMIDE,RO-may_treat
504170009,7/17/2014 10:38:54,,1325145118,7/17/2014 10:38:36,clixsense,0.8958,19803139,NLD,06,Veldhoven,212.61.84.196,THALIDOMIDE treats REFRACTORY MYELOMA,41,0,,58,11,treats,0.9701425001453321,908083-FS1-2,THALIDOMIDE was used in 73 patients with REFRACTORY MYELOMA in 15 of 45 institutes participating in the Japan Myeloma Study Group.,REFRACTORY MYELOMA,THALIDOMIDE,RO-may_treat
504170009,7/17/2014 10:45:38,,1325150449,7/17/2014 10:45:25,prodege,0.8333,9525153,CAN,ON,Toronto,65.95.92.180,THALIDOMIDE treats REFRACTORY MYELOMA,41,0,,58,11,treats,0.9701425001453321,908083-FS1-2,THALIDOMIDE was used in 73 patients with REFRACTORY MYELOMA in 15 of 45 institutes participating in the Japan Myeloma Study Group.,REFRACTORY MYELOMA,THALIDOMIDE,RO-may_treat
504170009,7/17/2014 11:22:30,,1325178805,7/17/2014 11:22:16,prodege,0.6181,15439740,AUS,02,Jannali,27.96.208.89,THALIDOMIDE treats REFRACTORY MYELOMA,41,0,,58,11,treats,0.9701425001453321,908083-FS1-2,THALIDOMIDE was used in 73 patients with REFRACTORY MYELOMA in 15 of 45 institutes participating in the Japan Myeloma Study Group.,REFRACTORY MYELOMA,THALIDOMIDE,RO-may_treat
504170009,7/17/2014 11:26:16,,1325181369,7/17/2014 11:25:40,fusioncash,0.5583,7012325,USA,CT,Stamford,24.185.182.15,THALIDOMIDE treats REFRACTORY MYELOMA,41,0,,58,11,treats,0.9701425001453321,908083-FS1-2,THALIDOMIDE was used in 73 patients with REFRACTORY MYELOMA in 15 of 45 institutes participating in the Japan Myeloma Study Group.,REFRACTORY MYELOMA,THALIDOMIDE,RO-may_treat
504170009,7/17/2014 11:51:57,,1325201409,7/17/2014 11:51:40,gifthulk,0.8375,21916793,GBR,,,87.115.178.12,THALIDOMIDE treats REFRACTORY MYELOMA,41,0,,58,11,treats,0.9701425001453321,908083-FS1-2,THALIDOMIDE was used in 73 patients with REFRACTORY MYELOMA in 15 of 45 institutes participating in the Japan Myeloma Study Group.,REFRACTORY MYELOMA,THALIDOMIDE,RO-may_treat
504170009,7/17/2014 13:25:49,,1325277088,7/17/2014 13:25:16,prodege,0.6909,24945126,GBR,F6,Romford,82.12.220.44,THALIDOMIDE treats REFRACTORY MYELOMA,41,0,,58,11,treats,0.9701425001453321,908083-FS1-2,THALIDOMIDE was used in 73 patients with REFRACTORY MYELOMA in 15 of 45 institutes participating in the Japan Myeloma Study Group.,REFRACTORY MYELOMA,THALIDOMIDE,RO-may_treat
504170011,7/17/2014 10:39:46,,1325145871,7/17/2014 10:39:25,clixsense,0.8958,19803139,NLD,06,Veldhoven,212.61.84.196,PATELLO FEMORAL JOINT is location of ARTHROSIS OF THE KNEE,44,109,,64,130,is location of,0.9000703207408192,902308-FS1-9,The progressive radiological changes in the PATELLO FEMORAL JOINT after upper tibial osteotomy performed for ARTHROSIS OF THE KNEE were studied more than 10 years after the surgical procedure.,PATELLO FEMORAL JOINT,ARTHROSIS OF THE KNEE,RO-disease_has_primary_anatomic_site
504170011,7/17/2014 10:46:39,,1325151220,7/17/2014 10:46:14,prodege,0.8333,9525153,CAN,ON,Toronto,65.95.92.180,ARTHROSIS OF THE KNEE is location of PATELLO FEMORAL JOINT,44,109,,64,130,is location of,0.9000703207408192,902308-FS1-9,The progressive radiological changes in the PATELLO FEMORAL JOINT after upper tibial osteotomy performed for ARTHROSIS OF THE KNEE were studied more than 10 years after the surgical procedure.,PATELLO FEMORAL JOINT,ARTHROSIS OF THE KNEE,RO-disease_has_primary_anatomic_site
504170011,7/17/2014 11:26:16,,1325181371,7/17/2014 11:25:40,fusioncash,0.5583,7012325,USA,CT,Stamford,24.185.182.15,no_relation,44,109,,64,130,is location of,0.9000703207408192,902308-FS1-9,The progressive radiological changes in the PATELLO FEMORAL JOINT after upper tibial osteotomy performed for ARTHROSIS OF THE KNEE were studied more than 10 years after the surgical procedure.,PATELLO FEMORAL JOINT,ARTHROSIS OF THE KNEE,RO-disease_has_primary_anatomic_site
504170011,7/17/2014 12:15:27,,1325218494,7/17/2014 12:15:09,elite,0.6262,28503042,USA,NJ,Woodbridge,54.191.150.115,PATELLO FEMORAL JOINT is location of ARTHROSIS OF THE KNEE,44,109,,64,130,is location of,0.9000703207408192,902308-FS1-9,The progressive radiological changes in the PATELLO FEMORAL JOINT after upper tibial osteotomy performed for ARTHROSIS OF THE KNEE were studied more than 10 years after the surgical procedure.,PATELLO FEMORAL JOINT,ARTHROSIS OF THE KNEE,RO-disease_has_primary_anatomic_site
504170011,7/17/2014 13:23:50,,1325275237,7/17/2014 13:23:32,prodege,0.6909,24945126,GBR,F6,Romford,82.12.220.44,PATELLO FEMORAL JOINT is location of ARTHROSIS OF THE KNEE,44,109,,64,130,is location of,0.9000703207408192,902308-FS1-9,The progressive radiological changes in the PATELLO FEMORAL JOINT after upper tibial osteotomy performed for ARTHROSIS OF THE KNEE were studied more than 10 years after the surgical procedure.,PATELLO FEMORAL JOINT,ARTHROSIS OF THE KNEE,RO-disease_has_primary_anatomic_site
504170011,7/17/2014 14:32:24,,1325340353,7/17/2014 14:32:13,clixsense,0.4918,20614047,USA,MO,Maryville,174.32.162.147,no_relation,44,109,,64,130,is location of,0.9000703207408192,902308-FS1-9,The progressive radiological changes in the PATELLO FEMORAL JOINT after upper tibial osteotomy performed for ARTHROSIS OF THE KNEE were studied more than 10 years after the surgical procedure.,PATELLO FEMORAL JOINT,ARTHROSIS OF THE KNEE,RO-disease_has_primary_anatomic_site
504170011,7/17/2014 15:05:04,,1325369662,7/17/2014 15:04:41,elite,0.534,28276268,USA,MI,Taylor,67.149.247.166,PATELLO FEMORAL JOINT is location of ARTHROSIS OF THE KNEE,44,109,,64,130,is location of,0.9000703207408192,902308-FS1-9,The progressive radiological changes in the PATELLO FEMORAL JOINT after upper tibial osteotomy performed for ARTHROSIS OF THE KNEE were studied more than 10 years after the surgical procedure.,PATELLO FEMORAL JOINT,ARTHROSIS OF THE KNEE,RO-disease_has_primary_anatomic_site
504170018,7/17/2014 11:19:39,,1325176607,7/17/2014 11:19:08,prodege,0.6597,27934334,GBR,,,86.130.153.15,no_relation,98,131,,112,155,treats,0.439057039958762,902861-FS1-2,This case report draws the attention to the possibility of a conservative surgical treatment of a SPLENIC RUPTURE in the course of INFECTIOUS MONONUCLEOSIS,SPLENIC RUPTURE,INFECTIOUS MONONUCLEOSIS,RO-disease_may_have_finding
504170018,7/17/2014 11:23:15,,1325179292,7/17/2014 11:22:31,prodege,0.6181,15439740,AUS,02,Jannali,27.96.208.89,no_relation,98,131,,112,155,treats,0.439057039958762,902861-FS1-2,This case report draws the attention to the possibility of a conservative surgical treatment of a SPLENIC RUPTURE in the course of INFECTIOUS MONONUCLEOSIS,SPLENIC RUPTURE,INFECTIOUS MONONUCLEOSIS,RO-disease_may_have_finding
504170018,7/17/2014 11:52:14,,1325201655,7/17/2014 11:51:58,gifthulk,0.8375,21916793,GBR,,,87.115.178.12,no_relation,98,131,,112,155,treats,0.439057039958762,902861-FS1-2,This case report draws the attention to the possibility of a conservative surgical treatment of a SPLENIC RUPTURE in the course of INFECTIOUS MONONUCLEOSIS,SPLENIC RUPTURE,INFECTIOUS MONONUCLEOSIS,RO-disease_may_have_finding
504170018,7/17/2014 12:55:30,,1325251027,7/17/2014 12:55:05,clixsense,0.7,16827630,GBR,A7,Birmingham,86.146.169.103,no_relation,98,131,,112,155,treats,0.439057039958762,902861-FS1-2,This case report draws the attention to the possibility of a conservative surgical treatment of a SPLENIC RUPTURE in the course of INFECTIOUS MONONUCLEOSIS,SPLENIC RUPTURE,INFECTIOUS MONONUCLEOSIS,RO-disease_may_have_finding
504170018,7/17/2014 13:39:06,,1325291273,7/17/2014 13:38:40,prodege,0.5202,28039757,GBR,L8,Southport,109.155.158.54,SPLENIC RUPTURE treats INFECTIOUS MONONUCLEOSIS,98,131,,112,155,treats,0.439057039958762,902861-FS1-2,This case report draws the attention to the possibility of a conservative surgical treatment of a SPLENIC RUPTURE in the course of INFECTIOUS MONONUCLEOSIS,SPLENIC RUPTURE,INFECTIOUS MONONUCLEOSIS,RO-disease_may_have_finding
504170018,7/17/2014 13:40:04,,1325292187,7/17/2014 13:39:26,clixsense,0.6825,6574199,USA,TX,San Antonio,207.230.144.242,no_relation,98,131,,112,155,treats,0.439057039958762,902861-FS1-2,This case report draws the attention to the possibility of a conservative surgical treatment of a SPLENIC RUPTURE in the course of INFECTIOUS MONONUCLEOSIS,SPLENIC RUPTURE,INFECTIOUS MONONUCLEOSIS,RO-disease_may_have_finding
504170018,7/17/2014 14:05:23,,1325315835,7/17/2014 14:04:51,clixsense,0.5901,15189335,GBR,T5,Aberdeen,90.218.222.164,no_relation,98,131,,112,155,treats,0.439057039958762,902861-FS1-2,This case report draws the attention to the possibility of a conservative surgical treatment of a SPLENIC RUPTURE in the course of INFECTIOUS MONONUCLEOSIS,SPLENIC RUPTURE,INFECTIOUS MONONUCLEOSIS,RO-disease_may_have_finding
504170025,7/17/2014 10:35:05,,1325142283,7/17/2014 10:34:58,clixsense,0.8472,19162475,GBR,M3,Frome,82.33.126.30,SPLENIC RUPTURE causes INFECTIOUS MONONUCLEOSIS,98,131,,112,155,causes,0.878114079917523,902861-FS1-4,This case report draws the attention to the possibility of a conservative surgical treatment of a SPLENIC RUPTURE in the course of INFECTIOUS MONONUCLEOSIS,SPLENIC RUPTURE,INFECTIOUS MONONUCLEOSIS,RO-disease_may_have_finding
504170025,7/17/2014 10:39:24,,1325145541,7/17/2014 10:38:56,clixsense,0.8958,19803139,NLD,06,Veldhoven,212.61.84.196,no_relation,98,131,,112,155,causes,0.878114079917523,902861-FS1-4,This case report draws the attention to the possibility of a conservative surgical treatment of a SPLENIC RUPTURE in the course of INFECTIOUS MONONUCLEOSIS,SPLENIC RUPTURE,INFECTIOUS MONONUCLEOSIS,RO-disease_may_have_finding
504170025,7/17/2014 12:16:10,,1325219184,7/17/2014 12:15:52,elite,0.6262,28503042,USA,NJ,Woodbridge,54.191.150.115,INFECTIOUS MONONUCLEOSIS causes SPLENIC RUPTURE,98,131,,112,155,causes,0.878114079917523,902861-FS1-4,This case report draws the attention to the possibility of a conservative surgical treatment of a SPLENIC RUPTURE in the course of INFECTIOUS MONONUCLEOSIS,SPLENIC RUPTURE,INFECTIOUS MONONUCLEOSIS,RO-disease_may_have_finding
504170025,7/17/2014 12:31:33,,1325231279,7/17/2014 12:31:13,prodege,0.6827,7664351,USA,NY,Cicero,74.111.0.21,no_relation,98,131,,112,155,causes,0.878114079917523,902861-FS1-4,This case report draws the attention to the possibility of a conservative surgical treatment of a SPLENIC RUPTURE in the course of INFECTIOUS MONONUCLEOSIS,SPLENIC RUPTURE,INFECTIOUS MONONUCLEOSIS,RO-disease_may_have_finding
504170025,7/17/2014 13:37:34,,1325289823,7/17/2014 13:36:57,clixsense,0.6825,6574199,USA,TX,San Antonio,207.230.144.242,INFECTIOUS MONONUCLEOSIS causes SPLENIC RUPTURE,98,131,,112,155,causes,0.878114079917523,902861-FS1-4,This case report draws the attention to the possibility of a conservative surgical treatment of a SPLENIC RUPTURE in the course of INFECTIOUS MONONUCLEOSIS,SPLENIC RUPTURE,INFECTIOUS MONONUCLEOSIS,RO-disease_may_have_finding
504170025,7/17/2014 14:00:16,,1325310917,7/17/2014 13:59:57,clixsense,0.6744,6579377,CAN,BC,Richmond,174.6.142.227,INFECTIOUS MONONUCLEOSIS causes SPLENIC RUPTURE,98,131,,112,155,causes,0.878114079917523,902861-FS1-4,This case report draws the attention to the possibility of a conservative surgical treatment of a SPLENIC RUPTURE in the course of INFECTIOUS MONONUCLEOSIS,SPLENIC RUPTURE,INFECTIOUS MONONUCLEOSIS,RO-disease_may_have_finding
504170025,7/17/2014 14:06:28,,1325316710,7/17/2014 14:06:04,neodev,0.5669,18339121,USA,SC,Sumter,173.93.188.194,SPLENIC RUPTURE causes INFECTIOUS MONONUCLEOSIS,98,131,,112,155,causes,0.878114079917523,902861-FS1-4,This case report draws the attention to the possibility of a conservative surgical treatment of a SPLENIC RUPTURE in the course of INFECTIOUS MONONUCLEOSIS,SPLENIC RUPTURE,INFECTIOUS MONONUCLEOSIS,RO-disease_may_have_finding
504170032,7/17/2014 10:23:12,,1325132556,7/17/2014 10:23:03,clixsense,1.0,27793793,GBR,C5,Chester,151.230.27.155,CANDIDA treats CANDIDEMIA,84,13,,90,23,treats,0.351123441588392,903897-FS1-2,Treatment of CANDIDEMIA is more complicated because of the changing epidemiology of CANDIDA and introduction of newer antifungal agents.,CANDIDA,CANDIDEMIA,RO-has_causative_agent
504170032,7/17/2014 10:28:01,,1325136323,7/17/2014 10:27:45,instagc,0.9583,24252915,GBR,B7,Bristol,77.98.139.82,no_relation,84,13,,90,23,treats,0.351123441588392,903897-FS1-2,Treatment of CANDIDEMIA is more complicated because of the changing epidemiology of CANDIDA and introduction of newer antifungal agents.,CANDIDA,CANDIDEMIA,RO-has_causative_agent
504170032,7/17/2014 10:34:22,,1325141666,7/17/2014 10:33:52,clixsense,0.8472,19162475,GBR,M3,Frome,82.33.126.30,CANDIDA treats CANDIDEMIA,84,13,,90,23,treats,0.351123441588392,903897-FS1-2,Treatment of CANDIDEMIA is more complicated because of the changing epidemiology of CANDIDA and introduction of newer antifungal agents.,CANDIDA,CANDIDEMIA,RO-has_causative_agent
504170032,7/17/2014 10:40:06,,1325146146,7/17/2014 10:39:48,clixsense,0.8958,19803139,NLD,06,Veldhoven,212.61.84.196,CANDIDA treats CANDIDEMIA,84,13,,90,23,treats,0.351123441588392,903897-FS1-2,Treatment of CANDIDEMIA is more complicated because of the changing epidemiology of CANDIDA and introduction of newer antifungal agents.,CANDIDA,CANDIDEMIA,RO-has_causative_agent
504170032,7/17/2014 11:10:37,,1325169295,7/17/2014 11:10:26,instagc,0.6556,23149109,USA,NC,Durham,75.189.206.205,CANDIDEMIA treats CANDIDA,84,13,,90,23,treats,0.351123441588392,903897-FS1-2,Treatment of CANDIDEMIA is more complicated because of the changing epidemiology of CANDIDA and introduction of newer antifungal agents.,CANDIDA,CANDIDEMIA,RO-has_causative_agent
504170032,7/17/2014 11:53:34,,1325202666,7/17/2014 11:53:20,instagc,0.6653,13763729,USA,,,75.182.89.225,no_relation,84,13,,90,23,treats,0.351123441588392,903897-FS1-2,Treatment of CANDIDEMIA is more complicated because of the changing epidemiology of CANDIDA and introduction of newer antifungal agents.,CANDIDA,CANDIDEMIA,RO-has_causative_agent
504170032,7/17/2014 12:30:56,,1325230668,7/17/2014 12:30:28,prodege,0.6827,7664351,USA,NY,Cicero,74.111.0.21,CANDIDA treats CANDIDEMIA,84,13,,90,23,treats,0.351123441588392,903897-FS1-2,Treatment of CANDIDEMIA is more complicated because of the changing epidemiology of CANDIDA and introduction of newer antifungal agents.,CANDIDA,CANDIDEMIA,RO-has_causative_agent
504170040,7/17/2014 10:34:57,,1325142164,7/17/2014 10:34:51,clixsense,0.8472,19162475,GBR,M3,Frome,82.33.126.30,LIPOSOMAL AMPHOTERICIN B treats DRUG RESISTANT VISCERAL LEISHMANIASIS,70,152,,106,176,treats,0.979957887012223,908300-FS1-2,"This report is of the successful treatment of a patient with multiply DRUG RESISTANT VISCERAL LEISHMANIASIS with a commercially prepared formulation of LIPOSOMAL AMPHOTERICIN B (L AmB) ('AmBisome', Vestar, San Dimas, California, USA.",DRUG RESISTANT VISCERAL LEISHMANIASIS,LIPOSOMAL AMPHOTERICIN B,RO-may_treat
504170040,7/17/2014 10:47:13,,1325151616,7/17/2014 10:46:40,prodege,0.8333,9525153,CAN,ON,Toronto,65.95.92.180,LIPOSOMAL AMPHOTERICIN B treats DRUG RESISTANT VISCERAL LEISHMANIASIS,70,152,,106,176,treats,0.979957887012223,908300-FS1-2,"This report is of the successful treatment of a patient with multiply DRUG RESISTANT VISCERAL LEISHMANIASIS with a commercially prepared formulation of LIPOSOMAL AMPHOTERICIN B (L AmB) ('AmBisome', Vestar, San Dimas, California, USA.",DRUG RESISTANT VISCERAL LEISHMANIASIS,LIPOSOMAL AMPHOTERICIN B,RO-may_treat
504170040,7/17/2014 11:10:48,,1325169433,7/17/2014 11:10:38,instagc,0.6556,23149109,USA,NC,Durham,75.189.206.205,LIPOSOMAL AMPHOTERICIN B treats DRUG RESISTANT VISCERAL LEISHMANIASIS,70,152,,106,176,treats,0.979957887012223,908300-FS1-2,"This report is of the successful treatment of a patient with multiply DRUG RESISTANT VISCERAL LEISHMANIASIS with a commercially prepared formulation of LIPOSOMAL AMPHOTERICIN B (L AmB) ('AmBisome', Vestar, San Dimas, California, USA.",DRUG RESISTANT VISCERAL LEISHMANIASIS,LIPOSOMAL AMPHOTERICIN B,RO-may_treat
504170040,7/17/2014 11:51:28,,1325201135,7/17/2014 11:51:18,gifthulk,0.8375,21916793,GBR,,,87.115.178.12,LIPOSOMAL AMPHOTERICIN B treats DRUG RESISTANT VISCERAL LEISHMANIASIS,70,152,,106,176,treats,0.979957887012223,908300-FS1-2,"This report is of the successful treatment of a patient with multiply DRUG RESISTANT VISCERAL LEISHMANIASIS with a commercially prepared formulation of LIPOSOMAL AMPHOTERICIN B (L AmB) ('AmBisome', Vestar, San Dimas, California, USA.",DRUG RESISTANT VISCERAL LEISHMANIASIS,LIPOSOMAL AMPHOTERICIN B,RO-may_treat
504170040,7/17/2014 12:32:09,,1325231609,7/17/2014 12:31:34,prodege,0.6827,7664351,USA,NY,Cicero,74.111.0.21,LIPOSOMAL AMPHOTERICIN B treats DRUG RESISTANT VISCERAL LEISHMANIASIS,70,152,,106,176,treats,0.979957887012223,908300-FS1-2,"This report is of the successful treatment of a patient with multiply DRUG RESISTANT VISCERAL LEISHMANIASIS with a commercially prepared formulation of LIPOSOMAL AMPHOTERICIN B (L AmB) ('AmBisome', Vestar, San Dimas, California, USA.",DRUG RESISTANT VISCERAL LEISHMANIASIS,LIPOSOMAL AMPHOTERICIN B,RO-may_treat
504170040,7/17/2014 12:54:23,,1325250090,7/17/2014 12:54:12,clixsense,0.7,16827630,GBR,A7,Birmingham,86.146.169.103,no_relation,70,152,,106,176,treats,0.979957887012223,908300-FS1-2,"This report is of the successful treatment of a patient with multiply DRUG RESISTANT VISCERAL LEISHMANIASIS with a commercially prepared formulation of LIPOSOMAL AMPHOTERICIN B (L AmB) ('AmBisome', Vestar, San Dimas, California, USA.",DRUG RESISTANT VISCERAL LEISHMANIASIS,LIPOSOMAL AMPHOTERICIN B,RO-may_treat
504170040,7/17/2014 13:11:17,,1325264370,7/17/2014 13:10:50,neodev,0.7137,21515166,NLD,11,Nootdorp,83.86.58.179,LIPOSOMAL AMPHOTERICIN B treats DRUG RESISTANT VISCERAL LEISHMANIASIS,70,152,,106,176,treats,0.979957887012223,908300-FS1-2,"This report is of the successful treatment of a patient with multiply DRUG RESISTANT VISCERAL LEISHMANIASIS with a commercially prepared formulation of LIPOSOMAL AMPHOTERICIN B (L AmB) ('AmBisome', Vestar, San Dimas, California, USA.",DRUG RESISTANT VISCERAL LEISHMANIASIS,LIPOSOMAL AMPHOTERICIN B,RO-may_treat
497762775,7/3/2014 10:27:07,,1313874528,7/3/2014 10:27:02,instagc,0.0,27753923,GBR,,,92.40.75.232,SYSTEMIC DISEASE causes MULTICENTRIC RETICULOHISTIOCYTOSIS,45,0,,61,34,causes,0.4375949745,901779-FS1-4,MULTICENTRIC RETICULOHISTIOCYTOSIS (MR) is a SYSTEMIC DISEASE of unknown cause characterized by the presence of a heavy macrophage infiltrate in skin and synovial tissues and the development of an erosive polyarthritis,SYSTEMIC DISEASE,MULTICENTRIC RETICULOHISTIOCYTOSIS,RO-disease_has_finding
497762775,7/3/2014 10:34:56,,1313879996,7/3/2014 10:34:32,clixsense,0.0,15189335,GBR,I9,Dereham,86.157.163.112,no_relation,45,0,,61,34,causes,0.4375949745,901779-FS1-4,MULTICENTRIC RETICULOHISTIOCYTOSIS (MR) is a SYSTEMIC DISEASE of unknown cause characterized by the presence of a heavy macrophage infiltrate in skin and synovial tissues and the development of an erosive polyarthritis,SYSTEMIC DISEASE,MULTICENTRIC RETICULOHISTIOCYTOSIS,RO-disease_has_finding
497762775,7/3/2014 10:51:02,,1313890465,7/3/2014 10:50:33,vivatic,0.0,25451531,GBR,,,83.67.28.193,no_relation,45,0,,61,34,causes,0.4375949745,901779-FS1-4,MULTICENTRIC RETICULOHISTIOCYTOSIS (MR) is a SYSTEMIC DISEASE of unknown cause characterized by the presence of a heavy macrophage infiltrate in skin and synovial tissues and the development of an erosive polyarthritis,SYSTEMIC DISEASE,MULTICENTRIC RETICULOHISTIOCYTOSIS,RO-disease_has_finding
497762775,7/3/2014 14:15:57,,1313994783,7/3/2014 14:15:11,instagc,0.0,21838928,GBR,U1,Alloa,86.155.175.33,no_relation,45,0,,61,34,causes,0.4375949745,901779-FS1-4,MULTICENTRIC RETICULOHISTIOCYTOSIS (MR) is a SYSTEMIC DISEASE of unknown cause characterized by the presence of a heavy macrophage infiltrate in skin and synovial tissues and the development of an erosive polyarthritis,SYSTEMIC DISEASE,MULTICENTRIC RETICULOHISTIOCYTOSIS,RO-disease_has_finding
497762775,7/3/2014 15:06:43,,1314032947,7/3/2014 15:06:19,instagc,0.0,20183814,USA,,,166.182.80.97,MULTICENTRIC RETICULOHISTIOCYTOSIS causes SYSTEMIC DISEASE,45,0,,61,34,causes,0.4375949745,901779-FS1-4,MULTICENTRIC RETICULOHISTIOCYTOSIS (MR) is a SYSTEMIC DISEASE of unknown cause characterized by the presence of a heavy macrophage infiltrate in skin and synovial tissues and the development of an erosive polyarthritis,SYSTEMIC DISEASE,MULTICENTRIC RETICULOHISTIOCYTOSIS,RO-disease_has_finding
497762775,7/3/2014 15:10:04,,1314035473,7/3/2014 15:09:27,clixsense,0.0,27871219,NLD,7,Amsterdam,87.210.207.223,no_relation,45,0,,61,34,causes,0.4375949745,901779-FS1-4,MULTICENTRIC RETICULOHISTIOCYTOSIS (MR) is a SYSTEMIC DISEASE of unknown cause characterized by the presence of a heavy macrophage infiltrate in skin and synovial tissues and the development of an erosive polyarthritis,SYSTEMIC DISEASE,MULTICENTRIC RETICULOHISTIOCYTOSIS,RO-disease_has_finding
497762775,7/3/2014 15:19:39,,1314042929,7/3/2014 15:19:18,neodev,0.0,21405167,USA,MD,Pasadena,69.243.35.97,no_relation,45,0,,61,34,causes,0.4375949745,901779-FS1-4,MULTICENTRIC RETICULOHISTIOCYTOSIS (MR) is a SYSTEMIC DISEASE of unknown cause characterized by the presence of a heavy macrophage infiltrate in skin and synovial tissues and the development of an erosive polyarthritis,SYSTEMIC DISEASE,MULTICENTRIC RETICULOHISTIOCYTOSIS,RO-disease_has_finding
497762775,7/3/2014 15:47:24,,1314065967,7/3/2014 15:46:30,clixsense,0.0,17950689,GBR,X5,Cardiff,89.168.38.216,MULTICENTRIC RETICULOHISTIOCYTOSIS causes SYSTEMIC DISEASE,45,0,,61,34,causes,0.4375949745,901779-FS1-4,MULTICENTRIC RETICULOHISTIOCYTOSIS (MR) is a SYSTEMIC DISEASE of unknown cause characterized by the presence of a heavy macrophage infiltrate in skin and synovial tissues and the development of an erosive polyarthritis,SYSTEMIC DISEASE,MULTICENTRIC RETICULOHISTIOCYTOSIS,RO-disease_has_finding
497762775,7/3/2014 16:00:23,,1314076991,7/3/2014 16:00:04,superrewards,0.0,22638731,USA,IL,Carterville,50.40.185.175,MULTICENTRIC RETICULOHISTIOCYTOSIS causes SYSTEMIC DISEASE,45,0,,61,34,causes,0.4375949745,901779-FS1-4,MULTICENTRIC RETICULOHISTIOCYTOSIS (MR) is a SYSTEMIC DISEASE of unknown cause characterized by the presence of a heavy macrophage infiltrate in skin and synovial tissues and the development of an erosive polyarthritis,SYSTEMIC DISEASE,MULTICENTRIC RETICULOHISTIOCYTOSIS,RO-disease_has_finding
497762775,7/3/2014 16:42:32,,1314112288,7/3/2014 16:42:24,prodege,0.0,2143114,CAN,BC,Vancouver,24.84.160.12,MULTICENTRIC RETICULOHISTIOCYTOSIS causes SYSTEMIC DISEASE,45,0,,61,34,causes,0.4375949745,901779-FS1-4,MULTICENTRIC RETICULOHISTIOCYTOSIS (MR) is a SYSTEMIC DISEASE of unknown cause characterized by the presence of a heavy macrophage infiltrate in skin and synovial tissues and the development of an erosive polyarthritis,SYSTEMIC DISEASE,MULTICENTRIC RETICULOHISTIOCYTOSIS,RO-disease_has_finding
497762775,7/3/2014 17:01:22,,1314126445,7/3/2014 17:01:04,neodev,0.0,18517457,GBR,,,86.29.55.201,no_relation,45,0,,61,34,causes,0.4375949745,901779-FS1-4,MULTICENTRIC RETICULOHISTIOCYTOSIS (MR) is a SYSTEMIC DISEASE of unknown cause characterized by the presence of a heavy macrophage infiltrate in skin and synovial tissues and the development of an erosive polyarthritis,SYSTEMIC DISEASE,MULTICENTRIC RETICULOHISTIOCYTOSIS,RO-disease_has_finding
497762775,7/3/2014 17:52:25,,1314174916,7/3/2014 17:52:08,instagc,0.0,19636746,USA,NY,Canandaigua,192.182.211.200,no_relation,45,0,,61,34,causes,0.4375949745,901779-FS1-4,MULTICENTRIC RETICULOHISTIOCYTOSIS (MR) is a SYSTEMIC DISEASE of unknown cause characterized by the presence of a heavy macrophage infiltrate in skin and synovial tissues and the development of an erosive polyarthritis,SYSTEMIC DISEASE,MULTICENTRIC RETICULOHISTIOCYTOSIS,RO-disease_has_finding
497762775,7/3/2014 18:13:04,,1314193222,7/3/2014 18:12:31,zoombucks,0.0,27687111,USA,CA,Corona,99.44.120.153,no_relation,45,0,,61,34,causes,0.4375949745,901779-FS1-4,MULTICENTRIC RETICULOHISTIOCYTOSIS (MR) is a SYSTEMIC DISEASE of unknown cause characterized by the presence of a heavy macrophage infiltrate in skin and synovial tissues and the development of an erosive polyarthritis,SYSTEMIC DISEASE,MULTICENTRIC RETICULOHISTIOCYTOSIS,RO-disease_has_finding
497762775,7/3/2014 19:08:44,,1314235588,7/3/2014 19:08:31,prodege,0.0,18960400,GBR,A2,Edgware,31.54.207.221,no_relation,45,0,,61,34,causes,0.4375949745,901779-FS1-4,MULTICENTRIC RETICULOHISTIOCYTOSIS (MR) is a SYSTEMIC DISEASE of unknown cause characterized by the presence of a heavy macrophage infiltrate in skin and synovial tissues and the development of an erosive polyarthritis,SYSTEMIC DISEASE,MULTICENTRIC RETICULOHISTIOCYTOSIS,RO-disease_has_finding
497762775,7/3/2014 19:25:32,,1314249193,7/3/2014 19:25:17,clixsense,0.0,6331514,CAN,ON,Sault Sainte Marie,65.95.60.150,MULTICENTRIC RETICULOHISTIOCYTOSIS causes SYSTEMIC DISEASE,45,0,,61,34,causes,0.4375949745,901779-FS1-4,MULTICENTRIC RETICULOHISTIOCYTOSIS (MR) is a SYSTEMIC DISEASE of unknown cause characterized by the presence of a heavy macrophage infiltrate in skin and synovial tissues and the development of an erosive polyarthritis,SYSTEMIC DISEASE,MULTICENTRIC RETICULOHISTIOCYTOSIS,RO-disease_has_finding
497762775,7/3/2014 20:21:17,,1314299201,7/3/2014 20:20:56,eup_slw,0.0,20818028,GBR,A7,Birmingham,92.232.139.254,no_relation,45,0,,61,34,causes,0.4375949745,901779-FS1-4,MULTICENTRIC RETICULOHISTIOCYTOSIS (MR) is a SYSTEMIC DISEASE of unknown cause characterized by the presence of a heavy macrophage infiltrate in skin and synovial tissues and the development of an erosive polyarthritis,SYSTEMIC DISEASE,MULTICENTRIC RETICULOHISTIOCYTOSIS,RO-disease_has_finding
497762775,7/3/2014 21:22:41,,1314353564,7/3/2014 21:21:59,clixsense,0.0,10428985,GBR,M3,South Petherton,86.186.150.111,no_relation,45,0,,61,34,causes,0.4375949745,901779-FS1-4,MULTICENTRIC RETICULOHISTIOCYTOSIS (MR) is a SYSTEMIC DISEASE of unknown cause characterized by the presence of a heavy macrophage infiltrate in skin and synovial tissues and the development of an erosive polyarthritis,SYSTEMIC DISEASE,MULTICENTRIC RETICULOHISTIOCYTOSIS,RO-disease_has_finding
497762775,7/3/2014 21:38:04,,1314366255,7/3/2014 21:37:42,bitcoinget,0.0,21490602,USA,NJ,Bound Brook,68.193.36.186,no_relation,45,0,,61,34,causes,0.4375949745,901779-FS1-4,MULTICENTRIC RETICULOHISTIOCYTOSIS (MR) is a SYSTEMIC DISEASE of unknown cause characterized by the presence of a heavy macrophage infiltrate in skin and synovial tissues and the development of an erosive polyarthritis,SYSTEMIC DISEASE,MULTICENTRIC RETICULOHISTIOCYTOSIS,RO-disease_has_finding
497762775,7/3/2014 21:49:31,,1314376511,7/3/2014 21:49:14,instagc,0.0,26801585,USA,WA,Everett,76.28.248.228,SYSTEMIC DISEASE causes MULTICENTRIC RETICULOHISTIOCYTOSIS,45,0,,61,34,causes,0.4375949745,901779-FS1-4,MULTICENTRIC RETICULOHISTIOCYTOSIS (MR) is a SYSTEMIC DISEASE of unknown cause characterized by the presence of a heavy macrophage infiltrate in skin and synovial tissues and the development of an erosive polyarthritis,SYSTEMIC DISEASE,MULTICENTRIC RETICULOHISTIOCYTOSIS,RO-disease_has_finding
497762775,7/3/2014 22:53:08,,1314415239,7/3/2014 22:52:52,clixsense,0.0,19803139,NLD,6,Veldhoven,212.61.84.196,no_relation,45,0,,61,34,causes,0.4375949745,901779-FS1-4,MULTICENTRIC RETICULOHISTIOCYTOSIS (MR) is a SYSTEMIC DISEASE of unknown cause characterized by the presence of a heavy macrophage infiltrate in skin and synovial tissues and the development of an erosive polyarthritis,SYSTEMIC DISEASE,MULTICENTRIC RETICULOHISTIOCYTOSIS,RO-disease_has_finding
497762775,7/3/2014 23:39:41,,1314439558,7/3/2014 23:39:30,neodev,0.0,25804244,USA,IL,Chicago,216.104.36.236,MULTICENTRIC RETICULOHISTIOCYTOSIS causes SYSTEMIC DISEASE,45,0,,61,34,causes,0.4375949745,901779-FS1-4,MULTICENTRIC RETICULOHISTIOCYTOSIS (MR) is a SYSTEMIC DISEASE of unknown cause characterized by the presence of a heavy macrophage infiltrate in skin and synovial tissues and the development of an erosive polyarthritis,SYSTEMIC DISEASE,MULTICENTRIC RETICULOHISTIOCYTOSIS,RO-disease_has_finding
497762775,7/4/2014 01:02:55,,1314483644,7/4/2014 01:02:50,clixsense,0.0,17121874,GBR,U9,Falkirk,80.192.66.214,SYSTEMIC DISEASE causes MULTICENTRIC RETICULOHISTIOCYTOSIS,45,0,,61,34,causes,0.4375949745,901779-FS1-4,MULTICENTRIC RETICULOHISTIOCYTOSIS (MR) is a SYSTEMIC DISEASE of unknown cause characterized by the presence of a heavy macrophage infiltrate in skin and synovial tissues and the development of an erosive polyarthritis,SYSTEMIC DISEASE,MULTICENTRIC RETICULOHISTIOCYTOSIS,RO-disease_has_finding
497762775,7/4/2014 01:59:10,,1314518291,7/4/2014 01:58:31,instagc,0.0,19686223,CAN,BC,Surrey,184.65.16.6,no_relation,45,0,,61,34,causes,0.4375949745,901779-FS1-4,MULTICENTRIC RETICULOHISTIOCYTOSIS (MR) is a SYSTEMIC DISEASE of unknown cause characterized by the presence of a heavy macrophage infiltrate in skin and synovial tissues and the development of an erosive polyarthritis,SYSTEMIC DISEASE,MULTICENTRIC RETICULOHISTIOCYTOSIS,RO-disease_has_finding
497762775,7/4/2014 02:33:56,,1314540230,7/4/2014 02:33:38,zoombucks,0.0,28232452,USA,NC,Cary,174.97.217.113,no_relation,45,0,,61,34,causes,0.4375949745,901779-FS1-4,MULTICENTRIC RETICULOHISTIOCYTOSIS (MR) is a SYSTEMIC DISEASE of unknown cause characterized by the presence of a heavy macrophage infiltrate in skin and synovial tissues and the development of an erosive polyarthritis,SYSTEMIC DISEASE,MULTICENTRIC RETICULOHISTIOCYTOSIS,RO-disease_has_finding
497762775,7/4/2014 02:43:31,,1314544951,7/4/2014 02:43:10,rewardsspot,0.0,24482174,GBR,H9,London,46.23.68.180,SYSTEMIC DISEASE causes MULTICENTRIC RETICULOHISTIOCYTOSIS,45,0,,61,34,causes,0.4375949745,901779-FS1-4,MULTICENTRIC RETICULOHISTIOCYTOSIS (MR) is a SYSTEMIC DISEASE of unknown cause characterized by the presence of a heavy macrophage infiltrate in skin and synovial tissues and the development of an erosive polyarthritis,SYSTEMIC DISEASE,MULTICENTRIC RETICULOHISTIOCYTOSIS,RO-disease_has_finding
497762775,7/4/2014 02:47:55,,1314547244,7/4/2014 02:47:31,rewardsspot,0.0,17763704,USA,IL,Chicago,67.212.175.123,SYSTEMIC DISEASE causes MULTICENTRIC RETICULOHISTIOCYTOSIS,45,0,,61,34,causes,0.4375949745,901779-FS1-4,MULTICENTRIC RETICULOHISTIOCYTOSIS (MR) is a SYSTEMIC DISEASE of unknown cause characterized by the presence of a heavy macrophage infiltrate in skin and synovial tissues and the development of an erosive polyarthritis,SYSTEMIC DISEASE,MULTICENTRIC RETICULOHISTIOCYTOSIS,RO-disease_has_finding
497762775,7/4/2014 03:39:45,,1314570862,7/4/2014 03:39:10,clixsense,0.0,17722340,CAN,BC,Mission,50.98.185.25,SYSTEMIC DISEASE causes MULTICENTRIC RETICULOHISTIOCYTOSIS,45,0,,61,34,causes,0.4375949745,901779-FS1-4,MULTICENTRIC RETICULOHISTIOCYTOSIS (MR) is a SYSTEMIC DISEASE of unknown cause characterized by the presence of a heavy macrophage infiltrate in skin and synovial tissues and the development of an erosive polyarthritis,SYSTEMIC DISEASE,MULTICENTRIC RETICULOHISTIOCYTOSIS,RO-disease_has_finding
497762775,7/4/2014 04:39:57,,1314597214,7/4/2014 04:39:51,gptbanks,0.0,18496428,USA,CA,Newhall,199.244.112.121,SYSTEMIC DISEASE causes MULTICENTRIC RETICULOHISTIOCYTOSIS,45,0,,61,34,causes,0.4375949745,901779-FS1-4,MULTICENTRIC RETICULOHISTIOCYTOSIS (MR) is a SYSTEMIC DISEASE of unknown cause characterized by the presence of a heavy macrophage infiltrate in skin and synovial tissues and the development of an erosive polyarthritis,SYSTEMIC DISEASE,MULTICENTRIC RETICULOHISTIOCYTOSIS,RO-disease_has_finding
497762775,7/4/2014 04:52:40,,1314603410,7/4/2014 04:52:13,instagc,0.0,13846187,USA,MO,Chesterfield,63.137.150.235,MULTICENTRIC RETICULOHISTIOCYTOSIS causes SYSTEMIC DISEASE,45,0,,61,34,causes,0.4375949745,901779-FS1-4,MULTICENTRIC RETICULOHISTIOCYTOSIS (MR) is a SYSTEMIC DISEASE of unknown cause characterized by the presence of a heavy macrophage infiltrate in skin and synovial tissues and the development of an erosive polyarthritis,SYSTEMIC DISEASE,MULTICENTRIC RETICULOHISTIOCYTOSIS,RO-disease_has_finding
497762775,7/4/2014 05:07:21,,1314609907,7/4/2014 05:06:56,clixsense,0.0,24429778,AUS,2,Sydney,125.255.54.86,MULTICENTRIC RETICULOHISTIOCYTOSIS causes SYSTEMIC DISEASE,45,0,,61,34,causes,0.4375949745,901779-FS1-4,MULTICENTRIC RETICULOHISTIOCYTOSIS (MR) is a SYSTEMIC DISEASE of unknown cause characterized by the presence of a heavy macrophage infiltrate in skin and synovial tissues and the development of an erosive polyarthritis,SYSTEMIC DISEASE,MULTICENTRIC RETICULOHISTIOCYTOSIS,RO-disease_has_finding
497762775,7/4/2014 06:53:21,,1314657266,7/4/2014 06:52:43,clixsense,0.0,27969116,NLD,,,91.213.37.165,SYSTEMIC DISEASE causes MULTICENTRIC RETICULOHISTIOCYTOSIS,45,0,,61,34,causes,0.4375949745,901779-FS1-4,MULTICENTRIC RETICULOHISTIOCYTOSIS (MR) is a SYSTEMIC DISEASE of unknown cause characterized by the presence of a heavy macrophage infiltrate in skin and synovial tissues and the development of an erosive polyarthritis,SYSTEMIC DISEASE,MULTICENTRIC RETICULOHISTIOCYTOSIS,RO-disease_has_finding
497762775,7/4/2014 07:10:44,,1314668889,7/4/2014 07:10:06,clixsense,0.0,19190439,GBR,H9,London,86.15.32.131,no_relation,45,0,,61,34,causes,0.4375949745,901779-FS1-4,MULTICENTRIC RETICULOHISTIOCYTOSIS (MR) is a SYSTEMIC DISEASE of unknown cause characterized by the presence of a heavy macrophage infiltrate in skin and synovial tissues and the development of an erosive polyarthritis,SYSTEMIC DISEASE,MULTICENTRIC RETICULOHISTIOCYTOSIS,RO-disease_has_finding
497762775,7/4/2014 08:06:56,,1314695252,7/4/2014 08:06:24,clixsense,0.0,23138831,NLD,,,77.174.95.58,no_relation,45,0,,61,34,causes,0.4375949745,901779-FS1-4,MULTICENTRIC RETICULOHISTIOCYTOSIS (MR) is a SYSTEMIC DISEASE of unknown cause characterized by the presence of a heavy macrophage infiltrate in skin and synovial tissues and the development of an erosive polyarthritis,SYSTEMIC DISEASE,MULTICENTRIC RETICULOHISTIOCYTOSIS,RO-disease_has_finding
497762775,7/4/2014 08:36:32,,1314708677,7/4/2014 08:36:21,prodege,0.0,15439740,AUS,2,Jannali,27.96.208.89,no_relation,45,0,,61,34,causes,0.4375949745,901779-FS1-4,MULTICENTRIC RETICULOHISTIOCYTOSIS (MR) is a SYSTEMIC DISEASE of unknown cause characterized by the presence of a heavy macrophage infiltrate in skin and synovial tissues and the development of an erosive polyarthritis,SYSTEMIC DISEASE,MULTICENTRIC RETICULOHISTIOCYTOSIS,RO-disease_has_finding
497762775,7/4/2014 09:15:39,,1314728020,7/4/2014 09:14:55,eup_slw,0.0,21338859,GBR,K6,Portsmouth,86.6.113.168,no_relation,45,0,,61,34,causes,0.4375949745,901779-FS1-4,MULTICENTRIC RETICULOHISTIOCYTOSIS (MR) is a SYSTEMIC DISEASE of unknown cause characterized by the presence of a heavy macrophage infiltrate in skin and synovial tissues and the development of an erosive polyarthritis,SYSTEMIC DISEASE,MULTICENTRIC RETICULOHISTIOCYTOSIS,RO-disease_has_finding
497762786,7/3/2014 10:26:08,,1313873950,7/3/2014 10:26:01,instagc,0.0,27753923,GBR,,,92.40.75.232,MCCUNE-ALBRIGHT SYNDROME causes PRECOCIOUS PUBERTY,88,0,,106,24,causes,0.9799578870000001,901704-FS1-4,"MCCUNE-ALBRIGHT SYNDROME (MAS) is a rare disorder characterized by the classic triad of PRECOCIOUS PUBERTY, polyostotic fibrous dysplasia and caf????����鰹申��申���鐃初�膩��鐃緒申鐃緒申鐔顔��э申?鐃緒��鰹申羝�申����渇���申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃初�鐃�??����渇���申��申鐃緒申鐃緒申鐃緒申??鐃緒��鰹申羝�申��申?鐃緒申�鰹申羝�申���鐃初���申鐃緒申鐃緒申薜合����鐃�鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃�����鰹申��申���鐃初�膩��鐃緒申????����鰹申薜合�����渇�膩��鐃緒申鐃緒申羝�申鐃遵�������渇���申��申鐃緒申鐃緒申鐃醇柑鐃初���申鐃緒申�渇�膩��鐃醇�鐃初�鐃�鐃緒��鰹申羝�申��申鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃緒申羇誌申���鐃緒申鐃緒申����活�鐃緒申鐃緒申鐃緒申羝�申����渇�膩��鐃緒申鐃緒申羝�申鐃緒申鐃�??鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃緒申羇誌申���鐃緒申鐃緒申��申鐃緒申鐃緒申鐃緒申�鰹申薜合���申?鐃緒��鰹申羝�申��申t spots",PRECOCIOUS PUBERTY,MCCUNE-ALBRIGHT SYNDROME,RO-disease_has_finding
497762786,7/3/2014 10:33:13,,1313878799,7/3/2014 10:32:50,clixsense,0.0,15189335,GBR,I9,Dereham,86.157.163.112,PRECOCIOUS PUBERTY causes MCCUNE-ALBRIGHT SYNDROME,88,0,,106,24,causes,0.9799578870000001,901704-FS1-4,"MCCUNE-ALBRIGHT SYNDROME (MAS) is a rare disorder characterized by the classic triad of PRECOCIOUS PUBERTY, polyostotic fibrous dysplasia and caf????����鰹申��申���鐃初�膩��鐃緒申鐃緒申鐔顔��э申?鐃緒��鰹申羝�申����渇���申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃初�鐃�??����渇���申��申鐃緒申鐃緒申鐃緒申??鐃緒��鰹申羝�申��申?鐃緒申�鰹申羝�申���鐃初���申鐃緒申鐃緒申薜合����鐃�鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃�����鰹申��申���鐃初�膩��鐃緒申????����鰹申薜合�����渇�膩��鐃緒申鐃緒申羝�申鐃遵�������渇���申��申鐃緒申鐃緒申鐃醇柑鐃初���申鐃緒申�渇�膩��鐃醇�鐃初�鐃�鐃緒��鰹申羝�申��申鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃緒申羇誌申���鐃緒申鐃緒申����活�鐃緒申鐃緒申鐃緒申羝�申����渇�膩��鐃緒申鐃緒申羝�申鐃緒申鐃�??鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃緒申羇誌申���鐃緒申鐃緒申��申鐃緒申鐃緒申鐃緒申�鰹申薜合���申?鐃緒��鰹申羝�申��申t spots",PRECOCIOUS PUBERTY,MCCUNE-ALBRIGHT SYNDROME,RO-disease_has_finding
497762786,7/3/2014 10:51:51,,1313891097,7/3/2014 10:51:03,vivatic,0.0,25451531,GBR,,,83.67.28.193,MCCUNE-ALBRIGHT SYNDROME causes PRECOCIOUS PUBERTY,88,0,,106,24,causes,0.9799578870000001,901704-FS1-4,"MCCUNE-ALBRIGHT SYNDROME (MAS) is a rare disorder characterized by the classic triad of PRECOCIOUS PUBERTY, polyostotic fibrous dysplasia and caf????����鰹申��申���鐃初�膩��鐃緒申鐃緒申鐔顔��э申?鐃緒��鰹申羝�申����渇���申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃初�鐃�??����渇���申��申鐃緒申鐃緒申鐃緒申??鐃緒��鰹申羝�申��申?鐃緒申�鰹申羝�申���鐃初���申鐃緒申鐃緒申薜合����鐃�鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃�����鰹申��申���鐃初�膩��鐃緒申????����鰹申薜合�����渇�膩��鐃緒申鐃緒申羝�申鐃遵�������渇���申��申鐃緒申鐃緒申鐃醇柑鐃初���申鐃緒申�渇�膩��鐃醇�鐃初�鐃�鐃緒��鰹申羝�申��申鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃緒申羇誌申���鐃緒申鐃緒申����活�鐃緒申鐃緒申鐃緒申羝�申����渇�膩��鐃緒申鐃緒申羝�申鐃緒申鐃�??鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃緒申羇誌申���鐃緒申鐃緒申��申鐃緒申鐃緒申鐃緒申�鰹申薜合���申?鐃緒��鰹申羝�申��申t spots",PRECOCIOUS PUBERTY,MCCUNE-ALBRIGHT SYNDROME,RO-disease_has_finding
497762786,7/3/2014 14:18:33,,1313996267,7/3/2014 14:18:19,instagc,0.0,21838928,GBR,U1,Alloa,86.155.175.33,no_relation,88,0,,106,24,causes,0.9799578870000001,901704-FS1-4,"MCCUNE-ALBRIGHT SYNDROME (MAS) is a rare disorder characterized by the classic triad of PRECOCIOUS PUBERTY, polyostotic fibrous dysplasia and caf????����鰹申��申���鐃初�膩��鐃緒申鐃緒申鐔顔��э申?鐃緒��鰹申羝�申����渇���申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃初�鐃�??����渇���申��申鐃緒申鐃緒申鐃緒申??鐃緒��鰹申羝�申��申?鐃緒申�鰹申羝�申���鐃初���申鐃緒申鐃緒申薜合����鐃�鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃�����鰹申��申���鐃初�膩��鐃緒申????����鰹申薜合�����渇�膩��鐃緒申鐃緒申羝�申鐃遵�������渇���申��申鐃緒申鐃緒申鐃醇柑鐃初���申鐃緒申�渇�膩��鐃醇�鐃初�鐃�鐃緒��鰹申羝�申��申鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃緒申羇誌申���鐃緒申鐃緒申����活�鐃緒申鐃緒申鐃緒申羝�申����渇�膩��鐃緒申鐃緒申羝�申鐃緒申鐃�??鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃緒申羇誌申���鐃緒申鐃緒申��申鐃緒申鐃緒申鐃緒申�鰹申薜合���申?鐃緒��鰹申羝�申��申t spots",PRECOCIOUS PUBERTY,MCCUNE-ALBRIGHT SYNDROME,RO-disease_has_finding
497762786,7/3/2014 15:05:38,,1314032047,7/3/2014 15:04:44,instagc,0.0,20183814,USA,,,166.182.80.97,MCCUNE-ALBRIGHT SYNDROME causes PRECOCIOUS PUBERTY,88,0,,106,24,causes,0.9799578870000001,901704-FS1-4,"MCCUNE-ALBRIGHT SYNDROME (MAS) is a rare disorder characterized by the classic triad of PRECOCIOUS PUBERTY, polyostotic fibrous dysplasia and caf????����鰹申��申���鐃初�膩��鐃緒申鐃緒申鐔顔��э申?鐃緒��鰹申羝�申����渇���申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃初�鐃�??����渇���申��申鐃緒申鐃緒申鐃緒申??鐃緒��鰹申羝�申��申?鐃緒申�鰹申羝�申���鐃初���申鐃緒申鐃緒申薜合����鐃�鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃�����鰹申��申���鐃初�膩��鐃緒申????����鰹申薜合�����渇�膩��鐃緒申鐃緒申羝�申鐃遵�������渇���申��申鐃緒申鐃緒申鐃醇柑鐃初���申鐃緒申�渇�膩��鐃醇�鐃初�鐃�鐃緒��鰹申羝�申��申鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃緒申羇誌申���鐃緒申鐃緒申����活�鐃緒申鐃緒申鐃緒申羝�申����渇�膩��鐃緒申鐃緒申羝�申鐃緒申鐃�??鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃緒申羇誌申���鐃緒申鐃緒申��申鐃緒申鐃緒申鐃緒申�鰹申薜合���申?鐃緒��鰹申羝�申��申t spots",PRECOCIOUS PUBERTY,MCCUNE-ALBRIGHT SYNDROME,RO-disease_has_finding
497762786,7/3/2014 15:23:30,,1314046207,7/3/2014 15:23:08,neodev,0.0,21405167,USA,MD,Pasadena,69.243.35.97,MCCUNE-ALBRIGHT SYNDROME causes PRECOCIOUS PUBERTY,88,0,,106,24,causes,0.9799578870000001,901704-FS1-4,"MCCUNE-ALBRIGHT SYNDROME (MAS) is a rare disorder characterized by the classic triad of PRECOCIOUS PUBERTY, polyostotic fibrous dysplasia and caf????����鰹申��申���鐃初�膩��鐃緒申鐃緒申鐔顔��э申?鐃緒��鰹申羝�申����渇���申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃初�鐃�??����渇���申��申鐃緒申鐃緒申鐃緒申??鐃緒��鰹申羝�申��申?鐃緒申�鰹申羝�申���鐃初���申鐃緒申鐃緒申薜合����鐃�鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃�����鰹申��申���鐃初�膩��鐃緒申????����鰹申薜合�����渇�膩��鐃緒申鐃緒申羝�申鐃遵�������渇���申��申鐃緒申鐃緒申鐃醇柑鐃初���申鐃緒申�渇�膩��鐃醇�鐃初�鐃�鐃緒��鰹申羝�申��申鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃緒申羇誌申���鐃緒申鐃緒申����活�鐃緒申鐃緒申鐃緒申羝�申����渇�膩��鐃緒申鐃緒申羝�申鐃緒申鐃�??鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃緒申羇誌申���鐃緒申鐃緒申��申鐃緒申鐃緒申鐃緒申�鰹申薜合���申?鐃緒��鰹申羝�申��申t spots",PRECOCIOUS PUBERTY,MCCUNE-ALBRIGHT SYNDROME,RO-disease_has_finding
497762786,7/3/2014 15:32:20,,1314053382,7/3/2014 15:32:09,prodege,0.0,18960400,GBR,H9,London,109.154.7.94,MCCUNE-ALBRIGHT SYNDROME causes PRECOCIOUS PUBERTY,88,0,,106,24,causes,0.9799578870000001,901704-FS1-4,"MCCUNE-ALBRIGHT SYNDROME (MAS) is a rare disorder characterized by the classic triad of PRECOCIOUS PUBERTY, polyostotic fibrous dysplasia and caf????����鰹申��申���鐃初�膩��鐃緒申鐃緒申鐔顔��э申?鐃緒��鰹申羝�申����渇���申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃初�鐃�??����渇���申��申鐃緒申鐃緒申鐃緒申??鐃緒��鰹申羝�申��申?鐃緒申�鰹申羝�申���鐃初���申鐃緒申鐃緒申薜合����鐃�鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃�����鰹申��申���鐃初�膩��鐃緒申????����鰹申薜合�����渇�膩��鐃緒申鐃緒申羝�申鐃遵�������渇���申��申鐃緒申鐃緒申鐃醇柑鐃初���申鐃緒申�渇�膩��鐃醇�鐃初�鐃�鐃緒��鰹申羝�申��申鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃緒申羇誌申���鐃緒申鐃緒申����活�鐃緒申鐃緒申鐃緒申羝�申����渇�膩��鐃緒申鐃緒申羝�申鐃緒申鐃�??鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃緒申羇誌申���鐃緒申鐃緒申��申鐃緒申鐃緒申鐃緒申�鰹申薜合���申?鐃緒��鰹申羝�申��申t spots",PRECOCIOUS PUBERTY,MCCUNE-ALBRIGHT SYNDROME,RO-disease_has_finding
497762786,7/3/2014 15:46:12,,1314064852,7/3/2014 15:46:05,clixsense,0.0,17950689,GBR,X5,Cardiff,89.168.38.216,no_relation,88,0,,106,24,causes,0.9799578870000001,901704-FS1-4,"MCCUNE-ALBRIGHT SYNDROME (MAS) is a rare disorder characterized by the classic triad of PRECOCIOUS PUBERTY, polyostotic fibrous dysplasia and caf????����鰹申��申���鐃初�膩��鐃緒申鐃緒申鐔顔��э申?鐃緒��鰹申羝�申����渇���申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃初�鐃�??����渇���申��申鐃緒申鐃緒申鐃緒申??鐃緒��鰹申羝�申��申?鐃緒申�鰹申羝�申���鐃初���申鐃緒申鐃緒申薜合����鐃�鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃�����鰹申��申���鐃初�膩��鐃緒申????����鰹申薜合�����渇�膩��鐃緒申鐃緒申羝�申鐃遵�������渇���申��申鐃緒申鐃緒申鐃醇柑鐃初���申鐃緒申�渇�膩��鐃醇�鐃初�鐃�鐃緒��鰹申羝�申��申鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃緒申羇誌申���鐃緒申鐃緒申����活�鐃緒申鐃緒申鐃緒申羝�申����渇�膩��鐃緒申鐃緒申羝�申鐃緒申鐃�??鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃緒申羇誌申���鐃緒申鐃緒申��申鐃緒申鐃緒申鐃緒申�鰹申薜合���申?鐃緒��鰹申羝�申��申t spots",PRECOCIOUS PUBERTY,MCCUNE-ALBRIGHT SYNDROME,RO-disease_has_finding
497762786,7/3/2014 15:54:19,,1314071899,7/3/2014 15:53:52,clixsense,0.0,21917173,CAN,,,24.71.41.51,no_relation,88,0,,106,24,causes,0.9799578870000001,901704-FS1-4,"MCCUNE-ALBRIGHT SYNDROME (MAS) is a rare disorder characterized by the classic triad of PRECOCIOUS PUBERTY, polyostotic fibrous dysplasia and caf????����鰹申��申���鐃初�膩��鐃緒申鐃緒申鐔顔��э申?鐃緒��鰹申羝�申����渇���申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃初�鐃�??����渇���申��申鐃緒申鐃緒申鐃緒申??鐃緒��鰹申羝�申��申?鐃緒申�鰹申羝�申���鐃初���申鐃緒申鐃緒申薜合����鐃�鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃�����鰹申��申���鐃初�膩��鐃緒申????����鰹申薜合�����渇�膩��鐃緒申鐃緒申羝�申鐃遵�������渇���申��申鐃緒申鐃緒申鐃醇柑鐃初���申鐃緒申�渇�膩��鐃醇�鐃初�鐃�鐃緒��鰹申羝�申��申鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃緒申羇誌申���鐃緒申鐃緒申����活�鐃緒申鐃緒申鐃緒申羝�申����渇�膩��鐃緒申鐃緒申羝�申鐃緒申鐃�??鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃緒申羇誌申���鐃緒申鐃緒申��申鐃緒申鐃緒申鐃緒申�鰹申薜合���申?鐃緒��鰹申羝�申��申t spots",PRECOCIOUS PUBERTY,MCCUNE-ALBRIGHT SYNDROME,RO-disease_has_finding
497762786,7/3/2014 16:01:13,,1314077734,7/3/2014 16:00:49,superrewards,0.0,22638731,USA,IL,Carterville,50.40.185.175,MCCUNE-ALBRIGHT SYNDROME causes PRECOCIOUS PUBERTY,88,0,,106,24,causes,0.9799578870000001,901704-FS1-4,"MCCUNE-ALBRIGHT SYNDROME (MAS) is a rare disorder characterized by the classic triad of PRECOCIOUS PUBERTY, polyostotic fibrous dysplasia and caf????����鰹申��申���鐃初�膩��鐃緒申鐃緒申鐔顔��э申?鐃緒��鰹申羝�申����渇���申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃初�鐃�??����渇���申��申鐃緒申鐃緒申鐃緒申??鐃緒��鰹申羝�申��申?鐃緒申�鰹申羝�申���鐃初���申鐃緒申鐃緒申薜合����鐃�鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃�����鰹申��申���鐃初�膩��鐃緒申????����鰹申薜合�����渇�膩��鐃緒申鐃緒申羝�申鐃遵�������渇���申��申鐃緒申鐃緒申鐃醇柑鐃初���申鐃緒申�渇�膩��鐃醇�鐃初�鐃�鐃緒��鰹申羝�申��申鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃緒申羇誌申���鐃緒申鐃緒申����活�鐃緒申鐃緒申鐃緒申羝�申����渇�膩��鐃緒申鐃緒申羝�申鐃緒申鐃�??鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃緒申羇誌申���鐃緒申鐃緒申��申鐃緒申鐃緒申鐃緒申�鰹申薜合���申?鐃緒��鰹申羝�申��申t spots",PRECOCIOUS PUBERTY,MCCUNE-ALBRIGHT SYNDROME,RO-disease_has_finding
497762786,7/3/2014 16:40:32,,1314110794,7/3/2014 16:40:22,prodege,0.0,2143114,CAN,BC,Vancouver,24.84.160.12,MCCUNE-ALBRIGHT SYNDROME causes PRECOCIOUS PUBERTY,88,0,,106,24,causes,0.9799578870000001,901704-FS1-4,"MCCUNE-ALBRIGHT SYNDROME (MAS) is a rare disorder characterized by the classic triad of PRECOCIOUS PUBERTY, polyostotic fibrous dysplasia and caf????����鰹申��申���鐃初�膩��鐃緒申鐃緒申鐔顔��э申?鐃緒��鰹申羝�申����渇���申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃初�鐃�??����渇���申��申鐃緒申鐃緒申鐃緒申??鐃緒��鰹申羝�申��申?鐃緒申�鰹申羝�申���鐃初���申鐃緒申鐃緒申薜合����鐃�鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃�����鰹申��申���鐃初�膩��鐃緒申????����鰹申薜合�����渇�膩��鐃緒申鐃緒申羝�申鐃遵�������渇���申��申鐃緒申鐃緒申鐃醇柑鐃初���申鐃緒申�渇�膩��鐃醇�鐃初�鐃�鐃緒��鰹申羝�申��申鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃緒申羇誌申���鐃緒申鐃緒申����活�鐃緒申鐃緒申鐃緒申羝�申����渇�膩��鐃緒申鐃緒申羝�申鐃緒申鐃�??鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃緒申羇誌申���鐃緒申鐃緒申��申鐃緒申鐃緒申鐃緒申�鰹申薜合���申?鐃緒��鰹申羝�申��申t spots",PRECOCIOUS PUBERTY,MCCUNE-ALBRIGHT SYNDROME,RO-disease_has_finding
497762786,7/3/2014 17:00:02,,1314125383,7/3/2014 16:59:51,neodev,0.0,18517457,GBR,,,86.29.55.201,MCCUNE-ALBRIGHT SYNDROME causes PRECOCIOUS PUBERTY,88,0,,106,24,causes,0.9799578870000001,901704-FS1-4,"MCCUNE-ALBRIGHT SYNDROME (MAS) is a rare disorder characterized by the classic triad of PRECOCIOUS PUBERTY, polyostotic fibrous dysplasia and caf????����鰹申��申���鐃初�膩��鐃緒申鐃緒申鐔顔��э申?鐃緒��鰹申羝�申����渇���申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃初�鐃�??����渇���申��申鐃緒申鐃緒申鐃緒申??鐃緒��鰹申羝�申��申?鐃緒申�鰹申羝�申���鐃初���申鐃緒申鐃緒申薜合����鐃�鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃�����鰹申��申���鐃初�膩��鐃緒申????����鰹申薜合�����渇�膩��鐃緒申鐃緒申羝�申鐃遵�������渇���申��申鐃緒申鐃緒申鐃醇柑鐃初���申鐃緒申�渇�膩��鐃醇�鐃初�鐃�鐃緒��鰹申羝�申��申鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃緒申羇誌申���鐃緒申鐃緒申����活�鐃緒申鐃緒申鐃緒申羝�申����渇�膩��鐃緒申鐃緒申羝�申鐃緒申鐃�??鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃緒申羇誌申���鐃緒申鐃緒申��申鐃緒申鐃緒申鐃緒申�鰹申薜合���申?鐃緒��鰹申羝�申��申t spots",PRECOCIOUS PUBERTY,MCCUNE-ALBRIGHT SYNDROME,RO-disease_has_finding
497762786,7/3/2014 17:00:13,,1314125501,7/3/2014 16:59:48,clixsense,0.0,27871219,NLD,7,Amsterdam,87.210.207.223,MCCUNE-ALBRIGHT SYNDROME causes PRECOCIOUS PUBERTY,88,0,,106,24,causes,0.9799578870000001,901704-FS1-4,"MCCUNE-ALBRIGHT SYNDROME (MAS) is a rare disorder characterized by the classic triad of PRECOCIOUS PUBERTY, polyostotic fibrous dysplasia and caf????����鰹申��申���鐃初�膩��鐃緒申鐃緒申鐔顔��э申?鐃緒��鰹申羝�申����渇���申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃初�鐃�??����渇���申��申鐃緒申鐃緒申鐃緒申??鐃緒��鰹申羝�申��申?鐃緒申�鰹申羝�申���鐃初���申鐃緒申鐃緒申薜合����鐃�鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃�����鰹申��申���鐃初�膩��鐃緒申????����鰹申薜合�����渇�膩��鐃緒申鐃緒申羝�申鐃遵�������渇���申��申鐃緒申鐃緒申鐃醇柑鐃初���申鐃緒申�渇�膩��鐃醇�鐃初�鐃�鐃緒��鰹申羝�申��申鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃緒申羇誌申���鐃緒申鐃緒申����活�鐃緒申鐃緒申鐃緒申羝�申����渇�膩��鐃緒申鐃緒申羝�申鐃緒申鐃�??鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃緒申羇誌申���鐃緒申鐃緒申��申鐃緒申鐃緒申鐃緒申�鰹申薜合���申?鐃緒��鰹申羝�申��申t spots",PRECOCIOUS PUBERTY,MCCUNE-ALBRIGHT SYNDROME,RO-disease_has_finding
497762786,7/3/2014 17:23:16,,1314145350,7/3/2014 17:22:48,bitcoinget,0.0,26217831,GBR,H9,London,82.35.240.150,MCCUNE-ALBRIGHT SYNDROME causes PRECOCIOUS PUBERTY,88,0,,106,24,causes,0.9799578870000001,901704-FS1-4,"MCCUNE-ALBRIGHT SYNDROME (MAS) is a rare disorder characterized by the classic triad of PRECOCIOUS PUBERTY, polyostotic fibrous dysplasia and caf????����鰹申��申���鐃初�膩��鐃緒申鐃緒申鐔顔��э申?鐃緒��鰹申羝�申����渇���申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃初�鐃�??����渇���申��申鐃緒申鐃緒申鐃緒申??鐃緒��鰹申羝�申��申?鐃緒申�鰹申羝�申���鐃初���申鐃緒申鐃緒申薜合����鐃�鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃�����鰹申��申���鐃初�膩��鐃緒申????����鰹申薜合�����渇�膩��鐃緒申鐃緒申羝�申鐃遵�������渇���申��申鐃緒申鐃緒申鐃醇柑鐃初���申鐃緒申�渇�膩��鐃醇�鐃初�鐃�鐃緒��鰹申羝�申��申鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃緒申羇誌申���鐃緒申鐃緒申����活�鐃緒申鐃緒申鐃緒申羝�申����渇�膩��鐃緒申鐃緒申羝�申鐃緒申鐃�??鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃緒申羇誌申���鐃緒申鐃緒申��申鐃緒申鐃緒申鐃緒申�鰹申薜合���申?鐃緒��鰹申羝�申��申t spots",PRECOCIOUS PUBERTY,MCCUNE-ALBRIGHT SYNDROME,RO-disease_has_finding
497762786,7/3/2014 19:24:19,,1314248292,7/3/2014 19:23:58,clixsense,0.0,6331514,CAN,ON,Sault Sainte Marie,65.95.60.150,PRECOCIOUS PUBERTY causes MCCUNE-ALBRIGHT SYNDROME,88,0,,106,24,causes,0.9799578870000001,901704-FS1-4,"MCCUNE-ALBRIGHT SYNDROME (MAS) is a rare disorder characterized by the classic triad of PRECOCIOUS PUBERTY, polyostotic fibrous dysplasia and caf????����鰹申��申���鐃初�膩��鐃緒申鐃緒申鐔顔��э申?鐃緒��鰹申羝�申����渇���申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃初�鐃�??����渇���申��申鐃緒申鐃緒申鐃緒申??鐃緒��鰹申羝�申��申?鐃緒申�鰹申羝�申���鐃初���申鐃緒申鐃緒申薜合����鐃�鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃�����鰹申��申���鐃初�膩��鐃緒申????����鰹申薜合�����渇�膩��鐃緒申鐃緒申羝�申鐃遵�������渇���申��申鐃緒申鐃緒申鐃醇柑鐃初���申鐃緒申�渇�膩��鐃醇�鐃初�鐃�鐃緒��鰹申羝�申��申鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃緒申羇誌申���鐃緒申鐃緒申����活�鐃緒申鐃緒申鐃緒申羝�申����渇�膩��鐃緒申鐃緒申羝�申鐃緒申鐃�??鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃緒申羇誌申���鐃緒申鐃緒申��申鐃緒申鐃緒申鐃緒申�鰹申薜合���申?鐃緒��鰹申羝�申��申t spots",PRECOCIOUS PUBERTY,MCCUNE-ALBRIGHT SYNDROME,RO-disease_has_finding
497762786,7/3/2014 19:26:12,,1314249747,7/3/2014 19:25:46,instagc,0.0,19636746,USA,NY,Canandaigua,192.182.211.200,MCCUNE-ALBRIGHT SYNDROME causes PRECOCIOUS PUBERTY,88,0,,106,24,causes,0.9799578870000001,901704-FS1-4,"MCCUNE-ALBRIGHT SYNDROME (MAS) is a rare disorder characterized by the classic triad of PRECOCIOUS PUBERTY, polyostotic fibrous dysplasia and caf????����鰹申��申���鐃初�膩��鐃緒申鐃緒申鐔顔��э申?鐃緒��鰹申羝�申����渇���申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃初�鐃�??����渇���申��申鐃緒申鐃緒申鐃緒申??鐃緒��鰹申羝�申��申?鐃緒申�鰹申羝�申���鐃初���申鐃緒申鐃緒申薜合����鐃�鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃�����鰹申��申���鐃初�膩��鐃緒申????����鰹申薜合�����渇�膩��鐃緒申鐃緒申羝�申鐃遵�������渇���申��申鐃緒申鐃緒申鐃醇柑鐃初���申鐃緒申�渇�膩��鐃醇�鐃初�鐃�鐃緒��鰹申羝�申��申鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃緒申羇誌申���鐃緒申鐃緒申����活�鐃緒申鐃緒申鐃緒申羝�申����渇�膩��鐃緒申鐃緒申羝�申鐃緒申鐃�??鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃緒申羇誌申���鐃緒申鐃緒申��申鐃緒申鐃緒申鐃緒申�鰹申薜合���申?鐃緒��鰹申羝�申��申t spots",PRECOCIOUS PUBERTY,MCCUNE-ALBRIGHT SYNDROME,RO-disease_has_finding
497762786,7/3/2014 20:21:17,,1314299202,7/3/2014 20:20:56,eup_slw,0.0,20818028,GBR,A7,Birmingham,92.232.139.254,MCCUNE-ALBRIGHT SYNDROME causes PRECOCIOUS PUBERTY,88,0,,106,24,causes,0.9799578870000001,901704-FS1-4,"MCCUNE-ALBRIGHT SYNDROME (MAS) is a rare disorder characterized by the classic triad of PRECOCIOUS PUBERTY, polyostotic fibrous dysplasia and caf????����鰹申��申���鐃初�膩��鐃緒申鐃緒申鐔顔��э申?鐃緒��鰹申羝�申����渇���申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃初�鐃�??����渇���申��申鐃緒申鐃緒申鐃緒申??鐃緒��鰹申羝�申��申?鐃緒申�鰹申羝�申���鐃初���申鐃緒申鐃緒申薜合����鐃�鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃�����鰹申��申���鐃初�膩��鐃緒申????����鰹申薜合�����渇�膩��鐃緒申鐃緒申羝�申鐃遵�������渇���申��申鐃緒申鐃緒申鐃醇柑鐃初���申鐃緒申�渇�膩��鐃醇�鐃初�鐃�鐃緒��鰹申羝�申��申鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃緒申羇誌申���鐃緒申鐃緒申����活�鐃緒申鐃緒申鐃緒申羝�申����渇�膩��鐃緒申鐃緒申羝�申鐃緒申鐃�??鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃緒申羇誌申���鐃緒申鐃緒申��申鐃緒申鐃緒申鐃緒申�鰹申薜合���申?鐃緒��鰹申羝�申��申t spots",PRECOCIOUS PUBERTY,MCCUNE-ALBRIGHT SYNDROME,RO-disease_has_finding
497762786,7/3/2014 21:29:13,,1314358136,7/3/2014 21:28:35,clixsense,0.0,10428985,GBR,M3,South Petherton,86.186.150.111,MCCUNE-ALBRIGHT SYNDROME causes PRECOCIOUS PUBERTY,88,0,,106,24,causes,0.9799578870000001,901704-FS1-4,"MCCUNE-ALBRIGHT SYNDROME (MAS) is a rare disorder characterized by the classic triad of PRECOCIOUS PUBERTY, polyostotic fibrous dysplasia and caf????����鰹申��申���鐃初�膩��鐃緒申鐃緒申鐔顔��э申?鐃緒��鰹申羝�申����渇���申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃初�鐃�??����渇���申��申鐃緒申鐃緒申鐃緒申??鐃緒��鰹申羝�申��申?鐃緒申�鰹申羝�申���鐃初���申鐃緒申鐃緒申薜合����鐃�鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃�����鰹申��申���鐃初�膩��鐃緒申????����鰹申薜合�����渇�膩��鐃緒申鐃緒申羝�申鐃遵�������渇���申��申鐃緒申鐃緒申鐃醇柑鐃初���申鐃緒申�渇�膩��鐃醇�鐃初�鐃�鐃緒��鰹申羝�申��申鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃緒申羇誌申���鐃緒申鐃緒申����活�鐃緒申鐃緒申鐃緒申羝�申����渇�膩��鐃緒申鐃緒申羝�申鐃緒申鐃�??鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃緒申羇誌申���鐃緒申鐃緒申��申鐃緒申鐃緒申鐃緒申�鰹申薜合���申?鐃緒��鰹申羝�申��申t spots",PRECOCIOUS PUBERTY,MCCUNE-ALBRIGHT SYNDROME,RO-disease_has_finding
497762786,7/3/2014 21:37:41,,1314365941,7/3/2014 21:37:13,bitcoinget,0.0,21490602,USA,NJ,Bound Brook,68.193.36.186,MCCUNE-ALBRIGHT SYNDROME causes PRECOCIOUS PUBERTY,88,0,,106,24,causes,0.9799578870000001,901704-FS1-4,"MCCUNE-ALBRIGHT SYNDROME (MAS) is a rare disorder characterized by the classic triad of PRECOCIOUS PUBERTY, polyostotic fibrous dysplasia and caf????����鰹申��申���鐃初�膩��鐃緒申鐃緒申鐔顔��э申?鐃緒��鰹申羝�申����渇���申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃初�鐃�??����渇���申��申鐃緒申鐃緒申鐃緒申??鐃緒��鰹申羝�申��申?鐃緒申�鰹申羝�申���鐃初���申鐃緒申鐃緒申薜合����鐃�鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃�����鰹申��申���鐃初�膩��鐃緒申????����鰹申薜合�����渇�膩��鐃緒申鐃緒申羝�申鐃遵�������渇���申��申鐃緒申鐃緒申鐃醇柑鐃初���申鐃緒申�渇�膩��鐃醇�鐃初�鐃�鐃緒��鰹申羝�申��申鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃緒申羇誌申���鐃緒申鐃緒申����活�鐃緒申鐃緒申鐃緒申羝�申����渇�膩��鐃緒申鐃緒申羝�申鐃緒申鐃�??鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃緒申羇誌申���鐃緒申鐃緒申��申鐃緒申鐃緒申鐃緒申�鰹申薜合���申?鐃緒��鰹申羝�申��申t spots",PRECOCIOUS PUBERTY,MCCUNE-ALBRIGHT SYNDROME,RO-disease_has_finding
497762786,7/3/2014 21:46:51,,1314374763,7/3/2014 21:46:31,instagc,0.0,26801585,USA,WA,Everett,76.28.248.228,MCCUNE-ALBRIGHT SYNDROME causes PRECOCIOUS PUBERTY,88,0,,106,24,causes,0.9799578870000001,901704-FS1-4,"MCCUNE-ALBRIGHT SYNDROME (MAS) is a rare disorder characterized by the classic triad of PRECOCIOUS PUBERTY, polyostotic fibrous dysplasia and caf????����鰹申��申���鐃初�膩��鐃緒申鐃緒申鐔顔��э申?鐃緒��鰹申羝�申����渇���申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃初�鐃�??����渇���申��申鐃緒申鐃緒申鐃緒申??鐃緒��鰹申羝�申��申?鐃緒申�鰹申羝�申���鐃初���申鐃緒申鐃緒申薜合����鐃�鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃�����鰹申��申���鐃初�膩��鐃緒申????����鰹申薜合�����渇�膩��鐃緒申鐃緒申羝�申鐃遵�������渇���申��申鐃緒申鐃緒申鐃醇柑鐃初���申鐃緒申�渇�膩��鐃醇�鐃初�鐃�鐃緒��鰹申羝�申��申鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃緒申羇誌申���鐃緒申鐃緒申����活�鐃緒申鐃緒申鐃緒申羝�申����渇�膩��鐃緒申鐃緒申羝�申鐃緒申鐃�??鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃緒申羇誌申���鐃緒申鐃緒申��申鐃緒申鐃緒申鐃緒申�鰹申薜合���申?鐃緒��鰹申羝�申��申t spots",PRECOCIOUS PUBERTY,MCCUNE-ALBRIGHT SYNDROME,RO-disease_has_finding
497762786,7/3/2014 22:54:54,,1314416204,7/3/2014 22:54:37,clixsense,0.0,19803139,NLD,6,Veldhoven,212.61.84.196,MCCUNE-ALBRIGHT SYNDROME causes PRECOCIOUS PUBERTY,88,0,,106,24,causes,0.9799578870000001,901704-FS1-4,"MCCUNE-ALBRIGHT SYNDROME (MAS) is a rare disorder characterized by the classic triad of PRECOCIOUS PUBERTY, polyostotic fibrous dysplasia and caf????����鰹申��申���鐃初�膩��鐃緒申鐃緒申鐔顔��э申?鐃緒��鰹申羝�申����渇���申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃初�鐃�??����渇���申��申鐃緒申鐃緒申鐃緒申??鐃緒��鰹申羝�申��申?鐃緒申�鰹申羝�申���鐃初���申鐃緒申鐃緒申薜合����鐃�鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃�����鰹申��申���鐃初�膩��鐃緒申????����鰹申薜合�����渇�膩��鐃緒申鐃緒申羝�申鐃遵�������渇���申��申鐃緒申鐃緒申鐃醇柑鐃初���申鐃緒申�渇�膩��鐃醇�鐃初�鐃�鐃緒��鰹申羝�申��申鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃緒申羇誌申���鐃緒申鐃緒申����活�鐃緒申鐃緒申鐃緒申羝�申����渇�膩��鐃緒申鐃緒申羝�申鐃緒申鐃�??鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃緒申羇誌申���鐃緒申鐃緒申��申鐃緒申鐃緒申鐃緒申�鰹申薜合���申?鐃緒��鰹申羝�申��申t spots",PRECOCIOUS PUBERTY,MCCUNE-ALBRIGHT SYNDROME,RO-disease_has_finding
497762786,7/4/2014 01:01:57,,1314483049,7/4/2014 01:01:46,clixsense,0.0,17121874,GBR,U9,Falkirk,80.192.66.214,no_relation,88,0,,106,24,causes,0.9799578870000001,901704-FS1-4,"MCCUNE-ALBRIGHT SYNDROME (MAS) is a rare disorder characterized by the classic triad of PRECOCIOUS PUBERTY, polyostotic fibrous dysplasia and caf????����鰹申��申���鐃初�膩��鐃緒申鐃緒申鐔顔��э申?鐃緒��鰹申羝�申����渇���申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃初�鐃�??����渇���申��申鐃緒申鐃緒申鐃緒申??鐃緒��鰹申羝�申��申?鐃緒申�鰹申羝�申���鐃初���申鐃緒申鐃緒申薜合����鐃�鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃�����鰹申��申���鐃初�膩��鐃緒申????����鰹申薜合�����渇�膩��鐃緒申鐃緒申羝�申鐃遵�������渇���申��申鐃緒申鐃緒申鐃醇柑鐃初���申鐃緒申�渇�膩��鐃醇�鐃初�鐃�鐃緒��鰹申羝�申��申鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃緒申羇誌申���鐃緒申鐃緒申����活�鐃緒申鐃緒申鐃緒申羝�申����渇�膩��鐃緒申鐃緒申羝�申鐃緒申鐃�??鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃緒申羇誌申���鐃緒申鐃緒申��申鐃緒申鐃緒申鐃緒申�鰹申薜合���申?鐃緒��鰹申羝�申��申t spots",PRECOCIOUS PUBERTY,MCCUNE-ALBRIGHT SYNDROME,RO-disease_has_finding
497762786,7/4/2014 02:02:52,,1314520793,7/4/2014 02:02:24,instagc,0.0,19686223,CAN,BC,Surrey,184.65.16.6,MCCUNE-ALBRIGHT SYNDROME causes PRECOCIOUS PUBERTY,88,0,,106,24,causes,0.9799578870000001,901704-FS1-4,"MCCUNE-ALBRIGHT SYNDROME (MAS) is a rare disorder characterized by the classic triad of PRECOCIOUS PUBERTY, polyostotic fibrous dysplasia and caf????����鰹申��申���鐃初�膩��鐃緒申鐃緒申鐔顔��э申?鐃緒��鰹申羝�申����渇���申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃初�鐃�??����渇���申��申鐃緒申鐃緒申鐃緒申??鐃緒��鰹申羝�申��申?鐃緒申�鰹申羝�申���鐃初���申鐃緒申鐃緒申薜合����鐃�鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃�����鰹申��申���鐃初�膩��鐃緒申????����鰹申薜合�����渇�膩��鐃緒申鐃緒申羝�申鐃遵�������渇���申��申鐃緒申鐃緒申鐃醇柑鐃初���申鐃緒申�渇�膩��鐃醇�鐃初�鐃�鐃緒��鰹申羝�申��申鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃緒申羇誌申���鐃緒申鐃緒申����活�鐃緒申鐃緒申鐃緒申羝�申����渇�膩��鐃緒申鐃緒申羝�申鐃緒申鐃�??鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃緒申羇誌申���鐃緒申鐃緒申��申鐃緒申鐃緒申鐃緒申�鰹申薜合���申?鐃緒��鰹申羝�申��申t spots",PRECOCIOUS PUBERTY,MCCUNE-ALBRIGHT SYNDROME,RO-disease_has_finding
497762786,7/4/2014 02:37:24,,1314541823,7/4/2014 02:36:56,zoombucks,0.0,28232452,USA,NC,Cary,174.97.217.113,MCCUNE-ALBRIGHT SYNDROME causes PRECOCIOUS PUBERTY,88,0,,106,24,causes,0.9799578870000001,901704-FS1-4,"MCCUNE-ALBRIGHT SYNDROME (MAS) is a rare disorder characterized by the classic triad of PRECOCIOUS PUBERTY, polyostotic fibrous dysplasia and caf????����鰹申��申���鐃初�膩��鐃緒申鐃緒申鐔顔��э申?鐃緒��鰹申羝�申����渇���申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃初�鐃�??����渇���申��申鐃緒申鐃緒申鐃緒申??鐃緒��鰹申羝�申��申?鐃緒申�鰹申羝�申���鐃初���申鐃緒申鐃緒申薜合����鐃�鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃�����鰹申��申���鐃初�膩��鐃緒申????����鰹申薜合�����渇�膩��鐃緒申鐃緒申羝�申鐃遵�������渇���申��申鐃緒申鐃緒申鐃醇柑鐃初���申鐃緒申�渇�膩��鐃醇�鐃初�鐃�鐃緒��鰹申羝�申��申鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃緒申羇誌申���鐃緒申鐃緒申����活�鐃緒申鐃緒申鐃緒申羝�申����渇�膩��鐃緒申鐃緒申羝�申鐃緒申鐃�??鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃緒申羇誌申���鐃緒申鐃緒申��申鐃緒申鐃緒申鐃緒申�鰹申薜合���申?鐃緒��鰹申羝�申��申t spots",PRECOCIOUS PUBERTY,MCCUNE-ALBRIGHT SYNDROME,RO-disease_has_finding
497762786,7/4/2014 02:42:35,,1314544439,7/4/2014 02:42:07,rewardsspot,0.0,24482174,GBR,H9,London,46.23.68.180,MCCUNE-ALBRIGHT SYNDROME causes PRECOCIOUS PUBERTY,88,0,,106,24,causes,0.9799578870000001,901704-FS1-4,"MCCUNE-ALBRIGHT SYNDROME (MAS) is a rare disorder characterized by the classic triad of PRECOCIOUS PUBERTY, polyostotic fibrous dysplasia and caf????����鰹申��申���鐃初�膩��鐃緒申鐃緒申鐔顔��э申?鐃緒��鰹申羝�申����渇���申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃初�鐃�??����渇���申��申鐃緒申鐃緒申鐃緒申??鐃緒��鰹申羝�申��申?鐃緒申�鰹申羝�申���鐃初���申鐃緒申鐃緒申薜合����鐃�鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃�����鰹申��申���鐃初�膩��鐃緒申????����鰹申薜合�����渇�膩��鐃緒申鐃緒申羝�申鐃遵�������渇���申��申鐃緒申鐃緒申鐃醇柑鐃初���申鐃緒申�渇�膩��鐃醇�鐃初�鐃�鐃緒��鰹申羝�申��申鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃緒申羇誌申���鐃緒申鐃緒申����活�鐃緒申鐃緒申鐃緒申羝�申����渇�膩��鐃緒申鐃緒申羝�申鐃緒申鐃�??鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃緒申羇誌申���鐃緒申鐃緒申��申鐃緒申鐃緒申鐃緒申�鰹申薜合���申?鐃緒��鰹申羝�申��申t spots",PRECOCIOUS PUBERTY,MCCUNE-ALBRIGHT SYNDROME,RO-disease_has_finding
497762786,7/4/2014 02:43:16,,1314544838,7/4/2014 02:42:53,rewardsspot,0.0,17763704,USA,IL,Chicago,67.212.175.123,MCCUNE-ALBRIGHT SYNDROME causes PRECOCIOUS PUBERTY,88,0,,106,24,causes,0.9799578870000001,901704-FS1-4,"MCCUNE-ALBRIGHT SYNDROME (MAS) is a rare disorder characterized by the classic triad of PRECOCIOUS PUBERTY, polyostotic fibrous dysplasia and caf????����鰹申��申���鐃初�膩��鐃緒申鐃緒申鐔顔��э申?鐃緒��鰹申羝�申����渇���申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃初�鐃�??����渇���申��申鐃緒申鐃緒申鐃緒申??鐃緒��鰹申羝�申��申?鐃緒申�鰹申羝�申���鐃初���申鐃緒申鐃緒申薜合����鐃�鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃�����鰹申��申���鐃初�膩��鐃緒申????����鰹申薜合�����渇�膩��鐃緒申鐃緒申羝�申鐃遵�������渇���申��申鐃緒申鐃緒申鐃醇柑鐃初���申鐃緒申�渇�膩��鐃醇�鐃初�鐃�鐃緒��鰹申羝�申��申鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃緒申羇誌申���鐃緒申鐃緒申����活�鐃緒申鐃緒申鐃緒申羝�申����渇�膩��鐃緒申鐃緒申羝�申鐃緒申鐃�??鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃緒申羇誌申���鐃緒申鐃緒申��申鐃緒申鐃緒申鐃緒申�鰹申薜合���申?鐃緒��鰹申羝�申��申t spots",PRECOCIOUS PUBERTY,MCCUNE-ALBRIGHT SYNDROME,RO-disease_has_finding
497762786,7/4/2014 03:42:04,,1314571979,7/4/2014 03:41:24,clixsense,0.0,17722340,CAN,BC,Mission,50.98.185.25,MCCUNE-ALBRIGHT SYNDROME causes PRECOCIOUS PUBERTY,88,0,,106,24,causes,0.9799578870000001,901704-FS1-4,"MCCUNE-ALBRIGHT SYNDROME (MAS) is a rare disorder characterized by the classic triad of PRECOCIOUS PUBERTY, polyostotic fibrous dysplasia and caf????����鰹申��申���鐃初�膩��鐃緒申鐃緒申鐔顔��э申?鐃緒��鰹申羝�申����渇���申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃初�鐃�??����渇���申��申鐃緒申鐃緒申鐃緒申??鐃緒��鰹申羝�申��申?鐃緒申�鰹申羝�申���鐃初���申鐃緒申鐃緒申薜合����鐃�鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃�����鰹申��申���鐃初�膩��鐃緒申????����鰹申薜合�����渇�膩��鐃緒申鐃緒申羝�申鐃遵�������渇���申��申鐃緒申鐃緒申鐃醇柑鐃初���申鐃緒申�渇�膩��鐃醇�鐃初�鐃�鐃緒��鰹申羝�申��申鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃緒申羇誌申���鐃緒申鐃緒申����活�鐃緒申鐃緒申鐃緒申羝�申����渇�膩��鐃緒申鐃緒申羝�申鐃緒申鐃�??鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃緒申羇誌申���鐃緒申鐃緒申��申鐃緒申鐃緒申鐃緒申�鰹申薜合���申?鐃緒��鰹申羝�申��申t spots",PRECOCIOUS PUBERTY,MCCUNE-ALBRIGHT SYNDROME,RO-disease_has_finding
497762786,7/4/2014 04:39:49,,1314597036,7/4/2014 04:38:58,gptbanks,0.0,18496428,USA,CA,Newhall,199.244.112.121,PRECOCIOUS PUBERTY causes MCCUNE-ALBRIGHT SYNDROME,88,0,,106,24,causes,0.9799578870000001,901704-FS1-4,"MCCUNE-ALBRIGHT SYNDROME (MAS) is a rare disorder characterized by the classic triad of PRECOCIOUS PUBERTY, polyostotic fibrous dysplasia and caf????����鰹申��申���鐃初�膩��鐃緒申鐃緒申鐔顔��э申?鐃緒��鰹申羝�申����渇���申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃初�鐃�??����渇���申��申鐃緒申鐃緒申鐃緒申??鐃緒��鰹申羝�申��申?鐃緒申�鰹申羝�申���鐃初���申鐃緒申鐃緒申薜合����鐃�鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃�����鰹申��申���鐃初�膩��鐃緒申????����鰹申薜合�����渇�膩��鐃緒申鐃緒申羝�申鐃遵�������渇���申��申鐃緒申鐃緒申鐃醇柑鐃初���申鐃緒申�渇�膩��鐃醇�鐃初�鐃�鐃緒��鰹申羝�申��申鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃緒申羇誌申���鐃緒申鐃緒申����活�鐃緒申鐃緒申鐃緒申羝�申����渇�膩��鐃緒申鐃緒申羝�申鐃緒申鐃�??鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃緒申羇誌申���鐃緒申鐃緒申��申鐃緒申鐃緒申鐃緒申�鰹申薜合���申?鐃緒��鰹申羝�申��申t spots",PRECOCIOUS PUBERTY,MCCUNE-ALBRIGHT SYNDROME,RO-disease_has_finding
497762786,7/4/2014 04:51:55,,1314603109,7/4/2014 04:51:37,instagc,0.0,13846187,USA,MO,Chesterfield,63.137.150.235,MCCUNE-ALBRIGHT SYNDROME causes PRECOCIOUS PUBERTY,88,0,,106,24,causes,0.9799578870000001,901704-FS1-4,"MCCUNE-ALBRIGHT SYNDROME (MAS) is a rare disorder characterized by the classic triad of PRECOCIOUS PUBERTY, polyostotic fibrous dysplasia and caf????����鰹申��申���鐃初�膩��鐃緒申鐃緒申鐔顔��э申?鐃緒��鰹申羝�申����渇���申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃初�鐃�??����渇���申��申鐃緒申鐃緒申鐃緒申??鐃緒��鰹申羝�申��申?鐃緒申�鰹申羝�申���鐃初���申鐃緒申鐃緒申薜合����鐃�鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃�����鰹申��申���鐃初�膩��鐃緒申????����鰹申薜合�����渇�膩��鐃緒申鐃緒申羝�申鐃遵�������渇���申��申鐃緒申鐃緒申鐃醇柑鐃初���申鐃緒申�渇�膩��鐃醇�鐃初�鐃�鐃緒��鰹申羝�申��申鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃緒申羇誌申���鐃緒申鐃緒申����活�鐃緒申鐃緒申鐃緒申羝�申����渇�膩��鐃緒申鐃緒申羝�申鐃緒申鐃�??鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃緒申羇誌申���鐃緒申鐃緒申��申鐃緒申鐃緒申鐃緒申�鰹申薜合���申?鐃緒��鰹申羝�申��申t spots",PRECOCIOUS PUBERTY,MCCUNE-ALBRIGHT SYNDROME,RO-disease_has_finding
497762786,7/4/2014 06:54:55,,1314658274,7/4/2014 06:54:30,clixsense,0.0,27969116,NLD,,,91.213.37.165,PRECOCIOUS PUBERTY causes MCCUNE-ALBRIGHT SYNDROME,88,0,,106,24,causes,0.9799578870000001,901704-FS1-4,"MCCUNE-ALBRIGHT SYNDROME (MAS) is a rare disorder characterized by the classic triad of PRECOCIOUS PUBERTY, polyostotic fibrous dysplasia and caf????����鰹申��申���鐃初�膩��鐃緒申鐃緒申鐔顔��э申?鐃緒��鰹申羝�申����渇���申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃初�鐃�??����渇���申��申鐃緒申鐃緒申鐃緒申??鐃緒��鰹申羝�申��申?鐃緒申�鰹申羝�申���鐃初���申鐃緒申鐃緒申薜合����鐃�鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃�����鰹申��申���鐃初�膩��鐃緒申????����鰹申薜合�����渇�膩��鐃緒申鐃緒申羝�申鐃遵�������渇���申��申鐃緒申鐃緒申鐃醇柑鐃初���申鐃緒申�渇�膩��鐃醇�鐃初�鐃�鐃緒��鰹申羝�申��申鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃緒申羇誌申���鐃緒申鐃緒申����活�鐃緒申鐃緒申鐃緒申羝�申����渇�膩��鐃緒申鐃緒申羝�申鐃緒申鐃�??鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃緒申羇誌申���鐃緒申鐃緒申��申鐃緒申鐃緒申鐃緒申�鰹申薜合���申?鐃緒��鰹申羝�申��申t spots",PRECOCIOUS PUBERTY,MCCUNE-ALBRIGHT SYNDROME,RO-disease_has_finding
497762786,7/4/2014 07:10:44,,1314668876,7/4/2014 07:10:06,clixsense,0.0,19190439,GBR,H9,London,86.15.32.131,MCCUNE-ALBRIGHT SYNDROME causes PRECOCIOUS PUBERTY,88,0,,106,24,causes,0.9799578870000001,901704-FS1-4,"MCCUNE-ALBRIGHT SYNDROME (MAS) is a rare disorder characterized by the classic triad of PRECOCIOUS PUBERTY, polyostotic fibrous dysplasia and caf????����鰹申��申���鐃初�膩��鐃緒申鐃緒申鐔顔��э申?鐃緒��鰹申羝�申����渇���申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃初�鐃�??����渇���申��申鐃緒申鐃緒申鐃緒申??鐃緒��鰹申羝�申��申?鐃緒申�鰹申羝�申���鐃初���申鐃緒申鐃緒申薜合����鐃�鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃�����鰹申��申���鐃初�膩��鐃緒申????����鰹申薜合�����渇�膩��鐃緒申鐃緒申羝�申鐃遵�������渇���申��申鐃緒申鐃緒申鐃醇柑鐃初���申鐃緒申�渇�膩��鐃醇�鐃初�鐃�鐃緒��鰹申羝�申��申鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃緒申羇誌申���鐃緒申鐃緒申����活�鐃緒申鐃緒申鐃緒申羝�申����渇�膩��鐃緒申鐃緒申羝�申鐃緒申鐃�??鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃緒申羇誌申���鐃緒申鐃緒申��申鐃緒申鐃緒申鐃緒申�鰹申薜合���申?鐃緒��鰹申羝�申��申t spots",PRECOCIOUS PUBERTY,MCCUNE-ALBRIGHT SYNDROME,RO-disease_has_finding
497762786,7/4/2014 08:07:16,,1314695430,7/4/2014 08:06:57,clixsense,0.0,23138831,NLD,,,77.174.95.58,no_relation,88,0,,106,24,causes,0.9799578870000001,901704-FS1-4,"MCCUNE-ALBRIGHT SYNDROME (MAS) is a rare disorder characterized by the classic triad of PRECOCIOUS PUBERTY, polyostotic fibrous dysplasia and caf????����鰹申��申���鐃初�膩��鐃緒申鐃緒申鐔顔��э申?鐃緒��鰹申羝�申����渇���申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃初�鐃�??����渇���申��申鐃緒申鐃緒申鐃緒申??鐃緒��鰹申羝�申��申?鐃緒申�鰹申羝�申���鐃初���申鐃緒申鐃緒申薜合����鐃�鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃�����鰹申��申���鐃初�膩��鐃緒申????����鰹申薜合�����渇�膩��鐃緒申鐃緒申羝�申鐃遵�������渇���申��申鐃緒申鐃緒申鐃醇柑鐃初���申鐃緒申�渇�膩��鐃醇�鐃初�鐃�鐃緒��鰹申羝�申��申鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃緒申羇誌申���鐃緒申鐃緒申����活�鐃緒申鐃緒申鐃緒申羝�申����渇�膩��鐃緒申鐃緒申羝�申鐃緒申鐃�??鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃緒申羇誌申���鐃緒申鐃緒申��申鐃緒申鐃緒申鐃緒申�鰹申薜合���申?鐃緒��鰹申羝�申��申t spots",PRECOCIOUS PUBERTY,MCCUNE-ALBRIGHT SYNDROME,RO-disease_has_finding
497762786,7/4/2014 08:38:30,,1314709822,7/4/2014 08:38:16,prodege,0.0,15439740,AUS,2,Jannali,27.96.208.89,PRECOCIOUS PUBERTY causes MCCUNE-ALBRIGHT SYNDROME,88,0,,106,24,causes,0.9799578870000001,901704-FS1-4,"MCCUNE-ALBRIGHT SYNDROME (MAS) is a rare disorder characterized by the classic triad of PRECOCIOUS PUBERTY, polyostotic fibrous dysplasia and caf????����鰹申��申���鐃初�膩��鐃緒申鐃緒申鐔顔��э申?鐃緒��鰹申羝�申����渇���申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃初�鐃�??����渇���申��申鐃緒申鐃緒申鐃緒申??鐃緒��鰹申羝�申��申?鐃緒申�鰹申羝�申���鐃初���申鐃緒申鐃緒申薜合����鐃�鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃�����鰹申��申���鐃初�膩��鐃緒申????����鰹申薜合�����渇�膩��鐃緒申鐃緒申羝�申鐃遵�������渇���申��申鐃緒申鐃緒申鐃醇柑鐃初���申鐃緒申�渇�膩��鐃醇�鐃初�鐃�鐃緒��鰹申羝�申��申鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃緒申羇誌申���鐃緒申鐃緒申����活�鐃緒申鐃緒申鐃緒申羝�申����渇�膩��鐃緒申鐃緒申羝�申鐃緒申鐃�??鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃緒申羇誌申���鐃緒申鐃緒申��申鐃緒申鐃緒申鐃緒申�鰹申薜合���申?鐃緒��鰹申羝�申��申t spots",PRECOCIOUS PUBERTY,MCCUNE-ALBRIGHT SYNDROME,RO-disease_has_finding
497762786,7/4/2014 09:12:49,,1314726602,7/4/2014 09:12:03,eup_slw,0.0,21338859,GBR,K6,Portsmouth,86.6.113.168,no_relation,88,0,,106,24,causes,0.9799578870000001,901704-FS1-4,"MCCUNE-ALBRIGHT SYNDROME (MAS) is a rare disorder characterized by the classic triad of PRECOCIOUS PUBERTY, polyostotic fibrous dysplasia and caf????����鰹申��申���鐃初�膩��鐃緒申鐃緒申鐔顔��э申?鐃緒��鰹申羝�申����渇���申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃初�鐃�??����渇���申��申鐃緒申鐃緒申鐃緒申??鐃緒��鰹申羝�申��申?鐃緒申�鰹申羝�申���鐃初���申鐃緒申鐃緒申薜合����鐃�鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃�����鰹申��申���鐃初�膩��鐃緒申????����鰹申薜合�����渇�膩��鐃緒申鐃緒申羝�申鐃遵�������渇���申��申鐃緒申鐃緒申鐃醇柑鐃初���申鐃緒申�渇�膩��鐃醇�鐃初�鐃�鐃緒��鰹申羝�申��申鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃緒申羇誌申���鐃緒申鐃緒申����活�鐃緒申鐃緒申鐃緒申羝�申����渇�膩��鐃緒申鐃緒申羝�申鐃緒申鐃�??鐃緒��鰹申羝�申鐃緒申�渇���申鐃醇�鐃処�鐃緒申鐃緒申鐃初���申��申鐃初�膩�����鐃処�鐃緒申鐃緒申鐃緒申羇誌申���鐃緒申鐃緒申��申鐃緒申鐃緒申鐃緒申�鰹申薜合���申?鐃緒��鰹申羝�申��申t spots",PRECOCIOUS PUBERTY,MCCUNE-ALBRIGHT SYNDROME,RO-disease_has_finding
502250152,7/11/2014 13:43:03,,1320737029,7/11/2014 13:42:49,clixsense,0.9583,17950689,GBR,X5,Cardiff,89.168.38.216,DIABETIC POLYNEUROPATHY causes DIABETES,184,117,,207,125,causes,0.7559289460184542,900367-FS1-4,"15   In this study and other large studies, the prevalence of diabetic polyneuropathy increased with the duration of DIABETES, and a strong correlation existed between the presence of DIABETIC POLYNEUROPATHY, retinopathy, and nephropathy",DIABETIC POLYNEUROPATHY,DIABETES,RO-disease_may_have_finding
502250152,7/11/2014 13:51:26,,1320740034,7/11/2014 13:51:19,clixsense,0.5764,19162475,GBR,M3,Frome,82.33.126.30,DIABETIC POLYNEUROPATHY causes DIABETES,184,117,,207,125,causes,0.7559289460184542,900367-FS1-4,"15   In this study and other large studies, the prevalence of diabetic polyneuropathy increased with the duration of DIABETES, and a strong correlation existed between the presence of DIABETIC POLYNEUROPATHY, retinopathy, and nephropathy",DIABETIC POLYNEUROPATHY,DIABETES,RO-disease_may_have_finding
502250152,7/11/2014 14:04:31,,1320744954,7/11/2014 14:03:52,vivatic,0.6889,25451531,GBR,,,83.67.28.193,DIABETES causes DIABETIC POLYNEUROPATHY,184,117,,207,125,causes,0.7559289460184542,900367-FS1-4,"15   In this study and other large studies, the prevalence of diabetic polyneuropathy increased with the duration of DIABETES, and a strong correlation existed between the presence of DIABETIC POLYNEUROPATHY, retinopathy, and nephropathy",DIABETIC POLYNEUROPATHY,DIABETES,RO-disease_may_have_finding
502250152,7/11/2014 14:20:37,,1320751418,7/11/2014 14:19:36,gifthulk,0.4155,20382530,CAN,ON,Hamilton,216.209.129.7,no_relation,184,117,,207,125,causes,0.7559289460184542,900367-FS1-4,"15   In this study and other large studies, the prevalence of diabetic polyneuropathy increased with the duration of DIABETES, and a strong correlation existed between the presence of DIABETIC POLYNEUROPATHY, retinopathy, and nephropathy",DIABETIC POLYNEUROPATHY,DIABETES,RO-disease_may_have_finding
502250152,7/11/2014 14:23:40,,1320752549,7/11/2014 14:23:12,zoombucks,0.5657,5919735,USA,PA,Doylestown,173.49.91.231,DIABETES causes DIABETIC POLYNEUROPATHY,184,117,,207,125,causes,0.7559289460184542,900367-FS1-4,"15   In this study and other large studies, the prevalence of diabetic polyneuropathy increased with the duration of DIABETES, and a strong correlation existed between the presence of DIABETIC POLYNEUROPATHY, retinopathy, and nephropathy",DIABETIC POLYNEUROPATHY,DIABETES,RO-disease_may_have_finding
502250152,7/11/2014 14:36:11,,1320757469,7/11/2014 14:35:49,clixsense,0.6339,25595227,CAN,SK,North Battleford,24.72.96.119,DIABETES causes DIABETIC POLYNEUROPATHY,184,117,,207,125,causes,0.7559289460184542,900367-FS1-4,"15   In this study and other large studies, the prevalence of diabetic polyneuropathy increased with the duration of DIABETES, and a strong correlation existed between the presence of DIABETIC POLYNEUROPATHY, retinopathy, and nephropathy",DIABETIC POLYNEUROPATHY,DIABETES,RO-disease_may_have_finding
502250152,7/11/2014 14:37:56,,1320758180,7/11/2014 14:37:05,instagc,0.5833,19874561,GBR,C3,Saint Ives,80.4.147.14,no_relation,184,117,,207,125,causes,0.7559289460184542,900367-FS1-4,"15   In this study and other large studies, the prevalence of diabetic polyneuropathy increased with the duration of DIABETES, and a strong correlation existed between the presence of DIABETIC POLYNEUROPATHY, retinopathy, and nephropathy",DIABETIC POLYNEUROPATHY,DIABETES,RO-disease_may_have_finding
502250155,7/11/2014 13:43:28,,1320737201,7/11/2014 13:43:04,clixsense,0.9583,17950689,GBR,X5,Cardiff,89.168.38.216,PRECOCIOUS PUBERTY causes MCCUNE-ALBRIGHT SYNDROME,69,4,,87,28,causes,1.0,901675-FS1-4,"The MCCUNE-ALBRIGHT SYNDROME is characterized by cafe-au-lait spots, PRECOCIOUS PUBERTY and fibrous dysplasia",PRECOCIOUS PUBERTY,MCCUNE-ALBRIGHT SYNDROME,RO-disease_may_have_finding
502250155,7/11/2014 13:50:51,,1320739902,7/11/2014 13:50:45,clixsense,0.5764,19162475,GBR,M3,Frome,82.33.126.30,PRECOCIOUS PUBERTY causes MCCUNE-ALBRIGHT SYNDROME,69,4,,87,28,causes,1.0,901675-FS1-4,"The MCCUNE-ALBRIGHT SYNDROME is characterized by cafe-au-lait spots, PRECOCIOUS PUBERTY and fibrous dysplasia",PRECOCIOUS PUBERTY,MCCUNE-ALBRIGHT SYNDROME,RO-disease_may_have_finding
502250155,7/11/2014 14:01:13,,1320743551,7/11/2014 14:00:19,vivatic,0.6889,25451531,GBR,,,83.67.28.193,MCCUNE-ALBRIGHT SYNDROME causes PRECOCIOUS PUBERTY,69,4,,87,28,causes,1.0,901675-FS1-4,"The MCCUNE-ALBRIGHT SYNDROME is characterized by cafe-au-lait spots, PRECOCIOUS PUBERTY and fibrous dysplasia",PRECOCIOUS PUBERTY,MCCUNE-ALBRIGHT SYNDROME,RO-disease_may_have_finding
502250155,7/11/2014 14:22:15,,1320752039,7/11/2014 14:21:29,gifthulk,0.4155,20382530,CAN,ON,Hamilton,216.209.129.7,no_relation,69,4,,87,28,causes,1.0,901675-FS1-4,"The MCCUNE-ALBRIGHT SYNDROME is characterized by cafe-au-lait spots, PRECOCIOUS PUBERTY and fibrous dysplasia",PRECOCIOUS PUBERTY,MCCUNE-ALBRIGHT SYNDROME,RO-disease_may_have_finding
502250155,7/11/2014 14:25:29,,1320753197,7/11/2014 14:25:01,prodege,0.5169,19192508,USA,OK,Broken Arrow,70.177.111.89,MCCUNE-ALBRIGHT SYNDROME causes PRECOCIOUS PUBERTY,69,4,,87,28,causes,1.0,901675-FS1-4,"The MCCUNE-ALBRIGHT SYNDROME is characterized by cafe-au-lait spots, PRECOCIOUS PUBERTY and fibrous dysplasia",PRECOCIOUS PUBERTY,MCCUNE-ALBRIGHT SYNDROME,RO-disease_may_have_finding
502250155,7/11/2014 14:30:49,,1320755204,7/11/2014 14:30:09,clixsense,0.6764,15189335,GBR,I9,Norwich,86.155.45.231,MCCUNE-ALBRIGHT SYNDROME causes PRECOCIOUS PUBERTY,69,4,,87,28,causes,1.0,901675-FS1-4,"The MCCUNE-ALBRIGHT SYNDROME is characterized by cafe-au-lait spots, PRECOCIOUS PUBERTY and fibrous dysplasia",PRECOCIOUS PUBERTY,MCCUNE-ALBRIGHT SYNDROME,RO-disease_may_have_finding
502250155,7/11/2014 14:31:58,,1320755637,7/11/2014 14:31:50,neodev,0.4786,25224036,CAN,ON,Sudbury,67.204.218.187,MCCUNE-ALBRIGHT SYNDROME causes PRECOCIOUS PUBERTY,69,4,,87,28,causes,1.0,901675-FS1-4,"The MCCUNE-ALBRIGHT SYNDROME is characterized by cafe-au-lait spots, PRECOCIOUS PUBERTY and fibrous dysplasia",PRECOCIOUS PUBERTY,MCCUNE-ALBRIGHT SYNDROME,RO-disease_may_have_finding
502250160,7/11/2014 14:32:01,,1320755661,7/11/2014 14:31:43,clixsense,0.6764,15189335,GBR,I9,Norwich,86.155.45.231,MULTICENTRIC CASTLEMAN'S DISEASE causes FEVER,32,80,,37,112,causes,0.979957887012223,901863-FS1-4,Generalized lymphadenopathy and FEVER appeared and the patient was diagnosed as MULTICENTRIC CASTLEMAN'S DISEASE (MCD) at 40 years of age,FEVER,MULTICENTRIC CASTLEMAN'S DISEASE,RO-disease_may_have_finding
502250160,7/11/2014 14:32:12,,1320755744,7/11/2014 14:32:06,neodev,0.4786,25224036,CAN,ON,Sudbury,67.204.218.187,FEVER causes MULTICENTRIC CASTLEMAN'S DISEASE,32,80,,37,112,causes,0.979957887012223,901863-FS1-4,Generalized lymphadenopathy and FEVER appeared and the patient was diagnosed as MULTICENTRIC CASTLEMAN'S DISEASE (MCD) at 40 years of age,FEVER,MULTICENTRIC CASTLEMAN'S DISEASE,RO-disease_may_have_finding
502250160,7/11/2014 14:34:43,,1320756813,7/11/2014 14:34:03,elite,0.5333,27385296,GBR,U8,Edinburgh,77.102.46.226,FEVER causes MULTICENTRIC CASTLEMAN'S DISEASE,32,80,,37,112,causes,0.979957887012223,901863-FS1-4,Generalized lymphadenopathy and FEVER appeared and the patient was diagnosed as MULTICENTRIC CASTLEMAN'S DISEASE (MCD) at 40 years of age,FEVER,MULTICENTRIC CASTLEMAN'S DISEASE,RO-disease_may_have_finding
502250160,7/11/2014 14:42:28,,1320759939,7/11/2014 14:42:05,prodege,0.6349,7664351,USA,NY,Cicero,74.111.0.21,MULTICENTRIC CASTLEMAN'S DISEASE causes FEVER,32,80,,37,112,causes,0.979957887012223,901863-FS1-4,Generalized lymphadenopathy and FEVER appeared and the patient was diagnosed as MULTICENTRIC CASTLEMAN'S DISEASE (MCD) at 40 years of age,FEVER,MULTICENTRIC CASTLEMAN'S DISEASE,RO-disease_may_have_finding
502250160,7/11/2014 14:51:05,,1320763359,7/11/2014 14:50:44,gifthulk,0.5328,22144176,GBR,U8,Edinburgh,129.215.149.97,no_relation,32,80,,37,112,causes,0.979957887012223,901863-FS1-4,Generalized lymphadenopathy and FEVER appeared and the patient was diagnosed as MULTICENTRIC CASTLEMAN'S DISEASE (MCD) at 40 years of age,FEVER,MULTICENTRIC CASTLEMAN'S DISEASE,RO-disease_may_have_finding
502250160,7/11/2014 14:53:06,,1320764108,7/11/2014 14:53:00,prodege,0.3571,18960400,GBR,A2,Edgware,31.54.207.221,FEVER causes MULTICENTRIC CASTLEMAN'S DISEASE,32,80,,37,112,causes,0.979957887012223,901863-FS1-4,Generalized lymphadenopathy and FEVER appeared and the patient was diagnosed as MULTICENTRIC CASTLEMAN'S DISEASE (MCD) at 40 years of age,FEVER,MULTICENTRIC CASTLEMAN'S DISEASE,RO-disease_may_have_finding
502250160,7/11/2014 14:58:55,,1320766556,7/11/2014 14:58:34,prodege,0.5833,1852770,USA,TX,Abilene,76.198.102.54,MULTICENTRIC CASTLEMAN'S DISEASE causes FEVER,32,80,,37,112,causes,0.979957887012223,901863-FS1-4,Generalized lymphadenopathy and FEVER appeared and the patient was diagnosed as MULTICENTRIC CASTLEMAN'S DISEASE (MCD) at 40 years of age,FEVER,MULTICENTRIC CASTLEMAN'S DISEASE,RO-disease_may_have_finding
502254069,7/11/2014 16:11:31,,1320798736,7/11/2014 16:10:36,prodege,0.7222,9559045,USA,TX,Katy,107.204.186.172,no_relation,101,86,,116,92,causes,0.676123403782813,900265-FS1-4,"The incidence and mortality, pathogenesis, clinical manifestations, and management of SEPSIS and the SEPSIS SYNDROME are reviewed, and the use of antiendotoxin monoclonal antibodies to treat patients with sepsis is discussed",SEPSIS SYNDROME,SEPSIS,RO-has_manifestation
502254069,7/11/2014 16:16:25,,1320800110,7/11/2014 16:16:03,clixsense,0.6375,25419319,GBR,H8,Liverpool,94.4.192.228,no_relation,101,86,,116,92,causes,0.676123403782813,900265-FS1-4,"The incidence and mortality, pathogenesis, clinical manifestations, and management of SEPSIS and the SEPSIS SYNDROME are reviewed, and the use of antiendotoxin monoclonal antibodies to treat patients with sepsis is discussed",SEPSIS SYNDROME,SEPSIS,RO-has_manifestation
502254069,7/11/2014 16:18:15,,1320800854,7/11/2014 16:17:19,clixsense,0.7097,27871219,NLD,7,Amsterdam,87.210.207.223,SEPSIS SYNDROME causes SEPSIS,101,86,,116,92,causes,0.676123403782813,900265-FS1-4,"The incidence and mortality, pathogenesis, clinical manifestations, and management of SEPSIS and the SEPSIS SYNDROME are reviewed, and the use of antiendotoxin monoclonal antibodies to treat patients with sepsis is discussed",SEPSIS SYNDROME,SEPSIS,RO-has_manifestation
502254069,7/11/2014 16:32:49,,1320805010,7/11/2014 16:32:32,clixsense,0.6942,6355977,NLD,7,Amsterdam,46.129.42.165,no_relation,101,86,,116,92,causes,0.676123403782813,900265-FS1-4,"The incidence and mortality, pathogenesis, clinical manifestations, and management of SEPSIS and the SEPSIS SYNDROME are reviewed, and the use of antiendotoxin monoclonal antibodies to treat patients with sepsis is discussed",SEPSIS SYNDROME,SEPSIS,RO-has_manifestation
502254069,7/11/2014 16:33:03,,1320805057,7/11/2014 16:32:50,clixsense,0.5175,27793793,GBR,C5,Chester,151.230.27.155,SEPSIS causes SEPSIS SYNDROME,101,86,,116,92,causes,0.676123403782813,900265-FS1-4,"The incidence and mortality, pathogenesis, clinical manifestations, and management of SEPSIS and the SEPSIS SYNDROME are reviewed, and the use of antiendotoxin monoclonal antibodies to treat patients with sepsis is discussed",SEPSIS SYNDROME,SEPSIS,RO-has_manifestation
502254069,7/11/2014 16:33:40,,1320805231,7/11/2014 16:33:20,zoombucks,0.6433,5919735,USA,PA,Doylestown,173.49.91.231,SEPSIS causes SEPSIS SYNDROME,101,86,,116,92,causes,0.676123403782813,900265-FS1-4,"The incidence and mortality, pathogenesis, clinical manifestations, and management of SEPSIS and the SEPSIS SYNDROME are reviewed, and the use of antiendotoxin monoclonal antibodies to treat patients with sepsis is discussed",SEPSIS SYNDROME,SEPSIS,RO-has_manifestation
502254069,7/11/2014 16:36:24,,1320806446,7/11/2014 16:36:18,clixsense,0.3913,19162475,GBR,M3,Frome,82.33.126.30,SEPSIS causes SEPSIS SYNDROME,101,86,,116,92,causes,0.676123403782813,900265-FS1-4,"The incidence and mortality, pathogenesis, clinical manifestations, and management of SEPSIS and the SEPSIS SYNDROME are reviewed, and the use of antiendotoxin monoclonal antibodies to treat patients with sepsis is discussed",SEPSIS SYNDROME,SEPSIS,RO-has_manifestation
502254073,7/11/2014 16:06:54,,1320796949,7/11/2014 16:06:25,neodev,0.7097,18755947,GBR,H2,Accrington,80.47.185.52,no_relation,156,67,,177,82,causes,0.452267016866645,900001-FS1-4,This case provides further evidence of a genetic predisposition to RHEUMATIC FEVER and demonstrates the continued value of penicillin in the prophylaxis of ACUTE RHEUMATIC FEVER,ACUTE RHEUMATIC FEVER,RHEUMATIC FEVER,RO-has_manifestation
502254073,7/11/2014 16:08:20,,1320797441,7/11/2014 16:07:33,instagc,0.8333,13763729,USA,,,75.182.89.225,RHEUMATIC FEVER causes ACUTE RHEUMATIC FEVER,156,67,,177,82,causes,0.452267016866645,900001-FS1-4,This case provides further evidence of a genetic predisposition to RHEUMATIC FEVER and demonstrates the continued value of penicillin in the prophylaxis of ACUTE RHEUMATIC FEVER,ACUTE RHEUMATIC FEVER,RHEUMATIC FEVER,RO-has_manifestation
502254073,7/11/2014 16:19:26,,1320801168,7/11/2014 16:18:42,clixsense,0.7097,27871219,NLD,7,Amsterdam,87.210.207.223,RHEUMATIC FEVER causes ACUTE RHEUMATIC FEVER,156,67,,177,82,causes,0.452267016866645,900001-FS1-4,This case provides further evidence of a genetic predisposition to RHEUMATIC FEVER and demonstrates the continued value of penicillin in the prophylaxis of ACUTE RHEUMATIC FEVER,ACUTE RHEUMATIC FEVER,RHEUMATIC FEVER,RO-has_manifestation
502254073,7/11/2014 16:25:33,,1320802825,7/11/2014 16:24:53,elite,0.6389,27788262,USA,,,172.162.25.242,no_relation,156,67,,177,82,causes,0.452267016866645,900001-FS1-4,This case provides further evidence of a genetic predisposition to RHEUMATIC FEVER and demonstrates the continued value of penicillin in the prophylaxis of ACUTE RHEUMATIC FEVER,ACUTE RHEUMATIC FEVER,RHEUMATIC FEVER,RO-has_manifestation
502254073,7/11/2014 16:27:55,,1320803469,7/11/2014 16:27:41,clixsense,0.3913,19162475,GBR,M3,Frome,82.33.126.30,ACUTE RHEUMATIC FEVER causes RHEUMATIC FEVER,156,67,,177,82,causes,0.452267016866645,900001-FS1-4,This case provides further evidence of a genetic predisposition to RHEUMATIC FEVER and demonstrates the continued value of penicillin in the prophylaxis of ACUTE RHEUMATIC FEVER,ACUTE RHEUMATIC FEVER,RHEUMATIC FEVER,RO-has_manifestation
502254073,7/11/2014 16:28:41,,1320803740,7/11/2014 16:27:49,clixsense,0.5833,26283440,GBR,C7,Coventry,86.20.175.18,no_relation,156,67,,177,82,causes,0.452267016866645,900001-FS1-4,This case provides further evidence of a genetic predisposition to RHEUMATIC FEVER and demonstrates the continued value of penicillin in the prophylaxis of ACUTE RHEUMATIC FEVER,ACUTE RHEUMATIC FEVER,RHEUMATIC FEVER,RO-has_manifestation
502254073,7/11/2014 16:32:16,,1320804836,7/11/2014 16:31:54,zoombucks,0.6433,5919735,USA,PA,Doylestown,173.49.91.231,no_relation,156,67,,177,82,causes,0.452267016866645,900001-FS1-4,This case provides further evidence of a genetic predisposition to RHEUMATIC FEVER and demonstrates the continued value of penicillin in the prophylaxis of ACUTE RHEUMATIC FEVER,ACUTE RHEUMATIC FEVER,RHEUMATIC FEVER,RO-has_manifestation
502254074,7/11/2014 16:16:01,,1320800007,7/11/2014 16:15:29,clixsense,0.6375,25419319,GBR,H8,Liverpool,94.4.192.228,no_relation,64,43,,85,59,causes,0.42426406871192895,900031-FS1-4,"They include increased oxygen consumption, HYPERVENTILATION and RESPIRATORY ALKALOSIS; increased cardiac output, systemic peripheral resistance and blood pressure; delayed gastric emptying; impaired uterine contractility and diminished uterine perfusion; and metabolic acidaemia",RESPIRATORY ALKALOSIS,HYPERVENTILATION,RO-has_manifestation
502254074,7/11/2014 16:21:50,,1320801792,7/11/2014 16:21:34,neodev,0.7097,18755947,GBR,H2,Accrington,80.47.185.52,no_relation,64,43,,85,59,causes,0.42426406871192895,900031-FS1-4,"They include increased oxygen consumption, HYPERVENTILATION and RESPIRATORY ALKALOSIS; increased cardiac output, systemic peripheral resistance and blood pressure; delayed gastric emptying; impaired uterine contractility and diminished uterine perfusion; and metabolic acidaemia",RESPIRATORY ALKALOSIS,HYPERVENTILATION,RO-has_manifestation
502254074,7/11/2014 16:29:51,,1320804140,7/11/2014 16:29:38,clixsense,0.3913,19162475,GBR,M3,Frome,82.33.126.30,RESPIRATORY ALKALOSIS causes HYPERVENTILATION,64,43,,85,59,causes,0.42426406871192895,900031-FS1-4,"They include increased oxygen consumption, HYPERVENTILATION and RESPIRATORY ALKALOSIS; increased cardiac output, systemic peripheral resistance and blood pressure; delayed gastric emptying; impaired uterine contractility and diminished uterine perfusion; and metabolic acidaemia",RESPIRATORY ALKALOSIS,HYPERVENTILATION,RO-has_manifestation
502254074,7/11/2014 16:32:21,,1320804861,7/11/2014 16:32:06,clixsense,0.5175,27793793,GBR,C5,Chester,151.230.27.155,no_relation,64,43,,85,59,causes,0.42426406871192895,900031-FS1-4,"They include increased oxygen consumption, HYPERVENTILATION and RESPIRATORY ALKALOSIS; increased cardiac output, systemic peripheral resistance and blood pressure; delayed gastric emptying; impaired uterine contractility and diminished uterine perfusion; and metabolic acidaemia",RESPIRATORY ALKALOSIS,HYPERVENTILATION,RO-has_manifestation
502254074,7/11/2014 16:32:30,,1320804908,7/11/2014 16:32:18,zoombucks,0.6433,5919735,USA,PA,Doylestown,173.49.91.231,no_relation,64,43,,85,59,causes,0.42426406871192895,900031-FS1-4,"They include increased oxygen consumption, HYPERVENTILATION and RESPIRATORY ALKALOSIS; increased cardiac output, systemic peripheral resistance and blood pressure; delayed gastric emptying; impaired uterine contractility and diminished uterine perfusion; and metabolic acidaemia",RESPIRATORY ALKALOSIS,HYPERVENTILATION,RO-has_manifestation
502254074,7/11/2014 16:37:16,,1320806669,7/11/2014 16:37:05,prodege,0.373,2143114,CAN,BC,Vancouver,24.84.160.12,HYPERVENTILATION causes RESPIRATORY ALKALOSIS,64,43,,85,59,causes,0.42426406871192895,900031-FS1-4,"They include increased oxygen consumption, HYPERVENTILATION and RESPIRATORY ALKALOSIS; increased cardiac output, systemic peripheral resistance and blood pressure; delayed gastric emptying; impaired uterine contractility and diminished uterine perfusion; and metabolic acidaemia",RESPIRATORY ALKALOSIS,HYPERVENTILATION,RO-has_manifestation
502254074,7/11/2014 16:38:02,,1320806926,7/11/2014 16:37:39,instagc,0.7067,28301350,GBR,K4,Plymouth,78.145.138.230,no_relation,64,43,,85,59,causes,0.42426406871192895,900031-FS1-4,"They include increased oxygen consumption, HYPERVENTILATION and RESPIRATORY ALKALOSIS; increased cardiac output, systemic peripheral resistance and blood pressure; delayed gastric emptying; impaired uterine contractility and diminished uterine perfusion; and metabolic acidaemia",RESPIRATORY ALKALOSIS,HYPERVENTILATION,RO-has_manifestation
502254078,7/11/2014 16:07:28,,1320797169,7/11/2014 16:06:55,neodev,0.7097,18755947,GBR,H2,Accrington,80.47.185.52,INFECTIOUS MONONUCLEOSIS causes LYMPHADENOPATHY,61,31,,76,55,causes,0.875189948987367,901800-FS1-4,"Acute toxoplasmosis  may mimic INFECTIOUS MONONUCLEOSIS with LYMPHADENOPATHY, fever, malaise, myalgia, hepatosplenomegaly, and less commonly, pharyngitis",LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS,RO-has_manifestation
502254078,7/11/2014 16:16:25,,1320800111,7/11/2014 16:16:03,clixsense,0.6375,25419319,GBR,H8,Liverpool,94.4.192.228,INFECTIOUS MONONUCLEOSIS causes LYMPHADENOPATHY,61,31,,76,55,causes,0.875189948987367,901800-FS1-4,"Acute toxoplasmosis  may mimic INFECTIOUS MONONUCLEOSIS with LYMPHADENOPATHY, fever, malaise, myalgia, hepatosplenomegaly, and less commonly, pharyngitis",LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS,RO-has_manifestation
502254078,7/11/2014 16:26:42,,1320803127,7/11/2014 16:26:04,elite,0.6389,27788262,USA,,,172.162.25.242,no_relation,61,31,,76,55,causes,0.875189948987367,901800-FS1-4,"Acute toxoplasmosis  may mimic INFECTIOUS MONONUCLEOSIS with LYMPHADENOPATHY, fever, malaise, myalgia, hepatosplenomegaly, and less commonly, pharyngitis",LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS,RO-has_manifestation
502254078,7/11/2014 16:32:30,,1320804907,7/11/2014 16:32:18,zoombucks,0.6433,5919735,USA,PA,Doylestown,173.49.91.231,no_relation,61,31,,76,55,causes,0.875189948987367,901800-FS1-4,"Acute toxoplasmosis  may mimic INFECTIOUS MONONUCLEOSIS with LYMPHADENOPATHY, fever, malaise, myalgia, hepatosplenomegaly, and less commonly, pharyngitis",LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS,RO-has_manifestation
502254078,7/11/2014 16:33:35,,1320805213,7/11/2014 16:33:15,clixsense,0.6942,6355977,NLD,7,Amsterdam,46.129.42.165,no_relation,61,31,,76,55,causes,0.875189948987367,901800-FS1-4,"Acute toxoplasmosis  may mimic INFECTIOUS MONONUCLEOSIS with LYMPHADENOPATHY, fever, malaise, myalgia, hepatosplenomegaly, and less commonly, pharyngitis",LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS,RO-has_manifestation
502254078,7/11/2014 16:39:10,,1320807190,7/11/2014 16:38:52,instagc,0.7067,28301350,GBR,K4,Plymouth,78.145.138.230,no_relation,61,31,,76,55,causes,0.875189948987367,901800-FS1-4,"Acute toxoplasmosis  may mimic INFECTIOUS MONONUCLEOSIS with LYMPHADENOPATHY, fever, malaise, myalgia, hepatosplenomegaly, and less commonly, pharyngitis",LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS,RO-has_manifestation
502254078,7/11/2014 16:52:14,,1320811253,7/11/2014 16:51:57,prodege,0.4524,12944140,GBR,C8,Croydon,92.21.54.140,no_relation,61,31,,76,55,causes,0.875189948987367,901800-FS1-4,"Acute toxoplasmosis  may mimic INFECTIOUS MONONUCLEOSIS with LYMPHADENOPATHY, fever, malaise, myalgia, hepatosplenomegaly, and less commonly, pharyngitis",LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS,RO-has_manifestation
502254080,7/11/2014 16:06:54,,1320796935,7/11/2014 16:06:25,neodev,0.7097,18755947,GBR,H2,Accrington,80.47.185.52,HYPERTENSIVE DISEASE causes HYPERTENSIVE CRISIS,61,122,,81,141,causes,0.857492925712544,901765-FS1-4,The blood antidiuretic activity was studied in patients with HYPERTENSIVE DISEASE in a period between crises and during a HYPERTENSIVE CRISIS,HYPERTENSIVE DISEASE,HYPERTENSIVE CRISIS,RO-has_manifestation
502254080,7/11/2014 16:08:43,,1320797560,7/11/2014 16:08:21,instagc,0.8333,13763729,USA,,,75.182.89.225,no_relation,61,122,,81,141,causes,0.857492925712544,901765-FS1-4,The blood antidiuretic activity was studied in patients with HYPERTENSIVE DISEASE in a period between crises and during a HYPERTENSIVE CRISIS,HYPERTENSIVE DISEASE,HYPERTENSIVE CRISIS,RO-has_manifestation
502254080,7/11/2014 16:15:29,,1320799869,7/11/2014 16:14:35,clixsense,0.6375,25419319,GBR,H8,Liverpool,94.4.192.228,HYPERTENSIVE DISEASE causes HYPERTENSIVE CRISIS,61,122,,81,141,causes,0.857492925712544,901765-FS1-4,The blood antidiuretic activity was studied in patients with HYPERTENSIVE DISEASE in a period between crises and during a HYPERTENSIVE CRISIS,HYPERTENSIVE DISEASE,HYPERTENSIVE CRISIS,RO-has_manifestation
502254080,7/11/2014 16:18:41,,1320800956,7/11/2014 16:18:16,clixsense,0.7097,27871219,NLD,7,Amsterdam,87.210.207.223,HYPERTENSIVE DISEASE causes HYPERTENSIVE CRISIS,61,122,,81,141,causes,0.857492925712544,901765-FS1-4,The blood antidiuretic activity was studied in patients with HYPERTENSIVE DISEASE in a period between crises and during a HYPERTENSIVE CRISIS,HYPERTENSIVE DISEASE,HYPERTENSIVE CRISIS,RO-has_manifestation
502254080,7/11/2014 16:28:24,,1320803647,7/11/2014 16:28:05,clixsense,0.3913,19162475,GBR,M3,Frome,82.33.126.30,HYPERTENSIVE DISEASE causes HYPERTENSIVE CRISIS,61,122,,81,141,causes,0.857492925712544,901765-FS1-4,The blood antidiuretic activity was studied in patients with HYPERTENSIVE DISEASE in a period between crises and during a HYPERTENSIVE CRISIS,HYPERTENSIVE DISEASE,HYPERTENSIVE CRISIS,RO-has_manifestation
502254080,7/11/2014 16:32:33,,1320804912,7/11/2014 16:32:22,clixsense,0.5175,27793793,GBR,C5,Chester,151.230.27.155,HYPERTENSIVE DISEASE causes HYPERTENSIVE CRISIS,61,122,,81,141,causes,0.857492925712544,901765-FS1-4,The blood antidiuretic activity was studied in patients with HYPERTENSIVE DISEASE in a period between crises and during a HYPERTENSIVE CRISIS,HYPERTENSIVE DISEASE,HYPERTENSIVE CRISIS,RO-has_manifestation
502254080,7/11/2014 16:38:52,,1320807126,7/11/2014 16:38:33,instagc,0.7067,28301350,GBR,K4,Plymouth,78.145.138.230,HYPERTENSIVE DISEASE causes HYPERTENSIVE CRISIS,61,122,,81,141,causes,0.857492925712544,901765-FS1-4,The blood antidiuretic activity was studied in patients with HYPERTENSIVE DISEASE in a period between crises and during a HYPERTENSIVE CRISIS,HYPERTENSIVE DISEASE,HYPERTENSIVE CRISIS,RO-has_manifestation
497243647,7/2/2014 17:28:40,,1313102564,7/2/2014 17:28:19,prodege,0,14890188,GBR,C5,Crewe,151.230.22.222,DYSPLASIA causes FAMILIAL ADENOMATOUS POLYPOSIS,70,25,,79,55,causes,0.768221279597376,901680-FS1-4,"We report a patient with FAMILIAL ADENOMATOUS POLYPOSIS who developed DYSPLASIA in a large exophytic hyperplastic gastric tumor that appeared to arise on a background of diffuse fundic gland polyposis and presented with anemia, hypoalbuminemia, and a protein-losing enteropathy",DYSPLASIA,FAMILIAL ADENOMATOUS POLYPOSIS,RO-disease_has_finding
497243647,7/2/2014 17:40:50,,1313114360,7/2/2014 17:40:05,prodege,0,14848125,GBR,V2,Glasgow,86.130.194.252,FAMILIAL ADENOMATOUS POLYPOSIS causes DYSPLASIA,70,25,,79,55,causes,0.768221279597376,901680-FS1-4,"We report a patient with FAMILIAL ADENOMATOUS POLYPOSIS who developed DYSPLASIA in a large exophytic hyperplastic gastric tumor that appeared to arise on a background of diffuse fundic gland polyposis and presented with anemia, hypoalbuminemia, and a protein-losing enteropathy",DYSPLASIA,FAMILIAL ADENOMATOUS POLYPOSIS,RO-disease_has_finding
497243647,7/2/2014 18:26:39,,1313158720,7/2/2014 18:26:29,prodege,0,2143114,CAN,BC,Vancouver,24.84.160.12,DYSPLASIA causes FAMILIAL ADENOMATOUS POLYPOSIS,70,25,,79,55,causes,0.768221279597376,901680-FS1-4,"We report a patient with FAMILIAL ADENOMATOUS POLYPOSIS who developed DYSPLASIA in a large exophytic hyperplastic gastric tumor that appeared to arise on a background of diffuse fundic gland polyposis and presented with anemia, hypoalbuminemia, and a protein-losing enteropathy",DYSPLASIA,FAMILIAL ADENOMATOUS POLYPOSIS,RO-disease_has_finding
497243647,7/2/2014 18:27:40,,1313159606,7/2/2014 18:27:30,neodev,0,22098386,GBR,,,213.160.119.242,DYSPLASIA causes FAMILIAL ADENOMATOUS POLYPOSIS,70,25,,79,55,causes,0.768221279597376,901680-FS1-4,"We report a patient with FAMILIAL ADENOMATOUS POLYPOSIS who developed DYSPLASIA in a large exophytic hyperplastic gastric tumor that appeared to arise on a background of diffuse fundic gland polyposis and presented with anemia, hypoalbuminemia, and a protein-losing enteropathy",DYSPLASIA,FAMILIAL ADENOMATOUS POLYPOSIS,RO-disease_has_finding
497243647,7/2/2014 20:43:33,,1313360658,7/2/2014 20:43:07,prodege,0,20018366,GBR,K8,Ilford,86.167.106.124,FAMILIAL ADENOMATOUS POLYPOSIS causes DYSPLASIA,70,25,,79,55,causes,0.768221279597376,901680-FS1-4,"We report a patient with FAMILIAL ADENOMATOUS POLYPOSIS who developed DYSPLASIA in a large exophytic hyperplastic gastric tumor that appeared to arise on a background of diffuse fundic gland polyposis and presented with anemia, hypoalbuminemia, and a protein-losing enteropathy",DYSPLASIA,FAMILIAL ADENOMATOUS POLYPOSIS,RO-disease_has_finding
497243647,7/2/2014 21:45:12,,1313403177,7/2/2014 21:45:02,clixsense,0,17950689,GBR,X5,Cardiff,89.168.38.216,FAMILIAL ADENOMATOUS POLYPOSIS causes DYSPLASIA,70,25,,79,55,causes,0.768221279597376,901680-FS1-4,"We report a patient with FAMILIAL ADENOMATOUS POLYPOSIS who developed DYSPLASIA in a large exophytic hyperplastic gastric tumor that appeared to arise on a background of diffuse fundic gland polyposis and presented with anemia, hypoalbuminemia, and a protein-losing enteropathy",DYSPLASIA,FAMILIAL ADENOMATOUS POLYPOSIS,RO-disease_has_finding
497243647,7/2/2014 22:44:29,,1313442210,7/2/2014 22:44:14,fepcrowdflower,0,17940235,GBR,X5,Cardiff,176.252.22.6,FAMILIAL ADENOMATOUS POLYPOSIS causes DYSPLASIA,70,25,,79,55,causes,0.768221279597376,901680-FS1-4,"We report a patient with FAMILIAL ADENOMATOUS POLYPOSIS who developed DYSPLASIA in a large exophytic hyperplastic gastric tumor that appeared to arise on a background of diffuse fundic gland polyposis and presented with anemia, hypoalbuminemia, and a protein-losing enteropathy",DYSPLASIA,FAMILIAL ADENOMATOUS POLYPOSIS,RO-disease_has_finding
497243647,7/3/2014 03:06:12,,1313604144,7/3/2014 03:05:32,instagc,0,23149109,USA,NC,Durham,75.189.206.205,DYSPLASIA causes FAMILIAL ADENOMATOUS POLYPOSIS,70,25,,79,55,causes,0.768221279597376,901680-FS1-4,"We report a patient with FAMILIAL ADENOMATOUS POLYPOSIS who developed DYSPLASIA in a large exophytic hyperplastic gastric tumor that appeared to arise on a background of diffuse fundic gland polyposis and presented with anemia, hypoalbuminemia, and a protein-losing enteropathy",DYSPLASIA,FAMILIAL ADENOMATOUS POLYPOSIS,RO-disease_has_finding
497243647,7/3/2014 03:25:47,,1313614813,7/3/2014 03:25:18,rewardsspot,0,17763704,USA,VA,Manassas,198.7.62.204,FAMILIAL ADENOMATOUS POLYPOSIS causes DYSPLASIA,70,25,,79,55,causes,0.768221279597376,901680-FS1-4,"We report a patient with FAMILIAL ADENOMATOUS POLYPOSIS who developed DYSPLASIA in a large exophytic hyperplastic gastric tumor that appeared to arise on a background of diffuse fundic gland polyposis and presented with anemia, hypoalbuminemia, and a protein-losing enteropathy",DYSPLASIA,FAMILIAL ADENOMATOUS POLYPOSIS,RO-disease_has_finding
497243647,7/3/2014 09:28:50,,1313837380,7/3/2014 09:28:17,clixsense,0,15189335,GBR,I9,Dereham,86.157.163.112,FAMILIAL ADENOMATOUS POLYPOSIS causes DYSPLASIA,70,25,,79,55,causes,0.768221279597376,901680-FS1-4,"We report a patient with FAMILIAL ADENOMATOUS POLYPOSIS who developed DYSPLASIA in a large exophytic hyperplastic gastric tumor that appeared to arise on a background of diffuse fundic gland polyposis and presented with anemia, hypoalbuminemia, and a protein-losing enteropathy",DYSPLASIA,FAMILIAL ADENOMATOUS POLYPOSIS,RO-disease_has_finding
497243647,7/3/2014 11:04:46,,1313902320,7/3/2014 11:04:02,vivatic,0,25451531,GBR,,,83.67.28.193,FAMILIAL ADENOMATOUS POLYPOSIS causes DYSPLASIA,70,25,,79,55,causes,0.768221279597376,901680-FS1-4,"We report a patient with FAMILIAL ADENOMATOUS POLYPOSIS who developed DYSPLASIA in a large exophytic hyperplastic gastric tumor that appeared to arise on a background of diffuse fundic gland polyposis and presented with anemia, hypoalbuminemia, and a protein-losing enteropathy",DYSPLASIA,FAMILIAL ADENOMATOUS POLYPOSIS,RO-disease_has_finding
497243647,7/3/2014 15:31:33,,1314052791,7/3/2014 15:31:21,prodege,0,18960400,GBR,H9,London,109.154.7.94,FAMILIAL ADENOMATOUS POLYPOSIS causes DYSPLASIA,70,25,,79,55,causes,0.768221279597376,901680-FS1-4,"We report a patient with FAMILIAL ADENOMATOUS POLYPOSIS who developed DYSPLASIA in a large exophytic hyperplastic gastric tumor that appeared to arise on a background of diffuse fundic gland polyposis and presented with anemia, hypoalbuminemia, and a protein-losing enteropathy",DYSPLASIA,FAMILIAL ADENOMATOUS POLYPOSIS,RO-disease_has_finding
497243647,7/3/2014 18:13:06,,1314193285,7/3/2014 18:12:47,instagc,0,19636746,USA,NY,Canandaigua,192.182.211.200,FAMILIAL ADENOMATOUS POLYPOSIS causes DYSPLASIA,70,25,,79,55,causes,0.768221279597376,901680-FS1-4,"We report a patient with FAMILIAL ADENOMATOUS POLYPOSIS who developed DYSPLASIA in a large exophytic hyperplastic gastric tumor that appeared to arise on a background of diffuse fundic gland polyposis and presented with anemia, hypoalbuminemia, and a protein-losing enteropathy",DYSPLASIA,FAMILIAL ADENOMATOUS POLYPOSIS,RO-disease_has_finding
497243647,7/3/2014 19:29:03,,1314251909,7/3/2014 19:28:42,clixsense,0,6331514,CAN,ON,Sault Sainte Marie,65.95.60.150,DYSPLASIA causes FAMILIAL ADENOMATOUS POLYPOSIS,70,25,,79,55,causes,0.768221279597376,901680-FS1-4,"We report a patient with FAMILIAL ADENOMATOUS POLYPOSIS who developed DYSPLASIA in a large exophytic hyperplastic gastric tumor that appeared to arise on a background of diffuse fundic gland polyposis and presented with anemia, hypoalbuminemia, and a protein-losing enteropathy",DYSPLASIA,FAMILIAL ADENOMATOUS POLYPOSIS,RO-disease_has_finding
497243647,7/3/2014 20:43:49,,1314323969,7/3/2014 20:42:54,bitcoinget,0,21490602,USA,NJ,Bound Brook,68.193.36.186,FAMILIAL ADENOMATOUS POLYPOSIS causes DYSPLASIA,70,25,,79,55,causes,0.768221279597376,901680-FS1-4,"We report a patient with FAMILIAL ADENOMATOUS POLYPOSIS who developed DYSPLASIA in a large exophytic hyperplastic gastric tumor that appeared to arise on a background of diffuse fundic gland polyposis and presented with anemia, hypoalbuminemia, and a protein-losing enteropathy",DYSPLASIA,FAMILIAL ADENOMATOUS POLYPOSIS,RO-disease_has_finding
497243647,7/3/2014 21:17:10,,1314349888,7/3/2014 21:16:13,clixsense,0,10428985,GBR,M3,South Petherton,86.186.150.111,FAMILIAL ADENOMATOUS POLYPOSIS causes DYSPLASIA,70,25,,79,55,causes,0.768221279597376,901680-FS1-4,"We report a patient with FAMILIAL ADENOMATOUS POLYPOSIS who developed DYSPLASIA in a large exophytic hyperplastic gastric tumor that appeared to arise on a background of diffuse fundic gland polyposis and presented with anemia, hypoalbuminemia, and a protein-losing enteropathy",DYSPLASIA,FAMILIAL ADENOMATOUS POLYPOSIS,RO-disease_has_finding
497243647,7/4/2014 00:08:32,,1314455702,7/4/2014 00:08:17,neodev,0,25804244,USA,IL,Chicago,216.104.36.236,FAMILIAL ADENOMATOUS POLYPOSIS causes DYSPLASIA,70,25,,79,55,causes,0.768221279597376,901680-FS1-4,"We report a patient with FAMILIAL ADENOMATOUS POLYPOSIS who developed DYSPLASIA in a large exophytic hyperplastic gastric tumor that appeared to arise on a background of diffuse fundic gland polyposis and presented with anemia, hypoalbuminemia, and a protein-losing enteropathy",DYSPLASIA,FAMILIAL ADENOMATOUS POLYPOSIS,RO-disease_has_finding
497243647,7/4/2014 03:48:02,,1314574437,7/4/2014 03:47:41,bitcoinget,0,21384744,USA,MN,Saint Paul,75.73.34.174,FAMILIAL ADENOMATOUS POLYPOSIS causes DYSPLASIA,70,25,,79,55,causes,0.768221279597376,901680-FS1-4,"We report a patient with FAMILIAL ADENOMATOUS POLYPOSIS who developed DYSPLASIA in a large exophytic hyperplastic gastric tumor that appeared to arise on a background of diffuse fundic gland polyposis and presented with anemia, hypoalbuminemia, and a protein-losing enteropathy",DYSPLASIA,FAMILIAL ADENOMATOUS POLYPOSIS,RO-disease_has_finding
497243647,7/4/2014 04:43:15,,1314599008,7/4/2014 04:42:45,instagc,0,13846187,USA,MO,Chesterfield,63.137.150.235,FAMILIAL ADENOMATOUS POLYPOSIS causes DYSPLASIA,70,25,,79,55,causes,0.768221279597376,901680-FS1-4,"We report a patient with FAMILIAL ADENOMATOUS POLYPOSIS who developed DYSPLASIA in a large exophytic hyperplastic gastric tumor that appeared to arise on a background of diffuse fundic gland polyposis and presented with anemia, hypoalbuminemia, and a protein-losing enteropathy",DYSPLASIA,FAMILIAL ADENOMATOUS POLYPOSIS,RO-disease_has_finding
497243647,7/4/2014 07:35:04,,1314680805,7/4/2014 07:34:37,clixsense,0,27969116,NLD,,,91.213.37.165,FAMILIAL ADENOMATOUS POLYPOSIS causes DYSPLASIA,70,25,,79,55,causes,0.768221279597376,901680-FS1-4,"We report a patient with FAMILIAL ADENOMATOUS POLYPOSIS who developed DYSPLASIA in a large exophytic hyperplastic gastric tumor that appeared to arise on a background of diffuse fundic gland polyposis and presented with anemia, hypoalbuminemia, and a protein-losing enteropathy",DYSPLASIA,FAMILIAL ADENOMATOUS POLYPOSIS,RO-disease_has_finding
497243647,7/4/2014 08:03:00,,1314693390,7/4/2014 08:02:36,clixsense,0,23138831,NLD,,,77.174.95.58,FAMILIAL ADENOMATOUS POLYPOSIS causes DYSPLASIA,70,25,,79,55,causes,0.768221279597376,901680-FS1-4,"We report a patient with FAMILIAL ADENOMATOUS POLYPOSIS who developed DYSPLASIA in a large exophytic hyperplastic gastric tumor that appeared to arise on a background of diffuse fundic gland polyposis and presented with anemia, hypoalbuminemia, and a protein-losing enteropathy",DYSPLASIA,FAMILIAL ADENOMATOUS POLYPOSIS,RO-disease_has_finding
497243648,7/2/2014 18:21:56,,1313154670,7/2/2014 18:21:24,clixsense,0,6518883,GBR,E6,Westbury,217.43.36.187,no_relation,78,31,,83,55,causes,0.95257934441568,901979-FS1-4,"Acute toxoplasmosis  may mimic INFECTIOUS MONONUCLEOSIS with lymphadenopathy, FEVER, malaise, myalgia, hepatosplenomegaly, and less commonly, pharyngitis",FEVER,INFECTIOUS MONONUCLEOSIS,RO-disease_has_finding
497243648,7/2/2014 18:27:51,,1313159747,7/2/2014 18:27:41,neodev,0,22098386,GBR,,,213.160.119.242,INFECTIOUS MONONUCLEOSIS causes FEVER,78,31,,83,55,causes,0.95257934441568,901979-FS1-4,"Acute toxoplasmosis  may mimic INFECTIOUS MONONUCLEOSIS with lymphadenopathy, FEVER, malaise, myalgia, hepatosplenomegaly, and less commonly, pharyngitis",FEVER,INFECTIOUS MONONUCLEOSIS,RO-disease_has_finding
497243648,7/2/2014 18:50:50,,1313181820,7/2/2014 18:50:24,instagc,0,14656399,USA,KY,Richmond,69.23.61.189,FEVER causes INFECTIOUS MONONUCLEOSIS,78,31,,83,55,causes,0.95257934441568,901979-FS1-4,"Acute toxoplasmosis  may mimic INFECTIOUS MONONUCLEOSIS with lymphadenopathy, FEVER, malaise, myalgia, hepatosplenomegaly, and less commonly, pharyngitis",FEVER,INFECTIOUS MONONUCLEOSIS,RO-disease_has_finding
497243648,7/2/2014 20:39:55,,1313357676,7/2/2014 20:38:54,clixsense,0,27871219,NLD,7,Amsterdam,87.210.207.223,INFECTIOUS MONONUCLEOSIS causes FEVER,78,31,,83,55,causes,0.95257934441568,901979-FS1-4,"Acute toxoplasmosis  may mimic INFECTIOUS MONONUCLEOSIS with lymphadenopathy, FEVER, malaise, myalgia, hepatosplenomegaly, and less commonly, pharyngitis",FEVER,INFECTIOUS MONONUCLEOSIS,RO-disease_has_finding
497243648,7/2/2014 20:42:29,,1313359722,7/2/2014 20:42:03,prodege,0,20018366,GBR,K8,Ilford,86.167.106.124,INFECTIOUS MONONUCLEOSIS causes FEVER,78,31,,83,55,causes,0.95257934441568,901979-FS1-4,"Acute toxoplasmosis  may mimic INFECTIOUS MONONUCLEOSIS with lymphadenopathy, FEVER, malaise, myalgia, hepatosplenomegaly, and less commonly, pharyngitis",FEVER,INFECTIOUS MONONUCLEOSIS,RO-disease_has_finding
497243648,7/2/2014 21:38:44,,1313398885,7/2/2014 21:37:33,instagc,0,26852700,USA,CA,San Francisco,99.112.70.66,INFECTIOUS MONONUCLEOSIS causes FEVER,78,31,,83,55,causes,0.95257934441568,901979-FS1-4,"Acute toxoplasmosis  may mimic INFECTIOUS MONONUCLEOSIS with lymphadenopathy, FEVER, malaise, myalgia, hepatosplenomegaly, and less commonly, pharyngitis",FEVER,INFECTIOUS MONONUCLEOSIS,RO-disease_has_finding
497243648,7/2/2014 22:28:13,,1313431826,7/2/2014 22:27:28,neodev,0,19795508,USA,TX,Irving,199.83.189.175,no_relation,78,31,,83,55,causes,0.95257934441568,901979-FS1-4,"Acute toxoplasmosis  may mimic INFECTIOUS MONONUCLEOSIS with lymphadenopathy, FEVER, malaise, myalgia, hepatosplenomegaly, and less commonly, pharyngitis",FEVER,INFECTIOUS MONONUCLEOSIS,RO-disease_has_finding
497243648,7/3/2014 01:53:30,,1313561402,7/3/2014 01:53:00,prodege,0,1878608,CAN,BC,Vancouver,108.180.143.28,no_relation,78,31,,83,55,causes,0.95257934441568,901979-FS1-4,"Acute toxoplasmosis  may mimic INFECTIOUS MONONUCLEOSIS with lymphadenopathy, FEVER, malaise, myalgia, hepatosplenomegaly, and less commonly, pharyngitis",FEVER,INFECTIOUS MONONUCLEOSIS,RO-disease_has_finding
497243648,7/3/2014 03:03:42,,1313602482,7/3/2014 03:02:29,instagc,0,23149109,USA,NC,Durham,75.189.206.205,INFECTIOUS MONONUCLEOSIS causes FEVER,78,31,,83,55,causes,0.95257934441568,901979-FS1-4,"Acute toxoplasmosis  may mimic INFECTIOUS MONONUCLEOSIS with lymphadenopathy, FEVER, malaise, myalgia, hepatosplenomegaly, and less commonly, pharyngitis",FEVER,INFECTIOUS MONONUCLEOSIS,RO-disease_has_finding
497243648,7/3/2014 03:09:24,,1313606010,7/3/2014 03:08:49,rewardsspot,0,24482174,GBR,H9,London,46.23.68.180,no_relation,78,31,,83,55,causes,0.95257934441568,901979-FS1-4,"Acute toxoplasmosis  may mimic INFECTIOUS MONONUCLEOSIS with lymphadenopathy, FEVER, malaise, myalgia, hepatosplenomegaly, and less commonly, pharyngitis",FEVER,INFECTIOUS MONONUCLEOSIS,RO-disease_has_finding
497243648,7/3/2014 03:26:13,,1313615078,7/3/2014 03:25:49,rewardsspot,0,17763704,USA,VA,Manassas,198.7.62.204,INFECTIOUS MONONUCLEOSIS causes FEVER,78,31,,83,55,causes,0.95257934441568,901979-FS1-4,"Acute toxoplasmosis  may mimic INFECTIOUS MONONUCLEOSIS with lymphadenopathy, FEVER, malaise, myalgia, hepatosplenomegaly, and less commonly, pharyngitis",FEVER,INFECTIOUS MONONUCLEOSIS,RO-disease_has_finding
497243648,7/3/2014 09:28:50,,1313837374,7/3/2014 09:28:17,clixsense,0,15189335,GBR,I9,Dereham,86.157.163.112,INFECTIOUS MONONUCLEOSIS causes FEVER,78,31,,83,55,causes,0.95257934441568,901979-FS1-4,"Acute toxoplasmosis  may mimic INFECTIOUS MONONUCLEOSIS with lymphadenopathy, FEVER, malaise, myalgia, hepatosplenomegaly, and less commonly, pharyngitis",FEVER,INFECTIOUS MONONUCLEOSIS,RO-disease_has_finding
497243648,7/3/2014 13:56:52,,1313986996,7/3/2014 13:56:45,instagc,0,27753923,GBR,,,92.40.75.232,FEVER causes INFECTIOUS MONONUCLEOSIS,78,31,,83,55,causes,0.95257934441568,901979-FS1-4,"Acute toxoplasmosis  may mimic INFECTIOUS MONONUCLEOSIS with lymphadenopathy, FEVER, malaise, myalgia, hepatosplenomegaly, and less commonly, pharyngitis",FEVER,INFECTIOUS MONONUCLEOSIS,RO-disease_has_finding
497243648,7/3/2014 15:31:33,,1314052790,7/3/2014 15:31:21,prodege,0,18960400,GBR,H9,London,109.154.7.94,INFECTIOUS MONONUCLEOSIS causes FEVER,78,31,,83,55,causes,0.95257934441568,901979-FS1-4,"Acute toxoplasmosis  may mimic INFECTIOUS MONONUCLEOSIS with lymphadenopathy, FEVER, malaise, myalgia, hepatosplenomegaly, and less commonly, pharyngitis",FEVER,INFECTIOUS MONONUCLEOSIS,RO-disease_has_finding
497243648,7/3/2014 22:01:07,,1314383815,7/3/2014 22:00:23,clixsense,0,19803139,NLD,6,Veldhoven,212.61.84.196,INFECTIOUS MONONUCLEOSIS causes FEVER,78,31,,83,55,causes,0.95257934441568,901979-FS1-4,"Acute toxoplasmosis  may mimic INFECTIOUS MONONUCLEOSIS with lymphadenopathy, FEVER, malaise, myalgia, hepatosplenomegaly, and less commonly, pharyngitis",FEVER,INFECTIOUS MONONUCLEOSIS,RO-disease_has_finding
497243648,7/4/2014 00:38:39,,1314470965,7/4/2014 00:37:45,instagc,0,19686223,CAN,BC,Surrey,184.65.16.6,no_relation,78,31,,83,55,causes,0.95257934441568,901979-FS1-4,"Acute toxoplasmosis  may mimic INFECTIOUS MONONUCLEOSIS with lymphadenopathy, FEVER, malaise, myalgia, hepatosplenomegaly, and less commonly, pharyngitis",FEVER,INFECTIOUS MONONUCLEOSIS,RO-disease_has_finding
497243648,7/4/2014 00:55:39,,1314479848,7/4/2014 00:54:39,neodev,0,16871906,CAN,ON,Kanata,99.224.9.12,INFECTIOUS MONONUCLEOSIS causes FEVER,78,31,,83,55,causes,0.95257934441568,901979-FS1-4,"Acute toxoplasmosis  may mimic INFECTIOUS MONONUCLEOSIS with lymphadenopathy, FEVER, malaise, myalgia, hepatosplenomegaly, and less commonly, pharyngitis",FEVER,INFECTIOUS MONONUCLEOSIS,RO-disease_has_finding
497243648,7/4/2014 02:23:16,,1314534802,7/4/2014 02:22:33,zoombucks,0,28232452,USA,NC,Cary,174.97.217.113,INFECTIOUS MONONUCLEOSIS causes FEVER,78,31,,83,55,causes,0.95257934441568,901979-FS1-4,"Acute toxoplasmosis  may mimic INFECTIOUS MONONUCLEOSIS with lymphadenopathy, FEVER, malaise, myalgia, hepatosplenomegaly, and less commonly, pharyngitis",FEVER,INFECTIOUS MONONUCLEOSIS,RO-disease_has_finding
497243648,7/4/2014 03:49:19,,1314574958,7/4/2014 03:48:52,clixsense,0,17722340,CAN,BC,Mission,50.98.185.25,FEVER causes INFECTIOUS MONONUCLEOSIS,78,31,,83,55,causes,0.95257934441568,901979-FS1-4,"Acute toxoplasmosis  may mimic INFECTIOUS MONONUCLEOSIS with lymphadenopathy, FEVER, malaise, myalgia, hepatosplenomegaly, and less commonly, pharyngitis",FEVER,INFECTIOUS MONONUCLEOSIS,RO-disease_has_finding
497243648,7/4/2014 04:28:53,,1314590988,7/4/2014 04:28:08,instagc,0,18973775,USA,TX,Garland,108.69.194.105,no_relation,78,31,,83,55,causes,0.95257934441568,901979-FS1-4,"Acute toxoplasmosis  may mimic INFECTIOUS MONONUCLEOSIS with lymphadenopathy, FEVER, malaise, myalgia, hepatosplenomegaly, and less commonly, pharyngitis",FEVER,INFECTIOUS MONONUCLEOSIS,RO-disease_has_finding
497243648,7/4/2014 08:03:40,,1314693700,7/4/2014 08:03:01,clixsense,0,23138831,NLD,,,77.174.95.58,no_relation,78,31,,83,55,causes,0.95257934441568,901979-FS1-4,"Acute toxoplasmosis  may mimic INFECTIOUS MONONUCLEOSIS with lymphadenopathy, FEVER, malaise, myalgia, hepatosplenomegaly, and less commonly, pharyngitis",FEVER,INFECTIOUS MONONUCLEOSIS,RO-disease_has_finding
497243651,7/2/2014 18:04:54,,1313140276,7/2/2014 18:04:42,clixsense,0,19162475,GBR,M3,Frome,82.33.126.30,INEFFECTIVE HEMATOPOIESIS causes MYELODYSPLASTIC SYNDROMES,78,0,,103,25,causes,0.993883734673619,901577-FS1-4,MYELODYSPLASTIC SYNDROMES (MDS) are clonal myeloid disorders characterized by INEFFECTIVE HEMATOPOIESIS resulting in refractory cytopenias,INEFFECTIVE HEMATOPOIESIS,MYELODYSPLASTIC SYNDROMES,RO-disease_has_finding
497243651,7/2/2014 18:22:30,,1313155217,7/2/2014 18:21:30,instagc,0,14656399,USA,KY,Richmond,69.23.61.189,INEFFECTIVE HEMATOPOIESIS causes MYELODYSPLASTIC SYNDROMES,78,0,,103,25,causes,0.993883734673619,901577-FS1-4,MYELODYSPLASTIC SYNDROMES (MDS) are clonal myeloid disorders characterized by INEFFECTIVE HEMATOPOIESIS resulting in refractory cytopenias,INEFFECTIVE HEMATOPOIESIS,MYELODYSPLASTIC SYNDROMES,RO-disease_has_finding
497243651,7/2/2014 18:26:28,,1313158565,7/2/2014 18:26:10,prodege,0,2143114,CAN,BC,Vancouver,24.84.160.12,INEFFECTIVE HEMATOPOIESIS causes MYELODYSPLASTIC SYNDROMES,78,0,,103,25,causes,0.993883734673619,901577-FS1-4,MYELODYSPLASTIC SYNDROMES (MDS) are clonal myeloid disorders characterized by INEFFECTIVE HEMATOPOIESIS resulting in refractory cytopenias,INEFFECTIVE HEMATOPOIESIS,MYELODYSPLASTIC SYNDROMES,RO-disease_has_finding
497243651,7/2/2014 19:39:29,,1313228882,7/2/2014 19:39:03,instagc,0,13763729,USA,,,75.182.89.225,no_relation,78,0,,103,25,causes,0.993883734673619,901577-FS1-4,MYELODYSPLASTIC SYNDROMES (MDS) are clonal myeloid disorders characterized by INEFFECTIVE HEMATOPOIESIS resulting in refractory cytopenias,INEFFECTIVE HEMATOPOIESIS,MYELODYSPLASTIC SYNDROMES,RO-disease_has_finding
497243651,7/2/2014 21:45:33,,1313403430,7/2/2014 21:45:26,clixsense,0,17950689,GBR,X5,Cardiff,89.168.38.216,MYELODYSPLASTIC SYNDROMES causes INEFFECTIVE HEMATOPOIESIS,78,0,,103,25,causes,0.993883734673619,901577-FS1-4,MYELODYSPLASTIC SYNDROMES (MDS) are clonal myeloid disorders characterized by INEFFECTIVE HEMATOPOIESIS resulting in refractory cytopenias,INEFFECTIVE HEMATOPOIESIS,MYELODYSPLASTIC SYNDROMES,RO-disease_has_finding
497243651,7/2/2014 22:27:37,,1313431463,7/2/2014 22:26:57,clixsense,0,24429778,AUS,,,121.211.46.103,INEFFECTIVE HEMATOPOIESIS causes MYELODYSPLASTIC SYNDROMES,78,0,,103,25,causes,0.993883734673619,901577-FS1-4,MYELODYSPLASTIC SYNDROMES (MDS) are clonal myeloid disorders characterized by INEFFECTIVE HEMATOPOIESIS resulting in refractory cytopenias,INEFFECTIVE HEMATOPOIESIS,MYELODYSPLASTIC SYNDROMES,RO-disease_has_finding
497243651,7/2/2014 22:28:40,,1313432145,7/2/2014 22:28:15,neodev,0,19795508,USA,TX,Irving,199.83.189.175,no_relation,78,0,,103,25,causes,0.993883734673619,901577-FS1-4,MYELODYSPLASTIC SYNDROMES (MDS) are clonal myeloid disorders characterized by INEFFECTIVE HEMATOPOIESIS resulting in refractory cytopenias,INEFFECTIVE HEMATOPOIESIS,MYELODYSPLASTIC SYNDROMES,RO-disease_has_finding
497243651,7/3/2014 01:52:26,,1313560908,7/3/2014 01:51:53,prodege,0,1878608,CAN,BC,Vancouver,108.180.143.28,no_relation,78,0,,103,25,causes,0.993883734673619,901577-FS1-4,MYELODYSPLASTIC SYNDROMES (MDS) are clonal myeloid disorders characterized by INEFFECTIVE HEMATOPOIESIS resulting in refractory cytopenias,INEFFECTIVE HEMATOPOIESIS,MYELODYSPLASTIC SYNDROMES,RO-disease_has_finding
497243651,7/3/2014 02:11:54,,1313572675,7/3/2014 02:11:15,zoombucks,0,27687111,USA,CA,Corona,99.44.120.153,MYELODYSPLASTIC SYNDROMES causes INEFFECTIVE HEMATOPOIESIS,78,0,,103,25,causes,0.993883734673619,901577-FS1-4,MYELODYSPLASTIC SYNDROMES (MDS) are clonal myeloid disorders characterized by INEFFECTIVE HEMATOPOIESIS resulting in refractory cytopenias,INEFFECTIVE HEMATOPOIESIS,MYELODYSPLASTIC SYNDROMES,RO-disease_has_finding
497243651,7/3/2014 08:13:15,,1313771882,7/3/2014 08:12:43,paiddailysurveys,0,11786001,USA,NC,Matthews,174.130.2.189,MYELODYSPLASTIC SYNDROMES causes INEFFECTIVE HEMATOPOIESIS,78,0,,103,25,causes,0.993883734673619,901577-FS1-4,MYELODYSPLASTIC SYNDROMES (MDS) are clonal myeloid disorders characterized by INEFFECTIVE HEMATOPOIESIS resulting in refractory cytopenias,INEFFECTIVE HEMATOPOIESIS,MYELODYSPLASTIC SYNDROMES,RO-disease_has_finding
497243651,7/3/2014 08:55:43,,1313804446,7/3/2014 08:54:57,prodege,0,21891314,AUS,7,Mornington,203.214.41.115,INEFFECTIVE HEMATOPOIESIS causes MYELODYSPLASTIC SYNDROMES,78,0,,103,25,causes,0.993883734673619,901577-FS1-4,MYELODYSPLASTIC SYNDROMES (MDS) are clonal myeloid disorders characterized by INEFFECTIVE HEMATOPOIESIS resulting in refractory cytopenias,INEFFECTIVE HEMATOPOIESIS,MYELODYSPLASTIC SYNDROMES,RO-disease_has_finding
497243651,7/3/2014 09:31:17,,1313839055,7/3/2014 09:30:46,clixsense,0,15189335,GBR,I9,Dereham,86.157.163.112,MYELODYSPLASTIC SYNDROMES causes INEFFECTIVE HEMATOPOIESIS,78,0,,103,25,causes,0.993883734673619,901577-FS1-4,MYELODYSPLASTIC SYNDROMES (MDS) are clonal myeloid disorders characterized by INEFFECTIVE HEMATOPOIESIS resulting in refractory cytopenias,INEFFECTIVE HEMATOPOIESIS,MYELODYSPLASTIC SYNDROMES,RO-disease_has_finding
497243651,7/3/2014 14:59:09,,1314027240,7/3/2014 14:58:36,neodev,0,27597779,CAN,AB,Calgary,72.29.251.209,MYELODYSPLASTIC SYNDROMES causes INEFFECTIVE HEMATOPOIESIS,78,0,,103,25,causes,0.993883734673619,901577-FS1-4,MYELODYSPLASTIC SYNDROMES (MDS) are clonal myeloid disorders characterized by INEFFECTIVE HEMATOPOIESIS resulting in refractory cytopenias,INEFFECTIVE HEMATOPOIESIS,MYELODYSPLASTIC SYNDROMES,RO-disease_has_finding
497243651,7/3/2014 15:13:23,,1314038003,7/3/2014 15:12:55,neodev,0,21405167,USA,MD,Pasadena,69.243.35.97,MYELODYSPLASTIC SYNDROMES causes INEFFECTIVE HEMATOPOIESIS,78,0,,103,25,causes,0.993883734673619,901577-FS1-4,MYELODYSPLASTIC SYNDROMES (MDS) are clonal myeloid disorders characterized by INEFFECTIVE HEMATOPOIESIS resulting in refractory cytopenias,INEFFECTIVE HEMATOPOIESIS,MYELODYSPLASTIC SYNDROMES,RO-disease_has_finding
497243651,7/3/2014 21:14:15,,1314347529,7/3/2014 21:13:01,clixsense,0,10428985,GBR,M3,South Petherton,86.186.150.111,no_relation,78,0,,103,25,causes,0.993883734673619,901577-FS1-4,MYELODYSPLASTIC SYNDROMES (MDS) are clonal myeloid disorders characterized by INEFFECTIVE HEMATOPOIESIS resulting in refractory cytopenias,INEFFECTIVE HEMATOPOIESIS,MYELODYSPLASTIC SYNDROMES,RO-disease_has_finding
497243651,7/3/2014 21:59:20,,1314382532,7/3/2014 21:58:05,clixsense,0,19803139,NLD,6,Veldhoven,212.61.84.196,no_relation,78,0,,103,25,causes,0.993883734673619,901577-FS1-4,MYELODYSPLASTIC SYNDROMES (MDS) are clonal myeloid disorders characterized by INEFFECTIVE HEMATOPOIESIS resulting in refractory cytopenias,INEFFECTIVE HEMATOPOIESIS,MYELODYSPLASTIC SYNDROMES,RO-disease_has_finding
497243651,7/4/2014 00:11:22,,1314457046,7/4/2014 00:10:58,clixsense,0,6331514,CAN,ON,Sault Sainte Marie,65.95.60.150,MYELODYSPLASTIC SYNDROMES causes INEFFECTIVE HEMATOPOIESIS,78,0,,103,25,causes,0.993883734673619,901577-FS1-4,MYELODYSPLASTIC SYNDROMES (MDS) are clonal myeloid disorders characterized by INEFFECTIVE HEMATOPOIESIS resulting in refractory cytopenias,INEFFECTIVE HEMATOPOIESIS,MYELODYSPLASTIC SYNDROMES,RO-disease_has_finding
497243651,7/4/2014 00:38:39,,1314470975,7/4/2014 00:37:45,instagc,0,19686223,CAN,BC,Surrey,184.65.16.6,INEFFECTIVE HEMATOPOIESIS causes MYELODYSPLASTIC SYNDROMES,78,0,,103,25,causes,0.993883734673619,901577-FS1-4,MYELODYSPLASTIC SYNDROMES (MDS) are clonal myeloid disorders characterized by INEFFECTIVE HEMATOPOIESIS resulting in refractory cytopenias,INEFFECTIVE HEMATOPOIESIS,MYELODYSPLASTIC SYNDROMES,RO-disease_has_finding
497243651,7/4/2014 01:46:54,,1314509943,7/4/2014 01:46:41,elite,0,22155198,USA,IL,Chicago,108.233.0.38,no_relation,78,0,,103,25,causes,0.993883734673619,901577-FS1-4,MYELODYSPLASTIC SYNDROMES (MDS) are clonal myeloid disorders characterized by INEFFECTIVE HEMATOPOIESIS resulting in refractory cytopenias,INEFFECTIVE HEMATOPOIESIS,MYELODYSPLASTIC SYNDROMES,RO-disease_has_finding
497243651,7/4/2014 02:23:41,,1314535072,7/4/2014 02:23:17,zoombucks,0,28232452,USA,NC,Cary,174.97.217.113,MYELODYSPLASTIC SYNDROMES causes INEFFECTIVE HEMATOPOIESIS,78,0,,103,25,causes,0.993883734673619,901577-FS1-4,MYELODYSPLASTIC SYNDROMES (MDS) are clonal myeloid disorders characterized by INEFFECTIVE HEMATOPOIESIS resulting in refractory cytopenias,INEFFECTIVE HEMATOPOIESIS,MYELODYSPLASTIC SYNDROMES,RO-disease_has_finding
497243651,7/4/2014 03:35:05,,1314568562,7/4/2014 03:34:36,prodege,0,6011370,CAN,BC,Richmond,70.79.45.148,MYELODYSPLASTIC SYNDROMES causes INEFFECTIVE HEMATOPOIESIS,78,0,,103,25,causes,0.993883734673619,901577-FS1-4,MYELODYSPLASTIC SYNDROMES (MDS) are clonal myeloid disorders characterized by INEFFECTIVE HEMATOPOIESIS resulting in refractory cytopenias,INEFFECTIVE HEMATOPOIESIS,MYELODYSPLASTIC SYNDROMES,RO-disease_has_finding
497243659,7/2/2014 18:26:28,,1313158577,7/2/2014 18:26:10,prodege,0,2143114,CAN,BC,Vancouver,24.84.160.12,HAIR FOLLICLES location of BENIGN FOLLICULAR TUMORS,32,101,,46,125,location of,0.7624928516630229,902455-FS1-9,"However, the deeper portions of HAIR FOLLICLES were also found to be unlabeled, and further study of BENIGN FOLLICULAR TUMORS which may histologically mimic basal cell carcinomas is suggested",HAIR FOLLICLES,BENIGN FOLLICULAR TUMORS,RO-disease_has_primary_anatomic_site
497243659,7/2/2014 19:39:29,,1313228881,7/2/2014 19:39:03,instagc,0,13763729,USA,,,75.182.89.225,HAIR FOLLICLES location of BENIGN FOLLICULAR TUMORS,32,101,,46,125,location of,0.7624928516630229,902455-FS1-9,"However, the deeper portions of HAIR FOLLICLES were also found to be unlabeled, and further study of BENIGN FOLLICULAR TUMORS which may histologically mimic basal cell carcinomas is suggested",HAIR FOLLICLES,BENIGN FOLLICULAR TUMORS,RO-disease_has_primary_anatomic_site
497243659,7/2/2014 22:43:07,,1313441243,7/2/2014 22:42:18,fepcrowdflower,0,17940235,GBR,X5,Cardiff,176.252.22.6,HAIR FOLLICLES location of BENIGN FOLLICULAR TUMORS,32,101,,46,125,location of,0.7624928516630229,902455-FS1-9,"However, the deeper portions of HAIR FOLLICLES were also found to be unlabeled, and further study of BENIGN FOLLICULAR TUMORS which may histologically mimic basal cell carcinomas is suggested",HAIR FOLLICLES,BENIGN FOLLICULAR TUMORS,RO-disease_has_primary_anatomic_site
497243659,7/2/2014 23:51:05,,1313493009,7/2/2014 23:50:33,clixsense,0,9289735,USA,IL,Chicago,69.210.253.196,no_relation,32,101,,46,125,location of,0.7624928516630229,902455-FS1-9,"However, the deeper portions of HAIR FOLLICLES were also found to be unlabeled, and further study of BENIGN FOLLICULAR TUMORS which may histologically mimic basal cell carcinomas is suggested",HAIR FOLLICLES,BENIGN FOLLICULAR TUMORS,RO-disease_has_primary_anatomic_site
497243659,7/2/2014 23:53:35,,1313494301,7/2/2014 23:52:36,instagc,0,19686223,CAN,BC,Surrey,184.65.16.6,BENIGN FOLLICULAR TUMORS location of HAIR FOLLICLES,32,101,,46,125,location of,0.7624928516630229,902455-FS1-9,"However, the deeper portions of HAIR FOLLICLES were also found to be unlabeled, and further study of BENIGN FOLLICULAR TUMORS which may histologically mimic basal cell carcinomas is suggested",HAIR FOLLICLES,BENIGN FOLLICULAR TUMORS,RO-disease_has_primary_anatomic_site
497243659,7/3/2014 00:02:01,,1313498264,7/3/2014 00:01:27,sendearnings,0,11896941,USA,FL,Seminole,97.106.105.251,BENIGN FOLLICULAR TUMORS location of HAIR FOLLICLES,32,101,,46,125,location of,0.7624928516630229,902455-FS1-9,"However, the deeper portions of HAIR FOLLICLES were also found to be unlabeled, and further study of BENIGN FOLLICULAR TUMORS which may histologically mimic basal cell carcinomas is suggested",HAIR FOLLICLES,BENIGN FOLLICULAR TUMORS,RO-disease_has_primary_anatomic_site
497243659,7/3/2014 00:46:39,,1313519133,7/3/2014 00:46:34,clixsense,0,17121874,GBR,U9,Falkirk,80.192.66.214,no_relation,32,101,,46,125,location of,0.7624928516630229,902455-FS1-9,"However, the deeper portions of HAIR FOLLICLES were also found to be unlabeled, and further study of BENIGN FOLLICULAR TUMORS which may histologically mimic basal cell carcinomas is suggested",HAIR FOLLICLES,BENIGN FOLLICULAR TUMORS,RO-disease_has_primary_anatomic_site
497243659,7/3/2014 02:11:14,,1313572307,7/3/2014 02:10:44,zoombucks,0,27687111,USA,CA,Corona,99.44.120.153,no_relation,32,101,,46,125,location of,0.7624928516630229,902455-FS1-9,"However, the deeper portions of HAIR FOLLICLES were also found to be unlabeled, and further study of BENIGN FOLLICULAR TUMORS which may histologically mimic basal cell carcinomas is suggested",HAIR FOLLICLES,BENIGN FOLLICULAR TUMORS,RO-disease_has_primary_anatomic_site
497243659,7/3/2014 03:08:45,,1313605646,7/3/2014 03:07:59,rewardsspot,0,24482174,GBR,H9,London,46.23.68.180,HAIR FOLLICLES location of BENIGN FOLLICULAR TUMORS,32,101,,46,125,location of,0.7624928516630229,902455-FS1-9,"However, the deeper portions of HAIR FOLLICLES were also found to be unlabeled, and further study of BENIGN FOLLICULAR TUMORS which may histologically mimic basal cell carcinomas is suggested",HAIR FOLLICLES,BENIGN FOLLICULAR TUMORS,RO-disease_has_primary_anatomic_site
497243659,7/3/2014 03:27:02,,1313615513,7/3/2014 03:26:44,rewardsspot,0,17763704,USA,VA,Manassas,198.7.62.204,HAIR FOLLICLES location of BENIGN FOLLICULAR TUMORS,32,101,,46,125,location of,0.7624928516630229,902455-FS1-9,"However, the deeper portions of HAIR FOLLICLES were also found to be unlabeled, and further study of BENIGN FOLLICULAR TUMORS which may histologically mimic basal cell carcinomas is suggested",HAIR FOLLICLES,BENIGN FOLLICULAR TUMORS,RO-disease_has_primary_anatomic_site
497243659,7/3/2014 08:08:21,,1313769047,7/3/2014 08:07:25,paiddailysurveys,0,11786001,USA,NC,Matthews,174.130.2.189,HAIR FOLLICLES location of BENIGN FOLLICULAR TUMORS,32,101,,46,125,location of,0.7624928516630229,902455-FS1-9,"However, the deeper portions of HAIR FOLLICLES were also found to be unlabeled, and further study of BENIGN FOLLICULAR TUMORS which may histologically mimic basal cell carcinomas is suggested",HAIR FOLLICLES,BENIGN FOLLICULAR TUMORS,RO-disease_has_primary_anatomic_site
497243659,7/3/2014 08:54:55,,1313803514,7/3/2014 08:54:10,prodege,0,21891314,AUS,7,Mornington,203.214.41.115,HAIR FOLLICLES location of BENIGN FOLLICULAR TUMORS,32,101,,46,125,location of,0.7624928516630229,902455-FS1-9,"However, the deeper portions of HAIR FOLLICLES were also found to be unlabeled, and further study of BENIGN FOLLICULAR TUMORS which may histologically mimic basal cell carcinomas is suggested",HAIR FOLLICLES,BENIGN FOLLICULAR TUMORS,RO-disease_has_primary_anatomic_site
497243659,7/3/2014 11:04:00,,1313901645,7/3/2014 11:03:11,vivatic,0,25451531,GBR,,,83.67.28.193,HAIR FOLLICLES location of BENIGN FOLLICULAR TUMORS,32,101,,46,125,location of,0.7624928516630229,902455-FS1-9,"However, the deeper portions of HAIR FOLLICLES were also found to be unlabeled, and further study of BENIGN FOLLICULAR TUMORS which may histologically mimic basal cell carcinomas is suggested",HAIR FOLLICLES,BENIGN FOLLICULAR TUMORS,RO-disease_has_primary_anatomic_site
497243659,7/3/2014 13:56:36,,1313986889,7/3/2014 13:56:31,instagc,0,27753923,GBR,,,92.40.75.232,BENIGN FOLLICULAR TUMORS location of HAIR FOLLICLES,32,101,,46,125,location of,0.7624928516630229,902455-FS1-9,"However, the deeper portions of HAIR FOLLICLES were also found to be unlabeled, and further study of BENIGN FOLLICULAR TUMORS which may histologically mimic basal cell carcinomas is suggested",HAIR FOLLICLES,BENIGN FOLLICULAR TUMORS,RO-disease_has_primary_anatomic_site
497243659,7/4/2014 00:07:39,,1314455314,7/4/2014 00:07:15,neodev,0,25804244,USA,IL,Chicago,216.104.36.236,no_relation,32,101,,46,125,location of,0.7624928516630229,902455-FS1-9,"However, the deeper portions of HAIR FOLLICLES were also found to be unlabeled, and further study of BENIGN FOLLICULAR TUMORS which may histologically mimic basal cell carcinomas is suggested",HAIR FOLLICLES,BENIGN FOLLICULAR TUMORS,RO-disease_has_primary_anatomic_site
497243659,7/4/2014 00:57:15,,1314480598,7/4/2014 00:56:25,neodev,0,16871906,CAN,ON,Kanata,99.224.9.12,HAIR FOLLICLES location of BENIGN FOLLICULAR TUMORS,32,101,,46,125,location of,0.7624928516630229,902455-FS1-9,"However, the deeper portions of HAIR FOLLICLES were also found to be unlabeled, and further study of BENIGN FOLLICULAR TUMORS which may histologically mimic basal cell carcinomas is suggested",HAIR FOLLICLES,BENIGN FOLLICULAR TUMORS,RO-disease_has_primary_anatomic_site
497243659,7/4/2014 01:47:10,,1314510143,7/4/2014 01:46:56,elite,0,22155198,USA,IL,Chicago,108.233.0.38,no_relation,32,101,,46,125,location of,0.7624928516630229,902455-FS1-9,"However, the deeper portions of HAIR FOLLICLES were also found to be unlabeled, and further study of BENIGN FOLLICULAR TUMORS which may histologically mimic basal cell carcinomas is suggested",HAIR FOLLICLES,BENIGN FOLLICULAR TUMORS,RO-disease_has_primary_anatomic_site
497243659,7/4/2014 03:35:05,,1314568556,7/4/2014 03:34:36,prodege,0,6011370,CAN,BC,Richmond,70.79.45.148,no_relation,32,101,,46,125,location of,0.7624928516630229,902455-FS1-9,"However, the deeper portions of HAIR FOLLICLES were also found to be unlabeled, and further study of BENIGN FOLLICULAR TUMORS which may histologically mimic basal cell carcinomas is suggested",HAIR FOLLICLES,BENIGN FOLLICULAR TUMORS,RO-disease_has_primary_anatomic_site
497243659,7/4/2014 03:47:40,,1314574251,7/4/2014 03:47:10,bitcoinget,0,21384744,USA,MN,Saint Paul,75.73.34.174,HAIR FOLLICLES location of BENIGN FOLLICULAR TUMORS,32,101,,46,125,location of,0.7624928516630229,902455-FS1-9,"However, the deeper portions of HAIR FOLLICLES were also found to be unlabeled, and further study of BENIGN FOLLICULAR TUMORS which may histologically mimic basal cell carcinomas is suggested",HAIR FOLLICLES,BENIGN FOLLICULAR TUMORS,RO-disease_has_primary_anatomic_site
497243659,7/4/2014 04:27:25,,1314590405,7/4/2014 04:26:19,instagc,0,18973775,USA,TX,Garland,108.69.194.105,no_relation,32,101,,46,125,location of,0.7624928516630229,902455-FS1-9,"However, the deeper portions of HAIR FOLLICLES were also found to be unlabeled, and further study of BENIGN FOLLICULAR TUMORS which may histologically mimic basal cell carcinomas is suggested",HAIR FOLLICLES,BENIGN FOLLICULAR TUMORS,RO-disease_has_primary_anatomic_site
497243659,7/4/2014 04:39:13,,1314596591,7/4/2014 04:39:08,gptbanks,0,18496428,USA,CA,Newhall,199.244.112.121,BENIGN FOLLICULAR TUMORS location of HAIR FOLLICLES,32,101,,46,125,location of,0.7624928516630229,902455-FS1-9,"However, the deeper portions of HAIR FOLLICLES were also found to be unlabeled, and further study of BENIGN FOLLICULAR TUMORS which may histologically mimic basal cell carcinomas is suggested",HAIR FOLLICLES,BENIGN FOLLICULAR TUMORS,RO-disease_has_primary_anatomic_site
497243665,7/2/2014 17:27:56,,1313101960,7/2/2014 17:27:06,prodege,0,14890188,GBR,C5,Crewe,151.230.22.222,no_relation,15,59,,20,83,causes,0.666666666666667,901948-FS1-4,It may produce FEVER and sore throat in young children and INFECTIOUS MONONUCLEOSIS in teenagers and young adults,FEVER,INFECTIOUS MONONUCLEOSIS,RO-disease_has_finding
497243665,7/2/2014 17:39:41,,1313113194,7/2/2014 17:38:53,prodege,0,14848125,GBR,V2,Glasgow,86.130.194.252,no_relation,15,59,,20,83,causes,0.666666666666667,901948-FS1-4,It may produce FEVER and sore throat in young children and INFECTIOUS MONONUCLEOSIS in teenagers and young adults,FEVER,INFECTIOUS MONONUCLEOSIS,RO-disease_has_finding
497243665,7/2/2014 20:40:44,,1313358270,7/2/2014 20:39:57,clixsense,0,27871219,NLD,7,Amsterdam,87.210.207.223,no_relation,15,59,,20,83,causes,0.666666666666667,901948-FS1-4,It may produce FEVER and sore throat in young children and INFECTIOUS MONONUCLEOSIS in teenagers and young adults,FEVER,INFECTIOUS MONONUCLEOSIS,RO-disease_has_finding
497243665,7/2/2014 20:42:29,,1313359715,7/2/2014 20:42:03,prodege,0,20018366,GBR,K8,Ilford,86.167.106.124,no_relation,15,59,,20,83,causes,0.666666666666667,901948-FS1-4,It may produce FEVER and sore throat in young children and INFECTIOUS MONONUCLEOSIS in teenagers and young adults,FEVER,INFECTIOUS MONONUCLEOSIS,RO-disease_has_finding
497243665,7/2/2014 21:40:52,,1313400257,7/2/2014 21:40:20,instagc,0,26852700,USA,CA,San Francisco,99.112.70.66,no_relation,15,59,,20,83,causes,0.666666666666667,901948-FS1-4,It may produce FEVER and sore throat in young children and INFECTIOUS MONONUCLEOSIS in teenagers and young adults,FEVER,INFECTIOUS MONONUCLEOSIS,RO-disease_has_finding
497243665,7/2/2014 21:45:01,,1313403046,7/2/2014 21:44:10,clixsense,0,17950689,GBR,X5,Cardiff,89.168.38.216,FEVER causes INFECTIOUS MONONUCLEOSIS,15,59,,20,83,causes,0.666666666666667,901948-FS1-4,It may produce FEVER and sore throat in young children and INFECTIOUS MONONUCLEOSIS in teenagers and young adults,FEVER,INFECTIOUS MONONUCLEOSIS,RO-disease_has_finding
497243665,7/2/2014 22:26:55,,1313431044,7/2/2014 22:26:38,clixsense,0,24429778,AUS,,,121.211.46.103,INFECTIOUS MONONUCLEOSIS causes FEVER,15,59,,20,83,causes,0.666666666666667,901948-FS1-4,It may produce FEVER and sore throat in young children and INFECTIOUS MONONUCLEOSIS in teenagers and young adults,FEVER,INFECTIOUS MONONUCLEOSIS,RO-disease_has_finding
497243665,7/3/2014 01:53:30,,1313561403,7/3/2014 01:53:00,prodege,0,1878608,CAN,BC,Vancouver,108.180.143.28,no_relation,15,59,,20,83,causes,0.666666666666667,901948-FS1-4,It may produce FEVER and sore throat in young children and INFECTIOUS MONONUCLEOSIS in teenagers and young adults,FEVER,INFECTIOUS MONONUCLEOSIS,RO-disease_has_finding
497243665,7/3/2014 09:54:52,,1313854216,7/3/2014 09:54:26,clixsense,0,18408026,USA,WA,Tacoma,131.191.72.163,no_relation,15,59,,20,83,causes,0.666666666666667,901948-FS1-4,It may produce FEVER and sore throat in young children and INFECTIOUS MONONUCLEOSIS in teenagers and young adults,FEVER,INFECTIOUS MONONUCLEOSIS,RO-disease_has_finding
497243665,7/3/2014 15:04:36,,1314031414,7/3/2014 15:03:54,instagc,0,20183814,USA,,,166.182.80.97,INFECTIOUS MONONUCLEOSIS causes FEVER,15,59,,20,83,causes,0.666666666666667,901948-FS1-4,It may produce FEVER and sore throat in young children and INFECTIOUS MONONUCLEOSIS in teenagers and young adults,FEVER,INFECTIOUS MONONUCLEOSIS,RO-disease_has_finding
497243665,7/3/2014 15:12:55,,1314037612,7/3/2014 15:12:17,neodev,0,21405167,USA,MD,Pasadena,69.243.35.97,no_relation,15,59,,20,83,causes,0.666666666666667,901948-FS1-4,It may produce FEVER and sore throat in young children and INFECTIOUS MONONUCLEOSIS in teenagers and young adults,FEVER,INFECTIOUS MONONUCLEOSIS,RO-disease_has_finding
497243665,7/3/2014 15:53:02,,1314070646,7/3/2014 15:52:31,clixsense,0,21917173,CAN,,,24.71.41.51,INFECTIOUS MONONUCLEOSIS causes FEVER,15,59,,20,83,causes,0.666666666666667,901948-FS1-4,It may produce FEVER and sore throat in young children and INFECTIOUS MONONUCLEOSIS in teenagers and young adults,FEVER,INFECTIOUS MONONUCLEOSIS,RO-disease_has_finding
497243665,7/3/2014 15:56:25,,1314073543,7/3/2014 15:55:58,superrewards,0,22638731,USA,IL,Carterville,50.40.185.175,no_relation,15,59,,20,83,causes,0.666666666666667,901948-FS1-4,It may produce FEVER and sore throat in young children and INFECTIOUS MONONUCLEOSIS in teenagers and young adults,FEVER,INFECTIOUS MONONUCLEOSIS,RO-disease_has_finding
497243665,7/3/2014 16:46:29,,1314115106,7/3/2014 16:46:06,neodev,0,18517457,GBR,,,86.29.55.201,no_relation,15,59,,20,83,causes,0.666666666666667,901948-FS1-4,It may produce FEVER and sore throat in young children and INFECTIOUS MONONUCLEOSIS in teenagers and young adults,FEVER,INFECTIOUS MONONUCLEOSIS,RO-disease_has_finding
497243665,7/3/2014 21:14:15,,1314347528,7/3/2014 21:13:01,clixsense,0,10428985,GBR,M3,South Petherton,86.186.150.111,no_relation,15,59,,20,83,causes,0.666666666666667,901948-FS1-4,It may produce FEVER and sore throat in young children and INFECTIOUS MONONUCLEOSIS in teenagers and young adults,FEVER,INFECTIOUS MONONUCLEOSIS,RO-disease_has_finding
497243665,7/4/2014 00:07:56,,1314455428,7/4/2014 00:07:40,neodev,0,25804244,USA,IL,Chicago,216.104.36.236,INFECTIOUS MONONUCLEOSIS causes FEVER,15,59,,20,83,causes,0.666666666666667,901948-FS1-4,It may produce FEVER and sore throat in young children and INFECTIOUS MONONUCLEOSIS in teenagers and young adults,FEVER,INFECTIOUS MONONUCLEOSIS,RO-disease_has_finding
497243665,7/4/2014 03:35:41,,1314568904,7/4/2014 03:35:08,prodege,0,6011370,CAN,BC,Richmond,70.79.45.148,INFECTIOUS MONONUCLEOSIS causes FEVER,15,59,,20,83,causes,0.666666666666667,901948-FS1-4,It may produce FEVER and sore throat in young children and INFECTIOUS MONONUCLEOSIS in teenagers and young adults,FEVER,INFECTIOUS MONONUCLEOSIS,RO-disease_has_finding
497243665,7/4/2014 03:49:01,,1314574831,7/4/2014 03:48:45,bitcoinget,0,21384744,USA,MN,Saint Paul,75.73.34.174,no_relation,15,59,,20,83,causes,0.666666666666667,901948-FS1-4,It may produce FEVER and sore throat in young children and INFECTIOUS MONONUCLEOSIS in teenagers and young adults,FEVER,INFECTIOUS MONONUCLEOSIS,RO-disease_has_finding
497243665,7/4/2014 07:08:11,,1314667545,7/4/2014 07:07:49,clixsense,0,19190439,GBR,H9,London,86.15.32.131,FEVER causes INFECTIOUS MONONUCLEOSIS,15,59,,20,83,causes,0.666666666666667,901948-FS1-4,It may produce FEVER and sore throat in young children and INFECTIOUS MONONUCLEOSIS in teenagers and young adults,FEVER,INFECTIOUS MONONUCLEOSIS,RO-disease_has_finding
497243665,7/4/2014 07:35:04,,1314680798,7/4/2014 07:34:37,clixsense,0,27969116,NLD,,,91.213.37.165,no_relation,15,59,,20,83,causes,0.666666666666667,901948-FS1-4,It may produce FEVER and sore throat in young children and INFECTIOUS MONONUCLEOSIS in teenagers and young adults,FEVER,INFECTIOUS MONONUCLEOSIS,RO-disease_has_finding
497243665,7/4/2014 08:03:00,,1314693353,7/4/2014 08:02:36,clixsense,0,23138831,NLD,,,77.174.95.58,no_relation,15,59,,20,83,causes,0.666666666666667,901948-FS1-4,It may produce FEVER and sore throat in young children and INFECTIOUS MONONUCLEOSIS in teenagers and young adults,FEVER,INFECTIOUS MONONUCLEOSIS,RO-disease_has_finding
498010594,7/4/2014 12:47:12,False,1314840735,7/4/2014 12:46:46,rewardsspot,0.75,17763704,USA,VA,Manassas,198.7.62.204,FEVER causes INFECTIOUS MONONUCLEOSIS,70,40,,75,64,causes,0.8944271909999159,901960-FS1-4,"Alternatively, the disease may resemble INFECTIOUS MONONUCLEOSIS with FEVER, pharyngitis, hepatosplenomegaly, and adenopathy",FEVER,INFECTIOUS MONONUCLEOSIS,RO-disease_has_finding
498010594,7/4/2014 13:05:12,False,1314854888,7/4/2014 13:04:49,clixsense,0.7024,17950689,GBR,X5,Cardiff,89.168.38.216,INFECTIOUS MONONUCLEOSIS causes FEVER,70,40,,75,64,causes,0.8944271909999159,901960-FS1-4,"Alternatively, the disease may resemble INFECTIOUS MONONUCLEOSIS with FEVER, pharyngitis, hepatosplenomegaly, and adenopathy",FEVER,INFECTIOUS MONONUCLEOSIS,RO-disease_has_finding
498010594,7/4/2014 13:06:22,False,1314855680,7/4/2014 13:06:17,prodege,0.5238,18960400,GBR,A2,Edgware,31.54.207.221,INFECTIOUS MONONUCLEOSIS causes FEVER,70,40,,75,64,causes,0.8944271909999159,901960-FS1-4,"Alternatively, the disease may resemble INFECTIOUS MONONUCLEOSIS with FEVER, pharyngitis, hepatosplenomegaly, and adenopathy",FEVER,INFECTIOUS MONONUCLEOSIS,RO-disease_has_finding
498010606,7/4/2014 12:48:10,False,1314841453,7/4/2014 12:47:55,rewardsspot,0.75,17763704,USA,VA,Manassas,198.7.62.204,RADIAL GROWTH PHASE causes SUPERFICIAL SPREADING MELANOMA,93,57,,112,87,causes,0.384110639798688,901985-FS1-4,The biologic behavior of the intraepidermal component of SUPERFICIAL SPREADING MELANOMA (the RADIAL GROWTH PHASE) has been demonstrated to have significantly different properties than those of the cells in the vertical growth phase,RADIAL GROWTH PHASE,SUPERFICIAL SPREADING MELANOMA,RO-disease_has_finding
498010606,7/4/2014 13:03:09,False,1314853384,7/4/2014 13:03:02,clixsense,0.7024,17950689,GBR,X5,Cardiff,89.168.38.216,RADIAL GROWTH PHASE causes SUPERFICIAL SPREADING MELANOMA,93,57,,112,87,causes,0.384110639798688,901985-FS1-4,The biologic behavior of the intraepidermal component of SUPERFICIAL SPREADING MELANOMA (the RADIAL GROWTH PHASE) has been demonstrated to have significantly different properties than those of the cells in the vertical growth phase,RADIAL GROWTH PHASE,SUPERFICIAL SPREADING MELANOMA,RO-disease_has_finding
498010606,7/4/2014 12:40:12,False,1314836010,7/4/2014 12:39:22,rewardsspot,0.6905,24482174,GBR,H9,London,46.23.68.180,no_relation,93,57,,112,87,causes,0.384110639798688,901985-FS1-4,The biologic behavior of the intraepidermal component of SUPERFICIAL SPREADING MELANOMA (the RADIAL GROWTH PHASE) has been demonstrated to have significantly different properties than those of the cells in the vertical growth phase,RADIAL GROWTH PHASE,SUPERFICIAL SPREADING MELANOMA,RO-disease_has_finding
498010591,7/4/2014 12:22:43,False,1314824886,7/4/2014 12:22:21,clixsense,1.0,15189335,GBR,I9,Dereham,86.157.163.112,ESSENTIAL THROMBOCYTHEMIA causes ELEVATED PLATELET COUNT,23,93,,46,118,causes,0.308606699924184,901991-FS1-4,"When accompanied by an ELEVATED PLATELET COUNT, these precursor stages may clinically mimick ESSENTIAL THROMBOCYTHEMIA because they are not recognized by the conventional criteria",ELEVATED PLATELET COUNT,ESSENTIAL THROMBOCYTHEMIA,RO-disease_has_finding
498010591,7/4/2014 12:39:31,False,1314835565,7/4/2014 12:38:57,clixsense,0.8809999999999999,26649250,GBR,N7,Epsom,193.117.31.2,no_relation,23,93,,46,118,causes,0.308606699924184,901991-FS1-4,"When accompanied by an ELEVATED PLATELET COUNT, these precursor stages may clinically mimick ESSENTIAL THROMBOCYTHEMIA because they are not recognized by the conventional criteria",ELEVATED PLATELET COUNT,ESSENTIAL THROMBOCYTHEMIA,RO-disease_has_finding
498010591,7/4/2014 12:53:31,False,1314846001,7/4/2014 12:52:25,prodege,0.7778,27939470,GBR,X5,Cardiff,2.97.141.128,no_relation,23,93,,46,118,causes,0.308606699924184,901991-FS1-4,"When accompanied by an ELEVATED PLATELET COUNT, these precursor stages may clinically mimick ESSENTIAL THROMBOCYTHEMIA because they are not recognized by the conventional criteria",ELEVATED PLATELET COUNT,ESSENTIAL THROMBOCYTHEMIA,RO-disease_has_finding
498010607,7/4/2014 12:48:45,False,1314841894,7/4/2014 12:48:14,rewardsspot,0.75,17763704,USA,VA,Manassas,198.7.62.204,HAEMOPHAGOCYTIC SYNDROME causes PANCYTOPENIA,61,118,,73,142,causes,0.8682431421244592,902511-FS1-4,"However, the patient deteriorated, with fevers, weight loss, PANCYTOPENIA and laboratory features consistent with the HAEMOPHAGOCYTIC SYNDROME",PANCYTOPENIA,HAEMOPHAGOCYTIC SYNDROME,RO-disease_may_have_finding
498010607,7/4/2014 13:03:01,False,1314853284,7/4/2014 13:02:50,clixsense,0.7024,17950689,GBR,X5,Cardiff,89.168.38.216,PANCYTOPENIA causes HAEMOPHAGOCYTIC SYNDROME,61,118,,73,142,causes,0.8682431421244592,902511-FS1-4,"However, the patient deteriorated, with fevers, weight loss, PANCYTOPENIA and laboratory features consistent with the HAEMOPHAGOCYTIC SYNDROME",PANCYTOPENIA,HAEMOPHAGOCYTIC SYNDROME,RO-disease_may_have_finding
498010607,7/4/2014 13:06:35,False,1314855818,7/4/2014 13:06:30,prodege,0.5238,18960400,GBR,A2,Edgware,31.54.207.221,PANCYTOPENIA causes HAEMOPHAGOCYTIC SYNDROME,61,118,,73,142,causes,0.8682431421244592,902511-FS1-4,"However, the patient deteriorated, with fevers, weight loss, PANCYTOPENIA and laboratory features consistent with the HAEMOPHAGOCYTIC SYNDROME",PANCYTOPENIA,HAEMOPHAGOCYTIC SYNDROME,RO-disease_may_have_finding
497984443,7/4/2014 10:28:44,,1314761211,7/4/2014 10:28:39,clixsense,0.8875,19162475,GBR,M3,Frome,82.33.126.30,HAEMOPHAGOCYTIC SYNDROME causes PANCYTOPENIA,61,118,,73,142,causes,0.8682431421244592,902511-FS1-4,"However, the patient deteriorated, with fevers, weight loss, PANCYTOPENIA and laboratory features consistent with the HAEMOPHAGOCYTIC SYNDROME",PANCYTOPENIA,HAEMOPHAGOCYTIC SYNDROME,RO-disease_may_have_finding
497984443,7/4/2014 10:29:38,,1314761609,7/4/2014 10:29:06,clixsense,0.7,15189335,GBR,I9,Dereham,86.157.163.112,HAEMOPHAGOCYTIC SYNDROME causes PANCYTOPENIA,61,118,,73,142,causes,0.8682431421244592,902511-FS1-4,"However, the patient deteriorated, with fevers, weight loss, PANCYTOPENIA and laboratory features consistent with the HAEMOPHAGOCYTIC SYNDROME",PANCYTOPENIA,HAEMOPHAGOCYTIC SYNDROME,RO-disease_may_have_finding
497984443,7/4/2014 11:06:00,,1314778839,7/4/2014 11:05:16,clixsense,0.5958,27969116,NLD,,,91.213.37.165,HAEMOPHAGOCYTIC SYNDROME causes PANCYTOPENIA,61,118,,73,142,causes,0.8682431421244592,902511-FS1-4,"However, the patient deteriorated, with fevers, weight loss, PANCYTOPENIA and laboratory features consistent with the HAEMOPHAGOCYTIC SYNDROME",PANCYTOPENIA,HAEMOPHAGOCYTIC SYNDROME,RO-disease_may_have_finding
498010576,7/4/2014 13:04:48,False,1314854636,7/4/2014 13:04:33,clixsense,0.7024,17950689,GBR,X5,Cardiff,89.168.38.216,HEPATOCELLULAR CARCINOMA causes FEVER,82,23,,87,47,causes,0.964901281354015,902533-FS1-4,A 52-year-old man with HEPATOCELLULAR CARCINOMA (HCC) was admitted with cough and FEVER,FEVER,HEPATOCELLULAR CARCINOMA,RO-disease_may_have_finding
498010576,7/4/2014 13:06:29,False,1314855796,7/4/2014 13:06:23,prodege,0.5238,18960400,GBR,A2,Edgware,31.54.207.221,FEVER causes HEPATOCELLULAR CARCINOMA,82,23,,87,47,causes,0.964901281354015,902533-FS1-4,A 52-year-old man with HEPATOCELLULAR CARCINOMA (HCC) was admitted with cough and FEVER,FEVER,HEPATOCELLULAR CARCINOMA,RO-disease_may_have_finding
498010576,7/4/2014 13:15:33,False,1314863025,7/4/2014 13:15:06,clixsense,0.7051,27871219,NLD,7,Amsterdam,87.210.207.223,HEPATOCELLULAR CARCINOMA causes FEVER,82,23,,87,47,causes,0.964901281354015,902533-FS1-4,A 52-year-old man with HEPATOCELLULAR CARCINOMA (HCC) was admitted with cough and FEVER,FEVER,HEPATOCELLULAR CARCINOMA,RO-disease_may_have_finding
498010575,7/4/2014 13:04:32,False,1314854477,7/4/2014 13:03:58,clixsense,0.7024,17950689,GBR,X5,Cardiff,89.168.38.216,SPLENOMEGALY causes GAMMA HEAVY CHAIN DISEASE,116,15,,128,40,causes,0.50709255283711,902622-FS1-4,A patient with GAMMA HEAVY CHAIN DISEASE (Franklin's disease) was discovered during evaluation for pancytopenia and SPLENOMEGALY,SPLENOMEGALY,GAMMA HEAVY CHAIN DISEASE,RO-disease_may_have_finding
498010575,7/4/2014 13:06:35,False,1314855830,7/4/2014 13:06:30,prodege,0.5238,18960400,GBR,A2,Edgware,31.54.207.221,GAMMA HEAVY CHAIN DISEASE causes SPLENOMEGALY,116,15,,128,40,causes,0.50709255283711,902622-FS1-4,A patient with GAMMA HEAVY CHAIN DISEASE (Franklin's disease) was discovered during evaluation for pancytopenia and SPLENOMEGALY,SPLENOMEGALY,GAMMA HEAVY CHAIN DISEASE,RO-disease_may_have_finding
498010575,7/4/2014 13:15:31,False,1314863005,7/4/2014 13:14:19,instagc,0.5833,18960682,GBR,,,86.29.55.201,no_relation,116,15,,128,40,causes,0.50709255283711,902622-FS1-4,A patient with GAMMA HEAVY CHAIN DISEASE (Franklin's disease) was discovered during evaluation for pancytopenia and SPLENOMEGALY,SPLENOMEGALY,GAMMA HEAVY CHAIN DISEASE,RO-disease_may_have_finding
498010610,7/4/2014 12:23:56,False,1314825739,7/4/2014 12:23:38,clixsense,1.0,15189335,GBR,I9,Dereham,86.157.163.112,LIVER is location of HEPATIC METASTASIS,74,48,,79,66,is location of,0.956182887467515,905138-FS1-9,A 45-year-old woman underwent a resection for a HEPATIC METASTASIS of the LIVER caused by a carcinoma of the colon,LIVER,HEPATIC METASTASIS,RO-has_finding_site
498010610,7/4/2014 12:47:52,False,1314841222,7/4/2014 12:47:38,rewardsspot,0.75,17763704,USA,VA,Manassas,198.7.62.204,LIVER is location of HEPATIC METASTASIS,74,48,,79,66,is location of,0.956182887467515,905138-FS1-9,A 45-year-old woman underwent a resection for a HEPATIC METASTASIS of the LIVER caused by a carcinoma of the colon,LIVER,HEPATIC METASTASIS,RO-has_finding_site
498010610,7/4/2014 12:36:30,False,1314833640,7/4/2014 12:35:35,rewardsspot,0.6905,24482174,GBR,H9,London,46.23.68.180,HEPATIC METASTASIS is location of LIVER,74,48,,79,66,is location of,0.956182887467515,905138-FS1-9,A 45-year-old woman underwent a resection for a HEPATIC METASTASIS of the LIVER caused by a carcinoma of the colon,LIVER,HEPATIC METASTASIS,RO-has_finding_site
498010604,7/4/2014 13:15:31,False,1314863006,7/4/2014 13:14:19,instagc,0.5833,18960682,GBR,,,86.29.55.201,no_relation,65,121,,76,141,is diagnosed by,0.452267016866645,905148-FS1-13,"Recognizing that the patient's disease was localized only to the SPINAL CORD led to an eventual serological diagnosis of NEUROMYELITIS OPTICA (Devic's disease), a demyelinating syndrome that is now considered distinct from multiple sclerosis and that primarily affects the spinal cord and optic nerves",SPINAL CORD,NEUROMYELITIS OPTICA,RO-has_finding_site
498010604,7/4/2014 13:49:18,False,1314891066,7/4/2014 13:49:09,instagc,0.3333,27753923,GBR,,,188.29.74.234,SPINAL CORD is diagnosed by NEUROMYELITIS OPTICA,65,121,,76,141,is diagnosed by,0.452267016866645,905148-FS1-13,"Recognizing that the patient's disease was localized only to the SPINAL CORD led to an eventual serological diagnosis of NEUROMYELITIS OPTICA (Devic's disease), a demyelinating syndrome that is now considered distinct from multiple sclerosis and that primarily affects the spinal cord and optic nerves",SPINAL CORD,NEUROMYELITIS OPTICA,RO-has_finding_site
498010604,7/4/2014 13:13:59,False,1314861834,7/4/2014 13:13:24,clixsense,0.7051,27871219,NLD,7,Amsterdam,87.210.207.223,NEUROMYELITIS OPTICA is diagnosed by SPINAL CORD,65,121,,76,141,is diagnosed by,0.452267016866645,905148-FS1-13,"Recognizing that the patient's disease was localized only to the SPINAL CORD led to an eventual serological diagnosis of NEUROMYELITIS OPTICA (Devic's disease), a demyelinating syndrome that is now considered distinct from multiple sclerosis and that primarily affects the spinal cord and optic nerves",SPINAL CORD,NEUROMYELITIS OPTICA,RO-has_finding_site
498010579,7/4/2014 13:03:57,False,1314853960,7/4/2014 13:03:11,clixsense,0.7024,17950689,GBR,X5,Cardiff,89.168.38.216,PANCREAS causes PANCREATITIS,98,154,,106,166,causes,0.48666426339228797,905240-FS1-4,"The changes in ductal vascularity correlated with the severity of the histological changes to the PANCREAS and may, thus, in part explain the progress of PANCREATITIS",PANCREAS,PANCREATITIS,RO-has_finding_site
498010579,7/4/2014 12:39:31,False,1314835575,7/4/2014 12:38:57,clixsense,0.8809999999999999,26649250,GBR,N7,Epsom,193.117.31.2,no_relation,98,154,,106,166,causes,0.48666426339228797,905240-FS1-4,"The changes in ductal vascularity correlated with the severity of the histological changes to the PANCREAS and may, thus, in part explain the progress of PANCREATITIS",PANCREAS,PANCREATITIS,RO-has_finding_site
498010579,7/4/2014 12:55:35,False,1314847590,7/4/2014 12:54:37,prodege,0.7778,27939470,GBR,X5,Cardiff,2.97.141.128,PANCREAS causes PANCREATITIS,98,154,,106,166,causes,0.48666426339228797,905240-FS1-4,"The changes in ductal vascularity correlated with the severity of the histological changes to the PANCREAS and may, thus, in part explain the progress of PANCREATITIS",PANCREAS,PANCREATITIS,RO-has_finding_site
497984434,7/4/2014 10:29:04,,1314761333,7/4/2014 10:28:32,clixsense,0.7,15189335,GBR,I9,Dereham,86.157.163.112,no_relation,198,256,,203,263,causes,0.462910049886276,905254-FS1-4,"In conclusion, chronic exposure to CSC alters relevant neuronal, neuroendocrine and immune functions that could be directly or indirectly involved in the damage of the histological integrity of the COLON comparable with that seen during the development of COLITIS",COLON,COLITIS,RO-has_finding_site
497984434,7/4/2014 10:29:41,,1314761648,7/4/2014 10:29:29,clixsense,0.8875,19162475,GBR,M3,Frome,82.33.126.30,COLITIS causes COLON,198,256,,203,263,causes,0.462910049886276,905254-FS1-4,"In conclusion, chronic exposure to CSC alters relevant neuronal, neuroendocrine and immune functions that could be directly or indirectly involved in the damage of the histological integrity of the COLON comparable with that seen during the development of COLITIS",COLON,COLITIS,RO-has_finding_site
497984434,7/4/2014 11:02:31,,1314776793,7/4/2014 11:01:42,clixsense,0.5958,27969116,NLD,,,91.213.37.165,COLITIS causes COLON,198,256,,203,263,causes,0.462910049886276,905254-FS1-4,"In conclusion, chronic exposure to CSC alters relevant neuronal, neuroendocrine and immune functions that could be directly or indirectly involved in the damage of the histological integrity of the COLON comparable with that seen during the development of COLITIS",COLON,COLITIS,RO-has_finding_site
498010589,7/4/2014 12:21:41,False,1314824194,7/4/2014 12:21:23,clixsense,1.0,15189335,GBR,I9,Dereham,86.157.163.112,COLON is location of COLITIS,198,256,,203,263,is location of,0.617213399848368,905254-FS1-9,"In conclusion, chronic exposure to CSC alters relevant neuronal, neuroendocrine and immune functions that could be directly or indirectly involved in the damage of the histological integrity of the COLON comparable with that seen during the development of COLITIS",COLON,COLITIS,RO-has_finding_site
498010589,7/4/2014 12:38:56,False,1314835227,7/4/2014 12:38:21,clixsense,0.8809999999999999,26649250,GBR,N7,Epsom,193.117.31.2,COLON is location of COLITIS,198,256,,203,263,is location of,0.617213399848368,905254-FS1-9,"In conclusion, chronic exposure to CSC alters relevant neuronal, neuroendocrine and immune functions that could be directly or indirectly involved in the damage of the histological integrity of the COLON comparable with that seen during the development of COLITIS",COLON,COLITIS,RO-has_finding_site
498010589,7/4/2014 13:15:33,False,1314863024,7/4/2014 13:15:06,clixsense,0.7051,27871219,NLD,7,Amsterdam,87.210.207.223,COLON is location of COLITIS,198,256,,203,263,is location of,0.617213399848368,905254-FS1-9,"In conclusion, chronic exposure to CSC alters relevant neuronal, neuroendocrine and immune functions that could be directly or indirectly involved in the damage of the histological integrity of the COLON comparable with that seen during the development of COLITIS",COLON,COLITIS,RO-has_finding_site
497984425,7/4/2014 10:28:20,,1314761080,7/4/2014 10:28:09,clixsense,0.8875,19162475,GBR,M3,Frome,82.33.126.30,COLITIS is location of COLON,198,256,,203,263,is location of,0.617213399848368,905254-FS1-9,"In conclusion, chronic exposure to CSC alters relevant neuronal, neuroendocrine and immune functions that could be directly or indirectly involved in the damage of the histological integrity of the COLON comparable with that seen during the development of COLITIS",COLON,COLITIS,RO-has_finding_site
497984425,7/4/2014 10:34:52,,1314763737,7/4/2014 10:34:39,clixsense,0.7,15189335,GBR,I9,Dereham,86.157.163.112,COLON is location of COLITIS,198,256,,203,263,is location of,0.617213399848368,905254-FS1-9,"In conclusion, chronic exposure to CSC alters relevant neuronal, neuroendocrine and immune functions that could be directly or indirectly involved in the damage of the histological integrity of the COLON comparable with that seen during the development of COLITIS",COLON,COLITIS,RO-has_finding_site
497984425,7/4/2014 10:59:00,,1314775001,7/4/2014 10:58:18,clixsense,0.5958,27969116,NLD,,,91.213.37.165,no_relation,198,256,,203,263,is location of,0.617213399848368,905254-FS1-9,"In conclusion, chronic exposure to CSC alters relevant neuronal, neuroendocrine and immune functions that could be directly or indirectly involved in the damage of the histological integrity of the COLON comparable with that seen during the development of COLITIS",COLON,COLITIS,RO-has_finding_site
497984416,7/4/2014 10:28:00,,1314760921,7/4/2014 10:27:43,clixsense,0.8875,19162475,GBR,M3,Frome,82.33.126.30,HUNTINGTON'S DISEASE causes BASAL GANGLIA STRUCTURES,101,42,,125,62,causes,0.676123403782813,905446-FS1-4,Studies of eye movements in patients with HUNTINGTON'S DISEASE (HD) have suggested that frontal lobe-BASAL GANGLIA STRUCTURES are more involved in HD than the parietal lobes,BASAL GANGLIA STRUCTURES,HUNTINGTON'S DISEASE,RO-has_finding_site
497984416,7/4/2014 10:30:38,,1314762062,7/4/2014 10:30:03,clixsense,0.7,15189335,GBR,I9,Dereham,86.157.163.112,no_relation,101,42,,125,62,causes,0.676123403782813,905446-FS1-4,Studies of eye movements in patients with HUNTINGTON'S DISEASE (HD) have suggested that frontal lobe-BASAL GANGLIA STRUCTURES are more involved in HD than the parietal lobes,BASAL GANGLIA STRUCTURES,HUNTINGTON'S DISEASE,RO-has_finding_site
497984416,7/4/2014 11:06:35,,1314779186,7/4/2014 11:06:01,clixsense,0.5958,27969116,NLD,,,91.213.37.165,no_relation,101,42,,125,62,causes,0.676123403782813,905446-FS1-4,Studies of eye movements in patients with HUNTINGTON'S DISEASE (HD) have suggested that frontal lobe-BASAL GANGLIA STRUCTURES are more involved in HD than the parietal lobes,BASAL GANGLIA STRUCTURES,HUNTINGTON'S DISEASE,RO-has_finding_site
497984445,7/4/2014 10:29:16,,1314761409,7/4/2014 10:29:11,clixsense,0.8875,19162475,GBR,M3,Frome,82.33.126.30,HUNTINGTON'S DISEASE is location of BASAL GANGLIA STRUCTURES,101,42,,125,62,is location of,0.50709255283711,905446-FS1-9,Studies of eye movements in patients with HUNTINGTON'S DISEASE (HD) have suggested that frontal lobe-BASAL GANGLIA STRUCTURES are more involved in HD than the parietal lobes,BASAL GANGLIA STRUCTURES,HUNTINGTON'S DISEASE,RO-has_finding_site
497984445,7/4/2014 10:31:38,,1314762450,7/4/2014 10:31:12,clixsense,0.7,15189335,GBR,I9,Dereham,86.157.163.112,no_relation,101,42,,125,62,is location of,0.50709255283711,905446-FS1-9,Studies of eye movements in patients with HUNTINGTON'S DISEASE (HD) have suggested that frontal lobe-BASAL GANGLIA STRUCTURES are more involved in HD than the parietal lobes,BASAL GANGLIA STRUCTURES,HUNTINGTON'S DISEASE,RO-has_finding_site
497984445,7/4/2014 10:59:44,,1314775312,7/4/2014 10:59:01,clixsense,0.5958,27969116,NLD,,,91.213.37.165,HUNTINGTON'S DISEASE is location of BASAL GANGLIA STRUCTURES,101,42,,125,62,is location of,0.50709255283711,905446-FS1-9,Studies of eye movements in patients with HUNTINGTON'S DISEASE (HD) have suggested that frontal lobe-BASAL GANGLIA STRUCTURES are more involved in HD than the parietal lobes,BASAL GANGLIA STRUCTURES,HUNTINGTON'S DISEASE,RO-has_finding_site
498010588,7/4/2014 13:03:57,False,1314853961,7/4/2014 13:03:11,clixsense,0.7024,17950689,GBR,X5,Cardiff,89.168.38.216,SPINAL CORD treats SPINAL CORD INJURY,91,134,,102,152,treats,0.617213399848368,905460-FS1-2,"Recent reports have also shown that exercise induces molecular mechanisms that benefit the SPINAL CORD and can improve recovery after SPINAL CORD INJURY (SCI); therefore, we repeated the assays in the spinal cord",SPINAL CORD,SPINAL CORD INJURY,RO-has_finding_site
498010588,7/4/2014 13:06:11,False,1314855493,7/4/2014 13:06:04,prodege,0.5238,18960400,GBR,A2,Edgware,31.54.207.221,SPINAL CORD INJURY treats SPINAL CORD,91,134,,102,152,treats,0.617213399848368,905460-FS1-2,"Recent reports have also shown that exercise induces molecular mechanisms that benefit the SPINAL CORD and can improve recovery after SPINAL CORD INJURY (SCI); therefore, we repeated the assays in the spinal cord",SPINAL CORD,SPINAL CORD INJURY,RO-has_finding_site
498010588,7/4/2014 12:37:43,False,1314834374,7/4/2014 12:37:24,clixsense,0.8809999999999999,26649250,GBR,N7,Epsom,193.117.31.2,SPINAL CORD treats SPINAL CORD INJURY,91,134,,102,152,treats,0.617213399848368,905460-FS1-2,"Recent reports have also shown that exercise induces molecular mechanisms that benefit the SPINAL CORD and can improve recovery after SPINAL CORD INJURY (SCI); therefore, we repeated the assays in the spinal cord",SPINAL CORD,SPINAL CORD INJURY,RO-has_finding_site
497984438,7/4/2014 10:29:04,,1314761332,7/4/2014 10:28:32,clixsense,0.7,15189335,GBR,I9,Dereham,86.157.163.112,no_relation,186,198,,195,222,causes,0.514495755427526,906105-FS1-4,DISEASE NAME AND SYNONYMS: Syndromic diarrhea - Phenotypic diarrhea - Tricho-hepato-enteric syndrome - Intractable diarrhea of infancy with facial dysmorphism - Trichorrhexis nodosa and CIRRHOSIS - NEONATAL HEMOCHROMATOSIS phenotype with intractable diarrhea and hair abnormalities - Intractable infant diarrhea associated with phenotypic abnormalities and immune deficiency,CIRRHOSIS,NEONATAL HEMOCHROMATOSIS,RO-has_manifestation
497984438,7/4/2014 10:29:41,,1314761647,7/4/2014 10:29:29,clixsense,0.8875,19162475,GBR,M3,Frome,82.33.126.30,CIRRHOSIS causes NEONATAL HEMOCHROMATOSIS,186,198,,195,222,causes,0.514495755427526,906105-FS1-4,DISEASE NAME AND SYNONYMS: Syndromic diarrhea - Phenotypic diarrhea - Tricho-hepato-enteric syndrome - Intractable diarrhea of infancy with facial dysmorphism - Trichorrhexis nodosa and CIRRHOSIS - NEONATAL HEMOCHROMATOSIS phenotype with intractable diarrhea and hair abnormalities - Intractable infant diarrhea associated with phenotypic abnormalities and immune deficiency,CIRRHOSIS,NEONATAL HEMOCHROMATOSIS,RO-has_manifestation
497984438,7/4/2014 10:58:17,,1314774680,7/4/2014 10:57:29,clixsense,0.5958,27969116,NLD,,,91.213.37.165,no_relation,186,198,,195,222,causes,0.514495755427526,906105-FS1-4,DISEASE NAME AND SYNONYMS: Syndromic diarrhea - Phenotypic diarrhea - Tricho-hepato-enteric syndrome - Intractable diarrhea of infancy with facial dysmorphism - Trichorrhexis nodosa and CIRRHOSIS - NEONATAL HEMOCHROMATOSIS phenotype with intractable diarrhea and hair abnormalities - Intractable infant diarrhea associated with phenotypic abnormalities and immune deficiency,CIRRHOSIS,NEONATAL HEMOCHROMATOSIS,RO-has_manifestation
498010572,7/4/2014 12:48:45,False,1314841896,7/4/2014 12:48:14,rewardsspot,0.75,17763704,USA,VA,Manassas,198.7.62.204,ASTHMA causes ATOPIC DERMATITIS,255,206,,261,223,causes,0.98058067569092,906135-FS1-4,"Indeed, epicutaneous sensitization of mice to a protein antigen induces both a localized allergic dermatitis and hyperresponsiveness to methacholine, which suggests that epicutaneous exposure to antigen in ATOPIC DERMATITIS may enhance the development of ASTHMA",ASTHMA,ATOPIC DERMATITIS,RO-has_manifestation
498010572,7/4/2014 12:39:17,False,1314835402,7/4/2014 12:38:39,rewardsspot,0.6905,24482174,GBR,H9,London,46.23.68.180,ATOPIC DERMATITIS causes ASTHMA,255,206,,261,223,causes,0.98058067569092,906135-FS1-4,"Indeed, epicutaneous sensitization of mice to a protein antigen induces both a localized allergic dermatitis and hyperresponsiveness to methacholine, which suggests that epicutaneous exposure to antigen in ATOPIC DERMATITIS may enhance the development of ASTHMA",ASTHMA,ATOPIC DERMATITIS,RO-has_manifestation
498010572,7/4/2014 12:40:00,False,1314835828,7/4/2014 12:39:33,clixsense,0.8809999999999999,26649250,GBR,N7,Epsom,193.117.31.2,ATOPIC DERMATITIS causes ASTHMA,255,206,,261,223,causes,0.98058067569092,906135-FS1-4,"Indeed, epicutaneous sensitization of mice to a protein antigen induces both a localized allergic dermatitis and hyperresponsiveness to methacholine, which suggests that epicutaneous exposure to antigen in ATOPIC DERMATITIS may enhance the development of ASTHMA",ASTHMA,ATOPIC DERMATITIS,RO-has_manifestation
498010592,7/4/2014 12:49:29,False,1314842433,7/4/2014 12:49:09,rewardsspot,0.75,17763704,USA,VA,Manassas,198.7.62.204,STURGE-WEBER SYNDROME causes GLAUCOMA,96,146,,104,167,causes,0.629940788348712,906189-FS1-4,"The results of our data can serve as a guide for estimating relative risk figures for seizures, GLAUCOMA, and mental retardation in children with STURGE-WEBER SYNDROME",GLAUCOMA,STURGE-WEBER SYNDROME,RO-has_manifestation
498010592,7/4/2014 13:06:22,False,1314855671,7/4/2014 13:06:17,prodege,0.5238,18960400,GBR,A2,Edgware,31.54.207.221,STURGE-WEBER SYNDROME causes GLAUCOMA,96,146,,104,167,causes,0.629940788348712,906189-FS1-4,"The results of our data can serve as a guide for estimating relative risk figures for seizures, GLAUCOMA, and mental retardation in children with STURGE-WEBER SYNDROME",GLAUCOMA,STURGE-WEBER SYNDROME,RO-has_manifestation
498010592,7/4/2014 12:58:12,False,1314849602,7/4/2014 12:57:25,prodege,0.7778,27939470,GBR,X5,Cardiff,2.97.141.128,no_relation,96,146,,104,167,causes,0.629940788348712,906189-FS1-4,"The results of our data can serve as a guide for estimating relative risk figures for seizures, GLAUCOMA, and mental retardation in children with STURGE-WEBER SYNDROME",GLAUCOMA,STURGE-WEBER SYNDROME,RO-has_manifestation
498010570,7/4/2014 12:47:52,False,1314841223,7/4/2014 12:47:38,rewardsspot,0.75,17763704,USA,VA,Manassas,198.7.62.204,LUPUS causes HAEMOLYTIC ANAEMIA,16,38,,34,43,causes,0.927172649945531,906260-FS1-4,"The presence of HAEMOLYTIC ANAEMIA in LUPUS patients was associated with a higher frequency of proteinuria (OR = 2.70, P = 0.000031), urinary cellular casts (OR = 2.83, P = 0.000062), seizures (OR = 2.96, P = 0.00024), pericarditis (OR = 2.21, P = 0.0019), pleuritis (OR = 1.72, P = 0.028) and lymphopenia (OR = 1.79, P = 0.015",HAEMOLYTIC ANAEMIA,LUPUS,RO-has_manifestation
498010570,7/4/2014 13:03:01,False,1314853285,7/4/2014 13:02:50,clixsense,0.7024,17950689,GBR,X5,Cardiff,89.168.38.216,LUPUS causes HAEMOLYTIC ANAEMIA,16,38,,34,43,causes,0.927172649945531,906260-FS1-4,"The presence of HAEMOLYTIC ANAEMIA in LUPUS patients was associated with a higher frequency of proteinuria (OR = 2.70, P = 0.000031), urinary cellular casts (OR = 2.83, P = 0.000062), seizures (OR = 2.96, P = 0.00024), pericarditis (OR = 2.21, P = 0.0019), pleuritis (OR = 1.72, P = 0.028) and lymphopenia (OR = 1.79, P = 0.015",HAEMOLYTIC ANAEMIA,LUPUS,RO-has_manifestation
498010570,7/4/2014 12:38:33,False,1314834967,7/4/2014 12:38:02,rewardsspot,0.6905,24482174,GBR,H9,London,46.23.68.180,HAEMOLYTIC ANAEMIA causes LUPUS,16,38,,34,43,causes,0.927172649945531,906260-FS1-4,"The presence of HAEMOLYTIC ANAEMIA in LUPUS patients was associated with a higher frequency of proteinuria (OR = 2.70, P = 0.000031), urinary cellular casts (OR = 2.83, P = 0.000062), seizures (OR = 2.96, P = 0.00024), pericarditis (OR = 2.21, P = 0.0019), pleuritis (OR = 1.72, P = 0.028) and lymphopenia (OR = 1.79, P = 0.015",HAEMOLYTIC ANAEMIA,LUPUS,RO-has_manifestation
497984431,7/4/2014 10:28:30,,1314761139,7/4/2014 10:28:22,clixsense,0.8875,19162475,GBR,M3,Frome,82.33.126.30,no_relation,163,174,,169,189,causes,0.493196961916072,906266-FS1-4,"The cleavage of MUC5AC and the generation of the reactive new C-terminus could contribute to the adherent and viscous mucus found at chronic lung diseases such as ASTHMA and CYSTIC FIBROSIS, characterized by mucus hypersecretion and lowered pH of the airways",ASTHMA,CYSTIC FIBROSIS,RO-has_manifestation
497984431,7/4/2014 10:32:10,,1314762642,7/4/2014 10:31:40,clixsense,0.7,15189335,GBR,I9,Dereham,86.157.163.112,no_relation,163,174,,169,189,causes,0.493196961916072,906266-FS1-4,"The cleavage of MUC5AC and the generation of the reactive new C-terminus could contribute to the adherent and viscous mucus found at chronic lung diseases such as ASTHMA and CYSTIC FIBROSIS, characterized by mucus hypersecretion and lowered pH of the airways",ASTHMA,CYSTIC FIBROSIS,RO-has_manifestation
497984431,7/4/2014 10:59:00,,1314775003,7/4/2014 10:58:18,clixsense,0.5958,27969116,NLD,,,91.213.37.165,no_relation,163,174,,169,189,causes,0.493196961916072,906266-FS1-4,"The cleavage of MUC5AC and the generation of the reactive new C-terminus could contribute to the adherent and viscous mucus found at chronic lung diseases such as ASTHMA and CYSTIC FIBROSIS, characterized by mucus hypersecretion and lowered pH of the airways",ASTHMA,CYSTIC FIBROSIS,RO-has_manifestation
498010584,7/4/2014 12:22:00,False,1314824450,7/4/2014 12:21:42,clixsense,1.0,15189335,GBR,I9,Dereham,86.157.163.112,HUNTINGTON'S DISEASE causes DEMENTIA,195,130,,203,150,causes,0.8888888888888891,906278-FS1-4,"A controlled prospective study compared the performance of 14 patients with dementia of Alzheimer type (DAT) and 14 patients with HUNTINGTON'S DISEASE (HD), who were matched for overall level of DEMENTIA, on a battery of semantic and episodic memory tests",DEMENTIA,HUNTINGTON'S DISEASE,RO-has_manifestation
498010584,7/4/2014 13:04:48,False,1314854624,7/4/2014 13:04:33,clixsense,0.7024,17950689,GBR,X5,Cardiff,89.168.38.216,DEMENTIA causes HUNTINGTON'S DISEASE,195,130,,203,150,causes,0.8888888888888891,906278-FS1-4,"A controlled prospective study compared the performance of 14 patients with dementia of Alzheimer type (DAT) and 14 patients with HUNTINGTON'S DISEASE (HD), who were matched for overall level of DEMENTIA, on a battery of semantic and episodic memory tests",DEMENTIA,HUNTINGTON'S DISEASE,RO-has_manifestation
498010584,7/4/2014 13:06:11,False,1314855502,7/4/2014 13:06:04,prodege,0.5238,18960400,GBR,A2,Edgware,31.54.207.221,DEMENTIA causes HUNTINGTON'S DISEASE,195,130,,203,150,causes,0.8888888888888891,906278-FS1-4,"A controlled prospective study compared the performance of 14 patients with dementia of Alzheimer type (DAT) and 14 patients with HUNTINGTON'S DISEASE (HD), who were matched for overall level of DEMENTIA, on a battery of semantic and episodic memory tests",DEMENTIA,HUNTINGTON'S DISEASE,RO-has_manifestation
498010603,7/4/2014 12:22:20,False,1314824717,7/4/2014 12:22:01,clixsense,1.0,15189335,GBR,I9,Dereham,86.157.163.112,no_relation,99,156,,111,172,treats,0.609994281330419,906386-FS1-2,Investigations of the affective and sensory states contributing to the etiology and maintenance of HAIR PULLING may help to elucidate the classification of TRICHOTILLOMANIA (TTM) as an impulse control disorder or obsessive-compulsive spectrum disorder,HAIR PULLING,TRICHOTILLOMANIA,RO-has_manifestation
498010603,7/4/2014 12:37:56,False,1314834542,7/4/2014 12:37:09,rewardsspot,0.6905,24482174,GBR,H9,London,46.23.68.180,HAIR PULLING treats TRICHOTILLOMANIA,99,156,,111,172,treats,0.609994281330419,906386-FS1-2,Investigations of the affective and sensory states contributing to the etiology and maintenance of HAIR PULLING may help to elucidate the classification of TRICHOTILLOMANIA (TTM) as an impulse control disorder or obsessive-compulsive spectrum disorder,HAIR PULLING,TRICHOTILLOMANIA,RO-has_manifestation
498010603,7/4/2014 12:55:35,False,1314847588,7/4/2014 12:54:37,prodege,0.7778,27939470,GBR,X5,Cardiff,2.97.141.128,no_relation,99,156,,111,172,treats,0.609994281330419,906386-FS1-2,Investigations of the affective and sensory states contributing to the etiology and maintenance of HAIR PULLING may help to elucidate the classification of TRICHOTILLOMANIA (TTM) as an impulse control disorder or obsessive-compulsive spectrum disorder,HAIR PULLING,TRICHOTILLOMANIA,RO-has_manifestation
497984439,7/4/2014 10:28:30,,1314761141,7/4/2014 10:27:40,clixsense,0.7,15189335,GBR,I9,Dereham,86.157.163.112,no_relation,99,156,,111,172,treats,0.609994281330419,906386-FS1-2,Investigations of the affective and sensory states contributing to the etiology and maintenance of HAIR PULLING may help to elucidate the classification of TRICHOTILLOMANIA (TTM) as an impulse control disorder or obsessive-compulsive spectrum disorder,HAIR PULLING,TRICHOTILLOMANIA,RO-has_manifestation
497984439,7/4/2014 10:28:30,,1314761143,7/4/2014 10:28:22,clixsense,0.8875,19162475,GBR,M3,Frome,82.33.126.30,TRICHOTILLOMANIA treats HAIR PULLING,99,156,,111,172,treats,0.609994281330419,906386-FS1-2,Investigations of the affective and sensory states contributing to the etiology and maintenance of HAIR PULLING may help to elucidate the classification of TRICHOTILLOMANIA (TTM) as an impulse control disorder or obsessive-compulsive spectrum disorder,HAIR PULLING,TRICHOTILLOMANIA,RO-has_manifestation
497984439,7/4/2014 11:07:24,,1314779615,7/4/2014 11:06:37,clixsense,0.5958,27969116,NLD,,,91.213.37.165,HAIR PULLING treats TRICHOTILLOMANIA,99,156,,111,172,treats,0.609994281330419,906386-FS1-2,Investigations of the affective and sensory states contributing to the etiology and maintenance of HAIR PULLING may help to elucidate the classification of TRICHOTILLOMANIA (TTM) as an impulse control disorder or obsessive-compulsive spectrum disorder,HAIR PULLING,TRICHOTILLOMANIA,RO-has_manifestation
497999920,7/4/2014 11:41:06,,1314797139,7/4/2014 11:40:55,neodev,0.9875,18517457,GBR,,,86.29.55.201,DEXAMETHASONE treats CUSHING SYNDROME,84,66,,100,79,treats,0.7624928516630229,906631-FS1-2,"We tried to detect salivary cortisol level with drug loading test(DEXAMETHASONE for CUSHING SYNDROME, and ACTH for adrenal insufficiency) with time interval",CUSHING SYNDROME,DEXAMETHASONE,RO-may_diagnose
497999920,7/4/2014 11:53:15,,1314804500,7/4/2014 11:52:39,clixsense,0.902,27871219,NLD,7,Amsterdam,87.210.207.223,DEXAMETHASONE treats CUSHING SYNDROME,84,66,,100,79,treats,0.7624928516630229,906631-FS1-2,"We tried to detect salivary cortisol level with drug loading test(DEXAMETHASONE for CUSHING SYNDROME, and ACTH for adrenal insufficiency) with time interval",CUSHING SYNDROME,DEXAMETHASONE,RO-may_diagnose
497999920,7/4/2014 12:21:16,,1314823803,7/4/2014 12:20:45,clixsense,0.775,27969116,NLD,,,91.213.37.165,no_relation,84,66,,100,79,treats,0.7624928516630229,906631-FS1-2,"We tried to detect salivary cortisol level with drug loading test(DEXAMETHASONE for CUSHING SYNDROME, and ACTH for adrenal insufficiency) with time interval",CUSHING SYNDROME,DEXAMETHASONE,RO-may_diagnose
497999922,7/4/2014 11:34:55,,1314793811,7/4/2014 11:34:45,neodev,0.9875,18517457,GBR,,,86.29.55.201,WARFARIN treats PULMONARY EMBOLISM,93,137,,111,145,treats,0.9950371902099889,907168-FS1-2,Clinical trials are currently investigating the potential value of LMWHs in the treatment of PULMONARY EMBOLISM and as an alternative to WARFARIN in secondary prevention of DVT,PULMONARY EMBOLISM,WARFARIN,RO-may_prevent
497999922,7/4/2014 11:46:58,,1314800744,7/4/2014 11:46:32,tremorgames,0.875,25257192,CAN,ON,North York,207.188.64.245,WARFARIN treats PULMONARY EMBOLISM,93,137,,111,145,treats,0.9950371902099889,907168-FS1-2,Clinical trials are currently investigating the potential value of LMWHs in the treatment of PULMONARY EMBOLISM and as an alternative to WARFARIN in secondary prevention of DVT,PULMONARY EMBOLISM,WARFARIN,RO-may_prevent
497999922,7/4/2014 12:17:15,,1314820749,7/4/2014 12:16:44,clixsense,0.775,27969116,NLD,,,91.213.37.165,no_relation,93,137,,111,145,treats,0.9950371902099889,907168-FS1-2,Clinical trials are currently investigating the potential value of LMWHs in the treatment of PULMONARY EMBOLISM and as an alternative to WARFARIN in secondary prevention of DVT,PULMONARY EMBOLISM,WARFARIN,RO-may_prevent
497999923,7/4/2014 11:34:44,,1314793720,7/4/2014 11:34:30,neodev,0.9875,18517457,GBR,,,86.29.55.201,ADEFOVIR treats HBV,28,48,,31,56,treats,1.0,907937-FS1-2,Individuals Coinfected with HBV and HIV  Use of ADEFOVIR for the treatment of chronic HBV infection in patients with unrecognized or untreated HIV infection may result in emergence of HIV resistance,HBV,ADEFOVIR,RO-may_treat
497999923,7/4/2014 11:44:31,,1314799115,7/4/2014 11:43:56,tremorgames,0.875,25257192,CAN,ON,North York,207.188.64.245,ADEFOVIR treats HBV,28,48,,31,56,treats,1.0,907937-FS1-2,Individuals Coinfected with HBV and HIV  Use of ADEFOVIR for the treatment of chronic HBV infection in patients with unrecognized or untreated HIV infection may result in emergence of HIV resistance,HBV,ADEFOVIR,RO-may_treat
497999923,7/4/2014 11:52:13,,1314803824,7/4/2014 11:51:17,clixsense,0.902,27871219,NLD,7,Amsterdam,87.210.207.223,ADEFOVIR treats HBV,28,48,,31,56,treats,1.0,907937-FS1-2,Individuals Coinfected with HBV and HIV  Use of ADEFOVIR for the treatment of chronic HBV infection in patients with unrecognized or untreated HIV infection may result in emergence of HIV resistance,HBV,ADEFOVIR,RO-may_treat
497999926,7/4/2014 11:33:42,,1314793167,7/4/2014 11:33:20,neodev,0.9875,18517457,GBR,,,86.29.55.201,RHEUMATOID ARTHRITIS is diagnosed by DIFLUNISAL,67,53,,87,63,is diagnosed by,0.34874291623145803,907638-FS1-13,"Palmer DG, Ferry DG, Gibbins BL et al. Ibuprofen and DIFLUNISAL in RHEUMATOID ARTHRITIS: a double-blind comparative trial",RHEUMATOID ARTHRITIS,DIFLUNISAL,RO-may_treat
497999926,7/4/2014 11:50:28,,1314802913,7/4/2014 11:50:08,clixsense,0.902,27871219,NLD,7,Amsterdam,87.210.207.223,no_relation,67,53,,87,63,is diagnosed by,0.34874291623145803,907638-FS1-13,"Palmer DG, Ferry DG, Gibbins BL et al. Ibuprofen and DIFLUNISAL in RHEUMATOID ARTHRITIS: a double-blind comparative trial",RHEUMATOID ARTHRITIS,DIFLUNISAL,RO-may_treat
497999926,7/4/2014 12:17:44,,1314821084,7/4/2014 12:17:16,clixsense,0.775,27969116,NLD,,,91.213.37.165,no_relation,67,53,,87,63,is diagnosed by,0.34874291623145803,907638-FS1-13,"Palmer DG, Ferry DG, Gibbins BL et al. Ibuprofen and DIFLUNISAL in RHEUMATOID ARTHRITIS: a double-blind comparative trial",RHEUMATOID ARTHRITIS,DIFLUNISAL,RO-may_treat
497999927,7/4/2014 11:51:16,,1314803346,7/4/2014 11:50:54,clixsense,0.902,27871219,NLD,7,Amsterdam,87.210.207.223,EPINEPHRINE treats ANAPHYLAXIS,52,80,,63,91,treats,1.0,907663-FS1-2,Allergic reactions are treated with antihistamines; ANAPHYLAXIS is treated with EPINEPHRINE with IV fluids and vasopressors if necessary (see  Anaphylaxis,ANAPHYLAXIS,EPINEPHRINE,RO-may_treat
497999927,7/4/2014 12:17:44,,1314821080,7/4/2014 12:17:16,clixsense,0.775,27969116,NLD,,,91.213.37.165,EPINEPHRINE treats ANAPHYLAXIS,52,80,,63,91,treats,1.0,907663-FS1-2,Allergic reactions are treated with antihistamines; ANAPHYLAXIS is treated with EPINEPHRINE with IV fluids and vasopressors if necessary (see  Anaphylaxis,ANAPHYLAXIS,EPINEPHRINE,RO-may_treat
497999927,7/4/2014 12:27:24,,1314828079,7/4/2014 12:27:01,neodev,0.8048,11014534,GBR,H9,London,80.254.147.52,EPINEPHRINE treats ANAPHYLAXIS,52,80,,63,91,treats,1.0,907663-FS1-2,Allergic reactions are treated with antihistamines; ANAPHYLAXIS is treated with EPINEPHRINE with IV fluids and vasopressors if necessary (see  Anaphylaxis,ANAPHYLAXIS,EPINEPHRINE,RO-may_treat
497999941,7/4/2014 11:50:52,,1314803182,7/4/2014 11:50:29,clixsense,0.902,27871219,NLD,7,Amsterdam,87.210.207.223,ENDOMETRIAL CARCINOMA contraindicates POSTMENOPAUSAL BLEEDING,5,30,,28,51,contraindicates,0.308606699924184,902767-FS1-10,"With POSTMENOPAUSAL BLEEDING, ENDOMETRIAL CARCINOMA must always be ruled out",POSTMENOPAUSAL BLEEDING,ENDOMETRIAL CARCINOMA,RO-disease_may_have_finding
497999941,7/4/2014 12:20:44,,1314823400,7/4/2014 12:20:15,clixsense,0.775,27969116,NLD,,,91.213.37.165,no_relation,5,30,,28,51,contraindicates,0.308606699924184,902767-FS1-10,"With POSTMENOPAUSAL BLEEDING, ENDOMETRIAL CARCINOMA must always be ruled out",POSTMENOPAUSAL BLEEDING,ENDOMETRIAL CARCINOMA,RO-disease_may_have_finding
497999941,7/4/2014 12:30:36,,1314829937,7/4/2014 12:30:16,neodev,0.8048,11014534,GBR,H9,London,80.254.147.52,POSTMENOPAUSAL BLEEDING contraindicates ENDOMETRIAL CARCINOMA,5,30,,28,51,contraindicates,0.308606699924184,902767-FS1-10,"With POSTMENOPAUSAL BLEEDING, ENDOMETRIAL CARCINOMA must always be ruled out",POSTMENOPAUSAL BLEEDING,ENDOMETRIAL CARCINOMA,RO-disease_may_have_finding
497999943,7/4/2014 11:48:09,,1314801466,7/4/2014 11:47:09,clixsense,0.902,27871219,NLD,7,Amsterdam,87.210.207.223,PHENYTOIN treats POST-TRAUMATIC EPILEPSY,64,11,,87,20,treats,1.0,907396-FS1-2,The use of PHENYTOIN in headache syndromes and in prevention of POST-TRAUMATIC EPILEPSY is discussed,POST-TRAUMATIC EPILEPSY,PHENYTOIN,RO-may_prevent
497999943,7/4/2014 12:15:31,,1314819454,7/4/2014 12:14:58,clixsense,0.775,27969116,NLD,,,91.213.37.165,PHENYTOIN treats POST-TRAUMATIC EPILEPSY,64,11,,87,20,treats,1.0,907396-FS1-2,The use of PHENYTOIN in headache syndromes and in prevention of POST-TRAUMATIC EPILEPSY is discussed,POST-TRAUMATIC EPILEPSY,PHENYTOIN,RO-may_prevent
497999943,7/4/2014 12:27:45,,1314828193,7/4/2014 12:27:25,neodev,0.8048,11014534,GBR,H9,London,80.254.147.52,PHENYTOIN treats POST-TRAUMATIC EPILEPSY,64,11,,87,20,treats,1.0,907396-FS1-2,The use of PHENYTOIN in headache syndromes and in prevention of POST-TRAUMATIC EPILEPSY is discussed,POST-TRAUMATIC EPILEPSY,PHENYTOIN,RO-may_prevent
497999944,7/4/2014 11:46:43,,1314800617,7/4/2014 11:46:08,clixsense,0.902,27871219,NLD,7,Amsterdam,87.210.207.223,GLIBENCLAMIDE treats MATURITY ONSET DIABETES,105,59,,128,72,treats,0.811107105653813,907865-FS1-2,A clinical comparison between glipizide (Glibenese ����渇�膩��臂�申�鰹申鐃順����鐃初���申���紮�申羝�申鐃緒申��LIBENCLAMIDEnclamide (Daonil ����渇�膩��臂�申�鰹申鐃順����鐃初���申���紮�申羝�申鐃緒申�渇�膩������括�鐃順�����鰹申鐃� tMATURITY ONSET DIABETESy onset diabetes: a controlled double-blind cross-over study,MATURITY ONSET DIABETES,GLIBENCLAMIDE,RO-may_treat
497999944,7/4/2014 12:32:23,,1314830965,7/4/2014 12:31:57,neodev,0.8048,11014534,GBR,H9,London,80.254.147.52,no_relation,105,59,,128,72,treats,0.811107105653813,907865-FS1-2,A clinical comparison between glipizide (Glibenese ����渇�膩��臂�申�鰹申鐃順����鐃初���申���紮�申羝�申鐃緒申��LIBENCLAMIDEnclamide (Daonil ����渇�膩��臂�申�鰹申鐃順����鐃初���申���紮�申羝�申鐃緒申�渇�膩������括�鐃順�����鰹申鐃� tMATURITY ONSET DIABETESy onset diabetes: a controlled double-blind cross-over study,MATURITY ONSET DIABETES,GLIBENCLAMIDE,RO-may_treat
497999944,7/4/2014 12:32:37,,1314831076,7/4/2014 12:32:04,rewardsspot,0.7879,24482174,GBR,H9,London,46.23.68.180,GLIBENCLAMIDE treats MATURITY ONSET DIABETES,105,59,,128,72,treats,0.811107105653813,907865-FS1-2,A clinical comparison between glipizide (Glibenese ����渇�膩��臂�申�鰹申鐃順����鐃初���申���紮�申羝�申鐃緒申��LIBENCLAMIDEnclamide (Daonil ����渇�膩��臂�申�鰹申鐃順����鐃初���申���紮�申羝�申鐃緒申�渇�膩������括�鐃順�����鰹申鐃� tMATURITY ONSET DIABETESy onset diabetes: a controlled double-blind cross-over study,MATURITY ONSET DIABETES,GLIBENCLAMIDE,RO-may_treat
497999945,7/4/2014 11:33:18,,1314792929,7/4/2014 11:33:06,neodev,0.9875,18517457,GBR,,,86.29.55.201,FOLIC ACID treats NEURAL TUBE DEFECTS,115,77,,134,87,treats,0.997054485501582,907088-FS1-2,"These areas include rubella virus as a cause of congenital rubella syndrome, FOLIC ACID as a preventive factor for NEURAL TUBE DEFECTS, cytomegalovirus infection as a cause of birth defects and developmental disabilities, and alcohol as a cause of fetal alcohol spectrum disorders",NEURAL TUBE DEFECTS,FOLIC ACID,RO-may_prevent
497999945,7/4/2014 12:27:52,,1314828256,7/4/2014 12:26:53,clixsense,0.8073,15189335,GBR,I9,Dereham,86.157.163.112,FOLIC ACID treats NEURAL TUBE DEFECTS,115,77,,134,87,treats,0.997054485501582,907088-FS1-2,"These areas include rubella virus as a cause of congenital rubella syndrome, FOLIC ACID as a preventive factor for NEURAL TUBE DEFECTS, cytomegalovirus infection as a cause of birth defects and developmental disabilities, and alcohol as a cause of fetal alcohol spectrum disorders",NEURAL TUBE DEFECTS,FOLIC ACID,RO-may_prevent
497999945,7/4/2014 12:29:34,,1314829301,7/4/2014 12:29:22,neodev,0.8048,11014534,GBR,H9,London,80.254.147.52,FOLIC ACID treats NEURAL TUBE DEFECTS,115,77,,134,87,treats,0.997054485501582,907088-FS1-2,"These areas include rubella virus as a cause of congenital rubella syndrome, FOLIC ACID as a preventive factor for NEURAL TUBE DEFECTS, cytomegalovirus infection as a cause of birth defects and developmental disabilities, and alcohol as a cause of fetal alcohol spectrum disorders",NEURAL TUBE DEFECTS,FOLIC ACID,RO-may_prevent
497999950,7/4/2014 11:39:53,,1314796395,7/4/2014 11:39:41,neodev,0.9875,18517457,GBR,,,86.29.55.201,LIGNOCAINE treats PAIN,116,172,,120,182,treats,0.9958932064677041,907183-FS1-2,When administered intravenously in the dorsum of the hand the pain score and the number of patients who experienced PAIN was reduced significantly by mixing the agent with LIGNOCAINE when compared with a bolus injection,PAIN,LIGNOCAINE,RO-may_prevent
497999950,7/4/2014 12:31:56,,1314830747,7/4/2014 12:31:34,neodev,0.8048,11014534,GBR,H9,London,80.254.147.52,LIGNOCAINE treats PAIN,116,172,,120,182,treats,0.9958932064677041,907183-FS1-2,When administered intravenously in the dorsum of the hand the pain score and the number of patients who experienced PAIN was reduced significantly by mixing the agent with LIGNOCAINE when compared with a bolus injection,PAIN,LIGNOCAINE,RO-may_prevent
497999950,7/4/2014 12:31:57,,1314830766,7/4/2014 12:31:21,clixsense,0.8073,15189335,GBR,I9,Dereham,86.157.163.112,LIGNOCAINE treats PAIN,116,172,,120,182,treats,0.9958932064677041,907183-FS1-2,When administered intravenously in the dorsum of the hand the pain score and the number of patients who experienced PAIN was reduced significantly by mixing the agent with LIGNOCAINE when compared with a bolus injection,PAIN,LIGNOCAINE,RO-may_prevent
497999957,7/4/2014 11:34:03,,1314793328,7/4/2014 11:33:44,neodev,0.9875,18517457,GBR,,,86.29.55.201,MONONUCLEOSIS causes SPLENIC RUPTURE,35,68,,50,81,causes,0.9704949588309459,902649-FS1-4,We do not recommend observation of SPLENIC RUPTURE in patients with MONONUCLEOSIS because of the danger of delayed hemorrhage,SPLENIC RUPTURE,MONONUCLEOSIS,RO-disease_may_have_finding
497999957,7/4/2014 11:39:29,,1314796214,7/4/2014 11:38:32,clixsense,0.902,27871219,NLD,7,Amsterdam,87.210.207.223,MONONUCLEOSIS causes SPLENIC RUPTURE,35,68,,50,81,causes,0.9704949588309459,902649-FS1-4,We do not recommend observation of SPLENIC RUPTURE in patients with MONONUCLEOSIS because of the danger of delayed hemorrhage,SPLENIC RUPTURE,MONONUCLEOSIS,RO-disease_may_have_finding
497999957,7/4/2014 12:19:00,,1314822053,7/4/2014 12:18:19,clixsense,0.775,27969116,NLD,,,91.213.37.165,no_relation,35,68,,50,81,causes,0.9704949588309459,902649-FS1-4,We do not recommend observation of SPLENIC RUPTURE in patients with MONONUCLEOSIS because of the danger of delayed hemorrhage,SPLENIC RUPTURE,MONONUCLEOSIS,RO-disease_may_have_finding
497999958,7/4/2014 11:41:23,,1314797283,7/4/2014 11:41:07,neodev,0.9875,18517457,GBR,,,86.29.55.201,INVASIVE DUCTAL CARCINOMA causes SOLID PATTERN,39,4,,52,29,causes,0.975900072948533,902666-FS1-4,"The INVASIVE DUCTAL CARCINOMA showed a SOLID PATTERN, high nuclear and structural atypia and frequent mitotic figures, while the tubular adenoma consisted of a proliferation of small ducts lined by single layers of epithelial and myoepithelial cells with bland nuclei and inconspicuous nucleoli",SOLID PATTERN,INVASIVE DUCTAL CARCINOMA,RO-disease_may_have_finding
497999958,7/4/2014 11:45:30,,1314799745,7/4/2014 11:44:52,tremorgames,0.875,25257192,CAN,ON,North York,207.188.64.245,no_relation,39,4,,52,29,causes,0.975900072948533,902666-FS1-4,"The INVASIVE DUCTAL CARCINOMA showed a SOLID PATTERN, high nuclear and structural atypia and frequent mitotic figures, while the tubular adenoma consisted of a proliferation of small ducts lined by single layers of epithelial and myoepithelial cells with bland nuclei and inconspicuous nucleoli",SOLID PATTERN,INVASIVE DUCTAL CARCINOMA,RO-disease_may_have_finding
497999958,7/4/2014 12:18:18,,1314821516,7/4/2014 12:17:45,clixsense,0.775,27969116,NLD,,,91.213.37.165,no_relation,39,4,,52,29,causes,0.975900072948533,902666-FS1-4,"The INVASIVE DUCTAL CARCINOMA showed a SOLID PATTERN, high nuclear and structural atypia and frequent mitotic figures, while the tubular adenoma consisted of a proliferation of small ducts lined by single layers of epithelial and myoepithelial cells with bland nuclei and inconspicuous nucleoli",SOLID PATTERN,INVASIVE DUCTAL CARCINOMA,RO-disease_may_have_finding
497999959,7/4/2014 11:44:50,,1314799257,7/4/2014 11:44:32,tremorgames,0.875,25257192,CAN,ON,North York,207.188.64.245,PAPAVERINE treats ERECTILE DYSFUNCTION,118,87,,138,97,treats,0.9838699100999069,906513-FS1-2,"In our experience, E1-PG intracavernous injection has proven to be more effective than PAPAVERINE in the treatment of ERECTILE DYSFUNCTION and therefore, added to its safety and degree of acceptance, we consider it a first choice approach in the diagnosis and treatment of erectile dysfunction in males",ERECTILE DYSFUNCTION,PAPAVERINE,RO-may_diagnose
497999959,7/4/2014 12:26:52,,1314827771,7/4/2014 12:26:36,clixsense,0.8073,15189335,GBR,I9,Dereham,86.157.163.112,PAPAVERINE treats ERECTILE DYSFUNCTION,118,87,,138,97,treats,0.9838699100999069,906513-FS1-2,"In our experience, E1-PG intracavernous injection has proven to be more effective than PAPAVERINE in the treatment of ERECTILE DYSFUNCTION and therefore, added to its safety and degree of acceptance, we consider it a first choice approach in the diagnosis and treatment of erectile dysfunction in males",ERECTILE DYSFUNCTION,PAPAVERINE,RO-may_diagnose
497999959,7/4/2014 12:27:24,,1314828081,7/4/2014 12:27:01,neodev,0.8048,11014534,GBR,H9,London,80.254.147.52,PAPAVERINE treats ERECTILE DYSFUNCTION,118,87,,138,97,treats,0.9838699100999069,906513-FS1-2,"In our experience, E1-PG intracavernous injection has proven to be more effective than PAPAVERINE in the treatment of ERECTILE DYSFUNCTION and therefore, added to its safety and degree of acceptance, we consider it a first choice approach in the diagnosis and treatment of erectile dysfunction in males",ERECTILE DYSFUNCTION,PAPAVERINE,RO-may_diagnose
497999964,7/4/2014 11:33:05,,1314792856,7/4/2014 11:32:44,neodev,0.9875,18517457,GBR,,,86.29.55.201,CHOLECALCIFEROL treats OSTEOPOROSIS,103,55,,115,70,treats,1.0,907503-FS1-2,Alendronate is used alone or in fixed combination with CHOLECALCIFEROL (vitamin D 3 ) for treatment of OSTEOPOROSIS in postmenopausal women,OSTEOPOROSIS,CHOLECALCIFEROL,RO-may_treat
497999964,7/4/2014 11:44:31,,1314799114,7/4/2014 11:43:56,tremorgames,0.875,25257192,CAN,ON,North York,207.188.64.245,CHOLECALCIFEROL treats OSTEOPOROSIS,103,55,,115,70,treats,1.0,907503-FS1-2,Alendronate is used alone or in fixed combination with CHOLECALCIFEROL (vitamin D 3 ) for treatment of OSTEOPOROSIS in postmenopausal women,OSTEOPOROSIS,CHOLECALCIFEROL,RO-may_treat
497999964,7/4/2014 12:25:29,,1314826773,7/4/2014 12:24:55,clixsense,0.775,27969116,NLD,,,91.213.37.165,CHOLECALCIFEROL treats OSTEOPOROSIS,103,55,,115,70,treats,1.0,907503-FS1-2,Alendronate is used alone or in fixed combination with CHOLECALCIFEROL (vitamin D 3 ) for treatment of OSTEOPOROSIS in postmenopausal women,OSTEOPOROSIS,CHOLECALCIFEROL,RO-may_treat
497999971,7/4/2014 12:25:29,,1314826772,7/4/2014 12:24:55,clixsense,0.775,27969116,NLD,,,91.213.37.165,no_relation,50,96,,62,112,causes,0.34815531191139604,902671-FS1-4,Evidence: ? Vigilant intraoperative management of HYPERTENSION is essential during resection of PHEOCHROMOCYTOMA,HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
497999971,7/4/2014 12:30:49,,1314830060,7/4/2014 12:30:37,neodev,0.8048,11014534,GBR,H9,London,80.254.147.52,no_relation,50,96,,62,112,causes,0.34815531191139604,902671-FS1-4,Evidence: ? Vigilant intraoperative management of HYPERTENSION is essential during resection of PHEOCHROMOCYTOMA,HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
497999971,7/4/2014 12:31:03,,1314830223,7/4/2014 12:30:37,clixsense,0.8073,15189335,GBR,I9,Dereham,86.157.163.112,no_relation,50,96,,62,112,causes,0.34815531191139604,902671-FS1-4,Evidence: ? Vigilant intraoperative management of HYPERTENSION is essential during resection of PHEOCHROMOCYTOMA,HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
497999972,7/4/2014 12:20:14,,1314823003,7/4/2014 12:19:45,clixsense,0.775,27969116,NLD,,,91.213.37.165,no_relation,5,30,,28,51,causes,0.7715167498104591,902767-FS1-4,"With POSTMENOPAUSAL BLEEDING, ENDOMETRIAL CARCINOMA must always be ruled out",POSTMENOPAUSAL BLEEDING,ENDOMETRIAL CARCINOMA,RO-disease_may_have_finding
497999972,7/4/2014 12:26:34,,1314827569,7/4/2014 12:26:06,clixsense,0.8073,15189335,GBR,I9,Dereham,86.157.163.112,ENDOMETRIAL CARCINOMA causes POSTMENOPAUSAL BLEEDING,5,30,,28,51,causes,0.7715167498104591,902767-FS1-4,"With POSTMENOPAUSAL BLEEDING, ENDOMETRIAL CARCINOMA must always be ruled out",POSTMENOPAUSAL BLEEDING,ENDOMETRIAL CARCINOMA,RO-disease_may_have_finding
497999972,7/4/2014 12:30:49,,1314830054,7/4/2014 12:30:37,neodev,0.8048,11014534,GBR,H9,London,80.254.147.52,POSTMENOPAUSAL BLEEDING causes ENDOMETRIAL CARCINOMA,5,30,,28,51,causes,0.7715167498104591,902767-FS1-4,"With POSTMENOPAUSAL BLEEDING, ENDOMETRIAL CARCINOMA must always be ruled out",POSTMENOPAUSAL BLEEDING,ENDOMETRIAL CARCINOMA,RO-disease_may_have_finding
497999975,7/4/2014 12:29:51,,1314829535,7/4/2014 12:29:35,neodev,0.8048,11014534,GBR,H9,London,80.254.147.52,ITRACONAZOLE treats BLASTOMYCOSIS,14,51,,27,63,treats,1.0,907822-FS1-2,"Children with BLASTOMYCOSIS should be treated with ITRACONAZOLE, 5 to 7 mg/kg/day",BLASTOMYCOSIS,ITRACONAZOLE,RO-may_treat
497999975,7/4/2014 12:30:35,,1314829888,7/4/2014 12:30:19,clixsense,0.8073,15189335,GBR,I9,Dereham,86.157.163.112,ITRACONAZOLE treats BLASTOMYCOSIS,14,51,,27,63,treats,1.0,907822-FS1-2,"Children with BLASTOMYCOSIS should be treated with ITRACONAZOLE, 5 to 7 mg/kg/day",BLASTOMYCOSIS,ITRACONAZOLE,RO-may_treat
497999975,7/4/2014 12:34:03,,1314832014,7/4/2014 12:33:38,rewardsspot,0.7879,24482174,GBR,H9,London,46.23.68.180,ITRACONAZOLE treats BLASTOMYCOSIS,14,51,,27,63,treats,1.0,907822-FS1-2,"Children with BLASTOMYCOSIS should be treated with ITRACONAZOLE, 5 to 7 mg/kg/day",BLASTOMYCOSIS,ITRACONAZOLE,RO-may_treat
497999977,7/4/2014 11:46:09,,1314800288,7/4/2014 11:45:32,tremorgames,0.875,25257192,CAN,ON,North York,207.188.64.245,TERBINAFINE treats TINEA CAPITIS,140,108,,153,119,treats,0.9950371902099889,907640-FS1-2,"Kullavanijaya P, Reangchainam S, Ungpakorn R. Randomized single-blind study of efficacy and tolerability of TERBINAFINE in the treatment of TINEA CAPITIS",TINEA CAPITIS,TERBINAFINE,RO-may_treat
497999977,7/4/2014 12:19:00,,1314822062,7/4/2014 12:18:19,clixsense,0.775,27969116,NLD,,,91.213.37.165,TERBINAFINE treats TINEA CAPITIS,140,108,,153,119,treats,0.9950371902099889,907640-FS1-2,"Kullavanijaya P, Reangchainam S, Ungpakorn R. Randomized single-blind study of efficacy and tolerability of TERBINAFINE in the treatment of TINEA CAPITIS",TINEA CAPITIS,TERBINAFINE,RO-may_treat
497999977,7/4/2014 12:25:17,,1314826632,7/4/2014 12:24:38,clixsense,0.8073,15189335,GBR,I9,Dereham,86.157.163.112,TERBINAFINE treats TINEA CAPITIS,140,108,,153,119,treats,0.9950371902099889,907640-FS1-2,"Kullavanijaya P, Reangchainam S, Ungpakorn R. Randomized single-blind study of efficacy and tolerability of TERBINAFINE in the treatment of TINEA CAPITIS",TINEA CAPITIS,TERBINAFINE,RO-may_treat
497999979,7/4/2014 11:38:09,,1314795486,7/4/2014 11:37:39,clixsense,0.902,27871219,NLD,7,Amsterdam,87.210.207.223,DCIS is diagnosed by MICROCALCIFICATION,43,14,,61,18,is diagnosed by,0.635000635000953,902739-FS1-13,Many cases of DCIS are detected because of MICROCALCIFICATION on mammograms; 20% of screen-detected cancers are of this type,MICROCALCIFICATION,DCIS,RO-disease_may_have_finding
497999979,7/4/2014 11:41:46,,1314797516,7/4/2014 11:41:24,neodev,0.9875,18517457,GBR,,,86.29.55.201,DCIS is diagnosed by MICROCALCIFICATION,43,14,,61,18,is diagnosed by,0.635000635000953,902739-FS1-13,Many cases of DCIS are detected because of MICROCALCIFICATION on mammograms; 20% of screen-detected cancers are of this type,MICROCALCIFICATION,DCIS,RO-disease_may_have_finding
497999979,7/4/2014 12:16:42,,1314820326,7/4/2014 12:16:05,clixsense,0.775,27969116,NLD,,,91.213.37.165,DCIS is diagnosed by MICROCALCIFICATION,43,14,,61,18,is diagnosed by,0.635000635000953,902739-FS1-13,Many cases of DCIS are detected because of MICROCALCIFICATION on mammograms; 20% of screen-detected cancers are of this type,MICROCALCIFICATION,DCIS,RO-disease_may_have_finding
497999983,7/4/2014 11:52:38,,1314804047,7/4/2014 11:52:14,clixsense,0.902,27871219,NLD,7,Amsterdam,87.210.207.223,SIMVASTATIN treats HYPERCHOLESTEROLEMIA,53,107,,73,118,treats,1.0,907900-FS1-2,"Tikkanen MJ, Laakso M, Ilmonen M et al. Treatment of HYPERCHOLESTEROLEMIA and combined hyperlipidemia with SIMVASTATIN and gemfibrozil in patients with NIDDM",HYPERCHOLESTEROLEMIA,SIMVASTATIN,RO-may_treat
497999983,7/4/2014 12:20:44,,1314823401,7/4/2014 12:20:15,clixsense,0.775,27969116,NLD,,,91.213.37.165,no_relation,53,107,,73,118,treats,1.0,907900-FS1-2,"Tikkanen MJ, Laakso M, Ilmonen M et al. Treatment of HYPERCHOLESTEROLEMIA and combined hyperlipidemia with SIMVASTATIN and gemfibrozil in patients with NIDDM",HYPERCHOLESTEROLEMIA,SIMVASTATIN,RO-may_treat
497999983,7/4/2014 12:24:37,,1314826161,7/4/2014 12:24:14,clixsense,0.8073,15189335,GBR,I9,Dereham,86.157.163.112,SIMVASTATIN treats HYPERCHOLESTEROLEMIA,53,107,,73,118,treats,1.0,907900-FS1-2,"Tikkanen MJ, Laakso M, Ilmonen M et al. Treatment of HYPERCHOLESTEROLEMIA and combined hyperlipidemia with SIMVASTATIN and gemfibrozil in patients with NIDDM",HYPERCHOLESTEROLEMIA,SIMVASTATIN,RO-may_treat
497999985,7/4/2014 11:39:50,,1314796372,7/4/2014 11:39:30,clixsense,0.902,27871219,NLD,7,Amsterdam,87.210.207.223,no_relation,90,0,,102,5,causes,0.416025147168922,906474-FS1-4,"SMMCI has also been found as an isolated finding or together with other anomalies such as MICROCEPHALY, short stature, endocrine pathology, and choanal atresia",MICROCEPHALY,SMMCI,RO-has_manifestation
497999985,7/4/2014 11:40:34,,1314796796,7/4/2014 11:40:21,neodev,0.9875,18517457,GBR,,,86.29.55.201,no_relation,90,0,,102,5,causes,0.416025147168922,906474-FS1-4,"SMMCI has also been found as an isolated finding or together with other anomalies such as MICROCEPHALY, short stature, endocrine pathology, and choanal atresia",MICROCEPHALY,SMMCI,RO-has_manifestation
497999985,7/4/2014 12:31:33,,1314830533,7/4/2014 12:31:15,neodev,0.8048,11014534,GBR,H9,London,80.254.147.52,no_relation,90,0,,102,5,causes,0.416025147168922,906474-FS1-4,"SMMCI has also been found as an isolated finding or together with other anomalies such as MICROCEPHALY, short stature, endocrine pathology, and choanal atresia",MICROCEPHALY,SMMCI,RO-has_manifestation
498023346,7/4/2014 14:48:00,False,1314936203,7/4/2014 14:47:49,prodege,0.8625,14890188,GBR,I2,Manchester,151.230.18.68,RUBELLA VACCINE treats RUBELLA,87,0,,94,15,treats,1.0,907308-FS1-2,RUBELLA VACCINE should continue to be used to immunize susceptible adult women against RUBELLA in order to further the goal of elimination of the congenital rubella syndrome,RUBELLA,RUBELLA VACCINE,RO-may_prevent
498023346,7/4/2014 15:14:48,False,1314957596,7/4/2014 15:14:26,clixsense,0.6479,6394333,GBR,,,86.29.240.182,no_relation,87,0,,94,15,treats,1.0,907308-FS1-2,RUBELLA VACCINE should continue to be used to immunize susceptible adult women against RUBELLA in order to further the goal of elimination of the congenital rubella syndrome,RUBELLA,RUBELLA VACCINE,RO-may_prevent
498023346,7/4/2014 15:19:28,False,1314961330,7/4/2014 15:19:07,clixsense,0.6246,15189335,GBR,I9,Dereham,86.157.163.112,RUBELLA VACCINE treats RUBELLA,87,0,,94,15,treats,1.0,907308-FS1-2,RUBELLA VACCINE should continue to be used to immunize susceptible adult women against RUBELLA in order to further the goal of elimination of the congenital rubella syndrome,RUBELLA,RUBELLA VACCINE,RO-may_prevent
498023346,7/4/2014 15:29:47,False,1314970019,7/4/2014 15:29:23,prodege,0.6637,14848125,GBR,V2,Glasgow,86.130.194.252,no_relation,87,0,,94,15,treats,1.0,907308-FS1-2,RUBELLA VACCINE should continue to be used to immunize susceptible adult women against RUBELLA in order to further the goal of elimination of the congenital rubella syndrome,RUBELLA,RUBELLA VACCINE,RO-may_prevent
498023346,7/4/2014 15:33:38,False,1314973618,7/4/2014 15:33:26,gptbanks,0.4263,18496428,USA,CA,Newhall,199.244.112.44,RUBELLA VACCINE treats RUBELLA,87,0,,94,15,treats,1.0,907308-FS1-2,RUBELLA VACCINE should continue to be used to immunize susceptible adult women against RUBELLA in order to further the goal of elimination of the congenital rubella syndrome,RUBELLA,RUBELLA VACCINE,RO-may_prevent
498023349,7/4/2014 14:45:47,False,1314933878,7/4/2014 14:45:19,clixsense,0.8625,19803139,NLD,6,Veldhoven,212.61.84.196,no_relation,67,53,,87,63,is diagnosed by,0.34874291623145803,907638-FS1-13,"Palmer DG, Ferry DG, Gibbins BL et al. Ibuprofen and DIFLUNISAL in RHEUMATOID ARTHRITIS: a double-blind comparative trial",RHEUMATOID ARTHRITIS,DIFLUNISAL,RO-may_treat
498023349,7/4/2014 14:46:31,False,1314934760,7/4/2014 14:46:16,prodege,0.8625,14890188,GBR,I2,Manchester,151.230.18.68,RHEUMATOID ARTHRITIS is diagnosed by DIFLUNISAL,67,53,,87,63,is diagnosed by,0.34874291623145803,907638-FS1-13,"Palmer DG, Ferry DG, Gibbins BL et al. Ibuprofen and DIFLUNISAL in RHEUMATOID ARTHRITIS: a double-blind comparative trial",RHEUMATOID ARTHRITIS,DIFLUNISAL,RO-may_treat
498023349,7/4/2014 15:00:10,False,1314945895,7/4/2014 14:59:45,clixsense,0.7667,27969116,NLD,4,Veendam,185.12.216.74,no_relation,67,53,,87,63,is diagnosed by,0.34874291623145803,907638-FS1-13,"Palmer DG, Ferry DG, Gibbins BL et al. Ibuprofen and DIFLUNISAL in RHEUMATOID ARTHRITIS: a double-blind comparative trial",RHEUMATOID ARTHRITIS,DIFLUNISAL,RO-may_treat
498023349,7/4/2014 15:11:16,False,1314955262,7/4/2014 15:10:54,clixsense,0.6479,6394333,GBR,,,86.29.240.182,no_relation,67,53,,87,63,is diagnosed by,0.34874291623145803,907638-FS1-13,"Palmer DG, Ferry DG, Gibbins BL et al. Ibuprofen and DIFLUNISAL in RHEUMATOID ARTHRITIS: a double-blind comparative trial",RHEUMATOID ARTHRITIS,DIFLUNISAL,RO-may_treat
498023349,7/4/2014 15:30:11,False,1314970372,7/4/2014 15:30:02,gptbanks,0.4263,18496428,USA,CA,Newhall,199.244.112.44,RHEUMATOID ARTHRITIS is diagnosed by DIFLUNISAL,67,53,,87,63,is diagnosed by,0.34874291623145803,907638-FS1-13,"Palmer DG, Ferry DG, Gibbins BL et al. Ibuprofen and DIFLUNISAL in RHEUMATOID ARTHRITIS: a double-blind comparative trial",RHEUMATOID ARTHRITIS,DIFLUNISAL,RO-may_treat
498023350,7/4/2014 14:50:40,False,1314938330,7/4/2014 14:50:19,clixsense,0.8625,19803139,NLD,6,Veldhoven,212.61.84.196,ANAPHYLAXIS treats EPINEPHRINE,52,80,,63,91,treats,1.0,907663-FS1-2,Allergic reactions are treated with antihistamines; ANAPHYLAXIS is treated with EPINEPHRINE with IV fluids and vasopressors if necessary (see  Anaphylaxis,ANAPHYLAXIS,EPINEPHRINE,RO-may_treat
498023350,7/4/2014 15:11:47,False,1314955633,7/4/2014 15:11:32,clixsense,0.6479,6394333,GBR,,,86.29.240.182,no_relation,52,80,,63,91,treats,1.0,907663-FS1-2,Allergic reactions are treated with antihistamines; ANAPHYLAXIS is treated with EPINEPHRINE with IV fluids and vasopressors if necessary (see  Anaphylaxis,ANAPHYLAXIS,EPINEPHRINE,RO-may_treat
498023350,7/4/2014 15:24:34,False,1314965430,7/4/2014 15:24:22,clixsense,0.6246,15189335,GBR,I9,Dereham,86.157.163.112,EPINEPHRINE treats ANAPHYLAXIS,52,80,,63,91,treats,1.0,907663-FS1-2,Allergic reactions are treated with antihistamines; ANAPHYLAXIS is treated with EPINEPHRINE with IV fluids and vasopressors if necessary (see  Anaphylaxis,ANAPHYLAXIS,EPINEPHRINE,RO-may_treat
498023350,7/4/2014 15:27:45,False,1314968045,7/4/2014 15:27:14,prodege,0.6637,14848125,GBR,V2,Glasgow,86.130.194.252,EPINEPHRINE treats ANAPHYLAXIS,52,80,,63,91,treats,1.0,907663-FS1-2,Allergic reactions are treated with antihistamines; ANAPHYLAXIS is treated with EPINEPHRINE with IV fluids and vasopressors if necessary (see  Anaphylaxis,ANAPHYLAXIS,EPINEPHRINE,RO-may_treat
498023350,7/4/2014 15:36:34,False,1314975650,7/4/2014 15:36:18,gptbanks,0.4263,18496428,USA,CA,Newhall,199.244.112.44,ANAPHYLAXIS treats EPINEPHRINE,52,80,,63,91,treats,1.0,907663-FS1-2,Allergic reactions are treated with antihistamines; ANAPHYLAXIS is treated with EPINEPHRINE with IV fluids and vasopressors if necessary (see  Anaphylaxis,ANAPHYLAXIS,EPINEPHRINE,RO-may_treat
498023358,7/4/2014 14:49:28,False,1314937465,7/4/2014 14:49:11,prodege,0.8625,14890188,GBR,I2,Manchester,151.230.18.68,MALIGNANT PLEURAL MESOTHELIOMA causes CHEST PAIN,105,17,,115,47,causes,0.98058067569092,902728-FS1-4,"In patients with MALIGNANT PLEURAL MESOTHELIOMA, radiotherapy is useful in the palliation of symptoms of CHEST PAIN and painful masses",CHEST PAIN,MALIGNANT PLEURAL MESOTHELIOMA,RO-disease_may_have_finding
498023358,7/4/2014 14:51:25,False,1314938997,7/4/2014 14:51:02,clixsense,0.8625,19803139,NLD,6,Veldhoven,212.61.84.196,MALIGNANT PLEURAL MESOTHELIOMA causes CHEST PAIN,105,17,,115,47,causes,0.98058067569092,902728-FS1-4,"In patients with MALIGNANT PLEURAL MESOTHELIOMA, radiotherapy is useful in the palliation of symptoms of CHEST PAIN and painful masses",CHEST PAIN,MALIGNANT PLEURAL MESOTHELIOMA,RO-disease_may_have_finding
498023358,7/4/2014 15:04:06,False,1314949516,7/4/2014 15:03:34,clixsense,0.7667,27969116,NLD,4,Veendam,185.12.216.74,no_relation,105,17,,115,47,causes,0.98058067569092,902728-FS1-4,"In patients with MALIGNANT PLEURAL MESOTHELIOMA, radiotherapy is useful in the palliation of symptoms of CHEST PAIN and painful masses",CHEST PAIN,MALIGNANT PLEURAL MESOTHELIOMA,RO-disease_may_have_finding
498023358,7/4/2014 15:10:10,False,1314954451,7/4/2014 15:09:50,clixsense,0.6479,6394333,GBR,,,86.29.240.182,no_relation,105,17,,115,47,causes,0.98058067569092,902728-FS1-4,"In patients with MALIGNANT PLEURAL MESOTHELIOMA, radiotherapy is useful in the palliation of symptoms of CHEST PAIN and painful masses",CHEST PAIN,MALIGNANT PLEURAL MESOTHELIOMA,RO-disease_may_have_finding
498023358,7/4/2014 15:32:23,False,1314972495,7/4/2014 15:31:49,prodege,0.6637,14848125,GBR,V2,Glasgow,86.130.194.252,MALIGNANT PLEURAL MESOTHELIOMA causes CHEST PAIN,105,17,,115,47,causes,0.98058067569092,902728-FS1-4,"In patients with MALIGNANT PLEURAL MESOTHELIOMA, radiotherapy is useful in the palliation of symptoms of CHEST PAIN and painful masses",CHEST PAIN,MALIGNANT PLEURAL MESOTHELIOMA,RO-disease_may_have_finding
498023363,7/4/2014 15:15:45,False,1314958258,7/4/2014 15:15:34,clixsense,0.6479,6394333,GBR,,,86.29.240.182,no_relation,53,14,,73,25,treats,0.896258159530272,907846-FS1-2,Comparison of CEFTRIAXONE and traditional therapy of BACTERIAL MENINGITIS,BACTERIAL MENINGITIS,CEFTRIAXONE,RO-may_treat
498023363,7/4/2014 15:24:20,False,1314965218,7/4/2014 15:24:09,clixsense,0.6246,15189335,GBR,I9,Dereham,86.157.163.112,CEFTRIAXONE treats BACTERIAL MENINGITIS,53,14,,73,25,treats,0.896258159530272,907846-FS1-2,Comparison of CEFTRIAXONE and traditional therapy of BACTERIAL MENINGITIS,BACTERIAL MENINGITIS,CEFTRIAXONE,RO-may_treat
498023363,7/4/2014 15:33:25,False,1314973343,7/4/2014 15:33:12,gptbanks,0.4263,18496428,USA,CA,Newhall,199.244.112.44,CEFTRIAXONE treats BACTERIAL MENINGITIS,53,14,,73,25,treats,0.896258159530272,907846-FS1-2,Comparison of CEFTRIAXONE and traditional therapy of BACTERIAL MENINGITIS,BACTERIAL MENINGITIS,CEFTRIAXONE,RO-may_treat
498023363,7/4/2014 15:47:52,False,1314983770,7/4/2014 15:47:19,bitcoinget,0.6363,21490602,USA,NJ,Dunellen,68.193.37.224,CEFTRIAXONE treats BACTERIAL MENINGITIS,53,14,,73,25,treats,0.896258159530272,907846-FS1-2,Comparison of CEFTRIAXONE and traditional therapy of BACTERIAL MENINGITIS,BACTERIAL MENINGITIS,CEFTRIAXONE,RO-may_treat
498023363,7/4/2014 15:52:22,False,1314987466,7/4/2014 15:52:07,neodev,0.5875,25804244,USA,IL,Chicago,99.198.108.116,CEFTRIAXONE treats BACTERIAL MENINGITIS,53,14,,73,25,treats,0.896258159530272,907846-FS1-2,Comparison of CEFTRIAXONE and traditional therapy of BACTERIAL MENINGITIS,BACTERIAL MENINGITIS,CEFTRIAXONE,RO-may_treat
498023376,7/4/2014 14:48:22,False,1314936515,7/4/2014 14:48:01,prodege,0.8625,14890188,GBR,I2,Manchester,151.230.18.68,DEXAMETHASONE treats HYPERCORTISOLISM,48,104,,64,117,treats,0.78086880944303,906657-FS1-2,"Very high plasma androgen levels or evidence of HYPERCORTISOLISM, which is not normally suppressible by DEXAMETHASONE, should lead to the search for a tumor or Cushing's syndrome",HYPERCORTISOLISM,DEXAMETHASONE,RO-may_diagnose
498023376,7/4/2014 15:12:55,False,1314956340,7/4/2014 15:12:35,clixsense,0.6479,6394333,GBR,,,86.29.240.182,no_relation,48,104,,64,117,treats,0.78086880944303,906657-FS1-2,"Very high plasma androgen levels or evidence of HYPERCORTISOLISM, which is not normally suppressible by DEXAMETHASONE, should lead to the search for a tumor or Cushing's syndrome",HYPERCORTISOLISM,DEXAMETHASONE,RO-may_diagnose
498023376,7/4/2014 15:21:36,False,1314963059,7/4/2014 15:21:19,clixsense,0.6246,15189335,GBR,I9,Dereham,86.157.163.112,DEXAMETHASONE treats HYPERCORTISOLISM,48,104,,64,117,treats,0.78086880944303,906657-FS1-2,"Very high plasma androgen levels or evidence of HYPERCORTISOLISM, which is not normally suppressible by DEXAMETHASONE, should lead to the search for a tumor or Cushing's syndrome",HYPERCORTISOLISM,DEXAMETHASONE,RO-may_diagnose
498023376,7/4/2014 15:31:11,False,1314971434,7/4/2014 15:31:06,gptbanks,0.4263,18496428,USA,CA,Newhall,199.244.112.44,DEXAMETHASONE treats HYPERCORTISOLISM,48,104,,64,117,treats,0.78086880944303,906657-FS1-2,"Very high plasma androgen levels or evidence of HYPERCORTISOLISM, which is not normally suppressible by DEXAMETHASONE, should lead to the search for a tumor or Cushing's syndrome",HYPERCORTISOLISM,DEXAMETHASONE,RO-may_diagnose
498023376,7/4/2014 15:33:44,False,1314973745,7/4/2014 15:33:32,prodege,0.6637,14848125,GBR,V2,Glasgow,86.130.194.252,DEXAMETHASONE treats HYPERCORTISOLISM,48,104,,64,117,treats,0.78086880944303,906657-FS1-2,"Very high plasma androgen levels or evidence of HYPERCORTISOLISM, which is not normally suppressible by DEXAMETHASONE, should lead to the search for a tumor or Cushing's syndrome",HYPERCORTISOLISM,DEXAMETHASONE,RO-may_diagnose
498023378,7/4/2014 14:46:15,False,1314934397,7/4/2014 14:46:01,prodege,0.8625,14890188,GBR,I2,Manchester,151.230.18.68,ISOTRETINOIN treats ACNE,37,61,,41,73,treats,0.9838699100999069,907655-FS1-2,Association of suicide attempts with ACNE and treatment with ISOTRETINOIN: retrospective Swedish cohort study,ACNE,ISOTRETINOIN,RO-may_treat
498023378,7/4/2014 14:50:17,False,1314938069,7/4/2014 14:49:52,clixsense,0.8625,19803139,NLD,6,Veldhoven,212.61.84.196,ISOTRETINOIN treats ACNE,37,61,,41,73,treats,0.9838699100999069,907655-FS1-2,Association of suicide attempts with ACNE and treatment with ISOTRETINOIN: retrospective Swedish cohort study,ACNE,ISOTRETINOIN,RO-may_treat
498023378,7/4/2014 15:14:48,False,1314957594,7/4/2014 15:14:26,clixsense,0.6479,6394333,GBR,,,86.29.240.182,no_relation,37,61,,41,73,treats,0.9838699100999069,907655-FS1-2,Association of suicide attempts with ACNE and treatment with ISOTRETINOIN: retrospective Swedish cohort study,ACNE,ISOTRETINOIN,RO-may_treat
498023378,7/4/2014 15:25:58,False,1314966501,7/4/2014 15:25:18,clixsense,0.6246,15189335,GBR,I9,Dereham,86.157.163.112,ISOTRETINOIN treats ACNE,37,61,,41,73,treats,0.9838699100999069,907655-FS1-2,Association of suicide attempts with ACNE and treatment with ISOTRETINOIN: retrospective Swedish cohort study,ACNE,ISOTRETINOIN,RO-may_treat
498023378,7/4/2014 15:31:31,False,1314971795,7/4/2014 15:31:16,prodege,0.6637,14848125,GBR,V2,Glasgow,86.130.194.252,ISOTRETINOIN treats ACNE,37,61,,41,73,treats,0.9838699100999069,907655-FS1-2,Association of suicide attempts with ACNE and treatment with ISOTRETINOIN: retrospective Swedish cohort study,ACNE,ISOTRETINOIN,RO-may_treat
498023382,7/4/2014 14:45:01,False,1314933246,7/4/2014 14:44:28,prodege,0.8625,14890188,GBR,I2,Manchester,151.230.18.68,PAPAVERINE treats ERECTILE DYSFUNCTION,118,87,,138,97,treats,0.9838699100999069,906513-FS1-2,"In our experience, E1-PG intracavernous injection has proven to be more effective than PAPAVERINE in the treatment of ERECTILE DYSFUNCTION and therefore, added to its safety and degree of acceptance, we consider it a first choice approach in the diagnosis and treatment of erectile dysfunction in males",ERECTILE DYSFUNCTION,PAPAVERINE,RO-may_diagnose
498023382,7/4/2014 14:57:48,False,1314944021,7/4/2014 14:57:29,clixsense,0.7667,27969116,NLD,4,Veendam,185.12.216.74,PAPAVERINE treats ERECTILE DYSFUNCTION,118,87,,138,97,treats,0.9838699100999069,906513-FS1-2,"In our experience, E1-PG intracavernous injection has proven to be more effective than PAPAVERINE in the treatment of ERECTILE DYSFUNCTION and therefore, added to its safety and degree of acceptance, we consider it a first choice approach in the diagnosis and treatment of erectile dysfunction in males",ERECTILE DYSFUNCTION,PAPAVERINE,RO-may_diagnose
498023382,7/4/2014 15:11:31,False,1314955468,7/4/2014 15:11:17,clixsense,0.6479,6394333,GBR,,,86.29.240.182,no_relation,118,87,,138,97,treats,0.9838699100999069,906513-FS1-2,"In our experience, E1-PG intracavernous injection has proven to be more effective than PAPAVERINE in the treatment of ERECTILE DYSFUNCTION and therefore, added to its safety and degree of acceptance, we consider it a first choice approach in the diagnosis and treatment of erectile dysfunction in males",ERECTILE DYSFUNCTION,PAPAVERINE,RO-may_diagnose
498023382,7/4/2014 15:21:54,False,1314963329,7/4/2014 15:21:39,clixsense,0.6246,15189335,GBR,I9,Dereham,86.157.163.112,PAPAVERINE treats ERECTILE DYSFUNCTION,118,87,,138,97,treats,0.9838699100999069,906513-FS1-2,"In our experience, E1-PG intracavernous injection has proven to be more effective than PAPAVERINE in the treatment of ERECTILE DYSFUNCTION and therefore, added to its safety and degree of acceptance, we consider it a first choice approach in the diagnosis and treatment of erectile dysfunction in males",ERECTILE DYSFUNCTION,PAPAVERINE,RO-may_diagnose
498023382,7/4/2014 15:31:04,False,1314971312,7/4/2014 15:30:59,gptbanks,0.4263,18496428,USA,CA,Newhall,199.244.112.44,ERECTILE DYSFUNCTION treats PAPAVERINE,118,87,,138,97,treats,0.9838699100999069,906513-FS1-2,"In our experience, E1-PG intracavernous injection has proven to be more effective than PAPAVERINE in the treatment of ERECTILE DYSFUNCTION and therefore, added to its safety and degree of acceptance, we consider it a first choice approach in the diagnosis and treatment of erectile dysfunction in males",ERECTILE DYSFUNCTION,PAPAVERINE,RO-may_diagnose
498023384,7/4/2014 14:45:46,False,1314933870,7/4/2014 14:45:17,prodege,0.8625,14890188,GBR,I2,Manchester,151.230.18.68,IMIPRAMINE treats DEPRESSION,102,71,,112,81,treats,1.0,907634-FS1-2,A double-blind comparison of the efficacy and safety of paroxetine and IMIPRAMINE in the treatment of DEPRESSION with dementia,DEPRESSION,IMIPRAMINE,RO-may_treat
498023384,7/4/2014 14:56:21,False,1314942899,7/4/2014 14:56:01,clixsense,0.7667,27969116,NLD,4,Veendam,185.12.216.74,IMIPRAMINE treats DEPRESSION,102,71,,112,81,treats,1.0,907634-FS1-2,A double-blind comparison of the efficacy and safety of paroxetine and IMIPRAMINE in the treatment of DEPRESSION with dementia,DEPRESSION,IMIPRAMINE,RO-may_treat
498023384,7/4/2014 15:15:14,False,1314957885,7/4/2014 15:14:50,clixsense,0.6479,6394333,GBR,,,86.29.240.182,no_relation,102,71,,112,81,treats,1.0,907634-FS1-2,A double-blind comparison of the efficacy and safety of paroxetine and IMIPRAMINE in the treatment of DEPRESSION with dementia,DEPRESSION,IMIPRAMINE,RO-may_treat
498023384,7/4/2014 15:26:33,False,1314967019,7/4/2014 15:26:02,clixsense,0.6246,15189335,GBR,I9,Dereham,86.157.163.112,IMIPRAMINE treats DEPRESSION,102,71,,112,81,treats,1.0,907634-FS1-2,A double-blind comparison of the efficacy and safety of paroxetine and IMIPRAMINE in the treatment of DEPRESSION with dementia,DEPRESSION,IMIPRAMINE,RO-may_treat
498023384,7/4/2014 15:33:10,False,1314973220,7/4/2014 15:32:46,gptbanks,0.4263,18496428,USA,CA,Newhall,199.244.112.44,DEPRESSION treats IMIPRAMINE,102,71,,112,81,treats,1.0,907634-FS1-2,A double-blind comparison of the efficacy and safety of paroxetine and IMIPRAMINE in the treatment of DEPRESSION with dementia,DEPRESSION,IMIPRAMINE,RO-may_treat
498023387,7/4/2014 15:00:37,False,1314946284,7/4/2014 15:00:11,clixsense,0.7667,27969116,NLD,4,Veendam,185.12.216.74,CHOLECALCIFEROL treats OSTEOPOROSIS,103,55,,115,70,treats,1.0,907503-FS1-2,Alendronate is used alone or in fixed combination with CHOLECALCIFEROL (vitamin D 3 ) for treatment of OSTEOPOROSIS in postmenopausal women,OSTEOPOROSIS,CHOLECALCIFEROL,RO-may_treat
498023387,7/4/2014 15:09:49,False,1314954236,7/4/2014 15:09:29,clixsense,0.6479,6394333,GBR,,,86.29.240.182,no_relation,103,55,,115,70,treats,1.0,907503-FS1-2,Alendronate is used alone or in fixed combination with CHOLECALCIFEROL (vitamin D 3 ) for treatment of OSTEOPOROSIS in postmenopausal women,OSTEOPOROSIS,CHOLECALCIFEROL,RO-may_treat
498023387,7/4/2014 15:22:19,False,1314963712,7/4/2014 15:21:55,clixsense,0.6246,15189335,GBR,I9,Dereham,86.157.163.112,CHOLECALCIFEROL treats OSTEOPOROSIS,103,55,,115,70,treats,1.0,907503-FS1-2,Alendronate is used alone or in fixed combination with CHOLECALCIFEROL (vitamin D 3 ) for treatment of OSTEOPOROSIS in postmenopausal women,OSTEOPOROSIS,CHOLECALCIFEROL,RO-may_treat
498023387,7/4/2014 15:30:00,False,1314970181,7/4/2014 15:29:49,prodege,0.6637,14848125,GBR,V2,Glasgow,86.130.194.252,CHOLECALCIFEROL treats OSTEOPOROSIS,103,55,,115,70,treats,1.0,907503-FS1-2,Alendronate is used alone or in fixed combination with CHOLECALCIFEROL (vitamin D 3 ) for treatment of OSTEOPOROSIS in postmenopausal women,OSTEOPOROSIS,CHOLECALCIFEROL,RO-may_treat
498023387,7/4/2014 15:31:28,False,1314971772,7/4/2014 15:31:14,gptbanks,0.4263,18496428,USA,CA,Newhall,199.244.112.44,OSTEOPOROSIS treats CHOLECALCIFEROL,103,55,,115,70,treats,1.0,907503-FS1-2,Alendronate is used alone or in fixed combination with CHOLECALCIFEROL (vitamin D 3 ) for treatment of OSTEOPOROSIS in postmenopausal women,OSTEOPOROSIS,CHOLECALCIFEROL,RO-may_treat
498023392,7/4/2014 14:45:47,False,1314933879,7/4/2014 14:45:19,clixsense,0.8625,19803139,NLD,6,Veldhoven,212.61.84.196,no_relation,106,76,,113,84,treats,0.9578262852211508,907616-FS1-2,"James WP, Avenell A, Broom J et al. A one-year trial to assess the value of ORLISTAT in the management of OBESITY",OBESITY,ORLISTAT,RO-may_treat
498023392,7/4/2014 14:58:16,False,1314944395,7/4/2014 14:57:49,clixsense,0.7667,27969116,NLD,4,Veendam,185.12.216.74,ORLISTAT treats OBESITY,106,76,,113,84,treats,0.9578262852211508,907616-FS1-2,"James WP, Avenell A, Broom J et al. A one-year trial to assess the value of ORLISTAT in the management of OBESITY",OBESITY,ORLISTAT,RO-may_treat
498023392,7/4/2014 15:28:21,False,1314968768,7/4/2014 15:28:10,prodege,0.6637,14848125,GBR,V2,Glasgow,86.130.194.252,ORLISTAT treats OBESITY,106,76,,113,84,treats,0.9578262852211508,907616-FS1-2,"James WP, Avenell A, Broom J et al. A one-year trial to assess the value of ORLISTAT in the management of OBESITY",OBESITY,ORLISTAT,RO-may_treat
498023392,7/4/2014 15:40:13,False,1314978260,7/4/2014 15:39:41,bitcoinget,0.6363,21490602,USA,NJ,Dunellen,68.193.37.224,ORLISTAT treats OBESITY,106,76,,113,84,treats,0.9578262852211508,907616-FS1-2,"James WP, Avenell A, Broom J et al. A one-year trial to assess the value of ORLISTAT in the management of OBESITY",OBESITY,ORLISTAT,RO-may_treat
498023392,7/4/2014 15:49:23,False,1314985082,7/4/2014 15:48:50,rewardsspot,0.6639,24482174,GBR,H9,London,146.185.23.27,ORLISTAT treats OBESITY,106,76,,113,84,treats,0.9578262852211508,907616-FS1-2,"James WP, Avenell A, Broom J et al. A one-year trial to assess the value of ORLISTAT in the management of OBESITY",OBESITY,ORLISTAT,RO-may_treat
498023394,7/4/2014 14:45:17,False,1314933501,7/4/2014 14:45:02,prodege,0.8625,14890188,GBR,I2,Manchester,151.230.18.68,KETOPROFEN treats RHEUMATOID ARTHRITIS,130,82,,150,92,treats,1.0,907589-FS1-2,"El-Ghobarey AF, Rennie JAN, Hadidi T et al. A comparative trial of large doses of KETOPROFEN and indomethacin in the treatment of RHEUMATOID ARTHRITIS",RHEUMATOID ARTHRITIS,KETOPROFEN,RO-may_treat
498023394,7/4/2014 15:13:33,False,1314956742,7/4/2014 15:13:08,clixsense,0.6479,6394333,GBR,,,86.29.240.182,no_relation,130,82,,150,92,treats,1.0,907589-FS1-2,"El-Ghobarey AF, Rennie JAN, Hadidi T et al. A comparative trial of large doses of KETOPROFEN and indomethacin in the treatment of RHEUMATOID ARTHRITIS",RHEUMATOID ARTHRITIS,KETOPROFEN,RO-may_treat
498023394,7/4/2014 15:27:17,False,1314967608,7/4/2014 15:27:05,clixsense,0.6246,15189335,GBR,I9,Dereham,86.157.163.112,KETOPROFEN treats RHEUMATOID ARTHRITIS,130,82,,150,92,treats,1.0,907589-FS1-2,"El-Ghobarey AF, Rennie JAN, Hadidi T et al. A comparative trial of large doses of KETOPROFEN and indomethacin in the treatment of RHEUMATOID ARTHRITIS",RHEUMATOID ARTHRITIS,KETOPROFEN,RO-may_treat
498023394,7/4/2014 15:33:44,False,1314973725,7/4/2014 15:33:32,prodege,0.6637,14848125,GBR,V2,Glasgow,86.130.194.252,KETOPROFEN treats RHEUMATOID ARTHRITIS,130,82,,150,92,treats,1.0,907589-FS1-2,"El-Ghobarey AF, Rennie JAN, Hadidi T et al. A comparative trial of large doses of KETOPROFEN and indomethacin in the treatment of RHEUMATOID ARTHRITIS",RHEUMATOID ARTHRITIS,KETOPROFEN,RO-may_treat
498023394,7/4/2014 15:47:22,False,1314983333,7/4/2014 15:46:36,rewardsspot,0.6639,24482174,GBR,H9,London,146.185.23.27,KETOPROFEN treats RHEUMATOID ARTHRITIS,130,82,,150,92,treats,1.0,907589-FS1-2,"El-Ghobarey AF, Rennie JAN, Hadidi T et al. A comparative trial of large doses of KETOPROFEN and indomethacin in the treatment of RHEUMATOID ARTHRITIS",RHEUMATOID ARTHRITIS,KETOPROFEN,RO-may_treat
498023395,7/4/2014 14:49:28,False,1314937458,7/4/2014 14:49:11,prodege,0.8625,14890188,GBR,I2,Manchester,151.230.18.68,PHEOCHROMOCYTOMA causes HYPERTENSION,50,96,,62,112,causes,0.34815531191139604,902671-FS1-4,Evidence: ? Vigilant intraoperative management of HYPERTENSION is essential during resection of PHEOCHROMOCYTOMA,HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
498023395,7/4/2014 14:59:03,False,1314944962,7/4/2014 14:58:40,clixsense,0.7667,27969116,NLD,4,Veendam,185.12.216.74,no_relation,50,96,,62,112,causes,0.34815531191139604,902671-FS1-4,Evidence: ? Vigilant intraoperative management of HYPERTENSION is essential during resection of PHEOCHROMOCYTOMA,HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
498023395,7/4/2014 15:13:06,False,1314956486,7/4/2014 15:12:56,clixsense,0.6479,6394333,GBR,,,86.29.240.182,no_relation,50,96,,62,112,causes,0.34815531191139604,902671-FS1-4,Evidence: ? Vigilant intraoperative management of HYPERTENSION is essential during resection of PHEOCHROMOCYTOMA,HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
498023395,7/4/2014 15:25:58,False,1314966479,7/4/2014 15:25:18,clixsense,0.6246,15189335,GBR,I9,Dereham,86.157.163.112,PHEOCHROMOCYTOMA causes HYPERTENSION,50,96,,62,112,causes,0.34815531191139604,902671-FS1-4,Evidence: ? Vigilant intraoperative management of HYPERTENSION is essential during resection of PHEOCHROMOCYTOMA,HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
498023395,7/4/2014 15:27:45,False,1314968044,7/4/2014 15:27:14,prodege,0.6637,14848125,GBR,V2,Glasgow,86.130.194.252,no_relation,50,96,,62,112,causes,0.34815531191139604,902671-FS1-4,Evidence: ? Vigilant intraoperative management of HYPERTENSION is essential during resection of PHEOCHROMOCYTOMA,HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
498023398,7/4/2014 14:51:45,False,1314939324,7/4/2014 14:51:28,clixsense,0.8625,19803139,NLD,6,Veldhoven,212.61.84.196,INTERFERON treats MULTIPLE MYELOMA,42,11,,58,21,treats,1.0,907873-FS1-2,The use of INTERFERON in the treatment of MULTIPLE MYELOMA,MULTIPLE MYELOMA,INTERFERON,RO-may_treat
498023398,7/4/2014 14:57:48,False,1314944026,7/4/2014 14:57:29,clixsense,0.7667,27969116,NLD,4,Veendam,185.12.216.74,INTERFERON treats MULTIPLE MYELOMA,42,11,,58,21,treats,1.0,907873-FS1-2,The use of INTERFERON in the treatment of MULTIPLE MYELOMA,MULTIPLE MYELOMA,INTERFERON,RO-may_treat
498023398,7/4/2014 15:30:00,False,1314970186,7/4/2014 15:29:49,prodege,0.6637,14848125,GBR,V2,Glasgow,86.130.194.252,INTERFERON treats MULTIPLE MYELOMA,42,11,,58,21,treats,1.0,907873-FS1-2,The use of INTERFERON in the treatment of MULTIPLE MYELOMA,MULTIPLE MYELOMA,INTERFERON,RO-may_treat
498023398,7/4/2014 15:32:44,False,1314972852,7/4/2014 15:31:54,gptbanks,0.4263,18496428,USA,CA,Newhall,199.244.112.44,MULTIPLE MYELOMA treats INTERFERON,42,11,,58,21,treats,1.0,907873-FS1-2,The use of INTERFERON in the treatment of MULTIPLE MYELOMA,MULTIPLE MYELOMA,INTERFERON,RO-may_treat
498023398,7/4/2014 15:42:34,False,1314979819,7/4/2014 15:42:12,bitcoinget,0.6363,21490602,USA,NJ,Dunellen,68.193.37.224,INTERFERON treats MULTIPLE MYELOMA,42,11,,58,21,treats,1.0,907873-FS1-2,The use of INTERFERON in the treatment of MULTIPLE MYELOMA,MULTIPLE MYELOMA,INTERFERON,RO-may_treat
498023401,7/4/2014 14:47:00,False,1314935137,7/4/2014 14:46:49,prodege,0.8625,14890188,GBR,I2,Manchester,151.230.18.68,TERBINAFINE treats TINEA CAPITIS,140,108,,153,119,treats,0.9950371902099889,907640-FS1-2,"Kullavanijaya P, Reangchainam S, Ungpakorn R. Randomized single-blind study of efficacy and tolerability of TERBINAFINE in the treatment of TINEA CAPITIS",TINEA CAPITIS,TERBINAFINE,RO-may_treat
498023401,7/4/2014 14:57:27,False,1314943772,7/4/2014 14:56:46,clixsense,0.7667,27969116,NLD,4,Veendam,185.12.216.74,TERBINAFINE treats TINEA CAPITIS,140,108,,153,119,treats,0.9950371902099889,907640-FS1-2,"Kullavanijaya P, Reangchainam S, Ungpakorn R. Randomized single-blind study of efficacy and tolerability of TERBINAFINE in the treatment of TINEA CAPITIS",TINEA CAPITIS,TERBINAFINE,RO-may_treat
498023401,7/4/2014 15:23:43,False,1314964726,7/4/2014 15:23:16,clixsense,0.6246,15189335,GBR,I9,Dereham,86.157.163.112,TERBINAFINE treats TINEA CAPITIS,140,108,,153,119,treats,0.9950371902099889,907640-FS1-2,"Kullavanijaya P, Reangchainam S, Ungpakorn R. Randomized single-blind study of efficacy and tolerability of TERBINAFINE in the treatment of TINEA CAPITIS",TINEA CAPITIS,TERBINAFINE,RO-may_treat
498023401,7/4/2014 15:35:34,False,1314974891,7/4/2014 15:35:29,gptbanks,0.4263,18496428,USA,CA,Newhall,199.244.112.44,TINEA CAPITIS treats TERBINAFINE,140,108,,153,119,treats,0.9950371902099889,907640-FS1-2,"Kullavanijaya P, Reangchainam S, Ungpakorn R. Randomized single-blind study of efficacy and tolerability of TERBINAFINE in the treatment of TINEA CAPITIS",TINEA CAPITIS,TERBINAFINE,RO-may_treat
498023401,7/4/2014 15:45:11,False,1314981640,7/4/2014 15:44:40,bitcoinget,0.6363,21490602,USA,NJ,Dunellen,68.193.37.224,TERBINAFINE treats TINEA CAPITIS,140,108,,153,119,treats,0.9950371902099889,907640-FS1-2,"Kullavanijaya P, Reangchainam S, Ungpakorn R. Randomized single-blind study of efficacy and tolerability of TERBINAFINE in the treatment of TINEA CAPITIS",TINEA CAPITIS,TERBINAFINE,RO-may_treat
498023402,7/4/2014 14:45:46,False,1314933869,7/4/2014 14:45:17,prodege,0.8625,14890188,GBR,I2,Manchester,151.230.18.68,ONDANSETRON treats EMESIS,51,109,,57,120,treats,0.964901281354015,907273-FS1-2,Eight patients achieved good control of nausea and EMESIS with ondansetron alone while two patients required ONDANSETRON and diphenhydramine,EMESIS,ONDANSETRON,RO-may_prevent
498023402,7/4/2014 14:46:52,False,1314934982,7/4/2014 14:46:32,clixsense,0.8625,19803139,NLD,6,Veldhoven,212.61.84.196,ONDANSETRON treats EMESIS,51,109,,57,120,treats,0.964901281354015,907273-FS1-2,Eight patients achieved good control of nausea and EMESIS with ondansetron alone while two patients required ONDANSETRON and diphenhydramine,EMESIS,ONDANSETRON,RO-may_prevent
498023402,7/4/2014 14:56:45,False,1314943223,7/4/2014 14:56:22,clixsense,0.7667,27969116,NLD,4,Veendam,185.12.216.74,no_relation,51,109,,57,120,treats,0.964901281354015,907273-FS1-2,Eight patients achieved good control of nausea and EMESIS with ondansetron alone while two patients required ONDANSETRON and diphenhydramine,EMESIS,ONDANSETRON,RO-may_prevent
498023402,7/4/2014 15:23:15,False,1314964405,7/4/2014 15:22:51,clixsense,0.6246,15189335,GBR,I9,Dereham,86.157.163.112,ONDANSETRON treats EMESIS,51,109,,57,120,treats,0.964901281354015,907273-FS1-2,Eight patients achieved good control of nausea and EMESIS with ondansetron alone while two patients required ONDANSETRON and diphenhydramine,EMESIS,ONDANSETRON,RO-may_prevent
498023402,7/4/2014 15:30:58,False,1314971220,7/4/2014 15:30:44,prodege,0.6637,14848125,GBR,V2,Glasgow,86.130.194.252,ONDANSETRON treats EMESIS,51,109,,57,120,treats,0.964901281354015,907273-FS1-2,Eight patients achieved good control of nausea and EMESIS with ondansetron alone while two patients required ONDANSETRON and diphenhydramine,EMESIS,ONDANSETRON,RO-may_prevent
498023406,7/4/2014 14:46:48,False,1314934904,7/4/2014 14:46:33,prodege,0.8625,14890188,GBR,I2,Manchester,151.230.18.68,DEXAMETHASONE contraindicates HYPERCORTISOLISM,48,104,,64,117,contraindicates,0.468521285665818,906657-FS1-10,"Very high plasma androgen levels or evidence of HYPERCORTISOLISM, which is not normally suppressible by DEXAMETHASONE, should lead to the search for a tumor or Cushing's syndrome",HYPERCORTISOLISM,DEXAMETHASONE,RO-may_diagnose
498023406,7/4/2014 14:47:56,False,1314936115,7/4/2014 14:47:31,clixsense,0.8625,19803139,NLD,6,Veldhoven,212.61.84.196,HYPERCORTISOLISM contraindicates DEXAMETHASONE,48,104,,64,117,contraindicates,0.468521285665818,906657-FS1-10,"Very high plasma androgen levels or evidence of HYPERCORTISOLISM, which is not normally suppressible by DEXAMETHASONE, should lead to the search for a tumor or Cushing's syndrome",HYPERCORTISOLISM,DEXAMETHASONE,RO-may_diagnose
498023406,7/4/2014 15:19:51,False,1314961724,7/4/2014 15:19:30,clixsense,0.6246,15189335,GBR,I9,Dereham,86.157.163.112,HYPERCORTISOLISM contraindicates DEXAMETHASONE,48,104,,64,117,contraindicates,0.468521285665818,906657-FS1-10,"Very high plasma androgen levels or evidence of HYPERCORTISOLISM, which is not normally suppressible by DEXAMETHASONE, should lead to the search for a tumor or Cushing's syndrome",HYPERCORTISOLISM,DEXAMETHASONE,RO-may_diagnose
498023406,7/4/2014 15:31:28,False,1314971740,7/4/2014 15:31:14,gptbanks,0.4263,18496428,USA,CA,Newhall,199.244.112.44,DEXAMETHASONE contraindicates HYPERCORTISOLISM,48,104,,64,117,contraindicates,0.468521285665818,906657-FS1-10,"Very high plasma androgen levels or evidence of HYPERCORTISOLISM, which is not normally suppressible by DEXAMETHASONE, should lead to the search for a tumor or Cushing's syndrome",HYPERCORTISOLISM,DEXAMETHASONE,RO-may_diagnose
498023406,7/4/2014 15:34:12,False,1314974134,7/4/2014 15:33:45,prodege,0.6637,14848125,GBR,V2,Glasgow,86.130.194.252,no_relation,48,104,,64,117,contraindicates,0.468521285665818,906657-FS1-10,"Very high plasma androgen levels or evidence of HYPERCORTISOLISM, which is not normally suppressible by DEXAMETHASONE, should lead to the search for a tumor or Cushing's syndrome",HYPERCORTISOLISM,DEXAMETHASONE,RO-may_diagnose
498023407,7/4/2014 14:46:31,False,1314934673,7/4/2014 14:46:15,clixsense,0.8625,19803139,NLD,6,Veldhoven,212.61.84.196,no_relation,53,107,,73,118,treats,1.0,907900-FS1-2,"Tikkanen MJ, Laakso M, Ilmonen M et al. Treatment of HYPERCHOLESTEROLEMIA and combined hyperlipidemia with SIMVASTATIN and gemfibrozil in patients with NIDDM",HYPERCHOLESTEROLEMIA,SIMVASTATIN,RO-may_treat
498023407,7/4/2014 15:22:47,False,1314964007,7/4/2014 15:22:20,clixsense,0.6246,15189335,GBR,I9,Dereham,86.157.163.112,SIMVASTATIN treats HYPERCHOLESTEROLEMIA,53,107,,73,118,treats,1.0,907900-FS1-2,"Tikkanen MJ, Laakso M, Ilmonen M et al. Treatment of HYPERCHOLESTEROLEMIA and combined hyperlipidemia with SIMVASTATIN and gemfibrozil in patients with NIDDM",HYPERCHOLESTEROLEMIA,SIMVASTATIN,RO-may_treat
498023407,7/4/2014 15:32:37,False,1314972774,7/4/2014 15:32:24,prodege,0.6637,14848125,GBR,V2,Glasgow,86.130.194.252,SIMVASTATIN treats HYPERCHOLESTEROLEMIA,53,107,,73,118,treats,1.0,907900-FS1-2,"Tikkanen MJ, Laakso M, Ilmonen M et al. Treatment of HYPERCHOLESTEROLEMIA and combined hyperlipidemia with SIMVASTATIN and gemfibrozil in patients with NIDDM",HYPERCHOLESTEROLEMIA,SIMVASTATIN,RO-may_treat
498023407,7/4/2014 15:39:03,False,1314977311,7/4/2014 15:38:30,bitcoinget,0.6363,21490602,USA,NJ,Dunellen,68.193.37.224,SIMVASTATIN treats HYPERCHOLESTEROLEMIA,53,107,,73,118,treats,1.0,907900-FS1-2,"Tikkanen MJ, Laakso M, Ilmonen M et al. Treatment of HYPERCHOLESTEROLEMIA and combined hyperlipidemia with SIMVASTATIN and gemfibrozil in patients with NIDDM",HYPERCHOLESTEROLEMIA,SIMVASTATIN,RO-may_treat
498023407,7/4/2014 15:50:44,False,1314986180,7/4/2014 15:50:10,rewardsspot,0.6639,24482174,GBR,H9,London,146.185.23.27,SIMVASTATIN treats HYPERCHOLESTEROLEMIA,53,107,,73,118,treats,1.0,907900-FS1-2,"Tikkanen MJ, Laakso M, Ilmonen M et al. Treatment of HYPERCHOLESTEROLEMIA and combined hyperlipidemia with SIMVASTATIN and gemfibrozil in patients with NIDDM",HYPERCHOLESTEROLEMIA,SIMVASTATIN,RO-may_treat
502804127,7/13/2014 11:04:00,,1321827555,7/13/2014 11:02:51,clixsense,0.9167,15189335,GBR,I9,Norwich,86.155.45.231,OSTEOPOROSIS diagnose_by_test_or_drug BONE,97,157,,100,168,diagnose_by_test_or_drug,0.44721359549999995,905499-FS1-13,The aim of this paper is to present the current state of knowledge on the biochemical markers of BONE turnover and their place at diagnosis and treatment of OSTEOPOROSIS,BONE,OSTEOPOROSIS,RO-has_finding_site
502804127,7/13/2014 11:22:22,,1321835312,7/13/2014 11:21:36,rewardsspot,0.7222,24482174,GBR,H9,London,46.23.68.180,OSTEOPOROSIS diagnose_by_test_or_drug BONE,97,157,,100,168,diagnose_by_test_or_drug,0.44721359549999995,905499-FS1-13,The aim of this paper is to present the current state of knowledge on the biochemical markers of BONE turnover and their place at diagnosis and treatment of OSTEOPOROSIS,BONE,OSTEOPOROSIS,RO-has_finding_site
502804127,7/13/2014 11:50:02,,1321845955,7/13/2014 11:49:38,prodege,0.5986,12944140,GBR,I4,Mitcham,92.21.66.102,no_relation,97,157,,100,168,diagnose_by_test_or_drug,0.44721359549999995,905499-FS1-13,The aim of this paper is to present the current state of knowledge on the biochemical markers of BONE turnover and their place at diagnosis and treatment of OSTEOPOROSIS,BONE,OSTEOPOROSIS,RO-has_finding_site
502804127,7/13/2014 11:51:28,,1321846460,7/13/2014 11:51:10,instagc,0.6486,19004168,GBR,H2,Accrington,80.47.185.52,no_relation,97,157,,100,168,diagnose_by_test_or_drug,0.44721359549999995,905499-FS1-13,The aim of this paper is to present the current state of knowledge on the biochemical markers of BONE turnover and their place at diagnosis and treatment of OSTEOPOROSIS,BONE,OSTEOPOROSIS,RO-has_finding_site
502804127,7/13/2014 11:59:54,,1321849841,7/13/2014 11:59:18,prodege,0.4611,28039757,GBR,L8,Southport,109.155.158.54,BONE diagnose_by_test_or_drug OSTEOPOROSIS,97,157,,100,168,diagnose_by_test_or_drug,0.44721359549999995,905499-FS1-13,The aim of this paper is to present the current state of knowledge on the biochemical markers of BONE turnover and their place at diagnosis and treatment of OSTEOPOROSIS,BONE,OSTEOPOROSIS,RO-has_finding_site
502804127,7/13/2014 12:07:03,,1321852327,7/13/2014 12:06:32,instagc,0.6389,15445601,USA,FL,Jacksonville,24.129.68.254,OSTEOPOROSIS diagnose_by_test_or_drug BONE,97,157,,100,168,diagnose_by_test_or_drug,0.44721359549999995,905499-FS1-13,The aim of this paper is to present the current state of knowledge on the biochemical markers of BONE turnover and their place at diagnosis and treatment of OSTEOPOROSIS,BONE,OSTEOPOROSIS,RO-has_finding_site
502804127,7/13/2014 12:15:08,,1321855003,7/13/2014 12:14:44,clixsense,0.5603,27871219,NLD,07,Amsterdam,87.210.207.223,BONE diagnose_by_test_or_drug OSTEOPOROSIS,97,157,,100,168,diagnose_by_test_or_drug,0.44721359549999995,905499-FS1-13,The aim of this paper is to present the current state of knowledge on the biochemical markers of BONE turnover and their place at diagnosis and treatment of OSTEOPOROSIS,BONE,OSTEOPOROSIS,RO-has_finding_site
502804137,7/13/2014 11:06:34,,1321828444,7/13/2014 11:06:23,clixsense,0.6806,27793793,GBR,C5,Chester,151.230.27.155,SPONDYLOARTHROPATHIES causes ANKYLOSING SPONDYLITIS,94,58,,115,78,causes,0.8333333333,906306-FS1-4,Involvement of the sacroiliac joints is a hallmark of the SPONDYLOARTHROPATHIES especially in ANKYLOSING SPONDYLITIS,ANKYLOSING SPONDYLITIS,SPONDYLOARTHROPATHIES,RO-has_manifestation
502804137,7/13/2014 11:50:18,,1321846034,7/13/2014 11:50:11,prodege,0.5986,12944140,GBR,I4,Mitcham,92.21.66.102,no_relation,94,58,,115,78,causes,0.8333333333,906306-FS1-4,Involvement of the sacroiliac joints is a hallmark of the SPONDYLOARTHROPATHIES especially in ANKYLOSING SPONDYLITIS,ANKYLOSING SPONDYLITIS,SPONDYLOARTHROPATHIES,RO-has_manifestation
502804137,7/13/2014 12:07:49,,1321852583,7/13/2014 12:07:33,instagc,0.6389,15445601,USA,FL,Jacksonville,24.129.68.254,no_relation,94,58,,115,78,causes,0.8333333333,906306-FS1-4,Involvement of the sacroiliac joints is a hallmark of the SPONDYLOARTHROPATHIES especially in ANKYLOSING SPONDYLITIS,ANKYLOSING SPONDYLITIS,SPONDYLOARTHROPATHIES,RO-has_manifestation
502804137,7/13/2014 12:13:54,,1321854649,7/13/2014 12:12:47,sendearnings,0.3333,11896941,USA,FL,Seminole,97.106.105.251,SPONDYLOARTHROPATHIES causes ANKYLOSING SPONDYLITIS,94,58,,115,78,causes,0.8333333333,906306-FS1-4,Involvement of the sacroiliac joints is a hallmark of the SPONDYLOARTHROPATHIES especially in ANKYLOSING SPONDYLITIS,ANKYLOSING SPONDYLITIS,SPONDYLOARTHROPATHIES,RO-has_manifestation
502804137,7/13/2014 12:18:25,,1321856235,7/13/2014 12:18:07,instagc,0.6246,13763729,USA,,,75.182.89.225,no_relation,94,58,,115,78,causes,0.8333333333,906306-FS1-4,Involvement of the sacroiliac joints is a hallmark of the SPONDYLOARTHROPATHIES especially in ANKYLOSING SPONDYLITIS,ANKYLOSING SPONDYLITIS,SPONDYLOARTHROPATHIES,RO-has_manifestation
502804137,7/13/2014 13:07:14,,1321876161,7/13/2014 13:06:45,instagc,0.6448,23149109,USA,NC,Durham,75.189.206.205,ANKYLOSING SPONDYLITIS causes SPONDYLOARTHROPATHIES,94,58,,115,78,causes,0.8333333333,906306-FS1-4,Involvement of the sacroiliac joints is a hallmark of the SPONDYLOARTHROPATHIES especially in ANKYLOSING SPONDYLITIS,ANKYLOSING SPONDYLITIS,SPONDYLOARTHROPATHIES,RO-has_manifestation
502804137,7/13/2014 13:18:38,,1321880773,7/13/2014 13:18:11,neodev,0.6736,14861092,GBR,I2,Manchester,90.194.137.76,no_relation,94,58,,115,78,causes,0.8333333333,906306-FS1-4,Involvement of the sacroiliac joints is a hallmark of the SPONDYLOARTHROPATHIES especially in ANKYLOSING SPONDYLITIS,ANKYLOSING SPONDYLITIS,SPONDYLOARTHROPATHIES,RO-has_manifestation
502804141,7/13/2014 11:00:30,,1321826032,7/13/2014 10:59:48,clixsense,0.9167,15189335,GBR,I9,Norwich,86.155.45.231,DEPRESSION diagnose_by_test_or_drug DEXAMETHASONE,122,190,,131,202,diagnose_by_test_or_drug,0.9958932065,906529-FS1-13,Impaired regulation of the hypothalamus pituitary adrenocortical (HPA) system is a consistent finding among patients with DEPRESSION which can be most sensitively detected with the combined DEXAMETHASONE (dex)/corticotrophin releasing hormone (CRH) test.,DEPRESSION,DEXAMETHASONE,RO-may_diagnose
502804141,7/13/2014 11:50:11,,1321845988,7/13/2014 11:50:03,prodege,0.5986,12944140,GBR,I4,Mitcham,92.21.66.102,no_relation,122,190,,131,202,diagnose_by_test_or_drug,0.9958932065,906529-FS1-13,Impaired regulation of the hypothalamus pituitary adrenocortical (HPA) system is a consistent finding among patients with DEPRESSION which can be most sensitively detected with the combined DEXAMETHASONE (dex)/corticotrophin releasing hormone (CRH) test.,DEPRESSION,DEXAMETHASONE,RO-may_diagnose
502804141,7/13/2014 12:32:40,,1321862039,7/13/2014 12:32:35,prodege,0.4998,28480832,GBR,J1,Northampton,78.151.200.222,DEPRESSION diagnose_by_test_or_drug DEXAMETHASONE,122,190,,131,202,diagnose_by_test_or_drug,0.9958932065,906529-FS1-13,Impaired regulation of the hypothalamus pituitary adrenocortical (HPA) system is a consistent finding among patients with DEPRESSION which can be most sensitively detected with the combined DEXAMETHASONE (dex)/corticotrophin releasing hormone (CRH) test.,DEPRESSION,DEXAMETHASONE,RO-may_diagnose
502804141,7/13/2014 13:13:33,,1321878812,7/13/2014 13:12:36,instagc,0.7056,19686223,CAN,BC,Surrey,154.20.155.106,no_relation,122,190,,131,202,diagnose_by_test_or_drug,0.9958932065,906529-FS1-13,Impaired regulation of the hypothalamus pituitary adrenocortical (HPA) system is a consistent finding among patients with DEPRESSION which can be most sensitively detected with the combined DEXAMETHASONE (dex)/corticotrophin releasing hormone (CRH) test.,DEPRESSION,DEXAMETHASONE,RO-may_diagnose
502804141,7/13/2014 13:19:48,,1321881262,7/13/2014 13:19:05,instagc,0.7079,21551272,GBR,Q3,Wolverhampton,2.103.57.104,DEPRESSION diagnose_by_test_or_drug DEXAMETHASONE,122,190,,131,202,diagnose_by_test_or_drug,0.9958932065,906529-FS1-13,Impaired regulation of the hypothalamus pituitary adrenocortical (HPA) system is a consistent finding among patients with DEPRESSION which can be most sensitively detected with the combined DEXAMETHASONE (dex)/corticotrophin releasing hormone (CRH) test.,DEPRESSION,DEXAMETHASONE,RO-may_diagnose
502804141,7/13/2014 13:23:36,,1321882828,7/13/2014 13:23:29,neodev,0.302,25224036,CAN,ON,Sudbury,67.204.218.187,DEPRESSION diagnose_by_test_or_drug DEXAMETHASONE,122,190,,131,202,diagnose_by_test_or_drug,0.9958932065,906529-FS1-13,Impaired regulation of the hypothalamus pituitary adrenocortical (HPA) system is a consistent finding among patients with DEPRESSION which can be most sensitively detected with the combined DEXAMETHASONE (dex)/corticotrophin releasing hormone (CRH) test.,DEPRESSION,DEXAMETHASONE,RO-may_diagnose
502804141,7/13/2014 13:33:11,,1321886537,7/13/2014 13:32:50,clixsense,0.4762,6500439,AUS,02,Ingleburn,115.146.65.99,DEPRESSION diagnose_by_test_or_drug DEXAMETHASONE,122,190,,131,202,diagnose_by_test_or_drug,0.9958932065,906529-FS1-13,Impaired regulation of the hypothalamus pituitary adrenocortical (HPA) system is a consistent finding among patients with DEPRESSION which can be most sensitively detected with the combined DEXAMETHASONE (dex)/corticotrophin releasing hormone (CRH) test.,DEPRESSION,DEXAMETHASONE,RO-may_diagnose
502804143,7/13/2014 10:59:47,,1321825859,7/13/2014 10:59:22,clixsense,0.9167,15189335,GBR,I9,Norwich,86.155.45.231,PHAEOCHROMOCYTOMA causes HYPERTENSION,31,103,,42,119,causes,0.8944271909999999,902902-FS1-4,The recurrence of symptoms and HYPERTENSION in a patient who has previously undergone an operation for PHAEOCHROMOCYTOMA should alert the physician to the need to investigate for recurrent tumour.,HYPERTENSION,PHAEOCHROMOCYTOMA,RO-disease_may_have_finding
502804143,7/13/2014 11:18:38,,1321833729,7/13/2014 11:18:01,rewardsspot,0.7222,24482174,GBR,H9,London,46.23.68.180,HYPERTENSION causes PHAEOCHROMOCYTOMA,31,103,,42,119,causes,0.8944271909999999,902902-FS1-4,The recurrence of symptoms and HYPERTENSION in a patient who has previously undergone an operation for PHAEOCHROMOCYTOMA should alert the physician to the need to investigate for recurrent tumour.,HYPERTENSION,PHAEOCHROMOCYTOMA,RO-disease_may_have_finding
502804143,7/13/2014 11:51:28,,1321846461,7/13/2014 11:51:10,instagc,0.6486,19004168,GBR,H2,Accrington,80.47.185.52,no_relation,31,103,,42,119,causes,0.8944271909999999,902902-FS1-4,The recurrence of symptoms and HYPERTENSION in a patient who has previously undergone an operation for PHAEOCHROMOCYTOMA should alert the physician to the need to investigate for recurrent tumour.,HYPERTENSION,PHAEOCHROMOCYTOMA,RO-disease_may_have_finding
502804143,7/13/2014 11:59:17,,1321849564,7/13/2014 11:58:43,prodege,0.4611,28039757,GBR,L8,Southport,109.155.158.54,no_relation,31,103,,42,119,causes,0.8944271909999999,902902-FS1-4,The recurrence of symptoms and HYPERTENSION in a patient who has previously undergone an operation for PHAEOCHROMOCYTOMA should alert the physician to the need to investigate for recurrent tumour.,HYPERTENSION,PHAEOCHROMOCYTOMA,RO-disease_may_have_finding
502804143,7/13/2014 12:07:17,,1321852410,7/13/2014 12:07:04,instagc,0.6389,15445601,USA,FL,Jacksonville,24.129.68.254,PHAEOCHROMOCYTOMA causes HYPERTENSION,31,103,,42,119,causes,0.8944271909999999,902902-FS1-4,The recurrence of symptoms and HYPERTENSION in a patient who has previously undergone an operation for PHAEOCHROMOCYTOMA should alert the physician to the need to investigate for recurrent tumour.,HYPERTENSION,PHAEOCHROMOCYTOMA,RO-disease_may_have_finding
502804143,7/13/2014 12:07:43,,1321852554,7/13/2014 12:06:57,vivatic,0.5236,25451531,GBR,,,83.67.28.193,HYPERTENSION causes PHAEOCHROMOCYTOMA,31,103,,42,119,causes,0.8944271909999999,902902-FS1-4,The recurrence of symptoms and HYPERTENSION in a patient who has previously undergone an operation for PHAEOCHROMOCYTOMA should alert the physician to the need to investigate for recurrent tumour.,HYPERTENSION,PHAEOCHROMOCYTOMA,RO-disease_may_have_finding
502804143,7/13/2014 12:18:49,,1321856432,7/13/2014 12:18:25,instagc,0.6246,13763729,USA,,,75.182.89.225,PHAEOCHROMOCYTOMA causes HYPERTENSION,31,103,,42,119,causes,0.8944271909999999,902902-FS1-4,The recurrence of symptoms and HYPERTENSION in a patient who has previously undergone an operation for PHAEOCHROMOCYTOMA should alert the physician to the need to investigate for recurrent tumour.,HYPERTENSION,PHAEOCHROMOCYTOMA,RO-disease_may_have_finding
502804146,7/13/2014 11:06:09,,1321828290,7/13/2014 11:05:47,clixsense,0.6806,27793793,GBR,C5,Chester,151.230.27.155,THALIDOMIDE treats CUTANEOUS MANIFESTATIONS OF LUPUS ERYTHEMATOSUS,75,39,,121,49,treats,0.9701425001,907641-FS1-2,"Stevens RJ, Andujar C, Edwards CJ et alTHALIDOMIDE in the treatment of the CUTANEOUS MANIFESTATIONS OF LUPUS ERYTHEMATOSUS experience in sixteen consecutive patients.",CUTANEOUS MANIFESTATIONS OF LUPUS ERYTHEMATOSUS,THALIDOMIDE,RO-may_treat
502804146,7/13/2014 11:50:33,,1321846124,7/13/2014 11:50:19,prodege,0.5986,12944140,GBR,I4,Mitcham,92.21.66.102,THALIDOMIDE treats CUTANEOUS MANIFESTATIONS OF LUPUS ERYTHEMATOSUS,75,39,,121,49,treats,0.9701425001,907641-FS1-2,"Stevens RJ, Andujar C, Edwards CJ et alTHALIDOMIDE in the treatment of the CUTANEOUS MANIFESTATIONS OF LUPUS ERYTHEMATOSUS experience in sixteen consecutive patients.",CUTANEOUS MANIFESTATIONS OF LUPUS ERYTHEMATOSUS,THALIDOMIDE,RO-may_treat
502804146,7/13/2014 12:16:01,,1321855289,7/13/2014 12:15:33,clixsense,0.5603,27871219,NLD,07,Amsterdam,87.210.207.223,THALIDOMIDE treats CUTANEOUS MANIFESTATIONS OF LUPUS ERYTHEMATOSUS,75,39,,121,49,treats,0.9701425001,907641-FS1-2,"Stevens RJ, Andujar C, Edwards CJ et alTHALIDOMIDE in the treatment of the CUTANEOUS MANIFESTATIONS OF LUPUS ERYTHEMATOSUS experience in sixteen consecutive patients.",CUTANEOUS MANIFESTATIONS OF LUPUS ERYTHEMATOSUS,THALIDOMIDE,RO-may_treat
502804146,7/13/2014 13:05:20,,1321875374,7/13/2014 13:04:46,instagc,0.6448,23149109,USA,NC,Durham,75.189.206.205,THALIDOMIDE treats CUTANEOUS MANIFESTATIONS OF LUPUS ERYTHEMATOSUS,75,39,,121,49,treats,0.9701425001,907641-FS1-2,"Stevens RJ, Andujar C, Edwards CJ et alTHALIDOMIDE in the treatment of the CUTANEOUS MANIFESTATIONS OF LUPUS ERYTHEMATOSUS experience in sixteen consecutive patients.",CUTANEOUS MANIFESTATIONS OF LUPUS ERYTHEMATOSUS,THALIDOMIDE,RO-may_treat
502804146,7/13/2014 13:12:34,,1321878421,7/13/2014 13:11:36,instagc,0.7056,19686223,CAN,BC,Surrey,154.20.155.106,THALIDOMIDE treats CUTANEOUS MANIFESTATIONS OF LUPUS ERYTHEMATOSUS,75,39,,121,49,treats,0.9701425001,907641-FS1-2,"Stevens RJ, Andujar C, Edwards CJ et alTHALIDOMIDE in the treatment of the CUTANEOUS MANIFESTATIONS OF LUPUS ERYTHEMATOSUS experience in sixteen consecutive patients.",CUTANEOUS MANIFESTATIONS OF LUPUS ERYTHEMATOSUS,THALIDOMIDE,RO-may_treat
502804146,7/13/2014 13:16:24,,1321879908,7/13/2014 13:15:20,instagc,0.7079,21551272,GBR,Q3,Wolverhampton,2.103.57.104,THALIDOMIDE treats CUTANEOUS MANIFESTATIONS OF LUPUS ERYTHEMATOSUS,75,39,,121,49,treats,0.9701425001,907641-FS1-2,"Stevens RJ, Andujar C, Edwards CJ et alTHALIDOMIDE in the treatment of the CUTANEOUS MANIFESTATIONS OF LUPUS ERYTHEMATOSUS experience in sixteen consecutive patients.",CUTANEOUS MANIFESTATIONS OF LUPUS ERYTHEMATOSUS,THALIDOMIDE,RO-may_treat
502804146,7/13/2014 13:19:29,,1321881117,7/13/2014 13:18:59,neodev,0.6736,14861092,GBR,I2,Manchester,90.194.137.76,THALIDOMIDE treats CUTANEOUS MANIFESTATIONS OF LUPUS ERYTHEMATOSUS,75,39,,121,49,treats,0.9701425001,907641-FS1-2,"Stevens RJ, Andujar C, Edwards CJ et alTHALIDOMIDE in the treatment of the CUTANEOUS MANIFESTATIONS OF LUPUS ERYTHEMATOSUS experience in sixteen consecutive patients.",CUTANEOUS MANIFESTATIONS OF LUPUS ERYTHEMATOSUS,THALIDOMIDE,RO-may_treat
502804154,7/13/2014 11:17:37,,1321833303,7/13/2014 11:17:15,neodev,0.9167,28336203,USA,PA,Harrisburg,50.149.53.150,TUBERCULIN treats 10 (FOR M TUBERCULOSIS SPECIFIC ANTIGEN 10),34,124,,76,133,treats,0.6123724357,906978-FS1-2,"The antigen, which was named MTSA 10 (FOR M TUBERCULOSIS SPECIFIC ANTIGEN 10) is a prime candidate for a component of a new TUBERCULIN that will allow discrimination by a skin test of latent M. tuberculosis infection from vaccination with BCG or from sensitization with environmental, nontuberculous mycobacteria.",10 (FOR M TUBERCULOSIS SPECIFIC ANTIGEN 10),TUBERCULIN,RO-may_diagnose
502804154,7/13/2014 11:22:22,,1321835311,7/13/2014 11:21:36,rewardsspot,0.7222,24482174,GBR,H9,London,46.23.68.180,no_relation,34,124,,76,133,treats,0.6123724357,906978-FS1-2,"The antigen, which was named MTSA 10 (FOR M TUBERCULOSIS SPECIFIC ANTIGEN 10) is a prime candidate for a component of a new TUBERCULIN that will allow discrimination by a skin test of latent M. tuberculosis infection from vaccination with BCG or from sensitization with environmental, nontuberculous mycobacteria.",10 (FOR M TUBERCULOSIS SPECIFIC ANTIGEN 10),TUBERCULIN,RO-may_diagnose
502804154,7/13/2014 11:46:40,,1321844835,7/13/2014 11:46:03,instagc,0.6583,24252915,GBR,B7,Bristol,77.98.139.82,no_relation,34,124,,76,133,treats,0.6123724357,906978-FS1-2,"The antigen, which was named MTSA 10 (FOR M TUBERCULOSIS SPECIFIC ANTIGEN 10) is a prime candidate for a component of a new TUBERCULIN that will allow discrimination by a skin test of latent M. tuberculosis infection from vaccination with BCG or from sensitization with environmental, nontuberculous mycobacteria.",10 (FOR M TUBERCULOSIS SPECIFIC ANTIGEN 10),TUBERCULIN,RO-may_diagnose
502804154,7/13/2014 11:50:18,,1321846033,7/13/2014 11:50:11,prodege,0.5986,12944140,GBR,I4,Mitcham,92.21.66.102,no_relation,34,124,,76,133,treats,0.6123724357,906978-FS1-2,"The antigen, which was named MTSA 10 (FOR M TUBERCULOSIS SPECIFIC ANTIGEN 10) is a prime candidate for a component of a new TUBERCULIN that will allow discrimination by a skin test of latent M. tuberculosis infection from vaccination with BCG or from sensitization with environmental, nontuberculous mycobacteria.",10 (FOR M TUBERCULOSIS SPECIFIC ANTIGEN 10),TUBERCULIN,RO-may_diagnose
502804154,7/13/2014 11:57:58,,1321849003,7/13/2014 11:57:29,prodege,0.4611,28039757,GBR,L8,Southport,109.155.158.54,10 (FOR M TUBERCULOSIS SPECIFIC ANTIGEN 10) treats TUBERCULIN,34,124,,76,133,treats,0.6123724357,906978-FS1-2,"The antigen, which was named MTSA 10 (FOR M TUBERCULOSIS SPECIFIC ANTIGEN 10) is a prime candidate for a component of a new TUBERCULIN that will allow discrimination by a skin test of latent M. tuberculosis infection from vaccination with BCG or from sensitization with environmental, nontuberculous mycobacteria.",10 (FOR M TUBERCULOSIS SPECIFIC ANTIGEN 10),TUBERCULIN,RO-may_diagnose
502804154,7/13/2014 12:06:57,,1321852274,7/13/2014 12:06:18,vivatic,0.5236,25451531,GBR,,,83.67.28.193,no_relation,34,124,,76,133,treats,0.6123724357,906978-FS1-2,"The antigen, which was named MTSA 10 (FOR M TUBERCULOSIS SPECIFIC ANTIGEN 10) is a prime candidate for a component of a new TUBERCULIN that will allow discrimination by a skin test of latent M. tuberculosis infection from vaccination with BCG or from sensitization with environmental, nontuberculous mycobacteria.",10 (FOR M TUBERCULOSIS SPECIFIC ANTIGEN 10),TUBERCULIN,RO-may_diagnose
502804154,7/13/2014 13:19:04,,1321880957,7/13/2014 13:18:28,instagc,0.7079,21551272,GBR,Q3,Wolverhampton,2.103.57.104,no_relation,34,124,,76,133,treats,0.6123724357,906978-FS1-2,"The antigen, which was named MTSA 10 (FOR M TUBERCULOSIS SPECIFIC ANTIGEN 10) is a prime candidate for a component of a new TUBERCULIN that will allow discrimination by a skin test of latent M. tuberculosis infection from vaccination with BCG or from sensitization with environmental, nontuberculous mycobacteria.",10 (FOR M TUBERCULOSIS SPECIFIC ANTIGEN 10),TUBERCULIN,RO-may_diagnose
718228466,5/10/2015 11:59:26,1633619560,5/10/2015 11:58:52,False,prodege,1.0,21417560,GBR,C3,Cambridge,151.225.116.143,INFLUENZA VIRUS causes PANDEMIC INFLUENZA,51,110,,1,68,causes,0.913811548620257,811845-FS1-4,51  Pandemic Influenza  Treatment or prevention of PANDEMIC INFLUENZA   +    caused by susceptible strains of INFLUENZA VIRUS,PANDEMIC INFLUENZA,INFLUENZA VIRUS,TWrex-cause
718228466,5/10/2015 12:13:03,1633622437,5/10/2015 12:12:38,False,meprizescf,0.6014,28483210,USA,WI,Minocqua,75.143.134.247,INFLUENZA VIRUS causes PANDEMIC INFLUENZA,51,110,,1,68,causes,0.913811548620257,811845-FS1-4,51  Pandemic Influenza  Treatment or prevention of PANDEMIC INFLUENZA   +    caused by susceptible strains of INFLUENZA VIRUS,PANDEMIC INFLUENZA,INFLUENZA VIRUS,TWrex-cause
718228466,5/10/2015 12:13:58,1633622560,5/10/2015 12:13:46,False,clixsense,0.5639,28457001,CAN,ON,North Bay,24.204.202.220,INFLUENZA VIRUS causes PANDEMIC INFLUENZA,51,110,,1,68,causes,0.913811548620257,811845-FS1-4,51  Pandemic Influenza  Treatment or prevention of PANDEMIC INFLUENZA   +    caused by susceptible strains of INFLUENZA VIRUS,PANDEMIC INFLUENZA,INFLUENZA VIRUS,TWrex-cause
718228466,5/10/2015 12:16:14,1633623016,5/10/2015 12:15:32,False,instagc,0.6708,18531561,CAN,ON,Mississauga,99.229.92.227,INFLUENZA VIRUS causes PANDEMIC INFLUENZA,51,110,,1,68,causes,0.913811548620257,811845-FS1-4,51  Pandemic Influenza  Treatment or prevention of PANDEMIC INFLUENZA   +    caused by susceptible strains of INFLUENZA VIRUS,PANDEMIC INFLUENZA,INFLUENZA VIRUS,TWrex-cause
718228466,5/10/2015 12:17:14,1633623279,5/10/2015 12:16:47,False,clixsense,0.5944,19638651,USA,SC,Summerville,174.107.73.211,INFLUENZA VIRUS causes PANDEMIC INFLUENZA,51,110,,1,68,causes,0.913811548620257,811845-FS1-4,51  Pandemic Influenza  Treatment or prevention of PANDEMIC INFLUENZA   +    caused by susceptible strains of INFLUENZA VIRUS,PANDEMIC INFLUENZA,INFLUENZA VIRUS,TWrex-cause
718228466,5/10/2015 12:29:50,1633626241,5/10/2015 12:29:19,False,points4rewards,0.6171,20113482,USA,OR,Portland,67.213.218.72,INFLUENZA VIRUS causes PANDEMIC INFLUENZA,51,110,,1,68,causes,0.913811548620257,811845-FS1-4,51  Pandemic Influenza  Treatment or prevention of PANDEMIC INFLUENZA   +    caused by susceptible strains of INFLUENZA VIRUS,PANDEMIC INFLUENZA,INFLUENZA VIRUS,TWrex-cause
718228466,5/10/2015 12:31:10,1633626587,5/10/2015 12:30:55,False,inboxpounds,0.9,30211697,GBR,B7,Bristol,90.222.102.171,no_relation,51,110,,1,68,causes,0.913811548620257,811845-FS1-4,51  Pandemic Influenza  Treatment or prevention of PANDEMIC INFLUENZA   +    caused by susceptible strains of INFLUENZA VIRUS,PANDEMIC INFLUENZA,INFLUENZA VIRUS,TWrex-cause
718228472,5/10/2015 11:58:51,1633619463,5/10/2015 11:58:17,False,prodege,1.0,21417560,GBR,C3,Cambridge,151.225.116.143,no_relation,131,76,,-1,142,causes,0.557086014531156,803039-FS1-4,This finding could have serious implications for using the test to diagnose LATENT TB in populations where empirical treatment for TUBERCULOSIS is widespread.,TUBERCULOSIS,LATENT TB,TWrex-cause
718228472,5/10/2015 12:05:39,1633620918,5/10/2015 12:05:29,False,gifthunterclub,0.55,31241093,GBR,L9,Sheffield,90.217.213.219,LATENT TB causes TUBERCULOSIS,131,76,,-1,142,causes,0.557086014531156,803039-FS1-4,This finding could have serious implications for using the test to diagnose LATENT TB in populations where empirical treatment for TUBERCULOSIS is widespread.,TUBERCULOSIS,LATENT TB,TWrex-cause
718228472,5/10/2015 12:12:37,1633622324,5/10/2015 12:12:21,False,meprizescf,0.6014,28483210,USA,WI,Minocqua,75.143.134.247,no_relation,131,76,,-1,142,causes,0.557086014531156,803039-FS1-4,This finding could have serious implications for using the test to diagnose LATENT TB in populations where empirical treatment for TUBERCULOSIS is widespread.,TUBERCULOSIS,LATENT TB,TWrex-cause
718228472,5/10/2015 12:13:45,1633622519,5/10/2015 12:13:32,False,clixsense,0.5639,28457001,CAN,ON,North Bay,24.204.202.220,no_relation,131,76,,-1,142,causes,0.557086014531156,803039-FS1-4,This finding could have serious implications for using the test to diagnose LATENT TB in populations where empirical treatment for TUBERCULOSIS is widespread.,TUBERCULOSIS,LATENT TB,TWrex-cause
718228472,5/10/2015 12:15:31,1633622904,5/10/2015 12:14:50,False,instagc,0.6708,18531561,CAN,ON,Mississauga,99.229.92.227,no_relation,131,76,,-1,142,causes,0.557086014531156,803039-FS1-4,This finding could have serious implications for using the test to diagnose LATENT TB in populations where empirical treatment for TUBERCULOSIS is widespread.,TUBERCULOSIS,LATENT TB,TWrex-cause
718228472,5/10/2015 12:16:46,1633623139,5/10/2015 12:16:27,False,clixsense,0.5944,19638651,USA,SC,Summerville,174.107.73.211,no_relation,131,76,,-1,142,causes,0.557086014531156,803039-FS1-4,This finding could have serious implications for using the test to diagnose LATENT TB in populations where empirical treatment for TUBERCULOSIS is widespread.,TUBERCULOSIS,LATENT TB,TWrex-cause
718228472,5/10/2015 12:29:13,1633626158,5/10/2015 12:28:22,False,points4rewards,0.6171,20113482,USA,OR,Portland,67.213.218.72,no_relation,131,76,,-1,142,causes,0.557086014531156,803039-FS1-4,This finding could have serious implications for using the test to diagnose LATENT TB in populations where empirical treatment for TUBERCULOSIS is widespread.,TUBERCULOSIS,LATENT TB,TWrex-cause
718228473,5/10/2015 13:32:41,1633642120,5/10/2015 13:32:30,False,elite,0.8690000000000001,31883685,GBR,H2,Accrington,80.47.186.28,NF2 causes HEARING LOSS,49,36,,1,60,causes,0.9,813511-FS1-4,"edit] Management of Hearing Loss in NF2  Because HEARING LOSS in those with NF2 almost always occurs after acquisition of verbal language skills, patients do not always integrate well into the Deaf culture and are more likely to resort to auditory assistive technology.",HEARING LOSS,NF2,TWrex-cause
718228473,5/10/2015 13:58:53,1633648824,5/10/2015 13:58:23,False,sharecashgpt,0.75,28627999,CAN,ON,Sudbury,66.103.55.12,NF2 causes HEARING LOSS,49,36,,1,60,causes,0.9,813511-FS1-4,"edit] Management of Hearing Loss in NF2  Because HEARING LOSS in those with NF2 almost always occurs after acquisition of verbal language skills, patients do not always integrate well into the Deaf culture and are more likely to resort to auditory assistive technology.",HEARING LOSS,NF2,TWrex-cause
718228473,5/10/2015 14:14:46,1633652977,5/10/2015 14:13:57,False,instagc,0.625,31184650,USA,IA,Mason City,173.26.27.82,no_relation,49,36,,1,60,causes,0.9,813511-FS1-4,"edit] Management of Hearing Loss in NF2  Because HEARING LOSS in those with NF2 almost always occurs after acquisition of verbal language skills, patients do not always integrate well into the Deaf culture and are more likely to resort to auditory assistive technology.",HEARING LOSS,NF2,TWrex-cause
718228473,5/10/2015 14:15:26,1633653174,5/10/2015 14:14:59,False,prodege,0.5,4853734,CAN,ON,Milton,108.170.128.226,no_relation,49,36,,1,60,causes,0.9,813511-FS1-4,"edit] Management of Hearing Loss in NF2  Because HEARING LOSS in those with NF2 almost always occurs after acquisition of verbal language skills, patients do not always integrate well into the Deaf culture and are more likely to resort to auditory assistive technology.",HEARING LOSS,NF2,TWrex-cause
718228473,5/10/2015 14:25:33,1633655898,5/10/2015 14:24:46,False,clixsense,0.5327,10798016,GBR,C7,Coventry,86.24.245.191,no_relation,49,36,,1,60,causes,0.9,813511-FS1-4,"edit] Management of Hearing Loss in NF2  Because HEARING LOSS in those with NF2 almost always occurs after acquisition of verbal language skills, patients do not always integrate well into the Deaf culture and are more likely to resort to auditory assistive technology.",HEARING LOSS,NF2,TWrex-cause
718228473,5/10/2015 14:37:35,1633659020,5/10/2015 14:37:13,False,neodev,0.3542,32103286,CAN,AB,Edmonton,208.123.223.44,NF2 causes HEARING LOSS,49,36,,1,60,causes,0.9,813511-FS1-4,"edit] Management of Hearing Loss in NF2  Because HEARING LOSS in those with NF2 almost always occurs after acquisition of verbal language skills, patients do not always integrate well into the Deaf culture and are more likely to resort to auditory assistive technology.",HEARING LOSS,NF2,TWrex-cause
718228473,5/10/2015 14:58:17,1633664383,5/10/2015 14:57:29,False,neodev,0.6022,24564999,GBR,H9,London,86.145.227.9,NF2 causes HEARING LOSS,49,36,,1,60,causes,0.9,813511-FS1-4,"edit] Management of Hearing Loss in NF2  Because HEARING LOSS in those with NF2 almost always occurs after acquisition of verbal language skills, patients do not always integrate well into the Deaf culture and are more likely to resort to auditory assistive technology.",HEARING LOSS,NF2,TWrex-cause
718228476,5/10/2015 15:00:45,1633664970,5/10/2015 15:00:24,False,neodev,0.6022,24564999,GBR,H9,London,86.145.227.9,no_relation,0,39,,-1,17,causes,0.9237604307034009,803045-FS1-4,DIABETES INSIPIDUS may develop if less VASOPRESSIN is released because the hypothalamus is compressed.,DIABETES INSIPIDUS,VASOPRESSIN,TWrex-cause
718228476,5/10/2015 15:06:25,1633666565,5/10/2015 15:05:56,False,neodev,0.7119,14096345,NLD,03,Eibergen,77.174.124.109,VASOPRESSIN causes DIABETES INSIPIDUS,0,39,,-1,17,causes,0.9237604307034009,803045-FS1-4,DIABETES INSIPIDUS may develop if less VASOPRESSIN is released because the hypothalamus is compressed.,DIABETES INSIPIDUS,VASOPRESSIN,TWrex-cause
718228476,5/10/2015 15:26:14,1633671804,5/10/2015 15:25:58,False,clixsense,0.7052,9343409,NLD,03,Hattem,77.171.50.249,VASOPRESSIN causes DIABETES INSIPIDUS,0,39,,-1,17,causes,0.9237604307034009,803045-FS1-4,DIABETES INSIPIDUS may develop if less VASOPRESSIN is released because the hypothalamus is compressed.,DIABETES INSIPIDUS,VASOPRESSIN,TWrex-cause
718228476,5/10/2015 15:45:24,1633676876,5/10/2015 15:45:00,False,prodege,0.7608,13300986,CAN,AB,Edmonton,68.150.40.134,no_relation,0,39,,-1,17,causes,0.9237604307034009,803045-FS1-4,DIABETES INSIPIDUS may develop if less VASOPRESSIN is released because the hypothalamus is compressed.,DIABETES INSIPIDUS,VASOPRESSIN,TWrex-cause
718228476,5/10/2015 15:49:29,1633677908,5/10/2015 15:49:04,False,gifthulk,0.6799,18666417,USA,PA,Meadville,24.101.97.237,DIABETES INSIPIDUS causes VASOPRESSIN,0,39,,-1,17,causes,0.9237604307034009,803045-FS1-4,DIABETES INSIPIDUS may develop if less VASOPRESSIN is released because the hypothalamus is compressed.,DIABETES INSIPIDUS,VASOPRESSIN,TWrex-cause
718228476,5/10/2015 15:58:19,1633680011,5/10/2015 15:58:03,False,prodege,0.8214,24403612,CAN,ON,Ajax,99.239.181.149,no_relation,0,39,,-1,17,causes,0.9237604307034009,803045-FS1-4,DIABETES INSIPIDUS may develop if less VASOPRESSIN is released because the hypothalamus is compressed.,DIABETES INSIPIDUS,VASOPRESSIN,TWrex-cause
718228476,5/10/2015 16:02:37,1633681116,5/10/2015 16:01:46,False,neodev,0.6667,11029325,CAN,QC,Vaudreuil,70.80.60.146,no_relation,0,39,,-1,17,causes,0.9237604307034009,803045-FS1-4,DIABETES INSIPIDUS may develop if less VASOPRESSIN is released because the hypothalamus is compressed.,DIABETES INSIPIDUS,VASOPRESSIN,TWrex-cause
718228483,5/10/2015 12:41:09,1633628954,5/10/2015 12:40:39,False,prodege,0.75,16101132,GBR,F9,Hayes,2.223.214.149,no_relation,296,122,,1,308,causes,0.8427009716003839,814738-FS1-4,"175 ,   176 ,   177 ,   178 ,   179 ,   187 ,   188    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cefixime, and may range in severity from MILD DIARRHEA to fatal colitis.",MILD DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA,TWrex-cause
718228483,5/10/2015 12:59:52,1633633715,5/10/2015 12:59:21,False,instagc,0.6667,13581319,USA,IL,Mount Vernon,66.232.166.86,ANTIBIOTIC ASSOCIATED DIARRHEA causes MILD DIARRHEA,296,122,,1,308,causes,0.8427009716003839,814738-FS1-4,"175 ,   176 ,   177 ,   178 ,   179 ,   187 ,   188    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cefixime, and may range in severity from MILD DIARRHEA to fatal colitis.",MILD DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA,TWrex-cause
718228483,5/10/2015 13:03:32,1633634643,5/10/2015 13:03:04,False,instagc,0.5958,32352104,USA,ME,Bangor,74.75.63.81,ANTIBIOTIC ASSOCIATED DIARRHEA causes MILD DIARRHEA,296,122,,1,308,causes,0.8427009716003839,814738-FS1-4,"175 ,   176 ,   177 ,   178 ,   179 ,   187 ,   188    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cefixime, and may range in severity from MILD DIARRHEA to fatal colitis.",MILD DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA,TWrex-cause
718228483,5/10/2015 13:07:55,1633635819,5/10/2015 13:07:04,False,clixsense,0.6639,11106820,USA,MA,Taunton,173.48.52.95,ANTIBIOTIC ASSOCIATED DIARRHEA causes MILD DIARRHEA,296,122,,1,308,causes,0.8427009716003839,814738-FS1-4,"175 ,   176 ,   177 ,   178 ,   179 ,   187 ,   188    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cefixime, and may range in severity from MILD DIARRHEA to fatal colitis.",MILD DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA,TWrex-cause
718228483,5/10/2015 13:21:49,1633639300,5/10/2015 13:21:03,False,points4rewards,0.6476,28755767,USA,VA,Chester,68.57.118.32,no_relation,296,122,,1,308,causes,0.8427009716003839,814738-FS1-4,"175 ,   176 ,   177 ,   178 ,   179 ,   187 ,   188    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cefixime, and may range in severity from MILD DIARRHEA to fatal colitis.",MILD DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA,TWrex-cause
718228483,5/10/2015 13:30:50,1633641544,5/10/2015 13:30:34,False,elite,0.8690000000000001,31883685,GBR,H2,Accrington,80.47.186.28,no_relation,296,122,,1,308,causes,0.8427009716003839,814738-FS1-4,"175 ,   176 ,   177 ,   178 ,   179 ,   187 ,   188    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cefixime, and may range in severity from MILD DIARRHEA to fatal colitis.",MILD DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA,TWrex-cause
718228483,5/10/2015 13:32:03,1633641933,5/10/2015 13:31:55,False,neodev,0.6667,31743852,GBR,G5,Margate,85.210.112.40,ANTIBIOTIC ASSOCIATED DIARRHEA causes MILD DIARRHEA,296,122,,1,308,causes,0.8427009716003839,814738-FS1-4,"175 ,   176 ,   177 ,   178 ,   179 ,   187 ,   188    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cefixime, and may range in severity from MILD DIARRHEA to fatal colitis.",MILD DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA,TWrex-cause
718228485,5/10/2015 15:27:09,1633672023,5/10/2015 15:26:41,False,clixsense,0.7052,9343409,NLD,03,Hattem,77.171.50.249,BACTERIA causes INFECTIVE ENDOCARDITIS,206,308,,1,227,causes,0.9950371902099889,810737-FS1-4,"Abstract  November 2010  7 Infectious Disease  XVIII Infective Endocarditis  ELIZABETH G. NABEL, MD, FACP President, Brigham and Women's Hospital, Professor of Medicine, Harvard Medical School, Boston, MA  INFECTIVE ENDOCARDITIS is a microbial infection of a cardiac valve or the mural endocardium caused by BACTERIA or fungi.",INFECTIVE ENDOCARDITIS,BACTERIA,TWrex-cause
718228485,5/10/2015 15:46:07,1633677087,5/10/2015 15:45:40,False,prodege,0.7608,13300986,CAN,AB,Edmonton,68.150.40.134,BACTERIA causes INFECTIVE ENDOCARDITIS,206,308,,1,227,causes,0.9950371902099889,810737-FS1-4,"Abstract  November 2010  7 Infectious Disease  XVIII Infective Endocarditis  ELIZABETH G. NABEL, MD, FACP President, Brigham and Women's Hospital, Professor of Medicine, Harvard Medical School, Boston, MA  INFECTIVE ENDOCARDITIS is a microbial infection of a cardiac valve or the mural endocardium caused by BACTERIA or fungi.",INFECTIVE ENDOCARDITIS,BACTERIA,TWrex-cause
718228485,5/10/2015 15:50:44,1633678140,5/10/2015 15:50:12,False,gifthulk,0.6799,18666417,USA,PA,Meadville,24.101.97.237,BACTERIA causes INFECTIVE ENDOCARDITIS,206,308,,1,227,causes,0.9950371902099889,810737-FS1-4,"Abstract  November 2010  7 Infectious Disease  XVIII Infective Endocarditis  ELIZABETH G. NABEL, MD, FACP President, Brigham and Women's Hospital, Professor of Medicine, Harvard Medical School, Boston, MA  INFECTIVE ENDOCARDITIS is a microbial infection of a cardiac valve or the mural endocardium caused by BACTERIA or fungi.",INFECTIVE ENDOCARDITIS,BACTERIA,TWrex-cause
718228485,5/10/2015 15:59:23,1633680331,5/10/2015 15:58:39,False,prodege,0.8214,24403612,CAN,ON,Ajax,99.239.181.149,BACTERIA causes INFECTIVE ENDOCARDITIS,206,308,,1,227,causes,0.9950371902099889,810737-FS1-4,"Abstract  November 2010  7 Infectious Disease  XVIII Infective Endocarditis  ELIZABETH G. NABEL, MD, FACP President, Brigham and Women's Hospital, Professor of Medicine, Harvard Medical School, Boston, MA  INFECTIVE ENDOCARDITIS is a microbial infection of a cardiac valve or the mural endocardium caused by BACTERIA or fungi.",INFECTIVE ENDOCARDITIS,BACTERIA,TWrex-cause
718228485,5/10/2015 16:04:49,1633681757,5/10/2015 16:04:28,False,prodege,0.91,29849805,GBR,Z1,Swansea,82.1.37.235,BACTERIA causes INFECTIVE ENDOCARDITIS,206,308,,1,227,causes,0.9950371902099889,810737-FS1-4,"Abstract  November 2010  7 Infectious Disease  XVIII Infective Endocarditis  ELIZABETH G. NABEL, MD, FACP President, Brigham and Women's Hospital, Professor of Medicine, Harvard Medical School, Boston, MA  INFECTIVE ENDOCARDITIS is a microbial infection of a cardiac valve or the mural endocardium caused by BACTERIA or fungi.",INFECTIVE ENDOCARDITIS,BACTERIA,TWrex-cause
718228485,5/10/2015 16:12:02,1633683486,5/10/2015 16:11:31,False,clixsense,0.3171,17950689,GBR,Y9,Porth,217.43.32.119,INFECTIVE ENDOCARDITIS causes BACTERIA,206,308,,1,227,causes,0.9950371902099889,810737-FS1-4,"Abstract  November 2010  7 Infectious Disease  XVIII Infective Endocarditis  ELIZABETH G. NABEL, MD, FACP President, Brigham and Women's Hospital, Professor of Medicine, Harvard Medical School, Boston, MA  INFECTIVE ENDOCARDITIS is a microbial infection of a cardiac valve or the mural endocardium caused by BACTERIA or fungi.",INFECTIVE ENDOCARDITIS,BACTERIA,TWrex-cause
718228485,5/10/2015 16:12:27,1633683614,5/10/2015 16:11:50,False,memolink,0.4841,6587538,CAN,ON,Toronto,65.95.204.180,BACTERIA causes INFECTIVE ENDOCARDITIS,206,308,,1,227,causes,0.9950371902099889,810737-FS1-4,"Abstract  November 2010  7 Infectious Disease  XVIII Infective Endocarditis  ELIZABETH G. NABEL, MD, FACP President, Brigham and Women's Hospital, Professor of Medicine, Harvard Medical School, Boston, MA  INFECTIVE ENDOCARDITIS is a microbial infection of a cardiac valve or the mural endocardium caused by BACTERIA or fungi.",INFECTIVE ENDOCARDITIS,BACTERIA,TWrex-cause
718228497,5/10/2015 15:00:45,1633664971,5/10/2015 15:00:24,False,neodev,0.6022,24564999,GBR,H9,London,86.145.227.9,COCAINE causes COCAINE ADDICTION,0,0,,1,16,causes,0.668153104781061,811998-FS1-4,"COCAINE ADDICTION continues to be the most difficult to manage behind heroin, and according to some scientists, addiction to COCAINE may be almost impossible to stop.",COCAINE ADDICTION,COCAINE,TWrex-cause
718228497,5/10/2015 15:06:25,1633666564,5/10/2015 15:05:56,False,neodev,0.7119,14096345,NLD,03,Eibergen,77.174.124.109,COCAINE causes COCAINE ADDICTION,0,0,,1,16,causes,0.668153104781061,811998-FS1-4,"COCAINE ADDICTION continues to be the most difficult to manage behind heroin, and according to some scientists, addiction to COCAINE may be almost impossible to stop.",COCAINE ADDICTION,COCAINE,TWrex-cause
718228497,5/10/2015 15:26:14,1633671806,5/10/2015 15:25:58,False,clixsense,0.7052,9343409,NLD,03,Hattem,77.171.50.249,COCAINE causes COCAINE ADDICTION,0,0,,1,16,causes,0.668153104781061,811998-FS1-4,"COCAINE ADDICTION continues to be the most difficult to manage behind heroin, and according to some scientists, addiction to COCAINE may be almost impossible to stop.",COCAINE ADDICTION,COCAINE,TWrex-cause
718228497,5/10/2015 15:45:24,1633676875,5/10/2015 15:45:00,False,prodege,0.7608,13300986,CAN,AB,Edmonton,68.150.40.134,no_relation,0,0,,1,16,causes,0.668153104781061,811998-FS1-4,"COCAINE ADDICTION continues to be the most difficult to manage behind heroin, and according to some scientists, addiction to COCAINE may be almost impossible to stop.",COCAINE ADDICTION,COCAINE,TWrex-cause
718228497,5/10/2015 15:49:29,1633677910,5/10/2015 15:49:04,False,gifthulk,0.6799,18666417,USA,PA,Meadville,24.101.97.237,COCAINE causes COCAINE ADDICTION,0,0,,1,16,causes,0.668153104781061,811998-FS1-4,"COCAINE ADDICTION continues to be the most difficult to manage behind heroin, and according to some scientists, addiction to COCAINE may be almost impossible to stop.",COCAINE ADDICTION,COCAINE,TWrex-cause
718228497,5/10/2015 15:58:19,1633680010,5/10/2015 15:58:03,False,prodege,0.8214,24403612,CAN,ON,Ajax,99.239.181.149,COCAINE causes COCAINE ADDICTION,0,0,,1,16,causes,0.668153104781061,811998-FS1-4,"COCAINE ADDICTION continues to be the most difficult to manage behind heroin, and according to some scientists, addiction to COCAINE may be almost impossible to stop.",COCAINE ADDICTION,COCAINE,TWrex-cause
718228497,5/10/2015 16:02:37,1633681128,5/10/2015 16:01:46,False,neodev,0.6667,11029325,CAN,QC,Vaudreuil,70.80.60.146,COCAINE causes COCAINE ADDICTION,0,0,,1,16,causes,0.668153104781061,811998-FS1-4,"COCAINE ADDICTION continues to be the most difficult to manage behind heroin, and according to some scientists, addiction to COCAINE may be almost impossible to stop.",COCAINE ADDICTION,COCAINE,TWrex-cause
718434601,5/11/2015 10:14:54,1634004761,5/11/2015 10:14:34,False,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,BELL'S PALSY causes ACUTE FACIAL NERVE PARALYSIS,89,48,,1,116,causes,1.0,813382-FS1-4,edit] Infranuclear lesions [edit] Bell's palsy  BELL'S PALSY is the most common cause of ACUTE FACIAL NERVE PARALYSIS,ACUTE FACIAL NERVE PARALYSIS,BELL'S PALSY,TWrex-cause
718434601,5/11/2015 10:17:02,1634005409,5/11/2015 10:16:21,False,points4rewards,0.625,20113482,USA,OR,Portland,67.213.218.72,BELL'S PALSY causes ACUTE FACIAL NERVE PARALYSIS,89,48,,1,116,causes,1.0,813382-FS1-4,edit] Infranuclear lesions [edit] Bell's palsy  BELL'S PALSY is the most common cause of ACUTE FACIAL NERVE PARALYSIS,ACUTE FACIAL NERVE PARALYSIS,BELL'S PALSY,TWrex-cause
718434601,5/11/2015 10:23:13,1634007059,5/11/2015 10:22:53,False,instagc,0.7222,18531561,CAN,ON,Mississauga,99.229.92.227,BELL'S PALSY causes ACUTE FACIAL NERVE PARALYSIS,89,48,,1,116,causes,1.0,813382-FS1-4,edit] Infranuclear lesions [edit] Bell's palsy  BELL'S PALSY is the most common cause of ACUTE FACIAL NERVE PARALYSIS,ACUTE FACIAL NERVE PARALYSIS,BELL'S PALSY,TWrex-cause
718434601,5/11/2015 10:37:21,1634011174,5/11/2015 10:36:45,False,meprizescf,0.4792,28483210,USA,WI,Minocqua,75.143.134.247,BELL'S PALSY causes ACUTE FACIAL NERVE PARALYSIS,89,48,,1,116,causes,1.0,813382-FS1-4,edit] Infranuclear lesions [edit] Bell's palsy  BELL'S PALSY is the most common cause of ACUTE FACIAL NERVE PARALYSIS,ACUTE FACIAL NERVE PARALYSIS,BELL'S PALSY,TWrex-cause
718434601,5/11/2015 10:40:01,1634011782,5/11/2015 10:39:24,False,superrewards,0.6167,31767535,GBR,V2,Glasgow,94.9.182.127,BELL'S PALSY causes ACUTE FACIAL NERVE PARALYSIS,89,48,,1,116,causes,1.0,813382-FS1-4,edit] Infranuclear lesions [edit] Bell's palsy  BELL'S PALSY is the most common cause of ACUTE FACIAL NERVE PARALYSIS,ACUTE FACIAL NERVE PARALYSIS,BELL'S PALSY,TWrex-cause
718434601,5/11/2015 10:50:27,1634014453,5/11/2015 10:49:36,False,clixsense,0.6389,6338946,CAN,QC,Montréal,209.197.170.96,BELL'S PALSY causes ACUTE FACIAL NERVE PARALYSIS,89,48,,1,116,causes,1.0,813382-FS1-4,edit] Infranuclear lesions [edit] Bell's palsy  BELL'S PALSY is the most common cause of ACUTE FACIAL NERVE PARALYSIS,ACUTE FACIAL NERVE PARALYSIS,BELL'S PALSY,TWrex-cause
718434601,5/11/2015 11:00:46,1634017044,5/11/2015 11:00:25,False,elite,0.6071,31883685,GBR,H2,Accrington,80.47.186.28,BELL'S PALSY causes ACUTE FACIAL NERVE PARALYSIS,89,48,,1,116,causes,1.0,813382-FS1-4,edit] Infranuclear lesions [edit] Bell's palsy  BELL'S PALSY is the most common cause of ACUTE FACIAL NERVE PARALYSIS,ACUTE FACIAL NERVE PARALYSIS,BELL'S PALSY,TWrex-cause
718434625,5/11/2015 11:48:21,1634028616,5/11/2015 11:47:48,False,neodev,0.7619,20961587,NLD,05,Maastricht,84.26.48.136,ASBESTOS FIBERS causes ASBESTOSIS,56,116,,1,65,causes,0.981980506061966,811665-FS1-4,Rationale: • Epidemiologic studies clearly suggest that ASBESTOSIS develops after significant and heavy exposure to ASBESTOS FIBERS,ASBESTOSIS,ASBESTOS FIBERS,TWrex-cause
718434625,5/11/2015 12:01:56,1634032141,5/11/2015 12:01:37,False,prodege,1.0,29686407,GBR,E4,Billericay,109.153.202.28,ASBESTOS FIBERS causes ASBESTOSIS,56,116,,1,65,causes,0.981980506061966,811665-FS1-4,Rationale: • Epidemiologic studies clearly suggest that ASBESTOSIS develops after significant and heavy exposure to ASBESTOS FIBERS,ASBESTOSIS,ASBESTOS FIBERS,TWrex-cause
718434625,5/11/2015 12:20:23,1634037630,5/11/2015 12:19:56,False,points4rewards,0.8125,28755767,USA,VA,Chester,68.57.118.32,ASBESTOS FIBERS causes ASBESTOSIS,56,116,,1,65,causes,0.981980506061966,811665-FS1-4,Rationale: • Epidemiologic studies clearly suggest that ASBESTOSIS develops after significant and heavy exposure to ASBESTOS FIBERS,ASBESTOSIS,ASBESTOS FIBERS,TWrex-cause
718434625,5/11/2015 12:20:33,1634037673,5/11/2015 12:19:57,False,instagc,0.8542,18960682,GBR,C9,Carlisle,92.18.171.231,ASBESTOS FIBERS causes ASBESTOSIS,56,116,,1,65,causes,0.981980506061966,811665-FS1-4,Rationale: • Epidemiologic studies clearly suggest that ASBESTOSIS develops after significant and heavy exposure to ASBESTOS FIBERS,ASBESTOSIS,ASBESTOS FIBERS,TWrex-cause
718434625,5/11/2015 12:24:10,1634038776,5/11/2015 12:23:42,False,clixsense,0.7556,21933552,CAN,ON,Ottawa,70.49.14.161,ASBESTOS FIBERS causes ASBESTOSIS,56,116,,1,65,causes,0.981980506061966,811665-FS1-4,Rationale: • Epidemiologic studies clearly suggest that ASBESTOSIS develops after significant and heavy exposure to ASBESTOS FIBERS,ASBESTOSIS,ASBESTOS FIBERS,TWrex-cause
718434625,5/11/2015 12:31:35,1634041055,5/11/2015 12:31:24,False,clixsense,0.7768,8888883,USA,,,73.21.180.112,ASBESTOS FIBERS causes ASBESTOSIS,56,116,,1,65,causes,0.981980506061966,811665-FS1-4,Rationale: • Epidemiologic studies clearly suggest that ASBESTOSIS develops after significant and heavy exposure to ASBESTOS FIBERS,ASBESTOSIS,ASBESTOS FIBERS,TWrex-cause
718434625,5/11/2015 12:33:45,1634042000,5/11/2015 12:33:17,False,neodev,0.4971,32124234,USA,DE,,108.59.8.218,ASBESTOS FIBERS causes ASBESTOSIS,56,116,,1,65,causes,0.981980506061966,811665-FS1-4,Rationale: • Epidemiologic studies clearly suggest that ASBESTOSIS develops after significant and heavy exposure to ASBESTOS FIBERS,ASBESTOSIS,ASBESTOS FIBERS,TWrex-cause
718434628,5/11/2015 12:46:16,1634046121,5/11/2015 12:46:00,False,prodege,0.7646,22031444,GBR,K6,Portsmouth,89.240.160.95,RAT TAILED MAGGOT ( E causes INTESTINAL MYIASIS,59,18,,1,76,causes,1.0,811199-FS1-4,"The larva, called RAT TAILED MAGGOT ( E tenax ), may cause INTESTINAL MYIASIS in humans.",INTESTINAL MYIASIS,RAT TAILED MAGGOT ( E,TWrex-cause
718434628,5/11/2015 12:46:35,1634046182,5/11/2015 12:46:26,False,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,RAT TAILED MAGGOT ( E causes INTESTINAL MYIASIS,59,18,,1,76,causes,1.0,811199-FS1-4,"The larva, called RAT TAILED MAGGOT ( E tenax ), may cause INTESTINAL MYIASIS in humans.",INTESTINAL MYIASIS,RAT TAILED MAGGOT ( E,TWrex-cause
718434628,5/11/2015 12:47:50,1634046585,5/11/2015 12:47:31,False,clixsense,1.0,30130805,USA,MI,Wyandotte,63.141.31.35,RAT TAILED MAGGOT ( E causes INTESTINAL MYIASIS,59,18,,1,76,causes,1.0,811199-FS1-4,"The larva, called RAT TAILED MAGGOT ( E tenax ), may cause INTESTINAL MYIASIS in humans.",INTESTINAL MYIASIS,RAT TAILED MAGGOT ( E,TWrex-cause
718434628,5/11/2015 12:48:11,1634046728,5/11/2015 12:47:56,False,clixsense,0.6971,28351359,GBR,F6,Upminster,80.43.233.94,RAT TAILED MAGGOT ( E causes INTESTINAL MYIASIS,59,18,,1,76,causes,1.0,811199-FS1-4,"The larva, called RAT TAILED MAGGOT ( E tenax ), may cause INTESTINAL MYIASIS in humans.",INTESTINAL MYIASIS,RAT TAILED MAGGOT ( E,TWrex-cause
718434628,5/11/2015 12:50:08,1634047311,5/11/2015 12:49:54,False,elite,0.7809999999999999,29768955,GBR,,,213.152.52.145,RAT TAILED MAGGOT ( E causes INTESTINAL MYIASIS,59,18,,1,76,causes,1.0,811199-FS1-4,"The larva, called RAT TAILED MAGGOT ( E tenax ), may cause INTESTINAL MYIASIS in humans.",INTESTINAL MYIASIS,RAT TAILED MAGGOT ( E,TWrex-cause
718434628,5/11/2015 12:53:31,1634048295,5/11/2015 12:53:09,False,elite,0.4286,31913360,USA,DE,Wilmington,199.115.115.214,RAT TAILED MAGGOT ( E causes INTESTINAL MYIASIS,59,18,,1,76,causes,1.0,811199-FS1-4,"The larva, called RAT TAILED MAGGOT ( E tenax ), may cause INTESTINAL MYIASIS in humans.",INTESTINAL MYIASIS,RAT TAILED MAGGOT ( E,TWrex-cause
718434628,5/11/2015 13:03:36,1634051516,5/11/2015 13:02:46,False,elite,1.0,32732290,GBR,A7,Birmingham,80.249.56.149,RAT TAILED MAGGOT ( E causes INTESTINAL MYIASIS,59,18,,1,76,causes,1.0,811199-FS1-4,"The larva, called RAT TAILED MAGGOT ( E tenax ), may cause INTESTINAL MYIASIS in humans.",INTESTINAL MYIASIS,RAT TAILED MAGGOT ( E,TWrex-cause
720316442,5/11/2015 22:51:12,1634416655,5/11/2015 22:50:44,False,prodege,0.8417,1924522,USA,NY,New York,96.224.13.217,BURKHOLDERIA PSEUDOMALLEI causes DISEASE KNOWN AS MELIOIDOSIS THAT IS MOSTLY,45,0,,1,87,causes,0.997054485501582,812253-FS1-4,BURKHOLDERIA PSEUDOMALLEI  causes a distinct DISEASE KNOWN AS MELIOIDOSIS THAT IS MOSTLY limited to the Asian tropics (see  Melioidosis.,DISEASE KNOWN AS MELIOIDOSIS THAT IS MOSTLY,BURKHOLDERIA PSEUDOMALLEI,TWrex-cause
720316442,5/11/2015 22:52:23,1634417044,5/11/2015 22:52:05,False,instagc,0.7667,18531561,CAN,ON,Mississauga,99.229.92.227,BURKHOLDERIA PSEUDOMALLEI causes DISEASE KNOWN AS MELIOIDOSIS THAT IS MOSTLY,45,0,,1,87,causes,0.997054485501582,812253-FS1-4,BURKHOLDERIA PSEUDOMALLEI  causes a distinct DISEASE KNOWN AS MELIOIDOSIS THAT IS MOSTLY limited to the Asian tropics (see  Melioidosis.,DISEASE KNOWN AS MELIOIDOSIS THAT IS MOSTLY,BURKHOLDERIA PSEUDOMALLEI,TWrex-cause
720316442,5/11/2015 23:04:36,1634421040,5/11/2015 23:04:10,False,instagc,0.6925,30506788,USA,MO,Springfield,50.81.216.165,BURKHOLDERIA PSEUDOMALLEI causes DISEASE KNOWN AS MELIOIDOSIS THAT IS MOSTLY,45,0,,1,87,causes,0.997054485501582,812253-FS1-4,BURKHOLDERIA PSEUDOMALLEI  causes a distinct DISEASE KNOWN AS MELIOIDOSIS THAT IS MOSTLY limited to the Asian tropics (see  Melioidosis.,DISEASE KNOWN AS MELIOIDOSIS THAT IS MOSTLY,BURKHOLDERIA PSEUDOMALLEI,TWrex-cause
720316442,5/11/2015 23:07:23,1634422160,5/11/2015 23:07:04,False,neodev,0.6327,15848372,AUS,02,Jannali,14.200.59.55,DISEASE KNOWN AS MELIOIDOSIS THAT IS MOSTLY causes BURKHOLDERIA PSEUDOMALLEI,45,0,,1,87,causes,0.997054485501582,812253-FS1-4,BURKHOLDERIA PSEUDOMALLEI  causes a distinct DISEASE KNOWN AS MELIOIDOSIS THAT IS MOSTLY limited to the Asian tropics (see  Melioidosis.,DISEASE KNOWN AS MELIOIDOSIS THAT IS MOSTLY,BURKHOLDERIA PSEUDOMALLEI,TWrex-cause
720316442,5/11/2015 23:14:28,1634426676,5/11/2015 23:14:10,False,instagc,0.7619,24252915,GBR,K6,Portsmouth,89.240.160.95,BURKHOLDERIA PSEUDOMALLEI causes DISEASE KNOWN AS MELIOIDOSIS THAT IS MOSTLY,45,0,,1,87,causes,0.997054485501582,812253-FS1-4,BURKHOLDERIA PSEUDOMALLEI  causes a distinct DISEASE KNOWN AS MELIOIDOSIS THAT IS MOSTLY limited to the Asian tropics (see  Melioidosis.,DISEASE KNOWN AS MELIOIDOSIS THAT IS MOSTLY,BURKHOLDERIA PSEUDOMALLEI,TWrex-cause
720316442,5/11/2015 23:15:10,1634427074,5/11/2015 23:14:55,False,prodege,0.5143,29197974,USA,CA,Carmichael,73.41.174.119,BURKHOLDERIA PSEUDOMALLEI causes DISEASE KNOWN AS MELIOIDOSIS THAT IS MOSTLY,45,0,,1,87,causes,0.997054485501582,812253-FS1-4,BURKHOLDERIA PSEUDOMALLEI  causes a distinct DISEASE KNOWN AS MELIOIDOSIS THAT IS MOSTLY limited to the Asian tropics (see  Melioidosis.,DISEASE KNOWN AS MELIOIDOSIS THAT IS MOSTLY,BURKHOLDERIA PSEUDOMALLEI,TWrex-cause
720316442,5/11/2015 23:15:33,1634427242,5/11/2015 23:15:08,False,elite,0.7619,32173500,GBR,,,90.194.126.118,BURKHOLDERIA PSEUDOMALLEI causes DISEASE KNOWN AS MELIOIDOSIS THAT IS MOSTLY,45,0,,1,87,causes,0.997054485501582,812253-FS1-4,BURKHOLDERIA PSEUDOMALLEI  causes a distinct DISEASE KNOWN AS MELIOIDOSIS THAT IS MOSTLY limited to the Asian tropics (see  Melioidosis.,DISEASE KNOWN AS MELIOIDOSIS THAT IS MOSTLY,BURKHOLDERIA PSEUDOMALLEI,TWrex-cause
720316451,5/11/2015 22:16:46,1634400880,5/11/2015 22:16:30,False,instagc,0.9583,13581319,USA,IL,Mount Vernon,66.232.166.86,PRESCRIPTION OPIOIDS causes OPIOID ABUSE,13,54,,1,24,causes,0.43301270189221897,815137-FS1-4,Rationale: • OPIOID ABUSE including nonmedical use of PRESCRIPTION OPIOIDS is a significant public health problem.,OPIOID ABUSE,PRESCRIPTION OPIOIDS,TWrex-cause
720316451,5/11/2015 22:19:09,1634401992,5/11/2015 22:18:28,False,clixsense,0.7083,17950689,GBR,Y9,Tonypandy,92.2.44.79,OPIOID ABUSE causes PRESCRIPTION OPIOIDS,13,54,,1,24,causes,0.43301270189221897,815137-FS1-4,Rationale: • OPIOID ABUSE including nonmedical use of PRESCRIPTION OPIOIDS is a significant public health problem.,OPIOID ABUSE,PRESCRIPTION OPIOIDS,TWrex-cause
720316451,5/11/2015 22:22:17,1634403558,5/11/2015 22:21:45,False,clixsense,0.6361,17201951,GBR,L9,Sheffield,109.145.116.218,PRESCRIPTION OPIOIDS causes OPIOID ABUSE,13,54,,1,24,causes,0.43301270189221897,815137-FS1-4,Rationale: • OPIOID ABUSE including nonmedical use of PRESCRIPTION OPIOIDS is a significant public health problem.,OPIOID ABUSE,PRESCRIPTION OPIOIDS,TWrex-cause
720316451,5/11/2015 22:23:17,1634404075,5/11/2015 22:22:38,False,points4rewards,0.5778,20113482,USA,OR,Portland,67.213.218.72,no_relation,13,54,,1,24,causes,0.43301270189221897,815137-FS1-4,Rationale: • OPIOID ABUSE including nonmedical use of PRESCRIPTION OPIOIDS is a significant public health problem.,OPIOID ABUSE,PRESCRIPTION OPIOIDS,TWrex-cause
720316451,5/11/2015 22:28:57,1634406418,5/11/2015 22:28:18,False,elite,0.7397,31883685,GBR,H2,Accrington,80.47.186.28,no_relation,13,54,,1,24,causes,0.43301270189221897,815137-FS1-4,Rationale: • OPIOID ABUSE including nonmedical use of PRESCRIPTION OPIOIDS is a significant public health problem.,OPIOID ABUSE,PRESCRIPTION OPIOIDS,TWrex-cause
720316451,5/11/2015 22:31:31,1634407337,5/11/2015 22:30:47,False,neodev,0.8651,18881135,CAN,ON,Ajax,99.243.87.224,PRESCRIPTION OPIOIDS causes OPIOID ABUSE,13,54,,1,24,causes,0.43301270189221897,815137-FS1-4,Rationale: • OPIOID ABUSE including nonmedical use of PRESCRIPTION OPIOIDS is a significant public health problem.,OPIOID ABUSE,PRESCRIPTION OPIOIDS,TWrex-cause
720316451,5/11/2015 22:31:33,1634407379,5/11/2015 22:31:02,False,cotter,0.6964,13805544,USA,MI,Battle Creek,107.140.176.37,no_relation,13,54,,1,24,causes,0.43301270189221897,815137-FS1-4,Rationale: • OPIOID ABUSE including nonmedical use of PRESCRIPTION OPIOIDS is a significant public health problem.,OPIOID ABUSE,PRESCRIPTION OPIOIDS,TWrex-cause
720316456,5/11/2015 23:17:29,1634427957,5/11/2015 23:16:42,False,elite,0.7619,32173500,GBR,,,90.194.126.118,no_relation,126,161,,1,151,causes,0.33968311024337894,814406-FS1-4,Rationale: • Chronic pelvic pain may emerge from latent pain generators following trauma or stress and can overlap with other IDIOPATHIC PAIN CONDITIONS such as FIBROMYALGIA,IDIOPATHIC PAIN CONDITIONS,FIBROMYALGIA,TWrex-cause
720316456,5/11/2015 23:41:10,1634440441,5/11/2015 23:40:40,False,instagc,0.7576,22396848,USA,MA,Waltham,146.115.168.153,no_relation,126,161,,1,151,causes,0.33968311024337894,814406-FS1-4,Rationale: • Chronic pelvic pain may emerge from latent pain generators following trauma or stress and can overlap with other IDIOPATHIC PAIN CONDITIONS such as FIBROMYALGIA,IDIOPATHIC PAIN CONDITIONS,FIBROMYALGIA,TWrex-cause
720316456,5/11/2015 23:44:20,1634441948,5/11/2015 23:43:39,False,neodev,0.816,11382239,AUS,02,Strathfield,60.241.129.81,no_relation,126,161,,1,151,causes,0.33968311024337894,814406-FS1-4,Rationale: • Chronic pelvic pain may emerge from latent pain generators following trauma or stress and can overlap with other IDIOPATHIC PAIN CONDITIONS such as FIBROMYALGIA,IDIOPATHIC PAIN CONDITIONS,FIBROMYALGIA,TWrex-cause
720316456,5/11/2015 23:47:43,1634443306,5/11/2015 23:47:22,False,instagc,0.8111,20342442,USA,NJ,Westfield,108.53.92.41,no_relation,126,161,,1,151,causes,0.33968311024337894,814406-FS1-4,Rationale: • Chronic pelvic pain may emerge from latent pain generators following trauma or stress and can overlap with other IDIOPATHIC PAIN CONDITIONS such as FIBROMYALGIA,IDIOPATHIC PAIN CONDITIONS,FIBROMYALGIA,TWrex-cause
720316456,5/12/2015 00:01:18,1634448226,5/12/2015 00:01:06,False,clixsense,0.4286,10798016,GBR,C7,Coventry,86.24.245.191,FIBROMYALGIA causes IDIOPATHIC PAIN CONDITIONS,126,161,,1,151,causes,0.33968311024337894,814406-FS1-4,Rationale: • Chronic pelvic pain may emerge from latent pain generators following trauma or stress and can overlap with other IDIOPATHIC PAIN CONDITIONS such as FIBROMYALGIA,IDIOPATHIC PAIN CONDITIONS,FIBROMYALGIA,TWrex-cause
720316456,5/12/2015 00:05:46,1634450041,5/12/2015 00:05:19,False,instagc,0.5,21956458,USA,MN,Thief River Falls,24.225.118.170,FIBROMYALGIA causes IDIOPATHIC PAIN CONDITIONS,126,161,,1,151,causes,0.33968311024337894,814406-FS1-4,Rationale: • Chronic pelvic pain may emerge from latent pain generators following trauma or stress and can overlap with other IDIOPATHIC PAIN CONDITIONS such as FIBROMYALGIA,IDIOPATHIC PAIN CONDITIONS,FIBROMYALGIA,TWrex-cause
720316456,5/12/2015 00:08:48,1634451093,5/12/2015 00:07:52,False,zoombucks,0.5646,4711962,CAN,ON,Markham,174.88.29.12,IDIOPATHIC PAIN CONDITIONS causes FIBROMYALGIA,126,161,,1,151,causes,0.33968311024337894,814406-FS1-4,Rationale: • Chronic pelvic pain may emerge from latent pain generators following trauma or stress and can overlap with other IDIOPATHIC PAIN CONDITIONS such as FIBROMYALGIA,IDIOPATHIC PAIN CONDITIONS,FIBROMYALGIA,TWrex-cause
720316458,5/11/2015 22:34:13,1634408721,5/11/2015 22:33:25,False,neodev,0.8651,18881135,CAN,ON,Ajax,99.243.87.224,HEREDITARY FANCONI SYNDROME causes POLYURIA,125,3,,1,132,causes,0.997458699830735,813317-FS1-4,"In HEREDITARY FANCONI SYNDROME the chief clinical features—proximal tubular acidosis, hypophosphatemic rickets, hypokalemia, POLYURIA and polydipsia—usually appear in infancy.",POLYURIA,HEREDITARY FANCONI SYNDROME,TWrex-cause
720316458,5/11/2015 22:49:25,1634415905,5/11/2015 22:48:32,False,prodege,0.8417,1924522,USA,NY,New York,96.224.13.217,HEREDITARY FANCONI SYNDROME causes POLYURIA,125,3,,1,132,causes,0.997458699830735,813317-FS1-4,"In HEREDITARY FANCONI SYNDROME the chief clinical features—proximal tubular acidosis, hypophosphatemic rickets, hypokalemia, POLYURIA and polydipsia—usually appear in infancy.",POLYURIA,HEREDITARY FANCONI SYNDROME,TWrex-cause
720316458,5/11/2015 22:51:14,1634416667,5/11/2015 22:50:24,False,instagc,0.7667,18531561,CAN,ON,Mississauga,99.229.92.227,HEREDITARY FANCONI SYNDROME causes POLYURIA,125,3,,1,132,causes,0.997458699830735,813317-FS1-4,"In HEREDITARY FANCONI SYNDROME the chief clinical features—proximal tubular acidosis, hypophosphatemic rickets, hypokalemia, POLYURIA and polydipsia—usually appear in infancy.",POLYURIA,HEREDITARY FANCONI SYNDROME,TWrex-cause
720316458,5/11/2015 23:02:10,1634420269,5/11/2015 23:01:38,False,instagc,0.6925,30506788,USA,MO,Springfield,50.81.216.165,HEREDITARY FANCONI SYNDROME causes POLYURIA,125,3,,1,132,causes,0.997458699830735,813317-FS1-4,"In HEREDITARY FANCONI SYNDROME the chief clinical features—proximal tubular acidosis, hypophosphatemic rickets, hypokalemia, POLYURIA and polydipsia—usually appear in infancy.",POLYURIA,HEREDITARY FANCONI SYNDROME,TWrex-cause
720316458,5/11/2015 23:06:20,1634421688,5/11/2015 23:06:04,False,neodev,0.6327,15848372,AUS,02,Jannali,14.200.59.55,no_relation,125,3,,1,132,causes,0.997458699830735,813317-FS1-4,"In HEREDITARY FANCONI SYNDROME the chief clinical features—proximal tubular acidosis, hypophosphatemic rickets, hypokalemia, POLYURIA and polydipsia—usually appear in infancy.",POLYURIA,HEREDITARY FANCONI SYNDROME,TWrex-cause
720316458,5/11/2015 23:12:58,1634425851,5/11/2015 23:12:31,False,instagc,0.7619,24252915,GBR,K6,Portsmouth,89.240.160.95,no_relation,125,3,,1,132,causes,0.997458699830735,813317-FS1-4,"In HEREDITARY FANCONI SYNDROME the chief clinical features—proximal tubular acidosis, hypophosphatemic rickets, hypokalemia, POLYURIA and polydipsia—usually appear in infancy.",POLYURIA,HEREDITARY FANCONI SYNDROME,TWrex-cause
720316458,5/11/2015 23:14:29,1634426685,5/11/2015 23:14:15,False,prodege,0.5143,29197974,USA,CA,Carmichael,73.41.174.119,POLYURIA causes HEREDITARY FANCONI SYNDROME,125,3,,1,132,causes,0.997458699830735,813317-FS1-4,"In HEREDITARY FANCONI SYNDROME the chief clinical features—proximal tubular acidosis, hypophosphatemic rickets, hypokalemia, POLYURIA and polydipsia—usually appear in infancy.",POLYURIA,HEREDITARY FANCONI SYNDROME,TWrex-cause
720316461,5/11/2015 22:15:57,1634400496,5/11/2015 22:15:41,False,instagc,0.9583,13581319,USA,IL,Mount Vernon,66.232.166.86,MS RELATED SYMPTOMS causes SPASTICITY,114,84,,1,123,causes,0.896258159530272,813120-FS1-4,"COMMENTARY  It has been suggested that marijuana has a beneficial effect on various MS RELATED SYMPTOMS including SPASTICITY pain, and tremor.",SPASTICITY,MS RELATED SYMPTOMS,TWrex-cause
720316461,5/11/2015 22:17:23,1634401158,5/11/2015 22:16:46,False,clixsense,0.7083,17950689,GBR,Y9,Tonypandy,92.2.44.79,SPASTICITY causes MS RELATED SYMPTOMS,114,84,,1,123,causes,0.896258159530272,813120-FS1-4,"COMMENTARY  It has been suggested that marijuana has a beneficial effect on various MS RELATED SYMPTOMS including SPASTICITY pain, and tremor.",SPASTICITY,MS RELATED SYMPTOMS,TWrex-cause
720316461,5/11/2015 22:21:00,1634403023,5/11/2015 22:20:33,False,points4rewards,0.5778,20113482,USA,OR,Portland,67.213.218.72,no_relation,114,84,,1,123,causes,0.896258159530272,813120-FS1-4,"COMMENTARY  It has been suggested that marijuana has a beneficial effect on various MS RELATED SYMPTOMS including SPASTICITY pain, and tremor.",SPASTICITY,MS RELATED SYMPTOMS,TWrex-cause
720316461,5/11/2015 22:21:07,1634403095,5/11/2015 22:20:55,False,clixsense,0.6361,17201951,GBR,L9,Sheffield,109.145.116.218,MS RELATED SYMPTOMS causes SPASTICITY,114,84,,1,123,causes,0.896258159530272,813120-FS1-4,"COMMENTARY  It has been suggested that marijuana has a beneficial effect on various MS RELATED SYMPTOMS including SPASTICITY pain, and tremor.",SPASTICITY,MS RELATED SYMPTOMS,TWrex-cause
720316461,5/11/2015 22:25:17,1634404877,5/11/2015 22:24:56,False,clixsense,0.5874,23197581,NLD,11,Den Haag,82.217.5.55,no_relation,114,84,,1,123,causes,0.896258159530272,813120-FS1-4,"COMMENTARY  It has been suggested that marijuana has a beneficial effect on various MS RELATED SYMPTOMS including SPASTICITY pain, and tremor.",SPASTICITY,MS RELATED SYMPTOMS,TWrex-cause
720316461,5/11/2015 22:26:51,1634405598,5/11/2015 22:26:14,False,elite,0.7397,31883685,GBR,H2,Accrington,80.47.186.28,MS RELATED SYMPTOMS causes SPASTICITY,114,84,,1,123,causes,0.896258159530272,813120-FS1-4,"COMMENTARY  It has been suggested that marijuana has a beneficial effect on various MS RELATED SYMPTOMS including SPASTICITY pain, and tremor.",SPASTICITY,MS RELATED SYMPTOMS,TWrex-cause
720316461,5/11/2015 22:29:55,1634406674,5/11/2015 22:29:38,False,cotter,0.6964,13805544,USA,MI,Battle Creek,107.140.176.37,no_relation,114,84,,1,123,causes,0.896258159530272,813120-FS1-4,"COMMENTARY  It has been suggested that marijuana has a beneficial effect on various MS RELATED SYMPTOMS including SPASTICITY pain, and tremor.",SPASTICITY,MS RELATED SYMPTOMS,TWrex-cause
720316466,5/11/2015 23:15:16,1634427117,5/11/2015 23:14:45,False,instagc,0.7619,24252915,GBR,K6,Portsmouth,89.240.160.95,no_relation,70,264,,1,81,causes,0.99654575824488,813602-FS1-4,"◊ Pyramidal signs such as hyperreflexia, spasticity, Babinski signs ◊ SENSORY LOSS especially sensory level and impaired vibratory and proprioceptive sensation in limbs ◊ Ataxia of gait and limb movements • See table  History and Physical Examination Elements for MS",SENSORY LOSS,MS,TWrex-cause
720316466,5/11/2015 23:16:41,1634427618,5/11/2015 23:15:55,False,elite,0.7619,32173500,GBR,,,90.194.126.118,MS causes SENSORY LOSS,70,264,,1,81,causes,0.99654575824488,813602-FS1-4,"◊ Pyramidal signs such as hyperreflexia, spasticity, Babinski signs ◊ SENSORY LOSS especially sensory level and impaired vibratory and proprioceptive sensation in limbs ◊ Ataxia of gait and limb movements • See table  History and Physical Examination Elements for MS",SENSORY LOSS,MS,TWrex-cause
720316466,5/11/2015 23:40:38,1634440211,5/11/2015 23:40:23,False,instagc,0.7576,22396848,USA,MA,Waltham,146.115.168.153,MS causes SENSORY LOSS,70,264,,1,81,causes,0.99654575824488,813602-FS1-4,"◊ Pyramidal signs such as hyperreflexia, spasticity, Babinski signs ◊ SENSORY LOSS especially sensory level and impaired vibratory and proprioceptive sensation in limbs ◊ Ataxia of gait and limb movements • See table  History and Physical Examination Elements for MS",SENSORY LOSS,MS,TWrex-cause
720316466,5/11/2015 23:43:37,1634441622,5/11/2015 23:42:44,False,neodev,0.816,11382239,AUS,02,Strathfield,60.241.129.81,MS causes SENSORY LOSS,70,264,,1,81,causes,0.99654575824488,813602-FS1-4,"◊ Pyramidal signs such as hyperreflexia, spasticity, Babinski signs ◊ SENSORY LOSS especially sensory level and impaired vibratory and proprioceptive sensation in limbs ◊ Ataxia of gait and limb movements • See table  History and Physical Examination Elements for MS",SENSORY LOSS,MS,TWrex-cause
720316466,5/11/2015 23:47:21,1634443199,5/11/2015 23:46:41,False,instagc,0.8111,20342442,USA,NJ,Westfield,108.53.92.41,no_relation,70,264,,1,81,causes,0.99654575824488,813602-FS1-4,"◊ Pyramidal signs such as hyperreflexia, spasticity, Babinski signs ◊ SENSORY LOSS especially sensory level and impaired vibratory and proprioceptive sensation in limbs ◊ Ataxia of gait and limb movements • See table  History and Physical Examination Elements for MS",SENSORY LOSS,MS,TWrex-cause
720316466,5/11/2015 23:50:44,1634444414,5/11/2015 23:50:34,False,clixsense,0.6,28457001,CAN,ON,North Bay,24.204.202.220,MS causes SENSORY LOSS,70,264,,1,81,causes,0.99654575824488,813602-FS1-4,"◊ Pyramidal signs such as hyperreflexia, spasticity, Babinski signs ◊ SENSORY LOSS especially sensory level and impaired vibratory and proprioceptive sensation in limbs ◊ Ataxia of gait and limb movements • See table  History and Physical Examination Elements for MS",SENSORY LOSS,MS,TWrex-cause
720316466,5/11/2015 23:57:00,1634446764,5/11/2015 23:56:52,False,instagc,0.5714,19602039,USA,WA,Bellevue,50.135.214.140,MS causes SENSORY LOSS,70,264,,1,81,causes,0.99654575824488,813602-FS1-4,"◊ Pyramidal signs such as hyperreflexia, spasticity, Babinski signs ◊ SENSORY LOSS especially sensory level and impaired vibratory and proprioceptive sensation in limbs ◊ Ataxia of gait and limb movements • See table  History and Physical Examination Elements for MS",SENSORY LOSS,MS,TWrex-cause
720316470,5/11/2015 22:29:39,1634406631,5/11/2015 22:29:00,False,elite,0.7397,31883685,GBR,H2,Accrington,80.47.186.28,no_relation,28,104,,1,57,causes,0.985329278164293,814144-FS1-4,"Less commonly, in newborns, SPONTANEOUS ADRENAL HEMORRHAGE may produce large adrenal masses, simulating NEUROBLASTOMA or Wilms' tumor.",SPONTANEOUS ADRENAL HEMORRHAGE,NEUROBLASTOMA,TWrex-cause
720316470,5/11/2015 22:31:54,1634407475,5/11/2015 22:31:34,False,cotter,0.6964,13805544,USA,MI,Battle Creek,107.140.176.37,SPONTANEOUS ADRENAL HEMORRHAGE causes NEUROBLASTOMA,28,104,,1,57,causes,0.985329278164293,814144-FS1-4,"Less commonly, in newborns, SPONTANEOUS ADRENAL HEMORRHAGE may produce large adrenal masses, simulating NEUROBLASTOMA or Wilms' tumor.",SPONTANEOUS ADRENAL HEMORRHAGE,NEUROBLASTOMA,TWrex-cause
720316470,5/11/2015 22:32:28,1634407610,5/11/2015 22:31:40,False,neodev,0.8651,18881135,CAN,ON,Ajax,99.243.87.224,SPONTANEOUS ADRENAL HEMORRHAGE causes NEUROBLASTOMA,28,104,,1,57,causes,0.985329278164293,814144-FS1-4,"Less commonly, in newborns, SPONTANEOUS ADRENAL HEMORRHAGE may produce large adrenal masses, simulating NEUROBLASTOMA or Wilms' tumor.",SPONTANEOUS ADRENAL HEMORRHAGE,NEUROBLASTOMA,TWrex-cause
720316470,5/11/2015 22:48:05,1634415272,5/11/2015 22:47:36,False,prodege,0.8417,1924522,USA,NY,New York,96.224.13.217,SPONTANEOUS ADRENAL HEMORRHAGE causes NEUROBLASTOMA,28,104,,1,57,causes,0.985329278164293,814144-FS1-4,"Less commonly, in newborns, SPONTANEOUS ADRENAL HEMORRHAGE may produce large adrenal masses, simulating NEUROBLASTOMA or Wilms' tumor.",SPONTANEOUS ADRENAL HEMORRHAGE,NEUROBLASTOMA,TWrex-cause
720316470,5/11/2015 22:49:53,1634416034,5/11/2015 22:49:20,False,instagc,0.7667,18531561,CAN,ON,Mississauga,99.229.92.227,no_relation,28,104,,1,57,causes,0.985329278164293,814144-FS1-4,"Less commonly, in newborns, SPONTANEOUS ADRENAL HEMORRHAGE may produce large adrenal masses, simulating NEUROBLASTOMA or Wilms' tumor.",SPONTANEOUS ADRENAL HEMORRHAGE,NEUROBLASTOMA,TWrex-cause
720316470,5/11/2015 22:51:41,1634416841,5/11/2015 22:51:24,False,neodev,0.4167,31977841,USA,IL,Chicago,69.175.85.2,SPONTANEOUS ADRENAL HEMORRHAGE causes NEUROBLASTOMA,28,104,,1,57,causes,0.985329278164293,814144-FS1-4,"Less commonly, in newborns, SPONTANEOUS ADRENAL HEMORRHAGE may produce large adrenal masses, simulating NEUROBLASTOMA or Wilms' tumor.",SPONTANEOUS ADRENAL HEMORRHAGE,NEUROBLASTOMA,TWrex-cause
720316470,5/11/2015 23:00:57,1634419777,5/11/2015 23:00:04,False,instagc,0.6925,30506788,USA,MO,Springfield,50.81.216.165,NEUROBLASTOMA causes SPONTANEOUS ADRENAL HEMORRHAGE,28,104,,1,57,causes,0.985329278164293,814144-FS1-4,"Less commonly, in newborns, SPONTANEOUS ADRENAL HEMORRHAGE may produce large adrenal masses, simulating NEUROBLASTOMA or Wilms' tumor.",SPONTANEOUS ADRENAL HEMORRHAGE,NEUROBLASTOMA,TWrex-cause
720316472,5/11/2015 22:40:05,1634411546,5/11/2015 22:39:29,False,neodev,0.8651,18881135,CAN,ON,Ajax,99.243.87.224,NEUROFIBROMATOSIS TYPE I causes CAFÉ AU LAIT SPOTS,33,183,,1,50,causes,0.9091372900969901,812642-FS1-4,"Specifically, having six or more CAFÉ AU LAIT SPOTS greater than 5 mm in diameter before puberty, or greater than 15 mm in diameter after puberty, are cardinal diagnostic features of NEUROFIBROMATOSIS TYPE I.",CAFÉ AU LAIT SPOTS,NEUROFIBROMATOSIS TYPE I,TWrex-cause
720316472,5/11/2015 22:50:43,1634416452,5/11/2015 22:49:59,False,prodege,0.8417,1924522,USA,NY,New York,96.224.13.217,NEUROFIBROMATOSIS TYPE I causes CAFÉ AU LAIT SPOTS,33,183,,1,50,causes,0.9091372900969901,812642-FS1-4,"Specifically, having six or more CAFÉ AU LAIT SPOTS greater than 5 mm in diameter before puberty, or greater than 15 mm in diameter after puberty, are cardinal diagnostic features of NEUROFIBROMATOSIS TYPE I.",CAFÉ AU LAIT SPOTS,NEUROFIBROMATOSIS TYPE I,TWrex-cause
720316472,5/11/2015 22:52:04,1634416944,5/11/2015 22:51:38,False,instagc,0.7667,18531561,CAN,ON,Mississauga,99.229.92.227,NEUROFIBROMATOSIS TYPE I causes CAFÉ AU LAIT SPOTS,33,183,,1,50,causes,0.9091372900969901,812642-FS1-4,"Specifically, having six or more CAFÉ AU LAIT SPOTS greater than 5 mm in diameter before puberty, or greater than 15 mm in diameter after puberty, are cardinal diagnostic features of NEUROFIBROMATOSIS TYPE I.",CAFÉ AU LAIT SPOTS,NEUROFIBROMATOSIS TYPE I,TWrex-cause
720316472,5/11/2015 23:04:09,1634420906,5/11/2015 23:03:59,False,instagc,0.6925,30506788,USA,MO,Springfield,50.81.216.165,NEUROFIBROMATOSIS TYPE I causes CAFÉ AU LAIT SPOTS,33,183,,1,50,causes,0.9091372900969901,812642-FS1-4,"Specifically, having six or more CAFÉ AU LAIT SPOTS greater than 5 mm in diameter before puberty, or greater than 15 mm in diameter after puberty, are cardinal diagnostic features of NEUROFIBROMATOSIS TYPE I.",CAFÉ AU LAIT SPOTS,NEUROFIBROMATOSIS TYPE I,TWrex-cause
720316472,5/11/2015 23:07:03,1634422023,5/11/2015 23:06:50,False,neodev,0.6327,15848372,AUS,02,Jannali,14.200.59.55,no_relation,33,183,,1,50,causes,0.9091372900969901,812642-FS1-4,"Specifically, having six or more CAFÉ AU LAIT SPOTS greater than 5 mm in diameter before puberty, or greater than 15 mm in diameter after puberty, are cardinal diagnostic features of NEUROFIBROMATOSIS TYPE I.",CAFÉ AU LAIT SPOTS,NEUROFIBROMATOSIS TYPE I,TWrex-cause
720316472,5/11/2015 23:14:08,1634426549,5/11/2015 23:13:44,False,instagc,0.7619,24252915,GBR,K6,Portsmouth,89.240.160.95,NEUROFIBROMATOSIS TYPE I causes CAFÉ AU LAIT SPOTS,33,183,,1,50,causes,0.9091372900969901,812642-FS1-4,"Specifically, having six or more CAFÉ AU LAIT SPOTS greater than 5 mm in diameter before puberty, or greater than 15 mm in diameter after puberty, are cardinal diagnostic features of NEUROFIBROMATOSIS TYPE I.",CAFÉ AU LAIT SPOTS,NEUROFIBROMATOSIS TYPE I,TWrex-cause
720316472,5/11/2015 23:14:53,1634426918,5/11/2015 23:14:31,False,prodege,0.5143,29197974,USA,CA,Carmichael,73.41.174.119,NEUROFIBROMATOSIS TYPE I causes CAFÉ AU LAIT SPOTS,33,183,,1,50,causes,0.9091372900969901,812642-FS1-4,"Specifically, having six or more CAFÉ AU LAIT SPOTS greater than 5 mm in diameter before puberty, or greater than 15 mm in diameter after puberty, are cardinal diagnostic features of NEUROFIBROMATOSIS TYPE I.",CAFÉ AU LAIT SPOTS,NEUROFIBROMATOSIS TYPE I,TWrex-cause
720316473,5/11/2015 23:07:47,1634422359,5/11/2015 23:07:26,False,neodev,0.6327,15848372,AUS,02,Jannali,14.200.59.55,no_relation,0,46,,1,15,causes,0.9918365981341758,812888-FS1-4,CHRONIC DIARRHEA is another common feature of ETHYLMALONIC ENCEPHALOPATHY,CHRONIC DIARRHEA,ETHYLMALONIC ENCEPHALOPATHY,TWrex-cause
720316473,5/11/2015 23:14:43,1634426847,5/11/2015 23:14:29,False,instagc,0.7619,24252915,GBR,K6,Portsmouth,89.240.160.95,ETHYLMALONIC ENCEPHALOPATHY causes CHRONIC DIARRHEA,0,46,,1,15,causes,0.9918365981341758,812888-FS1-4,CHRONIC DIARRHEA is another common feature of ETHYLMALONIC ENCEPHALOPATHY,CHRONIC DIARRHEA,ETHYLMALONIC ENCEPHALOPATHY,TWrex-cause
720316473,5/11/2015 23:15:20,1634427136,5/11/2015 23:15:11,False,prodege,0.5143,29197974,USA,CA,Carmichael,73.41.174.119,ETHYLMALONIC ENCEPHALOPATHY causes CHRONIC DIARRHEA,0,46,,1,15,causes,0.9918365981341758,812888-FS1-4,CHRONIC DIARRHEA is another common feature of ETHYLMALONIC ENCEPHALOPATHY,CHRONIC DIARRHEA,ETHYLMALONIC ENCEPHALOPATHY,TWrex-cause
720316473,5/11/2015 23:15:54,1634427348,5/11/2015 23:15:34,False,elite,0.7619,32173500,GBR,,,90.194.126.118,CHRONIC DIARRHEA causes ETHYLMALONIC ENCEPHALOPATHY,0,46,,1,15,causes,0.9918365981341758,812888-FS1-4,CHRONIC DIARRHEA is another common feature of ETHYLMALONIC ENCEPHALOPATHY,CHRONIC DIARRHEA,ETHYLMALONIC ENCEPHALOPATHY,TWrex-cause
720316473,5/11/2015 23:32:35,1634434972,5/11/2015 23:31:47,False,quickrewards,0.5,8672587,USA,TX,El Paso,209.194.208.150,ETHYLMALONIC ENCEPHALOPATHY causes CHRONIC DIARRHEA,0,46,,1,15,causes,0.9918365981341758,812888-FS1-4,CHRONIC DIARRHEA is another common feature of ETHYLMALONIC ENCEPHALOPATHY,CHRONIC DIARRHEA,ETHYLMALONIC ENCEPHALOPATHY,TWrex-cause
720316473,5/11/2015 23:40:22,1634440130,5/11/2015 23:40:05,False,instagc,0.7576,22396848,USA,MA,Waltham,146.115.168.153,no_relation,0,46,,1,15,causes,0.9918365981341758,812888-FS1-4,CHRONIC DIARRHEA is another common feature of ETHYLMALONIC ENCEPHALOPATHY,CHRONIC DIARRHEA,ETHYLMALONIC ENCEPHALOPATHY,TWrex-cause
720316473,5/11/2015 23:42:42,1634441138,5/11/2015 23:42:02,False,neodev,0.816,11382239,AUS,02,Strathfield,60.241.129.81,no_relation,0,46,,1,15,causes,0.9918365981341758,812888-FS1-4,CHRONIC DIARRHEA is another common feature of ETHYLMALONIC ENCEPHALOPATHY,CHRONIC DIARRHEA,ETHYLMALONIC ENCEPHALOPATHY,TWrex-cause
720316474,5/11/2015 23:18:02,1634428196,5/11/2015 23:17:30,False,elite,0.7619,32173500,GBR,,,90.194.126.118,no_relation,0,77,,1,14,causes,0.9647638212377321,812921-FS1-4,"BLOODY DIARRHEA fever, and abdominal pain suggest inflammatory bowel disease (ULCERATIVE COLITIS CROHN'S DISEASE or an infectious colitis (eg,  Shigella,Salmonella,Campylobacter,  amebiasis.",BLOODY DIARRHEA,(ULCERATIVE COLITIS CROHN'S DISEASE,TWrex-cause
720316474,5/11/2015 23:41:23,1634440552,5/11/2015 23:41:12,False,instagc,0.7576,22396848,USA,MA,Waltham,146.115.168.153,(ULCERATIVE COLITIS CROHN'S DISEASE causes BLOODY DIARRHEA,0,77,,1,14,causes,0.9647638212377321,812921-FS1-4,"BLOODY DIARRHEA fever, and abdominal pain suggest inflammatory bowel disease (ULCERATIVE COLITIS CROHN'S DISEASE or an infectious colitis (eg,  Shigella,Salmonella,Campylobacter,  amebiasis.",BLOODY DIARRHEA,(ULCERATIVE COLITIS CROHN'S DISEASE,TWrex-cause
720316474,5/11/2015 23:44:58,1634442225,5/11/2015 23:44:22,False,neodev,0.816,11382239,AUS,02,Strathfield,60.241.129.81,(ULCERATIVE COLITIS CROHN'S DISEASE causes BLOODY DIARRHEA,0,77,,1,14,causes,0.9647638212377321,812921-FS1-4,"BLOODY DIARRHEA fever, and abdominal pain suggest inflammatory bowel disease (ULCERATIVE COLITIS CROHN'S DISEASE or an infectious colitis (eg,  Shigella,Salmonella,Campylobacter,  amebiasis.",BLOODY DIARRHEA,(ULCERATIVE COLITIS CROHN'S DISEASE,TWrex-cause
720316474,5/11/2015 23:48:20,1634443536,5/11/2015 23:47:44,False,instagc,0.8111,20342442,USA,NJ,Westfield,108.53.92.41,(ULCERATIVE COLITIS CROHN'S DISEASE causes BLOODY DIARRHEA,0,77,,1,14,causes,0.9647638212377321,812921-FS1-4,"BLOODY DIARRHEA fever, and abdominal pain suggest inflammatory bowel disease (ULCERATIVE COLITIS CROHN'S DISEASE or an infectious colitis (eg,  Shigella,Salmonella,Campylobacter,  amebiasis.",BLOODY DIARRHEA,(ULCERATIVE COLITIS CROHN'S DISEASE,TWrex-cause
720316474,5/12/2015 00:01:59,1634448423,5/12/2015 00:01:20,False,clixsense,0.4286,10798016,GBR,C7,Coventry,86.24.245.191,no_relation,0,77,,1,14,causes,0.9647638212377321,812921-FS1-4,"BLOODY DIARRHEA fever, and abdominal pain suggest inflammatory bowel disease (ULCERATIVE COLITIS CROHN'S DISEASE or an infectious colitis (eg,  Shigella,Salmonella,Campylobacter,  amebiasis.",BLOODY DIARRHEA,(ULCERATIVE COLITIS CROHN'S DISEASE,TWrex-cause
720316474,5/12/2015 00:09:06,1634451215,5/12/2015 00:08:50,False,zoombucks,0.5646,4711962,CAN,ON,Markham,174.88.29.12,BLOODY DIARRHEA causes (ULCERATIVE COLITIS CROHN'S DISEASE,0,77,,1,14,causes,0.9647638212377321,812921-FS1-4,"BLOODY DIARRHEA fever, and abdominal pain suggest inflammatory bowel disease (ULCERATIVE COLITIS CROHN'S DISEASE or an infectious colitis (eg,  Shigella,Salmonella,Campylobacter,  amebiasis.",BLOODY DIARRHEA,(ULCERATIVE COLITIS CROHN'S DISEASE,TWrex-cause
720316474,5/12/2015 00:14:52,1634453270,5/12/2015 00:14:23,False,onestopgpt,0.8286,21275875,CAN,ON,Hamilton,24.36.121.10,(ULCERATIVE COLITIS CROHN'S DISEASE causes BLOODY DIARRHEA,0,77,,1,14,causes,0.9647638212377321,812921-FS1-4,"BLOODY DIARRHEA fever, and abdominal pain suggest inflammatory bowel disease (ULCERATIVE COLITIS CROHN'S DISEASE or an infectious colitis (eg,  Shigella,Salmonella,Campylobacter,  amebiasis.",BLOODY DIARRHEA,(ULCERATIVE COLITIS CROHN'S DISEASE,TWrex-cause
720316475,5/11/2015 22:15:09,1634400228,5/11/2015 22:14:40,False,instagc,0.9583,13581319,USA,IL,Mount Vernon,66.232.166.86,DRUG causes LUPUS SYNDROME,88,127,,1,101,causes,0.788263422531435,811911-FS1-4,"Long term, high dose (> 300 mg/day) hydralazine has been associated with a drug induced LUPUS SYNDROME which resolves when the DRUG is stopped.",LUPUS SYNDROME,DRUG,TWrex-cause
720316475,5/11/2015 22:16:12,1634400630,5/11/2015 22:15:41,False,clixsense,0.7083,17950689,GBR,Y9,Tonypandy,92.2.44.79,LUPUS SYNDROME causes DRUG,88,127,,1,101,causes,0.788263422531435,811911-FS1-4,"Long term, high dose (> 300 mg/day) hydralazine has been associated with a drug induced LUPUS SYNDROME which resolves when the DRUG is stopped.",LUPUS SYNDROME,DRUG,TWrex-cause
720316475,5/11/2015 22:19:40,1634402268,5/11/2015 22:19:03,False,points4rewards,0.5778,20113482,USA,OR,Portland,67.213.218.72,DRUG causes LUPUS SYNDROME,88,127,,1,101,causes,0.788263422531435,811911-FS1-4,"Long term, high dose (> 300 mg/day) hydralazine has been associated with a drug induced LUPUS SYNDROME which resolves when the DRUG is stopped.",LUPUS SYNDROME,DRUG,TWrex-cause
720316475,5/11/2015 22:20:28,1634402700,5/11/2015 22:20:08,False,clixsense,0.6361,17201951,GBR,L9,Sheffield,109.145.116.218,DRUG causes LUPUS SYNDROME,88,127,,1,101,causes,0.788263422531435,811911-FS1-4,"Long term, high dose (> 300 mg/day) hydralazine has been associated with a drug induced LUPUS SYNDROME which resolves when the DRUG is stopped.",LUPUS SYNDROME,DRUG,TWrex-cause
720316475,5/11/2015 22:20:30,1634402725,5/11/2015 22:19:51,False,clixsense,0.6375,6344072,CAN,BC,Burnaby,172.218.166.58,DRUG causes LUPUS SYNDROME,88,127,,1,101,causes,0.788263422531435,811911-FS1-4,"Long term, high dose (> 300 mg/day) hydralazine has been associated with a drug induced LUPUS SYNDROME which resolves when the DRUG is stopped.",LUPUS SYNDROME,DRUG,TWrex-cause
720316475,5/11/2015 22:23:06,1634403981,5/11/2015 22:22:37,False,prodege,0.9,21417560,GBR,C3,Cambridge,151.225.116.143,DRUG causes LUPUS SYNDROME,88,127,,1,101,causes,0.788263422531435,811911-FS1-4,"Long term, high dose (> 300 mg/day) hydralazine has been associated with a drug induced LUPUS SYNDROME which resolves when the DRUG is stopped.",LUPUS SYNDROME,DRUG,TWrex-cause
720316475,5/11/2015 22:24:30,1634404575,5/11/2015 22:24:08,False,clixsense,0.5874,23197581,NLD,11,Den Haag,82.217.5.55,DRUG causes LUPUS SYNDROME,88,127,,1,101,causes,0.788263422531435,811911-FS1-4,"Long term, high dose (> 300 mg/day) hydralazine has been associated with a drug induced LUPUS SYNDROME which resolves when the DRUG is stopped.",LUPUS SYNDROME,DRUG,TWrex-cause
721149604,5/13/2015 11:02:09,1635694863,5/13/2015 11:01:46,False,neodev,0.8631,11014534,GBR,B8,Bromley,86.18.149.6,no_relation,62,135,,74,137,causes,0.9434563530497259,814883-FS1-4,167  Typhoid Fever and Other Salmonella Infections   +  >     TYPHOID FEVER or Septicemia caused by S. typhi or S. paratyphi  +  IV or IM:  2 4 g once daily.,TYPHOID FEVER,IM,TWrex-cause
721149604,5/13/2015 11:26:45,1635701067,5/13/2015 11:26:09,False,neodev,0.7,18881135,CAN,ON,Ajax,99.243.87.224,IM causes TYPHOID FEVER,62,135,,74,137,causes,0.9434563530497259,814883-FS1-4,167  Typhoid Fever and Other Salmonella Infections   +  >     TYPHOID FEVER or Septicemia caused by S. typhi or S. paratyphi  +  IV or IM:  2 4 g once daily.,TYPHOID FEVER,IM,TWrex-cause
721149604,5/13/2015 11:27:39,1635701311,5/13/2015 11:26:59,False,clixsense,0.65,29594612,NLD,11,Rotterdam,82.156.132.195,IM causes TYPHOID FEVER,62,135,,74,137,causes,0.9434563530497259,814883-FS1-4,167  Typhoid Fever and Other Salmonella Infections   +  >     TYPHOID FEVER or Septicemia caused by S. typhi or S. paratyphi  +  IV or IM:  2 4 g once daily.,TYPHOID FEVER,IM,TWrex-cause
721149604,5/13/2015 11:39:47,1635704792,5/13/2015 11:39:07,False,prodege,0.7381,27934334,GBR,D3,Swadlincote,109.150.228.127,no_relation,62,135,,74,137,causes,0.9434563530497259,814883-FS1-4,167  Typhoid Fever and Other Salmonella Infections   +  >     TYPHOID FEVER or Septicemia caused by S. typhi or S. paratyphi  +  IV or IM:  2 4 g once daily.,TYPHOID FEVER,IM,TWrex-cause
721149604,5/13/2015 11:41:25,1635705122,5/13/2015 11:40:59,False,clixsense,0.5,21933552,CAN,ON,Ottawa,70.49.14.161,no_relation,62,135,,74,137,causes,0.9434563530497259,814883-FS1-4,167  Typhoid Fever and Other Salmonella Infections   +  >     TYPHOID FEVER or Septicemia caused by S. typhi or S. paratyphi  +  IV or IM:  2 4 g once daily.,TYPHOID FEVER,IM,TWrex-cause
721149604,5/13/2015 11:41:29,1635705143,5/13/2015 11:41:00,False,clixsense,0.7694,6338946,CAN,QC,Montréal,209.197.141.151,IM causes TYPHOID FEVER,62,135,,74,137,causes,0.9434563530497259,814883-FS1-4,167  Typhoid Fever and Other Salmonella Infections   +  >     TYPHOID FEVER or Septicemia caused by S. typhi or S. paratyphi  +  IV or IM:  2 4 g once daily.,TYPHOID FEVER,IM,TWrex-cause
721149604,5/13/2015 12:29:31,1635721015,5/13/2015 12:29:16,False,bitcoinget,0.622,21614812,USA,PA,Erie,174.100.250.115,no_relation,62,135,,74,137,causes,0.9434563530497259,814883-FS1-4,167  Typhoid Fever and Other Salmonella Infections   +  >     TYPHOID FEVER or Septicemia caused by S. typhi or S. paratyphi  +  IV or IM:  2 4 g once daily.,TYPHOID FEVER,IM,TWrex-cause
721149609,5/13/2015 10:44:19,1635689601,5/13/2015 10:43:50,False,prodege,1.0,21417560,GBR,C3,Cambridge,151.225.116.143,MUMPS VIRUS causes PAROTITIS,43,210,,51,221,causes,1.0,810325-FS1-4,"The association of aseptic meningitis with PAROTITIS pancreatitis (abdominal pain and increased serum amylase levels), or oophoritis (abdominal pain and ovarian tenderness on pelvic examination) is a clue that MUMPS VIRUS is the causative agent.",PAROTITIS,MUMPS VIRUS,TWrex-cause
721149609,5/13/2015 10:52:43,1635692134,5/13/2015 10:52:09,False,clixsense,0.5639,17950689,GBR,Y9,Tonypandy,92.2.44.79,MUMPS VIRUS causes PAROTITIS,43,210,,51,221,causes,1.0,810325-FS1-4,"The association of aseptic meningitis with PAROTITIS pancreatitis (abdominal pain and increased serum amylase levels), or oophoritis (abdominal pain and ovarian tenderness on pelvic examination) is a clue that MUMPS VIRUS is the causative agent.",PAROTITIS,MUMPS VIRUS,TWrex-cause
721149609,5/13/2015 10:53:05,1635692259,5/13/2015 10:52:50,False,instagc,0.6458,13581319,USA,IL,Mount Vernon,66.232.166.86,MUMPS VIRUS causes PAROTITIS,43,210,,51,221,causes,1.0,810325-FS1-4,"The association of aseptic meningitis with PAROTITIS pancreatitis (abdominal pain and increased serum amylase levels), or oophoritis (abdominal pain and ovarian tenderness on pelvic examination) is a clue that MUMPS VIRUS is the causative agent.",PAROTITIS,MUMPS VIRUS,TWrex-cause
721149609,5/13/2015 10:53:16,1635692304,5/13/2015 10:52:50,False,neodev,0.6389,14096345,NLD,03,Eibergen,77.174.124.109,MUMPS VIRUS causes PAROTITIS,43,210,,51,221,causes,1.0,810325-FS1-4,"The association of aseptic meningitis with PAROTITIS pancreatitis (abdominal pain and increased serum amylase levels), or oophoritis (abdominal pain and ovarian tenderness on pelvic examination) is a clue that MUMPS VIRUS is the causative agent.",PAROTITIS,MUMPS VIRUS,TWrex-cause
721149609,5/13/2015 10:53:55,1635692481,5/13/2015 10:53:33,False,neodev,0.4972,29579905,GBR,,,5.152.206.71,MUMPS VIRUS causes PAROTITIS,43,210,,51,221,causes,1.0,810325-FS1-4,"The association of aseptic meningitis with PAROTITIS pancreatitis (abdominal pain and increased serum amylase levels), or oophoritis (abdominal pain and ovarian tenderness on pelvic examination) is a clue that MUMPS VIRUS is the causative agent.",PAROTITIS,MUMPS VIRUS,TWrex-cause
721149609,5/13/2015 10:54:04,1635692497,5/13/2015 10:53:21,False,clixsense,0.5972,10798016,GBR,C7,Coventry,86.24.245.191,MUMPS VIRUS causes PAROTITIS,43,210,,51,221,causes,1.0,810325-FS1-4,"The association of aseptic meningitis with PAROTITIS pancreatitis (abdominal pain and increased serum amylase levels), or oophoritis (abdominal pain and ovarian tenderness on pelvic examination) is a clue that MUMPS VIRUS is the causative agent.",PAROTITIS,MUMPS VIRUS,TWrex-cause
721149609,5/13/2015 11:00:13,1635694191,5/13/2015 11:00:00,False,neodev,0.8631,11014534,GBR,B8,Bromley,86.18.149.6,MUMPS VIRUS causes PAROTITIS,43,210,,51,221,causes,1.0,810325-FS1-4,"The association of aseptic meningitis with PAROTITIS pancreatitis (abdominal pain and increased serum amylase levels), or oophoritis (abdominal pain and ovarian tenderness on pelvic examination) is a clue that MUMPS VIRUS is the causative agent.",PAROTITIS,MUMPS VIRUS,TWrex-cause
721149619,5/13/2015 10:42:42,1635688988,5/13/2015 10:42:15,False,prodege,1.0,21417560,GBR,C3,Cambridge,151.225.116.143,AMEBIASIS causes ENTAMOEBA HISTOLYTICA,0,56,,8,77,causes,0.838627869377535,812595-FS1-4,AMEBIASIS  (Entamebiasis)  AMEBIASIS is infection with  ENTAMOEBA HISTOLYTICA.,AMEBIASIS,ENTAMOEBA HISTOLYTICA,TWrex-cause
721149619,5/13/2015 10:51:12,1635691682,5/13/2015 10:50:52,False,clixsense,0.5639,17950689,GBR,Y9,Tonypandy,92.2.44.79,AMEBIASIS causes ENTAMOEBA HISTOLYTICA,0,56,,8,77,causes,0.838627869377535,812595-FS1-4,AMEBIASIS  (Entamebiasis)  AMEBIASIS is infection with  ENTAMOEBA HISTOLYTICA.,AMEBIASIS,ENTAMOEBA HISTOLYTICA,TWrex-cause
721149619,5/13/2015 10:51:12,1635691696,5/13/2015 10:50:56,False,neodev,0.4972,29579905,GBR,,,5.152.206.71,ENTAMOEBA HISTOLYTICA causes AMEBIASIS,0,56,,8,77,causes,0.838627869377535,812595-FS1-4,AMEBIASIS  (Entamebiasis)  AMEBIASIS is infection with  ENTAMOEBA HISTOLYTICA.,AMEBIASIS,ENTAMOEBA HISTOLYTICA,TWrex-cause
721149619,5/13/2015 10:52:06,1635691959,5/13/2015 10:51:47,False,neodev,0.6389,14096345,NLD,03,Eibergen,77.174.124.109,no_relation,0,56,,8,77,causes,0.838627869377535,812595-FS1-4,AMEBIASIS  (Entamebiasis)  AMEBIASIS is infection with  ENTAMOEBA HISTOLYTICA.,AMEBIASIS,ENTAMOEBA HISTOLYTICA,TWrex-cause
721149619,5/13/2015 10:52:06,1635691962,5/13/2015 10:51:49,False,instagc,0.6458,13581319,USA,IL,Mount Vernon,66.232.166.86,AMEBIASIS causes ENTAMOEBA HISTOLYTICA,0,56,,8,77,causes,0.838627869377535,812595-FS1-4,AMEBIASIS  (Entamebiasis)  AMEBIASIS is infection with  ENTAMOEBA HISTOLYTICA.,AMEBIASIS,ENTAMOEBA HISTOLYTICA,TWrex-cause
721149619,5/13/2015 10:52:11,1635691998,5/13/2015 10:51:47,False,clixsense,0.5972,10798016,GBR,C7,Coventry,86.24.245.191,no_relation,0,56,,8,77,causes,0.838627869377535,812595-FS1-4,AMEBIASIS  (Entamebiasis)  AMEBIASIS is infection with  ENTAMOEBA HISTOLYTICA.,AMEBIASIS,ENTAMOEBA HISTOLYTICA,TWrex-cause
721149619,5/13/2015 10:59:35,1635694008,5/13/2015 10:59:16,False,elite,0.7817,31856422,GBR,C9,Workington,92.18.169.149,no_relation,0,56,,8,77,causes,0.838627869377535,812595-FS1-4,AMEBIASIS  (Entamebiasis)  AMEBIASIS is infection with  ENTAMOEBA HISTOLYTICA.,AMEBIASIS,ENTAMOEBA HISTOLYTICA,TWrex-cause
721149625,5/13/2015 09:56:37,1635676412,5/13/2015 09:56:12,False,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,HANTAAN VIRUS causes EPIDEMIC HEMORRHAGIC FEVER,60,33,,85,46,causes,1.0,810337-FS1-4,"22   The prototype hantavirus is HANTAAN VIRUS which causes EPIDEMIC HEMORRHAGIC FEVER in China and Korea, but many different hantaviruses are now recognized.",EPIDEMIC HEMORRHAGIC FEVER,HANTAAN VIRUS,TWrex-cause
721149625,5/13/2015 10:03:06,1635678120,5/13/2015 10:02:50,False,instagc,0.7083,18531561,CAN,ON,Mississauga,99.229.92.227,HANTAAN VIRUS causes EPIDEMIC HEMORRHAGIC FEVER,60,33,,85,46,causes,1.0,810337-FS1-4,"22   The prototype hantavirus is HANTAAN VIRUS which causes EPIDEMIC HEMORRHAGIC FEVER in China and Korea, but many different hantaviruses are now recognized.",EPIDEMIC HEMORRHAGIC FEVER,HANTAAN VIRUS,TWrex-cause
721149625,5/13/2015 10:03:50,1635678337,5/13/2015 10:03:29,False,neodev,0.8056,30627835,GBR,H9,London,5.81.27.94,HANTAAN VIRUS causes EPIDEMIC HEMORRHAGIC FEVER,60,33,,85,46,causes,1.0,810337-FS1-4,"22   The prototype hantavirus is HANTAAN VIRUS which causes EPIDEMIC HEMORRHAGIC FEVER in China and Korea, but many different hantaviruses are now recognized.",EPIDEMIC HEMORRHAGIC FEVER,HANTAAN VIRUS,TWrex-cause
721149625,5/13/2015 10:05:24,1635678629,5/13/2015 10:05:05,False,neodev,0.7708,11001780,AUS,07,Elwood,14.201.215.31,HANTAAN VIRUS causes EPIDEMIC HEMORRHAGIC FEVER,60,33,,85,46,causes,1.0,810337-FS1-4,"22   The prototype hantavirus is HANTAAN VIRUS which causes EPIDEMIC HEMORRHAGIC FEVER in China and Korea, but many different hantaviruses are now recognized.",EPIDEMIC HEMORRHAGIC FEVER,HANTAAN VIRUS,TWrex-cause
721149625,5/13/2015 10:11:40,1635680447,5/13/2015 10:11:26,False,gifthunterclub,0.75,30901412,GBR,H9,London,77.89.149.62,HANTAAN VIRUS causes EPIDEMIC HEMORRHAGIC FEVER,60,33,,85,46,causes,1.0,810337-FS1-4,"22   The prototype hantavirus is HANTAAN VIRUS which causes EPIDEMIC HEMORRHAGIC FEVER in China and Korea, but many different hantaviruses are now recognized.",EPIDEMIC HEMORRHAGIC FEVER,HANTAAN VIRUS,TWrex-cause
721149625,5/13/2015 10:13:48,1635680865,5/13/2015 10:13:30,False,neodev,0.4444,31326282,NLD,,,82.169.243.65,HANTAAN VIRUS causes EPIDEMIC HEMORRHAGIC FEVER,60,33,,85,46,causes,1.0,810337-FS1-4,"22   The prototype hantavirus is HANTAAN VIRUS which causes EPIDEMIC HEMORRHAGIC FEVER in China and Korea, but many different hantaviruses are now recognized.",EPIDEMIC HEMORRHAGIC FEVER,HANTAAN VIRUS,TWrex-cause
721149625,5/13/2015 10:19:14,1635682191,5/13/2015 10:18:59,False,pocketmoneygpt,0.7024,28884030,USA,WI,Minocqua,75.143.134.247,HANTAAN VIRUS causes EPIDEMIC HEMORRHAGIC FEVER,60,33,,85,46,causes,1.0,810337-FS1-4,"22   The prototype hantavirus is HANTAAN VIRUS which causes EPIDEMIC HEMORRHAGIC FEVER in China and Korea, but many different hantaviruses are now recognized.",EPIDEMIC HEMORRHAGIC FEVER,HANTAAN VIRUS,TWrex-cause
721149628,5/13/2015 11:45:36,1635705926,5/13/2015 11:44:51,False,clixsense,0.7694,6338946,CAN,QC,Montréal,209.197.141.151,no_relation,43,83,,56,104,causes,0.48666426339228797,814028-FS1-4,Treatment with C1 inhibitor concentrate in ABDOMINAL PAIN attacks of patients with HEREDITARY ANGIOEDEMA,ABDOMINAL PAIN,HEREDITARY ANGIOEDEMA,TWrex-cause
721149628,5/13/2015 12:37:16,1635723121,5/13/2015 12:36:58,False,neodev,0.7209,32216655,NLD,07,Amsterdam,145.100.72.168,HEREDITARY ANGIOEDEMA causes ABDOMINAL PAIN,43,83,,56,104,causes,0.48666426339228797,814028-FS1-4,Treatment with C1 inhibitor concentrate in ABDOMINAL PAIN attacks of patients with HEREDITARY ANGIOEDEMA,ABDOMINAL PAIN,HEREDITARY ANGIOEDEMA,TWrex-cause
721149628,5/13/2015 12:49:47,1635726087,5/13/2015 12:49:20,False,prodege,0.65,14848125,GBR,L6,Shrewsbury,86.138.223.142,no_relation,43,83,,56,104,causes,0.48666426339228797,814028-FS1-4,Treatment with C1 inhibitor concentrate in ABDOMINAL PAIN attacks of patients with HEREDITARY ANGIOEDEMA,ABDOMINAL PAIN,HEREDITARY ANGIOEDEMA,TWrex-cause
721149628,5/13/2015 12:55:59,1635727426,5/13/2015 12:55:37,False,points4rewards,0.7095,28755767,USA,VA,Chester,68.57.118.32,HEREDITARY ANGIOEDEMA causes ABDOMINAL PAIN,43,83,,56,104,causes,0.48666426339228797,814028-FS1-4,Treatment with C1 inhibitor concentrate in ABDOMINAL PAIN attacks of patients with HEREDITARY ANGIOEDEMA,ABDOMINAL PAIN,HEREDITARY ANGIOEDEMA,TWrex-cause
721149628,5/13/2015 13:06:40,1635730918,5/13/2015 13:06:16,False,clixsense,0.7599,17609394,CAN,ON,Mississauga,99.229.57.218,HEREDITARY ANGIOEDEMA causes ABDOMINAL PAIN,43,83,,56,104,causes,0.48666426339228797,814028-FS1-4,Treatment with C1 inhibitor concentrate in ABDOMINAL PAIN attacks of patients with HEREDITARY ANGIOEDEMA,ABDOMINAL PAIN,HEREDITARY ANGIOEDEMA,TWrex-cause
721149628,5/13/2015 13:11:47,1635732057,5/13/2015 13:11:24,False,clixsense,0.7714,32254355,CAN,ON,London,64.229.237.183,HEREDITARY ANGIOEDEMA causes ABDOMINAL PAIN,43,83,,56,104,causes,0.48666426339228797,814028-FS1-4,Treatment with C1 inhibitor concentrate in ABDOMINAL PAIN attacks of patients with HEREDITARY ANGIOEDEMA,ABDOMINAL PAIN,HEREDITARY ANGIOEDEMA,TWrex-cause
721149628,5/13/2015 13:24:22,1635735574,5/13/2015 13:23:27,False,instagc,0.619,22981457,CAN,ON,Dundas,72.38.94.178,no_relation,43,83,,56,104,causes,0.48666426339228797,814028-FS1-4,Treatment with C1 inhibitor concentrate in ABDOMINAL PAIN attacks of patients with HEREDITARY ANGIOEDEMA,ABDOMINAL PAIN,HEREDITARY ANGIOEDEMA,TWrex-cause
721149630,5/13/2015 11:01:45,1635694743,5/13/2015 11:01:29,False,neodev,0.8631,11014534,GBR,B8,Bromley,86.18.149.6,ENDOMETRIOSIS causes PELVIC PAIN,148,239,,158,252,causes,0.985329278164293,814348-FS1-4,Evidence: • A review article ( 19 ) describes three criteria that must be met to indicate that endometriosis is the cause of chronic pelvic pain: ◊ PELVIC PAIN must be cyclic ◊ Endometriosis must be diagnosed surgically ◊ The treatment of ENDOMETRIOSIS results in prolonged pain relief  Comments: • None.,PELVIC PAIN,ENDOMETRIOSIS,TWrex-cause
721149630,5/13/2015 11:03:10,1635695348,5/13/2015 11:02:38,False,neodev,0.6667,12115558,USA,OH,Twinsburg,98.27.164.131,ENDOMETRIOSIS causes PELVIC PAIN,148,239,,158,252,causes,0.985329278164293,814348-FS1-4,Evidence: • A review article ( 19 ) describes three criteria that must be met to indicate that endometriosis is the cause of chronic pelvic pain: ◊ PELVIC PAIN must be cyclic ◊ Endometriosis must be diagnosed surgically ◊ The treatment of ENDOMETRIOSIS results in prolonged pain relief  Comments: • None.,PELVIC PAIN,ENDOMETRIOSIS,TWrex-cause
721149630,5/13/2015 11:26:07,1635700845,5/13/2015 11:25:21,False,neodev,0.7,18881135,CAN,ON,Ajax,99.243.87.224,ENDOMETRIOSIS causes PELVIC PAIN,148,239,,158,252,causes,0.985329278164293,814348-FS1-4,Evidence: • A review article ( 19 ) describes three criteria that must be met to indicate that endometriosis is the cause of chronic pelvic pain: ◊ PELVIC PAIN must be cyclic ◊ Endometriosis must be diagnosed surgically ◊ The treatment of ENDOMETRIOSIS results in prolonged pain relief  Comments: • None.,PELVIC PAIN,ENDOMETRIOSIS,TWrex-cause
721149630,5/13/2015 11:26:58,1635701105,5/13/2015 11:26:36,False,clixsense,0.65,29594612,NLD,11,Rotterdam,82.156.132.195,ENDOMETRIOSIS causes PELVIC PAIN,148,239,,158,252,causes,0.985329278164293,814348-FS1-4,Evidence: • A review article ( 19 ) describes three criteria that must be met to indicate that endometriosis is the cause of chronic pelvic pain: ◊ PELVIC PAIN must be cyclic ◊ Endometriosis must be diagnosed surgically ◊ The treatment of ENDOMETRIOSIS results in prolonged pain relief  Comments: • None.,PELVIC PAIN,ENDOMETRIOSIS,TWrex-cause
721149630,5/13/2015 11:33:09,1635702310,5/13/2015 11:32:43,False,clixsense,0.7292,6599120,GBR,B7,Bristol,185.14.137.237,ENDOMETRIOSIS causes PELVIC PAIN,148,239,,158,252,causes,0.985329278164293,814348-FS1-4,Evidence: • A review article ( 19 ) describes three criteria that must be met to indicate that endometriosis is the cause of chronic pelvic pain: ◊ PELVIC PAIN must be cyclic ◊ Endometriosis must be diagnosed surgically ◊ The treatment of ENDOMETRIOSIS results in prolonged pain relief  Comments: • None.,PELVIC PAIN,ENDOMETRIOSIS,TWrex-cause
721149630,5/13/2015 11:39:06,1635704598,5/13/2015 11:38:40,False,prodege,0.7381,27934334,GBR,D3,Swadlincote,109.150.228.127,ENDOMETRIOSIS causes PELVIC PAIN,148,239,,158,252,causes,0.985329278164293,814348-FS1-4,Evidence: • A review article ( 19 ) describes three criteria that must be met to indicate that endometriosis is the cause of chronic pelvic pain: ◊ PELVIC PAIN must be cyclic ◊ Endometriosis must be diagnosed surgically ◊ The treatment of ENDOMETRIOSIS results in prolonged pain relief  Comments: • None.,PELVIC PAIN,ENDOMETRIOSIS,TWrex-cause
721149630,5/13/2015 11:40:58,1635705018,5/13/2015 11:40:06,False,clixsense,0.7694,6338946,CAN,QC,Montréal,209.197.141.151,ENDOMETRIOSIS causes PELVIC PAIN,148,239,,158,252,causes,0.985329278164293,814348-FS1-4,Evidence: • A review article ( 19 ) describes three criteria that must be met to indicate that endometriosis is the cause of chronic pelvic pain: ◊ PELVIC PAIN must be cyclic ◊ Endometriosis must be diagnosed surgically ◊ The treatment of ENDOMETRIOSIS results in prolonged pain relief  Comments: • None.,PELVIC PAIN,ENDOMETRIOSIS,TWrex-cause
721149634,5/13/2015 11:00:30,1635694306,5/13/2015 11:00:17,False,elite,0.7817,31856422,GBR,C9,Workington,92.18.169.149,no_relation,29,98,,47,102,causes,0.8838834764831841,814905-FS1-4,"Nonendocrine tumors, such as FACIAL ANGIOFIBROMA and truncal collagenoma, are highly specific for MEN1",FACIAL ANGIOFIBROMA,MEN1,TWrex-cause
721149634,5/13/2015 11:00:57,1635694406,5/13/2015 11:00:29,False,neodev,0.8631,11014534,GBR,B8,Bromley,86.18.149.6,FACIAL ANGIOFIBROMA causes MEN1,29,98,,47,102,causes,0.8838834764831841,814905-FS1-4,"Nonendocrine tumors, such as FACIAL ANGIOFIBROMA and truncal collagenoma, are highly specific for MEN1",FACIAL ANGIOFIBROMA,MEN1,TWrex-cause
721149634,5/13/2015 11:02:01,1635694834,5/13/2015 11:01:45,False,neodev,0.6667,12115558,USA,OH,Twinsburg,98.27.164.131,no_relation,29,98,,47,102,causes,0.8838834764831841,814905-FS1-4,"Nonendocrine tumors, such as FACIAL ANGIOFIBROMA and truncal collagenoma, are highly specific for MEN1",FACIAL ANGIOFIBROMA,MEN1,TWrex-cause
721149634,5/13/2015 11:24:41,1635700403,5/13/2015 11:24:02,False,neodev,0.7,18881135,CAN,ON,Ajax,99.243.87.224,MEN1 causes FACIAL ANGIOFIBROMA,29,98,,47,102,causes,0.8838834764831841,814905-FS1-4,"Nonendocrine tumors, such as FACIAL ANGIOFIBROMA and truncal collagenoma, are highly specific for MEN1",FACIAL ANGIOFIBROMA,MEN1,TWrex-cause
721149634,5/13/2015 11:26:05,1635700837,5/13/2015 11:25:34,False,clixsense,0.65,29594612,NLD,11,Rotterdam,82.156.132.195,MEN1 causes FACIAL ANGIOFIBROMA,29,98,,47,102,causes,0.8838834764831841,814905-FS1-4,"Nonendocrine tumors, such as FACIAL ANGIOFIBROMA and truncal collagenoma, are highly specific for MEN1",FACIAL ANGIOFIBROMA,MEN1,TWrex-cause
721149634,5/13/2015 11:32:13,1635702091,5/13/2015 11:31:51,False,clixsense,0.7292,6599120,GBR,B7,Bristol,185.14.137.237,no_relation,29,98,,47,102,causes,0.8838834764831841,814905-FS1-4,"Nonendocrine tumors, such as FACIAL ANGIOFIBROMA and truncal collagenoma, are highly specific for MEN1",FACIAL ANGIOFIBROMA,MEN1,TWrex-cause
721149634,5/13/2015 11:38:09,1635704381,5/13/2015 11:37:19,False,prodege,0.7381,27934334,GBR,D3,Swadlincote,109.150.228.127,no_relation,29,98,,47,102,causes,0.8838834764831841,814905-FS1-4,"Nonendocrine tumors, such as FACIAL ANGIOFIBROMA and truncal collagenoma, are highly specific for MEN1",FACIAL ANGIOFIBROMA,MEN1,TWrex-cause
721149636,5/13/2015 10:43:18,1635689242,5/13/2015 10:42:44,False,prodege,1.0,21417560,GBR,C3,Cambridge,151.225.116.143,HPV causes WARTS (CONDYLOMATA ACUMINATA,149,22,,176,25,causes,0.99654575824488,810508-FS1-4,Human Papillomavirus (HPV) Infections: External Genital and Perianal Warts  Interferon alfa 2b: Treatment of external genital and perianal exophytic WARTS (CONDYLOMATA ACUMINATA caused by HPV,WARTS (CONDYLOMATA ACUMINATA,HPV,TWrex-cause
721149636,5/13/2015 10:51:27,1635691736,5/13/2015 10:51:15,False,neodev,0.4972,29579905,GBR,,,5.152.206.71,HPV causes WARTS (CONDYLOMATA ACUMINATA,149,22,,176,25,causes,0.99654575824488,810508-FS1-4,Human Papillomavirus (HPV) Infections: External Genital and Perianal Warts  Interferon alfa 2b: Treatment of external genital and perianal exophytic WARTS (CONDYLOMATA ACUMINATA caused by HPV,WARTS (CONDYLOMATA ACUMINATA,HPV,TWrex-cause
721149636,5/13/2015 10:51:32,1635691771,5/13/2015 10:51:13,False,clixsense,0.5639,17950689,GBR,Y9,Tonypandy,92.2.44.79,WARTS (CONDYLOMATA ACUMINATA causes HPV,149,22,,176,25,causes,0.99654575824488,810508-FS1-4,Human Papillomavirus (HPV) Infections: External Genital and Perianal Warts  Interferon alfa 2b: Treatment of external genital and perianal exophytic WARTS (CONDYLOMATA ACUMINATA caused by HPV,WARTS (CONDYLOMATA ACUMINATA,HPV,TWrex-cause
721149636,5/13/2015 10:52:29,1635692081,5/13/2015 10:52:07,False,neodev,0.6389,14096345,NLD,03,Eibergen,77.174.124.109,HPV causes WARTS (CONDYLOMATA ACUMINATA,149,22,,176,25,causes,0.99654575824488,810508-FS1-4,Human Papillomavirus (HPV) Infections: External Genital and Perianal Warts  Interferon alfa 2b: Treatment of external genital and perianal exophytic WARTS (CONDYLOMATA ACUMINATA caused by HPV,WARTS (CONDYLOMATA ACUMINATA,HPV,TWrex-cause
721149636,5/13/2015 10:52:34,1635692088,5/13/2015 10:52:08,False,instagc,0.6458,13581319,USA,IL,Mount Vernon,66.232.166.86,HPV causes WARTS (CONDYLOMATA ACUMINATA,149,22,,176,25,causes,0.99654575824488,810508-FS1-4,Human Papillomavirus (HPV) Infections: External Genital and Perianal Warts  Interferon alfa 2b: Treatment of external genital and perianal exophytic WARTS (CONDYLOMATA ACUMINATA caused by HPV,WARTS (CONDYLOMATA ACUMINATA,HPV,TWrex-cause
721149636,5/13/2015 10:52:51,1635692202,5/13/2015 10:52:12,False,clixsense,0.5972,10798016,GBR,C7,Coventry,86.24.245.191,WARTS (CONDYLOMATA ACUMINATA causes HPV,149,22,,176,25,causes,0.99654575824488,810508-FS1-4,Human Papillomavirus (HPV) Infections: External Genital and Perianal Warts  Interferon alfa 2b: Treatment of external genital and perianal exophytic WARTS (CONDYLOMATA ACUMINATA caused by HPV,WARTS (CONDYLOMATA ACUMINATA,HPV,TWrex-cause
721149636,5/13/2015 10:59:49,1635694114,5/13/2015 10:59:36,False,elite,0.7817,31856422,GBR,C9,Workington,92.18.169.149,HPV causes WARTS (CONDYLOMATA ACUMINATA,149,22,,176,25,causes,0.99654575824488,810508-FS1-4,Human Papillomavirus (HPV) Infections: External Genital and Perianal Warts  Interferon alfa 2b: Treatment of external genital and perianal exophytic WARTS (CONDYLOMATA ACUMINATA caused by HPV,WARTS (CONDYLOMATA ACUMINATA,HPV,TWrex-cause
721149730,5/13/2015 11:02:29,1635695008,5/13/2015 11:02:19,False,elite,0.875,31856422,GBR,C9,Workington,92.18.169.149,VULVODYNIA causes PAIN,56,5,,59,15,causes,0.982707629823991,812935-FS1-4,"60   VULVODYNIA is further characterized by whether the PAIN is generalized or localized and whether it occurs with or without provocation, or both.",PAIN,VULVODYNIA,TWrex-cause
721149730,5/13/2015 11:44:18,1635705620,5/13/2015 11:43:56,False,prodege,0.7472,27934334,GBR,D3,Swadlincote,109.150.228.127,VULVODYNIA causes PAIN,56,5,,59,15,causes,0.982707629823991,812935-FS1-4,"60   VULVODYNIA is further characterized by whether the PAIN is generalized or localized and whether it occurs with or without provocation, or both.",PAIN,VULVODYNIA,TWrex-cause
721149730,5/13/2015 11:50:33,1635707267,5/13/2015 11:50:03,False,clixsense,0.6319,6338946,CAN,QC,Montréal,209.197.141.151,VULVODYNIA causes PAIN,56,5,,59,15,causes,0.982707629823991,812935-FS1-4,"60   VULVODYNIA is further characterized by whether the PAIN is generalized or localized and whether it occurs with or without provocation, or both.",PAIN,VULVODYNIA,TWrex-cause
721149730,5/13/2015 11:57:26,1635709185,5/13/2015 11:57:08,False,neodev,0.7083,18881135,CAN,ON,Ajax,99.243.87.224,VULVODYNIA causes PAIN,56,5,,59,15,causes,0.982707629823991,812935-FS1-4,"60   VULVODYNIA is further characterized by whether the PAIN is generalized or localized and whether it occurs with or without provocation, or both.",PAIN,VULVODYNIA,TWrex-cause
721149730,5/13/2015 12:36:21,1635722913,5/13/2015 12:35:48,False,prodege,0.8786,23482077,USA,TX,Garland,71.164.238.226,VULVODYNIA causes PAIN,56,5,,59,15,causes,0.982707629823991,812935-FS1-4,"60   VULVODYNIA is further characterized by whether the PAIN is generalized or localized and whether it occurs with or without provocation, or both.",PAIN,VULVODYNIA,TWrex-cause
721149730,5/13/2015 12:50:42,1635726248,5/13/2015 12:50:17,False,prodege,0.8333,14848125,GBR,L6,Shrewsbury,86.138.223.142,VULVODYNIA causes PAIN,56,5,,59,15,causes,0.982707629823991,812935-FS1-4,"60   VULVODYNIA is further characterized by whether the PAIN is generalized or localized and whether it occurs with or without provocation, or both.",PAIN,VULVODYNIA,TWrex-cause
721149730,5/13/2015 12:53:36,1635727003,5/13/2015 12:53:15,False,points4rewards,0.8333,28755767,USA,VA,Chester,68.57.118.32,VULVODYNIA causes PAIN,56,5,,59,15,causes,0.982707629823991,812935-FS1-4,"60   VULVODYNIA is further characterized by whether the PAIN is generalized or localized and whether it occurs with or without provocation, or both.",PAIN,VULVODYNIA,TWrex-cause
721149735,5/13/2015 12:37:28,1635723155,5/13/2015 12:36:51,False,prodege,0.8786,23482077,USA,TX,Garland,71.164.238.226,no_relation,81,120,,92,139,causes,0.981980506061966,813677-FS1-4,"In 1933, the discovery of a cohort of people with sinusitis, bronchiectasis, and DEXTROCARDIA led to the description of KARTAGENER SYNDROME",DEXTROCARDIA,KARTAGENER SYNDROME,TWrex-cause
721149735,5/13/2015 12:51:41,1635726490,5/13/2015 12:50:59,False,prodege,0.8333,14848125,GBR,L6,Shrewsbury,86.138.223.142,no_relation,81,120,,92,139,causes,0.981980506061966,813677-FS1-4,"In 1933, the discovery of a cohort of people with sinusitis, bronchiectasis, and DEXTROCARDIA led to the description of KARTAGENER SYNDROME",DEXTROCARDIA,KARTAGENER SYNDROME,TWrex-cause
721149735,5/13/2015 12:54:35,1635727262,5/13/2015 12:53:58,False,points4rewards,0.8333,28755767,USA,VA,Chester,68.57.118.32,no_relation,81,120,,92,139,causes,0.981980506061966,813677-FS1-4,"In 1933, the discovery of a cohort of people with sinusitis, bronchiectasis, and DEXTROCARDIA led to the description of KARTAGENER SYNDROME",DEXTROCARDIA,KARTAGENER SYNDROME,TWrex-cause
721149735,5/13/2015 13:05:32,1635730586,5/13/2015 13:05:16,False,clixsense,0.6875,17609394,CAN,ON,Mississauga,99.229.57.218,no_relation,81,120,,92,139,causes,0.981980506061966,813677-FS1-4,"In 1933, the discovery of a cohort of people with sinusitis, bronchiectasis, and DEXTROCARDIA led to the description of KARTAGENER SYNDROME",DEXTROCARDIA,KARTAGENER SYNDROME,TWrex-cause
721149735,5/13/2015 13:15:14,1635733095,5/13/2015 13:14:37,False,neodev,0.75,20233773,USA,NY,New York,198.211.101.21,no_relation,81,120,,92,139,causes,0.981980506061966,813677-FS1-4,"In 1933, the discovery of a cohort of people with sinusitis, bronchiectasis, and DEXTROCARDIA led to the description of KARTAGENER SYNDROME",DEXTROCARDIA,KARTAGENER SYNDROME,TWrex-cause
721149735,5/13/2015 13:26:10,1635735956,5/13/2015 13:25:44,False,gifthunterclub,0.7917,29582088,GBR,I2,Manchester,89.240.68.44,no_relation,81,120,,92,139,causes,0.981980506061966,813677-FS1-4,"In 1933, the discovery of a cohort of people with sinusitis, bronchiectasis, and DEXTROCARDIA led to the description of KARTAGENER SYNDROME",DEXTROCARDIA,KARTAGENER SYNDROME,TWrex-cause
721149735,5/13/2015 13:36:14,1635738592,5/13/2015 13:35:39,False,neodev,0.5714,24564999,GBR,H9,London,86.145.227.9,KARTAGENER SYNDROME causes DEXTROCARDIA,81,120,,92,139,causes,0.981980506061966,813677-FS1-4,"In 1933, the discovery of a cohort of people with sinusitis, bronchiectasis, and DEXTROCARDIA led to the description of KARTAGENER SYNDROME",DEXTROCARDIA,KARTAGENER SYNDROME,TWrex-cause
721149742,5/13/2015 11:01:07,1635694481,5/13/2015 11:00:45,False,clixsense,0.6964,10798016,GBR,C7,Coventry,86.24.245.191,no_relation,82,160,,103,173,causes,0.7826237921249258,802597-FS1-4,"Infants born with this disease may have facial angiofibromas, astrocytomas of the CENTRAL NERVOUS SYSTEM hamartomas of the retina, and other lesions, producing HYDROCEPHALUS mental retardation, autism, and seizures.",CENTRAL NERVOUS SYSTEM,HYDROCEPHALUS,TWrex-cause
721149742,5/13/2015 11:02:04,1635694842,5/13/2015 11:01:53,False,elite,0.875,31856422,GBR,C9,Workington,92.18.169.149,no_relation,82,160,,103,173,causes,0.7826237921249258,802597-FS1-4,"Infants born with this disease may have facial angiofibromas, astrocytomas of the CENTRAL NERVOUS SYSTEM hamartomas of the retina, and other lesions, producing HYDROCEPHALUS mental retardation, autism, and seizures.",CENTRAL NERVOUS SYSTEM,HYDROCEPHALUS,TWrex-cause
721149742,5/13/2015 11:43:17,1635705471,5/13/2015 11:42:59,False,prodege,0.7472,27934334,GBR,D3,Swadlincote,109.150.228.127,no_relation,82,160,,103,173,causes,0.7826237921249258,802597-FS1-4,"Infants born with this disease may have facial angiofibromas, astrocytomas of the CENTRAL NERVOUS SYSTEM hamartomas of the retina, and other lesions, producing HYDROCEPHALUS mental retardation, autism, and seizures.",CENTRAL NERVOUS SYSTEM,HYDROCEPHALUS,TWrex-cause
721149742,5/13/2015 11:49:35,1635707050,5/13/2015 11:49:00,False,clixsense,0.6319,6338946,CAN,QC,Montréal,209.197.141.151,CENTRAL NERVOUS SYSTEM causes HYDROCEPHALUS,82,160,,103,173,causes,0.7826237921249258,802597-FS1-4,"Infants born with this disease may have facial angiofibromas, astrocytomas of the CENTRAL NERVOUS SYSTEM hamartomas of the retina, and other lesions, producing HYDROCEPHALUS mental retardation, autism, and seizures.",CENTRAL NERVOUS SYSTEM,HYDROCEPHALUS,TWrex-cause
721149742,5/13/2015 11:56:47,1635709026,5/13/2015 11:56:27,False,neodev,0.7083,18881135,CAN,ON,Ajax,99.243.87.224,CENTRAL NERVOUS SYSTEM causes HYDROCEPHALUS,82,160,,103,173,causes,0.7826237921249258,802597-FS1-4,"Infants born with this disease may have facial angiofibromas, astrocytomas of the CENTRAL NERVOUS SYSTEM hamartomas of the retina, and other lesions, producing HYDROCEPHALUS mental retardation, autism, and seizures.",CENTRAL NERVOUS SYSTEM,HYDROCEPHALUS,TWrex-cause
721149742,5/13/2015 12:31:05,1635721380,5/13/2015 12:30:51,False,bitcoinget,0.5625,21614812,USA,PA,Erie,174.100.250.115,no_relation,82,160,,103,173,causes,0.7826237921249258,802597-FS1-4,"Infants born with this disease may have facial angiofibromas, astrocytomas of the CENTRAL NERVOUS SYSTEM hamartomas of the retina, and other lesions, producing HYDROCEPHALUS mental retardation, autism, and seizures.",CENTRAL NERVOUS SYSTEM,HYDROCEPHALUS,TWrex-cause
721149742,5/13/2015 12:35:06,1635722734,5/13/2015 12:34:55,False,prodege,0.8786,23482077,USA,TX,Garland,71.164.238.226,no_relation,82,160,,103,173,causes,0.7826237921249258,802597-FS1-4,"Infants born with this disease may have facial angiofibromas, astrocytomas of the CENTRAL NERVOUS SYSTEM hamartomas of the retina, and other lesions, producing HYDROCEPHALUS mental retardation, autism, and seizures.",CENTRAL NERVOUS SYSTEM,HYDROCEPHALUS,TWrex-cause
721149747,5/13/2015 10:02:02,1635677869,5/13/2015 10:01:38,False,neodev,1.0,30627835,GBR,H9,London,5.81.27.94,DRUGS causes IMPAIRED GLUCOSE TOLERANCE,95,0,,120,5,causes,0.9958932064677041,810018-FS1-4,"DRUGS Chemical Agents, and Toxins  INTRODUCTION  Many pharmaceutical agents are known to cause IMPAIRED GLUCOSE TOLERANCE and, occasionally, diabetes [ see  Table 2.",IMPAIRED GLUCOSE TOLERANCE,DRUGS,TWrex-cause
721149747,5/13/2015 10:07:14,1635679116,5/13/2015 10:06:52,False,instagc,0.75,18531561,CAN,ON,Mississauga,99.229.92.227,DRUGS causes IMPAIRED GLUCOSE TOLERANCE,95,0,,120,5,causes,0.9958932064677041,810018-FS1-4,"DRUGS Chemical Agents, and Toxins  INTRODUCTION  Many pharmaceutical agents are known to cause IMPAIRED GLUCOSE TOLERANCE and, occasionally, diabetes [ see  Table 2.",IMPAIRED GLUCOSE TOLERANCE,DRUGS,TWrex-cause
721149747,5/13/2015 10:09:24,1635679696,5/13/2015 10:09:00,False,gifthunterclub,0.5278,30901412,GBR,H9,London,77.89.149.62,no_relation,95,0,,120,5,causes,0.9958932064677041,810018-FS1-4,"DRUGS Chemical Agents, and Toxins  INTRODUCTION  Many pharmaceutical agents are known to cause IMPAIRED GLUCOSE TOLERANCE and, occasionally, diabetes [ see  Table 2.",IMPAIRED GLUCOSE TOLERANCE,DRUGS,TWrex-cause
721149747,5/13/2015 10:15:54,1635681369,5/13/2015 10:15:40,False,neodev,0.5292,31326282,NLD,,,82.169.243.65,DRUGS causes IMPAIRED GLUCOSE TOLERANCE,95,0,,120,5,causes,0.9958932064677041,810018-FS1-4,"DRUGS Chemical Agents, and Toxins  INTRODUCTION  Many pharmaceutical agents are known to cause IMPAIRED GLUCOSE TOLERANCE and, occasionally, diabetes [ see  Table 2.",IMPAIRED GLUCOSE TOLERANCE,DRUGS,TWrex-cause
721149747,5/13/2015 10:17:49,1635681828,5/13/2015 10:17:20,False,prodege,0.6333,21417560,GBR,C3,Cambridge,151.225.116.143,DRUGS causes IMPAIRED GLUCOSE TOLERANCE,95,0,,120,5,causes,0.9958932064677041,810018-FS1-4,"DRUGS Chemical Agents, and Toxins  INTRODUCTION  Many pharmaceutical agents are known to cause IMPAIRED GLUCOSE TOLERANCE and, occasionally, diabetes [ see  Table 2.",IMPAIRED GLUCOSE TOLERANCE,DRUGS,TWrex-cause
721149747,5/13/2015 10:21:10,1635683004,5/13/2015 10:20:54,False,pocketmoneygpt,0.6349,28884030,USA,WI,Minocqua,75.143.134.247,DRUGS causes IMPAIRED GLUCOSE TOLERANCE,95,0,,120,5,causes,0.9958932064677041,810018-FS1-4,"DRUGS Chemical Agents, and Toxins  INTRODUCTION  Many pharmaceutical agents are known to cause IMPAIRED GLUCOSE TOLERANCE and, occasionally, diabetes [ see  Table 2.",IMPAIRED GLUCOSE TOLERANCE,DRUGS,TWrex-cause
721149747,5/13/2015 10:22:41,1635683409,5/13/2015 10:22:00,False,points4rewards,0.5833,20113482,USA,OR,Portland,67.213.218.72,no_relation,95,0,,120,5,causes,0.9958932064677041,810018-FS1-4,"DRUGS Chemical Agents, and Toxins  INTRODUCTION  Many pharmaceutical agents are known to cause IMPAIRED GLUCOSE TOLERANCE and, occasionally, diabetes [ see  Table 2.",IMPAIRED GLUCOSE TOLERANCE,DRUGS,TWrex-cause
721149750,5/13/2015 10:46:24,1635690183,5/13/2015 10:45:56,False,prodege,0.875,3056891,CAN,ON,Niagara Falls,173.238.144.19,HUMAN VIRUSES causes VIRAL HEPATITIS,243,195,,257,208,causes,0.5714285714285711,810183-FS1-4,"116  Warnings/Precautions  Warnings  Risk of Transmissible Agents in Plasma derived Preparations  Because HBIG is prepared from pooled human plasma, it is a potential vehicle for transmission of HUMAN VIRUSES including the causative agents of VIRAL HEPATITIS and HIV infection, and theoretically may carry a risk of transmitting the causative agent of Creutzfeldt Jakob disease (CJD) or variant CJD (vCJD.",VIRAL HEPATITIS,HUMAN VIRUSES,TWrex-cause
721149750,5/13/2015 10:51:25,1635691708,5/13/2015 10:51:04,False,clixsense,0.5972,17950689,GBR,Y9,Tonypandy,92.2.44.79,VIRAL HEPATITIS causes HUMAN VIRUSES,243,195,,257,208,causes,0.5714285714285711,810183-FS1-4,"116  Warnings/Precautions  Warnings  Risk of Transmissible Agents in Plasma derived Preparations  Because HBIG is prepared from pooled human plasma, it is a potential vehicle for transmission of HUMAN VIRUSES including the causative agents of VIRAL HEPATITIS and HIV infection, and theoretically may carry a risk of transmitting the causative agent of Creutzfeldt Jakob disease (CJD) or variant CJD (vCJD.",VIRAL HEPATITIS,HUMAN VIRUSES,TWrex-cause
721149750,5/13/2015 10:51:35,1635691786,5/13/2015 10:51:15,False,neodev,0.6127,29579905,GBR,,,5.152.206.71,VIRAL HEPATITIS causes HUMAN VIRUSES,243,195,,257,208,causes,0.5714285714285711,810183-FS1-4,"116  Warnings/Precautions  Warnings  Risk of Transmissible Agents in Plasma derived Preparations  Because HBIG is prepared from pooled human plasma, it is a potential vehicle for transmission of HUMAN VIRUSES including the causative agents of VIRAL HEPATITIS and HIV infection, and theoretically may carry a risk of transmitting the causative agent of Creutzfeldt Jakob disease (CJD) or variant CJD (vCJD.",VIRAL HEPATITIS,HUMAN VIRUSES,TWrex-cause
721149750,5/13/2015 10:54:26,1635692588,5/13/2015 10:54:08,False,instagc,0.5,13581319,USA,IL,Mount Vernon,66.232.166.86,no_relation,243,195,,257,208,causes,0.5714285714285711,810183-FS1-4,"116  Warnings/Precautions  Warnings  Risk of Transmissible Agents in Plasma derived Preparations  Because HBIG is prepared from pooled human plasma, it is a potential vehicle for transmission of HUMAN VIRUSES including the causative agents of VIRAL HEPATITIS and HIV infection, and theoretically may carry a risk of transmitting the causative agent of Creutzfeldt Jakob disease (CJD) or variant CJD (vCJD.",VIRAL HEPATITIS,HUMAN VIRUSES,TWrex-cause
721149750,5/13/2015 10:55:23,1635692732,5/13/2015 10:54:46,False,neodev,0.5083,14096345,NLD,03,Eibergen,77.174.124.109,HUMAN VIRUSES causes VIRAL HEPATITIS,243,195,,257,208,causes,0.5714285714285711,810183-FS1-4,"116  Warnings/Precautions  Warnings  Risk of Transmissible Agents in Plasma derived Preparations  Because HBIG is prepared from pooled human plasma, it is a potential vehicle for transmission of HUMAN VIRUSES including the causative agents of VIRAL HEPATITIS and HIV infection, and theoretically may carry a risk of transmitting the causative agent of Creutzfeldt Jakob disease (CJD) or variant CJD (vCJD.",VIRAL HEPATITIS,HUMAN VIRUSES,TWrex-cause
721149750,5/13/2015 10:55:49,1635692883,5/13/2015 10:54:57,False,pocketmoneygpt,0.4732,21432964,GBR,T5,Aberdeen,88.104.216.210,HUMAN VIRUSES causes VIRAL HEPATITIS,243,195,,257,208,causes,0.5714285714285711,810183-FS1-4,"116  Warnings/Precautions  Warnings  Risk of Transmissible Agents in Plasma derived Preparations  Because HBIG is prepared from pooled human plasma, it is a potential vehicle for transmission of HUMAN VIRUSES including the causative agents of VIRAL HEPATITIS and HIV infection, and theoretically may carry a risk of transmitting the causative agent of Creutzfeldt Jakob disease (CJD) or variant CJD (vCJD.",VIRAL HEPATITIS,HUMAN VIRUSES,TWrex-cause
721149750,5/13/2015 10:57:59,1635693675,5/13/2015 10:57:10,False,neodev,0.7440000000000001,11014534,GBR,B8,Bromley,86.18.149.6,HUMAN VIRUSES causes VIRAL HEPATITIS,243,195,,257,208,causes,0.5714285714285711,810183-FS1-4,"116  Warnings/Precautions  Warnings  Risk of Transmissible Agents in Plasma derived Preparations  Because HBIG is prepared from pooled human plasma, it is a potential vehicle for transmission of HUMAN VIRUSES including the causative agents of VIRAL HEPATITIS and HIV infection, and theoretically may carry a risk of transmitting the causative agent of Creutzfeldt Jakob disease (CJD) or variant CJD (vCJD.",VIRAL HEPATITIS,HUMAN VIRUSES,TWrex-cause
721149751,5/13/2015 10:45:56,1635690047,5/13/2015 10:45:35,False,prodege,0.875,3056891,CAN,ON,Niagara Falls,173.238.144.19,ITP causes PERSISTENT SEVERE THROMBOCYTOPENIA,165,143,,198,146,causes,0.481125224324688,814188-FS1-4,• Note that splenectomy is recommended for patients with persistent platelet counts  9  cells/L for 4 to 6 weeks and for patients who have had ITP for 3 months with PERSISTENT SEVERE THROMBOCYTOPENIA (platelet count  9  cells/L) despite treatment.,PERSISTENT SEVERE THROMBOCYTOPENIA,ITP,TWrex-cause
721149751,5/13/2015 10:51:03,1635691585,5/13/2015 10:50:40,False,clixsense,0.5972,17950689,GBR,Y9,Tonypandy,92.2.44.79,PERSISTENT SEVERE THROMBOCYTOPENIA causes ITP,165,143,,198,146,causes,0.481125224324688,814188-FS1-4,• Note that splenectomy is recommended for patients with persistent platelet counts  9  cells/L for 4 to 6 weeks and for patients who have had ITP for 3 months with PERSISTENT SEVERE THROMBOCYTOPENIA (platelet count  9  cells/L) despite treatment.,PERSISTENT SEVERE THROMBOCYTOPENIA,ITP,TWrex-cause
721149751,5/13/2015 10:51:10,1635691634,5/13/2015 10:50:43,False,neodev,0.6127,29579905,GBR,,,5.152.206.71,no_relation,165,143,,198,146,causes,0.481125224324688,814188-FS1-4,• Note that splenectomy is recommended for patients with persistent platelet counts  9  cells/L for 4 to 6 weeks and for patients who have had ITP for 3 months with PERSISTENT SEVERE THROMBOCYTOPENIA (platelet count  9  cells/L) despite treatment.,PERSISTENT SEVERE THROMBOCYTOPENIA,ITP,TWrex-cause
721149751,5/13/2015 10:54:06,1635692512,5/13/2015 10:53:50,False,instagc,0.5,13581319,USA,IL,Mount Vernon,66.232.166.86,no_relation,165,143,,198,146,causes,0.481125224324688,814188-FS1-4,• Note that splenectomy is recommended for patients with persistent platelet counts  9  cells/L for 4 to 6 weeks and for patients who have had ITP for 3 months with PERSISTENT SEVERE THROMBOCYTOPENIA (platelet count  9  cells/L) despite treatment.,PERSISTENT SEVERE THROMBOCYTOPENIA,ITP,TWrex-cause
721149751,5/13/2015 10:54:46,1635692646,5/13/2015 10:54:21,False,neodev,0.5083,14096345,NLD,03,Eibergen,77.174.124.109,no_relation,165,143,,198,146,causes,0.481125224324688,814188-FS1-4,• Note that splenectomy is recommended for patients with persistent platelet counts  9  cells/L for 4 to 6 weeks and for patients who have had ITP for 3 months with PERSISTENT SEVERE THROMBOCYTOPENIA (platelet count  9  cells/L) despite treatment.,PERSISTENT SEVERE THROMBOCYTOPENIA,ITP,TWrex-cause
721149751,5/13/2015 10:54:56,1635692669,5/13/2015 10:54:27,False,pocketmoneygpt,0.4732,21432964,GBR,T5,Aberdeen,88.104.216.210,ITP causes PERSISTENT SEVERE THROMBOCYTOPENIA,165,143,,198,146,causes,0.481125224324688,814188-FS1-4,• Note that splenectomy is recommended for patients with persistent platelet counts  9  cells/L for 4 to 6 weeks and for patients who have had ITP for 3 months with PERSISTENT SEVERE THROMBOCYTOPENIA (platelet count  9  cells/L) despite treatment.,PERSISTENT SEVERE THROMBOCYTOPENIA,ITP,TWrex-cause
721149751,5/13/2015 10:57:10,1635693335,5/13/2015 10:56:42,False,neodev,0.7440000000000001,11014534,GBR,B8,Bromley,86.18.149.6,no_relation,165,143,,198,146,causes,0.481125224324688,814188-FS1-4,• Note that splenectomy is recommended for patients with persistent platelet counts  9  cells/L for 4 to 6 weeks and for patients who have had ITP for 3 months with PERSISTENT SEVERE THROMBOCYTOPENIA (platelet count  9  cells/L) despite treatment.,PERSISTENT SEVERE THROMBOCYTOPENIA,ITP,TWrex-cause
721149754,5/13/2015 11:02:17,1635694902,5/13/2015 11:02:06,False,elite,0.875,31856422,GBR,C9,Workington,92.18.169.149,POSTPARTUM THYROTOXICOSIS causes GRAVES DISEASE,98,26,,111,51,causes,0.7559289460184542,814787-FS1-4,"For example, a woman with POSTPARTUM THYROTOXICOSIS could have painless (postpartum) thyroiditis, GRAVES DISEASE or even factitious thyrotoxicosis—each of which would be treated quite differently.",GRAVES DISEASE,POSTPARTUM THYROTOXICOSIS,TWrex-cause
721149754,5/13/2015 11:43:54,1635705555,5/13/2015 11:43:18,False,prodege,0.7472,27934334,GBR,D3,Swadlincote,109.150.228.127,GRAVES DISEASE causes POSTPARTUM THYROTOXICOSIS,98,26,,111,51,causes,0.7559289460184542,814787-FS1-4,"For example, a woman with POSTPARTUM THYROTOXICOSIS could have painless (postpartum) thyroiditis, GRAVES DISEASE or even factitious thyrotoxicosis—each of which would be treated quite differently.",GRAVES DISEASE,POSTPARTUM THYROTOXICOSIS,TWrex-cause
721149754,5/13/2015 11:50:02,1635707147,5/13/2015 11:49:35,False,clixsense,0.6319,6338946,CAN,QC,Montréal,209.197.141.151,no_relation,98,26,,111,51,causes,0.7559289460184542,814787-FS1-4,"For example, a woman with POSTPARTUM THYROTOXICOSIS could have painless (postpartum) thyroiditis, GRAVES DISEASE or even factitious thyrotoxicosis—each of which would be treated quite differently.",GRAVES DISEASE,POSTPARTUM THYROTOXICOSIS,TWrex-cause
721149754,5/13/2015 11:57:06,1635709082,5/13/2015 11:56:48,False,neodev,0.7083,18881135,CAN,ON,Ajax,99.243.87.224,POSTPARTUM THYROTOXICOSIS causes GRAVES DISEASE,98,26,,111,51,causes,0.7559289460184542,814787-FS1-4,"For example, a woman with POSTPARTUM THYROTOXICOSIS could have painless (postpartum) thyroiditis, GRAVES DISEASE or even factitious thyrotoxicosis—each of which would be treated quite differently.",GRAVES DISEASE,POSTPARTUM THYROTOXICOSIS,TWrex-cause
721149754,5/13/2015 12:31:11,1635721389,5/13/2015 12:31:06,False,bitcoinget,0.5625,21614812,USA,PA,Erie,174.100.250.115,no_relation,98,26,,111,51,causes,0.7559289460184542,814787-FS1-4,"For example, a woman with POSTPARTUM THYROTOXICOSIS could have painless (postpartum) thyroiditis, GRAVES DISEASE or even factitious thyrotoxicosis—each of which would be treated quite differently.",GRAVES DISEASE,POSTPARTUM THYROTOXICOSIS,TWrex-cause
721149754,5/13/2015 12:35:45,1635722835,5/13/2015 12:35:07,False,prodege,0.8786,23482077,USA,TX,Garland,71.164.238.226,no_relation,98,26,,111,51,causes,0.7559289460184542,814787-FS1-4,"For example, a woman with POSTPARTUM THYROTOXICOSIS could have painless (postpartum) thyroiditis, GRAVES DISEASE or even factitious thyrotoxicosis—each of which would be treated quite differently.",GRAVES DISEASE,POSTPARTUM THYROTOXICOSIS,TWrex-cause
721149754,5/13/2015 12:42:58,1635724540,5/13/2015 12:42:48,False,neodev,0.25,32216655,NLD,07,Amsterdam,145.100.72.168,no_relation,98,26,,111,51,causes,0.7559289460184542,814787-FS1-4,"For example, a woman with POSTPARTUM THYROTOXICOSIS could have painless (postpartum) thyroiditis, GRAVES DISEASE or even factitious thyrotoxicosis—each of which would be treated quite differently.",GRAVES DISEASE,POSTPARTUM THYROTOXICOSIS,TWrex-cause
721702150,5/14/2015 18:24:44,1636448469,5/14/2015 18:24:24,False,neodev,1.0,31743852,GBR,G5,Margate,85.210.120.188,CHONDROITIN SULFATE TREATED causes PAIN,39,51,,42,78,causes,0.48336824452283206,803399-FS1-4,There was a significant alleviation of PAIN in the CHONDROITIN SULFATE TREATED groups compared to placebo.,PAIN,CHONDROITIN SULFATE TREATED,TWrex-cause
721702150,5/14/2015 18:35:21,1636454815,5/14/2015 18:35:00,False,prodege,0.5306,1878608,CAN,BC,Vancouver,216.251.132.22,no_relation,39,51,,42,78,causes,0.48336824452283206,803399-FS1-4,There was a significant alleviation of PAIN in the CHONDROITIN SULFATE TREATED groups compared to placebo.,PAIN,CHONDROITIN SULFATE TREATED,TWrex-cause
721702150,5/14/2015 18:35:58,1636455121,5/14/2015 18:35:41,False,elite,0.6153,31883685,GBR,H2,Accrington,80.47.186.28,no_relation,39,51,,42,78,causes,0.48336824452283206,803399-FS1-4,There was a significant alleviation of PAIN in the CHONDROITIN SULFATE TREATED groups compared to placebo.,PAIN,CHONDROITIN SULFATE TREATED,TWrex-cause
721702150,5/14/2015 18:36:17,1636455225,5/14/2015 18:35:59,False,clixsense,0.6639,22751911,NLD,04,Groningen,195.241.153.97,no_relation,39,51,,42,78,causes,0.48336824452283206,803399-FS1-4,There was a significant alleviation of PAIN in the CHONDROITIN SULFATE TREATED groups compared to placebo.,PAIN,CHONDROITIN SULFATE TREATED,TWrex-cause
721702150,5/14/2015 18:37:33,1636455815,5/14/2015 18:37:09,False,points4rewards,0.6131,20113482,USA,OR,Portland,67.213.218.72,no_relation,39,51,,42,78,causes,0.48336824452283206,803399-FS1-4,There was a significant alleviation of PAIN in the CHONDROITIN SULFATE TREATED groups compared to placebo.,PAIN,CHONDROITIN SULFATE TREATED,TWrex-cause
721702150,5/14/2015 18:37:49,1636455963,5/14/2015 18:37:30,False,instagc,0.5179,13581319,USA,IL,Mount Vernon,66.232.166.86,CHONDROITIN SULFATE TREATED causes PAIN,39,51,,42,78,causes,0.48336824452283206,803399-FS1-4,There was a significant alleviation of PAIN in the CHONDROITIN SULFATE TREATED groups compared to placebo.,PAIN,CHONDROITIN SULFATE TREATED,TWrex-cause
721702150,5/14/2015 18:39:46,1636456834,5/14/2015 18:39:08,False,prodege,0.5613,3587109,CAN,NS,Sydney,142.177.43.253,CHONDROITIN SULFATE TREATED causes PAIN,39,51,,42,78,causes,0.48336824452283206,803399-FS1-4,There was a significant alleviation of PAIN in the CHONDROITIN SULFATE TREATED groups compared to placebo.,PAIN,CHONDROITIN SULFATE TREATED,TWrex-cause
721702151,5/14/2015 18:41:44,1636457790,5/14/2015 18:41:25,False,clixsense,0.5111,6362702,GBR,B7,Bristol,90.222.95.91,ASCENDING PARALYSIS causes ACUTE HEPATIC PORPHYRIA,122,24,,140,47,causes,0.44172610429938597,814004-FS1-4,• Reviews indicate that ACUTE HEPATIC PORPHYRIA with neuropsychiatric disturbances and signs of autonomic dysfunction and ASCENDING PARALYSIS with bilateral facial weakness may mimic rabies.,ASCENDING PARALYSIS,ACUTE HEPATIC PORPHYRIA,TWrex-cause
721702151,5/14/2015 18:42:16,1636457976,5/14/2015 18:41:35,False,prodege,0.5833,21417560,GBR,C3,Cambridge,151.225.116.143,no_relation,122,24,,140,47,causes,0.44172610429938597,814004-FS1-4,• Reviews indicate that ACUTE HEPATIC PORPHYRIA with neuropsychiatric disturbances and signs of autonomic dysfunction and ASCENDING PARALYSIS with bilateral facial weakness may mimic rabies.,ASCENDING PARALYSIS,ACUTE HEPATIC PORPHYRIA,TWrex-cause
721702151,5/14/2015 18:42:46,1636458182,5/14/2015 18:42:17,False,neodev,0.5972,18881135,CAN,ON,Ajax,99.243.87.224,ACUTE HEPATIC PORPHYRIA causes ASCENDING PARALYSIS,122,24,,140,47,causes,0.44172610429938597,814004-FS1-4,• Reviews indicate that ACUTE HEPATIC PORPHYRIA with neuropsychiatric disturbances and signs of autonomic dysfunction and ASCENDING PARALYSIS with bilateral facial weakness may mimic rabies.,ASCENDING PARALYSIS,ACUTE HEPATIC PORPHYRIA,TWrex-cause
721702151,5/14/2015 18:48:51,1636460592,5/14/2015 18:48:44,False,neodev,0.6478,31706957,NLD,07,Amsterdam,145.100.72.165,no_relation,122,24,,140,47,causes,0.44172610429938597,814004-FS1-4,• Reviews indicate that ACUTE HEPATIC PORPHYRIA with neuropsychiatric disturbances and signs of autonomic dysfunction and ASCENDING PARALYSIS with bilateral facial weakness may mimic rabies.,ASCENDING PARALYSIS,ACUTE HEPATIC PORPHYRIA,TWrex-cause
721702151,5/14/2015 18:54:36,1636463198,5/14/2015 18:54:09,False,instagc,0.6881,30326470,USA,CA,Santee,99.44.37.73,ACUTE HEPATIC PORPHYRIA causes ASCENDING PARALYSIS,122,24,,140,47,causes,0.44172610429938597,814004-FS1-4,• Reviews indicate that ACUTE HEPATIC PORPHYRIA with neuropsychiatric disturbances and signs of autonomic dysfunction and ASCENDING PARALYSIS with bilateral facial weakness may mimic rabies.,ASCENDING PARALYSIS,ACUTE HEPATIC PORPHYRIA,TWrex-cause
721702151,5/14/2015 19:00:40,1636465659,5/14/2015 19:00:10,False,clixsense,0.7083,28351359,GBR,F6,Romford,80.43.183.92,no_relation,122,24,,140,47,causes,0.44172610429938597,814004-FS1-4,• Reviews indicate that ACUTE HEPATIC PORPHYRIA with neuropsychiatric disturbances and signs of autonomic dysfunction and ASCENDING PARALYSIS with bilateral facial weakness may mimic rabies.,ASCENDING PARALYSIS,ACUTE HEPATIC PORPHYRIA,TWrex-cause
721702151,5/14/2015 19:29:17,1636493192,5/14/2015 19:28:41,False,clixsense,0.6607,10798016,GBR,C7,Coventry,86.24.245.191,no_relation,122,24,,140,47,causes,0.44172610429938597,814004-FS1-4,• Reviews indicate that ACUTE HEPATIC PORPHYRIA with neuropsychiatric disturbances and signs of autonomic dysfunction and ASCENDING PARALYSIS with bilateral facial weakness may mimic rabies.,ASCENDING PARALYSIS,ACUTE HEPATIC PORPHYRIA,TWrex-cause
721702152,5/14/2015 19:01:44,1636466117,5/14/2015 19:01:14,False,clixsense,0.7083,28351359,GBR,F6,Romford,80.43.183.92,BORRELIA RECURRENTIS causes FEVER,49,66,,53,86,causes,0.986393923832143,811179-FS1-4,"i ,   l  Relapsing Fever  Treatment of relapsing FEVER caused by  BORRELIA RECURRENTIS.",FEVER,BORRELIA RECURRENTIS,TWrex-cause
721702152,5/14/2015 19:30:31,1636494272,5/14/2015 19:29:52,False,clixsense,0.6607,10798016,GBR,C7,Coventry,86.24.245.191,BORRELIA RECURRENTIS causes FEVER,49,66,,53,86,causes,0.986393923832143,811179-FS1-4,"i ,   l  Relapsing Fever  Treatment of relapsing FEVER caused by  BORRELIA RECURRENTIS.",FEVER,BORRELIA RECURRENTIS,TWrex-cause
721702152,5/14/2015 19:37:37,1636499708,5/14/2015 19:37:23,False,instagc,0.7986,22535866,GBR,M2,Solihull,80.195.193.86,BORRELIA RECURRENTIS causes FEVER,49,66,,53,86,causes,0.986393923832143,811179-FS1-4,"i ,   l  Relapsing Fever  Treatment of relapsing FEVER caused by  BORRELIA RECURRENTIS.",FEVER,BORRELIA RECURRENTIS,TWrex-cause
721702152,5/14/2015 19:56:03,1636507138,5/14/2015 19:55:54,False,clixsense,0.7875,32549163,CAN,MB,Winnipeg,206.45.167.246,BORRELIA RECURRENTIS causes FEVER,49,66,,53,86,causes,0.986393923832143,811179-FS1-4,"i ,   l  Relapsing Fever  Treatment of relapsing FEVER caused by  BORRELIA RECURRENTIS.",FEVER,BORRELIA RECURRENTIS,TWrex-cause
721702152,5/14/2015 20:02:38,1636509617,5/14/2015 20:02:18,False,instagc,0.6667,32352104,USA,ME,Bangor,74.75.63.81,BORRELIA RECURRENTIS causes FEVER,49,66,,53,86,causes,0.986393923832143,811179-FS1-4,"i ,   l  Relapsing Fever  Treatment of relapsing FEVER caused by  BORRELIA RECURRENTIS.",FEVER,BORRELIA RECURRENTIS,TWrex-cause
721702152,5/14/2015 20:04:12,1636510414,5/14/2015 20:03:57,False,clixsense,0.7579,11106820,USA,MA,Taunton,173.48.52.95,BORRELIA RECURRENTIS causes FEVER,49,66,,53,86,causes,0.986393923832143,811179-FS1-4,"i ,   l  Relapsing Fever  Treatment of relapsing FEVER caused by  BORRELIA RECURRENTIS.",FEVER,BORRELIA RECURRENTIS,TWrex-cause
721702152,5/14/2015 20:14:41,1636518384,5/14/2015 20:14:05,False,clixsense,0.8373,30313955,GBR,K5,Poole,2.30.145.202,BORRELIA RECURRENTIS causes FEVER,49,66,,53,86,causes,0.986393923832143,811179-FS1-4,"i ,   l  Relapsing Fever  Treatment of relapsing FEVER caused by  BORRELIA RECURRENTIS.",FEVER,BORRELIA RECURRENTIS,TWrex-cause
721702173,5/14/2015 20:16:44,1636520455,5/14/2015 20:16:19,False,clixsense,0.8373,30313955,GBR,K5,Poole,2.30.145.202,HTLV 1 causes HAM/TSP,9,54,,15,60,causes,0.9778024140774091,812523-FS1-4,"However, HAM/TSP is a relatively rare complication of HTLV 1 with an incidence roughly comparable to that of adult T cell leukemia, another rare condition associated with HTLV 1.",HAM/TSP,HTLV 1,TWrex-cause
721702173,5/14/2015 20:17:10,1636520794,5/14/2015 20:16:42,False,neodev,0.7333,31091664,USA,CA,Sunnyvale,199.168.148.136,HTLV 1 causes HAM/TSP,9,54,,15,60,causes,0.9778024140774091,812523-FS1-4,"However, HAM/TSP is a relatively rare complication of HTLV 1 with an incidence roughly comparable to that of adult T cell leukemia, another rare condition associated with HTLV 1.",HAM/TSP,HTLV 1,TWrex-cause
721702173,5/14/2015 20:27:16,1636531093,5/14/2015 20:27:02,False,elite,0.5524,30064988,GBR,H3,Leeds,92.22.198.222,no_relation,9,54,,15,60,causes,0.9778024140774091,812523-FS1-4,"However, HAM/TSP is a relatively rare complication of HTLV 1 with an incidence roughly comparable to that of adult T cell leukemia, another rare condition associated with HTLV 1.",HAM/TSP,HTLV 1,TWrex-cause
721702173,5/14/2015 20:35:04,1636539518,5/14/2015 20:34:50,False,instagc,0.6339,20845955,GBR,I2,Manchester,90.214.24.62,HTLV 1 causes HAM/TSP,9,54,,15,60,causes,0.9778024140774091,812523-FS1-4,"However, HAM/TSP is a relatively rare complication of HTLV 1 with an incidence roughly comparable to that of adult T cell leukemia, another rare condition associated with HTLV 1.",HAM/TSP,HTLV 1,TWrex-cause
721702173,5/14/2015 20:36:56,1636541635,5/14/2015 20:36:09,False,fusioncash,0.7286,5620345,USA,HI,Honolulu,132.160.235.13,HTLV 1 causes HAM/TSP,9,54,,15,60,causes,0.9778024140774091,812523-FS1-4,"However, HAM/TSP is a relatively rare complication of HTLV 1 with an incidence roughly comparable to that of adult T cell leukemia, another rare condition associated with HTLV 1.",HAM/TSP,HTLV 1,TWrex-cause
721702173,5/14/2015 20:40:02,1636545127,5/14/2015 20:39:41,False,instagc,0.4167,27914150,USA,TX,Dallas,72.190.59.224,HAM/TSP causes HTLV 1,9,54,,15,60,causes,0.9778024140774091,812523-FS1-4,"However, HAM/TSP is a relatively rare complication of HTLV 1 with an incidence roughly comparable to that of adult T cell leukemia, another rare condition associated with HTLV 1.",HAM/TSP,HTLV 1,TWrex-cause
721702173,5/14/2015 20:51:14,1636553493,5/14/2015 20:50:50,False,instagc,0.6667,32352104,USA,ME,Bangor,74.75.63.81,HTLV 1 causes HAM/TSP,9,54,,15,60,causes,0.9778024140774091,812523-FS1-4,"However, HAM/TSP is a relatively rare complication of HTLV 1 with an incidence roughly comparable to that of adult T cell leukemia, another rare condition associated with HTLV 1.",HAM/TSP,HTLV 1,TWrex-cause
723907892,5/20/2015 12:33:28,1639651428,5/20/2015 12:33:02,False,neodev,0.7972,12115558,USA,OH,Twinsburg,98.27.164.131,no_relation,18,87,,33,103,causes,0.34188172937891403,811362-FS1-4,"1 ,   60 ,   171  NEOMYCIN ALLERGY  Havrix ®  and Twinrix ®  contains trace amounts of NEOMYCIN SULFATE.",NEOMYCIN ALLERGY,NEOMYCIN SULFATE,TWrex-cause
723907892,5/20/2015 12:35:46,1639652276,5/20/2015 12:35:32,False,neodev,0.7587,31326282,NLD,,,82.169.243.65,no_relation,18,87,,33,103,causes,0.34188172937891403,811362-FS1-4,"1 ,   60 ,   171  NEOMYCIN ALLERGY  Havrix ®  and Twinrix ®  contains trace amounts of NEOMYCIN SULFATE.",NEOMYCIN ALLERGY,NEOMYCIN SULFATE,TWrex-cause
723907892,5/20/2015 12:37:55,1639652945,5/20/2015 12:37:41,False,meprizescf,0.8204,28483210,USA,WI,Minocqua,75.143.134.247,no_relation,18,87,,33,103,causes,0.34188172937891403,811362-FS1-4,"1 ,   60 ,   171  NEOMYCIN ALLERGY  Havrix ®  and Twinrix ®  contains trace amounts of NEOMYCIN SULFATE.",NEOMYCIN ALLERGY,NEOMYCIN SULFATE,TWrex-cause
723907892,5/20/2015 12:43:53,1639655097,5/20/2015 12:43:35,False,points4rewards,0.7821,28755767,USA,VA,Chester,68.57.118.32,no_relation,18,87,,33,103,causes,0.34188172937891403,811362-FS1-4,"1 ,   60 ,   171  NEOMYCIN ALLERGY  Havrix ®  and Twinrix ®  contains trace amounts of NEOMYCIN SULFATE.",NEOMYCIN ALLERGY,NEOMYCIN SULFATE,TWrex-cause
723907892,5/20/2015 12:44:47,1639655405,5/20/2015 12:44:39,False,neodev,0.125,31789301,USA,CA,San Jose,23.27.44.161,NEOMYCIN ALLERGY causes NEOMYCIN SULFATE,18,87,,33,103,causes,0.34188172937891403,811362-FS1-4,"1 ,   60 ,   171  NEOMYCIN ALLERGY  Havrix ®  and Twinrix ®  contains trace amounts of NEOMYCIN SULFATE.",NEOMYCIN ALLERGY,NEOMYCIN SULFATE,TWrex-cause
723907892,5/20/2015 12:46:06,1639655933,5/20/2015 12:45:47,False,clixsense,0.5071,6488338,USA,HI,Honolulu,72.130.214.250,NEOMYCIN SULFATE causes NEOMYCIN ALLERGY,18,87,,33,103,causes,0.34188172937891403,811362-FS1-4,"1 ,   60 ,   171  NEOMYCIN ALLERGY  Havrix ®  and Twinrix ®  contains trace amounts of NEOMYCIN SULFATE.",NEOMYCIN ALLERGY,NEOMYCIN SULFATE,TWrex-cause
723907892,5/20/2015 12:49:46,1639657272,5/20/2015 12:49:07,False,neodev,0.5179,11382239,AUS,02,Strathfield,60.241.129.81,no_relation,18,87,,33,103,causes,0.34188172937891403,811362-FS1-4,"1 ,   60 ,   171  NEOMYCIN ALLERGY  Havrix ®  and Twinrix ®  contains trace amounts of NEOMYCIN SULFATE.",NEOMYCIN ALLERGY,NEOMYCIN SULFATE,TWrex-cause
723907894,5/20/2015 12:38:26,1639653083,5/20/2015 12:38:11,False,meprizescf,0.8204,28483210,USA,WI,Minocqua,75.143.134.247,BACILLUS ANTHRACIS causes ANTHRAX,27,0,,33,18,causes,0.9958932064677041,811045-FS1-4,BACILLUS ANTHRACIS  causes ANTHRAX and has been used in biological warfare.,ANTHRAX,BACILLUS ANTHRACIS,TWrex-cause
723907894,5/20/2015 12:44:39,1639655385,5/20/2015 12:44:15,False,points4rewards,0.7821,28755767,USA,VA,Chester,68.57.118.32,BACILLUS ANTHRACIS causes ANTHRAX,27,0,,33,18,causes,0.9958932064677041,811045-FS1-4,BACILLUS ANTHRACIS  causes ANTHRAX and has been used in biological warfare.,ANTHRAX,BACILLUS ANTHRACIS,TWrex-cause
723907894,5/20/2015 12:52:03,1639658099,5/20/2015 12:51:51,False,instagc,0.9333,31184650,USA,IA,Mason City,173.26.27.82,BACILLUS ANTHRACIS causes ANTHRAX,27,0,,33,18,causes,0.9958932064677041,811045-FS1-4,BACILLUS ANTHRACIS  causes ANTHRAX and has been used in biological warfare.,ANTHRAX,BACILLUS ANTHRACIS,TWrex-cause
723907894,5/20/2015 13:10:39,1639665375,5/20/2015 13:10:13,False,clixsense,0.8105,11106820,USA,MA,Taunton,173.48.52.95,BACILLUS ANTHRACIS causes ANTHRAX,27,0,,33,18,causes,0.9958932064677041,811045-FS1-4,BACILLUS ANTHRACIS  causes ANTHRAX and has been used in biological warfare.,ANTHRAX,BACILLUS ANTHRACIS,TWrex-cause
723907894,5/20/2015 13:11:37,1639665592,5/20/2015 13:11:27,False,elite,0.5848,31913360,USA,DE,,108.59.8.217,BACILLUS ANTHRACIS causes ANTHRAX,27,0,,33,18,causes,0.9958932064677041,811045-FS1-4,BACILLUS ANTHRACIS  causes ANTHRAX and has been used in biological warfare.,ANTHRAX,BACILLUS ANTHRACIS,TWrex-cause
723907894,5/20/2015 13:37:23,1639670092,5/20/2015 13:37:08,False,clixsense,0.5794,22751911,NLD,04,Groningen,195.241.153.97,BACILLUS ANTHRACIS causes ANTHRAX,27,0,,33,18,causes,0.9958932064677041,811045-FS1-4,BACILLUS ANTHRACIS  causes ANTHRAX and has been used in biological warfare.,ANTHRAX,BACILLUS ANTHRACIS,TWrex-cause
723907894,5/20/2015 13:40:57,1639671906,5/20/2015 13:40:34,False,gifthunterclub,0.6786,30901412,GBR,G5,Margate,85.210.124.18,BACILLUS ANTHRACIS causes ANTHRAX,27,0,,33,18,causes,0.9958932064677041,811045-FS1-4,BACILLUS ANTHRACIS  causes ANTHRAX and has been used in biological warfare.,ANTHRAX,BACILLUS ANTHRACIS,TWrex-cause
723907901,5/20/2015 14:07:44,1639679665,5/20/2015 14:07:22,False,prodege,0.6212,29849805,GBR,Z1,Swansea,82.1.37.235,no_relation,0,54,,3,76,causes,0.9878291611472622,814560-FS1-4,PAIN with mastication (jaw claudication) may indicate POLYMYALGIA RHEUMATICA or giant cell (temporal) arteritis.,PAIN,POLYMYALGIA RHEUMATICA,TWrex-cause
723907901,5/20/2015 14:07:54,1639679704,5/20/2015 14:07:06,False,onestopgpt,0.7151,21275875,CAN,ON,Hamilton,24.36.121.10,POLYMYALGIA RHEUMATICA causes PAIN,0,54,,3,76,causes,0.9878291611472622,814560-FS1-4,PAIN with mastication (jaw claudication) may indicate POLYMYALGIA RHEUMATICA or giant cell (temporal) arteritis.,PAIN,POLYMYALGIA RHEUMATICA,TWrex-cause
723907901,5/20/2015 14:23:47,1639684798,5/20/2015 14:22:52,False,bitcoinget,0.637,30546513,GBR,G6,Hull,194.42.67.50,POLYMYALGIA RHEUMATICA causes PAIN,0,54,,3,76,causes,0.9878291611472622,814560-FS1-4,PAIN with mastication (jaw claudication) may indicate POLYMYALGIA RHEUMATICA or giant cell (temporal) arteritis.,PAIN,POLYMYALGIA RHEUMATICA,TWrex-cause
723907901,5/20/2015 14:31:56,1639687430,5/20/2015 14:30:59,False,clixsense,0.5605,6338946,CAN,ON,Ottawa,23.91.230.44,POLYMYALGIA RHEUMATICA causes PAIN,0,54,,3,76,causes,0.9878291611472622,814560-FS1-4,PAIN with mastication (jaw claudication) may indicate POLYMYALGIA RHEUMATICA or giant cell (temporal) arteritis.,PAIN,POLYMYALGIA RHEUMATICA,TWrex-cause
723907901,5/20/2015 14:33:10,1639687912,5/20/2015 14:32:30,False,clixsense,0.67,30681826,GBR,I3,Rochester,86.163.150.232,POLYMYALGIA RHEUMATICA causes PAIN,0,54,,3,76,causes,0.9878291611472622,814560-FS1-4,PAIN with mastication (jaw claudication) may indicate POLYMYALGIA RHEUMATICA or giant cell (temporal) arteritis.,PAIN,POLYMYALGIA RHEUMATICA,TWrex-cause
723907901,5/20/2015 14:39:41,1639690137,5/20/2015 14:38:53,False,zoombucks,0.5933,6744840,CAN,BC,Kelowna,174.4.58.160,PAIN causes POLYMYALGIA RHEUMATICA,0,54,,3,76,causes,0.9878291611472622,814560-FS1-4,PAIN with mastication (jaw claudication) may indicate POLYMYALGIA RHEUMATICA or giant cell (temporal) arteritis.,PAIN,POLYMYALGIA RHEUMATICA,TWrex-cause
723907901,5/20/2015 14:45:18,1639691888,5/20/2015 14:44:33,False,neodev,0.6587,11014534,GBR,,,213.205.194.99,POLYMYALGIA RHEUMATICA causes PAIN,0,54,,3,76,causes,0.9878291611472622,814560-FS1-4,PAIN with mastication (jaw claudication) may indicate POLYMYALGIA RHEUMATICA or giant cell (temporal) arteritis.,PAIN,POLYMYALGIA RHEUMATICA,TWrex-cause
723907902,5/20/2015 12:07:39,1639641944,5/20/2015 12:07:09,False,prodege,0.6048,21417560,GBR,C3,Cambridge,151.225.116.143,no_relation,100,125,,107,144,causes,0.468521285665818,813871-FS1-4,Enterotoxigenic and enteropathogenic strains are major causes of diarrhea in infants and traveler's DIARRHEA in adults (see  TRAVELER'S DIARRHEA.,DIARRHEA,TRAVELER'S DIARRHEA,TWrex-cause
723907902,5/20/2015 12:09:33,1639642621,5/20/2015 12:09:24,False,clixsense,0.375,28457001,CAN,ON,North Bay,24.204.202.220,TRAVELER'S DIARRHEA causes DIARRHEA,100,125,,107,144,causes,0.468521285665818,813871-FS1-4,Enterotoxigenic and enteropathogenic strains are major causes of diarrhea in infants and traveler's DIARRHEA in adults (see  TRAVELER'S DIARRHEA.,DIARRHEA,TRAVELER'S DIARRHEA,TWrex-cause
723907902,5/20/2015 12:12:39,1639643810,5/20/2015 12:12:22,False,clixsense,0.6167,6352682,GBR,H9,London,2.122.19.138,TRAVELER'S DIARRHEA causes DIARRHEA,100,125,,107,144,causes,0.468521285665818,813871-FS1-4,Enterotoxigenic and enteropathogenic strains are major causes of diarrhea in infants and traveler's DIARRHEA in adults (see  TRAVELER'S DIARRHEA.,DIARRHEA,TRAVELER'S DIARRHEA,TWrex-cause
723907902,5/20/2015 12:19:39,1639646308,5/20/2015 12:19:23,False,instagc,0.7014,13581319,USA,IL,Mount Vernon,66.232.166.86,TRAVELER'S DIARRHEA causes DIARRHEA,100,125,,107,144,causes,0.468521285665818,813871-FS1-4,Enterotoxigenic and enteropathogenic strains are major causes of diarrhea in infants and traveler's DIARRHEA in adults (see  TRAVELER'S DIARRHEA.,DIARRHEA,TRAVELER'S DIARRHEA,TWrex-cause
723907902,5/20/2015 12:21:42,1639647132,5/20/2015 12:21:32,False,clixsense,0.5071,6488338,USA,HI,Honolulu,72.130.214.250,TRAVELER'S DIARRHEA causes DIARRHEA,100,125,,107,144,causes,0.468521285665818,813871-FS1-4,Enterotoxigenic and enteropathogenic strains are major causes of diarrhea in infants and traveler's DIARRHEA in adults (see  TRAVELER'S DIARRHEA.,DIARRHEA,TRAVELER'S DIARRHEA,TWrex-cause
723907902,5/20/2015 12:28:05,1639649517,5/20/2015 12:27:45,False,prodege,0.6238,27934334,GBR,D2,Derby,86.162.35.12,no_relation,100,125,,107,144,causes,0.468521285665818,813871-FS1-4,Enterotoxigenic and enteropathogenic strains are major causes of diarrhea in infants and traveler's DIARRHEA in adults (see  TRAVELER'S DIARRHEA.,DIARRHEA,TRAVELER'S DIARRHEA,TWrex-cause
723907902,5/20/2015 12:29:19,1639649982,5/20/2015 12:28:43,False,neodev,0.6827,14096345,NLD,03,Eibergen,77.174.124.109,no_relation,100,125,,107,144,causes,0.468521285665818,813871-FS1-4,Enterotoxigenic and enteropathogenic strains are major causes of diarrhea in infants and traveler's DIARRHEA in adults (see  TRAVELER'S DIARRHEA.,DIARRHEA,TRAVELER'S DIARRHEA,TWrex-cause
723907911,5/20/2015 12:08:31,1639642242,5/20/2015 12:07:40,False,prodege,0.6048,21417560,GBR,C3,Cambridge,151.225.116.143,no_relation,199,246,,220,249,causes,0.442325868464691,812154-FS1-4,"Enormous quantities of fluid may be ingested, and large volumes (3 to 30 L/day) of very dilute urine (sp gr usually  Diagnosis  CDI must be differentiated from other causes of polyuria, particularly PSYCHOGENIC POLYDIPSIA (see  Table 151 4 ) and NDI",PSYCHOGENIC POLYDIPSIA,NDI,TWrex-cause
723907911,5/20/2015 12:12:53,1639643898,5/20/2015 12:12:41,False,clixsense,0.6167,6352682,GBR,H9,London,2.122.19.138,NDI causes PSYCHOGENIC POLYDIPSIA,199,246,,220,249,causes,0.442325868464691,812154-FS1-4,"Enormous quantities of fluid may be ingested, and large volumes (3 to 30 L/day) of very dilute urine (sp gr usually  Diagnosis  CDI must be differentiated from other causes of polyuria, particularly PSYCHOGENIC POLYDIPSIA (see  Table 151 4 ) and NDI",PSYCHOGENIC POLYDIPSIA,NDI,TWrex-cause
723907911,5/20/2015 12:20:04,1639646463,5/20/2015 12:19:40,False,instagc,0.7014,13581319,USA,IL,Mount Vernon,66.232.166.86,no_relation,199,246,,220,249,causes,0.442325868464691,812154-FS1-4,"Enormous quantities of fluid may be ingested, and large volumes (3 to 30 L/day) of very dilute urine (sp gr usually  Diagnosis  CDI must be differentiated from other causes of polyuria, particularly PSYCHOGENIC POLYDIPSIA (see  Table 151 4 ) and NDI",PSYCHOGENIC POLYDIPSIA,NDI,TWrex-cause
723907911,5/20/2015 12:29:33,1639650045,5/20/2015 12:29:23,False,prodege,0.6238,27934334,GBR,D2,Derby,86.162.35.12,no_relation,199,246,,220,249,causes,0.442325868464691,812154-FS1-4,"Enormous quantities of fluid may be ingested, and large volumes (3 to 30 L/day) of very dilute urine (sp gr usually  Diagnosis  CDI must be differentiated from other causes of polyuria, particularly PSYCHOGENIC POLYDIPSIA (see  Table 151 4 ) and NDI",PSYCHOGENIC POLYDIPSIA,NDI,TWrex-cause
723907911,5/20/2015 12:29:44,1639650133,5/20/2015 12:29:21,False,neodev,0.6827,14096345,NLD,03,Eibergen,77.174.124.109,no_relation,199,246,,220,249,causes,0.442325868464691,812154-FS1-4,"Enormous quantities of fluid may be ingested, and large volumes (3 to 30 L/day) of very dilute urine (sp gr usually  Diagnosis  CDI must be differentiated from other causes of polyuria, particularly PSYCHOGENIC POLYDIPSIA (see  Table 151 4 ) and NDI",PSYCHOGENIC POLYDIPSIA,NDI,TWrex-cause
723907911,5/20/2015 12:31:17,1639650692,5/20/2015 12:30:28,False,neodev,0.7972,12115558,USA,OH,Twinsburg,98.27.164.131,no_relation,199,246,,220,249,causes,0.442325868464691,812154-FS1-4,"Enormous quantities of fluid may be ingested, and large volumes (3 to 30 L/day) of very dilute urine (sp gr usually  Diagnosis  CDI must be differentiated from other causes of polyuria, particularly PSYCHOGENIC POLYDIPSIA (see  Table 151 4 ) and NDI",PSYCHOGENIC POLYDIPSIA,NDI,TWrex-cause
723907911,5/20/2015 12:34:11,1639651676,5/20/2015 12:33:43,False,neodev,0.7587,31326282,NLD,,,82.169.243.65,no_relation,199,246,,220,249,causes,0.442325868464691,812154-FS1-4,"Enormous quantities of fluid may be ingested, and large volumes (3 to 30 L/day) of very dilute urine (sp gr usually  Diagnosis  CDI must be differentiated from other causes of polyuria, particularly PSYCHOGENIC POLYDIPSIA (see  Table 151 4 ) and NDI",PSYCHOGENIC POLYDIPSIA,NDI,TWrex-cause
723907914,5/20/2015 14:07:44,1639679664,5/20/2015 14:07:22,False,prodege,0.6212,29849805,GBR,Z1,Swansea,82.1.37.235,TACHYCARDIA causes CARDIAC TACHYARRHYTHMIA,44,3,,54,26,causes,0.538815906080325,813764-FS1-4,a  CARDIAC TACHYARRHYTHMIA  Investigate any TACHYCARDIA before administration since dicyclomine may increase heart rate.,TACHYCARDIA,CARDIAC TACHYARRHYTHMIA,TWrex-cause
723907914,5/20/2015 14:07:54,1639679703,5/20/2015 14:07:06,False,onestopgpt,0.7151,21275875,CAN,ON,Hamilton,24.36.121.10,no_relation,44,3,,54,26,causes,0.538815906080325,813764-FS1-4,a  CARDIAC TACHYARRHYTHMIA  Investigate any TACHYCARDIA before administration since dicyclomine may increase heart rate.,TACHYCARDIA,CARDIAC TACHYARRHYTHMIA,TWrex-cause
723907914,5/20/2015 14:23:47,1639684795,5/20/2015 14:22:52,False,bitcoinget,0.637,30546513,GBR,G6,Hull,194.42.67.50,no_relation,44,3,,54,26,causes,0.538815906080325,813764-FS1-4,a  CARDIAC TACHYARRHYTHMIA  Investigate any TACHYCARDIA before administration since dicyclomine may increase heart rate.,TACHYCARDIA,CARDIAC TACHYARRHYTHMIA,TWrex-cause
723907914,5/20/2015 14:31:56,1639687426,5/20/2015 14:30:59,False,clixsense,0.5605,6338946,CAN,ON,Ottawa,23.91.230.44,no_relation,44,3,,54,26,causes,0.538815906080325,813764-FS1-4,a  CARDIAC TACHYARRHYTHMIA  Investigate any TACHYCARDIA before administration since dicyclomine may increase heart rate.,TACHYCARDIA,CARDIAC TACHYARRHYTHMIA,TWrex-cause
723907914,5/20/2015 14:33:10,1639687914,5/20/2015 14:32:30,False,clixsense,0.67,30681826,GBR,I3,Rochester,86.163.150.232,CARDIAC TACHYARRHYTHMIA causes TACHYCARDIA,44,3,,54,26,causes,0.538815906080325,813764-FS1-4,a  CARDIAC TACHYARRHYTHMIA  Investigate any TACHYCARDIA before administration since dicyclomine may increase heart rate.,TACHYCARDIA,CARDIAC TACHYARRHYTHMIA,TWrex-cause
723907914,5/20/2015 14:39:41,1639690132,5/20/2015 14:38:53,False,zoombucks,0.5933,6744840,CAN,BC,Kelowna,174.4.58.160,TACHYCARDIA causes CARDIAC TACHYARRHYTHMIA,44,3,,54,26,causes,0.538815906080325,813764-FS1-4,a  CARDIAC TACHYARRHYTHMIA  Investigate any TACHYCARDIA before administration since dicyclomine may increase heart rate.,TACHYCARDIA,CARDIAC TACHYARRHYTHMIA,TWrex-cause
723907914,5/20/2015 14:45:18,1639691892,5/20/2015 14:44:33,False,neodev,0.6587,11014534,GBR,,,213.205.194.99,TACHYCARDIA causes CARDIAC TACHYARRHYTHMIA,44,3,,54,26,causes,0.538815906080325,813764-FS1-4,a  CARDIAC TACHYARRHYTHMIA  Investigate any TACHYCARDIA before administration since dicyclomine may increase heart rate.,TACHYCARDIA,CARDIAC TACHYARRHYTHMIA,TWrex-cause
723907922,5/20/2015 12:31:33,1639650787,5/20/2015 12:31:19,False,neodev,0.6827,14096345,NLD,03,Eibergen,77.174.124.109,no_relation,87,55,,95,73,causes,0.308606699924184,803133-FS1-4,"daughter, DES    The daughter of a mother who received DIETHYLSTILBESTROL (DES) during PREGNANCY",PREGNANCY,DIETHYLSTILBESTROL,TWrex-cause
723907922,5/20/2015 12:33:01,1639651260,5/20/2015 12:32:37,False,neodev,0.7972,12115558,USA,OH,Twinsburg,98.27.164.131,no_relation,87,55,,95,73,causes,0.308606699924184,803133-FS1-4,"daughter, DES    The daughter of a mother who received DIETHYLSTILBESTROL (DES) during PREGNANCY",PREGNANCY,DIETHYLSTILBESTROL,TWrex-cause
723907922,5/20/2015 12:35:31,1639652202,5/20/2015 12:35:15,False,neodev,0.7587,31326282,NLD,,,82.169.243.65,no_relation,87,55,,95,73,causes,0.308606699924184,803133-FS1-4,"daughter, DES    The daughter of a mother who received DIETHYLSTILBESTROL (DES) during PREGNANCY",PREGNANCY,DIETHYLSTILBESTROL,TWrex-cause
723907922,5/20/2015 12:37:40,1639652882,5/20/2015 12:37:24,False,meprizescf,0.8204,28483210,USA,WI,Minocqua,75.143.134.247,no_relation,87,55,,95,73,causes,0.308606699924184,803133-FS1-4,"daughter, DES    The daughter of a mother who received DIETHYLSTILBESTROL (DES) during PREGNANCY",PREGNANCY,DIETHYLSTILBESTROL,TWrex-cause
723907922,5/20/2015 12:43:34,1639655002,5/20/2015 12:43:08,False,points4rewards,0.7821,28755767,USA,VA,Chester,68.57.118.32,no_relation,87,55,,95,73,causes,0.308606699924184,803133-FS1-4,"daughter, DES    The daughter of a mother who received DIETHYLSTILBESTROL (DES) during PREGNANCY",PREGNANCY,DIETHYLSTILBESTROL,TWrex-cause
723907922,5/20/2015 12:44:35,1639655363,5/20/2015 12:44:10,False,neodev,0.125,31789301,USA,CA,San Jose,23.27.44.161,PREGNANCY causes DIETHYLSTILBESTROL,87,55,,95,73,causes,0.308606699924184,803133-FS1-4,"daughter, DES    The daughter of a mother who received DIETHYLSTILBESTROL (DES) during PREGNANCY",PREGNANCY,DIETHYLSTILBESTROL,TWrex-cause
723907922,5/20/2015 12:45:46,1639655746,5/20/2015 12:45:20,False,clixsense,0.5071,6488338,USA,HI,Honolulu,72.130.214.250,PREGNANCY causes DIETHYLSTILBESTROL,87,55,,95,73,causes,0.308606699924184,803133-FS1-4,"daughter, DES    The daughter of a mother who received DIETHYLSTILBESTROL (DES) during PREGNANCY",PREGNANCY,DIETHYLSTILBESTROL,TWrex-cause
723907923,5/20/2015 13:55:29,1639676462,5/20/2015 13:55:07,False,sharecashgpt,0.4429,28627999,CAN,ON,Sudbury,66.103.55.12,no_relation,78,27,,96,43,causes,0.830747160735697,811553-FS1-4,Symptoms of abscess due to AEROBIC BACTERIA develop more acutely and resemble BACTERIAL PNEUMONIA,BACTERIAL PNEUMONIA,AEROBIC BACTERIA,TWrex-cause
723907923,5/20/2015 13:58:07,1639677368,5/20/2015 13:57:53,False,clixsense,0.7448,27754226,GBR,O3,South Ockendon,92.232.236.243,no_relation,78,27,,96,43,causes,0.830747160735697,811553-FS1-4,Symptoms of abscess due to AEROBIC BACTERIA develop more acutely and resemble BACTERIAL PNEUMONIA,BACTERIAL PNEUMONIA,AEROBIC BACTERIA,TWrex-cause
723907923,5/20/2015 14:06:17,1639679310,5/20/2015 14:05:35,False,onestopgpt,0.7151,21275875,CAN,ON,Hamilton,24.36.121.10,no_relation,78,27,,96,43,causes,0.830747160735697,811553-FS1-4,Symptoms of abscess due to AEROBIC BACTERIA develop more acutely and resemble BACTERIAL PNEUMONIA,BACTERIAL PNEUMONIA,AEROBIC BACTERIA,TWrex-cause
723907923,5/20/2015 14:06:47,1639679402,5/20/2015 14:06:14,False,prodege,0.6212,29849805,GBR,Z1,Swansea,82.1.37.235,AEROBIC BACTERIA causes BACTERIAL PNEUMONIA,78,27,,96,43,causes,0.830747160735697,811553-FS1-4,Symptoms of abscess due to AEROBIC BACTERIA develop more acutely and resemble BACTERIAL PNEUMONIA,BACTERIAL PNEUMONIA,AEROBIC BACTERIA,TWrex-cause
723907923,5/20/2015 14:12:21,1639681172,5/20/2015 14:12:06,False,neodev,0.3024,32456300,USA,IL,Chicago,69.175.85.2,BACTERIAL PNEUMONIA causes AEROBIC BACTERIA,78,27,,96,43,causes,0.830747160735697,811553-FS1-4,Symptoms of abscess due to AEROBIC BACTERIA develop more acutely and resemble BACTERIAL PNEUMONIA,BACTERIAL PNEUMONIA,AEROBIC BACTERIA,TWrex-cause
723907923,5/20/2015 14:22:10,1639684390,5/20/2015 14:21:27,False,bitcoinget,0.637,30546513,GBR,G6,Hull,194.42.67.50,no_relation,78,27,,96,43,causes,0.830747160735697,811553-FS1-4,Symptoms of abscess due to AEROBIC BACTERIA develop more acutely and resemble BACTERIAL PNEUMONIA,BACTERIAL PNEUMONIA,AEROBIC BACTERIA,TWrex-cause
723907923,5/20/2015 14:29:31,1639686674,5/20/2015 14:29:02,False,prodege,0.6048,21417560,GBR,C3,Cambridge,151.225.116.143,no_relation,78,27,,96,43,causes,0.830747160735697,811553-FS1-4,Symptoms of abscess due to AEROBIC BACTERIA develop more acutely and resemble BACTERIAL PNEUMONIA,BACTERIAL PNEUMONIA,AEROBIC BACTERIA,TWrex-cause
724124091,5/20/2015 21:13:06,1639872429,5/20/2015 21:12:41,False,neodev,0.748,18881135,CAN,ON,Ajax,99.243.87.224,no_relation,92,58,,103,74,causes,0.47809144373375806,813381-FS1-4,Evidence:  The estimated pretest probability is ~0.5% for PHEOCHROMOCYTOMA In patients with HYPERTENSION ( 1.,HYPERTENSION,PHEOCHROMOCYTOMA,TWrex-cause
724124091,5/20/2015 21:14:17,1639872954,5/20/2015 21:13:54,False,instagc,0.7401,30326470,USA,CA,Santee,99.44.37.73,HYPERTENSION causes PHEOCHROMOCYTOMA,92,58,,103,74,causes,0.47809144373375806,813381-FS1-4,Evidence:  The estimated pretest probability is ~0.5% for PHEOCHROMOCYTOMA In patients with HYPERTENSION ( 1.,HYPERTENSION,PHEOCHROMOCYTOMA,TWrex-cause
724124091,5/20/2015 21:29:46,1639878843,5/20/2015 21:29:20,False,neodev,0.8278,11014534,GBR,,,213.205.194.72,no_relation,92,58,,103,74,causes,0.47809144373375806,813381-FS1-4,Evidence:  The estimated pretest probability is ~0.5% for PHEOCHROMOCYTOMA In patients with HYPERTENSION ( 1.,HYPERTENSION,PHEOCHROMOCYTOMA,TWrex-cause
724124091,5/20/2015 21:33:40,1639880212,5/20/2015 21:32:45,False,instagc,0.772,18531561,CAN,ON,Mississauga,99.229.92.227,PHEOCHROMOCYTOMA causes HYPERTENSION,92,58,,103,74,causes,0.47809144373375806,813381-FS1-4,Evidence:  The estimated pretest probability is ~0.5% for PHEOCHROMOCYTOMA In patients with HYPERTENSION ( 1.,HYPERTENSION,PHEOCHROMOCYTOMA,TWrex-cause
724124091,5/20/2015 21:36:08,1639881070,5/20/2015 21:35:29,False,elite,0.7361,32173500,GBR,E4,Rayleigh,176.24.16.182,HYPERTENSION causes PHEOCHROMOCYTOMA,92,58,,103,74,causes,0.47809144373375806,813381-FS1-4,Evidence:  The estimated pretest probability is ~0.5% for PHEOCHROMOCYTOMA In patients with HYPERTENSION ( 1.,HYPERTENSION,PHEOCHROMOCYTOMA,TWrex-cause
724124091,5/20/2015 21:36:10,1639881071,5/20/2015 21:35:17,False,points4rewards,0.754,20113482,USA,OR,Portland,67.213.218.72,no_relation,92,58,,103,74,causes,0.47809144373375806,813381-FS1-4,Evidence:  The estimated pretest probability is ~0.5% for PHEOCHROMOCYTOMA In patients with HYPERTENSION ( 1.,HYPERTENSION,PHEOCHROMOCYTOMA,TWrex-cause
724124091,5/20/2015 22:28:05,1639890130,5/20/2015 22:27:45,False,clixsense,0.8381,10798016,GBR,C7,Coventry,86.24.245.191,no_relation,92,58,,103,74,causes,0.47809144373375806,813381-FS1-4,Evidence:  The estimated pretest probability is ~0.5% for PHEOCHROMOCYTOMA In patients with HYPERTENSION ( 1.,HYPERTENSION,PHEOCHROMOCYTOMA,TWrex-cause
724124093,5/20/2015 23:44:51,1639919883,5/20/2015 23:44:38,False,prodege,0.875,15439740,AUS,02,Jannali,14.200.59.55,no_relation,174,361,,182,386,causes,0.7330166661378309,813861-FS1-4,"Many of these patients are later found to have Alzheimer disease in addition to Parkinson disease Creutzfeldt Jakob disease  Rapid progression, early age of onset, prominent MYOCLONUS characteristic EEG pattern of triphasic sharp waves (1 2 Hz)  Cerebrospinal fluid test (commercially available) identifying protein 14 3 3 has a moderately high specificity for CREUTZFELDT JAKOB DISEASE",MYOCLONUS,CREUTZFELDT JAKOB DISEASE,TWrex-cause
724124093,5/20/2015 23:45:28,1639920177,5/20/2015 23:44:34,False,neodev,0.7559999999999999,11382239,AUS,02,Strathfield,60.241.129.81,MYOCLONUS causes CREUTZFELDT JAKOB DISEASE,174,361,,182,386,causes,0.7330166661378309,813861-FS1-4,"Many of these patients are later found to have Alzheimer disease in addition to Parkinson disease Creutzfeldt Jakob disease  Rapid progression, early age of onset, prominent MYOCLONUS characteristic EEG pattern of triphasic sharp waves (1 2 Hz)  Cerebrospinal fluid test (commercially available) identifying protein 14 3 3 has a moderately high specificity for CREUTZFELDT JAKOB DISEASE",MYOCLONUS,CREUTZFELDT JAKOB DISEASE,TWrex-cause
724124093,5/20/2015 23:48:40,1639921553,5/20/2015 23:48:16,False,pocketmoneygpt,0.5764,28884030,USA,WI,Minocqua,75.143.134.247,CREUTZFELDT JAKOB DISEASE causes MYOCLONUS,174,361,,182,386,causes,0.7330166661378309,813861-FS1-4,"Many of these patients are later found to have Alzheimer disease in addition to Parkinson disease Creutzfeldt Jakob disease  Rapid progression, early age of onset, prominent MYOCLONUS characteristic EEG pattern of triphasic sharp waves (1 2 Hz)  Cerebrospinal fluid test (commercially available) identifying protein 14 3 3 has a moderately high specificity for CREUTZFELDT JAKOB DISEASE",MYOCLONUS,CREUTZFELDT JAKOB DISEASE,TWrex-cause
724124093,5/21/2015 00:06:36,1639929062,5/21/2015 00:05:51,False,onestopgpt,0.7284,21275875,CAN,ON,Hamilton,24.36.121.10,no_relation,174,361,,182,386,causes,0.7330166661378309,813861-FS1-4,"Many of these patients are later found to have Alzheimer disease in addition to Parkinson disease Creutzfeldt Jakob disease  Rapid progression, early age of onset, prominent MYOCLONUS characteristic EEG pattern of triphasic sharp waves (1 2 Hz)  Cerebrospinal fluid test (commercially available) identifying protein 14 3 3 has a moderately high specificity for CREUTZFELDT JAKOB DISEASE",MYOCLONUS,CREUTZFELDT JAKOB DISEASE,TWrex-cause
724124093,5/21/2015 00:14:35,1639932740,5/21/2015 00:13:38,False,gifthulk,0.5149,18666417,USA,PA,Meadville,24.101.97.237,MYOCLONUS causes CREUTZFELDT JAKOB DISEASE,174,361,,182,386,causes,0.7330166661378309,813861-FS1-4,"Many of these patients are later found to have Alzheimer disease in addition to Parkinson disease Creutzfeldt Jakob disease  Rapid progression, early age of onset, prominent MYOCLONUS characteristic EEG pattern of triphasic sharp waves (1 2 Hz)  Cerebrospinal fluid test (commercially available) identifying protein 14 3 3 has a moderately high specificity for CREUTZFELDT JAKOB DISEASE",MYOCLONUS,CREUTZFELDT JAKOB DISEASE,TWrex-cause
724124093,5/21/2015 00:23:46,1639937228,5/21/2015 00:23:21,False,clixsense,0.4952,17950689,GBR,Y9,Tonypandy,92.2.44.79,no_relation,174,361,,182,386,causes,0.7330166661378309,813861-FS1-4,"Many of these patients are later found to have Alzheimer disease in addition to Parkinson disease Creutzfeldt Jakob disease  Rapid progression, early age of onset, prominent MYOCLONUS characteristic EEG pattern of triphasic sharp waves (1 2 Hz)  Cerebrospinal fluid test (commercially available) identifying protein 14 3 3 has a moderately high specificity for CREUTZFELDT JAKOB DISEASE",MYOCLONUS,CREUTZFELDT JAKOB DISEASE,TWrex-cause
724124093,5/21/2015 00:29:34,1639940246,5/21/2015 00:29:29,False,neodev,0.25,31789301,USA,,,178.62.40.84,MYOCLONUS causes CREUTZFELDT JAKOB DISEASE,174,361,,182,386,causes,0.7330166661378309,813861-FS1-4,"Many of these patients are later found to have Alzheimer disease in addition to Parkinson disease Creutzfeldt Jakob disease  Rapid progression, early age of onset, prominent MYOCLONUS characteristic EEG pattern of triphasic sharp waves (1 2 Hz)  Cerebrospinal fluid test (commercially available) identifying protein 14 3 3 has a moderately high specificity for CREUTZFELDT JAKOB DISEASE",MYOCLONUS,CREUTZFELDT JAKOB DISEASE,TWrex-cause
724124107,5/20/2015 20:45:25,1639861828,5/20/2015 20:45:03,False,prodege,1.0,21417560,GBR,C3,Cambridge,151.225.116.143,VZV M causes NFECTION,24,1,,31,6,causes,1.0,811099-FS1-4," VZV May cause serious iNFECTION particularly pneumonia, in adult women.",NFECTION,VZV M,TWrex-cause
724124107,5/20/2015 20:50:22,1639863931,5/20/2015 20:49:58,False,neodev,0.875,32216655,NLD,07,Amsterdam,145.100.72.168,VZV M causes NFECTION,24,1,,31,6,causes,1.0,811099-FS1-4," VZV May cause serious iNFECTION particularly pneumonia, in adult women.",NFECTION,VZV M,TWrex-cause
724124107,5/20/2015 20:56:20,1639866363,5/20/2015 20:56:01,False,sharecashgpt,0.4917,28627999,CAN,ON,Sudbury,66.103.55.12,VZV M causes NFECTION,24,1,,31,6,causes,1.0,811099-FS1-4," VZV May cause serious iNFECTION particularly pneumonia, in adult women.",NFECTION,VZV M,TWrex-cause
724124107,5/20/2015 20:58:00,1639866983,5/20/2015 20:57:44,False,clixsense,0.7167,30130805,USA,MI,Wyandotte,63.141.31.35,VZV M causes NFECTION,24,1,,31,6,causes,1.0,811099-FS1-4," VZV May cause serious iNFECTION particularly pneumonia, in adult women.",NFECTION,VZV M,TWrex-cause
724124107,5/20/2015 20:58:14,1639867093,5/20/2015 20:57:57,False,instagc,0.7333,23032978,USA,PA,Philadelphia,76.98.187.59,VZV M causes NFECTION,24,1,,31,6,causes,1.0,811099-FS1-4," VZV May cause serious iNFECTION particularly pneumonia, in adult women.",NFECTION,VZV M,TWrex-cause
724124107,5/20/2015 21:04:20,1639869268,5/20/2015 21:04:02,False,instagc,0.5675,13581319,USA,IL,Mount Vernon,66.232.166.86,VZV M causes NFECTION,24,1,,31,6,causes,1.0,811099-FS1-4," VZV May cause serious iNFECTION particularly pneumonia, in adult women.",NFECTION,VZV M,TWrex-cause
724124107,5/20/2015 21:09:57,1639871124,5/20/2015 21:09:31,False,instagc,0.7401,30326470,USA,CA,Santee,99.44.37.73,VZV M causes NFECTION,24,1,,31,6,causes,1.0,811099-FS1-4," VZV May cause serious iNFECTION particularly pneumonia, in adult women.",NFECTION,VZV M,TWrex-cause
724124127,5/21/2015 00:15:48,1639933511,5/21/2015 00:15:18,False,gifthulk,0.5149,18666417,USA,PA,Meadville,24.101.97.237,no_relation,75,88,,83,115,causes,0.375,814852-FS1-4,"Richmond GW, Ray I, Korenblitt A. Initial stabilization preceding enhanced HEMOLYSIS in AUTOIMMUNE HEMOLYTIC ANEMIA treated with intravenous gammaglobulin.",HEMOLYSIS,AUTOIMMUNE HEMOLYTIC ANEMIA,TWrex-cause
724124127,5/21/2015 00:25:22,1639938114,5/21/2015 00:24:33,False,clixsense,0.4952,17950689,GBR,Y9,Tonypandy,92.2.44.79,AUTOIMMUNE HEMOLYTIC ANEMIA causes HEMOLYSIS,75,88,,83,115,causes,0.375,814852-FS1-4,"Richmond GW, Ray I, Korenblitt A. Initial stabilization preceding enhanced HEMOLYSIS in AUTOIMMUNE HEMOLYTIC ANEMIA treated with intravenous gammaglobulin.",HEMOLYSIS,AUTOIMMUNE HEMOLYTIC ANEMIA,TWrex-cause
724124127,5/21/2015 00:34:49,1639942954,5/21/2015 00:34:37,False,elite,0.6556,32306791,GBR,,,109.200.26.4,AUTOIMMUNE HEMOLYTIC ANEMIA causes HEMOLYSIS,75,88,,83,115,causes,0.375,814852-FS1-4,"Richmond GW, Ray I, Korenblitt A. Initial stabilization preceding enhanced HEMOLYSIS in AUTOIMMUNE HEMOLYTIC ANEMIA treated with intravenous gammaglobulin.",HEMOLYSIS,AUTOIMMUNE HEMOLYTIC ANEMIA,TWrex-cause
724124127,5/21/2015 00:58:37,1639957470,5/21/2015 00:57:59,False,instagc,0.5556,23287154,USA,CA,San Jose,130.65.251.20,AUTOIMMUNE HEMOLYTIC ANEMIA causes HEMOLYSIS,75,88,,83,115,causes,0.375,814852-FS1-4,"Richmond GW, Ray I, Korenblitt A. Initial stabilization preceding enhanced HEMOLYSIS in AUTOIMMUNE HEMOLYTIC ANEMIA treated with intravenous gammaglobulin.",HEMOLYSIS,AUTOIMMUNE HEMOLYTIC ANEMIA,TWrex-cause
724124127,5/21/2015 01:14:40,1639966905,5/21/2015 01:13:09,False,neodev,0.65,24564999,GBR,H9,London,86.148.196.204,AUTOIMMUNE HEMOLYTIC ANEMIA causes HEMOLYSIS,75,88,,83,115,causes,0.375,814852-FS1-4,"Richmond GW, Ray I, Korenblitt A. Initial stabilization preceding enhanced HEMOLYSIS in AUTOIMMUNE HEMOLYTIC ANEMIA treated with intravenous gammaglobulin.",HEMOLYSIS,AUTOIMMUNE HEMOLYTIC ANEMIA,TWrex-cause
724124127,5/21/2015 01:25:05,1639972795,5/21/2015 01:22:54,False,neodev,0.5,31670127,USA,FL,Key West,162.233.108.112,AUTOIMMUNE HEMOLYTIC ANEMIA causes HEMOLYSIS,75,88,,83,115,causes,0.375,814852-FS1-4,"Richmond GW, Ray I, Korenblitt A. Initial stabilization preceding enhanced HEMOLYSIS in AUTOIMMUNE HEMOLYTIC ANEMIA treated with intravenous gammaglobulin.",HEMOLYSIS,AUTOIMMUNE HEMOLYTIC ANEMIA,TWrex-cause
724124127,5/21/2015 01:27:59,1639974285,5/21/2015 01:23:08,False,clixsense,0.2857,24170547,USA,NJ,Moorestown,71.168.207.190,HEMOLYSIS causes AUTOIMMUNE HEMOLYTIC ANEMIA,75,88,,83,115,causes,0.375,814852-FS1-4,"Richmond GW, Ray I, Korenblitt A. Initial stabilization preceding enhanced HEMOLYSIS in AUTOIMMUNE HEMOLYTIC ANEMIA treated with intravenous gammaglobulin.",HEMOLYSIS,AUTOIMMUNE HEMOLYTIC ANEMIA,TWrex-cause
724124128,5/20/2015 21:30:09,1639878943,5/20/2015 21:29:47,False,neodev,0.8278,11014534,GBR,,,213.205.194.72,no_relation,285,158,,295,185,causes,0.404061017820884,804414-FS1-4,"117   Compliance date for preparations with annual sales   117  Hemorrhoids  Anorectal preparations (e.g., creams, gels, ointments, suppositories) containing PHENYLEPHRINE HYDROCHLORIDE are used  topically  or  rectally  to provide temporary symptomatic relief of external or internal HEMORRHOIDS.",HEMORRHOIDS,PHENYLEPHRINE HYDROCHLORIDE,TWrex-cause
724124128,5/20/2015 21:34:11,1639880340,5/20/2015 21:33:41,False,instagc,0.772,18531561,CAN,ON,Mississauga,99.229.92.227,no_relation,285,158,,295,185,causes,0.404061017820884,804414-FS1-4,"117   Compliance date for preparations with annual sales   117  Hemorrhoids  Anorectal preparations (e.g., creams, gels, ointments, suppositories) containing PHENYLEPHRINE HYDROCHLORIDE are used  topically  or  rectally  to provide temporary symptomatic relief of external or internal HEMORRHOIDS.",HEMORRHOIDS,PHENYLEPHRINE HYDROCHLORIDE,TWrex-cause
724124128,5/20/2015 21:36:42,1639881232,5/20/2015 21:36:15,False,points4rewards,0.754,20113482,USA,OR,Portland,67.213.218.72,no_relation,285,158,,295,185,causes,0.404061017820884,804414-FS1-4,"117   Compliance date for preparations with annual sales   117  Hemorrhoids  Anorectal preparations (e.g., creams, gels, ointments, suppositories) containing PHENYLEPHRINE HYDROCHLORIDE are used  topically  or  rectally  to provide temporary symptomatic relief of external or internal HEMORRHOIDS.",HEMORRHOIDS,PHENYLEPHRINE HYDROCHLORIDE,TWrex-cause
724124128,5/20/2015 22:26:12,1639889540,5/20/2015 22:25:24,False,elite,0.7361,32173500,GBR,E4,Rayleigh,176.24.16.182,no_relation,285,158,,295,185,causes,0.404061017820884,804414-FS1-4,"117   Compliance date for preparations with annual sales   117  Hemorrhoids  Anorectal preparations (e.g., creams, gels, ointments, suppositories) containing PHENYLEPHRINE HYDROCHLORIDE are used  topically  or  rectally  to provide temporary symptomatic relief of external or internal HEMORRHOIDS.",HEMORRHOIDS,PHENYLEPHRINE HYDROCHLORIDE,TWrex-cause
724124128,5/20/2015 22:27:19,1639889920,5/20/2015 22:26:52,False,clixsense,0.8381,10798016,GBR,C7,Coventry,86.24.245.191,no_relation,285,158,,295,185,causes,0.404061017820884,804414-FS1-4,"117   Compliance date for preparations with annual sales   117  Hemorrhoids  Anorectal preparations (e.g., creams, gels, ointments, suppositories) containing PHENYLEPHRINE HYDROCHLORIDE are used  topically  or  rectally  to provide temporary symptomatic relief of external or internal HEMORRHOIDS.",HEMORRHOIDS,PHENYLEPHRINE HYDROCHLORIDE,TWrex-cause
724124128,5/20/2015 22:29:16,1639890463,5/20/2015 22:28:55,False,elite,0.875,31883685,GBR,H2,Accrington,80.47.186.28,no_relation,285,158,,295,185,causes,0.404061017820884,804414-FS1-4,"117   Compliance date for preparations with annual sales   117  Hemorrhoids  Anorectal preparations (e.g., creams, gels, ointments, suppositories) containing PHENYLEPHRINE HYDROCHLORIDE are used  topically  or  rectally  to provide temporary symptomatic relief of external or internal HEMORRHOIDS.",HEMORRHOIDS,PHENYLEPHRINE HYDROCHLORIDE,TWrex-cause
724124128,5/20/2015 22:34:00,1639892213,5/20/2015 22:33:41,False,superrewards,0.8304,32390657,CAN,BC,Vancouver,108.180.109.12,no_relation,285,158,,295,185,causes,0.404061017820884,804414-FS1-4,"117   Compliance date for preparations with annual sales   117  Hemorrhoids  Anorectal preparations (e.g., creams, gels, ointments, suppositories) containing PHENYLEPHRINE HYDROCHLORIDE are used  topically  or  rectally  to provide temporary symptomatic relief of external or internal HEMORRHOIDS.",HEMORRHOIDS,PHENYLEPHRINE HYDROCHLORIDE,TWrex-cause
724124129,5/20/2015 20:45:25,1639861829,5/20/2015 20:45:03,False,prodege,1.0,21417560,GBR,C3,Cambridge,151.225.116.143,NOCARDIA causes NOCARDIOSIS,65,95,,75,103,causes,0.948683298050514,810975-FS1-4,106  Nocardiosis  Alternative to co trimoxazole for treatment of NOCARDIOSIS   +    caused by  NOCARDIA,NOCARDIOSIS,NOCARDIA,TWrex-cause
724124129,5/20/2015 20:50:22,1639863930,5/20/2015 20:49:58,False,neodev,0.875,32216655,NLD,07,Amsterdam,145.100.72.168,NOCARDIA causes NOCARDIOSIS,65,95,,75,103,causes,0.948683298050514,810975-FS1-4,106  Nocardiosis  Alternative to co trimoxazole for treatment of NOCARDIOSIS   +    caused by  NOCARDIA,NOCARDIOSIS,NOCARDIA,TWrex-cause
724124129,5/20/2015 20:56:20,1639866365,5/20/2015 20:56:01,False,sharecashgpt,0.4917,28627999,CAN,ON,Sudbury,66.103.55.12,NOCARDIOSIS causes NOCARDIA,65,95,,75,103,causes,0.948683298050514,810975-FS1-4,106  Nocardiosis  Alternative to co trimoxazole for treatment of NOCARDIOSIS   +    caused by  NOCARDIA,NOCARDIOSIS,NOCARDIA,TWrex-cause
724124129,5/20/2015 20:58:00,1639866975,5/20/2015 20:57:44,False,clixsense,0.7167,30130805,USA,MI,Wyandotte,63.141.31.35,NOCARDIA causes NOCARDIOSIS,65,95,,75,103,causes,0.948683298050514,810975-FS1-4,106  Nocardiosis  Alternative to co trimoxazole for treatment of NOCARDIOSIS   +    caused by  NOCARDIA,NOCARDIOSIS,NOCARDIA,TWrex-cause
724124129,5/20/2015 20:58:14,1639867062,5/20/2015 20:57:57,False,instagc,0.7333,23032978,USA,PA,Philadelphia,76.98.187.59,NOCARDIA causes NOCARDIOSIS,65,95,,75,103,causes,0.948683298050514,810975-FS1-4,106  Nocardiosis  Alternative to co trimoxazole for treatment of NOCARDIOSIS   +    caused by  NOCARDIA,NOCARDIOSIS,NOCARDIA,TWrex-cause
724124129,5/20/2015 21:04:20,1639869264,5/20/2015 21:04:02,False,instagc,0.5675,13581319,USA,IL,Mount Vernon,66.232.166.86,NOCARDIA causes NOCARDIOSIS,65,95,,75,103,causes,0.948683298050514,810975-FS1-4,106  Nocardiosis  Alternative to co trimoxazole for treatment of NOCARDIOSIS   +    caused by  NOCARDIA,NOCARDIOSIS,NOCARDIA,TWrex-cause
724124129,5/20/2015 21:09:57,1639871123,5/20/2015 21:09:31,False,instagc,0.7401,30326470,USA,CA,Santee,99.44.37.73,NOCARDIOSIS causes NOCARDIA,65,95,,75,103,causes,0.948683298050514,810975-FS1-4,106  Nocardiosis  Alternative to co trimoxazole for treatment of NOCARDIOSIS   +    caused by  NOCARDIA,NOCARDIOSIS,NOCARDIA,TWrex-cause
724398411,5/21/2015 09:03:54,1640189017,5/21/2015 09:03:23,False,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,no_relation,203,0,,214,17,causes,0.976546150525391,812979-FS1-4,"ANDERSEN SYNDROME is characterized by periodic paralysis, which may be accompanied by fixed weakness; long QT syndrome with cardiac ventricular arrhythmias; and dysmorphic craniofacial features, such as MICROGNATHIA low set ears, short stature, and syndactyly.",MICROGNATHIA,ANDERSEN SYNDROME,TWrex-cause
724398411,5/21/2015 09:23:53,1640198941,5/21/2015 09:23:31,False,prodege,0.7917,15439740,AUS,02,Jannali,14.200.59.55,no_relation,203,0,,214,17,causes,0.976546150525391,812979-FS1-4,"ANDERSEN SYNDROME is characterized by periodic paralysis, which may be accompanied by fixed weakness; long QT syndrome with cardiac ventricular arrhythmias; and dysmorphic craniofacial features, such as MICROGNATHIA low set ears, short stature, and syndactyly.",MICROGNATHIA,ANDERSEN SYNDROME,TWrex-cause
724398411,5/21/2015 09:31:14,1640202844,5/21/2015 09:30:48,False,neodev,0.8056,14096345,NLD,03,Eibergen,77.174.124.109,ANDERSEN SYNDROME causes MICROGNATHIA,203,0,,214,17,causes,0.976546150525391,812979-FS1-4,"ANDERSEN SYNDROME is characterized by periodic paralysis, which may be accompanied by fixed weakness; long QT syndrome with cardiac ventricular arrhythmias; and dysmorphic craniofacial features, such as MICROGNATHIA low set ears, short stature, and syndactyly.",MICROGNATHIA,ANDERSEN SYNDROME,TWrex-cause
724398411,5/21/2015 09:46:26,1640210230,5/21/2015 09:45:30,False,neodev,0.75,11001780,AUS,07,Elwood,14.201.215.31,ANDERSEN SYNDROME causes MICROGNATHIA,203,0,,214,17,causes,0.976546150525391,812979-FS1-4,"ANDERSEN SYNDROME is characterized by periodic paralysis, which may be accompanied by fixed weakness; long QT syndrome with cardiac ventricular arrhythmias; and dysmorphic craniofacial features, such as MICROGNATHIA low set ears, short stature, and syndactyly.",MICROGNATHIA,ANDERSEN SYNDROME,TWrex-cause
724398411,5/21/2015 09:54:02,1640213888,5/21/2015 09:52:20,False,clixsense,0.65,10798016,GBR,C7,Coventry,86.24.245.191,ANDERSEN SYNDROME causes MICROGNATHIA,203,0,,214,17,causes,0.976546150525391,812979-FS1-4,"ANDERSEN SYNDROME is characterized by periodic paralysis, which may be accompanied by fixed weakness; long QT syndrome with cardiac ventricular arrhythmias; and dysmorphic craniofacial features, such as MICROGNATHIA low set ears, short stature, and syndactyly.",MICROGNATHIA,ANDERSEN SYNDROME,TWrex-cause
724398411,5/21/2015 09:59:22,1640216745,5/21/2015 09:58:42,False,neodev,0.7917,30627835,GBR,H9,London,5.81.27.94,ANDERSEN SYNDROME causes MICROGNATHIA,203,0,,214,17,causes,0.976546150525391,812979-FS1-4,"ANDERSEN SYNDROME is characterized by periodic paralysis, which may be accompanied by fixed weakness; long QT syndrome with cardiac ventricular arrhythmias; and dysmorphic craniofacial features, such as MICROGNATHIA low set ears, short stature, and syndactyly.",MICROGNATHIA,ANDERSEN SYNDROME,TWrex-cause
724398411,5/21/2015 10:27:06,1640230045,5/21/2015 10:25:49,False,points4rewards,0.75,20113482,USA,OR,Portland,67.213.218.72,no_relation,203,0,,214,17,causes,0.976546150525391,812979-FS1-4,"ANDERSEN SYNDROME is characterized by periodic paralysis, which may be accompanied by fixed weakness; long QT syndrome with cardiac ventricular arrhythmias; and dysmorphic craniofacial features, such as MICROGNATHIA low set ears, short stature, and syndactyly.",MICROGNATHIA,ANDERSEN SYNDROME,TWrex-cause
724398419,5/21/2015 13:52:12,1640324827,5/21/2015 13:51:45,False,sharecashgpt,0.55,28627999,CAN,ON,Sudbury,66.103.55.12,MALIGNANT TERTIAN MALARIA causes PLASMODIUM VIVAX,92,74,,116,90,causes,0.762000762001143,810368-FS1-4,Febrile stage varies from 4 to 6 hr. Benign tertian malaria is caused by  PLASMODIUM VIVAX  MALIGNANT TERTIAN MALARIA by  Plasmodium falciparum.,MALIGNANT TERTIAN MALARIA,PLASMODIUM VIVAX,TWrex-cause
724398419,5/21/2015 14:03:29,1640331533,5/21/2015 14:03:14,False,clixsense,0.5833,22751911,NLD,04,Groningen,195.241.153.97,MALIGNANT TERTIAN MALARIA causes PLASMODIUM VIVAX,92,74,,116,90,causes,0.762000762001143,810368-FS1-4,Febrile stage varies from 4 to 6 hr. Benign tertian malaria is caused by  PLASMODIUM VIVAX  MALIGNANT TERTIAN MALARIA by  Plasmodium falciparum.,MALIGNANT TERTIAN MALARIA,PLASMODIUM VIVAX,TWrex-cause
724398419,5/21/2015 14:12:27,1640337255,5/21/2015 14:12:05,False,prodege,0.6071,22031444,GBR,F2,Gosport,92.24.208.136,no_relation,92,74,,116,90,causes,0.762000762001143,810368-FS1-4,Febrile stage varies from 4 to 6 hr. Benign tertian malaria is caused by  PLASMODIUM VIVAX  MALIGNANT TERTIAN MALARIA by  Plasmodium falciparum.,MALIGNANT TERTIAN MALARIA,PLASMODIUM VIVAX,TWrex-cause
724398419,5/21/2015 14:12:59,1640337534,5/21/2015 14:08:41,False,prodege,0.6488,14571439,CAN,ON,Toronto,142.20.20.193,no_relation,92,74,,116,90,causes,0.762000762001143,810368-FS1-4,Febrile stage varies from 4 to 6 hr. Benign tertian malaria is caused by  PLASMODIUM VIVAX  MALIGNANT TERTIAN MALARIA by  Plasmodium falciparum.,MALIGNANT TERTIAN MALARIA,PLASMODIUM VIVAX,TWrex-cause
724398419,5/21/2015 14:14:22,1640338242,5/21/2015 14:13:22,False,onestopgpt,0.75,21275875,CAN,ON,Hamilton,24.36.121.10,no_relation,92,74,,116,90,causes,0.762000762001143,810368-FS1-4,Febrile stage varies from 4 to 6 hr. Benign tertian malaria is caused by  PLASMODIUM VIVAX  MALIGNANT TERTIAN MALARIA by  Plasmodium falciparum.,MALIGNANT TERTIAN MALARIA,PLASMODIUM VIVAX,TWrex-cause
724398419,5/21/2015 14:15:36,1640339062,5/21/2015 14:14:32,False,clixsense,0.5833,30681826,GBR,I3,Rochester,86.163.150.232,PLASMODIUM VIVAX causes MALIGNANT TERTIAN MALARIA,92,74,,116,90,causes,0.762000762001143,810368-FS1-4,Febrile stage varies from 4 to 6 hr. Benign tertian malaria is caused by  PLASMODIUM VIVAX  MALIGNANT TERTIAN MALARIA by  Plasmodium falciparum.,MALIGNANT TERTIAN MALARIA,PLASMODIUM VIVAX,TWrex-cause
724398419,5/21/2015 14:20:58,1640342592,5/21/2015 14:19:39,False,vivatic,0.7857,32338429,GBR,G1,Feltham,92.24.40.208,no_relation,92,74,,116,90,causes,0.762000762001143,810368-FS1-4,Febrile stage varies from 4 to 6 hr. Benign tertian malaria is caused by  PLASMODIUM VIVAX  MALIGNANT TERTIAN MALARIA by  Plasmodium falciparum.,MALIGNANT TERTIAN MALARIA,PLASMODIUM VIVAX,TWrex-cause
724398424,5/21/2015 12:03:18,1640274687,5/21/2015 12:03:10,False,elite,0.4821,31913360,USA,DE,,108.59.8.218,PHOTOSENSITIVITY causes PORPHYRIA CUTANEA TARDA,44,0,,59,23,causes,0.9704949588309459,813042-FS1-4,"PORPHYRIA CUTANEA TARDA is characterized by PHOTOSENSITIVITY vesicle formation (especially on the dorsa of the hands) [ see Figure 13 ], and hypertrichosis.",PHOTOSENSITIVITY,PORPHYRIA CUTANEA TARDA,TWrex-cause
724398424,5/21/2015 12:04:02,1640274991,5/21/2015 12:03:39,False,cotter,0.8294,13805544,USA,MI,Battle Creek,107.140.176.37,no_relation,44,0,,59,23,causes,0.9704949588309459,813042-FS1-4,"PORPHYRIA CUTANEA TARDA is characterized by PHOTOSENSITIVITY vesicle formation (especially on the dorsa of the hands) [ see Figure 13 ], and hypertrichosis.",PHOTOSENSITIVITY,PORPHYRIA CUTANEA TARDA,TWrex-cause
724398424,5/21/2015 12:05:29,1640275696,5/21/2015 12:04:28,False,instagc,0.6786,15176395,USA,IN,Greenwood,50.195.163.121,PORPHYRIA CUTANEA TARDA causes PHOTOSENSITIVITY,44,0,,59,23,causes,0.9704949588309459,813042-FS1-4,"PORPHYRIA CUTANEA TARDA is characterized by PHOTOSENSITIVITY vesicle formation (especially on the dorsa of the hands) [ see Figure 13 ], and hypertrichosis.",PHOTOSENSITIVITY,PORPHYRIA CUTANEA TARDA,TWrex-cause
724398424,5/21/2015 12:06:09,1640275963,5/21/2015 12:05:34,False,neodev,0.7917,12115558,USA,OH,Twinsburg,98.27.164.131,PORPHYRIA CUTANEA TARDA causes PHOTOSENSITIVITY,44,0,,59,23,causes,0.9704949588309459,813042-FS1-4,"PORPHYRIA CUTANEA TARDA is characterized by PHOTOSENSITIVITY vesicle formation (especially on the dorsa of the hands) [ see Figure 13 ], and hypertrichosis.",PHOTOSENSITIVITY,PORPHYRIA CUTANEA TARDA,TWrex-cause
724398424,5/21/2015 12:08:58,1640277264,5/21/2015 12:08:52,False,neodev,0.375,31789301,USA,NY,New York,198.199.68.152,PORPHYRIA CUTANEA TARDA causes PHOTOSENSITIVITY,44,0,,59,23,causes,0.9704949588309459,813042-FS1-4,"PORPHYRIA CUTANEA TARDA is characterized by PHOTOSENSITIVITY vesicle formation (especially on the dorsa of the hands) [ see Figure 13 ], and hypertrichosis.",PHOTOSENSITIVITY,PORPHYRIA CUTANEA TARDA,TWrex-cause
724398424,5/21/2015 12:25:42,1640284794,5/21/2015 12:24:48,False,neodev,0.6944,30588889,NLD,07,Amsterdam,77.248.175.222,no_relation,44,0,,59,23,causes,0.9704949588309459,813042-FS1-4,"PORPHYRIA CUTANEA TARDA is characterized by PHOTOSENSITIVITY vesicle formation (especially on the dorsa of the hands) [ see Figure 13 ], and hypertrichosis.",PHOTOSENSITIVITY,PORPHYRIA CUTANEA TARDA,TWrex-cause
724398424,5/21/2015 12:31:08,1640287209,5/21/2015 12:29:42,False,clixsense,0.6062,22947672,GBR,,,88.144.127.68,no_relation,44,0,,59,23,causes,0.9704949588309459,813042-FS1-4,"PORPHYRIA CUTANEA TARDA is characterized by PHOTOSENSITIVITY vesicle formation (especially on the dorsa of the hands) [ see Figure 13 ], and hypertrichosis.",PHOTOSENSITIVITY,PORPHYRIA CUTANEA TARDA,TWrex-cause
724398427,5/21/2015 09:02:50,1640188495,5/21/2015 09:02:26,False,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,HEREDITARY ANGIOEDEMA causes ABDOMINAL PAIN,48,15,,61,36,causes,0.964901281354015,813122-FS1-4,A patient with HEREDITARY ANGIOEDEMA has severe ABDOMINAL PAIN,ABDOMINAL PAIN,HEREDITARY ANGIOEDEMA,TWrex-cause
724398427,5/21/2015 09:23:04,1640198642,5/21/2015 09:22:51,False,prodege,0.7917,15439740,AUS,02,Jannali,14.200.59.55,no_relation,48,15,,61,36,causes,0.964901281354015,813122-FS1-4,A patient with HEREDITARY ANGIOEDEMA has severe ABDOMINAL PAIN,ABDOMINAL PAIN,HEREDITARY ANGIOEDEMA,TWrex-cause
724398427,5/21/2015 09:30:07,1640202274,5/21/2015 09:29:52,False,neodev,0.8056,14096345,NLD,03,Eibergen,77.174.124.109,no_relation,48,15,,61,36,causes,0.964901281354015,813122-FS1-4,A patient with HEREDITARY ANGIOEDEMA has severe ABDOMINAL PAIN,ABDOMINAL PAIN,HEREDITARY ANGIOEDEMA,TWrex-cause
724398427,5/21/2015 09:44:13,1640209119,5/21/2015 09:43:33,False,neodev,0.75,11001780,AUS,07,Elwood,14.201.215.31,HEREDITARY ANGIOEDEMA causes ABDOMINAL PAIN,48,15,,61,36,causes,0.964901281354015,813122-FS1-4,A patient with HEREDITARY ANGIOEDEMA has severe ABDOMINAL PAIN,ABDOMINAL PAIN,HEREDITARY ANGIOEDEMA,TWrex-cause
724398427,5/21/2015 09:50:27,1640212205,5/21/2015 09:49:28,False,clixsense,0.65,10798016,GBR,C7,Coventry,86.24.245.191,no_relation,48,15,,61,36,causes,0.964901281354015,813122-FS1-4,A patient with HEREDITARY ANGIOEDEMA has severe ABDOMINAL PAIN,ABDOMINAL PAIN,HEREDITARY ANGIOEDEMA,TWrex-cause
724398427,5/21/2015 09:58:01,1640215970,5/21/2015 09:57:42,False,neodev,0.7917,30627835,GBR,H9,London,5.81.27.94,HEREDITARY ANGIOEDEMA causes ABDOMINAL PAIN,48,15,,61,36,causes,0.964901281354015,813122-FS1-4,A patient with HEREDITARY ANGIOEDEMA has severe ABDOMINAL PAIN,ABDOMINAL PAIN,HEREDITARY ANGIOEDEMA,TWrex-cause
724398427,5/21/2015 10:24:43,1640229013,5/21/2015 10:22:56,False,points4rewards,0.75,20113482,USA,OR,Portland,67.213.218.72,HEREDITARY ANGIOEDEMA causes ABDOMINAL PAIN,48,15,,61,36,causes,0.964901281354015,813122-FS1-4,A patient with HEREDITARY ANGIOEDEMA has severe ABDOMINAL PAIN,ABDOMINAL PAIN,HEREDITARY ANGIOEDEMA,TWrex-cause
724398433,5/21/2015 12:48:03,1640294411,5/21/2015 12:47:48,False,pocketmoneygpt,0.675,28884030,USA,WI,Minocqua,75.143.134.247,BENIGN PROSTATIC HYPERPLASIA causes FINASTERIDE,131,107,,158,118,causes,0.6741998624632421,805078-FS1-4,"1]  Gormley GJ, Stoner E, Bruskewitz RC, Imperato McGinley J, Walsh PC, McConnell JD, et al. The effect of FINASTERIDE in men with BENIGN PROSTATIC HYPERPLASIA",BENIGN PROSTATIC HYPERPLASIA,FINASTERIDE,TWrex-cause
724398433,5/21/2015 12:49:53,1640295232,5/21/2015 12:49:38,False,instagc,0.6417,13581319,USA,IL,Mount Vernon,66.232.166.86,no_relation,131,107,,158,118,causes,0.6741998624632421,805078-FS1-4,"1]  Gormley GJ, Stoner E, Bruskewitz RC, Imperato McGinley J, Walsh PC, McConnell JD, et al. The effect of FINASTERIDE in men with BENIGN PROSTATIC HYPERPLASIA",BENIGN PROSTATIC HYPERPLASIA,FINASTERIDE,TWrex-cause
724398433,5/21/2015 12:57:08,1640298241,5/21/2015 12:56:39,False,prodege,0.6825,21417560,GBR,C3,Cambridge,151.225.116.143,no_relation,131,107,,158,118,causes,0.6741998624632421,805078-FS1-4,"1]  Gormley GJ, Stoner E, Bruskewitz RC, Imperato McGinley J, Walsh PC, McConnell JD, et al. The effect of FINASTERIDE in men with BENIGN PROSTATIC HYPERPLASIA",BENIGN PROSTATIC HYPERPLASIA,FINASTERIDE,TWrex-cause
724398433,5/21/2015 13:26:00,1640311679,5/21/2015 13:25:14,False,clixsense,0.8958,17950689,GBR,Y9,Tonypandy,92.2.44.79,FINASTERIDE causes BENIGN PROSTATIC HYPERPLASIA,131,107,,158,118,causes,0.6741998624632421,805078-FS1-4,"1]  Gormley GJ, Stoner E, Bruskewitz RC, Imperato McGinley J, Walsh PC, McConnell JD, et al. The effect of FINASTERIDE in men with BENIGN PROSTATIC HYPERPLASIA",BENIGN PROSTATIC HYPERPLASIA,FINASTERIDE,TWrex-cause
724398433,5/21/2015 13:41:25,1640319213,5/21/2015 13:39:25,False,instagc,0.6964,15285653,USA,,,172.162.76.35,BENIGN PROSTATIC HYPERPLASIA causes FINASTERIDE,131,107,,158,118,causes,0.6741998624632421,805078-FS1-4,"1]  Gormley GJ, Stoner E, Bruskewitz RC, Imperato McGinley J, Walsh PC, McConnell JD, et al. The effect of FINASTERIDE in men with BENIGN PROSTATIC HYPERPLASIA",BENIGN PROSTATIC HYPERPLASIA,FINASTERIDE,TWrex-cause
724398433,5/21/2015 13:43:02,1640319977,5/21/2015 13:40:42,False,points4rewards,0.6548,28755767,USA,VA,Chester,68.57.118.32,BENIGN PROSTATIC HYPERPLASIA causes FINASTERIDE,131,107,,158,118,causes,0.6741998624632421,805078-FS1-4,"1]  Gormley GJ, Stoner E, Bruskewitz RC, Imperato McGinley J, Walsh PC, McConnell JD, et al. The effect of FINASTERIDE in men with BENIGN PROSTATIC HYPERPLASIA",BENIGN PROSTATIC HYPERPLASIA,FINASTERIDE,TWrex-cause
724398433,5/21/2015 13:44:03,1640320546,5/21/2015 13:42:52,False,prodege,0.6032,16101132,GBR,G1,Hounslow,90.207.88.197,no_relation,131,107,,158,118,causes,0.6741998624632421,805078-FS1-4,"1]  Gormley GJ, Stoner E, Bruskewitz RC, Imperato McGinley J, Walsh PC, McConnell JD, et al. The effect of FINASTERIDE in men with BENIGN PROSTATIC HYPERPLASIA",BENIGN PROSTATIC HYPERPLASIA,FINASTERIDE,TWrex-cause
724534005,5/21/2015 17:13:26,1640447792,5/21/2015 17:13:12,False,clixsense,0.96,32549163,CAN,MB,Winnipeg,206.45.167.246,no_relation,90,23,,113,49,causes,0.7293249574894731,815002-FS1-4,"Sensitivity Reactions  HYPERSENSITIVITY REACTIONS  Serious cutaneous reactions, including STEVENS JOHNSON SYNDROME  1 ,   2 ,   93 ,   99   erythema multiforme.",STEVENS JOHNSON SYNDROME,HYPERSENSITIVITY REACTIONS,TWrex-cause
724534005,5/21/2015 17:14:10,1640448296,5/21/2015 17:13:48,False,clixsense,0.95,6417722,USA,MI,Taylor,99.170.106.105,no_relation,90,23,,113,49,causes,0.7293249574894731,815002-FS1-4,"Sensitivity Reactions  HYPERSENSITIVITY REACTIONS  Serious cutaneous reactions, including STEVENS JOHNSON SYNDROME  1 ,   2 ,   93 ,   99   erythema multiforme.",STEVENS JOHNSON SYNDROME,HYPERSENSITIVITY REACTIONS,TWrex-cause
724534005,5/21/2015 17:16:32,1640449807,5/21/2015 17:15:52,False,gifthunterclub,0.8611,29582088,GBR,I2,Manchester,89.240.68.44,HYPERSENSITIVITY REACTIONS causes STEVENS JOHNSON SYNDROME,90,23,,113,49,causes,0.7293249574894731,815002-FS1-4,"Sensitivity Reactions  HYPERSENSITIVITY REACTIONS  Serious cutaneous reactions, including STEVENS JOHNSON SYNDROME  1 ,   2 ,   93 ,   99   erythema multiforme.",STEVENS JOHNSON SYNDROME,HYPERSENSITIVITY REACTIONS,TWrex-cause
724534005,5/21/2015 17:27:59,1640457504,5/21/2015 17:27:25,False,vivatic,0.8809999999999999,32338429,GBR,G1,Feltham,92.24.40.208,no_relation,90,23,,113,49,causes,0.7293249574894731,815002-FS1-4,"Sensitivity Reactions  HYPERSENSITIVITY REACTIONS  Serious cutaneous reactions, including STEVENS JOHNSON SYNDROME  1 ,   2 ,   93 ,   99   erythema multiforme.",STEVENS JOHNSON SYNDROME,HYPERSENSITIVITY REACTIONS,TWrex-cause
724534005,5/21/2015 17:30:12,1640458849,5/21/2015 17:29:48,False,instagc,0.7264,32352104,USA,ME,Bangor,74.75.63.81,no_relation,90,23,,113,49,causes,0.7293249574894731,815002-FS1-4,"Sensitivity Reactions  HYPERSENSITIVITY REACTIONS  Serious cutaneous reactions, including STEVENS JOHNSON SYNDROME  1 ,   2 ,   93 ,   99   erythema multiforme.",STEVENS JOHNSON SYNDROME,HYPERSENSITIVITY REACTIONS,TWrex-cause
724534005,5/21/2015 17:34:27,1640461221,5/21/2015 17:33:31,False,clixsense,0.7083,10798016,GBR,C7,Coventry,86.24.245.191,no_relation,90,23,,113,49,causes,0.7293249574894731,815002-FS1-4,"Sensitivity Reactions  HYPERSENSITIVITY REACTIONS  Serious cutaneous reactions, including STEVENS JOHNSON SYNDROME  1 ,   2 ,   93 ,   99   erythema multiforme.",STEVENS JOHNSON SYNDROME,HYPERSENSITIVITY REACTIONS,TWrex-cause
724534005,5/21/2015 17:39:41,1640464892,5/21/2015 17:39:27,False,instagc,0.6607,13581319,USA,IL,Mount Vernon,66.232.166.86,STEVENS JOHNSON SYNDROME causes HYPERSENSITIVITY REACTIONS,90,23,,113,49,causes,0.7293249574894731,815002-FS1-4,"Sensitivity Reactions  HYPERSENSITIVITY REACTIONS  Serious cutaneous reactions, including STEVENS JOHNSON SYNDROME  1 ,   2 ,   93 ,   99   erythema multiforme.",STEVENS JOHNSON SYNDROME,HYPERSENSITIVITY REACTIONS,TWrex-cause
724534012,5/21/2015 17:59:35,1640477738,5/21/2015 17:57:37,False,points4rewards,0.7576,20113482,USA,OR,Portland,67.213.218.72,DEMENTIA WITH LEWY BODIES causes VISUAL HALLUCINATIONS,100,2,,120,27,causes,0.9958932064677041,812738-FS1-4,"◊ DEMENTIA WITH LEWY BODIES is a progressive cognitive decline with fluctuating symptoms, recurrent VISUAL HALLUCINATIONS and spontaneous, extrapyramidal signs ( 45.",VISUAL HALLUCINATIONS,DEMENTIA WITH LEWY BODIES,TWrex-cause
724534012,5/21/2015 18:33:55,1640495341,5/21/2015 18:33:04,False,neodev,0.6778,32216655,NLD,07,Amsterdam,145.100.72.168,DEMENTIA WITH LEWY BODIES causes VISUAL HALLUCINATIONS,100,2,,120,27,causes,0.9958932064677041,812738-FS1-4,"◊ DEMENTIA WITH LEWY BODIES is a progressive cognitive decline with fluctuating symptoms, recurrent VISUAL HALLUCINATIONS and spontaneous, extrapyramidal signs ( 45.",VISUAL HALLUCINATIONS,DEMENTIA WITH LEWY BODIES,TWrex-cause
724534012,5/21/2015 18:39:25,1640500177,5/21/2015 18:39:02,False,neodev,0.7011,31448050,GBR,,,92.24.68.74,DEMENTIA WITH LEWY BODIES causes VISUAL HALLUCINATIONS,100,2,,120,27,causes,0.9958932064677041,812738-FS1-4,"◊ DEMENTIA WITH LEWY BODIES is a progressive cognitive decline with fluctuating symptoms, recurrent VISUAL HALLUCINATIONS and spontaneous, extrapyramidal signs ( 45.",VISUAL HALLUCINATIONS,DEMENTIA WITH LEWY BODIES,TWrex-cause
724534012,5/21/2015 19:09:15,1640523695,5/21/2015 19:07:04,False,neodev,0.5459,11035031,CAN,ON,Scarborough,99.244.36.47,DEMENTIA WITH LEWY BODIES causes VISUAL HALLUCINATIONS,100,2,,120,27,causes,0.9958932064677041,812738-FS1-4,"◊ DEMENTIA WITH LEWY BODIES is a progressive cognitive decline with fluctuating symptoms, recurrent VISUAL HALLUCINATIONS and spontaneous, extrapyramidal signs ( 45.",VISUAL HALLUCINATIONS,DEMENTIA WITH LEWY BODIES,TWrex-cause
724534012,5/21/2015 19:13:29,1640526378,5/21/2015 19:11:33,False,clixsense,0.6667,10032240,USA,FL,Naples,76.101.211.223,DEMENTIA WITH LEWY BODIES causes VISUAL HALLUCINATIONS,100,2,,120,27,causes,0.9958932064677041,812738-FS1-4,"◊ DEMENTIA WITH LEWY BODIES is a progressive cognitive decline with fluctuating symptoms, recurrent VISUAL HALLUCINATIONS and spontaneous, extrapyramidal signs ( 45.",VISUAL HALLUCINATIONS,DEMENTIA WITH LEWY BODIES,TWrex-cause
724534012,5/21/2015 19:32:55,1640554232,5/21/2015 19:31:14,False,neodev,0.7143,11257883,CAN,BC,Surrey,76.77.82.83,DEMENTIA WITH LEWY BODIES causes VISUAL HALLUCINATIONS,100,2,,120,27,causes,0.9958932064677041,812738-FS1-4,"◊ DEMENTIA WITH LEWY BODIES is a progressive cognitive decline with fluctuating symptoms, recurrent VISUAL HALLUCINATIONS and spontaneous, extrapyramidal signs ( 45.",VISUAL HALLUCINATIONS,DEMENTIA WITH LEWY BODIES,TWrex-cause
724534012,5/21/2015 19:35:55,1640556859,5/21/2015 19:35:24,False,instagc,0.3905,30326470,USA,CA,Santee,99.44.37.73,no_relation,100,2,,120,27,causes,0.9958932064677041,812738-FS1-4,"◊ DEMENTIA WITH LEWY BODIES is a progressive cognitive decline with fluctuating symptoms, recurrent VISUAL HALLUCINATIONS and spontaneous, extrapyramidal signs ( 45.",VISUAL HALLUCINATIONS,DEMENTIA WITH LEWY BODIES,TWrex-cause
724534018,5/21/2015 16:34:25,1640422879,5/21/2015 16:33:42,False,neodev,0.7857,19004420,GBR,P8,Devizes,31.54.209.43,PROPRANOLOL causes SUPRAVENTRICULAR TACHYCARDIA,157,101,,184,112,causes,0.442325868464691,803991-FS1-4,"• Hypoglycemia and respiratory depression were reported in a newborn whose mother received 160 mg of PROPRANOLOL during pregnancy, labor, and delivery for a SUPRAVENTRICULAR TACHYCARDIA",SUPRAVENTRICULAR TACHYCARDIA,PROPRANOLOL,TWrex-cause
724534018,5/21/2015 16:34:42,1640423036,5/21/2015 16:33:44,False,instagc,0.8571,31184650,USA,IA,West Des Moines,63.153.203.116,no_relation,157,101,,184,112,causes,0.442325868464691,803991-FS1-4,"• Hypoglycemia and respiratory depression were reported in a newborn whose mother received 160 mg of PROPRANOLOL during pregnancy, labor, and delivery for a SUPRAVENTRICULAR TACHYCARDIA",SUPRAVENTRICULAR TACHYCARDIA,PROPRANOLOL,TWrex-cause
724534018,5/21/2015 16:36:00,1640423764,5/21/2015 16:35:06,False,instagc,0.8333,23287154,USA,CA,San Jose,130.65.251.20,no_relation,157,101,,184,112,causes,0.442325868464691,803991-FS1-4,"• Hypoglycemia and respiratory depression were reported in a newborn whose mother received 160 mg of PROPRANOLOL during pregnancy, labor, and delivery for a SUPRAVENTRICULAR TACHYCARDIA",SUPRAVENTRICULAR TACHYCARDIA,PROPRANOLOL,TWrex-cause
724534018,5/21/2015 16:36:13,1640424016,5/21/2015 16:35:08,False,prodege,0.7222,29208173,USA,PA,Philadelphia,50.191.35.177,PROPRANOLOL causes SUPRAVENTRICULAR TACHYCARDIA,157,101,,184,112,causes,0.442325868464691,803991-FS1-4,"• Hypoglycemia and respiratory depression were reported in a newborn whose mother received 160 mg of PROPRANOLOL during pregnancy, labor, and delivery for a SUPRAVENTRICULAR TACHYCARDIA",SUPRAVENTRICULAR TACHYCARDIA,PROPRANOLOL,TWrex-cause
724534018,5/21/2015 16:38:53,1640425669,5/21/2015 16:38:31,False,neodev,0.8472,14096345,NLD,03,Eibergen,77.174.124.109,no_relation,157,101,,184,112,causes,0.442325868464691,803991-FS1-4,"• Hypoglycemia and respiratory depression were reported in a newborn whose mother received 160 mg of PROPRANOLOL during pregnancy, labor, and delivery for a SUPRAVENTRICULAR TACHYCARDIA",SUPRAVENTRICULAR TACHYCARDIA,PROPRANOLOL,TWrex-cause
724534018,5/21/2015 16:39:35,1640426158,5/21/2015 16:39:10,False,neodev,0.852,18881135,CAN,ON,Ajax,99.243.87.224,no_relation,157,101,,184,112,causes,0.442325868464691,803991-FS1-4,"• Hypoglycemia and respiratory depression were reported in a newborn whose mother received 160 mg of PROPRANOLOL during pregnancy, labor, and delivery for a SUPRAVENTRICULAR TACHYCARDIA",SUPRAVENTRICULAR TACHYCARDIA,PROPRANOLOL,TWrex-cause
724534018,5/21/2015 17:02:56,1640441470,5/21/2015 17:02:49,False,prodege,0.5714,2143114,CAN,BC,Vancouver,24.85.153.181,SUPRAVENTRICULAR TACHYCARDIA causes PROPRANOLOL,157,101,,184,112,causes,0.442325868464691,803991-FS1-4,"• Hypoglycemia and respiratory depression were reported in a newborn whose mother received 160 mg of PROPRANOLOL during pregnancy, labor, and delivery for a SUPRAVENTRICULAR TACHYCARDIA",SUPRAVENTRICULAR TACHYCARDIA,PROPRANOLOL,TWrex-cause
724534023,5/21/2015 17:32:50,1640460323,5/21/2015 17:32:16,False,instagc,0.7264,32352104,USA,ME,Bangor,74.75.63.81,no_relation,0,65,,28,92,causes,0.6488856845230501,804447-FS1-4,"LACTATIONAL AMENORRHEA METHOD  LH    luteinizing hormone  MPA    MEDROXYPROGESTERONE ACETATE  OR    odds ratio  PE    pulmonary embolism  PID    pelvic inflammatory disease  POC    progestin only contraceptive pill  RR    risk ratio  STD    sexually transmitted disease  STI    sexually transmitted infection  TOP    termination of pregnancy, medical abortion  TSS    toxic shock syndrome  UTI    urinary tract infection  VTE    venous thromboembolism.",LACTATIONAL AMENORRHEA METHOD,MEDROXYPROGESTERONE ACETATE,TWrex-cause
724534023,5/21/2015 17:40:36,1640465451,5/21/2015 17:40:12,False,instagc,0.6607,13581319,USA,IL,Mount Vernon,66.232.166.86,no_relation,0,65,,28,92,causes,0.6488856845230501,804447-FS1-4,"LACTATIONAL AMENORRHEA METHOD  LH    luteinizing hormone  MPA    MEDROXYPROGESTERONE ACETATE  OR    odds ratio  PE    pulmonary embolism  PID    pelvic inflammatory disease  POC    progestin only contraceptive pill  RR    risk ratio  STD    sexually transmitted disease  STI    sexually transmitted infection  TOP    termination of pregnancy, medical abortion  TSS    toxic shock syndrome  UTI    urinary tract infection  VTE    venous thromboembolism.",LACTATIONAL AMENORRHEA METHOD,MEDROXYPROGESTERONE ACETATE,TWrex-cause
724534023,5/21/2015 17:41:12,1640465898,5/21/2015 17:40:48,False,neodev,0.7798,20961587,NLD,05,Maastricht,84.26.48.136,no_relation,0,65,,28,92,causes,0.6488856845230501,804447-FS1-4,"LACTATIONAL AMENORRHEA METHOD  LH    luteinizing hormone  MPA    MEDROXYPROGESTERONE ACETATE  OR    odds ratio  PE    pulmonary embolism  PID    pelvic inflammatory disease  POC    progestin only contraceptive pill  RR    risk ratio  STD    sexually transmitted disease  STI    sexually transmitted infection  TOP    termination of pregnancy, medical abortion  TSS    toxic shock syndrome  UTI    urinary tract infection  VTE    venous thromboembolism.",LACTATIONAL AMENORRHEA METHOD,MEDROXYPROGESTERONE ACETATE,TWrex-cause
724534023,5/21/2015 17:45:54,1640468864,5/21/2015 17:45:32,False,neodev,0.4167,31977841,USA,IL,Chicago,69.175.85.2,LACTATIONAL AMENORRHEA METHOD causes MEDROXYPROGESTERONE ACETATE,0,65,,28,92,causes,0.6488856845230501,804447-FS1-4,"LACTATIONAL AMENORRHEA METHOD  LH    luteinizing hormone  MPA    MEDROXYPROGESTERONE ACETATE  OR    odds ratio  PE    pulmonary embolism  PID    pelvic inflammatory disease  POC    progestin only contraceptive pill  RR    risk ratio  STD    sexually transmitted disease  STI    sexually transmitted infection  TOP    termination of pregnancy, medical abortion  TSS    toxic shock syndrome  UTI    urinary tract infection  VTE    venous thromboembolism.",LACTATIONAL AMENORRHEA METHOD,MEDROXYPROGESTERONE ACETATE,TWrex-cause
724534023,5/21/2015 17:46:30,1640469487,5/21/2015 17:44:57,False,clixsense,0.475,6330997,USA,PA,Greencastle,98.237.7.75,LACTATIONAL AMENORRHEA METHOD causes MEDROXYPROGESTERONE ACETATE,0,65,,28,92,causes,0.6488856845230501,804447-FS1-4,"LACTATIONAL AMENORRHEA METHOD  LH    luteinizing hormone  MPA    MEDROXYPROGESTERONE ACETATE  OR    odds ratio  PE    pulmonary embolism  PID    pelvic inflammatory disease  POC    progestin only contraceptive pill  RR    risk ratio  STD    sexually transmitted disease  STI    sexually transmitted infection  TOP    termination of pregnancy, medical abortion  TSS    toxic shock syndrome  UTI    urinary tract infection  VTE    venous thromboembolism.",LACTATIONAL AMENORRHEA METHOD,MEDROXYPROGESTERONE ACETATE,TWrex-cause
724534023,5/21/2015 17:53:04,1640473355,5/21/2015 17:51:16,False,points4rewards,0.7576,20113482,USA,OR,Portland,67.213.218.72,no_relation,0,65,,28,92,causes,0.6488856845230501,804447-FS1-4,"LACTATIONAL AMENORRHEA METHOD  LH    luteinizing hormone  MPA    MEDROXYPROGESTERONE ACETATE  OR    odds ratio  PE    pulmonary embolism  PID    pelvic inflammatory disease  POC    progestin only contraceptive pill  RR    risk ratio  STD    sexually transmitted disease  STI    sexually transmitted infection  TOP    termination of pregnancy, medical abortion  TSS    toxic shock syndrome  UTI    urinary tract infection  VTE    venous thromboembolism.",LACTATIONAL AMENORRHEA METHOD,MEDROXYPROGESTERONE ACETATE,TWrex-cause
724534023,5/21/2015 18:15:21,1640488712,5/21/2015 18:14:24,False,instagc,0.6134,15864091,USA,OK,Oklahoma City,104.0.113.133,no_relation,0,65,,28,92,causes,0.6488856845230501,804447-FS1-4,"LACTATIONAL AMENORRHEA METHOD  LH    luteinizing hormone  MPA    MEDROXYPROGESTERONE ACETATE  OR    odds ratio  PE    pulmonary embolism  PID    pelvic inflammatory disease  POC    progestin only contraceptive pill  RR    risk ratio  STD    sexually transmitted disease  STI    sexually transmitted infection  TOP    termination of pregnancy, medical abortion  TSS    toxic shock syndrome  UTI    urinary tract infection  VTE    venous thromboembolism.",LACTATIONAL AMENORRHEA METHOD,MEDROXYPROGESTERONE ACETATE,TWrex-cause
724534027,5/21/2015 17:59:35,1640477750,5/21/2015 17:57:37,False,points4rewards,0.7576,20113482,USA,OR,Portland,67.213.218.72,no_relation,14,35,,33,74,causes,0.857492925712544,810489-FS1-4,Prevalence of TOXIC SHOCK SYNDROME TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS and the presence of antibodies to this superantigen in menstruating women.,TOXIC SHOCK SYNDROME,TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS,TWrex-cause
724534027,5/21/2015 18:33:55,1640495346,5/21/2015 18:33:04,False,neodev,0.6778,32216655,NLD,07,Amsterdam,145.100.72.168,TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS causes TOXIC SHOCK SYNDROME,14,35,,33,74,causes,0.857492925712544,810489-FS1-4,Prevalence of TOXIC SHOCK SYNDROME TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS and the presence of antibodies to this superantigen in menstruating women.,TOXIC SHOCK SYNDROME,TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS,TWrex-cause
724534027,5/21/2015 18:39:25,1640500178,5/21/2015 18:39:02,False,neodev,0.7011,31448050,GBR,,,92.24.68.74,TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS causes TOXIC SHOCK SYNDROME,14,35,,33,74,causes,0.857492925712544,810489-FS1-4,Prevalence of TOXIC SHOCK SYNDROME TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS and the presence of antibodies to this superantigen in menstruating women.,TOXIC SHOCK SYNDROME,TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS,TWrex-cause
724534027,5/21/2015 19:09:15,1640523697,5/21/2015 19:07:04,False,neodev,0.5459,11035031,CAN,ON,Scarborough,99.244.36.47,TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS causes TOXIC SHOCK SYNDROME,14,35,,33,74,causes,0.857492925712544,810489-FS1-4,Prevalence of TOXIC SHOCK SYNDROME TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS and the presence of antibodies to this superantigen in menstruating women.,TOXIC SHOCK SYNDROME,TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS,TWrex-cause
724534027,5/21/2015 19:13:29,1640526376,5/21/2015 19:11:33,False,clixsense,0.6667,10032240,USA,FL,Naples,76.101.211.223,no_relation,14,35,,33,74,causes,0.857492925712544,810489-FS1-4,Prevalence of TOXIC SHOCK SYNDROME TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS and the presence of antibodies to this superantigen in menstruating women.,TOXIC SHOCK SYNDROME,TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS,TWrex-cause
724534027,5/21/2015 19:32:55,1640554204,5/21/2015 19:31:14,False,neodev,0.7143,11257883,CAN,BC,Surrey,76.77.82.83,TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS causes TOXIC SHOCK SYNDROME,14,35,,33,74,causes,0.857492925712544,810489-FS1-4,Prevalence of TOXIC SHOCK SYNDROME TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS and the presence of antibodies to this superantigen in menstruating women.,TOXIC SHOCK SYNDROME,TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS,TWrex-cause
724534027,5/21/2015 19:35:55,1640556862,5/21/2015 19:35:24,False,instagc,0.3905,30326470,USA,CA,Santee,99.44.37.73,no_relation,14,35,,33,74,causes,0.857492925712544,810489-FS1-4,Prevalence of TOXIC SHOCK SYNDROME TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS and the presence of antibodies to this superantigen in menstruating women.,TOXIC SHOCK SYNDROME,TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS,TWrex-cause
724534037,5/21/2015 17:13:11,1640447602,5/21/2015 17:12:52,False,clixsense,0.96,32549163,CAN,MB,Winnipeg,206.45.167.246,NEGATIVE IRON BALANCE causes IRON DEFICIENCY ANEMIA,40,3,,61,24,causes,0.975900072948533,804416-FS1-4,"If NEGATIVE IRON BALANCE persists, then IRON DEFICIENCY ANEMIA is the result.",IRON DEFICIENCY ANEMIA,NEGATIVE IRON BALANCE,TWrex-cause
724534037,5/21/2015 17:13:47,1640448105,5/21/2015 17:13:32,False,clixsense,0.95,6417722,USA,MI,Taylor,99.170.106.105,NEGATIVE IRON BALANCE causes IRON DEFICIENCY ANEMIA,40,3,,61,24,causes,0.975900072948533,804416-FS1-4,"If NEGATIVE IRON BALANCE persists, then IRON DEFICIENCY ANEMIA is the result.",IRON DEFICIENCY ANEMIA,NEGATIVE IRON BALANCE,TWrex-cause
724534037,5/21/2015 17:15:51,1640449402,5/21/2015 17:15:28,False,gifthunterclub,0.8611,29582088,GBR,I2,Manchester,89.240.68.44,NEGATIVE IRON BALANCE causes IRON DEFICIENCY ANEMIA,40,3,,61,24,causes,0.975900072948533,804416-FS1-4,"If NEGATIVE IRON BALANCE persists, then IRON DEFICIENCY ANEMIA is the result.",IRON DEFICIENCY ANEMIA,NEGATIVE IRON BALANCE,TWrex-cause
724534037,5/21/2015 17:27:23,1640457120,5/21/2015 17:26:44,False,vivatic,0.8809999999999999,32338429,GBR,G1,Feltham,92.24.40.208,NEGATIVE IRON BALANCE causes IRON DEFICIENCY ANEMIA,40,3,,61,24,causes,0.975900072948533,804416-FS1-4,"If NEGATIVE IRON BALANCE persists, then IRON DEFICIENCY ANEMIA is the result.",IRON DEFICIENCY ANEMIA,NEGATIVE IRON BALANCE,TWrex-cause
724534037,5/21/2015 17:29:47,1640458654,5/21/2015 17:29:26,False,instagc,0.7264,32352104,USA,ME,Bangor,74.75.63.81,NEGATIVE IRON BALANCE causes IRON DEFICIENCY ANEMIA,40,3,,61,24,causes,0.975900072948533,804416-FS1-4,"If NEGATIVE IRON BALANCE persists, then IRON DEFICIENCY ANEMIA is the result.",IRON DEFICIENCY ANEMIA,NEGATIVE IRON BALANCE,TWrex-cause
724534037,5/21/2015 17:33:30,1640460669,5/21/2015 17:31:32,False,clixsense,0.7083,10798016,GBR,C7,Coventry,86.24.245.191,no_relation,40,3,,61,24,causes,0.975900072948533,804416-FS1-4,"If NEGATIVE IRON BALANCE persists, then IRON DEFICIENCY ANEMIA is the result.",IRON DEFICIENCY ANEMIA,NEGATIVE IRON BALANCE,TWrex-cause
724534037,5/21/2015 17:44:56,1640468309,5/21/2015 17:43:28,False,clixsense,0.475,6330997,USA,PA,Greencastle,98.237.7.75,NEGATIVE IRON BALANCE causes IRON DEFICIENCY ANEMIA,40,3,,61,24,causes,0.975900072948533,804416-FS1-4,"If NEGATIVE IRON BALANCE persists, then IRON DEFICIENCY ANEMIA is the result.",IRON DEFICIENCY ANEMIA,NEGATIVE IRON BALANCE,TWrex-cause
724534039,5/21/2015 16:16:58,1640411229,5/21/2015 16:16:26,False,pocketmoneygpt,0.9722,28884030,USA,WI,Minocqua,75.143.134.247,TTP causes THROMBOCYTOPENIA,74,19,,89,22,causes,0.9045340337332909,813092-FS1-4,"Common features of TTP and HUS include microangiopathic hemolytic anemia, THROMBOCYTOPENIA and the presence of platelet fibrin thrombi in the small vessels.",THROMBOCYTOPENIA,TTP,TWrex-cause
724534039,5/21/2015 16:19:19,1640412695,5/21/2015 16:19:02,False,neodev,0.6667,31066862,USA,CA,San Jose,128.107.241.176,no_relation,74,19,,89,22,causes,0.9045340337332909,813092-FS1-4,"Common features of TTP and HUS include microangiopathic hemolytic anemia, THROMBOCYTOPENIA and the presence of platelet fibrin thrombi in the small vessels.",THROMBOCYTOPENIA,TTP,TWrex-cause
724534039,5/21/2015 16:22:31,1640414945,5/21/2015 16:18:58,False,clixsense,0.7569,30681826,GBR,I3,Rochester,86.163.150.232,TTP causes THROMBOCYTOPENIA,74,19,,89,22,causes,0.9045340337332909,813092-FS1-4,"Common features of TTP and HUS include microangiopathic hemolytic anemia, THROMBOCYTOPENIA and the presence of platelet fibrin thrombi in the small vessels.",THROMBOCYTOPENIA,TTP,TWrex-cause
724534039,5/21/2015 16:23:58,1640415887,5/21/2015 16:23:38,False,onestopgpt,0.6458,21275875,CAN,ON,Hamilton,24.36.121.10,TTP causes THROMBOCYTOPENIA,74,19,,89,22,causes,0.9045340337332909,813092-FS1-4,"Common features of TTP and HUS include microangiopathic hemolytic anemia, THROMBOCYTOPENIA and the presence of platelet fibrin thrombi in the small vessels.",THROMBOCYTOPENIA,TTP,TWrex-cause
724534039,5/21/2015 16:30:12,1640420173,5/21/2015 16:29:50,False,sharecashgpt,0.4208,28627999,CAN,ON,Sudbury,66.103.55.12,no_relation,74,19,,89,22,causes,0.9045340337332909,813092-FS1-4,"Common features of TTP and HUS include microangiopathic hemolytic anemia, THROMBOCYTOPENIA and the presence of platelet fibrin thrombi in the small vessels.",THROMBOCYTOPENIA,TTP,TWrex-cause
724534039,5/21/2015 16:31:44,1640421278,5/21/2015 16:31:02,False,prodege,0.7321,14848125,GBR,U8,Edinburgh,86.149.215.103,TTP causes THROMBOCYTOPENIA,74,19,,89,22,causes,0.9045340337332909,813092-FS1-4,"Common features of TTP and HUS include microangiopathic hemolytic anemia, THROMBOCYTOPENIA and the presence of platelet fibrin thrombi in the small vessels.",THROMBOCYTOPENIA,TTP,TWrex-cause
724534039,5/21/2015 16:33:27,1640422336,5/21/2015 16:33:12,False,instagc,0.8571,31184650,USA,IA,West Des Moines,63.153.203.116,TTP causes THROMBOCYTOPENIA,74,19,,89,22,causes,0.9045340337332909,813092-FS1-4,"Common features of TTP and HUS include microangiopathic hemolytic anemia, THROMBOCYTOPENIA and the presence of platelet fibrin thrombi in the small vessels.",THROMBOCYTOPENIA,TTP,TWrex-cause
724534041,5/21/2015 18:00:31,1640478298,5/21/2015 17:59:39,False,points4rewards,0.7576,20113482,USA,OR,Portland,67.213.218.72,MEGALOBLASTOSIS causes PANCYTOPENIA,28,103,,39,118,causes,0.881917103688197,814020-FS1-4,"Other conditions that cause PANCYTOPENIA include hypoplastic myelodysplastic syndrome, acute leukemia, MEGALOBLASTOSIS and large granular lymphocytic leukemia.",PANCYTOPENIA,MEGALOBLASTOSIS,TWrex-cause
724534041,5/21/2015 18:34:11,1640495529,5/21/2015 18:33:57,False,neodev,0.6778,32216655,NLD,07,Amsterdam,145.100.72.168,MEGALOBLASTOSIS causes PANCYTOPENIA,28,103,,39,118,causes,0.881917103688197,814020-FS1-4,"Other conditions that cause PANCYTOPENIA include hypoplastic myelodysplastic syndrome, acute leukemia, MEGALOBLASTOSIS and large granular lymphocytic leukemia.",PANCYTOPENIA,MEGALOBLASTOSIS,TWrex-cause
724534041,5/21/2015 18:39:53,1640500519,5/21/2015 18:39:26,False,neodev,0.7011,31448050,GBR,,,92.24.68.74,no_relation,28,103,,39,118,causes,0.881917103688197,814020-FS1-4,"Other conditions that cause PANCYTOPENIA include hypoplastic myelodysplastic syndrome, acute leukemia, MEGALOBLASTOSIS and large granular lymphocytic leukemia.",PANCYTOPENIA,MEGALOBLASTOSIS,TWrex-cause
724534041,5/21/2015 19:12:07,1640525493,5/21/2015 19:11:30,False,neodev,0.5459,11035031,CAN,ON,Scarborough,99.244.36.47,no_relation,28,103,,39,118,causes,0.881917103688197,814020-FS1-4,"Other conditions that cause PANCYTOPENIA include hypoplastic myelodysplastic syndrome, acute leukemia, MEGALOBLASTOSIS and large granular lymphocytic leukemia.",PANCYTOPENIA,MEGALOBLASTOSIS,TWrex-cause
724534041,5/21/2015 19:13:54,1640526629,5/21/2015 19:13:31,False,clixsense,0.6667,10032240,USA,FL,Naples,76.101.211.223,MEGALOBLASTOSIS causes PANCYTOPENIA,28,103,,39,118,causes,0.881917103688197,814020-FS1-4,"Other conditions that cause PANCYTOPENIA include hypoplastic myelodysplastic syndrome, acute leukemia, MEGALOBLASTOSIS and large granular lymphocytic leukemia.",PANCYTOPENIA,MEGALOBLASTOSIS,TWrex-cause
724534041,5/21/2015 19:36:12,1640557108,5/21/2015 19:35:56,False,instagc,0.3905,30326470,USA,CA,Santee,99.44.37.73,MEGALOBLASTOSIS causes PANCYTOPENIA,28,103,,39,118,causes,0.881917103688197,814020-FS1-4,"Other conditions that cause PANCYTOPENIA include hypoplastic myelodysplastic syndrome, acute leukemia, MEGALOBLASTOSIS and large granular lymphocytic leukemia.",PANCYTOPENIA,MEGALOBLASTOSIS,TWrex-cause
724534041,5/21/2015 19:37:13,1640557755,5/21/2015 19:32:56,False,neodev,0.7143,11257883,CAN,BC,Surrey,76.77.82.83,MEGALOBLASTOSIS causes PANCYTOPENIA,28,103,,39,118,causes,0.881917103688197,814020-FS1-4,"Other conditions that cause PANCYTOPENIA include hypoplastic myelodysplastic syndrome, acute leukemia, MEGALOBLASTOSIS and large granular lymphocytic leukemia.",PANCYTOPENIA,MEGALOBLASTOSIS,TWrex-cause
724534044,5/21/2015 16:15:47,1640410557,5/21/2015 16:15:31,False,pocketmoneygpt,0.9722,28884030,USA,WI,Minocqua,75.143.134.247,OVARIAN HYPERSTIMULATION SYNDROME causes ASCITES,208,0,,214,33,causes,0.9931270663228409,812960-FS1-4,"OVARIAN HYPERSTIMULATION SYNDROME occurs in 10 to 20% of patients; ovaries can become massively enlarged, and intravascular fluid volume shifts into the peritoneal space, causing potentially life threatening ASCITES and hypovolemia.",ASCITES,OVARIAN HYPERSTIMULATION SYNDROME,TWrex-cause
724534044,5/21/2015 16:16:59,1640411257,5/21/2015 16:16:27,False,clixsense,0.7569,30681826,GBR,I3,Rochester,86.163.150.232,OVARIAN HYPERSTIMULATION SYNDROME causes ASCITES,208,0,,214,33,causes,0.9931270663228409,812960-FS1-4,"OVARIAN HYPERSTIMULATION SYNDROME occurs in 10 to 20% of patients; ovaries can become massively enlarged, and intravascular fluid volume shifts into the peritoneal space, causing potentially life threatening ASCITES and hypovolemia.",ASCITES,OVARIAN HYPERSTIMULATION SYNDROME,TWrex-cause
724534044,5/21/2015 16:18:05,1640411897,5/21/2015 16:17:37,False,neodev,0.6667,31066862,USA,CA,San Jose,128.107.241.176,OVARIAN HYPERSTIMULATION SYNDROME causes ASCITES,208,0,,214,33,causes,0.9931270663228409,812960-FS1-4,"OVARIAN HYPERSTIMULATION SYNDROME occurs in 10 to 20% of patients; ovaries can become massively enlarged, and intravascular fluid volume shifts into the peritoneal space, causing potentially life threatening ASCITES and hypovolemia.",ASCITES,OVARIAN HYPERSTIMULATION SYNDROME,TWrex-cause
724534044,5/21/2015 16:22:08,1640414640,5/21/2015 16:21:21,False,onestopgpt,0.6458,21275875,CAN,ON,Hamilton,24.36.121.10,OVARIAN HYPERSTIMULATION SYNDROME causes ASCITES,208,0,,214,33,causes,0.9931270663228409,812960-FS1-4,"OVARIAN HYPERSTIMULATION SYNDROME occurs in 10 to 20% of patients; ovaries can become massively enlarged, and intravascular fluid volume shifts into the peritoneal space, causing potentially life threatening ASCITES and hypovolemia.",ASCITES,OVARIAN HYPERSTIMULATION SYNDROME,TWrex-cause
724534044,5/21/2015 16:29:01,1640419331,5/21/2015 16:28:18,False,sharecashgpt,0.4208,28627999,CAN,ON,Sudbury,66.103.55.12,no_relation,208,0,,214,33,causes,0.9931270663228409,812960-FS1-4,"OVARIAN HYPERSTIMULATION SYNDROME occurs in 10 to 20% of patients; ovaries can become massively enlarged, and intravascular fluid volume shifts into the peritoneal space, causing potentially life threatening ASCITES and hypovolemia.",ASCITES,OVARIAN HYPERSTIMULATION SYNDROME,TWrex-cause
724534044,5/21/2015 16:29:36,1640419740,5/21/2015 16:29:14,False,prodege,0.7321,14848125,GBR,U8,Edinburgh,86.149.215.103,OVARIAN HYPERSTIMULATION SYNDROME causes ASCITES,208,0,,214,33,causes,0.9931270663228409,812960-FS1-4,"OVARIAN HYPERSTIMULATION SYNDROME occurs in 10 to 20% of patients; ovaries can become massively enlarged, and intravascular fluid volume shifts into the peritoneal space, causing potentially life threatening ASCITES and hypovolemia.",ASCITES,OVARIAN HYPERSTIMULATION SYNDROME,TWrex-cause
724534044,5/21/2015 16:32:38,1640421889,5/21/2015 16:32:15,False,neodev,0.7857,19004420,GBR,P8,Devizes,31.54.209.43,OVARIAN HYPERSTIMULATION SYNDROME causes ASCITES,208,0,,214,33,causes,0.9931270663228409,812960-FS1-4,"OVARIAN HYPERSTIMULATION SYNDROME occurs in 10 to 20% of patients; ovaries can become massively enlarged, and intravascular fluid volume shifts into the peritoneal space, causing potentially life threatening ASCITES and hypovolemia.",ASCITES,OVARIAN HYPERSTIMULATION SYNDROME,TWrex-cause
724534046,5/21/2015 16:15:22,1640410196,5/21/2015 16:15:07,False,pocketmoneygpt,0.9722,28884030,USA,WI,Minocqua,75.143.134.247,RSD causes SPONTANOUS PAIN,66,8,,80,11,causes,0.887356509416114,813857-FS1-4,"Pain in RSD starts typically more distally in a limb Gout  Acute, SPONTANOUS PAIN most commonly in first metatarsophalangeal joint but can affect other joints (ankle >knee >wrist.",SPONTANOUS PAIN,RSD,TWrex-cause
724534046,5/21/2015 16:16:26,1640410972,5/21/2015 16:16:02,False,clixsense,0.7569,30681826,GBR,I3,Rochester,86.163.150.232,RSD causes SPONTANOUS PAIN,66,8,,80,11,causes,0.887356509416114,813857-FS1-4,"Pain in RSD starts typically more distally in a limb Gout  Acute, SPONTANOUS PAIN most commonly in first metatarsophalangeal joint but can affect other joints (ankle >knee >wrist.",SPONTANOUS PAIN,RSD,TWrex-cause
724534046,5/21/2015 16:17:36,1640411581,5/21/2015 16:16:59,False,neodev,0.6667,31066862,USA,CA,San Jose,128.107.241.176,no_relation,66,8,,80,11,causes,0.887356509416114,813857-FS1-4,"Pain in RSD starts typically more distally in a limb Gout  Acute, SPONTANOUS PAIN most commonly in first metatarsophalangeal joint but can affect other joints (ankle >knee >wrist.",SPONTANOUS PAIN,RSD,TWrex-cause
724534046,5/21/2015 16:21:20,1640414064,5/21/2015 16:20:24,False,onestopgpt,0.6458,21275875,CAN,ON,Hamilton,24.36.121.10,RSD causes SPONTANOUS PAIN,66,8,,80,11,causes,0.887356509416114,813857-FS1-4,"Pain in RSD starts typically more distally in a limb Gout  Acute, SPONTANOUS PAIN most commonly in first metatarsophalangeal joint but can affect other joints (ankle >knee >wrist.",SPONTANOUS PAIN,RSD,TWrex-cause
724534046,5/21/2015 16:28:17,1640418898,5/21/2015 16:27:55,False,sharecashgpt,0.4208,28627999,CAN,ON,Sudbury,66.103.55.12,RSD causes SPONTANOUS PAIN,66,8,,80,11,causes,0.887356509416114,813857-FS1-4,"Pain in RSD starts typically more distally in a limb Gout  Acute, SPONTANOUS PAIN most commonly in first metatarsophalangeal joint but can affect other joints (ankle >knee >wrist.",SPONTANOUS PAIN,RSD,TWrex-cause
724534046,5/21/2015 16:29:12,1640419471,5/21/2015 16:28:49,False,prodege,0.7321,14848125,GBR,U8,Edinburgh,86.149.215.103,RSD causes SPONTANOUS PAIN,66,8,,80,11,causes,0.887356509416114,813857-FS1-4,"Pain in RSD starts typically more distally in a limb Gout  Acute, SPONTANOUS PAIN most commonly in first metatarsophalangeal joint but can affect other joints (ankle >knee >wrist.",SPONTANOUS PAIN,RSD,TWrex-cause
724534046,5/21/2015 16:42:23,1640428159,5/21/2015 16:42:07,False,neodev,0.852,18881135,CAN,ON,Ajax,99.243.87.224,RSD causes SPONTANOUS PAIN,66,8,,80,11,causes,0.887356509416114,813857-FS1-4,"Pain in RSD starts typically more distally in a limb Gout  Acute, SPONTANOUS PAIN most commonly in first metatarsophalangeal joint but can affect other joints (ankle >knee >wrist.",SPONTANOUS PAIN,RSD,TWrex-cause
724919797,5/22/2015 08:49:34,1641132095,5/22/2015 08:48:53,False,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,DEMENTIA WITH LEWY BODIES causes RECURRENT VISUAL HALLUCINATIONS,90,2,,120,27,causes,0.993883734673619,812738-FS1-4,"◊ DEMENTIA WITH LEWY BODIES is a progressive cognitive decline with fluctuating symptoms, RECURRENT VISUAL HALLUCINATIONS and spontaneous, extrapyramidal signs ( 45.",RECURRENT VISUAL HALLUCINATIONS,DEMENTIA WITH LEWY BODIES,TWrex-cause
724919797,5/22/2015 08:56:29,1641135531,5/22/2015 08:56:13,False,neodev,0.7361,14096345,NLD,03,Eibergen,77.174.124.109,no_relation,90,2,,120,27,causes,0.993883734673619,812738-FS1-4,"◊ DEMENTIA WITH LEWY BODIES is a progressive cognitive decline with fluctuating symptoms, RECURRENT VISUAL HALLUCINATIONS and spontaneous, extrapyramidal signs ( 45.",RECURRENT VISUAL HALLUCINATIONS,DEMENTIA WITH LEWY BODIES,TWrex-cause
724919797,5/22/2015 09:07:56,1641141399,5/22/2015 09:07:37,False,instagc,0.6917,13581319,USA,IL,Mount Vernon,66.232.166.86,DEMENTIA WITH LEWY BODIES causes RECURRENT VISUAL HALLUCINATIONS,90,2,,120,27,causes,0.993883734673619,812738-FS1-4,"◊ DEMENTIA WITH LEWY BODIES is a progressive cognitive decline with fluctuating symptoms, RECURRENT VISUAL HALLUCINATIONS and spontaneous, extrapyramidal signs ( 45.",RECURRENT VISUAL HALLUCINATIONS,DEMENTIA WITH LEWY BODIES,TWrex-cause
724919797,5/22/2015 09:14:27,1641144650,5/22/2015 09:13:48,False,vivatic,0.7359,32338429,GBR,G1,Feltham,92.24.40.208,no_relation,90,2,,120,27,causes,0.993883734673619,812738-FS1-4,"◊ DEMENTIA WITH LEWY BODIES is a progressive cognitive decline with fluctuating symptoms, RECURRENT VISUAL HALLUCINATIONS and spontaneous, extrapyramidal signs ( 45.",RECURRENT VISUAL HALLUCINATIONS,DEMENTIA WITH LEWY BODIES,TWrex-cause
724919797,5/22/2015 09:15:39,1641145250,5/22/2015 09:15:11,False,neodev,0.696,30627835,GBR,H9,London,5.81.27.94,DEMENTIA WITH LEWY BODIES causes RECURRENT VISUAL HALLUCINATIONS,90,2,,120,27,causes,0.993883734673619,812738-FS1-4,"◊ DEMENTIA WITH LEWY BODIES is a progressive cognitive decline with fluctuating symptoms, RECURRENT VISUAL HALLUCINATIONS and spontaneous, extrapyramidal signs ( 45.",RECURRENT VISUAL HALLUCINATIONS,DEMENTIA WITH LEWY BODIES,TWrex-cause
724919797,5/22/2015 09:25:07,1641150095,5/22/2015 09:24:44,False,prodege,0.8095,27934334,GBR,D2,Derby,86.162.35.12,DEMENTIA WITH LEWY BODIES causes RECURRENT VISUAL HALLUCINATIONS,90,2,,120,27,causes,0.993883734673619,812738-FS1-4,"◊ DEMENTIA WITH LEWY BODIES is a progressive cognitive decline with fluctuating symptoms, RECURRENT VISUAL HALLUCINATIONS and spontaneous, extrapyramidal signs ( 45.",RECURRENT VISUAL HALLUCINATIONS,DEMENTIA WITH LEWY BODIES,TWrex-cause
724919797,5/22/2015 09:29:30,1641152482,5/22/2015 09:29:16,False,clixsense,0.4881,6352682,GBR,H9,London,2.122.19.138,DEMENTIA WITH LEWY BODIES causes RECURRENT VISUAL HALLUCINATIONS,90,2,,120,27,causes,0.993883734673619,812738-FS1-4,"◊ DEMENTIA WITH LEWY BODIES is a progressive cognitive decline with fluctuating symptoms, RECURRENT VISUAL HALLUCINATIONS and spontaneous, extrapyramidal signs ( 45.",RECURRENT VISUAL HALLUCINATIONS,DEMENTIA WITH LEWY BODIES,TWrex-cause
724919802,5/22/2015 10:26:09,1641182650,5/22/2015 10:25:30,False,cotter,0.877,13805544,USA,MI,Battle Creek,107.140.176.37,no_relation,128,75,,149,107,causes,0.43759497449368395,803197-FS1-4,"HRT is contraindicated in women who smoke or in women with a history of an ESTROGEN DEPENDENT BREAST CANCER endometrial cancer, THROMBOEMBOLIC DISEASE acute liver disease, and vaginal bleeding of unknown cause.",THROMBOEMBOLIC DISEASE,ESTROGEN DEPENDENT BREAST CANCER,TWrex-cause
724919802,5/22/2015 10:30:51,1641185510,5/22/2015 10:29:35,False,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,no_relation,128,75,,149,107,causes,0.43759497449368395,803197-FS1-4,"HRT is contraindicated in women who smoke or in women with a history of an ESTROGEN DEPENDENT BREAST CANCER endometrial cancer, THROMBOEMBOLIC DISEASE acute liver disease, and vaginal bleeding of unknown cause.",THROMBOEMBOLIC DISEASE,ESTROGEN DEPENDENT BREAST CANCER,TWrex-cause
724919802,5/22/2015 10:41:16,1641192017,5/22/2015 10:40:48,False,gifthunterclub,0.7778,30901412,GBR,G5,Margate,85.210.124.44,ESTROGEN DEPENDENT BREAST CANCER causes THROMBOEMBOLIC DISEASE,128,75,,149,107,causes,0.43759497449368395,803197-FS1-4,"HRT is contraindicated in women who smoke or in women with a history of an ESTROGEN DEPENDENT BREAST CANCER endometrial cancer, THROMBOEMBOLIC DISEASE acute liver disease, and vaginal bleeding of unknown cause.",THROMBOEMBOLIC DISEASE,ESTROGEN DEPENDENT BREAST CANCER,TWrex-cause
724919802,5/22/2015 10:46:44,1641195522,5/22/2015 10:46:23,False,instagc,0.7222,20845955,GBR,I2,Manchester,90.214.24.62,no_relation,128,75,,149,107,causes,0.43759497449368395,803197-FS1-4,"HRT is contraindicated in women who smoke or in women with a history of an ESTROGEN DEPENDENT BREAST CANCER endometrial cancer, THROMBOEMBOLIC DISEASE acute liver disease, and vaginal bleeding of unknown cause.",THROMBOEMBOLIC DISEASE,ESTROGEN DEPENDENT BREAST CANCER,TWrex-cause
724919802,5/22/2015 11:21:27,1641216331,5/22/2015 11:21:02,False,instagc,0.5375,32352104,USA,ME,Bangor,74.75.63.81,ESTROGEN DEPENDENT BREAST CANCER causes THROMBOEMBOLIC DISEASE,128,75,,149,107,causes,0.43759497449368395,803197-FS1-4,"HRT is contraindicated in women who smoke or in women with a history of an ESTROGEN DEPENDENT BREAST CANCER endometrial cancer, THROMBOEMBOLIC DISEASE acute liver disease, and vaginal bleeding of unknown cause.",THROMBOEMBOLIC DISEASE,ESTROGEN DEPENDENT BREAST CANCER,TWrex-cause
724919802,5/22/2015 11:33:33,1641223747,5/22/2015 11:33:20,False,neodev,0.3117,31789301,USA,NY,New York,198.199.78.230,ESTROGEN DEPENDENT BREAST CANCER causes THROMBOEMBOLIC DISEASE,128,75,,149,107,causes,0.43759497449368395,803197-FS1-4,"HRT is contraindicated in women who smoke or in women with a history of an ESTROGEN DEPENDENT BREAST CANCER endometrial cancer, THROMBOEMBOLIC DISEASE acute liver disease, and vaginal bleeding of unknown cause.",THROMBOEMBOLIC DISEASE,ESTROGEN DEPENDENT BREAST CANCER,TWrex-cause
724919802,5/22/2015 11:34:38,1641224300,5/22/2015 11:32:29,False,prodege,0.6433,3056891,CAN,ON,Niagara Falls,173.238.144.19,no_relation,128,75,,149,107,causes,0.43759497449368395,803197-FS1-4,"HRT is contraindicated in women who smoke or in women with a history of an ESTROGEN DEPENDENT BREAST CANCER endometrial cancer, THROMBOEMBOLIC DISEASE acute liver disease, and vaginal bleeding of unknown cause.",THROMBOEMBOLIC DISEASE,ESTROGEN DEPENDENT BREAST CANCER,TWrex-cause
724919813,5/22/2015 10:32:36,1641186564,5/22/2015 10:31:39,False,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,CALYMMATOBACTERIUM GRANULOMATIS causes GRANULOMA INGUINALE,53,98,,71,129,causes,0.8741572761215379,810527-FS1-4,102  Granuloma Inguinale (Donovanosis)  Treatment of GRANULOMA INGUINALE (donovanosis) caused by  CALYMMATOBACTERIUM GRANULOMATIS,GRANULOMA INGUINALE,CALYMMATOBACTERIUM GRANULOMATIS,TWrex-cause
724919813,5/22/2015 10:42:07,1641192582,5/22/2015 10:41:43,False,gifthunterclub,0.7778,30901412,GBR,G5,Margate,85.210.124.44,CALYMMATOBACTERIUM GRANULOMATIS causes GRANULOMA INGUINALE,53,98,,71,129,causes,0.8741572761215379,810527-FS1-4,102  Granuloma Inguinale (Donovanosis)  Treatment of GRANULOMA INGUINALE (donovanosis) caused by  CALYMMATOBACTERIUM GRANULOMATIS,GRANULOMA INGUINALE,CALYMMATOBACTERIUM GRANULOMATIS,TWrex-cause
724919813,5/22/2015 10:47:25,1641195969,5/22/2015 10:47:11,False,instagc,0.7222,20845955,GBR,I2,Manchester,90.214.24.62,CALYMMATOBACTERIUM GRANULOMATIS causes GRANULOMA INGUINALE,53,98,,71,129,causes,0.8741572761215379,810527-FS1-4,102  Granuloma Inguinale (Donovanosis)  Treatment of GRANULOMA INGUINALE (donovanosis) caused by  CALYMMATOBACTERIUM GRANULOMATIS,GRANULOMA INGUINALE,CALYMMATOBACTERIUM GRANULOMATIS,TWrex-cause
724919813,5/22/2015 11:22:09,1641216776,5/22/2015 11:21:49,False,instagc,0.5375,32352104,USA,ME,Bangor,74.75.63.81,CALYMMATOBACTERIUM GRANULOMATIS causes GRANULOMA INGUINALE,53,98,,71,129,causes,0.8741572761215379,810527-FS1-4,102  Granuloma Inguinale (Donovanosis)  Treatment of GRANULOMA INGUINALE (donovanosis) caused by  CALYMMATOBACTERIUM GRANULOMATIS,GRANULOMA INGUINALE,CALYMMATOBACTERIUM GRANULOMATIS,TWrex-cause
724919813,5/22/2015 11:33:58,1641223949,5/22/2015 11:33:48,False,neodev,0.3117,31789301,USA,NY,New York,198.199.78.230,GRANULOMA INGUINALE causes CALYMMATOBACTERIUM GRANULOMATIS,53,98,,71,129,causes,0.8741572761215379,810527-FS1-4,102  Granuloma Inguinale (Donovanosis)  Treatment of GRANULOMA INGUINALE (donovanosis) caused by  CALYMMATOBACTERIUM GRANULOMATIS,GRANULOMA INGUINALE,CALYMMATOBACTERIUM GRANULOMATIS,TWrex-cause
724919813,5/22/2015 11:36:22,1641225375,5/22/2015 11:35:33,False,prodege,0.6433,3056891,CAN,ON,Niagara Falls,173.238.144.19,CALYMMATOBACTERIUM GRANULOMATIS causes GRANULOMA INGUINALE,53,98,,71,129,causes,0.8741572761215379,810527-FS1-4,102  Granuloma Inguinale (Donovanosis)  Treatment of GRANULOMA INGUINALE (donovanosis) caused by  CALYMMATOBACTERIUM GRANULOMATIS,GRANULOMA INGUINALE,CALYMMATOBACTERIUM GRANULOMATIS,TWrex-cause
724919813,5/22/2015 11:48:15,1641232345,5/22/2015 11:47:54,False,prodege,0.7103,21417560,GBR,C3,Cambridge,151.225.116.143,CALYMMATOBACTERIUM GRANULOMATIS causes GRANULOMA INGUINALE,53,98,,71,129,causes,0.8741572761215379,810527-FS1-4,102  Granuloma Inguinale (Donovanosis)  Treatment of GRANULOMA INGUINALE (donovanosis) caused by  CALYMMATOBACTERIUM GRANULOMATIS,GRANULOMA INGUINALE,CALYMMATOBACTERIUM GRANULOMATIS,TWrex-cause
724919819,5/22/2015 08:48:31,1641131616,5/22/2015 08:47:48,False,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,NEGATIVE IRON BALANCE causes IRON DEFICIENCY ANEMIA,40,3,,61,24,causes,0.9630868246861541,804416-FS1-4,"If NEGATIVE IRON BALANCE persists, then IRON DEFICIENCY ANEMIA is the result.",IRON DEFICIENCY ANEMIA,NEGATIVE IRON BALANCE,TWrex-cause
724919819,5/22/2015 08:55:56,1641135213,5/22/2015 08:55:38,False,neodev,0.7361,14096345,NLD,03,Eibergen,77.174.124.109,no_relation,40,3,,61,24,causes,0.9630868246861541,804416-FS1-4,"If NEGATIVE IRON BALANCE persists, then IRON DEFICIENCY ANEMIA is the result.",IRON DEFICIENCY ANEMIA,NEGATIVE IRON BALANCE,TWrex-cause
724919819,5/22/2015 09:00:36,1641137673,5/22/2015 08:59:47,False,prodege,0.5625,19854505,GBR,H8,Liverpool,92.28.85.177,NEGATIVE IRON BALANCE causes IRON DEFICIENCY ANEMIA,40,3,,61,24,causes,0.9630868246861541,804416-FS1-4,"If NEGATIVE IRON BALANCE persists, then IRON DEFICIENCY ANEMIA is the result.",IRON DEFICIENCY ANEMIA,NEGATIVE IRON BALANCE,TWrex-cause
724919819,5/22/2015 09:07:18,1641141095,5/22/2015 09:07:00,False,instagc,0.6917,13581319,USA,IL,Mount Vernon,66.232.166.86,NEGATIVE IRON BALANCE causes IRON DEFICIENCY ANEMIA,40,3,,61,24,causes,0.9630868246861541,804416-FS1-4,"If NEGATIVE IRON BALANCE persists, then IRON DEFICIENCY ANEMIA is the result.",IRON DEFICIENCY ANEMIA,NEGATIVE IRON BALANCE,TWrex-cause
724919819,5/22/2015 09:13:21,1641144038,5/22/2015 09:12:35,False,vivatic,0.7359,32338429,GBR,G1,Feltham,92.24.40.208,NEGATIVE IRON BALANCE causes IRON DEFICIENCY ANEMIA,40,3,,61,24,causes,0.9630868246861541,804416-FS1-4,"If NEGATIVE IRON BALANCE persists, then IRON DEFICIENCY ANEMIA is the result.",IRON DEFICIENCY ANEMIA,NEGATIVE IRON BALANCE,TWrex-cause
724919819,5/22/2015 09:14:49,1641144856,5/22/2015 09:14:30,False,neodev,0.696,30627835,GBR,H9,London,5.81.27.94,NEGATIVE IRON BALANCE causes IRON DEFICIENCY ANEMIA,40,3,,61,24,causes,0.9630868246861541,804416-FS1-4,"If NEGATIVE IRON BALANCE persists, then IRON DEFICIENCY ANEMIA is the result.",IRON DEFICIENCY ANEMIA,NEGATIVE IRON BALANCE,TWrex-cause
724919819,5/22/2015 09:24:23,1641149766,5/22/2015 09:23:56,False,prodege,0.8095,27934334,GBR,D2,Derby,86.162.35.12,NEGATIVE IRON BALANCE causes IRON DEFICIENCY ANEMIA,40,3,,61,24,causes,0.9630868246861541,804416-FS1-4,"If NEGATIVE IRON BALANCE persists, then IRON DEFICIENCY ANEMIA is the result.",IRON DEFICIENCY ANEMIA,NEGATIVE IRON BALANCE,TWrex-cause
724919825,5/22/2015 08:50:42,1641132675,5/22/2015 08:49:59,False,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,no_relation,98,141,,103,144,causes,0.811107105653813,812762-FS1-4,"40,41   In GSS, which is transmitted as an autosomal dominant trait, the affected persons develop ATAXIA followed by dementia; patients with FFI are unable to sleep.",ATAXIA,FFI,TWrex-cause
724919825,5/22/2015 08:57:14,1641135901,5/22/2015 08:56:49,False,neodev,0.7361,14096345,NLD,03,Eibergen,77.174.124.109,no_relation,98,141,,103,144,causes,0.811107105653813,812762-FS1-4,"40,41   In GSS, which is transmitted as an autosomal dominant trait, the affected persons develop ATAXIA followed by dementia; patients with FFI are unable to sleep.",ATAXIA,FFI,TWrex-cause
724919825,5/22/2015 09:08:35,1641141692,5/22/2015 09:08:12,False,instagc,0.6917,13581319,USA,IL,Mount Vernon,66.232.166.86,no_relation,98,141,,103,144,causes,0.811107105653813,812762-FS1-4,"40,41   In GSS, which is transmitted as an autosomal dominant trait, the affected persons develop ATAXIA followed by dementia; patients with FFI are unable to sleep.",ATAXIA,FFI,TWrex-cause
724919825,5/22/2015 09:15:29,1641145165,5/22/2015 09:15:00,False,vivatic,0.7359,32338429,GBR,G1,Feltham,92.24.40.208,no_relation,98,141,,103,144,causes,0.811107105653813,812762-FS1-4,"40,41   In GSS, which is transmitted as an autosomal dominant trait, the affected persons develop ATAXIA followed by dementia; patients with FFI are unable to sleep.",ATAXIA,FFI,TWrex-cause
724919825,5/22/2015 09:16:22,1641145568,5/22/2015 09:16:02,False,neodev,0.696,30627835,GBR,H9,London,5.81.27.94,no_relation,98,141,,103,144,causes,0.811107105653813,812762-FS1-4,"40,41   In GSS, which is transmitted as an autosomal dominant trait, the affected persons develop ATAXIA followed by dementia; patients with FFI are unable to sleep.",ATAXIA,FFI,TWrex-cause
724919825,5/22/2015 09:26:00,1641150540,5/22/2015 09:25:34,False,prodege,0.8095,27934334,GBR,D2,Derby,86.162.35.12,no_relation,98,141,,103,144,causes,0.811107105653813,812762-FS1-4,"40,41   In GSS, which is transmitted as an autosomal dominant trait, the affected persons develop ATAXIA followed by dementia; patients with FFI are unable to sleep.",ATAXIA,FFI,TWrex-cause
724919825,5/22/2015 09:30:00,1641152647,5/22/2015 09:29:52,False,clixsense,0.4881,6352682,GBR,H9,London,2.122.19.138,ATAXIA causes FFI,98,141,,103,144,causes,0.811107105653813,812762-FS1-4,"40,41   In GSS, which is transmitted as an autosomal dominant trait, the affected persons develop ATAXIA followed by dementia; patients with FFI are unable to sleep.",ATAXIA,FFI,TWrex-cause
724919826,5/22/2015 09:32:23,1641153580,5/22/2015 09:32:08,False,cointasker,0.9167,21783324,NLD,11,Schiedam,194.13.104.198,no_relation,66,8,,80,11,causes,0.9610744623271421,813857-FS1-4,"Pain in RSD starts typically more distally in a limb Gout  Acute, SPONTANOUS PAIN most commonly in first metatarsophalangeal joint but can affect other joints (ankle >knee >wrist.",SPONTANOUS PAIN,RSD,TWrex-cause
724919826,5/22/2015 09:42:37,1641158832,5/22/2015 09:41:40,False,coinworker,0.7778,20231698,USA,,,172.56.32.164,RSD causes SPONTANOUS PAIN,66,8,,80,11,causes,0.9610744623271421,813857-FS1-4,"Pain in RSD starts typically more distally in a limb Gout  Acute, SPONTANOUS PAIN most commonly in first metatarsophalangeal joint but can affect other joints (ankle >knee >wrist.",SPONTANOUS PAIN,RSD,TWrex-cause
724919826,5/22/2015 10:09:15,1641173172,5/22/2015 10:08:30,False,points4rewards,0.7986,20113482,USA,OR,Portland,67.213.218.72,RSD causes SPONTANOUS PAIN,66,8,,80,11,causes,0.9610744623271421,813857-FS1-4,"Pain in RSD starts typically more distally in a limb Gout  Acute, SPONTANOUS PAIN most commonly in first metatarsophalangeal joint but can affect other joints (ankle >knee >wrist.",SPONTANOUS PAIN,RSD,TWrex-cause
724919826,5/22/2015 10:19:44,1641178981,5/22/2015 10:19:05,False,instagc,0.8042,18531561,CAN,ON,Mississauga,99.229.92.227,no_relation,66,8,,80,11,causes,0.9610744623271421,813857-FS1-4,"Pain in RSD starts typically more distally in a limb Gout  Acute, SPONTANOUS PAIN most commonly in first metatarsophalangeal joint but can affect other joints (ankle >knee >wrist.",SPONTANOUS PAIN,RSD,TWrex-cause
724919826,5/22/2015 10:25:09,1641182079,5/22/2015 10:24:44,False,cotter,0.877,13805544,USA,MI,Battle Creek,107.140.176.37,RSD causes SPONTANOUS PAIN,66,8,,80,11,causes,0.9610744623271421,813857-FS1-4,"Pain in RSD starts typically more distally in a limb Gout  Acute, SPONTANOUS PAIN most commonly in first metatarsophalangeal joint but can affect other joints (ankle >knee >wrist.",SPONTANOUS PAIN,RSD,TWrex-cause
724919826,5/22/2015 10:25:39,1641182408,5/22/2015 10:25:03,False,clixsense,0.8175,26648627,GBR,,,87.115.101.39,no_relation,66,8,,80,11,causes,0.9610744623271421,813857-FS1-4,"Pain in RSD starts typically more distally in a limb Gout  Acute, SPONTANOUS PAIN most commonly in first metatarsophalangeal joint but can affect other joints (ankle >knee >wrist.",SPONTANOUS PAIN,RSD,TWrex-cause
724919826,5/22/2015 10:27:44,1641183654,5/22/2015 10:27:16,False,clixsense,0.7857,22947672,GBR,,,88.144.127.68,no_relation,66,8,,80,11,causes,0.9610744623271421,813857-FS1-4,"Pain in RSD starts typically more distally in a limb Gout  Acute, SPONTANOUS PAIN most commonly in first metatarsophalangeal joint but can affect other joints (ankle >knee >wrist.",SPONTANOUS PAIN,RSD,TWrex-cause
724992207,5/22/2015 16:52:16,1641421081,5/22/2015 16:52:04,False,neodev,0.875,14096345,NLD,03,Eibergen,77.174.124.109,no_relation,70,14,,87,32,causes,0.7525766947068779,813670-FS1-4,Patients with MYOTONIA CONGENITA present with myotonia and often with MUSCLE HYPERTROPHY,MUSCLE HYPERTROPHY,MYOTONIA CONGENITA,TWrex-cause
724992207,5/22/2015 17:00:46,1641426972,5/22/2015 16:59:53,False,clixsense,0.8889,22947672,GBR,,,88.144.127.68,no_relation,70,14,,87,32,causes,0.7525766947068779,813670-FS1-4,Patients with MYOTONIA CONGENITA present with myotonia and often with MUSCLE HYPERTROPHY,MUSCLE HYPERTROPHY,MYOTONIA CONGENITA,TWrex-cause
724992207,5/22/2015 17:05:49,1641429839,5/22/2015 17:05:38,False,instagc,0.6806,13581319,USA,IL,Mount Vernon,66.232.166.86,no_relation,70,14,,87,32,causes,0.7525766947068779,813670-FS1-4,Patients with MYOTONIA CONGENITA present with myotonia and often with MUSCLE HYPERTROPHY,MUSCLE HYPERTROPHY,MYOTONIA CONGENITA,TWrex-cause
724992207,5/22/2015 17:11:26,1641433755,5/22/2015 17:09:51,False,points4rewards,0.7069,20113482,USA,OR,Portland,67.213.218.72,MYOTONIA CONGENITA causes MUSCLE HYPERTROPHY,70,14,,87,32,causes,0.7525766947068779,813670-FS1-4,Patients with MYOTONIA CONGENITA present with myotonia and often with MUSCLE HYPERTROPHY,MUSCLE HYPERTROPHY,MYOTONIA CONGENITA,TWrex-cause
724992207,5/22/2015 17:16:13,1641437064,5/22/2015 17:15:52,False,gifthunterclub,0.7183,29582088,GBR,I2,Manchester,89.240.68.44,no_relation,70,14,,87,32,causes,0.7525766947068779,813670-FS1-4,Patients with MYOTONIA CONGENITA present with myotonia and often with MUSCLE HYPERTROPHY,MUSCLE HYPERTROPHY,MYOTONIA CONGENITA,TWrex-cause
724992207,5/22/2015 17:17:36,1641437919,5/22/2015 17:17:09,False,sharecashgpt,0.6067,28627999,CAN,ON,Sudbury,66.103.55.12,no_relation,70,14,,87,32,causes,0.7525766947068779,813670-FS1-4,Patients with MYOTONIA CONGENITA present with myotonia and often with MUSCLE HYPERTROPHY,MUSCLE HYPERTROPHY,MYOTONIA CONGENITA,TWrex-cause
724992207,5/22/2015 17:27:11,1641443775,5/22/2015 17:24:53,False,instagc,0.7599,30326470,USA,CA,Santee,99.44.37.73,no_relation,70,14,,87,32,causes,0.7525766947068779,813670-FS1-4,Patients with MYOTONIA CONGENITA present with myotonia and often with MUSCLE HYPERTROPHY,MUSCLE HYPERTROPHY,MYOTONIA CONGENITA,TWrex-cause
724992210,5/22/2015 18:13:56,1641480199,5/22/2015 18:13:26,False,instagc,0.6905,32352104,USA,ME,Bangor,74.75.63.81,L MICDADEI causes PITTSBURGH PNEUMONIA,75,39,,94,49,causes,0.9438798074485389,812582-FS1-4,"Previously known as TATLOCK and HEBA,  L MICDADEI  was rediscovered as the PITTSBURGH PNEUMONIA agent that caused acute suppurative pneumonia in eight immunosuppressed patients from two centers in 1979.",PITTSBURGH PNEUMONIA,L MICDADEI,TWrex-cause
724992210,5/22/2015 18:22:16,1641488754,5/22/2015 18:21:20,False,neodev,0.7798,18703384,GBR,T5,Aberdeen,151.229.113.63,no_relation,75,39,,94,49,causes,0.9438798074485389,812582-FS1-4,"Previously known as TATLOCK and HEBA,  L MICDADEI  was rediscovered as the PITTSBURGH PNEUMONIA agent that caused acute suppurative pneumonia in eight immunosuppressed patients from two centers in 1979.",PITTSBURGH PNEUMONIA,L MICDADEI,TWrex-cause
724992210,5/22/2015 18:34:28,1641502329,5/22/2015 18:32:58,False,clixsense,0.75,23398628,USA,WA,Tacoma,50.149.99.43,no_relation,75,39,,94,49,causes,0.9438798074485389,812582-FS1-4,"Previously known as TATLOCK and HEBA,  L MICDADEI  was rediscovered as the PITTSBURGH PNEUMONIA agent that caused acute suppurative pneumonia in eight immunosuppressed patients from two centers in 1979.",PITTSBURGH PNEUMONIA,L MICDADEI,TWrex-cause
724992210,5/22/2015 18:35:48,1641503459,5/22/2015 18:34:19,False,pocketmoneygpt,0.5893,32162555,CAN,BC,Vancouver,108.180.194.80,PITTSBURGH PNEUMONIA causes L MICDADEI,75,39,,94,49,causes,0.9438798074485389,812582-FS1-4,"Previously known as TATLOCK and HEBA,  L MICDADEI  was rediscovered as the PITTSBURGH PNEUMONIA agent that caused acute suppurative pneumonia in eight immunosuppressed patients from two centers in 1979.",PITTSBURGH PNEUMONIA,L MICDADEI,TWrex-cause
724992210,5/22/2015 18:39:48,1641508029,5/22/2015 18:39:24,False,prodege,0.8,1924522,USA,NY,New York,96.224.13.217,L MICDADEI causes PITTSBURGH PNEUMONIA,75,39,,94,49,causes,0.9438798074485389,812582-FS1-4,"Previously known as TATLOCK and HEBA,  L MICDADEI  was rediscovered as the PITTSBURGH PNEUMONIA agent that caused acute suppurative pneumonia in eight immunosuppressed patients from two centers in 1979.",PITTSBURGH PNEUMONIA,L MICDADEI,TWrex-cause
724992210,5/22/2015 19:06:50,1641536487,5/22/2015 19:05:28,False,fusioncash,0.8542,5656294,USA,TN,Cookeville,75.136.162.83,no_relation,75,39,,94,49,causes,0.9438798074485389,812582-FS1-4,"Previously known as TATLOCK and HEBA,  L MICDADEI  was rediscovered as the PITTSBURGH PNEUMONIA agent that caused acute suppurative pneumonia in eight immunosuppressed patients from two centers in 1979.",PITTSBURGH PNEUMONIA,L MICDADEI,TWrex-cause
724992210,5/22/2015 19:42:45,1641591045,5/22/2015 19:41:07,False,neodev,0.8839,30940715,USA,IL,Lisle,50.247.189.225,no_relation,75,39,,94,49,causes,0.9438798074485389,812582-FS1-4,"Previously known as TATLOCK and HEBA,  L MICDADEI  was rediscovered as the PITTSBURGH PNEUMONIA agent that caused acute suppurative pneumonia in eight immunosuppressed patients from two centers in 1979.",PITTSBURGH PNEUMONIA,L MICDADEI,TWrex-cause
724992212,5/22/2015 16:26:49,1641401716,5/22/2015 16:26:36,False,neodev,0.9583,31743852,GBR,G5,Maidstone,85.210.127.64,ULTRAVIOLET RAYS causes PHOTOAGING,0,53,,9,69,causes,1.0,811572-FS1-4,PHOTOAGING    Skin damage as a result of exposure to ULTRAVIOLET RAYS,PHOTOAGING,ULTRAVIOLET RAYS,TWrex-cause
724992212,5/22/2015 16:27:53,1641402589,5/22/2015 16:25:38,False,neodev,0.7389,18881135,CAN,ON,Ajax,99.243.87.224,ULTRAVIOLET RAYS causes PHOTOAGING,0,53,,9,69,causes,1.0,811572-FS1-4,PHOTOAGING    Skin damage as a result of exposure to ULTRAVIOLET RAYS,PHOTOAGING,ULTRAVIOLET RAYS,TWrex-cause
724992212,5/22/2015 16:33:18,1641406621,5/22/2015 16:32:46,False,pocketmoneygpt,0.675,21432964,GBR,K5,Poole,109.155.122.13,ULTRAVIOLET RAYS causes PHOTOAGING,0,53,,9,69,causes,1.0,811572-FS1-4,PHOTOAGING    Skin damage as a result of exposure to ULTRAVIOLET RAYS,PHOTOAGING,ULTRAVIOLET RAYS,TWrex-cause
724992212,5/22/2015 16:34:21,1641407317,5/22/2015 16:33:41,False,prodege,0.8167,27934334,GBR,D2,Derby,86.162.35.12,ULTRAVIOLET RAYS causes PHOTOAGING,0,53,,9,69,causes,1.0,811572-FS1-4,PHOTOAGING    Skin damage as a result of exposure to ULTRAVIOLET RAYS,PHOTOAGING,ULTRAVIOLET RAYS,TWrex-cause
724992212,5/22/2015 16:35:29,1641408245,5/22/2015 16:31:09,False,clixsense,0.7214,30681826,GBR,I3,Rochester,86.163.150.232,ULTRAVIOLET RAYS causes PHOTOAGING,0,53,,9,69,causes,1.0,811572-FS1-4,PHOTOAGING    Skin damage as a result of exposure to ULTRAVIOLET RAYS,PHOTOAGING,ULTRAVIOLET RAYS,TWrex-cause
724992212,5/22/2015 16:36:31,1641409075,5/22/2015 16:36:18,False,elite,0.8333,31883685,GBR,H2,Accrington,80.47.186.28,ULTRAVIOLET RAYS causes PHOTOAGING,0,53,,9,69,causes,1.0,811572-FS1-4,PHOTOAGING    Skin damage as a result of exposure to ULTRAVIOLET RAYS,PHOTOAGING,ULTRAVIOLET RAYS,TWrex-cause
724992212,5/22/2015 16:40:45,1641412490,5/22/2015 16:39:16,False,onestopgpt,0.7976,21275875,CAN,ON,Hamilton,24.36.121.10,ULTRAVIOLET RAYS causes PHOTOAGING,0,53,,9,69,causes,1.0,811572-FS1-4,PHOTOAGING    Skin damage as a result of exposure to ULTRAVIOLET RAYS,PHOTOAGING,ULTRAVIOLET RAYS,TWrex-cause
724992214,5/22/2015 17:02:59,1641428470,5/22/2015 17:01:29,False,clixsense,0.8889,22947672,GBR,,,88.144.127.68,TOXOPLASMA GONDII causes TOXOPLASMOSIS,0,48,,12,65,causes,0.8867963503478641,812422-FS1-4,TOXOPLASMOSIS  TOXOPLASMOSIS is infection with  TOXOPLASMA GONDII.,TOXOPLASMOSIS,TOXOPLASMA GONDII,TWrex-cause
724992214,5/22/2015 17:06:19,1641430146,5/22/2015 17:06:08,False,instagc,0.6806,13581319,USA,IL,Mount Vernon,66.232.166.86,no_relation,0,48,,12,65,causes,0.8867963503478641,812422-FS1-4,TOXOPLASMOSIS  TOXOPLASMOSIS is infection with  TOXOPLASMA GONDII.,TOXOPLASMOSIS,TOXOPLASMA GONDII,TWrex-cause
724992214,5/22/2015 17:13:44,1641435340,5/22/2015 17:12:27,False,points4rewards,0.7069,20113482,USA,OR,Portland,67.213.218.72,TOXOPLASMA GONDII causes TOXOPLASMOSIS,0,48,,12,65,causes,0.8867963503478641,812422-FS1-4,TOXOPLASMOSIS  TOXOPLASMOSIS is infection with  TOXOPLASMA GONDII.,TOXOPLASMOSIS,TOXOPLASMA GONDII,TWrex-cause
724992214,5/22/2015 17:16:58,1641437623,5/22/2015 17:16:32,False,gifthunterclub,0.7183,29582088,GBR,I2,Manchester,89.240.68.44,no_relation,0,48,,12,65,causes,0.8867963503478641,812422-FS1-4,TOXOPLASMOSIS  TOXOPLASMOSIS is infection with  TOXOPLASMA GONDII.,TOXOPLASMOSIS,TOXOPLASMA GONDII,TWrex-cause
724992214,5/22/2015 17:18:43,1641438679,5/22/2015 17:18:10,False,sharecashgpt,0.6067,28627999,CAN,ON,Sudbury,66.103.55.12,no_relation,0,48,,12,65,causes,0.8867963503478641,812422-FS1-4,TOXOPLASMOSIS  TOXOPLASMOSIS is infection with  TOXOPLASMA GONDII.,TOXOPLASMOSIS,TOXOPLASMA GONDII,TWrex-cause
724992214,5/22/2015 17:28:59,1641444694,5/22/2015 17:28:24,False,instagc,0.7599,30326470,USA,CA,Santee,99.44.37.73,TOXOPLASMA GONDII causes TOXOPLASMOSIS,0,48,,12,65,causes,0.8867963503478641,812422-FS1-4,TOXOPLASMOSIS  TOXOPLASMOSIS is infection with  TOXOPLASMA GONDII.,TOXOPLASMOSIS,TOXOPLASMA GONDII,TWrex-cause
724992214,5/22/2015 17:33:20,1641446754,5/22/2015 17:32:45,False,prodege,0.8393,21417560,GBR,C3,Cambridge,151.225.116.143,TOXOPLASMOSIS causes TOXOPLASMA GONDII,0,48,,12,65,causes,0.8867963503478641,812422-FS1-4,TOXOPLASMOSIS  TOXOPLASMOSIS is infection with  TOXOPLASMA GONDII.,TOXOPLASMOSIS,TOXOPLASMA GONDII,TWrex-cause
724992215,5/22/2015 17:46:52,1641455448,5/22/2015 17:45:18,False,instagc,0.9375,24252915,GBR,K6,Southsea,80.44.194.25,VZV INFECTION causes HERPES ZOSTER,62,15,,74,28,causes,0.997458699830735,810761-FS1-4,Herpes Zoster  HERPES ZOSTER results from the reactivation of VZV INFECTION,VZV INFECTION,HERPES ZOSTER,TWrex-cause
724992215,5/22/2015 17:52:15,1641459117,5/22/2015 17:51:21,False,clixsense,0.7958,10798016,GBR,C7,Coventry,86.24.245.191,VZV INFECTION causes HERPES ZOSTER,62,15,,74,28,causes,0.997458699830735,810761-FS1-4,Herpes Zoster  HERPES ZOSTER results from the reactivation of VZV INFECTION,VZV INFECTION,HERPES ZOSTER,TWrex-cause
724992215,5/22/2015 18:10:04,1641475748,5/22/2015 18:09:25,False,clixsense,0.6312,11106820,USA,MA,Taunton,173.48.52.95,no_relation,62,15,,74,28,causes,0.997458699830735,810761-FS1-4,Herpes Zoster  HERPES ZOSTER results from the reactivation of VZV INFECTION,VZV INFECTION,HERPES ZOSTER,TWrex-cause
724992215,5/22/2015 18:12:04,1641478018,5/22/2015 18:11:15,False,instagc,0.7337,20312760,GBR,I2,Manchester,90.244.158.78,HERPES ZOSTER causes VZV INFECTION,62,15,,74,28,causes,0.997458699830735,810761-FS1-4,Herpes Zoster  HERPES ZOSTER results from the reactivation of VZV INFECTION,VZV INFECTION,HERPES ZOSTER,TWrex-cause
724992215,5/22/2015 18:13:25,1641479505,5/22/2015 18:12:58,False,instagc,0.6905,32352104,USA,ME,Bangor,74.75.63.81,VZV INFECTION causes HERPES ZOSTER,62,15,,74,28,causes,0.997458699830735,810761-FS1-4,Herpes Zoster  HERPES ZOSTER results from the reactivation of VZV INFECTION,VZV INFECTION,HERPES ZOSTER,TWrex-cause
724992215,5/22/2015 18:21:19,1641487730,5/22/2015 18:20:48,False,neodev,0.7798,18703384,GBR,T5,Aberdeen,151.229.113.63,VZV INFECTION causes HERPES ZOSTER,62,15,,74,28,causes,0.997458699830735,810761-FS1-4,Herpes Zoster  HERPES ZOSTER results from the reactivation of VZV INFECTION,VZV INFECTION,HERPES ZOSTER,TWrex-cause
724992215,5/22/2015 18:34:18,1641502118,5/22/2015 18:32:41,False,pocketmoneygpt,0.5893,32162555,CAN,BC,Vancouver,108.180.194.80,VZV INFECTION causes HERPES ZOSTER,62,15,,74,28,causes,0.997458699830735,810761-FS1-4,Herpes Zoster  HERPES ZOSTER results from the reactivation of VZV INFECTION,VZV INFECTION,HERPES ZOSTER,TWrex-cause
724992219,5/22/2015 18:23:05,1641489467,5/22/2015 18:22:39,False,neodev,0.7798,18703384,GBR,T5,Aberdeen,151.229.113.63,MEFLOQUINE RESISTANT PLASMODIUM FALCIPARUM causes CEREBRAL MALARIA,15,39,,30,81,causes,0.997054485501582,811457-FS1-4,Smear negative CEREBRAL MALARIA due to MEFLOQUINE RESISTANT PLASMODIUM FALCIPARUM acquired in the Amazon.,CEREBRAL MALARIA,MEFLOQUINE RESISTANT PLASMODIUM FALCIPARUM,TWrex-cause
724992219,5/22/2015 18:40:32,1641508960,5/22/2015 18:40:20,False,prodege,0.8,1924522,USA,NY,New York,96.224.13.217,MEFLOQUINE RESISTANT PLASMODIUM FALCIPARUM causes CEREBRAL MALARIA,15,39,,30,81,causes,0.997054485501582,811457-FS1-4,Smear negative CEREBRAL MALARIA due to MEFLOQUINE RESISTANT PLASMODIUM FALCIPARUM acquired in the Amazon.,CEREBRAL MALARIA,MEFLOQUINE RESISTANT PLASMODIUM FALCIPARUM,TWrex-cause
724992219,5/22/2015 19:08:31,1641538525,5/22/2015 19:07:37,False,fusioncash,0.8542,5656294,USA,TN,Cookeville,75.136.162.83,MEFLOQUINE RESISTANT PLASMODIUM FALCIPARUM causes CEREBRAL MALARIA,15,39,,30,81,causes,0.997054485501582,811457-FS1-4,Smear negative CEREBRAL MALARIA due to MEFLOQUINE RESISTANT PLASMODIUM FALCIPARUM acquired in the Amazon.,CEREBRAL MALARIA,MEFLOQUINE RESISTANT PLASMODIUM FALCIPARUM,TWrex-cause
724992219,5/22/2015 19:44:22,1641593141,5/22/2015 19:43:40,False,neodev,0.8839,30940715,USA,IL,Lisle,50.247.189.225,MEFLOQUINE RESISTANT PLASMODIUM FALCIPARUM causes CEREBRAL MALARIA,15,39,,30,81,causes,0.997054485501582,811457-FS1-4,Smear negative CEREBRAL MALARIA due to MEFLOQUINE RESISTANT PLASMODIUM FALCIPARUM acquired in the Amazon.,CEREBRAL MALARIA,MEFLOQUINE RESISTANT PLASMODIUM FALCIPARUM,TWrex-cause
724992219,5/22/2015 20:11:51,1641631513,5/22/2015 20:11:39,False,neodev,0.475,31789301,GBR,H9,London,193.109.196.182,CEREBRAL MALARIA causes MEFLOQUINE RESISTANT PLASMODIUM FALCIPARUM,15,39,,30,81,causes,0.997054485501582,811457-FS1-4,Smear negative CEREBRAL MALARIA due to MEFLOQUINE RESISTANT PLASMODIUM FALCIPARUM acquired in the Amazon.,CEREBRAL MALARIA,MEFLOQUINE RESISTANT PLASMODIUM FALCIPARUM,TWrex-cause
724992219,5/22/2015 20:14:09,1641634500,5/22/2015 20:13:11,False,clixsense,0.5992,21139796,USA,NC,Rocky Mount,184.3.161.91,MEFLOQUINE RESISTANT PLASMODIUM FALCIPARUM causes CEREBRAL MALARIA,15,39,,30,81,causes,0.997054485501582,811457-FS1-4,Smear negative CEREBRAL MALARIA due to MEFLOQUINE RESISTANT PLASMODIUM FALCIPARUM acquired in the Amazon.,CEREBRAL MALARIA,MEFLOQUINE RESISTANT PLASMODIUM FALCIPARUM,TWrex-cause
724992219,5/22/2015 20:15:17,1641636326,5/22/2015 20:14:32,False,elite,0.7063,32732290,GBR,A7,Birmingham,86.147.79.250,MEFLOQUINE RESISTANT PLASMODIUM FALCIPARUM causes CEREBRAL MALARIA,15,39,,30,81,causes,0.997054485501582,811457-FS1-4,Smear negative CEREBRAL MALARIA due to MEFLOQUINE RESISTANT PLASMODIUM FALCIPARUM acquired in the Amazon.,CEREBRAL MALARIA,MEFLOQUINE RESISTANT PLASMODIUM FALCIPARUM,TWrex-cause
724992225,5/22/2015 17:02:59,1641428471,5/22/2015 17:01:29,False,clixsense,0.8889,22947672,GBR,,,88.144.127.68,no_relation,192,42,,204,84,causes,0.50395263067897,800011-FS1-4,"Podzamczer D, Salazar A, Jimenez J et al. INTERMITTENT TRIMETHOPRIM SULFAMETHOXAZOLE compared with dapsone pyrimethamine for the simultaneous primary prophylaxis of pneumocystis pneumonia and TOXOPLASMOSIS in patients infected with HIV.",TOXOPLASMOSIS,INTERMITTENT TRIMETHOPRIM SULFAMETHOXAZOLE,TWrex-cause
724992225,5/22/2015 17:06:19,1641430149,5/22/2015 17:06:08,False,instagc,0.6806,13581319,USA,IL,Mount Vernon,66.232.166.86,no_relation,192,42,,204,84,causes,0.50395263067897,800011-FS1-4,"Podzamczer D, Salazar A, Jimenez J et al. INTERMITTENT TRIMETHOPRIM SULFAMETHOXAZOLE compared with dapsone pyrimethamine for the simultaneous primary prophylaxis of pneumocystis pneumonia and TOXOPLASMOSIS in patients infected with HIV.",TOXOPLASMOSIS,INTERMITTENT TRIMETHOPRIM SULFAMETHOXAZOLE,TWrex-cause
724992225,5/22/2015 17:13:44,1641435341,5/22/2015 17:12:27,False,points4rewards,0.7069,20113482,USA,OR,Portland,67.213.218.72,no_relation,192,42,,204,84,causes,0.50395263067897,800011-FS1-4,"Podzamczer D, Salazar A, Jimenez J et al. INTERMITTENT TRIMETHOPRIM SULFAMETHOXAZOLE compared with dapsone pyrimethamine for the simultaneous primary prophylaxis of pneumocystis pneumonia and TOXOPLASMOSIS in patients infected with HIV.",TOXOPLASMOSIS,INTERMITTENT TRIMETHOPRIM SULFAMETHOXAZOLE,TWrex-cause
724992225,5/22/2015 17:16:58,1641437624,5/22/2015 17:16:32,False,gifthunterclub,0.7183,29582088,GBR,I2,Manchester,89.240.68.44,no_relation,192,42,,204,84,causes,0.50395263067897,800011-FS1-4,"Podzamczer D, Salazar A, Jimenez J et al. INTERMITTENT TRIMETHOPRIM SULFAMETHOXAZOLE compared with dapsone pyrimethamine for the simultaneous primary prophylaxis of pneumocystis pneumonia and TOXOPLASMOSIS in patients infected with HIV.",TOXOPLASMOSIS,INTERMITTENT TRIMETHOPRIM SULFAMETHOXAZOLE,TWrex-cause
724992225,5/22/2015 17:18:43,1641438681,5/22/2015 17:18:10,False,sharecashgpt,0.6067,28627999,CAN,ON,Sudbury,66.103.55.12,no_relation,192,42,,204,84,causes,0.50395263067897,800011-FS1-4,"Podzamczer D, Salazar A, Jimenez J et al. INTERMITTENT TRIMETHOPRIM SULFAMETHOXAZOLE compared with dapsone pyrimethamine for the simultaneous primary prophylaxis of pneumocystis pneumonia and TOXOPLASMOSIS in patients infected with HIV.",TOXOPLASMOSIS,INTERMITTENT TRIMETHOPRIM SULFAMETHOXAZOLE,TWrex-cause
724992225,5/22/2015 17:28:59,1641444696,5/22/2015 17:28:24,False,instagc,0.7599,30326470,USA,CA,Santee,99.44.37.73,no_relation,192,42,,204,84,causes,0.50395263067897,800011-FS1-4,"Podzamczer D, Salazar A, Jimenez J et al. INTERMITTENT TRIMETHOPRIM SULFAMETHOXAZOLE compared with dapsone pyrimethamine for the simultaneous primary prophylaxis of pneumocystis pneumonia and TOXOPLASMOSIS in patients infected with HIV.",TOXOPLASMOSIS,INTERMITTENT TRIMETHOPRIM SULFAMETHOXAZOLE,TWrex-cause
724992225,5/22/2015 17:33:20,1641446750,5/22/2015 17:32:45,False,prodege,0.8393,21417560,GBR,C3,Cambridge,151.225.116.143,no_relation,192,42,,204,84,causes,0.50395263067897,800011-FS1-4,"Podzamczer D, Salazar A, Jimenez J et al. INTERMITTENT TRIMETHOPRIM SULFAMETHOXAZOLE compared with dapsone pyrimethamine for the simultaneous primary prophylaxis of pneumocystis pneumonia and TOXOPLASMOSIS in patients infected with HIV.",TOXOPLASMOSIS,INTERMITTENT TRIMETHOPRIM SULFAMETHOXAZOLE,TWrex-cause
724992227,5/22/2015 17:04:20,1641428963,5/22/2015 17:03:09,False,clixsense,0.8889,22947672,GBR,,,88.144.127.68,no_relation,186,224,,194,247,causes,0.727606875108999,813047-FS1-4,"Evidence: • Two clinical randomized, double blind trials have shown that alendronate (40 mg, orally, daily, for 6 months) results in reduction in bone turnover markers, radiographs, and BONE PAIN when given to patients with PAGET'S DISEASE OF BONE.",BONE PAIN,PAGET'S DISEASE OF BONE,TWrex-cause
724992227,5/22/2015 17:06:31,1641430295,5/22/2015 17:06:21,False,instagc,0.6806,13581319,USA,IL,Mount Vernon,66.232.166.86,PAGET'S DISEASE OF BONE causes BONE PAIN,186,224,,194,247,causes,0.727606875108999,813047-FS1-4,"Evidence: • Two clinical randomized, double blind trials have shown that alendronate (40 mg, orally, daily, for 6 months) results in reduction in bone turnover markers, radiographs, and BONE PAIN when given to patients with PAGET'S DISEASE OF BONE.",BONE PAIN,PAGET'S DISEASE OF BONE,TWrex-cause
724992227,5/22/2015 17:14:47,1641436037,5/22/2015 17:13:48,False,points4rewards,0.7069,20113482,USA,OR,Portland,67.213.218.72,no_relation,186,224,,194,247,causes,0.727606875108999,813047-FS1-4,"Evidence: • Two clinical randomized, double blind trials have shown that alendronate (40 mg, orally, daily, for 6 months) results in reduction in bone turnover markers, radiographs, and BONE PAIN when given to patients with PAGET'S DISEASE OF BONE.",BONE PAIN,PAGET'S DISEASE OF BONE,TWrex-cause
724992227,5/22/2015 17:17:37,1641437923,5/22/2015 17:16:59,False,gifthunterclub,0.7183,29582088,GBR,I2,Manchester,89.240.68.44,no_relation,186,224,,194,247,causes,0.727606875108999,813047-FS1-4,"Evidence: • Two clinical randomized, double blind trials have shown that alendronate (40 mg, orally, daily, for 6 months) results in reduction in bone turnover markers, radiographs, and BONE PAIN when given to patients with PAGET'S DISEASE OF BONE.",BONE PAIN,PAGET'S DISEASE OF BONE,TWrex-cause
724992227,5/22/2015 17:19:26,1641439170,5/22/2015 17:18:44,False,sharecashgpt,0.6067,28627999,CAN,ON,Sudbury,66.103.55.12,no_relation,186,224,,194,247,causes,0.727606875108999,813047-FS1-4,"Evidence: • Two clinical randomized, double blind trials have shown that alendronate (40 mg, orally, daily, for 6 months) results in reduction in bone turnover markers, radiographs, and BONE PAIN when given to patients with PAGET'S DISEASE OF BONE.",BONE PAIN,PAGET'S DISEASE OF BONE,TWrex-cause
724992227,5/22/2015 17:30:42,1641445232,5/22/2015 17:29:06,False,instagc,0.7599,30326470,USA,CA,Santee,99.44.37.73,PAGET'S DISEASE OF BONE causes BONE PAIN,186,224,,194,247,causes,0.727606875108999,813047-FS1-4,"Evidence: • Two clinical randomized, double blind trials have shown that alendronate (40 mg, orally, daily, for 6 months) results in reduction in bone turnover markers, radiographs, and BONE PAIN when given to patients with PAGET'S DISEASE OF BONE.",BONE PAIN,PAGET'S DISEASE OF BONE,TWrex-cause
724992227,5/22/2015 17:33:56,1641447157,5/22/2015 17:33:21,False,prodege,0.8393,21417560,GBR,C3,Cambridge,151.225.116.143,PAGET'S DISEASE OF BONE causes BONE PAIN,186,224,,194,247,causes,0.727606875108999,813047-FS1-4,"Evidence: • Two clinical randomized, double blind trials have shown that alendronate (40 mg, orally, daily, for 6 months) results in reduction in bone turnover markers, radiographs, and BONE PAIN when given to patients with PAGET'S DISEASE OF BONE.",BONE PAIN,PAGET'S DISEASE OF BONE,TWrex-cause
724992239,5/22/2015 16:52:16,1641421080,5/22/2015 16:52:04,False,neodev,0.875,14096345,NLD,03,Eibergen,77.174.124.109,no_relation,53,18,,76,32,causes,0.843274042711568,811399-FS1-4,Although all four DENGUE VIRUSES are able to produce DENGUE HEMORRHAGIC FEVER dengue 2 and dengue 3 viruses are more frequently associated with severe disease ( 9 ;  21.,DENGUE HEMORRHAGIC FEVER,DENGUE VIRUSES,TWrex-cause
724992239,5/22/2015 17:00:46,1641426968,5/22/2015 16:59:53,False,clixsense,0.8889,22947672,GBR,,,88.144.127.68,DENGUE VIRUSES causes DENGUE HEMORRHAGIC FEVER,53,18,,76,32,causes,0.843274042711568,811399-FS1-4,Although all four DENGUE VIRUSES are able to produce DENGUE HEMORRHAGIC FEVER dengue 2 and dengue 3 viruses are more frequently associated with severe disease ( 9 ;  21.,DENGUE HEMORRHAGIC FEVER,DENGUE VIRUSES,TWrex-cause
724992239,5/22/2015 17:05:49,1641429842,5/22/2015 17:05:38,False,instagc,0.6806,13581319,USA,IL,Mount Vernon,66.232.166.86,no_relation,53,18,,76,32,causes,0.843274042711568,811399-FS1-4,Although all four DENGUE VIRUSES are able to produce DENGUE HEMORRHAGIC FEVER dengue 2 and dengue 3 viruses are more frequently associated with severe disease ( 9 ;  21.,DENGUE HEMORRHAGIC FEVER,DENGUE VIRUSES,TWrex-cause
724992239,5/22/2015 17:11:26,1641433760,5/22/2015 17:09:51,False,points4rewards,0.7069,20113482,USA,OR,Portland,67.213.218.72,DENGUE VIRUSES causes DENGUE HEMORRHAGIC FEVER,53,18,,76,32,causes,0.843274042711568,811399-FS1-4,Although all four DENGUE VIRUSES are able to produce DENGUE HEMORRHAGIC FEVER dengue 2 and dengue 3 viruses are more frequently associated with severe disease ( 9 ;  21.,DENGUE HEMORRHAGIC FEVER,DENGUE VIRUSES,TWrex-cause
724992239,5/22/2015 17:16:13,1641437061,5/22/2015 17:15:52,False,gifthunterclub,0.7183,29582088,GBR,I2,Manchester,89.240.68.44,DENGUE VIRUSES causes DENGUE HEMORRHAGIC FEVER,53,18,,76,32,causes,0.843274042711568,811399-FS1-4,Although all four DENGUE VIRUSES are able to produce DENGUE HEMORRHAGIC FEVER dengue 2 and dengue 3 viruses are more frequently associated with severe disease ( 9 ;  21.,DENGUE HEMORRHAGIC FEVER,DENGUE VIRUSES,TWrex-cause
724992239,5/22/2015 17:17:36,1641437930,5/22/2015 17:17:09,False,sharecashgpt,0.6067,28627999,CAN,ON,Sudbury,66.103.55.12,no_relation,53,18,,76,32,causes,0.843274042711568,811399-FS1-4,Although all four DENGUE VIRUSES are able to produce DENGUE HEMORRHAGIC FEVER dengue 2 and dengue 3 viruses are more frequently associated with severe disease ( 9 ;  21.,DENGUE HEMORRHAGIC FEVER,DENGUE VIRUSES,TWrex-cause
724992239,5/22/2015 17:27:11,1641443774,5/22/2015 17:24:53,False,instagc,0.7599,30326470,USA,CA,Santee,99.44.37.73,DENGUE VIRUSES causes DENGUE HEMORRHAGIC FEVER,53,18,,76,32,causes,0.843274042711568,811399-FS1-4,Although all four DENGUE VIRUSES are able to produce DENGUE HEMORRHAGIC FEVER dengue 2 and dengue 3 viruses are more frequently associated with severe disease ( 9 ;  21.,DENGUE HEMORRHAGIC FEVER,DENGUE VIRUSES,TWrex-cause
724992243,5/22/2015 18:13:56,1641480201,5/22/2015 18:13:26,False,instagc,0.6905,32352104,USA,ME,Bangor,74.75.63.81,POSTTRAUMATIC RSD causes PAIN,42,165,,45,182,causes,0.544331053951817,813736-FS1-4,"• Alendronate has been shown to alleviate PAIN and improve joint mobility and pressure tolerance in a randomized, controlled, double blind study in 40 patients with POSTTRAUMATIC RSD ( 50.",PAIN,POSTTRAUMATIC RSD,TWrex-cause
724992243,5/22/2015 18:22:16,1641488752,5/22/2015 18:21:20,False,neodev,0.7798,18703384,GBR,T5,Aberdeen,151.229.113.63,POSTTRAUMATIC RSD causes PAIN,42,165,,45,182,causes,0.544331053951817,813736-FS1-4,"• Alendronate has been shown to alleviate PAIN and improve joint mobility and pressure tolerance in a randomized, controlled, double blind study in 40 patients with POSTTRAUMATIC RSD ( 50.",PAIN,POSTTRAUMATIC RSD,TWrex-cause
724992243,5/22/2015 18:34:28,1641502324,5/22/2015 18:32:58,False,clixsense,0.75,23398628,USA,WA,Tacoma,50.149.99.43,POSTTRAUMATIC RSD causes PAIN,42,165,,45,182,causes,0.544331053951817,813736-FS1-4,"• Alendronate has been shown to alleviate PAIN and improve joint mobility and pressure tolerance in a randomized, controlled, double blind study in 40 patients with POSTTRAUMATIC RSD ( 50.",PAIN,POSTTRAUMATIC RSD,TWrex-cause
724992243,5/22/2015 18:35:48,1641503460,5/22/2015 18:34:19,False,pocketmoneygpt,0.5893,32162555,CAN,BC,Vancouver,108.180.194.80,POSTTRAUMATIC RSD causes PAIN,42,165,,45,182,causes,0.544331053951817,813736-FS1-4,"• Alendronate has been shown to alleviate PAIN and improve joint mobility and pressure tolerance in a randomized, controlled, double blind study in 40 patients with POSTTRAUMATIC RSD ( 50.",PAIN,POSTTRAUMATIC RSD,TWrex-cause
724992243,5/22/2015 18:39:48,1641508024,5/22/2015 18:39:24,False,prodege,0.8,1924522,USA,NY,New York,96.224.13.217,POSTTRAUMATIC RSD causes PAIN,42,165,,45,182,causes,0.544331053951817,813736-FS1-4,"• Alendronate has been shown to alleviate PAIN and improve joint mobility and pressure tolerance in a randomized, controlled, double blind study in 40 patients with POSTTRAUMATIC RSD ( 50.",PAIN,POSTTRAUMATIC RSD,TWrex-cause
724992243,5/22/2015 19:06:50,1641536474,5/22/2015 19:05:28,False,fusioncash,0.8542,5656294,USA,TN,Cookeville,75.136.162.83,POSTTRAUMATIC RSD causes PAIN,42,165,,45,182,causes,0.544331053951817,813736-FS1-4,"• Alendronate has been shown to alleviate PAIN and improve joint mobility and pressure tolerance in a randomized, controlled, double blind study in 40 patients with POSTTRAUMATIC RSD ( 50.",PAIN,POSTTRAUMATIC RSD,TWrex-cause
724992243,5/22/2015 19:42:45,1641591044,5/22/2015 19:41:07,False,neodev,0.8839,30940715,USA,IL,Lisle,50.247.189.225,POSTTRAUMATIC RSD causes PAIN,42,165,,45,182,causes,0.544331053951817,813736-FS1-4,"• Alendronate has been shown to alleviate PAIN and improve joint mobility and pressure tolerance in a randomized, controlled, double blind study in 40 patients with POSTTRAUMATIC RSD ( 50.",PAIN,POSTTRAUMATIC RSD,TWrex-cause
724992245,5/22/2015 16:25:37,1641400840,5/22/2015 16:25:06,False,neodev,0.7389,18881135,CAN,ON,Ajax,99.243.87.224,ASPIRIN causes BLEEDING DIATHESES,191,83,,208,90,causes,0.997458699830735,811559-FS1-4,"History  Use of prescription, over the counter, and illicit drugs  Anticoagulants, ASPIRIN or nonsteroidal anti inflammatory drugs, antiplatelet agents, and many prescription drugs may cause BLEEDING DIATHESES",BLEEDING DIATHESES,ASPIRIN,TWrex-cause
724992245,5/22/2015 16:26:34,1641401535,5/22/2015 16:26:12,False,neodev,0.9583,31743852,GBR,G5,Maidstone,85.210.127.64,ASPIRIN causes BLEEDING DIATHESES,191,83,,208,90,causes,0.997458699830735,811559-FS1-4,"History  Use of prescription, over the counter, and illicit drugs  Anticoagulants, ASPIRIN or nonsteroidal anti inflammatory drugs, antiplatelet agents, and many prescription drugs may cause BLEEDING DIATHESES",BLEEDING DIATHESES,ASPIRIN,TWrex-cause
724992245,5/22/2015 16:31:06,1641404996,5/22/2015 16:30:37,False,clixsense,0.7214,30681826,GBR,I3,Rochester,86.163.150.232,ASPIRIN causes BLEEDING DIATHESES,191,83,,208,90,causes,0.997458699830735,811559-FS1-4,"History  Use of prescription, over the counter, and illicit drugs  Anticoagulants, ASPIRIN or nonsteroidal anti inflammatory drugs, antiplatelet agents, and many prescription drugs may cause BLEEDING DIATHESES",BLEEDING DIATHESES,ASPIRIN,TWrex-cause
724992245,5/22/2015 16:32:35,1641405857,5/22/2015 16:31:33,False,pocketmoneygpt,0.675,21432964,GBR,K5,Poole,109.155.122.13,ASPIRIN causes BLEEDING DIATHESES,191,83,,208,90,causes,0.997458699830735,811559-FS1-4,"History  Use of prescription, over the counter, and illicit drugs  Anticoagulants, ASPIRIN or nonsteroidal anti inflammatory drugs, antiplatelet agents, and many prescription drugs may cause BLEEDING DIATHESES",BLEEDING DIATHESES,ASPIRIN,TWrex-cause
724992245,5/22/2015 16:33:40,1641406896,5/22/2015 16:33:17,False,prodege,0.8167,27934334,GBR,D2,Derby,86.162.35.12,ASPIRIN causes BLEEDING DIATHESES,191,83,,208,90,causes,0.997458699830735,811559-FS1-4,"History  Use of prescription, over the counter, and illicit drugs  Anticoagulants, ASPIRIN or nonsteroidal anti inflammatory drugs, antiplatelet agents, and many prescription drugs may cause BLEEDING DIATHESES",BLEEDING DIATHESES,ASPIRIN,TWrex-cause
724992245,5/22/2015 16:36:17,1641408858,5/22/2015 16:36:04,False,elite,0.8333,31883685,GBR,H2,Accrington,80.47.186.28,ASPIRIN causes BLEEDING DIATHESES,191,83,,208,90,causes,0.997458699830735,811559-FS1-4,"History  Use of prescription, over the counter, and illicit drugs  Anticoagulants, ASPIRIN or nonsteroidal anti inflammatory drugs, antiplatelet agents, and many prescription drugs may cause BLEEDING DIATHESES",BLEEDING DIATHESES,ASPIRIN,TWrex-cause
724992245,5/22/2015 16:39:14,1641411334,5/22/2015 16:38:18,False,onestopgpt,0.7976,21275875,CAN,ON,Hamilton,24.36.121.10,ASPIRIN causes BLEEDING DIATHESES,191,83,,208,90,causes,0.997458699830735,811559-FS1-4,"History  Use of prescription, over the counter, and illicit drugs  Anticoagulants, ASPIRIN or nonsteroidal anti inflammatory drugs, antiplatelet agents, and many prescription drugs may cause BLEEDING DIATHESES",BLEEDING DIATHESES,ASPIRIN,TWrex-cause
725204818,5/23/2015 14:09:10,1642190744,5/23/2015 14:08:43,False,clixsense,1.0,30544555,USA,TX,Longview,208.180.9.42,OPHTHALMIA NEONATORUM causes GONORRHOEAE,26,67,,46,78,causes,0.9950371902099889,810592-FS1-4,"167 ,   292  Treatment of OPHTHALMIA NEONATORUM   +    caused by  NGONORRHOEAE",OPHTHALMIA NEONATORUM,GONORRHOEAE,TWrex-cause
725204818,5/23/2015 14:16:37,1642192764,5/23/2015 14:16:18,False,clixsense,0.8194,22518719,GBR,J8,Nottingham,86.10.69.152,GONORRHOEAE causes OPHTHALMIA NEONATORUM,26,67,,46,78,causes,0.9950371902099889,810592-FS1-4,"167 ,   292  Treatment of OPHTHALMIA NEONATORUM   +    caused by  NGONORRHOEAE",OPHTHALMIA NEONATORUM,GONORRHOEAE,TWrex-cause
725204818,5/23/2015 14:20:23,1642193838,5/23/2015 14:20:06,False,neodev,0.6708,31448050,GBR,Q3,Wolverhampton,80.43.86.150,GONORRHOEAE causes OPHTHALMIA NEONATORUM,26,67,,46,78,causes,0.9950371902099889,810592-FS1-4,"167 ,   292  Treatment of OPHTHALMIA NEONATORUM   +    caused by  NGONORRHOEAE",OPHTHALMIA NEONATORUM,GONORRHOEAE,TWrex-cause
725204818,5/23/2015 14:25:20,1642195255,5/23/2015 14:24:59,False,gifthunterclub,0.6359,30901412,GBR,I3,Gillingham,85.210.125.10,GONORRHOEAE causes OPHTHALMIA NEONATORUM,26,67,,46,78,causes,0.9950371902099889,810592-FS1-4,"167 ,   292  Treatment of OPHTHALMIA NEONATORUM   +    caused by  NGONORRHOEAE",OPHTHALMIA NEONATORUM,GONORRHOEAE,TWrex-cause
725204818,5/23/2015 14:25:53,1642195450,5/23/2015 14:25:28,False,sharecashgpt,0.5786,28627999,CAN,ON,Sudbury,66.103.55.12,no_relation,26,67,,46,78,causes,0.9950371902099889,810592-FS1-4,"167 ,   292  Treatment of OPHTHALMIA NEONATORUM   +    caused by  NGONORRHOEAE",OPHTHALMIA NEONATORUM,GONORRHOEAE,TWrex-cause
725204818,5/23/2015 14:31:45,1642197181,5/23/2015 14:31:15,False,prodege,0.7361,21417560,GBR,C3,Cambridge,151.225.116.143,GONORRHOEAE causes OPHTHALMIA NEONATORUM,26,67,,46,78,causes,0.9950371902099889,810592-FS1-4,"167 ,   292  Treatment of OPHTHALMIA NEONATORUM   +    caused by  NGONORRHOEAE",OPHTHALMIA NEONATORUM,GONORRHOEAE,TWrex-cause
725204818,5/23/2015 14:35:04,1642198017,5/23/2015 14:30:57,False,onestopgpt,0.7133,21275875,CAN,ON,Hamilton,24.36.121.10,GONORRHOEAE causes OPHTHALMIA NEONATORUM,26,67,,46,78,causes,0.9950371902099889,810592-FS1-4,"167 ,   292  Treatment of OPHTHALMIA NEONATORUM   +    caused by  NGONORRHOEAE",OPHTHALMIA NEONATORUM,GONORRHOEAE,TWrex-cause
725204830,5/23/2015 14:56:11,1642203678,5/23/2015 14:55:52,False,instagc,0.6667,20312760,GBR,I2,Manchester,90.244.149.130,no_relation,104,136,,113,146,causes,0.549442255794756,804248-FS1-4,"A double blind cross over study of maximal expiratory flows and arterial blood gas tensions in normals, ASTHMATICS and bronchitis after SALBUTAMOL and ipratropin.",ASTHMATICS,SALBUTAMOL,TWrex-cause
725204830,5/23/2015 14:58:17,1642204192,5/23/2015 14:56:14,False,instagc,0.5683,18531561,CAN,ON,Mississauga,99.229.92.227,no_relation,104,136,,113,146,causes,0.549442255794756,804248-FS1-4,"A double blind cross over study of maximal expiratory flows and arterial blood gas tensions in normals, ASTHMATICS and bronchitis after SALBUTAMOL and ipratropin.",ASTHMATICS,SALBUTAMOL,TWrex-cause
725204830,5/23/2015 14:59:33,1642204544,5/23/2015 14:59:14,False,elite,0.7667,31856422,GBR,C9,Carlisle,92.19.36.179,no_relation,104,136,,113,146,causes,0.549442255794756,804248-FS1-4,"A double blind cross over study of maximal expiratory flows and arterial blood gas tensions in normals, ASTHMATICS and bronchitis after SALBUTAMOL and ipratropin.",ASTHMATICS,SALBUTAMOL,TWrex-cause
725204830,5/23/2015 15:07:53,1642206488,5/23/2015 15:06:19,False,zoombucks,0.9167,6744840,CAN,BC,Kelowna,174.4.58.160,no_relation,104,136,,113,146,causes,0.549442255794756,804248-FS1-4,"A double blind cross over study of maximal expiratory flows and arterial blood gas tensions in normals, ASTHMATICS and bronchitis after SALBUTAMOL and ipratropin.",ASTHMATICS,SALBUTAMOL,TWrex-cause
725204830,5/23/2015 15:11:18,1642207558,5/23/2015 15:10:12,False,neodev,0.7257,31463401,USA,OH,Columbus,216.185.58.236,no_relation,104,136,,113,146,causes,0.549442255794756,804248-FS1-4,"A double blind cross over study of maximal expiratory flows and arterial blood gas tensions in normals, ASTHMATICS and bronchitis after SALBUTAMOL and ipratropin.",ASTHMATICS,SALBUTAMOL,TWrex-cause
725204830,5/23/2015 15:13:18,1642208372,5/23/2015 15:07:43,False,clixsense,0.4576,17950689,GBR,Y9,Porth,217.43.32.119,SALBUTAMOL causes ASTHMATICS,104,136,,113,146,causes,0.549442255794756,804248-FS1-4,"A double blind cross over study of maximal expiratory flows and arterial blood gas tensions in normals, ASTHMATICS and bronchitis after SALBUTAMOL and ipratropin.",ASTHMATICS,SALBUTAMOL,TWrex-cause
725204830,5/23/2015 15:17:48,1642209557,5/23/2015 15:15:45,False,neodev,0.4095,27667288,CAN,MB,Brandon,216.36.187.168,ASTHMATICS causes SALBUTAMOL,104,136,,113,146,causes,0.549442255794756,804248-FS1-4,"A double blind cross over study of maximal expiratory flows and arterial blood gas tensions in normals, ASTHMATICS and bronchitis after SALBUTAMOL and ipratropin.",ASTHMATICS,SALBUTAMOL,TWrex-cause
725204842,5/23/2015 14:56:29,1642203751,5/23/2015 14:56:12,False,instagc,0.6667,20312760,GBR,I2,Manchester,90.244.149.130,TREPONEMA PERTENUE causes YAWS,45,61,,48,79,causes,0.948683298050514,810971-FS1-4,Alternative to penicillin G for treatment of YAWS caused by  TREPONEMA PERTENUE.,YAWS,TREPONEMA PERTENUE,TWrex-cause
725204842,5/23/2015 14:59:42,1642204587,5/23/2015 14:59:34,False,elite,0.7667,31856422,GBR,C9,Carlisle,92.19.36.179,TREPONEMA PERTENUE causes YAWS,45,61,,48,79,causes,0.948683298050514,810971-FS1-4,Alternative to penicillin G for treatment of YAWS caused by  TREPONEMA PERTENUE.,YAWS,TREPONEMA PERTENUE,TWrex-cause
725204842,5/23/2015 15:09:36,1642206996,5/23/2015 15:07:54,False,zoombucks,0.9167,6744840,CAN,BC,Kelowna,174.4.58.160,TREPONEMA PERTENUE causes YAWS,45,61,,48,79,causes,0.948683298050514,810971-FS1-4,Alternative to penicillin G for treatment of YAWS caused by  TREPONEMA PERTENUE.,YAWS,TREPONEMA PERTENUE,TWrex-cause
725204842,5/23/2015 15:11:35,1642207697,5/23/2015 15:11:20,False,neodev,0.7257,31463401,USA,OH,Columbus,216.185.58.236,TREPONEMA PERTENUE causes YAWS,45,61,,48,79,causes,0.948683298050514,810971-FS1-4,Alternative to penicillin G for treatment of YAWS caused by  TREPONEMA PERTENUE.,YAWS,TREPONEMA PERTENUE,TWrex-cause
725204842,5/23/2015 15:14:05,1642208605,5/23/2015 15:13:20,False,clixsense,0.4576,17950689,GBR,Y9,Porth,217.43.32.119,YAWS causes TREPONEMA PERTENUE,45,61,,48,79,causes,0.948683298050514,810971-FS1-4,Alternative to penicillin G for treatment of YAWS caused by  TREPONEMA PERTENUE.,YAWS,TREPONEMA PERTENUE,TWrex-cause
725204842,5/23/2015 15:18:08,1642209612,5/23/2015 15:17:49,False,neodev,0.4095,27667288,CAN,MB,Brandon,216.36.187.168,TREPONEMA PERTENUE causes YAWS,45,61,,48,79,causes,0.948683298050514,810971-FS1-4,Alternative to penicillin G for treatment of YAWS caused by  TREPONEMA PERTENUE.,YAWS,TREPONEMA PERTENUE,TWrex-cause
725204842,5/23/2015 15:32:56,1642213836,5/23/2015 15:32:31,False,prodege,0.8571,29849805,GBR,Z1,Swansea,82.1.37.235,TREPONEMA PERTENUE causes YAWS,45,61,,48,79,causes,0.948683298050514,810971-FS1-4,Alternative to penicillin G for treatment of YAWS caused by  TREPONEMA PERTENUE.,YAWS,TREPONEMA PERTENUE,TWrex-cause
725204845,5/23/2015 13:27:58,1642180113,5/23/2015 13:27:20,False,points4rewards,0.6806,20113482,USA,OR,Portland,67.213.218.72,CONFUSIONAL MIGRAINE causes HEADACHE,37,0,,44,20,causes,0.9282791216329142,813802-FS1-4,"CONFUSIONAL MIGRAINE presents with a HEADACHE which can be minimal, associated with a confusional state that can last from 10 minutes to 2 days.",HEADACHE,CONFUSIONAL MIGRAINE,TWrex-cause
725204845,5/23/2015 13:29:24,1642180506,5/23/2015 13:29:14,False,instagc,0.7917,13581319,USA,IL,Mount Vernon,66.232.166.86,CONFUSIONAL MIGRAINE causes HEADACHE,37,0,,44,20,causes,0.9282791216329142,813802-FS1-4,"CONFUSIONAL MIGRAINE presents with a HEADACHE which can be minimal, associated with a confusional state that can last from 10 minutes to 2 days.",HEADACHE,CONFUSIONAL MIGRAINE,TWrex-cause
725204845,5/23/2015 13:31:20,1642181093,5/23/2015 13:27:56,False,clixsense,0.7222,30681350,GBR,Q3,Wolverhampton,92.26.249.197,HEADACHE causes CONFUSIONAL MIGRAINE,37,0,,44,20,causes,0.9282791216329142,813802-FS1-4,"CONFUSIONAL MIGRAINE presents with a HEADACHE which can be minimal, associated with a confusional state that can last from 10 minutes to 2 days.",HEADACHE,CONFUSIONAL MIGRAINE,TWrex-cause
725204845,5/23/2015 13:36:01,1642182255,5/23/2015 13:35:57,False,neodev,0.3333,31977841,USA,VA,Chantilly,173.193.200.124,CONFUSIONAL MIGRAINE causes HEADACHE,37,0,,44,20,causes,0.9282791216329142,813802-FS1-4,"CONFUSIONAL MIGRAINE presents with a HEADACHE which can be minimal, associated with a confusional state that can last from 10 minutes to 2 days.",HEADACHE,CONFUSIONAL MIGRAINE,TWrex-cause
725204845,5/23/2015 13:39:14,1642183162,5/23/2015 13:38:15,False,neodev,0.7083,18881135,CAN,ON,Ajax,99.243.87.224,CONFUSIONAL MIGRAINE causes HEADACHE,37,0,,44,20,causes,0.9282791216329142,813802-FS1-4,"CONFUSIONAL MIGRAINE presents with a HEADACHE which can be minimal, associated with a confusional state that can last from 10 minutes to 2 days.",HEADACHE,CONFUSIONAL MIGRAINE,TWrex-cause
725204845,5/23/2015 13:41:55,1642184015,5/23/2015 13:41:38,False,instagc,0.6875,31184650,USA,IA,Mason City,173.26.27.82,no_relation,37,0,,44,20,causes,0.9282791216329142,813802-FS1-4,"CONFUSIONAL MIGRAINE presents with a HEADACHE which can be minimal, associated with a confusional state that can last from 10 minutes to 2 days.",HEADACHE,CONFUSIONAL MIGRAINE,TWrex-cause
725204845,5/23/2015 13:47:10,1642185564,5/23/2015 13:46:23,False,elite,0.6817,29768955,GBR,H9,London,213.205.231.165,no_relation,37,0,,44,20,causes,0.9282791216329142,813802-FS1-4,"CONFUSIONAL MIGRAINE presents with a HEADACHE which can be minimal, associated with a confusional state that can last from 10 minutes to 2 days.",HEADACHE,CONFUSIONAL MIGRAINE,TWrex-cause
725258426,5/23/2015 21:04:01,1642375414,5/23/2015 21:03:36,False,elite,0.9028,31883685,GBR,H2,Accrington,80.47.186.28,RSD causes REGIONAL PAIN,125,51,,137,54,causes,0.9036961141150641,814592-FS1-4,"DIAGNOSIS  Introduction  Consider the diagnosis of RSD in all patients with a history of trauma; characteristic, persistent, REGIONAL PAIN out of proportion to the injury; vasomotor or sudomotor instability in the affected region at presentation or by history; and no alternative diagnosis to explain their symptoms.",REGIONAL PAIN,RSD,TWrex-cause
725258426,5/23/2015 21:10:50,1642378705,5/23/2015 21:09:59,False,neodev,0.6208,22052203,USA,KS,Manhattan,70.179.128.5,RSD causes REGIONAL PAIN,125,51,,137,54,causes,0.9036961141150641,814592-FS1-4,"DIAGNOSIS  Introduction  Consider the diagnosis of RSD in all patients with a history of trauma; characteristic, persistent, REGIONAL PAIN out of proportion to the injury; vasomotor or sudomotor instability in the affected region at presentation or by history; and no alternative diagnosis to explain their symptoms.",REGIONAL PAIN,RSD,TWrex-cause
725258426,5/23/2015 21:25:50,1642385752,5/23/2015 21:25:32,False,clixsense,0.7153,30313955,GBR,K5,Poole,2.30.145.202,RSD causes REGIONAL PAIN,125,51,,137,54,causes,0.9036961141150641,814592-FS1-4,"DIAGNOSIS  Introduction  Consider the diagnosis of RSD in all patients with a history of trauma; characteristic, persistent, REGIONAL PAIN out of proportion to the injury; vasomotor or sudomotor instability in the affected region at presentation or by history; and no alternative diagnosis to explain their symptoms.",REGIONAL PAIN,RSD,TWrex-cause
725258426,5/23/2015 21:27:23,1642386577,5/23/2015 21:26:56,False,neodev,0.7905,30627835,GBR,H9,London,5.81.27.94,RSD causes REGIONAL PAIN,125,51,,137,54,causes,0.9036961141150641,814592-FS1-4,"DIAGNOSIS  Introduction  Consider the diagnosis of RSD in all patients with a history of trauma; characteristic, persistent, REGIONAL PAIN out of proportion to the injury; vasomotor or sudomotor instability in the affected region at presentation or by history; and no alternative diagnosis to explain their symptoms.",REGIONAL PAIN,RSD,TWrex-cause
725258426,5/23/2015 21:36:31,1642391323,5/23/2015 21:35:44,False,neodev,0.8194,11460728,CAN,BC,Burnaby,70.79.16.165,RSD causes REGIONAL PAIN,125,51,,137,54,causes,0.9036961141150641,814592-FS1-4,"DIAGNOSIS  Introduction  Consider the diagnosis of RSD in all patients with a history of trauma; characteristic, persistent, REGIONAL PAIN out of proportion to the injury; vasomotor or sudomotor instability in the affected region at presentation or by history; and no alternative diagnosis to explain their symptoms.",REGIONAL PAIN,RSD,TWrex-cause
725258426,5/23/2015 22:10:11,1642406621,5/23/2015 22:09:40,False,instagc,0.6389,15864091,USA,OK,Oklahoma City,104.0.113.133,RSD causes REGIONAL PAIN,125,51,,137,54,causes,0.9036961141150641,814592-FS1-4,"DIAGNOSIS  Introduction  Consider the diagnosis of RSD in all patients with a history of trauma; characteristic, persistent, REGIONAL PAIN out of proportion to the injury; vasomotor or sudomotor instability in the affected region at presentation or by history; and no alternative diagnosis to explain their symptoms.",REGIONAL PAIN,RSD,TWrex-cause
725258426,5/23/2015 22:17:07,1642410025,5/23/2015 22:15:24,False,clixsense,0.6194,10798016,GBR,C7,Coventry,86.24.245.191,no_relation,125,51,,137,54,causes,0.9036961141150641,814592-FS1-4,"DIAGNOSIS  Introduction  Consider the diagnosis of RSD in all patients with a history of trauma; characteristic, persistent, REGIONAL PAIN out of proportion to the injury; vasomotor or sudomotor instability in the affected region at presentation or by history; and no alternative diagnosis to explain their symptoms.",REGIONAL PAIN,RSD,TWrex-cause
725258431,5/23/2015 20:37:58,1642361561,5/23/2015 20:37:44,False,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,COLD AGGLUTININ DISEASE causes INTRAVASCULAR HEMOLYSIS,62,254,,84,277,causes,0.3779644730092271,813068-FS1-4,"Paroxysmal cold hemoglobinuria is very rare, characterized by INTRAVASCULAR HEMOLYSIS often following infection  Immune hemolytic anemias are often characterized by numerous spherocytes on the blood smear; erythrocyte agglutination is seen on smear with COLD AGGLUTININ DISEASE",INTRAVASCULAR HEMOLYSIS,COLD AGGLUTININ DISEASE,TWrex-cause
725258431,5/23/2015 20:41:21,1642363611,5/23/2015 20:40:26,False,prodege,0.5944,21417560,GBR,C3,Cambridge,151.225.116.143,no_relation,62,254,,84,277,causes,0.3779644730092271,813068-FS1-4,"Paroxysmal cold hemoglobinuria is very rare, characterized by INTRAVASCULAR HEMOLYSIS often following infection  Immune hemolytic anemias are often characterized by numerous spherocytes on the blood smear; erythrocyte agglutination is seen on smear with COLD AGGLUTININ DISEASE",INTRAVASCULAR HEMOLYSIS,COLD AGGLUTININ DISEASE,TWrex-cause
725258431,5/23/2015 20:42:55,1642364358,5/23/2015 20:42:32,False,pocketmoneygpt,0.6181,28884030,USA,WI,Minocqua,75.143.134.247,COLD AGGLUTININ DISEASE causes INTRAVASCULAR HEMOLYSIS,62,254,,84,277,causes,0.3779644730092271,813068-FS1-4,"Paroxysmal cold hemoglobinuria is very rare, characterized by INTRAVASCULAR HEMOLYSIS often following infection  Immune hemolytic anemias are often characterized by numerous spherocytes on the blood smear; erythrocyte agglutination is seen on smear with COLD AGGLUTININ DISEASE",INTRAVASCULAR HEMOLYSIS,COLD AGGLUTININ DISEASE,TWrex-cause
725258431,5/23/2015 20:44:11,1642365224,5/23/2015 20:43:20,False,points4rewards,0.6806,20113482,USA,OR,Portland,67.213.218.72,no_relation,62,254,,84,277,causes,0.3779644730092271,813068-FS1-4,"Paroxysmal cold hemoglobinuria is very rare, characterized by INTRAVASCULAR HEMOLYSIS often following infection  Immune hemolytic anemias are often characterized by numerous spherocytes on the blood smear; erythrocyte agglutination is seen on smear with COLD AGGLUTININ DISEASE",INTRAVASCULAR HEMOLYSIS,COLD AGGLUTININ DISEASE,TWrex-cause
725258431,5/23/2015 20:51:16,1642369365,5/23/2015 20:50:29,False,instagc,0.6754,18531561,CAN,ON,Mississauga,99.229.92.227,no_relation,62,254,,84,277,causes,0.3779644730092271,813068-FS1-4,"Paroxysmal cold hemoglobinuria is very rare, characterized by INTRAVASCULAR HEMOLYSIS often following infection  Immune hemolytic anemias are often characterized by numerous spherocytes on the blood smear; erythrocyte agglutination is seen on smear with COLD AGGLUTININ DISEASE",INTRAVASCULAR HEMOLYSIS,COLD AGGLUTININ DISEASE,TWrex-cause
725258431,5/23/2015 20:52:03,1642369830,5/23/2015 20:51:52,False,cointasker,0.7190000000000001,21783324,NLD,,,31.151.239.133,no_relation,62,254,,84,277,causes,0.3779644730092271,813068-FS1-4,"Paroxysmal cold hemoglobinuria is very rare, characterized by INTRAVASCULAR HEMOLYSIS often following infection  Immune hemolytic anemias are often characterized by numerous spherocytes on the blood smear; erythrocyte agglutination is seen on smear with COLD AGGLUTININ DISEASE",INTRAVASCULAR HEMOLYSIS,COLD AGGLUTININ DISEASE,TWrex-cause
725258431,5/23/2015 20:54:18,1642370973,5/23/2015 20:45:29,False,neodev,0.6643,18881135,CAN,ON,Ajax,99.243.87.224,no_relation,62,254,,84,277,causes,0.3779644730092271,813068-FS1-4,"Paroxysmal cold hemoglobinuria is very rare, characterized by INTRAVASCULAR HEMOLYSIS often following infection  Immune hemolytic anemias are often characterized by numerous spherocytes on the blood smear; erythrocyte agglutination is seen on smear with COLD AGGLUTININ DISEASE",INTRAVASCULAR HEMOLYSIS,COLD AGGLUTININ DISEASE,TWrex-cause
725258433,5/23/2015 20:57:36,1642372598,5/23/2015 20:56:25,False,instagc,0.9524,30326470,USA,CA,Santee,99.44.37.73,no_relation,46,0,,53,19,causes,0.48507125007266605,812256-FS1-4,BOTULINUM ANTITOXIN also may be indicated for BOTULISM that occurs in the context of biologic warfare or bioterrorism.,BOTULISM,BOTULINUM ANTITOXIN,TWrex-cause
725258433,5/23/2015 21:03:35,1642375219,5/23/2015 21:03:22,False,elite,0.9028,31883685,GBR,H2,Accrington,80.47.186.28,no_relation,46,0,,53,19,causes,0.48507125007266605,812256-FS1-4,BOTULINUM ANTITOXIN also may be indicated for BOTULISM that occurs in the context of biologic warfare or bioterrorism.,BOTULISM,BOTULINUM ANTITOXIN,TWrex-cause
725258433,5/23/2015 21:09:57,1642378252,5/23/2015 21:09:26,False,neodev,0.6208,22052203,USA,KS,Manhattan,70.179.128.5,BOTULINUM ANTITOXIN causes BOTULISM,46,0,,53,19,causes,0.48507125007266605,812256-FS1-4,BOTULINUM ANTITOXIN also may be indicated for BOTULISM that occurs in the context of biologic warfare or bioterrorism.,BOTULISM,BOTULINUM ANTITOXIN,TWrex-cause
725258433,5/23/2015 21:25:31,1642385602,5/23/2015 21:25:05,False,clixsense,0.7153,30313955,GBR,K5,Poole,2.30.145.202,BOTULISM causes BOTULINUM ANTITOXIN,46,0,,53,19,causes,0.48507125007266605,812256-FS1-4,BOTULINUM ANTITOXIN also may be indicated for BOTULISM that occurs in the context of biologic warfare or bioterrorism.,BOTULISM,BOTULINUM ANTITOXIN,TWrex-cause
725258433,5/23/2015 21:26:55,1642386341,5/23/2015 21:26:41,False,neodev,0.7905,30627835,GBR,H9,London,5.81.27.94,no_relation,46,0,,53,19,causes,0.48507125007266605,812256-FS1-4,BOTULINUM ANTITOXIN also may be indicated for BOTULISM that occurs in the context of biologic warfare or bioterrorism.,BOTULISM,BOTULINUM ANTITOXIN,TWrex-cause
725258433,5/23/2015 21:35:43,1642390890,5/23/2015 21:34:54,False,neodev,0.8194,11460728,CAN,BC,Burnaby,70.79.16.165,no_relation,46,0,,53,19,causes,0.48507125007266605,812256-FS1-4,BOTULINUM ANTITOXIN also may be indicated for BOTULISM that occurs in the context of biologic warfare or bioterrorism.,BOTULISM,BOTULINUM ANTITOXIN,TWrex-cause
725258433,5/23/2015 22:09:39,1642406395,5/23/2015 22:09:21,False,instagc,0.6389,15864091,USA,OK,Oklahoma City,104.0.113.133,no_relation,46,0,,53,19,causes,0.48507125007266605,812256-FS1-4,BOTULINUM ANTITOXIN also may be indicated for BOTULISM that occurs in the context of biologic warfare or bioterrorism.,BOTULISM,BOTULINUM ANTITOXIN,TWrex-cause
725258435,5/23/2015 21:28:06,1642386951,5/23/2015 21:27:48,False,neodev,0.7905,30627835,GBR,H9,London,5.81.27.94,TOXOPLASMA GONDII causes TOXOPLASMOSIS,34,59,,46,76,causes,0.99654575824488,810355-FS1-4,173  Toxoplasmosis  Prevention of TOXOPLASMOSIS caused by  TOXOPLASMA GONDII  in conjunction with other anti infectives.,TOXOPLASMOSIS,TOXOPLASMA GONDII,TWrex-cause
725258435,5/23/2015 21:37:41,1642391898,5/23/2015 21:37:03,False,neodev,0.8194,11460728,CAN,BC,Burnaby,70.79.16.165,TOXOPLASMA GONDII causes TOXOPLASMOSIS,34,59,,46,76,causes,0.99654575824488,810355-FS1-4,173  Toxoplasmosis  Prevention of TOXOPLASMOSIS caused by  TOXOPLASMA GONDII  in conjunction with other anti infectives.,TOXOPLASMOSIS,TOXOPLASMA GONDII,TWrex-cause
725258435,5/23/2015 22:11:02,1642407118,5/23/2015 22:10:44,False,instagc,0.6389,15864091,USA,OK,Oklahoma City,104.0.113.133,TOXOPLASMA GONDII causes TOXOPLASMOSIS,34,59,,46,76,causes,0.99654575824488,810355-FS1-4,173  Toxoplasmosis  Prevention of TOXOPLASMOSIS caused by  TOXOPLASMA GONDII  in conjunction with other anti infectives.,TOXOPLASMOSIS,TOXOPLASMA GONDII,TWrex-cause
725258435,5/23/2015 22:19:38,1642411393,5/23/2015 22:17:08,False,clixsense,0.6296,17950689,GBR,Y9,Tonypandy,92.2.44.79,TOXOPLASMA GONDII causes TOXOPLASMOSIS,34,59,,46,76,causes,0.99654575824488,810355-FS1-4,173  Toxoplasmosis  Prevention of TOXOPLASMOSIS caused by  TOXOPLASMA GONDII  in conjunction with other anti infectives.,TOXOPLASMOSIS,TOXOPLASMA GONDII,TWrex-cause
725258435,5/23/2015 22:19:45,1642411428,5/23/2015 22:18:48,False,clixsense,0.6194,10798016,GBR,C7,Coventry,86.24.245.191,TOXOPLASMA GONDII causes TOXOPLASMOSIS,34,59,,46,76,causes,0.99654575824488,810355-FS1-4,173  Toxoplasmosis  Prevention of TOXOPLASMOSIS caused by  TOXOPLASMA GONDII  in conjunction with other anti infectives.,TOXOPLASMOSIS,TOXOPLASMA GONDII,TWrex-cause
725258435,5/23/2015 22:21:32,1642412256,5/23/2015 22:21:04,False,neodev,0.6679999999999999,30588889,NLD,07,Amsterdam,77.248.175.222,TOXOPLASMA GONDII causes TOXOPLASMOSIS,34,59,,46,76,causes,0.99654575824488,810355-FS1-4,173  Toxoplasmosis  Prevention of TOXOPLASMOSIS caused by  TOXOPLASMA GONDII  in conjunction with other anti infectives.,TOXOPLASMOSIS,TOXOPLASMA GONDII,TWrex-cause
725258435,5/23/2015 22:26:09,1642414591,5/23/2015 22:25:53,False,instagc,0.6508,31184650,USA,IA,Mason City,173.26.27.82,TOXOPLASMA GONDII causes TOXOPLASMOSIS,34,59,,46,76,causes,0.99654575824488,810355-FS1-4,173  Toxoplasmosis  Prevention of TOXOPLASMOSIS caused by  TOXOPLASMA GONDII  in conjunction with other anti infectives.,TOXOPLASMOSIS,TOXOPLASMA GONDII,TWrex-cause
725258443,5/23/2015 20:55:12,1642371381,5/23/2015 20:54:43,False,instagc,0.9524,30326470,USA,CA,Santee,99.44.37.73,ADENOMYOSIS causes SEVERE CYCLIC MENSTRUAL PAIN,256,162,,283,173,causes,0.9918365981341758,812708-FS1-4,Two patterns of disease were observed: a large heterogeneous pelvic mass and an endometrial mass that mimicked endometrial carcinoma (tvml 106tvml ) Adenomyosis  ADENOMYOSIS is the occurrence of ectopic endometrial tissue in the uterus and commonly causes SEVERE CYCLIC MENSTRUAL PAIN and menorrhagia.,SEVERE CYCLIC MENSTRUAL PAIN,ADENOMYOSIS,TWrex-cause
725258443,5/23/2015 21:02:20,1642374717,5/23/2015 21:01:55,False,elite,0.9028,31883685,GBR,H2,Accrington,80.47.186.28,ADENOMYOSIS causes SEVERE CYCLIC MENSTRUAL PAIN,256,162,,283,173,causes,0.9918365981341758,812708-FS1-4,Two patterns of disease were observed: a large heterogeneous pelvic mass and an endometrial mass that mimicked endometrial carcinoma (tvml 106tvml ) Adenomyosis  ADENOMYOSIS is the occurrence of ectopic endometrial tissue in the uterus and commonly causes SEVERE CYCLIC MENSTRUAL PAIN and menorrhagia.,SEVERE CYCLIC MENSTRUAL PAIN,ADENOMYOSIS,TWrex-cause
725258443,5/23/2015 21:04:43,1642375684,5/23/2015 21:00:17,False,neodev,0.6,27667288,CAN,MB,Brandon,216.36.187.168,ADENOMYOSIS causes SEVERE CYCLIC MENSTRUAL PAIN,256,162,,283,173,causes,0.9918365981341758,812708-FS1-4,Two patterns of disease were observed: a large heterogeneous pelvic mass and an endometrial mass that mimicked endometrial carcinoma (tvml 106tvml ) Adenomyosis  ADENOMYOSIS is the occurrence of ectopic endometrial tissue in the uterus and commonly causes SEVERE CYCLIC MENSTRUAL PAIN and menorrhagia.,SEVERE CYCLIC MENSTRUAL PAIN,ADENOMYOSIS,TWrex-cause
725258443,5/23/2015 21:06:11,1642376300,5/23/2015 20:58:40,False,neodev,0.6643,18881135,CAN,ON,Ajax,99.243.87.224,ADENOMYOSIS causes SEVERE CYCLIC MENSTRUAL PAIN,256,162,,283,173,causes,0.9918365981341758,812708-FS1-4,Two patterns of disease were observed: a large heterogeneous pelvic mass and an endometrial mass that mimicked endometrial carcinoma (tvml 106tvml ) Adenomyosis  ADENOMYOSIS is the occurrence of ectopic endometrial tissue in the uterus and commonly causes SEVERE CYCLIC MENSTRUAL PAIN and menorrhagia.,SEVERE CYCLIC MENSTRUAL PAIN,ADENOMYOSIS,TWrex-cause
725258443,5/23/2015 21:06:24,1642376434,5/23/2015 21:05:44,False,neodev,0.6208,22052203,USA,KS,Manhattan,70.179.128.5,ADENOMYOSIS causes SEVERE CYCLIC MENSTRUAL PAIN,256,162,,283,173,causes,0.9918365981341758,812708-FS1-4,Two patterns of disease were observed: a large heterogeneous pelvic mass and an endometrial mass that mimicked endometrial carcinoma (tvml 106tvml ) Adenomyosis  ADENOMYOSIS is the occurrence of ectopic endometrial tissue in the uterus and commonly causes SEVERE CYCLIC MENSTRUAL PAIN and menorrhagia.,SEVERE CYCLIC MENSTRUAL PAIN,ADENOMYOSIS,TWrex-cause
725258443,5/23/2015 21:23:50,1642384775,5/23/2015 21:23:10,False,clixsense,0.7153,30313955,GBR,K5,Poole,2.30.145.202,ADENOMYOSIS causes SEVERE CYCLIC MENSTRUAL PAIN,256,162,,283,173,causes,0.9918365981341758,812708-FS1-4,Two patterns of disease were observed: a large heterogeneous pelvic mass and an endometrial mass that mimicked endometrial carcinoma (tvml 106tvml ) Adenomyosis  ADENOMYOSIS is the occurrence of ectopic endometrial tissue in the uterus and commonly causes SEVERE CYCLIC MENSTRUAL PAIN and menorrhagia.,SEVERE CYCLIC MENSTRUAL PAIN,ADENOMYOSIS,TWrex-cause
725258443,5/23/2015 21:32:46,1642389279,5/23/2015 21:32:37,False,prodege,0.1667,2143114,CAN,BC,Vancouver,24.85.153.181,SEVERE CYCLIC MENSTRUAL PAIN causes ADENOMYOSIS,256,162,,283,173,causes,0.9918365981341758,812708-FS1-4,Two patterns of disease were observed: a large heterogeneous pelvic mass and an endometrial mass that mimicked endometrial carcinoma (tvml 106tvml ) Adenomyosis  ADENOMYOSIS is the occurrence of ectopic endometrial tissue in the uterus and commonly causes SEVERE CYCLIC MENSTRUAL PAIN and menorrhagia.,SEVERE CYCLIC MENSTRUAL PAIN,ADENOMYOSIS,TWrex-cause
725258451,5/23/2015 21:28:06,1642386949,5/23/2015 21:27:48,False,neodev,0.7905,30627835,GBR,H9,London,5.81.27.94,ANESTHETICS causes MALIGNANT HYPERTHERMIA,29,87,,50,98,causes,0.9950371902099889,810141-FS1-4,Malignant hyperthermia (see  MALIGNANT HYPERTHERMIA ) can result from exposure to some ANESTHETICS and antipsychotics; this genetic disorder has a high mortality rate.,MALIGNANT HYPERTHERMIA,ANESTHETICS,TWrex-cause
725258451,5/23/2015 21:37:41,1642391892,5/23/2015 21:37:03,False,neodev,0.8194,11460728,CAN,BC,Burnaby,70.79.16.165,ANESTHETICS causes MALIGNANT HYPERTHERMIA,29,87,,50,98,causes,0.9950371902099889,810141-FS1-4,Malignant hyperthermia (see  MALIGNANT HYPERTHERMIA ) can result from exposure to some ANESTHETICS and antipsychotics; this genetic disorder has a high mortality rate.,MALIGNANT HYPERTHERMIA,ANESTHETICS,TWrex-cause
725258451,5/23/2015 22:11:02,1642407116,5/23/2015 22:10:44,False,instagc,0.6389,15864091,USA,OK,Oklahoma City,104.0.113.133,ANESTHETICS causes MALIGNANT HYPERTHERMIA,29,87,,50,98,causes,0.9950371902099889,810141-FS1-4,Malignant hyperthermia (see  MALIGNANT HYPERTHERMIA ) can result from exposure to some ANESTHETICS and antipsychotics; this genetic disorder has a high mortality rate.,MALIGNANT HYPERTHERMIA,ANESTHETICS,TWrex-cause
725258451,5/23/2015 22:19:38,1642411391,5/23/2015 22:17:08,False,clixsense,0.6296,17950689,GBR,Y9,Tonypandy,92.2.44.79,MALIGNANT HYPERTHERMIA causes ANESTHETICS,29,87,,50,98,causes,0.9950371902099889,810141-FS1-4,Malignant hyperthermia (see  MALIGNANT HYPERTHERMIA ) can result from exposure to some ANESTHETICS and antipsychotics; this genetic disorder has a high mortality rate.,MALIGNANT HYPERTHERMIA,ANESTHETICS,TWrex-cause
725258451,5/23/2015 22:19:45,1642411409,5/23/2015 22:18:48,False,clixsense,0.6194,10798016,GBR,C7,Coventry,86.24.245.191,ANESTHETICS causes MALIGNANT HYPERTHERMIA,29,87,,50,98,causes,0.9950371902099889,810141-FS1-4,Malignant hyperthermia (see  MALIGNANT HYPERTHERMIA ) can result from exposure to some ANESTHETICS and antipsychotics; this genetic disorder has a high mortality rate.,MALIGNANT HYPERTHERMIA,ANESTHETICS,TWrex-cause
725258451,5/23/2015 22:21:32,1642412261,5/23/2015 22:21:04,False,neodev,0.6679999999999999,30588889,NLD,07,Amsterdam,77.248.175.222,ANESTHETICS causes MALIGNANT HYPERTHERMIA,29,87,,50,98,causes,0.9950371902099889,810141-FS1-4,Malignant hyperthermia (see  MALIGNANT HYPERTHERMIA ) can result from exposure to some ANESTHETICS and antipsychotics; this genetic disorder has a high mortality rate.,MALIGNANT HYPERTHERMIA,ANESTHETICS,TWrex-cause
725258451,5/23/2015 22:26:09,1642414588,5/23/2015 22:25:53,False,instagc,0.6508,31184650,USA,IA,Mason City,173.26.27.82,ANESTHETICS causes MALIGNANT HYPERTHERMIA,29,87,,50,98,causes,0.9950371902099889,810141-FS1-4,Malignant hyperthermia (see  MALIGNANT HYPERTHERMIA ) can result from exposure to some ANESTHETICS and antipsychotics; this genetic disorder has a high mortality rate.,MALIGNANT HYPERTHERMIA,ANESTHETICS,TWrex-cause
725258455,5/23/2015 20:55:40,1642371589,5/23/2015 20:55:13,False,instagc,0.9524,30326470,USA,CA,Santee,99.44.37.73,no_relation,14,134,,37,147,causes,0.8944271909999159,810983-FS1-4,"Patients with STAPHYLOCOCCAL PNEUMONIA are acutely ill; purulent sputum production is the rule, and polymorpho nuclear leukocytes and STAPHYLOCOCCI can be identified on Gram stain of the sputum.",STAPHYLOCOCCAL PNEUMONIA,STAPHYLOCOCCI,TWrex-cause
725258455,5/23/2015 21:02:55,1642374860,5/23/2015 21:02:24,False,elite,0.9028,31883685,GBR,H2,Accrington,80.47.186.28,no_relation,14,134,,37,147,causes,0.8944271909999159,810983-FS1-4,"Patients with STAPHYLOCOCCAL PNEUMONIA are acutely ill; purulent sputum production is the rule, and polymorpho nuclear leukocytes and STAPHYLOCOCCI can be identified on Gram stain of the sputum.",STAPHYLOCOCCAL PNEUMONIA,STAPHYLOCOCCI,TWrex-cause
725258455,5/23/2015 21:08:55,1642377712,5/23/2015 21:06:25,False,neodev,0.6208,22052203,USA,KS,Manhattan,70.179.128.5,STAPHYLOCOCCI causes STAPHYLOCOCCAL PNEUMONIA,14,134,,37,147,causes,0.8944271909999159,810983-FS1-4,"Patients with STAPHYLOCOCCAL PNEUMONIA are acutely ill; purulent sputum production is the rule, and polymorpho nuclear leukocytes and STAPHYLOCOCCI can be identified on Gram stain of the sputum.",STAPHYLOCOCCAL PNEUMONIA,STAPHYLOCOCCI,TWrex-cause
725258455,5/23/2015 21:10:33,1642378562,5/23/2015 21:06:13,False,neodev,0.6643,18881135,CAN,ON,Ajax,99.243.87.224,STAPHYLOCOCCI causes STAPHYLOCOCCAL PNEUMONIA,14,134,,37,147,causes,0.8944271909999159,810983-FS1-4,"Patients with STAPHYLOCOCCAL PNEUMONIA are acutely ill; purulent sputum production is the rule, and polymorpho nuclear leukocytes and STAPHYLOCOCCI can be identified on Gram stain of the sputum.",STAPHYLOCOCCAL PNEUMONIA,STAPHYLOCOCCI,TWrex-cause
725258455,5/23/2015 21:14:53,1642380503,5/23/2015 21:11:05,False,neodev,0.6,27667288,CAN,MB,Brandon,216.36.187.168,no_relation,14,134,,37,147,causes,0.8944271909999159,810983-FS1-4,"Patients with STAPHYLOCOCCAL PNEUMONIA are acutely ill; purulent sputum production is the rule, and polymorpho nuclear leukocytes and STAPHYLOCOCCI can be identified on Gram stain of the sputum.",STAPHYLOCOCCAL PNEUMONIA,STAPHYLOCOCCI,TWrex-cause
725258455,5/23/2015 21:24:37,1642385102,5/23/2015 21:23:52,False,clixsense,0.7153,30313955,GBR,K5,Poole,2.30.145.202,STAPHYLOCOCCAL PNEUMONIA causes STAPHYLOCOCCI,14,134,,37,147,causes,0.8944271909999159,810983-FS1-4,"Patients with STAPHYLOCOCCAL PNEUMONIA are acutely ill; purulent sputum production is the rule, and polymorpho nuclear leukocytes and STAPHYLOCOCCI can be identified on Gram stain of the sputum.",STAPHYLOCOCCAL PNEUMONIA,STAPHYLOCOCCI,TWrex-cause
725258455,5/23/2015 21:26:23,1642386095,5/23/2015 21:25:59,False,neodev,0.7905,30627835,GBR,H9,London,5.81.27.94,no_relation,14,134,,37,147,causes,0.8944271909999159,810983-FS1-4,"Patients with STAPHYLOCOCCAL PNEUMONIA are acutely ill; purulent sputum production is the rule, and polymorpho nuclear leukocytes and STAPHYLOCOCCI can be identified on Gram stain of the sputum.",STAPHYLOCOCCAL PNEUMONIA,STAPHYLOCOCCI,TWrex-cause
725343167,5/24/2015 13:18:20,1642623008,5/24/2015 13:17:57,False,instagc,0.9167,31184650,USA,IA,Mason City,173.26.27.82,DRUGS causes BENZODIAZEPINE TOLERANCE,64,135,,87,140,causes,0.5,811250-FS1-4,1  Drug and Alcohol Dependence  Possible increased frequency of BENZODIAZEPINE TOLERANCE and dependence in patients dependent on other DRUGS or alcohol; use with caution.,BENZODIAZEPINE TOLERANCE,DRUGS,TWrex-cause
725343167,5/24/2015 13:27:54,1642624798,5/24/2015 13:27:41,False,bitcoinget,0.6607,21614812,USA,NJ,Blackwood,50.153.127.35,no_relation,64,135,,87,140,causes,0.5,811250-FS1-4,1  Drug and Alcohol Dependence  Possible increased frequency of BENZODIAZEPINE TOLERANCE and dependence in patients dependent on other DRUGS or alcohol; use with caution.,BENZODIAZEPINE TOLERANCE,DRUGS,TWrex-cause
725343167,5/24/2015 13:33:52,1642625906,5/24/2015 13:33:33,False,clixsense,0.7528,17609394,CAN,ON,Mississauga,99.229.57.218,no_relation,64,135,,87,140,causes,0.5,811250-FS1-4,1  Drug and Alcohol Dependence  Possible increased frequency of BENZODIAZEPINE TOLERANCE and dependence in patients dependent on other DRUGS or alcohol; use with caution.,BENZODIAZEPINE TOLERANCE,DRUGS,TWrex-cause
725343167,5/24/2015 13:37:25,1642626674,5/24/2015 13:37:03,False,neodev,0.7669,19004420,GBR,P8,Devizes,86.167.180.107,no_relation,64,135,,87,140,causes,0.5,811250-FS1-4,1  Drug and Alcohol Dependence  Possible increased frequency of BENZODIAZEPINE TOLERANCE and dependence in patients dependent on other DRUGS or alcohol; use with caution.,BENZODIAZEPINE TOLERANCE,DRUGS,TWrex-cause
725343167,5/24/2015 13:40:14,1642627131,5/24/2015 13:38:44,False,fusioncash,0.6601,5656294,USA,TN,Cookeville,75.136.162.83,DRUGS causes BENZODIAZEPINE TOLERANCE,64,135,,87,140,causes,0.5,811250-FS1-4,1  Drug and Alcohol Dependence  Possible increased frequency of BENZODIAZEPINE TOLERANCE and dependence in patients dependent on other DRUGS or alcohol; use with caution.,BENZODIAZEPINE TOLERANCE,DRUGS,TWrex-cause
725343167,5/24/2015 13:59:50,1642630609,5/24/2015 13:58:11,False,fusioncash,0.7506,7012325,USA,NY,Pelham,74.88.63.28,DRUGS causes BENZODIAZEPINE TOLERANCE,64,135,,87,140,causes,0.5,811250-FS1-4,1  Drug and Alcohol Dependence  Possible increased frequency of BENZODIAZEPINE TOLERANCE and dependence in patients dependent on other DRUGS or alcohol; use with caution.,BENZODIAZEPINE TOLERANCE,DRUGS,TWrex-cause
725343167,5/24/2015 14:03:21,1642631157,5/24/2015 14:02:36,False,neodev,0.7917,18881135,CAN,ON,Ajax,99.243.87.224,DRUGS causes BENZODIAZEPINE TOLERANCE,64,135,,87,140,causes,0.5,811250-FS1-4,1  Drug and Alcohol Dependence  Possible increased frequency of BENZODIAZEPINE TOLERANCE and dependence in patients dependent on other DRUGS or alcohol; use with caution.,BENZODIAZEPINE TOLERANCE,DRUGS,TWrex-cause
725343168,5/24/2015 12:31:17,1642614156,5/24/2015 12:30:52,False,points4rewards,0.7292,28755767,USA,VA,Chester,68.57.118.32,LEPROSY causes MYCOBACTERIUM LEPRAE DNA AND MRNA,115,51,,121,84,causes,0.583459965991578,811650-FS1-4,2009 06 01  Quantitative real time PCR analysis of MYCOBACTERIUM LEPRAE DNA AND MRNA in human biopsy material from LEPROSY and reactional cases.,LEPROSY,MYCOBACTERIUM LEPRAE DNA AND MRNA,TWrex-cause
725343168,5/24/2015 12:31:56,1642614329,5/24/2015 12:31:25,False,clixsense,0.6409,31482589,NLD,,,31.201.11.16,MYCOBACTERIUM LEPRAE DNA AND MRNA causes LEPROSY,115,51,,121,84,causes,0.583459965991578,811650-FS1-4,2009 06 01  Quantitative real time PCR analysis of MYCOBACTERIUM LEPRAE DNA AND MRNA in human biopsy material from LEPROSY and reactional cases.,LEPROSY,MYCOBACTERIUM LEPRAE DNA AND MRNA,TWrex-cause
725343168,5/24/2015 12:32:25,1642614363,5/24/2015 12:31:38,False,vivatic,0.7778,32338429,GBR,G1,Feltham,92.24.40.208,LEPROSY causes MYCOBACTERIUM LEPRAE DNA AND MRNA,115,51,,121,84,causes,0.583459965991578,811650-FS1-4,2009 06 01  Quantitative real time PCR analysis of MYCOBACTERIUM LEPRAE DNA AND MRNA in human biopsy material from LEPROSY and reactional cases.,LEPROSY,MYCOBACTERIUM LEPRAE DNA AND MRNA,TWrex-cause
725343168,5/24/2015 12:34:41,1642614756,5/24/2015 12:32:58,False,fusioncash,0.6497,31757234,USA,KY,London,76.177.136.50,MYCOBACTERIUM LEPRAE DNA AND MRNA causes LEPROSY,115,51,,121,84,causes,0.583459965991578,811650-FS1-4,2009 06 01  Quantitative real time PCR analysis of MYCOBACTERIUM LEPRAE DNA AND MRNA in human biopsy material from LEPROSY and reactional cases.,LEPROSY,MYCOBACTERIUM LEPRAE DNA AND MRNA,TWrex-cause
725343168,5/24/2015 12:38:30,1642615557,5/24/2015 12:38:14,False,elite,0.775,31913360,GBR,,,5.152.201.148,MYCOBACTERIUM LEPRAE DNA AND MRNA causes LEPROSY,115,51,,121,84,causes,0.583459965991578,811650-FS1-4,2009 06 01  Quantitative real time PCR analysis of MYCOBACTERIUM LEPRAE DNA AND MRNA in human biopsy material from LEPROSY and reactional cases.,LEPROSY,MYCOBACTERIUM LEPRAE DNA AND MRNA,TWrex-cause
725343168,5/24/2015 12:39:37,1642615750,5/24/2015 12:39:08,False,neodev,0.0,30627835,GBR,H9,London,5.81.27.94,no_relation,115,51,,121,84,causes,0.583459965991578,811650-FS1-4,2009 06 01  Quantitative real time PCR analysis of MYCOBACTERIUM LEPRAE DNA AND MRNA in human biopsy material from LEPROSY and reactional cases.,LEPROSY,MYCOBACTERIUM LEPRAE DNA AND MRNA,TWrex-cause
725343168,5/24/2015 13:26:27,1642624589,5/24/2015 13:26:16,False,bitcoinget,0.6607,21614812,USA,NJ,Blackwood,50.153.127.35,MYCOBACTERIUM LEPRAE DNA AND MRNA causes LEPROSY,115,51,,121,84,causes,0.583459965991578,811650-FS1-4,2009 06 01  Quantitative real time PCR analysis of MYCOBACTERIUM LEPRAE DNA AND MRNA in human biopsy material from LEPROSY and reactional cases.,LEPROSY,MYCOBACTERIUM LEPRAE DNA AND MRNA,TWrex-cause
725343179,5/24/2015 12:11:28,1642610953,5/24/2015 12:11:14,False,instagc,0.7976,13581319,USA,IL,Mount Vernon,66.232.166.86,DYSMENORRHEA causes PAIN,4,121,,7,133,causes,0.8682431421244592,814610-FS1-4,"The PAIN caused her to miss school frequently, but was not considered to be severe by her family physician who diagnosed DYSMENORRHEA",PAIN,DYSMENORRHEA,TWrex-cause
725343179,5/24/2015 12:17:18,1642611906,5/24/2015 12:16:59,False,instagc,0.7569,18531561,CAN,ON,Mississauga,99.229.92.227,DYSMENORRHEA causes PAIN,4,121,,7,133,causes,0.8682431421244592,814610-FS1-4,"The PAIN caused her to miss school frequently, but was not considered to be severe by her family physician who diagnosed DYSMENORRHEA",PAIN,DYSMENORRHEA,TWrex-cause
725343179,5/24/2015 12:27:41,1642613606,5/24/2015 12:27:24,False,neodev,0.6944,31743852,GBR,G5,Maidstone,85.210.127.98,DYSMENORRHEA causes PAIN,4,121,,7,133,causes,0.8682431421244592,814610-FS1-4,"The PAIN caused her to miss school frequently, but was not considered to be severe by her family physician who diagnosed DYSMENORRHEA",PAIN,DYSMENORRHEA,TWrex-cause
725343179,5/24/2015 12:28:36,1642613766,5/24/2015 12:28:16,False,neodev,0.626,12115558,USA,OH,Twinsburg,98.27.164.131,DYSMENORRHEA causes PAIN,4,121,,7,133,causes,0.8682431421244592,814610-FS1-4,"The PAIN caused her to miss school frequently, but was not considered to be severe by her family physician who diagnosed DYSMENORRHEA",PAIN,DYSMENORRHEA,TWrex-cause
725343179,5/24/2015 12:29:03,1642613832,5/24/2015 12:28:30,False,points4rewards,0.7292,28755767,USA,VA,Chester,68.57.118.32,DYSMENORRHEA causes PAIN,4,121,,7,133,causes,0.8682431421244592,814610-FS1-4,"The PAIN caused her to miss school frequently, but was not considered to be severe by her family physician who diagnosed DYSMENORRHEA",PAIN,DYSMENORRHEA,TWrex-cause
725343179,5/24/2015 12:29:10,1642613841,5/24/2015 12:28:25,False,vivatic,0.7778,32338429,GBR,G1,Feltham,92.24.40.208,DYSMENORRHEA causes PAIN,4,121,,7,133,causes,0.8682431421244592,814610-FS1-4,"The PAIN caused her to miss school frequently, but was not considered to be severe by her family physician who diagnosed DYSMENORRHEA",PAIN,DYSMENORRHEA,TWrex-cause
725343179,5/24/2015 12:29:26,1642613902,5/24/2015 12:28:54,False,clixsense,0.6409,31482589,NLD,,,31.201.11.16,DYSMENORRHEA causes PAIN,4,121,,7,133,causes,0.8682431421244592,814610-FS1-4,"The PAIN caused her to miss school frequently, but was not considered to be severe by her family physician who diagnosed DYSMENORRHEA",PAIN,DYSMENORRHEA,TWrex-cause
725343180,5/24/2015 14:04:31,1642631419,5/24/2015 14:03:56,False,fusioncash,0.7506,7012325,USA,NY,Pelham,74.88.63.28,no_relation,62,0,,69,18,causes,0.7548294124240691,802873-FS1-4,"ACUTE PANCREATITIS  ACUTE PANCREATITIS is inflammation of the PANCREAS (and, sometimes, adjacent tissues) caused by the release of activated pancreatic enzymes.",PANCREAS,ACUTE PANCREATITIS,TWrex-cause
725343180,5/24/2015 14:06:37,1642631780,5/24/2015 14:06:07,False,clixsense,0.8333,22947672,GBR,,,88.144.127.68,no_relation,62,0,,69,18,causes,0.7548294124240691,802873-FS1-4,"ACUTE PANCREATITIS  ACUTE PANCREATITIS is inflammation of the PANCREAS (and, sometimes, adjacent tissues) caused by the release of activated pancreatic enzymes.",PANCREAS,ACUTE PANCREATITIS,TWrex-cause
725343180,5/24/2015 14:09:23,1642632236,5/24/2015 14:08:42,False,neodev,0.7917,18881135,CAN,ON,Ajax,99.243.87.224,no_relation,62,0,,69,18,causes,0.7548294124240691,802873-FS1-4,"ACUTE PANCREATITIS  ACUTE PANCREATITIS is inflammation of the PANCREAS (and, sometimes, adjacent tissues) caused by the release of activated pancreatic enzymes.",PANCREAS,ACUTE PANCREATITIS,TWrex-cause
725343180,5/24/2015 14:09:27,1642632239,5/24/2015 14:06:08,False,clixsense,0.8929,24170547,USA,NJ,Clementon,71.168.199.135,no_relation,62,0,,69,18,causes,0.7548294124240691,802873-FS1-4,"ACUTE PANCREATITIS  ACUTE PANCREATITIS is inflammation of the PANCREAS (and, sometimes, adjacent tissues) caused by the release of activated pancreatic enzymes.",PANCREAS,ACUTE PANCREATITIS,TWrex-cause
725343180,5/24/2015 14:20:14,1642634311,5/24/2015 14:16:36,False,clixsense,0.4167,17950689,GBR,Y9,Tonypandy,92.2.44.79,PANCREAS causes ACUTE PANCREATITIS,62,0,,69,18,causes,0.7548294124240691,802873-FS1-4,"ACUTE PANCREATITIS  ACUTE PANCREATITIS is inflammation of the PANCREAS (and, sometimes, adjacent tissues) caused by the release of activated pancreatic enzymes.",PANCREAS,ACUTE PANCREATITIS,TWrex-cause
725343180,5/24/2015 14:24:12,1642635107,5/24/2015 14:23:15,False,gifthunterclub,0.6,24043308,GBR,,,94.102.147.250,no_relation,62,0,,69,18,causes,0.7548294124240691,802873-FS1-4,"ACUTE PANCREATITIS  ACUTE PANCREATITIS is inflammation of the PANCREAS (and, sometimes, adjacent tissues) caused by the release of activated pancreatic enzymes.",PANCREAS,ACUTE PANCREATITIS,TWrex-cause
725343180,5/24/2015 14:26:24,1642635573,5/24/2015 14:25:53,False,fusioncash,0.6497,31757234,USA,KY,London,76.177.136.50,PANCREAS causes ACUTE PANCREATITIS,62,0,,69,18,causes,0.7548294124240691,802873-FS1-4,"ACUTE PANCREATITIS  ACUTE PANCREATITIS is inflammation of the PANCREAS (and, sometimes, adjacent tissues) caused by the release of activated pancreatic enzymes.",PANCREAS,ACUTE PANCREATITIS,TWrex-cause
725343182,5/24/2015 11:32:09,1642604599,5/24/2015 11:31:41,False,prodege,1.0,21417560,GBR,C3,Cambridge,151.225.116.143,PHEOCHROMOCYTOMA causes HYPERTENSION,41,126,,52,142,causes,1.0,812710-FS1-4,"Curable forms of hypertension (secondary HYPERTENSION), which are relatively rare, may be caused by coarctation of the aorta, PHEOCHROMOCYTOMA renal artery stenosis, primary aldosteronism, and Cushing's syndrome.",HYPERTENSION,PHEOCHROMOCYTOMA,TWrex-cause
725343182,5/24/2015 11:38:56,1642605599,5/24/2015 11:36:28,False,points4rewards,0.8333,20113482,USA,OR,Portland,67.213.218.72,PHEOCHROMOCYTOMA causes HYPERTENSION,41,126,,52,142,causes,1.0,812710-FS1-4,"Curable forms of hypertension (secondary HYPERTENSION), which are relatively rare, may be caused by coarctation of the aorta, PHEOCHROMOCYTOMA renal artery stenosis, primary aldosteronism, and Cushing's syndrome.",HYPERTENSION,PHEOCHROMOCYTOMA,TWrex-cause
725343182,5/24/2015 11:50:20,1642607395,5/24/2015 11:49:09,False,clixsense,0.7847,32173073,GBR,L9,Sheffield,146.200.132.135,HYPERTENSION causes PHEOCHROMOCYTOMA,41,126,,52,142,causes,1.0,812710-FS1-4,"Curable forms of hypertension (secondary HYPERTENSION), which are relatively rare, may be caused by coarctation of the aorta, PHEOCHROMOCYTOMA renal artery stenosis, primary aldosteronism, and Cushing's syndrome.",HYPERTENSION,PHEOCHROMOCYTOMA,TWrex-cause
725343182,5/24/2015 11:51:40,1642607589,5/24/2015 11:51:23,False,pocketmoneygpt,0.625,28884030,USA,WI,Minocqua,75.143.134.247,PHEOCHROMOCYTOMA causes HYPERTENSION,41,126,,52,142,causes,1.0,812710-FS1-4,"Curable forms of hypertension (secondary HYPERTENSION), which are relatively rare, may be caused by coarctation of the aorta, PHEOCHROMOCYTOMA renal artery stenosis, primary aldosteronism, and Cushing's syndrome.",HYPERTENSION,PHEOCHROMOCYTOMA,TWrex-cause
725343182,5/24/2015 11:55:11,1642608332,5/24/2015 11:54:54,False,neodev,0.65,14096345,NLD,03,Eibergen,77.174.124.109,HYPERTENSION causes PHEOCHROMOCYTOMA,41,126,,52,142,causes,1.0,812710-FS1-4,"Curable forms of hypertension (secondary HYPERTENSION), which are relatively rare, may be caused by coarctation of the aorta, PHEOCHROMOCYTOMA renal artery stenosis, primary aldosteronism, and Cushing's syndrome.",HYPERTENSION,PHEOCHROMOCYTOMA,TWrex-cause
725343182,5/24/2015 11:59:16,1642608861,5/24/2015 11:56:54,False,clixsense,0.6131,10798016,GBR,C7,Coventry,86.24.245.191,PHEOCHROMOCYTOMA causes HYPERTENSION,41,126,,52,142,causes,1.0,812710-FS1-4,"Curable forms of hypertension (secondary HYPERTENSION), which are relatively rare, may be caused by coarctation of the aorta, PHEOCHROMOCYTOMA renal artery stenosis, primary aldosteronism, and Cushing's syndrome.",HYPERTENSION,PHEOCHROMOCYTOMA,TWrex-cause
725343182,5/24/2015 12:10:44,1642610886,5/24/2015 12:10:24,False,instagc,0.7976,13581319,USA,IL,Mount Vernon,66.232.166.86,HYPERTENSION causes PHEOCHROMOCYTOMA,41,126,,52,142,causes,1.0,812710-FS1-4,"Curable forms of hypertension (secondary HYPERTENSION), which are relatively rare, may be caused by coarctation of the aorta, PHEOCHROMOCYTOMA renal artery stenosis, primary aldosteronism, and Cushing's syndrome.",HYPERTENSION,PHEOCHROMOCYTOMA,TWrex-cause
725343188,5/24/2015 12:36:24,1642615146,5/24/2015 12:34:42,False,fusioncash,0.6497,31757234,USA,KY,London,76.177.136.50,no_relation,94,54,,106,82,causes,0.700140042014005,813172-FS1-4,"polydactyly, retinitis pigmentosa, mental retardation MULTIPLE LENTIGINES SYNDROME  Deafness, SHORT STATURE cardiac defects, multiple lentigines, genital or urologic defects Rud syndrome  Congenital ichthyosis, mental retardation, epilepsy Cerebellar ataxia and hypogonadotropic hypogonadism  Cerebellar ataxia, pes cavus deformity of the chest, spina bifida A large number of hypothalamic syndromes associated with hypogonadotropic hypogonadism have been described.",SHORT STATURE,MULTIPLE LENTIGINES SYNDROME,TWrex-cause
725343188,5/24/2015 12:38:41,1642615574,5/24/2015 12:38:32,False,elite,0.775,31913360,GBR,,,5.152.201.148,SHORT STATURE causes MULTIPLE LENTIGINES SYNDROME,94,54,,106,82,causes,0.700140042014005,813172-FS1-4,"polydactyly, retinitis pigmentosa, mental retardation MULTIPLE LENTIGINES SYNDROME  Deafness, SHORT STATURE cardiac defects, multiple lentigines, genital or urologic defects Rud syndrome  Congenital ichthyosis, mental retardation, epilepsy Cerebellar ataxia and hypogonadotropic hypogonadism  Cerebellar ataxia, pes cavus deformity of the chest, spina bifida A large number of hypothalamic syndromes associated with hypogonadotropic hypogonadism have been described.",SHORT STATURE,MULTIPLE LENTIGINES SYNDROME,TWrex-cause
725343188,5/24/2015 13:16:40,1642622721,5/24/2015 13:16:30,False,instagc,0.9167,31184650,USA,IA,Mason City,173.26.27.82,no_relation,94,54,,106,82,causes,0.700140042014005,813172-FS1-4,"polydactyly, retinitis pigmentosa, mental retardation MULTIPLE LENTIGINES SYNDROME  Deafness, SHORT STATURE cardiac defects, multiple lentigines, genital or urologic defects Rud syndrome  Congenital ichthyosis, mental retardation, epilepsy Cerebellar ataxia and hypogonadotropic hypogonadism  Cerebellar ataxia, pes cavus deformity of the chest, spina bifida A large number of hypothalamic syndromes associated with hypogonadotropic hypogonadism have been described.",SHORT STATURE,MULTIPLE LENTIGINES SYNDROME,TWrex-cause
725343188,5/24/2015 13:26:48,1642624624,5/24/2015 13:26:28,False,bitcoinget,0.6607,21614812,USA,NJ,Blackwood,50.153.127.35,no_relation,94,54,,106,82,causes,0.700140042014005,813172-FS1-4,"polydactyly, retinitis pigmentosa, mental retardation MULTIPLE LENTIGINES SYNDROME  Deafness, SHORT STATURE cardiac defects, multiple lentigines, genital or urologic defects Rud syndrome  Congenital ichthyosis, mental retardation, epilepsy Cerebellar ataxia and hypogonadotropic hypogonadism  Cerebellar ataxia, pes cavus deformity of the chest, spina bifida A large number of hypothalamic syndromes associated with hypogonadotropic hypogonadism have been described.",SHORT STATURE,MULTIPLE LENTIGINES SYNDROME,TWrex-cause
725343188,5/24/2015 13:32:31,1642625635,5/24/2015 13:32:07,False,clixsense,0.7528,17609394,CAN,ON,Mississauga,99.229.57.218,no_relation,94,54,,106,82,causes,0.700140042014005,813172-FS1-4,"polydactyly, retinitis pigmentosa, mental retardation MULTIPLE LENTIGINES SYNDROME  Deafness, SHORT STATURE cardiac defects, multiple lentigines, genital or urologic defects Rud syndrome  Congenital ichthyosis, mental retardation, epilepsy Cerebellar ataxia and hypogonadotropic hypogonadism  Cerebellar ataxia, pes cavus deformity of the chest, spina bifida A large number of hypothalamic syndromes associated with hypogonadotropic hypogonadism have been described.",SHORT STATURE,MULTIPLE LENTIGINES SYNDROME,TWrex-cause
725343188,5/24/2015 13:34:57,1642626135,5/24/2015 13:32:41,False,fusioncash,0.6601,5656294,USA,TN,Cookeville,75.136.162.83,MULTIPLE LENTIGINES SYNDROME causes SHORT STATURE,94,54,,106,82,causes,0.700140042014005,813172-FS1-4,"polydactyly, retinitis pigmentosa, mental retardation MULTIPLE LENTIGINES SYNDROME  Deafness, SHORT STATURE cardiac defects, multiple lentigines, genital or urologic defects Rud syndrome  Congenital ichthyosis, mental retardation, epilepsy Cerebellar ataxia and hypogonadotropic hypogonadism  Cerebellar ataxia, pes cavus deformity of the chest, spina bifida A large number of hypothalamic syndromes associated with hypogonadotropic hypogonadism have been described.",SHORT STATURE,MULTIPLE LENTIGINES SYNDROME,TWrex-cause
725343188,5/24/2015 13:35:27,1642626273,5/24/2015 13:34:53,False,neodev,0.7669,19004420,GBR,P8,Devizes,86.167.180.107,no_relation,94,54,,106,82,causes,0.700140042014005,813172-FS1-4,"polydactyly, retinitis pigmentosa, mental retardation MULTIPLE LENTIGINES SYNDROME  Deafness, SHORT STATURE cardiac defects, multiple lentigines, genital or urologic defects Rud syndrome  Congenital ichthyosis, mental retardation, epilepsy Cerebellar ataxia and hypogonadotropic hypogonadism  Cerebellar ataxia, pes cavus deformity of the chest, spina bifida A large number of hypothalamic syndromes associated with hypogonadotropic hypogonadism have been described.",SHORT STATURE,MULTIPLE LENTIGINES SYNDROME,TWrex-cause
725343189,5/24/2015 12:31:17,1642614157,5/24/2015 12:30:52,False,points4rewards,0.7292,28755767,USA,VA,Chester,68.57.118.32,PRIMARY FIBROMYALGIA causes PAIN,22,44,,25,64,causes,0.857492925712544,814185-FS1-4,Functional imaging of PAIN in patients with PRIMARY FIBROMYALGIA,PAIN,PRIMARY FIBROMYALGIA,TWrex-cause
725343189,5/24/2015 12:31:56,1642614327,5/24/2015 12:31:25,False,clixsense,0.6409,31482589,NLD,,,31.201.11.16,PRIMARY FIBROMYALGIA causes PAIN,22,44,,25,64,causes,0.857492925712544,814185-FS1-4,Functional imaging of PAIN in patients with PRIMARY FIBROMYALGIA,PAIN,PRIMARY FIBROMYALGIA,TWrex-cause
725343189,5/24/2015 12:32:25,1642614357,5/24/2015 12:31:38,False,vivatic,0.7778,32338429,GBR,G1,Feltham,92.24.40.208,PRIMARY FIBROMYALGIA causes PAIN,22,44,,25,64,causes,0.857492925712544,814185-FS1-4,Functional imaging of PAIN in patients with PRIMARY FIBROMYALGIA,PAIN,PRIMARY FIBROMYALGIA,TWrex-cause
725343189,5/24/2015 12:34:41,1642614755,5/24/2015 12:32:58,False,fusioncash,0.6497,31757234,USA,KY,London,76.177.136.50,PRIMARY FIBROMYALGIA causes PAIN,22,44,,25,64,causes,0.857492925712544,814185-FS1-4,Functional imaging of PAIN in patients with PRIMARY FIBROMYALGIA,PAIN,PRIMARY FIBROMYALGIA,TWrex-cause
725343189,5/24/2015 12:38:30,1642615558,5/24/2015 12:38:14,False,elite,0.775,31913360,GBR,,,5.152.201.148,PRIMARY FIBROMYALGIA causes PAIN,22,44,,25,64,causes,0.857492925712544,814185-FS1-4,Functional imaging of PAIN in patients with PRIMARY FIBROMYALGIA,PAIN,PRIMARY FIBROMYALGIA,TWrex-cause
725343189,5/24/2015 12:39:37,1642615752,5/24/2015 12:39:08,False,neodev,0.0,30627835,GBR,H9,London,5.81.27.94,no_relation,22,44,,25,64,causes,0.857492925712544,814185-FS1-4,Functional imaging of PAIN in patients with PRIMARY FIBROMYALGIA,PAIN,PRIMARY FIBROMYALGIA,TWrex-cause
725343189,5/24/2015 13:26:27,1642624588,5/24/2015 13:26:16,False,bitcoinget,0.6607,21614812,USA,NJ,Blackwood,50.153.127.35,PRIMARY FIBROMYALGIA causes PAIN,22,44,,25,64,causes,0.857492925712544,814185-FS1-4,Functional imaging of PAIN in patients with PRIMARY FIBROMYALGIA,PAIN,PRIMARY FIBROMYALGIA,TWrex-cause
725343194,5/24/2015 13:17:26,1642622822,5/24/2015 13:16:41,False,instagc,0.9167,31184650,USA,IA,Mason City,173.26.27.82,ANTIBIOTIC ASSOCIATED DIARRHEA causes MILD DIARRHEA,250,74,,262,104,causes,0.6741998624632421,814740-FS1-4,"230    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cefotaxime, and may range in severity from MILD DIARRHEA to fatal colitis.",MILD DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA,TWrex-cause
725343194,5/24/2015 13:27:05,1642624676,5/24/2015 13:26:53,False,bitcoinget,0.6607,21614812,USA,NJ,Blackwood,50.153.127.35,no_relation,250,74,,262,104,causes,0.6741998624632421,814740-FS1-4,"230    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cefotaxime, and may range in severity from MILD DIARRHEA to fatal colitis.",MILD DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA,TWrex-cause
725343194,5/24/2015 13:32:53,1642625760,5/24/2015 13:32:32,False,clixsense,0.7528,17609394,CAN,ON,Mississauga,99.229.57.218,ANTIBIOTIC ASSOCIATED DIARRHEA causes MILD DIARRHEA,250,74,,262,104,causes,0.6741998624632421,814740-FS1-4,"230    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cefotaxime, and may range in severity from MILD DIARRHEA to fatal colitis.",MILD DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA,TWrex-cause
725343194,5/24/2015 13:36:03,1642626450,5/24/2015 13:35:29,False,neodev,0.7669,19004420,GBR,P8,Devizes,86.167.180.107,no_relation,250,74,,262,104,causes,0.6741998624632421,814740-FS1-4,"230    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cefotaxime, and may range in severity from MILD DIARRHEA to fatal colitis.",MILD DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA,TWrex-cause
725343194,5/24/2015 13:36:27,1642626512,5/24/2015 13:34:57,False,fusioncash,0.6601,5656294,USA,TN,Cookeville,75.136.162.83,ANTIBIOTIC ASSOCIATED DIARRHEA causes MILD DIARRHEA,250,74,,262,104,causes,0.6741998624632421,814740-FS1-4,"230    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cefotaxime, and may range in severity from MILD DIARRHEA to fatal colitis.",MILD DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA,TWrex-cause
725343194,5/24/2015 13:52:36,1642629330,5/24/2015 13:51:40,False,neodev,0.7917,18881135,CAN,ON,Ajax,99.243.87.224,ANTIBIOTIC ASSOCIATED DIARRHEA causes MILD DIARRHEA,250,74,,262,104,causes,0.6741998624632421,814740-FS1-4,"230    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cefotaxime, and may range in severity from MILD DIARRHEA to fatal colitis.",MILD DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA,TWrex-cause
725343194,5/24/2015 14:03:55,1642631308,5/24/2015 14:02:00,False,fusioncash,0.7506,7012325,USA,NY,Pelham,74.88.63.28,ANTIBIOTIC ASSOCIATED DIARRHEA causes MILD DIARRHEA,250,74,,262,104,causes,0.6741998624632421,814740-FS1-4,"230    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cefotaxime, and may range in severity from MILD DIARRHEA to fatal colitis.",MILD DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA,TWrex-cause
725373416,5/24/2015 19:41:51,1642748233,5/24/2015 19:41:31,False,instagc,0.7905,18531561,CAN,ON,Mississauga,99.229.92.227,no_relation,156,190,,169,208,causes,0.9365858115816941,814751-FS1-4,"d   One patient died after developing encephalopathy 36 hours after receiving intraventricular liposomal cytarabine;  d ,   i   the other patient developed FOCAL SEIZURES that progressed to STATUS EPILEPTICUS and died approximately 8 weeks after the last intraventricular dose of liposomal cytarabine.",FOCAL SEIZURES,STATUS EPILEPTICUS,TWrex-cause
725373416,5/24/2015 19:43:21,1642748764,5/24/2015 19:42:58,False,clixsense,0.8671,31482589,NLD,,,31.201.11.16,no_relation,156,190,,169,208,causes,0.9365858115816941,814751-FS1-4,"d   One patient died after developing encephalopathy 36 hours after receiving intraventricular liposomal cytarabine;  d ,   i   the other patient developed FOCAL SEIZURES that progressed to STATUS EPILEPTICUS and died approximately 8 weeks after the last intraventricular dose of liposomal cytarabine.",FOCAL SEIZURES,STATUS EPILEPTICUS,TWrex-cause
725373416,5/24/2015 19:53:04,1642751737,5/24/2015 19:52:25,False,clixsense,0.8194,28351359,GBR,H9,London,80.43.180.102,FOCAL SEIZURES causes STATUS EPILEPTICUS,156,190,,169,208,causes,0.9365858115816941,814751-FS1-4,"d   One patient died after developing encephalopathy 36 hours after receiving intraventricular liposomal cytarabine;  d ,   i   the other patient developed FOCAL SEIZURES that progressed to STATUS EPILEPTICUS and died approximately 8 weeks after the last intraventricular dose of liposomal cytarabine.",FOCAL SEIZURES,STATUS EPILEPTICUS,TWrex-cause
725373416,5/24/2015 19:56:33,1642752968,5/24/2015 19:56:24,False,neodev,0.3833,32562748,CAN,BC,Vancouver,108.180.140.140,STATUS EPILEPTICUS causes FOCAL SEIZURES,156,190,,169,208,causes,0.9365858115816941,814751-FS1-4,"d   One patient died after developing encephalopathy 36 hours after receiving intraventricular liposomal cytarabine;  d ,   i   the other patient developed FOCAL SEIZURES that progressed to STATUS EPILEPTICUS and died approximately 8 weeks after the last intraventricular dose of liposomal cytarabine.",FOCAL SEIZURES,STATUS EPILEPTICUS,TWrex-cause
725373416,5/24/2015 20:02:23,1642754490,5/24/2015 20:02:07,False,clixsense,0.7093,23585686,GBR,H9,London,86.148.196.204,FOCAL SEIZURES causes STATUS EPILEPTICUS,156,190,,169,208,causes,0.9365858115816941,814751-FS1-4,"d   One patient died after developing encephalopathy 36 hours after receiving intraventricular liposomal cytarabine;  d ,   i   the other patient developed FOCAL SEIZURES that progressed to STATUS EPILEPTICUS and died approximately 8 weeks after the last intraventricular dose of liposomal cytarabine.",FOCAL SEIZURES,STATUS EPILEPTICUS,TWrex-cause
725373416,5/24/2015 20:03:08,1642754706,5/24/2015 20:02:01,False,clixsense,0.8145,32549163,CAN,MB,Winnipeg,206.45.167.246,no_relation,156,190,,169,208,causes,0.9365858115816941,814751-FS1-4,"d   One patient died after developing encephalopathy 36 hours after receiving intraventricular liposomal cytarabine;  d ,   i   the other patient developed FOCAL SEIZURES that progressed to STATUS EPILEPTICUS and died approximately 8 weeks after the last intraventricular dose of liposomal cytarabine.",FOCAL SEIZURES,STATUS EPILEPTICUS,TWrex-cause
725373416,5/24/2015 20:24:49,1642760192,5/24/2015 20:24:08,False,instagc,0.8838,19602039,USA,WA,Bellevue,50.135.214.140,no_relation,156,190,,169,208,causes,0.9365858115816941,814751-FS1-4,"d   One patient died after developing encephalopathy 36 hours after receiving intraventricular liposomal cytarabine;  d ,   i   the other patient developed FOCAL SEIZURES that progressed to STATUS EPILEPTICUS and died approximately 8 weeks after the last intraventricular dose of liposomal cytarabine.",FOCAL SEIZURES,STATUS EPILEPTICUS,TWrex-cause
725373434,5/24/2015 19:41:30,1642748118,5/24/2015 19:41:05,False,instagc,0.7905,18531561,CAN,ON,Mississauga,99.229.92.227,no_relation,187,236,,205,265,causes,0.31980107453341605,805301-FS1-4,"b  May maintain normal sinus rhythm for long periods in recent onset of atrial fibrillation or flutter without CHF, atrial enlargement, or left ventricular hypertrophy, but long standing ATRIAL FIBRILLATION is likely to recur even with QUINIDINE MAINTENANCE THERAPY.",ATRIAL FIBRILLATION,QUINIDINE MAINTENANCE THERAPY,TWrex-cause
725373434,5/24/2015 19:42:58,1642748609,5/24/2015 19:42:34,False,clixsense,0.8671,31482589,NLD,,,31.201.11.16,no_relation,187,236,,205,265,causes,0.31980107453341605,805301-FS1-4,"b  May maintain normal sinus rhythm for long periods in recent onset of atrial fibrillation or flutter without CHF, atrial enlargement, or left ventricular hypertrophy, but long standing ATRIAL FIBRILLATION is likely to recur even with QUINIDINE MAINTENANCE THERAPY.",ATRIAL FIBRILLATION,QUINIDINE MAINTENANCE THERAPY,TWrex-cause
725373434,5/24/2015 19:44:53,1642749303,5/24/2015 19:44:36,False,neodev,0.627,21662458,NLD,11,Spijkenisse,92.108.205.125,ATRIAL FIBRILLATION causes QUINIDINE MAINTENANCE THERAPY,187,236,,205,265,causes,0.31980107453341605,805301-FS1-4,"b  May maintain normal sinus rhythm for long periods in recent onset of atrial fibrillation or flutter without CHF, atrial enlargement, or left ventricular hypertrophy, but long standing ATRIAL FIBRILLATION is likely to recur even with QUINIDINE MAINTENANCE THERAPY.",ATRIAL FIBRILLATION,QUINIDINE MAINTENANCE THERAPY,TWrex-cause
725373434,5/24/2015 19:52:24,1642751565,5/24/2015 19:51:50,False,clixsense,0.8194,28351359,GBR,H9,London,80.43.180.102,no_relation,187,236,,205,265,causes,0.31980107453341605,805301-FS1-4,"b  May maintain normal sinus rhythm for long periods in recent onset of atrial fibrillation or flutter without CHF, atrial enlargement, or left ventricular hypertrophy, but long standing ATRIAL FIBRILLATION is likely to recur even with QUINIDINE MAINTENANCE THERAPY.",ATRIAL FIBRILLATION,QUINIDINE MAINTENANCE THERAPY,TWrex-cause
725373434,5/24/2015 19:56:23,1642752904,5/24/2015 19:56:12,False,neodev,0.3833,32562748,CAN,BC,Vancouver,108.180.140.140,ATRIAL FIBRILLATION causes QUINIDINE MAINTENANCE THERAPY,187,236,,205,265,causes,0.31980107453341605,805301-FS1-4,"b  May maintain normal sinus rhythm for long periods in recent onset of atrial fibrillation or flutter without CHF, atrial enlargement, or left ventricular hypertrophy, but long standing ATRIAL FIBRILLATION is likely to recur even with QUINIDINE MAINTENANCE THERAPY.",ATRIAL FIBRILLATION,QUINIDINE MAINTENANCE THERAPY,TWrex-cause
725373434,5/24/2015 20:01:59,1642754379,5/24/2015 20:01:27,False,clixsense,0.8145,32549163,CAN,MB,Winnipeg,206.45.167.246,no_relation,187,236,,205,265,causes,0.31980107453341605,805301-FS1-4,"b  May maintain normal sinus rhythm for long periods in recent onset of atrial fibrillation or flutter without CHF, atrial enlargement, or left ventricular hypertrophy, but long standing ATRIAL FIBRILLATION is likely to recur even with QUINIDINE MAINTENANCE THERAPY.",ATRIAL FIBRILLATION,QUINIDINE MAINTENANCE THERAPY,TWrex-cause
725373434,5/24/2015 20:02:06,1642754403,5/24/2015 20:00:55,False,clixsense,0.7093,23585686,GBR,H9,London,86.148.196.204,no_relation,187,236,,205,265,causes,0.31980107453341605,805301-FS1-4,"b  May maintain normal sinus rhythm for long periods in recent onset of atrial fibrillation or flutter without CHF, atrial enlargement, or left ventricular hypertrophy, but long standing ATRIAL FIBRILLATION is likely to recur even with QUINIDINE MAINTENANCE THERAPY.",ATRIAL FIBRILLATION,QUINIDINE MAINTENANCE THERAPY,TWrex-cause
725373439,5/24/2015 19:07:16,1642726869,5/24/2015 19:07:05,False,bitcoinget,0.7458,21614812,USA,NJ,Burlington,50.153.125.0,MYCOBACTERIUM TUBERCULOSIS causes DRUG RESISTANT TB,60,89,,76,115,causes,0.959264193758544,811227-FS1-4,"100 ,   101 ,   102  Second line agent used in treatment of DRUG RESISTANT TB caused by  MYCOBACTERIUM TUBERCULOSIS  known or presumed to be susceptible to capreomycin.",DRUG RESISTANT TB,MYCOBACTERIUM TUBERCULOSIS,TWrex-cause
725373439,5/24/2015 19:08:53,1642727582,5/24/2015 19:08:41,False,neodev,0.8611,31448050,GBR,,,92.24.65.218,MYCOBACTERIUM TUBERCULOSIS causes DRUG RESISTANT TB,60,89,,76,115,causes,0.959264193758544,811227-FS1-4,"100 ,   101 ,   102  Second line agent used in treatment of DRUG RESISTANT TB caused by  MYCOBACTERIUM TUBERCULOSIS  known or presumed to be susceptible to capreomycin.",DRUG RESISTANT TB,MYCOBACTERIUM TUBERCULOSIS,TWrex-cause
725373439,5/24/2015 19:09:12,1642727767,5/24/2015 19:02:43,False,neodev,0.7123,18881135,CAN,ON,Ajax,99.243.87.224,MYCOBACTERIUM TUBERCULOSIS causes DRUG RESISTANT TB,60,89,,76,115,causes,0.959264193758544,811227-FS1-4,"100 ,   101 ,   102  Second line agent used in treatment of DRUG RESISTANT TB caused by  MYCOBACTERIUM TUBERCULOSIS  known or presumed to be susceptible to capreomycin.",DRUG RESISTANT TB,MYCOBACTERIUM TUBERCULOSIS,TWrex-cause
725373439,5/24/2015 19:09:50,1642728007,5/24/2015 19:09:16,False,prodege,0.6764,21417560,GBR,C3,Cambridge,151.225.116.143,MYCOBACTERIUM TUBERCULOSIS causes DRUG RESISTANT TB,60,89,,76,115,causes,0.959264193758544,811227-FS1-4,"100 ,   101 ,   102  Second line agent used in treatment of DRUG RESISTANT TB caused by  MYCOBACTERIUM TUBERCULOSIS  known or presumed to be susceptible to capreomycin.",DRUG RESISTANT TB,MYCOBACTERIUM TUBERCULOSIS,TWrex-cause
725373439,5/24/2015 19:10:40,1642728404,5/24/2015 19:10:07,False,sharecashgpt,0.5431,28627999,CAN,ON,Sudbury,66.103.55.12,no_relation,60,89,,76,115,causes,0.959264193758544,811227-FS1-4,"100 ,   101 ,   102  Second line agent used in treatment of DRUG RESISTANT TB caused by  MYCOBACTERIUM TUBERCULOSIS  known or presumed to be susceptible to capreomycin.",DRUG RESISTANT TB,MYCOBACTERIUM TUBERCULOSIS,TWrex-cause
725373439,5/24/2015 19:12:53,1642729340,5/24/2015 19:12:33,False,neodev,0.6167,30627835,GBR,H9,London,5.81.27.94,MYCOBACTERIUM TUBERCULOSIS causes DRUG RESISTANT TB,60,89,,76,115,causes,0.959264193758544,811227-FS1-4,"100 ,   101 ,   102  Second line agent used in treatment of DRUG RESISTANT TB caused by  MYCOBACTERIUM TUBERCULOSIS  known or presumed to be susceptible to capreomycin.",DRUG RESISTANT TB,MYCOBACTERIUM TUBERCULOSIS,TWrex-cause
725373439,5/24/2015 19:18:32,1642732934,5/24/2015 19:17:25,False,points4rewards,0.8333,20113482,USA,OR,Portland,67.213.218.72,MYCOBACTERIUM TUBERCULOSIS causes DRUG RESISTANT TB,60,89,,76,115,causes,0.959264193758544,811227-FS1-4,"100 ,   101 ,   102  Second line agent used in treatment of DRUG RESISTANT TB caused by  MYCOBACTERIUM TUBERCULOSIS  known or presumed to be susceptible to capreomycin.",DRUG RESISTANT TB,MYCOBACTERIUM TUBERCULOSIS,TWrex-cause
725373440,5/24/2015 19:54:01,1642752146,5/24/2015 19:53:30,False,clixsense,0.8194,28351359,GBR,H9,London,80.43.180.102,no_relation,34,93,,36,100,causes,0.848874687627165,803209-FS1-4,"43   In the case of decompensated DIC in which bleeding is the major clinical manifestation, HEPARIN may significantly exacerbate the bleeding and is therefore generally not indicated.",DIC,HEPARIN,TWrex-cause
725373440,5/24/2015 20:03:17,1642754745,5/24/2015 20:02:50,False,clixsense,0.7093,23585686,GBR,H9,London,86.148.196.204,no_relation,34,93,,36,100,causes,0.848874687627165,803209-FS1-4,"43   In the case of decompensated DIC in which bleeding is the major clinical manifestation, HEPARIN may significantly exacerbate the bleeding and is therefore generally not indicated.",DIC,HEPARIN,TWrex-cause
725373440,5/24/2015 20:04:01,1642754921,5/24/2015 20:03:37,False,clixsense,0.8145,32549163,CAN,MB,Winnipeg,206.45.167.246,no_relation,34,93,,36,100,causes,0.848874687627165,803209-FS1-4,"43   In the case of decompensated DIC in which bleeding is the major clinical manifestation, HEPARIN may significantly exacerbate the bleeding and is therefore generally not indicated.",DIC,HEPARIN,TWrex-cause
725373440,5/24/2015 20:26:19,1642760466,5/24/2015 20:25:27,False,instagc,0.8838,19602039,USA,WA,Bellevue,50.135.214.140,no_relation,34,93,,36,100,causes,0.848874687627165,803209-FS1-4,"43   In the case of decompensated DIC in which bleeding is the major clinical manifestation, HEPARIN may significantly exacerbate the bleeding and is therefore generally not indicated.",DIC,HEPARIN,TWrex-cause
725373440,5/24/2015 20:29:35,1642761589,5/24/2015 20:29:23,False,cointasker,0.7245,21783324,NLD,,,31.151.239.133,no_relation,34,93,,36,100,causes,0.848874687627165,803209-FS1-4,"43   In the case of decompensated DIC in which bleeding is the major clinical manifestation, HEPARIN may significantly exacerbate the bleeding and is therefore generally not indicated.",DIC,HEPARIN,TWrex-cause
725373440,5/24/2015 20:29:42,1642761639,5/24/2015 20:29:32,False,neodev,0.2143,31789301,USA,,,178.62.105.32,DIC causes HEPARIN,34,93,,36,100,causes,0.848874687627165,803209-FS1-4,"43   In the case of decompensated DIC in which bleeding is the major clinical manifestation, HEPARIN may significantly exacerbate the bleeding and is therefore generally not indicated.",DIC,HEPARIN,TWrex-cause
725373440,5/24/2015 20:29:48,1642761648,5/24/2015 20:29:30,False,clixsense,0.727,30313955,GBR,K5,Poole,2.30.145.202,HEPARIN causes DIC,34,93,,36,100,causes,0.848874687627165,803209-FS1-4,"43   In the case of decompensated DIC in which bleeding is the major clinical manifestation, HEPARIN may significantly exacerbate the bleeding and is therefore generally not indicated.",DIC,HEPARIN,TWrex-cause
725480733,5/25/2015 10:23:20,1642960263,5/25/2015 10:22:23,False,clixsense,0.877,10798016,GBR,C7,Coventry,86.24.245.191,no_relation,105,139,,136,174,causes,0.45749571099781394,814190-FS1-4,"In  type II (intermediate) spinal muscular atrophy,  symptoms usually manifest between age 3 and 15 mo;  TYPE III SPINAL MUSCULAR ATROPHY (WOHLFART KUGELBERG WELANDER DISEASE)  usually manifests between age 15 mo and 19 yr. Findings are similar to those of type I, but progression is slower and life expectancy is longer; some patients have a normal life span.",TYPE III SPINAL MUSCULAR ATROPHY,WOHLFART KUGELBERG WELANDER DISEASE,TWrex-cause
725480733,5/25/2015 10:28:13,1642962085,5/25/2015 10:27:10,False,vivatic,0.9333,13889585,GBR,A1,Dagenham,2.28.66.9,no_relation,105,139,,136,174,causes,0.45749571099781394,814190-FS1-4,"In  type II (intermediate) spinal muscular atrophy,  symptoms usually manifest between age 3 and 15 mo;  TYPE III SPINAL MUSCULAR ATROPHY (WOHLFART KUGELBERG WELANDER DISEASE)  usually manifests between age 15 mo and 19 yr. Findings are similar to those of type I, but progression is slower and life expectancy is longer; some patients have a normal life span.",TYPE III SPINAL MUSCULAR ATROPHY,WOHLFART KUGELBERG WELANDER DISEASE,TWrex-cause
725480733,5/25/2015 10:31:54,1642964121,5/25/2015 10:30:49,False,instagc,0.8306,18531561,CAN,ON,Mississauga,99.229.92.227,no_relation,105,139,,136,174,causes,0.45749571099781394,814190-FS1-4,"In  type II (intermediate) spinal muscular atrophy,  symptoms usually manifest between age 3 and 15 mo;  TYPE III SPINAL MUSCULAR ATROPHY (WOHLFART KUGELBERG WELANDER DISEASE)  usually manifests between age 15 mo and 19 yr. Findings are similar to those of type I, but progression is slower and life expectancy is longer; some patients have a normal life span.",TYPE III SPINAL MUSCULAR ATROPHY,WOHLFART KUGELBERG WELANDER DISEASE,TWrex-cause
725480733,5/25/2015 10:34:44,1642966104,5/25/2015 10:33:50,False,points4rewards,0.8083,20113482,USA,OR,Portland,67.213.218.72,no_relation,105,139,,136,174,causes,0.45749571099781394,814190-FS1-4,"In  type II (intermediate) spinal muscular atrophy,  symptoms usually manifest between age 3 and 15 mo;  TYPE III SPINAL MUSCULAR ATROPHY (WOHLFART KUGELBERG WELANDER DISEASE)  usually manifests between age 15 mo and 19 yr. Findings are similar to those of type I, but progression is slower and life expectancy is longer; some patients have a normal life span.",TYPE III SPINAL MUSCULAR ATROPHY,WOHLFART KUGELBERG WELANDER DISEASE,TWrex-cause
725480733,5/25/2015 10:41:33,1642972336,5/25/2015 10:41:17,False,clixsense,0.7062,22751911,NLD,04,Groningen,195.241.153.97,no_relation,105,139,,136,174,causes,0.45749571099781394,814190-FS1-4,"In  type II (intermediate) spinal muscular atrophy,  symptoms usually manifest between age 3 and 15 mo;  TYPE III SPINAL MUSCULAR ATROPHY (WOHLFART KUGELBERG WELANDER DISEASE)  usually manifests between age 15 mo and 19 yr. Findings are similar to those of type I, but progression is slower and life expectancy is longer; some patients have a normal life span.",TYPE III SPINAL MUSCULAR ATROPHY,WOHLFART KUGELBERG WELANDER DISEASE,TWrex-cause
725480733,5/25/2015 10:47:52,1642975100,5/25/2015 10:47:22,False,clixsense,0.7545,30313955,GBR,K5,Poole,2.30.145.202,WOHLFART KUGELBERG WELANDER DISEASE causes TYPE III SPINAL MUSCULAR ATROPHY,105,139,,136,174,causes,0.45749571099781394,814190-FS1-4,"In  type II (intermediate) spinal muscular atrophy,  symptoms usually manifest between age 3 and 15 mo;  TYPE III SPINAL MUSCULAR ATROPHY (WOHLFART KUGELBERG WELANDER DISEASE)  usually manifests between age 15 mo and 19 yr. Findings are similar to those of type I, but progression is slower and life expectancy is longer; some patients have a normal life span.",TYPE III SPINAL MUSCULAR ATROPHY,WOHLFART KUGELBERG WELANDER DISEASE,TWrex-cause
725480733,5/25/2015 11:06:28,1642978174,5/25/2015 11:05:19,False,prodege,0.7056,29849805,GBR,Z1,Swansea,82.1.37.235,no_relation,105,139,,136,174,causes,0.45749571099781394,814190-FS1-4,"In  type II (intermediate) spinal muscular atrophy,  symptoms usually manifest between age 3 and 15 mo;  TYPE III SPINAL MUSCULAR ATROPHY (WOHLFART KUGELBERG WELANDER DISEASE)  usually manifests between age 15 mo and 19 yr. Findings are similar to those of type I, but progression is slower and life expectancy is longer; some patients have a normal life span.",TYPE III SPINAL MUSCULAR ATROPHY,WOHLFART KUGELBERG WELANDER DISEASE,TWrex-cause
725480735,5/25/2015 09:13:59,1642948422,5/25/2015 09:13:27,False,pocketmoneygpt,0.7857,21432964,GBR,K5,Poole,109.155.122.13,PREGNANCY causes THALIDOMIDE,147,180,,155,191,causes,0.768221279597376,803143-FS1-4,Warnings/Precautions  Warnings  Fetal/Neonatal Morbidity and Mortality  Extremely high risk of severe birth defects (possibly life threatening) if PREGNANCY occurs while receiving THALIDOMIDE in any amount.,PREGNANCY,THALIDOMIDE,TWrex-cause
725480735,5/25/2015 09:26:54,1642950404,5/25/2015 09:26:42,False,instagc,0.8333,13581319,USA,IL,Mount Vernon,66.232.166.86,no_relation,147,180,,155,191,causes,0.768221279597376,803143-FS1-4,Warnings/Precautions  Warnings  Fetal/Neonatal Morbidity and Mortality  Extremely high risk of severe birth defects (possibly life threatening) if PREGNANCY occurs while receiving THALIDOMIDE in any amount.,PREGNANCY,THALIDOMIDE,TWrex-cause
725480735,5/25/2015 09:32:27,1642951315,5/25/2015 09:32:07,False,elite,0.7153,31856422,GBR,C9,Carlisle,92.19.36.179,no_relation,147,180,,155,191,causes,0.768221279597376,803143-FS1-4,Warnings/Precautions  Warnings  Fetal/Neonatal Morbidity and Mortality  Extremely high risk of severe birth defects (possibly life threatening) if PREGNANCY occurs while receiving THALIDOMIDE in any amount.,PREGNANCY,THALIDOMIDE,TWrex-cause
725480735,5/25/2015 09:36:53,1642952203,5/25/2015 09:36:18,False,clixsense,0.7556,31345986,GBR,,,86.165.143.234,no_relation,147,180,,155,191,causes,0.768221279597376,803143-FS1-4,Warnings/Precautions  Warnings  Fetal/Neonatal Morbidity and Mortality  Extremely high risk of severe birth defects (possibly life threatening) if PREGNANCY occurs while receiving THALIDOMIDE in any amount.,PREGNANCY,THALIDOMIDE,TWrex-cause
725480735,5/25/2015 09:45:48,1642953491,5/25/2015 09:45:35,False,cointasker,0.6236,21783324,NLD,,,31.151.239.133,no_relation,147,180,,155,191,causes,0.768221279597376,803143-FS1-4,Warnings/Precautions  Warnings  Fetal/Neonatal Morbidity and Mortality  Extremely high risk of severe birth defects (possibly life threatening) if PREGNANCY occurs while receiving THALIDOMIDE in any amount.,PREGNANCY,THALIDOMIDE,TWrex-cause
725480735,5/25/2015 10:10:34,1642957410,5/25/2015 10:10:09,False,neodev,0.7143,11014534,GBR,B8,Bromley,86.18.149.6,no_relation,147,180,,155,191,causes,0.768221279597376,803143-FS1-4,Warnings/Precautions  Warnings  Fetal/Neonatal Morbidity and Mortality  Extremely high risk of severe birth defects (possibly life threatening) if PREGNANCY occurs while receiving THALIDOMIDE in any amount.,PREGNANCY,THALIDOMIDE,TWrex-cause
725480735,5/25/2015 10:16:00,1642958439,5/25/2015 10:15:36,False,points4rewards,0.6786,28755767,USA,VA,Chester,68.57.118.32,no_relation,147,180,,155,191,causes,0.768221279597376,803143-FS1-4,Warnings/Precautions  Warnings  Fetal/Neonatal Morbidity and Mortality  Extremely high risk of severe birth defects (possibly life threatening) if PREGNANCY occurs while receiving THALIDOMIDE in any amount.,PREGNANCY,THALIDOMIDE,TWrex-cause
725480741,5/25/2015 09:27:21,1642950506,5/25/2015 09:27:07,False,instagc,0.8333,13581319,USA,IL,Mount Vernon,66.232.166.86,CLOSTRIDIUM BOTULINUM  TOXIN causes BOTULISM,0,52,,7,80,causes,0.9958932064677041,810958-FS1-4,BOTULISM  BOTULISM is neuromuscular poisoning from  CLOSTRIDIUM BOTULINUM  TOXIN,BOTULISM,CLOSTRIDIUM BOTULINUM  TOXIN,TWrex-cause
725480741,5/25/2015 09:32:56,1642951498,5/25/2015 09:32:46,False,elite,0.7153,31856422,GBR,C9,Carlisle,92.19.36.179,CLOSTRIDIUM BOTULINUM  TOXIN causes BOTULISM,0,52,,7,80,causes,0.9958932064677041,810958-FS1-4,BOTULISM  BOTULISM is neuromuscular poisoning from  CLOSTRIDIUM BOTULINUM  TOXIN,BOTULISM,CLOSTRIDIUM BOTULINUM  TOXIN,TWrex-cause
725480741,5/25/2015 09:39:54,1642952713,5/25/2015 09:39:07,False,clixsense,0.7556,31345986,GBR,,,86.165.143.234,CLOSTRIDIUM BOTULINUM  TOXIN causes BOTULISM,0,52,,7,80,causes,0.9958932064677041,810958-FS1-4,BOTULISM  BOTULISM is neuromuscular poisoning from  CLOSTRIDIUM BOTULINUM  TOXIN,BOTULISM,CLOSTRIDIUM BOTULINUM  TOXIN,TWrex-cause
725480741,5/25/2015 09:46:26,1642953547,5/25/2015 09:46:08,False,cointasker,0.6236,21783324,NLD,,,31.151.239.133,CLOSTRIDIUM BOTULINUM  TOXIN causes BOTULISM,0,52,,7,80,causes,0.9958932064677041,810958-FS1-4,BOTULISM  BOTULISM is neuromuscular poisoning from  CLOSTRIDIUM BOTULINUM  TOXIN,BOTULISM,CLOSTRIDIUM BOTULINUM  TOXIN,TWrex-cause
725480741,5/25/2015 10:12:02,1642957671,5/25/2015 10:11:27,False,neodev,0.7143,11014534,GBR,B8,Bromley,86.18.149.6,CLOSTRIDIUM BOTULINUM  TOXIN causes BOTULISM,0,52,,7,80,causes,0.9958932064677041,810958-FS1-4,BOTULISM  BOTULISM is neuromuscular poisoning from  CLOSTRIDIUM BOTULINUM  TOXIN,BOTULISM,CLOSTRIDIUM BOTULINUM  TOXIN,TWrex-cause
725480741,5/25/2015 10:17:18,1642958637,5/25/2015 10:16:50,False,points4rewards,0.6786,28755767,USA,VA,Chester,68.57.118.32,CLOSTRIDIUM BOTULINUM  TOXIN causes BOTULISM,0,52,,7,80,causes,0.9958932064677041,810958-FS1-4,BOTULISM  BOTULISM is neuromuscular poisoning from  CLOSTRIDIUM BOTULINUM  TOXIN,BOTULISM,CLOSTRIDIUM BOTULINUM  TOXIN,TWrex-cause
725480741,5/25/2015 10:18:27,1642958862,5/25/2015 10:17:01,False,clixsense,0.877,10798016,GBR,C7,Coventry,86.24.245.191,CLOSTRIDIUM BOTULINUM  TOXIN causes BOTULISM,0,52,,7,80,causes,0.9958932064677041,810958-FS1-4,BOTULISM  BOTULISM is neuromuscular poisoning from  CLOSTRIDIUM BOTULINUM  TOXIN,BOTULISM,CLOSTRIDIUM BOTULINUM  TOXIN,TWrex-cause
725480742,5/25/2015 08:23:46,1642940383,5/25/2015 08:23:26,False,gifthunterclub,1.0,30901412,GBR,G5,Margate,85.210.116.56,OXYBUTYNIN causes GLAUCOMA,135,0,,142,10,causes,0.9918365981341758,811093-FS1-4,"OXYBUTYNIN is short acting and often produces significant anticholinergic side effects of constipation, dry mouth, and exacerbation of GLAUCOMA",GLAUCOMA,OXYBUTYNIN,TWrex-cause
725480742,5/25/2015 08:32:45,1642941714,5/25/2015 08:32:15,False,instagc,0.8333,30326470,USA,CA,Santee,99.44.37.73,no_relation,135,0,,142,10,causes,0.9918365981341758,811093-FS1-4,"OXYBUTYNIN is short acting and often produces significant anticholinergic side effects of constipation, dry mouth, and exacerbation of GLAUCOMA",GLAUCOMA,OXYBUTYNIN,TWrex-cause
725480742,5/25/2015 08:40:45,1642943288,5/25/2015 08:39:13,False,bitcoinget,0.6667,30546513,GBR,G6,Hull,194.42.67.50,OXYBUTYNIN causes GLAUCOMA,135,0,,142,10,causes,0.9918365981341758,811093-FS1-4,"OXYBUTYNIN is short acting and often produces significant anticholinergic side effects of constipation, dry mouth, and exacerbation of GLAUCOMA",GLAUCOMA,OXYBUTYNIN,TWrex-cause
725480742,5/25/2015 08:45:31,1642944051,5/25/2015 08:44:38,False,prodege,0.8125,21417560,GBR,C3,Cambridge,151.225.116.143,OXYBUTYNIN causes GLAUCOMA,135,0,,142,10,causes,0.9918365981341758,811093-FS1-4,"OXYBUTYNIN is short acting and often produces significant anticholinergic side effects of constipation, dry mouth, and exacerbation of GLAUCOMA",GLAUCOMA,OXYBUTYNIN,TWrex-cause
725480742,5/25/2015 09:03:06,1642946796,5/25/2015 09:02:22,False,clixsense,0.7595,19587102,NLD,11,Den Haag,84.87.89.153,no_relation,135,0,,142,10,causes,0.9918365981341758,811093-FS1-4,"OXYBUTYNIN is short acting and often produces significant anticholinergic side effects of constipation, dry mouth, and exacerbation of GLAUCOMA",GLAUCOMA,OXYBUTYNIN,TWrex-cause
725480742,5/25/2015 09:05:18,1642947118,5/25/2015 09:04:57,False,prodege,0.7837,27934334,GBR,D2,Derby,86.162.35.12,no_relation,135,0,,142,10,causes,0.9918365981341758,811093-FS1-4,"OXYBUTYNIN is short acting and often produces significant anticholinergic side effects of constipation, dry mouth, and exacerbation of GLAUCOMA",GLAUCOMA,OXYBUTYNIN,TWrex-cause
725480742,5/25/2015 09:11:45,1642948101,5/25/2015 09:11:08,False,pocketmoneygpt,0.7857,21432964,GBR,K5,Poole,109.155.122.13,OXYBUTYNIN causes GLAUCOMA,135,0,,142,10,causes,0.9918365981341758,811093-FS1-4,"OXYBUTYNIN is short acting and often produces significant anticholinergic side effects of constipation, dry mouth, and exacerbation of GLAUCOMA",GLAUCOMA,OXYBUTYNIN,TWrex-cause
725480743,5/25/2015 10:18:07,1642958781,5/25/2015 10:17:45,False,clixsense,0.8095,31482589,NLD,,,31.201.11.16,PRIMARY VZV INFECTION causes HERPES ZOSTER,6,100,,26,113,causes,0.9733285267845749,810161-FS1-4,49 •  PRIMARY VZV INFECTION results in varicella (chickenpox); reactivation of infection results in HERPES ZOSTER,PRIMARY VZV INFECTION,HERPES ZOSTER,TWrex-cause
725480743,5/25/2015 10:18:46,1642958911,5/25/2015 10:17:53,False,points4rewards,0.6786,28755767,USA,VA,Chester,68.57.118.32,PRIMARY VZV INFECTION causes HERPES ZOSTER,6,100,,26,113,causes,0.9733285267845749,810161-FS1-4,49 •  PRIMARY VZV INFECTION results in varicella (chickenpox); reactivation of infection results in HERPES ZOSTER,PRIMARY VZV INFECTION,HERPES ZOSTER,TWrex-cause
725480743,5/25/2015 10:19:13,1642959028,5/25/2015 10:18:27,False,clixsense,0.877,10798016,GBR,C7,Coventry,86.24.245.191,no_relation,6,100,,26,113,causes,0.9733285267845749,810161-FS1-4,49 •  PRIMARY VZV INFECTION results in varicella (chickenpox); reactivation of infection results in HERPES ZOSTER,PRIMARY VZV INFECTION,HERPES ZOSTER,TWrex-cause
725480743,5/25/2015 10:24:28,1642960694,5/25/2015 10:24:08,False,points4rewards,0.8083,20113482,USA,OR,Portland,67.213.218.72,no_relation,6,100,,26,113,causes,0.9733285267845749,810161-FS1-4,49 •  PRIMARY VZV INFECTION results in varicella (chickenpox); reactivation of infection results in HERPES ZOSTER,PRIMARY VZV INFECTION,HERPES ZOSTER,TWrex-cause
725480743,5/25/2015 10:24:50,1642960818,5/25/2015 10:23:50,False,vivatic,0.9333,13889585,GBR,A1,Dagenham,2.28.66.9,PRIMARY VZV INFECTION causes HERPES ZOSTER,6,100,,26,113,causes,0.9733285267845749,810161-FS1-4,49 •  PRIMARY VZV INFECTION results in varicella (chickenpox); reactivation of infection results in HERPES ZOSTER,PRIMARY VZV INFECTION,HERPES ZOSTER,TWrex-cause
725480743,5/25/2015 10:29:07,1642962522,5/25/2015 10:28:38,False,instagc,0.8306,18531561,CAN,ON,Mississauga,99.229.92.227,no_relation,6,100,,26,113,causes,0.9733285267845749,810161-FS1-4,49 •  PRIMARY VZV INFECTION results in varicella (chickenpox); reactivation of infection results in HERPES ZOSTER,PRIMARY VZV INFECTION,HERPES ZOSTER,TWrex-cause
725480743,5/25/2015 10:40:25,1642971405,5/25/2015 10:40:09,False,clixsense,0.7062,22751911,NLD,04,Groningen,195.241.153.97,PRIMARY VZV INFECTION causes HERPES ZOSTER,6,100,,26,113,causes,0.9733285267845749,810161-FS1-4,49 •  PRIMARY VZV INFECTION results in varicella (chickenpox); reactivation of infection results in HERPES ZOSTER,PRIMARY VZV INFECTION,HERPES ZOSTER,TWrex-cause
725480747,5/25/2015 08:23:05,1642940271,5/25/2015 08:22:38,False,gifthunterclub,1.0,30901412,GBR,G5,Margate,85.210.116.56,SEIZURES causes STATUS EPILEPTICUS,57,164,,64,182,causes,0.937042571331636,814003-FS1-4,"HOSPITALIZATION  Introduction  Hospitalize patients when SEIZURES may be due to acute brain pathology, if consciousness does not return to normal, or for impending STATUS EPILEPTICUS",SEIZURES,STATUS EPILEPTICUS,TWrex-cause
725480747,5/25/2015 08:31:07,1642941429,5/25/2015 08:30:13,False,instagc,0.8333,30326470,USA,CA,Santee,99.44.37.73,no_relation,57,164,,64,182,causes,0.937042571331636,814003-FS1-4,"HOSPITALIZATION  Introduction  Hospitalize patients when SEIZURES may be due to acute brain pathology, if consciousness does not return to normal, or for impending STATUS EPILEPTICUS",SEIZURES,STATUS EPILEPTICUS,TWrex-cause
725480747,5/25/2015 08:38:26,1642942877,5/25/2015 08:37:39,False,bitcoinget,0.6667,30546513,GBR,G6,Hull,194.42.67.50,no_relation,57,164,,64,182,causes,0.937042571331636,814003-FS1-4,"HOSPITALIZATION  Introduction  Hospitalize patients when SEIZURES may be due to acute brain pathology, if consciousness does not return to normal, or for impending STATUS EPILEPTICUS",SEIZURES,STATUS EPILEPTICUS,TWrex-cause
725480747,5/25/2015 08:43:43,1642943761,5/25/2015 08:42:46,False,prodege,0.8125,21417560,GBR,C3,Cambridge,151.225.116.143,no_relation,57,164,,64,182,causes,0.937042571331636,814003-FS1-4,"HOSPITALIZATION  Introduction  Hospitalize patients when SEIZURES may be due to acute brain pathology, if consciousness does not return to normal, or for impending STATUS EPILEPTICUS",SEIZURES,STATUS EPILEPTICUS,TWrex-cause
725480747,5/25/2015 09:01:13,1642946588,5/25/2015 08:58:37,False,clixsense,0.7595,19587102,NLD,11,Den Haag,84.87.89.153,SEIZURES causes STATUS EPILEPTICUS,57,164,,64,182,causes,0.937042571331636,814003-FS1-4,"HOSPITALIZATION  Introduction  Hospitalize patients when SEIZURES may be due to acute brain pathology, if consciousness does not return to normal, or for impending STATUS EPILEPTICUS",SEIZURES,STATUS EPILEPTICUS,TWrex-cause
725480747,5/25/2015 09:04:25,1642946910,5/25/2015 09:03:45,False,prodege,0.7837,27934334,GBR,D2,Derby,86.162.35.12,no_relation,57,164,,64,182,causes,0.937042571331636,814003-FS1-4,"HOSPITALIZATION  Introduction  Hospitalize patients when SEIZURES may be due to acute brain pathology, if consciousness does not return to normal, or for impending STATUS EPILEPTICUS",SEIZURES,STATUS EPILEPTICUS,TWrex-cause
725480747,5/25/2015 09:10:27,1642947930,5/25/2015 09:09:26,False,pocketmoneygpt,0.7857,21432964,GBR,K5,Poole,109.155.122.13,STATUS EPILEPTICUS causes SEIZURES,57,164,,64,182,causes,0.937042571331636,814003-FS1-4,"HOSPITALIZATION  Introduction  Hospitalize patients when SEIZURES may be due to acute brain pathology, if consciousness does not return to normal, or for impending STATUS EPILEPTICUS",SEIZURES,STATUS EPILEPTICUS,TWrex-cause
725480748,5/25/2015 10:18:22,1642958853,5/25/2015 10:18:08,False,clixsense,0.8095,31482589,NLD,,,31.201.11.16,MEFLOQUINE causes PSYCHOSIS,157,0,,165,10,causes,0.997054485501582,811256-FS1-4,"MEFLOQUINE causes side effects, including nausea, dizziness, vertigo, light headedness (described as an inability to concentrate), bad dreams, seizures, and PSYCHOSIS",PSYCHOSIS,MEFLOQUINE,TWrex-cause
725480748,5/25/2015 10:20:12,1642959304,5/25/2015 10:19:14,False,clixsense,0.877,10798016,GBR,C7,Coventry,86.24.245.191,MEFLOQUINE causes PSYCHOSIS,157,0,,165,10,causes,0.997054485501582,811256-FS1-4,"MEFLOQUINE causes side effects, including nausea, dizziness, vertigo, light headedness (described as an inability to concentrate), bad dreams, seizures, and PSYCHOSIS",PSYCHOSIS,MEFLOQUINE,TWrex-cause
725480748,5/25/2015 10:25:30,1642961074,5/25/2015 10:24:51,False,vivatic,0.9333,13889585,GBR,A1,Dagenham,2.28.66.9,MEFLOQUINE causes PSYCHOSIS,157,0,,165,10,causes,0.997054485501582,811256-FS1-4,"MEFLOQUINE causes side effects, including nausea, dizziness, vertigo, light headedness (described as an inability to concentrate), bad dreams, seizures, and PSYCHOSIS",PSYCHOSIS,MEFLOQUINE,TWrex-cause
725480748,5/25/2015 10:25:33,1642961086,5/25/2015 10:24:32,False,points4rewards,0.8083,20113482,USA,OR,Portland,67.213.218.72,MEFLOQUINE causes PSYCHOSIS,157,0,,165,10,causes,0.997054485501582,811256-FS1-4,"MEFLOQUINE causes side effects, including nausea, dizziness, vertigo, light headedness (described as an inability to concentrate), bad dreams, seizures, and PSYCHOSIS",PSYCHOSIS,MEFLOQUINE,TWrex-cause
725480748,5/25/2015 10:29:35,1642962736,5/25/2015 10:29:08,False,instagc,0.8306,18531561,CAN,ON,Mississauga,99.229.92.227,MEFLOQUINE causes PSYCHOSIS,157,0,,165,10,causes,0.997054485501582,811256-FS1-4,"MEFLOQUINE causes side effects, including nausea, dizziness, vertigo, light headedness (described as an inability to concentrate), bad dreams, seizures, and PSYCHOSIS",PSYCHOSIS,MEFLOQUINE,TWrex-cause
725480748,5/25/2015 10:40:44,1642971690,5/25/2015 10:40:27,False,clixsense,0.7062,22751911,NLD,04,Groningen,195.241.153.97,MEFLOQUINE causes PSYCHOSIS,157,0,,165,10,causes,0.997054485501582,811256-FS1-4,"MEFLOQUINE causes side effects, including nausea, dizziness, vertigo, light headedness (described as an inability to concentrate), bad dreams, seizures, and PSYCHOSIS",PSYCHOSIS,MEFLOQUINE,TWrex-cause
725480748,5/25/2015 10:42:10,1642972758,5/25/2015 10:41:49,False,neodev,0.7976,30588889,NLD,07,Amsterdam,77.248.175.222,MEFLOQUINE causes PSYCHOSIS,157,0,,165,10,causes,0.997054485501582,811256-FS1-4,"MEFLOQUINE causes side effects, including nausea, dizziness, vertigo, light headedness (described as an inability to concentrate), bad dreams, seizures, and PSYCHOSIS",PSYCHOSIS,MEFLOQUINE,TWrex-cause
725480758,5/25/2015 09:27:06,1642950430,5/25/2015 09:26:56,False,instagc,0.8333,13581319,USA,IL,Mount Vernon,66.232.166.86,CLOSTRIDIUM causes CLOSTRIDIAL MYONECROSIS (GAS GANGRENE),74,159,,111,170,causes,0.9103664774626049,810254-FS1-4,120  Clostridium Infections  Alternative to penicillin G for treatment of CLOSTRIDIAL MYONECROSIS (GAS GANGRENE) caused by  Clostridium perfringens  or other  CLOSTRIDIUM,CLOSTRIDIAL MYONECROSIS (GAS GANGRENE),CLOSTRIDIUM,TWrex-cause
725480758,5/25/2015 09:32:45,1642951401,5/25/2015 09:32:28,False,elite,0.7153,31856422,GBR,C9,Carlisle,92.19.36.179,CLOSTRIDIUM causes CLOSTRIDIAL MYONECROSIS (GAS GANGRENE),74,159,,111,170,causes,0.9103664774626049,810254-FS1-4,120  Clostridium Infections  Alternative to penicillin G for treatment of CLOSTRIDIAL MYONECROSIS (GAS GANGRENE) caused by  Clostridium perfringens  or other  CLOSTRIDIUM,CLOSTRIDIAL MYONECROSIS (GAS GANGRENE),CLOSTRIDIUM,TWrex-cause
725480758,5/25/2015 09:39:06,1642952585,5/25/2015 09:36:53,False,clixsense,0.7556,31345986,GBR,,,86.165.143.234,CLOSTRIDIUM causes CLOSTRIDIAL MYONECROSIS (GAS GANGRENE),74,159,,111,170,causes,0.9103664774626049,810254-FS1-4,120  Clostridium Infections  Alternative to penicillin G for treatment of CLOSTRIDIAL MYONECROSIS (GAS GANGRENE) caused by  Clostridium perfringens  or other  CLOSTRIDIUM,CLOSTRIDIAL MYONECROSIS (GAS GANGRENE),CLOSTRIDIUM,TWrex-cause
725480758,5/25/2015 09:46:06,1642953511,5/25/2015 09:45:50,False,cointasker,0.6236,21783324,NLD,,,31.151.239.133,CLOSTRIDIUM causes CLOSTRIDIAL MYONECROSIS (GAS GANGRENE),74,159,,111,170,causes,0.9103664774626049,810254-FS1-4,120  Clostridium Infections  Alternative to penicillin G for treatment of CLOSTRIDIAL MYONECROSIS (GAS GANGRENE) caused by  Clostridium perfringens  or other  CLOSTRIDIUM,CLOSTRIDIAL MYONECROSIS (GAS GANGRENE),CLOSTRIDIUM,TWrex-cause
725480758,5/25/2015 10:11:26,1642957559,5/25/2015 10:10:35,False,neodev,0.7143,11014534,GBR,B8,Bromley,86.18.149.6,CLOSTRIDIUM causes CLOSTRIDIAL MYONECROSIS (GAS GANGRENE),74,159,,111,170,causes,0.9103664774626049,810254-FS1-4,120  Clostridium Infections  Alternative to penicillin G for treatment of CLOSTRIDIAL MYONECROSIS (GAS GANGRENE) caused by  Clostridium perfringens  or other  CLOSTRIDIUM,CLOSTRIDIAL MYONECROSIS (GAS GANGRENE),CLOSTRIDIUM,TWrex-cause
725480758,5/25/2015 10:16:49,1642958608,5/25/2015 10:16:01,False,points4rewards,0.6786,28755767,USA,VA,Chester,68.57.118.32,no_relation,74,159,,111,170,causes,0.9103664774626049,810254-FS1-4,120  Clostridium Infections  Alternative to penicillin G for treatment of CLOSTRIDIAL MYONECROSIS (GAS GANGRENE) caused by  Clostridium perfringens  or other  CLOSTRIDIUM,CLOSTRIDIAL MYONECROSIS (GAS GANGRENE),CLOSTRIDIUM,TWrex-cause
725480758,5/25/2015 10:17:20,1642958640,5/25/2015 10:16:53,False,clixsense,0.8095,31482589,NLD,,,31.201.11.16,CLOSTRIDIUM causes CLOSTRIDIAL MYONECROSIS (GAS GANGRENE),74,159,,111,170,causes,0.9103664774626049,810254-FS1-4,120  Clostridium Infections  Alternative to penicillin G for treatment of CLOSTRIDIAL MYONECROSIS (GAS GANGRENE) caused by  Clostridium perfringens  or other  CLOSTRIDIUM,CLOSTRIDIAL MYONECROSIS (GAS GANGRENE),CLOSTRIDIUM,TWrex-cause
725480762,5/25/2015 08:22:20,1642940069,5/25/2015 08:21:52,False,gifthunterclub,1.0,30901412,GBR,G5,Margate,85.210.116.56,no_relation,58,0,,72,26,causes,0.9931270663228409,813963-FS1-4,"INFLAMMATORY BREAST CANCER has a clinical presentation of BREAST SWELLING erythema, warmth, and a peau d'orange appearance (characterized by a dimpled appearance caused by tumor infiltration of intradermal lymphatics); it may or may not be associated with a mass. These lesions are associated with a high risk of recurrence of local disease and with distant metastases.",BREAST SWELLING,INFLAMMATORY BREAST CANCER,TWrex-cause
725480762,5/25/2015 08:28:22,1642941104,5/25/2015 08:26:40,False,instagc,0.8333,30326470,USA,CA,Santee,99.44.37.73,no_relation,58,0,,72,26,causes,0.9931270663228409,813963-FS1-4,"INFLAMMATORY BREAST CANCER has a clinical presentation of BREAST SWELLING erythema, warmth, and a peau d'orange appearance (characterized by a dimpled appearance caused by tumor infiltration of intradermal lymphatics); it may or may not be associated with a mass. These lesions are associated with a high risk of recurrence of local disease and with distant metastases.",BREAST SWELLING,INFLAMMATORY BREAST CANCER,TWrex-cause
725480762,5/25/2015 08:36:52,1642942589,5/25/2015 08:35:57,False,bitcoinget,0.6667,30546513,GBR,G6,Hull,194.42.67.50,INFLAMMATORY BREAST CANCER causes BREAST SWELLING,58,0,,72,26,causes,0.9931270663228409,813963-FS1-4,"INFLAMMATORY BREAST CANCER has a clinical presentation of BREAST SWELLING erythema, warmth, and a peau d'orange appearance (characterized by a dimpled appearance caused by tumor infiltration of intradermal lymphatics); it may or may not be associated with a mass. These lesions are associated with a high risk of recurrence of local disease and with distant metastases.",BREAST SWELLING,INFLAMMATORY BREAST CANCER,TWrex-cause
725480762,5/25/2015 08:42:01,1642943401,5/25/2015 08:40:53,False,prodege,0.8125,21417560,GBR,C3,Cambridge,151.225.116.143,no_relation,58,0,,72,26,causes,0.9931270663228409,813963-FS1-4,"INFLAMMATORY BREAST CANCER has a clinical presentation of BREAST SWELLING erythema, warmth, and a peau d'orange appearance (characterized by a dimpled appearance caused by tumor infiltration of intradermal lymphatics); it may or may not be associated with a mass. These lesions are associated with a high risk of recurrence of local disease and with distant metastases.",BREAST SWELLING,INFLAMMATORY BREAST CANCER,TWrex-cause
725480762,5/25/2015 08:47:59,1642944337,5/25/2015 08:47:20,False,neodev,0.7976,30588889,NLD,07,Amsterdam,77.248.175.222,INFLAMMATORY BREAST CANCER causes BREAST SWELLING,58,0,,72,26,causes,0.9931270663228409,813963-FS1-4,"INFLAMMATORY BREAST CANCER has a clinical presentation of BREAST SWELLING erythema, warmth, and a peau d'orange appearance (characterized by a dimpled appearance caused by tumor infiltration of intradermal lymphatics); it may or may not be associated with a mass. These lesions are associated with a high risk of recurrence of local disease and with distant metastases.",BREAST SWELLING,INFLAMMATORY BREAST CANCER,TWrex-cause
725480762,5/25/2015 08:57:45,1642946079,5/25/2015 08:57:05,False,clixsense,0.7595,19587102,NLD,11,Den Haag,84.87.89.153,INFLAMMATORY BREAST CANCER causes BREAST SWELLING,58,0,,72,26,causes,0.9931270663228409,813963-FS1-4,"INFLAMMATORY BREAST CANCER has a clinical presentation of BREAST SWELLING erythema, warmth, and a peau d'orange appearance (characterized by a dimpled appearance caused by tumor infiltration of intradermal lymphatics); it may or may not be associated with a mass. These lesions are associated with a high risk of recurrence of local disease and with distant metastases.",BREAST SWELLING,INFLAMMATORY BREAST CANCER,TWrex-cause
725480762,5/25/2015 09:03:12,1642946802,5/25/2015 09:02:54,False,prodege,0.7837,27934334,GBR,D2,Derby,86.162.35.12,INFLAMMATORY BREAST CANCER causes BREAST SWELLING,58,0,,72,26,causes,0.9931270663228409,813963-FS1-4,"INFLAMMATORY BREAST CANCER has a clinical presentation of BREAST SWELLING erythema, warmth, and a peau d'orange appearance (characterized by a dimpled appearance caused by tumor infiltration of intradermal lymphatics); it may or may not be associated with a mass. These lesions are associated with a high risk of recurrence of local disease and with distant metastases.",BREAST SWELLING,INFLAMMATORY BREAST CANCER,TWrex-cause
725480767,5/25/2015 08:23:05,1642940288,5/25/2015 08:22:38,False,gifthunterclub,1.0,30901412,GBR,G5,Margate,85.210.116.56,no_relation,70,70,,101,81,causes,0.609994281330419,812361-FS1-4,"Fluid resuscitation:  IV fluids are initiated as for any patient with HYPOVOLEMIA OR HEMORRHAGIC SHOCK (see  Intravenous Fluid Resuscitation ): healthy adults are given normal saline IV in 500  to 1000 mL aliquots until signs of HYPOVOLEMIA remit—up to a maximum of 2 L (for children 20 mL/kg, which may be repeated once.",HYPOVOLEMIA OR HEMORRHAGIC SHOCK,HYPOVOLEMIA,TWrex-cause
725480767,5/25/2015 08:31:07,1642941431,5/25/2015 08:30:13,False,instagc,0.8333,30326470,USA,CA,Santee,99.44.37.73,no_relation,70,70,,101,81,causes,0.609994281330419,812361-FS1-4,"Fluid resuscitation:  IV fluids are initiated as for any patient with HYPOVOLEMIA OR HEMORRHAGIC SHOCK (see  Intravenous Fluid Resuscitation ): healthy adults are given normal saline IV in 500  to 1000 mL aliquots until signs of HYPOVOLEMIA remit—up to a maximum of 2 L (for children 20 mL/kg, which may be repeated once.",HYPOVOLEMIA OR HEMORRHAGIC SHOCK,HYPOVOLEMIA,TWrex-cause
725480767,5/25/2015 08:38:26,1642942872,5/25/2015 08:37:39,False,bitcoinget,0.6667,30546513,GBR,G6,Hull,194.42.67.50,HYPOVOLEMIA OR HEMORRHAGIC SHOCK causes HYPOVOLEMIA,70,70,,101,81,causes,0.609994281330419,812361-FS1-4,"Fluid resuscitation:  IV fluids are initiated as for any patient with HYPOVOLEMIA OR HEMORRHAGIC SHOCK (see  Intravenous Fluid Resuscitation ): healthy adults are given normal saline IV in 500  to 1000 mL aliquots until signs of HYPOVOLEMIA remit—up to a maximum of 2 L (for children 20 mL/kg, which may be repeated once.",HYPOVOLEMIA OR HEMORRHAGIC SHOCK,HYPOVOLEMIA,TWrex-cause
725480767,5/25/2015 08:43:43,1642943764,5/25/2015 08:42:46,False,prodege,0.8125,21417560,GBR,C3,Cambridge,151.225.116.143,HYPOVOLEMIA OR HEMORRHAGIC SHOCK causes HYPOVOLEMIA,70,70,,101,81,causes,0.609994281330419,812361-FS1-4,"Fluid resuscitation:  IV fluids are initiated as for any patient with HYPOVOLEMIA OR HEMORRHAGIC SHOCK (see  Intravenous Fluid Resuscitation ): healthy adults are given normal saline IV in 500  to 1000 mL aliquots until signs of HYPOVOLEMIA remit—up to a maximum of 2 L (for children 20 mL/kg, which may be repeated once.",HYPOVOLEMIA OR HEMORRHAGIC SHOCK,HYPOVOLEMIA,TWrex-cause
725480767,5/25/2015 09:01:13,1642946587,5/25/2015 08:58:37,False,clixsense,0.7595,19587102,NLD,11,Den Haag,84.87.89.153,no_relation,70,70,,101,81,causes,0.609994281330419,812361-FS1-4,"Fluid resuscitation:  IV fluids are initiated as for any patient with HYPOVOLEMIA OR HEMORRHAGIC SHOCK (see  Intravenous Fluid Resuscitation ): healthy adults are given normal saline IV in 500  to 1000 mL aliquots until signs of HYPOVOLEMIA remit—up to a maximum of 2 L (for children 20 mL/kg, which may be repeated once.",HYPOVOLEMIA OR HEMORRHAGIC SHOCK,HYPOVOLEMIA,TWrex-cause
725480767,5/25/2015 09:04:25,1642946891,5/25/2015 09:03:45,False,prodege,0.7837,27934334,GBR,D2,Derby,86.162.35.12,no_relation,70,70,,101,81,causes,0.609994281330419,812361-FS1-4,"Fluid resuscitation:  IV fluids are initiated as for any patient with HYPOVOLEMIA OR HEMORRHAGIC SHOCK (see  Intravenous Fluid Resuscitation ): healthy adults are given normal saline IV in 500  to 1000 mL aliquots until signs of HYPOVOLEMIA remit—up to a maximum of 2 L (for children 20 mL/kg, which may be repeated once.",HYPOVOLEMIA OR HEMORRHAGIC SHOCK,HYPOVOLEMIA,TWrex-cause
725480767,5/25/2015 09:10:27,1642947931,5/25/2015 09:09:26,False,pocketmoneygpt,0.7857,21432964,GBR,K5,Poole,109.155.122.13,no_relation,70,70,,101,81,causes,0.609994281330419,812361-FS1-4,"Fluid resuscitation:  IV fluids are initiated as for any patient with HYPOVOLEMIA OR HEMORRHAGIC SHOCK (see  Intravenous Fluid Resuscitation ): healthy adults are given normal saline IV in 500  to 1000 mL aliquots until signs of HYPOVOLEMIA remit—up to a maximum of 2 L (for children 20 mL/kg, which may be repeated once.",HYPOVOLEMIA OR HEMORRHAGIC SHOCK,HYPOVOLEMIA,TWrex-cause
725540688,5/25/2015 16:14:16,1643046655,5/25/2015 16:13:55,False,clixsense,0.9333,28351359,GBR,H9,London,80.43.180.102,SALMONELLA TYPHI causes TYPHOID FEVER (ENTERIC FEVER),79,132,,107,148,causes,0.9701425001453321,811574-FS1-4,9  Typhoid Fever and Other Salmonella Infections  Alternative for treatment of TYPHOID FEVER (ENTERIC FEVER) caused by susceptible  SALMONELLA TYPHI,TYPHOID FEVER (ENTERIC FEVER),SALMONELLA TYPHI,TWrex-cause
725540688,5/25/2015 16:17:25,1643047489,5/25/2015 16:17:06,False,instagc,0.9444,15864091,USA,OK,Oklahoma City,104.0.113.133,SALMONELLA TYPHI causes TYPHOID FEVER (ENTERIC FEVER),79,132,,107,148,causes,0.9701425001453321,811574-FS1-4,9  Typhoid Fever and Other Salmonella Infections  Alternative for treatment of TYPHOID FEVER (ENTERIC FEVER) caused by susceptible  SALMONELLA TYPHI,TYPHOID FEVER (ENTERIC FEVER),SALMONELLA TYPHI,TWrex-cause
725540688,5/25/2015 16:19:22,1643048014,5/25/2015 16:19:00,False,neodev,0.873,27667288,CAN,MB,Brandon,216.36.187.168,SALMONELLA TYPHI causes TYPHOID FEVER (ENTERIC FEVER),79,132,,107,148,causes,0.9701425001453321,811574-FS1-4,9  Typhoid Fever and Other Salmonella Infections  Alternative for treatment of TYPHOID FEVER (ENTERIC FEVER) caused by susceptible  SALMONELLA TYPHI,TYPHOID FEVER (ENTERIC FEVER),SALMONELLA TYPHI,TWrex-cause
725540688,5/25/2015 16:39:47,1643052431,5/25/2015 16:39:34,False,neodev,0.9792,31743852,GBR,G5,Margate,85.210.126.147,SALMONELLA TYPHI causes TYPHOID FEVER (ENTERIC FEVER),79,132,,107,148,causes,0.9701425001453321,811574-FS1-4,9  Typhoid Fever and Other Salmonella Infections  Alternative for treatment of TYPHOID FEVER (ENTERIC FEVER) caused by susceptible  SALMONELLA TYPHI,TYPHOID FEVER (ENTERIC FEVER),SALMONELLA TYPHI,TWrex-cause
725540688,5/25/2015 16:49:51,1643054891,5/25/2015 16:49:20,False,superrewards,0.8194,32390657,CAN,BC,Vancouver,108.180.109.12,SALMONELLA TYPHI causes TYPHOID FEVER (ENTERIC FEVER),79,132,,107,148,causes,0.9701425001453321,811574-FS1-4,9  Typhoid Fever and Other Salmonella Infections  Alternative for treatment of TYPHOID FEVER (ENTERIC FEVER) caused by susceptible  SALMONELLA TYPHI,TYPHOID FEVER (ENTERIC FEVER),SALMONELLA TYPHI,TWrex-cause
725540688,5/25/2015 16:50:38,1643055154,5/25/2015 16:50:23,False,neodev,0.8889,18881135,CAN,ON,Ajax,99.243.87.224,SALMONELLA TYPHI causes TYPHOID FEVER (ENTERIC FEVER),79,132,,107,148,causes,0.9701425001453321,811574-FS1-4,9  Typhoid Fever and Other Salmonella Infections  Alternative for treatment of TYPHOID FEVER (ENTERIC FEVER) caused by susceptible  SALMONELLA TYPHI,TYPHOID FEVER (ENTERIC FEVER),SALMONELLA TYPHI,TWrex-cause
725540688,5/25/2015 16:56:18,1643056815,5/25/2015 16:55:04,False,gifthunterclub,0.8734,29582088,GBR,I2,Manchester,89.240.68.44,SALMONELLA TYPHI causes TYPHOID FEVER (ENTERIC FEVER),79,132,,107,148,causes,0.9701425001453321,811574-FS1-4,9  Typhoid Fever and Other Salmonella Infections  Alternative for treatment of TYPHOID FEVER (ENTERIC FEVER) caused by susceptible  SALMONELLA TYPHI,TYPHOID FEVER (ENTERIC FEVER),SALMONELLA TYPHI,TWrex-cause
725540689,5/25/2015 16:10:47,1643045500,5/25/2015 16:09:40,False,onestopgpt,0.6905,21275875,CAN,ON,Hamilton,24.36.121.10,MONOCLONAL GAMMOPATHY causes MACROGLOBULINEMIA,57,0,,77,17,causes,0.8192880303729141,814523-FS1-4,MACROGLOBULINEMIA develops in about 12% of patients with MONOCLONAL GAMMOPATHY,MONOCLONAL GAMMOPATHY,MACROGLOBULINEMIA,TWrex-cause
725540689,5/25/2015 16:12:28,1643046046,5/25/2015 16:11:54,False,clixsense,0.9333,28351359,GBR,H9,London,80.43.180.102,MONOCLONAL GAMMOPATHY causes MACROGLOBULINEMIA,57,0,,77,17,causes,0.8192880303729141,814523-FS1-4,MACROGLOBULINEMIA develops in about 12% of patients with MONOCLONAL GAMMOPATHY,MONOCLONAL GAMMOPATHY,MACROGLOBULINEMIA,TWrex-cause
725540689,5/25/2015 16:13:06,1643046293,5/25/2015 16:11:00,False,neodev,0.873,27667288,CAN,MB,Brandon,216.36.187.168,MONOCLONAL GAMMOPATHY causes MACROGLOBULINEMIA,57,0,,77,17,causes,0.8192880303729141,814523-FS1-4,MACROGLOBULINEMIA develops in about 12% of patients with MONOCLONAL GAMMOPATHY,MONOCLONAL GAMMOPATHY,MACROGLOBULINEMIA,TWrex-cause
725540689,5/25/2015 16:15:26,1643046967,5/25/2015 16:15:08,False,instagc,0.9444,15864091,USA,OK,Oklahoma City,104.0.113.133,MONOCLONAL GAMMOPATHY causes MACROGLOBULINEMIA,57,0,,77,17,causes,0.8192880303729141,814523-FS1-4,MACROGLOBULINEMIA develops in about 12% of patients with MONOCLONAL GAMMOPATHY,MONOCLONAL GAMMOPATHY,MACROGLOBULINEMIA,TWrex-cause
725540689,5/25/2015 16:38:39,1643052120,5/25/2015 16:38:23,False,neodev,0.9792,31743852,GBR,G5,Margate,85.210.126.147,MONOCLONAL GAMMOPATHY causes MACROGLOBULINEMIA,57,0,,77,17,causes,0.8192880303729141,814523-FS1-4,MACROGLOBULINEMIA develops in about 12% of patients with MONOCLONAL GAMMOPATHY,MONOCLONAL GAMMOPATHY,MACROGLOBULINEMIA,TWrex-cause
725540689,5/25/2015 16:45:06,1643053764,5/25/2015 16:44:46,False,neodev,0.8889,18881135,CAN,ON,Ajax,99.243.87.224,MONOCLONAL GAMMOPATHY causes MACROGLOBULINEMIA,57,0,,77,17,causes,0.8192880303729141,814523-FS1-4,MACROGLOBULINEMIA develops in about 12% of patients with MONOCLONAL GAMMOPATHY,MONOCLONAL GAMMOPATHY,MACROGLOBULINEMIA,TWrex-cause
725540689,5/25/2015 16:48:14,1643054379,5/25/2015 16:47:44,False,superrewards,0.8194,32390657,CAN,BC,Vancouver,108.180.109.12,MONOCLONAL GAMMOPATHY causes MACROGLOBULINEMIA,57,0,,77,17,causes,0.8192880303729141,814523-FS1-4,MACROGLOBULINEMIA develops in about 12% of patients with MONOCLONAL GAMMOPATHY,MONOCLONAL GAMMOPATHY,MACROGLOBULINEMIA,TWrex-cause
725540692,5/25/2015 15:19:58,1643031654,5/25/2015 15:19:44,False,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,ENTEROTOXIGENIC E COLI causes TRAVELER'S DIARRHEA,113,140,,131,162,causes,0.9630868246861541,810766-FS1-4,"edit] Antimotility agents  Loperamide can reduce diarrhea in patients with shigella,[6] but not in patients with TRAVELER'S DIARRHEA due to ENTEROTOXIGENIC E COLI[7]  A systematic review of randomized controlled trials found that loperamide may harm children less than 3 years old.",TRAVELER'S DIARRHEA,ENTEROTOXIGENIC E COLI,TWrex-cause
725540692,5/25/2015 15:25:32,1643033380,5/25/2015 15:25:14,False,bitcoinget,0.8333,30546513,GBR,G6,Hull,194.42.67.50,ENTEROTOXIGENIC E COLI causes TRAVELER'S DIARRHEA,113,140,,131,162,causes,0.9630868246861541,810766-FS1-4,"edit] Antimotility agents  Loperamide can reduce diarrhea in patients with shigella,[6] but not in patients with TRAVELER'S DIARRHEA due to ENTEROTOXIGENIC E COLI[7]  A systematic review of randomized controlled trials found that loperamide may harm children less than 3 years old.",TRAVELER'S DIARRHEA,ENTEROTOXIGENIC E COLI,TWrex-cause
725540692,5/25/2015 15:28:18,1643034134,5/25/2015 15:27:44,False,neodev,0.5417,31977841,USA,IL,Chicago,69.175.85.2,ENTEROTOXIGENIC E COLI causes TRAVELER'S DIARRHEA,113,140,,131,162,causes,0.9630868246861541,810766-FS1-4,"edit] Antimotility agents  Loperamide can reduce diarrhea in patients with shigella,[6] but not in patients with TRAVELER'S DIARRHEA due to ENTEROTOXIGENIC E COLI[7]  A systematic review of randomized controlled trials found that loperamide may harm children less than 3 years old.",TRAVELER'S DIARRHEA,ENTEROTOXIGENIC E COLI,TWrex-cause
725540692,5/25/2015 15:30:19,1643034769,5/25/2015 15:30:03,False,meprizescf,0.5625,28483210,USA,WI,Minocqua,75.143.134.247,TRAVELER'S DIARRHEA causes ENTEROTOXIGENIC E COLI,113,140,,131,162,causes,0.9630868246861541,810766-FS1-4,"edit] Antimotility agents  Loperamide can reduce diarrhea in patients with shigella,[6] but not in patients with TRAVELER'S DIARRHEA due to ENTEROTOXIGENIC E COLI[7]  A systematic review of randomized controlled trials found that loperamide may harm children less than 3 years old.",TRAVELER'S DIARRHEA,ENTEROTOXIGENIC E COLI,TWrex-cause
725540692,5/25/2015 15:32:09,1643035373,5/25/2015 15:31:53,False,instagc,0.5833,13581319,USA,IL,Mount Vernon,66.232.166.86,ENTEROTOXIGENIC E COLI causes TRAVELER'S DIARRHEA,113,140,,131,162,causes,0.9630868246861541,810766-FS1-4,"edit] Antimotility agents  Loperamide can reduce diarrhea in patients with shigella,[6] but not in patients with TRAVELER'S DIARRHEA due to ENTEROTOXIGENIC E COLI[7]  A systematic review of randomized controlled trials found that loperamide may harm children less than 3 years old.",TRAVELER'S DIARRHEA,ENTEROTOXIGENIC E COLI,TWrex-cause
725540692,5/25/2015 15:35:03,1643036287,5/25/2015 15:32:38,False,elite,0.3532,32306791,USA,DE,Wilmington,199.58.86.213,ENTEROTOXIGENIC E COLI causes TRAVELER'S DIARRHEA,113,140,,131,162,causes,0.9630868246861541,810766-FS1-4,"edit] Antimotility agents  Loperamide can reduce diarrhea in patients with shigella,[6] but not in patients with TRAVELER'S DIARRHEA due to ENTEROTOXIGENIC E COLI[7]  A systematic review of randomized controlled trials found that loperamide may harm children less than 3 years old.",TRAVELER'S DIARRHEA,ENTEROTOXIGENIC E COLI,TWrex-cause
725540692,5/25/2015 15:36:06,1643036563,5/25/2015 15:35:52,False,cointasker,0.2619,21783324,NLD,,,31.151.239.133,no_relation,113,140,,131,162,causes,0.9630868246861541,810766-FS1-4,"edit] Antimotility agents  Loperamide can reduce diarrhea in patients with shigella,[6] but not in patients with TRAVELER'S DIARRHEA due to ENTEROTOXIGENIC E COLI[7]  A systematic review of randomized controlled trials found that loperamide may harm children less than 3 years old.",TRAVELER'S DIARRHEA,ENTEROTOXIGENIC E COLI,TWrex-cause
725540695,5/25/2015 15:45:24,1643039562,5/25/2015 15:45:00,False,neodev,0.8571,30504276,CAN,ON,Sudbury,66.103.55.12,ASCITES causes HEPATOCELLULAR CARCINOMA,84,155,,90,179,causes,0.8660254037844392,814293-FS1-4,"Commonly, portal hypertension (often with esophageal varices and upper GI bleeding, ASCITES portal systemic encephalopathy), hepatorenal syndrome, or even HEPATOCELLULAR CARCINOMA is present.",ASCITES,HEPATOCELLULAR CARCINOMA,TWrex-cause
725540695,5/25/2015 15:47:31,1643040265,5/25/2015 15:46:54,False,points4rewards,0.7708,28755767,USA,VA,Chester,68.57.118.32,ASCITES causes HEPATOCELLULAR CARCINOMA,84,155,,90,179,causes,0.8660254037844392,814293-FS1-4,"Commonly, portal hypertension (often with esophageal varices and upper GI bleeding, ASCITES portal systemic encephalopathy), hepatorenal syndrome, or even HEPATOCELLULAR CARCINOMA is present.",ASCITES,HEPATOCELLULAR CARCINOMA,TWrex-cause
725540695,5/25/2015 15:49:54,1643040902,5/25/2015 15:48:26,False,clixsense,0.4931,17950689,GBR,Y9,Tonypandy,92.2.44.79,HEPATOCELLULAR CARCINOMA causes ASCITES,84,155,,90,179,causes,0.8660254037844392,814293-FS1-4,"Commonly, portal hypertension (often with esophageal varices and upper GI bleeding, ASCITES portal systemic encephalopathy), hepatorenal syndrome, or even HEPATOCELLULAR CARCINOMA is present.",ASCITES,HEPATOCELLULAR CARCINOMA,TWrex-cause
725540695,5/25/2015 15:52:08,1643041502,5/25/2015 15:50:00,False,neodev,0.5661,31086320,NLD,05,Brunssum,84.28.176.117,no_relation,84,155,,90,179,causes,0.8660254037844392,814293-FS1-4,"Commonly, portal hypertension (often with esophageal varices and upper GI bleeding, ASCITES portal systemic encephalopathy), hepatorenal syndrome, or even HEPATOCELLULAR CARCINOMA is present.",ASCITES,HEPATOCELLULAR CARCINOMA,TWrex-cause
725540695,5/25/2015 15:57:58,1643042712,5/25/2015 15:56:41,False,clixsense,0.5,10798016,GBR,C7,Coventry,86.24.245.191,no_relation,84,155,,90,179,causes,0.8660254037844392,814293-FS1-4,"Commonly, portal hypertension (often with esophageal varices and upper GI bleeding, ASCITES portal systemic encephalopathy), hepatorenal syndrome, or even HEPATOCELLULAR CARCINOMA is present.",ASCITES,HEPATOCELLULAR CARCINOMA,TWrex-cause
725540695,5/25/2015 16:00:38,1643043352,5/25/2015 15:59:57,False,neodev,0.5722,14096345,NLD,03,Eibergen,77.174.124.109,no_relation,84,155,,90,179,causes,0.8660254037844392,814293-FS1-4,"Commonly, portal hypertension (often with esophageal varices and upper GI bleeding, ASCITES portal systemic encephalopathy), hepatorenal syndrome, or even HEPATOCELLULAR CARCINOMA is present.",ASCITES,HEPATOCELLULAR CARCINOMA,TWrex-cause
725540695,5/25/2015 16:05:57,1643044368,5/25/2015 16:05:10,False,prodege,0.5893,21417560,GBR,C3,Cambridge,151.225.116.143,no_relation,84,155,,90,179,causes,0.8660254037844392,814293-FS1-4,"Commonly, portal hypertension (often with esophageal varices and upper GI bleeding, ASCITES portal systemic encephalopathy), hepatorenal syndrome, or even HEPATOCELLULAR CARCINOMA is present.",ASCITES,HEPATOCELLULAR CARCINOMA,TWrex-cause
725540709,5/25/2015 16:39:59,1643052448,5/25/2015 16:39:48,False,neodev,0.9792,31743852,GBR,G5,Margate,85.210.126.147,YERSINIA PESTIS causes PLAGUE PNEUMONIA DISEASE,43,79,,66,94,causes,1.0,810389-FS1-4,"Cleri DJ, Vernaleo JR, Lombardi LJ, et al: PLAGUE PNEUMONIA DISEASE caused by  YERSINIA PESTIS",PLAGUE PNEUMONIA DISEASE,YERSINIA PESTIS,TWrex-cause
725540709,5/25/2015 16:50:11,1643054984,5/25/2015 16:49:52,False,superrewards,0.8194,32390657,CAN,BC,Vancouver,108.180.109.12,YERSINIA PESTIS causes PLAGUE PNEUMONIA DISEASE,43,79,,66,94,causes,1.0,810389-FS1-4,"Cleri DJ, Vernaleo JR, Lombardi LJ, et al: PLAGUE PNEUMONIA DISEASE caused by  YERSINIA PESTIS",PLAGUE PNEUMONIA DISEASE,YERSINIA PESTIS,TWrex-cause
725540709,5/25/2015 16:50:51,1643055235,5/25/2015 16:50:40,False,neodev,0.8889,18881135,CAN,ON,Ajax,99.243.87.224,YERSINIA PESTIS causes PLAGUE PNEUMONIA DISEASE,43,79,,66,94,causes,1.0,810389-FS1-4,"Cleri DJ, Vernaleo JR, Lombardi LJ, et al: PLAGUE PNEUMONIA DISEASE caused by  YERSINIA PESTIS",PLAGUE PNEUMONIA DISEASE,YERSINIA PESTIS,TWrex-cause
725540709,5/25/2015 16:56:36,1643056935,5/25/2015 16:56:19,False,gifthunterclub,0.8734,29582088,GBR,I2,Manchester,89.240.68.44,YERSINIA PESTIS causes PLAGUE PNEUMONIA DISEASE,43,79,,66,94,causes,1.0,810389-FS1-4,"Cleri DJ, Vernaleo JR, Lombardi LJ, et al: PLAGUE PNEUMONIA DISEASE caused by  YERSINIA PESTIS",PLAGUE PNEUMONIA DISEASE,YERSINIA PESTIS,TWrex-cause
725540709,5/25/2015 17:03:16,1643059509,5/25/2015 17:02:49,False,instagc,0.96,18985376,GBR,D2,Derby,86.27.159.112,YERSINIA PESTIS causes PLAGUE PNEUMONIA DISEASE,43,79,,66,94,causes,1.0,810389-FS1-4,"Cleri DJ, Vernaleo JR, Lombardi LJ, et al: PLAGUE PNEUMONIA DISEASE caused by  YERSINIA PESTIS",PLAGUE PNEUMONIA DISEASE,YERSINIA PESTIS,TWrex-cause
725540709,5/25/2015 17:21:11,1643068071,5/25/2015 17:20:15,False,instagc,0.7,31861996,USA,FL,Homestead,73.46.199.178,YERSINIA PESTIS causes PLAGUE PNEUMONIA DISEASE,43,79,,66,94,causes,1.0,810389-FS1-4,"Cleri DJ, Vernaleo JR, Lombardi LJ, et al: PLAGUE PNEUMONIA DISEASE caused by  YERSINIA PESTIS",PLAGUE PNEUMONIA DISEASE,YERSINIA PESTIS,TWrex-cause
725540709,5/25/2015 17:24:38,1643069694,5/25/2015 17:24:25,False,bitcoinget,0.8381,21614812,USA,NJ,Blackwood,50.153.127.136,YERSINIA PESTIS causes PLAGUE PNEUMONIA DISEASE,43,79,,66,94,causes,1.0,810389-FS1-4,"Cleri DJ, Vernaleo JR, Lombardi LJ, et al: PLAGUE PNEUMONIA DISEASE caused by  YERSINIA PESTIS",PLAGUE PNEUMONIA DISEASE,YERSINIA PESTIS,TWrex-cause
725582630,5/25/2015 21:46:55,1643169834,5/25/2015 21:46:44,False,prodege,0.9206,26159434,CAN,ON,Thornhill,99.238.74.196,HUMAN PAPILLOMAVIRUS (HPV INFECTION) causes WARTS,0,20,,4,56,causes,0.99654575824488,810676-FS1-4,WARTS are caused by HUMAN PAPILLOMAVIRUS (HPV INFECTION); at least 70 HPV types are linked to skin lesions.,WARTS,HUMAN PAPILLOMAVIRUS (HPV INFECTION),TWrex-cause
725582630,5/25/2015 21:47:09,1643169904,5/25/2015 21:46:40,False,points4rewards,0.6865,20113482,USA,OR,Portland,67.213.218.72,HUMAN PAPILLOMAVIRUS (HPV INFECTION) causes WARTS,0,20,,4,56,causes,0.99654575824488,810676-FS1-4,WARTS are caused by HUMAN PAPILLOMAVIRUS (HPV INFECTION); at least 70 HPV types are linked to skin lesions.,WARTS,HUMAN PAPILLOMAVIRUS (HPV INFECTION),TWrex-cause
725582630,5/25/2015 21:47:14,1643169926,5/25/2015 21:46:50,False,instagc,0.9048,15864091,USA,OK,Oklahoma City,104.0.113.133,HUMAN PAPILLOMAVIRUS (HPV INFECTION) causes WARTS,0,20,,4,56,causes,0.99654575824488,810676-FS1-4,WARTS are caused by HUMAN PAPILLOMAVIRUS (HPV INFECTION); at least 70 HPV types are linked to skin lesions.,WARTS,HUMAN PAPILLOMAVIRUS (HPV INFECTION),TWrex-cause
725582630,5/25/2015 21:49:54,1643170876,5/25/2015 21:48:21,False,neodev,0.627,27667288,CAN,MB,Brandon,216.36.187.168,HUMAN PAPILLOMAVIRUS (HPV INFECTION) causes WARTS,0,20,,4,56,causes,0.99654575824488,810676-FS1-4,WARTS are caused by HUMAN PAPILLOMAVIRUS (HPV INFECTION); at least 70 HPV types are linked to skin lesions.,WARTS,HUMAN PAPILLOMAVIRUS (HPV INFECTION),TWrex-cause
725582630,5/25/2015 21:50:54,1643171236,5/25/2015 21:49:24,False,bitcoinget,0.6833,21614812,USA,NJ,Blackwood,50.153.127.136,HUMAN PAPILLOMAVIRUS (HPV INFECTION) causes WARTS,0,20,,4,56,causes,0.99654575824488,810676-FS1-4,WARTS are caused by HUMAN PAPILLOMAVIRUS (HPV INFECTION); at least 70 HPV types are linked to skin lesions.,WARTS,HUMAN PAPILLOMAVIRUS (HPV INFECTION),TWrex-cause
725582630,5/25/2015 21:57:43,1643172862,5/25/2015 21:57:11,False,pocketmoneygpt,0.9389,21432964,GBR,K5,Poole,109.155.122.13,HUMAN PAPILLOMAVIRUS (HPV INFECTION) causes WARTS,0,20,,4,56,causes,0.99654575824488,810676-FS1-4,WARTS are caused by HUMAN PAPILLOMAVIRUS (HPV INFECTION); at least 70 HPV types are linked to skin lesions.,WARTS,HUMAN PAPILLOMAVIRUS (HPV INFECTION),TWrex-cause
725582630,5/25/2015 22:03:38,1643174346,5/25/2015 22:02:28,False,prodege,0.7679,18793920,USA,CA,Salinas,73.162.0.87,HUMAN PAPILLOMAVIRUS (HPV INFECTION) causes WARTS,0,20,,4,56,causes,0.99654575824488,810676-FS1-4,WARTS are caused by HUMAN PAPILLOMAVIRUS (HPV INFECTION); at least 70 HPV types are linked to skin lesions.,WARTS,HUMAN PAPILLOMAVIRUS (HPV INFECTION),TWrex-cause
725582631,5/25/2015 21:37:23,1643166870,5/25/2015 21:36:54,False,prodege,1.0,21417560,GBR,C3,Cambridge,151.225.116.143,no_relation,0,70,,20,91,causes,0.577350269189626,814758-FS1-4,"MACROSCOPIC HEMATURIA usually resolves spontaneously within days, and MICROSCOPIC HEMATURIA often occurs between mucosal infections.",MACROSCOPIC HEMATURIA,MICROSCOPIC HEMATURIA,TWrex-cause
725582631,5/25/2015 21:40:24,1643167850,5/25/2015 21:40:03,False,bitcoinget,0.6889,21678835,USA,OH,Ironton,76.177.160.209,no_relation,0,70,,20,91,causes,0.577350269189626,814758-FS1-4,"MACROSCOPIC HEMATURIA usually resolves spontaneously within days, and MICROSCOPIC HEMATURIA often occurs between mucosal infections.",MACROSCOPIC HEMATURIA,MICROSCOPIC HEMATURIA,TWrex-cause
725582631,5/25/2015 21:40:45,1643168079,5/25/2015 21:40:20,False,clixsense,0.7597,32254355,CAN,ON,London,50.101.209.220,no_relation,0,70,,20,91,causes,0.577350269189626,814758-FS1-4,"MACROSCOPIC HEMATURIA usually resolves spontaneously within days, and MICROSCOPIC HEMATURIA often occurs between mucosal infections.",MACROSCOPIC HEMATURIA,MICROSCOPIC HEMATURIA,TWrex-cause
725582631,5/25/2015 21:41:36,1643168301,5/25/2015 21:41:20,False,meprizescf,0.6042,28483210,USA,WI,Minocqua,75.143.134.247,MACROSCOPIC HEMATURIA causes MICROSCOPIC HEMATURIA,0,70,,20,91,causes,0.577350269189626,814758-FS1-4,"MACROSCOPIC HEMATURIA usually resolves spontaneously within days, and MICROSCOPIC HEMATURIA often occurs between mucosal infections.",MACROSCOPIC HEMATURIA,MICROSCOPIC HEMATURIA,TWrex-cause
725582631,5/25/2015 21:44:47,1643169196,5/25/2015 21:44:32,False,onestopgpt,0.6008,21275875,CAN,ON,Hamilton,24.36.121.10,no_relation,0,70,,20,91,causes,0.577350269189626,814758-FS1-4,"MACROSCOPIC HEMATURIA usually resolves spontaneously within days, and MICROSCOPIC HEMATURIA often occurs between mucosal infections.",MACROSCOPIC HEMATURIA,MICROSCOPIC HEMATURIA,TWrex-cause
725582631,5/25/2015 21:46:43,1643169778,5/25/2015 21:46:16,False,prodege,0.9206,26159434,CAN,ON,Thornhill,99.238.74.196,no_relation,0,70,,20,91,causes,0.577350269189626,814758-FS1-4,"MACROSCOPIC HEMATURIA usually resolves spontaneously within days, and MICROSCOPIC HEMATURIA often occurs between mucosal infections.",MACROSCOPIC HEMATURIA,MICROSCOPIC HEMATURIA,TWrex-cause
725582631,5/25/2015 21:46:49,1643169794,5/25/2015 21:46:34,False,instagc,0.9048,15864091,USA,OK,Oklahoma City,104.0.113.133,no_relation,0,70,,20,91,causes,0.577350269189626,814758-FS1-4,"MACROSCOPIC HEMATURIA usually resolves spontaneously within days, and MICROSCOPIC HEMATURIA often occurs between mucosal infections.",MACROSCOPIC HEMATURIA,MICROSCOPIC HEMATURIA,TWrex-cause
725582633,5/25/2015 21:37:23,1643166867,5/25/2015 21:36:54,False,prodege,1.0,21417560,GBR,C3,Cambridge,151.225.116.143,B MALLEI causes GLANDERS,57,84,,64,92,causes,0.9434563530497259,810912-FS1-4,"280 ,   281 ,   283 ,   285  Altenative for treatment of GLANDERS   +    caused by  B MALLEI",GLANDERS,B MALLEI,TWrex-cause
725582633,5/25/2015 21:40:24,1643167851,5/25/2015 21:40:03,False,bitcoinget,0.6889,21678835,USA,OH,Ironton,76.177.160.209,B MALLEI causes GLANDERS,57,84,,64,92,causes,0.9434563530497259,810912-FS1-4,"280 ,   281 ,   283 ,   285  Altenative for treatment of GLANDERS   +    caused by  B MALLEI",GLANDERS,B MALLEI,TWrex-cause
725582633,5/25/2015 21:40:45,1643168074,5/25/2015 21:40:20,False,clixsense,0.7597,32254355,CAN,ON,London,50.101.209.220,B MALLEI causes GLANDERS,57,84,,64,92,causes,0.9434563530497259,810912-FS1-4,"280 ,   281 ,   283 ,   285  Altenative for treatment of GLANDERS   +    caused by  B MALLEI",GLANDERS,B MALLEI,TWrex-cause
725582633,5/25/2015 21:41:36,1643168299,5/25/2015 21:41:20,False,meprizescf,0.6042,28483210,USA,WI,Minocqua,75.143.134.247,B MALLEI causes GLANDERS,57,84,,64,92,causes,0.9434563530497259,810912-FS1-4,"280 ,   281 ,   283 ,   285  Altenative for treatment of GLANDERS   +    caused by  B MALLEI",GLANDERS,B MALLEI,TWrex-cause
725582633,5/25/2015 21:44:47,1643169211,5/25/2015 21:44:32,False,onestopgpt,0.6008,21275875,CAN,ON,Hamilton,24.36.121.10,B MALLEI causes GLANDERS,57,84,,64,92,causes,0.9434563530497259,810912-FS1-4,"280 ,   281 ,   283 ,   285  Altenative for treatment of GLANDERS   +    caused by  B MALLEI",GLANDERS,B MALLEI,TWrex-cause
725582633,5/25/2015 21:46:43,1643169780,5/25/2015 21:46:16,False,prodege,0.9206,26159434,CAN,ON,Thornhill,99.238.74.196,B MALLEI causes GLANDERS,57,84,,64,92,causes,0.9434563530497259,810912-FS1-4,"280 ,   281 ,   283 ,   285  Altenative for treatment of GLANDERS   +    caused by  B MALLEI",GLANDERS,B MALLEI,TWrex-cause
725582633,5/25/2015 21:46:49,1643169793,5/25/2015 21:46:34,False,instagc,0.9048,15864091,USA,OK,Oklahoma City,104.0.113.133,B MALLEI causes GLANDERS,57,84,,64,92,causes,0.9434563530497259,810912-FS1-4,"280 ,   281 ,   283 ,   285  Altenative for treatment of GLANDERS   +    caused by  B MALLEI",GLANDERS,B MALLEI,TWrex-cause
725582642,5/25/2015 21:35:16,1643166386,5/25/2015 21:34:42,False,prodege,1.0,21417560,GBR,C3,Cambridge,151.225.116.143,CNS causes ENCEPHALITIS,29,53,,31,65,causes,0.997054485501582,802622-FS1-4,"• Although HSV affecting the CNS primarily causes an ENCEPHALITIS or encephalomyelitis, cases of HSV presenting as primarily meningitis have been reported ( 20.",CNS,ENCEPHALITIS,TWrex-cause
725582642,5/25/2015 21:38:50,1643167331,5/25/2015 21:38:01,False,clixsense,0.7597,32254355,CAN,ON,London,50.101.209.220,CNS causes ENCEPHALITIS,29,53,,31,65,causes,0.997054485501582,802622-FS1-4,"• Although HSV affecting the CNS primarily causes an ENCEPHALITIS or encephalomyelitis, cases of HSV presenting as primarily meningitis have been reported ( 20.",CNS,ENCEPHALITIS,TWrex-cause
725582642,5/25/2015 21:39:07,1643167440,5/25/2015 21:38:28,False,bitcoinget,0.6889,21678835,USA,OH,Ironton,76.177.160.209,no_relation,29,53,,31,65,causes,0.997054485501582,802622-FS1-4,"• Although HSV affecting the CNS primarily causes an ENCEPHALITIS or encephalomyelitis, cases of HSV presenting as primarily meningitis have been reported ( 20.",CNS,ENCEPHALITIS,TWrex-cause
725582642,5/25/2015 21:40:42,1643168044,5/25/2015 21:40:28,False,meprizescf,0.6042,28483210,USA,WI,Minocqua,75.143.134.247,CNS causes ENCEPHALITIS,29,53,,31,65,causes,0.997054485501582,802622-FS1-4,"• Although HSV affecting the CNS primarily causes an ENCEPHALITIS or encephalomyelitis, cases of HSV presenting as primarily meningitis have been reported ( 20.",CNS,ENCEPHALITIS,TWrex-cause
725582642,5/25/2015 21:43:08,1643168786,5/25/2015 21:40:52,False,neodev,0.627,27667288,CAN,MB,Brandon,216.36.187.168,CNS causes ENCEPHALITIS,29,53,,31,65,causes,0.997054485501582,802622-FS1-4,"• Although HSV affecting the CNS primarily causes an ENCEPHALITIS or encephalomyelitis, cases of HSV presenting as primarily meningitis have been reported ( 20.",CNS,ENCEPHALITIS,TWrex-cause
725582642,5/25/2015 21:43:31,1643168871,5/25/2015 21:42:45,False,onestopgpt,0.6008,21275875,CAN,ON,Hamilton,24.36.121.10,no_relation,29,53,,31,65,causes,0.997054485501582,802622-FS1-4,"• Although HSV affecting the CNS primarily causes an ENCEPHALITIS or encephalomyelitis, cases of HSV presenting as primarily meningitis have been reported ( 20.",CNS,ENCEPHALITIS,TWrex-cause
725582642,5/25/2015 21:45:15,1643169377,5/25/2015 21:44:33,False,points4rewards,0.6865,20113482,USA,OR,Portland,67.213.218.72,no_relation,29,53,,31,65,causes,0.997054485501582,802622-FS1-4,"• Although HSV affecting the CNS primarily causes an ENCEPHALITIS or encephalomyelitis, cases of HSV presenting as primarily meningitis have been reported ( 20.",CNS,ENCEPHALITIS,TWrex-cause
725582643,5/25/2015 21:33:52,1643165859,5/25/2015 21:33:07,False,prodege,1.0,21417560,GBR,C3,Cambridge,151.225.116.143,STURGE WEBER SYNDROME causes CONTRALATERAL SEIZURES,75,22,,134,43,causes,0.9237604307034009,813359-FS1-4,Other features of the STURGE WEBER SYNDROME include ipsilateral congenital glaucoma anda CONTRALATERAL SEIZURES caused by leptomeningeal angiomatosis.,CONTRALATERAL SEIZURES,STURGE WEBER SYNDROME,TWrex-cause
725582643,5/25/2015 21:37:12,1643166835,5/25/2015 21:36:16,False,clixsense,0.7597,32254355,CAN,ON,London,50.101.209.220,STURGE WEBER SYNDROME causes CONTRALATERAL SEIZURES,75,22,,134,43,causes,0.9237604307034009,813359-FS1-4,Other features of the STURGE WEBER SYNDROME include ipsilateral congenital glaucoma anda CONTRALATERAL SEIZURES caused by leptomeningeal angiomatosis.,CONTRALATERAL SEIZURES,STURGE WEBER SYNDROME,TWrex-cause
725582643,5/25/2015 21:37:41,1643166938,5/25/2015 21:36:49,False,bitcoinget,0.6889,21678835,USA,OH,Ironton,76.177.160.209,STURGE WEBER SYNDROME causes CONTRALATERAL SEIZURES,75,22,,134,43,causes,0.9237604307034009,813359-FS1-4,Other features of the STURGE WEBER SYNDROME include ipsilateral congenital glaucoma anda CONTRALATERAL SEIZURES caused by leptomeningeal angiomatosis.,CONTRALATERAL SEIZURES,STURGE WEBER SYNDROME,TWrex-cause
725582643,5/25/2015 21:38:24,1643167132,5/25/2015 21:36:56,False,neodev,0.627,27667288,CAN,MB,Brandon,216.36.187.168,no_relation,75,22,,134,43,causes,0.9237604307034009,813359-FS1-4,Other features of the STURGE WEBER SYNDROME include ipsilateral congenital glaucoma anda CONTRALATERAL SEIZURES caused by leptomeningeal angiomatosis.,CONTRALATERAL SEIZURES,STURGE WEBER SYNDROME,TWrex-cause
725582643,5/25/2015 21:40:12,1643167798,5/25/2015 21:39:58,False,meprizescf,0.6042,28483210,USA,WI,Minocqua,75.143.134.247,STURGE WEBER SYNDROME causes CONTRALATERAL SEIZURES,75,22,,134,43,causes,0.9237604307034009,813359-FS1-4,Other features of the STURGE WEBER SYNDROME include ipsilateral congenital glaucoma anda CONTRALATERAL SEIZURES caused by leptomeningeal angiomatosis.,CONTRALATERAL SEIZURES,STURGE WEBER SYNDROME,TWrex-cause
725582643,5/25/2015 21:42:07,1643168447,5/25/2015 21:41:36,False,onestopgpt,0.6008,21275875,CAN,ON,Hamilton,24.36.121.10,no_relation,75,22,,134,43,causes,0.9237604307034009,813359-FS1-4,Other features of the STURGE WEBER SYNDROME include ipsilateral congenital glaucoma anda CONTRALATERAL SEIZURES caused by leptomeningeal angiomatosis.,CONTRALATERAL SEIZURES,STURGE WEBER SYNDROME,TWrex-cause
725582643,5/25/2015 21:43:23,1643168841,5/25/2015 21:42:27,False,points4rewards,0.6865,20113482,USA,OR,Portland,67.213.218.72,STURGE WEBER SYNDROME causes CONTRALATERAL SEIZURES,75,22,,134,43,causes,0.9237604307034009,813359-FS1-4,Other features of the STURGE WEBER SYNDROME include ipsilateral congenital glaucoma anda CONTRALATERAL SEIZURES caused by leptomeningeal angiomatosis.,CONTRALATERAL SEIZURES,STURGE WEBER SYNDROME,TWrex-cause
725582646,5/25/2015 22:00:29,1643173667,5/25/2015 21:59:53,False,pocketmoneygpt,0.9389,21432964,GBR,K5,Poole,109.155.122.13,no_relation,51,73,,54,82,causes,0.824163383692134,802702-FS1-4,Other Factors  Trauma to the clinically uninvolved SKIN of patients with PSORIASIS can cause a lesion to appear at the exact site of injury; this phenomenon is known as the Kobner response.,SKIN,PSORIASIS,TWrex-cause
725582646,5/25/2015 22:06:29,1643175184,5/25/2015 22:06:05,False,prodege,0.7679,18793920,USA,CA,Salinas,73.162.0.87,no_relation,51,73,,54,82,causes,0.824163383692134,802702-FS1-4,Other Factors  Trauma to the clinically uninvolved SKIN of patients with PSORIASIS can cause a lesion to appear at the exact site of injury; this phenomenon is known as the Kobner response.,SKIN,PSORIASIS,TWrex-cause
725582646,5/25/2015 22:16:10,1643178340,5/25/2015 22:15:56,False,neodev,0.8444,31326282,NLD,,,82.169.243.65,no_relation,51,73,,54,82,causes,0.824163383692134,802702-FS1-4,Other Factors  Trauma to the clinically uninvolved SKIN of patients with PSORIASIS can cause a lesion to appear at the exact site of injury; this phenomenon is known as the Kobner response.,SKIN,PSORIASIS,TWrex-cause
725582646,5/25/2015 22:20:17,1643179565,5/25/2015 22:19:52,False,neodev,0.5387,11257883,CAN,BC,Surrey,76.77.82.83,PSORIASIS causes SKIN,51,73,,54,82,causes,0.824163383692134,802702-FS1-4,Other Factors  Trauma to the clinically uninvolved SKIN of patients with PSORIASIS can cause a lesion to appear at the exact site of injury; this phenomenon is known as the Kobner response.,SKIN,PSORIASIS,TWrex-cause
725582646,5/25/2015 22:26:23,1643181373,5/25/2015 22:25:59,False,clixsense,0.7556,28351359,GBR,H9,London,80.43.180.102,no_relation,51,73,,54,82,causes,0.824163383692134,802702-FS1-4,Other Factors  Trauma to the clinically uninvolved SKIN of patients with PSORIASIS can cause a lesion to appear at the exact site of injury; this phenomenon is known as the Kobner response.,SKIN,PSORIASIS,TWrex-cause
725582646,5/25/2015 22:34:14,1643183882,5/25/2015 22:32:31,False,superrewards,0.7119,24796792,USA,NY,New York,72.80.63.240,no_relation,51,73,,54,82,causes,0.824163383692134,802702-FS1-4,Other Factors  Trauma to the clinically uninvolved SKIN of patients with PSORIASIS can cause a lesion to appear at the exact site of injury; this phenomenon is known as the Kobner response.,SKIN,PSORIASIS,TWrex-cause
725582646,5/25/2015 22:35:38,1643184265,5/25/2015 22:33:50,False,prodege,0.6256,28103910,GBR,C3,Wisbech,2.222.58.164,SKIN causes PSORIASIS,51,73,,54,82,causes,0.824163383692134,802702-FS1-4,Other Factors  Trauma to the clinically uninvolved SKIN of patients with PSORIASIS can cause a lesion to appear at the exact site of injury; this phenomenon is known as the Kobner response.,SKIN,PSORIASIS,TWrex-cause
725582647,5/25/2015 22:16:32,1643178447,5/25/2015 22:16:12,False,neodev,0.8444,31326282,NLD,,,82.169.243.65,HEADACHE causes TENSION TYPE HEADACHE,102,131,,109,152,causes,0.474712663277541,812902-FS1-4,"Finally, the headache started suddenly in an otherwise healthy individual, and a new daily persistent HEADACHE commonly can become TENSION TYPE HEADACHE",HEADACHE,TENSION TYPE HEADACHE,TWrex-cause
725582647,5/25/2015 22:21:26,1643179867,5/25/2015 22:20:18,False,neodev,0.5387,11257883,CAN,BC,Surrey,76.77.82.83,TENSION TYPE HEADACHE causes HEADACHE,102,131,,109,152,causes,0.474712663277541,812902-FS1-4,"Finally, the headache started suddenly in an otherwise healthy individual, and a new daily persistent HEADACHE commonly can become TENSION TYPE HEADACHE",HEADACHE,TENSION TYPE HEADACHE,TWrex-cause
725582647,5/25/2015 22:26:48,1643181558,5/25/2015 22:26:24,False,clixsense,0.7556,28351359,GBR,H9,London,80.43.180.102,no_relation,102,131,,109,152,causes,0.474712663277541,812902-FS1-4,"Finally, the headache started suddenly in an otherwise healthy individual, and a new daily persistent HEADACHE commonly can become TENSION TYPE HEADACHE",HEADACHE,TENSION TYPE HEADACHE,TWrex-cause
725582647,5/25/2015 22:34:35,1643183993,5/25/2015 22:34:12,False,neodev,0.875,11014811,GBR,G6,Hull,87.102.82.212,HEADACHE causes TENSION TYPE HEADACHE,102,131,,109,152,causes,0.474712663277541,812902-FS1-4,"Finally, the headache started suddenly in an otherwise healthy individual, and a new daily persistent HEADACHE commonly can become TENSION TYPE HEADACHE",HEADACHE,TENSION TYPE HEADACHE,TWrex-cause
725582647,5/25/2015 22:34:46,1643184053,5/25/2015 22:34:15,False,superrewards,0.7119,24796792,USA,NY,New York,72.80.63.240,HEADACHE causes TENSION TYPE HEADACHE,102,131,,109,152,causes,0.474712663277541,812902-FS1-4,"Finally, the headache started suddenly in an otherwise healthy individual, and a new daily persistent HEADACHE commonly can become TENSION TYPE HEADACHE",HEADACHE,TENSION TYPE HEADACHE,TWrex-cause
725582647,5/25/2015 22:36:00,1643184388,5/25/2015 22:35:33,False,instagc,0.8190000000000001,26024737,GBR,A9,Blackpool,2.97.97.40,HEADACHE causes TENSION TYPE HEADACHE,102,131,,109,152,causes,0.474712663277541,812902-FS1-4,"Finally, the headache started suddenly in an otherwise healthy individual, and a new daily persistent HEADACHE commonly can become TENSION TYPE HEADACHE",HEADACHE,TENSION TYPE HEADACHE,TWrex-cause
725582647,5/25/2015 22:36:29,1643184558,5/25/2015 22:35:40,False,prodege,0.6256,28103910,GBR,C3,Wisbech,2.222.58.164,HEADACHE causes TENSION TYPE HEADACHE,102,131,,109,152,causes,0.474712663277541,812902-FS1-4,"Finally, the headache started suddenly in an otherwise healthy individual, and a new daily persistent HEADACHE commonly can become TENSION TYPE HEADACHE",HEADACHE,TENSION TYPE HEADACHE,TWrex-cause
725582662,5/25/2015 21:47:58,1643170129,5/25/2015 21:47:29,False,instagc,0.9048,15864091,USA,OK,Oklahoma City,104.0.113.133,no_relation,150,118,,164,134,causes,0.328797974610715,800424-FS1-4,"Heise T, Nosek L, Ronn BB et al. Lower within subject variability of insulin detemir in comparison to NPH insulin and INSULIN GLARGINE in people with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN GLARGINE,TWrex-cause
725582662,5/25/2015 21:58:55,1643173168,5/25/2015 21:58:16,False,pocketmoneygpt,0.9389,21432964,GBR,K5,Poole,109.155.122.13,no_relation,150,118,,164,134,causes,0.328797974610715,800424-FS1-4,"Heise T, Nosek L, Ronn BB et al. Lower within subject variability of insulin detemir in comparison to NPH insulin and INSULIN GLARGINE in people with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN GLARGINE,TWrex-cause
725582662,5/25/2015 22:04:47,1643174647,5/25/2015 22:04:11,False,prodege,0.7679,18793920,USA,CA,Salinas,73.162.0.87,TYPE 1 DIABETES causes INSULIN GLARGINE,150,118,,164,134,causes,0.328797974610715,800424-FS1-4,"Heise T, Nosek L, Ronn BB et al. Lower within subject variability of insulin detemir in comparison to NPH insulin and INSULIN GLARGINE in people with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN GLARGINE,TWrex-cause
725582662,5/25/2015 22:15:22,1643178125,5/25/2015 22:14:57,False,neodev,0.8444,31326282,NLD,,,82.169.243.65,no_relation,150,118,,164,134,causes,0.328797974610715,800424-FS1-4,"Heise T, Nosek L, Ronn BB et al. Lower within subject variability of insulin detemir in comparison to NPH insulin and INSULIN GLARGINE in people with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN GLARGINE,TWrex-cause
725582662,5/25/2015 22:15:53,1643178236,5/25/2015 22:15:04,False,neodev,0.5387,11257883,CAN,BC,Surrey,76.77.82.83,no_relation,150,118,,164,134,causes,0.328797974610715,800424-FS1-4,"Heise T, Nosek L, Ronn BB et al. Lower within subject variability of insulin detemir in comparison to NPH insulin and INSULIN GLARGINE in people with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN GLARGINE,TWrex-cause
725582662,5/25/2015 22:25:13,1643180995,5/25/2015 22:24:46,False,clixsense,0.7556,28351359,GBR,H9,London,80.43.180.102,no_relation,150,118,,164,134,causes,0.328797974610715,800424-FS1-4,"Heise T, Nosek L, Ronn BB et al. Lower within subject variability of insulin detemir in comparison to NPH insulin and INSULIN GLARGINE in people with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN GLARGINE,TWrex-cause
725582662,5/25/2015 22:39:36,1643185608,5/25/2015 22:38:38,False,clixsense,0.7052,22947672,GBR,,,88.144.128.65,no_relation,150,118,,164,134,causes,0.328797974610715,800424-FS1-4,"Heise T, Nosek L, Ronn BB et al. Lower within subject variability of insulin detemir in comparison to NPH insulin and INSULIN GLARGINE in people with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN GLARGINE,TWrex-cause
788211717,9/14/2015 15:01:07,1737925234,9/14/2015 14:59:20,False,neodev,0.8036,33238512,GBR,C5,Runcorn,109.147.217.212,THALIDOMIDE treats ERYTHEMA NODOSUM LEPROSUM,149,39,,173,50,treats,0.99654575824488,803403,"Hastings RC, Trautman JR, Enna CD et alTHALIDOMIDE in the treatment of erythema nodosum leprosum with a note on selected laboratory abnormalities in ERYTHEMA NODOSUM LEPROSUM.",ERYTHEMA NODOSUM LEPROSUM,THALIDOMIDE,TWrex-cause
788211717,9/14/2015 15:04:06,1737926563,9/14/2015 15:03:21,False,prodege,0.8889,24403612,CAN,ON,Ajax,99.239.181.149,THALIDOMIDE treats ERYTHEMA NODOSUM LEPROSUM,149,39,,173,50,treats,0.99654575824488,803403,"Hastings RC, Trautman JR, Enna CD et alTHALIDOMIDE in the treatment of erythema nodosum leprosum with a note on selected laboratory abnormalities in ERYTHEMA NODOSUM LEPROSUM.",ERYTHEMA NODOSUM LEPROSUM,THALIDOMIDE,TWrex-cause
788211717,9/14/2015 15:07:02,1737927837,9/14/2015 15:06:02,False,neodev,0.7986,33758777,USA,,,38.95.108.251,THALIDOMIDE treats ERYTHEMA NODOSUM LEPROSUM,149,39,,173,50,treats,0.99654575824488,803403,"Hastings RC, Trautman JR, Enna CD et alTHALIDOMIDE in the treatment of erythema nodosum leprosum with a note on selected laboratory abnormalities in ERYTHEMA NODOSUM LEPROSUM.",ERYTHEMA NODOSUM LEPROSUM,THALIDOMIDE,TWrex-cause
788211717,9/14/2015 15:07:23,1737927975,9/14/2015 15:05:20,False,points4rewards,0.8165,20113482,USA,PA,Philadelphia,162.208.49.45,THALIDOMIDE treats ERYTHEMA NODOSUM LEPROSUM,149,39,,173,50,treats,0.99654575824488,803403,"Hastings RC, Trautman JR, Enna CD et alTHALIDOMIDE in the treatment of erythema nodosum leprosum with a note on selected laboratory abnormalities in ERYTHEMA NODOSUM LEPROSUM.",ERYTHEMA NODOSUM LEPROSUM,THALIDOMIDE,TWrex-cause
788211717,9/14/2015 15:13:00,1737930417,9/14/2015 15:12:38,False,meprizescf,0.8115,28483210,USA,WI,Minocqua,75.143.134.247,THALIDOMIDE treats ERYTHEMA NODOSUM LEPROSUM,149,39,,173,50,treats,0.99654575824488,803403,"Hastings RC, Trautman JR, Enna CD et alTHALIDOMIDE in the treatment of erythema nodosum leprosum with a note on selected laboratory abnormalities in ERYTHEMA NODOSUM LEPROSUM.",ERYTHEMA NODOSUM LEPROSUM,THALIDOMIDE,TWrex-cause
788211717,9/14/2015 15:13:34,1737930656,9/14/2015 15:12:10,False,prodege,0.7778,21417560,GBR,C3,Cambridge,151.224.120.191,no_relation,149,39,,173,50,treats,0.99654575824488,803403,"Hastings RC, Trautman JR, Enna CD et alTHALIDOMIDE in the treatment of erythema nodosum leprosum with a note on selected laboratory abnormalities in ERYTHEMA NODOSUM LEPROSUM.",ERYTHEMA NODOSUM LEPROSUM,THALIDOMIDE,TWrex-cause
788211717,9/14/2015 15:15:05,1737931302,9/14/2015 15:14:43,False,dailyrewardsca,0.7867,32219778,CAN,ON,Ottawa,99.241.19.27,THALIDOMIDE treats ERYTHEMA NODOSUM LEPROSUM,149,39,,173,50,treats,0.99654575824488,803403,"Hastings RC, Trautman JR, Enna CD et alTHALIDOMIDE in the treatment of erythema nodosum leprosum with a note on selected laboratory abnormalities in ERYTHEMA NODOSUM LEPROSUM.",ERYTHEMA NODOSUM LEPROSUM,THALIDOMIDE,TWrex-cause
788211719,9/14/2015 17:45:55,1738006453,9/14/2015 17:45:38,False,neodev,0.6994,31984900,CAN,AB,Edmonton,208.123.223.100,WARFARIN treats STROKE,141,41,,146,49,treats,0.964901281354015,804297,A meta analysis of 3 RCTs has shown that WARFARIN given after MI to achieve an international normalized ratio of 2.0 to 3.0 reduced risk for STROKE,STROKE,WARFARIN,TWrex-cause
788211719,9/14/2015 17:46:01,1738006491,9/14/2015 17:45:52,False,instagc,0.7589,26024737,GBR,H2,Preston,92.23.186.130,WARFARIN treats STROKE,141,41,,146,49,treats,0.964901281354015,804297,A meta analysis of 3 RCTs has shown that WARFARIN given after MI to achieve an international normalized ratio of 2.0 to 3.0 reduced risk for STROKE,STROKE,WARFARIN,TWrex-cause
788211719,9/14/2015 17:51:09,1738009200,9/14/2015 17:50:44,False,neodev,0.75,20306047,GBR,,,80.41.0.252,WARFARIN treats STROKE,141,41,,146,49,treats,0.964901281354015,804297,A meta analysis of 3 RCTs has shown that WARFARIN given after MI to achieve an international normalized ratio of 2.0 to 3.0 reduced risk for STROKE,STROKE,WARFARIN,TWrex-cause
788211719,9/14/2015 17:53:18,1738010549,9/14/2015 17:51:55,False,neodev,0.6577,34281269,USA,VA,Mclean,63.141.204.170,no_relation,141,41,,146,49,treats,0.964901281354015,804297,A meta analysis of 3 RCTs has shown that WARFARIN given after MI to achieve an international normalized ratio of 2.0 to 3.0 reduced risk for STROKE,STROKE,WARFARIN,TWrex-cause
788211719,9/14/2015 17:54:27,1738011043,9/14/2015 17:52:54,False,clixsense,0.8601,30777913,GBR,U8,Edinburgh,92.239.140.40,WARFARIN treats STROKE,141,41,,146,49,treats,0.964901281354015,804297,A meta analysis of 3 RCTs has shown that WARFARIN given after MI to achieve an international normalized ratio of 2.0 to 3.0 reduced risk for STROKE,STROKE,WARFARIN,TWrex-cause
788211719,9/14/2015 17:54:54,1738011301,9/14/2015 17:53:02,False,clixsense,0.7738,33878524,CAN,BC,Princeton,75.156.83.71,WARFARIN treats STROKE,141,41,,146,49,treats,0.964901281354015,804297,A meta analysis of 3 RCTs has shown that WARFARIN given after MI to achieve an international normalized ratio of 2.0 to 3.0 reduced risk for STROKE,STROKE,WARFARIN,TWrex-cause
788211719,9/14/2015 17:55:12,1738011457,9/14/2015 17:53:55,False,instagc,0.8155,22192177,CAN,AB,Calgary,108.181.28.71,WARFARIN treats STROKE,141,41,,146,49,treats,0.964901281354015,804297,A meta analysis of 3 RCTs has shown that WARFARIN given after MI to achieve an international normalized ratio of 2.0 to 3.0 reduced risk for STROKE,STROKE,WARFARIN,TWrex-cause
788211734,9/14/2015 17:41:48,1738004581,9/14/2015 17:41:25,False,inboxpounds,0.7917,34449186,GBR,H9,London,82.23.2.74,no_relation,39,129,,61,145,treats,0.9494253265550829,218376,It is used prophylactically to prevent [PNEUMOCYSTIS PNEUMONIA] and toxoplasmosis in patients unable to tolerate trimethoprim with [SULFAMETHOXAZOLE].,PNEUMOCYSTIS PNEUMONIA,SULFAMETHOXAZOLE,TWrex-treat
788211734,9/14/2015 17:45:37,1738006345,9/14/2015 17:45:17,False,neodev,0.6994,31984900,CAN,AB,Edmonton,208.123.223.100,PNEUMOCYSTIS PNEUMONIA treats SULFAMETHOXAZOLE,39,129,,61,145,treats,0.9494253265550829,218376,It is used prophylactically to prevent [PNEUMOCYSTIS PNEUMONIA] and toxoplasmosis in patients unable to tolerate trimethoprim with [SULFAMETHOXAZOLE].,PNEUMOCYSTIS PNEUMONIA,SULFAMETHOXAZOLE,TWrex-treat
788211734,9/14/2015 17:45:49,1738006397,9/14/2015 17:45:38,False,instagc,0.7589,26024737,GBR,H2,Preston,92.23.186.130,SULFAMETHOXAZOLE treats PNEUMOCYSTIS PNEUMONIA,39,129,,61,145,treats,0.9494253265550829,218376,It is used prophylactically to prevent [PNEUMOCYSTIS PNEUMONIA] and toxoplasmosis in patients unable to tolerate trimethoprim with [SULFAMETHOXAZOLE].,PNEUMOCYSTIS PNEUMONIA,SULFAMETHOXAZOLE,TWrex-treat
788211734,9/14/2015 17:50:43,1738009010,9/14/2015 17:49:29,False,neodev,0.75,20306047,GBR,,,80.41.0.252,no_relation,39,129,,61,145,treats,0.9494253265550829,218376,It is used prophylactically to prevent [PNEUMOCYSTIS PNEUMONIA] and toxoplasmosis in patients unable to tolerate trimethoprim with [SULFAMETHOXAZOLE].,PNEUMOCYSTIS PNEUMONIA,SULFAMETHOXAZOLE,TWrex-treat
788211734,9/14/2015 17:51:54,1738009604,9/14/2015 17:50:56,False,neodev,0.6577,34281269,USA,VA,Mclean,63.141.204.170,PNEUMOCYSTIS PNEUMONIA treats SULFAMETHOXAZOLE,39,129,,61,145,treats,0.9494253265550829,218376,It is used prophylactically to prevent [PNEUMOCYSTIS PNEUMONIA] and toxoplasmosis in patients unable to tolerate trimethoprim with [SULFAMETHOXAZOLE].,PNEUMOCYSTIS PNEUMONIA,SULFAMETHOXAZOLE,TWrex-treat
788211734,9/14/2015 17:52:53,1738010264,9/14/2015 17:51:14,False,clixsense,0.8601,30777913,GBR,U8,Edinburgh,92.239.140.40,SULFAMETHOXAZOLE treats PNEUMOCYSTIS PNEUMONIA,39,129,,61,145,treats,0.9494253265550829,218376,It is used prophylactically to prevent [PNEUMOCYSTIS PNEUMONIA] and toxoplasmosis in patients unable to tolerate trimethoprim with [SULFAMETHOXAZOLE].,PNEUMOCYSTIS PNEUMONIA,SULFAMETHOXAZOLE,TWrex-treat
788211734,9/14/2015 17:53:01,1738010391,9/14/2015 17:50:01,False,clixsense,0.7738,33878524,CAN,BC,Princeton,75.156.83.71,SULFAMETHOXAZOLE treats PNEUMOCYSTIS PNEUMONIA,39,129,,61,145,treats,0.9494253265550829,218376,It is used prophylactically to prevent [PNEUMOCYSTIS PNEUMONIA] and toxoplasmosis in patients unable to tolerate trimethoprim with [SULFAMETHOXAZOLE].,PNEUMOCYSTIS PNEUMONIA,SULFAMETHOXAZOLE,TWrex-treat
788211735,9/14/2015 15:55:58,1737951360,9/14/2015 15:55:35,False,bitcoinget,0.8714,21743413,USA,WA,Port Angeles,24.113.29.97,LIPOSOMAL AMPHOTERICIN B treats VISCERAL LEISHMANIASIS,70,98,,91,122,treats,0.9901475429766742,800170,"Davidson RN, di Martino L, Gradoni L et al. Short course treatment of VISCERAL LEISHMANIASIS with LIPOSOMAL AMPHOTERICIN B (AmBisome.",VISCERAL LEISHMANIASIS,LIPOSOMAL AMPHOTERICIN B,TWrex-cause
788211735,9/14/2015 16:08:39,1737957517,9/14/2015 16:08:27,False,instagc,0.8659,31888345,USA,CA,Hayward,24.7.3.180,VISCERAL LEISHMANIASIS treats LIPOSOMAL AMPHOTERICIN B,70,98,,91,122,treats,0.9901475429766742,800170,"Davidson RN, di Martino L, Gradoni L et al. Short course treatment of VISCERAL LEISHMANIASIS with LIPOSOMAL AMPHOTERICIN B (AmBisome.",VISCERAL LEISHMANIASIS,LIPOSOMAL AMPHOTERICIN B,TWrex-cause
788211735,9/14/2015 16:09:08,1737957864,9/14/2015 16:08:21,False,neodev,0.8464,13253916,GBR,K4,Plymouth,92.17.245.86,LIPOSOMAL AMPHOTERICIN B treats VISCERAL LEISHMANIASIS,70,98,,91,122,treats,0.9901475429766742,800170,"Davidson RN, di Martino L, Gradoni L et al. Short course treatment of VISCERAL LEISHMANIASIS with LIPOSOMAL AMPHOTERICIN B (AmBisome.",VISCERAL LEISHMANIASIS,LIPOSOMAL AMPHOTERICIN B,TWrex-cause
788211735,9/14/2015 16:15:29,1737960576,9/14/2015 16:15:08,False,clixsense,0.8958,9001027,CAN,QC,Dollard-des-ormeaux,96.21.122.219,LIPOSOMAL AMPHOTERICIN B treats VISCERAL LEISHMANIASIS,70,98,,91,122,treats,0.9901475429766742,800170,"Davidson RN, di Martino L, Gradoni L et al. Short course treatment of VISCERAL LEISHMANIASIS with LIPOSOMAL AMPHOTERICIN B (AmBisome.",VISCERAL LEISHMANIASIS,LIPOSOMAL AMPHOTERICIN B,TWrex-cause
788211735,9/14/2015 16:20:45,1737963572,9/14/2015 16:20:29,False,prodege,0.904,22031444,GBR,M4,Southampton,80.44.195.214,LIPOSOMAL AMPHOTERICIN B treats VISCERAL LEISHMANIASIS,70,98,,91,122,treats,0.9901475429766742,800170,"Davidson RN, di Martino L, Gradoni L et al. Short course treatment of VISCERAL LEISHMANIASIS with LIPOSOMAL AMPHOTERICIN B (AmBisome.",VISCERAL LEISHMANIASIS,LIPOSOMAL AMPHOTERICIN B,TWrex-cause
788211735,9/14/2015 16:33:39,1737969641,9/14/2015 16:33:03,False,instagc,0.8373,18672993,CAN,BC,Surrey,76.77.82.83,LIPOSOMAL AMPHOTERICIN B treats VISCERAL LEISHMANIASIS,70,98,,91,122,treats,0.9901475429766742,800170,"Davidson RN, di Martino L, Gradoni L et al. Short course treatment of VISCERAL LEISHMANIASIS with LIPOSOMAL AMPHOTERICIN B (AmBisome.",VISCERAL LEISHMANIASIS,LIPOSOMAL AMPHOTERICIN B,TWrex-cause
788211735,9/14/2015 16:34:42,1737970180,9/14/2015 16:33:56,False,elite,0.25,33798502,USA,DE,,108.59.8.218,LIPOSOMAL AMPHOTERICIN B treats VISCERAL LEISHMANIASIS,70,98,,91,122,treats,0.9901475429766742,800170,"Davidson RN, di Martino L, Gradoni L et al. Short course treatment of VISCERAL LEISHMANIASIS with LIPOSOMAL AMPHOTERICIN B (AmBisome.",VISCERAL LEISHMANIASIS,LIPOSOMAL AMPHOTERICIN B,TWrex-cause
788211738,9/14/2015 17:19:34,1737993568,9/14/2015 17:19:27,False,instagc,0.9267,16469970,USA,OK,Broken Arrow,72.192.89.181,WARFARIN treats PULMONARY EMBOLISM,93,137,,111,145,treats,0.98058067569092,907168,Clinical trials are currently investigating the potential value of LMWHs in the treatment of PULMONARY EMBOLISM and as an alternative to WARFARIN in secondary prevention of DVT,PULMONARY EMBOLISM,WARFARIN,RO-may_prevent
788211738,9/14/2015 17:23:23,1737995636,9/14/2015 17:22:35,False,clixsense,0.9226,6338159,CAN,ON,Ottawa,108.168.124.170,WARFARIN treats PULMONARY EMBOLISM,93,137,,111,145,treats,0.98058067569092,907168,Clinical trials are currently investigating the potential value of LMWHs in the treatment of PULMONARY EMBOLISM and as an alternative to WARFARIN in secondary prevention of DVT,PULMONARY EMBOLISM,WARFARIN,RO-may_prevent
788211738,9/14/2015 17:28:58,1737997937,9/14/2015 17:28:34,False,neodev,0.9246,11014811,GBR,G6,Hull,87.102.82.212,WARFARIN treats PULMONARY EMBOLISM,93,137,,111,145,treats,0.98058067569092,907168,Clinical trials are currently investigating the potential value of LMWHs in the treatment of PULMONARY EMBOLISM and as an alternative to WARFARIN in secondary prevention of DVT,PULMONARY EMBOLISM,WARFARIN,RO-may_prevent
788211738,9/14/2015 17:34:44,1738000764,9/14/2015 17:34:16,False,neodev,0.9583,12115558,USA,OH,Twinsburg,98.27.164.131,WARFARIN treats PULMONARY EMBOLISM,93,137,,111,145,treats,0.98058067569092,907168,Clinical trials are currently investigating the potential value of LMWHs in the treatment of PULMONARY EMBOLISM and as an alternative to WARFARIN in secondary prevention of DVT,PULMONARY EMBOLISM,WARFARIN,RO-may_prevent
788211738,9/14/2015 17:35:15,1738001049,9/14/2015 17:35:07,False,instagc,0.95,15577915,USA,IL,Trenton,208.70.36.12,WARFARIN treats PULMONARY EMBOLISM,93,137,,111,145,treats,0.98058067569092,907168,Clinical trials are currently investigating the potential value of LMWHs in the treatment of PULMONARY EMBOLISM and as an alternative to WARFARIN in secondary prevention of DVT,PULMONARY EMBOLISM,WARFARIN,RO-may_prevent
788211738,9/14/2015 17:39:09,1738003385,9/14/2015 17:38:48,False,inboxpounds,0.7917,34449186,GBR,H9,London,82.23.2.74,WARFARIN treats PULMONARY EMBOLISM,93,137,,111,145,treats,0.98058067569092,907168,Clinical trials are currently investigating the potential value of LMWHs in the treatment of PULMONARY EMBOLISM and as an alternative to WARFARIN in secondary prevention of DVT,PULMONARY EMBOLISM,WARFARIN,RO-may_prevent
788211738,9/14/2015 17:50:54,1738009078,9/14/2015 17:50:00,False,neodev,0.6577,34281269,USA,VA,Mclean,63.141.204.170,WARFARIN treats PULMONARY EMBOLISM,93,137,,111,145,treats,0.98058067569092,907168,Clinical trials are currently investigating the potential value of LMWHs in the treatment of PULMONARY EMBOLISM and as an alternative to WARFARIN in secondary prevention of DVT,PULMONARY EMBOLISM,WARFARIN,RO-may_prevent
788211739,9/14/2015 16:09:29,1737958027,9/14/2015 16:09:18,False,instagc,0.8659,31888345,USA,CA,Hayward,24.7.3.180,NEOSTIGMINE treats MYASTHENIA GRAVIS,23,84,,39,95,treats,1.0,906775,A 52 year old man with MYASTHENIA GRAVIS and normal liver function was treated with NEOSTIGMINE prednisolone and azathioprine.,MYASTHENIA GRAVIS,NEOSTIGMINE,RO-may_diagnose
788211739,9/14/2015 16:22:01,1737964086,9/14/2015 16:21:42,False,prodege,0.904,22031444,GBR,M4,Southampton,80.44.195.214,NEOSTIGMINE treats MYASTHENIA GRAVIS,23,84,,39,95,treats,1.0,906775,A 52 year old man with MYASTHENIA GRAVIS and normal liver function was treated with NEOSTIGMINE prednisolone and azathioprine.,MYASTHENIA GRAVIS,NEOSTIGMINE,RO-may_diagnose
788211739,9/14/2015 16:45:53,1737975651,9/14/2015 16:45:35,False,prodege,0.9167,27934334,GBR,C8,Croydon,81.159.60.206,NEOSTIGMINE treats MYASTHENIA GRAVIS,23,84,,39,95,treats,1.0,906775,A 52 year old man with MYASTHENIA GRAVIS and normal liver function was treated with NEOSTIGMINE prednisolone and azathioprine.,MYASTHENIA GRAVIS,NEOSTIGMINE,RO-may_diagnose
788211739,9/14/2015 16:46:04,1737975737,9/14/2015 16:45:28,False,clixsense,0.8889,31813170,GBR,I7,Newcastle Upon Tyne,151.227.167.232,NEOSTIGMINE treats MYASTHENIA GRAVIS,23,84,,39,95,treats,1.0,906775,A 52 year old man with MYASTHENIA GRAVIS and normal liver function was treated with NEOSTIGMINE prednisolone and azathioprine.,MYASTHENIA GRAVIS,NEOSTIGMINE,RO-may_diagnose
788211739,9/14/2015 16:48:51,1737977225,9/14/2015 16:46:17,False,instagc,0.8373,18672993,CAN,BC,Surrey,76.77.82.83,NEOSTIGMINE treats MYASTHENIA GRAVIS,23,84,,39,95,treats,1.0,906775,A 52 year old man with MYASTHENIA GRAVIS and normal liver function was treated with NEOSTIGMINE prednisolone and azathioprine.,MYASTHENIA GRAVIS,NEOSTIGMINE,RO-may_diagnose
788211739,9/14/2015 16:55:04,1737980539,9/14/2015 16:54:46,False,prodege,0.8125,2143114,CAN,BC,Vancouver,24.85.153.181,NEOSTIGMINE treats MYASTHENIA GRAVIS,23,84,,39,95,treats,1.0,906775,A 52 year old man with MYASTHENIA GRAVIS and normal liver function was treated with NEOSTIGMINE prednisolone and azathioprine.,MYASTHENIA GRAVIS,NEOSTIGMINE,RO-may_diagnose
788211739,9/14/2015 17:05:46,1737986597,9/14/2015 17:05:31,False,clixsense,0.8292,19162475,GBR,P8,Trowbridge,82.33.126.30,NEOSTIGMINE treats MYASTHENIA GRAVIS,23,84,,39,95,treats,1.0,906775,A 52 year old man with MYASTHENIA GRAVIS and normal liver function was treated with NEOSTIGMINE prednisolone and azathioprine.,MYASTHENIA GRAVIS,NEOSTIGMINE,RO-may_diagnose
788211743,9/14/2015 18:03:12,1738015425,9/14/2015 18:03:04,False,neodev,0.8,33895262,USA,CA,San Jose,50.118.172.54,AMPHOTERICIN B treats NEUTROPENIA,195,128,,205,142,treats,0.9116846116771039,800301,"1]  Rex JH, Bennett JE, Sugar AM, Pappas PG, van der Horst CM, Edwards JE, et al. A randomized trial comparing fluconazole with AMPHOTERICIN B for the treatment of candidemia in patients without NEUTROPENIA",NEUTROPENIA,AMPHOTERICIN B,TWrex-cause
788211743,9/14/2015 18:15:14,1738022006,9/14/2015 18:14:52,False,clixsense,0.7381,23144069,GBR,G6,Hull,83.100.235.226,no_relation,195,128,,205,142,treats,0.9116846116771039,800301,"1]  Rex JH, Bennett JE, Sugar AM, Pappas PG, van der Horst CM, Edwards JE, et al. A randomized trial comparing fluconazole with AMPHOTERICIN B for the treatment of candidemia in patients without NEUTROPENIA",NEUTROPENIA,AMPHOTERICIN B,TWrex-cause
788211743,9/14/2015 18:23:46,1738026560,9/14/2015 18:23:00,False,neodev,0.6401,33011398,USA,DE,,108.59.8.208,AMPHOTERICIN B treats NEUTROPENIA,195,128,,205,142,treats,0.9116846116771039,800301,"1]  Rex JH, Bennett JE, Sugar AM, Pappas PG, van der Horst CM, Edwards JE, et al. A randomized trial comparing fluconazole with AMPHOTERICIN B for the treatment of candidemia in patients without NEUTROPENIA",NEUTROPENIA,AMPHOTERICIN B,TWrex-cause
788211743,9/14/2015 18:25:47,1738027824,9/14/2015 18:25:15,False,clixsense,0.5694,32916182,GBR,L9,Sheffield,5.81.109.21,no_relation,195,128,,205,142,treats,0.9116846116771039,800301,"1]  Rex JH, Bennett JE, Sugar AM, Pappas PG, van der Horst CM, Edwards JE, et al. A randomized trial comparing fluconazole with AMPHOTERICIN B for the treatment of candidemia in patients without NEUTROPENIA",NEUTROPENIA,AMPHOTERICIN B,TWrex-cause
788211743,9/14/2015 18:27:03,1738028433,9/14/2015 18:26:57,False,neodev,0.4222,33701549,USA,CA,San Jose,23.27.248.77,AMPHOTERICIN B treats NEUTROPENIA,195,128,,205,142,treats,0.9116846116771039,800301,"1]  Rex JH, Bennett JE, Sugar AM, Pappas PG, van der Horst CM, Edwards JE, et al. A randomized trial comparing fluconazole with AMPHOTERICIN B for the treatment of candidemia in patients without NEUTROPENIA",NEUTROPENIA,AMPHOTERICIN B,TWrex-cause
788211743,9/14/2015 18:34:28,1738033078,9/14/2015 18:33:45,False,instagc,0.748,33058612,USA,IL,Glenview,162.229.106.229,no_relation,195,128,,205,142,treats,0.9116846116771039,800301,"1]  Rex JH, Bennett JE, Sugar AM, Pappas PG, van der Horst CM, Edwards JE, et al. A randomized trial comparing fluconazole with AMPHOTERICIN B for the treatment of candidemia in patients without NEUTROPENIA",NEUTROPENIA,AMPHOTERICIN B,TWrex-cause
788211743,9/14/2015 18:36:08,1738033983,9/14/2015 18:35:06,False,clixsense,0.7123,33115750,GBR,I3,Rochester,90.222.106.192,AMPHOTERICIN B treats NEUTROPENIA,195,128,,205,142,treats,0.9116846116771039,800301,"1]  Rex JH, Bennett JE, Sugar AM, Pappas PG, van der Horst CM, Edwards JE, et al. A randomized trial comparing fluconazole with AMPHOTERICIN B for the treatment of candidemia in patients without NEUTROPENIA",NEUTROPENIA,AMPHOTERICIN B,TWrex-cause
788211746,9/14/2015 14:51:56,1737921193,9/14/2015 14:51:43,False,tremorgames,0.8167,24449707,CAN,QC,Laval,96.20.14.148,UROKINASE THERAPY treats CLINICAL PULMONARY EMBOLISM,63,42,,89,59,treats,0.9950371902099889,800311,"Sasahara AA, Cannilla JE, Belko JS et al. UROKINASE THERAPY in CLINICAL PULMONARY EMBOLISM: a new thrombolytic agent.",CLINICAL PULMONARY EMBOLISM,UROKINASE THERAPY,TWrex-cause
788211746,9/14/2015 14:52:59,1737921610,9/14/2015 14:52:47,False,elite,0.8333,31883685,GBR,,,79.66.254.237,UROKINASE THERAPY treats CLINICAL PULMONARY EMBOLISM,63,42,,89,59,treats,0.9950371902099889,800311,"Sasahara AA, Cannilla JE, Belko JS et al. UROKINASE THERAPY in CLINICAL PULMONARY EMBOLISM: a new thrombolytic agent.",CLINICAL PULMONARY EMBOLISM,UROKINASE THERAPY,TWrex-cause
788211746,9/14/2015 14:53:17,1737921726,9/14/2015 14:53:05,False,clixsense,0.8458,22751911,NLD,04,Groningen,195.241.153.97,UROKINASE THERAPY treats CLINICAL PULMONARY EMBOLISM,63,42,,89,59,treats,0.9950371902099889,800311,"Sasahara AA, Cannilla JE, Belko JS et al. UROKINASE THERAPY in CLINICAL PULMONARY EMBOLISM: a new thrombolytic agent.",CLINICAL PULMONARY EMBOLISM,UROKINASE THERAPY,TWrex-cause
788211746,9/14/2015 14:54:26,1737922291,9/14/2015 14:53:50,False,clixsense,0.8792,30681826,GBR,E4,Clacton-on-sea,109.157.135.57,UROKINASE THERAPY treats CLINICAL PULMONARY EMBOLISM,63,42,,89,59,treats,0.9950371902099889,800311,"Sasahara AA, Cannilla JE, Belko JS et al. UROKINASE THERAPY in CLINICAL PULMONARY EMBOLISM: a new thrombolytic agent.",CLINICAL PULMONARY EMBOLISM,UROKINASE THERAPY,TWrex-cause
788211746,9/14/2015 14:56:40,1737923375,9/14/2015 14:56:19,False,elite,0.6468,34356654,USA,DE,Wilmington,108.59.2.230,UROKINASE THERAPY treats CLINICAL PULMONARY EMBOLISM,63,42,,89,59,treats,0.9950371902099889,800311,"Sasahara AA, Cannilla JE, Belko JS et al. UROKINASE THERAPY in CLINICAL PULMONARY EMBOLISM: a new thrombolytic agent.",CLINICAL PULMONARY EMBOLISM,UROKINASE THERAPY,TWrex-cause
788211746,9/14/2015 14:56:45,1737923441,9/14/2015 14:55:31,False,onestopgpt,0.775,21275875,CAN,ON,Hamilton,24.36.124.79,UROKINASE THERAPY treats CLINICAL PULMONARY EMBOLISM,63,42,,89,59,treats,0.9950371902099889,800311,"Sasahara AA, Cannilla JE, Belko JS et al. UROKINASE THERAPY in CLINICAL PULMONARY EMBOLISM: a new thrombolytic agent.",CLINICAL PULMONARY EMBOLISM,UROKINASE THERAPY,TWrex-cause
788211746,9/14/2015 14:57:05,1737923593,9/14/2015 14:56:24,False,neodev,0.8036,33238512,GBR,C5,Runcorn,109.147.217.212,UROKINASE THERAPY treats CLINICAL PULMONARY EMBOLISM,63,42,,89,59,treats,0.9950371902099889,800311,"Sasahara AA, Cannilla JE, Belko JS et al. UROKINASE THERAPY in CLINICAL PULMONARY EMBOLISM: a new thrombolytic agent.",CLINICAL PULMONARY EMBOLISM,UROKINASE THERAPY,TWrex-cause
788211747,9/14/2015 17:46:56,1738006893,9/14/2015 17:46:38,False,neodev,0.6994,31984900,CAN,AB,Edmonton,208.123.223.100,BENIGN PROSTATIC HYPERPLASIA treats FINASTERIDE,101,85,,128,96,treats,0.99654575824488,804571,"Kaplan SA, McConnell JD, Roehrborn CG, et al: Combination therapy with doxazosin and FINASTERIDE for BENIGN PROSTATIC HYPERPLASIA in patients with lower urinary tract symptoms and a baseline total prostate volume of 25 Ml or greater.",BENIGN PROSTATIC HYPERPLASIA,FINASTERIDE,TWrex-cause
788211747,9/14/2015 17:55:27,1738011611,9/14/2015 17:54:57,False,clixsense,0.8601,30777913,GBR,U8,Edinburgh,92.239.140.40,FINASTERIDE treats BENIGN PROSTATIC HYPERPLASIA,101,85,,128,96,treats,0.99654575824488,804571,"Kaplan SA, McConnell JD, Roehrborn CG, et al: Combination therapy with doxazosin and FINASTERIDE for BENIGN PROSTATIC HYPERPLASIA in patients with lower urinary tract symptoms and a baseline total prostate volume of 25 Ml or greater.",BENIGN PROSTATIC HYPERPLASIA,FINASTERIDE,TWrex-cause
788211747,9/14/2015 17:55:37,1738011726,9/14/2015 17:54:25,False,neodev,0.6577,34281269,USA,VA,Mclean,63.141.204.170,FINASTERIDE treats BENIGN PROSTATIC HYPERPLASIA,101,85,,128,96,treats,0.99654575824488,804571,"Kaplan SA, McConnell JD, Roehrborn CG, et al: Combination therapy with doxazosin and FINASTERIDE for BENIGN PROSTATIC HYPERPLASIA in patients with lower urinary tract symptoms and a baseline total prostate volume of 25 Ml or greater.",BENIGN PROSTATIC HYPERPLASIA,FINASTERIDE,TWrex-cause
788211747,9/14/2015 17:56:53,1738012409,9/14/2015 17:56:11,False,instagc,0.8155,22192177,CAN,AB,Calgary,108.181.28.71,FINASTERIDE treats BENIGN PROSTATIC HYPERPLASIA,101,85,,128,96,treats,0.99654575824488,804571,"Kaplan SA, McConnell JD, Roehrborn CG, et al: Combination therapy with doxazosin and FINASTERIDE for BENIGN PROSTATIC HYPERPLASIA in patients with lower urinary tract symptoms and a baseline total prostate volume of 25 Ml or greater.",BENIGN PROSTATIC HYPERPLASIA,FINASTERIDE,TWrex-cause
788211747,9/14/2015 18:02:21,1738015046,9/14/2015 18:01:46,False,neodev,0.8,33895262,USA,CA,San Jose,50.118.172.54,BENIGN PROSTATIC HYPERPLASIA treats FINASTERIDE,101,85,,128,96,treats,0.99654575824488,804571,"Kaplan SA, McConnell JD, Roehrborn CG, et al: Combination therapy with doxazosin and FINASTERIDE for BENIGN PROSTATIC HYPERPLASIA in patients with lower urinary tract symptoms and a baseline total prostate volume of 25 Ml or greater.",BENIGN PROSTATIC HYPERPLASIA,FINASTERIDE,TWrex-cause
788211747,9/14/2015 18:12:56,1738020903,9/14/2015 18:12:32,False,clixsense,0.7381,23144069,GBR,G6,Hull,83.100.235.226,FINASTERIDE treats BENIGN PROSTATIC HYPERPLASIA,101,85,,128,96,treats,0.99654575824488,804571,"Kaplan SA, McConnell JD, Roehrborn CG, et al: Combination therapy with doxazosin and FINASTERIDE for BENIGN PROSTATIC HYPERPLASIA in patients with lower urinary tract symptoms and a baseline total prostate volume of 25 Ml or greater.",BENIGN PROSTATIC HYPERPLASIA,FINASTERIDE,TWrex-cause
788211747,9/14/2015 18:21:35,1738025325,9/14/2015 18:20:01,False,neodev,0.6401,33011398,USA,DE,,108.59.8.208,FINASTERIDE treats BENIGN PROSTATIC HYPERPLASIA,101,85,,128,96,treats,0.99654575824488,804571,"Kaplan SA, McConnell JD, Roehrborn CG, et al: Combination therapy with doxazosin and FINASTERIDE for BENIGN PROSTATIC HYPERPLASIA in patients with lower urinary tract symptoms and a baseline total prostate volume of 25 Ml or greater.",BENIGN PROSTATIC HYPERPLASIA,FINASTERIDE,TWrex-cause
788211753,9/14/2015 18:24:49,1738027213,9/14/2015 18:23:46,False,neodev,0.6401,33011398,USA,DE,,108.59.8.208,PENICILLIN G BENZATHINE treats RHEUMATIC FEVER,119,157,,133,180,treats,0.984731927834662,800843,"Yaws, Pinta, and Bejel  >     IM  Penicillin G benzathine: A single dose of 300,000 units in children    Prevention of RHEUMATIC FEVER Recurrence  >     IM  PENICILLIN G BENZATHINE: 1.2 million units once every 3 4 weeks.",RHEUMATIC FEVER,PENICILLIN G BENZATHINE,TWrex-cause
788211753,9/14/2015 18:26:33,1738028137,9/14/2015 18:25:48,False,clixsense,0.5694,32916182,GBR,L9,Sheffield,5.81.109.21,no_relation,119,157,,133,180,treats,0.984731927834662,800843,"Yaws, Pinta, and Bejel  >     IM  Penicillin G benzathine: A single dose of 300,000 units in children    Prevention of RHEUMATIC FEVER Recurrence  >     IM  PENICILLIN G BENZATHINE: 1.2 million units once every 3 4 weeks.",RHEUMATIC FEVER,PENICILLIN G BENZATHINE,TWrex-cause
788211753,9/14/2015 18:35:00,1738033346,9/14/2015 18:34:28,False,instagc,0.748,33058612,USA,IL,Glenview,162.229.106.229,PENICILLIN G BENZATHINE treats RHEUMATIC FEVER,119,157,,133,180,treats,0.984731927834662,800843,"Yaws, Pinta, and Bejel  >     IM  Penicillin G benzathine: A single dose of 300,000 units in children    Prevention of RHEUMATIC FEVER Recurrence  >     IM  PENICILLIN G BENZATHINE: 1.2 million units once every 3 4 weeks.",RHEUMATIC FEVER,PENICILLIN G BENZATHINE,TWrex-cause
788211753,9/14/2015 18:36:59,1738034722,9/14/2015 18:36:09,False,clixsense,0.7123,33115750,GBR,I3,Rochester,90.222.106.192,PENICILLIN G BENZATHINE treats RHEUMATIC FEVER,119,157,,133,180,treats,0.984731927834662,800843,"Yaws, Pinta, and Bejel  >     IM  Penicillin G benzathine: A single dose of 300,000 units in children    Prevention of RHEUMATIC FEVER Recurrence  >     IM  PENICILLIN G BENZATHINE: 1.2 million units once every 3 4 weeks.",RHEUMATIC FEVER,PENICILLIN G BENZATHINE,TWrex-cause
788211753,9/14/2015 19:23:28,1738101021,9/14/2015 19:23:08,False,clixsense,0.7806,19638651,USA,SC,Summerville,174.107.73.211,PENICILLIN G BENZATHINE treats RHEUMATIC FEVER,119,157,,133,180,treats,0.984731927834662,800843,"Yaws, Pinta, and Bejel  >     IM  Penicillin G benzathine: A single dose of 300,000 units in children    Prevention of RHEUMATIC FEVER Recurrence  >     IM  PENICILLIN G BENZATHINE: 1.2 million units once every 3 4 weeks.",RHEUMATIC FEVER,PENICILLIN G BENZATHINE,TWrex-cause
788211753,9/14/2015 19:26:20,1738105351,9/14/2015 19:24:00,False,elite,0.7857,33238902,NLD,06,Budel,77.248.148.5,PENICILLIN G BENZATHINE treats RHEUMATIC FEVER,119,157,,133,180,treats,0.984731927834662,800843,"Yaws, Pinta, and Bejel  >     IM  Penicillin G benzathine: A single dose of 300,000 units in children    Prevention of RHEUMATIC FEVER Recurrence  >     IM  PENICILLIN G BENZATHINE: 1.2 million units once every 3 4 weeks.",RHEUMATIC FEVER,PENICILLIN G BENZATHINE,TWrex-cause
788211753,9/14/2015 19:35:38,1738118144,9/14/2015 19:35:17,False,clixsense,0.8881,11106820,USA,MA,Taunton,173.48.52.95,PENICILLIN G BENZATHINE treats RHEUMATIC FEVER,119,157,,133,180,treats,0.984731927834662,800843,"Yaws, Pinta, and Bejel  >     IM  Penicillin G benzathine: A single dose of 300,000 units in children    Prevention of RHEUMATIC FEVER Recurrence  >     IM  PENICILLIN G BENZATHINE: 1.2 million units once every 3 4 weeks.",RHEUMATIC FEVER,PENICILLIN G BENZATHINE,TWrex-cause
788211767,9/14/2015 18:37:07,1738034780,9/14/2015 18:36:37,False,instagc,0.748,33058612,USA,IL,Glenview,162.229.106.229,TRIMETHOPRIM SULFAMETHOXAZOLE treats URINARY TRACT INFECTIONS,143,97,,166,126,treats,0.9701425001453321,800514,"Allais JM, Preheim LC, Cuevas TA et al. Randomized, double blind comparison of ciprofloxacin and TRIMETHOPRIM SULFAMETHOXAZOLE for complicated URINARY TRACT INFECTIONS",URINARY TRACT INFECTIONS,TRIMETHOPRIM SULFAMETHOXAZOLE,TWrex-cause
788211767,9/14/2015 19:24:58,1738103261,9/14/2015 19:24:42,False,clixsense,0.7806,19638651,USA,SC,Summerville,174.107.73.211,TRIMETHOPRIM SULFAMETHOXAZOLE treats URINARY TRACT INFECTIONS,143,97,,166,126,treats,0.9701425001453321,800514,"Allais JM, Preheim LC, Cuevas TA et al. Randomized, double blind comparison of ciprofloxacin and TRIMETHOPRIM SULFAMETHOXAZOLE for complicated URINARY TRACT INFECTIONS",URINARY TRACT INFECTIONS,TRIMETHOPRIM SULFAMETHOXAZOLE,TWrex-cause
788211767,9/14/2015 19:29:19,1738109424,9/14/2015 19:29:09,False,instagc,0.7604,32352104,USA,ME,Bangor,74.75.63.81,TRIMETHOPRIM SULFAMETHOXAZOLE treats URINARY TRACT INFECTIONS,143,97,,166,126,treats,0.9701425001453321,800514,"Allais JM, Preheim LC, Cuevas TA et al. Randomized, double blind comparison of ciprofloxacin and TRIMETHOPRIM SULFAMETHOXAZOLE for complicated URINARY TRACT INFECTIONS",URINARY TRACT INFECTIONS,TRIMETHOPRIM SULFAMETHOXAZOLE,TWrex-cause
788211767,9/14/2015 19:36:38,1738119717,9/14/2015 19:36:13,False,clixsense,0.8881,11106820,USA,MA,Taunton,173.48.52.95,TRIMETHOPRIM SULFAMETHOXAZOLE treats URINARY TRACT INFECTIONS,143,97,,166,126,treats,0.9701425001453321,800514,"Allais JM, Preheim LC, Cuevas TA et al. Randomized, double blind comparison of ciprofloxacin and TRIMETHOPRIM SULFAMETHOXAZOLE for complicated URINARY TRACT INFECTIONS",URINARY TRACT INFECTIONS,TRIMETHOPRIM SULFAMETHOXAZOLE,TWrex-cause
788211767,9/14/2015 19:46:37,1738133097,9/14/2015 19:46:18,False,clixsense,0.8333,21665495,CAN,,,24.105.69.70,TRIMETHOPRIM SULFAMETHOXAZOLE treats URINARY TRACT INFECTIONS,143,97,,166,126,treats,0.9701425001453321,800514,"Allais JM, Preheim LC, Cuevas TA et al. Randomized, double blind comparison of ciprofloxacin and TRIMETHOPRIM SULFAMETHOXAZOLE for complicated URINARY TRACT INFECTIONS",URINARY TRACT INFECTIONS,TRIMETHOPRIM SULFAMETHOXAZOLE,TWrex-cause
788211767,9/14/2015 19:51:20,1738138926,9/14/2015 19:50:33,False,instagc,1.0,21467491,USA,PA,Erie,24.165.145.54,TRIMETHOPRIM SULFAMETHOXAZOLE treats URINARY TRACT INFECTIONS,143,97,,166,126,treats,0.9701425001453321,800514,"Allais JM, Preheim LC, Cuevas TA et al. Randomized, double blind comparison of ciprofloxacin and TRIMETHOPRIM SULFAMETHOXAZOLE for complicated URINARY TRACT INFECTIONS",URINARY TRACT INFECTIONS,TRIMETHOPRIM SULFAMETHOXAZOLE,TWrex-cause
788211767,9/14/2015 19:53:00,1738140946,9/14/2015 19:52:41,False,zoombucks,0.7321,4688131,CAN,BC,Vancouver,216.251.132.22,TRIMETHOPRIM SULFAMETHOXAZOLE treats URINARY TRACT INFECTIONS,143,97,,166,126,treats,0.9701425001453321,800514,"Allais JM, Preheim LC, Cuevas TA et al. Randomized, double blind comparison of ciprofloxacin and TRIMETHOPRIM SULFAMETHOXAZOLE for complicated URINARY TRACT INFECTIONS",URINARY TRACT INFECTIONS,TRIMETHOPRIM SULFAMETHOXAZOLE,TWrex-cause
788211771,9/14/2015 18:24:49,1738027225,9/14/2015 18:23:46,False,neodev,0.6401,33011398,USA,DE,,108.59.8.208,[PREDNISOLONE 60 MG DAILY] treats [PERICARDITIS],13,29,,24,52,treats,0.9931270663228421,222045,The dose for [PERICARDITIS] is [PREDNISOLONE 60 MG DAILY] tapered off over four to eight weeks.,[PERICARDITIS],[PREDNISOLONE 60 MG DAILY],TWrex-treat
788211771,9/14/2015 18:26:33,1738028138,9/14/2015 18:25:48,False,clixsense,0.5694,32916182,GBR,L9,Sheffield,5.81.109.21,no_relation,13,29,,24,52,treats,0.9931270663228421,222045,The dose for [PERICARDITIS] is [PREDNISOLONE 60 MG DAILY] tapered off over four to eight weeks.,[PERICARDITIS],[PREDNISOLONE 60 MG DAILY],TWrex-treat
788211771,9/14/2015 18:35:00,1738033345,9/14/2015 18:34:28,False,instagc,0.748,33058612,USA,IL,Glenview,162.229.106.229,[PREDNISOLONE 60 MG DAILY] treats [PERICARDITIS],13,29,,24,52,treats,0.9931270663228421,222045,The dose for [PERICARDITIS] is [PREDNISOLONE 60 MG DAILY] tapered off over four to eight weeks.,[PERICARDITIS],[PREDNISOLONE 60 MG DAILY],TWrex-treat
788211771,9/14/2015 18:36:59,1738034723,9/14/2015 18:36:09,False,clixsense,0.7123,33115750,GBR,I3,Rochester,90.222.106.192,[PREDNISOLONE 60 MG DAILY] treats [PERICARDITIS],13,29,,24,52,treats,0.9931270663228421,222045,The dose for [PERICARDITIS] is [PREDNISOLONE 60 MG DAILY] tapered off over four to eight weeks.,[PERICARDITIS],[PREDNISOLONE 60 MG DAILY],TWrex-treat
788211771,9/14/2015 19:23:28,1738101019,9/14/2015 19:23:08,False,clixsense,0.7806,19638651,USA,SC,Summerville,174.107.73.211,[PREDNISOLONE 60 MG DAILY] treats [PERICARDITIS],13,29,,24,52,treats,0.9931270663228421,222045,The dose for [PERICARDITIS] is [PREDNISOLONE 60 MG DAILY] tapered off over four to eight weeks.,[PERICARDITIS],[PREDNISOLONE 60 MG DAILY],TWrex-treat
788211771,9/14/2015 19:26:20,1738105350,9/14/2015 19:24:00,False,elite,0.7857,33238902,NLD,06,Budel,77.248.148.5,[PREDNISOLONE 60 MG DAILY] treats [PERICARDITIS],13,29,,24,52,treats,0.9931270663228421,222045,The dose for [PERICARDITIS] is [PREDNISOLONE 60 MG DAILY] tapered off over four to eight weeks.,[PERICARDITIS],[PREDNISOLONE 60 MG DAILY],TWrex-treat
788211771,9/14/2015 19:35:38,1738118150,9/14/2015 19:35:17,False,clixsense,0.8881,11106820,USA,MA,Taunton,173.48.52.95,[PREDNISOLONE 60 MG DAILY] treats [PERICARDITIS],13,29,,24,52,treats,0.9931270663228421,222045,The dose for [PERICARDITIS] is [PREDNISOLONE 60 MG DAILY] tapered off over four to eight weeks.,[PERICARDITIS],[PREDNISOLONE 60 MG DAILY],TWrex-treat
788211772,9/14/2015 16:09:29,1737958012,9/14/2015 16:09:18,False,instagc,0.8659,31888345,USA,CA,Hayward,24.7.3.180,SINGLE DOSE OFLOXACIN treats UNCOMPLICATED GONORRHOEA,71,33,,94,54,treats,1.0,803453,"Chan AS, Tang KC, Fung KK et al. SINGLE DOSE OFLOXACIN in treatment of UNCOMPLICATED GONORRHOEA",UNCOMPLICATED GONORRHOEA,SINGLE DOSE OFLOXACIN,TWrex-cause
788211772,9/14/2015 16:22:01,1737964078,9/14/2015 16:21:42,False,prodege,0.904,22031444,GBR,M4,Southampton,80.44.195.214,SINGLE DOSE OFLOXACIN treats UNCOMPLICATED GONORRHOEA,71,33,,94,54,treats,1.0,803453,"Chan AS, Tang KC, Fung KK et al. SINGLE DOSE OFLOXACIN in treatment of UNCOMPLICATED GONORRHOEA",UNCOMPLICATED GONORRHOEA,SINGLE DOSE OFLOXACIN,TWrex-cause
788211772,9/14/2015 16:45:53,1737975652,9/14/2015 16:45:35,False,prodege,0.9167,27934334,GBR,C8,Croydon,81.159.60.206,SINGLE DOSE OFLOXACIN treats UNCOMPLICATED GONORRHOEA,71,33,,94,54,treats,1.0,803453,"Chan AS, Tang KC, Fung KK et al. SINGLE DOSE OFLOXACIN in treatment of UNCOMPLICATED GONORRHOEA",UNCOMPLICATED GONORRHOEA,SINGLE DOSE OFLOXACIN,TWrex-cause
788211772,9/14/2015 16:46:04,1737975736,9/14/2015 16:45:28,False,clixsense,0.8889,31813170,GBR,I7,Newcastle Upon Tyne,151.227.167.232,SINGLE DOSE OFLOXACIN treats UNCOMPLICATED GONORRHOEA,71,33,,94,54,treats,1.0,803453,"Chan AS, Tang KC, Fung KK et al. SINGLE DOSE OFLOXACIN in treatment of UNCOMPLICATED GONORRHOEA",UNCOMPLICATED GONORRHOEA,SINGLE DOSE OFLOXACIN,TWrex-cause
788211772,9/14/2015 16:48:51,1737977231,9/14/2015 16:46:17,False,instagc,0.8373,18672993,CAN,BC,Surrey,76.77.82.83,SINGLE DOSE OFLOXACIN treats UNCOMPLICATED GONORRHOEA,71,33,,94,54,treats,1.0,803453,"Chan AS, Tang KC, Fung KK et al. SINGLE DOSE OFLOXACIN in treatment of UNCOMPLICATED GONORRHOEA",UNCOMPLICATED GONORRHOEA,SINGLE DOSE OFLOXACIN,TWrex-cause
788211772,9/14/2015 16:55:04,1737980534,9/14/2015 16:54:46,False,prodege,0.8125,2143114,CAN,BC,Vancouver,24.85.153.181,SINGLE DOSE OFLOXACIN treats UNCOMPLICATED GONORRHOEA,71,33,,94,54,treats,1.0,803453,"Chan AS, Tang KC, Fung KK et al. SINGLE DOSE OFLOXACIN in treatment of UNCOMPLICATED GONORRHOEA",UNCOMPLICATED GONORRHOEA,SINGLE DOSE OFLOXACIN,TWrex-cause
788211772,9/14/2015 17:05:46,1737986595,9/14/2015 17:05:31,False,clixsense,0.8292,19162475,GBR,P8,Trowbridge,82.33.126.30,SINGLE DOSE OFLOXACIN treats UNCOMPLICATED GONORRHOEA,71,33,,94,54,treats,1.0,803453,"Chan AS, Tang KC, Fung KK et al. SINGLE DOSE OFLOXACIN in treatment of UNCOMPLICATED GONORRHOEA",UNCOMPLICATED GONORRHOEA,SINGLE DOSE OFLOXACIN,TWrex-cause
788211776,9/14/2015 14:50:01,1737920400,9/14/2015 14:47:14,False,clixsense,0.8792,30681826,GBR,E4,Clacton-on-sea,109.157.135.57,no_relation,182,157,,190,169,treats,0.790569415042095,907669,"Alternative Therapies for Hepatitis     Normal; Alternative Therapies for Hepatitis  Therapy Best Evidencea Probably Usefulb Least Evidencec         Herbals MILK THISTLE (hepatitis, CIRRHOSIS 70 140 mg t.i.d.",CIRRHOSIS,MILK THISTLE,RO-may_treat
788211776,9/14/2015 14:50:09,1737920467,9/14/2015 14:49:36,False,tremorgames,0.8167,24449707,CAN,QC,Laval,96.20.14.148,no_relation,182,157,,190,169,treats,0.790569415042095,907669,"Alternative Therapies for Hepatitis     Normal; Alternative Therapies for Hepatitis  Therapy Best Evidencea Probably Usefulb Least Evidencec         Herbals MILK THISTLE (hepatitis, CIRRHOSIS 70 140 mg t.i.d.",CIRRHOSIS,MILK THISTLE,RO-may_treat
788211776,9/14/2015 14:51:25,1737920966,9/14/2015 14:50:12,False,onestopgpt,0.775,21275875,CAN,ON,Hamilton,24.36.124.79,MILK THISTLE treats CIRRHOSIS,182,157,,190,169,treats,0.790569415042095,907669,"Alternative Therapies for Hepatitis     Normal; Alternative Therapies for Hepatitis  Therapy Best Evidencea Probably Usefulb Least Evidencec         Herbals MILK THISTLE (hepatitis, CIRRHOSIS 70 140 mg t.i.d.",CIRRHOSIS,MILK THISTLE,RO-may_treat
788211776,9/14/2015 14:51:39,1737921096,9/14/2015 14:51:08,False,elite,0.8333,31883685,GBR,,,79.66.254.237,no_relation,182,157,,190,169,treats,0.790569415042095,907669,"Alternative Therapies for Hepatitis     Normal; Alternative Therapies for Hepatitis  Therapy Best Evidencea Probably Usefulb Least Evidencec         Herbals MILK THISTLE (hepatitis, CIRRHOSIS 70 140 mg t.i.d.",CIRRHOSIS,MILK THISTLE,RO-may_treat
788211776,9/14/2015 14:51:44,1737921117,9/14/2015 14:51:07,False,clixsense,0.8458,22751911,NLD,04,Groningen,195.241.153.97,CIRRHOSIS treats MILK THISTLE,182,157,,190,169,treats,0.790569415042095,907669,"Alternative Therapies for Hepatitis     Normal; Alternative Therapies for Hepatitis  Therapy Best Evidencea Probably Usefulb Least Evidencec         Herbals MILK THISTLE (hepatitis, CIRRHOSIS 70 140 mg t.i.d.",CIRRHOSIS,MILK THISTLE,RO-may_treat
788211776,9/14/2015 14:54:53,1737922536,9/14/2015 14:52:03,False,neodev,0.7,11314968,CAN,BC,,173.180.132.26,no_relation,182,157,,190,169,treats,0.790569415042095,907669,"Alternative Therapies for Hepatitis     Normal; Alternative Therapies for Hepatitis  Therapy Best Evidencea Probably Usefulb Least Evidencec         Herbals MILK THISTLE (hepatitis, CIRRHOSIS 70 140 mg t.i.d.",CIRRHOSIS,MILK THISTLE,RO-may_treat
788211776,9/14/2015 15:02:10,1737925778,9/14/2015 15:01:09,False,neodev,0.8036,33238512,GBR,C5,Runcorn,109.147.217.212,no_relation,182,157,,190,169,treats,0.790569415042095,907669,"Alternative Therapies for Hepatitis     Normal; Alternative Therapies for Hepatitis  Therapy Best Evidencea Probably Usefulb Least Evidencec         Herbals MILK THISTLE (hepatitis, CIRRHOSIS 70 140 mg t.i.d.",CIRRHOSIS,MILK THISTLE,RO-may_treat
788211782,9/14/2015 17:29:21,1737998062,9/14/2015 17:29:13,False,neodev,0.9246,11014811,GBR,G6,Hull,87.102.82.212,FONDAPARINUX treats THROMBOEMBOLIC EVENTS,72,154,,92,166,treats,0.975900072948533,907030,"In the trial based analysis, fondaparinux was estimated to prevent 15.1 THROMBOEMBOLIC EVENTS per 1000 patients at three months compared with enoxaparin; FONDAPARINUX produced cost savings per patient at 30 days, 3 months, and 5 years postdischarge.",THROMBOEMBOLIC EVENTS,FONDAPARINUX,RO-may_prevent
788211782,9/14/2015 17:35:35,1738001244,9/14/2015 17:35:15,False,neodev,0.9583,12115558,USA,OH,Twinsburg,98.27.164.131,FONDAPARINUX treats THROMBOEMBOLIC EVENTS,72,154,,92,166,treats,0.975900072948533,907030,"In the trial based analysis, fondaparinux was estimated to prevent 15.1 THROMBOEMBOLIC EVENTS per 1000 patients at three months compared with enoxaparin; FONDAPARINUX produced cost savings per patient at 30 days, 3 months, and 5 years postdischarge.",THROMBOEMBOLIC EVENTS,FONDAPARINUX,RO-may_prevent
788211782,9/14/2015 17:40:53,1738004164,9/14/2015 17:40:12,False,inboxpounds,0.7917,34449186,GBR,H9,London,82.23.2.74,FONDAPARINUX treats THROMBOEMBOLIC EVENTS,72,154,,92,166,treats,0.975900072948533,907030,"In the trial based analysis, fondaparinux was estimated to prevent 15.1 THROMBOEMBOLIC EVENTS per 1000 patients at three months compared with enoxaparin; FONDAPARINUX produced cost savings per patient at 30 days, 3 months, and 5 years postdischarge.",THROMBOEMBOLIC EVENTS,FONDAPARINUX,RO-may_prevent
788211782,9/14/2015 17:41:36,1738004481,9/14/2015 17:41:03,False,clixsense,0.7381,23144069,GBR,G6,Hull,83.100.235.226,FONDAPARINUX treats THROMBOEMBOLIC EVENTS,72,154,,92,166,treats,0.975900072948533,907030,"In the trial based analysis, fondaparinux was estimated to prevent 15.1 THROMBOEMBOLIC EVENTS per 1000 patients at three months compared with enoxaparin; FONDAPARINUX produced cost savings per patient at 30 days, 3 months, and 5 years postdischarge.",THROMBOEMBOLIC EVENTS,FONDAPARINUX,RO-may_prevent
788211782,9/14/2015 17:44:55,1738005998,9/14/2015 17:44:25,False,neodev,0.6994,31984900,CAN,AB,Edmonton,208.123.223.100,FONDAPARINUX treats THROMBOEMBOLIC EVENTS,72,154,,92,166,treats,0.975900072948533,907030,"In the trial based analysis, fondaparinux was estimated to prevent 15.1 THROMBOEMBOLIC EVENTS per 1000 patients at three months compared with enoxaparin; FONDAPARINUX produced cost savings per patient at 30 days, 3 months, and 5 years postdischarge.",THROMBOEMBOLIC EVENTS,FONDAPARINUX,RO-may_prevent
788211782,9/14/2015 17:45:07,1738006111,9/14/2015 17:44:50,False,instagc,0.7589,26024737,GBR,H2,Preston,92.23.186.130,FONDAPARINUX treats THROMBOEMBOLIC EVENTS,72,154,,92,166,treats,0.975900072948533,907030,"In the trial based analysis, fondaparinux was estimated to prevent 15.1 THROMBOEMBOLIC EVENTS per 1000 patients at three months compared with enoxaparin; FONDAPARINUX produced cost savings per patient at 30 days, 3 months, and 5 years postdischarge.",THROMBOEMBOLIC EVENTS,FONDAPARINUX,RO-may_prevent
788211782,9/14/2015 17:46:05,1738006513,9/14/2015 17:43:53,False,clixsense,0.7738,33878524,CAN,BC,Princeton,75.156.83.71,FONDAPARINUX treats THROMBOEMBOLIC EVENTS,72,154,,92,166,treats,0.975900072948533,907030,"In the trial based analysis, fondaparinux was estimated to prevent 15.1 THROMBOEMBOLIC EVENTS per 1000 patients at three months compared with enoxaparin; FONDAPARINUX produced cost savings per patient at 30 days, 3 months, and 5 years postdischarge.",THROMBOEMBOLIC EVENTS,FONDAPARINUX,RO-may_prevent
788211795,9/14/2015 18:25:24,1738027620,9/14/2015 18:24:52,False,neodev,0.6401,33011398,USA,DE,,108.59.8.208,[INTRA ARTERIAL IODINE 131 LIPIODOL] treats [PORTAL VEIN THROMBUS],109,0,,129,33,treats,0.9950371902099889,214211,"[INTRA ARTERIAL IODINE 131 LIPIODOL] administration Efficacy demonstrated in unresectable patients, those with [PORTAL VEIN THROMBUS]",[PORTAL VEIN THROMBUS],[INTRA ARTERIAL IODINE 131 LIPIODOL],TWrex-treat
788211795,9/14/2015 18:28:07,1738029076,9/14/2015 18:26:38,False,clixsense,0.5694,32916182,GBR,L9,Sheffield,5.81.109.21,no_relation,109,0,,129,33,treats,0.9950371902099889,214211,"[INTRA ARTERIAL IODINE 131 LIPIODOL] administration Efficacy demonstrated in unresectable patients, those with [PORTAL VEIN THROMBUS]",[PORTAL VEIN THROMBUS],[INTRA ARTERIAL IODINE 131 LIPIODOL],TWrex-treat
788211795,9/14/2015 18:35:23,1738033583,9/14/2015 18:35:00,False,instagc,0.748,33058612,USA,IL,Glenview,162.229.106.229,[INTRA ARTERIAL IODINE 131 LIPIODOL] treats [PORTAL VEIN THROMBUS],109,0,,129,33,treats,0.9950371902099889,214211,"[INTRA ARTERIAL IODINE 131 LIPIODOL] administration Efficacy demonstrated in unresectable patients, those with [PORTAL VEIN THROMBUS]",[PORTAL VEIN THROMBUS],[INTRA ARTERIAL IODINE 131 LIPIODOL],TWrex-treat
788211795,9/14/2015 18:38:29,1738036208,9/14/2015 18:37:00,False,clixsense,0.7123,33115750,GBR,I3,Rochester,90.222.106.192,[INTRA ARTERIAL IODINE 131 LIPIODOL] treats [PORTAL VEIN THROMBUS],109,0,,129,33,treats,0.9950371902099889,214211,"[INTRA ARTERIAL IODINE 131 LIPIODOL] administration Efficacy demonstrated in unresectable patients, those with [PORTAL VEIN THROMBUS]",[PORTAL VEIN THROMBUS],[INTRA ARTERIAL IODINE 131 LIPIODOL],TWrex-treat
788211795,9/14/2015 19:23:53,1738101551,9/14/2015 19:23:29,False,clixsense,0.7806,19638651,USA,SC,Summerville,174.107.73.211,[INTRA ARTERIAL IODINE 131 LIPIODOL] treats [PORTAL VEIN THROMBUS],109,0,,129,33,treats,0.9950371902099889,214211,"[INTRA ARTERIAL IODINE 131 LIPIODOL] administration Efficacy demonstrated in unresectable patients, those with [PORTAL VEIN THROMBUS]",[PORTAL VEIN THROMBUS],[INTRA ARTERIAL IODINE 131 LIPIODOL],TWrex-treat
788211795,9/14/2015 19:27:39,1738107406,9/14/2015 19:26:22,False,elite,0.7857,33238902,NLD,06,Budel,77.248.148.5,[INTRA ARTERIAL IODINE 131 LIPIODOL] treats [PORTAL VEIN THROMBUS],109,0,,129,33,treats,0.9950371902099889,214211,"[INTRA ARTERIAL IODINE 131 LIPIODOL] administration Efficacy demonstrated in unresectable patients, those with [PORTAL VEIN THROMBUS]",[PORTAL VEIN THROMBUS],[INTRA ARTERIAL IODINE 131 LIPIODOL],TWrex-treat
788211795,9/14/2015 19:28:21,1738108159,9/14/2015 19:26:48,False,clixsense,0.8881,11106820,USA,MA,Taunton,173.48.52.95,[INTRA ARTERIAL IODINE 131 LIPIODOL] treats [PORTAL VEIN THROMBUS],109,0,,129,33,treats,0.9950371902099889,214211,"[INTRA ARTERIAL IODINE 131 LIPIODOL] administration Efficacy demonstrated in unresectable patients, those with [PORTAL VEIN THROMBUS]",[PORTAL VEIN THROMBUS],[INTRA ARTERIAL IODINE 131 LIPIODOL],TWrex-treat
788211797,9/14/2015 18:25:24,1738027622,9/14/2015 18:24:52,False,neodev,0.6401,33011398,USA,DE,,108.59.8.208,PAPAVERINE treats ERECTILE DYSFUNCTION,84,121,,103,131,treats,0.629940788348712,906676,To evaluate the use of papaverine induced erection as a diagnostic test in men with ERECTILE DYSFUNCTION 24 patients had PAPAVERINE injected into the corpus cavernosum.,ERECTILE DYSFUNCTION,PAPAVERINE,RO-may_diagnose
788211797,9/14/2015 18:28:07,1738029074,9/14/2015 18:26:38,False,clixsense,0.5694,32916182,GBR,L9,Sheffield,5.81.109.21,no_relation,84,121,,103,131,treats,0.629940788348712,906676,To evaluate the use of papaverine induced erection as a diagnostic test in men with ERECTILE DYSFUNCTION 24 patients had PAPAVERINE injected into the corpus cavernosum.,ERECTILE DYSFUNCTION,PAPAVERINE,RO-may_diagnose
788211797,9/14/2015 18:35:23,1738033584,9/14/2015 18:35:00,False,instagc,0.748,33058612,USA,IL,Glenview,162.229.106.229,PAPAVERINE treats ERECTILE DYSFUNCTION,84,121,,103,131,treats,0.629940788348712,906676,To evaluate the use of papaverine induced erection as a diagnostic test in men with ERECTILE DYSFUNCTION 24 patients had PAPAVERINE injected into the corpus cavernosum.,ERECTILE DYSFUNCTION,PAPAVERINE,RO-may_diagnose
788211797,9/14/2015 18:38:29,1738036209,9/14/2015 18:37:00,False,clixsense,0.7123,33115750,GBR,I3,Rochester,90.222.106.192,PAPAVERINE treats ERECTILE DYSFUNCTION,84,121,,103,131,treats,0.629940788348712,906676,To evaluate the use of papaverine induced erection as a diagnostic test in men with ERECTILE DYSFUNCTION 24 patients had PAPAVERINE injected into the corpus cavernosum.,ERECTILE DYSFUNCTION,PAPAVERINE,RO-may_diagnose
788211797,9/14/2015 19:23:53,1738101552,9/14/2015 19:23:29,False,clixsense,0.7806,19638651,USA,SC,Summerville,174.107.73.211,PAPAVERINE treats ERECTILE DYSFUNCTION,84,121,,103,131,treats,0.629940788348712,906676,To evaluate the use of papaverine induced erection as a diagnostic test in men with ERECTILE DYSFUNCTION 24 patients had PAPAVERINE injected into the corpus cavernosum.,ERECTILE DYSFUNCTION,PAPAVERINE,RO-may_diagnose
788211797,9/14/2015 19:27:39,1738107407,9/14/2015 19:26:22,False,elite,0.7857,33238902,NLD,06,Budel,77.248.148.5,PAPAVERINE treats ERECTILE DYSFUNCTION,84,121,,103,131,treats,0.629940788348712,906676,To evaluate the use of papaverine induced erection as a diagnostic test in men with ERECTILE DYSFUNCTION 24 patients had PAPAVERINE injected into the corpus cavernosum.,ERECTILE DYSFUNCTION,PAPAVERINE,RO-may_diagnose
788211797,9/14/2015 19:28:21,1738108156,9/14/2015 19:26:48,False,clixsense,0.8881,11106820,USA,MA,Taunton,173.48.52.95,PAPAVERINE treats ERECTILE DYSFUNCTION,84,121,,103,131,treats,0.629940788348712,906676,To evaluate the use of papaverine induced erection as a diagnostic test in men with ERECTILE DYSFUNCTION 24 patients had PAPAVERINE injected into the corpus cavernosum.,ERECTILE DYSFUNCTION,PAPAVERINE,RO-may_diagnose
788211799,9/14/2015 17:19:26,1737993499,9/14/2015 17:19:02,False,instagc,0.9267,16469970,USA,OK,Broken Arrow,72.192.89.181,ASPIRIN treats MYOCARDIAL INFARCTION,272,209,,293,216,treats,0.938314863256837,907118,Studies in patients scheduled for percutaneous coronary intervention and those with unstable angina or non-Q-wave myocardial infarction have shown that a combination of intravenous GP IIb-IIIa inhibitors with ASPIRIN and heparin is associated with a reduction in death or MYOCARDIAL INFARCTION compared with therapy with aspirin and heparin alone,MYOCARDIAL INFARCTION,ASPIRIN,RO-may_prevent
788211799,9/14/2015 17:22:34,1737995293,9/14/2015 17:21:21,False,clixsense,0.9226,6338159,CAN,ON,Ottawa,108.168.124.170,ASPIRIN treats MYOCARDIAL INFARCTION,272,209,,293,216,treats,0.938314863256837,907118,Studies in patients scheduled for percutaneous coronary intervention and those with unstable angina or non-Q-wave myocardial infarction have shown that a combination of intravenous GP IIb-IIIa inhibitors with ASPIRIN and heparin is associated with a reduction in death or MYOCARDIAL INFARCTION compared with therapy with aspirin and heparin alone,MYOCARDIAL INFARCTION,ASPIRIN,RO-may_prevent
788211799,9/14/2015 17:28:33,1737997744,9/14/2015 17:28:22,False,neodev,0.9246,11014811,GBR,G6,Hull,87.102.82.212,ASPIRIN treats MYOCARDIAL INFARCTION,272,209,,293,216,treats,0.938314863256837,907118,Studies in patients scheduled for percutaneous coronary intervention and those with unstable angina or non-Q-wave myocardial infarction have shown that a combination of intravenous GP IIb-IIIa inhibitors with ASPIRIN and heparin is associated with a reduction in death or MYOCARDIAL INFARCTION compared with therapy with aspirin and heparin alone,MYOCARDIAL INFARCTION,ASPIRIN,RO-may_prevent
788211799,9/14/2015 17:34:16,1738000537,9/14/2015 17:33:59,False,neodev,0.9583,12115558,USA,OH,Twinsburg,98.27.164.131,ASPIRIN treats MYOCARDIAL INFARCTION,272,209,,293,216,treats,0.938314863256837,907118,Studies in patients scheduled for percutaneous coronary intervention and those with unstable angina or non-Q-wave myocardial infarction have shown that a combination of intravenous GP IIb-IIIa inhibitors with ASPIRIN and heparin is associated with a reduction in death or MYOCARDIAL INFARCTION compared with therapy with aspirin and heparin alone,MYOCARDIAL INFARCTION,ASPIRIN,RO-may_prevent
788211799,9/14/2015 17:35:06,1738000983,9/14/2015 17:34:50,False,instagc,0.95,15577915,USA,IL,Trenton,208.70.36.12,ASPIRIN treats MYOCARDIAL INFARCTION,272,209,,293,216,treats,0.938314863256837,907118,Studies in patients scheduled for percutaneous coronary intervention and those with unstable angina or non-Q-wave myocardial infarction have shown that a combination of intravenous GP IIb-IIIa inhibitors with ASPIRIN and heparin is associated with a reduction in death or MYOCARDIAL INFARCTION compared with therapy with aspirin and heparin alone,MYOCARDIAL INFARCTION,ASPIRIN,RO-may_prevent
788211799,9/14/2015 17:38:47,1738003190,9/14/2015 17:38:11,False,inboxpounds,0.7917,34449186,GBR,H9,London,82.23.2.74,no_relation,272,209,,293,216,treats,0.938314863256837,907118,Studies in patients scheduled for percutaneous coronary intervention and those with unstable angina or non-Q-wave myocardial infarction have shown that a combination of intravenous GP IIb-IIIa inhibitors with ASPIRIN and heparin is associated with a reduction in death or MYOCARDIAL INFARCTION compared with therapy with aspirin and heparin alone,MYOCARDIAL INFARCTION,ASPIRIN,RO-may_prevent
788211799,9/14/2015 17:49:28,1738008216,9/14/2015 17:48:34,False,neodev,0.75,20306047,GBR,,,80.41.0.252,ASPIRIN treats MYOCARDIAL INFARCTION,272,209,,293,216,treats,0.938314863256837,907118,Studies in patients scheduled for percutaneous coronary intervention and those with unstable angina or non-Q-wave myocardial infarction have shown that a combination of intravenous GP IIb-IIIa inhibitors with ASPIRIN and heparin is associated with a reduction in death or MYOCARDIAL INFARCTION compared with therapy with aspirin and heparin alone,MYOCARDIAL INFARCTION,ASPIRIN,RO-may_prevent
788211805,9/14/2015 17:41:48,1738004564,9/14/2015 17:41:25,False,inboxpounds,0.7917,34449186,GBR,H9,London,82.23.2.74,no_relation,91,62,,99,73,treats,0.753778361444409,222455,Anecdotal reports have said that rubbing Vitamin E oil on the [VENIPUNCTURE] site may reduce [SCARRING],[SCARRING],[VENIPUNCTURE],TWrex-treat
788211805,9/14/2015 17:45:37,1738006351,9/14/2015 17:45:17,False,neodev,0.6994,31984900,CAN,AB,Edmonton,208.123.223.100,[VENIPUNCTURE] treats [SCARRING],91,62,,99,73,treats,0.753778361444409,222455,Anecdotal reports have said that rubbing Vitamin E oil on the [VENIPUNCTURE] site may reduce [SCARRING],[SCARRING],[VENIPUNCTURE],TWrex-treat
788211805,9/14/2015 17:45:49,1738006404,9/14/2015 17:45:38,False,instagc,0.7589,26024737,GBR,H2,Preston,92.23.186.130,[VENIPUNCTURE] treats [SCARRING],91,62,,99,73,treats,0.753778361444409,222455,Anecdotal reports have said that rubbing Vitamin E oil on the [VENIPUNCTURE] site may reduce [SCARRING],[SCARRING],[VENIPUNCTURE],TWrex-treat
788211805,9/14/2015 17:50:43,1738009009,9/14/2015 17:49:29,False,neodev,0.75,20306047,GBR,,,80.41.0.252,no_relation,91,62,,99,73,treats,0.753778361444409,222455,Anecdotal reports have said that rubbing Vitamin E oil on the [VENIPUNCTURE] site may reduce [SCARRING],[SCARRING],[VENIPUNCTURE],TWrex-treat
788211805,9/14/2015 17:51:54,1738009612,9/14/2015 17:50:56,False,neodev,0.6577,34281269,USA,VA,Mclean,63.141.204.170,[VENIPUNCTURE] treats [SCARRING],91,62,,99,73,treats,0.753778361444409,222455,Anecdotal reports have said that rubbing Vitamin E oil on the [VENIPUNCTURE] site may reduce [SCARRING],[SCARRING],[VENIPUNCTURE],TWrex-treat
788211805,9/14/2015 17:52:53,1738010263,9/14/2015 17:51:14,False,clixsense,0.8601,30777913,GBR,U8,Edinburgh,92.239.140.40,[VENIPUNCTURE] treats [SCARRING],91,62,,99,73,treats,0.753778361444409,222455,Anecdotal reports have said that rubbing Vitamin E oil on the [VENIPUNCTURE] site may reduce [SCARRING],[SCARRING],[VENIPUNCTURE],TWrex-treat
788211805,9/14/2015 17:53:01,1738010393,9/14/2015 17:50:01,False,clixsense,0.7738,33878524,CAN,BC,Princeton,75.156.83.71,no_relation,91,62,,99,73,treats,0.753778361444409,222455,Anecdotal reports have said that rubbing Vitamin E oil on the [VENIPUNCTURE] site may reduce [SCARRING],[SCARRING],[VENIPUNCTURE],TWrex-treat
788211807,9/14/2015 17:29:21,1737998063,9/14/2015 17:29:13,False,neodev,0.9246,11014811,GBR,G6,Hull,87.102.82.212,ALLICIN treats HELICOBACTER PYLORI,47,98,,66,105,treats,0.9830783046228491,205484,"It is also acts against the stomach ulcer germ [HELICOBACTER PYLORI], however not as efficiently as [ALLICIN].",HELICOBACTER PYLORI,ALLICIN,TWrex-treat
788211807,9/14/2015 17:35:35,1738001245,9/14/2015 17:35:15,False,neodev,0.9583,12115558,USA,OH,Twinsburg,98.27.164.131,ALLICIN treats HELICOBACTER PYLORI,47,98,,66,105,treats,0.9830783046228491,205484,"It is also acts against the stomach ulcer germ [HELICOBACTER PYLORI], however not as efficiently as [ALLICIN].",HELICOBACTER PYLORI,ALLICIN,TWrex-treat
788211807,9/14/2015 17:40:53,1738004166,9/14/2015 17:40:12,False,inboxpounds,0.7917,34449186,GBR,H9,London,82.23.2.74,ALLICIN treats HELICOBACTER PYLORI,47,98,,66,105,treats,0.9830783046228491,205484,"It is also acts against the stomach ulcer germ [HELICOBACTER PYLORI], however not as efficiently as [ALLICIN].",HELICOBACTER PYLORI,ALLICIN,TWrex-treat
788211807,9/14/2015 17:41:36,1738004482,9/14/2015 17:41:03,False,clixsense,0.7381,23144069,GBR,G6,Hull,83.100.235.226,ALLICIN treats HELICOBACTER PYLORI,47,98,,66,105,treats,0.9830783046228491,205484,"It is also acts against the stomach ulcer germ [HELICOBACTER PYLORI], however not as efficiently as [ALLICIN].",HELICOBACTER PYLORI,ALLICIN,TWrex-treat
788211807,9/14/2015 17:44:55,1738005997,9/14/2015 17:44:25,False,neodev,0.6994,31984900,CAN,AB,Edmonton,208.123.223.100,HELICOBACTER PYLORI treats ALLICIN,47,98,,66,105,treats,0.9830783046228491,205484,"It is also acts against the stomach ulcer germ [HELICOBACTER PYLORI], however not as efficiently as [ALLICIN].",HELICOBACTER PYLORI,ALLICIN,TWrex-treat
788211807,9/14/2015 17:45:07,1738006112,9/14/2015 17:44:50,False,instagc,0.7589,26024737,GBR,H2,Preston,92.23.186.130,ALLICIN treats HELICOBACTER PYLORI,47,98,,66,105,treats,0.9830783046228491,205484,"It is also acts against the stomach ulcer germ [HELICOBACTER PYLORI], however not as efficiently as [ALLICIN].",HELICOBACTER PYLORI,ALLICIN,TWrex-treat
788211807,9/14/2015 17:46:05,1738006512,9/14/2015 17:43:53,False,clixsense,0.7738,33878524,CAN,BC,Princeton,75.156.83.71,ALLICIN treats HELICOBACTER PYLORI,47,98,,66,105,treats,0.9830783046228491,205484,"It is also acts against the stomach ulcer germ [HELICOBACTER PYLORI], however not as efficiently as [ALLICIN].",HELICOBACTER PYLORI,ALLICIN,TWrex-treat
788211811,9/14/2015 19:29:38,1738109862,9/14/2015 19:29:20,False,instagc,0.7604,32352104,USA,ME,Bangor,74.75.63.81,ANTI-DEPRESSANT treats NUTCRACKER ESOPHAGUS,141,23,,161,38,treats,0.9799578870000001,207551,"Finally, trazodone, an [ANTI-DEPRESSANT] that reduces visceral sensitivity, has also been shown to reduce chest pain symptoms in patients with [NUTCRACKER ESOPHAGUS].",NUTCRACKER ESOPHAGUS,ANTI-DEPRESSANT,TWrex-treat
788211811,9/14/2015 19:36:59,1738120144,9/14/2015 19:36:39,False,clixsense,0.8881,11106820,USA,MA,Taunton,173.48.52.95,ANTI-DEPRESSANT treats NUTCRACKER ESOPHAGUS,141,23,,161,38,treats,0.9799578870000001,207551,"Finally, trazodone, an [ANTI-DEPRESSANT] that reduces visceral sensitivity, has also been shown to reduce chest pain symptoms in patients with [NUTCRACKER ESOPHAGUS].",NUTCRACKER ESOPHAGUS,ANTI-DEPRESSANT,TWrex-treat
788211811,9/14/2015 19:47:17,1738133894,9/14/2015 19:46:38,False,clixsense,0.8333,21665495,CAN,,,24.105.69.70,ANTI-DEPRESSANT treats NUTCRACKER ESOPHAGUS,141,23,,161,38,treats,0.9799578870000001,207551,"Finally, trazodone, an [ANTI-DEPRESSANT] that reduces visceral sensitivity, has also been shown to reduce chest pain symptoms in patients with [NUTCRACKER ESOPHAGUS].",NUTCRACKER ESOPHAGUS,ANTI-DEPRESSANT,TWrex-treat
788211811,9/14/2015 19:54:29,1738142783,9/14/2015 19:53:02,False,zoombucks,0.7321,4688131,CAN,BC,Vancouver,216.251.132.22,no_relation,141,23,,161,38,treats,0.9799578870000001,207551,"Finally, trazodone, an [ANTI-DEPRESSANT] that reduces visceral sensitivity, has also been shown to reduce chest pain symptoms in patients with [NUTCRACKER ESOPHAGUS].",NUTCRACKER ESOPHAGUS,ANTI-DEPRESSANT,TWrex-treat
788211811,9/14/2015 19:56:20,1738144933,9/14/2015 19:53:39,False,neodev,0.7,11658682,CAN,BC,Smithers,50.98.182.88,no_relation,141,23,,161,38,treats,0.9799578870000001,207551,"Finally, trazodone, an [ANTI-DEPRESSANT] that reduces visceral sensitivity, has also been shown to reduce chest pain symptoms in patients with [NUTCRACKER ESOPHAGUS].",NUTCRACKER ESOPHAGUS,ANTI-DEPRESSANT,TWrex-treat
788211811,9/14/2015 20:00:21,1738149954,9/14/2015 19:59:26,False,elite,0.8,29768955,GBR,C3,Gamlingay,31.50.187.165,ANTI-DEPRESSANT treats NUTCRACKER ESOPHAGUS,141,23,,161,38,treats,0.9799578870000001,207551,"Finally, trazodone, an [ANTI-DEPRESSANT] that reduces visceral sensitivity, has also been shown to reduce chest pain symptoms in patients with [NUTCRACKER ESOPHAGUS].",NUTCRACKER ESOPHAGUS,ANTI-DEPRESSANT,TWrex-treat
788211811,9/14/2015 20:39:51,1738222284,9/14/2015 20:39:20,False,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,ANTI-DEPRESSANT treats NUTCRACKER ESOPHAGUS,141,23,,161,38,treats,0.9799578870000001,207551,"Finally, trazodone, an [ANTI-DEPRESSANT] that reduces visceral sensitivity, has also been shown to reduce chest pain symptoms in patients with [NUTCRACKER ESOPHAGUS].",NUTCRACKER ESOPHAGUS,ANTI-DEPRESSANT,TWrex-treat
788211814,9/14/2015 14:57:00,1737923555,9/14/2015 14:56:42,False,elite,0.6468,34356654,USA,DE,Wilmington,108.59.2.230,INJECTION SITE treats PAIN,625,617,,638,621,treats,0.42008402520840293,802190,"Oral availability and safety should rapidly make it the preferred agent Influenza virus vaccine  Induces protective antibodies against influenza  0.5 mL im yearly  Prevents influenza, in turn preventing worsened anemia due to infection and complications of superinfections  Fever and sore arm in  Give to all patients with hemolytic anemias Pneumococcal polysaccharide vaccine  Develops antibodies to pneumococcal antigens  0.5 mL im every 5 6 years  Can prevent the most common form of overwhelming postsplenectomy sepsis; prevents worsened anemia and severe infection in all hemolytic anemia patients  Erythema and PAIN at INJECTION SITE in 50%; systemic fever in.",INJECTION SITE,PAIN,TWrex-cause
788211814,9/14/2015 14:58:13,1737924064,9/14/2015 14:57:08,False,neodev,0.8036,33238512,GBR,C5,Runcorn,109.147.217.212,INJECTION SITE treats PAIN,625,617,,638,621,treats,0.42008402520840293,802190,"Oral availability and safety should rapidly make it the preferred agent Influenza virus vaccine  Induces protective antibodies against influenza  0.5 mL im yearly  Prevents influenza, in turn preventing worsened anemia due to infection and complications of superinfections  Fever and sore arm in  Give to all patients with hemolytic anemias Pneumococcal polysaccharide vaccine  Develops antibodies to pneumococcal antigens  0.5 mL im every 5 6 years  Can prevent the most common form of overwhelming postsplenectomy sepsis; prevents worsened anemia and severe infection in all hemolytic anemia patients  Erythema and PAIN at INJECTION SITE in 50%; systemic fever in.",INJECTION SITE,PAIN,TWrex-cause
788211814,9/14/2015 15:02:36,1737925921,9/14/2015 15:01:44,False,prodege,0.8889,24403612,CAN,ON,Ajax,99.239.181.149,no_relation,625,617,,638,621,treats,0.42008402520840293,802190,"Oral availability and safety should rapidly make it the preferred agent Influenza virus vaccine  Induces protective antibodies against influenza  0.5 mL im yearly  Prevents influenza, in turn preventing worsened anemia due to infection and complications of superinfections  Fever and sore arm in  Give to all patients with hemolytic anemias Pneumococcal polysaccharide vaccine  Develops antibodies to pneumococcal antigens  0.5 mL im every 5 6 years  Can prevent the most common form of overwhelming postsplenectomy sepsis; prevents worsened anemia and severe infection in all hemolytic anemia patients  Erythema and PAIN at INJECTION SITE in 50%; systemic fever in.",INJECTION SITE,PAIN,TWrex-cause
788211814,9/14/2015 15:08:38,1737928545,9/14/2015 15:07:07,False,neodev,0.7986,33758777,USA,,,38.95.108.251,INJECTION SITE treats PAIN,625,617,,638,621,treats,0.42008402520840293,802190,"Oral availability and safety should rapidly make it the preferred agent Influenza virus vaccine  Induces protective antibodies against influenza  0.5 mL im yearly  Prevents influenza, in turn preventing worsened anemia due to infection and complications of superinfections  Fever and sore arm in  Give to all patients with hemolytic anemias Pneumococcal polysaccharide vaccine  Develops antibodies to pneumococcal antigens  0.5 mL im every 5 6 years  Can prevent the most common form of overwhelming postsplenectomy sepsis; prevents worsened anemia and severe infection in all hemolytic anemia patients  Erythema and PAIN at INJECTION SITE in 50%; systemic fever in.",INJECTION SITE,PAIN,TWrex-cause
788211814,9/14/2015 15:11:14,1737929540,9/14/2015 15:10:24,False,prodege,0.7778,21417560,GBR,C3,Cambridge,151.224.120.191,no_relation,625,617,,638,621,treats,0.42008402520840293,802190,"Oral availability and safety should rapidly make it the preferred agent Influenza virus vaccine  Induces protective antibodies against influenza  0.5 mL im yearly  Prevents influenza, in turn preventing worsened anemia due to infection and complications of superinfections  Fever and sore arm in  Give to all patients with hemolytic anemias Pneumococcal polysaccharide vaccine  Develops antibodies to pneumococcal antigens  0.5 mL im every 5 6 years  Can prevent the most common form of overwhelming postsplenectomy sepsis; prevents worsened anemia and severe infection in all hemolytic anemia patients  Erythema and PAIN at INJECTION SITE in 50%; systemic fever in.",INJECTION SITE,PAIN,TWrex-cause
788211814,9/14/2015 15:11:38,1737929745,9/14/2015 15:09:37,False,points4rewards,0.8165,20113482,USA,PA,Philadelphia,162.208.49.45,no_relation,625,617,,638,621,treats,0.42008402520840293,802190,"Oral availability and safety should rapidly make it the preferred agent Influenza virus vaccine  Induces protective antibodies against influenza  0.5 mL im yearly  Prevents influenza, in turn preventing worsened anemia due to infection and complications of superinfections  Fever and sore arm in  Give to all patients with hemolytic anemias Pneumococcal polysaccharide vaccine  Develops antibodies to pneumococcal antigens  0.5 mL im every 5 6 years  Can prevent the most common form of overwhelming postsplenectomy sepsis; prevents worsened anemia and severe infection in all hemolytic anemia patients  Erythema and PAIN at INJECTION SITE in 50%; systemic fever in.",INJECTION SITE,PAIN,TWrex-cause
788211814,9/14/2015 15:13:47,1737930718,9/14/2015 15:13:31,False,meprizescf,0.8115,28483210,USA,WI,Minocqua,75.143.134.247,INJECTION SITE treats PAIN,625,617,,638,621,treats,0.42008402520840293,802190,"Oral availability and safety should rapidly make it the preferred agent Influenza virus vaccine  Induces protective antibodies against influenza  0.5 mL im yearly  Prevents influenza, in turn preventing worsened anemia due to infection and complications of superinfections  Fever and sore arm in  Give to all patients with hemolytic anemias Pneumococcal polysaccharide vaccine  Develops antibodies to pneumococcal antigens  0.5 mL im every 5 6 years  Can prevent the most common form of overwhelming postsplenectomy sepsis; prevents worsened anemia and severe infection in all hemolytic anemia patients  Erythema and PAIN at INJECTION SITE in 50%; systemic fever in.",INJECTION SITE,PAIN,TWrex-cause
788659623,9/15/2015 09:57:09,1738648481,9/15/2015 09:57:00,False,neodev,1.0,14096345,NLD,03,Eibergen,178.85.94.186,no_relation,24,0,,41,19,treats,0.9970544855015809,803503,ALBENDAZOLE THERAPY for NEUROCYSTICERCOSIS: a prospective double blind trial comparing 7 versus 14 days of treatment.,NEUROCYSTICERCOSIS,ALBENDAZOLE THERAPY,TWrex-cause
788659623,9/15/2015 09:58:35,1738648831,9/15/2015 09:57:25,False,neodev,0.8889,33644825,USA,IL,Chicago,65.60.20.67,ALBENDAZOLE THERAPY treats NEUROCYSTICERCOSIS,24,0,,41,19,treats,0.9970544855015809,803503,ALBENDAZOLE THERAPY for NEUROCYSTICERCOSIS: a prospective double blind trial comparing 7 versus 14 days of treatment.,NEUROCYSTICERCOSIS,ALBENDAZOLE THERAPY,TWrex-cause
788659623,9/15/2015 09:59:11,1738648927,9/15/2015 09:58:49,False,gifthulk,0.8056,33936811,AUS,04,Brisbane,121.208.7.253,ALBENDAZOLE THERAPY treats NEUROCYSTICERCOSIS,24,0,,41,19,treats,0.9970544855015809,803503,ALBENDAZOLE THERAPY for NEUROCYSTICERCOSIS: a prospective double blind trial comparing 7 versus 14 days of treatment.,NEUROCYSTICERCOSIS,ALBENDAZOLE THERAPY,TWrex-cause
788659623,9/15/2015 10:04:22,1738650430,9/15/2015 10:04:09,False,meprizescf,0.8611,28483210,USA,WI,Minocqua,75.143.134.247,ALBENDAZOLE THERAPY treats NEUROCYSTICERCOSIS,24,0,,41,19,treats,0.9970544855015809,803503,ALBENDAZOLE THERAPY for NEUROCYSTICERCOSIS: a prospective double blind trial comparing 7 versus 14 days of treatment.,NEUROCYSTICERCOSIS,ALBENDAZOLE THERAPY,TWrex-cause
788659623,9/15/2015 10:16:05,1738653763,9/15/2015 10:15:39,False,prodege,0.8764,21417560,GBR,C3,Cambridge,151.224.120.191,ALBENDAZOLE THERAPY treats NEUROCYSTICERCOSIS,24,0,,41,19,treats,0.9970544855015809,803503,ALBENDAZOLE THERAPY for NEUROCYSTICERCOSIS: a prospective double blind trial comparing 7 versus 14 days of treatment.,NEUROCYSTICERCOSIS,ALBENDAZOLE THERAPY,TWrex-cause
788659623,9/15/2015 10:18:55,1738654428,9/15/2015 10:18:30,False,prodege,0.7056,4316379,CAN,ON,Windsor,198.91.219.55,ALBENDAZOLE THERAPY treats NEUROCYSTICERCOSIS,24,0,,41,19,treats,0.9970544855015809,803503,ALBENDAZOLE THERAPY for NEUROCYSTICERCOSIS: a prospective double blind trial comparing 7 versus 14 days of treatment.,NEUROCYSTICERCOSIS,ALBENDAZOLE THERAPY,TWrex-cause
788659623,9/15/2015 10:21:32,1738655095,9/15/2015 10:19:40,False,keeprewarding,0.8556,29139615,CAN,ON,Perth,192.186.81.178,ALBENDAZOLE THERAPY treats NEUROCYSTICERCOSIS,24,0,,41,19,treats,0.9970544855015809,803503,ALBENDAZOLE THERAPY for NEUROCYSTICERCOSIS: a prospective double blind trial comparing 7 versus 14 days of treatment.,NEUROCYSTICERCOSIS,ALBENDAZOLE THERAPY,TWrex-cause
788659630,9/15/2015 09:15:11,1738637475,9/15/2015 09:14:43,False,clixsense,0.9028,30681826,GBR,I9,Diss,31.49.71.254,LOW DOSE TRIMETHOPRIM SULFAMETHOXAZOLE PROPHYLAXIS treats TOXOPLASMIC ENCEPHALITIS,89,34,,112,84,treats,0.9941348467724341,800285,"Carr A, Tindall B, Brew BJ et al. LOW DOSE TRIMETHOPRIM SULFAMETHOXAZOLE PROPHYLAXIS for TOXOPLASMIC ENCEPHALITIS in patients with AIDS.",TOXOPLASMIC ENCEPHALITIS,LOW DOSE TRIMETHOPRIM SULFAMETHOXAZOLE PROPHYLAXIS,TWrex-cause
788659630,9/15/2015 09:16:29,1738637675,9/15/2015 09:16:08,False,neodev,0.7083,32053642,GBR,I7,Newcastle Upon Tyne,92.23.136.205,no_relation,89,34,,112,84,treats,0.9941348467724341,800285,"Carr A, Tindall B, Brew BJ et al. LOW DOSE TRIMETHOPRIM SULFAMETHOXAZOLE PROPHYLAXIS for TOXOPLASMIC ENCEPHALITIS in patients with AIDS.",TOXOPLASMIC ENCEPHALITIS,LOW DOSE TRIMETHOPRIM SULFAMETHOXAZOLE PROPHYLAXIS,TWrex-cause
788659630,9/15/2015 09:17:54,1738637863,9/15/2015 09:17:40,False,neodev,0.7778,20306047,GBR,,,80.41.0.252,LOW DOSE TRIMETHOPRIM SULFAMETHOXAZOLE PROPHYLAXIS treats TOXOPLASMIC ENCEPHALITIS,89,34,,112,84,treats,0.9941348467724341,800285,"Carr A, Tindall B, Brew BJ et al. LOW DOSE TRIMETHOPRIM SULFAMETHOXAZOLE PROPHYLAXIS for TOXOPLASMIC ENCEPHALITIS in patients with AIDS.",TOXOPLASMIC ENCEPHALITIS,LOW DOSE TRIMETHOPRIM SULFAMETHOXAZOLE PROPHYLAXIS,TWrex-cause
788659630,9/15/2015 09:27:38,1738639899,9/15/2015 09:27:04,False,tremorgames,0.8333,32655637,CAN,ON,Markham,135.23.223.26,LOW DOSE TRIMETHOPRIM SULFAMETHOXAZOLE PROPHYLAXIS treats TOXOPLASMIC ENCEPHALITIS,89,34,,112,84,treats,0.9941348467724341,800285,"Carr A, Tindall B, Brew BJ et al. LOW DOSE TRIMETHOPRIM SULFAMETHOXAZOLE PROPHYLAXIS for TOXOPLASMIC ENCEPHALITIS in patients with AIDS.",TOXOPLASMIC ENCEPHALITIS,LOW DOSE TRIMETHOPRIM SULFAMETHOXAZOLE PROPHYLAXIS,TWrex-cause
788659630,9/15/2015 09:36:25,1738642586,9/15/2015 09:36:06,False,clixsense,0.775,22751911,NLD,04,Groningen,195.241.153.97,LOW DOSE TRIMETHOPRIM SULFAMETHOXAZOLE PROPHYLAXIS treats TOXOPLASMIC ENCEPHALITIS,89,34,,112,84,treats,0.9941348467724341,800285,"Carr A, Tindall B, Brew BJ et al. LOW DOSE TRIMETHOPRIM SULFAMETHOXAZOLE PROPHYLAXIS for TOXOPLASMIC ENCEPHALITIS in patients with AIDS.",TOXOPLASMIC ENCEPHALITIS,LOW DOSE TRIMETHOPRIM SULFAMETHOXAZOLE PROPHYLAXIS,TWrex-cause
788659630,9/15/2015 09:38:40,1738643459,9/15/2015 09:38:12,False,treasuretrooper,0.625,17956656,AUS,02,Jannali,14.200.59.55,no_relation,89,34,,112,84,treats,0.9941348467724341,800285,"Carr A, Tindall B, Brew BJ et al. LOW DOSE TRIMETHOPRIM SULFAMETHOXAZOLE PROPHYLAXIS for TOXOPLASMIC ENCEPHALITIS in patients with AIDS.",TOXOPLASMIC ENCEPHALITIS,LOW DOSE TRIMETHOPRIM SULFAMETHOXAZOLE PROPHYLAXIS,TWrex-cause
788659630,9/15/2015 09:41:37,1738644352,9/15/2015 09:41:22,False,instagc,0.7857,18960682,GBR,U2,Annan,92.18.213.181,LOW DOSE TRIMETHOPRIM SULFAMETHOXAZOLE PROPHYLAXIS treats TOXOPLASMIC ENCEPHALITIS,89,34,,112,84,treats,0.9941348467724341,800285,"Carr A, Tindall B, Brew BJ et al. LOW DOSE TRIMETHOPRIM SULFAMETHOXAZOLE PROPHYLAXIS for TOXOPLASMIC ENCEPHALITIS in patients with AIDS.",TOXOPLASMIC ENCEPHALITIS,LOW DOSE TRIMETHOPRIM SULFAMETHOXAZOLE PROPHYLAXIS,TWrex-cause
788659635,9/15/2015 12:45:07,1738704786,9/15/2015 12:44:49,False,prodege,0.8024,3587109,CAN,NS,Sydney,142.177.43.123,CLOMIPRAMINE treats OBSESSIVE COMPULSIVE DISORDER,95,43,,123,91,treats,0.975900072948533,800358,"Freeman CPL, Trimble MR, Deakin JFW et al. FLUVOXAMINE VERSUS CLOMIPRAMINE IN THE TREATMENT OF OBSESSIVE COMPULSIVE DISORDER: a multicenter, randomized, double blind, parallel group comparison.",OBSESSIVE COMPULSIVE DISORDER,CLOMIPRAMINE,TWrex-cause
788659635,9/15/2015 13:35:53,1738718803,9/15/2015 13:35:32,False,dailyrewardsca,1.0,32219778,CAN,ON,Ottawa,99.241.19.27,CLOMIPRAMINE treats OBSESSIVE COMPULSIVE DISORDER,95,43,,123,91,treats,0.975900072948533,800358,"Freeman CPL, Trimble MR, Deakin JFW et al. FLUVOXAMINE VERSUS CLOMIPRAMINE IN THE TREATMENT OF OBSESSIVE COMPULSIVE DISORDER: a multicenter, randomized, double blind, parallel group comparison.",OBSESSIVE COMPULSIVE DISORDER,CLOMIPRAMINE,TWrex-cause
788659635,9/15/2015 13:49:53,1738724426,9/15/2015 13:48:14,False,zoombucks,0.875,6744840,CAN,BC,Kelowna,174.4.58.160,CLOMIPRAMINE treats OBSESSIVE COMPULSIVE DISORDER,95,43,,123,91,treats,0.975900072948533,800358,"Freeman CPL, Trimble MR, Deakin JFW et al. FLUVOXAMINE VERSUS CLOMIPRAMINE IN THE TREATMENT OF OBSESSIVE COMPULSIVE DISORDER: a multicenter, randomized, double blind, parallel group comparison.",OBSESSIVE COMPULSIVE DISORDER,CLOMIPRAMINE,TWrex-cause
788659635,9/15/2015 13:53:24,1738725152,9/15/2015 13:52:18,False,clixsense,1.0,25399403,GBR,H3,Leeds,81.157.142.21,CLOMIPRAMINE treats OBSESSIVE COMPULSIVE DISORDER,95,43,,123,91,treats,0.975900072948533,800358,"Freeman CPL, Trimble MR, Deakin JFW et al. FLUVOXAMINE VERSUS CLOMIPRAMINE IN THE TREATMENT OF OBSESSIVE COMPULSIVE DISORDER: a multicenter, randomized, double blind, parallel group comparison.",OBSESSIVE COMPULSIVE DISORDER,CLOMIPRAMINE,TWrex-cause
788659635,9/15/2015 14:01:11,1738726908,9/15/2015 14:00:54,False,clixsense,0.9167,9653950,CAN,SK,Yorkton,207.47.178.70,CLOMIPRAMINE treats OBSESSIVE COMPULSIVE DISORDER,95,43,,123,91,treats,0.975900072948533,800358,"Freeman CPL, Trimble MR, Deakin JFW et al. FLUVOXAMINE VERSUS CLOMIPRAMINE IN THE TREATMENT OF OBSESSIVE COMPULSIVE DISORDER: a multicenter, randomized, double blind, parallel group comparison.",OBSESSIVE COMPULSIVE DISORDER,CLOMIPRAMINE,TWrex-cause
788659635,9/15/2015 14:09:07,1738729034,9/15/2015 14:08:16,False,neodev,0.9375,22074628,GBR,I9,Norwich,92.3.60.138,CLOMIPRAMINE treats OBSESSIVE COMPULSIVE DISORDER,95,43,,123,91,treats,0.975900072948533,800358,"Freeman CPL, Trimble MR, Deakin JFW et al. FLUVOXAMINE VERSUS CLOMIPRAMINE IN THE TREATMENT OF OBSESSIVE COMPULSIVE DISORDER: a multicenter, randomized, double blind, parallel group comparison.",OBSESSIVE COMPULSIVE DISORDER,CLOMIPRAMINE,TWrex-cause
788659635,9/15/2015 14:17:06,1738731234,9/15/2015 14:16:11,False,eup_slw,0.7994,32022942,CAN,ON,Hamilton,76.67.173.137,CLOMIPRAMINE treats OBSESSIVE COMPULSIVE DISORDER,95,43,,123,91,treats,0.975900072948533,800358,"Freeman CPL, Trimble MR, Deakin JFW et al. FLUVOXAMINE VERSUS CLOMIPRAMINE IN THE TREATMENT OF OBSESSIVE COMPULSIVE DISORDER: a multicenter, randomized, double blind, parallel group comparison.",OBSESSIVE COMPULSIVE DISORDER,CLOMIPRAMINE,TWrex-cause
788659639,9/15/2015 12:36:18,1738702024,9/15/2015 12:36:04,False,neodev,0.9208,12115558,USA,OH,Twinsburg,98.27.164.131,PROCARBAZINE treats MANTLE CELL LYMPHOMA,45,97,,65,109,treats,0.9113223769,211717,"Oral combination chemotherapy with Pep-C for [MANTLE CELL LYMPHOMA] : Daily prednisone, etoposide, [PROCARBAZINE] and cyclophosphamide.",MANTLE CELL LYMPHOMA,PROCARBAZINE,TWrex-treat
788659639,9/15/2015 12:36:54,1738702233,9/15/2015 12:34:25,False,neodev,0.7528,33758777,USA,,,38.95.108.251,no_relation,45,97,,65,109,treats,0.9113223769,211717,"Oral combination chemotherapy with Pep-C for [MANTLE CELL LYMPHOMA] : Daily prednisone, etoposide, [PROCARBAZINE] and cyclophosphamide.",MANTLE CELL LYMPHOMA,PROCARBAZINE,TWrex-treat
788659639,9/15/2015 12:38:41,1738702874,9/15/2015 12:38:00,False,vivatic,0.7972,32338429,GBR,N7,Guildford,92.21.219.178,PROCARBAZINE treats MANTLE CELL LYMPHOMA,45,97,,65,109,treats,0.9113223769,211717,"Oral combination chemotherapy with Pep-C for [MANTLE CELL LYMPHOMA] : Daily prednisone, etoposide, [PROCARBAZINE] and cyclophosphamide.",MANTLE CELL LYMPHOMA,PROCARBAZINE,TWrex-treat
788659639,9/15/2015 12:44:27,1738704573,9/15/2015 12:44:01,False,prodege,0.8024,3587109,CAN,NS,Sydney,142.177.43.123,no_relation,45,97,,65,109,treats,0.9113223769,211717,"Oral combination chemotherapy with Pep-C for [MANTLE CELL LYMPHOMA] : Daily prednisone, etoposide, [PROCARBAZINE] and cyclophosphamide.",MANTLE CELL LYMPHOMA,PROCARBAZINE,TWrex-treat
788659639,9/15/2015 12:44:47,1738704714,9/15/2015 12:43:50,False,prodege,0.6643,24945126,GBR,K8,Ilford,82.12.220.44,PROCARBAZINE treats MANTLE CELL LYMPHOMA,45,97,,65,109,treats,0.9113223769,211717,"Oral combination chemotherapy with Pep-C for [MANTLE CELL LYMPHOMA] : Daily prednisone, etoposide, [PROCARBAZINE] and cyclophosphamide.",MANTLE CELL LYMPHOMA,PROCARBAZINE,TWrex-treat
788659639,9/15/2015 12:55:30,1738707408,9/15/2015 12:55:07,False,zoombucks,0.45,4711962,CAN,ON,Markham,174.88.29.138,PROCARBAZINE treats MANTLE CELL LYMPHOMA,45,97,,65,109,treats,0.9113223769,211717,"Oral combination chemotherapy with Pep-C for [MANTLE CELL LYMPHOMA] : Daily prednisone, etoposide, [PROCARBAZINE] and cyclophosphamide.",MANTLE CELL LYMPHOMA,PROCARBAZINE,TWrex-treat
788659639,9/15/2015 13:05:21,1738709915,9/15/2015 13:05:14,False,neodev,0.5,33701549,USA,CA,San Jose,23.27.248.252,PROCARBAZINE treats MANTLE CELL LYMPHOMA,45,97,,65,109,treats,0.9113223769,211717,"Oral combination chemotherapy with Pep-C for [MANTLE CELL LYMPHOMA] : Daily prednisone, etoposide, [PROCARBAZINE] and cyclophosphamide.",MANTLE CELL LYMPHOMA,PROCARBAZINE,TWrex-treat
788659640,9/15/2015 12:25:41,1738698286,9/15/2015 12:25:20,False,clixsense,0.9762,30777913,GBR,U8,Edinburgh,92.239.140.40,RIFAPENTINE treats PULMONARY TUBERCULOSIS,93,29,,114,40,treats,1.0,800362,"Tam CM, Chan SL, Lam CW et alRIFAPENTINE and isoniazid in the continuation phase of treating PULMONARY TUBERCULOSIS",PULMONARY TUBERCULOSIS,RIFAPENTINE,TWrex-cause
788659640,9/15/2015 12:26:50,1738698671,9/15/2015 12:26:36,False,neodev,0.7897,34429821,USA,CA,Torrance,66.171.228.249,RIFAPENTINE treats PULMONARY TUBERCULOSIS,93,29,,114,40,treats,1.0,800362,"Tam CM, Chan SL, Lam CW et alRIFAPENTINE and isoniazid in the continuation phase of treating PULMONARY TUBERCULOSIS",PULMONARY TUBERCULOSIS,RIFAPENTINE,TWrex-cause
788659640,9/15/2015 12:33:05,1738700761,9/15/2015 12:32:39,False,neodev,0.7528,33758777,USA,,,38.95.108.251,RIFAPENTINE treats PULMONARY TUBERCULOSIS,93,29,,114,40,treats,1.0,800362,"Tam CM, Chan SL, Lam CW et alRIFAPENTINE and isoniazid in the continuation phase of treating PULMONARY TUBERCULOSIS",PULMONARY TUBERCULOSIS,RIFAPENTINE,TWrex-cause
788659640,9/15/2015 12:35:36,1738701790,9/15/2015 12:35:19,False,neodev,0.9208,12115558,USA,OH,Twinsburg,98.27.164.131,RIFAPENTINE treats PULMONARY TUBERCULOSIS,93,29,,114,40,treats,1.0,800362,"Tam CM, Chan SL, Lam CW et alRIFAPENTINE and isoniazid in the continuation phase of treating PULMONARY TUBERCULOSIS",PULMONARY TUBERCULOSIS,RIFAPENTINE,TWrex-cause
788659640,9/15/2015 12:37:04,1738702302,9/15/2015 12:36:38,False,vivatic,0.7972,32338429,GBR,N7,Guildford,92.21.219.178,RIFAPENTINE treats PULMONARY TUBERCULOSIS,93,29,,114,40,treats,1.0,800362,"Tam CM, Chan SL, Lam CW et alRIFAPENTINE and isoniazid in the continuation phase of treating PULMONARY TUBERCULOSIS",PULMONARY TUBERCULOSIS,RIFAPENTINE,TWrex-cause
788659640,9/15/2015 12:42:29,1738704028,9/15/2015 12:42:18,False,instagc,1.0,13581319,USA,IL,Trenton,208.70.36.12,RIFAPENTINE treats PULMONARY TUBERCULOSIS,93,29,,114,40,treats,1.0,800362,"Tam CM, Chan SL, Lam CW et alRIFAPENTINE and isoniazid in the continuation phase of treating PULMONARY TUBERCULOSIS",PULMONARY TUBERCULOSIS,RIFAPENTINE,TWrex-cause
788659640,9/15/2015 12:42:48,1738704080,9/15/2015 12:42:22,False,prodege,0.6643,24945126,GBR,K8,Ilford,82.12.220.44,RIFAPENTINE treats PULMONARY TUBERCULOSIS,93,29,,114,40,treats,1.0,800362,"Tam CM, Chan SL, Lam CW et alRIFAPENTINE and isoniazid in the continuation phase of treating PULMONARY TUBERCULOSIS",PULMONARY TUBERCULOSIS,RIFAPENTINE,TWrex-cause
788659642,9/15/2015 13:36:51,1738720344,9/15/2015 13:36:30,False,dailyrewardsca,1.0,32219778,CAN,ON,Ottawa,99.241.19.27,no_relation,47,139,,65,154,treats,0.6933752452815359,104508,"Although the recurrence risk is not increased, [GENETIC COUNSELING] is often recommended for families who have had a pregnancy or child with [TURNER SYNDROME].",GENETIC COUNSELING,TURNER SYNDROME,TWrex-symptom
788659642,9/15/2015 13:53:55,1738725291,9/15/2015 13:53:15,False,zoombucks,0.875,6744840,CAN,BC,Kelowna,174.4.58.160,GENETIC COUNSELING treats TURNER SYNDROME,47,139,,65,154,treats,0.6933752452815359,104508,"Although the recurrence risk is not increased, [GENETIC COUNSELING] is often recommended for families who have had a pregnancy or child with [TURNER SYNDROME].",GENETIC COUNSELING,TURNER SYNDROME,TWrex-symptom
788659642,9/15/2015 14:01:55,1738727153,9/15/2015 14:01:43,False,clixsense,0.9167,9653950,CAN,SK,Yorkton,207.47.178.70,GENETIC COUNSELING treats TURNER SYNDROME,47,139,,65,154,treats,0.6933752452815359,104508,"Although the recurrence risk is not increased, [GENETIC COUNSELING] is often recommended for families who have had a pregnancy or child with [TURNER SYNDROME].",GENETIC COUNSELING,TURNER SYNDROME,TWrex-symptom
788659642,9/15/2015 14:11:17,1738729566,9/15/2015 14:10:51,False,neodev,0.9375,22074628,GBR,I9,Norwich,92.3.60.138,GENETIC COUNSELING treats TURNER SYNDROME,47,139,,65,154,treats,0.6933752452815359,104508,"Although the recurrence risk is not increased, [GENETIC COUNSELING] is often recommended for families who have had a pregnancy or child with [TURNER SYNDROME].",GENETIC COUNSELING,TURNER SYNDROME,TWrex-symptom
788659642,9/15/2015 14:19:23,1738731863,9/15/2015 14:18:49,False,eup_slw,0.7994,32022942,CAN,ON,Hamilton,76.67.173.137,no_relation,47,139,,65,154,treats,0.6933752452815359,104508,"Although the recurrence risk is not increased, [GENETIC COUNSELING] is often recommended for families who have had a pregnancy or child with [TURNER SYNDROME].",GENETIC COUNSELING,TURNER SYNDROME,TWrex-symptom
788659642,9/15/2015 14:23:19,1738733302,9/15/2015 14:22:47,False,instagc,0.9325,21551272,GBR,Q3,Wolverhampton,89.168.199.12,GENETIC COUNSELING treats TURNER SYNDROME,47,139,,65,154,treats,0.6933752452815359,104508,"Although the recurrence risk is not increased, [GENETIC COUNSELING] is often recommended for families who have had a pregnancy or child with [TURNER SYNDROME].",GENETIC COUNSELING,TURNER SYNDROME,TWrex-symptom
788659642,9/15/2015 14:40:37,1738737655,9/15/2015 14:36:17,False,onestopgpt,0.6571,21275875,CAN,ON,Hamilton,24.36.124.79,no_relation,47,139,,65,154,treats,0.6933752452815359,104508,"Although the recurrence risk is not increased, [GENETIC COUNSELING] is often recommended for families who have had a pregnancy or child with [TURNER SYNDROME].",GENETIC COUNSELING,TURNER SYNDROME,TWrex-symptom
788659648,9/15/2015 12:36:30,1738702094,9/15/2015 12:36:19,False,neodev,0.9208,12115558,USA,OH,Twinsburg,98.27.164.131,[PENTOBARBITAL INDUCED COMA] treats [MANNITOL],0,97,,25,105,treats,0.9036961141150641,224658,[PENTOBARBITAL INDUCED COMA] has been advocated in patients with acute liver failure refractory to [MANNITOL],[PENTOBARBITAL INDUCED COMA],[MANNITOL],TWrex-treat
788659648,9/15/2015 12:38:44,1738702877,9/15/2015 12:36:55,False,neodev,0.7528,33758777,USA,,,38.95.108.251,no_relation,0,97,,25,105,treats,0.9036961141150641,224658,[PENTOBARBITAL INDUCED COMA] has been advocated in patients with acute liver failure refractory to [MANNITOL],[PENTOBARBITAL INDUCED COMA],[MANNITOL],TWrex-treat
788659648,9/15/2015 12:39:09,1738703049,9/15/2015 12:38:43,False,vivatic,0.7972,32338429,GBR,N7,Guildford,92.21.219.178,[MANNITOL] treats [PENTOBARBITAL INDUCED COMA],0,97,,25,105,treats,0.9036961141150641,224658,[PENTOBARBITAL INDUCED COMA] has been advocated in patients with acute liver failure refractory to [MANNITOL],[PENTOBARBITAL INDUCED COMA],[MANNITOL],TWrex-treat
788659648,9/15/2015 12:44:48,1738704719,9/15/2015 12:44:28,False,prodege,0.8024,3587109,CAN,NS,Sydney,142.177.43.123,[PENTOBARBITAL INDUCED COMA] treats [MANNITOL],0,97,,25,105,treats,0.9036961141150641,224658,[PENTOBARBITAL INDUCED COMA] has been advocated in patients with acute liver failure refractory to [MANNITOL],[PENTOBARBITAL INDUCED COMA],[MANNITOL],TWrex-treat
788659648,9/15/2015 12:46:52,1738705370,9/15/2015 12:45:03,False,prodege,0.6643,24945126,GBR,K8,Ilford,82.12.220.44,no_relation,0,97,,25,105,treats,0.9036961141150641,224658,[PENTOBARBITAL INDUCED COMA] has been advocated in patients with acute liver failure refractory to [MANNITOL],[PENTOBARBITAL INDUCED COMA],[MANNITOL],TWrex-treat
788659648,9/15/2015 12:55:40,1738707435,9/15/2015 12:55:31,False,zoombucks,0.45,4711962,CAN,ON,Markham,174.88.29.138,[MANNITOL] treats [PENTOBARBITAL INDUCED COMA],0,97,,25,105,treats,0.9036961141150641,224658,[PENTOBARBITAL INDUCED COMA] has been advocated in patients with acute liver failure refractory to [MANNITOL],[PENTOBARBITAL INDUCED COMA],[MANNITOL],TWrex-treat
788659648,9/15/2015 13:21:00,1738714366,9/15/2015 13:20:52,False,clixsense,0.5714,19162475,GBR,P8,Trowbridge,82.33.126.30,[MANNITOL] treats [PENTOBARBITAL INDUCED COMA],0,97,,25,105,treats,0.9036961141150641,224658,[PENTOBARBITAL INDUCED COMA] has been advocated in patients with acute liver failure refractory to [MANNITOL],[PENTOBARBITAL INDUCED COMA],[MANNITOL],TWrex-treat
788659649,9/15/2015 12:45:32,1738704907,9/15/2015 12:45:08,False,prodege,0.8024,3587109,CAN,NS,Sydney,142.177.43.123,[CLONIDINE] treats [LOWER BLOOD PRESSURE],54,0,,74,8,treats,0.525785614053287,217358,[CLONIDINE] suppresses sympathetic outflow resulting in [LOWER BLOOD PRESSURE] but sudden discontinuation can cause rebound hypertension due to a rebound in sympathetic outflow.,[LOWER BLOOD PRESSURE],[CLONIDINE],TWrex-treat
788659649,9/15/2015 13:36:11,1738719264,9/15/2015 13:35:54,False,dailyrewardsca,1.0,32219778,CAN,ON,Ottawa,99.241.19.27,[CLONIDINE] treats [LOWER BLOOD PRESSURE],54,0,,74,8,treats,0.525785614053287,217358,[CLONIDINE] suppresses sympathetic outflow resulting in [LOWER BLOOD PRESSURE] but sudden discontinuation can cause rebound hypertension due to a rebound in sympathetic outflow.,[LOWER BLOOD PRESSURE],[CLONIDINE],TWrex-treat
788659649,9/15/2015 13:52:01,1738724810,9/15/2015 13:49:54,False,zoombucks,0.875,6744840,CAN,BC,Kelowna,174.4.58.160,[CLONIDINE] treats [LOWER BLOOD PRESSURE],54,0,,74,8,treats,0.525785614053287,217358,[CLONIDINE] suppresses sympathetic outflow resulting in [LOWER BLOOD PRESSURE] but sudden discontinuation can cause rebound hypertension due to a rebound in sympathetic outflow.,[LOWER BLOOD PRESSURE],[CLONIDINE],TWrex-treat
788659649,9/15/2015 14:01:31,1738727027,9/15/2015 14:01:12,False,clixsense,0.9167,9653950,CAN,SK,Yorkton,207.47.178.70,[CLONIDINE] treats [LOWER BLOOD PRESSURE],54,0,,74,8,treats,0.525785614053287,217358,[CLONIDINE] suppresses sympathetic outflow resulting in [LOWER BLOOD PRESSURE] but sudden discontinuation can cause rebound hypertension due to a rebound in sympathetic outflow.,[LOWER BLOOD PRESSURE],[CLONIDINE],TWrex-treat
788659649,9/15/2015 14:10:01,1738729236,9/15/2015 14:09:09,False,neodev,0.9375,22074628,GBR,I9,Norwich,92.3.60.138,[CLONIDINE] treats [LOWER BLOOD PRESSURE],54,0,,74,8,treats,0.525785614053287,217358,[CLONIDINE] suppresses sympathetic outflow resulting in [LOWER BLOOD PRESSURE] but sudden discontinuation can cause rebound hypertension due to a rebound in sympathetic outflow.,[LOWER BLOOD PRESSURE],[CLONIDINE],TWrex-treat
788659649,9/15/2015 14:18:01,1738731533,9/15/2015 14:17:08,False,eup_slw,0.7994,32022942,CAN,ON,Hamilton,76.67.173.137,[CLONIDINE] treats [LOWER BLOOD PRESSURE],54,0,,74,8,treats,0.525785614053287,217358,[CLONIDINE] suppresses sympathetic outflow resulting in [LOWER BLOOD PRESSURE] but sudden discontinuation can cause rebound hypertension due to a rebound in sympathetic outflow.,[LOWER BLOOD PRESSURE],[CLONIDINE],TWrex-treat
788659649,9/15/2015 14:18:42,1738731706,9/15/2015 14:17:51,False,points4rewards,0.9583,28755767,USA,VA,Chester,68.57.118.32,[CLONIDINE] treats [LOWER BLOOD PRESSURE],54,0,,74,8,treats,0.525785614053287,217358,[CLONIDINE] suppresses sympathetic outflow resulting in [LOWER BLOOD PRESSURE] but sudden discontinuation can cause rebound hypertension due to a rebound in sympathetic outflow.,[LOWER BLOOD PRESSURE],[CLONIDINE],TWrex-treat
788659650,9/15/2015 13:37:23,1738721144,9/15/2015 13:37:07,False,dailyrewardsca,1.0,32219778,CAN,ON,Ottawa,99.241.19.27,no_relation,121,48,,129,57,treats,0.400891862868637,223574,"Because of its possible anticholinergic action, [MECLIZINE] should be used carefully with patients who suffer from asthma, [GLAUCOMA], or an enlarged prostate gland.",GLAUCOMA,MECLIZINE,TWrex-treat
788659650,9/15/2015 13:56:32,1738725902,9/15/2015 13:55:15,False,zoombucks,0.875,6744840,CAN,BC,Kelowna,174.4.58.160,MECLIZINE treats GLAUCOMA,121,48,,129,57,treats,0.400891862868637,223574,"Because of its possible anticholinergic action, [MECLIZINE] should be used carefully with patients who suffer from asthma, [GLAUCOMA], or an enlarged prostate gland.",GLAUCOMA,MECLIZINE,TWrex-treat
788659650,9/15/2015 14:02:40,1738727417,9/15/2015 14:02:25,False,clixsense,0.9167,9653950,CAN,SK,Yorkton,207.47.178.70,MECLIZINE treats GLAUCOMA,121,48,,129,57,treats,0.400891862868637,223574,"Because of its possible anticholinergic action, [MECLIZINE] should be used carefully with patients who suffer from asthma, [GLAUCOMA], or an enlarged prostate gland.",GLAUCOMA,MECLIZINE,TWrex-treat
788659650,9/15/2015 14:12:11,1738729754,9/15/2015 14:11:52,False,neodev,0.9375,22074628,GBR,I9,Norwich,92.3.60.138,MECLIZINE treats GLAUCOMA,121,48,,129,57,treats,0.400891862868637,223574,"Because of its possible anticholinergic action, [MECLIZINE] should be used carefully with patients who suffer from asthma, [GLAUCOMA], or an enlarged prostate gland.",GLAUCOMA,MECLIZINE,TWrex-treat
788659650,9/15/2015 14:20:20,1738732302,9/15/2015 14:19:47,False,eup_slw,0.7994,32022942,CAN,ON,Hamilton,76.67.173.137,no_relation,121,48,,129,57,treats,0.400891862868637,223574,"Because of its possible anticholinergic action, [MECLIZINE] should be used carefully with patients who suffer from asthma, [GLAUCOMA], or an enlarged prostate gland.",GLAUCOMA,MECLIZINE,TWrex-treat
788659650,9/15/2015 14:24:14,1738733533,9/15/2015 14:23:51,False,instagc,0.9325,21551272,GBR,Q3,Wolverhampton,89.168.199.12,MECLIZINE treats GLAUCOMA,121,48,,129,57,treats,0.400891862868637,223574,"Because of its possible anticholinergic action, [MECLIZINE] should be used carefully with patients who suffer from asthma, [GLAUCOMA], or an enlarged prostate gland.",GLAUCOMA,MECLIZINE,TWrex-treat
788659650,9/15/2015 14:25:38,1738733894,9/15/2015 14:25:26,False,elite,0.9643,30064988,GBR,G8,Huddersfield,92.29.158.223,MECLIZINE treats GLAUCOMA,121,48,,129,57,treats,0.400891862868637,223574,"Because of its possible anticholinergic action, [MECLIZINE] should be used carefully with patients who suffer from asthma, [GLAUCOMA], or an enlarged prostate gland.",GLAUCOMA,MECLIZINE,TWrex-treat
788659659,9/15/2015 14:24:52,1738733714,9/15/2015 14:24:35,False,instagc,0.9325,21551272,GBR,Q3,Wolverhampton,89.168.199.12,PIRACETAM treats MYOCLONUS,49,25,,58,34,treats,0.9918365981,207755,Clonazepam and high-dose [PIRACETAM] can alleviate [MYOCLONUS].,MYOCLONUS,PIRACETAM,TWrex-treat
788659659,9/15/2015 14:26:21,1738734097,9/15/2015 14:26:03,False,elite,0.9643,30064988,GBR,G8,Huddersfield,92.29.158.223,PIRACETAM treats MYOCLONUS,49,25,,58,34,treats,0.9918365981,207755,Clonazepam and high-dose [PIRACETAM] can alleviate [MYOCLONUS].,MYOCLONUS,PIRACETAM,TWrex-treat
788659659,9/15/2015 14:39:53,1738737501,9/15/2015 14:39:12,False,clixsense,0.9583,30258829,NLD,05,Velden,84.104.254.214,PIRACETAM treats MYOCLONUS,49,25,,58,34,treats,0.9918365981,207755,Clonazepam and high-dose [PIRACETAM] can alleviate [MYOCLONUS].,MYOCLONUS,PIRACETAM,TWrex-treat
788659659,9/15/2015 14:44:00,1738738873,9/15/2015 14:43:06,False,gifthulk,0.9097,18666417,USA,PA,Meadville,24.101.32.13,PIRACETAM treats MYOCLONUS,49,25,,58,34,treats,0.9918365981,207755,Clonazepam and high-dose [PIRACETAM] can alleviate [MYOCLONUS].,MYOCLONUS,PIRACETAM,TWrex-treat
788659659,9/15/2015 14:50:43,1738740862,9/15/2015 14:49:59,False,elite,0.7861,30312592,CAN,ON,Sudbury,66.103.55.12,PIRACETAM treats MYOCLONUS,49,25,,58,34,treats,0.9918365981,207755,Clonazepam and high-dose [PIRACETAM] can alleviate [MYOCLONUS].,MYOCLONUS,PIRACETAM,TWrex-treat
788659659,9/15/2015 14:54:12,1738741670,9/15/2015 14:53:23,False,clixsense,0.8833,21785037,USA,NV,Henderson,98.160.228.174,PIRACETAM treats MYOCLONUS,49,25,,58,34,treats,0.9918365981,207755,Clonazepam and high-dose [PIRACETAM] can alleviate [MYOCLONUS].,MYOCLONUS,PIRACETAM,TWrex-treat
788659659,9/15/2015 15:11:11,1738747993,9/15/2015 15:10:49,False,superrewards,0.75,33199643,USA,WI,La Crosse,138.49.1.28,PIRACETAM treats MYOCLONUS,49,25,,58,34,treats,0.9918365981,207755,Clonazepam and high-dose [PIRACETAM] can alleviate [MYOCLONUS].,MYOCLONUS,PIRACETAM,TWrex-treat
788659661,9/15/2015 11:53:55,1738687613,9/15/2015 11:53:35,False,fusioncash,0.9389,31742806,USA,OH,Kent,66.61.82.242,ACTIVE FORM OF VITAMIN D treats OSTEOPOROSIS,117,71,,128,95,treats,1.0,907445,Some misunderstandings exist internationally about the efficacy of the ACTIVE FORM OF VITAMIN D for the treatment of OSTEOPOROSIS,OSTEOPOROSIS,ACTIVE FORM OF VITAMIN D,RO-may_prevent
788659661,9/15/2015 12:01:04,1738689892,9/15/2015 12:00:47,False,prodege,0.9167,27934334,GBR,C8,Croydon,81.159.60.206,ACTIVE FORM OF VITAMIN D treats OSTEOPOROSIS,117,71,,128,95,treats,1.0,907445,Some misunderstandings exist internationally about the efficacy of the ACTIVE FORM OF VITAMIN D for the treatment of OSTEOPOROSIS,OSTEOPOROSIS,ACTIVE FORM OF VITAMIN D,RO-may_prevent
788659661,9/15/2015 12:15:54,1738694830,9/15/2015 12:15:27,False,prodege,0.8754,3056891,CAN,ON,Niagara Falls,173.238.144.19,ACTIVE FORM OF VITAMIN D treats OSTEOPOROSIS,117,71,,128,95,treats,1.0,907445,Some misunderstandings exist internationally about the efficacy of the ACTIVE FORM OF VITAMIN D for the treatment of OSTEOPOROSIS,OSTEOPOROSIS,ACTIVE FORM OF VITAMIN D,RO-may_prevent
788659661,9/15/2015 12:17:57,1738695887,9/15/2015 12:15:22,False,clixsense,0.6972,17950689,GBR,L9,Sheffield,146.200.192.103,ACTIVE FORM OF VITAMIN D treats OSTEOPOROSIS,117,71,,128,95,treats,1.0,907445,Some misunderstandings exist internationally about the efficacy of the ACTIVE FORM OF VITAMIN D for the treatment of OSTEOPOROSIS,OSTEOPOROSIS,ACTIVE FORM OF VITAMIN D,RO-may_prevent
788659661,9/15/2015 12:20:46,1738696803,9/15/2015 12:20:05,False,pocketmoneygpt,0.877,21432964,GBR,F8,Borehamwood,81.159.185.70,ACTIVE FORM OF VITAMIN D treats OSTEOPOROSIS,117,71,,128,95,treats,1.0,907445,Some misunderstandings exist internationally about the efficacy of the ACTIVE FORM OF VITAMIN D for the treatment of OSTEOPOROSIS,OSTEOPOROSIS,ACTIVE FORM OF VITAMIN D,RO-may_prevent
788659661,9/15/2015 12:24:32,1738698027,9/15/2015 12:24:12,False,clixsense,0.9762,30777913,GBR,U8,Edinburgh,92.239.140.40,ACTIVE FORM OF VITAMIN D treats OSTEOPOROSIS,117,71,,128,95,treats,1.0,907445,Some misunderstandings exist internationally about the efficacy of the ACTIVE FORM OF VITAMIN D for the treatment of OSTEOPOROSIS,OSTEOPOROSIS,ACTIVE FORM OF VITAMIN D,RO-may_prevent
788659661,9/15/2015 12:25:39,1738698283,9/15/2015 12:24:48,False,neodev,0.7897,34429821,USA,CA,Torrance,66.171.228.249,ACTIVE FORM OF VITAMIN D treats OSTEOPOROSIS,117,71,,128,95,treats,1.0,907445,Some misunderstandings exist internationally about the efficacy of the ACTIVE FORM OF VITAMIN D for the treatment of OSTEOPOROSIS,OSTEOPOROSIS,ACTIVE FORM OF VITAMIN D,RO-may_prevent
788659664,9/15/2015 10:48:18,1738661813,9/15/2015 10:47:37,False,clixsense,0.8958,21490235,GBR,N7,Woking,86.30.254.232,HEPARIN treats DIC,73,54,,75,61,treats,0.942809041582063,812345,Rewarming by hemodialysis for hypothermia: failure of HEPARIN to prevent DIC,DIC,HEPARIN,TWrex-cause
788659664,9/15/2015 11:02:16,1738664918,9/15/2015 11:01:23,False,prodege,0.7103,6309240,USA,CA,San Diego,76.167.68.73,no_relation,73,54,,75,61,treats,0.942809041582063,812345,Rewarming by hemodialysis for hypothermia: failure of HEPARIN to prevent DIC,DIC,HEPARIN,TWrex-cause
788659664,9/15/2015 11:03:38,1738665217,9/15/2015 11:03:08,False,clixsense,0.6488,28351359,GBR,K8,Ilford,80.44.178.106,HEPARIN treats DIC,73,54,,75,61,treats,0.942809041582063,812345,Rewarming by hemodialysis for hypothermia: failure of HEPARIN to prevent DIC,DIC,HEPARIN,TWrex-cause
788659664,9/15/2015 11:09:32,1738666689,9/15/2015 11:07:24,False,points4rewards,0.5893,20113482,USA,PA,Philadelphia,162.208.49.45,no_relation,73,54,,75,61,treats,0.942809041582063,812345,Rewarming by hemodialysis for hypothermia: failure of HEPARIN to prevent DIC,DIC,HEPARIN,TWrex-cause
788659664,9/15/2015 11:10:31,1738666871,9/15/2015 11:09:50,False,elite,0.7333,34356654,USA,CA,San Jose,50.118.198.254,HEPARIN treats DIC,73,54,,75,61,treats,0.942809041582063,812345,Rewarming by hemodialysis for hypothermia: failure of HEPARIN to prevent DIC,DIC,HEPARIN,TWrex-cause
788659664,9/15/2015 11:13:33,1738667983,9/15/2015 11:12:31,False,neodev,0.6468,11001780,AUS,07,Elwood,14.201.215.31,HEPARIN treats DIC,73,54,,75,61,treats,0.942809041582063,812345,Rewarming by hemodialysis for hypothermia: failure of HEPARIN to prevent DIC,DIC,HEPARIN,TWrex-cause
788659664,9/15/2015 11:14:52,1738668521,9/15/2015 11:07:40,False,clixsense,0.7357,21875134,GBR,,,80.189.12.98,HEPARIN treats DIC,73,54,,75,61,treats,0.942809041582063,812345,Rewarming by hemodialysis for hypothermia: failure of HEPARIN to prevent DIC,DIC,HEPARIN,TWrex-cause
788659675,9/15/2015 11:12:11,1738667438,9/15/2015 11:11:53,False,elite,0.7333,34356654,USA,CA,San Jose,50.118.198.254,PROPAFENONE treats PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA,76,154,,114,165,treats,0.753778361444409,804941,"A randomized, placebo controlled trial of propafenone in the prophylaxis of PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA and paroxysmal atrial fibrillation.UK PROPAFENONE PSVT Study Group:  Circulation 92:2550, 1995  17.",PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA,PROPAFENONE,TWrex-cause
788659675,9/15/2015 11:17:09,1738669593,9/15/2015 11:16:31,False,neodev,0.6468,11001780,AUS,07,Elwood,14.201.215.31,PROPAFENONE treats PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA,76,154,,114,165,treats,0.753778361444409,804941,"A randomized, placebo controlled trial of propafenone in the prophylaxis of PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA and paroxysmal atrial fibrillation.UK PROPAFENONE PSVT Study Group:  Circulation 92:2550, 1995  17.",PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA,PROPAFENONE,TWrex-cause
788659675,9/15/2015 11:18:45,1738670223,9/15/2015 11:18:22,False,clixsense,0.8097,19638651,USA,SC,Summerville,174.107.73.211,PROPAFENONE treats PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA,76,154,,114,165,treats,0.753778361444409,804941,"A randomized, placebo controlled trial of propafenone in the prophylaxis of PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA and paroxysmal atrial fibrillation.UK PROPAFENONE PSVT Study Group:  Circulation 92:2550, 1995  17.",PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA,PROPAFENONE,TWrex-cause
788659675,9/15/2015 11:19:57,1738671083,9/15/2015 11:19:31,False,clixsense,0.6431,10390268,USA,NY,New Paltz,100.40.136.250,no_relation,76,154,,114,165,treats,0.753778361444409,804941,"A randomized, placebo controlled trial of propafenone in the prophylaxis of PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA and paroxysmal atrial fibrillation.UK PROPAFENONE PSVT Study Group:  Circulation 92:2550, 1995  17.",PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA,PROPAFENONE,TWrex-cause
788659675,9/15/2015 11:23:04,1738672739,9/15/2015 11:22:03,False,clixsense,0.7357,21875134,GBR,,,80.189.12.98,PROPAFENONE treats PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA,76,154,,114,165,treats,0.753778361444409,804941,"A randomized, placebo controlled trial of propafenone in the prophylaxis of PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA and paroxysmal atrial fibrillation.UK PROPAFENONE PSVT Study Group:  Circulation 92:2550, 1995  17.",PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA,PROPAFENONE,TWrex-cause
788659675,9/15/2015 11:33:20,1738678357,9/15/2015 11:32:02,False,clixsense,0.7559999999999999,24104564,AUS,02,Surry Hills,60.241.132.132,PROPAFENONE treats PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA,76,154,,114,165,treats,0.753778361444409,804941,"A randomized, placebo controlled trial of propafenone in the prophylaxis of PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA and paroxysmal atrial fibrillation.UK PROPAFENONE PSVT Study Group:  Circulation 92:2550, 1995  17.",PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA,PROPAFENONE,TWrex-cause
788659675,9/15/2015 11:36:55,1738679879,9/15/2015 11:36:32,False,prodege,0.9365,14848125,GBR,V8,Airdrie,86.151.77.161,PROPAFENONE treats PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA,76,154,,114,165,treats,0.753778361444409,804941,"A randomized, placebo controlled trial of propafenone in the prophylaxis of PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA and paroxysmal atrial fibrillation.UK PROPAFENONE PSVT Study Group:  Circulation 92:2550, 1995  17.",PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA,PROPAFENONE,TWrex-cause
788659676,9/15/2015 11:19:20,1738670642,9/15/2015 11:18:58,False,clixsense,0.8097,19638651,USA,SC,Summerville,174.107.73.211,[INTRAVENOUS FLUMAZENIL] treats [VENTILATORY DEPRESSION],111,0,,132,21,treats,0.824957911384306,219666,"[INTRAVENOUS FLUMAZENIL] has been shown to antagonize sedation, impairment of recall, psychomotor impairment and [VENTILATORY DEPRESSION] produced by benzodiazepines in healthy human volunteers.",[VENTILATORY DEPRESSION],[INTRAVENOUS FLUMAZENIL],TWrex-treat
788659676,9/15/2015 11:20:34,1738671316,9/15/2015 11:20:17,False,clixsense,0.6431,10390268,USA,NY,New Paltz,100.40.136.250,no_relation,111,0,,132,21,treats,0.824957911384306,219666,"[INTRAVENOUS FLUMAZENIL] has been shown to antagonize sedation, impairment of recall, psychomotor impairment and [VENTILATORY DEPRESSION] produced by benzodiazepines in healthy human volunteers.",[VENTILATORY DEPRESSION],[INTRAVENOUS FLUMAZENIL],TWrex-treat
788659676,9/15/2015 11:37:36,1738680209,9/15/2015 11:37:14,False,prodege,0.9365,14848125,GBR,V8,Airdrie,86.151.77.161,[INTRAVENOUS FLUMAZENIL] treats [VENTILATORY DEPRESSION],111,0,,132,21,treats,0.824957911384306,219666,"[INTRAVENOUS FLUMAZENIL] has been shown to antagonize sedation, impairment of recall, psychomotor impairment and [VENTILATORY DEPRESSION] produced by benzodiazepines in healthy human volunteers.",[VENTILATORY DEPRESSION],[INTRAVENOUS FLUMAZENIL],TWrex-treat
788659676,9/15/2015 11:46:07,1738684101,9/15/2015 11:45:42,False,elite,0.9048,31883685,GBR,,,79.66.254.237,no_relation,111,0,,132,21,treats,0.824957911384306,219666,"[INTRAVENOUS FLUMAZENIL] has been shown to antagonize sedation, impairment of recall, psychomotor impairment and [VENTILATORY DEPRESSION] produced by benzodiazepines in healthy human volunteers.",[VENTILATORY DEPRESSION],[INTRAVENOUS FLUMAZENIL],TWrex-treat
788659676,9/15/2015 11:50:47,1738686187,9/15/2015 11:49:15,False,fusioncash,0.9389,31742806,USA,OH,Kent,66.61.82.242,no_relation,111,0,,132,21,treats,0.824957911384306,219666,"[INTRAVENOUS FLUMAZENIL] has been shown to antagonize sedation, impairment of recall, psychomotor impairment and [VENTILATORY DEPRESSION] produced by benzodiazepines in healthy human volunteers.",[VENTILATORY DEPRESSION],[INTRAVENOUS FLUMAZENIL],TWrex-treat
788659676,9/15/2015 11:59:03,1738689328,9/15/2015 11:58:21,False,prodege,0.9167,27934334,GBR,C8,Croydon,81.159.60.206,[INTRAVENOUS FLUMAZENIL] treats [VENTILATORY DEPRESSION],111,0,,132,21,treats,0.824957911384306,219666,"[INTRAVENOUS FLUMAZENIL] has been shown to antagonize sedation, impairment of recall, psychomotor impairment and [VENTILATORY DEPRESSION] produced by benzodiazepines in healthy human volunteers.",[VENTILATORY DEPRESSION],[INTRAVENOUS FLUMAZENIL],TWrex-treat
788659676,9/15/2015 12:12:50,1738693782,9/15/2015 12:11:17,False,prodege,0.8754,3056891,CAN,ON,Niagara Falls,173.238.144.19,[INTRAVENOUS FLUMAZENIL] treats [VENTILATORY DEPRESSION],111,0,,132,21,treats,0.824957911384306,219666,"[INTRAVENOUS FLUMAZENIL] has been shown to antagonize sedation, impairment of recall, psychomotor impairment and [VENTILATORY DEPRESSION] produced by benzodiazepines in healthy human volunteers.",[VENTILATORY DEPRESSION],[INTRAVENOUS FLUMAZENIL],TWrex-treat
788659685,9/15/2015 12:19:50,1738696482,9/15/2015 12:17:57,False,clixsense,0.6972,17950689,GBR,L9,Sheffield,146.200.192.103,[DEET] treats [TICK BORNE MENINGOENCEPHALITIS],83,15,,112,18,treats,1.0,215661,"In particular, [DEET] protects against tick bites, preventing several rickettsioses, [TICK BORNE MENINGOENCEPHALITIS] and other tick borne diseases such as Lyme disease.",[TICK BORNE MENINGOENCEPHALITIS],[DEET],TWrex-treat
788659685,9/15/2015 12:25:19,1738698186,9/15/2015 12:24:33,False,clixsense,0.9762,30777913,GBR,U8,Edinburgh,92.239.140.40,[DEET] treats [TICK BORNE MENINGOENCEPHALITIS],83,15,,112,18,treats,1.0,215661,"In particular, [DEET] protects against tick bites, preventing several rickettsioses, [TICK BORNE MENINGOENCEPHALITIS] and other tick borne diseases such as Lyme disease.",[TICK BORNE MENINGOENCEPHALITIS],[DEET],TWrex-treat
788659685,9/15/2015 12:26:35,1738698547,9/15/2015 12:25:41,False,neodev,0.7897,34429821,USA,CA,Torrance,66.171.228.249,[DEET] treats [TICK BORNE MENINGOENCEPHALITIS],83,15,,112,18,treats,1.0,215661,"In particular, [DEET] protects against tick bites, preventing several rickettsioses, [TICK BORNE MENINGOENCEPHALITIS] and other tick borne diseases such as Lyme disease.",[TICK BORNE MENINGOENCEPHALITIS],[DEET],TWrex-treat
788659685,9/15/2015 12:32:38,1738700585,9/15/2015 12:31:41,False,neodev,0.7528,33758777,USA,,,38.95.108.251,[DEET] treats [TICK BORNE MENINGOENCEPHALITIS],83,15,,112,18,treats,1.0,215661,"In particular, [DEET] protects against tick bites, preventing several rickettsioses, [TICK BORNE MENINGOENCEPHALITIS] and other tick borne diseases such as Lyme disease.",[TICK BORNE MENINGOENCEPHALITIS],[DEET],TWrex-treat
788659685,9/15/2015 12:35:18,1738701759,9/15/2015 12:34:57,False,neodev,0.9208,12115558,USA,OH,Twinsburg,98.27.164.131,[DEET] treats [TICK BORNE MENINGOENCEPHALITIS],83,15,,112,18,treats,1.0,215661,"In particular, [DEET] protects against tick bites, preventing several rickettsioses, [TICK BORNE MENINGOENCEPHALITIS] and other tick borne diseases such as Lyme disease.",[TICK BORNE MENINGOENCEPHALITIS],[DEET],TWrex-treat
788659685,9/15/2015 12:36:37,1738702136,9/15/2015 12:36:01,False,vivatic,0.7972,32338429,GBR,N7,Guildford,92.21.219.178,[DEET] treats [TICK BORNE MENINGOENCEPHALITIS],83,15,,112,18,treats,1.0,215661,"In particular, [DEET] protects against tick bites, preventing several rickettsioses, [TICK BORNE MENINGOENCEPHALITIS] and other tick borne diseases such as Lyme disease.",[TICK BORNE MENINGOENCEPHALITIS],[DEET],TWrex-treat
788659685,9/15/2015 12:42:22,1738704024,9/15/2015 12:41:18,False,prodege,0.6643,24945126,GBR,K8,Ilford,82.12.220.44,no_relation,83,15,,112,18,treats,1.0,215661,"In particular, [DEET] protects against tick bites, preventing several rickettsioses, [TICK BORNE MENINGOENCEPHALITIS] and other tick borne diseases such as Lyme disease.",[TICK BORNE MENINGOENCEPHALITIS],[DEET],TWrex-treat
788659689,9/15/2015 09:59:29,1738649014,9/15/2015 09:58:36,False,neodev,0.8889,33644825,USA,IL,Chicago,65.60.20.67,VITAMIN D treats INHERITED RICKETS,143,188,,159,197,treats,0.589767824619589,908221,"Diseases associated to Vitamin D deficiency (rickets in children, and osteomalacia or osteoporosis in adults) and autosomal recessive forms of INHERITED RICKETS illustrate the key role of VITAMIN D in calcium homeostasis and bone metabolism.",INHERITED RICKETS,VITAMIN D,RO-may_treat
788659689,9/15/2015 09:59:55,1738649153,9/15/2015 09:59:13,False,gifthulk,0.8056,33936811,AUS,04,Brisbane,121.208.7.253,VITAMIN D treats INHERITED RICKETS,143,188,,159,197,treats,0.589767824619589,908221,"Diseases associated to Vitamin D deficiency (rickets in children, and osteomalacia or osteoporosis in adults) and autosomal recessive forms of INHERITED RICKETS illustrate the key role of VITAMIN D in calcium homeostasis and bone metabolism.",INHERITED RICKETS,VITAMIN D,RO-may_treat
788659689,9/15/2015 10:04:45,1738650507,9/15/2015 10:04:23,False,meprizescf,0.8611,28483210,USA,WI,Minocqua,75.143.134.247,VITAMIN D treats INHERITED RICKETS,143,188,,159,197,treats,0.589767824619589,908221,"Diseases associated to Vitamin D deficiency (rickets in children, and osteomalacia or osteoporosis in adults) and autosomal recessive forms of INHERITED RICKETS illustrate the key role of VITAMIN D in calcium homeostasis and bone metabolism.",INHERITED RICKETS,VITAMIN D,RO-may_treat
788659689,9/15/2015 10:16:46,1738653967,9/15/2015 10:16:06,False,prodege,0.8764,21417560,GBR,C3,Cambridge,151.224.120.191,VITAMIN D treats INHERITED RICKETS,143,188,,159,197,treats,0.589767824619589,908221,"Diseases associated to Vitamin D deficiency (rickets in children, and osteomalacia or osteoporosis in adults) and autosomal recessive forms of INHERITED RICKETS illustrate the key role of VITAMIN D in calcium homeostasis and bone metabolism.",INHERITED RICKETS,VITAMIN D,RO-may_treat
788659689,9/15/2015 10:19:37,1738654600,9/15/2015 10:18:56,False,prodege,0.7056,4316379,CAN,ON,Windsor,198.91.219.55,VITAMIN D treats INHERITED RICKETS,143,188,,159,197,treats,0.589767824619589,908221,"Diseases associated to Vitamin D deficiency (rickets in children, and osteomalacia or osteoporosis in adults) and autosomal recessive forms of INHERITED RICKETS illustrate the key role of VITAMIN D in calcium homeostasis and bone metabolism.",INHERITED RICKETS,VITAMIN D,RO-may_treat
788659689,9/15/2015 10:20:23,1738654791,9/15/2015 10:19:47,False,gifthunterclub,0.8036,30901412,GBR,H9,London,77.89.149.62,no_relation,143,188,,159,197,treats,0.589767824619589,908221,"Diseases associated to Vitamin D deficiency (rickets in children, and osteomalacia or osteoporosis in adults) and autosomal recessive forms of INHERITED RICKETS illustrate the key role of VITAMIN D in calcium homeostasis and bone metabolism.",INHERITED RICKETS,VITAMIN D,RO-may_treat
788659689,9/15/2015 10:21:24,1738655054,9/15/2015 10:20:43,False,bitcoinget,0.4857,29516942,USA,CA,Saratoga,107.178.41.143,no_relation,143,188,,159,197,treats,0.589767824619589,908221,"Diseases associated to Vitamin D deficiency (rickets in children, and osteomalacia or osteoporosis in adults) and autosomal recessive forms of INHERITED RICKETS illustrate the key role of VITAMIN D in calcium homeostasis and bone metabolism.",INHERITED RICKETS,VITAMIN D,RO-may_treat
788659693,9/15/2015 11:53:55,1738687609,9/15/2015 11:53:35,False,fusioncash,0.9389,31742806,USA,OH,Kent,66.61.82.242,FUROSEMIDE treats ASCITES,100,69,,106,79,treats,1.0,907842,"Herlong HF, Hunter FM, Koff RS et al. A comparison of bumetanide and FUROSEMIDE in the treatment of ASCITES: cooperative study.",ASCITES,FUROSEMIDE,RO-may_treat
788659693,9/15/2015 12:01:04,1738689891,9/15/2015 12:00:47,False,prodege,0.9167,27934334,GBR,C8,Croydon,81.159.60.206,FUROSEMIDE treats ASCITES,100,69,,106,79,treats,1.0,907842,"Herlong HF, Hunter FM, Koff RS et al. A comparison of bumetanide and FUROSEMIDE in the treatment of ASCITES: cooperative study.",ASCITES,FUROSEMIDE,RO-may_treat
788659693,9/15/2015 12:15:54,1738694825,9/15/2015 12:15:27,False,prodege,0.8754,3056891,CAN,ON,Niagara Falls,173.238.144.19,FUROSEMIDE treats ASCITES,100,69,,106,79,treats,1.0,907842,"Herlong HF, Hunter FM, Koff RS et al. A comparison of bumetanide and FUROSEMIDE in the treatment of ASCITES: cooperative study.",ASCITES,FUROSEMIDE,RO-may_treat
788659693,9/15/2015 12:17:57,1738695888,9/15/2015 12:15:22,False,clixsense,0.6972,17950689,GBR,L9,Sheffield,146.200.192.103,FUROSEMIDE treats ASCITES,100,69,,106,79,treats,1.0,907842,"Herlong HF, Hunter FM, Koff RS et al. A comparison of bumetanide and FUROSEMIDE in the treatment of ASCITES: cooperative study.",ASCITES,FUROSEMIDE,RO-may_treat
788659693,9/15/2015 12:20:46,1738696804,9/15/2015 12:20:05,False,pocketmoneygpt,0.877,21432964,GBR,F8,Borehamwood,81.159.185.70,FUROSEMIDE treats ASCITES,100,69,,106,79,treats,1.0,907842,"Herlong HF, Hunter FM, Koff RS et al. A comparison of bumetanide and FUROSEMIDE in the treatment of ASCITES: cooperative study.",ASCITES,FUROSEMIDE,RO-may_treat
788659693,9/15/2015 12:24:32,1738698015,9/15/2015 12:24:12,False,clixsense,0.9762,30777913,GBR,U8,Edinburgh,92.239.140.40,FUROSEMIDE treats ASCITES,100,69,,106,79,treats,1.0,907842,"Herlong HF, Hunter FM, Koff RS et al. A comparison of bumetanide and FUROSEMIDE in the treatment of ASCITES: cooperative study.",ASCITES,FUROSEMIDE,RO-may_treat
788659693,9/15/2015 12:25:39,1738698288,9/15/2015 12:24:48,False,neodev,0.7897,34429821,USA,CA,Torrance,66.171.228.249,no_relation,100,69,,106,79,treats,1.0,907842,"Herlong HF, Hunter FM, Koff RS et al. A comparison of bumetanide and FUROSEMIDE in the treatment of ASCITES: cooperative study.",ASCITES,FUROSEMIDE,RO-may_treat
788659696,9/15/2015 10:21:57,1738655212,9/15/2015 10:21:38,False,gifthunterclub,0.8036,30901412,GBR,H9,London,77.89.149.62,AZIDOTHYMIDINE treats AIDS,82,47,,85,61,treats,1.0,803723,"Richman DD, Fischl MA, Nusinoff Lehrman S et alAZIDOTHYMIDINE in the treatment of AIDS",AIDS,AZIDOTHYMIDINE,TWrex-cause
788659696,9/15/2015 10:22:48,1738655461,9/15/2015 10:22:23,False,bitcoinget,0.4857,29516942,USA,CA,Saratoga,107.178.41.143,AZIDOTHYMIDINE treats AIDS,82,47,,85,61,treats,1.0,803723,"Richman DD, Fischl MA, Nusinoff Lehrman S et alAZIDOTHYMIDINE in the treatment of AIDS",AIDS,AZIDOTHYMIDINE,TWrex-cause
788659696,9/15/2015 10:22:54,1738655472,9/15/2015 10:22:32,False,keeprewarding,0.8556,29139615,CAN,ON,Perth,192.186.81.178,AZIDOTHYMIDINE treats AIDS,82,47,,85,61,treats,1.0,803723,"Richman DD, Fischl MA, Nusinoff Lehrman S et alAZIDOTHYMIDINE in the treatment of AIDS",AIDS,AZIDOTHYMIDINE,TWrex-cause
788659696,9/15/2015 10:24:04,1738655821,9/15/2015 10:23:38,False,prodege,0.8151,9169061,CAN,ON,Kitchener,99.235.192.130,AZIDOTHYMIDINE treats AIDS,82,47,,85,61,treats,1.0,803723,"Richman DD, Fischl MA, Nusinoff Lehrman S et alAZIDOTHYMIDINE in the treatment of AIDS",AIDS,AZIDOTHYMIDINE,TWrex-cause
788659696,9/15/2015 10:25:00,1738656069,9/15/2015 10:24:10,False,neodev,0.5167,30588889,NLD,07,Amsterdam,77.248.175.222,AZIDOTHYMIDINE treats AIDS,82,47,,85,61,treats,1.0,803723,"Richman DD, Fischl MA, Nusinoff Lehrman S et alAZIDOTHYMIDINE in the treatment of AIDS",AIDS,AZIDOTHYMIDINE,TWrex-cause
788659696,9/15/2015 10:27:23,1738656582,9/15/2015 10:26:51,False,gifthunterclub,0.85,24043308,GBR,,,94.102.147.250,AZIDOTHYMIDINE treats AIDS,82,47,,85,61,treats,1.0,803723,"Richman DD, Fischl MA, Nusinoff Lehrman S et alAZIDOTHYMIDINE in the treatment of AIDS",AIDS,AZIDOTHYMIDINE,TWrex-cause
788659696,9/15/2015 10:34:22,1738658282,9/15/2015 10:33:26,False,neodev,0.7063,33238512,CAN,AB,Calgary,136.159.234.238,AZIDOTHYMIDINE treats AIDS,82,47,,85,61,treats,1.0,803723,"Richman DD, Fischl MA, Nusinoff Lehrman S et alAZIDOTHYMIDINE in the treatment of AIDS",AIDS,AZIDOTHYMIDINE,TWrex-cause
788659699,9/15/2015 14:43:10,1738738587,9/15/2015 14:41:57,False,clixsense,0.9583,30258829,NLD,05,Velden,84.104.254.214,no_relation,33,144,,60,168,treats,0.878114079917523,815038,"104 ,   152  Prevention of Avian INFLUENZA A VIRUS INFECTIONS   +  >     Oral  Dosage usually recommended for prophylaxis of seasonal influenza A AND B VIRUS INFECTIONS has been recommended.",INFLUENZA A VIRUS INFECTIONS,A AND B VIRUS INFECTIONS,TWrex-cause
788659699,9/15/2015 14:47:37,1738739969,9/15/2015 14:45:42,False,gifthulk,0.9097,18666417,USA,PA,Meadville,24.101.32.13,no_relation,33,144,,60,168,treats,0.878114079917523,815038,"104 ,   152  Prevention of Avian INFLUENZA A VIRUS INFECTIONS   +  >     Oral  Dosage usually recommended for prophylaxis of seasonal influenza A AND B VIRUS INFECTIONS has been recommended.",INFLUENZA A VIRUS INFECTIONS,A AND B VIRUS INFECTIONS,TWrex-cause
788659699,9/15/2015 14:52:28,1738741300,9/15/2015 14:51:52,False,elite,0.7861,30312592,CAN,ON,Sudbury,66.103.55.12,no_relation,33,144,,60,168,treats,0.878114079917523,815038,"104 ,   152  Prevention of Avian INFLUENZA A VIRUS INFECTIONS   +  >     Oral  Dosage usually recommended for prophylaxis of seasonal influenza A AND B VIRUS INFECTIONS has been recommended.",INFLUENZA A VIRUS INFECTIONS,A AND B VIRUS INFECTIONS,TWrex-cause
788659699,9/15/2015 15:37:31,1738757645,9/15/2015 15:36:43,False,clixsense,0.7083,22984878,CAN,ON,Kingston,67.193.186.57,no_relation,33,144,,60,168,treats,0.878114079917523,815038,"104 ,   152  Prevention of Avian INFLUENZA A VIRUS INFECTIONS   +  >     Oral  Dosage usually recommended for prophylaxis of seasonal influenza A AND B VIRUS INFECTIONS has been recommended.",INFLUENZA A VIRUS INFECTIONS,A AND B VIRUS INFECTIONS,TWrex-cause
788659699,9/15/2015 15:40:17,1738758473,9/15/2015 15:40:05,False,neodev,0.3857,33155316,GBR,I9,Dereham,31.50.244.140,INFLUENZA A VIRUS INFECTIONS treats A AND B VIRUS INFECTIONS,33,144,,60,168,treats,0.878114079917523,815038,"104 ,   152  Prevention of Avian INFLUENZA A VIRUS INFECTIONS   +  >     Oral  Dosage usually recommended for prophylaxis of seasonal influenza A AND B VIRUS INFECTIONS has been recommended.",INFLUENZA A VIRUS INFECTIONS,A AND B VIRUS INFECTIONS,TWrex-cause
788659699,9/15/2015 15:44:10,1738759523,9/15/2015 15:42:18,False,clixsense,0.6111,32053717,GBR,,,51.174.76.80,no_relation,33,144,,60,168,treats,0.878114079917523,815038,"104 ,   152  Prevention of Avian INFLUENZA A VIRUS INFECTIONS   +  >     Oral  Dosage usually recommended for prophylaxis of seasonal influenza A AND B VIRUS INFECTIONS has been recommended.",INFLUENZA A VIRUS INFECTIONS,A AND B VIRUS INFECTIONS,TWrex-cause
788659699,9/15/2015 15:47:47,1738760677,9/15/2015 15:47:24,False,bitcoinget,0.75,21743413,USA,WA,Port Angeles,24.113.29.97,no_relation,33,144,,60,168,treats,0.878114079917523,815038,"104 ,   152  Prevention of Avian INFLUENZA A VIRUS INFECTIONS   +  >     Oral  Dosage usually recommended for prophylaxis of seasonal influenza A AND B VIRUS INFECTIONS has been recommended.",INFLUENZA A VIRUS INFECTIONS,A AND B VIRUS INFECTIONS,TWrex-cause
788659707,9/15/2015 10:48:59,1738661967,9/15/2015 10:48:19,False,clixsense,0.8958,21490235,GBR,N7,Woking,86.30.254.232,ERGONOVINE treats VARIANT ANGINA PECTORIS,140,223,,162,233,treats,0.9434563530497271,906938,Transient prolongation of the corrected Q T interval preceded spontaneous or ergonovine maleate provoked coronary spasm in 11 patients with VARIANT ANGINA PECTORIS whereas no significant change in the Q T interval followed ERGONOVINE administration in 27 control patients with atypical chest pain who did not have coronary spasm.,VARIANT ANGINA PECTORIS,ERGONOVINE,RO-may_diagnose
788659707,9/15/2015 11:03:15,1738665124,9/15/2015 11:02:16,False,prodege,0.7103,6309240,USA,CA,San Diego,76.167.68.73,no_relation,140,223,,162,233,treats,0.9434563530497271,906938,Transient prolongation of the corrected Q T interval preceded spontaneous or ergonovine maleate provoked coronary spasm in 11 patients with VARIANT ANGINA PECTORIS whereas no significant change in the Q T interval followed ERGONOVINE administration in 27 control patients with atypical chest pain who did not have coronary spasm.,VARIANT ANGINA PECTORIS,ERGONOVINE,RO-may_diagnose
788659707,9/15/2015 11:04:12,1738665350,9/15/2015 11:03:39,False,clixsense,0.6488,28351359,GBR,K8,Ilford,80.44.178.106,no_relation,140,223,,162,233,treats,0.9434563530497271,906938,Transient prolongation of the corrected Q T interval preceded spontaneous or ergonovine maleate provoked coronary spasm in 11 patients with VARIANT ANGINA PECTORIS whereas no significant change in the Q T interval followed ERGONOVINE administration in 27 control patients with atypical chest pain who did not have coronary spasm.,VARIANT ANGINA PECTORIS,ERGONOVINE,RO-may_diagnose
788659707,9/15/2015 11:10:48,1738666937,9/15/2015 11:10:32,False,elite,0.7333,34356654,USA,CA,San Jose,50.118.198.254,VARIANT ANGINA PECTORIS treats ERGONOVINE,140,223,,162,233,treats,0.9434563530497271,906938,Transient prolongation of the corrected Q T interval preceded spontaneous or ergonovine maleate provoked coronary spasm in 11 patients with VARIANT ANGINA PECTORIS whereas no significant change in the Q T interval followed ERGONOVINE administration in 27 control patients with atypical chest pain who did not have coronary spasm.,VARIANT ANGINA PECTORIS,ERGONOVINE,RO-may_diagnose
788659707,9/15/2015 11:12:09,1738667425,9/15/2015 11:09:35,False,points4rewards,0.5893,20113482,USA,PA,Philadelphia,162.208.49.45,ERGONOVINE treats VARIANT ANGINA PECTORIS,140,223,,162,233,treats,0.9434563530497271,906938,Transient prolongation of the corrected Q T interval preceded spontaneous or ergonovine maleate provoked coronary spasm in 11 patients with VARIANT ANGINA PECTORIS whereas no significant change in the Q T interval followed ERGONOVINE administration in 27 control patients with atypical chest pain who did not have coronary spasm.,VARIANT ANGINA PECTORIS,ERGONOVINE,RO-may_diagnose
788659707,9/15/2015 11:14:10,1738668220,9/15/2015 11:13:35,False,neodev,0.6468,11001780,AUS,07,Elwood,14.201.215.31,ERGONOVINE treats VARIANT ANGINA PECTORIS,140,223,,162,233,treats,0.9434563530497271,906938,Transient prolongation of the corrected Q T interval preceded spontaneous or ergonovine maleate provoked coronary spasm in 11 patients with VARIANT ANGINA PECTORIS whereas no significant change in the Q T interval followed ERGONOVINE administration in 27 control patients with atypical chest pain who did not have coronary spasm.,VARIANT ANGINA PECTORIS,ERGONOVINE,RO-may_diagnose
788659707,9/15/2015 11:27:14,1738675233,9/15/2015 11:24:39,False,clixsense,0.7559999999999999,24104564,AUS,02,Surry Hills,60.241.132.132,no_relation,140,223,,162,233,treats,0.9434563530497271,906938,Transient prolongation of the corrected Q T interval preceded spontaneous or ergonovine maleate provoked coronary spasm in 11 patients with VARIANT ANGINA PECTORIS whereas no significant change in the Q T interval followed ERGONOVINE administration in 27 control patients with atypical chest pain who did not have coronary spasm.,VARIANT ANGINA PECTORIS,ERGONOVINE,RO-may_diagnose
788659711,9/15/2015 11:12:11,1738667436,9/15/2015 11:11:53,False,elite,0.7333,34356654,USA,CA,San Jose,50.118.198.254,(DORNASE ALFA treats CYSTIC FIBROSIS,98,72,,112,85,treats,0.987878339907213,800482,"Genentech, Inc. Patient information booklet: your guide to Pulmozyme ®  (DORNASE ALFA therapy for CYSTIC FIBROSIS (CF.",CYSTIC FIBROSIS,(DORNASE ALFA,TWrex-cause
788659711,9/15/2015 11:17:09,1738669594,9/15/2015 11:16:31,False,neodev,0.6468,11001780,AUS,07,Elwood,14.201.215.31,(DORNASE ALFA treats CYSTIC FIBROSIS,98,72,,112,85,treats,0.987878339907213,800482,"Genentech, Inc. Patient information booklet: your guide to Pulmozyme ®  (DORNASE ALFA therapy for CYSTIC FIBROSIS (CF.",CYSTIC FIBROSIS,(DORNASE ALFA,TWrex-cause
788659711,9/15/2015 11:18:45,1738670221,9/15/2015 11:18:22,False,clixsense,0.8097,19638651,USA,SC,Summerville,174.107.73.211,(DORNASE ALFA treats CYSTIC FIBROSIS,98,72,,112,85,treats,0.987878339907213,800482,"Genentech, Inc. Patient information booklet: your guide to Pulmozyme ®  (DORNASE ALFA therapy for CYSTIC FIBROSIS (CF.",CYSTIC FIBROSIS,(DORNASE ALFA,TWrex-cause
788659711,9/15/2015 11:19:57,1738671085,9/15/2015 11:19:31,False,clixsense,0.6431,10390268,USA,NY,New Paltz,100.40.136.250,(DORNASE ALFA treats CYSTIC FIBROSIS,98,72,,112,85,treats,0.987878339907213,800482,"Genentech, Inc. Patient information booklet: your guide to Pulmozyme ®  (DORNASE ALFA therapy for CYSTIC FIBROSIS (CF.",CYSTIC FIBROSIS,(DORNASE ALFA,TWrex-cause
788659711,9/15/2015 11:23:04,1738672756,9/15/2015 11:22:03,False,clixsense,0.7357,21875134,GBR,,,80.189.12.98,(DORNASE ALFA treats CYSTIC FIBROSIS,98,72,,112,85,treats,0.987878339907213,800482,"Genentech, Inc. Patient information booklet: your guide to Pulmozyme ®  (DORNASE ALFA therapy for CYSTIC FIBROSIS (CF.",CYSTIC FIBROSIS,(DORNASE ALFA,TWrex-cause
788659711,9/15/2015 11:33:20,1738678359,9/15/2015 11:32:02,False,clixsense,0.7559999999999999,24104564,AUS,02,Surry Hills,60.241.132.132,(DORNASE ALFA treats CYSTIC FIBROSIS,98,72,,112,85,treats,0.987878339907213,800482,"Genentech, Inc. Patient information booklet: your guide to Pulmozyme ®  (DORNASE ALFA therapy for CYSTIC FIBROSIS (CF.",CYSTIC FIBROSIS,(DORNASE ALFA,TWrex-cause
788659711,9/15/2015 11:36:55,1738679877,9/15/2015 11:36:32,False,prodege,0.9365,14848125,GBR,V8,Airdrie,86.151.77.161,(DORNASE ALFA treats CYSTIC FIBROSIS,98,72,,112,85,treats,0.987878339907213,800482,"Genentech, Inc. Patient information booklet: your guide to Pulmozyme ®  (DORNASE ALFA therapy for CYSTIC FIBROSIS (CF.",CYSTIC FIBROSIS,(DORNASE ALFA,TWrex-cause
788748020,9/15/2015 20:07:12,1738946180,9/15/2015 20:06:58,False,clixsense,0.8829,6641082,CAN,QC,Verdun,184.161.206.169,DONEPEZIL treats SLEEP APNEA,36,0,,47,9,treats,1.0,218890,[DONEPEZIL] has been found to improve [SLEEP APNEA] in Alzheimer's patients.,SLEEP APNEA,DONEPEZIL,TWrex-treat
788748020,9/15/2015 20:09:41,1738949009,9/15/2015 20:09:35,False,neodev,0.8552,33538351,USA,,,208.31.49.57,DONEPEZIL treats SLEEP APNEA,36,0,,47,9,treats,1.0,218890,[DONEPEZIL] has been found to improve [SLEEP APNEA] in Alzheimer's patients.,SLEEP APNEA,DONEPEZIL,TWrex-treat
788748020,9/15/2015 20:34:58,1738985582,9/15/2015 20:31:31,False,quickrewards,0.7979,8672587,USA,TX,El Paso,209.194.208.150,DONEPEZIL treats SLEEP APNEA,36,0,,47,9,treats,1.0,218890,[DONEPEZIL] has been found to improve [SLEEP APNEA] in Alzheimer's patients.,SLEEP APNEA,DONEPEZIL,TWrex-treat
788748020,9/15/2015 20:50:34,1738997558,9/15/2015 20:50:09,False,clixsense,0.7146,26531841,CAN,ON,Toronto,64.231.8.24,DONEPEZIL treats SLEEP APNEA,36,0,,47,9,treats,1.0,218890,[DONEPEZIL] has been found to improve [SLEEP APNEA] in Alzheimer's patients.,SLEEP APNEA,DONEPEZIL,TWrex-treat
788748020,9/15/2015 21:04:49,1739014179,9/15/2015 21:04:25,False,prodege,0.75,34271751,CAN,ON,Toronto,99.225.188.40,DONEPEZIL treats SLEEP APNEA,36,0,,47,9,treats,1.0,218890,[DONEPEZIL] has been found to improve [SLEEP APNEA] in Alzheimer's patients.,SLEEP APNEA,DONEPEZIL,TWrex-treat
788748020,9/15/2015 21:19:02,1739027767,9/15/2015 21:18:34,False,neodev,0.5278,31984900,CAN,AB,Edmonton,208.123.223.144,DONEPEZIL treats SLEEP APNEA,36,0,,47,9,treats,1.0,218890,[DONEPEZIL] has been found to improve [SLEEP APNEA] in Alzheimer's patients.,SLEEP APNEA,DONEPEZIL,TWrex-treat
788748020,9/15/2015 21:21:01,1739028888,9/15/2015 21:20:06,False,clixsense,0.7857,20587495,CAN,NB,Saint John,142.162.106.74,DONEPEZIL treats SLEEP APNEA,36,0,,47,9,treats,1.0,218890,[DONEPEZIL] has been found to improve [SLEEP APNEA] in Alzheimer's patients.,SLEEP APNEA,DONEPEZIL,TWrex-treat
788748022,9/15/2015 16:12:29,1738770423,9/15/2015 16:11:56,False,gifthunterclub,0.8036,24043308,GBR,,,94.102.147.250,EPINEPHRINE treats ANAPHYLAXIS,52,80,,63,91,treats,1.0,907663,Allergic reactions are treated with antihistamines; ANAPHYLAXIS is treated with EPINEPHRINE with IV fluids and vasopressors if necessary (see  Anaphylaxis,ANAPHYLAXIS,EPINEPHRINE,RO-may_treat
788748022,9/15/2015 16:12:49,1738770508,9/15/2015 16:12:27,False,neodev,0.9167,14096345,NLD,03,Eibergen,178.85.94.186,EPINEPHRINE treats ANAPHYLAXIS,52,80,,63,91,treats,1.0,907663,Allergic reactions are treated with antihistamines; ANAPHYLAXIS is treated with EPINEPHRINE with IV fluids and vasopressors if necessary (see  Anaphylaxis,ANAPHYLAXIS,EPINEPHRINE,RO-may_treat
788748022,9/15/2015 16:12:53,1738770533,9/15/2015 16:10:22,False,elite,0.8889,31883685,GBR,,,79.66.244.188,EPINEPHRINE treats ANAPHYLAXIS,52,80,,63,91,treats,1.0,907663,Allergic reactions are treated with antihistamines; ANAPHYLAXIS is treated with EPINEPHRINE with IV fluids and vasopressors if necessary (see  Anaphylaxis,ANAPHYLAXIS,EPINEPHRINE,RO-may_treat
788748022,9/15/2015 16:15:31,1738771586,9/15/2015 16:15:24,False,instagc,1.0,15577915,USA,IL,Trenton,208.70.36.12,EPINEPHRINE treats ANAPHYLAXIS,52,80,,63,91,treats,1.0,907663,Allergic reactions are treated with antihistamines; ANAPHYLAXIS is treated with EPINEPHRINE with IV fluids and vasopressors if necessary (see  Anaphylaxis,ANAPHYLAXIS,EPINEPHRINE,RO-may_treat
788748022,9/15/2015 16:17:00,1738772092,9/15/2015 16:16:46,False,prodege,0.8611,22031444,GBR,F2,Gosport,92.24.223.243,EPINEPHRINE treats ANAPHYLAXIS,52,80,,63,91,treats,1.0,907663,Allergic reactions are treated with antihistamines; ANAPHYLAXIS is treated with EPINEPHRINE with IV fluids and vasopressors if necessary (see  Anaphylaxis,ANAPHYLAXIS,EPINEPHRINE,RO-may_treat
788748022,9/15/2015 16:17:28,1738772234,9/15/2015 16:16:33,False,clixsense,0.8407,33878524,CAN,BC,Princeton,75.156.83.71,EPINEPHRINE treats ANAPHYLAXIS,52,80,,63,91,treats,1.0,907663,Allergic reactions are treated with antihistamines; ANAPHYLAXIS is treated with EPINEPHRINE with IV fluids and vasopressors if necessary (see  Anaphylaxis,ANAPHYLAXIS,EPINEPHRINE,RO-may_treat
788748022,9/15/2015 16:18:22,1738772594,9/15/2015 16:15:16,False,points4rewards,0.7282,20113482,USA,PA,Philadelphia,162.208.49.45,EPINEPHRINE treats ANAPHYLAXIS,52,80,,63,91,treats,1.0,907663,Allergic reactions are treated with antihistamines; ANAPHYLAXIS is treated with EPINEPHRINE with IV fluids and vasopressors if necessary (see  Anaphylaxis,ANAPHYLAXIS,EPINEPHRINE,RO-may_treat
788748023,9/15/2015 20:07:12,1738946179,9/15/2015 20:06:58,False,clixsense,0.8829,6641082,CAN,QC,Verdun,184.161.206.169,CLOMIPRAMINE HYDROCHLORIDE treats ADOLESCENT OBSESSIVE COMPULSIVE DISORDER,90,46,,129,72,treats,0.9282791216329142,800589,"DeVeaugh Geiss J, Moroz G, Biederman J et al. CLOMIPRAMINE HYDROCHLORIDE in childhood and ADOLESCENT OBSESSIVE COMPULSIVE DISORDER: a multicenter trial.",ADOLESCENT OBSESSIVE COMPULSIVE DISORDER,CLOMIPRAMINE HYDROCHLORIDE,TWrex-cause
788748023,9/15/2015 20:09:41,1738949008,9/15/2015 20:09:35,False,neodev,0.8552,33538351,USA,,,208.31.49.57,CLOMIPRAMINE HYDROCHLORIDE treats ADOLESCENT OBSESSIVE COMPULSIVE DISORDER,90,46,,129,72,treats,0.9282791216329142,800589,"DeVeaugh Geiss J, Moroz G, Biederman J et al. CLOMIPRAMINE HYDROCHLORIDE in childhood and ADOLESCENT OBSESSIVE COMPULSIVE DISORDER: a multicenter trial.",ADOLESCENT OBSESSIVE COMPULSIVE DISORDER,CLOMIPRAMINE HYDROCHLORIDE,TWrex-cause
788748023,9/15/2015 20:34:58,1738985581,9/15/2015 20:31:31,False,quickrewards,0.7979,8672587,USA,TX,El Paso,209.194.208.150,CLOMIPRAMINE HYDROCHLORIDE treats ADOLESCENT OBSESSIVE COMPULSIVE DISORDER,90,46,,129,72,treats,0.9282791216329142,800589,"DeVeaugh Geiss J, Moroz G, Biederman J et al. CLOMIPRAMINE HYDROCHLORIDE in childhood and ADOLESCENT OBSESSIVE COMPULSIVE DISORDER: a multicenter trial.",ADOLESCENT OBSESSIVE COMPULSIVE DISORDER,CLOMIPRAMINE HYDROCHLORIDE,TWrex-cause
788748023,9/15/2015 20:50:34,1738997557,9/15/2015 20:50:09,False,clixsense,0.7146,26531841,CAN,ON,Toronto,64.231.8.24,no_relation,90,46,,129,72,treats,0.9282791216329142,800589,"DeVeaugh Geiss J, Moroz G, Biederman J et al. CLOMIPRAMINE HYDROCHLORIDE in childhood and ADOLESCENT OBSESSIVE COMPULSIVE DISORDER: a multicenter trial.",ADOLESCENT OBSESSIVE COMPULSIVE DISORDER,CLOMIPRAMINE HYDROCHLORIDE,TWrex-cause
788748023,9/15/2015 21:04:49,1739014174,9/15/2015 21:04:25,False,prodege,0.75,34271751,CAN,ON,Toronto,99.225.188.40,no_relation,90,46,,129,72,treats,0.9282791216329142,800589,"DeVeaugh Geiss J, Moroz G, Biederman J et al. CLOMIPRAMINE HYDROCHLORIDE in childhood and ADOLESCENT OBSESSIVE COMPULSIVE DISORDER: a multicenter trial.",ADOLESCENT OBSESSIVE COMPULSIVE DISORDER,CLOMIPRAMINE HYDROCHLORIDE,TWrex-cause
788748023,9/15/2015 21:19:02,1739027764,9/15/2015 21:18:34,False,neodev,0.5278,31984900,CAN,AB,Edmonton,208.123.223.144,CLOMIPRAMINE HYDROCHLORIDE treats ADOLESCENT OBSESSIVE COMPULSIVE DISORDER,90,46,,129,72,treats,0.9282791216329142,800589,"DeVeaugh Geiss J, Moroz G, Biederman J et al. CLOMIPRAMINE HYDROCHLORIDE in childhood and ADOLESCENT OBSESSIVE COMPULSIVE DISORDER: a multicenter trial.",ADOLESCENT OBSESSIVE COMPULSIVE DISORDER,CLOMIPRAMINE HYDROCHLORIDE,TWrex-cause
788748023,9/15/2015 21:21:01,1739028890,9/15/2015 21:20:06,False,clixsense,0.7857,20587495,CAN,NB,Saint John,142.162.106.74,CLOMIPRAMINE HYDROCHLORIDE treats ADOLESCENT OBSESSIVE COMPULSIVE DISORDER,90,46,,129,72,treats,0.9282791216329142,800589,"DeVeaugh Geiss J, Moroz G, Biederman J et al. CLOMIPRAMINE HYDROCHLORIDE in childhood and ADOLESCENT OBSESSIVE COMPULSIVE DISORDER: a multicenter trial.",ADOLESCENT OBSESSIVE COMPULSIVE DISORDER,CLOMIPRAMINE HYDROCHLORIDE,TWrex-cause
788748024,9/15/2015 17:53:27,1738859501,9/15/2015 17:53:02,False,prodege,0.8532,27753453,USA,NY,Liverpool,71.176.126.145,[CONCOMITANT METHOTREXATE:] treats [RHEUMATOID ARTHRITIS],37,77,,56,101,treats,0.975900072948533,215430,title = Infliximab versus placebo in [RHEUMATOID ARTHRITIS] patients receiving [CONCOMITANT METHOTREXATE:] a randomised phase III trial.,[RHEUMATOID ARTHRITIS],[CONCOMITANT METHOTREXATE:],TWrex-treat
788748024,9/15/2015 18:00:03,1738870311,9/15/2015 17:59:27,False,neodev,0.6198,33238512,NLD,11,Delft,94.210.42.212,[CONCOMITANT METHOTREXATE:] treats [RHEUMATOID ARTHRITIS],37,77,,56,101,treats,0.975900072948533,215430,title = Infliximab versus placebo in [RHEUMATOID ARTHRITIS] patients receiving [CONCOMITANT METHOTREXATE:] a randomised phase III trial.,[RHEUMATOID ARTHRITIS],[CONCOMITANT METHOTREXATE:],TWrex-treat
788748024,9/15/2015 18:02:03,1738871664,9/15/2015 18:01:51,False,neodev,0.7889,20306047,GBR,,,80.41.0.252,[CONCOMITANT METHOTREXATE:] treats [RHEUMATOID ARTHRITIS],37,77,,56,101,treats,0.975900072948533,215430,title = Infliximab versus placebo in [RHEUMATOID ARTHRITIS] patients receiving [CONCOMITANT METHOTREXATE:] a randomised phase III trial.,[RHEUMATOID ARTHRITIS],[CONCOMITANT METHOTREXATE:],TWrex-treat
788748024,9/15/2015 18:09:38,1738879534,9/15/2015 18:09:07,False,clixsense,0.6484,17950689,GBR,L9,Sheffield,146.200.192.103,[CONCOMITANT METHOTREXATE:] treats [RHEUMATOID ARTHRITIS],37,77,,56,101,treats,0.975900072948533,215430,title = Infliximab versus placebo in [RHEUMATOID ARTHRITIS] patients receiving [CONCOMITANT METHOTREXATE:] a randomised phase III trial.,[RHEUMATOID ARTHRITIS],[CONCOMITANT METHOTREXATE:],TWrex-treat
788748024,9/15/2015 18:13:29,1738883801,9/15/2015 18:13:13,False,instagc,0.85,18985376,GBR,D2,Derby,86.27.159.112,[CONCOMITANT METHOTREXATE:] treats [RHEUMATOID ARTHRITIS],37,77,,56,101,treats,0.975900072948533,215430,title = Infliximab versus placebo in [RHEUMATOID ARTHRITIS] patients receiving [CONCOMITANT METHOTREXATE:] a randomised phase III trial.,[RHEUMATOID ARTHRITIS],[CONCOMITANT METHOTREXATE:],TWrex-treat
788748024,9/15/2015 18:15:52,1738885804,9/15/2015 18:14:15,False,zoombucks,0.8357,6744840,CAN,BC,Kelowna,174.4.58.160,[CONCOMITANT METHOTREXATE:] treats [RHEUMATOID ARTHRITIS],37,77,,56,101,treats,0.975900072948533,215430,title = Infliximab versus placebo in [RHEUMATOID ARTHRITIS] patients receiving [CONCOMITANT METHOTREXATE:] a randomised phase III trial.,[RHEUMATOID ARTHRITIS],[CONCOMITANT METHOTREXATE:],TWrex-treat
788748024,9/15/2015 18:19:55,1738888844,9/15/2015 18:19:42,False,clixsense,0.8357,19638651,USA,SC,Summerville,174.107.73.211,[CONCOMITANT METHOTREXATE:] treats [RHEUMATOID ARTHRITIS],37,77,,56,101,treats,0.975900072948533,215430,title = Infliximab versus placebo in [RHEUMATOID ARTHRITIS] patients receiving [CONCOMITANT METHOTREXATE:] a randomised phase III trial.,[RHEUMATOID ARTHRITIS],[CONCOMITANT METHOTREXATE:],TWrex-treat
788748038,9/15/2015 18:33:45,1738897171,9/15/2015 18:33:34,False,instagc,0.8861,31184650,USA,IA,Mason City,173.26.179.94,no_relation,105,2,,117,21,treats,0.997458699830735,805118,• HEPATITIS A VACCINE or immunoglobulin administered within 2 weeks of exposure can prevent or attenuate HAV INFECTION.,HAV INFECTION,HEPATITIS A VACCINE,TWrex-cause
788748038,9/15/2015 18:34:58,1738898035,9/15/2015 18:34:40,False,instagc,0.7607,20312760,GBR,O1,Dukinfield,2.96.59.31,HEPATITIS A VACCINE treats HAV INFECTION,105,2,,117,21,treats,0.997458699830735,805118,• HEPATITIS A VACCINE or immunoglobulin administered within 2 weeks of exposure can prevent or attenuate HAV INFECTION.,HAV INFECTION,HEPATITIS A VACCINE,TWrex-cause
788748038,9/15/2015 18:36:15,1738898842,9/15/2015 18:35:35,False,prodege,0.8167,6309240,USA,CA,San Diego,108.178.173.218,HEPATITIS A VACCINE treats HAV INFECTION,105,2,,117,21,treats,0.997458699830735,805118,• HEPATITIS A VACCINE or immunoglobulin administered within 2 weeks of exposure can prevent or attenuate HAV INFECTION.,HAV INFECTION,HEPATITIS A VACCINE,TWrex-cause
788748038,9/15/2015 18:36:30,1738898986,9/15/2015 18:36:12,False,bitcoinget,0.6607,29516942,USA,CA,Saratoga,107.178.35.226,no_relation,105,2,,117,21,treats,0.997458699830735,805118,• HEPATITIS A VACCINE or immunoglobulin administered within 2 weeks of exposure can prevent or attenuate HAV INFECTION.,HAV INFECTION,HEPATITIS A VACCINE,TWrex-cause
788748038,9/15/2015 18:41:40,1738902039,9/15/2015 18:41:04,False,clixsense,0.7532,32916182,GBR,L9,Sheffield,5.81.109.21,no_relation,105,2,,117,21,treats,0.997458699830735,805118,• HEPATITIS A VACCINE or immunoglobulin administered within 2 weeks of exposure can prevent or attenuate HAV INFECTION.,HAV INFECTION,HEPATITIS A VACCINE,TWrex-cause
788748038,9/15/2015 18:50:59,1738906995,9/15/2015 18:50:40,False,elite,0.8065,30507455,CAN,BC,Richmond,174.6.137.222,no_relation,105,2,,117,21,treats,0.997458699830735,805118,• HEPATITIS A VACCINE or immunoglobulin administered within 2 weeks of exposure can prevent or attenuate HAV INFECTION.,HAV INFECTION,HEPATITIS A VACCINE,TWrex-cause
788748038,9/15/2015 18:55:47,1738909468,9/15/2015 18:55:18,False,neodev,0.6052,34281269,USA,CA,Torrance,66.171.228.88,HAV INFECTION treats HEPATITIS A VACCINE,105,2,,117,21,treats,0.997458699830735,805118,• HEPATITIS A VACCINE or immunoglobulin administered within 2 weeks of exposure can prevent or attenuate HAV INFECTION.,HAV INFECTION,HEPATITIS A VACCINE,TWrex-cause
788748040,9/15/2015 16:50:23,1738787705,9/15/2015 16:49:39,False,prodege,0.9139,21417560,GBR,C3,Cambridge,151.224.120.191,AMANTADINE treats PARKINSON'S DISEASE,23,109,,41,119,treats,0.929981109950554,908349,A 61 year old man with PARKINSON'S DISEASE (PD) developed sudden onset visual impairment after initiation of AMANTADINE treatment.,PARKINSON'S DISEASE,AMANTADINE,RO-may_treat
788748040,9/15/2015 16:57:02,1738793914,9/15/2015 16:56:45,False,neodev,0.904,31743852,GBR,G5,Margate,85.210.124.152,AMANTADINE treats PARKINSON'S DISEASE,23,109,,41,119,treats,0.929981109950554,908349,A 61 year old man with PARKINSON'S DISEASE (PD) developed sudden onset visual impairment after initiation of AMANTADINE treatment.,PARKINSON'S DISEASE,AMANTADINE,RO-may_treat
788748040,9/15/2015 16:58:31,1738795250,9/15/2015 16:57:54,False,neodev,0.9159,18881135,CAN,ON,Ajax,99.243.87.224,AMANTADINE treats PARKINSON'S DISEASE,23,109,,41,119,treats,0.929981109950554,908349,A 61 year old man with PARKINSON'S DISEASE (PD) developed sudden onset visual impairment after initiation of AMANTADINE treatment.,PARKINSON'S DISEASE,AMANTADINE,RO-may_treat
788748040,9/15/2015 17:05:12,1738801665,9/15/2015 17:04:54,False,instagc,0.8214,33058612,USA,IL,Glenview,162.229.106.229,no_relation,23,109,,41,119,treats,0.929981109950554,908349,A 61 year old man with PARKINSON'S DISEASE (PD) developed sudden onset visual impairment after initiation of AMANTADINE treatment.,PARKINSON'S DISEASE,AMANTADINE,RO-may_treat
788748040,9/15/2015 17:06:52,1738803555,9/15/2015 17:05:16,False,neodev,0.5337,33701549,CAN,AB,Edmonton,208.123.223.189,AMANTADINE treats PARKINSON'S DISEASE,23,109,,41,119,treats,0.929981109950554,908349,A 61 year old man with PARKINSON'S DISEASE (PD) developed sudden onset visual impairment after initiation of AMANTADINE treatment.,PARKINSON'S DISEASE,AMANTADINE,RO-may_treat
788748040,9/15/2015 17:09:14,1738806143,9/15/2015 17:07:00,False,clixsense,0.7361,33115750,GBR,I3,Rochester,90.222.106.192,no_relation,23,109,,41,119,treats,0.929981109950554,908349,A 61 year old man with PARKINSON'S DISEASE (PD) developed sudden onset visual impairment after initiation of AMANTADINE treatment.,PARKINSON'S DISEASE,AMANTADINE,RO-may_treat
788748040,9/15/2015 17:14:19,1738810245,9/15/2015 17:11:48,False,clixsense,0.7214,21875134,GBR,,,80.189.12.98,AMANTADINE treats PARKINSON'S DISEASE,23,109,,41,119,treats,0.929981109950554,908349,A 61 year old man with PARKINSON'S DISEASE (PD) developed sudden onset visual impairment after initiation of AMANTADINE treatment.,PARKINSON'S DISEASE,AMANTADINE,RO-may_treat
788748047,9/15/2015 17:53:52,1738860690,9/15/2015 17:53:29,False,prodege,0.8532,27753453,USA,NY,Liverpool,71.176.126.145,no_relation,5,39,,19,51,treats,0.38490017950000005,207783,"With [CARBON DIOXIDE], it reacts to give [BENZOIC ACID] after an acidic workup.",CARBON DIOXIDE,BENZOIC ACID,TWrex-treat
788748047,9/15/2015 18:01:00,1738870974,9/15/2015 18:00:04,False,neodev,0.6198,33238512,NLD,11,Delft,94.210.42.212,CARBON DIOXIDE treats BENZOIC ACID,5,39,,19,51,treats,0.38490017950000005,207783,"With [CARBON DIOXIDE], it reacts to give [BENZOIC ACID] after an acidic workup.",CARBON DIOXIDE,BENZOIC ACID,TWrex-treat
788748047,9/15/2015 18:02:47,1738872174,9/15/2015 18:02:05,False,neodev,0.7889,20306047,GBR,,,80.41.0.252,no_relation,5,39,,19,51,treats,0.38490017950000005,207783,"With [CARBON DIOXIDE], it reacts to give [BENZOIC ACID] after an acidic workup.",CARBON DIOXIDE,BENZOIC ACID,TWrex-treat
788748047,9/15/2015 18:11:53,1738882091,9/15/2015 18:09:39,False,clixsense,0.6484,17950689,GBR,L9,Sheffield,146.200.192.103,BENZOIC ACID treats CARBON DIOXIDE,5,39,,19,51,treats,0.38490017950000005,207783,"With [CARBON DIOXIDE], it reacts to give [BENZOIC ACID] after an acidic workup.",CARBON DIOXIDE,BENZOIC ACID,TWrex-treat
788748047,9/15/2015 18:13:47,1738884096,9/15/2015 18:13:31,False,instagc,0.85,18985376,GBR,D2,Derby,86.27.159.112,no_relation,5,39,,19,51,treats,0.38490017950000005,207783,"With [CARBON DIOXIDE], it reacts to give [BENZOIC ACID] after an acidic workup.",CARBON DIOXIDE,BENZOIC ACID,TWrex-treat
788748047,9/15/2015 18:17:10,1738886912,9/15/2015 18:15:53,False,zoombucks,0.8357,6744840,CAN,BC,Kelowna,174.4.58.160,CARBON DIOXIDE treats BENZOIC ACID,5,39,,19,51,treats,0.38490017950000005,207783,"With [CARBON DIOXIDE], it reacts to give [BENZOIC ACID] after an acidic workup.",CARBON DIOXIDE,BENZOIC ACID,TWrex-treat
788748047,9/15/2015 18:20:19,1738889122,9/15/2015 18:19:56,False,clixsense,0.8357,19638651,USA,SC,Summerville,174.107.73.211,no_relation,5,39,,19,51,treats,0.38490017950000005,207783,"With [CARBON DIOXIDE], it reacts to give [BENZOIC ACID] after an acidic workup.",CARBON DIOXIDE,BENZOIC ACID,TWrex-treat
788748057,9/15/2015 16:38:40,1738780008,9/15/2015 16:38:26,False,instagc,0.9306,18960682,GBR,U2,Annan,92.18.213.181,BENZATHINE PENICILLIN G treats RHEUMATIC FEVER,135,42,,149,65,treats,0.929981109950554,805281,Three  versus four week administration of BENZATHINE PENICILLIN G: effects on incidence of streptococcal infections and recurrences of RHEUMATIC FEVER,RHEUMATIC FEVER,BENZATHINE PENICILLIN G,TWrex-cause
788748057,9/15/2015 16:43:24,1738782437,9/15/2015 16:43:09,False,elite,0.6895,34356654,USA,DE,,108.59.11.227,BENZATHINE PENICILLIN G treats RHEUMATIC FEVER,135,42,,149,65,treats,0.929981109950554,805281,Three  versus four week administration of BENZATHINE PENICILLIN G: effects on incidence of streptococcal infections and recurrences of RHEUMATIC FEVER,RHEUMATIC FEVER,BENZATHINE PENICILLIN G,TWrex-cause
788748057,9/15/2015 16:49:38,1738787201,9/15/2015 16:49:01,False,prodege,0.9139,21417560,GBR,C3,Cambridge,151.224.120.191,BENZATHINE PENICILLIN G treats RHEUMATIC FEVER,135,42,,149,65,treats,0.929981109950554,805281,Three  versus four week administration of BENZATHINE PENICILLIN G: effects on incidence of streptococcal infections and recurrences of RHEUMATIC FEVER,RHEUMATIC FEVER,BENZATHINE PENICILLIN G,TWrex-cause
788748057,9/15/2015 16:56:44,1738793683,9/15/2015 16:56:32,False,neodev,0.904,31743852,GBR,G5,Margate,85.210.124.152,BENZATHINE PENICILLIN G treats RHEUMATIC FEVER,135,42,,149,65,treats,0.929981109950554,805281,Three  versus four week administration of BENZATHINE PENICILLIN G: effects on incidence of streptococcal infections and recurrences of RHEUMATIC FEVER,RHEUMATIC FEVER,BENZATHINE PENICILLIN G,TWrex-cause
788748057,9/15/2015 16:57:53,1738794719,9/15/2015 16:57:35,False,neodev,0.9159,18881135,CAN,ON,Ajax,99.243.87.224,BENZATHINE PENICILLIN G treats RHEUMATIC FEVER,135,42,,149,65,treats,0.929981109950554,805281,Three  versus four week administration of BENZATHINE PENICILLIN G: effects on incidence of streptococcal infections and recurrences of RHEUMATIC FEVER,RHEUMATIC FEVER,BENZATHINE PENICILLIN G,TWrex-cause
788748057,9/15/2015 17:04:54,1738801318,9/15/2015 17:04:16,False,instagc,0.8214,33058612,USA,IL,Glenview,162.229.106.229,BENZATHINE PENICILLIN G treats RHEUMATIC FEVER,135,42,,149,65,treats,0.929981109950554,805281,Three  versus four week administration of BENZATHINE PENICILLIN G: effects on incidence of streptococcal infections and recurrences of RHEUMATIC FEVER,RHEUMATIC FEVER,BENZATHINE PENICILLIN G,TWrex-cause
788748057,9/15/2015 17:05:15,1738801718,9/15/2015 17:04:51,False,neodev,0.5337,33701549,CAN,AB,Edmonton,208.123.223.189,BENZATHINE PENICILLIN G treats RHEUMATIC FEVER,135,42,,149,65,treats,0.929981109950554,805281,Three  versus four week administration of BENZATHINE PENICILLIN G: effects on incidence of streptococcal infections and recurrences of RHEUMATIC FEVER,RHEUMATIC FEVER,BENZATHINE PENICILLIN G,TWrex-cause
788748061,9/15/2015 17:26:59,1738816495,9/15/2015 17:26:40,False,gifthunterclub,0.8413,29582088,GBR,I2,Manchester,2.99.153.19,TYPE A BOTULINUM TOXIN treats BLEPHAROSPASM,104,15,,116,37,treats,0.9950371902099889,908035,Treatment with TYPE A BOTULINUM TOXIN appears to be a safe and effective means of temporarily relieving BLEPHAROSPASM,BLEPHAROSPASM,TYPE A BOTULINUM TOXIN,RO-may_treat
788748061,9/15/2015 17:45:49,1738841868,9/15/2015 17:45:35,False,prodege,0.3786,2143114,CAN,BC,Vancouver,24.85.153.181,BLEPHAROSPASM treats TYPE A BOTULINUM TOXIN,104,15,,116,37,treats,0.9950371902099889,908035,Treatment with TYPE A BOTULINUM TOXIN appears to be a safe and effective means of temporarily relieving BLEPHAROSPASM,BLEPHAROSPASM,TYPE A BOTULINUM TOXIN,RO-may_treat
788748061,9/15/2015 17:52:11,1738856437,9/15/2015 17:51:53,False,prodege,0.8532,27753453,USA,NY,Liverpool,71.176.126.145,TYPE A BOTULINUM TOXIN treats BLEPHAROSPASM,104,15,,116,37,treats,0.9950371902099889,908035,Treatment with TYPE A BOTULINUM TOXIN appears to be a safe and effective means of temporarily relieving BLEPHAROSPASM,BLEPHAROSPASM,TYPE A BOTULINUM TOXIN,RO-may_treat
788748061,9/15/2015 17:57:35,1738868545,9/15/2015 17:55:41,False,neodev,0.6198,33238512,NLD,11,Delft,94.210.42.212,no_relation,104,15,,116,37,treats,0.9950371902099889,908035,Treatment with TYPE A BOTULINUM TOXIN appears to be a safe and effective means of temporarily relieving BLEPHAROSPASM,BLEPHAROSPASM,TYPE A BOTULINUM TOXIN,RO-may_treat
788748061,9/15/2015 17:58:49,1738869463,9/15/2015 17:58:17,False,neodev,0.7889,20306047,GBR,,,80.41.0.252,TYPE A BOTULINUM TOXIN treats BLEPHAROSPASM,104,15,,116,37,treats,0.9950371902099889,908035,Treatment with TYPE A BOTULINUM TOXIN appears to be a safe and effective means of temporarily relieving BLEPHAROSPASM,BLEPHAROSPASM,TYPE A BOTULINUM TOXIN,RO-may_treat
788748061,9/15/2015 18:07:19,1738876705,9/15/2015 18:07:05,False,clixsense,0.6484,17950689,GBR,L9,Sheffield,146.200.192.103,TYPE A BOTULINUM TOXIN treats BLEPHAROSPASM,104,15,,116,37,treats,0.9950371902099889,908035,Treatment with TYPE A BOTULINUM TOXIN appears to be a safe and effective means of temporarily relieving BLEPHAROSPASM,BLEPHAROSPASM,TYPE A BOTULINUM TOXIN,RO-may_treat
788748061,9/15/2015 18:19:25,1738888484,9/15/2015 18:19:07,False,clixsense,0.8357,19638651,USA,SC,Summerville,174.107.73.211,TYPE A BOTULINUM TOXIN treats BLEPHAROSPASM,104,15,,116,37,treats,0.9950371902099889,908035,Treatment with TYPE A BOTULINUM TOXIN appears to be a safe and effective means of temporarily relieving BLEPHAROSPASM,BLEPHAROSPASM,TYPE A BOTULINUM TOXIN,RO-may_treat
788748063,9/15/2015 18:14:33,1738884756,9/15/2015 18:14:18,False,instagc,0.85,18985376,GBR,D2,Derby,86.27.159.112,no_relation,41,84,,68,92,treats,0.474341649025257,224844,Recent clinical studies in patients with [PRE EXISTING CARDIAC DISEASE] indicate that [TRAZODONE] may be arrhythmogenic in some patients in that population.,[PRE EXISTING CARDIAC DISEASE],[TRAZODONE],TWrex-treat
788748063,9/15/2015 18:32:40,1738896449,9/15/2015 18:32:20,False,instagc,0.8861,31184650,USA,IA,Mason City,173.26.179.94,no_relation,41,84,,68,92,treats,0.474341649025257,224844,Recent clinical studies in patients with [PRE EXISTING CARDIAC DISEASE] indicate that [TRAZODONE] may be arrhythmogenic in some patients in that population.,[PRE EXISTING CARDIAC DISEASE],[TRAZODONE],TWrex-treat
788748063,9/15/2015 18:33:09,1738896715,9/15/2015 18:32:45,False,instagc,0.7607,20312760,GBR,O1,Dukinfield,2.96.59.31,[TRAZODONE] treats [PRE EXISTING CARDIAC DISEASE],41,84,,68,92,treats,0.474341649025257,224844,Recent clinical studies in patients with [PRE EXISTING CARDIAC DISEASE] indicate that [TRAZODONE] may be arrhythmogenic in some patients in that population.,[PRE EXISTING CARDIAC DISEASE],[TRAZODONE],TWrex-treat
788748063,9/15/2015 18:34:14,1738897492,9/15/2015 18:33:19,False,bitcoinget,0.6607,29516942,USA,CA,Saratoga,107.178.35.226,no_relation,41,84,,68,92,treats,0.474341649025257,224844,Recent clinical studies in patients with [PRE EXISTING CARDIAC DISEASE] indicate that [TRAZODONE] may be arrhythmogenic in some patients in that population.,[PRE EXISTING CARDIAC DISEASE],[TRAZODONE],TWrex-treat
788748063,9/15/2015 18:34:33,1738897724,9/15/2015 18:34:06,False,prodege,0.8167,6309240,USA,CA,San Diego,108.178.173.218,no_relation,41,84,,68,92,treats,0.474341649025257,224844,Recent clinical studies in patients with [PRE EXISTING CARDIAC DISEASE] indicate that [TRAZODONE] may be arrhythmogenic in some patients in that population.,[PRE EXISTING CARDIAC DISEASE],[TRAZODONE],TWrex-treat
788748063,9/15/2015 18:37:35,1738899602,9/15/2015 18:37:17,False,gifthunterclub,0.5714,31241093,GBR,Q1,Wallasey,2.217.117.151,no_relation,41,84,,68,92,treats,0.474341649025257,224844,Recent clinical studies in patients with [PRE EXISTING CARDIAC DISEASE] indicate that [TRAZODONE] may be arrhythmogenic in some patients in that population.,[PRE EXISTING CARDIAC DISEASE],[TRAZODONE],TWrex-treat
788748063,9/15/2015 18:39:36,1738900859,9/15/2015 18:38:48,False,clixsense,0.7532,32916182,GBR,L9,Sheffield,5.81.109.21,no_relation,41,84,,68,92,treats,0.474341649025257,224844,Recent clinical studies in patients with [PRE EXISTING CARDIAC DISEASE] indicate that [TRAZODONE] may be arrhythmogenic in some patients in that population.,[PRE EXISTING CARDIAC DISEASE],[TRAZODONE],TWrex-treat
788748065,9/15/2015 17:06:33,1738803201,9/15/2015 17:06:14,False,instagc,0.8214,33058612,USA,IL,Glenview,162.229.106.229,BOTOX treats DYSTONIA,82,0,,90,5,treats,0.6859943406,223247,"[BOTOX], however, merely targets the symptoms of the disorder and is not a cure for [DYSTONIA].",DYSTONIA,BOTOX,TWrex-treat
788748065,9/15/2015 17:08:25,1738805195,9/15/2015 17:07:47,False,neodev,0.5337,33701549,CAN,AB,Edmonton,208.123.223.189,DYSTONIA treats BOTOX,82,0,,90,5,treats,0.6859943406,223247,"[BOTOX], however, merely targets the symptoms of the disorder and is not a cure for [DYSTONIA].",DYSTONIA,BOTOX,TWrex-treat
788748065,9/15/2015 17:11:21,1738808135,9/15/2015 17:10:58,False,clixsense,0.7361,33115750,GBR,I3,Rochester,90.222.106.192,no_relation,82,0,,90,5,treats,0.6859943406,223247,"[BOTOX], however, merely targets the symptoms of the disorder and is not a cure for [DYSTONIA].",DYSTONIA,BOTOX,TWrex-treat
788748065,9/15/2015 17:16:48,1738811543,9/15/2015 17:16:21,False,clixsense,0.7893,33980820,USA,IL,Chicago,69.47.104.214,no_relation,82,0,,90,5,treats,0.6859943406,223247,"[BOTOX], however, merely targets the symptoms of the disorder and is not a cure for [DYSTONIA].",DYSTONIA,BOTOX,TWrex-treat
788748065,9/15/2015 17:17:27,1738811856,9/15/2015 17:17:11,False,zoombucks,0.7258,4711962,CAN,ON,Markham,174.88.29.138,BOTOX treats DYSTONIA,82,0,,90,5,treats,0.6859943406,223247,"[BOTOX], however, merely targets the symptoms of the disorder and is not a cure for [DYSTONIA].",DYSTONIA,BOTOX,TWrex-treat
788748065,9/15/2015 17:25:11,1738815679,9/15/2015 17:24:19,False,clixsense,0.7214,21875134,GBR,,,80.189.12.98,BOTOX treats DYSTONIA,82,0,,90,5,treats,0.6859943406,223247,"[BOTOX], however, merely targets the symptoms of the disorder and is not a cure for [DYSTONIA].",DYSTONIA,BOTOX,TWrex-treat
788748065,9/15/2015 17:25:16,1738815736,9/15/2015 17:24:38,False,gifthunterclub,0.8413,29582088,GBR,I2,Manchester,2.99.153.19,no_relation,82,0,,90,5,treats,0.6859943406,223247,"[BOTOX], however, merely targets the symptoms of the disorder and is not a cure for [DYSTONIA].",DYSTONIA,BOTOX,TWrex-treat
788748069,9/15/2015 19:06:32,1738914570,9/15/2015 19:06:17,False,prodege,0.9028,3587109,CAN,NS,Sydney,142.177.43.123,DICLOFENAC treats RHEUMATOID ARTHRITIS,151,136,,171,146,treats,0.990147543,224403,It is marketed by Pharmacia and its indication is for prophylaxis against NSAID-induced gastroduodenal ulceration in patients requiring [DICLOFENAC] for [RHEUMATOID ARTHRITIS] or osteoarthritis.,RHEUMATOID ARTHRITIS,DICLOFENAC,TWrex-treat
788748069,9/15/2015 19:18:50,1738920026,9/15/2015 19:18:37,False,zoombucks,0.8333,4688131,CAN,BC,Vancouver,216.251.132.22,DICLOFENAC treats RHEUMATOID ARTHRITIS,151,136,,171,146,treats,0.990147543,224403,It is marketed by Pharmacia and its indication is for prophylaxis against NSAID-induced gastroduodenal ulceration in patients requiring [DICLOFENAC] for [RHEUMATOID ARTHRITIS] or osteoarthritis.,RHEUMATOID ARTHRITIS,DICLOFENAC,TWrex-treat
788748069,9/15/2015 19:27:34,1738923814,9/15/2015 19:26:50,False,elite,0.6,30312592,CAN,ON,Sudbury,66.103.55.12,no_relation,151,136,,171,146,treats,0.990147543,224403,It is marketed by Pharmacia and its indication is for prophylaxis against NSAID-induced gastroduodenal ulceration in patients requiring [DICLOFENAC] for [RHEUMATOID ARTHRITIS] or osteoarthritis.,RHEUMATOID ARTHRITIS,DICLOFENAC,TWrex-treat
788748069,9/15/2015 19:33:48,1738925507,9/15/2015 19:33:02,False,instagc,0.8393,31157999,USA,KS,Topeka,68.102.220.35,DICLOFENAC treats RHEUMATOID ARTHRITIS,151,136,,171,146,treats,0.990147543,224403,It is marketed by Pharmacia and its indication is for prophylaxis against NSAID-induced gastroduodenal ulceration in patients requiring [DICLOFENAC] for [RHEUMATOID ARTHRITIS] or osteoarthritis.,RHEUMATOID ARTHRITIS,DICLOFENAC,TWrex-treat
788748069,9/15/2015 19:33:54,1738925541,9/15/2015 19:33:04,False,prodege,0.773,34247194,CAN,ON,Toronto,99.244.108.95,no_relation,151,136,,171,146,treats,0.990147543,224403,It is marketed by Pharmacia and its indication is for prophylaxis against NSAID-induced gastroduodenal ulceration in patients requiring [DICLOFENAC] for [RHEUMATOID ARTHRITIS] or osteoarthritis.,RHEUMATOID ARTHRITIS,DICLOFENAC,TWrex-treat
788748069,9/15/2015 19:37:24,1738926780,9/15/2015 19:36:53,False,elite,0.6639,29768955,GBR,C3,Gamlingay,31.50.187.165,DICLOFENAC treats RHEUMATOID ARTHRITIS,151,136,,171,146,treats,0.990147543,224403,It is marketed by Pharmacia and its indication is for prophylaxis against NSAID-induced gastroduodenal ulceration in patients requiring [DICLOFENAC] for [RHEUMATOID ARTHRITIS] or osteoarthritis.,RHEUMATOID ARTHRITIS,DICLOFENAC,TWrex-treat
788748069,9/15/2015 19:41:24,1738928072,9/15/2015 19:41:04,False,clixsense,0.6786,32053717,GBR,,,51.174.76.80,DICLOFENAC treats RHEUMATOID ARTHRITIS,151,136,,171,146,treats,0.990147543,224403,It is marketed by Pharmacia and its indication is for prophylaxis against NSAID-induced gastroduodenal ulceration in patients requiring [DICLOFENAC] for [RHEUMATOID ARTHRITIS] or osteoarthritis.,RHEUMATOID ARTHRITIS,DICLOFENAC,TWrex-treat
788748071,9/15/2015 19:06:45,1738914639,9/15/2015 19:06:33,False,prodege,0.9028,3587109,CAN,NS,Sydney,142.177.43.123,[RIBOFLAVIN] treats [HEADACHE],154,0,,162,9,treats,0.9941348467724341,213516,"[RIBOFLAVIN] has been rigorously studied and has demonstrated a reduction of migraine days and hours by 44%, although with no reduction in intensity of the [HEADACHE]",[HEADACHE],[RIBOFLAVIN],TWrex-treat
788748071,9/15/2015 19:19:03,1738920095,9/15/2015 19:18:50,False,zoombucks,0.8333,4688131,CAN,BC,Vancouver,216.251.132.22,[RIBOFLAVIN] treats [HEADACHE],154,0,,162,9,treats,0.9941348467724341,213516,"[RIBOFLAVIN] has been rigorously studied and has demonstrated a reduction of migraine days and hours by 44%, although with no reduction in intensity of the [HEADACHE]",[HEADACHE],[RIBOFLAVIN],TWrex-treat
788748071,9/15/2015 19:27:56,1738923896,9/15/2015 19:27:35,False,elite,0.6,30312592,CAN,ON,Sudbury,66.103.55.12,no_relation,154,0,,162,9,treats,0.9941348467724341,213516,"[RIBOFLAVIN] has been rigorously studied and has demonstrated a reduction of migraine days and hours by 44%, although with no reduction in intensity of the [HEADACHE]",[HEADACHE],[RIBOFLAVIN],TWrex-treat
788748071,9/15/2015 19:34:30,1738925733,9/15/2015 19:33:54,False,prodege,0.773,34247194,CAN,ON,Toronto,99.244.108.95,no_relation,154,0,,162,9,treats,0.9941348467724341,213516,"[RIBOFLAVIN] has been rigorously studied and has demonstrated a reduction of migraine days and hours by 44%, although with no reduction in intensity of the [HEADACHE]",[HEADACHE],[RIBOFLAVIN],TWrex-treat
788748071,9/15/2015 19:35:03,1738925940,9/15/2015 19:33:49,False,instagc,0.8393,31157999,USA,KS,Topeka,68.102.220.35,no_relation,154,0,,162,9,treats,0.9941348467724341,213516,"[RIBOFLAVIN] has been rigorously studied and has demonstrated a reduction of migraine days and hours by 44%, although with no reduction in intensity of the [HEADACHE]",[HEADACHE],[RIBOFLAVIN],TWrex-treat
788748071,9/15/2015 19:37:44,1738926890,9/15/2015 19:37:25,False,elite,0.6639,29768955,GBR,C3,Gamlingay,31.50.187.165,[RIBOFLAVIN] treats [HEADACHE],154,0,,162,9,treats,0.9941348467724341,213516,"[RIBOFLAVIN] has been rigorously studied and has demonstrated a reduction of migraine days and hours by 44%, although with no reduction in intensity of the [HEADACHE]",[HEADACHE],[RIBOFLAVIN],TWrex-treat
788748071,9/15/2015 19:41:53,1738928290,9/15/2015 19:41:19,False,prodege,0.7111,16101132,GBR,F9,Hayes,2.216.28.167,[RIBOFLAVIN] treats [HEADACHE],154,0,,162,9,treats,0.9941348467724341,213516,"[RIBOFLAVIN] has been rigorously studied and has demonstrated a reduction of migraine days and hours by 44%, although with no reduction in intensity of the [HEADACHE]",[HEADACHE],[RIBOFLAVIN],TWrex-treat
788748072,9/15/2015 19:06:32,1738914561,9/15/2015 19:06:17,False,prodege,0.9028,3587109,CAN,NS,Sydney,142.177.43.123,HYDROXYCHLOROQUINE treats DIABETES,73,15,,81,33,treats,0.979957887012223,209848,"In patients on [HYDROXYCHLOROQUINE] for rheumatoid arthritis, incidence of [DIABETES] was reduced by 77% though causal mechanisms are unclear.",DIABETES,HYDROXYCHLOROQUINE,TWrex-treat
788748072,9/15/2015 19:18:50,1738920025,9/15/2015 19:18:37,False,zoombucks,0.8333,4688131,CAN,BC,Vancouver,216.251.132.22,no_relation,73,15,,81,33,treats,0.979957887012223,209848,"In patients on [HYDROXYCHLOROQUINE] for rheumatoid arthritis, incidence of [DIABETES] was reduced by 77% though causal mechanisms are unclear.",DIABETES,HYDROXYCHLOROQUINE,TWrex-treat
788748072,9/15/2015 19:27:34,1738923809,9/15/2015 19:26:50,False,elite,0.6,30312592,CAN,ON,Sudbury,66.103.55.12,no_relation,73,15,,81,33,treats,0.979957887012223,209848,"In patients on [HYDROXYCHLOROQUINE] for rheumatoid arthritis, incidence of [DIABETES] was reduced by 77% though causal mechanisms are unclear.",DIABETES,HYDROXYCHLOROQUINE,TWrex-treat
788748072,9/15/2015 19:33:48,1738925508,9/15/2015 19:33:02,False,instagc,0.8393,31157999,USA,KS,Topeka,68.102.220.35,no_relation,73,15,,81,33,treats,0.979957887012223,209848,"In patients on [HYDROXYCHLOROQUINE] for rheumatoid arthritis, incidence of [DIABETES] was reduced by 77% though causal mechanisms are unclear.",DIABETES,HYDROXYCHLOROQUINE,TWrex-treat
788748072,9/15/2015 19:33:54,1738925540,9/15/2015 19:33:04,False,prodege,0.773,34247194,CAN,ON,Toronto,99.244.108.95,no_relation,73,15,,81,33,treats,0.979957887012223,209848,"In patients on [HYDROXYCHLOROQUINE] for rheumatoid arthritis, incidence of [DIABETES] was reduced by 77% though causal mechanisms are unclear.",DIABETES,HYDROXYCHLOROQUINE,TWrex-treat
788748072,9/15/2015 19:37:24,1738926773,9/15/2015 19:36:53,False,elite,0.6639,29768955,GBR,C3,Gamlingay,31.50.187.165,HYDROXYCHLOROQUINE treats DIABETES,73,15,,81,33,treats,0.979957887012223,209848,"In patients on [HYDROXYCHLOROQUINE] for rheumatoid arthritis, incidence of [DIABETES] was reduced by 77% though causal mechanisms are unclear.",DIABETES,HYDROXYCHLOROQUINE,TWrex-treat
788748072,9/15/2015 19:41:24,1738928073,9/15/2015 19:41:04,False,clixsense,0.6786,32053717,GBR,,,51.174.76.80,HYDROXYCHLOROQUINE treats DIABETES,73,15,,81,33,treats,0.979957887012223,209848,"In patients on [HYDROXYCHLOROQUINE] for rheumatoid arthritis, incidence of [DIABETES] was reduced by 77% though causal mechanisms are unclear.",DIABETES,HYDROXYCHLOROQUINE,TWrex-treat
788748073,9/15/2015 20:01:34,1738939527,9/15/2015 20:00:53,False,neodev,0.8433,33758777,USA,,,38.95.108.251,VALACICLOVIR treats HERPES ZOSTER,62,0,,74,12,treats,1.0,800404,VALACICLOVIR compared with acyclovir for improved therapy for HERPES ZOSTER in immunocompetent adults.,HERPES ZOSTER,VALACICLOVIR,TWrex-cause
788748073,9/15/2015 20:06:37,1738945730,9/15/2015 20:05:58,False,clixsense,0.8829,6641082,CAN,QC,Verdun,184.161.206.169,VALACICLOVIR treats HERPES ZOSTER,62,0,,74,12,treats,1.0,800404,VALACICLOVIR compared with acyclovir for improved therapy for HERPES ZOSTER in immunocompetent adults.,HERPES ZOSTER,VALACICLOVIR,TWrex-cause
788748073,9/15/2015 20:09:20,1738948546,9/15/2015 20:09:09,False,neodev,0.8552,33538351,USA,,,208.31.49.57,VALACICLOVIR treats HERPES ZOSTER,62,0,,74,12,treats,1.0,800404,VALACICLOVIR compared with acyclovir for improved therapy for HERPES ZOSTER in immunocompetent adults.,HERPES ZOSTER,VALACICLOVIR,TWrex-cause
788748073,9/15/2015 20:29:00,1738978010,9/15/2015 20:26:59,False,quickrewards,0.7979,8672587,USA,TX,El Paso,209.194.208.150,VALACICLOVIR treats HERPES ZOSTER,62,0,,74,12,treats,1.0,800404,VALACICLOVIR compared with acyclovir for improved therapy for HERPES ZOSTER in immunocompetent adults.,HERPES ZOSTER,VALACICLOVIR,TWrex-cause
788748073,9/15/2015 20:49:21,1738996257,9/15/2015 20:48:49,False,clixsense,0.7146,26531841,CAN,ON,Toronto,64.231.8.24,VALACICLOVIR treats HERPES ZOSTER,62,0,,74,12,treats,1.0,800404,VALACICLOVIR compared with acyclovir for improved therapy for HERPES ZOSTER in immunocompetent adults.,HERPES ZOSTER,VALACICLOVIR,TWrex-cause
788748073,9/15/2015 20:53:51,1739001965,9/15/2015 20:53:42,False,neodev,0.5655,33155316,GBR,I9,Dereham,31.50.244.140,VALACICLOVIR treats HERPES ZOSTER,62,0,,74,12,treats,1.0,800404,VALACICLOVIR compared with acyclovir for improved therapy for HERPES ZOSTER in immunocompetent adults.,HERPES ZOSTER,VALACICLOVIR,TWrex-cause
788748073,9/15/2015 21:17:47,1739026960,9/15/2015 21:17:28,False,neodev,0.5278,31984900,CAN,AB,Edmonton,208.123.223.144,HERPES ZOSTER treats VALACICLOVIR,62,0,,74,12,treats,1.0,800404,VALACICLOVIR compared with acyclovir for improved therapy for HERPES ZOSTER in immunocompetent adults.,HERPES ZOSTER,VALACICLOVIR,TWrex-cause
788748080,9/15/2015 16:13:29,1738770739,9/15/2015 16:13:18,False,neodev,0.9167,14096345,NLD,03,Eibergen,178.85.94.186,no_relation,59,134,,60,141,treats,0.9830783046228491,803546,"Low dose aspirin reduced combined 3 month risk for stroke, MI and death after carotid endarterectomy  Keywords: Myocardial infarction ASPIRIN Cerebrovascular disorders Endarterectomy, carotid  ACP Journal Club.",MI,ASPIRIN,TWrex-cause
788748080,9/15/2015 16:15:00,1738771421,9/15/2015 16:14:12,False,gifthunterclub,0.8036,24043308,GBR,,,94.102.147.250,ASPIRIN treats MI,59,134,,60,141,treats,0.9830783046228491,803546,"Low dose aspirin reduced combined 3 month risk for stroke, MI and death after carotid endarterectomy  Keywords: Myocardial infarction ASPIRIN Cerebrovascular disorders Endarterectomy, carotid  ACP Journal Club.",MI,ASPIRIN,TWrex-cause
788748080,9/15/2015 16:17:57,1738772417,9/15/2015 16:17:34,False,prodege,0.8611,22031444,GBR,F2,Gosport,92.24.223.243,no_relation,59,134,,60,141,treats,0.9830783046228491,803546,"Low dose aspirin reduced combined 3 month risk for stroke, MI and death after carotid endarterectomy  Keywords: Myocardial infarction ASPIRIN Cerebrovascular disorders Endarterectomy, carotid  ACP Journal Club.",MI,ASPIRIN,TWrex-cause
788748080,9/15/2015 16:20:11,1738773263,9/15/2015 16:19:55,False,onestopgpt,0.7087,21275875,CAN,ON,Hamilton,24.36.124.79,ASPIRIN treats MI,59,134,,60,141,treats,0.9830783046228491,803546,"Low dose aspirin reduced combined 3 month risk for stroke, MI and death after carotid endarterectomy  Keywords: Myocardial infarction ASPIRIN Cerebrovascular disorders Endarterectomy, carotid  ACP Journal Club.",MI,ASPIRIN,TWrex-cause
788748080,9/15/2015 16:21:48,1738773766,9/15/2015 16:20:49,False,clixsense,0.8407,33878524,CAN,BC,Princeton,75.156.83.71,ASPIRIN treats MI,59,134,,60,141,treats,0.9830783046228491,803546,"Low dose aspirin reduced combined 3 month risk for stroke, MI and death after carotid endarterectomy  Keywords: Myocardial infarction ASPIRIN Cerebrovascular disorders Endarterectomy, carotid  ACP Journal Club.",MI,ASPIRIN,TWrex-cause
788748080,9/15/2015 16:26:30,1738775723,9/15/2015 16:26:08,False,prodege,0.8302,27934334,GBR,C8,Croydon,81.159.60.206,no_relation,59,134,,60,141,treats,0.9830783046228491,803546,"Low dose aspirin reduced combined 3 month risk for stroke, MI and death after carotid endarterectomy  Keywords: Myocardial infarction ASPIRIN Cerebrovascular disorders Endarterectomy, carotid  ACP Journal Club.",MI,ASPIRIN,TWrex-cause
788748080,9/15/2015 16:27:35,1738776122,9/15/2015 16:27:23,False,bitcoinget,0.6592,21743413,USA,WA,Port Angeles,24.113.29.97,ASPIRIN treats MI,59,134,,60,141,treats,0.9830783046228491,803546,"Low dose aspirin reduced combined 3 month risk for stroke, MI and death after carotid endarterectomy  Keywords: Myocardial infarction ASPIRIN Cerebrovascular disorders Endarterectomy, carotid  ACP Journal Club.",MI,ASPIRIN,TWrex-cause
788748081,9/15/2015 17:06:12,1738802771,9/15/2015 17:05:40,False,instagc,0.8214,33058612,USA,IL,Glenview,162.229.106.229,no_relation,34,0,,52,8,treats,1.0,222206,"[ATROPINE] may be used to prevent a [REFLEX BRADYCARDIA] from vagal stimulation during laryngoscopy, especially in young children and infants.",REFLEX BRADYCARDIA,ATROPINE,TWrex-treat
788748081,9/15/2015 17:07:45,1738804475,9/15/2015 17:07:22,False,neodev,0.5337,33701549,CAN,AB,Edmonton,208.123.223.189,ATROPINE treats REFLEX BRADYCARDIA,34,0,,52,8,treats,1.0,222206,"[ATROPINE] may be used to prevent a [REFLEX BRADYCARDIA] from vagal stimulation during laryngoscopy, especially in young children and infants.",REFLEX BRADYCARDIA,ATROPINE,TWrex-treat
788748081,9/15/2015 17:10:57,1738807779,9/15/2015 17:10:38,False,clixsense,0.7361,33115750,GBR,I3,Rochester,90.222.106.192,ATROPINE treats REFLEX BRADYCARDIA,34,0,,52,8,treats,1.0,222206,"[ATROPINE] may be used to prevent a [REFLEX BRADYCARDIA] from vagal stimulation during laryngoscopy, especially in young children and infants.",REFLEX BRADYCARDIA,ATROPINE,TWrex-treat
788748081,9/15/2015 17:16:20,1738811296,9/15/2015 17:15:51,False,clixsense,0.7893,33980820,USA,IL,Chicago,69.47.104.214,ATROPINE treats REFLEX BRADYCARDIA,34,0,,52,8,treats,1.0,222206,"[ATROPINE] may be used to prevent a [REFLEX BRADYCARDIA] from vagal stimulation during laryngoscopy, especially in young children and infants.",REFLEX BRADYCARDIA,ATROPINE,TWrex-treat
788748081,9/15/2015 17:17:09,1738811741,9/15/2015 17:16:43,False,zoombucks,0.7258,4711962,CAN,ON,Markham,174.88.29.138,ATROPINE treats REFLEX BRADYCARDIA,34,0,,52,8,treats,1.0,222206,"[ATROPINE] may be used to prevent a [REFLEX BRADYCARDIA] from vagal stimulation during laryngoscopy, especially in young children and infants.",REFLEX BRADYCARDIA,ATROPINE,TWrex-treat
788748081,9/15/2015 17:21:58,1738814082,9/15/2015 17:21:50,False,elite,0.2143,33798502,USA,VA,Manassas,207.244.77.3,REFLEX BRADYCARDIA treats ATROPINE,34,0,,52,8,treats,1.0,222206,"[ATROPINE] may be used to prevent a [REFLEX BRADYCARDIA] from vagal stimulation during laryngoscopy, especially in young children and infants.",REFLEX BRADYCARDIA,ATROPINE,TWrex-treat
788748081,9/15/2015 17:24:18,1738815265,9/15/2015 17:20:22,False,clixsense,0.7214,21875134,GBR,,,80.189.12.98,ATROPINE treats REFLEX BRADYCARDIA,34,0,,52,8,treats,1.0,222206,"[ATROPINE] may be used to prevent a [REFLEX BRADYCARDIA] from vagal stimulation during laryngoscopy, especially in young children and infants.",REFLEX BRADYCARDIA,ATROPINE,TWrex-treat
788748082,9/15/2015 19:39:32,1738927465,9/15/2015 19:39:06,False,elite,0.6639,29768955,GBR,C3,Gamlingay,31.50.187.165,LOSARTAN treats ISOLATED SYSTOLIC HYPERTENSION,46,187,,75,195,treats,0.8427009716003839,804455,Losartan was more effective than atenolol for ISOLATED SYSTOLIC HYPERTENSION and left ventricular hypertrophy  Keywords: Antihypertensive agents Atenolol Hydrochlorothiazide Hypertension LOSARTAN  ACP Journal Club.,ISOLATED SYSTOLIC HYPERTENSION,LOSARTAN,TWrex-cause
788748082,9/15/2015 19:43:37,1738928929,9/15/2015 19:42:46,False,clixsense,0.6786,32053717,GBR,,,51.174.76.80,no_relation,46,187,,75,195,treats,0.8427009716003839,804455,Losartan was more effective than atenolol for ISOLATED SYSTOLIC HYPERTENSION and left ventricular hypertrophy  Keywords: Antihypertensive agents Atenolol Hydrochlorothiazide Hypertension LOSARTAN  ACP Journal Club.,ISOLATED SYSTOLIC HYPERTENSION,LOSARTAN,TWrex-cause
788748082,9/15/2015 19:44:02,1738929087,9/15/2015 19:43:42,False,prodege,0.7111,16101132,GBR,F9,Hayes,2.216.28.167,LOSARTAN treats ISOLATED SYSTOLIC HYPERTENSION,46,187,,75,195,treats,0.8427009716003839,804455,Losartan was more effective than atenolol for ISOLATED SYSTOLIC HYPERTENSION and left ventricular hypertrophy  Keywords: Antihypertensive agents Atenolol Hydrochlorothiazide Hypertension LOSARTAN  ACP Journal Club.,ISOLATED SYSTOLIC HYPERTENSION,LOSARTAN,TWrex-cause
788748082,9/15/2015 19:49:11,1738931291,9/15/2015 19:48:53,False,pocketmoneygpt,0.7604,34458129,USA,CA,Lake Forest,158.69.137.23,LOSARTAN treats ISOLATED SYSTOLIC HYPERTENSION,46,187,,75,195,treats,0.8427009716003839,804455,Losartan was more effective than atenolol for ISOLATED SYSTOLIC HYPERTENSION and left ventricular hypertrophy  Keywords: Antihypertensive agents Atenolol Hydrochlorothiazide Hypertension LOSARTAN  ACP Journal Club.,ISOLATED SYSTOLIC HYPERTENSION,LOSARTAN,TWrex-cause
788748082,9/15/2015 19:59:28,1738937536,9/15/2015 19:58:37,False,neodev,0.8433,33758777,USA,,,38.95.108.251,LOSARTAN treats ISOLATED SYSTOLIC HYPERTENSION,46,187,,75,195,treats,0.8427009716003839,804455,Losartan was more effective than atenolol for ISOLATED SYSTOLIC HYPERTENSION and left ventricular hypertrophy  Keywords: Antihypertensive agents Atenolol Hydrochlorothiazide Hypertension LOSARTAN  ACP Journal Club.,ISOLATED SYSTOLIC HYPERTENSION,LOSARTAN,TWrex-cause
788748082,9/15/2015 20:03:17,1738942191,9/15/2015 20:02:36,False,clixsense,0.8829,6641082,CAN,QC,Verdun,184.161.206.169,LOSARTAN treats ISOLATED SYSTOLIC HYPERTENSION,46,187,,75,195,treats,0.8427009716003839,804455,Losartan was more effective than atenolol for ISOLATED SYSTOLIC HYPERTENSION and left ventricular hypertrophy  Keywords: Antihypertensive agents Atenolol Hydrochlorothiazide Hypertension LOSARTAN  ACP Journal Club.,ISOLATED SYSTOLIC HYPERTENSION,LOSARTAN,TWrex-cause
788748082,9/15/2015 20:07:16,1738946197,9/15/2015 20:06:21,False,neodev,0.8552,33538351,USA,,,208.31.49.57,LOSARTAN treats ISOLATED SYSTOLIC HYPERTENSION,46,187,,75,195,treats,0.8427009716003839,804455,Losartan was more effective than atenolol for ISOLATED SYSTOLIC HYPERTENSION and left ventricular hypertrophy  Keywords: Antihypertensive agents Atenolol Hydrochlorothiazide Hypertension LOSARTAN  ACP Journal Club.,ISOLATED SYSTOLIC HYPERTENSION,LOSARTAN,TWrex-cause
788748085,9/15/2015 16:13:51,1738770948,9/15/2015 16:13:31,False,neodev,0.9167,14096345,NLD,03,Eibergen,178.85.94.186,RIBAVIRIN treats CHRONIC HEPATITIS C,153,118,,171,127,treats,1.0,800654,"Manns MP, McHutchison JG, Gordon SC et al. Peginterferon alfa 2b plus ribavirin compared with interferon alfa 2b plus RIBAVIRIN for initial treatment of CHRONIC HEPATITIS C: a randomised trial.",CHRONIC HEPATITIS C,RIBAVIRIN,TWrex-cause
788748085,9/15/2015 16:19:03,1738772821,9/15/2015 16:17:59,False,prodege,0.8611,22031444,GBR,F2,Gosport,92.24.223.243,RIBAVIRIN treats CHRONIC HEPATITIS C,153,118,,171,127,treats,1.0,800654,"Manns MP, McHutchison JG, Gordon SC et al. Peginterferon alfa 2b plus ribavirin compared with interferon alfa 2b plus RIBAVIRIN for initial treatment of CHRONIC HEPATITIS C: a randomised trial.",CHRONIC HEPATITIS C,RIBAVIRIN,TWrex-cause
788748085,9/15/2015 16:20:41,1738773394,9/15/2015 16:20:11,False,onestopgpt,0.7087,21275875,CAN,ON,Hamilton,24.36.124.79,RIBAVIRIN treats CHRONIC HEPATITIS C,153,118,,171,127,treats,1.0,800654,"Manns MP, McHutchison JG, Gordon SC et al. Peginterferon alfa 2b plus ribavirin compared with interferon alfa 2b plus RIBAVIRIN for initial treatment of CHRONIC HEPATITIS C: a randomised trial.",CHRONIC HEPATITIS C,RIBAVIRIN,TWrex-cause
788748085,9/15/2015 16:25:06,1738775228,9/15/2015 16:23:38,False,clixsense,0.8407,33878524,CAN,BC,Princeton,75.156.83.71,RIBAVIRIN treats CHRONIC HEPATITIS C,153,118,,171,127,treats,1.0,800654,"Manns MP, McHutchison JG, Gordon SC et al. Peginterferon alfa 2b plus ribavirin compared with interferon alfa 2b plus RIBAVIRIN for initial treatment of CHRONIC HEPATITIS C: a randomised trial.",CHRONIC HEPATITIS C,RIBAVIRIN,TWrex-cause
788748085,9/15/2015 16:26:56,1738775870,9/15/2015 16:26:32,False,prodege,0.8302,27934334,GBR,C8,Croydon,81.159.60.206,RIBAVIRIN treats CHRONIC HEPATITIS C,153,118,,171,127,treats,1.0,800654,"Manns MP, McHutchison JG, Gordon SC et al. Peginterferon alfa 2b plus ribavirin compared with interferon alfa 2b plus RIBAVIRIN for initial treatment of CHRONIC HEPATITIS C: a randomised trial.",CHRONIC HEPATITIS C,RIBAVIRIN,TWrex-cause
788748085,9/15/2015 16:27:45,1738776198,9/15/2015 16:27:35,False,bitcoinget,0.6592,21743413,USA,WA,Port Angeles,24.113.29.97,RIBAVIRIN treats CHRONIC HEPATITIS C,153,118,,171,127,treats,1.0,800654,"Manns MP, McHutchison JG, Gordon SC et al. Peginterferon alfa 2b plus ribavirin compared with interferon alfa 2b plus RIBAVIRIN for initial treatment of CHRONIC HEPATITIS C: a randomised trial.",CHRONIC HEPATITIS C,RIBAVIRIN,TWrex-cause
788748085,9/15/2015 16:31:48,1738777528,9/15/2015 16:31:43,False,instagc,0.8571,13581319,USA,IL,Trenton,208.70.36.12,RIBAVIRIN treats CHRONIC HEPATITIS C,153,118,,171,127,treats,1.0,800654,"Manns MP, McHutchison JG, Gordon SC et al. Peginterferon alfa 2b plus ribavirin compared with interferon alfa 2b plus RIBAVIRIN for initial treatment of CHRONIC HEPATITIS C: a randomised trial.",CHRONIC HEPATITIS C,RIBAVIRIN,TWrex-cause
788748086,9/15/2015 20:00:52,1738938866,9/15/2015 20:00:12,False,neodev,0.8433,33758777,USA,,,38.95.108.251,TRIVALENT INACTIVATED POLIOVIRUS VACCINE (IPV treats POLIOMYELITIS,72,36,,116,49,treats,0.9950371902099889,903549,"It is indicated for all children    POLIOMYELITIS:  A primary series of TRIVALENT INACTIVATED POLIOVIRUS VACCINE (IPV consisting of a mixture of formalin inactivated poliovirus types 1, 2, and 3, should be given during childhood and produces immunity in &gt; 99% of recipients.",TRIVALENT INACTIVATED POLIOVIRUS VACCINE (IPV,POLIOMYELITIS,RO-has_causative_agent
788748086,9/15/2015 20:05:50,1738945215,9/15/2015 20:04:33,False,clixsense,0.8829,6641082,CAN,QC,Verdun,184.161.206.169,TRIVALENT INACTIVATED POLIOVIRUS VACCINE (IPV treats POLIOMYELITIS,72,36,,116,49,treats,0.9950371902099889,903549,"It is indicated for all children    POLIOMYELITIS:  A primary series of TRIVALENT INACTIVATED POLIOVIRUS VACCINE (IPV consisting of a mixture of formalin inactivated poliovirus types 1, 2, and 3, should be given during childhood and produces immunity in &gt; 99% of recipients.",TRIVALENT INACTIVATED POLIOVIRUS VACCINE (IPV,POLIOMYELITIS,RO-has_causative_agent
788748086,9/15/2015 20:09:07,1738948370,9/15/2015 20:08:38,False,neodev,0.8552,33538351,USA,,,208.31.49.57,POLIOMYELITIS treats TRIVALENT INACTIVATED POLIOVIRUS VACCINE (IPV,72,36,,116,49,treats,0.9950371902099889,903549,"It is indicated for all children    POLIOMYELITIS:  A primary series of TRIVALENT INACTIVATED POLIOVIRUS VACCINE (IPV consisting of a mixture of formalin inactivated poliovirus types 1, 2, and 3, should be given during childhood and produces immunity in &gt; 99% of recipients.",TRIVALENT INACTIVATED POLIOVIRUS VACCINE (IPV,POLIOMYELITIS,RO-has_causative_agent
788748086,9/15/2015 20:13:10,1738952236,9/15/2015 20:12:20,False,neodev,0.8304,30588889,NLD,07,Amsterdam,77.248.175.222,TRIVALENT INACTIVATED POLIOVIRUS VACCINE (IPV treats POLIOMYELITIS,72,36,,116,49,treats,0.9950371902099889,903549,"It is indicated for all children    POLIOMYELITIS:  A primary series of TRIVALENT INACTIVATED POLIOVIRUS VACCINE (IPV consisting of a mixture of formalin inactivated poliovirus types 1, 2, and 3, should be given during childhood and produces immunity in &gt; 99% of recipients.",TRIVALENT INACTIVATED POLIOVIRUS VACCINE (IPV,POLIOMYELITIS,RO-has_causative_agent
788748086,9/15/2015 20:26:46,1738974052,9/15/2015 20:25:36,False,quickrewards,0.7979,8672587,USA,TX,El Paso,209.194.208.150,TRIVALENT INACTIVATED POLIOVIRUS VACCINE (IPV treats POLIOMYELITIS,72,36,,116,49,treats,0.9950371902099889,903549,"It is indicated for all children    POLIOMYELITIS:  A primary series of TRIVALENT INACTIVATED POLIOVIRUS VACCINE (IPV consisting of a mixture of formalin inactivated poliovirus types 1, 2, and 3, should be given during childhood and produces immunity in &gt; 99% of recipients.",TRIVALENT INACTIVATED POLIOVIRUS VACCINE (IPV,POLIOMYELITIS,RO-has_causative_agent
788748086,9/15/2015 20:48:44,1738995889,9/15/2015 20:47:34,False,clixsense,0.7146,26531841,CAN,ON,Toronto,64.231.8.24,no_relation,72,36,,116,49,treats,0.9950371902099889,903549,"It is indicated for all children    POLIOMYELITIS:  A primary series of TRIVALENT INACTIVATED POLIOVIRUS VACCINE (IPV consisting of a mixture of formalin inactivated poliovirus types 1, 2, and 3, should be given during childhood and produces immunity in &gt; 99% of recipients.",TRIVALENT INACTIVATED POLIOVIRUS VACCINE (IPV,POLIOMYELITIS,RO-has_causative_agent
788748086,9/15/2015 20:53:41,1739001810,9/15/2015 20:53:29,False,neodev,0.5655,33155316,GBR,I9,Dereham,31.50.244.140,POLIOMYELITIS treats TRIVALENT INACTIVATED POLIOVIRUS VACCINE (IPV,72,36,,116,49,treats,0.9950371902099889,903549,"It is indicated for all children    POLIOMYELITIS:  A primary series of TRIVALENT INACTIVATED POLIOVIRUS VACCINE (IPV consisting of a mixture of formalin inactivated poliovirus types 1, 2, and 3, should be given during childhood and produces immunity in &gt; 99% of recipients.",TRIVALENT INACTIVATED POLIOVIRUS VACCINE (IPV,POLIOMYELITIS,RO-has_causative_agent
788748088,9/15/2015 18:58:11,1738910569,9/15/2015 18:57:11,False,neodev,0.6052,34281269,USA,CA,Torrance,66.171.228.88,CEFTAZIDIME treats FEBRILE NEUTROPENIA,149,97,,167,108,treats,0.9878291611472622,803965,"Ariffin H, Arasu A, Mahfuzah M et al. Single daily ceftriaxone plus amikacin versus thrice daily CEFTAZIDIME plus amikacin as empirical treatment of FEBRILE NEUTROPENIA in children with cancer.",FEBRILE NEUTROPENIA,CEFTAZIDIME,TWrex-cause
788748088,9/15/2015 19:06:16,1738914398,9/15/2015 19:05:56,False,prodege,0.9028,3587109,CAN,NS,Sydney,142.177.43.123,CEFTAZIDIME treats FEBRILE NEUTROPENIA,149,97,,167,108,treats,0.9878291611472622,803965,"Ariffin H, Arasu A, Mahfuzah M et al. Single daily ceftriaxone plus amikacin versus thrice daily CEFTAZIDIME plus amikacin as empirical treatment of FEBRILE NEUTROPENIA in children with cancer.",FEBRILE NEUTROPENIA,CEFTAZIDIME,TWrex-cause
788748088,9/15/2015 19:18:36,1738919941,9/15/2015 19:18:18,False,zoombucks,0.8333,4688131,CAN,BC,Vancouver,216.251.132.22,CEFTAZIDIME treats FEBRILE NEUTROPENIA,149,97,,167,108,treats,0.9878291611472622,803965,"Ariffin H, Arasu A, Mahfuzah M et al. Single daily ceftriaxone plus amikacin versus thrice daily CEFTAZIDIME plus amikacin as empirical treatment of FEBRILE NEUTROPENIA in children with cancer.",FEBRILE NEUTROPENIA,CEFTAZIDIME,TWrex-cause
788748088,9/15/2015 19:26:49,1738923520,9/15/2015 19:26:25,False,elite,0.6,30312592,CAN,ON,Sudbury,66.103.55.12,no_relation,149,97,,167,108,treats,0.9878291611472622,803965,"Ariffin H, Arasu A, Mahfuzah M et al. Single daily ceftriaxone plus amikacin versus thrice daily CEFTAZIDIME plus amikacin as empirical treatment of FEBRILE NEUTROPENIA in children with cancer.",FEBRILE NEUTROPENIA,CEFTAZIDIME,TWrex-cause
788748088,9/15/2015 19:29:15,1738924220,9/15/2015 19:29:09,False,neodev,0.7321,11014811,GBR,G6,Hull,87.102.82.212,CEFTAZIDIME treats FEBRILE NEUTROPENIA,149,97,,167,108,treats,0.9878291611472622,803965,"Ariffin H, Arasu A, Mahfuzah M et al. Single daily ceftriaxone plus amikacin versus thrice daily CEFTAZIDIME plus amikacin as empirical treatment of FEBRILE NEUTROPENIA in children with cancer.",FEBRILE NEUTROPENIA,CEFTAZIDIME,TWrex-cause
788748088,9/15/2015 19:33:00,1738925280,9/15/2015 19:31:56,False,instagc,0.8393,31157999,USA,KS,Topeka,68.102.220.35,CEFTAZIDIME treats FEBRILE NEUTROPENIA,149,97,,167,108,treats,0.9878291611472622,803965,"Ariffin H, Arasu A, Mahfuzah M et al. Single daily ceftriaxone plus amikacin versus thrice daily CEFTAZIDIME plus amikacin as empirical treatment of FEBRILE NEUTROPENIA in children with cancer.",FEBRILE NEUTROPENIA,CEFTAZIDIME,TWrex-cause
788748088,9/15/2015 19:33:02,1738925291,9/15/2015 19:31:23,False,prodege,0.773,34247194,CAN,ON,Toronto,99.244.108.95,CEFTAZIDIME treats FEBRILE NEUTROPENIA,149,97,,167,108,treats,0.9878291611472622,803965,"Ariffin H, Arasu A, Mahfuzah M et al. Single daily ceftriaxone plus amikacin versus thrice daily CEFTAZIDIME plus amikacin as empirical treatment of FEBRILE NEUTROPENIA in children with cancer.",FEBRILE NEUTROPENIA,CEFTAZIDIME,TWrex-cause
788748098,9/15/2015 17:12:22,1738809053,9/15/2015 17:11:57,False,clixsense,0.7361,33115750,GBR,I3,Rochester,90.222.106.192,AMPHOTERICIN B treats NEUTROPENIA,111,70,,121,84,treats,0.99654575824488,804067,"CONCLUSION  In patients with cancer, itraconazole was as effective as AMPHOTERICIN B for eliminating fever and NEUTROPENIA and led to fewer adverse events.",NEUTROPENIA,AMPHOTERICIN B,TWrex-cause
788748098,9/15/2015 17:17:54,1738812028,9/15/2015 17:17:30,False,clixsense,0.7893,33980820,USA,IL,Chicago,69.47.104.214,AMPHOTERICIN B treats NEUTROPENIA,111,70,,121,84,treats,0.99654575824488,804067,"CONCLUSION  In patients with cancer, itraconazole was as effective as AMPHOTERICIN B for eliminating fever and NEUTROPENIA and led to fewer adverse events.",NEUTROPENIA,AMPHOTERICIN B,TWrex-cause
788748098,9/15/2015 17:18:28,1738812270,9/15/2015 17:17:58,False,zoombucks,0.7258,4711962,CAN,ON,Markham,174.88.29.138,AMPHOTERICIN B treats NEUTROPENIA,111,70,,121,84,treats,0.99654575824488,804067,"CONCLUSION  In patients with cancer, itraconazole was as effective as AMPHOTERICIN B for eliminating fever and NEUTROPENIA and led to fewer adverse events.",NEUTROPENIA,AMPHOTERICIN B,TWrex-cause
788748098,9/15/2015 17:26:16,1738816160,9/15/2015 17:25:42,False,gifthunterclub,0.8413,29582088,GBR,I2,Manchester,2.99.153.19,no_relation,111,70,,121,84,treats,0.99654575824488,804067,"CONCLUSION  In patients with cancer, itraconazole was as effective as AMPHOTERICIN B for eliminating fever and NEUTROPENIA and led to fewer adverse events.",NEUTROPENIA,AMPHOTERICIN B,TWrex-cause
788748098,9/15/2015 17:32:50,1738821340,9/15/2015 17:31:52,False,clixsense,0.7214,21875134,GBR,,,80.189.12.98,AMPHOTERICIN B treats NEUTROPENIA,111,70,,121,84,treats,0.99654575824488,804067,"CONCLUSION  In patients with cancer, itraconazole was as effective as AMPHOTERICIN B for eliminating fever and NEUTROPENIA and led to fewer adverse events.",NEUTROPENIA,AMPHOTERICIN B,TWrex-cause
788748098,9/15/2015 17:39:36,1738830314,9/15/2015 17:38:36,False,prodege,0.4306,1859229,USA,LA,Zachary,72.219.10.101,NEUTROPENIA treats AMPHOTERICIN B,111,70,,121,84,treats,0.99654575824488,804067,"CONCLUSION  In patients with cancer, itraconazole was as effective as AMPHOTERICIN B for eliminating fever and NEUTROPENIA and led to fewer adverse events.",NEUTROPENIA,AMPHOTERICIN B,TWrex-cause
788748098,9/15/2015 17:45:17,1738840700,9/15/2015 17:45:07,False,prodege,0.3786,2143114,CAN,BC,Vancouver,24.85.153.181,NEUTROPENIA treats AMPHOTERICIN B,111,70,,121,84,treats,0.99654575824488,804067,"CONCLUSION  In patients with cancer, itraconazole was as effective as AMPHOTERICIN B for eliminating fever and NEUTROPENIA and led to fewer adverse events.",NEUTROPENIA,AMPHOTERICIN B,TWrex-cause
788748103,9/15/2015 16:01:53,1738766437,9/15/2015 16:01:25,False,vivatic,0.9583,32338429,GBR,N7,Guildford,92.21.219.178,no_relation,38,67,,49,98,treats,0.4472135954999579,814342,1   Reduces duration and severity of nEUTROPENIA In patients with cHEMOTHERAPY INDUCED NEUTROPENIA..,EUTROPENIA I,HEMOTHERAPY INDUCED NEUTROPENIA,TWrex-cause
788748103,9/15/2015 16:04:49,1738767574,9/15/2015 16:03:40,False,neodev,0.7611,33644825,USA,FL,Fort Lauderdale,65.111.173.161,HEMOTHERAPY INDUCED NEUTROPENIA treats EUTROPENIA I,38,67,,49,98,treats,0.4472135954999579,814342,1   Reduces duration and severity of nEUTROPENIA In patients with cHEMOTHERAPY INDUCED NEUTROPENIA..,EUTROPENIA I,HEMOTHERAPY INDUCED NEUTROPENIA,TWrex-cause
788748103,9/15/2015 16:05:29,1738767782,9/15/2015 16:05:01,False,clixsense,0.8222,30681826,GBR,I9,Diss,31.49.71.254,no_relation,38,67,,49,98,treats,0.4472135954999579,814342,1   Reduces duration and severity of nEUTROPENIA In patients with cHEMOTHERAPY INDUCED NEUTROPENIA..,EUTROPENIA I,HEMOTHERAPY INDUCED NEUTROPENIA,TWrex-cause
788748103,9/15/2015 16:06:21,1738768168,9/15/2015 16:06:06,False,fusioncash,0.8375,5861591,USA,OK,Muskogee,74.197.206.241,no_relation,38,67,,49,98,treats,0.4472135954999579,814342,1   Reduces duration and severity of nEUTROPENIA In patients with cHEMOTHERAPY INDUCED NEUTROPENIA..,EUTROPENIA I,HEMOTHERAPY INDUCED NEUTROPENIA,TWrex-cause
788748103,9/15/2015 16:09:59,1738769611,9/15/2015 16:09:36,False,elite,0.8889,31883685,GBR,,,79.66.244.188,no_relation,38,67,,49,98,treats,0.4472135954999579,814342,1   Reduces duration and severity of nEUTROPENIA In patients with cHEMOTHERAPY INDUCED NEUTROPENIA..,EUTROPENIA I,HEMOTHERAPY INDUCED NEUTROPENIA,TWrex-cause
788748103,9/15/2015 16:11:52,1738770209,9/15/2015 16:10:46,False,clixsense,0.7282,6338159,CAN,ON,Ottawa,108.168.124.170,HEMOTHERAPY INDUCED NEUTROPENIA treats EUTROPENIA I,38,67,,49,98,treats,0.4472135954999579,814342,1   Reduces duration and severity of nEUTROPENIA In patients with cHEMOTHERAPY INDUCED NEUTROPENIA..,EUTROPENIA I,HEMOTHERAPY INDUCED NEUTROPENIA,TWrex-cause
788748103,9/15/2015 16:11:54,1738770222,9/15/2015 16:10:21,False,gifthunterclub,0.8036,24043308,GBR,,,94.102.147.250,no_relation,38,67,,49,98,treats,0.4472135954999579,814342,1   Reduces duration and severity of nEUTROPENIA In patients with cHEMOTHERAPY INDUCED NEUTROPENIA..,EUTROPENIA I,HEMOTHERAPY INDUCED NEUTROPENIA,TWrex-cause
788748104,9/15/2015 16:01:24,1738766215,9/15/2015 16:01:06,False,vivatic,0.9583,32338429,GBR,N7,Guildford,92.21.219.178,EPOETIN ALFA treats ANEMIA,106,181,,111,193,treats,0.938314863256837,907996,"Darbepoetin alfa administered at a dose of 3.0 microg/kg every 2 weeks is safe and effective for treating ANEMIA in patients with solid tumors on chemotherapy, and is comparable to EPOETIN ALFA",ANEMIA,EPOETIN ALFA,RO-may_treat
788748104,9/15/2015 16:03:37,1738767183,9/15/2015 16:03:00,False,neodev,0.7611,33644825,USA,FL,Fort Lauderdale,65.111.173.161,EPOETIN ALFA treats ANEMIA,106,181,,111,193,treats,0.938314863256837,907996,"Darbepoetin alfa administered at a dose of 3.0 microg/kg every 2 weeks is safe and effective for treating ANEMIA in patients with solid tumors on chemotherapy, and is comparable to EPOETIN ALFA",ANEMIA,EPOETIN ALFA,RO-may_treat
788748104,9/15/2015 16:05:00,1738767614,9/15/2015 16:04:30,False,clixsense,0.8222,30681826,GBR,I9,Diss,31.49.71.254,EPOETIN ALFA treats ANEMIA,106,181,,111,193,treats,0.938314863256837,907996,"Darbepoetin alfa administered at a dose of 3.0 microg/kg every 2 weeks is safe and effective for treating ANEMIA in patients with solid tumors on chemotherapy, and is comparable to EPOETIN ALFA",ANEMIA,EPOETIN ALFA,RO-may_treat
788748104,9/15/2015 16:06:05,1738768021,9/15/2015 16:05:49,False,fusioncash,0.8375,5861591,USA,OK,Muskogee,74.197.206.241,no_relation,106,181,,111,193,treats,0.938314863256837,907996,"Darbepoetin alfa administered at a dose of 3.0 microg/kg every 2 weeks is safe and effective for treating ANEMIA in patients with solid tumors on chemotherapy, and is comparable to EPOETIN ALFA",ANEMIA,EPOETIN ALFA,RO-may_treat
788748104,9/15/2015 16:09:35,1738769477,9/15/2015 16:09:19,False,elite,0.8889,31883685,GBR,,,79.66.244.188,no_relation,106,181,,111,193,treats,0.938314863256837,907996,"Darbepoetin alfa administered at a dose of 3.0 microg/kg every 2 weeks is safe and effective for treating ANEMIA in patients with solid tumors on chemotherapy, and is comparable to EPOETIN ALFA",ANEMIA,EPOETIN ALFA,RO-may_treat
788748104,9/15/2015 16:10:15,1738769707,9/15/2015 16:09:32,False,gifthunterclub,0.8036,24043308,GBR,,,94.102.147.250,EPOETIN ALFA treats ANEMIA,106,181,,111,193,treats,0.938314863256837,907996,"Darbepoetin alfa administered at a dose of 3.0 microg/kg every 2 weeks is safe and effective for treating ANEMIA in patients with solid tumors on chemotherapy, and is comparable to EPOETIN ALFA",ANEMIA,EPOETIN ALFA,RO-may_treat
788748104,9/15/2015 16:10:43,1738769841,9/15/2015 16:10:00,False,clixsense,0.7282,6338159,CAN,ON,Ottawa,108.168.124.170,no_relation,106,181,,111,193,treats,0.938314863256837,907996,"Darbepoetin alfa administered at a dose of 3.0 microg/kg every 2 weeks is safe and effective for treating ANEMIA in patients with solid tumors on chemotherapy, and is comparable to EPOETIN ALFA",ANEMIA,EPOETIN ALFA,RO-may_treat
788748110,9/15/2015 18:03:00,1738872302,9/15/2015 18:02:48,False,neodev,0.7889,20306047,GBR,,,80.41.0.252,ANTICONVULSANT treats EPILEPSY,78,5,,86,19,treats,0.9901475429766742,210128,Some [ANTICONVULSANT]s have shown antiepileptogenic effects in animal models of [EPILEPSY].,EPILEPSY,ANTICONVULSANT,TWrex-treat
788748110,9/15/2015 18:12:17,1738882508,9/15/2015 18:11:54,False,clixsense,0.6484,17950689,GBR,L9,Sheffield,146.200.192.103,no_relation,78,5,,86,19,treats,0.9901475429766742,210128,Some [ANTICONVULSANT]s have shown antiepileptogenic effects in animal models of [EPILEPSY].,EPILEPSY,ANTICONVULSANT,TWrex-treat
788748110,9/15/2015 18:14:02,1738884342,9/15/2015 18:13:48,False,instagc,0.85,18985376,GBR,D2,Derby,86.27.159.112,ANTICONVULSANT treats EPILEPSY,78,5,,86,19,treats,0.9901475429766742,210128,Some [ANTICONVULSANT]s have shown antiepileptogenic effects in animal models of [EPILEPSY].,EPILEPSY,ANTICONVULSANT,TWrex-treat
788748110,9/15/2015 18:19:16,1738888380,9/15/2015 18:17:11,False,zoombucks,0.8357,6744840,CAN,BC,Kelowna,174.4.58.160,ANTICONVULSANT treats EPILEPSY,78,5,,86,19,treats,0.9901475429766742,210128,Some [ANTICONVULSANT]s have shown antiepileptogenic effects in animal models of [EPILEPSY].,EPILEPSY,ANTICONVULSANT,TWrex-treat
788748110,9/15/2015 18:20:42,1738889349,9/15/2015 18:20:21,False,clixsense,0.8357,19638651,USA,SC,Summerville,174.107.73.211,ANTICONVULSANT treats EPILEPSY,78,5,,86,19,treats,0.9901475429766742,210128,Some [ANTICONVULSANT]s have shown antiepileptogenic effects in animal models of [EPILEPSY].,EPILEPSY,ANTICONVULSANT,TWrex-treat
788748110,9/15/2015 18:32:11,1738896199,9/15/2015 18:31:11,False,instagc,0.7607,20312760,GBR,O1,Dukinfield,2.96.59.31,ANTICONVULSANT treats EPILEPSY,78,5,,86,19,treats,0.9901475429766742,210128,Some [ANTICONVULSANT]s have shown antiepileptogenic effects in animal models of [EPILEPSY].,EPILEPSY,ANTICONVULSANT,TWrex-treat
788748110,9/15/2015 18:32:19,1738896247,9/15/2015 18:31:26,False,bitcoinget,0.6607,29516942,USA,CA,Saratoga,107.178.35.226,no_relation,78,5,,86,19,treats,0.9901475429766742,210128,Some [ANTICONVULSANT]s have shown antiepileptogenic effects in animal models of [EPILEPSY].,EPILEPSY,ANTICONVULSANT,TWrex-treat
788748113,9/15/2015 16:13:03,1738770581,9/15/2015 16:12:50,False,neodev,0.9167,14096345,NLD,03,Eibergen,178.85.94.186,PERMETHRIN 5% CREAM treats NEONATAL SCABIES,0,30,,15,49,treats,1.0,805159,NEONATAL SCABIES treated with PERMETHRIN 5% CREAM.,NEONATAL SCABIES,PERMETHRIN 5% CREAM,TWrex-cause
788748113,9/15/2015 16:13:04,1738770585,9/15/2015 16:12:32,False,gifthunterclub,0.8036,24043308,GBR,,,94.102.147.250,PERMETHRIN 5% CREAM treats NEONATAL SCABIES,0,30,,15,49,treats,1.0,805159,NEONATAL SCABIES treated with PERMETHRIN 5% CREAM.,NEONATAL SCABIES,PERMETHRIN 5% CREAM,TWrex-cause
788748113,9/15/2015 16:13:32,1738770743,9/15/2015 16:12:54,False,elite,0.8889,31883685,GBR,,,79.66.244.188,PERMETHRIN 5% CREAM treats NEONATAL SCABIES,0,30,,15,49,treats,1.0,805159,NEONATAL SCABIES treated with PERMETHRIN 5% CREAM.,NEONATAL SCABIES,PERMETHRIN 5% CREAM,TWrex-cause
788748113,9/15/2015 16:17:14,1738772161,9/15/2015 16:17:02,False,prodege,0.8611,22031444,GBR,F2,Gosport,92.24.223.243,PERMETHRIN 5% CREAM treats NEONATAL SCABIES,0,30,,15,49,treats,1.0,805159,NEONATAL SCABIES treated with PERMETHRIN 5% CREAM.,NEONATAL SCABIES,PERMETHRIN 5% CREAM,TWrex-cause
788748113,9/15/2015 16:17:37,1738772295,9/15/2015 16:17:01,False,neodev,0.5833,32053642,GBR,I7,Newcastle Upon Tyne,92.23.136.205,PERMETHRIN 5% CREAM treats NEONATAL SCABIES,0,30,,15,49,treats,1.0,805159,NEONATAL SCABIES treated with PERMETHRIN 5% CREAM.,NEONATAL SCABIES,PERMETHRIN 5% CREAM,TWrex-cause
788748113,9/15/2015 16:18:02,1738772463,9/15/2015 16:17:29,False,clixsense,0.8407,33878524,CAN,BC,Princeton,75.156.83.71,PERMETHRIN 5% CREAM treats NEONATAL SCABIES,0,30,,15,49,treats,1.0,805159,NEONATAL SCABIES treated with PERMETHRIN 5% CREAM.,NEONATAL SCABIES,PERMETHRIN 5% CREAM,TWrex-cause
788748113,9/15/2015 16:20:39,1738773389,9/15/2015 16:18:26,False,points4rewards,0.7282,20113482,USA,PA,Philadelphia,162.208.49.45,PERMETHRIN 5% CREAM treats NEONATAL SCABIES,0,30,,15,49,treats,1.0,805159,NEONATAL SCABIES treated with PERMETHRIN 5% CREAM.,NEONATAL SCABIES,PERMETHRIN 5% CREAM,TWrex-cause
788865466,9/15/2015 22:56:49,1739068412,9/15/2015 22:56:35,False,clixsense,0.85,21963184,GBR,L9,Sheffield,146.199.61.136,AMPHOTERICIN B treats OSTEOARTICULAR SPOROTRICHOSIS,59,5,,87,19,treats,0.99654575824488,804299,"429  AMPHOTERICIN B (a lipid formulation) in patients with OSTEOARTICULAR SPOROTRICHOSIS: 3 5 mg/kg daily or until a response is obtained, followed by oral itraconazole for a total treatment duration of at least 12 months.",OSTEOARTICULAR SPOROTRICHOSIS,AMPHOTERICIN B,TWrex-cause
788865466,9/15/2015 23:09:26,1739072966,9/15/2015 23:08:53,False,clixsense,0.9315,11106820,USA,MA,Taunton,173.48.52.95,AMPHOTERICIN B treats OSTEOARTICULAR SPOROTRICHOSIS,59,5,,87,19,treats,0.99654575824488,804299,"429  AMPHOTERICIN B (a lipid formulation) in patients with OSTEOARTICULAR SPOROTRICHOSIS: 3 5 mg/kg daily or until a response is obtained, followed by oral itraconazole for a total treatment duration of at least 12 months.",OSTEOARTICULAR SPOROTRICHOSIS,AMPHOTERICIN B,TWrex-cause
788865466,9/15/2015 23:44:03,1739083093,9/15/2015 23:43:36,False,neodev,0.9417,22074628,GBR,,,92.4.207.4,AMPHOTERICIN B treats OSTEOARTICULAR SPOROTRICHOSIS,59,5,,87,19,treats,0.99654575824488,804299,"429  AMPHOTERICIN B (a lipid formulation) in patients with OSTEOARTICULAR SPOROTRICHOSIS: 3 5 mg/kg daily or until a response is obtained, followed by oral itraconazole for a total treatment duration of at least 12 months.",OSTEOARTICULAR SPOROTRICHOSIS,AMPHOTERICIN B,TWrex-cause
788865466,9/15/2015 23:56:03,1739086457,9/15/2015 23:55:32,False,clixsense,0.9583,33980820,USA,IL,Chicago,69.47.104.214,AMPHOTERICIN B treats OSTEOARTICULAR SPOROTRICHOSIS,59,5,,87,19,treats,0.99654575824488,804299,"429  AMPHOTERICIN B (a lipid formulation) in patients with OSTEOARTICULAR SPOROTRICHOSIS: 3 5 mg/kg daily or until a response is obtained, followed by oral itraconazole for a total treatment duration of at least 12 months.",OSTEOARTICULAR SPOROTRICHOSIS,AMPHOTERICIN B,TWrex-cause
788865466,9/16/2015 00:03:36,1739088148,9/16/2015 00:03:25,False,clixsense,0.8333,28457001,CAN,ON,North Bay,24.204.202.220,AMPHOTERICIN B treats OSTEOARTICULAR SPOROTRICHOSIS,59,5,,87,19,treats,0.99654575824488,804299,"429  AMPHOTERICIN B (a lipid formulation) in patients with OSTEOARTICULAR SPOROTRICHOSIS: 3 5 mg/kg daily or until a response is obtained, followed by oral itraconazole for a total treatment duration of at least 12 months.",OSTEOARTICULAR SPOROTRICHOSIS,AMPHOTERICIN B,TWrex-cause
788865466,9/16/2015 00:12:25,1739090464,9/16/2015 00:12:10,False,instagc,0.9028,31888345,USA,CA,Hayward,24.7.3.180,AMPHOTERICIN B treats OSTEOARTICULAR SPOROTRICHOSIS,59,5,,87,19,treats,0.99654575824488,804299,"429  AMPHOTERICIN B (a lipid formulation) in patients with OSTEOARTICULAR SPOROTRICHOSIS: 3 5 mg/kg daily or until a response is obtained, followed by oral itraconazole for a total treatment duration of at least 12 months.",OSTEOARTICULAR SPOROTRICHOSIS,AMPHOTERICIN B,TWrex-cause
788865466,9/16/2015 01:03:06,1739104351,9/16/2015 01:02:53,False,prodege,0.8917,3587109,CAN,NS,Sydney,142.177.43.123,AMPHOTERICIN B treats OSTEOARTICULAR SPOROTRICHOSIS,59,5,,87,19,treats,0.99654575824488,804299,"429  AMPHOTERICIN B (a lipid formulation) in patients with OSTEOARTICULAR SPOROTRICHOSIS: 3 5 mg/kg daily or until a response is obtained, followed by oral itraconazole for a total treatment duration of at least 12 months.",OSTEOARTICULAR SPOROTRICHOSIS,AMPHOTERICIN B,TWrex-cause
788865473,9/15/2015 21:16:58,1739026268,9/15/2015 21:16:50,False,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,DULOXETINE treats STRESS URINARY INCONTINENCE,91,76,,118,86,treats,0.993883734673619,217466,"According to Lenzer, four completed suicides also occurred in the trials of [DULOXETINE] for [STRESS URINARY INCONTINENCE] .",STRESS URINARY INCONTINENCE,DULOXETINE,TWrex-treat
788865473,9/15/2015 21:17:26,1739026709,9/15/2015 21:17:12,False,neodev,1.0,20306047,GBR,,,80.41.0.252,DULOXETINE treats STRESS URINARY INCONTINENCE,91,76,,118,86,treats,0.993883734673619,217466,"According to Lenzer, four completed suicides also occurred in the trials of [DULOXETINE] for [STRESS URINARY INCONTINENCE] .",STRESS URINARY INCONTINENCE,DULOXETINE,TWrex-treat
788865473,9/15/2015 21:24:31,1739030870,9/15/2015 21:24:22,False,bitcoinget,1.0,21743413,USA,WA,Port Angeles,24.113.29.97,DULOXETINE treats STRESS URINARY INCONTINENCE,91,76,,118,86,treats,0.993883734673619,217466,"According to Lenzer, four completed suicides also occurred in the trials of [DULOXETINE] for [STRESS URINARY INCONTINENCE] .",STRESS URINARY INCONTINENCE,DULOXETINE,TWrex-treat
788865473,9/15/2015 21:24:34,1739030911,9/15/2015 21:23:41,False,clixsense,1.0,9051251,CAN,QC,Saint-mathieu,207.107.241.212,DULOXETINE treats STRESS URINARY INCONTINENCE,91,76,,118,86,treats,0.993883734673619,217466,"According to Lenzer, four completed suicides also occurred in the trials of [DULOXETINE] for [STRESS URINARY INCONTINENCE] .",STRESS URINARY INCONTINENCE,DULOXETINE,TWrex-treat
788865473,9/15/2015 21:28:13,1739032912,9/15/2015 21:28:01,False,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.138,DULOXETINE treats STRESS URINARY INCONTINENCE,91,76,,118,86,treats,0.993883734673619,217466,"According to Lenzer, four completed suicides also occurred in the trials of [DULOXETINE] for [STRESS URINARY INCONTINENCE] .",STRESS URINARY INCONTINENCE,DULOXETINE,TWrex-treat
788865473,9/15/2015 21:32:00,1739035112,9/15/2015 21:26:09,False,clixsense,0.919,21875134,GBR,,,80.189.12.98,DULOXETINE treats STRESS URINARY INCONTINENCE,91,76,,118,86,treats,0.993883734673619,217466,"According to Lenzer, four completed suicides also occurred in the trials of [DULOXETINE] for [STRESS URINARY INCONTINENCE] .",STRESS URINARY INCONTINENCE,DULOXETINE,TWrex-treat
788865473,9/15/2015 21:33:45,1739036023,9/15/2015 21:29:26,False,clixsense,0.9167,30681826,GBR,I9,Diss,31.49.71.254,DULOXETINE treats STRESS URINARY INCONTINENCE,91,76,,118,86,treats,0.993883734673619,217466,"According to Lenzer, four completed suicides also occurred in the trials of [DULOXETINE] for [STRESS URINARY INCONTINENCE] .",STRESS URINARY INCONTINENCE,DULOXETINE,TWrex-treat
788865474,9/16/2015 06:42:30,1739406906,9/16/2015 06:42:17,False,gifthunterclub,0.7639,33931170,AUS,04,Brisbane,121.208.7.253,THALIDOMIDE treats ERYTHEMA NODOSUM LEPROSUM[20],142,83,,170,94,treats,0.9950371902099889,800836,Corticosteroids and colchicine can be used in severe refractory cases.[17][18][19] THALIDOMIDE has been used successfully in the treatment of ERYTHEMA NODOSUM LEPROSUM[20] and it was approved by the U.S. FDA for this use in July 1998.[21.,ERYTHEMA NODOSUM LEPROSUM[20],THALIDOMIDE,TWrex-cause
788865474,9/16/2015 06:47:14,1739409470,9/16/2015 06:46:29,False,prodege,0.9018,30501999,CAN,ON,Ottawa,137.122.64.22,THALIDOMIDE treats ERYTHEMA NODOSUM LEPROSUM[20],142,83,,170,94,treats,0.9950371902099889,800836,Corticosteroids and colchicine can be used in severe refractory cases.[17][18][19] THALIDOMIDE has been used successfully in the treatment of ERYTHEMA NODOSUM LEPROSUM[20] and it was approved by the U.S. FDA for this use in July 1998.[21.,ERYTHEMA NODOSUM LEPROSUM[20],THALIDOMIDE,TWrex-cause
788865474,9/16/2015 06:52:35,1739410577,9/16/2015 06:52:13,False,bitcoinget,0.85,30546513,GBR,G6,Hull,194.42.67.50,THALIDOMIDE treats ERYTHEMA NODOSUM LEPROSUM[20],142,83,,170,94,treats,0.9950371902099889,800836,Corticosteroids and colchicine can be used in severe refractory cases.[17][18][19] THALIDOMIDE has been used successfully in the treatment of ERYTHEMA NODOSUM LEPROSUM[20] and it was approved by the U.S. FDA for this use in July 1998.[21.,ERYTHEMA NODOSUM LEPROSUM[20],THALIDOMIDE,TWrex-cause
788865474,9/16/2015 06:59:04,1739411533,9/16/2015 06:58:26,False,neodev,0.7813,11460728,CAN,BC,Burnaby,70.79.16.165,THALIDOMIDE treats ERYTHEMA NODOSUM LEPROSUM[20],142,83,,170,94,treats,0.9950371902099889,800836,Corticosteroids and colchicine can be used in severe refractory cases.[17][18][19] THALIDOMIDE has been used successfully in the treatment of ERYTHEMA NODOSUM LEPROSUM[20] and it was approved by the U.S. FDA for this use in July 1998.[21.,ERYTHEMA NODOSUM LEPROSUM[20],THALIDOMIDE,TWrex-cause
788865474,9/16/2015 07:01:02,1739411835,9/16/2015 07:00:14,False,fusioncash,0.9583,5626024,USA,AR,Clarksville,75.121.20.252,THALIDOMIDE treats ERYTHEMA NODOSUM LEPROSUM[20],142,83,,170,94,treats,0.9950371902099889,800836,Corticosteroids and colchicine can be used in severe refractory cases.[17][18][19] THALIDOMIDE has been used successfully in the treatment of ERYTHEMA NODOSUM LEPROSUM[20] and it was approved by the U.S. FDA for this use in July 1998.[21.,ERYTHEMA NODOSUM LEPROSUM[20],THALIDOMIDE,TWrex-cause
788865474,9/16/2015 07:01:42,1739411888,9/16/2015 07:00:33,False,neodev,0.7440000000000001,17963941,GBR,V2,Glasgow,2.24.248.140,THALIDOMIDE treats ERYTHEMA NODOSUM LEPROSUM[20],142,83,,170,94,treats,0.9950371902099889,800836,Corticosteroids and colchicine can be used in severe refractory cases.[17][18][19] THALIDOMIDE has been used successfully in the treatment of ERYTHEMA NODOSUM LEPROSUM[20] and it was approved by the U.S. FDA for this use in July 1998.[21.,ERYTHEMA NODOSUM LEPROSUM[20],THALIDOMIDE,TWrex-cause
788865474,9/16/2015 07:25:46,1739415919,9/16/2015 07:25:32,False,instagc,0.8333,18960682,GBR,U2,Annan,92.18.213.181,ERYTHEMA NODOSUM LEPROSUM[20] treats THALIDOMIDE,142,83,,170,94,treats,0.9950371902099889,800836,Corticosteroids and colchicine can be used in severe refractory cases.[17][18][19] THALIDOMIDE has been used successfully in the treatment of ERYTHEMA NODOSUM LEPROSUM[20] and it was approved by the U.S. FDA for this use in July 1998.[21.,ERYTHEMA NODOSUM LEPROSUM[20],THALIDOMIDE,TWrex-cause
788865481,9/15/2015 21:19:27,1739027964,9/15/2015 21:18:33,False,neodev,1.0,20306047,GBR,,,80.41.0.252,CEFACLOR treats BRONCHITIS,90,60,,99,68,treats,1.0,803919,"Chirurgi VA, Edelstein H, Oster SE et al. Ceftibuten versus CEFACLOR for the treatment of BRONCHITIS",BRONCHITIS,CEFACLOR,TWrex-cause
788865481,9/15/2015 21:39:33,1739039203,9/15/2015 21:36:56,False,clixsense,0.9167,30681826,GBR,I9,Diss,31.49.71.254,CEFACLOR treats BRONCHITIS,90,60,,99,68,treats,1.0,803919,"Chirurgi VA, Edelstein H, Oster SE et al. Ceftibuten versus CEFACLOR for the treatment of BRONCHITIS",BRONCHITIS,CEFACLOR,TWrex-cause
788865481,9/15/2015 21:42:12,1739040545,9/15/2015 21:40:24,False,neodev,0.8611,33644825,USA,FL,Fort Lauderdale,65.111.173.161,CEFACLOR treats BRONCHITIS,90,60,,99,68,treats,1.0,803919,"Chirurgi VA, Edelstein H, Oster SE et al. Ceftibuten versus CEFACLOR for the treatment of BRONCHITIS",BRONCHITIS,CEFACLOR,TWrex-cause
788865481,9/15/2015 21:45:42,1739042464,9/15/2015 21:43:42,False,clixsense,0.919,21875134,GBR,,,80.189.12.98,CEFACLOR treats BRONCHITIS,90,60,,99,68,treats,1.0,803919,"Chirurgi VA, Edelstein H, Oster SE et al. Ceftibuten versus CEFACLOR for the treatment of BRONCHITIS",BRONCHITIS,CEFACLOR,TWrex-cause
788865481,9/15/2015 21:48:12,1739043770,9/15/2015 21:47:05,False,prodege,0.9667,21417560,GBR,C3,Cambridge,151.224.120.191,CEFACLOR treats BRONCHITIS,90,60,,99,68,treats,1.0,803919,"Chirurgi VA, Edelstein H, Oster SE et al. Ceftibuten versus CEFACLOR for the treatment of BRONCHITIS",BRONCHITIS,CEFACLOR,TWrex-cause
788865481,9/15/2015 21:51:20,1739045184,9/15/2015 21:49:29,False,pocketmoneygpt,0.7877,21432964,GBR,F8,Borehamwood,81.159.185.70,CEFACLOR treats BRONCHITIS,90,60,,99,68,treats,1.0,803919,"Chirurgi VA, Edelstein H, Oster SE et al. Ceftibuten versus CEFACLOR for the treatment of BRONCHITIS",BRONCHITIS,CEFACLOR,TWrex-cause
788865481,9/15/2015 21:55:36,1739047027,9/15/2015 21:55:10,False,neodev,0.6843,33701549,NLD,,,85.203.17.204,CEFACLOR treats BRONCHITIS,90,60,,99,68,treats,1.0,803919,"Chirurgi VA, Edelstein H, Oster SE et al. Ceftibuten versus CEFACLOR for the treatment of BRONCHITIS",BRONCHITIS,CEFACLOR,TWrex-cause
788865484,9/15/2015 22:57:12,1739068530,9/15/2015 22:56:50,False,clixsense,0.85,21963184,GBR,L9,Sheffield,146.199.61.136,AZA treats ULCERATIVE COLITIS,11,60,,28,63,treats,0.9610744623271421,805064,"107 , 108  ULCERATIVE COLITIS   Both controlled trials with AZA and uncontrolled series with 6 MP have supported the role of purine analogues for the long term (maintenance) therapy of UC.",ULCERATIVE COLITIS,AZA,TWrex-cause
788865484,9/15/2015 23:09:42,1739073080,9/15/2015 23:09:27,False,clixsense,0.9315,11106820,USA,MA,Taunton,173.48.52.95,AZA treats ULCERATIVE COLITIS,11,60,,28,63,treats,0.9610744623271421,805064,"107 , 108  ULCERATIVE COLITIS   Both controlled trials with AZA and uncontrolled series with 6 MP have supported the role of purine analogues for the long term (maintenance) therapy of UC.",ULCERATIVE COLITIS,AZA,TWrex-cause
788865484,9/15/2015 23:44:37,1739083210,9/15/2015 23:44:09,False,neodev,0.9417,22074628,GBR,,,92.4.207.4,AZA treats ULCERATIVE COLITIS,11,60,,28,63,treats,0.9610744623271421,805064,"107 , 108  ULCERATIVE COLITIS   Both controlled trials with AZA and uncontrolled series with 6 MP have supported the role of purine analogues for the long term (maintenance) therapy of UC.",ULCERATIVE COLITIS,AZA,TWrex-cause
788865484,9/15/2015 23:56:24,1739086555,9/15/2015 23:56:03,False,clixsense,0.9583,33980820,USA,IL,Chicago,69.47.104.214,AZA treats ULCERATIVE COLITIS,11,60,,28,63,treats,0.9610744623271421,805064,"107 , 108  ULCERATIVE COLITIS   Both controlled trials with AZA and uncontrolled series with 6 MP have supported the role of purine analogues for the long term (maintenance) therapy of UC.",ULCERATIVE COLITIS,AZA,TWrex-cause
788865484,9/16/2015 00:03:44,1739088198,9/16/2015 00:03:37,False,clixsense,0.8333,28457001,CAN,ON,North Bay,24.204.202.220,AZA treats ULCERATIVE COLITIS,11,60,,28,63,treats,0.9610744623271421,805064,"107 , 108  ULCERATIVE COLITIS   Both controlled trials with AZA and uncontrolled series with 6 MP have supported the role of purine analogues for the long term (maintenance) therapy of UC.",ULCERATIVE COLITIS,AZA,TWrex-cause
788865484,9/16/2015 00:12:37,1739090521,9/16/2015 00:12:27,False,instagc,0.9028,31888345,USA,CA,Hayward,24.7.3.180,AZA treats ULCERATIVE COLITIS,11,60,,28,63,treats,0.9610744623271421,805064,"107 , 108  ULCERATIVE COLITIS   Both controlled trials with AZA and uncontrolled series with 6 MP have supported the role of purine analogues for the long term (maintenance) therapy of UC.",ULCERATIVE COLITIS,AZA,TWrex-cause
788865484,9/16/2015 01:03:18,1739104466,9/16/2015 01:03:07,False,prodege,0.8917,3587109,CAN,NS,Sydney,142.177.43.123,AZA treats ULCERATIVE COLITIS,11,60,,28,63,treats,0.9610744623271421,805064,"107 , 108  ULCERATIVE COLITIS   Both controlled trials with AZA and uncontrolled series with 6 MP have supported the role of purine analogues for the long term (maintenance) therapy of UC.",ULCERATIVE COLITIS,AZA,TWrex-cause
788865485,9/16/2015 05:51:23,1739369488,9/16/2015 05:50:04,False,instagc,0.7163,21613169,GBR,A7,Birmingham,109.156.129.221,CLONAZEPAM treats PANIC DISORDER,77,36,,90,46,treats,1.0,803530,"Kutcher SP, MacKenzie S. Successful CLONAZEPAM treatment of adolescents with PANIC DISORDER",PANIC DISORDER,CLONAZEPAM,TWrex-cause
788865485,9/16/2015 06:07:06,1739384663,9/16/2015 06:06:37,False,points4rewards,0.8065,20306700,USA,WA,Bothell,50.106.46.70,CLONAZEPAM treats PANIC DISORDER,77,36,,90,46,treats,1.0,803530,"Kutcher SP, MacKenzie S. Successful CLONAZEPAM treatment of adolescents with PANIC DISORDER",PANIC DISORDER,CLONAZEPAM,TWrex-cause
788865485,9/16/2015 06:18:29,1739392942,9/16/2015 06:18:04,False,prodege,0.825,27934334,GBR,C8,Croydon,81.159.60.206,CLONAZEPAM treats PANIC DISORDER,77,36,,90,46,treats,1.0,803530,"Kutcher SP, MacKenzie S. Successful CLONAZEPAM treatment of adolescents with PANIC DISORDER",PANIC DISORDER,CLONAZEPAM,TWrex-cause
788865485,9/16/2015 06:25:55,1739397378,9/16/2015 06:25:04,False,points4rewards,0.8859,28703583,USA,,,184.53.32.197,CLONAZEPAM treats PANIC DISORDER,77,36,,90,46,treats,1.0,803530,"Kutcher SP, MacKenzie S. Successful CLONAZEPAM treatment of adolescents with PANIC DISORDER",PANIC DISORDER,CLONAZEPAM,TWrex-cause
788865485,9/16/2015 06:29:58,1739399788,9/16/2015 06:28:50,False,clixsense,0.8762,28570371,NLD,,,91.213.37.165,CLONAZEPAM treats PANIC DISORDER,77,36,,90,46,treats,1.0,803530,"Kutcher SP, MacKenzie S. Successful CLONAZEPAM treatment of adolescents with PANIC DISORDER",PANIC DISORDER,CLONAZEPAM,TWrex-cause
788865485,9/16/2015 06:30:09,1739399886,9/16/2015 06:28:25,False,clixsense,0.8155,31482589,NLD,11,Gouda,77.167.232.121,CLONAZEPAM treats PANIC DISORDER,77,36,,90,46,treats,1.0,803530,"Kutcher SP, MacKenzie S. Successful CLONAZEPAM treatment of adolescents with PANIC DISORDER",PANIC DISORDER,CLONAZEPAM,TWrex-cause
788865485,9/16/2015 06:32:52,1739401456,9/16/2015 06:30:26,False,neodev,0.6019,21515166,NLD,11,Nieuwkoop,83.84.200.25,CLONAZEPAM treats PANIC DISORDER,77,36,,90,46,treats,1.0,803530,"Kutcher SP, MacKenzie S. Successful CLONAZEPAM treatment of adolescents with PANIC DISORDER",PANIC DISORDER,CLONAZEPAM,TWrex-cause
788865491,9/15/2015 22:05:49,1739051397,9/15/2015 22:05:18,False,clixsense,0.8375,31182465,GBR,A4,Bath,86.144.102.125,[INSULIN GLARGINE] treats [SEVERE NOCTURNAL HYPOGLYCAEMIA],37,0,,67,15,treats,0.9931270663228421,223209,[INSULIN GLARGINE] reduces the risk of [SEVERE NOCTURNAL HYPOGLYCAEMIA],[SEVERE NOCTURNAL HYPOGLYCAEMIA],[INSULIN GLARGINE],TWrex-treat
788865491,9/15/2015 22:10:03,1739052752,9/15/2015 22:09:22,False,onestopgpt,0.8546,21275875,CAN,ON,Hamilton,24.36.124.79,[INSULIN GLARGINE] treats [SEVERE NOCTURNAL HYPOGLYCAEMIA],37,0,,67,15,treats,0.9931270663228421,223209,[INSULIN GLARGINE] reduces the risk of [SEVERE NOCTURNAL HYPOGLYCAEMIA],[SEVERE NOCTURNAL HYPOGLYCAEMIA],[INSULIN GLARGINE],TWrex-treat
788865491,9/15/2015 22:12:18,1739053385,9/15/2015 22:11:59,False,prodege,0.6984,15439740,AUS,02,Jannali,14.200.59.55,no_relation,37,0,,67,15,treats,0.9931270663228421,223209,[INSULIN GLARGINE] reduces the risk of [SEVERE NOCTURNAL HYPOGLYCAEMIA],[SEVERE NOCTURNAL HYPOGLYCAEMIA],[INSULIN GLARGINE],TWrex-treat
788865491,9/15/2015 22:12:58,1739053581,9/15/2015 22:12:12,False,neodev,0.5536,33238512,CAN,NB,Miramichi,174.118.173.203,[INSULIN GLARGINE] treats [SEVERE NOCTURNAL HYPOGLYCAEMIA],37,0,,67,15,treats,0.9931270663228421,223209,[INSULIN GLARGINE] reduces the risk of [SEVERE NOCTURNAL HYPOGLYCAEMIA],[SEVERE NOCTURNAL HYPOGLYCAEMIA],[INSULIN GLARGINE],TWrex-treat
788865491,9/15/2015 22:16:18,1739054831,9/15/2015 22:14:36,False,neodev,0.7452,18881135,CAN,ON,Ajax,99.243.87.224,[INSULIN GLARGINE] treats [SEVERE NOCTURNAL HYPOGLYCAEMIA],37,0,,67,15,treats,0.9931270663228421,223209,[INSULIN GLARGINE] reduces the risk of [SEVERE NOCTURNAL HYPOGLYCAEMIA],[SEVERE NOCTURNAL HYPOGLYCAEMIA],[INSULIN GLARGINE],TWrex-treat
788865491,9/15/2015 22:17:21,1739055216,9/15/2015 22:16:47,False,neodev,0.8889,33758777,USA,,,38.95.108.251,[INSULIN GLARGINE] treats [SEVERE NOCTURNAL HYPOGLYCAEMIA],37,0,,67,15,treats,0.9931270663228421,223209,[INSULIN GLARGINE] reduces the risk of [SEVERE NOCTURNAL HYPOGLYCAEMIA],[SEVERE NOCTURNAL HYPOGLYCAEMIA],[INSULIN GLARGINE],TWrex-treat
788865491,9/15/2015 22:24:04,1739057491,9/15/2015 22:23:42,False,points4rewards,0.7798,20113482,USA,PA,Philadelphia,162.208.49.45,[INSULIN GLARGINE] treats [SEVERE NOCTURNAL HYPOGLYCAEMIA],37,0,,67,15,treats,0.9931270663228421,223209,[INSULIN GLARGINE] reduces the risk of [SEVERE NOCTURNAL HYPOGLYCAEMIA],[SEVERE NOCTURNAL HYPOGLYCAEMIA],[INSULIN GLARGINE],TWrex-treat
788865493,9/15/2015 21:18:04,1739027209,9/15/2015 21:17:28,False,neodev,1.0,20306047,GBR,,,80.41.0.252,ORAL AMPHOTERICIN B treats FUNGAL INFECTION,56,144,,71,163,treats,0.99654575824488,800036,"Menichetti F, Del Favero A, Martino P et al. Preventing FUNGAL INFECTION in neutropenic patients with acute leukemia: fluconazole compared with ORAL AMPHOTERICIN B.",FUNGAL INFECTION,ORAL AMPHOTERICIN B,TWrex-cause
788865493,9/15/2015 21:28:23,1739032981,9/15/2015 21:28:13,False,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.138,ORAL AMPHOTERICIN B treats FUNGAL INFECTION,56,144,,71,163,treats,0.99654575824488,800036,"Menichetti F, Del Favero A, Martino P et al. Preventing FUNGAL INFECTION in neutropenic patients with acute leukemia: fluconazole compared with ORAL AMPHOTERICIN B.",FUNGAL INFECTION,ORAL AMPHOTERICIN B,TWrex-cause
788865493,9/15/2015 21:34:46,1739036615,9/15/2015 21:33:46,False,clixsense,0.9167,30681826,GBR,I9,Diss,31.49.71.254,ORAL AMPHOTERICIN B treats FUNGAL INFECTION,56,144,,71,163,treats,0.99654575824488,800036,"Menichetti F, Del Favero A, Martino P et al. Preventing FUNGAL INFECTION in neutropenic patients with acute leukemia: fluconazole compared with ORAL AMPHOTERICIN B.",FUNGAL INFECTION,ORAL AMPHOTERICIN B,TWrex-cause
788865493,9/15/2015 21:35:28,1739036998,9/15/2015 21:32:02,False,clixsense,0.919,21875134,GBR,,,80.189.12.98,ORAL AMPHOTERICIN B treats FUNGAL INFECTION,56,144,,71,163,treats,0.99654575824488,800036,"Menichetti F, Del Favero A, Martino P et al. Preventing FUNGAL INFECTION in neutropenic patients with acute leukemia: fluconazole compared with ORAL AMPHOTERICIN B.",FUNGAL INFECTION,ORAL AMPHOTERICIN B,TWrex-cause
788865493,9/15/2015 21:39:06,1739038954,9/15/2015 21:39:00,False,prodege,0.1667,2143114,CAN,BC,Vancouver,24.85.153.181,FUNGAL INFECTION treats ORAL AMPHOTERICIN B,56,144,,71,163,treats,0.99654575824488,800036,"Menichetti F, Del Favero A, Martino P et al. Preventing FUNGAL INFECTION in neutropenic patients with acute leukemia: fluconazole compared with ORAL AMPHOTERICIN B.",FUNGAL INFECTION,ORAL AMPHOTERICIN B,TWrex-cause
788865493,9/15/2015 21:39:31,1739039185,9/15/2015 21:39:09,False,neodev,0.8611,33644825,USA,FL,Fort Lauderdale,65.111.173.161,ORAL AMPHOTERICIN B treats FUNGAL INFECTION,56,144,,71,163,treats,0.99654575824488,800036,"Menichetti F, Del Favero A, Martino P et al. Preventing FUNGAL INFECTION in neutropenic patients with acute leukemia: fluconazole compared with ORAL AMPHOTERICIN B.",FUNGAL INFECTION,ORAL AMPHOTERICIN B,TWrex-cause
788865493,9/15/2015 21:49:27,1739044370,9/15/2015 21:42:12,False,pocketmoneygpt,0.7877,21432964,GBR,F8,Borehamwood,81.159.185.70,no_relation,56,144,,71,163,treats,0.99654575824488,800036,"Menichetti F, Del Favero A, Martino P et al. Preventing FUNGAL INFECTION in neutropenic patients with acute leukemia: fluconazole compared with ORAL AMPHOTERICIN B.",FUNGAL INFECTION,ORAL AMPHOTERICIN B,TWrex-cause
788865499,9/15/2015 21:57:23,1739047820,9/15/2015 21:57:14,False,neodev,0.6843,33701549,NLD,,,85.203.17.204,[WARM COMPRESSES] treats [HYGIENE],50,81,,56,95,treats,0.522232967867094,219384,Treatment normally consists in maintaining a good [HYGIENE] of the eye and holding [WARM COMPRESSES] on the affected eyelid to remove the crusts.,[HYGIENE],[WARM COMPRESSES],TWrex-treat
788865499,9/15/2015 21:58:24,1739048355,9/15/2015 21:57:41,False,clixsense,0.7919,32053717,GBR,,,51.174.76.80,[WARM COMPRESSES] treats [HYGIENE],50,81,,56,95,treats,0.522232967867094,219384,Treatment normally consists in maintaining a good [HYGIENE] of the eye and holding [WARM COMPRESSES] on the affected eyelid to remove the crusts.,[HYGIENE],[WARM COMPRESSES],TWrex-treat
788865499,9/15/2015 22:05:16,1739051145,9/15/2015 22:04:28,False,clixsense,0.8375,31182465,GBR,A4,Bath,86.144.102.125,no_relation,50,81,,56,95,treats,0.522232967867094,219384,Treatment normally consists in maintaining a good [HYGIENE] of the eye and holding [WARM COMPRESSES] on the affected eyelid to remove the crusts.,[HYGIENE],[WARM COMPRESSES],TWrex-treat
788865499,9/15/2015 22:09:21,1739052560,9/15/2015 22:09:08,False,onestopgpt,0.8546,21275875,CAN,ON,Hamilton,24.36.124.79,no_relation,50,81,,56,95,treats,0.522232967867094,219384,Treatment normally consists in maintaining a good [HYGIENE] of the eye and holding [WARM COMPRESSES] on the affected eyelid to remove the crusts.,[HYGIENE],[WARM COMPRESSES],TWrex-treat
788865499,9/15/2015 22:11:57,1739053268,9/15/2015 22:11:04,False,prodege,0.6984,15439740,AUS,02,Jannali,14.200.59.55,no_relation,50,81,,56,95,treats,0.522232967867094,219384,Treatment normally consists in maintaining a good [HYGIENE] of the eye and holding [WARM COMPRESSES] on the affected eyelid to remove the crusts.,[HYGIENE],[WARM COMPRESSES],TWrex-treat
788865499,9/15/2015 22:12:03,1739053301,9/15/2015 22:10:40,False,neodev,0.5536,33238512,CAN,NB,Miramichi,174.118.173.203,[WARM COMPRESSES] treats [HYGIENE],50,81,,56,95,treats,0.522232967867094,219384,Treatment normally consists in maintaining a good [HYGIENE] of the eye and holding [WARM COMPRESSES] on the affected eyelid to remove the crusts.,[HYGIENE],[WARM COMPRESSES],TWrex-treat
788865499,9/15/2015 22:14:31,1739054160,9/15/2015 22:13:23,False,neodev,0.7452,18881135,CAN,ON,Ajax,99.243.87.224,no_relation,50,81,,56,95,treats,0.522232967867094,219384,Treatment normally consists in maintaining a good [HYGIENE] of the eye and holding [WARM COMPRESSES] on the affected eyelid to remove the crusts.,[HYGIENE],[WARM COMPRESSES],TWrex-treat
788865512,9/15/2015 21:19:47,1739028174,9/15/2015 21:19:27,False,neodev,1.0,20306047,GBR,,,80.41.0.252,no_relation,132,41,,191,82,treats,0.384900179459751,908111,"Eighteen children with steroid resistant NEPHROTIC SYNDROME RECEIVED CYCLOSPORINE A (CsA), including 7 patients with minimal change DISEASE 4 WITH FOCAL SEGMENTAL GLOMERULOSCLEROSIS AND 7 WITH mesangial hypercellurarity.",DISEASE 4 WITH FOCAL SEGMENTAL GLOMERULOSCLEROSIS AND 7 WITH,NEPHROTIC SYNDROME RECEIVED CYCLOSPORINE A,RO-may_treat
788865512,9/15/2015 21:41:38,1739040233,9/15/2015 21:39:33,False,clixsense,0.9167,30681826,GBR,I9,Diss,31.49.71.254,no_relation,132,41,,191,82,treats,0.384900179459751,908111,"Eighteen children with steroid resistant NEPHROTIC SYNDROME RECEIVED CYCLOSPORINE A (CsA), including 7 patients with minimal change DISEASE 4 WITH FOCAL SEGMENTAL GLOMERULOSCLEROSIS AND 7 WITH mesangial hypercellurarity.",DISEASE 4 WITH FOCAL SEGMENTAL GLOMERULOSCLEROSIS AND 7 WITH,NEPHROTIC SYNDROME RECEIVED CYCLOSPORINE A,RO-may_treat
788865512,9/15/2015 21:42:41,1739040833,9/15/2015 21:42:14,False,neodev,0.8611,33644825,USA,FL,Fort Lauderdale,65.111.173.161,NEPHROTIC SYNDROME RECEIVED CYCLOSPORINE A treats DISEASE 4 WITH FOCAL SEGMENTAL GLOMERULOSCLEROSIS AND 7 WITH,132,41,,191,82,treats,0.384900179459751,908111,"Eighteen children with steroid resistant NEPHROTIC SYNDROME RECEIVED CYCLOSPORINE A (CsA), including 7 patients with minimal change DISEASE 4 WITH FOCAL SEGMENTAL GLOMERULOSCLEROSIS AND 7 WITH mesangial hypercellurarity.",DISEASE 4 WITH FOCAL SEGMENTAL GLOMERULOSCLEROSIS AND 7 WITH,NEPHROTIC SYNDROME RECEIVED CYCLOSPORINE A,RO-may_treat
788865512,9/15/2015 21:48:50,1739044093,9/15/2015 21:45:43,False,clixsense,0.919,21875134,GBR,,,80.189.12.98,no_relation,132,41,,191,82,treats,0.384900179459751,908111,"Eighteen children with steroid resistant NEPHROTIC SYNDROME RECEIVED CYCLOSPORINE A (CsA), including 7 patients with minimal change DISEASE 4 WITH FOCAL SEGMENTAL GLOMERULOSCLEROSIS AND 7 WITH mesangial hypercellurarity.",DISEASE 4 WITH FOCAL SEGMENTAL GLOMERULOSCLEROSIS AND 7 WITH,NEPHROTIC SYNDROME RECEIVED CYCLOSPORINE A,RO-may_treat
788865512,9/15/2015 21:48:54,1739044124,9/15/2015 21:48:13,False,prodege,0.9667,21417560,GBR,C3,Cambridge,151.224.120.191,no_relation,132,41,,191,82,treats,0.384900179459751,908111,"Eighteen children with steroid resistant NEPHROTIC SYNDROME RECEIVED CYCLOSPORINE A (CsA), including 7 patients with minimal change DISEASE 4 WITH FOCAL SEGMENTAL GLOMERULOSCLEROSIS AND 7 WITH mesangial hypercellurarity.",DISEASE 4 WITH FOCAL SEGMENTAL GLOMERULOSCLEROSIS AND 7 WITH,NEPHROTIC SYNDROME RECEIVED CYCLOSPORINE A,RO-may_treat
788865512,9/15/2015 21:51:50,1739045474,9/15/2015 21:51:21,False,pocketmoneygpt,0.7877,21432964,GBR,F8,Borehamwood,81.159.185.70,no_relation,132,41,,191,82,treats,0.384900179459751,908111,"Eighteen children with steroid resistant NEPHROTIC SYNDROME RECEIVED CYCLOSPORINE A (CsA), including 7 patients with minimal change DISEASE 4 WITH FOCAL SEGMENTAL GLOMERULOSCLEROSIS AND 7 WITH mesangial hypercellurarity.",DISEASE 4 WITH FOCAL SEGMENTAL GLOMERULOSCLEROSIS AND 7 WITH,NEPHROTIC SYNDROME RECEIVED CYCLOSPORINE A,RO-may_treat
788865512,9/15/2015 21:55:50,1739047163,9/15/2015 21:55:17,False,clixsense,0.7919,32053717,GBR,,,51.174.76.80,NEPHROTIC SYNDROME RECEIVED CYCLOSPORINE A treats DISEASE 4 WITH FOCAL SEGMENTAL GLOMERULOSCLEROSIS AND 7 WITH,132,41,,191,82,treats,0.384900179459751,908111,"Eighteen children with steroid resistant NEPHROTIC SYNDROME RECEIVED CYCLOSPORINE A (CsA), including 7 patients with minimal change DISEASE 4 WITH FOCAL SEGMENTAL GLOMERULOSCLEROSIS AND 7 WITH mesangial hypercellurarity.",DISEASE 4 WITH FOCAL SEGMENTAL GLOMERULOSCLEROSIS AND 7 WITH,NEPHROTIC SYNDROME RECEIVED CYCLOSPORINE A,RO-may_treat
788865514,9/16/2015 04:48:02,1739302296,9/16/2015 04:47:47,False,gifthunterclub,0.894,30901412,GBR,G5,Margate,85.210.116.48,OMEPRAZOLE treats PEPTIC ESOPHAGITIS,110,150,,127,160,treats,1.0,800775,"1]  Hetzel DJ, Dent J, Reed WD, Narielvala FM, Mackinnon M, McCarthy JH, et al. Healing and relapse of severe PEPTIC ESOPHAGITIS after treatment with OMEPRAZOLE",PEPTIC ESOPHAGITIS,OMEPRAZOLE,TWrex-cause
788865514,9/16/2015 05:13:50,1739328856,9/16/2015 05:13:39,False,elite,0.8839,31883685,GBR,,,79.66.244.188,OMEPRAZOLE treats PEPTIC ESOPHAGITIS,110,150,,127,160,treats,1.0,800775,"1]  Hetzel DJ, Dent J, Reed WD, Narielvala FM, Mackinnon M, McCarthy JH, et al. Healing and relapse of severe PEPTIC ESOPHAGITIS after treatment with OMEPRAZOLE",PEPTIC ESOPHAGITIS,OMEPRAZOLE,TWrex-cause
788865514,9/16/2015 05:20:09,1739334994,9/16/2015 05:18:32,False,gifthunterclub,0.7778,24043308,GBR,,,94.102.147.250,OMEPRAZOLE treats PEPTIC ESOPHAGITIS,110,150,,127,160,treats,1.0,800775,"1]  Hetzel DJ, Dent J, Reed WD, Narielvala FM, Mackinnon M, McCarthy JH, et al. Healing and relapse of severe PEPTIC ESOPHAGITIS after treatment with OMEPRAZOLE",PEPTIC ESOPHAGITIS,OMEPRAZOLE,TWrex-cause
788865514,9/16/2015 05:33:58,1739349131,9/16/2015 05:33:25,False,neodev,0.7679,16854635,USA,OH,Lakewood,70.187.67.225,OMEPRAZOLE treats PEPTIC ESOPHAGITIS,110,150,,127,160,treats,1.0,800775,"1]  Hetzel DJ, Dent J, Reed WD, Narielvala FM, Mackinnon M, McCarthy JH, et al. Healing and relapse of severe PEPTIC ESOPHAGITIS after treatment with OMEPRAZOLE",PEPTIC ESOPHAGITIS,OMEPRAZOLE,TWrex-cause
788865514,9/16/2015 05:35:09,1739350399,9/16/2015 05:34:45,False,clixsense,0.8399,31304413,CAN,BC,Kelowna,66.183.36.177,OMEPRAZOLE treats PEPTIC ESOPHAGITIS,110,150,,127,160,treats,1.0,800775,"1]  Hetzel DJ, Dent J, Reed WD, Narielvala FM, Mackinnon M, McCarthy JH, et al. Healing and relapse of severe PEPTIC ESOPHAGITIS after treatment with OMEPRAZOLE",PEPTIC ESOPHAGITIS,OMEPRAZOLE,TWrex-cause
788865514,9/16/2015 05:49:03,1739366730,9/16/2015 05:48:33,False,instagc,0.7163,21613169,GBR,A7,Birmingham,109.156.129.221,OMEPRAZOLE treats PEPTIC ESOPHAGITIS,110,150,,127,160,treats,1.0,800775,"1]  Hetzel DJ, Dent J, Reed WD, Narielvala FM, Mackinnon M, McCarthy JH, et al. Healing and relapse of severe PEPTIC ESOPHAGITIS after treatment with OMEPRAZOLE",PEPTIC ESOPHAGITIS,OMEPRAZOLE,TWrex-cause
788865514,9/16/2015 05:51:05,1739369208,9/16/2015 05:50:50,False,neodev,0.5476,34429821,USA,CA,San Jose,50.118.172.120,OMEPRAZOLE treats PEPTIC ESOPHAGITIS,110,150,,127,160,treats,1.0,800775,"1]  Hetzel DJ, Dent J, Reed WD, Narielvala FM, Mackinnon M, McCarthy JH, et al. Healing and relapse of severe PEPTIC ESOPHAGITIS after treatment with OMEPRAZOLE",PEPTIC ESOPHAGITIS,OMEPRAZOLE,TWrex-cause
788865521,9/15/2015 21:49:47,1739044494,9/15/2015 21:49:19,False,prodege,0.9667,21417560,GBR,C3,Cambridge,151.224.120.191,IBUPROFEN treats FEVER,119,74,,123,83,treats,1.0,800250,"SEE:   epilepsy  TREATMENT: Appropriate therapy, such as acetaminophen or IBUPROFEN should be instituted to reduce the FEVER",FEVER,IBUPROFEN,TWrex-cause
788865521,9/15/2015 21:52:56,1739045911,9/15/2015 21:52:18,False,pocketmoneygpt,0.7877,21432964,GBR,F8,Borehamwood,81.159.185.70,IBUPROFEN treats FEVER,119,74,,123,83,treats,1.0,800250,"SEE:   epilepsy  TREATMENT: Appropriate therapy, such as acetaminophen or IBUPROFEN should be instituted to reduce the FEVER",FEVER,IBUPROFEN,TWrex-cause
788865521,9/15/2015 21:56:39,1739047487,9/15/2015 21:56:08,False,neodev,0.6843,33701549,NLD,,,85.203.17.204,FEVER treats IBUPROFEN,119,74,,123,83,treats,1.0,800250,"SEE:   epilepsy  TREATMENT: Appropriate therapy, such as acetaminophen or IBUPROFEN should be instituted to reduce the FEVER",FEVER,IBUPROFEN,TWrex-cause
788865521,9/15/2015 21:56:48,1739047552,9/15/2015 21:56:14,False,clixsense,0.7919,32053717,GBR,,,51.174.76.80,IBUPROFEN treats FEVER,119,74,,123,83,treats,1.0,800250,"SEE:   epilepsy  TREATMENT: Appropriate therapy, such as acetaminophen or IBUPROFEN should be instituted to reduce the FEVER",FEVER,IBUPROFEN,TWrex-cause
788865521,9/15/2015 22:03:13,1739050517,9/15/2015 22:02:32,False,clixsense,0.8375,31182465,GBR,A4,Bath,86.144.102.125,IBUPROFEN treats FEVER,119,74,,123,83,treats,1.0,800250,"SEE:   epilepsy  TREATMENT: Appropriate therapy, such as acetaminophen or IBUPROFEN should be instituted to reduce the FEVER",FEVER,IBUPROFEN,TWrex-cause
788865521,9/15/2015 22:07:01,1739051766,9/15/2015 22:06:47,False,onestopgpt,0.8546,21275875,CAN,ON,Hamilton,24.36.124.79,IBUPROFEN treats FEVER,119,74,,123,83,treats,1.0,800250,"SEE:   epilepsy  TREATMENT: Appropriate therapy, such as acetaminophen or IBUPROFEN should be instituted to reduce the FEVER",FEVER,IBUPROFEN,TWrex-cause
788865521,9/15/2015 22:18:32,1739055675,9/15/2015 22:16:20,False,neodev,0.7452,18881135,CAN,ON,Ajax,99.243.87.224,IBUPROFEN treats FEVER,119,74,,123,83,treats,1.0,800250,"SEE:   epilepsy  TREATMENT: Appropriate therapy, such as acetaminophen or IBUPROFEN should be instituted to reduce the FEVER",FEVER,IBUPROFEN,TWrex-cause
788865525,9/16/2015 02:39:49,1739180711,9/16/2015 02:38:58,False,elite,0.7847,30312592,CAN,ON,Sudbury,66.103.55.12,no_relation,75,118,,98,137,treats,0.42426406871192895,908182,"In patients with internal ophthalmoplegia, awareness of the possibility of PHARMACOLOGIC MYDRIASIS and correct use of TOPICAL PILOCARPINE testing can preclude the necessity for neuroradiologic and invasive diagnostic studies, even in cases with atypical or complex presentations.",PHARMACOLOGIC MYDRIASIS,TOPICAL PILOCARPINE,RO-may_treat
788865525,9/16/2015 02:55:46,1739196045,9/16/2015 02:55:33,False,zoombucks,0.7242,4688131,CAN,BC,Vancouver,75.157.35.92,no_relation,75,118,,98,137,treats,0.42426406871192895,908182,"In patients with internal ophthalmoplegia, awareness of the possibility of PHARMACOLOGIC MYDRIASIS and correct use of TOPICAL PILOCARPINE testing can preclude the necessity for neuroradiologic and invasive diagnostic studies, even in cases with atypical or complex presentations.",PHARMACOLOGIC MYDRIASIS,TOPICAL PILOCARPINE,RO-may_treat
788865525,9/16/2015 03:17:29,1739215398,9/16/2015 03:17:16,False,elite,0.648,34356654,USA,DE,,108.59.11.227,TOPICAL PILOCARPINE treats PHARMACOLOGIC MYDRIASIS,75,118,,98,137,treats,0.42426406871192895,908182,"In patients with internal ophthalmoplegia, awareness of the possibility of PHARMACOLOGIC MYDRIASIS and correct use of TOPICAL PILOCARPINE testing can preclude the necessity for neuroradiologic and invasive diagnostic studies, even in cases with atypical or complex presentations.",PHARMACOLOGIC MYDRIASIS,TOPICAL PILOCARPINE,RO-may_treat
788865525,9/16/2015 03:29:46,1739226957,9/16/2015 03:29:18,False,instagc,0.8145,33058612,USA,IL,Glenview,162.229.106.229,no_relation,75,118,,98,137,treats,0.42426406871192895,908182,"In patients with internal ophthalmoplegia, awareness of the possibility of PHARMACOLOGIC MYDRIASIS and correct use of TOPICAL PILOCARPINE testing can preclude the necessity for neuroradiologic and invasive diagnostic studies, even in cases with atypical or complex presentations.",PHARMACOLOGIC MYDRIASIS,TOPICAL PILOCARPINE,RO-may_treat
788865525,9/16/2015 03:48:56,1739245183,9/16/2015 03:47:23,False,clixsense,0.8056,17950689,GBR,L9,Sheffield,146.200.192.103,TOPICAL PILOCARPINE treats PHARMACOLOGIC MYDRIASIS,75,118,,98,137,treats,0.42426406871192895,908182,"In patients with internal ophthalmoplegia, awareness of the possibility of PHARMACOLOGIC MYDRIASIS and correct use of TOPICAL PILOCARPINE testing can preclude the necessity for neuroradiologic and invasive diagnostic studies, even in cases with atypical or complex presentations.",PHARMACOLOGIC MYDRIASIS,TOPICAL PILOCARPINE,RO-may_treat
788865525,9/16/2015 03:57:33,1739252759,9/16/2015 03:57:26,False,elite,0.1,33798502,USA,VA,Manassas,207.244.79.135,PHARMACOLOGIC MYDRIASIS treats TOPICAL PILOCARPINE,75,118,,98,137,treats,0.42426406871192895,908182,"In patients with internal ophthalmoplegia, awareness of the possibility of PHARMACOLOGIC MYDRIASIS and correct use of TOPICAL PILOCARPINE testing can preclude the necessity for neuroradiologic and invasive diagnostic studies, even in cases with atypical or complex presentations.",PHARMACOLOGIC MYDRIASIS,TOPICAL PILOCARPINE,RO-may_treat
788865525,9/16/2015 04:00:41,1739255445,9/16/2015 04:00:09,False,clixsense,0.8194,21665495,CAN,,,24.105.69.70,TOPICAL PILOCARPINE treats PHARMACOLOGIC MYDRIASIS,75,118,,98,137,treats,0.42426406871192895,908182,"In patients with internal ophthalmoplegia, awareness of the possibility of PHARMACOLOGIC MYDRIASIS and correct use of TOPICAL PILOCARPINE testing can preclude the necessity for neuroradiologic and invasive diagnostic studies, even in cases with atypical or complex presentations.",PHARMACOLOGIC MYDRIASIS,TOPICAL PILOCARPINE,RO-may_treat
788865527,9/15/2015 21:53:16,1739046064,9/15/2015 21:52:57,False,pocketmoneygpt,0.7877,21432964,GBR,F8,Borehamwood,81.159.185.70,CEFTAZIDIME treats URINARY TRACT INFECTION,115,91,,137,102,treats,1.0,804017,"Preheim LC, Childs SJ, Rajfer J et al. Randomized, double blind comparison of cefepime and CEFTAZIDIME therapy for URINARY TRACT INFECTION",URINARY TRACT INFECTION,CEFTAZIDIME,TWrex-cause
788865527,9/15/2015 21:56:55,1739047590,9/15/2015 21:56:39,False,neodev,0.6843,33701549,NLD,,,85.203.17.204,CEFTAZIDIME treats URINARY TRACT INFECTION,115,91,,137,102,treats,1.0,804017,"Preheim LC, Childs SJ, Rajfer J et al. Randomized, double blind comparison of cefepime and CEFTAZIDIME therapy for URINARY TRACT INFECTION",URINARY TRACT INFECTION,CEFTAZIDIME,TWrex-cause
788865527,9/15/2015 21:57:10,1739047709,9/15/2015 21:56:49,False,clixsense,0.7919,32053717,GBR,,,51.174.76.80,CEFTAZIDIME treats URINARY TRACT INFECTION,115,91,,137,102,treats,1.0,804017,"Preheim LC, Childs SJ, Rajfer J et al. Randomized, double blind comparison of cefepime and CEFTAZIDIME therapy for URINARY TRACT INFECTION",URINARY TRACT INFECTION,CEFTAZIDIME,TWrex-cause
788865527,9/15/2015 22:03:45,1739050680,9/15/2015 22:03:13,False,clixsense,0.8375,31182465,GBR,A4,Bath,86.144.102.125,CEFTAZIDIME treats URINARY TRACT INFECTION,115,91,,137,102,treats,1.0,804017,"Preheim LC, Childs SJ, Rajfer J et al. Randomized, double blind comparison of cefepime and CEFTAZIDIME therapy for URINARY TRACT INFECTION",URINARY TRACT INFECTION,CEFTAZIDIME,TWrex-cause
788865527,9/15/2015 22:08:23,1739052254,9/15/2015 22:07:02,False,onestopgpt,0.8546,21275875,CAN,ON,Hamilton,24.36.124.79,CEFTAZIDIME treats URINARY TRACT INFECTION,115,91,,137,102,treats,1.0,804017,"Preheim LC, Childs SJ, Rajfer J et al. Randomized, double blind comparison of cefepime and CEFTAZIDIME therapy for URINARY TRACT INFECTION",URINARY TRACT INFECTION,CEFTAZIDIME,TWrex-cause
788865527,9/15/2015 22:09:32,1739052648,9/15/2015 22:08:47,False,neodev,0.5536,33238512,CAN,NB,Miramichi,174.118.173.203,no_relation,115,91,,137,102,treats,1.0,804017,"Preheim LC, Childs SJ, Rajfer J et al. Randomized, double blind comparison of cefepime and CEFTAZIDIME therapy for URINARY TRACT INFECTION",URINARY TRACT INFECTION,CEFTAZIDIME,TWrex-cause
788865527,9/15/2015 22:10:20,1739052871,9/15/2015 22:09:57,False,prodege,0.6984,15439740,AUS,02,Jannali,14.200.59.55,CEFTAZIDIME treats URINARY TRACT INFECTION,115,91,,137,102,treats,1.0,804017,"Preheim LC, Childs SJ, Rajfer J et al. Randomized, double blind comparison of cefepime and CEFTAZIDIME therapy for URINARY TRACT INFECTION",URINARY TRACT INFECTION,CEFTAZIDIME,TWrex-cause
788865529,9/16/2015 06:47:25,1739409548,9/16/2015 06:47:15,False,prodege,0.9018,30501999,CAN,ON,Ottawa,137.122.64.22,PANCREATIC ISLETS treats STREPTOZOTOCIN INDUCED DIABETES,15,91,,31,122,treats,0.9797958971132711,902403,The ability of PANCREATIC ISLETS implanted into abdominal muscle to effect a recovery from STREPTOZOTOCIN INDUCED DIABETES was compared with that of i.p implants.,PANCREATIC ISLETS,STREPTOZOTOCIN INDUCED DIABETES,RO-disease_has_primary_anatomic_site
788865529,9/16/2015 06:52:52,1739410620,9/16/2015 06:52:37,False,bitcoinget,0.85,30546513,GBR,G6,Hull,194.42.67.50,PANCREATIC ISLETS treats STREPTOZOTOCIN INDUCED DIABETES,15,91,,31,122,treats,0.9797958971132711,902403,The ability of PANCREATIC ISLETS implanted into abdominal muscle to effect a recovery from STREPTOZOTOCIN INDUCED DIABETES was compared with that of i.p implants.,PANCREATIC ISLETS,STREPTOZOTOCIN INDUCED DIABETES,RO-disease_has_primary_anatomic_site
788865529,9/16/2015 06:59:38,1739411609,9/16/2015 06:59:05,False,neodev,0.7813,11460728,CAN,BC,Burnaby,70.79.16.165,PANCREATIC ISLETS treats STREPTOZOTOCIN INDUCED DIABETES,15,91,,31,122,treats,0.9797958971132711,902403,The ability of PANCREATIC ISLETS implanted into abdominal muscle to effect a recovery from STREPTOZOTOCIN INDUCED DIABETES was compared with that of i.p implants.,PANCREATIC ISLETS,STREPTOZOTOCIN INDUCED DIABETES,RO-disease_has_primary_anatomic_site
788865529,9/16/2015 07:02:05,1739411938,9/16/2015 07:01:03,False,fusioncash,0.9583,5626024,USA,AR,Clarksville,75.121.20.252,PANCREATIC ISLETS treats STREPTOZOTOCIN INDUCED DIABETES,15,91,,31,122,treats,0.9797958971132711,902403,The ability of PANCREATIC ISLETS implanted into abdominal muscle to effect a recovery from STREPTOZOTOCIN INDUCED DIABETES was compared with that of i.p implants.,PANCREATIC ISLETS,STREPTOZOTOCIN INDUCED DIABETES,RO-disease_has_primary_anatomic_site
788865529,9/16/2015 07:26:07,1739416036,9/16/2015 07:25:47,False,instagc,0.8333,18960682,GBR,U2,Annan,92.18.213.181,PANCREATIC ISLETS treats STREPTOZOTOCIN INDUCED DIABETES,15,91,,31,122,treats,0.9797958971132711,902403,The ability of PANCREATIC ISLETS implanted into abdominal muscle to effect a recovery from STREPTOZOTOCIN INDUCED DIABETES was compared with that of i.p implants.,PANCREATIC ISLETS,STREPTOZOTOCIN INDUCED DIABETES,RO-disease_has_primary_anatomic_site
788865529,9/16/2015 07:29:14,1739416711,9/16/2015 07:28:27,False,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,PANCREATIC ISLETS treats STREPTOZOTOCIN INDUCED DIABETES,15,91,,31,122,treats,0.9797958971132711,902403,The ability of PANCREATIC ISLETS implanted into abdominal muscle to effect a recovery from STREPTOZOTOCIN INDUCED DIABETES was compared with that of i.p implants.,PANCREATIC ISLETS,STREPTOZOTOCIN INDUCED DIABETES,RO-disease_has_primary_anatomic_site
788865529,9/16/2015 07:35:25,1739418073,9/16/2015 07:34:57,False,prodege,1.0,22031444,GBR,F2,Gosport,92.24.223.243,PANCREATIC ISLETS treats STREPTOZOTOCIN INDUCED DIABETES,15,91,,31,122,treats,0.9797958971132711,902403,The ability of PANCREATIC ISLETS implanted into abdominal muscle to effect a recovery from STREPTOZOTOCIN INDUCED DIABETES was compared with that of i.p implants.,PANCREATIC ISLETS,STREPTOZOTOCIN INDUCED DIABETES,RO-disease_has_primary_anatomic_site
788865531,9/16/2015 04:47:28,1739301636,9/16/2015 04:47:10,False,gifthunterclub,0.894,30901412,GBR,G5,Margate,85.210.116.48,DACARBAZINE treats METASTATIC MALIGNANT MELANOMA,196,161,,225,172,treats,0.8834522085987719,907722,"Phase III study of concurrent biochemotherapy with cisplatin, vinblastine, dacarbazine, interleukin 2, and interferon alfa 2b versus cisplatin, vinblastine, and DACARBAZINE alone in patients with METASTATIC MALIGNANT MELANOMA (summary last modified 10/1999.",METASTATIC MALIGNANT MELANOMA,DACARBAZINE,RO-may_treat
788865531,9/16/2015 05:13:23,1739328225,9/16/2015 05:13:10,False,elite,0.8839,31883685,GBR,,,79.66.244.188,DACARBAZINE treats METASTATIC MALIGNANT MELANOMA,196,161,,225,172,treats,0.8834522085987719,907722,"Phase III study of concurrent biochemotherapy with cisplatin, vinblastine, dacarbazine, interleukin 2, and interferon alfa 2b versus cisplatin, vinblastine, and DACARBAZINE alone in patients with METASTATIC MALIGNANT MELANOMA (summary last modified 10/1999.",METASTATIC MALIGNANT MELANOMA,DACARBAZINE,RO-may_treat
788865531,9/16/2015 05:15:39,1739330607,9/16/2015 05:13:54,False,prodege,0.7524,5007431,USA,MI,Saginaw,68.188.255.98,DACARBAZINE treats METASTATIC MALIGNANT MELANOMA,196,161,,225,172,treats,0.8834522085987719,907722,"Phase III study of concurrent biochemotherapy with cisplatin, vinblastine, dacarbazine, interleukin 2, and interferon alfa 2b versus cisplatin, vinblastine, and DACARBAZINE alone in patients with METASTATIC MALIGNANT MELANOMA (summary last modified 10/1999.",METASTATIC MALIGNANT MELANOMA,DACARBAZINE,RO-may_treat
788865531,9/16/2015 05:16:49,1739331756,9/16/2015 05:14:37,False,gifthunterclub,0.7778,24043308,GBR,,,94.102.147.250,DACARBAZINE treats METASTATIC MALIGNANT MELANOMA,196,161,,225,172,treats,0.8834522085987719,907722,"Phase III study of concurrent biochemotherapy with cisplatin, vinblastine, dacarbazine, interleukin 2, and interferon alfa 2b versus cisplatin, vinblastine, and DACARBAZINE alone in patients with METASTATIC MALIGNANT MELANOMA (summary last modified 10/1999.",METASTATIC MALIGNANT MELANOMA,DACARBAZINE,RO-may_treat
788865531,9/16/2015 05:32:59,1739347936,9/16/2015 05:31:56,False,neodev,0.7679,16854635,USA,OH,Lakewood,70.187.67.225,DACARBAZINE treats METASTATIC MALIGNANT MELANOMA,196,161,,225,172,treats,0.8834522085987719,907722,"Phase III study of concurrent biochemotherapy with cisplatin, vinblastine, dacarbazine, interleukin 2, and interferon alfa 2b versus cisplatin, vinblastine, and DACARBAZINE alone in patients with METASTATIC MALIGNANT MELANOMA (summary last modified 10/1999.",METASTATIC MALIGNANT MELANOMA,DACARBAZINE,RO-may_treat
788865531,9/16/2015 05:33:54,1739349075,9/16/2015 05:33:16,False,clixsense,0.8399,31304413,CAN,BC,Kelowna,66.183.36.177,DACARBAZINE treats METASTATIC MALIGNANT MELANOMA,196,161,,225,172,treats,0.8834522085987719,907722,"Phase III study of concurrent biochemotherapy with cisplatin, vinblastine, dacarbazine, interleukin 2, and interferon alfa 2b versus cisplatin, vinblastine, and DACARBAZINE alone in patients with METASTATIC MALIGNANT MELANOMA (summary last modified 10/1999.",METASTATIC MALIGNANT MELANOMA,DACARBAZINE,RO-may_treat
788865531,9/16/2015 06:04:36,1739383336,9/16/2015 06:03:29,False,points4rewards,0.8065,20306700,USA,WA,Bothell,50.106.46.70,METASTATIC MALIGNANT MELANOMA treats DACARBAZINE,196,161,,225,172,treats,0.8834522085987719,907722,"Phase III study of concurrent biochemotherapy with cisplatin, vinblastine, dacarbazine, interleukin 2, and interferon alfa 2b versus cisplatin, vinblastine, and DACARBAZINE alone in patients with METASTATIC MALIGNANT MELANOMA (summary last modified 10/1999.",METASTATIC MALIGNANT MELANOMA,DACARBAZINE,RO-may_treat
788865535,9/16/2015 06:33:39,1739401922,9/16/2015 06:33:15,False,clixsense,0.8155,31482589,NLD,11,Gouda,77.167.232.121,CHANCROID treats AZITHROMYCIN,27,62,,36,74,treats,0.9918365981,216137,The CDC recommendation for [CHANCROID] is a single oral dose of [AZITHROMYCIN] or a single IM dose of Ceftriaxone or oral Erythromycin for seven days.,CHANCROID,AZITHROMYCIN,TWrex-treat
788865535,9/16/2015 06:35:32,1739402857,9/16/2015 06:34:35,False,neodev,0.6019,21515166,NLD,11,Nieuwkoop,83.84.200.25,no_relation,27,62,,36,74,treats,0.9918365981,216137,The CDC recommendation for [CHANCROID] is a single oral dose of [AZITHROMYCIN] or a single IM dose of Ceftriaxone or oral Erythromycin for seven days.,CHANCROID,AZITHROMYCIN,TWrex-treat
788865535,9/16/2015 06:42:16,1739406788,9/16/2015 06:42:03,False,gifthunterclub,0.7639,33931170,AUS,04,Brisbane,121.208.7.253,AZITHROMYCIN treats CHANCROID,27,62,,36,74,treats,0.9918365981,216137,The CDC recommendation for [CHANCROID] is a single oral dose of [AZITHROMYCIN] or a single IM dose of Ceftriaxone or oral Erythromycin for seven days.,CHANCROID,AZITHROMYCIN,TWrex-treat
788865535,9/16/2015 06:46:29,1739409142,9/16/2015 06:45:55,False,prodege,0.9018,30501999,CAN,ON,Ottawa,137.122.64.22,AZITHROMYCIN treats CHANCROID,27,62,,36,74,treats,0.9918365981,216137,The CDC recommendation for [CHANCROID] is a single oral dose of [AZITHROMYCIN] or a single IM dose of Ceftriaxone or oral Erythromycin for seven days.,CHANCROID,AZITHROMYCIN,TWrex-treat
788865535,9/16/2015 06:52:12,1739410523,9/16/2015 06:51:34,False,bitcoinget,0.85,30546513,GBR,G6,Hull,194.42.67.50,no_relation,27,62,,36,74,treats,0.9918365981,216137,The CDC recommendation for [CHANCROID] is a single oral dose of [AZITHROMYCIN] or a single IM dose of Ceftriaxone or oral Erythromycin for seven days.,CHANCROID,AZITHROMYCIN,TWrex-treat
788865535,9/16/2015 06:58:25,1739411412,9/16/2015 06:57:34,False,neodev,0.7813,11460728,CAN,BC,Burnaby,70.79.16.165,AZITHROMYCIN treats CHANCROID,27,62,,36,74,treats,0.9918365981,216137,The CDC recommendation for [CHANCROID] is a single oral dose of [AZITHROMYCIN] or a single IM dose of Ceftriaxone or oral Erythromycin for seven days.,CHANCROID,AZITHROMYCIN,TWrex-treat
788865535,9/16/2015 07:00:31,1739411755,9/16/2015 06:58:00,False,neodev,0.7440000000000001,17963941,GBR,V2,Glasgow,2.24.248.140,AZITHROMYCIN treats CHANCROID,27,62,,36,74,treats,0.9918365981,216137,The CDC recommendation for [CHANCROID] is a single oral dose of [AZITHROMYCIN] or a single IM dose of Ceftriaxone or oral Erythromycin for seven days.,CHANCROID,AZITHROMYCIN,TWrex-treat
788865536,9/16/2015 05:24:50,1739339164,9/16/2015 05:22:51,False,gifthunterclub,0.7778,24043308,GBR,,,94.102.147.250,FACTOR VII (RFVIIA) treats HEMOPHILIA A,131,35,,142,54,treats,1.0,800617,"FACTOR VIIA  Recombinant activated FACTOR VII (RFVIIA) was approved in 1999 for the treatment of bleeding episodes in patients with HEMOPHILIA A or B who have antibodies (inhibitors) to factor VIII or IX, respectively.",HEMOPHILIA A,FACTOR VII (RFVIIA),TWrex-cause
788865536,9/16/2015 05:36:16,1739351680,9/16/2015 05:35:46,False,clixsense,0.8399,31304413,CAN,BC,Kelowna,66.183.36.177,FACTOR VII (RFVIIA) treats HEMOPHILIA A,131,35,,142,54,treats,1.0,800617,"FACTOR VIIA  Recombinant activated FACTOR VII (RFVIIA) was approved in 1999 for the treatment of bleeding episodes in patients with HEMOPHILIA A or B who have antibodies (inhibitors) to factor VIII or IX, respectively.",HEMOPHILIA A,FACTOR VII (RFVIIA),TWrex-cause
788865536,9/16/2015 05:50:03,1739368049,9/16/2015 05:49:32,False,instagc,0.7163,21613169,GBR,A7,Birmingham,109.156.129.221,FACTOR VII (RFVIIA) treats HEMOPHILIA A,131,35,,142,54,treats,1.0,800617,"FACTOR VIIA  Recombinant activated FACTOR VII (RFVIIA) was approved in 1999 for the treatment of bleeding episodes in patients with HEMOPHILIA A or B who have antibodies (inhibitors) to factor VIII or IX, respectively.",HEMOPHILIA A,FACTOR VII (RFVIIA),TWrex-cause
788865536,9/16/2015 06:06:36,1739384441,9/16/2015 06:06:04,False,points4rewards,0.8065,20306700,USA,WA,Bothell,50.106.46.70,FACTOR VII (RFVIIA) treats HEMOPHILIA A,131,35,,142,54,treats,1.0,800617,"FACTOR VIIA  Recombinant activated FACTOR VII (RFVIIA) was approved in 1999 for the treatment of bleeding episodes in patients with HEMOPHILIA A or B who have antibodies (inhibitors) to factor VIII or IX, respectively.",HEMOPHILIA A,FACTOR VII (RFVIIA),TWrex-cause
788865536,9/16/2015 06:18:03,1739392543,9/16/2015 06:17:34,False,prodege,0.825,27934334,GBR,C8,Croydon,81.159.60.206,FACTOR VII (RFVIIA) treats HEMOPHILIA A,131,35,,142,54,treats,1.0,800617,"FACTOR VIIA  Recombinant activated FACTOR VII (RFVIIA) was approved in 1999 for the treatment of bleeding episodes in patients with HEMOPHILIA A or B who have antibodies (inhibitors) to factor VIII or IX, respectively.",HEMOPHILIA A,FACTOR VII (RFVIIA),TWrex-cause
788865536,9/16/2015 06:24:58,1739396824,9/16/2015 06:23:19,False,points4rewards,0.8859,28703583,USA,,,184.53.32.197,FACTOR VII (RFVIIA) treats HEMOPHILIA A,131,35,,142,54,treats,1.0,800617,"FACTOR VIIA  Recombinant activated FACTOR VII (RFVIIA) was approved in 1999 for the treatment of bleeding episodes in patients with HEMOPHILIA A or B who have antibodies (inhibitors) to factor VIII or IX, respectively.",HEMOPHILIA A,FACTOR VII (RFVIIA),TWrex-cause
788865536,9/16/2015 06:28:47,1739398904,9/16/2015 06:26:43,False,clixsense,0.8762,28570371,NLD,,,91.213.37.165,FACTOR VII (RFVIIA) treats HEMOPHILIA A,131,35,,142,54,treats,1.0,800617,"FACTOR VIIA  Recombinant activated FACTOR VII (RFVIIA) was approved in 1999 for the treatment of bleeding episodes in patients with HEMOPHILIA A or B who have antibodies (inhibitors) to factor VIII or IX, respectively.",HEMOPHILIA A,FACTOR VII (RFVIIA),TWrex-cause
788865540,9/16/2015 05:14:14,1739329210,9/16/2015 05:13:50,False,elite,0.8839,31883685,GBR,,,79.66.244.188,no_relation,213,30,,228,40,treats,0.838627869377535,804019,Alternate therapies include α INTERFERON (with addition of ribavirin if creatinine clearance is > 50 mL/min) for hepatitis C virus associated disease and plasmapheresis with corticosteroids for concomitant severe CRYOGLOBULINEMIA or rapidly progressive GN.,CRYOGLOBULINEMIA,INTERFERON,TWrex-cause
788865540,9/16/2015 05:22:50,1739337195,9/16/2015 05:20:13,False,gifthunterclub,0.7778,24043308,GBR,,,94.102.147.250,INTERFERON treats CRYOGLOBULINEMIA,213,30,,228,40,treats,0.838627869377535,804019,Alternate therapies include α INTERFERON (with addition of ribavirin if creatinine clearance is > 50 mL/min) for hepatitis C virus associated disease and plasmapheresis with corticosteroids for concomitant severe CRYOGLOBULINEMIA or rapidly progressive GN.,CRYOGLOBULINEMIA,INTERFERON,TWrex-cause
788865540,9/16/2015 05:34:26,1739349572,9/16/2015 05:33:59,False,neodev,0.7679,16854635,USA,OH,Lakewood,70.187.67.225,INTERFERON treats CRYOGLOBULINEMIA,213,30,,228,40,treats,0.838627869377535,804019,Alternate therapies include α INTERFERON (with addition of ribavirin if creatinine clearance is > 50 mL/min) for hepatitis C virus associated disease and plasmapheresis with corticosteroids for concomitant severe CRYOGLOBULINEMIA or rapidly progressive GN.,CRYOGLOBULINEMIA,INTERFERON,TWrex-cause
788865540,9/16/2015 05:35:46,1739351017,9/16/2015 05:35:11,False,clixsense,0.8399,31304413,CAN,BC,Kelowna,66.183.36.177,INTERFERON treats CRYOGLOBULINEMIA,213,30,,228,40,treats,0.838627869377535,804019,Alternate therapies include α INTERFERON (with addition of ribavirin if creatinine clearance is > 50 mL/min) for hepatitis C virus associated disease and plasmapheresis with corticosteroids for concomitant severe CRYOGLOBULINEMIA or rapidly progressive GN.,CRYOGLOBULINEMIA,INTERFERON,TWrex-cause
788865540,9/16/2015 05:49:31,1739367392,9/16/2015 05:49:04,False,instagc,0.7163,21613169,GBR,A7,Birmingham,109.156.129.221,no_relation,213,30,,228,40,treats,0.838627869377535,804019,Alternate therapies include α INTERFERON (with addition of ribavirin if creatinine clearance is > 50 mL/min) for hepatitis C virus associated disease and plasmapheresis with corticosteroids for concomitant severe CRYOGLOBULINEMIA or rapidly progressive GN.,CRYOGLOBULINEMIA,INTERFERON,TWrex-cause
788865540,9/16/2015 05:51:13,1739369272,9/16/2015 05:51:06,False,neodev,0.5476,34429821,USA,CA,San Jose,50.118.172.120,INTERFERON treats CRYOGLOBULINEMIA,213,30,,228,40,treats,0.838627869377535,804019,Alternate therapies include α INTERFERON (with addition of ribavirin if creatinine clearance is > 50 mL/min) for hepatitis C virus associated disease and plasmapheresis with corticosteroids for concomitant severe CRYOGLOBULINEMIA or rapidly progressive GN.,CRYOGLOBULINEMIA,INTERFERON,TWrex-cause
788865540,9/16/2015 06:06:03,1739384198,9/16/2015 06:04:37,False,points4rewards,0.8065,20306700,USA,WA,Bothell,50.106.46.70,INTERFERON treats CRYOGLOBULINEMIA,213,30,,228,40,treats,0.838627869377535,804019,Alternate therapies include α INTERFERON (with addition of ribavirin if creatinine clearance is > 50 mL/min) for hepatitis C virus associated disease and plasmapheresis with corticosteroids for concomitant severe CRYOGLOBULINEMIA or rapidly progressive GN.,CRYOGLOBULINEMIA,INTERFERON,TWrex-cause
788865544,9/15/2015 22:20:18,1739056278,9/15/2015 22:19:39,False,neodev,0.8889,33758777,USA,,,38.95.108.251,BEVACIZUMAB treats ABNORMAL GROWTH,5,43,,20,54,treats,0.99654575824488,222560,"This [ABNORMAL GROWTH] is caused by VEGF, so [BEVACIZUMAB] has been successfully used to inhibit VEGF and slow this growth.",ABNORMAL GROWTH,BEVACIZUMAB,TWrex-treat
788865544,9/15/2015 22:31:31,1739059949,9/15/2015 22:30:51,False,fusioncash,0.8313,31742806,USA,OH,Kent,66.61.82.242,BEVACIZUMAB treats ABNORMAL GROWTH,5,43,,20,54,treats,0.99654575824488,222560,"This [ABNORMAL GROWTH] is caused by VEGF, so [BEVACIZUMAB] has been successfully used to inhibit VEGF and slow this growth.",ABNORMAL GROWTH,BEVACIZUMAB,TWrex-treat
788865544,9/15/2015 22:33:39,1739060631,9/15/2015 22:32:22,False,points4rewards,0.7798,20113482,USA,PA,Philadelphia,162.208.49.45,BEVACIZUMAB treats ABNORMAL GROWTH,5,43,,20,54,treats,0.99654575824488,222560,"This [ABNORMAL GROWTH] is caused by VEGF, so [BEVACIZUMAB] has been successfully used to inhibit VEGF and slow this growth.",ABNORMAL GROWTH,BEVACIZUMAB,TWrex-treat
788865544,9/15/2015 22:43:52,1739063980,9/15/2015 22:43:26,False,instagc,0.9048,23287154,USA,CA,San Jose,50.184.60.102,BEVACIZUMAB treats ABNORMAL GROWTH,5,43,,20,54,treats,0.99654575824488,222560,"This [ABNORMAL GROWTH] is caused by VEGF, so [BEVACIZUMAB] has been successfully used to inhibit VEGF and slow this growth.",ABNORMAL GROWTH,BEVACIZUMAB,TWrex-treat
788865544,9/15/2015 22:44:54,1739064273,9/15/2015 22:44:18,False,clixsense,0.8917,20587495,CAN,NB,Saint John,142.162.106.74,BEVACIZUMAB treats ABNORMAL GROWTH,5,43,,20,54,treats,0.99654575824488,222560,"This [ABNORMAL GROWTH] is caused by VEGF, so [BEVACIZUMAB] has been successfully used to inhibit VEGF and slow this growth.",ABNORMAL GROWTH,BEVACIZUMAB,TWrex-treat
788865544,9/15/2015 22:50:52,1739066071,9/15/2015 22:50:44,False,tremorgames,0.4107,24449707,CAN,QC,Laval,96.20.14.148,no_relation,5,43,,20,54,treats,0.99654575824488,222560,"This [ABNORMAL GROWTH] is caused by VEGF, so [BEVACIZUMAB] has been successfully used to inhibit VEGF and slow this growth.",ABNORMAL GROWTH,BEVACIZUMAB,TWrex-treat
788865544,9/15/2015 22:53:59,1739067472,9/15/2015 22:52:51,False,instagc,0.6222,20392280,USA,CA,Los Angeles,172.56.17.103,no_relation,5,43,,20,54,treats,0.99654575824488,222560,"This [ABNORMAL GROWTH] is caused by VEGF, so [BEVACIZUMAB] has been successfully used to inhibit VEGF and slow this growth.",ABNORMAL GROWTH,BEVACIZUMAB,TWrex-treat
788865548,9/15/2015 21:18:16,1739027296,9/15/2015 21:18:05,False,neodev,1.0,20306047,GBR,,,80.41.0.252,EPOETIN ALFA treats ANEMIA,68,0,,74,12,treats,0.9970544855015809,908038,"EPOETIN ALFA is, therefore, effective and safe in the management of ANEMIA in patients with breast cancer treated with chemotherapy.",ANEMIA,EPOETIN ALFA,RO-may_treat
788865548,9/15/2015 21:28:35,1739033149,9/15/2015 21:28:24,False,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.138,EPOETIN ALFA treats ANEMIA,68,0,,74,12,treats,0.9970544855015809,908038,"EPOETIN ALFA is, therefore, effective and safe in the management of ANEMIA in patients with breast cancer treated with chemotherapy.",ANEMIA,EPOETIN ALFA,RO-may_treat
788865548,9/15/2015 21:35:47,1739037209,9/15/2015 21:34:47,False,clixsense,0.9167,30681826,GBR,I9,Diss,31.49.71.254,EPOETIN ALFA treats ANEMIA,68,0,,74,12,treats,0.9970544855015809,908038,"EPOETIN ALFA is, therefore, effective and safe in the management of ANEMIA in patients with breast cancer treated with chemotherapy.",ANEMIA,EPOETIN ALFA,RO-may_treat
788865548,9/15/2015 21:37:08,1739037851,9/15/2015 21:35:29,False,clixsense,0.919,21875134,GBR,,,80.189.12.98,EPOETIN ALFA treats ANEMIA,68,0,,74,12,treats,0.9970544855015809,908038,"EPOETIN ALFA is, therefore, effective and safe in the management of ANEMIA in patients with breast cancer treated with chemotherapy.",ANEMIA,EPOETIN ALFA,RO-may_treat
788865548,9/15/2015 21:40:01,1739039419,9/15/2015 21:39:32,False,neodev,0.8611,33644825,USA,FL,Fort Lauderdale,65.111.173.161,EPOETIN ALFA treats ANEMIA,68,0,,74,12,treats,0.9970544855015809,908038,"EPOETIN ALFA is, therefore, effective and safe in the management of ANEMIA in patients with breast cancer treated with chemotherapy.",ANEMIA,EPOETIN ALFA,RO-may_treat
788865548,9/15/2015 21:43:41,1739041396,9/15/2015 21:43:34,False,instagc,1.0,13581319,USA,IL,Trenton,208.70.36.12,EPOETIN ALFA treats ANEMIA,68,0,,74,12,treats,0.9970544855015809,908038,"EPOETIN ALFA is, therefore, effective and safe in the management of ANEMIA in patients with breast cancer treated with chemotherapy.",ANEMIA,EPOETIN ALFA,RO-may_treat
788865548,9/15/2015 21:46:14,1739042759,9/15/2015 21:45:48,False,prodege,0.9667,21417560,GBR,C3,Cambridge,151.224.120.191,EPOETIN ALFA treats ANEMIA,68,0,,74,12,treats,0.9970544855015809,908038,"EPOETIN ALFA is, therefore, effective and safe in the management of ANEMIA in patients with breast cancer treated with chemotherapy.",ANEMIA,EPOETIN ALFA,RO-may_treat
788865553,9/15/2015 22:12:33,1739053480,9/15/2015 22:12:19,False,prodege,0.6984,15439740,AUS,02,Jannali,14.200.59.55,no_relation,61,8,,79,17,treats,1.0,805257,"Whether VITAMIN E protects against cardiovascular disorders, ALZHEIMER'S DISEASE tardive dyskinesia, and prostate cancer among smokers is controversial.",ALZHEIMER'S DISEASE,VITAMIN E,TWrex-cause
788865553,9/15/2015 22:14:00,1739054007,9/15/2015 22:13:00,False,neodev,0.5536,33238512,CAN,NB,Miramichi,174.118.173.203,VITAMIN E treats ALZHEIMER'S DISEASE,61,8,,79,17,treats,1.0,805257,"Whether VITAMIN E protects against cardiovascular disorders, ALZHEIMER'S DISEASE tardive dyskinesia, and prostate cancer among smokers is controversial.",ALZHEIMER'S DISEASE,VITAMIN E,TWrex-cause
788865553,9/15/2015 22:17:55,1739055453,9/15/2015 22:17:22,False,neodev,0.8889,33758777,USA,,,38.95.108.251,VITAMIN E treats ALZHEIMER'S DISEASE,61,8,,79,17,treats,1.0,805257,"Whether VITAMIN E protects against cardiovascular disorders, ALZHEIMER'S DISEASE tardive dyskinesia, and prostate cancer among smokers is controversial.",ALZHEIMER'S DISEASE,VITAMIN E,TWrex-cause
788865553,9/15/2015 22:21:35,1739056779,9/15/2015 22:18:35,False,neodev,0.7452,18881135,CAN,ON,Ajax,99.243.87.224,no_relation,61,8,,79,17,treats,1.0,805257,"Whether VITAMIN E protects against cardiovascular disorders, ALZHEIMER'S DISEASE tardive dyskinesia, and prostate cancer among smokers is controversial.",ALZHEIMER'S DISEASE,VITAMIN E,TWrex-cause
788865553,9/15/2015 22:26:20,1739058127,9/15/2015 22:24:09,False,points4rewards,0.7798,20113482,USA,PA,Philadelphia,162.208.49.45,no_relation,61,8,,79,17,treats,1.0,805257,"Whether VITAMIN E protects against cardiovascular disorders, ALZHEIMER'S DISEASE tardive dyskinesia, and prostate cancer among smokers is controversial.",ALZHEIMER'S DISEASE,VITAMIN E,TWrex-cause
788865553,9/15/2015 22:28:03,1739058645,9/15/2015 22:26:57,False,fusioncash,0.8313,31742806,USA,OH,Kent,66.61.82.242,no_relation,61,8,,79,17,treats,1.0,805257,"Whether VITAMIN E protects against cardiovascular disorders, ALZHEIMER'S DISEASE tardive dyskinesia, and prostate cancer among smokers is controversial.",ALZHEIMER'S DISEASE,VITAMIN E,TWrex-cause
788865553,9/15/2015 22:28:11,1739058703,9/15/2015 22:28:03,False,neodev,0.2143,30749660,USA,NC,Wake Forest,71.70.155.5,ALZHEIMER'S DISEASE treats VITAMIN E,61,8,,79,17,treats,1.0,805257,"Whether VITAMIN E protects against cardiovascular disorders, ALZHEIMER'S DISEASE tardive dyskinesia, and prostate cancer among smokers is controversial.",ALZHEIMER'S DISEASE,VITAMIN E,TWrex-cause
788865560,9/15/2015 22:05:49,1739051402,9/15/2015 22:05:18,False,clixsense,0.8375,31182465,GBR,A4,Bath,86.144.102.125,no_relation,57,84,,64,92,treats,0.314485451016576,810912,"280 ,   281 ,   283 ,   285  Altenative for treatment of GLANDERS   +    caused by  B MALLEI",GLANDERS,B MALLEI,TWrex-cause
788865560,9/15/2015 22:10:03,1739052757,9/15/2015 22:09:22,False,onestopgpt,0.8546,21275875,CAN,ON,Hamilton,24.36.124.79,no_relation,57,84,,64,92,treats,0.314485451016576,810912,"280 ,   281 ,   283 ,   285  Altenative for treatment of GLANDERS   +    caused by  B MALLEI",GLANDERS,B MALLEI,TWrex-cause
788865560,9/15/2015 22:12:18,1739053387,9/15/2015 22:11:59,False,prodege,0.6984,15439740,AUS,02,Jannali,14.200.59.55,no_relation,57,84,,64,92,treats,0.314485451016576,810912,"280 ,   281 ,   283 ,   285  Altenative for treatment of GLANDERS   +    caused by  B MALLEI",GLANDERS,B MALLEI,TWrex-cause
788865560,9/15/2015 22:12:58,1739053578,9/15/2015 22:12:12,False,neodev,0.5536,33238512,CAN,NB,Miramichi,174.118.173.203,B MALLEI treats GLANDERS,57,84,,64,92,treats,0.314485451016576,810912,"280 ,   281 ,   283 ,   285  Altenative for treatment of GLANDERS   +    caused by  B MALLEI",GLANDERS,B MALLEI,TWrex-cause
788865560,9/15/2015 22:16:18,1739054828,9/15/2015 22:14:36,False,neodev,0.7452,18881135,CAN,ON,Ajax,99.243.87.224,no_relation,57,84,,64,92,treats,0.314485451016576,810912,"280 ,   281 ,   283 ,   285  Altenative for treatment of GLANDERS   +    caused by  B MALLEI",GLANDERS,B MALLEI,TWrex-cause
788865560,9/15/2015 22:17:21,1739055213,9/15/2015 22:16:47,False,neodev,0.8889,33758777,USA,,,38.95.108.251,no_relation,57,84,,64,92,treats,0.314485451016576,810912,"280 ,   281 ,   283 ,   285  Altenative for treatment of GLANDERS   +    caused by  B MALLEI",GLANDERS,B MALLEI,TWrex-cause
788865560,9/15/2015 22:24:04,1739057490,9/15/2015 22:23:42,False,points4rewards,0.7798,20113482,USA,PA,Philadelphia,162.208.49.45,no_relation,57,84,,64,92,treats,0.314485451016576,810912,"280 ,   281 ,   283 ,   285  Altenative for treatment of GLANDERS   +    caused by  B MALLEI",GLANDERS,B MALLEI,TWrex-cause
789214458,9/16/2015 11:32:04,1739475706,9/16/2015 11:31:54,False,fusioncash,0.9194,31742806,USA,OH,Kent,66.61.82.242,PROPRANOLOL treats HYPERTENSION,98,73,,109,84,treats,0.9630868246861541,907590,"van Schaik BAM, Geyskes GG, Kettner N et al. Comparison of enalapril and PROPRANOLOL in essential HYPERTENSION",HYPERTENSION,PROPRANOLOL,RO-may_treat
789214458,9/16/2015 11:42:46,1739478428,9/16/2015 11:42:34,False,clixsense,0.8083,17950689,GBR,L9,Sheffield,146.200.192.103,HYPERTENSION treats PROPRANOLOL,98,73,,109,84,treats,0.9630868246861541,907590,"van Schaik BAM, Geyskes GG, Kettner N et al. Comparison of enalapril and PROPRANOLOL in essential HYPERTENSION",HYPERTENSION,PROPRANOLOL,RO-may_treat
789214458,9/16/2015 11:46:11,1739479290,9/16/2015 11:45:56,False,prodege,0.7014,22031444,GBR,F2,Gosport,92.24.223.243,PROPRANOLOL treats HYPERTENSION,98,73,,109,84,treats,0.9630868246861541,907590,"van Schaik BAM, Geyskes GG, Kettner N et al. Comparison of enalapril and PROPRANOLOL in essential HYPERTENSION",HYPERTENSION,PROPRANOLOL,RO-may_treat
789214458,9/16/2015 12:03:50,1739483495,9/16/2015 12:03:35,False,prodege,0.8139,27934334,GBR,C8,Croydon,81.159.60.206,PROPRANOLOL treats HYPERTENSION,98,73,,109,84,treats,0.9630868246861541,907590,"van Schaik BAM, Geyskes GG, Kettner N et al. Comparison of enalapril and PROPRANOLOL in essential HYPERTENSION",HYPERTENSION,PROPRANOLOL,RO-may_treat
789214458,9/16/2015 12:14:51,1739486159,9/16/2015 12:14:22,False,instagc,0.7488,16573689,USA,MI,Hanover,74.45.203.252,no_relation,98,73,,109,84,treats,0.9630868246861541,907590,"van Schaik BAM, Geyskes GG, Kettner N et al. Comparison of enalapril and PROPRANOLOL in essential HYPERTENSION",HYPERTENSION,PROPRANOLOL,RO-may_treat
789214458,9/16/2015 12:16:12,1739486570,9/16/2015 12:15:56,False,clixsense,0.7481,19638651,USA,SC,Summerville,174.107.73.211,PROPRANOLOL treats HYPERTENSION,98,73,,109,84,treats,0.9630868246861541,907590,"van Schaik BAM, Geyskes GG, Kettner N et al. Comparison of enalapril and PROPRANOLOL in essential HYPERTENSION",HYPERTENSION,PROPRANOLOL,RO-may_treat
789214458,9/16/2015 12:29:49,1739489575,9/16/2015 12:29:36,False,instagc,0.8397,13581319,USA,IL,Trenton,208.70.36.12,PROPRANOLOL treats HYPERTENSION,98,73,,109,84,treats,0.9630868246861541,907590,"van Schaik BAM, Geyskes GG, Kettner N et al. Comparison of enalapril and PROPRANOLOL in essential HYPERTENSION",HYPERTENSION,PROPRANOLOL,RO-may_treat
789214461,9/16/2015 09:41:50,1739444631,9/16/2015 09:38:18,False,clixsense,1.0,30681826,GBR,I9,Diss,31.49.71.254,HYPERTHERMIA treats HEPATOCELLULAR CARCINOMA,85,141,,96,165,treats,0.975900072948533,902641,This anecdotal case supports previous experimental evidence suggesting that TNF plus HYPERTHERMIA may be effective for treating unresectable HEPATOCELLULAR CARCINOMA,HYPERTHERMIA,HEPATOCELLULAR CARCINOMA,RO-disease_may_have_finding
789214461,9/16/2015 09:44:55,1739445278,9/16/2015 09:44:42,False,instagc,0.9583,18960682,GBR,U2,Annan,92.18.213.181,HYPERTHERMIA treats HEPATOCELLULAR CARCINOMA,85,141,,96,165,treats,0.975900072948533,902641,This anecdotal case supports previous experimental evidence suggesting that TNF plus HYPERTHERMIA may be effective for treating unresectable HEPATOCELLULAR CARCINOMA,HYPERTHERMIA,HEPATOCELLULAR CARCINOMA,RO-disease_may_have_finding
789214461,9/16/2015 09:52:23,1739447176,9/16/2015 09:51:54,False,gifthulk,0.9722,24928180,GBR,M1,Slough,90.206.237.191,HYPERTHERMIA treats HEPATOCELLULAR CARCINOMA,85,141,,96,165,treats,0.975900072948533,902641,This anecdotal case supports previous experimental evidence suggesting that TNF plus HYPERTHERMIA may be effective for treating unresectable HEPATOCELLULAR CARCINOMA,HYPERTHERMIA,HEPATOCELLULAR CARCINOMA,RO-disease_may_have_finding
789214461,9/16/2015 09:54:25,1739447780,9/16/2015 09:54:07,False,neodev,0.6667,14096345,NLD,03,Eibergen,178.85.94.186,HYPERTHERMIA treats HEPATOCELLULAR CARCINOMA,85,141,,96,165,treats,0.975900072948533,902641,This anecdotal case supports previous experimental evidence suggesting that TNF plus HYPERTHERMIA may be effective for treating unresectable HEPATOCELLULAR CARCINOMA,HYPERTHERMIA,HEPATOCELLULAR CARCINOMA,RO-disease_may_have_finding
789214461,9/16/2015 09:54:32,1739447820,9/16/2015 09:54:09,False,meprizescf,0.8167,28483210,USA,WI,Minocqua,75.143.134.247,HYPERTHERMIA treats HEPATOCELLULAR CARCINOMA,85,141,,96,165,treats,0.975900072948533,902641,This anecdotal case supports previous experimental evidence suggesting that TNF plus HYPERTHERMIA may be effective for treating unresectable HEPATOCELLULAR CARCINOMA,HYPERTHERMIA,HEPATOCELLULAR CARCINOMA,RO-disease_may_have_finding
789214461,9/16/2015 10:07:41,1739452055,9/16/2015 10:06:00,False,neodev,0.6746,31988911,USA,CA,Saratoga,107.178.37.2,HYPERTHERMIA treats HEPATOCELLULAR CARCINOMA,85,141,,96,165,treats,0.975900072948533,902641,This anecdotal case supports previous experimental evidence suggesting that TNF plus HYPERTHERMIA may be effective for treating unresectable HEPATOCELLULAR CARCINOMA,HYPERTHERMIA,HEPATOCELLULAR CARCINOMA,RO-disease_may_have_finding
789214461,9/16/2015 10:13:29,1739453692,9/16/2015 10:11:53,False,pocketmoneygpt,0.9643,21432964,GBR,F8,Borehamwood,81.159.185.70,HYPERTHERMIA treats HEPATOCELLULAR CARCINOMA,85,141,,96,165,treats,0.975900072948533,902641,This anecdotal case supports previous experimental evidence suggesting that TNF plus HYPERTHERMIA may be effective for treating unresectable HEPATOCELLULAR CARCINOMA,HYPERTHERMIA,HEPATOCELLULAR CARCINOMA,RO-disease_may_have_finding
789214464,9/16/2015 18:00:15,1739639054,9/16/2015 17:59:42,False,prodege,0.8929,13300986,CAN,AB,Edmonton,68.150.40.134,SOTALOL treats SVT,0,89,,2,96,treats,0.986393923832144,805021,SVT that does not involve the AV node may respond to other anti arrhythmic drugs such as SOTALOL or amiodarone.,SVT,SOTALOL,TWrex-cause
789214464,9/16/2015 18:17:29,1739665842,9/16/2015 18:16:12,False,elite,0.875,31883685,GBR,,,79.66.244.188,SVT treats SOTALOL,0,89,,2,96,treats,0.986393923832144,805021,SVT that does not involve the AV node may respond to other anti arrhythmic drugs such as SOTALOL or amiodarone.,SVT,SOTALOL,TWrex-cause
789214464,9/16/2015 18:24:54,1739680870,9/16/2015 18:23:58,False,prodege,0.8383,21417560,GBR,C3,Cambridge,151.224.120.191,SOTALOL treats SVT,0,89,,2,96,treats,0.986393923832144,805021,SVT that does not involve the AV node may respond to other anti arrhythmic drugs such as SOTALOL or amiodarone.,SVT,SOTALOL,TWrex-cause
789214464,9/16/2015 18:28:51,1739689632,9/16/2015 18:27:46,False,prodege,0.7438,1924522,USA,NY,New York,96.224.4.120,SOTALOL treats SVT,0,89,,2,96,treats,0.986393923832144,805021,SVT that does not involve the AV node may respond to other anti arrhythmic drugs such as SOTALOL or amiodarone.,SVT,SOTALOL,TWrex-cause
789214464,9/16/2015 18:54:38,1739753561,9/16/2015 18:53:30,False,clixsense,0.769,33878524,CAN,BC,Princeton,75.156.83.71,SOTALOL treats SVT,0,89,,2,96,treats,0.986393923832144,805021,SVT that does not involve the AV node may respond to other anti arrhythmic drugs such as SOTALOL or amiodarone.,SVT,SOTALOL,TWrex-cause
789214464,9/16/2015 19:07:40,1739773585,9/16/2015 19:06:53,False,neodev,0.7040000000000001,11026968,CAN,ON,Ottawa,108.168.124.170,no_relation,0,89,,2,96,treats,0.986393923832144,805021,SVT that does not involve the AV node may respond to other anti arrhythmic drugs such as SOTALOL or amiodarone.,SVT,SOTALOL,TWrex-cause
789214464,9/16/2015 19:27:43,1739783444,9/16/2015 19:27:18,False,clixsense,0.8036,23197581,NLD,11,Den Haag,82.217.6.160,SOTALOL treats SVT,0,89,,2,96,treats,0.986393923832144,805021,SVT that does not involve the AV node may respond to other anti arrhythmic drugs such as SOTALOL or amiodarone.,SVT,SOTALOL,TWrex-cause
789214471,9/16/2015 14:01:53,1739520851,9/16/2015 14:01:36,False,clixsense,0.8393,6340330,USA,NY,Canajoharie,67.248.115.74,BUPRENORPHINE HYDROCHLORIDE treats POST OPERATIVE PAIN,93,61,,111,88,treats,0.753778361444409,800578,"Dobkin AB, Esposito B, Philbin C. Double blind evaluation of BUPRENORPHINE HYDROCHLORIDE for POST OPERATIVE PAIN",POST OPERATIVE PAIN,BUPRENORPHINE HYDROCHLORIDE,TWrex-cause
789214471,9/16/2015 14:17:18,1739526264,9/16/2015 14:16:24,False,gifthulk,0.8833,18666417,USA,PA,Meadville,24.101.32.13,BUPRENORPHINE HYDROCHLORIDE treats POST OPERATIVE PAIN,93,61,,111,88,treats,0.753778361444409,800578,"Dobkin AB, Esposito B, Philbin C. Double blind evaluation of BUPRENORPHINE HYDROCHLORIDE for POST OPERATIVE PAIN",POST OPERATIVE PAIN,BUPRENORPHINE HYDROCHLORIDE,TWrex-cause
789214471,9/16/2015 14:20:53,1739527574,9/16/2015 14:20:40,False,points4rewards,0.7119,20306700,USA,WA,Bothell,50.106.46.70,BUPRENORPHINE HYDROCHLORIDE treats POST OPERATIVE PAIN,93,61,,111,88,treats,0.753778361444409,800578,"Dobkin AB, Esposito B, Philbin C. Double blind evaluation of BUPRENORPHINE HYDROCHLORIDE for POST OPERATIVE PAIN",POST OPERATIVE PAIN,BUPRENORPHINE HYDROCHLORIDE,TWrex-cause
789214471,9/16/2015 14:29:54,1739530703,9/16/2015 14:29:45,False,onestopgpt,0.8333,21275875,CAN,ON,Hamilton,24.36.124.79,BUPRENORPHINE HYDROCHLORIDE treats POST OPERATIVE PAIN,93,61,,111,88,treats,0.753778361444409,800578,"Dobkin AB, Esposito B, Philbin C. Double blind evaluation of BUPRENORPHINE HYDROCHLORIDE for POST OPERATIVE PAIN",POST OPERATIVE PAIN,BUPRENORPHINE HYDROCHLORIDE,TWrex-cause
789214471,9/16/2015 14:35:18,1739532678,9/16/2015 14:34:49,False,points4rewards,0.7123,28755767,USA,VA,Chester,68.57.118.32,BUPRENORPHINE HYDROCHLORIDE treats POST OPERATIVE PAIN,93,61,,111,88,treats,0.753778361444409,800578,"Dobkin AB, Esposito B, Philbin C. Double blind evaluation of BUPRENORPHINE HYDROCHLORIDE for POST OPERATIVE PAIN",POST OPERATIVE PAIN,BUPRENORPHINE HYDROCHLORIDE,TWrex-cause
789214471,9/16/2015 14:38:53,1739534042,9/16/2015 14:37:53,False,neodev,0.8095,18881135,CAN,ON,Ajax,99.243.87.224,BUPRENORPHINE HYDROCHLORIDE treats POST OPERATIVE PAIN,93,61,,111,88,treats,0.753778361444409,800578,"Dobkin AB, Esposito B, Philbin C. Double blind evaluation of BUPRENORPHINE HYDROCHLORIDE for POST OPERATIVE PAIN",POST OPERATIVE PAIN,BUPRENORPHINE HYDROCHLORIDE,TWrex-cause
789214471,9/16/2015 14:43:10,1739535714,9/16/2015 14:43:02,False,neodev,0.1429,11291592,USA,MI,Taylor,99.170.106.105,no_relation,93,61,,111,88,treats,0.753778361444409,800578,"Dobkin AB, Esposito B, Philbin C. Double blind evaluation of BUPRENORPHINE HYDROCHLORIDE for POST OPERATIVE PAIN",POST OPERATIVE PAIN,BUPRENORPHINE HYDROCHLORIDE,TWrex-cause
789214476,9/16/2015 10:14:42,1739454084,9/16/2015 10:14:19,False,neodev,1.0,20306047,GBR,,,80.41.0.252,DIMETHYLGLYCINE treats AUTISTIC BEHAVIOR,61,0,,78,15,treats,0.997458699830735,205470,"[DIMETHYLGLYCINE] is hypothesized to improve speech and reduce [AUTISTIC BEHAVIOR]s, and is a commonly used supplement.",AUTISTIC BEHAVIOR,DIMETHYLGLYCINE,TWrex-treat
789214476,9/16/2015 10:15:57,1739454587,9/16/2015 10:15:20,False,neodev,0.9167,30627835,GBR,D8,Bishop Auckland,217.44.84.223,DIMETHYLGLYCINE treats AUTISTIC BEHAVIOR,61,0,,78,15,treats,0.997458699830735,205470,"[DIMETHYLGLYCINE] is hypothesized to improve speech and reduce [AUTISTIC BEHAVIOR]s, and is a commonly used supplement.",AUTISTIC BEHAVIOR,DIMETHYLGLYCINE,TWrex-treat
789214476,9/16/2015 10:18:07,1739455384,9/16/2015 10:17:30,False,pocketmoneygpt,0.9643,21432964,GBR,F8,Borehamwood,81.159.185.70,DIMETHYLGLYCINE treats AUTISTIC BEHAVIOR,61,0,,78,15,treats,0.997458699830735,205470,"[DIMETHYLGLYCINE] is hypothesized to improve speech and reduce [AUTISTIC BEHAVIOR]s, and is a commonly used supplement.",AUTISTIC BEHAVIOR,DIMETHYLGLYCINE,TWrex-treat
789214476,9/16/2015 10:43:44,1739462675,9/16/2015 10:42:48,False,neodev,0.8806,33758777,USA,,,38.95.108.251,DIMETHYLGLYCINE treats AUTISTIC BEHAVIOR,61,0,,78,15,treats,0.997458699830735,205470,"[DIMETHYLGLYCINE] is hypothesized to improve speech and reduce [AUTISTIC BEHAVIOR]s, and is a commonly used supplement.",AUTISTIC BEHAVIOR,DIMETHYLGLYCINE,TWrex-treat
789214476,9/16/2015 10:45:02,1739463096,9/16/2015 10:44:26,False,neodev,0.9083,33644825,USA,FL,Fort Lauderdale,65.111.173.161,DIMETHYLGLYCINE treats AUTISTIC BEHAVIOR,61,0,,78,15,treats,0.997458699830735,205470,"[DIMETHYLGLYCINE] is hypothesized to improve speech and reduce [AUTISTIC BEHAVIOR]s, and is a commonly used supplement.",AUTISTIC BEHAVIOR,DIMETHYLGLYCINE,TWrex-treat
789214476,9/16/2015 10:50:15,1739464687,9/16/2015 10:46:57,False,neodev,0.5167,30581619,USA,CA,Laguna Niguel,216.177.129.147,DIMETHYLGLYCINE treats AUTISTIC BEHAVIOR,61,0,,78,15,treats,0.997458699830735,205470,"[DIMETHYLGLYCINE] is hypothesized to improve speech and reduce [AUTISTIC BEHAVIOR]s, and is a commonly used supplement.",AUTISTIC BEHAVIOR,DIMETHYLGLYCINE,TWrex-treat
789214476,9/16/2015 11:01:04,1739468051,9/16/2015 11:00:52,False,elite,0.4385,34356654,USA,DE,,108.59.11.227,no_relation,61,0,,78,15,treats,0.997458699830735,205470,"[DIMETHYLGLYCINE] is hypothesized to improve speech and reduce [AUTISTIC BEHAVIOR]s, and is a commonly used supplement.",AUTISTIC BEHAVIOR,DIMETHYLGLYCINE,TWrex-treat
789214479,9/16/2015 11:31:53,1739475673,9/16/2015 11:31:42,False,fusioncash,0.9194,31742806,USA,OH,Kent,66.61.82.242,LOSARTAN treats HYPERTENSION,84,166,,95,174,treats,0.9701425001453321,804786,"• The LIFE study prospectively randomized >9000 patients 55 to 80 years of age with HYPERTENSION and left ventricular hypertrophy to the angiotensin receptor blocker LOSARTAN or the β blocker atenolol, with additional therapy using a diuretic of a calcium channel blocker as needed to control BP.",HYPERTENSION,LOSARTAN,TWrex-cause
789214479,9/16/2015 11:42:33,1739478373,9/16/2015 11:34:57,False,clixsense,0.8083,17950689,GBR,L9,Sheffield,146.200.192.103,LOSARTAN treats HYPERTENSION,84,166,,95,174,treats,0.9701425001453321,804786,"• The LIFE study prospectively randomized >9000 patients 55 to 80 years of age with HYPERTENSION and left ventricular hypertrophy to the angiotensin receptor blocker LOSARTAN or the β blocker atenolol, with additional therapy using a diuretic of a calcium channel blocker as needed to control BP.",HYPERTENSION,LOSARTAN,TWrex-cause
789214479,9/16/2015 11:45:55,1739479201,9/16/2015 11:45:40,False,prodege,0.7014,22031444,GBR,F2,Gosport,92.24.223.243,no_relation,84,166,,95,174,treats,0.9701425001453321,804786,"• The LIFE study prospectively randomized >9000 patients 55 to 80 years of age with HYPERTENSION and left ventricular hypertrophy to the angiotensin receptor blocker LOSARTAN or the β blocker atenolol, with additional therapy using a diuretic of a calcium channel blocker as needed to control BP.",HYPERTENSION,LOSARTAN,TWrex-cause
789214479,9/16/2015 11:50:56,1739480465,9/16/2015 11:50:47,False,zoombucks,0.7833,4711962,CAN,ON,Markham,174.88.29.138,LOSARTAN treats HYPERTENSION,84,166,,95,174,treats,0.9701425001453321,804786,"• The LIFE study prospectively randomized >9000 patients 55 to 80 years of age with HYPERTENSION and left ventricular hypertrophy to the angiotensin receptor blocker LOSARTAN or the β blocker atenolol, with additional therapy using a diuretic of a calcium channel blocker as needed to control BP.",HYPERTENSION,LOSARTAN,TWrex-cause
789214479,9/16/2015 12:03:34,1739483448,9/16/2015 12:02:57,False,prodege,0.8139,27934334,GBR,C8,Croydon,81.159.60.206,LOSARTAN treats HYPERTENSION,84,166,,95,174,treats,0.9701425001453321,804786,"• The LIFE study prospectively randomized >9000 patients 55 to 80 years of age with HYPERTENSION and left ventricular hypertrophy to the angiotensin receptor blocker LOSARTAN or the β blocker atenolol, with additional therapy using a diuretic of a calcium channel blocker as needed to control BP.",HYPERTENSION,LOSARTAN,TWrex-cause
789214479,9/16/2015 12:14:21,1739486023,9/16/2015 12:13:14,False,instagc,0.7488,16573689,USA,MI,Hanover,74.45.203.252,LOSARTAN treats HYPERTENSION,84,166,,95,174,treats,0.9701425001453321,804786,"• The LIFE study prospectively randomized >9000 patients 55 to 80 years of age with HYPERTENSION and left ventricular hypertrophy to the angiotensin receptor blocker LOSARTAN or the β blocker atenolol, with additional therapy using a diuretic of a calcium channel blocker as needed to control BP.",HYPERTENSION,LOSARTAN,TWrex-cause
789214479,9/16/2015 12:15:54,1739486508,9/16/2015 12:12:54,False,clixsense,0.7481,19638651,USA,SC,Summerville,174.107.73.211,LOSARTAN treats HYPERTENSION,84,166,,95,174,treats,0.9701425001453321,804786,"• The LIFE study prospectively randomized >9000 patients 55 to 80 years of age with HYPERTENSION and left ventricular hypertrophy to the angiotensin receptor blocker LOSARTAN or the β blocker atenolol, with additional therapy using a diuretic of a calcium channel blocker as needed to control BP.",HYPERTENSION,LOSARTAN,TWrex-cause
789214481,9/16/2015 11:05:14,1739469291,9/16/2015 11:05:02,False,clixsense,0.9048,24104564,AUS,02,Surry Hills,60.241.245.92,ORAL TERBINAFINE treats TINEA CAPITIS,135,53,,147,69,treats,0.994936676326182,803524,"55 ,   61 ,   62 ,   63 ,   65 ,   68 ,   75 ,   77  ORAL TERBINAFINE appears to be as effective as oral griseofulvin for treatment of TINEA CAPITIS caused by  Trichophyton , and requires a shorter duration of treatment which may increase compliance.",TINEA CAPITIS,ORAL TERBINAFINE,TWrex-cause
789214481,9/16/2015 11:10:01,1739470391,9/16/2015 11:09:25,False,clixsense,0.875,32053717,GBR,,,51.174.76.80,ORAL TERBINAFINE treats TINEA CAPITIS,135,53,,147,69,treats,0.994936676326182,803524,"55 ,   61 ,   62 ,   63 ,   65 ,   68 ,   75 ,   77  ORAL TERBINAFINE appears to be as effective as oral griseofulvin for treatment of TINEA CAPITIS caused by  Trichophyton , and requires a shorter duration of treatment which may increase compliance.",TINEA CAPITIS,ORAL TERBINAFINE,TWrex-cause
789214481,9/16/2015 11:19:47,1739473069,9/16/2015 11:19:22,False,bitcoinget,0.9083,31256687,USA,NY,Brooklyn,24.146.181.193,ORAL TERBINAFINE treats TINEA CAPITIS,135,53,,147,69,treats,0.994936676326182,803524,"55 ,   61 ,   62 ,   63 ,   65 ,   68 ,   75 ,   77  ORAL TERBINAFINE appears to be as effective as oral griseofulvin for treatment of TINEA CAPITIS caused by  Trichophyton , and requires a shorter duration of treatment which may increase compliance.",TINEA CAPITIS,ORAL TERBINAFINE,TWrex-cause
789214481,9/16/2015 11:20:35,1739473329,9/16/2015 11:20:14,False,neodev,0.8264,31326282,NLD,,,82.169.243.65,ORAL TERBINAFINE treats TINEA CAPITIS,135,53,,147,69,treats,0.994936676326182,803524,"55 ,   61 ,   62 ,   63 ,   65 ,   68 ,   75 ,   77  ORAL TERBINAFINE appears to be as effective as oral griseofulvin for treatment of TINEA CAPITIS caused by  Trichophyton , and requires a shorter duration of treatment which may increase compliance.",TINEA CAPITIS,ORAL TERBINAFINE,TWrex-cause
789214481,9/16/2015 11:26:49,1739474458,9/16/2015 11:26:27,False,keeprewarding,0.8204,29139615,CAN,ON,Perth,192.186.81.178,ORAL TERBINAFINE treats TINEA CAPITIS,135,53,,147,69,treats,0.994936676326182,803524,"55 ,   61 ,   62 ,   63 ,   65 ,   68 ,   75 ,   77  ORAL TERBINAFINE appears to be as effective as oral griseofulvin for treatment of TINEA CAPITIS caused by  Trichophyton , and requires a shorter duration of treatment which may increase compliance.",TINEA CAPITIS,ORAL TERBINAFINE,TWrex-cause
789214481,9/16/2015 11:27:11,1739474578,9/16/2015 11:26:56,False,elite,0.5833,33798502,USA,DE,,108.59.8.208,TINEA CAPITIS treats ORAL TERBINAFINE,135,53,,147,69,treats,0.994936676326182,803524,"55 ,   61 ,   62 ,   63 ,   65 ,   68 ,   75 ,   77  ORAL TERBINAFINE appears to be as effective as oral griseofulvin for treatment of TINEA CAPITIS caused by  Trichophyton , and requires a shorter duration of treatment which may increase compliance.",TINEA CAPITIS,ORAL TERBINAFINE,TWrex-cause
789214481,9/16/2015 11:27:53,1739474782,9/16/2015 11:26:53,False,gifthunterclub,0.8694,24043308,GBR,,,94.102.147.250,ORAL TERBINAFINE treats TINEA CAPITIS,135,53,,147,69,treats,0.994936676326182,803524,"55 ,   61 ,   62 ,   63 ,   65 ,   68 ,   75 ,   77  ORAL TERBINAFINE appears to be as effective as oral griseofulvin for treatment of TINEA CAPITIS caused by  Trichophyton , and requires a shorter duration of treatment which may increase compliance.",TINEA CAPITIS,ORAL TERBINAFINE,TWrex-cause
789214492,9/16/2015 09:38:17,1739443707,9/16/2015 09:37:29,False,clixsense,1.0,30681826,GBR,I9,Diss,31.49.71.254,AMPHOTERICIN B treats PRESUMPTIVE BLASTOMYCOSIS,272,43,,296,57,treats,0.9970544855015809,800204,"36 ,   49 ,   50 ,   51 ,   52 ,   436  IV AMPHOTERICIN B is preferred for initial treatment of severe blastomycosis, especially infections involving the CNS  51 ,   52 ,   55 ,   56 ,   50 ,   51 ,   52 ,   53 ,   54 ,   61 ,   424 ,   436   and for initial treatment of PRESUMPTIVE BLASTOMYCOSIS in immunocompromised patients, including HIV infected individuals.",PRESUMPTIVE BLASTOMYCOSIS,AMPHOTERICIN B,TWrex-cause
789214492,9/16/2015 09:44:40,1739445216,9/16/2015 09:44:27,False,instagc,0.9583,18960682,GBR,U2,Annan,92.18.213.181,AMPHOTERICIN B treats PRESUMPTIVE BLASTOMYCOSIS,272,43,,296,57,treats,0.9970544855015809,800204,"36 ,   49 ,   50 ,   51 ,   52 ,   436  IV AMPHOTERICIN B is preferred for initial treatment of severe blastomycosis, especially infections involving the CNS  51 ,   52 ,   55 ,   56 ,   50 ,   51 ,   52 ,   53 ,   54 ,   61 ,   424 ,   436   and for initial treatment of PRESUMPTIVE BLASTOMYCOSIS in immunocompromised patients, including HIV infected individuals.",PRESUMPTIVE BLASTOMYCOSIS,AMPHOTERICIN B,TWrex-cause
789214492,9/16/2015 09:51:53,1739446974,9/16/2015 09:50:51,False,gifthulk,0.9722,24928180,GBR,M1,Slough,90.206.237.191,AMPHOTERICIN B treats PRESUMPTIVE BLASTOMYCOSIS,272,43,,296,57,treats,0.9970544855015809,800204,"36 ,   49 ,   50 ,   51 ,   52 ,   436  IV AMPHOTERICIN B is preferred for initial treatment of severe blastomycosis, especially infections involving the CNS  51 ,   52 ,   55 ,   56 ,   50 ,   51 ,   52 ,   53 ,   54 ,   61 ,   424 ,   436   and for initial treatment of PRESUMPTIVE BLASTOMYCOSIS in immunocompromised patients, including HIV infected individuals.",PRESUMPTIVE BLASTOMYCOSIS,AMPHOTERICIN B,TWrex-cause
789214492,9/16/2015 09:54:06,1739447676,9/16/2015 09:53:52,False,neodev,0.6667,14096345,NLD,03,Eibergen,178.85.94.186,AMPHOTERICIN B treats PRESUMPTIVE BLASTOMYCOSIS,272,43,,296,57,treats,0.9970544855015809,800204,"36 ,   49 ,   50 ,   51 ,   52 ,   436  IV AMPHOTERICIN B is preferred for initial treatment of severe blastomycosis, especially infections involving the CNS  51 ,   52 ,   55 ,   56 ,   50 ,   51 ,   52 ,   53 ,   54 ,   61 ,   424 ,   436   and for initial treatment of PRESUMPTIVE BLASTOMYCOSIS in immunocompromised patients, including HIV infected individuals.",PRESUMPTIVE BLASTOMYCOSIS,AMPHOTERICIN B,TWrex-cause
789214492,9/16/2015 09:54:08,1739447687,9/16/2015 09:53:45,False,meprizescf,0.8167,28483210,USA,WI,Minocqua,75.143.134.247,AMPHOTERICIN B treats PRESUMPTIVE BLASTOMYCOSIS,272,43,,296,57,treats,0.9970544855015809,800204,"36 ,   49 ,   50 ,   51 ,   52 ,   436  IV AMPHOTERICIN B is preferred for initial treatment of severe blastomycosis, especially infections involving the CNS  51 ,   52 ,   55 ,   56 ,   50 ,   51 ,   52 ,   53 ,   54 ,   61 ,   424 ,   436   and for initial treatment of PRESUMPTIVE BLASTOMYCOSIS in immunocompromised patients, including HIV infected individuals.",PRESUMPTIVE BLASTOMYCOSIS,AMPHOTERICIN B,TWrex-cause
789214492,9/16/2015 10:05:59,1739451523,9/16/2015 10:04:57,False,neodev,0.6746,31988911,USA,CA,Saratoga,107.178.37.2,AMPHOTERICIN B treats PRESUMPTIVE BLASTOMYCOSIS,272,43,,296,57,treats,0.9970544855015809,800204,"36 ,   49 ,   50 ,   51 ,   52 ,   436  IV AMPHOTERICIN B is preferred for initial treatment of severe blastomycosis, especially infections involving the CNS  51 ,   52 ,   55 ,   56 ,   50 ,   51 ,   52 ,   53 ,   54 ,   61 ,   424 ,   436   and for initial treatment of PRESUMPTIVE BLASTOMYCOSIS in immunocompromised patients, including HIV infected individuals.",PRESUMPTIVE BLASTOMYCOSIS,AMPHOTERICIN B,TWrex-cause
789214492,9/16/2015 10:11:51,1739453271,9/16/2015 10:11:29,False,pocketmoneygpt,0.9643,21432964,GBR,F8,Borehamwood,81.159.185.70,AMPHOTERICIN B treats PRESUMPTIVE BLASTOMYCOSIS,272,43,,296,57,treats,0.9970544855015809,800204,"36 ,   49 ,   50 ,   51 ,   52 ,   436  IV AMPHOTERICIN B is preferred for initial treatment of severe blastomycosis, especially infections involving the CNS  51 ,   52 ,   55 ,   56 ,   50 ,   51 ,   52 ,   53 ,   54 ,   61 ,   424 ,   436   and for initial treatment of PRESUMPTIVE BLASTOMYCOSIS in immunocompromised patients, including HIV infected individuals.",PRESUMPTIVE BLASTOMYCOSIS,AMPHOTERICIN B,TWrex-cause
789214498,9/16/2015 12:44:43,1739494028,9/16/2015 12:44:28,False,clixsense,0.9603,10390268,USA,NY,New Paltz,100.40.133.216,MAGNESIUM SULPHATE treats PRE ECLAMPSIA,95,59,,107,77,treats,0.948683298050514,804676,2007 03 01  The Magpie Trial: a randomised trial comparing MAGNESIUM SULPHATE with placebo for PRE ECLAMPSIA,PRE ECLAMPSIA,MAGNESIUM SULPHATE,TWrex-cause
789214498,9/16/2015 12:46:32,1739494668,9/16/2015 12:46:11,False,bitcoinget,0.9375,30546513,GBR,G6,Hull,194.42.67.50,MAGNESIUM SULPHATE treats PRE ECLAMPSIA,95,59,,107,77,treats,0.948683298050514,804676,2007 03 01  The Magpie Trial: a randomised trial comparing MAGNESIUM SULPHATE with placebo for PRE ECLAMPSIA,PRE ECLAMPSIA,MAGNESIUM SULPHATE,TWrex-cause
789214498,9/16/2015 13:26:23,1739507762,9/16/2015 13:26:00,False,clixsense,0.6944,21875134,GBR,,,80.189.12.98,MAGNESIUM SULPHATE treats PRE ECLAMPSIA,95,59,,107,77,treats,0.948683298050514,804676,2007 03 01  The Magpie Trial: a randomised trial comparing MAGNESIUM SULPHATE with placebo for PRE ECLAMPSIA,PRE ECLAMPSIA,MAGNESIUM SULPHATE,TWrex-cause
789214498,9/16/2015 13:39:25,1739513776,9/16/2015 13:38:50,False,neodev,0.7657,30588889,NLD,07,Amsterdam,77.248.175.222,MAGNESIUM SULPHATE treats PRE ECLAMPSIA,95,59,,107,77,treats,0.948683298050514,804676,2007 03 01  The Magpie Trial: a randomised trial comparing MAGNESIUM SULPHATE with placebo for PRE ECLAMPSIA,PRE ECLAMPSIA,MAGNESIUM SULPHATE,TWrex-cause
789214498,9/16/2015 13:53:06,1739517916,9/16/2015 13:52:46,False,clixsense,0.8809999999999999,9001027,CAN,QC,Dollard-des-ormeaux,96.21.122.219,MAGNESIUM SULPHATE treats PRE ECLAMPSIA,95,59,,107,77,treats,0.948683298050514,804676,2007 03 01  The Magpie Trial: a randomised trial comparing MAGNESIUM SULPHATE with placebo for PRE ECLAMPSIA,PRE ECLAMPSIA,MAGNESIUM SULPHATE,TWrex-cause
789214498,9/16/2015 13:59:03,1739519953,9/16/2015 13:58:15,False,clixsense,0.8393,6340330,USA,NY,Canajoharie,67.248.115.74,no_relation,95,59,,107,77,treats,0.948683298050514,804676,2007 03 01  The Magpie Trial: a randomised trial comparing MAGNESIUM SULPHATE with placebo for PRE ECLAMPSIA,PRE ECLAMPSIA,MAGNESIUM SULPHATE,TWrex-cause
789214498,9/16/2015 14:10:18,1739523925,9/16/2015 14:09:56,False,points4rewards,0.7119,20306700,USA,WA,Bothell,50.106.46.70,no_relation,95,59,,107,77,treats,0.948683298050514,804676,2007 03 01  The Magpie Trial: a randomised trial comparing MAGNESIUM SULPHATE with placebo for PRE ECLAMPSIA,PRE ECLAMPSIA,MAGNESIUM SULPHATE,TWrex-cause
789214503,9/16/2015 10:13:30,1739453693,9/16/2015 10:13:10,False,neodev,1.0,20306047,GBR,,,80.41.0.252,no_relation,35,101,,56,123,treats,0.583459965991578,811389,"Prevention of Seasonal Influenza A AND B VIRUS INFECTIONS  Prevention of illness caused by influenza A OR B VIRUS IN ADULTS adolescents, and children ≥1 year of age.",AND B VIRUS INFECTIONS,A OR B VIRUS IN ADULTS,TWrex-cause
789214503,9/16/2015 10:13:56,1739453805,9/16/2015 10:13:24,False,neodev,0.9167,30627835,GBR,D8,Bishop Auckland,217.44.84.223,no_relation,35,101,,56,123,treats,0.583459965991578,811389,"Prevention of Seasonal Influenza A AND B VIRUS INFECTIONS  Prevention of illness caused by influenza A OR B VIRUS IN ADULTS adolescents, and children ≥1 year of age.",AND B VIRUS INFECTIONS,A OR B VIRUS IN ADULTS,TWrex-cause
789214503,9/16/2015 10:14:46,1739454125,9/16/2015 10:13:30,False,pocketmoneygpt,0.9643,21432964,GBR,F8,Borehamwood,81.159.185.70,no_relation,35,101,,56,123,treats,0.583459965991578,811389,"Prevention of Seasonal Influenza A AND B VIRUS INFECTIONS  Prevention of illness caused by influenza A OR B VIRUS IN ADULTS adolescents, and children ≥1 year of age.",AND B VIRUS INFECTIONS,A OR B VIRUS IN ADULTS,TWrex-cause
789214503,9/16/2015 10:20:27,1739456000,9/16/2015 10:19:41,False,neodev,0.7657,30588889,NLD,07,Amsterdam,77.248.175.222,no_relation,35,101,,56,123,treats,0.583459965991578,811389,"Prevention of Seasonal Influenza A AND B VIRUS INFECTIONS  Prevention of illness caused by influenza A OR B VIRUS IN ADULTS adolescents, and children ≥1 year of age.",AND B VIRUS INFECTIONS,A OR B VIRUS IN ADULTS,TWrex-cause
789214503,9/16/2015 10:35:40,1739460491,9/16/2015 10:33:49,False,gifthunterclub,0.7,30884086,AUS,04,,118.208.145.92,no_relation,35,101,,56,123,treats,0.583459965991578,811389,"Prevention of Seasonal Influenza A AND B VIRUS INFECTIONS  Prevention of illness caused by influenza A OR B VIRUS IN ADULTS adolescents, and children ≥1 year of age.",AND B VIRUS INFECTIONS,A OR B VIRUS IN ADULTS,TWrex-cause
789214503,9/16/2015 10:41:38,1739462146,9/16/2015 10:40:45,False,neodev,0.8806,33758777,USA,,,38.95.108.251,no_relation,35,101,,56,123,treats,0.583459965991578,811389,"Prevention of Seasonal Influenza A AND B VIRUS INFECTIONS  Prevention of illness caused by influenza A OR B VIRUS IN ADULTS adolescents, and children ≥1 year of age.",AND B VIRUS INFECTIONS,A OR B VIRUS IN ADULTS,TWrex-cause
789214503,9/16/2015 11:00:15,1739467756,9/16/2015 10:59:46,False,elite,0.4385,34356654,USA,DE,,108.59.11.227,AND B VIRUS INFECTIONS treats A OR B VIRUS IN ADULTS,35,101,,56,123,treats,0.583459965991578,811389,"Prevention of Seasonal Influenza A AND B VIRUS INFECTIONS  Prevention of illness caused by influenza A OR B VIRUS IN ADULTS adolescents, and children ≥1 year of age.",AND B VIRUS INFECTIONS,A OR B VIRUS IN ADULTS,TWrex-cause
789214511,9/16/2015 10:13:30,1739453689,9/16/2015 10:13:10,False,neodev,1.0,20306047,GBR,,,80.41.0.252,TOPIRAMATE treats DIABETIC NEUROPATHY,35,0,,54,10,treats,0.737209780774486,216955,"[TOPIRAMATE] has not been studied in [DIABETIC NEUROPATHY], but has the beneficial side effect of causing mild anorexia and weight loss, and is anecdotally beneficial.",DIABETIC NEUROPATHY,TOPIRAMATE,TWrex-treat
789214511,9/16/2015 10:13:56,1739453801,9/16/2015 10:13:24,False,neodev,0.9167,30627835,GBR,D8,Bishop Auckland,217.44.84.223,TOPIRAMATE treats DIABETIC NEUROPATHY,35,0,,54,10,treats,0.737209780774486,216955,"[TOPIRAMATE] has not been studied in [DIABETIC NEUROPATHY], but has the beneficial side effect of causing mild anorexia and weight loss, and is anecdotally beneficial.",DIABETIC NEUROPATHY,TOPIRAMATE,TWrex-treat
789214511,9/16/2015 10:14:46,1739454115,9/16/2015 10:13:30,False,pocketmoneygpt,0.9643,21432964,GBR,F8,Borehamwood,81.159.185.70,TOPIRAMATE treats DIABETIC NEUROPATHY,35,0,,54,10,treats,0.737209780774486,216955,"[TOPIRAMATE] has not been studied in [DIABETIC NEUROPATHY], but has the beneficial side effect of causing mild anorexia and weight loss, and is anecdotally beneficial.",DIABETIC NEUROPATHY,TOPIRAMATE,TWrex-treat
789214511,9/16/2015 10:20:27,1739456004,9/16/2015 10:19:41,False,neodev,0.7657,30588889,NLD,07,Amsterdam,77.248.175.222,no_relation,35,0,,54,10,treats,0.737209780774486,216955,"[TOPIRAMATE] has not been studied in [DIABETIC NEUROPATHY], but has the beneficial side effect of causing mild anorexia and weight loss, and is anecdotally beneficial.",DIABETIC NEUROPATHY,TOPIRAMATE,TWrex-treat
789214511,9/16/2015 10:35:40,1739460488,9/16/2015 10:33:49,False,gifthunterclub,0.7,30884086,AUS,04,,118.208.145.92,no_relation,35,0,,54,10,treats,0.737209780774486,216955,"[TOPIRAMATE] has not been studied in [DIABETIC NEUROPATHY], but has the beneficial side effect of causing mild anorexia and weight loss, and is anecdotally beneficial.",DIABETIC NEUROPATHY,TOPIRAMATE,TWrex-treat
789214511,9/16/2015 10:41:38,1739462147,9/16/2015 10:40:45,False,neodev,0.8806,33758777,USA,,,38.95.108.251,TOPIRAMATE treats DIABETIC NEUROPATHY,35,0,,54,10,treats,0.737209780774486,216955,"[TOPIRAMATE] has not been studied in [DIABETIC NEUROPATHY], but has the beneficial side effect of causing mild anorexia and weight loss, and is anecdotally beneficial.",DIABETIC NEUROPATHY,TOPIRAMATE,TWrex-treat
789214511,9/16/2015 11:00:15,1739467758,9/16/2015 10:59:46,False,elite,0.4385,34356654,USA,DE,,108.59.11.227,DIABETIC NEUROPATHY treats TOPIRAMATE,35,0,,54,10,treats,0.737209780774486,216955,"[TOPIRAMATE] has not been studied in [DIABETIC NEUROPATHY], but has the beneficial side effect of causing mild anorexia and weight loss, and is anecdotally beneficial.",DIABETIC NEUROPATHY,TOPIRAMATE,TWrex-treat
789214520,9/16/2015 16:19:27,1739585602,9/16/2015 16:18:47,False,points4rewards,0.9083,28703583,USA,,,184.53.32.62,DEFERIPRONE AND DEFEROXAMINE (DFO) treats MYOCARDIAL IRON OVERLOAD,134,77,,157,111,treats,0.99654575824488,907233,"Regarding iron chelation treatment, patients receiving combined therapy with DEFERIPRONE AND DEFEROXAMINE (DFO) significantly reduced MYOCARDIAL IRON OVERLOAD during the 4 yr study period, whilst patients in monotherapy with DFO showed a significant increase in LIC.",MYOCARDIAL IRON OVERLOAD,DEFERIPRONE AND DEFEROXAMINE (DFO),RO-may_prevent
789214520,9/16/2015 16:40:07,1739594743,9/16/2015 16:39:52,False,elite,0.8889,30064988,GBR,B4,Bradford,92.22.135.111,DEFERIPRONE AND DEFEROXAMINE (DFO) treats MYOCARDIAL IRON OVERLOAD,134,77,,157,111,treats,0.99654575824488,907233,"Regarding iron chelation treatment, patients receiving combined therapy with DEFERIPRONE AND DEFEROXAMINE (DFO) significantly reduced MYOCARDIAL IRON OVERLOAD during the 4 yr study period, whilst patients in monotherapy with DFO showed a significant increase in LIC.",MYOCARDIAL IRON OVERLOAD,DEFERIPRONE AND DEFEROXAMINE (DFO),RO-may_prevent
789214520,9/16/2015 17:27:16,1739617753,9/16/2015 17:26:34,False,clixsense,0.9276,20587495,CAN,NL,St. John's,142.162.227.3,DEFERIPRONE AND DEFEROXAMINE (DFO) treats MYOCARDIAL IRON OVERLOAD,134,77,,157,111,treats,0.99654575824488,907233,"Regarding iron chelation treatment, patients receiving combined therapy with DEFERIPRONE AND DEFEROXAMINE (DFO) significantly reduced MYOCARDIAL IRON OVERLOAD during the 4 yr study period, whilst patients in monotherapy with DFO showed a significant increase in LIC.",MYOCARDIAL IRON OVERLOAD,DEFERIPRONE AND DEFEROXAMINE (DFO),RO-may_prevent
789214520,9/16/2015 17:38:09,1739624326,9/16/2015 17:37:44,False,gifthunterclub,0.8792,29582088,GBR,I2,Manchester,92.19.111.82,DEFERIPRONE AND DEFEROXAMINE (DFO) treats MYOCARDIAL IRON OVERLOAD,134,77,,157,111,treats,0.99654575824488,907233,"Regarding iron chelation treatment, patients receiving combined therapy with DEFERIPRONE AND DEFEROXAMINE (DFO) significantly reduced MYOCARDIAL IRON OVERLOAD during the 4 yr study period, whilst patients in monotherapy with DFO showed a significant increase in LIC.",MYOCARDIAL IRON OVERLOAD,DEFERIPRONE AND DEFEROXAMINE (DFO),RO-may_prevent
789214520,9/16/2015 17:53:03,1739630882,9/16/2015 17:52:37,False,prodege,0.8853,6309240,USA,CA,San Diego,205.241.40.254,DEFERIPRONE AND DEFEROXAMINE (DFO) treats MYOCARDIAL IRON OVERLOAD,134,77,,157,111,treats,0.99654575824488,907233,"Regarding iron chelation treatment, patients receiving combined therapy with DEFERIPRONE AND DEFEROXAMINE (DFO) significantly reduced MYOCARDIAL IRON OVERLOAD during the 4 yr study period, whilst patients in monotherapy with DFO showed a significant increase in LIC.",MYOCARDIAL IRON OVERLOAD,DEFERIPRONE AND DEFEROXAMINE (DFO),RO-may_prevent
789214520,9/16/2015 17:58:30,1739636875,9/16/2015 17:58:08,False,prodege,0.8929,13300986,CAN,AB,Edmonton,68.150.40.134,DEFERIPRONE AND DEFEROXAMINE (DFO) treats MYOCARDIAL IRON OVERLOAD,134,77,,157,111,treats,0.99654575824488,907233,"Regarding iron chelation treatment, patients receiving combined therapy with DEFERIPRONE AND DEFEROXAMINE (DFO) significantly reduced MYOCARDIAL IRON OVERLOAD during the 4 yr study period, whilst patients in monotherapy with DFO showed a significant increase in LIC.",MYOCARDIAL IRON OVERLOAD,DEFERIPRONE AND DEFEROXAMINE (DFO),RO-may_prevent
789214520,9/16/2015 18:13:26,1739658404,9/16/2015 18:13:05,False,clixsense,0.8809999999999999,9001027,CAN,QC,Dollard-des-ormeaux,96.21.122.219,DEFERIPRONE AND DEFEROXAMINE (DFO) treats MYOCARDIAL IRON OVERLOAD,134,77,,157,111,treats,0.99654575824488,907233,"Regarding iron chelation treatment, patients receiving combined therapy with DEFERIPRONE AND DEFEROXAMINE (DFO) significantly reduced MYOCARDIAL IRON OVERLOAD during the 4 yr study period, whilst patients in monotherapy with DFO showed a significant increase in LIC.",MYOCARDIAL IRON OVERLOAD,DEFERIPRONE AND DEFEROXAMINE (DFO),RO-may_prevent
789214532,9/16/2015 09:36:13,1739443143,9/16/2015 09:35:28,False,clixsense,1.0,30681826,GBR,I9,Diss,31.49.71.254,CHLORAMBUCIL treats CHRONIC LYMPHOCYTIC LEUKEMIA,101,65,,128,77,treats,1.0,803415,"Rai K, Peterson B, Appelbaum F, et al. Fludarabine compared with CHLORAMBUCIL as primary therapy for CHRONIC LYMPHOCYTIC LEUKEMIA",CHRONIC LYMPHOCYTIC LEUKEMIA,CHLORAMBUCIL,TWrex-cause
789214532,9/16/2015 09:44:10,1739445114,9/16/2015 09:43:55,False,instagc,0.9583,18960682,GBR,U2,Annan,92.18.213.181,CHLORAMBUCIL treats CHRONIC LYMPHOCYTIC LEUKEMIA,101,65,,128,77,treats,1.0,803415,"Rai K, Peterson B, Appelbaum F, et al. Fludarabine compared with CHLORAMBUCIL as primary therapy for CHRONIC LYMPHOCYTIC LEUKEMIA",CHRONIC LYMPHOCYTIC LEUKEMIA,CHLORAMBUCIL,TWrex-cause
789214532,9/16/2015 09:50:23,1739446591,9/16/2015 09:50:02,False,gifthulk,0.9722,24928180,GBR,M1,Slough,90.206.237.191,CHLORAMBUCIL treats CHRONIC LYMPHOCYTIC LEUKEMIA,101,65,,128,77,treats,1.0,803415,"Rai K, Peterson B, Appelbaum F, et al. Fludarabine compared with CHLORAMBUCIL as primary therapy for CHRONIC LYMPHOCYTIC LEUKEMIA",CHRONIC LYMPHOCYTIC LEUKEMIA,CHLORAMBUCIL,TWrex-cause
789214532,9/16/2015 09:53:09,1739447361,9/16/2015 09:52:48,False,meprizescf,0.8167,28483210,USA,WI,Minocqua,75.143.134.247,CHLORAMBUCIL treats CHRONIC LYMPHOCYTIC LEUKEMIA,101,65,,128,77,treats,1.0,803415,"Rai K, Peterson B, Appelbaum F, et al. Fludarabine compared with CHLORAMBUCIL as primary therapy for CHRONIC LYMPHOCYTIC LEUKEMIA",CHRONIC LYMPHOCYTIC LEUKEMIA,CHLORAMBUCIL,TWrex-cause
789214532,9/16/2015 09:53:35,1739447520,9/16/2015 09:53:25,False,neodev,0.6667,14096345,NLD,03,Eibergen,178.85.94.186,no_relation,101,65,,128,77,treats,1.0,803415,"Rai K, Peterson B, Appelbaum F, et al. Fludarabine compared with CHLORAMBUCIL as primary therapy for CHRONIC LYMPHOCYTIC LEUKEMIA",CHRONIC LYMPHOCYTIC LEUKEMIA,CHLORAMBUCIL,TWrex-cause
789214532,9/16/2015 10:03:57,1739450790,9/16/2015 10:03:20,False,neodev,0.6746,31988911,USA,CA,Saratoga,107.178.37.2,CHLORAMBUCIL treats CHRONIC LYMPHOCYTIC LEUKEMIA,101,65,,128,77,treats,1.0,803415,"Rai K, Peterson B, Appelbaum F, et al. Fludarabine compared with CHLORAMBUCIL as primary therapy for CHRONIC LYMPHOCYTIC LEUKEMIA",CHRONIC LYMPHOCYTIC LEUKEMIA,CHLORAMBUCIL,TWrex-cause
789214532,9/16/2015 10:04:10,1739450828,9/16/2015 10:03:56,False,clixsense,0.4905,19162475,GBR,P8,Trowbridge,82.33.126.30,CHLORAMBUCIL treats CHRONIC LYMPHOCYTIC LEUKEMIA,101,65,,128,77,treats,1.0,803415,"Rai K, Peterson B, Appelbaum F, et al. Fludarabine compared with CHLORAMBUCIL as primary therapy for CHRONIC LYMPHOCYTIC LEUKEMIA",CHRONIC LYMPHOCYTIC LEUKEMIA,CHLORAMBUCIL,TWrex-cause
789214540,9/16/2015 18:17:45,1739666391,9/16/2015 18:17:31,False,elite,0.875,31883685,GBR,,,79.66.244.188,WARFARIN treats STROKES,179,150,,185,158,treats,0.9615239476408229,805135,"Anticoagulation with warfarin in patients with atrial fibrillation significantly reduces the risk of stroke; in one meta analysis, patients receiving WARFARIN had a third as many STROKES as did control subjects.",STROKES,WARFARIN,TWrex-cause
789214540,9/16/2015 18:25:34,1739682324,9/16/2015 18:24:54,False,prodege,0.8383,21417560,GBR,C3,Cambridge,151.224.120.191,WARFARIN treats STROKES,179,150,,185,158,treats,0.9615239476408229,805135,"Anticoagulation with warfarin in patients with atrial fibrillation significantly reduces the risk of stroke; in one meta analysis, patients receiving WARFARIN had a third as many STROKES as did control subjects.",STROKES,WARFARIN,TWrex-cause
789214540,9/16/2015 18:29:02,1739690128,9/16/2015 18:28:53,False,prodege,0.7438,1924522,USA,NY,New York,96.224.4.120,WARFARIN treats STROKES,179,150,,185,158,treats,0.9615239476408229,805135,"Anticoagulation with warfarin in patients with atrial fibrillation significantly reduces the risk of stroke; in one meta analysis, patients receiving WARFARIN had a third as many STROKES as did control subjects.",STROKES,WARFARIN,TWrex-cause
789214540,9/16/2015 18:56:12,1739757615,9/16/2015 18:54:39,False,clixsense,0.769,33878524,CAN,BC,Princeton,75.156.83.71,no_relation,179,150,,185,158,treats,0.9615239476408229,805135,"Anticoagulation with warfarin in patients with atrial fibrillation significantly reduces the risk of stroke; in one meta analysis, patients receiving WARFARIN had a third as many STROKES as did control subjects.",STROKES,WARFARIN,TWrex-cause
789214540,9/16/2015 19:08:38,1739773951,9/16/2015 19:07:41,False,neodev,0.7040000000000001,11026968,CAN,ON,Ottawa,108.168.124.170,no_relation,179,150,,185,158,treats,0.9615239476408229,805135,"Anticoagulation with warfarin in patients with atrial fibrillation significantly reduces the risk of stroke; in one meta analysis, patients receiving WARFARIN had a third as many STROKES as did control subjects.",STROKES,WARFARIN,TWrex-cause
789214540,9/16/2015 19:28:02,1739783565,9/16/2015 19:27:44,False,clixsense,0.8036,23197581,NLD,11,Den Haag,82.217.6.160,WARFARIN treats STROKES,179,150,,185,158,treats,0.9615239476408229,805135,"Anticoagulation with warfarin in patients with atrial fibrillation significantly reduces the risk of stroke; in one meta analysis, patients receiving WARFARIN had a third as many STROKES as did control subjects.",STROKES,WARFARIN,TWrex-cause
789214540,9/16/2015 19:29:47,1739784334,9/16/2015 19:29:39,False,instagc,0.75,16469970,USA,OK,Broken Arrow,72.192.89.181,WARFARIN treats STROKES,179,150,,185,158,treats,0.9615239476408229,805135,"Anticoagulation with warfarin in patients with atrial fibrillation significantly reduces the risk of stroke; in one meta analysis, patients receiving WARFARIN had a third as many STROKES as did control subjects.",STROKES,WARFARIN,TWrex-cause
789214547,9/16/2015 18:00:15,1739639057,9/16/2015 17:59:42,False,prodege,0.8929,13300986,CAN,AB,Edmonton,68.150.40.134,[COMBINATION THERAPY] treats [INFLUENZA],155,131,,163,149,treats,0.996815278536125,206855,A 1984 study on complicated influenza had found levamisole to be an effective inducer of interferon and had recommended its use in [COMBINATION THERAPY] for [INFLUENZA].,[INFLUENZA],[COMBINATION THERAPY],TWrex-treat
789214547,9/16/2015 18:17:29,1739665838,9/16/2015 18:16:12,False,elite,0.875,31883685,GBR,,,79.66.244.188,[COMBINATION THERAPY] treats [INFLUENZA],155,131,,163,149,treats,0.996815278536125,206855,A 1984 study on complicated influenza had found levamisole to be an effective inducer of interferon and had recommended its use in [COMBINATION THERAPY] for [INFLUENZA].,[INFLUENZA],[COMBINATION THERAPY],TWrex-treat
789214547,9/16/2015 18:24:54,1739680869,9/16/2015 18:23:58,False,prodege,0.8383,21417560,GBR,C3,Cambridge,151.224.120.191,[COMBINATION THERAPY] treats [INFLUENZA],155,131,,163,149,treats,0.996815278536125,206855,A 1984 study on complicated influenza had found levamisole to be an effective inducer of interferon and had recommended its use in [COMBINATION THERAPY] for [INFLUENZA].,[INFLUENZA],[COMBINATION THERAPY],TWrex-treat
789214547,9/16/2015 18:28:51,1739689631,9/16/2015 18:27:46,False,prodege,0.7438,1924522,USA,NY,New York,96.224.4.120,[COMBINATION THERAPY] treats [INFLUENZA],155,131,,163,149,treats,0.996815278536125,206855,A 1984 study on complicated influenza had found levamisole to be an effective inducer of interferon and had recommended its use in [COMBINATION THERAPY] for [INFLUENZA].,[INFLUENZA],[COMBINATION THERAPY],TWrex-treat
789214547,9/16/2015 18:54:38,1739753595,9/16/2015 18:53:30,False,clixsense,0.769,33878524,CAN,BC,Princeton,75.156.83.71,[COMBINATION THERAPY] treats [INFLUENZA],155,131,,163,149,treats,0.996815278536125,206855,A 1984 study on complicated influenza had found levamisole to be an effective inducer of interferon and had recommended its use in [COMBINATION THERAPY] for [INFLUENZA].,[INFLUENZA],[COMBINATION THERAPY],TWrex-treat
789214547,9/16/2015 19:07:40,1739773587,9/16/2015 19:06:53,False,neodev,0.7040000000000001,11026968,CAN,ON,Ottawa,108.168.124.170,[COMBINATION THERAPY] treats [INFLUENZA],155,131,,163,149,treats,0.996815278536125,206855,A 1984 study on complicated influenza had found levamisole to be an effective inducer of interferon and had recommended its use in [COMBINATION THERAPY] for [INFLUENZA].,[INFLUENZA],[COMBINATION THERAPY],TWrex-treat
789214547,9/16/2015 19:27:43,1739783440,9/16/2015 19:27:18,False,clixsense,0.8036,23197581,NLD,11,Den Haag,82.217.6.160,[COMBINATION THERAPY] treats [INFLUENZA],155,131,,163,149,treats,0.996815278536125,206855,A 1984 study on complicated influenza had found levamisole to be an effective inducer of interferon and had recommended its use in [COMBINATION THERAPY] for [INFLUENZA].,[INFLUENZA],[COMBINATION THERAPY],TWrex-treat
789214551,9/16/2015 11:10:32,1739470485,9/16/2015 11:10:18,False,clixsense,0.875,32053717,GBR,,,51.174.76.80,PHENYTOIN treats POST-TRAUMATIC EPILEPSY,64,11,,87,20,treats,0.99654575824488,907396,The use of PHENYTOIN in headache syndromes and in prevention of POST-TRAUMATIC EPILEPSY is discussed,POST-TRAUMATIC EPILEPSY,PHENYTOIN,RO-may_prevent
789214551,9/16/2015 11:20:13,1739473228,9/16/2015 11:20:05,False,bitcoinget,0.9083,31256687,USA,NY,Brooklyn,24.146.181.193,PHENYTOIN treats POST-TRAUMATIC EPILEPSY,64,11,,87,20,treats,0.99654575824488,907396,The use of PHENYTOIN in headache syndromes and in prevention of POST-TRAUMATIC EPILEPSY is discussed,POST-TRAUMATIC EPILEPSY,PHENYTOIN,RO-may_prevent
789214551,9/16/2015 11:21:49,1739473589,9/16/2015 11:21:20,False,neodev,0.8264,31326282,NLD,,,82.169.243.65,PHENYTOIN treats POST-TRAUMATIC EPILEPSY,64,11,,87,20,treats,0.99654575824488,907396,The use of PHENYTOIN in headache syndromes and in prevention of POST-TRAUMATIC EPILEPSY is discussed,POST-TRAUMATIC EPILEPSY,PHENYTOIN,RO-may_prevent
789214551,9/16/2015 11:27:44,1739474717,9/16/2015 11:27:12,False,keeprewarding,0.8204,29139615,CAN,ON,Perth,192.186.81.178,no_relation,64,11,,87,20,treats,0.99654575824488,907396,The use of PHENYTOIN in headache syndromes and in prevention of POST-TRAUMATIC EPILEPSY is discussed,POST-TRAUMATIC EPILEPSY,PHENYTOIN,RO-may_prevent
789214551,9/16/2015 11:29:39,1739475185,9/16/2015 11:28:45,False,gifthunterclub,0.8694,24043308,GBR,,,94.102.147.250,PHENYTOIN treats POST-TRAUMATIC EPILEPSY,64,11,,87,20,treats,0.99654575824488,907396,The use of PHENYTOIN in headache syndromes and in prevention of POST-TRAUMATIC EPILEPSY is discussed,POST-TRAUMATIC EPILEPSY,PHENYTOIN,RO-may_prevent
789214551,9/16/2015 11:30:30,1739475389,9/16/2015 11:29:41,False,fusioncash,0.9194,31742806,USA,OH,Kent,66.61.82.242,PHENYTOIN treats POST-TRAUMATIC EPILEPSY,64,11,,87,20,treats,0.99654575824488,907396,The use of PHENYTOIN in headache syndromes and in prevention of POST-TRAUMATIC EPILEPSY is discussed,POST-TRAUMATIC EPILEPSY,PHENYTOIN,RO-may_prevent
789214551,9/16/2015 11:33:05,1739475966,9/16/2015 11:29:51,False,points4rewards,0.7956,20113482,USA,PA,Philadelphia,162.208.49.45,no_relation,64,11,,87,20,treats,0.99654575824488,907396,The use of PHENYTOIN in headache syndromes and in prevention of POST-TRAUMATIC EPILEPSY is discussed,POST-TRAUMATIC EPILEPSY,PHENYTOIN,RO-may_prevent
789214553,9/16/2015 15:55:39,1739574789,9/16/2015 15:55:13,False,prodege,0.9181,24945126,GBR,K8,Ilford,82.12.220.44,HYDROCORTISONE treats INFLAMMATION,158,124,,169,138,treats,0.9838699100999069,908222,Daktacort treatment induced a significant improvement of all symptoms within 1 week and was superior to both miconazole and HYDROCORTISONE in suppressing the INFLAMMATION,INFLAMMATION,HYDROCORTISONE,RO-may_treat
789214553,9/16/2015 16:16:15,1739584229,9/16/2015 16:15:52,False,points4rewards,0.9083,28703583,USA,,,184.53.32.62,HYDROCORTISONE treats INFLAMMATION,158,124,,169,138,treats,0.9838699100999069,908222,Daktacort treatment induced a significant improvement of all symptoms within 1 week and was superior to both miconazole and HYDROCORTISONE in suppressing the INFLAMMATION,INFLAMMATION,HYDROCORTISONE,RO-may_treat
789214553,9/16/2015 16:39:15,1739594339,9/16/2015 16:39:03,False,elite,0.8889,30064988,GBR,B4,Bradford,92.22.135.111,HYDROCORTISONE treats INFLAMMATION,158,124,,169,138,treats,0.9838699100999069,908222,Daktacort treatment induced a significant improvement of all symptoms within 1 week and was superior to both miconazole and HYDROCORTISONE in suppressing the INFLAMMATION,INFLAMMATION,HYDROCORTISONE,RO-may_treat
789214553,9/16/2015 16:52:18,1739600724,9/16/2015 16:52:07,False,instagc,0.8619,26024737,GBR,A9,Blackpool,92.23.159.7,HYDROCORTISONE treats INFLAMMATION,158,124,,169,138,treats,0.9838699100999069,908222,Daktacort treatment induced a significant improvement of all symptoms within 1 week and was superior to both miconazole and HYDROCORTISONE in suppressing the INFLAMMATION,INFLAMMATION,HYDROCORTISONE,RO-may_treat
789214553,9/16/2015 16:52:20,1739600730,9/16/2015 16:52:13,False,prodege,0.2,2143114,CAN,BC,Vancouver,24.85.153.181,INFLAMMATION treats HYDROCORTISONE,158,124,,169,138,treats,0.9838699100999069,908222,Daktacort treatment induced a significant improvement of all symptoms within 1 week and was superior to both miconazole and HYDROCORTISONE in suppressing the INFLAMMATION,INFLAMMATION,HYDROCORTISONE,RO-may_treat
789214553,9/16/2015 17:12:53,1739610906,9/16/2015 17:12:45,False,superrewards,0.8333,33199643,USA,WI,La Crosse,138.49.2.136,HYDROCORTISONE treats INFLAMMATION,158,124,,169,138,treats,0.9838699100999069,908222,Daktacort treatment induced a significant improvement of all symptoms within 1 week and was superior to both miconazole and HYDROCORTISONE in suppressing the INFLAMMATION,INFLAMMATION,HYDROCORTISONE,RO-may_treat
789214553,9/16/2015 17:24:23,1739615931,9/16/2015 17:23:54,False,clixsense,0.9276,20587495,CAN,NL,St. John's,142.162.227.3,HYDROCORTISONE treats INFLAMMATION,158,124,,169,138,treats,0.9838699100999069,908222,Daktacort treatment induced a significant improvement of all symptoms within 1 week and was superior to both miconazole and HYDROCORTISONE in suppressing the INFLAMMATION,INFLAMMATION,HYDROCORTISONE,RO-may_treat
789214554,9/16/2015 09:38:17,1739443708,9/16/2015 09:37:29,False,clixsense,1.0,30681826,GBR,I9,Diss,31.49.71.254,KETOPROFEN treats RHEUMATOID ARTHRITIS,130,82,,150,92,treats,1.0,907589,"El-Ghobarey AF, Rennie JAN, Hadidi T et al. A comparative trial of large doses of KETOPROFEN and indomethacin in the treatment of RHEUMATOID ARTHRITIS",RHEUMATOID ARTHRITIS,KETOPROFEN,RO-may_treat
789214554,9/16/2015 09:44:40,1739445215,9/16/2015 09:44:27,False,instagc,0.9583,18960682,GBR,U2,Annan,92.18.213.181,KETOPROFEN treats RHEUMATOID ARTHRITIS,130,82,,150,92,treats,1.0,907589,"El-Ghobarey AF, Rennie JAN, Hadidi T et al. A comparative trial of large doses of KETOPROFEN and indomethacin in the treatment of RHEUMATOID ARTHRITIS",RHEUMATOID ARTHRITIS,KETOPROFEN,RO-may_treat
789214554,9/16/2015 09:51:53,1739446964,9/16/2015 09:50:51,False,gifthulk,0.9722,24928180,GBR,M1,Slough,90.206.237.191,KETOPROFEN treats RHEUMATOID ARTHRITIS,130,82,,150,92,treats,1.0,907589,"El-Ghobarey AF, Rennie JAN, Hadidi T et al. A comparative trial of large doses of KETOPROFEN and indomethacin in the treatment of RHEUMATOID ARTHRITIS",RHEUMATOID ARTHRITIS,KETOPROFEN,RO-may_treat
789214554,9/16/2015 09:54:06,1739447674,9/16/2015 09:53:52,False,neodev,0.6667,14096345,NLD,03,Eibergen,178.85.94.186,KETOPROFEN treats RHEUMATOID ARTHRITIS,130,82,,150,92,treats,1.0,907589,"El-Ghobarey AF, Rennie JAN, Hadidi T et al. A comparative trial of large doses of KETOPROFEN and indomethacin in the treatment of RHEUMATOID ARTHRITIS",RHEUMATOID ARTHRITIS,KETOPROFEN,RO-may_treat
789214554,9/16/2015 09:54:08,1739447688,9/16/2015 09:53:45,False,meprizescf,0.8167,28483210,USA,WI,Minocqua,75.143.134.247,KETOPROFEN treats RHEUMATOID ARTHRITIS,130,82,,150,92,treats,1.0,907589,"El-Ghobarey AF, Rennie JAN, Hadidi T et al. A comparative trial of large doses of KETOPROFEN and indomethacin in the treatment of RHEUMATOID ARTHRITIS",RHEUMATOID ARTHRITIS,KETOPROFEN,RO-may_treat
789214554,9/16/2015 10:05:59,1739451528,9/16/2015 10:04:57,False,neodev,0.6746,31988911,USA,CA,Saratoga,107.178.37.2,KETOPROFEN treats RHEUMATOID ARTHRITIS,130,82,,150,92,treats,1.0,907589,"El-Ghobarey AF, Rennie JAN, Hadidi T et al. A comparative trial of large doses of KETOPROFEN and indomethacin in the treatment of RHEUMATOID ARTHRITIS",RHEUMATOID ARTHRITIS,KETOPROFEN,RO-may_treat
789214554,9/16/2015 10:11:51,1739453277,9/16/2015 10:11:29,False,pocketmoneygpt,0.9643,21432964,GBR,F8,Borehamwood,81.159.185.70,KETOPROFEN treats RHEUMATOID ARTHRITIS,130,82,,150,92,treats,1.0,907589,"El-Ghobarey AF, Rennie JAN, Hadidi T et al. A comparative trial of large doses of KETOPROFEN and indomethacin in the treatment of RHEUMATOID ARTHRITIS",RHEUMATOID ARTHRITIS,KETOPROFEN,RO-may_treat
789779020,9/16/2015 21:54:07,1739913823,9/16/2015 21:53:57,False,clixsense,0.7222,6340330,USA,NY,Canajoharie,67.248.115.74,MEPERIDINE treats CHRONIC PAIN,50,13,,61,23,treats,0.956182887467515,800890,"• A study of MEPERIDINE used for postoperative or CHRONIC PAIN found a high incidence of neuroexcitatory effects including nervousness, twitches, myoclonus, and seizures, as well as adverse mood alterations in patients with and without renal dysfunction.",CHRONIC PAIN,MEPERIDINE,TWrex-cause
789779020,9/16/2015 22:09:59,1739919950,9/16/2015 22:08:36,False,neodev,0.7679,33761260,USA,UT,Providence,206.190.151.208,MEPERIDINE treats CHRONIC PAIN,50,13,,61,23,treats,0.956182887467515,800890,"• A study of MEPERIDINE used for postoperative or CHRONIC PAIN found a high incidence of neuroexcitatory effects including nervousness, twitches, myoclonus, and seizures, as well as adverse mood alterations in patients with and without renal dysfunction.",CHRONIC PAIN,MEPERIDINE,TWrex-cause
789779020,9/16/2015 22:15:05,1739921866,9/16/2015 22:13:17,False,prodege,0.9444,25111984,USA,CO,Denver,75.166.201.119,MEPERIDINE treats CHRONIC PAIN,50,13,,61,23,treats,0.956182887467515,800890,"• A study of MEPERIDINE used for postoperative or CHRONIC PAIN found a high incidence of neuroexcitatory effects including nervousness, twitches, myoclonus, and seizures, as well as adverse mood alterations in patients with and without renal dysfunction.",CHRONIC PAIN,MEPERIDINE,TWrex-cause
789779020,9/16/2015 22:20:23,1739923711,9/16/2015 22:19:30,False,neodev,0.7119,32424428,USA,VA,Manassas,207.244.76.210,MEPERIDINE treats CHRONIC PAIN,50,13,,61,23,treats,0.956182887467515,800890,"• A study of MEPERIDINE used for postoperative or CHRONIC PAIN found a high incidence of neuroexcitatory effects including nervousness, twitches, myoclonus, and seizures, as well as adverse mood alterations in patients with and without renal dysfunction.",CHRONIC PAIN,MEPERIDINE,TWrex-cause
789779020,9/16/2015 22:34:21,1739928944,9/16/2015 22:33:27,False,fusioncash,0.925,31742806,USA,OH,Kent,66.61.82.242,MEPERIDINE treats CHRONIC PAIN,50,13,,61,23,treats,0.956182887467515,800890,"• A study of MEPERIDINE used for postoperative or CHRONIC PAIN found a high incidence of neuroexcitatory effects including nervousness, twitches, myoclonus, and seizures, as well as adverse mood alterations in patients with and without renal dysfunction.",CHRONIC PAIN,MEPERIDINE,TWrex-cause
789779020,9/16/2015 22:38:43,1739931316,9/16/2015 22:37:43,False,elite,0.9389,32173500,GBR,E4,Rayleigh,90.219.100.52,MEPERIDINE treats CHRONIC PAIN,50,13,,61,23,treats,0.956182887467515,800890,"• A study of MEPERIDINE used for postoperative or CHRONIC PAIN found a high incidence of neuroexcitatory effects including nervousness, twitches, myoclonus, and seizures, as well as adverse mood alterations in patients with and without renal dysfunction.",CHRONIC PAIN,MEPERIDINE,TWrex-cause
789779020,9/16/2015 22:47:50,1739936262,9/16/2015 22:46:39,False,clixsense,0.7599,6330007,AUS,,,101.178.25.217,no_relation,50,13,,61,23,treats,0.956182887467515,800890,"• A study of MEPERIDINE used for postoperative or CHRONIC PAIN found a high incidence of neuroexcitatory effects including nervousness, twitches, myoclonus, and seizures, as well as adverse mood alterations in patients with and without renal dysfunction.",CHRONIC PAIN,MEPERIDINE,TWrex-cause
789779034,9/16/2015 21:11:12,1739895826,9/16/2015 21:10:45,False,onestopgpt,0.823,21275875,CAN,ON,Hamilton,24.36.124.79,no_relation,332,202,,342,209,treats,0.488677777425221,812410,"Antimicrobial therapy should be changed to an active drug when in vitro resistance is noted even though the patient may appear to be improving Blood tests (CBC, ESR, CRP, electrolytes, BUN, creatinine, GLUCOSE pregnancy test, cultures)         To determine the severity of infection and underlying conditions such as renal failure, DEHYDRATION diabetes, and pregnancy.",DEHYDRATION,GLUCOSE,TWrex-cause
789779034,9/16/2015 21:19:55,1739901103,9/16/2015 21:19:22,False,prodege,0.9583,22031444,GBR,F2,Gosport,89.240.162.20,no_relation,332,202,,342,209,treats,0.488677777425221,812410,"Antimicrobial therapy should be changed to an active drug when in vitro resistance is noted even though the patient may appear to be improving Blood tests (CBC, ESR, CRP, electrolytes, BUN, creatinine, GLUCOSE pregnancy test, cultures)         To determine the severity of infection and underlying conditions such as renal failure, DEHYDRATION diabetes, and pregnancy.",DEHYDRATION,GLUCOSE,TWrex-cause
789779034,9/16/2015 21:23:45,1739902542,9/16/2015 21:21:10,False,prodege,0.7857,20693658,USA,WI,Chippewa Falls,75.105.241.192,no_relation,332,202,,342,209,treats,0.488677777425221,812410,"Antimicrobial therapy should be changed to an active drug when in vitro resistance is noted even though the patient may appear to be improving Blood tests (CBC, ESR, CRP, electrolytes, BUN, creatinine, GLUCOSE pregnancy test, cultures)         To determine the severity of infection and underlying conditions such as renal failure, DEHYDRATION diabetes, and pregnancy.",DEHYDRATION,GLUCOSE,TWrex-cause
789779034,9/16/2015 21:36:00,1739907093,9/16/2015 21:35:23,False,pocketmoneygpt,0.7321,21432964,GBR,F8,Borehamwood,81.159.185.70,GLUCOSE treats DEHYDRATION,332,202,,342,209,treats,0.488677777425221,812410,"Antimicrobial therapy should be changed to an active drug when in vitro resistance is noted even though the patient may appear to be improving Blood tests (CBC, ESR, CRP, electrolytes, BUN, creatinine, GLUCOSE pregnancy test, cultures)         To determine the severity of infection and underlying conditions such as renal failure, DEHYDRATION diabetes, and pregnancy.",DEHYDRATION,GLUCOSE,TWrex-cause
789779034,9/16/2015 21:41:08,1739908990,9/16/2015 21:40:47,False,treasuretrooper,0.85,17956656,AUS,02,Jannali,14.200.59.55,GLUCOSE treats DEHYDRATION,332,202,,342,209,treats,0.488677777425221,812410,"Antimicrobial therapy should be changed to an active drug when in vitro resistance is noted even though the patient may appear to be improving Blood tests (CBC, ESR, CRP, electrolytes, BUN, creatinine, GLUCOSE pregnancy test, cultures)         To determine the severity of infection and underlying conditions such as renal failure, DEHYDRATION diabetes, and pregnancy.",DEHYDRATION,GLUCOSE,TWrex-cause
789779034,9/16/2015 21:44:41,1739910469,9/16/2015 21:44:22,False,clixsense,0.6161,20587495,CAN,NL,St. John's,142.162.227.3,GLUCOSE treats DEHYDRATION,332,202,,342,209,treats,0.488677777425221,812410,"Antimicrobial therapy should be changed to an active drug when in vitro resistance is noted even though the patient may appear to be improving Blood tests (CBC, ESR, CRP, electrolytes, BUN, creatinine, GLUCOSE pregnancy test, cultures)         To determine the severity of infection and underlying conditions such as renal failure, DEHYDRATION diabetes, and pregnancy.",DEHYDRATION,GLUCOSE,TWrex-cause
789779034,9/16/2015 21:47:51,1739911494,9/16/2015 21:45:00,False,clixsense,0.6548,6363498,USA,GA,Fort Valley,23.125.3.6,no_relation,332,202,,342,209,treats,0.488677777425221,812410,"Antimicrobial therapy should be changed to an active drug when in vitro resistance is noted even though the patient may appear to be improving Blood tests (CBC, ESR, CRP, electrolytes, BUN, creatinine, GLUCOSE pregnancy test, cultures)         To determine the severity of infection and underlying conditions such as renal failure, DEHYDRATION diabetes, and pregnancy.",DEHYDRATION,GLUCOSE,TWrex-cause
789779040,9/16/2015 20:32:36,1739848644,9/16/2015 20:32:28,False,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[CAFFEIC ACID PHENETHYL ESTER] treats [TUMOR SHRINKING],73,33,,87,60,treats,0.920574617898323,225379,"Caffeic acid and its derivative, [CAFFEIC ACID PHENETHYL ESTER] have shown [TUMOR SHRINKING] properties.",[TUMOR SHRINKING],[CAFFEIC ACID PHENETHYL ESTER],TWrex-treat
789779040,9/16/2015 20:32:56,1739849193,9/16/2015 20:32:23,False,prodege,0.8809999999999999,21417560,GBR,C3,Cambridge,151.224.120.191,[CAFFEIC ACID PHENETHYL ESTER] treats [TUMOR SHRINKING],73,33,,87,60,treats,0.920574617898323,225379,"Caffeic acid and its derivative, [CAFFEIC ACID PHENETHYL ESTER] have shown [TUMOR SHRINKING] properties.",[TUMOR SHRINKING],[CAFFEIC ACID PHENETHYL ESTER],TWrex-treat
789779040,9/16/2015 20:35:06,1739852365,9/16/2015 20:34:53,False,instagc,1.0,16469970,USA,OK,Broken Arrow,72.192.89.181,[CAFFEIC ACID PHENETHYL ESTER] treats [TUMOR SHRINKING],73,33,,87,60,treats,0.920574617898323,225379,"Caffeic acid and its derivative, [CAFFEIC ACID PHENETHYL ESTER] have shown [TUMOR SHRINKING] properties.",[TUMOR SHRINKING],[CAFFEIC ACID PHENETHYL ESTER],TWrex-treat
789779040,9/16/2015 20:36:15,1739854384,9/16/2015 20:35:51,False,cotter,0.9504,34377132,USA,OH,Athens,107.10.138.13,[CAFFEIC ACID PHENETHYL ESTER] treats [TUMOR SHRINKING],73,33,,87,60,treats,0.920574617898323,225379,"Caffeic acid and its derivative, [CAFFEIC ACID PHENETHYL ESTER] have shown [TUMOR SHRINKING] properties.",[TUMOR SHRINKING],[CAFFEIC ACID PHENETHYL ESTER],TWrex-treat
789779040,9/16/2015 20:39:47,1739861202,9/16/2015 20:31:41,False,prodege,0.7857,20693658,USA,WI,Chippewa Falls,75.105.241.192,[CAFFEIC ACID PHENETHYL ESTER] treats [TUMOR SHRINKING],73,33,,87,60,treats,0.920574617898323,225379,"Caffeic acid and its derivative, [CAFFEIC ACID PHENETHYL ESTER] have shown [TUMOR SHRINKING] properties.",[TUMOR SHRINKING],[CAFFEIC ACID PHENETHYL ESTER],TWrex-treat
789779040,9/16/2015 20:42:35,1739864912,9/16/2015 20:41:57,False,neodev,0.6377,18881135,CAN,ON,Ajax,99.243.87.224,no_relation,73,33,,87,60,treats,0.920574617898323,225379,"Caffeic acid and its derivative, [CAFFEIC ACID PHENETHYL ESTER] have shown [TUMOR SHRINKING] properties.",[TUMOR SHRINKING],[CAFFEIC ACID PHENETHYL ESTER],TWrex-treat
789779040,9/16/2015 20:51:51,1739875468,9/16/2015 20:51:04,False,neodev,0.6022,33701549,USA,CA,Torrance,66.171.228.172,[TUMOR SHRINKING] treats [CAFFEIC ACID PHENETHYL ESTER],73,33,,87,60,treats,0.920574617898323,225379,"Caffeic acid and its derivative, [CAFFEIC ACID PHENETHYL ESTER] have shown [TUMOR SHRINKING] properties.",[TUMOR SHRINKING],[CAFFEIC ACID PHENETHYL ESTER],TWrex-treat
789779041,9/16/2015 22:18:58,1739923210,9/16/2015 22:18:03,False,prodege,0.9444,25111984,USA,CO,Denver,75.166.201.119,GANCICLOVIR PROPHYLAXIS treats CMV INFECTION,92,0,,104,23,treats,0.971285862357264,804545,"GANCICLOVIR PROPHYLAXIS beginning at the time of engraftment can prevent the development of CMV INFECTION in most patients, but ganciclovir causes significant marrow suppression in at least 30% of patients.",CMV INFECTION,GANCICLOVIR PROPHYLAXIS,TWrex-cause
789779041,9/16/2015 22:36:20,1739930111,9/16/2015 22:35:40,False,fusioncash,0.925,31742806,USA,OH,Kent,66.61.82.242,GANCICLOVIR PROPHYLAXIS treats CMV INFECTION,92,0,,104,23,treats,0.971285862357264,804545,"GANCICLOVIR PROPHYLAXIS beginning at the time of engraftment can prevent the development of CMV INFECTION in most patients, but ganciclovir causes significant marrow suppression in at least 30% of patients.",CMV INFECTION,GANCICLOVIR PROPHYLAXIS,TWrex-cause
789779041,9/16/2015 22:40:32,1739932235,9/16/2015 22:40:08,False,elite,0.9389,32173500,GBR,E4,Rayleigh,90.219.100.52,GANCICLOVIR PROPHYLAXIS treats CMV INFECTION,92,0,,104,23,treats,0.971285862357264,804545,"GANCICLOVIR PROPHYLAXIS beginning at the time of engraftment can prevent the development of CMV INFECTION in most patients, but ganciclovir causes significant marrow suppression in at least 30% of patients.",CMV INFECTION,GANCICLOVIR PROPHYLAXIS,TWrex-cause
789779041,9/16/2015 22:45:06,1739934667,9/16/2015 22:45:02,False,clixsense,0.7527,17950689,GBR,L9,Sheffield,146.200.192.103,GANCICLOVIR PROPHYLAXIS treats CMV INFECTION,92,0,,104,23,treats,0.971285862357264,804545,"GANCICLOVIR PROPHYLAXIS beginning at the time of engraftment can prevent the development of CMV INFECTION in most patients, but ganciclovir causes significant marrow suppression in at least 30% of patients.",CMV INFECTION,GANCICLOVIR PROPHYLAXIS,TWrex-cause
789779041,9/16/2015 22:45:52,1739935118,9/16/2015 22:44:55,False,clixsense,0.7599,6330007,AUS,,,101.178.25.217,no_relation,92,0,,104,23,treats,0.971285862357264,804545,"GANCICLOVIR PROPHYLAXIS beginning at the time of engraftment can prevent the development of CMV INFECTION in most patients, but ganciclovir causes significant marrow suppression in at least 30% of patients.",CMV INFECTION,GANCICLOVIR PROPHYLAXIS,TWrex-cause
789779041,9/16/2015 22:47:11,1739935838,9/16/2015 22:46:45,False,clixsense,0.9583,6344072,CAN,BC,Burnaby,172.218.166.58,GANCICLOVIR PROPHYLAXIS treats CMV INFECTION,92,0,,104,23,treats,0.971285862357264,804545,"GANCICLOVIR PROPHYLAXIS beginning at the time of engraftment can prevent the development of CMV INFECTION in most patients, but ganciclovir causes significant marrow suppression in at least 30% of patients.",CMV INFECTION,GANCICLOVIR PROPHYLAXIS,TWrex-cause
789779041,9/16/2015 23:15:57,1739951930,9/16/2015 23:15:16,False,points4rewards,0.9286,28703583,USA,,,184.53.32.49,GANCICLOVIR PROPHYLAXIS treats CMV INFECTION,92,0,,104,23,treats,0.971285862357264,804545,"GANCICLOVIR PROPHYLAXIS beginning at the time of engraftment can prevent the development of CMV INFECTION in most patients, but ganciclovir causes significant marrow suppression in at least 30% of patients.",CMV INFECTION,GANCICLOVIR PROPHYLAXIS,TWrex-cause
789779044,9/16/2015 20:40:16,1739862216,9/16/2015 20:39:33,False,cotter,0.9504,34377132,USA,OH,Athens,107.10.138.13,no_relation,114,54,,129,67,treats,0.9258200997725509,220266,"Certain spermicides and contraceptive creams can kill [L ACIDOPHILUS] in the vagina, clearing the path to possible [YEAST INFECTIONS].",[YEAST INFECTIONS],[L ACIDOPHILUS],TWrex-treat
789779044,9/16/2015 20:55:46,1739879201,9/16/2015 20:54:13,False,neodev,0.6022,33701549,USA,CA,Torrance,66.171.228.172,[YEAST INFECTIONS] treats [L ACIDOPHILUS],114,54,,129,67,treats,0.9258200997725509,220266,"Certain spermicides and contraceptive creams can kill [L ACIDOPHILUS] in the vagina, clearing the path to possible [YEAST INFECTIONS].",[YEAST INFECTIONS],[L ACIDOPHILUS],TWrex-treat
789779044,9/16/2015 20:55:48,1739879226,9/16/2015 20:55:29,False,prodege,0.8395,3587109,CAN,NS,Havre Boucher,142.166.204.244,no_relation,114,54,,129,67,treats,0.9258200997725509,220266,"Certain spermicides and contraceptive creams can kill [L ACIDOPHILUS] in the vagina, clearing the path to possible [YEAST INFECTIONS].",[YEAST INFECTIONS],[L ACIDOPHILUS],TWrex-treat
789779044,9/16/2015 20:56:58,1739880351,9/16/2015 20:55:21,False,points4rewards,0.6937,20113482,USA,PA,Philadelphia,162.208.49.45,no_relation,114,54,,129,67,treats,0.9258200997725509,220266,"Certain spermicides and contraceptive creams can kill [L ACIDOPHILUS] in the vagina, clearing the path to possible [YEAST INFECTIONS].",[YEAST INFECTIONS],[L ACIDOPHILUS],TWrex-treat
789779044,9/16/2015 20:57:35,1739880880,9/16/2015 20:57:15,False,bitcoinget,0.8659,21743413,USA,WA,Port Angeles,24.113.29.97,no_relation,114,54,,129,67,treats,0.9258200997725509,220266,"Certain spermicides and contraceptive creams can kill [L ACIDOPHILUS] in the vagina, clearing the path to possible [YEAST INFECTIONS].",[YEAST INFECTIONS],[L ACIDOPHILUS],TWrex-treat
789779044,9/16/2015 21:09:29,1739893242,9/16/2015 21:07:58,False,onestopgpt,0.823,21275875,CAN,ON,Hamilton,24.36.124.79,no_relation,114,54,,129,67,treats,0.9258200997725509,220266,"Certain spermicides and contraceptive creams can kill [L ACIDOPHILUS] in the vagina, clearing the path to possible [YEAST INFECTIONS].",[YEAST INFECTIONS],[L ACIDOPHILUS],TWrex-treat
789779044,9/16/2015 21:09:45,1739893642,9/16/2015 21:09:24,False,neodev,0.6377,18881135,CAN,ON,Ajax,99.243.87.224,no_relation,114,54,,129,67,treats,0.9258200997725509,220266,"Certain spermicides and contraceptive creams can kill [L ACIDOPHILUS] in the vagina, clearing the path to possible [YEAST INFECTIONS].",[YEAST INFECTIONS],[L ACIDOPHILUS],TWrex-treat
789779053,9/16/2015 20:12:05,1739809177,9/16/2015 20:11:35,False,clixsense,0.7877,32053717,GBR,,,51.174.76.80,CLOZAPINE treats SCHIZOPHRENIA,128,44,,140,53,treats,0.9931270663228421,908255,"Atypical antipsychotic drugs (APDs) such as CLOZAPINE but not the typical APD haloperidol, improve some aspects of cognition in SCHIZOPHRENIA",SCHIZOPHRENIA,CLOZAPINE,RO-may_treat
789779053,9/16/2015 20:13:14,1739810095,9/16/2015 20:13:01,False,neodev,0.8809999999999999,20306047,GBR,,,80.41.0.252,CLOZAPINE treats SCHIZOPHRENIA,128,44,,140,53,treats,0.9931270663228421,908255,"Atypical antipsychotic drugs (APDs) such as CLOZAPINE but not the typical APD haloperidol, improve some aspects of cognition in SCHIZOPHRENIA",SCHIZOPHRENIA,CLOZAPINE,RO-may_treat
789779053,9/16/2015 20:13:17,1739810155,9/16/2015 20:13:11,False,zoombucks,0.8929,4711962,CAN,ON,Markham,174.88.29.138,CLOZAPINE treats SCHIZOPHRENIA,128,44,,140,53,treats,0.9931270663228421,908255,"Atypical antipsychotic drugs (APDs) such as CLOZAPINE but not the typical APD haloperidol, improve some aspects of cognition in SCHIZOPHRENIA",SCHIZOPHRENIA,CLOZAPINE,RO-may_treat
789779053,9/16/2015 20:17:31,1739817434,9/16/2015 20:17:03,False,clixsense,0.9583,31304413,CAN,BC,Kelowna,66.183.36.177,CLOZAPINE treats SCHIZOPHRENIA,128,44,,140,53,treats,0.9931270663228421,908255,"Atypical antipsychotic drugs (APDs) such as CLOZAPINE but not the typical APD haloperidol, improve some aspects of cognition in SCHIZOPHRENIA",SCHIZOPHRENIA,CLOZAPINE,RO-may_treat
789779053,9/16/2015 20:17:49,1739817926,9/16/2015 20:17:36,False,elite,0.8889,31883685,GBR,,,79.66.244.188,CLOZAPINE treats SCHIZOPHRENIA,128,44,,140,53,treats,0.9931270663228421,908255,"Atypical antipsychotic drugs (APDs) such as CLOZAPINE but not the typical APD haloperidol, improve some aspects of cognition in SCHIZOPHRENIA",SCHIZOPHRENIA,CLOZAPINE,RO-may_treat
789779053,9/16/2015 20:25:35,1739834339,9/16/2015 20:25:02,False,clixsense,0.5306,32916182,GBR,L9,Sheffield,5.81.109.21,no_relation,128,44,,140,53,treats,0.9931270663228421,908255,"Atypical antipsychotic drugs (APDs) such as CLOZAPINE but not the typical APD haloperidol, improve some aspects of cognition in SCHIZOPHRENIA",SCHIZOPHRENIA,CLOZAPINE,RO-may_treat
789779053,9/16/2015 20:26:12,1739835310,9/16/2015 20:25:25,False,neodev,0.6956,33644825,USA,FL,Fort Lauderdale,65.111.173.161,CLOZAPINE treats SCHIZOPHRENIA,128,44,,140,53,treats,0.9931270663228421,908255,"Atypical antipsychotic drugs (APDs) such as CLOZAPINE but not the typical APD haloperidol, improve some aspects of cognition in SCHIZOPHRENIA",SCHIZOPHRENIA,CLOZAPINE,RO-may_treat
789779068,9/16/2015 19:45:07,1739791586,9/16/2015 19:43:58,False,clixsense,0.9722,30681826,GBR,I9,Diss,31.49.71.254,EPIDRIN treats MIGRAINE,98,141,,106,148,treats,0.9712858623999999,205511,"In combination with paracetamol and isometheptene, it is the active ingredient of medications for [MIGRAINE] and vascular headaches, including [EPIDRIN] and Midrin.",MIGRAINE,EPIDRIN,TWrex-treat
789779068,9/16/2015 19:51:24,1739794662,9/16/2015 19:50:59,False,clixsense,0.8944,33878524,CAN,BC,Princeton,75.156.83.71,EPIDRIN treats MIGRAINE,98,141,,106,148,treats,0.9712858623999999,205511,"In combination with paracetamol and isometheptene, it is the active ingredient of medications for [MIGRAINE] and vascular headaches, including [EPIDRIN] and Midrin.",MIGRAINE,EPIDRIN,TWrex-treat
789779068,9/16/2015 19:52:49,1739795359,9/16/2015 19:52:26,False,neodev,0.8806,30627835,GBR,D8,Bishop Auckland,217.44.84.223,EPIDRIN treats MIGRAINE,98,141,,106,148,treats,0.9712858623999999,205511,"In combination with paracetamol and isometheptene, it is the active ingredient of medications for [MIGRAINE] and vascular headaches, including [EPIDRIN] and Midrin.",MIGRAINE,EPIDRIN,TWrex-treat
789779068,9/16/2015 20:04:36,1739801495,9/16/2015 20:00:05,False,clixsense,0.8323,21875134,GBR,,,80.189.12.98,EPIDRIN treats MIGRAINE,98,141,,106,148,treats,0.9712858623999999,205511,"In combination with paracetamol and isometheptene, it is the active ingredient of medications for [MIGRAINE] and vascular headaches, including [EPIDRIN] and Midrin.",MIGRAINE,EPIDRIN,TWrex-treat
789779068,9/16/2015 20:09:54,1739806901,9/16/2015 20:09:37,False,tremorgames,0.4583,24449707,CAN,QC,Laval,96.20.14.148,EPIDRIN treats MIGRAINE,98,141,,106,148,treats,0.9712858623999999,205511,"In combination with paracetamol and isometheptene, it is the active ingredient of medications for [MIGRAINE] and vascular headaches, including [EPIDRIN] and Midrin.",MIGRAINE,EPIDRIN,TWrex-treat
789779068,9/16/2015 20:10:13,1739807214,9/16/2015 20:09:45,False,clixsense,0.7877,32053717,GBR,,,51.174.76.80,EPIDRIN treats MIGRAINE,98,141,,106,148,treats,0.9712858623999999,205511,"In combination with paracetamol and isometheptene, it is the active ingredient of medications for [MIGRAINE] and vascular headaches, including [EPIDRIN] and Midrin.",MIGRAINE,EPIDRIN,TWrex-treat
789779068,9/16/2015 20:12:24,1739809383,9/16/2015 20:11:15,False,neodev,0.8809999999999999,20306047,GBR,,,80.41.0.252,EPIDRIN treats MIGRAINE,98,141,,106,148,treats,0.9712858623999999,205511,"In combination with paracetamol and isometheptene, it is the active ingredient of medications for [MIGRAINE] and vascular headaches, including [EPIDRIN] and Midrin.",MIGRAINE,EPIDRIN,TWrex-treat
789779071,9/17/2015 00:38:07,1739976179,9/17/2015 00:37:44,False,cotter,0.9722,30870494,USA,TX,Houston,99.45.150.123,ERYTHROMYCIN treats PERTUSSIS,95,110,,103,122,treats,0.987878339907213,907514,Hoppe JE: Comparison of erythromycin estolate and erythromycin ethylsuccinate for treatment of PERTUSSIS: the ERYTHROMYCIN Study Group.,PERTUSSIS,ERYTHROMYCIN,RO-may_treat
789779071,9/17/2015 00:55:54,1739980198,9/17/2015 00:54:44,False,zoombucks,0.9375,6744840,CAN,BC,Kelowna,174.4.58.160,ERYTHROMYCIN treats PERTUSSIS,95,110,,103,122,treats,0.987878339907213,907514,Hoppe JE: Comparison of erythromycin estolate and erythromycin ethylsuccinate for treatment of PERTUSSIS: the ERYTHROMYCIN Study Group.,PERTUSSIS,ERYTHROMYCIN,RO-may_treat
789779071,9/17/2015 01:02:13,1739982084,9/17/2015 01:01:39,False,clixsense,0.8361,26531841,CAN,ON,Toronto,64.231.8.24,no_relation,95,110,,103,122,treats,0.987878339907213,907514,Hoppe JE: Comparison of erythromycin estolate and erythromycin ethylsuccinate for treatment of PERTUSSIS: the ERYTHROMYCIN Study Group.,PERTUSSIS,ERYTHROMYCIN,RO-may_treat
789779071,9/17/2015 01:15:49,1739988365,9/17/2015 01:15:23,False,prodege,0.9306,13300986,CAN,AB,Edmonton,68.150.40.134,ERYTHROMYCIN treats PERTUSSIS,95,110,,103,122,treats,0.987878339907213,907514,Hoppe JE: Comparison of erythromycin estolate and erythromycin ethylsuccinate for treatment of PERTUSSIS: the ERYTHROMYCIN Study Group.,PERTUSSIS,ERYTHROMYCIN,RO-may_treat
789779071,9/17/2015 01:21:53,1739992225,9/17/2015 01:21:10,False,elite,0.9071,33251186,USA,DE,Wilmington,199.115.114.229,ERYTHROMYCIN treats PERTUSSIS,95,110,,103,122,treats,0.987878339907213,907514,Hoppe JE: Comparison of erythromycin estolate and erythromycin ethylsuccinate for treatment of PERTUSSIS: the ERYTHROMYCIN Study Group.,PERTUSSIS,ERYTHROMYCIN,RO-may_treat
789779071,9/17/2015 01:26:17,1739995467,9/17/2015 01:25:57,False,prodege,0.9742,10959404,USA,CA,Studio City,108.217.110.104,ERYTHROMYCIN treats PERTUSSIS,95,110,,103,122,treats,0.987878339907213,907514,Hoppe JE: Comparison of erythromycin estolate and erythromycin ethylsuccinate for treatment of PERTUSSIS: the ERYTHROMYCIN Study Group.,PERTUSSIS,ERYTHROMYCIN,RO-may_treat
789779071,9/17/2015 01:27:26,1739996212,9/17/2015 01:26:45,False,instagc,0.8016,31861996,USA,FL,Homestead,73.46.199.178,ERYTHROMYCIN treats PERTUSSIS,95,110,,103,122,treats,0.987878339907213,907514,Hoppe JE: Comparison of erythromycin estolate and erythromycin ethylsuccinate for treatment of PERTUSSIS: the ERYTHROMYCIN Study Group.,PERTUSSIS,ERYTHROMYCIN,RO-may_treat
789779072,9/16/2015 22:18:58,1739923209,9/16/2015 22:18:03,False,prodege,0.9444,25111984,USA,CO,Denver,75.166.201.119,no_relation,135,62,,142,85,treats,0.676123403782813,813936,It is approved as monotherapy or adjunctive treatment for the LENNOX GASTAUT SYNDROME (absence variant) and for akinetic and myoclonic SEIZURES,SEIZURES,LENNOX GASTAUT SYNDROME,TWrex-cause
789779072,9/16/2015 22:36:20,1739930106,9/16/2015 22:35:40,False,fusioncash,0.925,31742806,USA,OH,Kent,66.61.82.242,no_relation,135,62,,142,85,treats,0.676123403782813,813936,It is approved as monotherapy or adjunctive treatment for the LENNOX GASTAUT SYNDROME (absence variant) and for akinetic and myoclonic SEIZURES,SEIZURES,LENNOX GASTAUT SYNDROME,TWrex-cause
789779072,9/16/2015 22:40:32,1739932244,9/16/2015 22:40:08,False,elite,0.9389,32173500,GBR,E4,Rayleigh,90.219.100.52,no_relation,135,62,,142,85,treats,0.676123403782813,813936,It is approved as monotherapy or adjunctive treatment for the LENNOX GASTAUT SYNDROME (absence variant) and for akinetic and myoclonic SEIZURES,SEIZURES,LENNOX GASTAUT SYNDROME,TWrex-cause
789779072,9/16/2015 22:45:06,1739934660,9/16/2015 22:45:02,False,clixsense,0.7527,17950689,GBR,L9,Sheffield,146.200.192.103,LENNOX GASTAUT SYNDROME treats SEIZURES,135,62,,142,85,treats,0.676123403782813,813936,It is approved as monotherapy or adjunctive treatment for the LENNOX GASTAUT SYNDROME (absence variant) and for akinetic and myoclonic SEIZURES,SEIZURES,LENNOX GASTAUT SYNDROME,TWrex-cause
789779072,9/16/2015 22:45:52,1739935117,9/16/2015 22:44:55,False,clixsense,0.7599,6330007,AUS,,,101.178.25.217,no_relation,135,62,,142,85,treats,0.676123403782813,813936,It is approved as monotherapy or adjunctive treatment for the LENNOX GASTAUT SYNDROME (absence variant) and for akinetic and myoclonic SEIZURES,SEIZURES,LENNOX GASTAUT SYNDROME,TWrex-cause
789779072,9/16/2015 22:47:11,1739935844,9/16/2015 22:46:45,False,clixsense,0.9583,6344072,CAN,BC,Burnaby,172.218.166.58,no_relation,135,62,,142,85,treats,0.676123403782813,813936,It is approved as monotherapy or adjunctive treatment for the LENNOX GASTAUT SYNDROME (absence variant) and for akinetic and myoclonic SEIZURES,SEIZURES,LENNOX GASTAUT SYNDROME,TWrex-cause
789779072,9/16/2015 23:15:57,1739951934,9/16/2015 23:15:16,False,points4rewards,0.9286,28703583,USA,,,184.53.32.49,LENNOX GASTAUT SYNDROME treats SEIZURES,135,62,,142,85,treats,0.676123403782813,813936,It is approved as monotherapy or adjunctive treatment for the LENNOX GASTAUT SYNDROME (absence variant) and for akinetic and myoclonic SEIZURES,SEIZURES,LENNOX GASTAUT SYNDROME,TWrex-cause
789779093,9/17/2015 00:38:07,1739976180,9/17/2015 00:37:44,False,cotter,0.9722,30870494,USA,TX,Houston,99.45.150.123,CHOLECALCIFEROL treats OSTEOPOROSIS,103,55,,115,70,treats,1.0,907503,Alendronate is used alone or in fixed combination with CHOLECALCIFEROL (vitamin D 3 ) for treatment of OSTEOPOROSIS in postmenopausal women,OSTEOPOROSIS,CHOLECALCIFEROL,RO-may_treat
789779093,9/17/2015 00:55:54,1739980197,9/17/2015 00:54:44,False,zoombucks,0.9375,6744840,CAN,BC,Kelowna,174.4.58.160,CHOLECALCIFEROL treats OSTEOPOROSIS,103,55,,115,70,treats,1.0,907503,Alendronate is used alone or in fixed combination with CHOLECALCIFEROL (vitamin D 3 ) for treatment of OSTEOPOROSIS in postmenopausal women,OSTEOPOROSIS,CHOLECALCIFEROL,RO-may_treat
789779093,9/17/2015 01:02:13,1739982085,9/17/2015 01:01:39,False,clixsense,0.8361,26531841,CAN,ON,Toronto,64.231.8.24,CHOLECALCIFEROL treats OSTEOPOROSIS,103,55,,115,70,treats,1.0,907503,Alendronate is used alone or in fixed combination with CHOLECALCIFEROL (vitamin D 3 ) for treatment of OSTEOPOROSIS in postmenopausal women,OSTEOPOROSIS,CHOLECALCIFEROL,RO-may_treat
789779093,9/17/2015 01:15:49,1739988366,9/17/2015 01:15:23,False,prodege,0.9306,13300986,CAN,AB,Edmonton,68.150.40.134,CHOLECALCIFEROL treats OSTEOPOROSIS,103,55,,115,70,treats,1.0,907503,Alendronate is used alone or in fixed combination with CHOLECALCIFEROL (vitamin D 3 ) for treatment of OSTEOPOROSIS in postmenopausal women,OSTEOPOROSIS,CHOLECALCIFEROL,RO-may_treat
789779093,9/17/2015 01:21:53,1739992224,9/17/2015 01:21:10,False,elite,0.9071,33251186,USA,DE,Wilmington,199.115.114.229,CHOLECALCIFEROL treats OSTEOPOROSIS,103,55,,115,70,treats,1.0,907503,Alendronate is used alone or in fixed combination with CHOLECALCIFEROL (vitamin D 3 ) for treatment of OSTEOPOROSIS in postmenopausal women,OSTEOPOROSIS,CHOLECALCIFEROL,RO-may_treat
789779093,9/17/2015 01:26:17,1739995468,9/17/2015 01:25:57,False,prodege,0.9742,10959404,USA,CA,Studio City,108.217.110.104,CHOLECALCIFEROL treats OSTEOPOROSIS,103,55,,115,70,treats,1.0,907503,Alendronate is used alone or in fixed combination with CHOLECALCIFEROL (vitamin D 3 ) for treatment of OSTEOPOROSIS in postmenopausal women,OSTEOPOROSIS,CHOLECALCIFEROL,RO-may_treat
789779093,9/17/2015 01:27:26,1739996214,9/17/2015 01:26:45,False,instagc,0.8016,31861996,USA,FL,Homestead,73.46.199.178,CHOLECALCIFEROL treats OSTEOPOROSIS,103,55,,115,70,treats,1.0,907503,Alendronate is used alone or in fixed combination with CHOLECALCIFEROL (vitamin D 3 ) for treatment of OSTEOPOROSIS in postmenopausal women,OSTEOPOROSIS,CHOLECALCIFEROL,RO-may_treat
789779097,9/16/2015 21:21:26,1739901698,9/16/2015 21:21:01,False,prodege,0.9583,22031444,GBR,F2,Gosport,89.240.162.20,MORPHINE treats DYSPNEA,96,9,,102,17,treats,0.880450906325624,800687,"Low dose MORPHINE may blunt the medullary response to CO 2  retention or O 2  decline, reducing DYSPNEA and decreasing anxiety without causing significant respiratory depression.",DYSPNEA,MORPHINE,TWrex-cause
789779097,9/16/2015 21:37:27,1739907629,9/16/2015 21:36:55,False,pocketmoneygpt,0.7321,21432964,GBR,F8,Borehamwood,81.159.185.70,MORPHINE treats DYSPNEA,96,9,,102,17,treats,0.880450906325624,800687,"Low dose MORPHINE may blunt the medullary response to CO 2  retention or O 2  decline, reducing DYSPNEA and decreasing anxiety without causing significant respiratory depression.",DYSPNEA,MORPHINE,TWrex-cause
789779097,9/16/2015 21:42:12,1739909413,9/16/2015 21:41:38,False,treasuretrooper,0.85,17956656,AUS,02,Jannali,14.200.59.55,MORPHINE treats DYSPNEA,96,9,,102,17,treats,0.880450906325624,800687,"Low dose MORPHINE may blunt the medullary response to CO 2  retention or O 2  decline, reducing DYSPNEA and decreasing anxiety without causing significant respiratory depression.",DYSPNEA,MORPHINE,TWrex-cause
789779097,9/16/2015 21:45:45,1739910806,9/16/2015 21:45:21,False,clixsense,0.6161,20587495,CAN,NL,St. John's,142.162.227.3,MORPHINE treats DYSPNEA,96,9,,102,17,treats,0.880450906325624,800687,"Low dose MORPHINE may blunt the medullary response to CO 2  retention or O 2  decline, reducing DYSPNEA and decreasing anxiety without causing significant respiratory depression.",DYSPNEA,MORPHINE,TWrex-cause
789779097,9/16/2015 21:50:18,1739912382,9/16/2015 21:49:03,False,clixsense,0.6548,6363498,USA,GA,Fort Valley,23.125.3.6,MORPHINE treats DYSPNEA,96,9,,102,17,treats,0.880450906325624,800687,"Low dose MORPHINE may blunt the medullary response to CO 2  retention or O 2  decline, reducing DYSPNEA and decreasing anxiety without causing significant respiratory depression.",DYSPNEA,MORPHINE,TWrex-cause
789779097,9/16/2015 21:52:57,1739913389,9/16/2015 21:52:39,False,clixsense,0.7222,6340330,USA,NY,Canajoharie,67.248.115.74,MORPHINE treats DYSPNEA,96,9,,102,17,treats,0.880450906325624,800687,"Low dose MORPHINE may blunt the medullary response to CO 2  retention or O 2  decline, reducing DYSPNEA and decreasing anxiety without causing significant respiratory depression.",DYSPNEA,MORPHINE,TWrex-cause
789779097,9/16/2015 22:07:42,1739918859,9/16/2015 22:04:56,False,neodev,0.7119,32424428,USA,VA,Manassas,207.244.76.210,MORPHINE treats DYSPNEA,96,9,,102,17,treats,0.880450906325624,800687,"Low dose MORPHINE may blunt the medullary response to CO 2  retention or O 2  decline, reducing DYSPNEA and decreasing anxiety without causing significant respiratory depression.",DYSPNEA,MORPHINE,TWrex-cause
789779101,9/16/2015 19:46:01,1739792007,9/16/2015 19:45:08,False,clixsense,0.9722,30681826,GBR,I9,Diss,31.49.71.254,LIPOSOMAL AMPHOTERICIN B GROUP treats FUNGAL INFECTIONS,98,123,,114,153,treats,0.8219949365267859,804403,"Success rates were similar between treatment groups, but there were fewer documented breakthrough FUNGAL INFECTIONS in the LIPOSOMAL AMPHOTERICIN B GROUP ( 215.",FUNGAL INFECTIONS,LIPOSOMAL AMPHOTERICIN B GROUP,TWrex-cause
789779101,9/16/2015 19:53:21,1739795609,9/16/2015 19:52:50,False,neodev,0.8806,30627835,GBR,D8,Bishop Auckland,217.44.84.223,LIPOSOMAL AMPHOTERICIN B GROUP treats FUNGAL INFECTIONS,98,123,,114,153,treats,0.8219949365267859,804403,"Success rates were similar between treatment groups, but there were fewer documented breakthrough FUNGAL INFECTIONS in the LIPOSOMAL AMPHOTERICIN B GROUP ( 215.",FUNGAL INFECTIONS,LIPOSOMAL AMPHOTERICIN B GROUP,TWrex-cause
789779101,9/16/2015 19:56:09,1739797043,9/16/2015 19:51:26,False,clixsense,0.8944,33878524,CAN,BC,Princeton,75.156.83.71,LIPOSOMAL AMPHOTERICIN B GROUP treats FUNGAL INFECTIONS,98,123,,114,153,treats,0.8219949365267859,804403,"Success rates were similar between treatment groups, but there were fewer documented breakthrough FUNGAL INFECTIONS in the LIPOSOMAL AMPHOTERICIN B GROUP ( 215.",FUNGAL INFECTIONS,LIPOSOMAL AMPHOTERICIN B GROUP,TWrex-cause
789779101,9/16/2015 20:05:39,1739802379,9/16/2015 20:04:41,False,clixsense,0.8323,21875134,GBR,,,80.189.12.98,LIPOSOMAL AMPHOTERICIN B GROUP treats FUNGAL INFECTIONS,98,123,,114,153,treats,0.8219949365267859,804403,"Success rates were similar between treatment groups, but there were fewer documented breakthrough FUNGAL INFECTIONS in the LIPOSOMAL AMPHOTERICIN B GROUP ( 215.",FUNGAL INFECTIONS,LIPOSOMAL AMPHOTERICIN B GROUP,TWrex-cause
789779101,9/16/2015 20:10:04,1739807099,9/16/2015 20:09:54,False,tremorgames,0.4583,24449707,CAN,QC,Laval,96.20.14.148,no_relation,98,123,,114,153,treats,0.8219949365267859,804403,"Success rates were similar between treatment groups, but there were fewer documented breakthrough FUNGAL INFECTIONS in the LIPOSOMAL AMPHOTERICIN B GROUP ( 215.",FUNGAL INFECTIONS,LIPOSOMAL AMPHOTERICIN B GROUP,TWrex-cause
789779101,9/16/2015 20:10:56,1739807938,9/16/2015 20:10:16,False,clixsense,0.7877,32053717,GBR,,,51.174.76.80,LIPOSOMAL AMPHOTERICIN B GROUP treats FUNGAL INFECTIONS,98,123,,114,153,treats,0.8219949365267859,804403,"Success rates were similar between treatment groups, but there were fewer documented breakthrough FUNGAL INFECTIONS in the LIPOSOMAL AMPHOTERICIN B GROUP ( 215.",FUNGAL INFECTIONS,LIPOSOMAL AMPHOTERICIN B GROUP,TWrex-cause
789779101,9/16/2015 20:12:58,1739809848,9/16/2015 20:12:29,False,neodev,0.8809999999999999,20306047,GBR,,,80.41.0.252,no_relation,98,123,,114,153,treats,0.8219949365267859,804403,"Success rates were similar between treatment groups, but there were fewer documented breakthrough FUNGAL INFECTIONS in the LIPOSOMAL AMPHOTERICIN B GROUP ( 215.",FUNGAL INFECTIONS,LIPOSOMAL AMPHOTERICIN B GROUP,TWrex-cause
789779107,9/16/2015 22:49:06,1739937006,9/16/2015 22:48:45,False,clixsense,0.9583,6344072,CAN,BC,Burnaby,172.218.166.58,[BACLOFEN] treats [SPACE SURROUNDING THE SPINAL CORD],56,18,,89,25,treats,0.569209978830308,218329,The pump delivers [BACLOFEN] via a catheter to the thecal [SPACE SURROUNDING THE SPINAL CORD],[SPACE SURROUNDING THE SPINAL CORD],[BACLOFEN],TWrex-treat
789779107,9/16/2015 23:17:49,1739952593,9/16/2015 23:17:17,False,points4rewards,0.9286,28703583,USA,,,184.53.32.49,[BACLOFEN] treats [SPACE SURROUNDING THE SPINAL CORD],56,18,,89,25,treats,0.569209978830308,218329,The pump delivers [BACLOFEN] via a catheter to the thecal [SPACE SURROUNDING THE SPINAL CORD],[SPACE SURROUNDING THE SPINAL CORD],[BACLOFEN],TWrex-treat
789779107,9/16/2015 23:18:44,1739952956,9/16/2015 23:18:07,False,elite,1.0,33238902,NLD,06,Budel,77.248.148.5,[BACLOFEN] treats [SPACE SURROUNDING THE SPINAL CORD],56,18,,89,25,treats,0.569209978830308,218329,The pump delivers [BACLOFEN] via a catheter to the thecal [SPACE SURROUNDING THE SPINAL CORD],[SPACE SURROUNDING THE SPINAL CORD],[BACLOFEN],TWrex-treat
789779107,9/16/2015 23:21:30,1739953739,9/16/2015 23:20:56,False,neodev,0.9056,11460728,CAN,BC,Burnaby,70.79.16.165,no_relation,56,18,,89,25,treats,0.569209978830308,218329,The pump delivers [BACLOFEN] via a catheter to the thecal [SPACE SURROUNDING THE SPINAL CORD],[SPACE SURROUNDING THE SPINAL CORD],[BACLOFEN],TWrex-treat
789779107,9/16/2015 23:21:29,1739953749,9/16/2015 23:20:55,False,instagc,0.9556,32654723,USA,MO,Columbia,150.199.20.174,[BACLOFEN] treats [SPACE SURROUNDING THE SPINAL CORD],56,18,,89,25,treats,0.569209978830308,218329,The pump delivers [BACLOFEN] via a catheter to the thecal [SPACE SURROUNDING THE SPINAL CORD],[SPACE SURROUNDING THE SPINAL CORD],[BACLOFEN],TWrex-treat
789779107,9/16/2015 23:44:09,1739961369,9/16/2015 23:44:01,False,instagc,0.7440000000000001,20043586,USA,NY,Gansevoort,67.248.253.125,[BACLOFEN] treats [SPACE SURROUNDING THE SPINAL CORD],56,18,,89,25,treats,0.569209978830308,218329,The pump delivers [BACLOFEN] via a catheter to the thecal [SPACE SURROUNDING THE SPINAL CORD],[SPACE SURROUNDING THE SPINAL CORD],[BACLOFEN],TWrex-treat
789779107,9/16/2015 23:56:34,1739964813,9/16/2015 23:55:56,False,clixsense,0.8798,33115750,GBR,I3,Rochester,90.222.106.192,[BACLOFEN] treats [SPACE SURROUNDING THE SPINAL CORD],56,18,,89,25,treats,0.569209978830308,218329,The pump delivers [BACLOFEN] via a catheter to the thecal [SPACE SURROUNDING THE SPINAL CORD],[SPACE SURROUNDING THE SPINAL CORD],[BACLOFEN],TWrex-treat
789779112,9/16/2015 19:46:49,1739792527,9/16/2015 19:46:02,False,clixsense,0.9722,30681826,GBR,I9,Diss,31.49.71.254,DIURETIC treats FLUID RETENTION,20,67,,35,75,treats,0.986393923832144,221950,"Diazoxide can cause [FLUID RETENTION] requiring concomitant use of a [DIURETIC], and prolonged use causes hypertrichosis.",FLUID RETENTION,DIURETIC,TWrex-treat
789779112,9/16/2015 19:54:00,1739795949,9/16/2015 19:53:22,False,neodev,0.8806,30627835,GBR,D8,Bishop Auckland,217.44.84.223,DIURETIC treats FLUID RETENTION,20,67,,35,75,treats,0.986393923832144,221950,"Diazoxide can cause [FLUID RETENTION] requiring concomitant use of a [DIURETIC], and prolonged use causes hypertrichosis.",FLUID RETENTION,DIURETIC,TWrex-treat
789779112,9/16/2015 19:57:21,1739797719,9/16/2015 19:56:14,False,clixsense,0.8944,33878524,CAN,BC,Princeton,75.156.83.71,DIURETIC treats FLUID RETENTION,20,67,,35,75,treats,0.986393923832144,221950,"Diazoxide can cause [FLUID RETENTION] requiring concomitant use of a [DIURETIC], and prolonged use causes hypertrichosis.",FLUID RETENTION,DIURETIC,TWrex-treat
789779112,9/16/2015 20:06:35,1739803249,9/16/2015 20:05:41,False,clixsense,0.8323,21875134,GBR,,,80.189.12.98,DIURETIC treats FLUID RETENTION,20,67,,35,75,treats,0.986393923832144,221950,"Diazoxide can cause [FLUID RETENTION] requiring concomitant use of a [DIURETIC], and prolonged use causes hypertrichosis.",FLUID RETENTION,DIURETIC,TWrex-treat
789779112,9/16/2015 20:10:11,1739807194,9/16/2015 20:10:05,False,tremorgames,0.4583,24449707,CAN,QC,Laval,96.20.14.148,no_relation,20,67,,35,75,treats,0.986393923832144,221950,"Diazoxide can cause [FLUID RETENTION] requiring concomitant use of a [DIURETIC], and prolonged use causes hypertrichosis.",FLUID RETENTION,DIURETIC,TWrex-treat
789779112,9/16/2015 20:11:33,1739808632,9/16/2015 20:10:58,False,clixsense,0.7877,32053717,GBR,,,51.174.76.80,FLUID RETENTION treats DIURETIC,20,67,,35,75,treats,0.986393923832144,221950,"Diazoxide can cause [FLUID RETENTION] requiring concomitant use of a [DIURETIC], and prolonged use causes hypertrichosis.",FLUID RETENTION,DIURETIC,TWrex-treat
789779112,9/16/2015 20:13:08,1739810072,9/16/2015 20:12:57,False,zoombucks,0.8929,4711962,CAN,ON,Markham,174.88.29.138,DIURETIC treats FLUID RETENTION,20,67,,35,75,treats,0.986393923832144,221950,"Diazoxide can cause [FLUID RETENTION] requiring concomitant use of a [DIURETIC], and prolonged use causes hypertrichosis.",FLUID RETENTION,DIURETIC,TWrex-treat
790084708,9/17/2015 14:26:15,1740441754,9/17/2015 14:26:04,False,neodev,0.7083,33155316,GBR,I9,Dereham,31.50.244.140,[IODINE 131 LIPIODOL] treats [VEIN THROMBUS],116,15,,129,33,treats,0.9113223768657671,214211,"Intra arterial [IODINE 131 LIPIODOL] administration Efficacy demonstrated in unresectable patients, those with portal [VEIN THROMBUS]",[VEIN THROMBUS],[IODINE 131 LIPIODOL],TWrex-treat
790084708,9/17/2015 14:34:02,1740444779,9/17/2015 14:33:24,False,clixsense,0.7798,20587495,CAN,NL,St. John's,142.162.225.210,[IODINE 131 LIPIODOL] treats [VEIN THROMBUS],116,15,,129,33,treats,0.9113223768657671,214211,"Intra arterial [IODINE 131 LIPIODOL] administration Efficacy demonstrated in unresectable patients, those with portal [VEIN THROMBUS]",[VEIN THROMBUS],[IODINE 131 LIPIODOL],TWrex-treat
790084708,9/17/2015 14:38:59,1740446683,9/17/2015 14:38:40,False,tremorgames,0.7167,31906954,USA,NY,Goshen,184.9.83.232,[IODINE 131 LIPIODOL] treats [VEIN THROMBUS],116,15,,129,33,treats,0.9113223768657671,214211,"Intra arterial [IODINE 131 LIPIODOL] administration Efficacy demonstrated in unresectable patients, those with portal [VEIN THROMBUS]",[VEIN THROMBUS],[IODINE 131 LIPIODOL],TWrex-treat
790084708,9/17/2015 14:41:57,1740447993,9/17/2015 14:41:31,False,prodege,0.7421,27934334,GBR,C8,Croydon,81.159.60.206,[IODINE 131 LIPIODOL] treats [VEIN THROMBUS],116,15,,129,33,treats,0.9113223768657671,214211,"Intra arterial [IODINE 131 LIPIODOL] administration Efficacy demonstrated in unresectable patients, those with portal [VEIN THROMBUS]",[VEIN THROMBUS],[IODINE 131 LIPIODOL],TWrex-treat
790084708,9/17/2015 14:43:43,1740448691,9/17/2015 14:42:31,False,zoombucks,0.8806,6744840,CAN,BC,Kelowna,174.4.58.160,[IODINE 131 LIPIODOL] treats [VEIN THROMBUS],116,15,,129,33,treats,0.9113223768657671,214211,"Intra arterial [IODINE 131 LIPIODOL] administration Efficacy demonstrated in unresectable patients, those with portal [VEIN THROMBUS]",[VEIN THROMBUS],[IODINE 131 LIPIODOL],TWrex-treat
790084708,9/17/2015 15:01:25,1740455399,9/17/2015 15:00:53,False,instagc,0.6935,22981457,CAN,ON,Ottawa,67.69.8.122,[IODINE 131 LIPIODOL] treats [VEIN THROMBUS],116,15,,129,33,treats,0.9113223768657671,214211,"Intra arterial [IODINE 131 LIPIODOL] administration Efficacy demonstrated in unresectable patients, those with portal [VEIN THROMBUS]",[VEIN THROMBUS],[IODINE 131 LIPIODOL],TWrex-treat
790084708,9/17/2015 15:18:03,1740460939,9/17/2015 15:17:45,False,prodege,0.8849,14848125,GBR,V8,Airdrie,86.151.77.161,[IODINE 131 LIPIODOL] treats [VEIN THROMBUS],116,15,,129,33,treats,0.9113223768657671,214211,"Intra arterial [IODINE 131 LIPIODOL] administration Efficacy demonstrated in unresectable patients, those with portal [VEIN THROMBUS]",[VEIN THROMBUS],[IODINE 131 LIPIODOL],TWrex-treat
790084710,9/17/2015 13:57:05,1740431255,9/17/2015 13:56:49,False,tremorgames,0.894,32916723,USA,NY,Attica,70.209.139.92,HEPARIN treats PULMONARY EMBOLISM,74,32,,91,39,treats,1.0,803544,Low molecular weight heparin vs HEPARIN in the treatment of patients with PULMONARY EMBOLISM,PULMONARY EMBOLISM,HEPARIN,TWrex-cause
790084710,9/17/2015 13:57:20,1740431354,9/17/2015 13:56:12,False,clixsense,0.7508,6336109,CAN,BC,Prince George,198.254.211.52,HEPARIN treats PULMONARY EMBOLISM,74,32,,91,39,treats,1.0,803544,Low molecular weight heparin vs HEPARIN in the treatment of patients with PULMONARY EMBOLISM,PULMONARY EMBOLISM,HEPARIN,TWrex-cause
790084710,9/17/2015 13:57:52,1740431545,9/17/2015 13:57:17,False,clixsense,0.7631,30258829,NLD,05,Velden,84.104.254.214,HEPARIN treats PULMONARY EMBOLISM,74,32,,91,39,treats,1.0,803544,Low molecular weight heparin vs HEPARIN in the treatment of patients with PULMONARY EMBOLISM,PULMONARY EMBOLISM,HEPARIN,TWrex-cause
790084710,9/17/2015 14:01:28,1740432814,9/17/2015 14:00:34,False,neodev,0.7518,33758777,USA,,,38.95.108.251,HEPARIN treats PULMONARY EMBOLISM,74,32,,91,39,treats,1.0,803544,Low molecular weight heparin vs HEPARIN in the treatment of patients with PULMONARY EMBOLISM,PULMONARY EMBOLISM,HEPARIN,TWrex-cause
790084710,9/17/2015 14:02:13,1740433138,9/17/2015 14:01:46,False,points4rewards,0.7685,28755767,USA,VA,Chester,68.57.118.32,HEPARIN treats PULMONARY EMBOLISM,74,32,,91,39,treats,1.0,803544,Low molecular weight heparin vs HEPARIN in the treatment of patients with PULMONARY EMBOLISM,PULMONARY EMBOLISM,HEPARIN,TWrex-cause
790084710,9/17/2015 14:05:48,1740434394,9/17/2015 14:05:26,False,onestopgpt,0.8512,21275875,CAN,ON,Hamilton,24.36.124.79,HEPARIN treats PULMONARY EMBOLISM,74,32,,91,39,treats,1.0,803544,Low molecular weight heparin vs HEPARIN in the treatment of patients with PULMONARY EMBOLISM,PULMONARY EMBOLISM,HEPARIN,TWrex-cause
790084710,9/17/2015 14:06:20,1740434651,9/17/2015 14:06:01,False,elite,0.8036,30507455,CAN,BC,Richmond,174.6.137.222,HEPARIN treats PULMONARY EMBOLISM,74,32,,91,39,treats,1.0,803544,Low molecular weight heparin vs HEPARIN in the treatment of patients with PULMONARY EMBOLISM,PULMONARY EMBOLISM,HEPARIN,TWrex-cause
790084726,9/17/2015 12:29:56,1740403556,9/17/2015 12:28:37,False,clixsense,0.9881,21490235,GBR,N7,Woking,86.30.254.232,MSM treats HAYFEVER,78,70,,86,73,treats,0.99654575824488,220103,Seasonal Allergic Rhinitis: Barrager et al. evaluated the efficacy of [MSM] for [HAYFEVER].,HAYFEVER,MSM,TWrex-treat
790084726,9/17/2015 12:45:18,1740407646,9/17/2015 12:42:16,False,neodev,0.9028,18881135,CAN,ON,Ajax,99.243.87.224,MSM treats HAYFEVER,78,70,,86,73,treats,0.99654575824488,220103,Seasonal Allergic Rhinitis: Barrager et al. evaluated the efficacy of [MSM] for [HAYFEVER].,HAYFEVER,MSM,TWrex-treat
790084726,9/17/2015 12:55:50,1740410461,9/17/2015 12:55:33,False,clixsense,0.9292,10390268,USA,NY,New Paltz,100.40.130.164,MSM treats HAYFEVER,78,70,,86,73,treats,0.99654575824488,220103,Seasonal Allergic Rhinitis: Barrager et al. evaluated the efficacy of [MSM] for [HAYFEVER].,HAYFEVER,MSM,TWrex-treat
790084726,9/17/2015 12:56:01,1740410553,9/17/2015 12:55:30,False,clixsense,0.8792,21875134,GBR,,,80.189.12.98,MSM treats HAYFEVER,78,70,,86,73,treats,0.99654575824488,220103,Seasonal Allergic Rhinitis: Barrager et al. evaluated the efficacy of [MSM] for [HAYFEVER].,HAYFEVER,MSM,TWrex-treat
790084726,9/17/2015 13:04:32,1740412851,9/17/2015 13:04:04,False,clixsense,0.6516,17950689,GBR,L9,Sheffield,146.200.192.103,MSM treats HAYFEVER,78,70,,86,73,treats,0.99654575824488,220103,Seasonal Allergic Rhinitis: Barrager et al. evaluated the efficacy of [MSM] for [HAYFEVER].,HAYFEVER,MSM,TWrex-treat
790084726,9/17/2015 13:16:13,1740416262,9/17/2015 13:15:56,False,instagc,0.8643,13581319,USA,IL,Trenton,208.70.36.12,MSM treats HAYFEVER,78,70,,86,73,treats,0.99654575824488,220103,Seasonal Allergic Rhinitis: Barrager et al. evaluated the efficacy of [MSM] for [HAYFEVER].,HAYFEVER,MSM,TWrex-treat
790084726,9/17/2015 13:17:03,1740416496,9/17/2015 13:16:34,False,prodege,0.8631,34236350,USA,IA,Des Moines,63.153.219.233,MSM treats HAYFEVER,78,70,,86,73,treats,0.99654575824488,220103,Seasonal Allergic Rhinitis: Barrager et al. evaluated the efficacy of [MSM] for [HAYFEVER].,HAYFEVER,MSM,TWrex-treat
790084729,9/17/2015 11:38:47,1740392914,9/17/2015 11:38:18,False,neodev,0.9127,30588889,NLD,07,Amsterdam,77.248.175.222,no_relation,42,14,,50,25,treats,0.8551861104941371,212140,<ref> ICAAC: N[OVEL ANTIBIO]tic Stops Travel[ERS' DIAR]rhea.,[ERS' DIAR],[OVEL ANTIBIO],TWrex-treat
790084729,9/17/2015 11:51:23,1740395347,9/17/2015 11:50:50,False,neodev,0.9464,12115558,USA,OH,Twinsburg,98.27.164.131,[OVEL ANTIBIO] treats [ERS' DIAR],42,14,,50,25,treats,0.8551861104941371,212140,<ref> ICAAC: N[OVEL ANTIBIO]tic Stops Travel[ERS' DIAR]rhea.,[ERS' DIAR],[OVEL ANTIBIO],TWrex-treat
790084729,9/17/2015 11:53:35,1740395731,9/17/2015 11:53:07,False,elite,0.9722,29768955,GBR,C3,Gamlingay,31.50.187.165,no_relation,42,14,,50,25,treats,0.8551861104941371,212140,<ref> ICAAC: N[OVEL ANTIBIO]tic Stops Travel[ERS' DIAR]rhea.,[ERS' DIAR],[OVEL ANTIBIO],TWrex-treat
790084729,9/17/2015 11:56:41,1740396392,9/17/2015 11:56:08,False,bitcoinget,0.7528,32306192,USA,TX,Austin,172.11.109.161,[OVEL ANTIBIO] treats [ERS' DIAR],42,14,,50,25,treats,0.8551861104941371,212140,<ref> ICAAC: N[OVEL ANTIBIO]tic Stops Travel[ERS' DIAR]rhea.,[ERS' DIAR],[OVEL ANTIBIO],TWrex-treat
790084729,9/17/2015 12:02:05,1740397464,9/17/2015 12:01:25,False,gifthulk,0.9042,18666417,USA,PA,Meadville,24.101.32.13,no_relation,42,14,,50,25,treats,0.8551861104941371,212140,<ref> ICAAC: N[OVEL ANTIBIO]tic Stops Travel[ERS' DIAR]rhea.,[ERS' DIAR],[OVEL ANTIBIO],TWrex-treat
790084729,9/17/2015 12:05:47,1740398244,9/17/2015 12:05:18,False,prodege,0.8929,3587109,CAN,NS,Eskasoni,142.134.240.160,[OVEL ANTIBIO] treats [ERS' DIAR],42,14,,50,25,treats,0.8551861104941371,212140,<ref> ICAAC: N[OVEL ANTIBIO]tic Stops Travel[ERS' DIAR]rhea.,[ERS' DIAR],[OVEL ANTIBIO],TWrex-treat
790084729,9/17/2015 12:12:01,1740399648,9/17/2015 12:09:41,False,prodege,0.9337,3056891,CAN,ON,Niagara Falls,173.238.144.19,[OVEL ANTIBIO] treats [ERS' DIAR],42,14,,50,25,treats,0.8551861104941371,212140,<ref> ICAAC: N[OVEL ANTIBIO]tic Stops Travel[ERS' DIAR]rhea.,[ERS' DIAR],[OVEL ANTIBIO],TWrex-treat
790084737,9/17/2015 14:02:50,1740433320,9/17/2015 14:01:57,False,neodev,0.7518,33758777,USA,,,38.95.108.251,no_relation,103,49,,133,80,treats,0.371390676354104,906013,This procedure has been used in 87 patients with UNILATERAL HEMIFACIAL MICROSOMIA and 19 patients with BILATERAL MANDIBULAR HYPOPLASIA,BILATERAL MANDIBULAR HYPOPLASIA,UNILATERAL HEMIFACIAL MICROSOMIA,RO-has_manifestation
790084737,9/17/2015 14:03:14,1740433444,9/17/2015 14:02:49,False,points4rewards,0.7685,28755767,USA,VA,Chester,68.57.118.32,no_relation,103,49,,133,80,treats,0.371390676354104,906013,This procedure has been used in 87 patients with UNILATERAL HEMIFACIAL MICROSOMIA and 19 patients with BILATERAL MANDIBULAR HYPOPLASIA,BILATERAL MANDIBULAR HYPOPLASIA,UNILATERAL HEMIFACIAL MICROSOMIA,RO-has_manifestation
790084737,9/17/2015 14:06:52,1740434848,9/17/2015 14:06:37,False,elite,0.8036,30507455,CAN,BC,Richmond,174.6.137.222,no_relation,103,49,,133,80,treats,0.371390676354104,906013,This procedure has been used in 87 patients with UNILATERAL HEMIFACIAL MICROSOMIA and 19 patients with BILATERAL MANDIBULAR HYPOPLASIA,BILATERAL MANDIBULAR HYPOPLASIA,UNILATERAL HEMIFACIAL MICROSOMIA,RO-has_manifestation
790084737,9/17/2015 14:07:17,1740435003,9/17/2015 14:06:38,False,onestopgpt,0.8512,21275875,CAN,ON,Hamilton,24.36.124.79,no_relation,103,49,,133,80,treats,0.371390676354104,906013,This procedure has been used in 87 patients with UNILATERAL HEMIFACIAL MICROSOMIA and 19 patients with BILATERAL MANDIBULAR HYPOPLASIA,BILATERAL MANDIBULAR HYPOPLASIA,UNILATERAL HEMIFACIAL MICROSOMIA,RO-has_manifestation
790084737,9/17/2015 14:18:02,1740439060,9/17/2015 14:17:26,False,elite,0.8452,33238902,NLD,06,Budel,77.248.148.5,no_relation,103,49,,133,80,treats,0.371390676354104,906013,This procedure has been used in 87 patients with UNILATERAL HEMIFACIAL MICROSOMIA and 19 patients with BILATERAL MANDIBULAR HYPOPLASIA,BILATERAL MANDIBULAR HYPOPLASIA,UNILATERAL HEMIFACIAL MICROSOMIA,RO-has_manifestation
790084737,9/17/2015 14:25:22,1740441430,9/17/2015 14:25:10,False,neodev,0.7083,33155316,GBR,I9,Dereham,31.50.244.140,UNILATERAL HEMIFACIAL MICROSOMIA treats BILATERAL MANDIBULAR HYPOPLASIA,103,49,,133,80,treats,0.371390676354104,906013,This procedure has been used in 87 patients with UNILATERAL HEMIFACIAL MICROSOMIA and 19 patients with BILATERAL MANDIBULAR HYPOPLASIA,BILATERAL MANDIBULAR HYPOPLASIA,UNILATERAL HEMIFACIAL MICROSOMIA,RO-has_manifestation
790084737,9/17/2015 14:31:39,1740443935,9/17/2015 14:31:00,False,clixsense,0.7798,20587495,CAN,NL,St. John's,142.162.225.210,no_relation,103,49,,133,80,treats,0.371390676354104,906013,This procedure has been used in 87 patients with UNILATERAL HEMIFACIAL MICROSOMIA and 19 patients with BILATERAL MANDIBULAR HYPOPLASIA,BILATERAL MANDIBULAR HYPOPLASIA,UNILATERAL HEMIFACIAL MICROSOMIA,RO-has_manifestation
790084745,9/17/2015 09:49:25,1740370643,9/17/2015 09:48:58,False,vivatic,0.9722,32338429,GBR,N7,Guildford,92.21.219.178,no_relation,153,18,,169,28,treats,0.668153104781061,813966,"In cases of known METASTASES surgical resection of the kidney ('cytoreductive nephrectomy') may improve survival,[43] as well as resection of a solitary METASTATIC LESION...",METASTATIC LESION,METASTASES,TWrex-cause
790084745,9/17/2015 10:19:12,1740377709,9/17/2015 10:17:59,False,pocketmoneygpt,0.8115,21432964,GBR,F8,Borehamwood,81.159.185.70,no_relation,153,18,,169,28,treats,0.668153104781061,813966,"In cases of known METASTASES surgical resection of the kidney ('cytoreductive nephrectomy') may improve survival,[43] as well as resection of a solitary METASTATIC LESION...",METASTATIC LESION,METASTASES,TWrex-cause
790084745,9/17/2015 10:20:16,1740377902,9/17/2015 10:18:57,False,eup_slw,0.8671,32718504,AUS,,,1.128.96.45,no_relation,153,18,,169,28,treats,0.668153104781061,813966,"In cases of known METASTASES surgical resection of the kidney ('cytoreductive nephrectomy') may improve survival,[43] as well as resection of a solitary METASTATIC LESION...",METASTATIC LESION,METASTASES,TWrex-cause
790084745,9/17/2015 11:11:17,1740387878,9/17/2015 11:03:35,False,points4rewards,0.7611,20113482,USA,PA,Philadelphia,162.208.49.45,no_relation,153,18,,169,28,treats,0.668153104781061,813966,"In cases of known METASTASES surgical resection of the kidney ('cytoreductive nephrectomy') may improve survival,[43] as well as resection of a solitary METASTATIC LESION...",METASTATIC LESION,METASTASES,TWrex-cause
790084745,9/17/2015 11:37:23,1740392561,9/17/2015 11:36:26,False,neodev,0.9127,30588889,NLD,07,Amsterdam,77.248.175.222,no_relation,153,18,,169,28,treats,0.668153104781061,813966,"In cases of known METASTASES surgical resection of the kidney ('cytoreductive nephrectomy') may improve survival,[43] as well as resection of a solitary METASTATIC LESION...",METASTATIC LESION,METASTASES,TWrex-cause
790084745,9/17/2015 11:45:18,1740394109,9/17/2015 11:45:11,False,neodev,0.3333,33701549,USA,CA,Torrance,66.171.228.66,METASTATIC LESION treats METASTASES,153,18,,169,28,treats,0.668153104781061,813966,"In cases of known METASTASES surgical resection of the kidney ('cytoreductive nephrectomy') may improve survival,[43] as well as resection of a solitary METASTATIC LESION...",METASTATIC LESION,METASTASES,TWrex-cause
790084745,9/17/2015 11:50:32,1740395218,9/17/2015 11:49:58,False,neodev,0.9464,12115558,USA,OH,Twinsburg,98.27.164.131,no_relation,153,18,,169,28,treats,0.668153104781061,813966,"In cases of known METASTASES surgical resection of the kidney ('cytoreductive nephrectomy') may improve survival,[43] as well as resection of a solitary METASTATIC LESION...",METASTATIC LESION,METASTASES,TWrex-cause
790084746,9/17/2015 14:02:50,1740433321,9/17/2015 14:01:57,False,neodev,0.7518,33758777,USA,,,38.95.108.251,[SYSTEMIC MONTELUKAST] treats [OCULAR ITCHING],118,9,,131,29,treats,0.997176464952738,206323,"However, [SYSTEMIC MONTELUKAST] as expected, provided better relief for symptoms distant from the nasal cavity such as [OCULAR ITCHING] and throat/palate itching.",[OCULAR ITCHING],[SYSTEMIC MONTELUKAST],TWrex-treat
790084746,9/17/2015 14:03:14,1740433443,9/17/2015 14:02:49,False,points4rewards,0.7685,28755767,USA,VA,Chester,68.57.118.32,[SYSTEMIC MONTELUKAST] treats [OCULAR ITCHING],118,9,,131,29,treats,0.997176464952738,206323,"However, [SYSTEMIC MONTELUKAST] as expected, provided better relief for symptoms distant from the nasal cavity such as [OCULAR ITCHING] and throat/palate itching.",[OCULAR ITCHING],[SYSTEMIC MONTELUKAST],TWrex-treat
790084746,9/17/2015 14:06:52,1740434850,9/17/2015 14:06:37,False,elite,0.8036,30507455,CAN,BC,Richmond,174.6.137.222,[SYSTEMIC MONTELUKAST] treats [OCULAR ITCHING],118,9,,131,29,treats,0.997176464952738,206323,"However, [SYSTEMIC MONTELUKAST] as expected, provided better relief for symptoms distant from the nasal cavity such as [OCULAR ITCHING] and throat/palate itching.",[OCULAR ITCHING],[SYSTEMIC MONTELUKAST],TWrex-treat
790084746,9/17/2015 14:07:17,1740435001,9/17/2015 14:06:38,False,onestopgpt,0.8512,21275875,CAN,ON,Hamilton,24.36.124.79,[SYSTEMIC MONTELUKAST] treats [OCULAR ITCHING],118,9,,131,29,treats,0.997176464952738,206323,"However, [SYSTEMIC MONTELUKAST] as expected, provided better relief for symptoms distant from the nasal cavity such as [OCULAR ITCHING] and throat/palate itching.",[OCULAR ITCHING],[SYSTEMIC MONTELUKAST],TWrex-treat
790084746,9/17/2015 14:18:02,1740439052,9/17/2015 14:17:26,False,elite,0.8452,33238902,NLD,06,Budel,77.248.148.5,[SYSTEMIC MONTELUKAST] treats [OCULAR ITCHING],118,9,,131,29,treats,0.997176464952738,206323,"However, [SYSTEMIC MONTELUKAST] as expected, provided better relief for symptoms distant from the nasal cavity such as [OCULAR ITCHING] and throat/palate itching.",[OCULAR ITCHING],[SYSTEMIC MONTELUKAST],TWrex-treat
790084746,9/17/2015 14:25:22,1740441429,9/17/2015 14:25:10,False,neodev,0.7083,33155316,GBR,I9,Dereham,31.50.244.140,[SYSTEMIC MONTELUKAST] treats [OCULAR ITCHING],118,9,,131,29,treats,0.997176464952738,206323,"However, [SYSTEMIC MONTELUKAST] as expected, provided better relief for symptoms distant from the nasal cavity such as [OCULAR ITCHING] and throat/palate itching.",[OCULAR ITCHING],[SYSTEMIC MONTELUKAST],TWrex-treat
790084746,9/17/2015 14:31:39,1740443933,9/17/2015 14:31:00,False,clixsense,0.7798,20587495,CAN,NL,St. John's,142.162.225.210,[SYSTEMIC MONTELUKAST] treats [OCULAR ITCHING],118,9,,131,29,treats,0.997176464952738,206323,"However, [SYSTEMIC MONTELUKAST] as expected, provided better relief for symptoms distant from the nasal cavity such as [OCULAR ITCHING] and throat/palate itching.",[OCULAR ITCHING],[SYSTEMIC MONTELUKAST],TWrex-treat
790084747,9/17/2015 15:52:41,1740475014,9/17/2015 15:52:20,False,prodege,0.9694,13300986,CAN,AB,Edmonton,68.150.40.134,no_relation,93,39,,109,50,treats,0.9970544855015809,803578,DRUG THERAPY  Introduction  Administer FACTOR VIII or factor IX replacement in patients with HEMOPHILIA A OR B for treatment of or prophylaxis against bleeding.,HEMOPHILIA A OR B,FACTOR VIII,TWrex-cause
790084747,9/17/2015 16:04:15,1740480316,9/17/2015 16:03:51,False,dailyrewardsca,0.9214,32219778,CAN,ON,Ottawa,99.241.19.27,no_relation,93,39,,109,50,treats,0.9970544855015809,803578,DRUG THERAPY  Introduction  Administer FACTOR VIII or factor IX replacement in patients with HEMOPHILIA A OR B for treatment of or prophylaxis against bleeding.,HEMOPHILIA A OR B,FACTOR VIII,TWrex-cause
790084747,9/17/2015 16:25:51,1740489501,9/17/2015 16:25:33,False,prodege,0.8056,22031444,GBR,K6,Portsmouth,78.146.10.68,no_relation,93,39,,109,50,treats,0.9970544855015809,803578,DRUG THERAPY  Introduction  Administer FACTOR VIII or factor IX replacement in patients with HEMOPHILIA A OR B for treatment of or prophylaxis against bleeding.,HEMOPHILIA A OR B,FACTOR VIII,TWrex-cause
790084747,9/17/2015 16:36:08,1740493574,9/17/2015 16:35:38,False,cotter,0.7679,33673171,USA,MO,Saint Louis,24.207.217.12,FACTOR VIII treats HEMOPHILIA A OR B,93,39,,109,50,treats,0.9970544855015809,803578,DRUG THERAPY  Introduction  Administer FACTOR VIII or factor IX replacement in patients with HEMOPHILIA A OR B for treatment of or prophylaxis against bleeding.,HEMOPHILIA A OR B,FACTOR VIII,TWrex-cause
790084747,9/17/2015 16:53:15,1740500689,9/17/2015 16:52:44,False,prodege,0.7917,34271751,CAN,ON,Toronto,38.116.192.247,FACTOR VIII treats HEMOPHILIA A OR B,93,39,,109,50,treats,0.9970544855015809,803578,DRUG THERAPY  Introduction  Administer FACTOR VIII or factor IX replacement in patients with HEMOPHILIA A OR B for treatment of or prophylaxis against bleeding.,HEMOPHILIA A OR B,FACTOR VIII,TWrex-cause
790084747,9/17/2015 16:53:32,1740500820,9/17/2015 16:53:24,False,superrewards,0.5833,33199643,USA,WI,La Crosse,138.49.2.136,FACTOR VIII treats HEMOPHILIA A OR B,93,39,,109,50,treats,0.9970544855015809,803578,DRUG THERAPY  Introduction  Administer FACTOR VIII or factor IX replacement in patients with HEMOPHILIA A OR B for treatment of or prophylaxis against bleeding.,HEMOPHILIA A OR B,FACTOR VIII,TWrex-cause
790084747,9/17/2015 16:56:23,1740502402,9/17/2015 16:55:40,False,keeprewarding,0.5417,29139615,CAN,ON,North Bay,70.30.60.217,FACTOR VIII treats HEMOPHILIA A OR B,93,39,,109,50,treats,0.9970544855015809,803578,DRUG THERAPY  Introduction  Administer FACTOR VIII or factor IX replacement in patients with HEMOPHILIA A OR B for treatment of or prophylaxis against bleeding.,HEMOPHILIA A OR B,FACTOR VIII,TWrex-cause
790084748,9/17/2015 15:53:09,1740475362,9/17/2015 15:52:42,False,prodege,0.9694,13300986,CAN,AB,Edmonton,68.150.40.134,no_relation,44,0,,55,12,treats,0.597614304667197,210667,[ALGINIC ACID] may coat the mucosa as well as [INCREASE PH] and decrease reflux.,INCREASE PH,ALGINIC ACID,TWrex-treat
790084748,9/17/2015 16:04:29,1740480407,9/17/2015 16:04:16,False,dailyrewardsca,0.9214,32219778,CAN,ON,Ottawa,99.241.19.27,no_relation,44,0,,55,12,treats,0.597614304667197,210667,[ALGINIC ACID] may coat the mucosa as well as [INCREASE PH] and decrease reflux.,INCREASE PH,ALGINIC ACID,TWrex-treat
790084748,9/17/2015 16:26:20,1740489751,9/17/2015 16:25:53,False,prodege,0.8056,22031444,GBR,K6,Portsmouth,78.146.10.68,no_relation,44,0,,55,12,treats,0.597614304667197,210667,[ALGINIC ACID] may coat the mucosa as well as [INCREASE PH] and decrease reflux.,INCREASE PH,ALGINIC ACID,TWrex-treat
790084748,9/17/2015 16:36:48,1740493787,9/17/2015 16:36:10,False,cotter,0.7679,33673171,USA,MO,Saint Louis,24.207.217.12,no_relation,44,0,,55,12,treats,0.597614304667197,210667,[ALGINIC ACID] may coat the mucosa as well as [INCREASE PH] and decrease reflux.,INCREASE PH,ALGINIC ACID,TWrex-treat
790084748,9/17/2015 16:54:02,1740501090,9/17/2015 16:53:16,False,prodege,0.7917,34271751,CAN,ON,Toronto,38.116.192.247,no_relation,44,0,,55,12,treats,0.597614304667197,210667,[ALGINIC ACID] may coat the mucosa as well as [INCREASE PH] and decrease reflux.,INCREASE PH,ALGINIC ACID,TWrex-treat
790084748,9/17/2015 16:56:53,1740502567,9/17/2015 16:56:23,False,keeprewarding,0.5417,29139615,CAN,ON,North Bay,70.30.60.217,ALGINIC ACID treats INCREASE PH,44,0,,55,12,treats,0.597614304667197,210667,[ALGINIC ACID] may coat the mucosa as well as [INCREASE PH] and decrease reflux.,INCREASE PH,ALGINIC ACID,TWrex-treat
790084748,9/17/2015 17:06:58,1740505838,9/17/2015 17:06:41,False,gifthunterclub,0.2143,30901412,GBR,G5,Margate,85.210.114.34,ALGINIC ACID treats INCREASE PH,44,0,,55,12,treats,0.597614304667197,210667,[ALGINIC ACID] may coat the mucosa as well as [INCREASE PH] and decrease reflux.,INCREASE PH,ALGINIC ACID,TWrex-treat
790084751,9/17/2015 11:54:55,1740396037,9/17/2015 11:54:33,False,elite,0.9722,29768955,GBR,C3,Gamlingay,31.50.187.165,DISOPYRAMIDE treats COUPLET,137,14,,144,26,treats,0.997458699830735,205399,"Compared with [DISOPYRAMIDE] and quinidine, moricizine was equally or more effective in suppressing ventricular premature depolarizations, [COUPLET]s, and nonsustained ventricular tachycardia.",COUPLET,DISOPYRAMIDE,TWrex-treat
790084751,9/17/2015 11:58:31,1740396803,9/17/2015 11:58:03,False,bitcoinget,0.7528,32306192,USA,TX,Austin,172.11.109.161,no_relation,137,14,,144,26,treats,0.997458699830735,205399,"Compared with [DISOPYRAMIDE] and quinidine, moricizine was equally or more effective in suppressing ventricular premature depolarizations, [COUPLET]s, and nonsustained ventricular tachycardia.",COUPLET,DISOPYRAMIDE,TWrex-treat
790084751,9/17/2015 12:04:47,1740398036,9/17/2015 12:04:17,False,gifthulk,0.9042,18666417,USA,PA,Meadville,24.101.32.13,DISOPYRAMIDE treats COUPLET,137,14,,144,26,treats,0.997458699830735,205399,"Compared with [DISOPYRAMIDE] and quinidine, moricizine was equally or more effective in suppressing ventricular premature depolarizations, [COUPLET]s, and nonsustained ventricular tachycardia.",COUPLET,DISOPYRAMIDE,TWrex-treat
790084751,9/17/2015 12:11:49,1740399588,9/17/2015 12:11:34,False,prodege,0.9438,9169061,CAN,ON,Kitchener,99.235.192.130,DISOPYRAMIDE treats COUPLET,137,14,,144,26,treats,0.997458699830735,205399,"Compared with [DISOPYRAMIDE] and quinidine, moricizine was equally or more effective in suppressing ventricular premature depolarizations, [COUPLET]s, and nonsustained ventricular tachycardia.",COUPLET,DISOPYRAMIDE,TWrex-treat
790084751,9/17/2015 12:15:03,1740400374,9/17/2015 12:14:17,False,prodege,0.9337,3056891,CAN,ON,Niagara Falls,173.238.144.19,DISOPYRAMIDE treats COUPLET,137,14,,144,26,treats,0.997458699830735,205399,"Compared with [DISOPYRAMIDE] and quinidine, moricizine was equally or more effective in suppressing ventricular premature depolarizations, [COUPLET]s, and nonsustained ventricular tachycardia.",COUPLET,DISOPYRAMIDE,TWrex-treat
790084751,9/17/2015 12:22:10,1740401757,9/17/2015 12:21:45,False,gifthulk,0.9742,24928180,GBR,M1,Slough,90.208.18.156,DISOPYRAMIDE treats COUPLET,137,14,,144,26,treats,0.997458699830735,205399,"Compared with [DISOPYRAMIDE] and quinidine, moricizine was equally or more effective in suppressing ventricular premature depolarizations, [COUPLET]s, and nonsustained ventricular tachycardia.",COUPLET,DISOPYRAMIDE,TWrex-treat
790084751,9/17/2015 12:26:58,1740402938,9/17/2015 12:26:44,False,clixsense,0.9881,21490235,GBR,N7,Woking,86.30.254.232,DISOPYRAMIDE treats COUPLET,137,14,,144,26,treats,0.997458699830735,205399,"Compared with [DISOPYRAMIDE] and quinidine, moricizine was equally or more effective in suppressing ventricular premature depolarizations, [COUPLET]s, and nonsustained ventricular tachycardia.",COUPLET,DISOPYRAMIDE,TWrex-treat
790084752,9/17/2015 13:17:15,1740416541,9/17/2015 13:17:07,False,instagc,0.8643,13581319,USA,IL,Trenton,208.70.36.12,MALATHION treats HEAD LICE,27,0,,35,9,treats,1.0,804184,MALATHION for treatment of HEAD LICE,HEAD LICE,MALATHION,TWrex-cause
790084752,9/17/2015 13:17:58,1740416768,9/17/2015 13:17:43,False,clixsense,0.9464,22751911,NLD,04,Groningen,195.241.153.97,MALATHION treats HEAD LICE,27,0,,35,9,treats,1.0,804184,MALATHION for treatment of HEAD LICE,HEAD LICE,MALATHION,TWrex-cause
790084752,9/17/2015 13:18:43,1740416974,9/17/2015 13:18:16,False,prodege,0.8631,34236350,USA,IA,Des Moines,63.153.219.233,MALATHION treats HEAD LICE,27,0,,35,9,treats,1.0,804184,MALATHION for treatment of HEAD LICE,HEAD LICE,MALATHION,TWrex-cause
790084752,9/17/2015 13:19:53,1740417351,9/17/2015 13:19:40,False,prodege,0.925,2145087,USA,NY,New York,107.107.57.52,MALATHION treats HEAD LICE,27,0,,35,9,treats,1.0,804184,MALATHION for treatment of HEAD LICE,HEAD LICE,MALATHION,TWrex-cause
790084752,9/17/2015 13:24:12,1740418776,9/17/2015 13:24:00,False,elite,0.7131,31883685,GBR,,,79.66.244.188,MALATHION treats HEAD LICE,27,0,,35,9,treats,1.0,804184,MALATHION for treatment of HEAD LICE,HEAD LICE,MALATHION,TWrex-cause
790084752,9/17/2015 13:32:27,1740421336,9/17/2015 13:31:56,False,elite,0.8165,30782237,GBR,H9,London,164.143.240.34,MALATHION treats HEAD LICE,27,0,,35,9,treats,1.0,804184,MALATHION for treatment of HEAD LICE,HEAD LICE,MALATHION,TWrex-cause
790084752,9/17/2015 13:39:45,1740425748,9/17/2015 13:38:48,False,elite,0.8452,33238902,NLD,06,Budel,77.248.148.5,MALATHION treats HEAD LICE,27,0,,35,9,treats,1.0,804184,MALATHION for treatment of HEAD LICE,HEAD LICE,MALATHION,TWrex-cause
790084753,9/17/2015 11:52:34,1740395541,9/17/2015 11:52:13,False,neodev,0.9464,12115558,USA,OH,Twinsburg,98.27.164.131,LOVASTATIN treats HYPERCHOLESTEROLEMIA,161,117,,180,127,treats,0.964901281354015,907513,"Jones P, Kafonek S, Laurora I et al. Comparative dose efficacy study of atorvastatin versus lovastatin, pravastatin, LOVASTATIN and fluvastatin in patients with HYPERCHOLESTEROLEMIA (the CURVES study.",HYPERCHOLESTEROLEMIA,LOVASTATIN,RO-may_treat
790084753,9/17/2015 11:54:32,1740395932,9/17/2015 11:54:18,False,elite,0.9722,29768955,GBR,C3,Gamlingay,31.50.187.165,LOVASTATIN treats HYPERCHOLESTEROLEMIA,161,117,,180,127,treats,0.964901281354015,907513,"Jones P, Kafonek S, Laurora I et al. Comparative dose efficacy study of atorvastatin versus lovastatin, pravastatin, LOVASTATIN and fluvastatin in patients with HYPERCHOLESTEROLEMIA (the CURVES study.",HYPERCHOLESTEROLEMIA,LOVASTATIN,RO-may_treat
790084753,9/17/2015 11:58:01,1740396681,9/17/2015 11:57:35,False,bitcoinget,0.7528,32306192,USA,TX,Austin,172.11.109.161,LOVASTATIN treats HYPERCHOLESTEROLEMIA,161,117,,180,127,treats,0.964901281354015,907513,"Jones P, Kafonek S, Laurora I et al. Comparative dose efficacy study of atorvastatin versus lovastatin, pravastatin, LOVASTATIN and fluvastatin in patients with HYPERCHOLESTEROLEMIA (the CURVES study.",HYPERCHOLESTEROLEMIA,LOVASTATIN,RO-may_treat
790084753,9/17/2015 12:04:16,1740397935,9/17/2015 12:03:54,False,gifthulk,0.9042,18666417,USA,PA,Meadville,24.101.32.13,LOVASTATIN treats HYPERCHOLESTEROLEMIA,161,117,,180,127,treats,0.964901281354015,907513,"Jones P, Kafonek S, Laurora I et al. Comparative dose efficacy study of atorvastatin versus lovastatin, pravastatin, LOVASTATIN and fluvastatin in patients with HYPERCHOLESTEROLEMIA (the CURVES study.",HYPERCHOLESTEROLEMIA,LOVASTATIN,RO-may_treat
790084753,9/17/2015 12:11:33,1740399549,9/17/2015 12:11:12,False,prodege,0.9438,9169061,CAN,ON,Kitchener,99.235.192.130,LOVASTATIN treats HYPERCHOLESTEROLEMIA,161,117,,180,127,treats,0.964901281354015,907513,"Jones P, Kafonek S, Laurora I et al. Comparative dose efficacy study of atorvastatin versus lovastatin, pravastatin, LOVASTATIN and fluvastatin in patients with HYPERCHOLESTEROLEMIA (the CURVES study.",HYPERCHOLESTEROLEMIA,LOVASTATIN,RO-may_treat
790084753,9/17/2015 12:14:17,1740400245,9/17/2015 12:13:26,False,prodege,0.9337,3056891,CAN,ON,Niagara Falls,173.238.144.19,LOVASTATIN treats HYPERCHOLESTEROLEMIA,161,117,,180,127,treats,0.964901281354015,907513,"Jones P, Kafonek S, Laurora I et al. Comparative dose efficacy study of atorvastatin versus lovastatin, pravastatin, LOVASTATIN and fluvastatin in patients with HYPERCHOLESTEROLEMIA (the CURVES study.",HYPERCHOLESTEROLEMIA,LOVASTATIN,RO-may_treat
790084753,9/17/2015 12:21:45,1740401686,9/17/2015 12:20:01,False,gifthulk,0.9742,24928180,GBR,M1,Slough,90.208.18.156,LOVASTATIN treats HYPERCHOLESTEROLEMIA,161,117,,180,127,treats,0.964901281354015,907513,"Jones P, Kafonek S, Laurora I et al. Comparative dose efficacy study of atorvastatin versus lovastatin, pravastatin, LOVASTATIN and fluvastatin in patients with HYPERCHOLESTEROLEMIA (the CURVES study.",HYPERCHOLESTEROLEMIA,LOVASTATIN,RO-may_treat
790084755,9/17/2015 12:23:08,1740402042,9/17/2015 12:22:45,False,gifthulk,0.9742,24928180,GBR,M1,Slough,90.208.18.156,CLINDAMYCIN treats SECONDARY PROPHYLAXIS OF TOXOPLASMOSIS,98,66,,135,77,treats,0.9667364890456641,907658,161  For pyrimethamine dosages of 25 50 mg once daily (given with CLINDAMYCIN or sulfadiazine for SECONDARY PROPHYLAXIS OF TOXOPLASMOSIS): 10 25 mg once daily.,SECONDARY PROPHYLAXIS OF TOXOPLASMOSIS,CLINDAMYCIN,RO-may_treat
790084755,9/17/2015 12:28:11,1740403148,9/17/2015 12:27:57,False,clixsense,0.9881,21490235,GBR,N7,Woking,86.30.254.232,CLINDAMYCIN treats SECONDARY PROPHYLAXIS OF TOXOPLASMOSIS,98,66,,135,77,treats,0.9667364890456641,907658,161  For pyrimethamine dosages of 25 50 mg once daily (given with CLINDAMYCIN or sulfadiazine for SECONDARY PROPHYLAXIS OF TOXOPLASMOSIS): 10 25 mg once daily.,SECONDARY PROPHYLAXIS OF TOXOPLASMOSIS,CLINDAMYCIN,RO-may_treat
790084755,9/17/2015 12:39:56,1740406054,9/17/2015 12:37:06,False,neodev,0.9028,18881135,CAN,ON,Ajax,99.243.87.224,CLINDAMYCIN treats SECONDARY PROPHYLAXIS OF TOXOPLASMOSIS,98,66,,135,77,treats,0.9667364890456641,907658,161  For pyrimethamine dosages of 25 50 mg once daily (given with CLINDAMYCIN or sulfadiazine for SECONDARY PROPHYLAXIS OF TOXOPLASMOSIS): 10 25 mg once daily.,SECONDARY PROPHYLAXIS OF TOXOPLASMOSIS,CLINDAMYCIN,RO-may_treat
790084755,9/17/2015 12:54:06,1740410053,9/17/2015 12:51:28,False,clixsense,0.8792,21875134,GBR,,,80.189.12.98,CLINDAMYCIN treats SECONDARY PROPHYLAXIS OF TOXOPLASMOSIS,98,66,,135,77,treats,0.9667364890456641,907658,161  For pyrimethamine dosages of 25 50 mg once daily (given with CLINDAMYCIN or sulfadiazine for SECONDARY PROPHYLAXIS OF TOXOPLASMOSIS): 10 25 mg once daily.,SECONDARY PROPHYLAXIS OF TOXOPLASMOSIS,CLINDAMYCIN,RO-may_treat
790084755,9/17/2015 12:54:51,1740410257,9/17/2015 12:54:31,False,clixsense,0.9292,10390268,USA,NY,New Paltz,100.40.130.164,CLINDAMYCIN treats SECONDARY PROPHYLAXIS OF TOXOPLASMOSIS,98,66,,135,77,treats,0.9667364890456641,907658,161  For pyrimethamine dosages of 25 50 mg once daily (given with CLINDAMYCIN or sulfadiazine for SECONDARY PROPHYLAXIS OF TOXOPLASMOSIS): 10 25 mg once daily.,SECONDARY PROPHYLAXIS OF TOXOPLASMOSIS,CLINDAMYCIN,RO-may_treat
790084755,9/17/2015 13:02:25,1740412267,9/17/2015 13:00:54,False,clixsense,0.6516,17950689,GBR,L9,Sheffield,146.200.192.103,CLINDAMYCIN treats SECONDARY PROPHYLAXIS OF TOXOPLASMOSIS,98,66,,135,77,treats,0.9667364890456641,907658,161  For pyrimethamine dosages of 25 50 mg once daily (given with CLINDAMYCIN or sulfadiazine for SECONDARY PROPHYLAXIS OF TOXOPLASMOSIS): 10 25 mg once daily.,SECONDARY PROPHYLAXIS OF TOXOPLASMOSIS,CLINDAMYCIN,RO-may_treat
790084755,9/17/2015 13:23:45,1740418674,9/17/2015 13:23:29,False,elite,0.7131,31883685,GBR,,,79.66.244.188,CLINDAMYCIN treats SECONDARY PROPHYLAXIS OF TOXOPLASMOSIS,98,66,,135,77,treats,0.9667364890456641,907658,161  For pyrimethamine dosages of 25 50 mg once daily (given with CLINDAMYCIN or sulfadiazine for SECONDARY PROPHYLAXIS OF TOXOPLASMOSIS): 10 25 mg once daily.,SECONDARY PROPHYLAXIS OF TOXOPLASMOSIS,CLINDAMYCIN,RO-may_treat
790084758,9/17/2015 14:50:26,1740451490,9/17/2015 14:48:37,False,zoombucks,0.8806,6744840,CAN,BC,Kelowna,174.4.58.160,ALEMTUZUMAB treats CELL CHRONIC LYMPHOCYTIC LEUKEMIA,115,71,,147,82,treats,0.99654575824488,803984,"2]  Demko S, Summers J, Keegan P, Pazdur R. FDA drug approval summary: ALEMTUZUMAB as single agent treatment for B CELL CHRONIC LYMPHOCYTIC LEUKEMIA",CELL CHRONIC LYMPHOCYTIC LEUKEMIA,ALEMTUZUMAB,TWrex-cause
790084758,9/17/2015 15:18:58,1740461346,9/17/2015 15:18:46,False,prodege,0.8849,14848125,GBR,V8,Airdrie,86.151.77.161,ALEMTUZUMAB treats CELL CHRONIC LYMPHOCYTIC LEUKEMIA,115,71,,147,82,treats,0.99654575824488,803984,"2]  Demko S, Summers J, Keegan P, Pazdur R. FDA drug approval summary: ALEMTUZUMAB as single agent treatment for B CELL CHRONIC LYMPHOCYTIC LEUKEMIA",CELL CHRONIC LYMPHOCYTIC LEUKEMIA,ALEMTUZUMAB,TWrex-cause
790084758,9/17/2015 15:24:15,1740463326,9/17/2015 15:23:52,False,instagc,0.6935,22981457,CAN,ON,Ottawa,67.69.8.122,ALEMTUZUMAB treats CELL CHRONIC LYMPHOCYTIC LEUKEMIA,115,71,,147,82,treats,0.99654575824488,803984,"2]  Demko S, Summers J, Keegan P, Pazdur R. FDA drug approval summary: ALEMTUZUMAB as single agent treatment for B CELL CHRONIC LYMPHOCYTIC LEUKEMIA",CELL CHRONIC LYMPHOCYTIC LEUKEMIA,ALEMTUZUMAB,TWrex-cause
790084758,9/17/2015 15:24:30,1740463382,9/17/2015 15:23:35,False,clixsense,0.9375,33878524,CAN,BC,Princeton,75.156.83.71,ALEMTUZUMAB treats CELL CHRONIC LYMPHOCYTIC LEUKEMIA,115,71,,147,82,treats,0.99654575824488,803984,"2]  Demko S, Summers J, Keegan P, Pazdur R. FDA drug approval summary: ALEMTUZUMAB as single agent treatment for B CELL CHRONIC LYMPHOCYTIC LEUKEMIA",CELL CHRONIC LYMPHOCYTIC LEUKEMIA,ALEMTUZUMAB,TWrex-cause
790084758,9/17/2015 15:37:30,1740468456,9/17/2015 15:37:02,False,instagc,0.823,31130954,USA,IL,Arlington Heights,99.135.174.103,ALEMTUZUMAB treats CELL CHRONIC LYMPHOCYTIC LEUKEMIA,115,71,,147,82,treats,0.99654575824488,803984,"2]  Demko S, Summers J, Keegan P, Pazdur R. FDA drug approval summary: ALEMTUZUMAB as single agent treatment for B CELL CHRONIC LYMPHOCYTIC LEUKEMIA",CELL CHRONIC LYMPHOCYTIC LEUKEMIA,ALEMTUZUMAB,TWrex-cause
790084758,9/17/2015 15:39:48,1740469673,9/17/2015 15:39:10,False,instagc,0.8681,19480545,USA,MA,Brookline,209.6.138.58,ALEMTUZUMAB treats CELL CHRONIC LYMPHOCYTIC LEUKEMIA,115,71,,147,82,treats,0.99654575824488,803984,"2]  Demko S, Summers J, Keegan P, Pazdur R. FDA drug approval summary: ALEMTUZUMAB as single agent treatment for B CELL CHRONIC LYMPHOCYTIC LEUKEMIA",CELL CHRONIC LYMPHOCYTIC LEUKEMIA,ALEMTUZUMAB,TWrex-cause
790084758,9/17/2015 15:46:59,1740472503,9/17/2015 15:46:45,False,clixsense,0.8673,24104564,AUS,02,Surry Hills,60.241.132.132,ALEMTUZUMAB treats CELL CHRONIC LYMPHOCYTIC LEUKEMIA,115,71,,147,82,treats,0.99654575824488,803984,"2]  Demko S, Summers J, Keegan P, Pazdur R. FDA drug approval summary: ALEMTUZUMAB as single agent treatment for B CELL CHRONIC LYMPHOCYTIC LEUKEMIA",CELL CHRONIC LYMPHOCYTIC LEUKEMIA,ALEMTUZUMAB,TWrex-cause
790084760,9/17/2015 09:34:54,1740367294,9/17/2015 09:34:40,False,prodege,0.8254,15439740,AUS,02,Jannali,14.200.59.55,[NSAID ANALGESIC AGENT] treats [SEVERE AND CHRONIC PAIN],86,35,,109,55,treats,0.99654575824488,222120,Ziconotide is a non opioid and non [NSAID ANALGESIC AGENT] used for the amelioration of [SEVERE AND CHRONIC PAIN],[SEVERE AND CHRONIC PAIN],[NSAID ANALGESIC AGENT],TWrex-treat
790084760,9/17/2015 09:39:04,1740368220,9/17/2015 09:37:55,False,gifthunterclub,0.8155,24043308,GBR,,,94.102.147.250,[NSAID ANALGESIC AGENT] treats [SEVERE AND CHRONIC PAIN],86,35,,109,55,treats,0.99654575824488,222120,Ziconotide is a non opioid and non [NSAID ANALGESIC AGENT] used for the amelioration of [SEVERE AND CHRONIC PAIN],[SEVERE AND CHRONIC PAIN],[NSAID ANALGESIC AGENT],TWrex-treat
790084760,9/17/2015 09:47:43,1740370213,9/17/2015 09:47:27,False,vivatic,0.9722,32338429,GBR,N7,Guildford,92.21.219.178,[NSAID ANALGESIC AGENT] treats [SEVERE AND CHRONIC PAIN],86,35,,109,55,treats,0.99654575824488,222120,Ziconotide is a non opioid and non [NSAID ANALGESIC AGENT] used for the amelioration of [SEVERE AND CHRONIC PAIN],[SEVERE AND CHRONIC PAIN],[NSAID ANALGESIC AGENT],TWrex-treat
790084760,9/17/2015 09:55:54,1740372191,9/17/2015 09:55:45,False,neodev,0.1667,14096345,NLD,03,Eibergen,178.85.94.186,no_relation,86,35,,109,55,treats,0.99654575824488,222120,Ziconotide is a non opioid and non [NSAID ANALGESIC AGENT] used for the amelioration of [SEVERE AND CHRONIC PAIN],[SEVERE AND CHRONIC PAIN],[NSAID ANALGESIC AGENT],TWrex-treat
790084760,9/17/2015 10:09:39,1740375735,9/17/2015 10:09:29,False,zoombucks,0.7,4711962,CAN,ON,Markham,174.88.29.138,[NSAID ANALGESIC AGENT] treats [SEVERE AND CHRONIC PAIN],86,35,,109,55,treats,0.99654575824488,222120,Ziconotide is a non opioid and non [NSAID ANALGESIC AGENT] used for the amelioration of [SEVERE AND CHRONIC PAIN],[SEVERE AND CHRONIC PAIN],[NSAID ANALGESIC AGENT],TWrex-treat
790084760,9/17/2015 10:15:11,1740376987,9/17/2015 10:14:10,False,pocketmoneygpt,0.8115,21432964,GBR,F8,Borehamwood,81.159.185.70,[NSAID ANALGESIC AGENT] treats [SEVERE AND CHRONIC PAIN],86,35,,109,55,treats,0.99654575824488,222120,Ziconotide is a non opioid and non [NSAID ANALGESIC AGENT] used for the amelioration of [SEVERE AND CHRONIC PAIN],[SEVERE AND CHRONIC PAIN],[NSAID ANALGESIC AGENT],TWrex-treat
790084760,9/17/2015 10:15:32,1740377070,9/17/2015 10:14:02,False,eup_slw,0.8671,32718504,AUS,,,1.128.96.45,[NSAID ANALGESIC AGENT] treats [SEVERE AND CHRONIC PAIN],86,35,,109,55,treats,0.99654575824488,222120,Ziconotide is a non opioid and non [NSAID ANALGESIC AGENT] used for the amelioration of [SEVERE AND CHRONIC PAIN],[SEVERE AND CHRONIC PAIN],[NSAID ANALGESIC AGENT],TWrex-treat
790084773,9/17/2015 11:18:38,1740389231,9/17/2015 11:11:21,False,points4rewards,0.7611,20113482,USA,PA,Philadelphia,162.208.49.45,RIBAVIRIN treats CHRONIC HEPATITIS C VIRUS (HCV INFECTION),16,126,,56,135,treats,0.9918365981341751,800117,b  Treatment of CHRONIC HEPATITIS C VIRUS (HCV INFECTION)  >    Concomitant Therapy with Interferon Alfa 2b (Intron ®  A) and RIBAVIRIN  Sub Q:  Children ≥3 years of age: Interferon alfa 2b 3 million units 3 times weekly.,CHRONIC HEPATITIS C VIRUS (HCV INFECTION),RIBAVIRIN,TWrex-cause
790084773,9/17/2015 11:38:17,1740392807,9/17/2015 11:37:25,False,neodev,0.9127,30588889,NLD,07,Amsterdam,77.248.175.222,RIBAVIRIN treats CHRONIC HEPATITIS C VIRUS (HCV INFECTION),16,126,,56,135,treats,0.9918365981341751,800117,b  Treatment of CHRONIC HEPATITIS C VIRUS (HCV INFECTION)  >    Concomitant Therapy with Interferon Alfa 2b (Intron ®  A) and RIBAVIRIN  Sub Q:  Children ≥3 years of age: Interferon alfa 2b 3 million units 3 times weekly.,CHRONIC HEPATITIS C VIRUS (HCV INFECTION),RIBAVIRIN,TWrex-cause
790084773,9/17/2015 11:50:49,1740395255,9/17/2015 11:50:33,False,neodev,0.9464,12115558,USA,OH,Twinsburg,98.27.164.131,RIBAVIRIN treats CHRONIC HEPATITIS C VIRUS (HCV INFECTION),16,126,,56,135,treats,0.9918365981341751,800117,b  Treatment of CHRONIC HEPATITIS C VIRUS (HCV INFECTION)  >    Concomitant Therapy with Interferon Alfa 2b (Intron ®  A) and RIBAVIRIN  Sub Q:  Children ≥3 years of age: Interferon alfa 2b 3 million units 3 times weekly.,CHRONIC HEPATITIS C VIRUS (HCV INFECTION),RIBAVIRIN,TWrex-cause
790084773,9/17/2015 11:53:06,1740395617,9/17/2015 11:52:42,False,elite,0.9722,29768955,GBR,C3,Gamlingay,31.50.187.165,RIBAVIRIN treats CHRONIC HEPATITIS C VIRUS (HCV INFECTION),16,126,,56,135,treats,0.9918365981341751,800117,b  Treatment of CHRONIC HEPATITIS C VIRUS (HCV INFECTION)  >    Concomitant Therapy with Interferon Alfa 2b (Intron ®  A) and RIBAVIRIN  Sub Q:  Children ≥3 years of age: Interferon alfa 2b 3 million units 3 times weekly.,CHRONIC HEPATITIS C VIRUS (HCV INFECTION),RIBAVIRIN,TWrex-cause
790084773,9/17/2015 11:56:05,1740396307,9/17/2015 11:54:20,False,bitcoinget,0.7528,32306192,USA,TX,Austin,172.11.109.161,RIBAVIRIN treats CHRONIC HEPATITIS C VIRUS (HCV INFECTION),16,126,,56,135,treats,0.9918365981341751,800117,b  Treatment of CHRONIC HEPATITIS C VIRUS (HCV INFECTION)  >    Concomitant Therapy with Interferon Alfa 2b (Intron ®  A) and RIBAVIRIN  Sub Q:  Children ≥3 years of age: Interferon alfa 2b 3 million units 3 times weekly.,CHRONIC HEPATITIS C VIRUS (HCV INFECTION),RIBAVIRIN,TWrex-cause
790084773,9/17/2015 12:01:24,1740397299,9/17/2015 12:00:51,False,gifthulk,0.9042,18666417,USA,PA,Meadville,24.101.32.13,RIBAVIRIN treats CHRONIC HEPATITIS C VIRUS (HCV INFECTION),16,126,,56,135,treats,0.9918365981341751,800117,b  Treatment of CHRONIC HEPATITIS C VIRUS (HCV INFECTION)  >    Concomitant Therapy with Interferon Alfa 2b (Intron ®  A) and RIBAVIRIN  Sub Q:  Children ≥3 years of age: Interferon alfa 2b 3 million units 3 times weekly.,CHRONIC HEPATITIS C VIRUS (HCV INFECTION),RIBAVIRIN,TWrex-cause
790084773,9/17/2015 12:05:17,1740398116,9/17/2015 12:05:07,False,prodege,0.8929,3587109,CAN,NS,Eskasoni,142.134.240.160,RIBAVIRIN treats CHRONIC HEPATITIS C VIRUS (HCV INFECTION),16,126,,56,135,treats,0.9918365981341751,800117,b  Treatment of CHRONIC HEPATITIS C VIRUS (HCV INFECTION)  >    Concomitant Therapy with Interferon Alfa 2b (Intron ®  A) and RIBAVIRIN  Sub Q:  Children ≥3 years of age: Interferon alfa 2b 3 million units 3 times weekly.,CHRONIC HEPATITIS C VIRUS (HCV INFECTION),RIBAVIRIN,TWrex-cause
790084775,9/17/2015 13:57:49,1740431521,9/17/2015 13:57:23,False,clixsense,0.7508,6336109,CAN,BC,Prince George,198.254.211.52,no_relation,100,19,,115,33,treats,0.9941348467724341,224595,Premedication with [CORTICOSTEROID]s is recommended before each administration of docetaxel to reduce [FLUID RETENTION] and hypersensitive reactions.,FLUID RETENTION,CORTICOSTEROID,TWrex-treat
790084775,9/17/2015 13:58:24,1740431777,9/17/2015 13:57:55,False,clixsense,0.7631,30258829,NLD,05,Velden,84.104.254.214,CORTICOSTEROID treats FLUID RETENTION,100,19,,115,33,treats,0.9941348467724341,224595,Premedication with [CORTICOSTEROID]s is recommended before each administration of docetaxel to reduce [FLUID RETENTION] and hypersensitive reactions.,FLUID RETENTION,CORTICOSTEROID,TWrex-treat
790084775,9/17/2015 14:01:55,1740433076,9/17/2015 14:01:29,False,neodev,0.7518,33758777,USA,,,38.95.108.251,CORTICOSTEROID treats FLUID RETENTION,100,19,,115,33,treats,0.9941348467724341,224595,Premedication with [CORTICOSTEROID]s is recommended before each administration of docetaxel to reduce [FLUID RETENTION] and hypersensitive reactions.,FLUID RETENTION,CORTICOSTEROID,TWrex-treat
790084775,9/17/2015 14:02:48,1740433297,9/17/2015 14:02:14,False,points4rewards,0.7685,28755767,USA,VA,Chester,68.57.118.32,CORTICOSTEROID treats FLUID RETENTION,100,19,,115,33,treats,0.9941348467724341,224595,Premedication with [CORTICOSTEROID]s is recommended before each administration of docetaxel to reduce [FLUID RETENTION] and hypersensitive reactions.,FLUID RETENTION,CORTICOSTEROID,TWrex-treat
790084775,9/17/2015 14:06:36,1740434761,9/17/2015 14:06:21,False,elite,0.8036,30507455,CAN,BC,Richmond,174.6.137.222,CORTICOSTEROID treats FLUID RETENTION,100,19,,115,33,treats,0.9941348467724341,224595,Premedication with [CORTICOSTEROID]s is recommended before each administration of docetaxel to reduce [FLUID RETENTION] and hypersensitive reactions.,FLUID RETENTION,CORTICOSTEROID,TWrex-treat
790084775,9/17/2015 14:06:37,1740434765,9/17/2015 14:05:49,False,onestopgpt,0.8512,21275875,CAN,ON,Hamilton,24.36.124.79,CORTICOSTEROID treats FLUID RETENTION,100,19,,115,33,treats,0.9941348467724341,224595,Premedication with [CORTICOSTEROID]s is recommended before each administration of docetaxel to reduce [FLUID RETENTION] and hypersensitive reactions.,FLUID RETENTION,CORTICOSTEROID,TWrex-treat
790084775,9/17/2015 14:17:24,1740438808,9/17/2015 14:16:42,False,elite,0.8452,33238902,NLD,06,Budel,77.248.148.5,CORTICOSTEROID treats FLUID RETENTION,100,19,,115,33,treats,0.9941348467724341,224595,Premedication with [CORTICOSTEROID]s is recommended before each administration of docetaxel to reduce [FLUID RETENTION] and hypersensitive reactions.,FLUID RETENTION,CORTICOSTEROID,TWrex-treat
790084778,9/17/2015 08:58:15,1740359087,9/17/2015 08:57:46,False,neodev,1.0,30627835,GBR,D8,Bishop Auckland,217.44.84.223,ASENAPINE treats ACUTE MANIA,74,42,,85,51,treats,0.933256525257383,207741,Organon Continues With The Development Of [ASENAPINE] For Schizophrenia And [ACUTE MANIA] Associated With Bipolar I Disorder.,ACUTE MANIA,ASENAPINE,TWrex-treat
790084778,9/17/2015 09:12:12,1740362251,9/17/2015 09:11:41,False,neodev,0.8194,33644825,USA,FL,Fort Lauderdale,65.111.173.161,ASENAPINE treats ACUTE MANIA,74,42,,85,51,treats,0.933256525257383,207741,Organon Continues With The Development Of [ASENAPINE] For Schizophrenia And [ACUTE MANIA] Associated With Bipolar I Disorder.,ACUTE MANIA,ASENAPINE,TWrex-treat
790084778,9/17/2015 09:17:11,1740363423,9/17/2015 09:16:34,False,clixsense,0.8528,30681826,GBR,I9,Diss,31.49.71.254,ASENAPINE treats ACUTE MANIA,74,42,,85,51,treats,0.933256525257383,207741,Organon Continues With The Development Of [ASENAPINE] For Schizophrenia And [ACUTE MANIA] Associated With Bipolar I Disorder.,ACUTE MANIA,ASENAPINE,TWrex-treat
790084778,9/17/2015 09:20:44,1740364192,9/17/2015 09:20:20,False,prodege,0.7559999999999999,21417560,GBR,C3,Cambridge,151.224.120.191,ASENAPINE treats ACUTE MANIA,74,42,,85,51,treats,0.933256525257383,207741,Organon Continues With The Development Of [ASENAPINE] For Schizophrenia And [ACUTE MANIA] Associated With Bipolar I Disorder.,ACUTE MANIA,ASENAPINE,TWrex-treat
790084778,9/17/2015 09:20:58,1740364216,9/17/2015 09:20:34,False,neodev,0.8059999999999999,20306047,GBR,,,80.41.0.252,ASENAPINE treats ACUTE MANIA,74,42,,85,51,treats,0.933256525257383,207741,Organon Continues With The Development Of [ASENAPINE] For Schizophrenia And [ACUTE MANIA] Associated With Bipolar I Disorder.,ACUTE MANIA,ASENAPINE,TWrex-treat
790084778,9/17/2015 09:34:38,1740367169,9/17/2015 09:34:24,False,prodege,0.8254,15439740,AUS,02,Jannali,14.200.59.55,no_relation,74,42,,85,51,treats,0.933256525257383,207741,Organon Continues With The Development Of [ASENAPINE] For Schizophrenia And [ACUTE MANIA] Associated With Bipolar I Disorder.,ACUTE MANIA,ASENAPINE,TWrex-treat
790084778,9/17/2015 09:37:53,1740367899,9/17/2015 09:36:07,False,gifthunterclub,0.8155,24043308,GBR,,,94.102.147.250,ASENAPINE treats ACUTE MANIA,74,42,,85,51,treats,0.933256525257383,207741,Organon Continues With The Development Of [ASENAPINE] For Schizophrenia And [ACUTE MANIA] Associated With Bipolar I Disorder.,ACUTE MANIA,ASENAPINE,TWrex-treat
790084783,9/17/2015 12:28:36,1740403236,9/17/2015 12:28:25,False,clixsense,0.9881,21490235,GBR,N7,Woking,86.30.254.232,TRANSDERMAL FENTANYL treats CHRONIC PAIN,4,47,,15,67,treats,1.0,803568,"For CHRONIC PAIN long acting preparations (eg, TRANSDERMAL FENTANYL oxycodone, oxymorphone) are usually best.",CHRONIC PAIN,TRANSDERMAL FENTANYL,TWrex-cause
790084783,9/17/2015 12:42:16,1740406628,9/17/2015 12:40:23,False,neodev,0.9028,18881135,CAN,ON,Ajax,99.243.87.224,TRANSDERMAL FENTANYL treats CHRONIC PAIN,4,47,,15,67,treats,1.0,803568,"For CHRONIC PAIN long acting preparations (eg, TRANSDERMAL FENTANYL oxycodone, oxymorphone) are usually best.",CHRONIC PAIN,TRANSDERMAL FENTANYL,TWrex-cause
790084783,9/17/2015 12:55:29,1740410377,9/17/2015 12:54:31,False,clixsense,0.8792,21875134,GBR,,,80.189.12.98,TRANSDERMAL FENTANYL treats CHRONIC PAIN,4,47,,15,67,treats,1.0,803568,"For CHRONIC PAIN long acting preparations (eg, TRANSDERMAL FENTANYL oxycodone, oxymorphone) are usually best.",CHRONIC PAIN,TRANSDERMAL FENTANYL,TWrex-cause
790084783,9/17/2015 12:55:32,1740410387,9/17/2015 12:55:11,False,clixsense,0.9292,10390268,USA,NY,New Paltz,100.40.130.164,TRANSDERMAL FENTANYL treats CHRONIC PAIN,4,47,,15,67,treats,1.0,803568,"For CHRONIC PAIN long acting preparations (eg, TRANSDERMAL FENTANYL oxycodone, oxymorphone) are usually best.",CHRONIC PAIN,TRANSDERMAL FENTANYL,TWrex-cause
790084783,9/17/2015 13:04:03,1740412698,9/17/2015 13:03:00,False,clixsense,0.6516,17950689,GBR,L9,Sheffield,146.200.192.103,TRANSDERMAL FENTANYL treats CHRONIC PAIN,4,47,,15,67,treats,1.0,803568,"For CHRONIC PAIN long acting preparations (eg, TRANSDERMAL FENTANYL oxycodone, oxymorphone) are usually best.",CHRONIC PAIN,TRANSDERMAL FENTANYL,TWrex-cause
790084783,9/17/2015 13:15:56,1740416183,9/17/2015 13:15:34,False,instagc,0.8643,13581319,USA,IL,Trenton,208.70.36.12,TRANSDERMAL FENTANYL treats CHRONIC PAIN,4,47,,15,67,treats,1.0,803568,"For CHRONIC PAIN long acting preparations (eg, TRANSDERMAL FENTANYL oxycodone, oxymorphone) are usually best.",CHRONIC PAIN,TRANSDERMAL FENTANYL,TWrex-cause
790084783,9/17/2015 13:16:33,1740416407,9/17/2015 13:15:47,False,prodege,0.8631,34236350,USA,IA,Des Moines,63.153.219.233,TRANSDERMAL FENTANYL treats CHRONIC PAIN,4,47,,15,67,treats,1.0,803568,"For CHRONIC PAIN long acting preparations (eg, TRANSDERMAL FENTANYL oxycodone, oxymorphone) are usually best.",CHRONIC PAIN,TRANSDERMAL FENTANYL,TWrex-cause
790084791,9/17/2015 14:07:07,1740434953,9/17/2015 14:06:53,False,elite,0.8036,30507455,CAN,BC,Richmond,174.6.137.222,RECOMBINANT ALPHA A INTERFERON treats HAIRY CELL LEUKEMIA,55,100,,73,130,treats,0.9897433186107869,803775,"Holmes R, Whiteside MG, Schwarz MA et al. Treatment of HAIRY CELL LEUKEMIA with increasing doses of RECOMBINANT ALPHA A INTERFERON",HAIRY CELL LEUKEMIA,RECOMBINANT ALPHA A INTERFERON,TWrex-cause
790084791,9/17/2015 14:07:46,1740435181,9/17/2015 14:07:18,False,onestopgpt,0.8512,21275875,CAN,ON,Hamilton,24.36.124.79,RECOMBINANT ALPHA A INTERFERON treats HAIRY CELL LEUKEMIA,55,100,,73,130,treats,0.9897433186107869,803775,"Holmes R, Whiteside MG, Schwarz MA et al. Treatment of HAIRY CELL LEUKEMIA with increasing doses of RECOMBINANT ALPHA A INTERFERON",HAIRY CELL LEUKEMIA,RECOMBINANT ALPHA A INTERFERON,TWrex-cause
790084791,9/17/2015 14:25:35,1740441501,9/17/2015 14:25:23,False,neodev,0.7083,33155316,GBR,I9,Dereham,31.50.244.140,HAIRY CELL LEUKEMIA treats RECOMBINANT ALPHA A INTERFERON,55,100,,73,130,treats,0.9897433186107869,803775,"Holmes R, Whiteside MG, Schwarz MA et al. Treatment of HAIRY CELL LEUKEMIA with increasing doses of RECOMBINANT ALPHA A INTERFERON",HAIRY CELL LEUKEMIA,RECOMBINANT ALPHA A INTERFERON,TWrex-cause
790084791,9/17/2015 14:32:17,1740444118,9/17/2015 14:31:40,False,clixsense,0.7798,20587495,CAN,NL,St. John's,142.162.225.210,RECOMBINANT ALPHA A INTERFERON treats HAIRY CELL LEUKEMIA,55,100,,73,130,treats,0.9897433186107869,803775,"Holmes R, Whiteside MG, Schwarz MA et al. Treatment of HAIRY CELL LEUKEMIA with increasing doses of RECOMBINANT ALPHA A INTERFERON",HAIRY CELL LEUKEMIA,RECOMBINANT ALPHA A INTERFERON,TWrex-cause
790084791,9/17/2015 14:38:03,1740446293,9/17/2015 14:37:52,False,tremorgames,0.7167,31906954,USA,NY,Goshen,184.9.83.232,RECOMBINANT ALPHA A INTERFERON treats HAIRY CELL LEUKEMIA,55,100,,73,130,treats,0.9897433186107869,803775,"Holmes R, Whiteside MG, Schwarz MA et al. Treatment of HAIRY CELL LEUKEMIA with increasing doses of RECOMBINANT ALPHA A INTERFERON",HAIRY CELL LEUKEMIA,RECOMBINANT ALPHA A INTERFERON,TWrex-cause
790084791,9/17/2015 14:40:15,1740447265,9/17/2015 14:40:01,False,tremorgames,0.7063,24449707,CAN,QC,Laval,96.20.14.148,RECOMBINANT ALPHA A INTERFERON treats HAIRY CELL LEUKEMIA,55,100,,73,130,treats,0.9897433186107869,803775,"Holmes R, Whiteside MG, Schwarz MA et al. Treatment of HAIRY CELL LEUKEMIA with increasing doses of RECOMBINANT ALPHA A INTERFERON",HAIRY CELL LEUKEMIA,RECOMBINANT ALPHA A INTERFERON,TWrex-cause
790084791,9/17/2015 14:40:27,1740447346,9/17/2015 14:40:07,False,prodege,0.7421,27934334,GBR,C8,Croydon,81.159.60.206,RECOMBINANT ALPHA A INTERFERON treats HAIRY CELL LEUKEMIA,55,100,,73,130,treats,0.9897433186107869,803775,"Holmes R, Whiteside MG, Schwarz MA et al. Treatment of HAIRY CELL LEUKEMIA with increasing doses of RECOMBINANT ALPHA A INTERFERON",HAIRY CELL LEUKEMIA,RECOMBINANT ALPHA A INTERFERON,TWrex-cause
790084792,9/17/2015 11:51:50,1740395418,9/17/2015 11:51:25,False,neodev,0.9464,12115558,USA,OH,Twinsburg,98.27.164.131,[ARTEMISININ BASED] treats [STRAINS OF P FALCIPARUM],53,88,,76,104,treats,0.9594032236002471,213746,Usage declined in the 1980s as piperaquine resistant [STRAINS OF P FALCIPARUM] arose and [ARTEMISININ BASED] antimalarials became available.,[STRAINS OF P FALCIPARUM],[ARTEMISININ BASED],TWrex-treat
790084792,9/17/2015 11:54:00,1740395807,9/17/2015 11:53:35,False,elite,0.9722,29768955,GBR,C3,Gamlingay,31.50.187.165,[ARTEMISININ BASED] treats [STRAINS OF P FALCIPARUM],53,88,,76,104,treats,0.9594032236002471,213746,Usage declined in the 1980s as piperaquine resistant [STRAINS OF P FALCIPARUM] arose and [ARTEMISININ BASED] antimalarials became available.,[STRAINS OF P FALCIPARUM],[ARTEMISININ BASED],TWrex-treat
790084792,9/17/2015 11:57:03,1740396450,9/17/2015 11:56:44,False,bitcoinget,0.7528,32306192,USA,TX,Austin,172.11.109.161,[ARTEMISININ BASED] treats [STRAINS OF P FALCIPARUM],53,88,,76,104,treats,0.9594032236002471,213746,Usage declined in the 1980s as piperaquine resistant [STRAINS OF P FALCIPARUM] arose and [ARTEMISININ BASED] antimalarials became available.,[STRAINS OF P FALCIPARUM],[ARTEMISININ BASED],TWrex-treat
790084792,9/17/2015 12:03:14,1740397703,9/17/2015 12:02:06,False,gifthulk,0.9042,18666417,USA,PA,Meadville,24.101.32.13,[ARTEMISININ BASED] treats [STRAINS OF P FALCIPARUM],53,88,,76,104,treats,0.9594032236002471,213746,Usage declined in the 1980s as piperaquine resistant [STRAINS OF P FALCIPARUM] arose and [ARTEMISININ BASED] antimalarials became available.,[STRAINS OF P FALCIPARUM],[ARTEMISININ BASED],TWrex-treat
790084792,9/17/2015 12:05:53,1740398270,9/17/2015 12:05:47,False,prodege,0.8929,3587109,CAN,NS,Eskasoni,142.134.240.160,[ARTEMISININ BASED] treats [STRAINS OF P FALCIPARUM],53,88,,76,104,treats,0.9594032236002471,213746,Usage declined in the 1980s as piperaquine resistant [STRAINS OF P FALCIPARUM] arose and [ARTEMISININ BASED] antimalarials became available.,[STRAINS OF P FALCIPARUM],[ARTEMISININ BASED],TWrex-treat
790084792,9/17/2015 12:10:55,1740399449,9/17/2015 12:10:28,False,prodege,0.9438,9169061,CAN,ON,Kitchener,99.235.192.130,[ARTEMISININ BASED] treats [STRAINS OF P FALCIPARUM],53,88,,76,104,treats,0.9594032236002471,213746,Usage declined in the 1980s as piperaquine resistant [STRAINS OF P FALCIPARUM] arose and [ARTEMISININ BASED] antimalarials became available.,[STRAINS OF P FALCIPARUM],[ARTEMISININ BASED],TWrex-treat
790084792,9/17/2015 12:12:36,1740399839,9/17/2015 12:12:02,False,prodege,0.9337,3056891,CAN,ON,Niagara Falls,173.238.144.19,[ARTEMISININ BASED] treats [STRAINS OF P FALCIPARUM],53,88,,76,104,treats,0.9594032236002471,213746,Usage declined in the 1980s as piperaquine resistant [STRAINS OF P FALCIPARUM] arose and [ARTEMISININ BASED] antimalarials became available.,[STRAINS OF P FALCIPARUM],[ARTEMISININ BASED],TWrex-treat
790084793,9/17/2015 12:29:56,1740403557,9/17/2015 12:28:37,False,clixsense,0.9881,21490235,GBR,N7,Woking,86.30.254.232,AGGRESSIVE CLINICAL COURSE treats PLASMA CELL LEUKAEMIA,63,17,,88,38,treats,0.42426406871192895,902607,"The diagnosis of PLASMA CELL LEUKAEMIA a rare disorder with an AGGRESSIVE CLINICAL COURSE and poor prognosis, is not always straightforward and may be dependent on the results of immunophenotyping.",AGGRESSIVE CLINICAL COURSE,PLASMA CELL LEUKAEMIA,RO-disease_may_have_finding
790084793,9/17/2015 12:45:18,1740407637,9/17/2015 12:42:16,False,neodev,0.9028,18881135,CAN,ON,Ajax,99.243.87.224,no_relation,63,17,,88,38,treats,0.42426406871192895,902607,"The diagnosis of PLASMA CELL LEUKAEMIA a rare disorder with an AGGRESSIVE CLINICAL COURSE and poor prognosis, is not always straightforward and may be dependent on the results of immunophenotyping.",AGGRESSIVE CLINICAL COURSE,PLASMA CELL LEUKAEMIA,RO-disease_may_have_finding
790084793,9/17/2015 12:55:50,1740410458,9/17/2015 12:55:33,False,clixsense,0.9292,10390268,USA,NY,New Paltz,100.40.130.164,no_relation,63,17,,88,38,treats,0.42426406871192895,902607,"The diagnosis of PLASMA CELL LEUKAEMIA a rare disorder with an AGGRESSIVE CLINICAL COURSE and poor prognosis, is not always straightforward and may be dependent on the results of immunophenotyping.",AGGRESSIVE CLINICAL COURSE,PLASMA CELL LEUKAEMIA,RO-disease_may_have_finding
790084793,9/17/2015 12:56:01,1740410549,9/17/2015 12:55:30,False,clixsense,0.8792,21875134,GBR,,,80.189.12.98,no_relation,63,17,,88,38,treats,0.42426406871192895,902607,"The diagnosis of PLASMA CELL LEUKAEMIA a rare disorder with an AGGRESSIVE CLINICAL COURSE and poor prognosis, is not always straightforward and may be dependent on the results of immunophenotyping.",AGGRESSIVE CLINICAL COURSE,PLASMA CELL LEUKAEMIA,RO-disease_may_have_finding
790084793,9/17/2015 13:04:32,1740412855,9/17/2015 13:04:04,False,clixsense,0.6516,17950689,GBR,L9,Sheffield,146.200.192.103,PLASMA CELL LEUKAEMIA treats AGGRESSIVE CLINICAL COURSE,63,17,,88,38,treats,0.42426406871192895,902607,"The diagnosis of PLASMA CELL LEUKAEMIA a rare disorder with an AGGRESSIVE CLINICAL COURSE and poor prognosis, is not always straightforward and may be dependent on the results of immunophenotyping.",AGGRESSIVE CLINICAL COURSE,PLASMA CELL LEUKAEMIA,RO-disease_may_have_finding
790084793,9/17/2015 13:16:13,1740416263,9/17/2015 13:15:56,False,instagc,0.8643,13581319,USA,IL,Trenton,208.70.36.12,no_relation,63,17,,88,38,treats,0.42426406871192895,902607,"The diagnosis of PLASMA CELL LEUKAEMIA a rare disorder with an AGGRESSIVE CLINICAL COURSE and poor prognosis, is not always straightforward and may be dependent on the results of immunophenotyping.",AGGRESSIVE CLINICAL COURSE,PLASMA CELL LEUKAEMIA,RO-disease_may_have_finding
790084793,9/17/2015 13:17:03,1740416497,9/17/2015 13:16:34,False,prodege,0.8631,34236350,USA,IA,Des Moines,63.153.219.233,no_relation,63,17,,88,38,treats,0.42426406871192895,902607,"The diagnosis of PLASMA CELL LEUKAEMIA a rare disorder with an AGGRESSIVE CLINICAL COURSE and poor prognosis, is not always straightforward and may be dependent on the results of immunophenotyping.",AGGRESSIVE CLINICAL COURSE,PLASMA CELL LEUKAEMIA,RO-disease_may_have_finding
790084794,9/17/2015 13:57:05,1740431256,9/17/2015 13:56:49,False,tremorgames,0.894,32916723,USA,NY,Attica,70.209.139.92,AFTER AN OVERNIGHT DEXAMETHASONE ADMINISTRATION treats CUSHING'S SYNDROME,52,115,,69,162,treats,0.5,906655,Although she had no characteristic feature of overt CUSHING'S SYNDROME her serum cortisol level was not suppressed AFTER AN OVERNIGHT DEXAMETHASONE ADMINISTRATION.,CUSHING'S SYNDROME,AFTER AN OVERNIGHT DEXAMETHASONE ADMINISTRATION,RO-may_diagnose
790084794,9/17/2015 13:57:20,1740431353,9/17/2015 13:56:12,False,clixsense,0.7508,6336109,CAN,BC,Prince George,198.254.211.52,no_relation,52,115,,69,162,treats,0.5,906655,Although she had no characteristic feature of overt CUSHING'S SYNDROME her serum cortisol level was not suppressed AFTER AN OVERNIGHT DEXAMETHASONE ADMINISTRATION.,CUSHING'S SYNDROME,AFTER AN OVERNIGHT DEXAMETHASONE ADMINISTRATION,RO-may_diagnose
790084794,9/17/2015 13:57:52,1740431544,9/17/2015 13:57:17,False,clixsense,0.7631,30258829,NLD,05,Velden,84.104.254.214,no_relation,52,115,,69,162,treats,0.5,906655,Although she had no characteristic feature of overt CUSHING'S SYNDROME her serum cortisol level was not suppressed AFTER AN OVERNIGHT DEXAMETHASONE ADMINISTRATION.,CUSHING'S SYNDROME,AFTER AN OVERNIGHT DEXAMETHASONE ADMINISTRATION,RO-may_diagnose
790084794,9/17/2015 14:01:28,1740432811,9/17/2015 14:00:34,False,neodev,0.7518,33758777,USA,,,38.95.108.251,AFTER AN OVERNIGHT DEXAMETHASONE ADMINISTRATION treats CUSHING'S SYNDROME,52,115,,69,162,treats,0.5,906655,Although she had no characteristic feature of overt CUSHING'S SYNDROME her serum cortisol level was not suppressed AFTER AN OVERNIGHT DEXAMETHASONE ADMINISTRATION.,CUSHING'S SYNDROME,AFTER AN OVERNIGHT DEXAMETHASONE ADMINISTRATION,RO-may_diagnose
790084794,9/17/2015 14:02:13,1740433142,9/17/2015 14:01:46,False,points4rewards,0.7685,28755767,USA,VA,Chester,68.57.118.32,no_relation,52,115,,69,162,treats,0.5,906655,Although she had no characteristic feature of overt CUSHING'S SYNDROME her serum cortisol level was not suppressed AFTER AN OVERNIGHT DEXAMETHASONE ADMINISTRATION.,CUSHING'S SYNDROME,AFTER AN OVERNIGHT DEXAMETHASONE ADMINISTRATION,RO-may_diagnose
790084794,9/17/2015 14:05:48,1740434399,9/17/2015 14:05:26,False,onestopgpt,0.8512,21275875,CAN,ON,Hamilton,24.36.124.79,no_relation,52,115,,69,162,treats,0.5,906655,Although she had no characteristic feature of overt CUSHING'S SYNDROME her serum cortisol level was not suppressed AFTER AN OVERNIGHT DEXAMETHASONE ADMINISTRATION.,CUSHING'S SYNDROME,AFTER AN OVERNIGHT DEXAMETHASONE ADMINISTRATION,RO-may_diagnose
790084794,9/17/2015 14:06:20,1740434650,9/17/2015 14:06:01,False,elite,0.8036,30507455,CAN,BC,Richmond,174.6.137.222,AFTER AN OVERNIGHT DEXAMETHASONE ADMINISTRATION treats CUSHING'S SYNDROME,52,115,,69,162,treats,0.5,906655,Although she had no characteristic feature of overt CUSHING'S SYNDROME her serum cortisol level was not suppressed AFTER AN OVERNIGHT DEXAMETHASONE ADMINISTRATION.,CUSHING'S SYNDROME,AFTER AN OVERNIGHT DEXAMETHASONE ADMINISTRATION,RO-may_diagnose
790084795,9/17/2015 09:39:57,1740368438,9/17/2015 09:39:06,False,gifthunterclub,0.8155,24043308,GBR,,,94.102.147.250,RAMIPRIL treats ANGIOEDEMA,101,58,,111,66,treats,0.3665083331,223800,The results revealed that telmisartan was as effective as [RAMIPRIL] but with lower rates of cough and [ANGIOEDEMA] which led to fewer discontinuations.,ANGIOEDEMA,RAMIPRIL,TWrex-treat
790084795,9/17/2015 09:48:16,1740370365,9/17/2015 09:47:44,False,vivatic,0.9722,32338429,GBR,N7,Guildford,92.21.219.178,RAMIPRIL treats ANGIOEDEMA,101,58,,111,66,treats,0.3665083331,223800,The results revealed that telmisartan was as effective as [RAMIPRIL] but with lower rates of cough and [ANGIOEDEMA] which led to fewer discontinuations.,ANGIOEDEMA,RAMIPRIL,TWrex-treat
790084795,9/17/2015 10:16:02,1740377186,9/17/2015 10:15:12,False,pocketmoneygpt,0.8115,21432964,GBR,F8,Borehamwood,81.159.185.70,no_relation,101,58,,111,66,treats,0.3665083331,223800,The results revealed that telmisartan was as effective as [RAMIPRIL] but with lower rates of cough and [ANGIOEDEMA] which led to fewer discontinuations.,ANGIOEDEMA,RAMIPRIL,TWrex-treat
790084795,9/17/2015 10:16:12,1740377192,9/17/2015 10:15:33,False,eup_slw,0.8671,32718504,AUS,,,1.128.96.45,RAMIPRIL treats ANGIOEDEMA,101,58,,111,66,treats,0.3665083331,223800,The results revealed that telmisartan was as effective as [RAMIPRIL] but with lower rates of cough and [ANGIOEDEMA] which led to fewer discontinuations.,ANGIOEDEMA,RAMIPRIL,TWrex-treat
790084795,9/17/2015 10:41:29,1740382249,9/17/2015 10:41:15,False,clixsense,0.8667,6340330,USA,NY,Canajoharie,67.248.115.74,RAMIPRIL treats ANGIOEDEMA,101,58,,111,66,treats,0.3665083331,223800,The results revealed that telmisartan was as effective as [RAMIPRIL] but with lower rates of cough and [ANGIOEDEMA] which led to fewer discontinuations.,ANGIOEDEMA,RAMIPRIL,TWrex-treat
790084795,9/17/2015 10:45:44,1740382958,9/17/2015 10:39:53,False,points4rewards,0.7611,20113482,USA,PA,Philadelphia,162.208.49.45,no_relation,101,58,,111,66,treats,0.3665083331,223800,The results revealed that telmisartan was as effective as [RAMIPRIL] but with lower rates of cough and [ANGIOEDEMA] which led to fewer discontinuations.,ANGIOEDEMA,RAMIPRIL,TWrex-treat
790084795,9/17/2015 11:23:30,1740389950,9/17/2015 11:22:54,False,clixsense,0.8333,29275930,GBR,H3,Leeds,160.9.192.63,RAMIPRIL treats ANGIOEDEMA,101,58,,111,66,treats,0.3665083331,223800,The results revealed that telmisartan was as effective as [RAMIPRIL] but with lower rates of cough and [ANGIOEDEMA] which led to fewer discontinuations.,ANGIOEDEMA,RAMIPRIL,TWrex-treat
791857686,9/21/2015 12:38:26,1743046328,9/21/2015 12:37:17,False,clixsense,0.8611,17950689,GBR,Q4,Bewdley,217.39.99.38,CHLORDIAZEPOXIDE treats FIRST TRIMESTER OF PREGNANCY,188,160,,215,176,treats,0.35921060405355,803083,"b ,   c ,   d ,   e  Fetal/Neonatal Morbidity  Some retrospective studies suggest increased risk of congenital malformations in infants of mothers who received CHLORDIAZEPOXIDE during the FIRST TRIMESTER OF PREGNANCY",FIRST TRIMESTER OF PREGNANCY,CHLORDIAZEPOXIDE,TWrex-cause
791857686,9/21/2015 12:39:26,1743046653,9/21/2015 12:39:09,False,instagc,0.7292,16469970,USA,OK,Broken Arrow,72.192.89.181,CHLORDIAZEPOXIDE treats FIRST TRIMESTER OF PREGNANCY,188,160,,215,176,treats,0.35921060405355,803083,"b ,   c ,   d ,   e  Fetal/Neonatal Morbidity  Some retrospective studies suggest increased risk of congenital malformations in infants of mothers who received CHLORDIAZEPOXIDE during the FIRST TRIMESTER OF PREGNANCY",FIRST TRIMESTER OF PREGNANCY,CHLORDIAZEPOXIDE,TWrex-cause
791857686,9/21/2015 12:42:44,1743047881,9/21/2015 12:42:15,False,clixsense,0.8881,32053717,GBR,,,51.174.76.80,CHLORDIAZEPOXIDE treats FIRST TRIMESTER OF PREGNANCY,188,160,,215,176,treats,0.35921060405355,803083,"b ,   c ,   d ,   e  Fetal/Neonatal Morbidity  Some retrospective studies suggest increased risk of congenital malformations in infants of mothers who received CHLORDIAZEPOXIDE during the FIRST TRIMESTER OF PREGNANCY",FIRST TRIMESTER OF PREGNANCY,CHLORDIAZEPOXIDE,TWrex-cause
791857686,9/21/2015 12:51:59,1743051896,9/21/2015 12:51:18,False,neodev,0.8448,33011398,USA,VA,Manassas,207.244.86.212,CHLORDIAZEPOXIDE treats FIRST TRIMESTER OF PREGNANCY,188,160,,215,176,treats,0.35921060405355,803083,"b ,   c ,   d ,   e  Fetal/Neonatal Morbidity  Some retrospective studies suggest increased risk of congenital malformations in infants of mothers who received CHLORDIAZEPOXIDE during the FIRST TRIMESTER OF PREGNANCY",FIRST TRIMESTER OF PREGNANCY,CHLORDIAZEPOXIDE,TWrex-cause
791857686,9/21/2015 12:52:11,1743051972,9/21/2015 12:50:37,False,points4rewards,0.5595,20113482,USA,PA,Philadelphia,162.208.49.45,no_relation,188,160,,215,176,treats,0.35921060405355,803083,"b ,   c ,   d ,   e  Fetal/Neonatal Morbidity  Some retrospective studies suggest increased risk of congenital malformations in infants of mothers who received CHLORDIAZEPOXIDE during the FIRST TRIMESTER OF PREGNANCY",FIRST TRIMESTER OF PREGNANCY,CHLORDIAZEPOXIDE,TWrex-cause
791857686,9/21/2015 12:56:22,1743053427,9/21/2015 12:52:41,False,neodev,0.7437,32216655,NLD,07,Amsterdam,145.100.72.166,CHLORDIAZEPOXIDE treats FIRST TRIMESTER OF PREGNANCY,188,160,,215,176,treats,0.35921060405355,803083,"b ,   c ,   d ,   e  Fetal/Neonatal Morbidity  Some retrospective studies suggest increased risk of congenital malformations in infants of mothers who received CHLORDIAZEPOXIDE during the FIRST TRIMESTER OF PREGNANCY",FIRST TRIMESTER OF PREGNANCY,CHLORDIAZEPOXIDE,TWrex-cause
791857686,9/21/2015 12:56:30,1743053484,9/21/2015 12:55:50,False,neodev,0.5476,31988911,USA,CA,Saratoga,107.178.43.21,no_relation,188,160,,215,176,treats,0.35921060405355,803083,"b ,   c ,   d ,   e  Fetal/Neonatal Morbidity  Some retrospective studies suggest increased risk of congenital malformations in infants of mothers who received CHLORDIAZEPOXIDE during the FIRST TRIMESTER OF PREGNANCY",FIRST TRIMESTER OF PREGNANCY,CHLORDIAZEPOXIDE,TWrex-cause
791857697,9/21/2015 13:04:55,1743057086,9/21/2015 13:03:56,False,elite,0.8514,33238902,NLD,06,Budel,77.248.148.5,VALPROIC ACID treats BIPOLAR DISORDER,111,40,,126,53,treats,1.0,800714,"Macritchie KAN, Geddes JR, Scott J et alVALPROIC ACID valproate and divalproex in the maintenance treatment of BIPOLAR DISORDER (Cochrane Review.",BIPOLAR DISORDER,VALPROIC ACID,TWrex-cause
791857697,9/21/2015 13:21:56,1743065880,9/21/2015 13:21:34,False,neodev,0.899,18881135,CAN,ON,Ajax,99.243.87.224,VALPROIC ACID treats BIPOLAR DISORDER,111,40,,126,53,treats,1.0,800714,"Macritchie KAN, Geddes JR, Scott J et alVALPROIC ACID valproate and divalproex in the maintenance treatment of BIPOLAR DISORDER (Cochrane Review.",BIPOLAR DISORDER,VALPROIC ACID,TWrex-cause
791857697,9/21/2015 13:37:36,1743074350,9/21/2015 13:36:39,False,clixsense,0.9603,21875134,GBR,,,80.189.12.98,VALPROIC ACID treats BIPOLAR DISORDER,111,40,,126,53,treats,1.0,800714,"Macritchie KAN, Geddes JR, Scott J et alVALPROIC ACID valproate and divalproex in the maintenance treatment of BIPOLAR DISORDER (Cochrane Review.",BIPOLAR DISORDER,VALPROIC ACID,TWrex-cause
791857697,9/21/2015 13:38:29,1743075623,9/21/2015 13:38:06,False,prodege,0.7798,22031444,GBR,M4,Southampton,78.147.179.241,VALPROIC ACID treats BIPOLAR DISORDER,111,40,,126,53,treats,1.0,800714,"Macritchie KAN, Geddes JR, Scott J et alVALPROIC ACID valproate and divalproex in the maintenance treatment of BIPOLAR DISORDER (Cochrane Review.",BIPOLAR DISORDER,VALPROIC ACID,TWrex-cause
791857697,9/21/2015 13:42:04,1743077595,9/21/2015 13:41:59,False,instagc,0.9167,21017840,USA,DE,Newark,128.4.123.224,VALPROIC ACID treats BIPOLAR DISORDER,111,40,,126,53,treats,1.0,800714,"Macritchie KAN, Geddes JR, Scott J et alVALPROIC ACID valproate and divalproex in the maintenance treatment of BIPOLAR DISORDER (Cochrane Review.",BIPOLAR DISORDER,VALPROIC ACID,TWrex-cause
791857697,9/21/2015 14:16:13,1743096352,9/21/2015 14:15:38,False,clixsense,0.9444,26531841,CAN,ON,Ottawa,76.69.154.187,VALPROIC ACID treats BIPOLAR DISORDER,111,40,,126,53,treats,1.0,800714,"Macritchie KAN, Geddes JR, Scott J et alVALPROIC ACID valproate and divalproex in the maintenance treatment of BIPOLAR DISORDER (Cochrane Review.",BIPOLAR DISORDER,VALPROIC ACID,TWrex-cause
791857697,9/21/2015 14:24:23,1743100673,9/21/2015 14:18:57,False,neodev,0.9,33110177,USA,DE,,108.59.8.208,VALPROIC ACID treats BIPOLAR DISORDER,111,40,,126,53,treats,1.0,800714,"Macritchie KAN, Geddes JR, Scott J et alVALPROIC ACID valproate and divalproex in the maintenance treatment of BIPOLAR DISORDER (Cochrane Review.",BIPOLAR DISORDER,VALPROIC ACID,TWrex-cause
791857698,9/21/2015 11:59:41,1743034933,9/21/2015 11:59:32,False,prodege,0.9278,14848125,GBR,V8,Airdrie,86.151.77.161,CLOZAPINE treats SCHIZOPHRENIA,125,78,,138,87,treats,0.9,908293,"Thus, the present data support the hypothesis that the therapeutic effects of CLOZAPINE in this primate model and perhaps in SCHIZOPHRENIA may be related at least in part to the restoration of DA tone in the prefrontal cortex.",SCHIZOPHRENIA,CLOZAPINE,RO-may_treat
791857698,9/21/2015 12:01:49,1743035574,9/21/2015 12:01:00,False,prodege,0.9694,3056891,CAN,ON,Niagara Falls,173.238.144.19,CLOZAPINE treats SCHIZOPHRENIA,125,78,,138,87,treats,0.9,908293,"Thus, the present data support the hypothesis that the therapeutic effects of CLOZAPINE in this primate model and perhaps in SCHIZOPHRENIA may be related at least in part to the restoration of DA tone in the prefrontal cortex.",SCHIZOPHRENIA,CLOZAPINE,RO-may_treat
791857698,9/21/2015 12:35:55,1743045592,9/21/2015 12:34:53,False,clixsense,0.8611,17950689,GBR,Q4,Bewdley,217.39.99.38,SCHIZOPHRENIA treats CLOZAPINE,125,78,,138,87,treats,0.9,908293,"Thus, the present data support the hypothesis that the therapeutic effects of CLOZAPINE in this primate model and perhaps in SCHIZOPHRENIA may be related at least in part to the restoration of DA tone in the prefrontal cortex.",SCHIZOPHRENIA,CLOZAPINE,RO-may_treat
791857698,9/21/2015 12:38:53,1743046439,9/21/2015 12:38:21,False,instagc,0.7292,16469970,USA,OK,Broken Arrow,72.192.89.181,CLOZAPINE treats SCHIZOPHRENIA,125,78,,138,87,treats,0.9,908293,"Thus, the present data support the hypothesis that the therapeutic effects of CLOZAPINE in this primate model and perhaps in SCHIZOPHRENIA may be related at least in part to the restoration of DA tone in the prefrontal cortex.",SCHIZOPHRENIA,CLOZAPINE,RO-may_treat
791857698,9/21/2015 12:41:46,1743047521,9/21/2015 12:41:22,False,clixsense,0.8881,32053717,GBR,,,51.174.76.80,CLOZAPINE treats SCHIZOPHRENIA,125,78,,138,87,treats,0.9,908293,"Thus, the present data support the hypothesis that the therapeutic effects of CLOZAPINE in this primate model and perhaps in SCHIZOPHRENIA may be related at least in part to the restoration of DA tone in the prefrontal cortex.",SCHIZOPHRENIA,CLOZAPINE,RO-may_treat
791857698,9/21/2015 12:48:12,1743050307,9/21/2015 12:41:29,False,points4rewards,0.5595,20113482,USA,PA,Philadelphia,162.208.49.45,no_relation,125,78,,138,87,treats,0.9,908293,"Thus, the present data support the hypothesis that the therapeutic effects of CLOZAPINE in this primate model and perhaps in SCHIZOPHRENIA may be related at least in part to the restoration of DA tone in the prefrontal cortex.",SCHIZOPHRENIA,CLOZAPINE,RO-may_treat
791857698,9/21/2015 12:50:48,1743051347,9/21/2015 12:50:02,False,neodev,0.8448,33011398,USA,VA,Manassas,207.244.86.212,CLOZAPINE treats SCHIZOPHRENIA,125,78,,138,87,treats,0.9,908293,"Thus, the present data support the hypothesis that the therapeutic effects of CLOZAPINE in this primate model and perhaps in SCHIZOPHRENIA may be related at least in part to the restoration of DA tone in the prefrontal cortex.",SCHIZOPHRENIA,CLOZAPINE,RO-may_treat
791857703,9/21/2015 11:15:17,1743021401,9/21/2015 11:14:56,False,instagc,0.7361,33467170,USA,WV,Martinsburg,76.106.109.7,SLE treats PERICARDITIS,98,32,,109,35,treats,0.338061701891407,812970,"Treatment  To simplify therapy, SLE should be classified as mild (eg, fever, arthritis, pleurisy, PERICARDITIS headache, rash) or severe (eg, hemolytic anemia, thrombocytopenic purpura, massive pleural and pericardial involvement, significant renal damage, acute vasculitis of the extremities or GI tract, florid CNS involvement.",PERICARDITIS,SLE,TWrex-cause
791857703,9/21/2015 11:26:10,1743024547,9/21/2015 11:25:49,False,bitcoinget,0.7083,26471938,USA,TX,Missouri City,98.198.169.91,SLE treats PERICARDITIS,98,32,,109,35,treats,0.338061701891407,812970,"Treatment  To simplify therapy, SLE should be classified as mild (eg, fever, arthritis, pleurisy, PERICARDITIS headache, rash) or severe (eg, hemolytic anemia, thrombocytopenic purpura, massive pleural and pericardial involvement, significant renal damage, acute vasculitis of the extremities or GI tract, florid CNS involvement.",PERICARDITIS,SLE,TWrex-cause
791857703,9/21/2015 11:35:36,1743027109,9/21/2015 11:34:02,False,fusioncash,0.7514,31742806,USA,OH,Kent,66.61.82.242,no_relation,98,32,,109,35,treats,0.338061701891407,812970,"Treatment  To simplify therapy, SLE should be classified as mild (eg, fever, arthritis, pleurisy, PERICARDITIS headache, rash) or severe (eg, hemolytic anemia, thrombocytopenic purpura, massive pleural and pericardial involvement, significant renal damage, acute vasculitis of the extremities or GI tract, florid CNS involvement.",PERICARDITIS,SLE,TWrex-cause
791857703,9/21/2015 11:42:57,1743029490,9/21/2015 11:42:20,False,prodege,0.6286,6309240,USA,CA,San Diego,76.167.68.73,no_relation,98,32,,109,35,treats,0.338061701891407,812970,"Treatment  To simplify therapy, SLE should be classified as mild (eg, fever, arthritis, pleurisy, PERICARDITIS headache, rash) or severe (eg, hemolytic anemia, thrombocytopenic purpura, massive pleural and pericardial involvement, significant renal damage, acute vasculitis of the extremities or GI tract, florid CNS involvement.",PERICARDITIS,SLE,TWrex-cause
791857703,9/21/2015 11:57:58,1743034303,9/21/2015 11:57:52,False,neodev,0.6125,32987272,USA,NY,Albany,74.76.228.48,SLE treats PERICARDITIS,98,32,,109,35,treats,0.338061701891407,812970,"Treatment  To simplify therapy, SLE should be classified as mild (eg, fever, arthritis, pleurisy, PERICARDITIS headache, rash) or severe (eg, hemolytic anemia, thrombocytopenic purpura, massive pleural and pericardial involvement, significant renal damage, acute vasculitis of the extremities or GI tract, florid CNS involvement.",PERICARDITIS,SLE,TWrex-cause
791857703,9/21/2015 11:58:25,1743034477,9/21/2015 11:57:47,False,prodege,0.9278,14848125,GBR,V8,Airdrie,86.151.77.161,no_relation,98,32,,109,35,treats,0.338061701891407,812970,"Treatment  To simplify therapy, SLE should be classified as mild (eg, fever, arthritis, pleurisy, PERICARDITIS headache, rash) or severe (eg, hemolytic anemia, thrombocytopenic purpura, massive pleural and pericardial involvement, significant renal damage, acute vasculitis of the extremities or GI tract, florid CNS involvement.",PERICARDITIS,SLE,TWrex-cause
791857703,9/21/2015 12:05:34,1743036565,9/21/2015 12:05:21,False,dailyrewardsca,0.8829,32219778,CAN,ON,Ottawa,99.241.19.27,no_relation,98,32,,109,35,treats,0.338061701891407,812970,"Treatment  To simplify therapy, SLE should be classified as mild (eg, fever, arthritis, pleurisy, PERICARDITIS headache, rash) or severe (eg, hemolytic anemia, thrombocytopenic purpura, massive pleural and pericardial involvement, significant renal damage, acute vasculitis of the extremities or GI tract, florid CNS involvement.",PERICARDITIS,SLE,TWrex-cause
791857705,9/21/2015 14:33:56,1743105133,9/21/2015 14:33:36,False,clixsense,0.9018,33115750,GBR,I3,Rochester,90.222.106.192,DOXEPIN treats DEPRESSION,142,101,,152,108,treats,0.8427009716003839,907617,"Dunner DL, Cohn JB, Walshe T et al. Two combined, multicenter double blind studies of paroxetine and DOXEPIN in geriatric patients with major DEPRESSION",DEPRESSION,DOXEPIN,RO-may_treat
791857705,9/21/2015 14:34:47,1743105545,9/21/2015 14:34:32,False,neodev,0.9792,12115558,USA,OH,Twinsburg,98.27.164.131,DOXEPIN treats DEPRESSION,142,101,,152,108,treats,0.8427009716003839,907617,"Dunner DL, Cohn JB, Walshe T et al. Two combined, multicenter double blind studies of paroxetine and DOXEPIN in geriatric patients with major DEPRESSION",DEPRESSION,DOXEPIN,RO-may_treat
791857705,9/21/2015 14:40:54,1743108672,9/21/2015 14:40:36,False,onestopgpt,0.9333,21275875,CAN,ON,Hamilton,24.36.124.79,DOXEPIN treats DEPRESSION,142,101,,152,108,treats,0.8427009716003839,907617,"Dunner DL, Cohn JB, Walshe T et al. Two combined, multicenter double blind studies of paroxetine and DOXEPIN in geriatric patients with major DEPRESSION",DEPRESSION,DOXEPIN,RO-may_treat
791857705,9/21/2015 14:50:04,1743113739,9/21/2015 14:48:47,False,elite,0.8849,30312592,CAN,ON,Sudbury,66.103.55.12,DOXEPIN treats DEPRESSION,142,101,,152,108,treats,0.8427009716003839,907617,"Dunner DL, Cohn JB, Walshe T et al. Two combined, multicenter double blind studies of paroxetine and DOXEPIN in geriatric patients with major DEPRESSION",DEPRESSION,DOXEPIN,RO-may_treat
791857705,9/21/2015 15:28:03,1743144106,9/21/2015 15:26:36,False,clixsense,0.8616,21490235,GBR,N7,Woking,86.30.254.232,DOXEPIN treats DEPRESSION,142,101,,152,108,treats,0.8427009716003839,907617,"Dunner DL, Cohn JB, Walshe T et al. Two combined, multicenter double blind studies of paroxetine and DOXEPIN in geriatric patients with major DEPRESSION",DEPRESSION,DOXEPIN,RO-may_treat
791857705,9/21/2015 15:36:28,1743150138,9/21/2015 15:36:08,False,instagc,0.9833,21551272,GBR,Q3,Wolverhampton,80.43.83.1,DOXEPIN treats DEPRESSION,142,101,,152,108,treats,0.8427009716003839,907617,"Dunner DL, Cohn JB, Walshe T et al. Two combined, multicenter double blind studies of paroxetine and DOXEPIN in geriatric patients with major DEPRESSION",DEPRESSION,DOXEPIN,RO-may_treat
791857705,9/21/2015 15:41:51,1743153785,9/21/2015 15:41:00,False,clixsense,0.8492,33878524,CAN,BC,Princeton,75.156.83.71,DOXEPIN treats DEPRESSION,142,101,,152,108,treats,0.8427009716003839,907617,"Dunner DL, Cohn JB, Walshe T et al. Two combined, multicenter double blind studies of paroxetine and DOXEPIN in geriatric patients with major DEPRESSION",DEPRESSION,DOXEPIN,RO-may_treat
791857709,9/21/2015 11:14:55,1743021320,9/21/2015 11:14:40,False,instagc,0.7361,33467170,USA,WV,Martinsburg,76.106.109.7,PROPRANOLOL treats ESSENTIAL TREMOR,62,47,,77,58,treats,0.9494253265550829,804967,"Teravainen H, Fogelholm R, Larsen A. Effect of PROPRANOLOL on ESSENTIAL TREMOR",ESSENTIAL TREMOR,PROPRANOLOL,TWrex-cause
791857709,9/21/2015 11:25:48,1743024427,9/21/2015 11:24:50,False,bitcoinget,0.7083,26471938,USA,TX,Missouri City,98.198.169.91,PROPRANOLOL treats ESSENTIAL TREMOR,62,47,,77,58,treats,0.9494253265550829,804967,"Teravainen H, Fogelholm R, Larsen A. Effect of PROPRANOLOL on ESSENTIAL TREMOR",ESSENTIAL TREMOR,PROPRANOLOL,TWrex-cause
791857709,9/21/2015 11:34:01,1743026727,9/21/2015 11:33:23,False,fusioncash,0.7514,31742806,USA,OH,Kent,66.61.82.242,PROPRANOLOL treats ESSENTIAL TREMOR,62,47,,77,58,treats,0.9494253265550829,804967,"Teravainen H, Fogelholm R, Larsen A. Effect of PROPRANOLOL on ESSENTIAL TREMOR",ESSENTIAL TREMOR,PROPRANOLOL,TWrex-cause
791857709,9/21/2015 11:42:19,1743029232,9/21/2015 11:41:41,False,prodege,0.6286,6309240,USA,CA,San Diego,76.167.68.73,no_relation,62,47,,77,58,treats,0.9494253265550829,804967,"Teravainen H, Fogelholm R, Larsen A. Effect of PROPRANOLOL on ESSENTIAL TREMOR",ESSENTIAL TREMOR,PROPRANOLOL,TWrex-cause
791857709,9/21/2015 11:53:05,1743032846,9/21/2015 11:52:42,False,dailyrewardsca,0.8829,32219778,CAN,ON,Ottawa,99.241.19.27,PROPRANOLOL treats ESSENTIAL TREMOR,62,47,,77,58,treats,0.9494253265550829,804967,"Teravainen H, Fogelholm R, Larsen A. Effect of PROPRANOLOL on ESSENTIAL TREMOR",ESSENTIAL TREMOR,PROPRANOLOL,TWrex-cause
791857709,9/21/2015 11:57:59,1743034316,9/21/2015 11:57:22,False,prodege,0.9694,3056891,CAN,ON,Niagara Falls,173.238.144.19,PROPRANOLOL treats ESSENTIAL TREMOR,62,47,,77,58,treats,0.9494253265550829,804967,"Teravainen H, Fogelholm R, Larsen A. Effect of PROPRANOLOL on ESSENTIAL TREMOR",ESSENTIAL TREMOR,PROPRANOLOL,TWrex-cause
791857709,9/21/2015 12:17:59,1743040198,9/21/2015 12:17:36,False,prodege,0.9571,3587109,CAN,NS,Antigonish,142.177.108.85,PROPRANOLOL treats ESSENTIAL TREMOR,62,47,,77,58,treats,0.9494253265550829,804967,"Teravainen H, Fogelholm R, Larsen A. Effect of PROPRANOLOL on ESSENTIAL TREMOR",ESSENTIAL TREMOR,PROPRANOLOL,TWrex-cause
791857714,9/21/2015 09:34:07,1742997296,9/21/2015 09:33:55,False,neodev,1.0,14096345,NLD,03,Eibergen,178.85.94.186,CIPROFLOXACIN treats BONE INFECTIONS,99,41,,113,54,treats,1.0,800523,"Nix DE, Cumbo TJ, Kuritzky P et al. Oral CIPROFLOXACIN in the treatment of serious soft tissue and BONE INFECTIONS: efficacy, safety, and pharmacokinetics.",BONE INFECTIONS,CIPROFLOXACIN,TWrex-cause
791857714,9/21/2015 09:55:00,1743002903,9/21/2015 09:54:49,False,elite,0.725,29768955,GBR,C3,Gamlingay,31.50.187.165,CIPROFLOXACIN treats BONE INFECTIONS,99,41,,113,54,treats,1.0,800523,"Nix DE, Cumbo TJ, Kuritzky P et al. Oral CIPROFLOXACIN in the treatment of serious soft tissue and BONE INFECTIONS: efficacy, safety, and pharmacokinetics.",BONE INFECTIONS,CIPROFLOXACIN,TWrex-cause
791857714,9/21/2015 09:56:55,1743003480,9/21/2015 09:56:39,False,neodev,0.7778,20306047,GBR,,,80.41.0.252,CIPROFLOXACIN treats BONE INFECTIONS,99,41,,113,54,treats,1.0,800523,"Nix DE, Cumbo TJ, Kuritzky P et al. Oral CIPROFLOXACIN in the treatment of serious soft tissue and BONE INFECTIONS: efficacy, safety, and pharmacokinetics.",BONE INFECTIONS,CIPROFLOXACIN,TWrex-cause
791857714,9/21/2015 09:57:36,1743003653,9/21/2015 09:57:14,False,gifthunterclub,0.8222,24043308,GBR,,,94.102.147.250,CIPROFLOXACIN treats BONE INFECTIONS,99,41,,113,54,treats,1.0,800523,"Nix DE, Cumbo TJ, Kuritzky P et al. Oral CIPROFLOXACIN in the treatment of serious soft tissue and BONE INFECTIONS: efficacy, safety, and pharmacokinetics.",BONE INFECTIONS,CIPROFLOXACIN,TWrex-cause
791857714,9/21/2015 09:57:52,1743003721,9/21/2015 09:57:01,False,neodev,0.8222,33758777,USA,,,38.95.108.251,CIPROFLOXACIN treats BONE INFECTIONS,99,41,,113,54,treats,1.0,800523,"Nix DE, Cumbo TJ, Kuritzky P et al. Oral CIPROFLOXACIN in the treatment of serious soft tissue and BONE INFECTIONS: efficacy, safety, and pharmacokinetics.",BONE INFECTIONS,CIPROFLOXACIN,TWrex-cause
791857714,9/21/2015 09:59:21,1743004083,9/21/2015 09:59:09,False,meprizescf,0.8512,28483210,USA,WI,Minocqua,75.143.134.247,CIPROFLOXACIN treats BONE INFECTIONS,99,41,,113,54,treats,1.0,800523,"Nix DE, Cumbo TJ, Kuritzky P et al. Oral CIPROFLOXACIN in the treatment of serious soft tissue and BONE INFECTIONS: efficacy, safety, and pharmacokinetics.",BONE INFECTIONS,CIPROFLOXACIN,TWrex-cause
791857714,9/21/2015 10:06:57,1743005775,9/21/2015 10:06:33,False,treasuretrooper,0.7381,17956656,AUS,02,Jannali,14.200.59.55,no_relation,99,41,,113,54,treats,1.0,800523,"Nix DE, Cumbo TJ, Kuritzky P et al. Oral CIPROFLOXACIN in the treatment of serious soft tissue and BONE INFECTIONS: efficacy, safety, and pharmacokinetics.",BONE INFECTIONS,CIPROFLOXACIN,TWrex-cause
791857725,9/21/2015 10:19:19,1743008531,9/21/2015 10:18:36,False,keeprewarding,0.9583,29139615,CAN,ON,Perth,192.186.81.178,no_relation,74,106,,86,114,treats,0.30151134457776396,902852,"Human alpha fetoproteins were purified from umbilical cord serum and from ASCITES FLUID of a patient with HEPATOMA by affinity chromatography, and their chemical compositions and terminal sequences were compared.",ASCITES FLUID,HEPATOMA,RO-disease_may_have_finding
791857725,9/21/2015 10:33:29,1743011638,9/21/2015 10:32:16,False,prodege,0.6458,21417560,GBR,C3,Cambridge,151.224.120.191,no_relation,74,106,,86,114,treats,0.30151134457776396,902852,"Human alpha fetoproteins were purified from umbilical cord serum and from ASCITES FLUID of a patient with HEPATOMA by affinity chromatography, and their chemical compositions and terminal sequences were compared.",ASCITES FLUID,HEPATOMA,RO-disease_may_have_finding
791857725,9/21/2015 10:35:45,1743012136,9/21/2015 10:35:23,False,prodege,0.6389,27934334,GBR,C8,Croydon,81.159.60.206,no_relation,74,106,,86,114,treats,0.30151134457776396,902852,"Human alpha fetoproteins were purified from umbilical cord serum and from ASCITES FLUID of a patient with HEPATOMA by affinity chromatography, and their chemical compositions and terminal sequences were compared.",ASCITES FLUID,HEPATOMA,RO-disease_may_have_finding
791857725,9/21/2015 10:42:13,1743013600,9/21/2015 10:41:30,False,neodev,0.7014,30588889,NLD,07,Amsterdam,77.248.175.222,no_relation,74,106,,86,114,treats,0.30151134457776396,902852,"Human alpha fetoproteins were purified from umbilical cord serum and from ASCITES FLUID of a patient with HEPATOMA by affinity chromatography, and their chemical compositions and terminal sequences were compared.",ASCITES FLUID,HEPATOMA,RO-disease_may_have_finding
791857725,9/21/2015 10:44:38,1743014049,9/21/2015 10:44:10,False,clixsense,0.6639,30258829,NLD,05,Velden,84.104.254.214,no_relation,74,106,,86,114,treats,0.30151134457776396,902852,"Human alpha fetoproteins were purified from umbilical cord serum and from ASCITES FLUID of a patient with HEPATOMA by affinity chromatography, and their chemical compositions and terminal sequences were compared.",ASCITES FLUID,HEPATOMA,RO-disease_may_have_finding
791857725,9/21/2015 11:07:12,1743019536,9/21/2015 11:07:00,False,clixsense,0.6369,24104564,AUS,02,Surry Hills,60.241.132.132,ASCITES FLUID treats HEPATOMA,74,106,,86,114,treats,0.30151134457776396,902852,"Human alpha fetoproteins were purified from umbilical cord serum and from ASCITES FLUID of a patient with HEPATOMA by affinity chromatography, and their chemical compositions and terminal sequences were compared.",ASCITES FLUID,HEPATOMA,RO-disease_may_have_finding
791857725,9/21/2015 11:11:48,1743020567,9/21/2015 11:11:32,False,prodege,0.8155,4316379,CAN,ON,Windsor,198.91.219.55,no_relation,74,106,,86,114,treats,0.30151134457776396,902852,"Human alpha fetoproteins were purified from umbilical cord serum and from ASCITES FLUID of a patient with HEPATOMA by affinity chromatography, and their chemical compositions and terminal sequences were compared.",ASCITES FLUID,HEPATOMA,RO-disease_may_have_finding
791857745,9/21/2015 10:07:34,1743005941,9/21/2015 10:07:19,False,treasuretrooper,0.7381,17956656,AUS,02,Jannali,14.200.59.55,[SKIN DIETARY PROANTHOCYANIDINS] treats [CARCINOGENESIS],73,22,,86,51,treats,1.0,224015,ultraviolet damage to [SKIN DIETARY PROANTHOCYANIDINS] may protect against [CARCINOGENESIS] and provide supplementation for sunscreen protection.,[CARCINOGENESIS],[SKIN DIETARY PROANTHOCYANIDINS],TWrex-treat
791857745,9/21/2015 10:15:20,1743007711,9/21/2015 10:14:04,False,keeprewarding,0.9583,29139615,CAN,ON,Perth,192.186.81.178,no_relation,73,22,,86,51,treats,1.0,224015,ultraviolet damage to [SKIN DIETARY PROANTHOCYANIDINS] may protect against [CARCINOGENESIS] and provide supplementation for sunscreen protection.,[CARCINOGENESIS],[SKIN DIETARY PROANTHOCYANIDINS],TWrex-treat
791857745,9/21/2015 10:30:52,1743011088,9/21/2015 10:30:07,False,prodege,0.6458,21417560,GBR,C3,Cambridge,151.224.120.191,no_relation,73,22,,86,51,treats,1.0,224015,ultraviolet damage to [SKIN DIETARY PROANTHOCYANIDINS] may protect against [CARCINOGENESIS] and provide supplementation for sunscreen protection.,[CARCINOGENESIS],[SKIN DIETARY PROANTHOCYANIDINS],TWrex-treat
791857745,9/21/2015 10:34:33,1743011901,9/21/2015 10:34:11,False,prodege,0.6389,27934334,GBR,C8,Croydon,81.159.60.206,no_relation,73,22,,86,51,treats,1.0,224015,ultraviolet damage to [SKIN DIETARY PROANTHOCYANIDINS] may protect against [CARCINOGENESIS] and provide supplementation for sunscreen protection.,[CARCINOGENESIS],[SKIN DIETARY PROANTHOCYANIDINS],TWrex-treat
791857745,9/21/2015 10:40:30,1743013267,9/21/2015 10:39:56,False,neodev,0.7014,30588889,NLD,07,Amsterdam,77.248.175.222,[SKIN DIETARY PROANTHOCYANIDINS] treats [CARCINOGENESIS],73,22,,86,51,treats,1.0,224015,ultraviolet damage to [SKIN DIETARY PROANTHOCYANIDINS] may protect against [CARCINOGENESIS] and provide supplementation for sunscreen protection.,[CARCINOGENESIS],[SKIN DIETARY PROANTHOCYANIDINS],TWrex-treat
791857745,9/21/2015 10:43:01,1743013754,9/21/2015 10:42:24,False,clixsense,0.6639,30258829,NLD,05,Velden,84.104.254.214,[SKIN DIETARY PROANTHOCYANIDINS] treats [CARCINOGENESIS],73,22,,86,51,treats,1.0,224015,ultraviolet damage to [SKIN DIETARY PROANTHOCYANIDINS] may protect against [CARCINOGENESIS] and provide supplementation for sunscreen protection.,[CARCINOGENESIS],[SKIN DIETARY PROANTHOCYANIDINS],TWrex-treat
791857745,9/21/2015 11:06:23,1743019314,9/21/2015 11:05:56,False,clixsense,0.6369,24104564,AUS,02,Surry Hills,60.241.132.132,[SKIN DIETARY PROANTHOCYANIDINS] treats [CARCINOGENESIS],73,22,,86,51,treats,1.0,224015,ultraviolet damage to [SKIN DIETARY PROANTHOCYANIDINS] may protect against [CARCINOGENESIS] and provide supplementation for sunscreen protection.,[CARCINOGENESIS],[SKIN DIETARY PROANTHOCYANIDINS],TWrex-treat
791857749,9/21/2015 11:28:04,1743025203,9/21/2015 11:26:11,False,bitcoinget,0.7083,26471938,USA,TX,Missouri City,98.198.169.91,METFORMIN treats TYPE 2 DIABETES MELLITUS,0,220,,23,229,treats,0.9838699100999069,803480,"TYPE 2 DIABETES MELLITUS who were treated with bedtime insulin plus metformin did not gain weight, had fewer hypoglycemic episodes, and had better glycemic control than those treated with bedtime insulin plus glyburide, METFORMIN and glyburide, or morning insulin.",TYPE 2 DIABETES MELLITUS,METFORMIN,TWrex-cause
791857749,9/21/2015 11:35:52,1743027157,9/21/2015 11:35:37,False,fusioncash,0.7514,31742806,USA,OH,Kent,66.61.82.242,METFORMIN treats TYPE 2 DIABETES MELLITUS,0,220,,23,229,treats,0.9838699100999069,803480,"TYPE 2 DIABETES MELLITUS who were treated with bedtime insulin plus metformin did not gain weight, had fewer hypoglycemic episodes, and had better glycemic control than those treated with bedtime insulin plus glyburide, METFORMIN and glyburide, or morning insulin.",TYPE 2 DIABETES MELLITUS,METFORMIN,TWrex-cause
791857749,9/21/2015 11:43:25,1743029657,9/21/2015 11:42:58,False,prodege,0.6286,6309240,USA,CA,San Diego,76.167.68.73,no_relation,0,220,,23,229,treats,0.9838699100999069,803480,"TYPE 2 DIABETES MELLITUS who were treated with bedtime insulin plus metformin did not gain weight, had fewer hypoglycemic episodes, and had better glycemic control than those treated with bedtime insulin plus glyburide, METFORMIN and glyburide, or morning insulin.",TYPE 2 DIABETES MELLITUS,METFORMIN,TWrex-cause
791857749,9/21/2015 11:58:37,1743034562,9/21/2015 11:57:59,False,prodege,0.9694,3056891,CAN,ON,Niagara Falls,173.238.144.19,METFORMIN treats TYPE 2 DIABETES MELLITUS,0,220,,23,229,treats,0.9838699100999069,803480,"TYPE 2 DIABETES MELLITUS who were treated with bedtime insulin plus metformin did not gain weight, had fewer hypoglycemic episodes, and had better glycemic control than those treated with bedtime insulin plus glyburide, METFORMIN and glyburide, or morning insulin.",TYPE 2 DIABETES MELLITUS,METFORMIN,TWrex-cause
791857749,9/21/2015 11:58:38,1743034568,9/21/2015 11:58:26,False,prodege,0.9278,14848125,GBR,V8,Airdrie,86.151.77.161,METFORMIN treats TYPE 2 DIABETES MELLITUS,0,220,,23,229,treats,0.9838699100999069,803480,"TYPE 2 DIABETES MELLITUS who were treated with bedtime insulin plus metformin did not gain weight, had fewer hypoglycemic episodes, and had better glycemic control than those treated with bedtime insulin plus glyburide, METFORMIN and glyburide, or morning insulin.",TYPE 2 DIABETES MELLITUS,METFORMIN,TWrex-cause
791857749,9/21/2015 12:05:49,1743036659,9/21/2015 12:05:35,False,dailyrewardsca,0.8829,32219778,CAN,ON,Ottawa,99.241.19.27,no_relation,0,220,,23,229,treats,0.9838699100999069,803480,"TYPE 2 DIABETES MELLITUS who were treated with bedtime insulin plus metformin did not gain weight, had fewer hypoglycemic episodes, and had better glycemic control than those treated with bedtime insulin plus glyburide, METFORMIN and glyburide, or morning insulin.",TYPE 2 DIABETES MELLITUS,METFORMIN,TWrex-cause
791857749,9/21/2015 12:18:13,1743040266,9/21/2015 12:18:00,False,prodege,0.9571,3587109,CAN,NS,Antigonish,142.177.108.85,METFORMIN treats TYPE 2 DIABETES MELLITUS,0,220,,23,229,treats,0.9838699100999069,803480,"TYPE 2 DIABETES MELLITUS who were treated with bedtime insulin plus metformin did not gain weight, had fewer hypoglycemic episodes, and had better glycemic control than those treated with bedtime insulin plus glyburide, METFORMIN and glyburide, or morning insulin.",TYPE 2 DIABETES MELLITUS,METFORMIN,TWrex-cause
791857755,9/21/2015 11:13:12,1743020894,9/21/2015 11:12:42,False,prodege,0.8155,4316379,CAN,ON,Windsor,198.91.219.55,LEVODOPA/DDCI treats FLUCTUATING PARKINSON'S DISEASE,52,102,,82,115,treats,0.9761870601839531,908084,"Thus, tolcapone is a useful option in patients with FLUCTUATING PARKINSON'S DISEASE who are receiving LEVODOPA/DDCI and are not responding to, or are not candidates for, other adjunctive treatments.",FLUCTUATING PARKINSON'S DISEASE,LEVODOPA/DDCI,RO-may_treat
791857755,9/21/2015 11:14:40,1743021303,9/21/2015 11:13:26,False,instagc,0.7361,33467170,USA,WV,Martinsburg,76.106.109.7,no_relation,52,102,,82,115,treats,0.9761870601839531,908084,"Thus, tolcapone is a useful option in patients with FLUCTUATING PARKINSON'S DISEASE who are receiving LEVODOPA/DDCI and are not responding to, or are not candidates for, other adjunctive treatments.",FLUCTUATING PARKINSON'S DISEASE,LEVODOPA/DDCI,RO-may_treat
791857755,9/21/2015 11:24:50,1743024089,9/21/2015 11:24:03,False,bitcoinget,0.7083,26471938,USA,TX,Missouri City,98.198.169.91,no_relation,52,102,,82,115,treats,0.9761870601839531,908084,"Thus, tolcapone is a useful option in patients with FLUCTUATING PARKINSON'S DISEASE who are receiving LEVODOPA/DDCI and are not responding to, or are not candidates for, other adjunctive treatments.",FLUCTUATING PARKINSON'S DISEASE,LEVODOPA/DDCI,RO-may_treat
791857755,9/21/2015 11:33:21,1743026620,9/21/2015 11:32:31,False,fusioncash,0.7514,31742806,USA,OH,Kent,66.61.82.242,LEVODOPA/DDCI treats FLUCTUATING PARKINSON'S DISEASE,52,102,,82,115,treats,0.9761870601839531,908084,"Thus, tolcapone is a useful option in patients with FLUCTUATING PARKINSON'S DISEASE who are receiving LEVODOPA/DDCI and are not responding to, or are not candidates for, other adjunctive treatments.",FLUCTUATING PARKINSON'S DISEASE,LEVODOPA/DDCI,RO-may_treat
791857755,9/21/2015 11:41:40,1743029042,9/21/2015 11:41:13,False,prodege,0.6286,6309240,USA,CA,San Diego,76.167.68.73,no_relation,52,102,,82,115,treats,0.9761870601839531,908084,"Thus, tolcapone is a useful option in patients with FLUCTUATING PARKINSON'S DISEASE who are receiving LEVODOPA/DDCI and are not responding to, or are not candidates for, other adjunctive treatments.",FLUCTUATING PARKINSON'S DISEASE,LEVODOPA/DDCI,RO-may_treat
791857755,9/21/2015 11:57:51,1743034290,9/21/2015 11:50:36,False,neodev,0.6125,32987272,USA,NY,Albany,74.76.228.48,LEVODOPA/DDCI treats FLUCTUATING PARKINSON'S DISEASE,52,102,,82,115,treats,0.9761870601839531,908084,"Thus, tolcapone is a useful option in patients with FLUCTUATING PARKINSON'S DISEASE who are receiving LEVODOPA/DDCI and are not responding to, or are not candidates for, other adjunctive treatments.",FLUCTUATING PARKINSON'S DISEASE,LEVODOPA/DDCI,RO-may_treat
791857755,9/21/2015 11:59:33,1743034891,9/21/2015 11:51:41,False,points4rewards,0.5595,20113482,USA,PA,Philadelphia,162.208.49.45,no_relation,52,102,,82,115,treats,0.9761870601839531,908084,"Thus, tolcapone is a useful option in patients with FLUCTUATING PARKINSON'S DISEASE who are receiving LEVODOPA/DDCI and are not responding to, or are not candidates for, other adjunctive treatments.",FLUCTUATING PARKINSON'S DISEASE,LEVODOPA/DDCI,RO-may_treat
862932336,1/18/2016 19:10:56,1862026439,1/18/2016 19:10:21,False,prodege,0.6766,34650780,GBR,M3,Dulverton,81.154.41.50,no_relation,12,67,,33,88,treats,0.92998111,820004,"The risk of NOCTURNAL HYPOGLYCEMIA is lower with this regimen, and FASTING BLOOD GLUCOSE is better controlled.",NOCTURNAL HYPOGLYCEMIA,FASTING BLOOD GLUCOSE,RO-may_treat
862932336,1/18/2016 19:12:04,1862026867,1/18/2016 19:11:46,False,points4rewards,0.6806,20306700,USA,WA,Kirkland,73.225.187.97,FASTING BLOOD GLUCOSE treats NOCTURNAL HYPOGLYCEMIA,12,67,,33,88,treats,0.92998111,820004,"The risk of NOCTURNAL HYPOGLYCEMIA is lower with this regimen, and FASTING BLOOD GLUCOSE is better controlled.",NOCTURNAL HYPOGLYCEMIA,FASTING BLOOD GLUCOSE,RO-may_treat
862932336,1/18/2016 19:20:16,1862030254,1/18/2016 19:19:35,False,gifthunterclub,0.6944,30901412,GBR,G5,Canterbury,78.148.187.102,no_relation,12,67,,33,88,treats,0.92998111,820004,"The risk of NOCTURNAL HYPOGLYCEMIA is lower with this regimen, and FASTING BLOOD GLUCOSE is better controlled.",NOCTURNAL HYPOGLYCEMIA,FASTING BLOOD GLUCOSE,RO-may_treat
862932336,1/18/2016 19:20:25,1862030338,1/18/2016 19:19:34,False,clixsense,0.7976,6349089,USA,NJ,Rockaway,108.35.211.250,no_relation,12,67,,33,88,treats,0.92998111,820004,"The risk of NOCTURNAL HYPOGLYCEMIA is lower with this regimen, and FASTING BLOOD GLUCOSE is better controlled.",NOCTURNAL HYPOGLYCEMIA,FASTING BLOOD GLUCOSE,RO-may_treat
862932336,1/18/2016 19:25:24,1862032466,1/18/2016 19:24:52,False,prodege,0.6875,25257275,CAN,BC,Coquitlam,70.68.58.9,no_relation,12,67,,33,88,treats,0.92998111,820004,"The risk of NOCTURNAL HYPOGLYCEMIA is lower with this regimen, and FASTING BLOOD GLUCOSE is better controlled.",NOCTURNAL HYPOGLYCEMIA,FASTING BLOOD GLUCOSE,RO-may_treat
862932336,1/18/2016 19:26:38,1862033121,1/18/2016 19:25:26,False,cotter,0.4653,1495820,USA,AL,Talladega,24.177.180.29,no_relation,12,67,,33,88,treats,0.92998111,820004,"The risk of NOCTURNAL HYPOGLYCEMIA is lower with this regimen, and FASTING BLOOD GLUCOSE is better controlled.",NOCTURNAL HYPOGLYCEMIA,FASTING BLOOD GLUCOSE,RO-may_treat
862932336,1/18/2016 19:40:38,1862038062,1/18/2016 19:39:11,False,prodege,0.6667,19520624,USA,CA,Riverside,108.244.25.24,NOCTURNAL HYPOGLYCEMIA treats FASTING BLOOD GLUCOSE,12,67,,33,88,treats,0.92998111,820004,"The risk of NOCTURNAL HYPOGLYCEMIA is lower with this regimen, and FASTING BLOOD GLUCOSE is better controlled.",NOCTURNAL HYPOGLYCEMIA,FASTING BLOOD GLUCOSE,RO-may_treat
862932344,1/18/2016 18:38:50,1862014443,1/18/2016 18:38:33,False,prodege,0.8532,1924522,USA,NY,New York,96.224.13.135,INSULIN treats DIABETES TYPE I AND II,67,107,,88,114,treats,0.9491579957999999,820140,Hypersecretion of insulin increases the chance of the incidence of DIABETES TYPE I AND II while inhibiting INSULIN secretion helps prevent diabetes.,DIABETES TYPE I AND II,INSULIN,RO-may_treat
862932344,1/18/2016 18:51:59,1862019348,1/18/2016 18:51:23,False,neodev,0.6563,13253916,GBR,C6,Saint Austell,92.17.245.86,INSULIN treats DIABETES TYPE I AND II,67,107,,88,114,treats,0.9491579957999999,820140,Hypersecretion of insulin increases the chance of the incidence of DIABETES TYPE I AND II while inhibiting INSULIN secretion helps prevent diabetes.,DIABETES TYPE I AND II,INSULIN,RO-may_treat
862932344,1/18/2016 19:04:53,1862024126,1/18/2016 19:04:43,False,neodev,0.622,33155316,GBR,M3,Bridgwater,86.138.4.186,DIABETES TYPE I AND II treats INSULIN,67,107,,88,114,treats,0.9491579957999999,820140,Hypersecretion of insulin increases the chance of the incidence of DIABETES TYPE I AND II while inhibiting INSULIN secretion helps prevent diabetes.,DIABETES TYPE I AND II,INSULIN,RO-may_treat
862932344,1/18/2016 19:09:07,1862025855,1/18/2016 19:08:31,False,prodege,0.6766,34650780,GBR,M3,Dulverton,81.154.41.50,no_relation,67,107,,88,114,treats,0.9491579957999999,820140,Hypersecretion of insulin increases the chance of the incidence of DIABETES TYPE I AND II while inhibiting INSULIN secretion helps prevent diabetes.,DIABETES TYPE I AND II,INSULIN,RO-may_treat
862932344,1/18/2016 19:09:25,1862025934,1/18/2016 19:08:14,False,points4rewards,0.6806,20306700,USA,WA,Kirkland,73.225.187.97,INSULIN treats DIABETES TYPE I AND II,67,107,,88,114,treats,0.9491579957999999,820140,Hypersecretion of insulin increases the chance of the incidence of DIABETES TYPE I AND II while inhibiting INSULIN secretion helps prevent diabetes.,DIABETES TYPE I AND II,INSULIN,RO-may_treat
862932344,1/18/2016 19:09:47,1862026057,1/18/2016 19:00:50,False,instagc,0.7020000000000001,18672993,CAN,BC,Vancouver,76.77.82.83,INSULIN treats DIABETES TYPE I AND II,67,107,,88,114,treats,0.9491579957999999,820140,Hypersecretion of insulin increases the chance of the incidence of DIABETES TYPE I AND II while inhibiting INSULIN secretion helps prevent diabetes.,DIABETES TYPE I AND II,INSULIN,RO-may_treat
862932344,1/18/2016 19:10:07,1862026177,1/18/2016 19:08:49,False,zoombucks,0.6528,6744840,CAN,BC,Kelowna,174.4.58.160,INSULIN treats DIABETES TYPE I AND II,67,107,,88,114,treats,0.9491579957999999,820140,Hypersecretion of insulin increases the chance of the incidence of DIABETES TYPE I AND II while inhibiting INSULIN secretion helps prevent diabetes.,DIABETES TYPE I AND II,INSULIN,RO-may_treat
862932349,1/18/2016 19:21:15,1862030648,1/18/2016 19:20:58,False,gifthunterclub,0.6944,30901412,GBR,G5,Canterbury,78.148.187.102,no_relation,116,145,,119,157,treats,0.6432675209000001,820037,"• A large, population based cohort study of 7195 isotretinoin users with acne and 13,700 oral antibiotic users with ACNE showed no evidence that ISOTRETINOIN increases risk of depression, suicide, or other psychiatric disorders ( 34.",ACNE,ISOTRETINOIN,RO-may_treat
862932349,1/18/2016 19:22:10,1862031083,1/18/2016 19:21:35,False,clixsense,0.7976,6349089,USA,NJ,Rockaway,108.35.211.250,ISOTRETINOIN treats ACNE,116,145,,119,157,treats,0.6432675209000001,820037,"• A large, population based cohort study of 7195 isotretinoin users with acne and 13,700 oral antibiotic users with ACNE showed no evidence that ISOTRETINOIN increases risk of depression, suicide, or other psychiatric disorders ( 34.",ACNE,ISOTRETINOIN,RO-may_treat
862932349,1/18/2016 19:26:06,1862032789,1/18/2016 19:25:53,False,prodege,0.6875,25257275,CAN,BC,Coquitlam,70.68.58.9,ISOTRETINOIN treats ACNE,116,145,,119,157,treats,0.6432675209000001,820037,"• A large, population based cohort study of 7195 isotretinoin users with acne and 13,700 oral antibiotic users with ACNE showed no evidence that ISOTRETINOIN increases risk of depression, suicide, or other psychiatric disorders ( 34.",ACNE,ISOTRETINOIN,RO-may_treat
862932349,1/18/2016 19:29:27,1862034331,1/18/2016 19:28:31,False,cotter,0.4653,1495820,USA,AL,Talladega,24.177.180.29,no_relation,116,145,,119,157,treats,0.6432675209000001,820037,"• A large, population based cohort study of 7195 isotretinoin users with acne and 13,700 oral antibiotic users with ACNE showed no evidence that ISOTRETINOIN increases risk of depression, suicide, or other psychiatric disorders ( 34.",ACNE,ISOTRETINOIN,RO-may_treat
862932349,1/18/2016 19:45:52,1862039603,1/18/2016 19:44:34,False,clixsense,0.7667,33878524,CAN,BC,Hope,75.156.80.18,ISOTRETINOIN treats ACNE,116,145,,119,157,treats,0.6432675209000001,820037,"• A large, population based cohort study of 7195 isotretinoin users with acne and 13,700 oral antibiotic users with ACNE showed no evidence that ISOTRETINOIN increases risk of depression, suicide, or other psychiatric disorders ( 34.",ACNE,ISOTRETINOIN,RO-may_treat
862932349,1/18/2016 19:46:29,1862039723,1/18/2016 19:44:00,False,clixsense,0.569,21875134,GBR,,,87.114.181.2,no_relation,116,145,,119,157,treats,0.6432675209000001,820037,"• A large, population based cohort study of 7195 isotretinoin users with acne and 13,700 oral antibiotic users with ACNE showed no evidence that ISOTRETINOIN increases risk of depression, suicide, or other psychiatric disorders ( 34.",ACNE,ISOTRETINOIN,RO-may_treat
862932349,1/18/2016 19:56:41,1862042868,1/18/2016 19:56:30,False,instagc,0.75,27753923,GBR,F2,Fareham,82.27.224.254,ISOTRETINOIN treats ACNE,116,145,,119,157,treats,0.6432675209000001,820037,"• A large, population based cohort study of 7195 isotretinoin users with acne and 13,700 oral antibiotic users with ACNE showed no evidence that ISOTRETINOIN increases risk of depression, suicide, or other psychiatric disorders ( 34.",ACNE,ISOTRETINOIN,RO-may_treat
862932352,1/18/2016 17:39:37,1861969953,1/18/2016 17:39:17,False,prodege,0.6885,22031444,GBR,M4,Southampton,92.24.213.252,no_relation,5,72,,20,88,treats,0.6509445549,820032,"136  RHABDOMYOSARCOMA  Commonly used with dactinomycin, with or without CYCLOPHOSPHAMIDE as an adjunct to surgery and/or radiation therapy.",RHABDOMYOSARCOMA,CYCLOPHOSPHAMIDE,RO-may_treat
862932352,1/18/2016 18:17:44,1862003887,1/18/2016 18:17:15,False,points4rewards,0.7262,20113482,USA,IN,Muncie,165.139.149.169,no_relation,5,72,,20,88,treats,0.6509445549,820032,"136  RHABDOMYOSARCOMA  Commonly used with dactinomycin, with or without CYCLOPHOSPHAMIDE as an adjunct to surgery and/or radiation therapy.",RHABDOMYOSARCOMA,CYCLOPHOSPHAMIDE,RO-may_treat
862932352,1/18/2016 18:21:56,1862006318,1/18/2016 18:21:14,False,zoombucks,0.6833,4711962,CAN,ON,Markham,76.69.102.4,CYCLOPHOSPHAMIDE treats RHABDOMYOSARCOMA,5,72,,20,88,treats,0.6509445549,820032,"136  RHABDOMYOSARCOMA  Commonly used with dactinomycin, with or without CYCLOPHOSPHAMIDE as an adjunct to surgery and/or radiation therapy.",RHABDOMYOSARCOMA,CYCLOPHOSPHAMIDE,RO-may_treat
862932352,1/18/2016 18:28:32,1862009781,1/18/2016 18:27:55,False,neodev,0.7131,14861092,GBR,J1,Northampton,90.199.155.70,no_relation,5,72,,20,88,treats,0.6509445549,820032,"136  RHABDOMYOSARCOMA  Commonly used with dactinomycin, with or without CYCLOPHOSPHAMIDE as an adjunct to surgery and/or radiation therapy.",RHABDOMYOSARCOMA,CYCLOPHOSPHAMIDE,RO-may_treat
862932352,1/18/2016 18:29:14,1862010141,1/18/2016 18:28:14,False,neodev,0.7095,20306047,GBR,E6,Cirencester,92.14.17.197,no_relation,5,72,,20,88,treats,0.6509445549,820032,"136  RHABDOMYOSARCOMA  Commonly used with dactinomycin, with or without CYCLOPHOSPHAMIDE as an adjunct to surgery and/or radiation therapy.",RHABDOMYOSARCOMA,CYCLOPHOSPHAMIDE,RO-may_treat
862932352,1/18/2016 18:30:55,1862010969,1/18/2016 18:29:57,False,inboxpounds,0.6944,25200832,GBR,P3,Stratford-upon-avon,86.164.155.48,no_relation,5,72,,20,88,treats,0.6509445549,820032,"136  RHABDOMYOSARCOMA  Commonly used with dactinomycin, with or without CYCLOPHOSPHAMIDE as an adjunct to surgery and/or radiation therapy.",RHABDOMYOSARCOMA,CYCLOPHOSPHAMIDE,RO-may_treat
862932352,1/18/2016 18:36:08,1862013180,1/18/2016 18:35:26,False,elite,0.8294,29768955,GBR,,,213.205.195.9,no_relation,5,72,,20,88,treats,0.6509445549,820032,"136  RHABDOMYOSARCOMA  Commonly used with dactinomycin, with or without CYCLOPHOSPHAMIDE as an adjunct to surgery and/or radiation therapy.",RHABDOMYOSARCOMA,CYCLOPHOSPHAMIDE,RO-may_treat
862932353,1/18/2016 16:54:19,1861950460,1/18/2016 16:54:13,False,clixsense,0.7107,10390268,USA,NY,New Paltz,100.40.135.136,INSULIN treats HYPERGLYCEMIA,110,63,,122,70,treats,0.8164965809,820021,"109  Hyperglycemia  In diabetic patients, dosage adjustment of INSULIN or oral hypoglycemics may be required; HYPERGLYCEMIA may occur and latent diabetes mellitus may become evident.",HYPERGLYCEMIA,INSULIN,RO-may_treat
862932353,1/18/2016 16:54:48,1861950620,1/18/2016 16:54:24,False,clixsense,0.6107,22751911,NLD,4,Groningen,195.241.153.97,no_relation,110,63,,122,70,treats,0.8164965809,820021,"109  Hyperglycemia  In diabetic patients, dosage adjustment of INSULIN or oral hypoglycemics may be required; HYPERGLYCEMIA may occur and latent diabetes mellitus may become evident.",HYPERGLYCEMIA,INSULIN,RO-may_treat
862932353,1/18/2016 17:26:49,1861964808,1/18/2016 17:26:33,False,gifthulk,0.9028,18666417,USA,PA,Linesville,72.23.136.188,INSULIN treats HYPERGLYCEMIA,110,63,,122,70,treats,0.8164965809,820021,"109  Hyperglycemia  In diabetic patients, dosage adjustment of INSULIN or oral hypoglycemics may be required; HYPERGLYCEMIA may occur and latent diabetes mellitus may become evident.",HYPERGLYCEMIA,INSULIN,RO-may_treat
862932353,1/18/2016 17:34:30,1861967598,1/18/2016 17:34:09,False,clixsense,0.8804,24104564,AUS,2,Sydney,60.241.132.132,INSULIN treats HYPERGLYCEMIA,110,63,,122,70,treats,0.8164965809,820021,"109  Hyperglycemia  In diabetic patients, dosage adjustment of INSULIN or oral hypoglycemics may be required; HYPERGLYCEMIA may occur and latent diabetes mellitus may become evident.",HYPERGLYCEMIA,INSULIN,RO-may_treat
862932353,1/18/2016 17:37:23,1861969000,1/18/2016 17:37:14,False,instagc,0.7679,13581319,USA,IL,Carlyle,208.70.36.12,INSULIN treats HYPERGLYCEMIA,110,63,,122,70,treats,0.8164965809,820021,"109  Hyperglycemia  In diabetic patients, dosage adjustment of INSULIN or oral hypoglycemics may be required; HYPERGLYCEMIA may occur and latent diabetes mellitus may become evident.",HYPERGLYCEMIA,INSULIN,RO-may_treat
862932353,1/18/2016 17:37:34,1861969081,1/18/2016 17:37:13,False,prodege,0.6885,22031444,GBR,M4,Southampton,92.24.213.252,no_relation,110,63,,122,70,treats,0.8164965809,820021,"109  Hyperglycemia  In diabetic patients, dosage adjustment of INSULIN or oral hypoglycemics may be required; HYPERGLYCEMIA may occur and latent diabetes mellitus may become evident.",HYPERGLYCEMIA,INSULIN,RO-may_treat
862932353,1/18/2016 18:13:37,1862000413,1/18/2016 18:12:34,False,points4rewards,0.7262,20113482,USA,IN,Muncie,165.139.149.169,no_relation,110,63,,122,70,treats,0.8164965809,820021,"109  Hyperglycemia  In diabetic patients, dosage adjustment of INSULIN or oral hypoglycemics may be required; HYPERGLYCEMIA may occur and latent diabetes mellitus may become evident.",HYPERGLYCEMIA,INSULIN,RO-may_treat
862932354,1/18/2016 16:54:12,1861950405,1/18/2016 16:54:00,False,clixsense,0.7107,10390268,USA,NY,New Paltz,100.40.135.136,METFORMIN treats NIDDM,0,48,,34,102,treats,0.5494422558,820122,"IN POORLY CONTROLLED NIDDM SUBJECTS the primary MECHANISM BY WHICH METFORMIN IMPROVES GLYCEMIC CONTROL is related to the suppression of accelerated basal HGP, and this most likely is secondary to an inhibition of hepatic glycogenolysis.",NIDDM,METFORMIN,RO-may_treat
862932354,1/18/2016 16:54:23,1861950486,1/18/2016 16:54:04,False,clixsense,0.6107,22751911,NLD,4,Groningen,195.241.153.97,no_relation,0,48,,34,102,treats,0.5494422558,820122,"IN POORLY CONTROLLED NIDDM SUBJECTS the primary MECHANISM BY WHICH METFORMIN IMPROVES GLYCEMIC CONTROL is related to the suppression of accelerated basal HGP, and this most likely is secondary to an inhibition of hepatic glycogenolysis.",NIDDM,METFORMIN,RO-may_treat
862932354,1/18/2016 16:54:35,1861950585,1/18/2016 16:54:05,False,prodege,0.7979999999999999,13300986,CAN,AB,Saint Albert,174.3.24.150,no_relation,0,48,,34,102,treats,0.5494422558,820122,"IN POORLY CONTROLLED NIDDM SUBJECTS the primary MECHANISM BY WHICH METFORMIN IMPROVES GLYCEMIC CONTROL is related to the suppression of accelerated basal HGP, and this most likely is secondary to an inhibition of hepatic glycogenolysis.",NIDDM,METFORMIN,RO-may_treat
862932354,1/18/2016 17:26:33,1861964730,1/18/2016 17:25:45,False,gifthulk,0.9028,18666417,USA,PA,Linesville,72.23.136.188,METFORMIN treats NIDDM,0,48,,34,102,treats,0.5494422558,820122,"IN POORLY CONTROLLED NIDDM SUBJECTS the primary MECHANISM BY WHICH METFORMIN IMPROVES GLYCEMIC CONTROL is related to the suppression of accelerated basal HGP, and this most likely is secondary to an inhibition of hepatic glycogenolysis.",NIDDM,METFORMIN,RO-may_treat
862932354,1/18/2016 17:34:08,1861967482,1/18/2016 17:33:28,False,clixsense,0.8804,24104564,AUS,2,Sydney,60.241.132.132,METFORMIN treats NIDDM,0,48,,34,102,treats,0.5494422558,820122,"IN POORLY CONTROLLED NIDDM SUBJECTS the primary MECHANISM BY WHICH METFORMIN IMPROVES GLYCEMIC CONTROL is related to the suppression of accelerated basal HGP, and this most likely is secondary to an inhibition of hepatic glycogenolysis.",NIDDM,METFORMIN,RO-may_treat
862932354,1/18/2016 17:37:12,1861968846,1/18/2016 17:36:42,False,prodege,0.6885,22031444,GBR,M4,Southampton,92.24.213.252,no_relation,0,48,,34,102,treats,0.5494422558,820122,"IN POORLY CONTROLLED NIDDM SUBJECTS the primary MECHANISM BY WHICH METFORMIN IMPROVES GLYCEMIC CONTROL is related to the suppression of accelerated basal HGP, and this most likely is secondary to an inhibition of hepatic glycogenolysis.",NIDDM,METFORMIN,RO-may_treat
862932354,1/18/2016 17:37:13,1861968878,1/18/2016 17:36:59,False,instagc,0.7679,13581319,USA,IL,Carlyle,208.70.36.12,METFORMIN treats NIDDM,0,48,,34,102,treats,0.5494422558,820122,"IN POORLY CONTROLLED NIDDM SUBJECTS the primary MECHANISM BY WHICH METFORMIN IMPROVES GLYCEMIC CONTROL is related to the suppression of accelerated basal HGP, and this most likely is secondary to an inhibition of hepatic glycogenolysis.",NIDDM,METFORMIN,RO-may_treat
862932356,1/18/2016 16:26:37,1861939295,1/18/2016 16:26:19,False,prodege,0.5694,4316379,CAN,ON,Windsor,206.47.90.133,INSULIN treats TYPE 2 DIABETES,149,124,,163,131,treats,0.9733285268,820093,These new biphasic insulin analog combinations provide better postprandial glycemic control compared with 70/30 regular/NPH INSULIN in subjects with TYPE 2 DIABETES ( 126.,TYPE 2 DIABETES,INSULIN,RO-may_treat
862932356,1/18/2016 16:28:22,1861940054,1/18/2016 16:27:43,False,points4rewards,0.6696,28755767,USA,TN,Jonesborough,68.57.118.32,INSULIN treats TYPE 2 DIABETES,149,124,,163,131,treats,0.9733285268,820093,These new biphasic insulin analog combinations provide better postprandial glycemic control compared with 70/30 regular/NPH INSULIN in subjects with TYPE 2 DIABETES ( 126.,TYPE 2 DIABETES,INSULIN,RO-may_treat
862932356,1/18/2016 16:29:35,1861940613,1/18/2016 16:29:05,False,instagc,0.6845,18386513,USA,TN,Kingston,98.70.100.182,no_relation,149,124,,163,131,treats,0.9733285268,820093,These new biphasic insulin analog combinations provide better postprandial glycemic control compared with 70/30 regular/NPH INSULIN in subjects with TYPE 2 DIABETES ( 126.,TYPE 2 DIABETES,INSULIN,RO-may_treat
862932356,1/18/2016 16:31:04,1861941229,1/18/2016 16:30:40,False,prizerebel,0.6643,35607359,USA,GA,Savannah,69.41.96.199,no_relation,149,124,,163,131,treats,0.9733285268,820093,These new biphasic insulin analog combinations provide better postprandial glycemic control compared with 70/30 regular/NPH INSULIN in subjects with TYPE 2 DIABETES ( 126.,TYPE 2 DIABETES,INSULIN,RO-may_treat
862932356,1/18/2016 16:34:39,1861942557,1/18/2016 16:34:08,False,clixsense,0.8548,19638651,USA,SC,Myrtle Beach,174.107.64.29,INSULIN treats TYPE 2 DIABETES,149,124,,163,131,treats,0.9733285268,820093,These new biphasic insulin analog combinations provide better postprandial glycemic control compared with 70/30 regular/NPH INSULIN in subjects with TYPE 2 DIABETES ( 126.,TYPE 2 DIABETES,INSULIN,RO-may_treat
862932356,1/18/2016 16:36:56,1861943456,1/18/2016 16:35:38,False,clixsense,0.6905,11106820,USA,MA,Taunton,173.76.210.82,INSULIN treats TYPE 2 DIABETES,149,124,,163,131,treats,0.9733285268,820093,These new biphasic insulin analog combinations provide better postprandial glycemic control compared with 70/30 regular/NPH INSULIN in subjects with TYPE 2 DIABETES ( 126.,TYPE 2 DIABETES,INSULIN,RO-may_treat
862932356,1/18/2016 16:37:36,1861943655,1/18/2016 16:35:30,False,clixsense,0.7063,35612952,GBR,C3,Cambridge,31.51.142.170,INSULIN treats TYPE 2 DIABETES,149,124,,163,131,treats,0.9733285268,820093,These new biphasic insulin analog combinations provide better postprandial glycemic control compared with 70/30 regular/NPH INSULIN in subjects with TYPE 2 DIABETES ( 126.,TYPE 2 DIABETES,INSULIN,RO-may_treat
862932358,1/18/2016 18:37:33,1862013780,1/18/2016 18:37:14,False,prodege,0.8532,1924522,USA,NY,New York,96.224.13.135,THALIDOMIDE treats HANSEN'S DISEASE,29,13,,44,24,treats,0.9138115486,820088,"FDA approves THALIDOMIDE for HANSEN'S DISEASE side effect, imposes unprecedented restrictions on distribution.",HANSEN'S DISEASE,THALIDOMIDE,RO-may_treat
862932358,1/18/2016 18:38:54,1862014479,1/18/2016 18:38:11,False,elite,0.8294,29768955,GBR,,,213.205.195.9,THALIDOMIDE treats HANSEN'S DISEASE,29,13,,44,24,treats,0.9138115486,820088,"FDA approves THALIDOMIDE for HANSEN'S DISEASE side effect, imposes unprecedented restrictions on distribution.",HANSEN'S DISEASE,THALIDOMIDE,RO-may_treat
862932358,1/18/2016 18:43:08,1862016213,1/18/2016 18:41:29,False,clixsense,0.4911,6338946,CAN,ON,Toronto,174.138.215.251,no_relation,29,13,,44,24,treats,0.9138115486,820088,"FDA approves THALIDOMIDE for HANSEN'S DISEASE side effect, imposes unprecedented restrictions on distribution.",HANSEN'S DISEASE,THALIDOMIDE,RO-may_treat
862932358,1/18/2016 18:47:18,1862017550,1/18/2016 18:46:07,False,neodev,0.6563,13253916,GBR,C6,Saint Austell,92.17.245.86,THALIDOMIDE treats HANSEN'S DISEASE,29,13,,44,24,treats,0.9138115486,820088,"FDA approves THALIDOMIDE for HANSEN'S DISEASE side effect, imposes unprecedented restrictions on distribution.",HANSEN'S DISEASE,THALIDOMIDE,RO-may_treat
862932358,1/18/2016 18:59:25,1862022224,1/18/2016 18:57:58,False,instagc,0.7020000000000001,18672993,CAN,BC,Vancouver,76.77.82.83,THALIDOMIDE treats HANSEN'S DISEASE,29,13,,44,24,treats,0.9138115486,820088,"FDA approves THALIDOMIDE for HANSEN'S DISEASE side effect, imposes unprecedented restrictions on distribution.",HANSEN'S DISEASE,THALIDOMIDE,RO-may_treat
862932358,1/18/2016 19:04:10,1862023950,1/18/2016 19:03:49,False,neodev,0.622,33155316,GBR,M3,Bridgwater,86.138.4.186,THALIDOMIDE treats HANSEN'S DISEASE,29,13,,44,24,treats,0.9138115486,820088,"FDA approves THALIDOMIDE for HANSEN'S DISEASE side effect, imposes unprecedented restrictions on distribution.",HANSEN'S DISEASE,THALIDOMIDE,RO-may_treat
862932358,1/18/2016 19:15:11,1862028144,1/18/2016 19:13:40,False,zoombucks,0.6528,6744840,CAN,BC,Kelowna,174.4.58.160,THALIDOMIDE treats HANSEN'S DISEASE,29,13,,44,24,treats,0.9138115486,820088,"FDA approves THALIDOMIDE for HANSEN'S DISEASE side effect, imposes unprecedented restrictions on distribution.",HANSEN'S DISEASE,THALIDOMIDE,RO-may_treat
862932360,1/18/2016 16:26:54,1861939421,1/18/2016 16:26:37,False,prodege,0.5694,4316379,CAN,ON,Windsor,206.47.90.133,no_relation,380,455,,407,471,treats,0.6681531048,820077,"Lovenox; Low molecular weight heparin; Medication; MI   myocardial infarction; Monitoring; Myocardial infarction; Myocardial ischemia; New onset angina; Non Q wave MI; Pacemakers; Partial thromboplastin time; Persistent ST segment elevation; Postoperative MI; Pre exposure prophylaxis; Preoperative ischemia; Prevention; Preventive measures; Primary prevention; Prophylaxis; PTT; Q WAVE MYOCARDIAL INFARCTION; Safety; South America; ST segment elevation; STANDARD HEPARIN; Stimulators, cardiac; Subcutaneous low molecular weight heparin; Tedelparin; Thrombocytopenia.",Q WAVE MYOCARDIAL INFARCTION,STANDARD HEPARIN,RO-may_treat
862932360,1/18/2016 16:29:06,1861940353,1/18/2016 16:28:24,False,points4rewards,0.6696,28755767,USA,TN,Jonesborough,68.57.118.32,no_relation,380,455,,407,471,treats,0.6681531048,820077,"Lovenox; Low molecular weight heparin; Medication; MI   myocardial infarction; Monitoring; Myocardial infarction; Myocardial ischemia; New onset angina; Non Q wave MI; Pacemakers; Partial thromboplastin time; Persistent ST segment elevation; Postoperative MI; Pre exposure prophylaxis; Preoperative ischemia; Prevention; Preventive measures; Primary prevention; Prophylaxis; PTT; Q WAVE MYOCARDIAL INFARCTION; Safety; South America; ST segment elevation; STANDARD HEPARIN; Stimulators, cardiac; Subcutaneous low molecular weight heparin; Tedelparin; Thrombocytopenia.",Q WAVE MYOCARDIAL INFARCTION,STANDARD HEPARIN,RO-may_treat
862932360,1/18/2016 16:30:04,1861940795,1/18/2016 16:29:36,False,instagc,0.6845,18386513,USA,TN,Kingston,98.70.100.182,no_relation,380,455,,407,471,treats,0.6681531048,820077,"Lovenox; Low molecular weight heparin; Medication; MI   myocardial infarction; Monitoring; Myocardial infarction; Myocardial ischemia; New onset angina; Non Q wave MI; Pacemakers; Partial thromboplastin time; Persistent ST segment elevation; Postoperative MI; Pre exposure prophylaxis; Preoperative ischemia; Prevention; Preventive measures; Primary prevention; Prophylaxis; PTT; Q WAVE MYOCARDIAL INFARCTION; Safety; South America; ST segment elevation; STANDARD HEPARIN; Stimulators, cardiac; Subcutaneous low molecular weight heparin; Tedelparin; Thrombocytopenia.",Q WAVE MYOCARDIAL INFARCTION,STANDARD HEPARIN,RO-may_treat
862932360,1/18/2016 16:31:21,1861941306,1/18/2016 16:31:05,False,prizerebel,0.6643,35607359,USA,GA,Savannah,69.41.96.199,no_relation,380,455,,407,471,treats,0.6681531048,820077,"Lovenox; Low molecular weight heparin; Medication; MI   myocardial infarction; Monitoring; Myocardial infarction; Myocardial ischemia; New onset angina; Non Q wave MI; Pacemakers; Partial thromboplastin time; Persistent ST segment elevation; Postoperative MI; Pre exposure prophylaxis; Preoperative ischemia; Prevention; Preventive measures; Primary prevention; Prophylaxis; PTT; Q WAVE MYOCARDIAL INFARCTION; Safety; South America; ST segment elevation; STANDARD HEPARIN; Stimulators, cardiac; Subcutaneous low molecular weight heparin; Tedelparin; Thrombocytopenia.",Q WAVE MYOCARDIAL INFARCTION,STANDARD HEPARIN,RO-may_treat
862932360,1/18/2016 16:35:19,1861942808,1/18/2016 16:34:40,False,clixsense,0.8548,19638651,USA,SC,Myrtle Beach,174.107.64.29,no_relation,380,455,,407,471,treats,0.6681531048,820077,"Lovenox; Low molecular weight heparin; Medication; MI   myocardial infarction; Monitoring; Myocardial infarction; Myocardial ischemia; New onset angina; Non Q wave MI; Pacemakers; Partial thromboplastin time; Persistent ST segment elevation; Postoperative MI; Pre exposure prophylaxis; Preoperative ischemia; Prevention; Preventive measures; Primary prevention; Prophylaxis; PTT; Q WAVE MYOCARDIAL INFARCTION; Safety; South America; ST segment elevation; STANDARD HEPARIN; Stimulators, cardiac; Subcutaneous low molecular weight heparin; Tedelparin; Thrombocytopenia.",Q WAVE MYOCARDIAL INFARCTION,STANDARD HEPARIN,RO-may_treat
862932360,1/18/2016 16:37:34,1861943654,1/18/2016 16:36:57,False,clixsense,0.6905,11106820,USA,MA,Taunton,173.76.210.82,no_relation,380,455,,407,471,treats,0.6681531048,820077,"Lovenox; Low molecular weight heparin; Medication; MI   myocardial infarction; Monitoring; Myocardial infarction; Myocardial ischemia; New onset angina; Non Q wave MI; Pacemakers; Partial thromboplastin time; Persistent ST segment elevation; Postoperative MI; Pre exposure prophylaxis; Preoperative ischemia; Prevention; Preventive measures; Primary prevention; Prophylaxis; PTT; Q WAVE MYOCARDIAL INFARCTION; Safety; South America; ST segment elevation; STANDARD HEPARIN; Stimulators, cardiac; Subcutaneous low molecular weight heparin; Tedelparin; Thrombocytopenia.",Q WAVE MYOCARDIAL INFARCTION,STANDARD HEPARIN,RO-may_treat
862932360,1/18/2016 16:38:10,1861943818,1/18/2016 16:35:42,False,clixsense,0.6667,6339764,CAN,NS,North Sydney,24.89.248.92,Q WAVE MYOCARDIAL INFARCTION treats STANDARD HEPARIN,380,455,,407,471,treats,0.6681531048,820077,"Lovenox; Low molecular weight heparin; Medication; MI   myocardial infarction; Monitoring; Myocardial infarction; Myocardial ischemia; New onset angina; Non Q wave MI; Pacemakers; Partial thromboplastin time; Persistent ST segment elevation; Postoperative MI; Pre exposure prophylaxis; Preoperative ischemia; Prevention; Preventive measures; Primary prevention; Prophylaxis; PTT; Q WAVE MYOCARDIAL INFARCTION; Safety; South America; ST segment elevation; STANDARD HEPARIN; Stimulators, cardiac; Subcutaneous low molecular weight heparin; Tedelparin; Thrombocytopenia.",Q WAVE MYOCARDIAL INFARCTION,STANDARD HEPARIN,RO-may_treat
862932362,1/18/2016 16:45:22,1861946070,1/18/2016 16:45:11,False,bitcoinget,0.9083,21865639,USA,WA,Port Angeles,24.113.29.97,PREDNISONE treats INFLAMMATION,523,501,,534,511,treats,0.9332565253,820039,Anecdotal reports of efficacy of penicillin G with or without silymarin/silibinin in ALF due to Amanita phalloides Antifungal agent (fluconazole)  Prophylaxis against fungal sepsis  100 200 mg po or iv; continue for the interval of compromised liver function  Prophylactic use of no proven benefit in patients with ALF  May interfere with other medications through CYP P450  There are no controlled trials of prophylactic antifungals that show a clinical utility in patients with ALF Corticosteroids (PREDNISONE  Decreases INFLAMMATION by suppression of migration of polymorphonuclear leukocytes and reversal of increased capillary permeability  20 mg/d.,INFLAMMATION,PREDNISONE,RO-may_treat
862932362,1/18/2016 16:47:17,1861946873,1/18/2016 16:47:06,False,instagc,0.8611,27914150,USA,KS,Emporia,67.61.154.33,PREDNISONE treats INFLAMMATION,523,501,,534,511,treats,0.9332565253,820039,Anecdotal reports of efficacy of penicillin G with or without silymarin/silibinin in ALF due to Amanita phalloides Antifungal agent (fluconazole)  Prophylaxis against fungal sepsis  100 200 mg po or iv; continue for the interval of compromised liver function  Prophylactic use of no proven benefit in patients with ALF  May interfere with other medications through CYP P450  There are no controlled trials of prophylactic antifungals that show a clinical utility in patients with ALF Corticosteroids (PREDNISONE  Decreases INFLAMMATION by suppression of migration of polymorphonuclear leukocytes and reversal of increased capillary permeability  20 mg/d.,INFLAMMATION,PREDNISONE,RO-may_treat
862932362,1/18/2016 16:47:30,1861946971,1/18/2016 16:46:41,False,points4rewards,0.7649,28703583,USA,,,184.53.32.59,PREDNISONE treats INFLAMMATION,523,501,,534,511,treats,0.9332565253,820039,Anecdotal reports of efficacy of penicillin G with or without silymarin/silibinin in ALF due to Amanita phalloides Antifungal agent (fluconazole)  Prophylaxis against fungal sepsis  100 200 mg po or iv; continue for the interval of compromised liver function  Prophylactic use of no proven benefit in patients with ALF  May interfere with other medications through CYP P450  There are no controlled trials of prophylactic antifungals that show a clinical utility in patients with ALF Corticosteroids (PREDNISONE  Decreases INFLAMMATION by suppression of migration of polymorphonuclear leukocytes and reversal of increased capillary permeability  20 mg/d.,INFLAMMATION,PREDNISONE,RO-may_treat
862932362,1/18/2016 16:50:19,1861948444,1/18/2016 16:49:55,False,instagc,0.8139,21088425,USA,MI,Battle Creek,107.140.176.37,PREDNISONE treats INFLAMMATION,523,501,,534,511,treats,0.9332565253,820039,Anecdotal reports of efficacy of penicillin G with or without silymarin/silibinin in ALF due to Amanita phalloides Antifungal agent (fluconazole)  Prophylaxis against fungal sepsis  100 200 mg po or iv; continue for the interval of compromised liver function  Prophylactic use of no proven benefit in patients with ALF  May interfere with other medications through CYP P450  There are no controlled trials of prophylactic antifungals that show a clinical utility in patients with ALF Corticosteroids (PREDNISONE  Decreases INFLAMMATION by suppression of migration of polymorphonuclear leukocytes and reversal of increased capillary permeability  20 mg/d.,INFLAMMATION,PREDNISONE,RO-may_treat
862932362,1/18/2016 16:52:11,1861949555,1/18/2016 16:51:35,False,prodege,0.7979999999999999,13300986,CAN,AB,Saint Albert,174.3.24.150,PREDNISONE treats INFLAMMATION,523,501,,534,511,treats,0.9332565253,820039,Anecdotal reports of efficacy of penicillin G with or without silymarin/silibinin in ALF due to Amanita phalloides Antifungal agent (fluconazole)  Prophylaxis against fungal sepsis  100 200 mg po or iv; continue for the interval of compromised liver function  Prophylactic use of no proven benefit in patients with ALF  May interfere with other medications through CYP P450  There are no controlled trials of prophylactic antifungals that show a clinical utility in patients with ALF Corticosteroids (PREDNISONE  Decreases INFLAMMATION by suppression of migration of polymorphonuclear leukocytes and reversal of increased capillary permeability  20 mg/d.,INFLAMMATION,PREDNISONE,RO-may_treat
862932362,1/18/2016 16:52:42,1861949735,1/18/2016 16:51:58,False,clixsense,0.6107,22751911,NLD,4,Groningen,195.241.153.97,PREDNISONE treats INFLAMMATION,523,501,,534,511,treats,0.9332565253,820039,Anecdotal reports of efficacy of penicillin G with or without silymarin/silibinin in ALF due to Amanita phalloides Antifungal agent (fluconazole)  Prophylaxis against fungal sepsis  100 200 mg po or iv; continue for the interval of compromised liver function  Prophylactic use of no proven benefit in patients with ALF  May interfere with other medications through CYP P450  There are no controlled trials of prophylactic antifungals that show a clinical utility in patients with ALF Corticosteroids (PREDNISONE  Decreases INFLAMMATION by suppression of migration of polymorphonuclear leukocytes and reversal of increased capillary permeability  20 mg/d.,INFLAMMATION,PREDNISONE,RO-may_treat
862932362,1/18/2016 16:53:02,1861949910,1/18/2016 16:52:06,False,clixsense,0.7107,10390268,USA,NY,New Paltz,100.40.135.136,PREDNISONE treats INFLAMMATION,523,501,,534,511,treats,0.9332565253,820039,Anecdotal reports of efficacy of penicillin G with or without silymarin/silibinin in ALF due to Amanita phalloides Antifungal agent (fluconazole)  Prophylaxis against fungal sepsis  100 200 mg po or iv; continue for the interval of compromised liver function  Prophylactic use of no proven benefit in patients with ALF  May interfere with other medications through CYP P450  There are no controlled trials of prophylactic antifungals that show a clinical utility in patients with ALF Corticosteroids (PREDNISONE  Decreases INFLAMMATION by suppression of migration of polymorphonuclear leukocytes and reversal of increased capillary permeability  20 mg/d.,INFLAMMATION,PREDNISONE,RO-may_treat
862932366,1/18/2016 16:36:45,1861943397,1/18/2016 16:36:11,False,clixsense,0.8548,19638651,USA,SC,Myrtle Beach,174.107.64.29,ANAKINRA treats RHEUMATOID ARTHRITIS,465,409,,484,417,treats,0.3015113446,820009,"1  Specific Drugs         Drug Interaction Comments   Abatacept Increased incidence of infection and serious infection, without additional clinical benefit, reported with abatacept and TNF blocking agents in rheumatoid arthritis  1 , 11  Concomitant use not recommended  1 , 11 , 15    Anakinra Increased incidence of serious infections and neutropenia, without additional clinical benefit, reported with ANAKINRA and etanercept (another TNF blocking agent) in RHEUMATOID ARTHRITIS  1 , 10.",RHEUMATOID ARTHRITIS,ANAKINRA,RO-may_treat
862932366,1/18/2016 16:41:18,1861944833,1/18/2016 16:40:33,False,clixsense,0.6667,6339764,CAN,NS,North Sydney,24.89.248.92,ANAKINRA treats RHEUMATOID ARTHRITIS,465,409,,484,417,treats,0.3015113446,820009,"1  Specific Drugs         Drug Interaction Comments   Abatacept Increased incidence of infection and serious infection, without additional clinical benefit, reported with abatacept and TNF blocking agents in rheumatoid arthritis  1 , 11  Concomitant use not recommended  1 , 11 , 15    Anakinra Increased incidence of serious infections and neutropenia, without additional clinical benefit, reported with ANAKINRA and etanercept (another TNF blocking agent) in RHEUMATOID ARTHRITIS  1 , 10.",RHEUMATOID ARTHRITIS,ANAKINRA,RO-may_treat
862932366,1/18/2016 16:44:40,1861945769,1/18/2016 16:44:24,False,bitcoinget,0.9083,21865639,USA,WA,Port Angeles,24.113.29.97,ANAKINRA treats RHEUMATOID ARTHRITIS,465,409,,484,417,treats,0.3015113446,820009,"1  Specific Drugs         Drug Interaction Comments   Abatacept Increased incidence of infection and serious infection, without additional clinical benefit, reported with abatacept and TNF blocking agents in rheumatoid arthritis  1 , 11  Concomitant use not recommended  1 , 11 , 15    Anakinra Increased incidence of serious infections and neutropenia, without additional clinical benefit, reported with ANAKINRA and etanercept (another TNF blocking agent) in RHEUMATOID ARTHRITIS  1 , 10.",RHEUMATOID ARTHRITIS,ANAKINRA,RO-may_treat
862932366,1/18/2016 16:45:22,1861946068,1/18/2016 16:44:18,False,points4rewards,0.7649,28703583,USA,,,184.53.32.59,ANAKINRA treats RHEUMATOID ARTHRITIS,465,409,,484,417,treats,0.3015113446,820009,"1  Specific Drugs         Drug Interaction Comments   Abatacept Increased incidence of infection and serious infection, without additional clinical benefit, reported with abatacept and TNF blocking agents in rheumatoid arthritis  1 , 11  Concomitant use not recommended  1 , 11 , 15    Anakinra Increased incidence of serious infections and neutropenia, without additional clinical benefit, reported with ANAKINRA and etanercept (another TNF blocking agent) in RHEUMATOID ARTHRITIS  1 , 10.",RHEUMATOID ARTHRITIS,ANAKINRA,RO-may_treat
862932366,1/18/2016 16:46:28,1861946541,1/18/2016 16:46:03,False,instagc,0.8611,27914150,USA,KS,Emporia,67.61.154.33,ANAKINRA treats RHEUMATOID ARTHRITIS,465,409,,484,417,treats,0.3015113446,820009,"1  Specific Drugs         Drug Interaction Comments   Abatacept Increased incidence of infection and serious infection, without additional clinical benefit, reported with abatacept and TNF blocking agents in rheumatoid arthritis  1 , 11  Concomitant use not recommended  1 , 11 , 15    Anakinra Increased incidence of serious infections and neutropenia, without additional clinical benefit, reported with ANAKINRA and etanercept (another TNF blocking agent) in RHEUMATOID ARTHRITIS  1 , 10.",RHEUMATOID ARTHRITIS,ANAKINRA,RO-may_treat
862932366,1/18/2016 16:47:29,1861946956,1/18/2016 16:46:31,False,neodev,0.8155,18215885,GBR,,,84.93.96.82,ANAKINRA treats RHEUMATOID ARTHRITIS,465,409,,484,417,treats,0.3015113446,820009,"1  Specific Drugs         Drug Interaction Comments   Abatacept Increased incidence of infection and serious infection, without additional clinical benefit, reported with abatacept and TNF blocking agents in rheumatoid arthritis  1 , 11  Concomitant use not recommended  1 , 11 , 15    Anakinra Increased incidence of serious infections and neutropenia, without additional clinical benefit, reported with ANAKINRA and etanercept (another TNF blocking agent) in RHEUMATOID ARTHRITIS  1 , 10.",RHEUMATOID ARTHRITIS,ANAKINRA,RO-may_treat
862932366,1/18/2016 16:49:21,1861947898,1/18/2016 16:48:25,False,instagc,0.8139,21088425,USA,MI,Battle Creek,107.140.176.37,ANAKINRA treats RHEUMATOID ARTHRITIS,465,409,,484,417,treats,0.3015113446,820009,"1  Specific Drugs         Drug Interaction Comments   Abatacept Increased incidence of infection and serious infection, without additional clinical benefit, reported with abatacept and TNF blocking agents in rheumatoid arthritis  1 , 11  Concomitant use not recommended  1 , 11 , 15    Anakinra Increased incidence of serious infections and neutropenia, without additional clinical benefit, reported with ANAKINRA and etanercept (another TNF blocking agent) in RHEUMATOID ARTHRITIS  1 , 10.",RHEUMATOID ARTHRITIS,ANAKINRA,RO-may_treat
862932379,1/18/2016 16:27:15,1861939541,1/18/2016 16:26:55,False,prodege,0.5694,4316379,CAN,ON,Windsor,206.47.90.133,WARFARIN treats ATRIAL FIBRILLATION,122,71,,140,79,treats,0.9138115486,820041,"2010 09 13  Risk of bleeding with single, dual, or triple therapy with WARFARIN aspirin, and clopidogrel in patients with ATRIAL FIBRILLATION",ATRIAL FIBRILLATION,WARFARIN,RO-may_treat
862932379,1/18/2016 16:30:03,1861940791,1/18/2016 16:29:07,False,points4rewards,0.6696,28755767,USA,TN,Jonesborough,68.57.118.32,no_relation,122,71,,140,79,treats,0.9138115486,820041,"2010 09 13  Risk of bleeding with single, dual, or triple therapy with WARFARIN aspirin, and clopidogrel in patients with ATRIAL FIBRILLATION",ATRIAL FIBRILLATION,WARFARIN,RO-may_treat
862932379,1/18/2016 16:30:40,1861941101,1/18/2016 16:30:05,False,instagc,0.6845,18386513,USA,TN,Kingston,98.70.100.182,no_relation,122,71,,140,79,treats,0.9138115486,820041,"2010 09 13  Risk of bleeding with single, dual, or triple therapy with WARFARIN aspirin, and clopidogrel in patients with ATRIAL FIBRILLATION",ATRIAL FIBRILLATION,WARFARIN,RO-may_treat
862932379,1/18/2016 16:31:48,1861941471,1/18/2016 16:31:22,False,prizerebel,0.6643,35607359,USA,GA,Savannah,69.41.96.199,WARFARIN treats ATRIAL FIBRILLATION,122,71,,140,79,treats,0.9138115486,820041,"2010 09 13  Risk of bleeding with single, dual, or triple therapy with WARFARIN aspirin, and clopidogrel in patients with ATRIAL FIBRILLATION",ATRIAL FIBRILLATION,WARFARIN,RO-may_treat
862932379,1/18/2016 16:35:38,1861942967,1/18/2016 16:35:20,False,clixsense,0.8548,19638651,USA,SC,Myrtle Beach,174.107.64.29,no_relation,122,71,,140,79,treats,0.9138115486,820041,"2010 09 13  Risk of bleeding with single, dual, or triple therapy with WARFARIN aspirin, and clopidogrel in patients with ATRIAL FIBRILLATION",ATRIAL FIBRILLATION,WARFARIN,RO-may_treat
862932379,1/18/2016 16:38:03,1861943782,1/18/2016 16:37:35,False,clixsense,0.6905,11106820,USA,MA,Taunton,173.76.210.82,WARFARIN treats ATRIAL FIBRILLATION,122,71,,140,79,treats,0.9138115486,820041,"2010 09 13  Risk of bleeding with single, dual, or triple therapy with WARFARIN aspirin, and clopidogrel in patients with ATRIAL FIBRILLATION",ATRIAL FIBRILLATION,WARFARIN,RO-may_treat
862932379,1/18/2016 16:38:27,1861943880,1/18/2016 16:37:37,False,clixsense,0.7063,35612952,GBR,C3,Cambridge,31.51.142.170,WARFARIN treats ATRIAL FIBRILLATION,122,71,,140,79,treats,0.9138115486,820041,"2010 09 13  Risk of bleeding with single, dual, or triple therapy with WARFARIN aspirin, and clopidogrel in patients with ATRIAL FIBRILLATION",ATRIAL FIBRILLATION,WARFARIN,RO-may_treat
862932380,1/18/2016 17:27:54,1861965223,1/18/2016 17:26:50,False,gifthulk,0.9028,18666417,USA,PA,Linesville,72.23.136.188,no_relation,111,86,,144,107,treats,0.35921060409999994,820012,133  Cautions  Contraindications  •  Known hypersensitivity to commercially available ANTIHEMOPHILIC FACTOR or VON WILLEBRAND FACTOR PREPARATIONS or any ingredient in the formulations.,VON WILLEBRAND FACTOR PREPARATIONS,ANTIHEMOPHILIC FACTOR,RO-may_treat
862932380,1/18/2016 17:34:50,1861967696,1/18/2016 17:34:32,False,clixsense,0.8804,24104564,AUS,2,Sydney,60.241.132.132,no_relation,111,86,,144,107,treats,0.35921060409999994,820012,133  Cautions  Contraindications  •  Known hypersensitivity to commercially available ANTIHEMOPHILIC FACTOR or VON WILLEBRAND FACTOR PREPARATIONS or any ingredient in the formulations.,VON WILLEBRAND FACTOR PREPARATIONS,ANTIHEMOPHILIC FACTOR,RO-may_treat
862932380,1/18/2016 17:38:01,1861969287,1/18/2016 17:37:36,False,prodege,0.6885,22031444,GBR,M4,Southampton,92.24.213.252,no_relation,111,86,,144,107,treats,0.35921060409999994,820012,133  Cautions  Contraindications  •  Known hypersensitivity to commercially available ANTIHEMOPHILIC FACTOR or VON WILLEBRAND FACTOR PREPARATIONS or any ingredient in the formulations.,VON WILLEBRAND FACTOR PREPARATIONS,ANTIHEMOPHILIC FACTOR,RO-may_treat
862932380,1/18/2016 18:14:26,1862001152,1/18/2016 18:13:42,False,points4rewards,0.7262,20113482,USA,IN,Muncie,165.139.149.169,no_relation,111,86,,144,107,treats,0.35921060409999994,820012,133  Cautions  Contraindications  •  Known hypersensitivity to commercially available ANTIHEMOPHILIC FACTOR or VON WILLEBRAND FACTOR PREPARATIONS or any ingredient in the formulations.,VON WILLEBRAND FACTOR PREPARATIONS,ANTIHEMOPHILIC FACTOR,RO-may_treat
862932380,1/18/2016 18:20:26,1862005494,1/18/2016 18:18:53,False,zoombucks,0.6833,4711962,CAN,ON,Markham,76.69.102.4,no_relation,111,86,,144,107,treats,0.35921060409999994,820012,133  Cautions  Contraindications  •  Known hypersensitivity to commercially available ANTIHEMOPHILIC FACTOR or VON WILLEBRAND FACTOR PREPARATIONS or any ingredient in the formulations.,VON WILLEBRAND FACTOR PREPARATIONS,ANTIHEMOPHILIC FACTOR,RO-may_treat
862932380,1/18/2016 18:25:50,1862008193,1/18/2016 18:24:54,False,neodev,0.7095,20306047,GBR,E6,Cirencester,92.14.17.197,no_relation,111,86,,144,107,treats,0.35921060409999994,820012,133  Cautions  Contraindications  •  Known hypersensitivity to commercially available ANTIHEMOPHILIC FACTOR or VON WILLEBRAND FACTOR PREPARATIONS or any ingredient in the formulations.,VON WILLEBRAND FACTOR PREPARATIONS,ANTIHEMOPHILIC FACTOR,RO-may_treat
862932380,1/18/2016 18:26:42,1862008720,1/18/2016 18:26:08,False,neodev,0.7131,14861092,GBR,J1,Northampton,90.199.155.70,no_relation,111,86,,144,107,treats,0.35921060409999994,820012,133  Cautions  Contraindications  •  Known hypersensitivity to commercially available ANTIHEMOPHILIC FACTOR or VON WILLEBRAND FACTOR PREPARATIONS or any ingredient in the formulations.,VON WILLEBRAND FACTOR PREPARATIONS,ANTIHEMOPHILIC FACTOR,RO-may_treat
862932382,1/18/2016 16:47:56,1861947216,1/18/2016 16:47:50,False,instagc,0.8611,27914150,USA,KS,Emporia,67.61.154.33,TRICYCLIC ANTIDEPRESSANTS treats DEPRESSION,410,426,,419,451,treats,0.9237604306999999,820025,"BC  Specific recommendation: • Treat: ◊ Sialorrhea with amitriptyline, glycopyrrolate, or transdermal scopolamine patches; if sialorrhea is refractory, consider radiation therapy of the salivary glands or botulinum toxin injections of the salivary glands ◊ Thick mucus with propranolol or metoprolol ◊ Pseudobulbar affect or emotional lability with dextromethorphan/quinidine, amitriptyline, or fluvoxamine ◊ DEPRESSION with TRICYCLIC ANTIDEPRESSANTS such as amitriptyline or newer agents such as sertraline ◊ Anxiety with anxiolytics such as benzodiazepines ◊ Insomnia with noninvasive ventilation, pain management, antidepressants, or hypnotics, depending on.",DEPRESSION,TRICYCLIC ANTIDEPRESSANTS,RO-may_treat
862932382,1/18/2016 16:51:25,1861949172,1/18/2016 16:51:06,False,instagc,0.8139,21088425,USA,MI,Battle Creek,107.140.176.37,TRICYCLIC ANTIDEPRESSANTS treats DEPRESSION,410,426,,419,451,treats,0.9237604306999999,820025,"BC  Specific recommendation: • Treat: ◊ Sialorrhea with amitriptyline, glycopyrrolate, or transdermal scopolamine patches; if sialorrhea is refractory, consider radiation therapy of the salivary glands or botulinum toxin injections of the salivary glands ◊ Thick mucus with propranolol or metoprolol ◊ Pseudobulbar affect or emotional lability with dextromethorphan/quinidine, amitriptyline, or fluvoxamine ◊ DEPRESSION with TRICYCLIC ANTIDEPRESSANTS such as amitriptyline or newer agents such as sertraline ◊ Anxiety with anxiolytics such as benzodiazepines ◊ Insomnia with noninvasive ventilation, pain management, antidepressants, or hypnotics, depending on.",DEPRESSION,TRICYCLIC ANTIDEPRESSANTS,RO-may_treat
862932382,1/18/2016 16:53:59,1861950329,1/18/2016 16:53:47,False,clixsense,0.7107,10390268,USA,NY,New Paltz,100.40.135.136,TRICYCLIC ANTIDEPRESSANTS treats DEPRESSION,410,426,,419,451,treats,0.9237604306999999,820025,"BC  Specific recommendation: • Treat: ◊ Sialorrhea with amitriptyline, glycopyrrolate, or transdermal scopolamine patches; if sialorrhea is refractory, consider radiation therapy of the salivary glands or botulinum toxin injections of the salivary glands ◊ Thick mucus with propranolol or metoprolol ◊ Pseudobulbar affect or emotional lability with dextromethorphan/quinidine, amitriptyline, or fluvoxamine ◊ DEPRESSION with TRICYCLIC ANTIDEPRESSANTS such as amitriptyline or newer agents such as sertraline ◊ Anxiety with anxiolytics such as benzodiazepines ◊ Insomnia with noninvasive ventilation, pain management, antidepressants, or hypnotics, depending on.",DEPRESSION,TRICYCLIC ANTIDEPRESSANTS,RO-may_treat
862932382,1/18/2016 16:54:04,1861950360,1/18/2016 16:53:26,False,prodege,0.7979999999999999,13300986,CAN,AB,Saint Albert,174.3.24.150,TRICYCLIC ANTIDEPRESSANTS treats DEPRESSION,410,426,,419,451,treats,0.9237604306999999,820025,"BC  Specific recommendation: • Treat: ◊ Sialorrhea with amitriptyline, glycopyrrolate, or transdermal scopolamine patches; if sialorrhea is refractory, consider radiation therapy of the salivary glands or botulinum toxin injections of the salivary glands ◊ Thick mucus with propranolol or metoprolol ◊ Pseudobulbar affect or emotional lability with dextromethorphan/quinidine, amitriptyline, or fluvoxamine ◊ DEPRESSION with TRICYCLIC ANTIDEPRESSANTS such as amitriptyline or newer agents such as sertraline ◊ Anxiety with anxiolytics such as benzodiazepines ◊ Insomnia with noninvasive ventilation, pain management, antidepressants, or hypnotics, depending on.",DEPRESSION,TRICYCLIC ANTIDEPRESSANTS,RO-may_treat
862932382,1/18/2016 16:54:03,1861950366,1/18/2016 16:53:33,False,clixsense,0.6107,22751911,NLD,4,Groningen,195.241.153.97,no_relation,410,426,,419,451,treats,0.9237604306999999,820025,"BC  Specific recommendation: • Treat: ◊ Sialorrhea with amitriptyline, glycopyrrolate, or transdermal scopolamine patches; if sialorrhea is refractory, consider radiation therapy of the salivary glands or botulinum toxin injections of the salivary glands ◊ Thick mucus with propranolol or metoprolol ◊ Pseudobulbar affect or emotional lability with dextromethorphan/quinidine, amitriptyline, or fluvoxamine ◊ DEPRESSION with TRICYCLIC ANTIDEPRESSANTS such as amitriptyline or newer agents such as sertraline ◊ Anxiety with anxiolytics such as benzodiazepines ◊ Insomnia with noninvasive ventilation, pain management, antidepressants, or hypnotics, depending on.",DEPRESSION,TRICYCLIC ANTIDEPRESSANTS,RO-may_treat
862932382,1/18/2016 17:25:45,1861964433,1/18/2016 17:25:13,False,gifthulk,0.9028,18666417,USA,PA,Linesville,72.23.136.188,TRICYCLIC ANTIDEPRESSANTS treats DEPRESSION,410,426,,419,451,treats,0.9237604306999999,820025,"BC  Specific recommendation: • Treat: ◊ Sialorrhea with amitriptyline, glycopyrrolate, or transdermal scopolamine patches; if sialorrhea is refractory, consider radiation therapy of the salivary glands or botulinum toxin injections of the salivary glands ◊ Thick mucus with propranolol or metoprolol ◊ Pseudobulbar affect or emotional lability with dextromethorphan/quinidine, amitriptyline, or fluvoxamine ◊ DEPRESSION with TRICYCLIC ANTIDEPRESSANTS such as amitriptyline or newer agents such as sertraline ◊ Anxiety with anxiolytics such as benzodiazepines ◊ Insomnia with noninvasive ventilation, pain management, antidepressants, or hypnotics, depending on.",DEPRESSION,TRICYCLIC ANTIDEPRESSANTS,RO-may_treat
862932382,1/18/2016 17:35:26,1861967921,1/18/2016 17:35:15,False,clixsense,0.8804,24104564,AUS,2,Sydney,60.241.132.132,TRICYCLIC ANTIDEPRESSANTS treats DEPRESSION,410,426,,419,451,treats,0.9237604306999999,820025,"BC  Specific recommendation: • Treat: ◊ Sialorrhea with amitriptyline, glycopyrrolate, or transdermal scopolamine patches; if sialorrhea is refractory, consider radiation therapy of the salivary glands or botulinum toxin injections of the salivary glands ◊ Thick mucus with propranolol or metoprolol ◊ Pseudobulbar affect or emotional lability with dextromethorphan/quinidine, amitriptyline, or fluvoxamine ◊ DEPRESSION with TRICYCLIC ANTIDEPRESSANTS such as amitriptyline or newer agents such as sertraline ◊ Anxiety with anxiolytics such as benzodiazepines ◊ Insomnia with noninvasive ventilation, pain management, antidepressants, or hypnotics, depending on.",DEPRESSION,TRICYCLIC ANTIDEPRESSANTS,RO-may_treat
862932383,1/18/2016 19:05:12,1862024249,1/18/2016 19:04:55,False,neodev,0.622,33155316,GBR,M3,Bridgwater,86.138.4.186,NIDDM treats INSULIN INJECTION TREATMENT GROUP,53,96,,57,129,treats,0.9712858623999999,820043,"• In a prospective study, 110 Japanese patients with NIDDM were randomly assigned to a multiple INSULIN INJECTION TREATMENT GROUP (MIT group) or to a conventional insulin injection treatment group (CIT group.",NIDDM,INSULIN INJECTION TREATMENT GROUP,RO-may_treat
862932383,1/18/2016 19:09:22,1862025913,1/18/2016 19:09:08,False,prodege,0.6766,34650780,GBR,M3,Dulverton,81.154.41.50,INSULIN INJECTION TREATMENT GROUP treats NIDDM,53,96,,57,129,treats,0.9712858623999999,820043,"• In a prospective study, 110 Japanese patients with NIDDM were randomly assigned to a multiple INSULIN INJECTION TREATMENT GROUP (MIT group) or to a conventional insulin injection treatment group (CIT group.",NIDDM,INSULIN INJECTION TREATMENT GROUP,RO-may_treat
862932383,1/18/2016 19:10:06,1862026176,1/18/2016 19:09:48,False,instagc,0.7020000000000001,18672993,CAN,BC,Vancouver,76.77.82.83,INSULIN INJECTION TREATMENT GROUP treats NIDDM,53,96,,57,129,treats,0.9712858623999999,820043,"• In a prospective study, 110 Japanese patients with NIDDM were randomly assigned to a multiple INSULIN INJECTION TREATMENT GROUP (MIT group) or to a conventional insulin injection treatment group (CIT group.",NIDDM,INSULIN INJECTION TREATMENT GROUP,RO-may_treat
862932383,1/18/2016 19:11:09,1862026521,1/18/2016 19:09:26,False,points4rewards,0.6806,20306700,USA,WA,Kirkland,73.225.187.97,INSULIN INJECTION TREATMENT GROUP treats NIDDM,53,96,,57,129,treats,0.9712858623999999,820043,"• In a prospective study, 110 Japanese patients with NIDDM were randomly assigned to a multiple INSULIN INJECTION TREATMENT GROUP (MIT group) or to a conventional insulin injection treatment group (CIT group.",NIDDM,INSULIN INJECTION TREATMENT GROUP,RO-may_treat
862932383,1/18/2016 19:11:36,1862026669,1/18/2016 19:10:08,False,zoombucks,0.6528,6744840,CAN,BC,Kelowna,174.4.58.160,no_relation,53,96,,57,129,treats,0.9712858623999999,820043,"• In a prospective study, 110 Japanese patients with NIDDM were randomly assigned to a multiple INSULIN INJECTION TREATMENT GROUP (MIT group) or to a conventional insulin injection treatment group (CIT group.",NIDDM,INSULIN INJECTION TREATMENT GROUP,RO-may_treat
862932383,1/18/2016 19:11:37,1862026678,1/18/2016 19:11:01,False,neodev,0.75,30627835,GBR,C9,Cockermouth,31.48.92.215,INSULIN INJECTION TREATMENT GROUP treats NIDDM,53,96,,57,129,treats,0.9712858623999999,820043,"• In a prospective study, 110 Japanese patients with NIDDM were randomly assigned to a multiple INSULIN INJECTION TREATMENT GROUP (MIT group) or to a conventional insulin injection treatment group (CIT group.",NIDDM,INSULIN INJECTION TREATMENT GROUP,RO-may_treat
862932383,1/18/2016 19:18:03,1862029369,1/18/2016 19:17:13,False,clixsense,0.7976,6349089,USA,NJ,Rockaway,108.35.211.250,INSULIN INJECTION TREATMENT GROUP treats NIDDM,53,96,,57,129,treats,0.9712858623999999,820043,"• In a prospective study, 110 Japanese patients with NIDDM were randomly assigned to a multiple INSULIN INJECTION TREATMENT GROUP (MIT group) or to a conventional insulin injection treatment group (CIT group.",NIDDM,INSULIN INJECTION TREATMENT GROUP,RO-may_treat
862932390,1/18/2016 17:28:20,1861965405,1/18/2016 17:27:55,False,gifthulk,0.9028,18666417,USA,PA,Linesville,72.23.136.188,WARFARIN treats ATRIAL FIBRILLATION,128,69,,146,77,treats,0.9897433186,820097,2009 08 15  Percutaneous closure of the left atrial appendage versus WARFARIN therapy for prevention of stroke in patients with ATRIAL FIBRILLATION: a randomised non inferiority trial.,ATRIAL FIBRILLATION,WARFARIN,RO-may_treat
862932390,1/18/2016 17:35:13,1861967842,1/18/2016 17:34:52,False,clixsense,0.8804,24104564,AUS,2,Sydney,60.241.132.132,WARFARIN treats ATRIAL FIBRILLATION,128,69,,146,77,treats,0.9897433186,820097,2009 08 15  Percutaneous closure of the left atrial appendage versus WARFARIN therapy for prevention of stroke in patients with ATRIAL FIBRILLATION: a randomised non inferiority trial.,ATRIAL FIBRILLATION,WARFARIN,RO-may_treat
862932390,1/18/2016 17:38:15,1861969382,1/18/2016 17:38:02,False,prodege,0.6885,22031444,GBR,M4,Southampton,92.24.213.252,no_relation,128,69,,146,77,treats,0.9897433186,820097,2009 08 15  Percutaneous closure of the left atrial appendage versus WARFARIN therapy for prevention of stroke in patients with ATRIAL FIBRILLATION: a randomised non inferiority trial.,ATRIAL FIBRILLATION,WARFARIN,RO-may_treat
862932390,1/18/2016 18:15:25,1862001942,1/18/2016 18:14:33,False,points4rewards,0.7262,20113482,USA,IN,Muncie,165.139.149.169,no_relation,128,69,,146,77,treats,0.9897433186,820097,2009 08 15  Percutaneous closure of the left atrial appendage versus WARFARIN therapy for prevention of stroke in patients with ATRIAL FIBRILLATION: a randomised non inferiority trial.,ATRIAL FIBRILLATION,WARFARIN,RO-may_treat
862932390,1/18/2016 18:21:01,1862005859,1/18/2016 18:20:27,False,zoombucks,0.6833,4711962,CAN,ON,Markham,76.69.102.4,WARFARIN treats ATRIAL FIBRILLATION,128,69,,146,77,treats,0.9897433186,820097,2009 08 15  Percutaneous closure of the left atrial appendage versus WARFARIN therapy for prevention of stroke in patients with ATRIAL FIBRILLATION: a randomised non inferiority trial.,ATRIAL FIBRILLATION,WARFARIN,RO-may_treat
862932390,1/18/2016 18:26:46,1862008746,1/18/2016 18:25:51,False,neodev,0.7095,20306047,GBR,E6,Cirencester,92.14.17.197,WARFARIN treats ATRIAL FIBRILLATION,128,69,,146,77,treats,0.9897433186,820097,2009 08 15  Percutaneous closure of the left atrial appendage versus WARFARIN therapy for prevention of stroke in patients with ATRIAL FIBRILLATION: a randomised non inferiority trial.,ATRIAL FIBRILLATION,WARFARIN,RO-may_treat
862932390,1/18/2016 18:27:10,1862008930,1/18/2016 18:26:44,False,neodev,0.7131,14861092,GBR,J1,Northampton,90.199.155.70,WARFARIN treats ATRIAL FIBRILLATION,128,69,,146,77,treats,0.9897433186,820097,2009 08 15  Percutaneous closure of the left atrial appendage versus WARFARIN therapy for prevention of stroke in patients with ATRIAL FIBRILLATION: a randomised non inferiority trial.,ATRIAL FIBRILLATION,WARFARIN,RO-may_treat
